PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Elsum, I; Massey, L; McEwan, C; LaGrappe, D; Kowal, E; Savarirayan, R; Baynam, G; Jenkins, M; Garvey, G; Kelaher, M				Elsum, Imogen; Massey, Libby; McEwan, Callum; LaGrappe, Desiree; Kowal, Emma; Savarirayan, Ravi; Baynam, Gareth; Jenkins, Misty; Garvey, Gail; Kelaher, Margaret			A community-based co-designed genetic health service model for Aboriginal Australians	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; INDIGENOUS PEOPLES; CARE; DELIVERY; CANCER; INHERITANCE; FAMILIES; ACCESS; CANADA	Background Aboriginal and Torres Strait Islander people experience a greater burden of disease and die younger than non-Indigenous Australians, with Aboriginal people living in remote areas of the Northern Territory of Australia having the lowest life expectancy estimates. Despite a high burden of chronic disease among Aboriginal and Torres Strait Islander people, access to specialist health services remains low and models of care that increase engagement, may improve health outcomes. Methods We describe client and staff perspectives of a model of clinical genetics services provided by the MJD Foundation (MJDF) in geographically and culturally complex contexts within the Northern Territory of Australia. We seek to understand the MJDF model's success in supporting Aboriginal families with the familial, neurodegenerative condition Machado-Joseph disease and how it could be applied in the provision of other specialist services. Thematic analysis was undertaken on semi-structured interviews with primary health care staff (n = 2), Non-Aboriginal MJDF Staff (n = 7) and Aboriginal MJDF Clients / Community workers (n = 13). Results Four key themes regarding the MJDF model of service delivery were identified with the service being; 1) client led 2) accepting of various understandings of genetic disease causation 3) focused on relationships, continuity and trust between the service provider and the clients, and 4) committed to incorporating an inclusive whole-of-family practice. The MJDF model takes a community-based, person-and family-centred approach to successfully deliver effective specialist genetic health services in remote community settings. We propose that these approaches have broad application in the future design and delivery of specialist health services particularly in culturally complex settings.	[Elsum, Imogen; McEwan, Callum; Kelaher, Margaret] Univ Melbourne, Ctr Hlth Policy, Melbourne, Vic, Australia; [Massey, Libby; LaGrappe, Desiree] MJD Fdn, Alyangula, NT, Australia; [Massey, Libby] James Cook Univ, Townsville, Qld, Australia; [Kowal, Emma] Alfred Deakin Inst, Melbourne, Vic, Australia; [Savarirayan, Ravi] Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Baynam, Gareth] Genet Serv Western Australia, Perth, WA, Australia; [Jenkins, Misty] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Garvey, Gail] Menzies Sch Hlth Res, Darwin, NT, Australia	University of Melbourne; James Cook University; Walter & Eliza Hall Institute; Charles Darwin University; Menzies School of Health Research	McEwan, C (corresponding author), Univ Melbourne, Ctr Hlth Policy, Melbourne, Vic, Australia.	callumjmcewan@gmail.com		Massey, Libby/0000-0002-7180-276X; Kowal, Emma/0000-0003-3866-3224; LaGrappe, Desiree/0000-0002-2921-1157; Garvey, Gail/0000-0001-5065-5716	Lowitja Institute [1364]; National Health and Medical Research Council (NHMRC) [1114437]; NHMRC	Lowitja Institute; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Lowitja Institute (Project Code: 1364) and the National Health and Medical Research Council (NHMRC ID: 1114437). Authors EK, GB, GG and MK are CIs on both grants, as RS is CI on the NHMRC grant only. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anindilyakwa Land Council, 2020, AN LANG; [Anonymous], 2017, NAT MATER, V16, P1, DOI 10.1038/nmat4841; [Anonymous], 2012, J ENDOCRIMOL META, V17, pS1; [Anonymous], 2016, CANC DISCOV; Auger M, 2016, CAN J PUBLIC HEALTH, V107, pE393, DOI [10.17269/CJPH.107.5366, 10.17269/cjph.107.5366]; Australian Institute of Health and Welfare, 2016, AUSTR HLTH 2016; BOUTTE MI, 1992, HUM ORGAN, V51, P144, DOI 10.17730/humo.51.2.m6065446707986x6; Burns BL, 2019, FRONT PUBLIC HEALTH, P7, DOI [10.3389/fpubh.2019.00007, DOI 10.3389/FPUBH.2019.00007]; Campbell MA, 2018, AUST HEALTH REV, V42, P218, DOI 10.1071/AH16149; Carr JJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212953; Clifford A, 2015, INT J QUAL HEALTH C, V27, P89, DOI 10.1093/intqhc/mzv010; Cloutier M, 2017, PRENATAL DIAG, V37, P1112, DOI 10.1002/pd.5149; CohenWeisz S, 2016, JEWISH LIFE IN AUSTRIA AND GERMANY SINCE 1945, P1, DOI 10.1007/s10897-016-9932-2; Commonwealth of Australia Department of Health, NAT HLTH GEN POL FRA; Condon JR, 2009, CANCER CAUSE CONTROL, V20, P67, DOI 10.1007/s10552-008-9218-6; Cornel MC, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00195; Corporation DA, YOLNG CULT; Cotter M, 2016, AM J MED GENET A, V170, P1439, DOI 10.1002/ajmg.a.37603; Dalton T, 2019, WEEKEND AUSTR M 0406; Davy C, 2016, AUST NZ J PUBL HEAL, V40, P535, DOI 10.1111/1753-6405.12553; Department of Health Western Australia, GEN COND; Developing Culturally Competent Services [online], 2007, DEV PRACTICE CHILD Y, P43; Downing R, 2011, INT J QUAL HEALTH C, V23, P247, DOI 10.1093/intqhc/mzr008; Durey A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1497-0; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Elliott EJ, 2015, AUST FAM PHYSICIAN, V44, P630; Ewen SC, 2019, HUMAN RESOURCES HLTH, P1, DOI [10.1186/s12960-018-0335-3, DOI 10.1186/S12960-018-0335-3]; Garvey G, 2012, MED J AUSTRALIA, V197, P383, DOI 10.5694/mja12.11075; Geffen L, 2014, MED J AUSTRALIA, V201, pS19, DOI 10.5694/mja14.00118; Gruen RL, 2002, J EPIDEMIOL COMMUN H, V56, P517, DOI 10.1136/jech.56.7.517; Hayman NE, 2009, MED J AUSTRALIA, V190, P604, DOI 10.5694/j.1326-5377.2009.tb02581.x; Haynes E, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0075-5; Human Rights Commission, 2018, CULT SAF AB TORR STR; Hunt Janet, 2008, CONTESTED GOVERNANCE; James CA, 2006, GENET MED, V8, P234, DOI 10.1097/01.gim.0000215177.28010.6e; Jardim LB, 2010, CEREBELLUM, V9, P419, DOI 10.1007/s12311-010-0179-4; Khoury P, 2015, INT J HEALTH SERV, V45, P471, DOI 10.1177/0020731415584557; Kieling C, 2007, CLIN GENET, V72, P543, DOI 10.1111/j.1399-0004.2007.00910.x; Kowal E, 2015, J EMPIR RES HUM RES, V10, P347, DOI 10.1177/1556264615604521; Kowal E, 2015, J GENET COUNS, V24, P597, DOI 10.1007/s10897-014-9782-8; Lindop N, 2017, PRODUCTIVITY COMMISS, DOI 10.23736/S1973-9087.16.04148-4; Martin DH, 2012, 2 EYED SEEING FRAMEW, P20; Martins S, 2007, ASIAN ORIGIN WORLDWI, V1502; Massey L., 2018, MJD FDN DISABILITY S; McColl GJ, 2012, MED J AUSTRALIA, V196, P409, DOI 10.5694/mja11.10474; McDonald E, 2014, J GENET COUNS, V23, P221, DOI 10.1007/s10897-013-9652-9; McGuinness K., 2013, BICULTURAL PRACTICE; MERLAN F, 1992, CULT ANTHROPOL, V7, P169, DOI 10.1525/can.1992.7.2.02a00020; MJD Foundation, STRAT PLAN 2018 2021; Oliver SJ, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-46; Panaretto KS, 2014, MED J AUSTRALIA, V200, P649, DOI 10.5694/mja13.00005; Pierle JM, 2019, CLIN J ONCOL NURS, V23, P60, DOI 10.1188/19.CJON.60-67; Ramsden I, 2002, CULTURAL SAFETY NURS; Reibel Tracy, 2010, Qual Prim Care, V18, P65; Remote Area Health Corps, 2009, COMM PROF NGUK UR 20; Russell D, 2017, HUM RESOUR HEALTH, V15, P1, DOI [10.1186/s12960-017-0229-941., DOI 10.1186/S12960-017-0229-941]; Shepherd S M., 2019, BMC HEALTH SERV RES, P1; Smith D, 2007, 362007 CAEPR; Stoll K, 2018, AM J MED GENET C, V178, P24, DOI 10.1002/ajmg.c.31602; Truong M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-99; VALDEZ R, 2016, PREV CHRONIC DIS, V13, DOI DOI 10.5888/PCD13.150491; Wakerman J, 2019, HUM RESOUR HEALTH, V17, DOI 10.1186/s12960-019-0432-y; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wild K, 2013, SOC SCI MED, V98, P351, DOI 10.1016/j.socscimed.2012.10.031	64	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0239765	10.1371/journal.pone.0239765	http://dx.doi.org/10.1371/journal.pone.0239765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119636	Green Published, Green Accepted, gold			2022-12-26	WOS:000600013600084
J	Gonzalez, N; Zapata, J; Martinez, V; Gadow, R; Garcia, J				Gonzalez, N.; Zapata, J.; Martinez, V.; Gadow, R.; Garcia, J.			Manufacturing parameter analysis for alumina coating on steel substrate by automated image processing of isolated splats samples	PLOS ONE			English	Article							PLASMA-SPRAYED PARTICLES; SURFACE; MORPHOLOGY; DROPLETS; BEHAVIOR; SOLIDIFICATION; DYNAMICS; VELOCITY; SHAPES	Thermal spray technology, which involves the Atmospheric Plasma Spraying (APS), encompasses a category of coating processes that supply surface properties to protect or improve the performance of a substrate or component. The coating produced by this technology is built by overlapped splats, whose morphology determines the coating properties. In the same way, the splats obtained in a separated distribution by interposing a perforated mask but using the same thermal spray parameters, has a relationship with the overlapped splats inside the coating. The samples with isolated splats have the advantage of being faster and cheaper to generate and analyse. This article analyses alumina plasma-sprayed splats on steel substrates by image processing techniques, which recognize individual splats and their corresponding morphology (doughnut and pancake) parameters. These parameters allow the user to efficiently classify the splats. After that classification, a quality control can be implemented by comparison between the original and checked sample of isolated splats and a new sample obtained during a small interruption in the normal operation. Additionally, these parameters obtained in an automated way can be used to evaluate the effect of different selections of spraying process parameters.	[Gonzalez, N.; Garcia, J.] Univ Politecn Cartagena, Dept Ingn Mecan, Cartagena, Spain; [Zapata, J.] Univ Politecn Cartagena, Dept Elect Tecnol Comp & Proyectos, Cartagena, Spain; [Martinez, V.; Gadow, R.] Univ Stuttgart, Inst Mfg Technol Ceram Components & Composites IM, Stuttgart, Germany	Universidad Politecnica de Cartagena; Universidad Politecnica de Cartagena; University of Stuttgart	Gonzalez, N (corresponding author), Univ Politecn Cartagena, Dept Ingn Mecan, Cartagena, Spain.	noeliagonzalezmorales@hotmail.com		Garcia Lopez, Jesus/0000-0002-7227-1649				Bianchi L, 1997, THIN SOLID FILMS, V305, P35, DOI 10.1016/S0040-6090(97)80005-3; Brossard S., 2010, MECH PHYSIC MED PH U; Chandra S, 2009, HIGH TEMP MATER P-US, V13, P247, DOI 10.1615/HighTempMatProc.v13.i3-4.10; Chandra S, 2009, J THERM SPRAY TECHN, V18, P148, DOI 10.1007/s11666-009-9294-5; Davis J.R., 2004, TENSILE TESTING; Dhiman R, 2007, SURF COAT TECH, V201, P7789, DOI 10.1016/j.surfcoat.2007.03.010; Fauchais P, 2004, J THERM SPRAY TECHN, V13, P337, DOI 10.1361/10599630419670; Fukumoto M, 2007, J THERM SPRAY TECHN, V16, P905, DOI 10.1007/s11666-007-9083-y; Fukumoto M, 1999, J THERM SPRAY TECHN, V8, P427, DOI 10.1361/105996399770350386; Haralick RM, 1991, COMPUTER ROBOT VISIO; Heimann R.B., 2008, PLASMA SPRAY COATING; Houben J., 1988, THESIS; Jiang XY, 2001, THIN SOLID FILMS, V385, P132, DOI 10.1016/S0040-6090(01)00769-6; Kudinov VV, 1989, HIGH TEMP DUST LADEN, P381; Kulkarni AA, 2005, J THERM SPRAY TECHN, V14, P239, DOI 10.1361/10599630523818; Li C., 1989, THESIS; Li C.J., 2003, THERMAL SPRAY 2003 A, P5; Li CJ, 2005, SURF COAT TECH, V191, P375, DOI 10.1016/j.surfcoat.2004.04.063; MADEJSKI J, 1976, INT J HEAT MASS TRAN, V19, P1009, DOI 10.1016/0017-9310(76)90183-6; Mantry S, 2014, INT J SMART NANO MAT, V5, P207, DOI 10.1080/19475411.2014.941041; McDonald A, 2007, INT J HEAT MASS TRAN, V50, P1737, DOI 10.1016/j.ijheatmasstransfer.2006.10.022; MONTAVON G, 1995, J THERM SPRAY TECHN, V4, P67, DOI 10.1007/BF02648530; Montavon G, 1997, SURF COAT TECH, V91, P107, DOI 10.1016/S0257-8972(96)03137-4; Mostaghimi J, 2002, PLASMA CHEM PLASMA P, V22, P59, DOI 10.1023/A:1012940515065; Mulero MA, 2015, SURF COAT TECH, V278, P1, DOI 10.1016/j.surfcoat.2015.07.065; Ohmori A., 1993, PLASMA SPRAYING THEO, P179; Oki S, 1998, THERMAL SPRAY, VOLS 1 AND 2, P593; Okumus SC, 2005, MATER LETT, V59, P3214, DOI 10.1016/j.matlet.2005.04.055; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pasandideh-Fard M, 2002, J THERM SPRAY TECHN, V11, P206, DOI 10.1361/105996302770348862; Pawlowski L., 2008, SCI ENG THERMAL SPRA, Vsecond; Pershin V, 2003, J THERM SPRAY TECHN, V12, P370, DOI 10.1361/105996303770348249; Raessi A, 2006, THIN SOLID FILMS, V506, P133, DOI 10.1016/j.tsf.2005.08.140; Reimer L, 2000, MEAS SCI TECHNOL, V11, DOI [10.1088/0957-0233/11/12/703.1826-1826, DOI 10.1088/0957-0233/11/12/703.1826-1826, DOI 10.1088/0957-0233/11/12/703]; Syed AA, 2005, SURF COAT TECH, V200, P2317, DOI 10.1016/j.surfcoat.2005.01.014; Tanaka Y, 1999, SURF COAT TECH, V120, P124, DOI 10.1016/S0257-8972(99)00348-5; Tanaka Y., 2000, ISAEM 2000, P518; Tran ATT, 2011, THIN SOLID FILMS, V519, P2445, DOI 10.1016/j.tsf.2010.11.047; Tran ATT, 2008, J THERM SPRAY TECHN, V17, P637, DOI 10.1007/s11666-008-9237-6; TRAPAGA G, 1991, METALL TRANS B, V22, P901, DOI 10.1007/BF02651166; Vardelle M, 1993, J THERM SPRAY TECHN, V2, P79; Vilar R, 2009, NDT&E INT, V42, P467, DOI 10.1016/j.ndteint.2009.02.004; Wenzelburger M, 2004, SURF COAT TECH, V180, P429, DOI 10.1016/j.surfcoat.2003.10.125; Yin ZJ, 2008, J EUR CERAM SOC, V28, P1143, DOI 10.1016/j.jeurceramsoc.2007.09.050; Zapata J, 2011, EXPERT SYST APPL, V38, P8812, DOI 10.1016/j.eswa.2011.01.092; Zapata J, 2010, NDT&E INT, V43, P191, DOI 10.1016/j.ndteint.2009.11.002; Zhang C, 2008, SURF COAT TECH, V202, P2654, DOI 10.1016/j.surfcoat.2007.09.037; Zhang C, 2009, SURF COAT TECH, V204, P463, DOI 10.1016/j.surfcoat.2009.08.009; Zhang H, 2001, INT J HEAT MASS TRAN, V44, P4579, DOI 10.1016/S0017-9310(01)00109-0	49	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240928	10.1371/journal.pone.0240928	http://dx.doi.org/10.1371/journal.pone.0240928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119624	Green Published, gold			2022-12-26	WOS:000600013600054
J	Hall, J; Jones, L; Robertson, G; Hiley, R; Nathwani, D; Perry, MR				Hall, Jennifer; Jones, Leah; Robertson, Gail; Hiley, Robin; Nathwani, Dilip; Perry, Meghan Rose			'The Mould that Changed the World': Quantitative and qualitative evaluation of children's knowledge and motivation for behavioural change following participation in an antimicrobial resistance musical	PLOS ONE			English	Article							HEALTH; HYGIENE; BUG	Background A primary school musical ("The Mould that Changed the World") was developed as a unique public engagement strategy to combat antimicrobial resistance (AMR) by engaging children in the story of the discovery of antibiotics, the risks of drug-resistant infections and the importance of prudent antibiotic use. Methods The musical intervention was implemented in two UK primary schools by music specialists through a series of workshops, associated learning resources and performances to relatives. Participating children (n = 182), aged 9 to 11 years, were given an online questionnaire in the classroom before rehearsals began and at two weeks post-performance with a six-month evaluation in one school. The impact of the musical was analysed using generalised linear models to control for confounding factors. For the qualitative evaluation, fifteen participating children were selected randomly from each school to take part in semi-structured focus groups (n = 5 per group) before rehearsals began and two weeks post-performance. Findings Knowledge gain was demonstrated with children being more likely to answer questions on key messages of the musical correctly at two weeks post- performance (response rate 88%, n = 161) compared with the pre-rehearsal questionnaire (response rate 99%, n = 180) (bacteria can become resistant to antibiotics OR 4.63, C.I. 2.46-9.31 p<0.0001, antibiotic resistant infections can be life threatening OR 3.26 C.I. 1.75-6.32 p = 0.0001, prudent use of antibiotics will slow the rise of antibiotic resistant infections OR 2.16, C.I. 1.39-3.38, p = 0.0006). Long term knowledge gain was demonstrated by a consistent level of correct answers on key messages between two weeks (response rate 95%, n = 89) and 6 months post musical (response rate 71%, n = 67). Following the musical children participating in the focus groups (n = 30) articulated a greater understanding of AMR and the risks of antibiotic overuse. They discussed motivation to minimise personal antibiotic use and influence attitudes to antibiotics in their family and friends. Interpretation This study demonstrates that musical theatre can improve both short and long-term knowledge. It demonstrates a hitherto infrequently reported change in attitude and motivation to change behaviour in children at an influential age for health beliefs. This unique public health tool has the potential for high impact particularly if rolled out within national education programmes for primary school aged children.	[Hall, Jennifer; Perry, Meghan Rose] Western Gen Hosp, Reg Infect Dis Unit, Edinburgh, Midlothian, Scotland; [Jones, Leah; Nathwani, Dilip; Perry, Meghan Rose] British Soc Antimicrobial Chemotherapy, Birmingham, W Midlands, England; [Jones, Leah] Publ Hlth England, London, England; [Robertson, Gail] Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland; [Hiley, Robin] Charades Theatre Co, Edinburgh, Midlothian, Scotland; [Nathwani, Dilip] Univ Dundee, Dundee, Scotland; [Perry, Meghan Rose] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Perry, Meghan Rose] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; Public Health England; University of Edinburgh; University of Dundee; University of Edinburgh; University of Edinburgh	Perry, MR (corresponding author), Western Gen Hosp, Reg Infect Dis Unit, Edinburgh, Midlothian, Scotland.; Perry, MR (corresponding author), British Soc Antimicrobial Chemotherapy, Birmingham, W Midlands, England.; Perry, MR (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.; Perry, MR (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	meghan.perry@ed.ac.uk			British Society of Antimicrobial Chemotherapy	British Society of Antimicrobial Chemotherapy	This study was funded by British Society of Antimicrobial Chemotherapy (www.bsac.org.uk) and funds awarded to author RH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2005, LANCET, V365, P579; [Anonymous], 2002, J SCH HLTH WILEY ONL, DOI [10.1111/j.1746-1561.2002.tb07339.x, DOI 10.1111/J.1746-1561.2002.TB07339.X]; [Anonymous], 2011, WEATHER, V66, pi, DOI 10.1002/wea.699; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buchman TG, 2008, J AM COLL SURGEONS, V207, P265, DOI 10.1016/j.jamcollsurg.2008.02.035; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Cuijpers P, 2002, ADDICT BEHAV, V27, P1009, DOI 10.1016/S0306-4603(02)00295-2; Damerell P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015016; Dawes RM, 1999, MESSAGE PSYCHOLOGIST, V12; Fox J, 2018, R COMPANION APPL REG, P608; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Glik, 2002, YOUTH PERFORMING ART; Grewe ME, 2015, SEX EDUC-SEX SOC LEA, V15, P303, DOI 10.1080/14681811.2015.1022820; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Joronen K, 2008, J ADV NURS, V63, P116, DOI 10.1111/j.1365-2648.2008.04634.x; KMIETOWICZ Z, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3038; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lecky DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104556; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; McNulty CAM, 2007, HEALTH EDUC, V107, P10, DOI 10.1108/09654280710716851; McParland, 2018, WHAT ARE ACTIVE INGR; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Morgan DL, 2013, INTEGRATING QUALITAT; Ogden J, 2016, HEALTH PSYCHOL REV, V10, P274, DOI 10.1080/17437199.2016.1190295; Perry CL, 1999, TOB CONTROL, V8, P169, DOI 10.1136/tc.8.2.169; Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits 2010-2011, 2010, JAMA JAMA NETWORK; Price L, 2018, J ANTIMICROB CHEMOTH, V73, P1464, DOI 10.1093/jac/dky076; R Core Team, 2018, R LANG ENV STAT COMP; Sambamurthy V, 2000, INFORM SYST RES, V11, P105, DOI 10.1287/isre.11.2.105.11780; Tobler N.S., 2000, J PRIM PREV, V20, P275, DOI [DOI 10.1023/A:1021314704811, 10.1023/A:1021314704811]; Trepka MJ, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e6; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Van Hecke O, 2019, J ANTIMICROB CHEMOTH, V74, P1741, DOI 10.1093/jac/dkz091; Williamson J, 2018, LANCET INFECT DIS, V18, P955	36	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240471	10.1371/journal.pone.0240471	http://dx.doi.org/10.1371/journal.pone.0240471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119647	Green Published, gold			2022-12-26	WOS:000600013600073
J	Sa, C; Cowley, S; Martinez, M; Kachynska, N; Sabzalieva, E				Sa, Creso; Cowley, Summer; Martinez, Magdalena; Kachynska, Nadiia; Sabzalieva, Emma			Gender gaps in research productivity and recognition among elite scientists in the US, Canada, and South Africa	PLOS ONE			English	Article							CUMULATIVE ADVANTAGE; INEQUALITY; SCIENCE; WOMEN; WORK; PRIZES; IMPACT; TIME	This study builds upon the literature documenting gender disparities in science by investigating research productivity and recognition among elite scientists in three countries. This analysis departs from both the general comparison of researchers across organizational settings and academic appointments on one hand, and the definition of "elite" by the research outcome variables on the other, which are common in previous studies. Instead, this paper's approach considers the stratification of scientific careers by carefully constructing matched samples of men and women holding research chairs in Canada, the United States and South Africa, along with a control group of departmental peers. The analysis is based on a unique, hand-curated dataset including 943 researchers, which allows for a systematic comparison of successful scientists vetted through similar selection mechanisms. Our results show that even among elite scientists a pattern of stratified productivity and recognition by gender remains, with more prominent gaps in recognition. Our results point to the need for gender equity initiatives in science policy to critically examine assessment criteria and evaluation mechanisms to emphasize multiple expressions of research excellence.	[Sa, Creso; Cowley, Summer; Martinez, Magdalena; Kachynska, Nadiia; Sabzalieva, Emma] Univ Toronto, Ontario Inst Studies Educ, Dept Leadership Higher & Adult Educ, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sa, C (corresponding author), Univ Toronto, Ontario Inst Studies Educ, Dept Leadership Higher & Adult Educ, Toronto, ON, Canada.	c.sa@utoronto.ca	Martinez, Magdalena/AAY-9149-2021; Sabzalieva, Emma/GRJ-2493-2022	Martinez, Magdalena/0000-0003-1107-3689; Sabzalieva, Emma/0000-0001-7849-6411; Kachynska, Nadiia/0000-0003-1204-0264; Cowley, Summer/0000-0003-2775-8025; Sa, Creso/0000-0002-1221-1484	Social Sciences and Humanities Research Council of Canada [435170605]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	C.S. is supported by the Social Sciences and Humanities Research Council of Canada through grant no.435170605. https://www.sshrccrsh.gc.ca/home-accueil-eng.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramo G, 2018, SCIENTOMETRICS, V114, P373, DOI 10.1007/s11192-017-2529-1; Abramo G, 2009, SCIENTOMETRICS, V81, P137, DOI 10.1007/s11192-008-2131-7; Aguinis H, 2018, J APPL PSYCHOL, V103, P1283, DOI 10.1037/apl0000331; ALLISON PD, 1982, AM SOCIOL REV, V47, P615, DOI 10.2307/2095162; ALLISON PD, 1974, AM SOCIOL REV, V39, P596, DOI 10.2307/2094424; [Anonymous], 2017, JLSRF, V3, pA104; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; Astegiano J, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181566; Babcock L, 2017, AM ECON REV, V107, P714, DOI 10.1257/aer.20141734; Bol T, 2018, P NATL ACAD SCI USA, V115, P4887, DOI 10.1073/pnas.1719557115; Cole JR, 1974, SCI SOC, V38, P374; Dion ML, 2018, POLIT ANAL, V26, P312, DOI 10.1017/pan.2018.12; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Duch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051332; European Commission, 2019, ADV GEND EQ RES INN; Fedderke JW, 2015, RES POLICY, V44, P467, DOI 10.1016/j.respol.2014.09.009; Ferretti F, 2018, SCI PUBL POLICY, V45, P731, DOI 10.1093/scipol/scy007; FOX MF, 1983, SOC STUD SCI, V13, P285, DOI 10.1177/030631283013002005; Freund KM, 2016, ACAD MED, V91, P1068, DOI 10.1097/ACM.0000000000001250; Geiger RL, 2005, MINERVA, V43, P1, DOI 10.1007/s11024-004-6623-1; Geraci L, 2015, SCIENTOMETRICS, V105, P2023, DOI 10.1007/s11192-015-1757-5; Government of Canada, 2010, REP MIN IND AD HOC P; Government of Canada, 2019, CAN RES CHAIRS EQ DI; Government of Canada IC, 2012, CAN RES CHAIRS; Hatch A, 2020, ELIFE, V9, DOI 10.7554/eLife.58654; Hearn JC, 2013, J HIGH EDUC, V84, P601, DOI 10.1080/00221546.2013.11777303; Helmer M, 2017, ELIFE, V6, DOI 10.7554/eLife.21718; Hermanowicz JosephC., 2009, LIVES SCI I AFFECT A; Huang JM, 2020, P NATL ACAD SCI USA, V117, P4609, DOI 10.1073/pnas.1914221117; Jadidi M, 2018, ADV COMPLEX SYST, V21, DOI 10.1142/S0219525917500114; Kelchtermans S, 2013, REV ECON STAT, V95, P273, DOI 10.1162/REST_a_00275; Knobloch-Westerwick S, 2013, SCI COMMUN, V35, P603, DOI 10.1177/1075547012472684; Kwiek M., 2019, CHANGING EUROPEAN AC; Kwiek M, 2016, HIGH EDUC, V71, P379, DOI 10.1007/s10734-015-9910-x; Lariviere V, 2015, J ASSOC INF SCI TECH, V66, P1323, DOI 10.1002/asi.23266; Lariviere V, 2010, RES EVALUAT, V19, P45, DOI 10.3152/095820210X492495; Leiyte L, 2019, HDB SCI PUBLIC POLIC; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Lincoln AE, 2012, SOC STUD SCI, V42, P307, DOI 10.1177/0306312711435830; Ma YF, 2019, NATURE, V565, P287, DOI 10.1038/d41586-019-00091-3; Mairesse J, 2015, REV ECON-FR, V66, P65, DOI 10.3917/reco.661.0065; MERTON RK, 1957, AM SOCIOL REV, V22, P635, DOI 10.2307/2089193; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; Misra J, 2012, SOCIOL FORUM, V27, P300, DOI 10.1111/j.1573-7861.2012.01319.x; National Research Foundation, 2006, S AFR RES CHAIRS IN; Nielsen MW, 2018, SCI TECHNOL STUD, V31, P2, DOI 10.23987/sts.60610; Nielsen MW, 2017, STUD HIGH EDUC, V42, P1033, DOI 10.1080/03075079.2015.1075197; Nielsen MW, 2016, STUD HIGH EDUC, V41, P2044, DOI 10.1080/03075079.2015.1007945; Petersen AM, 2011, P NATL ACAD SCI USA, V108, P18, DOI 10.1073/pnas.1016733108; Petersen AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036114; Pollack Eileen, 2015, ONLY WOMAN ROOM WHY; Powell S., 2016, GENDER EQUALITY MERI; RIP A, 1994, HIGH EDUC, V28, P3, DOI 10.1007/BF01383569; ROSSITER MW, 1993, SOC STUD SCI, V23, P325, DOI 10.1177/030631293023002004; Side K., 2007, NWSA J, V19, P163, DOI [DOI 10.1353/NWSA.2007.0046, 10.1353/nwsa.2007.0046]; Siler KS, 2008, CAN REV SOCIOL, V45, P93, DOI 10.1111/j.1755-618X.2008.00004.x; Stack S, 2004, RES HIGH EDUC, V45, P891, DOI 10.1007/s11162-004-5953-z; Stephan PE, 1996, J ECON LIT, V34, P1199; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Thelwall M, 2020, QUANT SCI STUD, V1, P290, DOI 10.1162/qss_a_00003; Toffoletti K, 2016, GENDER WORK ORGAN, V23, P489, DOI 10.1111/gwao.12133; Valian V., 1999, WHY SO SLOW ADV WOME, V1 1st; van den Brink M, 2012, ORGANIZATION, V19, P507, DOI 10.1177/1350508411414293; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; Wagner C, 2019, MEASURING INEQUALITY; Wagner C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001003; Ward K., 2012, ACAD MOTHERHOOD FACU; Woolgar S, 1986, LAB LIFE CONSTRUCTIO; Yair G, 2017, SCIENTOMETRICS, V113, P299, DOI 10.1007/s11192-017-2465-0; ZUCKERMAN H, 1975, MINERVA, V13, P82, DOI 10.1007/BF01096243; ZUCKERMAN H, 1970, SOCIOL INQ, V40, P235, DOI 10.1111/j.1475-682X.1970.tb01010.x	73	17	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240903	10.1371/journal.pone.0240903	http://dx.doi.org/10.1371/journal.pone.0240903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119671	gold, Green Published			2022-12-26	WOS:000600013600080
J	Nimmakayala, RK; Leon, F; Rachagani, S; Rauth, S; Nallasamy, P; Marimuthu, S; Shailendra, GK; Chhonker, YS; Chugh, S; Chirravuri, R; Gupta, R; Mallya, K; Prajapati, DR; Lele, SM; Caffrey, TC; Grem, JL; Grandgenett, PM; Hollingsworth, MA; Murry, DJ; Batra, SK; Ponnusamy, MP				Nimmakayala, Rama Krishna; Leon, Frank; Rachagani, Satyanarayana; Rauth, Sanchita; Nallasamy, Palanisamy; Marimuthu, Saravanakumar; Shailendra, Gautam K.; Chhonker, Yashpal S.; Chugh, Seema; Chirravuri, Ramakanth; Gupta, Rohitesh; Mallya, Kavita; Prajapati, Dipakkumar R.; Lele, Subodh M.; C. Caffrey, Thomas; L. Grem, Jean; Grandgenett, Paul M.; Hollingsworth, Michael A.; Murry, Daryl J.; Batra, Surinder K.; Ponnusamy, Moorthy P.			Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL BIOGENESIS; TUMOR-GROWTH; IDENTIFICATION; GLIOBLASTOMA; GEMCITABINE; PLASTICITY; RESISTANCE; BIOMARKER	Pancreatic ductal adenocarcinoma (PDAC) metastasizes to distant organs, which is the primary cause of mortality; however, specific features mediating organ-specific metastasis remain unexplored. Emerging evidence demonstrates that cancer stem cells (CSCs) and cellular metabolism play a pivotal role in metastasis. Here we investigated the role of distinct subtypes of pancreatic CSCs and their metabolomic signatures in organ-specific metastatic colonization. We found that PDAC consists of ALDH+/CD133+ and drug-resistant (MDR1+) subtypes of CSCs with specific metabolic and stemness signatures. Human PDAC tissues with gemcitabine treatment, autochthonous mouse tumors from Kras(G12D); Pdx1-Cre (KC) and Kras(G12D); Trp53(R172H); Pdx-1 Cre (KPC) mice, and KPC- Liver/Lung metastatic cells were used to evaluate the CSC, EMT (epithelial-to-mesenchymal transition), and metabolic profiles. A strong association was observed between distinct CSC subtypes and organ-specific colonization. The liver metastasis showed drug-resistant CSC- and EMT-like phenotype with aerobic glycolysis and fatty acid beta-oxidation-mediated oxidative (glyco-oxidative) metabolism. On the contrary, lung metastasis displayed ALDH+/CD133+ and MET-like phenotype with oxidative metabolism. These results were obtained by evaluating FACS-based side population (SP), autofluorescence (AF+) and Alde-red assays for CSCs, and Seahorse-based oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and fatty acid beta-oxidation (FAO)-mediated OCR assays for metabolic features along with specific gene signatures. Further, we developed in vitro human liver and lung PDAC metastasis models by using a combination of liver or lung decellularized scaffolds, a co-culture, and a sphere culture methods. PDAC cells grown in the liver-mimicking model showed the enrichment of MDR1+ and CPT1A+ populations, whereas the PDAC cells grown in the lung-mimicking environment showed the enrichment of ALDH+/CD133+ populations. In addition, we observed significantly elevated expression of ALDH1 in lung metastasis and MDR1/LDH-A expression in liver metastasis compared to human primary PDAC tumors. Our studies elucidate that distinct CSCs adapt unique metabolic signatures for organotropic metastasis, which will pave the way for the development of targeted therapy for PDAC metastasis.	[Nimmakayala, Rama Krishna; Leon, Frank; Rachagani, Satyanarayana; Rauth, Sanchita; Nallasamy, Palanisamy; Marimuthu, Saravanakumar; Shailendra, Gautam K.; Chugh, Seema; Chirravuri, Ramakanth; Gupta, Rohitesh; Mallya, Kavita; Batra, Surinder K.; Ponnusamy, Moorthy P.] Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Chhonker, Yashpal S.; Murry, Daryl J.] Univ Nebraska, Med Ctr, Coll Pharm, Dept Pharm Practice & Sci, 986145 Nebraska Med Ctr, Omaha, NE 68198 USA; [Prajapati, Dipakkumar R.; Lele, Subodh M.] Univ Nebraska, Coll Med, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [C. Caffrey, Thomas; L. Grem, Jean; Grandgenett, Paul M.; Hollingsworth, Michael A.; Batra, Surinder K.; Ponnusamy, Moorthy P.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK; Ponnusamy, MP (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Batra, SK; Ponnusamy, MP (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	sbatra@unmc.edu; mpalanim@unmc.edu	Gautam, Shailendra/GLQ-9528-2022; Nimmakayala, Rama Krishna/CAG-5670-2022; Prajapati, Dipakkumar R/AAH-7578-2021; Nallasamy, Palanisamy/AAH-7727-2021; Marimuthu, Saravanakumar/AAJ-2878-2021; Gautam, Shailendra/ABD-2991-2021	Nimmakayala, Rama Krishna/0000-0003-4637-4828; Prajapati, Dipakkumar R/0000-0001-8954-890X; Nallasamy, Palanisamy/0000-0001-8962-2487; Marimuthu, Saravanakumar/0000-0003-3640-5408; Gautam, Shailendra/0000-0002-8959-1331; gupta, rohitesh/0000-0001-8515-5869	National Institutes of Health [P01 CA217798, R01 CA210637, R01 CA183459, R01 CA195586, R01 CA201444, R01 CA228524, U01 CA200466, R01 CA247471, R50CA211462, P50CA12729, U01 CA210240]; Nebraska Department of Health and Human Services [LB595]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services	We thank Craig Semerad, Victoria B. Smith, and Samantha Wall of the Flow Cytometry Research Facility, University of Nebraska Medical Center, for assisting with flow cytometry. We thank Janice A. Taylor and James R. Talaska of the Advanced Microscopy Core Facility at the University of Nebraska Medical Center for assisting with confocal microscopy. Further, we thank Dr. Kelly Stauch, Seahorse Core director at the University of Nebraska Medical Center, for assisting with Seahorse experiments. We were supported primarily by the following grants from the National Institutes of Health P01 CA217798, R01 CA210637, R01 CA183459, R01 CA195586, R01 CA201444, R01 CA228524, U01 CA200466, R01 CA228524, R01 CA247471, R50CA211462, P50CA12729 and U01 CA210240, and the Nebraska Department of Health and Human Services LB595.	Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785; Bhagwandin VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148807; Celia-Terrassa T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08509-2; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Grillet F, 2017, GUT, V66, P1802, DOI 10.1136/gutjnl-2016-311447; Han SH, 2019, AUTOPHAGY, V15, P2076, DOI 10.1080/15548627.2019.1596492; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Duong HQ, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030052; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.72; Huang P, 2008, WORLD J GASTROENTERO, V14, P3903, DOI 10.3748/wjg.14.3903; Jiao L, 2018, AUTOPHAGY, V14, P671, DOI 10.1080/15548627.2017.1381804; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Lamb R, 2015, ONCOTARGET, V6, P30453, DOI 10.18632/oncotarget.5852; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Lin YH, 2018, HEPATOLOGY, V67, P188, DOI 10.1002/hep.29462; Liou GY, 2019, INT J BIOCHEM CELL B, V106, P1, DOI 10.1016/j.biocel.2018.10.013; Luo M, 2018, CELL METAB, V28, P69, DOI 10.1016/j.cmet.2018.06.006; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Menendez Javier A, 2014, Oncoscience, V1, P803; Menendez JA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00262; Miranda-Lorenzo I, 2014, NAT METHODS, V11, P1161, DOI [10.1038/NMETH.3112, 10.1038/nmeth.3112]; Niess H, 2015, TARGET ONCOL, V10, P215, DOI 10.1007/s11523-014-0323-z; Nimmakayala RK, 2019, BBA-REV CANCER, V1871, P50, DOI 10.1016/j.bbcan.2018.10.006; Nimmakayala RK, 2018, GASTROENTEROLOGY, V155, P892, DOI 10.1053/j.gastro.2018.05.041; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Poruk KE, 2017, CLIN CANCER RES, V23, P2681, DOI 10.1158/1078-0432.CCR-16-1467; Ramamoorthy P, 2019, CANCER RES, V79, P1681, DOI 10.1158/0008-5472.CAN-18-2602; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rawla P, 2019, WORLD J ONCOL, V10, P10, DOI 10.14740/wjon1166; Richard V, 2013, J BIOMED RES INT, V2013, P8; Rubin MA, 2014, CANCER DISCOV, V4, P1262, DOI 10.1158/2159-8290.CD-14-1075; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Schild T, 2018, CANCER CELL, V33, P347, DOI 10.1016/j.ccell.2018.02.001; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Wang TY, 2018, CELL METAB, V27, P136, DOI 10.1016/j.cmet.2017.11.001; Wang YN, 2018, ONCOGENE, V37, P6025, DOI 10.1038/s41388-018-0384-z; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	48	32	32	5	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					215	231		10.1038/s41388-020-01518-2	http://dx.doi.org/10.1038/s41388-020-01518-2		OCT 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33110235				2022-12-26	WOS:000582768100004
J	Spotorno, N; Lindberg, O; Nilsson, C; Waldo, ML; van Westen, D; Nilsson, K; Vestberg, S; Englund, E; Zetterberg, H; Blennow, K; Latt, J; Markus, N; Lars-Olof, W; Alexander, S				Spotorno, Nicola; Lindberg, Olof; Nilsson, Christer; Waldo, Maria Landqvist; van Westen, Danielle; Nilsson, Karin; Vestberg, Susanna; Englund, Elisabet; Zetterberg, Henrik; Blennow, Kaj; Latt, Jimmy; Markus, Nilsson; Lars-Olof, Wahlund; Alexander, Santillo			Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CHAIN; DIAGNOSIS; DEGENERATION; BIOMARKER; PATHOLOGY; CRITERIA; TDP-43	Neurofilaments are structural components of neurons and are particularly abundant in highly myelinated axons. The levels of neurofilament light chain (NfL) in both cerebrospinal fluid (CSF) and plasma have been related to degeneration in several neurodegenerative conditions including frontotemporal dementia (FTD) and NfL is currently considered as the most promising diagnostic and prognostic fluid biomarker in FTD. Although the location and function of filaments in the healthy nervous system suggests a link between increased NfL and white matter degeneration, such a claim has not been fully elucidated in vivo, especially in the context of FTD. The present study provides evidence of an association between the plasma levels of NfL and white matter involvement in behavioral variant FTD (bvFTD) by relating plasma concentration of NfL to diffusion tensor imaging (DTI) metrics in a group of 20 bvFTD patients. The results of both voxel-wise and tract specific analysis showed that increased plasma NfL concentration is associated with a reduction in fractional anisotropy (FA) in a widespread set of white matter tracts including the superior longitudinal fasciculus, the fronto-occipital fasciculus the anterior thalamic radiation and the dorsal cingulum bundle. Plasma NfL concentration also correlated with cortical thinning in a portion of the right medial prefrontal cortex and of the right lateral orbitofrontal cortex. These results support the hypothesis that blood NfL levels reflect the global level of neurodegeneration in bvFTD and help to advance our understanding of the association between this blood biomarker for FTD and the disease process.	[Spotorno, Nicola] Univ Penn, Penn Frontotemporal Degenerat Ctr, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Spotorno, Nicola; Nilsson, Karin; Alexander, Santillo] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden; [Lindberg, Olof; Lars-Olof, Wahlund] Karolinska Inst, Div Clin Geriatr, Stockholm, Sweden; [Nilsson, Christer] Lund Univ, Dept Clin Sci, Div Neurol, Lund, Sweden; [Waldo, Maria Landqvist] Lund Univ, Dept Clin Sci, Clin Sci Helsingborg, Lund, Sweden; [van Westen, Danielle; Markus, Nilsson] Lund Univ, Dept Diagnost Radiol, Clin Sci, Lund, Sweden; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden; [Englund, Elisabet] Dept Clin Sci, Div Pathol, Lund, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Latt, Jimmy] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden	University of Pennsylvania; Pennsylvania Medicine; Lund University; Karolinska Institutet; Lund University; Lund University; Lund University; Lund University; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London; Lund University; Skane University Hospital	Spotorno, N (corresponding author), Univ Penn, Penn Frontotemporal Degenerat Ctr, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Spotorno, N (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden.	nicola.spotorno@pennmedicine.upenn.edu		Santillo, Alexander/0000-0001-9717-0820; Spotorno, Nicola/0000-0001-5404-8788; van Westen, Danielle/0000-0001-8649-9874	Schorling foundation; National Institute on Aging (NIA) [AG052943, AG017586]; Swedish Society for Medical Research; Benthe Rexhed Gersteds foundation; Bundy Academy; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Region Skane; Swedish Research Council [2018-02532, 2017-00915]; European Research Council [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]; Alzheimer Drug Discovery Foundation (ADDF), USA [201809-2016862, RDAPB-201809-2016615]; UK Dementia Research Institute at UCL; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; Swedish government [ALFGBG-715986]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]	Schorling foundation; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Society for Medical Research; Benthe Rexhed Gersteds foundation; Bundy Academy; Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University; Region Skane; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish State Support for Clinical Research; Alzheimer Drug Discovery Foundation (ADDF), USA; UK Dementia Research Institute at UCL; Swedish Alzheimer Foundation; Hjarnfonden, Sweden; Swedish government; European Union Joint Program for Neurodegenerative Disorders	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NS, OL, LOW and AS were all supported by the Schorling foundation. NS is also supported by the National Institute on Aging (NIA), grant numbers: AG052943, AG017586. AS is also supported by the Swedish Society for Medical Research, The Benthe Rexhed Gersteds foundation, The Bundy Academy, The Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson's disease) at Lund University, and Region Skane. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017-00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615), the Swedish Alzheimer Foundation (#AF-742881), Hjarnfonden, Sweden (#FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236).	Acosta-Cabronero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049072; Bridel C, 2019, JAMA NEUROL, V76, P1035, DOI 10.1001/jamaneurol.2019.1534; de Carvalho M, 2008, CLIN NEUROPHYSIOL, V119, P497, DOI 10.1016/j.clinph.2007.09.143; Dopper EGP, 2014, NEUROLOGY, V83, pE19, DOI 10.1212/WNL.0000000000000583; Ducharme S, 2020, BRAIN, V143, P1632, DOI 10.1093/brain/awaa018; ENGLUND E, 1987, ARCH GERONTOL GERIAT, V6, P235, DOI 10.1016/0167-4943(87)90024-0; Eratne D, 2020, AUST NZ J PSYCHIAT, V54, P57, DOI 10.1177/0004867419857811; Eriksson S, 2013, J MAGN RESON, V226, P13, DOI 10.1016/j.jmr.2012.10.015; Gaiani A, 2017, JAMA NEUROL, V74, P525, DOI 10.1001/jamaneurol.2016.5398; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Katisko K, 2020, J NEUROL, V267, P162, DOI 10.1007/s00415-019-09567-8; Lam BYK, 2014, HUM BRAIN MAPP, V35, P3547, DOI 10.1002/hbm.22420; Lampinen B, 2019, HUM BRAIN MAPP, V40, P2529, DOI 10.1002/hbm.24542; Landqvist Waldo Maria, 2013, BMC Neurol, V13, P54, DOI 10.1186/1471-2377-13-54; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468; Mattsson N, 2019, JAMA NEUROL, V76, P791, DOI 10.1001/jamaneurol.2019.0765; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Meeter LH, 2017, NAT REV NEUROL, V13, P406, DOI 10.1038/nrneurol.2017.75; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Meeter LHH, 2019, J NEUROL NEUROSUR PS, V90, P997, DOI 10.1136/jnnp-2018-319784; Meeter LHH, 2018, ANN CLIN TRANSL NEUR, V5, P583, DOI 10.1002/acn3.559; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nilsson M, 2015, PLOS ONE; Olsson B, 2019, JAMA NEUROL, V76, P318, DOI 10.1001/jamaneurol.2018.3746; Poesen K, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01167; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Brigida ABS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166473; Santoro AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065813, 10.1371/journal.pone.0066932]; Scherling CS, 2014, ANN NEUROL, V75, P116, DOI 10.1002/ana.24052; Schreiber S, 2018, J NEUROL, V265, P2633, DOI 10.1007/s00415-018-9043-0; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Shemesh N, 2010, NMR BIOMED, V23, P757, DOI 10.1002/nbm.1550; Sjogren M, 2000, NEUROLOGY, V54, P1960, DOI 10.1212/WNL.54.10.1960; Sjogren M, 2001, J NEUROSCI RES, V66, P510, DOI 10.1002/jnr.1242; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spinelli EG, 2017, ANN NEUROL, V81, P430, DOI 10.1002/ana.24885; Spotorno N, 2019, RADIOLOGY, V293, P646, DOI 10.1148/radiol.2019190406; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Steinacker P, 2018, NEUROLOGY, V91, pE1390, DOI 10.1212/WNL.0000000000006318; Steinacker P, 2016, J NEUROL NEUROSUR PS, V87, P12, DOI 10.1136/jnnp-2015-311387; van der Ende EL, 2019, LANCET NEUROL, V18, P1103, DOI 10.1016/S1474-4422(19)30354-0; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060	51	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0236384	10.1371/journal.pone.0236384	http://dx.doi.org/10.1371/journal.pone.0236384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108404	Green Published, gold, Green Submitted			2022-12-26	WOS:000588372400040
J	Zurawski, AL; Kiebzak, WP; Kowalski, IM; Sliwinski, G; Sliwinski, Z				Zurawski, Arkadiusz Lukaz; Kiebzak, Wojciech Piotr; Kowalski, Ireneusz M.; Sliwinski, Grzegorz; Sliwinski, Zbigniew			Evaluation of the association between postural control and sagittal curvature of the spine	PLOS ONE			English	Article							FUNCTIONAL SCOLIOSIS; BODY POSTURE; BACK; BALANCE; PARAMETERS; STABILITY; LOAD	Introduction Balance is key to controlling body posture. Balance is typically assessed by measures of the body's vertical orientation, obtained by balancing out the forces acting on different body segments. The ability to maintain balance is assessed by evaluating centre of pressure (CoP) displacement; such assessments are typically used to evaluate responses to a treatment process. Purpose of study This study evaluated the efficiency of compensatory reactions in children according to the extent of thoracic kyphosis and lumbar lordosis. Materials and method The study enrolled 312 children aged 8-12 years, including 211 patients with postural disorders: thoracic kyphosis outside the 47-50-degree range and lordosis outside the 38-42-degree range (study group). A control group was also recruited and comprised 101 children without postural disorders. The DIERS formetric 4D system was used to assess posture and CoP displacement. Results Children in the study group showed a significantly greater range of CoP displacement than children in the control group. The kyphosis angle correlated with the maximum CoP displacement in the coronal plane and the maximum CoP displacement in the sagittal plane during gait. The kyphosis angle also correlated with the maximum CoP displacement back in the static test. The size of the lordosis angle correlated with the maximum displacement of CoP in the coronary plane during gait, and with the maximum displacement of CoP toward the left, forward, and backward in the static test. The correlation coefficient of the lordosis angle with displacement of the CoP in the sagittal plane was 0.999. Conclusions We found an association between kyphosis and lordosis and the amplitude of CoP displacement, which may reflect the postural control system's response to biomechanical destabilisation caused by changes in kyphosis and lordosis. The lordosis angle correlation strength for displacement of CoP in sagittal plane is 0.999 and adopts a linear value.	[Zurawski, Arkadiusz Lukaz; Kiebzak, Wojciech Piotr; Sliwinski, Grzegorz; Sliwinski, Zbigniew] Jan Kochanowski Univ Humanities & Sci, Coll Med, Inst Hlth Sci, Kielce, Poland; [Zurawski, Arkadiusz Lukaz; Kiebzak, Wojciech Piotr] Prov Integrated Hosp, Swietokrzyskie Ctr Paediat, Kielce, Poland; [Kowalski, Ireneusz M.] Univ Warmia & Mazury, Olsztyn, Poland; [Sliwinski, Grzegorz] Tech Univ Dresden, Inst Biomed Engn, Dresden, Germany	Jan Kochanowski University; University of Warmia & Mazury; Technische Universitat Dresden	Zurawski, AL (corresponding author), Jan Kochanowski Univ Humanities & Sci, Coll Med, Inst Hlth Sci, Kielce, Poland.; Zurawski, AL (corresponding author), Prov Integrated Hosp, Swietokrzyskie Ctr Paediat, Kielce, Poland.	azurawski@onet.eu	Żurawski, Arkadiusz/A-9073-2016	Żurawski, Arkadiusz/0000-0003-2564-8607; Kiebzak, Wojciech/0000-0001-6035-6568; Kowalski, Ireneusz/0000-0002-5758-8904	 [024/RID/2018/19]		Project financed under the program of the Minister of Science and Higher Education called "Regional Initiative of Excellence" in the years 2019-2022, project no. 024/RID/2018/19, amount of financing 11 999 000,00 zl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuthota V, 2008, CURR SPORT MED REP, V7, P39, DOI 10.1097/01.CSMR.0000308663.13278.69; Alrwaily M, 2011, OTOLARYNG CLIN N AM, V44, P473, DOI 10.1016/j.otc.2011.01.015; [Anonymous], 2010, ZAHEDAN J RES MED SC, V12, P29; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; [Anonymous], 1999, HPV INFECT CERVICAL, V2, P15; Baczkowicz Dawid, 2008, Ortop Traumatol Rehabil, V10, P478; Bettany-Saltikov J, 2008, STUD HEALTH TECHNOL, V140, P221, DOI 10.3233/978-1-58603-888-5-221; CARLSOO S, 1961, ERGONOMICS, V4, P193, DOI 10.1080/00140136108930520; D'Amico M, 2002, STUD HEALTH TECHNOL, V88, P285; Damasceno Luiz Henrique Fonseca, 2006, Acta ortop. bras., V14, P193, DOI 10.1590/S1413-78522006000400003; Degenhardt B, 2017, SCOLIOSIS SPINAL DIS, V12, DOI 10.1186/s13013-017-0134-y; Degenhardt BF, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1796247; Dietz V, 1996, J BIOMECH, V29, P841, DOI 10.1016/0021-9290(95)00175-1; Draus C, 2015, OPEN J THER REHABIL, V3, P70, DOI [10.4236/ojtr.2015.33010, DOI 10.4236/OJTR.2015.33010]; Drzal-Grabiec J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-186; Ghandhari H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/842624; Ishikawa Y, 2009, OSTEOPOROSIS INT, V20, P2049, DOI 10.1007/s00198-009-0919-9; Jackson RP, 2000, SPINE, V25, P575, DOI 10.1097/00007632-200003010-00008; Jin Kim Soo, 2017, [Korean Journal of Youth Studies, 청소년학연구], V24, P31, DOI 10.21509/KJYS.2017.09.24.9.31; Kostiukow A, 2009, ANN ACAD MED STETINE; Lamartina C, 2014, EUR SPINE J, V23, P1177, DOI 10.1007/s00586-014-3227-9; Lason G, 2015, INT J OSTEOPATH MED, V18, P247, DOI 10.1016/j.ijosm.2015.04.002; Lee RS, 2012, EUR SPINE J, V21, P1106, DOI 10.1007/s00586-012-2175-5; Liao K, 2010, RESTOR NEUROL NEUROS, V28, P91, DOI 10.3233/RNN-2010-0507; Lin R M, 1992, J Formos Med Assoc, V91, P329; Mac-Thiong Jean-Marc, 2011, Eur Spine J, V20 Suppl 5, P586, DOI 10.1007/s00586-011-1925-0; Macialczyk-Paprocka K., 2011, PROBL HIG EPIDEMIOL, V92, P286; Mangone M, 2013, EUR SPINE J, V22, P367, DOI 10.1007/s00586-012-2564-9; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Park YH, 2016, J INT MED RES, V44, P728, DOI 10.1177/0300060516639750; Pearson's C., 2011, COMP VALUES PERSONS; Raczkowski JW, 2010, ARCH MED SCI, V6, P393, DOI 10.5114/aoms.2010.14262; Radzeviciene L, 2016, SOC WELF INTERDISCIP, V6, P118, DOI 10.21277/sw.v1i6.241; Rajnics P, 2002, J SPINAL DISORD TECH, V15, P24, DOI 10.1097/00024720-200202000-00004; Rosa K, 2013, J HEALTH SCI, V3, P107; Rougler PR, 2007, J BIOMECH, V40, P2477, DOI 10.1016/j.jbiomech.2006.11.003; Schroder J, 2011, MAN MED, V49, P161, DOI 10.1007/s00337-011-0831-1; Sheha ED, 2018, JBJS REV, V6, DOI 10.2106/JBJS.RVW.17.00148; Souza JA, 2014, J MANIP PHYSIOL THER, V37, P407, DOI 10.1016/j.jmpt.2014.04.003; Stricker SJ, 2004, INT PEDIAT, V19, P134; Tao FH, 2012, J SPINAL DISORD TECH, V25, P303, DOI 10.1097/BSD.0b013e3182204c3e; Tuzun C, 1999, CLIN RHEUMATOL, V18, P308, DOI 10.1007/s100670050107; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Wawrzyniak A, 2017, PEDIATR MED RODZ, V13, P72, DOI 10.15557/PiMR.2017.0007; Weiss HR, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-22; Wenger DR, 1999, SPINE, V24, P2630, DOI 10.1097/00007632-199912150-00010; Wilczyski J., 2014, CHILD NEUROLOGY, V23, P27; Wilczyski J, 2016, J ED HLTH SPORT, V6, P38; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Young RS, 2000, GAIT POSTURE, V11, P217, DOI 10.1016/S0966-6362(00)00048-5; Zmyslna A, 2019, INT J OCCUP MED ENV, V32, P25, DOI 10.13075/ijomeh.1896.01314	51	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241228	10.1371/journal.pone.0241228	http://dx.doi.org/10.1371/journal.pone.0241228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108407	Green Published, gold			2022-12-26	WOS:000588372400002
J	Gamaev, L; Mizrahi, L; Friehmann, T; Rosenberg, N; Pappo, O; Olam, D; Zeira, E; Halpern, KB; Caruso, S; Zucman-Rossi, J; Axelrod, JH; Galun, E; Goldenberg, DS				Gamaev, Lika; Mizrahi, Lina; Friehmann, Tomer; Rosenberg, Nofar; Pappo, Orit; Olam, Devorah; Zeira, Evelyne; Bahar Halpern, Keren; Caruso, Stefano; Zucman-Rossi, Jessica; Axelrod, Jonathan H.; Galun, Eithan; Goldenberg, Daniel S.			The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma	ONCOGENE			English	Article							NONCODING RNA H19; LIVER CARCINOGENESIS; MOLECULAR-MECHANISMS; MURINE; GENE; EXPRESSION; POLYPLOIDIZATION; CLASSIFICATION; PROLIFERATION; CONTRIBUTES	The oncofetal long noncoding RNA (lncRNA) H19 is postnatally repressed in most tissues, and re-expressed in many cancers, including hepatocellular carcinoma (HCC). The role of H19 in carcinogenesis is a subject of controversy. We aimed to examine the role of H19 in chronic inflammation-mediated hepatocarcinogenesis using the Mdr2/Abcb4 knockout (Mdr2-KO) mouse, a well-established HCC model. For this goal, we have generated Mdr2-KO/H19-KO double knockout (dKO) mice and followed spontaneous tumor development in the dKO and control Mdr2-KO mice. Cellular localization of H19 and effects of H19 loss in the liver were determined in young and old Mdr2-KO mice. Tumor incidence and tumor load were both significantly decreased in the liver of dKO versus Mdr2-KO females. The expression levels of H19 and Igf2 were variable in nontumor liver tissues of Mdr2-KO females and were significantly downregulated in most matched tumors. In nontumor liver tissue of aged Mdr2-KO females, H19 was expressed mainly in hepatocytes, and hepatocyte proliferation was increased compared to dKO females. At an early age, dKO females displayed lower levels of liver injury and B-cell infiltration, with higher percentage of binuclear hepatocytes. In human samples, H19 expression was higher in females, positively correlated with cirrhosis (in nontumor liver samples) and negatively correlated with CTNNB1 (beta-catenin) mutations and patients' survival (in tumors). Our data demonstrate that the lncRNA H19 is pro-oncogenic during the development of chronic inflammation-mediated HCC in the Mdr2-KO mouse model, mainly by increasing liver injury and decreasing hepatocyte polyploidy in young mice.	[Gamaev, Lika; Mizrahi, Lina; Friehmann, Tomer; Rosenberg, Nofar; Olam, Devorah; Zeira, Evelyne; Axelrod, Jonathan H.; Galun, Eithan; Goldenberg, Daniel S.] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene & Cell Therapy, Jerusalem, Israel; [Pappo, Orit] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel; [Bahar Halpern, Keren] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Caruso, Stefano; Zucman-Rossi, Jessica] Univ Paris, Sorbonne Univ, INSERM, Ctr Rech Cordeliers,Funct Genom Solid Tumors Lab, F-75006 Paris, France; [Zucman-Rossi, Jessica] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Goldenberg, DS (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene & Cell Therapy, Jerusalem, Israel.	goldenberg@hadassah.org.il	Caruso, Stefano/AAA-9564-2020; zucman-rossi, Jessica/B-5098-2009; Galun, Eithan/AAD-9117-2022; j, zucman-rossi/AAV-3594-2021	Caruso, Stefano/0000-0002-6319-3642; zucman-rossi, Jessica/0000-0002-5687-0334; Galun, Eithan/0000-0002-6243-6702; j, zucman-rossi/0000-0002-5687-0334; Goldenberg, Daniel/0000-0002-1618-4145	Robert H. Benson Living Trust; Selma Kron Foundation; Kamea Scientific Foundation of the Israeli Government; ISF [923/14, 486/2017]; Labex OncoImunology; CARPEM; INSERM; Ligue Nationale contre le Cancer (Equipe Labellisee); Labex OncoImmunology (investissement d'avenir); grant IREB; Coup d'Elan de la Fondation Bettencourt-Schueller; SIRIC CARPEM; Raymond Rosen Award from the Fondation pour le Recherche Medicale; Prix Rene and Andree Duquesne-Comite de Paris Ligue Contre le Cancer; Fondation Merieux; ERC [786575-RxmiRcanceR]; Deutsche Forschungsgemeinschaft (DFG) [SFB841]; NIH [CA197081-02]; MOST; ISF collaboration with Canada [2473/2017]; ICORE-ISF [41/2011]; DKFZ-MOST	Robert H. Benson Living Trust; Selma Kron Foundation; Kamea Scientific Foundation of the Israeli Government; ISF(Israel Science Foundation); Labex OncoImunology; CARPEM; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Labex OncoImmunology (investissement d'avenir)(French National Research Agency (ANR)); grant IREB; Coup d'Elan de la Fondation Bettencourt-Schueller; SIRIC CARPEM; Raymond Rosen Award from the Fondation pour le Recherche Medicale; Prix Rene and Andree Duquesne-Comite de Paris Ligue Contre le Cancer; Fondation Merieux; ERC(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MOST; ISF collaboration with Canada; ICORE-ISF; DKFZ-MOST	Robert H. Benson Living Trust and Selma Kron Foundation to student fellowships. DSG is supported by the Kamea Scientific Foundation of the Israeli Government. JHA was supported by ISF 923/14. SC was supported by a funding from Labex OncoImunology and CARPEM. The JZR group was supported by INSERM, Ligue Nationale contre le Cancer (Equipe Labellisee), Labex OncoImmunology (investissement d'avenir), grant IREB, Coup d'Elan de la Fondation Bettencourt-Schueller, the SIRIC CARPEM, Raymond Rosen Award from the Fondation pour le Recherche Medicale, Prix Rene and Andree Duquesne-Comite de Paris Ligue Contre le Cancer and Fondation Merieux. The work of EG was supported by the: ERC advance-GA No. 786575-RxmiRcanceR, Deutsche Forschungsgemeinschaft (DFG) SFB841 project C3, NIH CA197081-02, MOST, ISF collaboration with Canada (2473/2017), personal ISF (486/2017), ICORE-ISF (41/2011), and by DKFZ-MOST.	Adriaenssens E, 1999, ONCOGENE, V18, P4460, DOI 10.1038/sj.onc.1202819; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chen X, 2015, CANCER SCI, V106, P972, DOI 10.1111/cas.12700; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Ella E, 2014, ONCOTARGET, V5, P10318, DOI 10.18632/oncotarget.2515; Faggioli F, 2018, HEPATOLOGY, V67, P1970, DOI 10.1002/hep.29636; Goyal N, 2019, J MOL MED, V97, P115, DOI 10.1007/s00109-018-1718-6; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Hao PP, 2015, J HEPATOL, V62, P1278, DOI 10.1016/j.jhep.2014.12.033; Hoppstadter J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01446; Jiang YC, 2018, HEPATOL COMMUN, V2, P1356, DOI 10.1002/hep4.1252; Jones SA, 2016, ANN RHEUM DIS, V75, P739, DOI 10.1136/annrheumdis-2015-207744; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Lecerf C, 2019, CELL MOL LIFE SCI, V76, P4673, DOI 10.1007/s00018-019-03240-z; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Li XJY, 2018, HEPATOLOGY, V68, P599, DOI 10.1002/hep.29838; Li XJY, 2017, HEPATOLOGY, V66, P869, DOI 10.1002/hep.29145; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Martinez-Quetglas I, 2016, GASTROENTEROLOGY, V151, P1192, DOI 10.1053/j.gastro.2016.09.001; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Pope C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187557; Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335; Raveh E, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0458-2; Ricci E, 2019, J LEUKOCYTE BIOL, V105, P187, DOI 10.1002/JLB.3AB0718-255R; Robert O, 2016, J HEPATOL, V64, P916, DOI 10.1016/j.jhep.2015.11.023; Schultheiss CS, 2017, CELL STRESS, V1, P37, DOI 10.15698/cst2017.10.105; Shoshani O, 2012, CANCER RES, V72, P6403, DOI 10.1158/0008-5472.CAN-12-1155; Stoyanov E, 2015, ONCOTARGET, V6, P11047, DOI 10.18632/oncotarget.3567; Uehara T, 2013, TOXICOL SCI, V132, P53, DOI 10.1093/toxsci/kfs342; Wilkinson PD, 2019, HEPATOLOGY, V69, P1242, DOI 10.1002/hep.30286; Xu GQ, 2015, ONCOTARGET, V6, P33636, DOI 10.18632/oncotarget.5602; Yamamoto Y, 2004, J HEPATOL, V40, P808, DOI 10.1016/j.jhep.2004.01.022; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x; Yang JB, 2018, ONCOGENE, V37, P1192, DOI 10.1038/s41388-017-0048-4; Yang NM, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0756-7; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-909; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zhang JQ, 2019, HEPATOLOGY, V69, P1549, DOI 10.1002/hep.30153; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381; Zhang SY, 2018, DEV CELL, V44, P447, DOI 10.1016/j.devcel.2018.01.010; Zhang YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20559; Zhao RZ, 2020, NATURE, V577, P416, DOI 10.1038/s41586-019-1873-0; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122	47	14	14	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					127	139		10.1038/s41388-020-01513-7	http://dx.doi.org/10.1038/s41388-020-01513-7		OCT 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33093654	Green Published			2022-12-26	WOS:000581554300001
J	Micho, H; Fantahun, M; Gebreyohannes, Z; Bedaso, A; Bereka, N; Abebayehu, B; Mekonnen, AB; Taye, B; Desta, K; Tsegaye, A				Micho, Haileleul; Fantahun, Mengistu; Gebreyohannes, Zenebe; Bedaso, Ashenafi; Bereka, Neima; Abebayehu, Bethelehem; Mekonnen, Asaye Birhanu; Taye, Bineyam; Desta, Kassu; Tsegaye, Aster			High rate of intestinal parasites among a closed community of Zay populations residing on three islands of Lake Ziway, Ethiopia	PLOS ONE			English	Article							SCHOOLCHILDREN; INFECTIONS; MANSONI	Background Several factors including socio-economic and access to health facility influence burden of intestinal parasites. Epidemiological data from hard to reach areas will help to identify high-risk communities for targeted intervention. We, therefore, assessed the magnitude of intestinal parasites among Zay people residing in three islands of Lake Ziway in Ethiopia. Methods This cross-sectional survey was conducted in March 2013 on 444 individuals aged 6 months to 85 years. Stool samples were analyzed using wet mount and formol-ether concentration methods. Data were collected using interviewer-administered questionnaire and analyzed using STATA version 10. Results Among the study participants, 52% (321/444) were children under 15 years. While 72.8% were positive for at least one intestinal parasite, single, dual and triple infections were found in 42.1%, 23.9% and 6.3%, respectively. Four types of intestinal parasites were detected in two children. The commonest parasites wereEntamoeba histolytica/dispar(51.4%),Schistosoma mansoni(17.8%),Giardia lamblia(14.4%),Trichuris trichiura(10.8%), Taenia species (5.6%),Hymenolopis nana(4.5%),Ascaris lumbricoides(4.1%),Entrobius vermicularis(0.9%), Hookworm (0.7%), andStrongyloides stercoralis(0.2%). Remarkable proportion of study participants (51.3%) had no latrine and >85% of the islanders use the lake water for drinking, cleaning or both. About 36% had no information about waterborne and related diseases, while 31% never heard about bilharziasis. Fishing and farming were the main source of income. In the multivariate model, being in the age group > 15 years (AOR = 0.49; 95%CI = 0.28-0.85) and not using lake water for drinking or washing (AOR = 0.52; 95%CI = 0.28-0.99) had protective effect, after adjusting for education, occupation and hand wash after latrine use. Conclusion The observed high rate of intestinal parasites (72.8%) in these hard to reach Islanders of Lake Ziway, warrants targeted and sustainable intervention.	[Micho, Haileleul] Dilla Univ, Coll Hlth Sci, Dept Biomed Sci, Dilla, Ethiopia; [Micho, Haileleul; Fantahun, Mengistu; Gebreyohannes, Zenebe; Bedaso, Ashenafi; Bereka, Neima; Abebayehu, Bethelehem; Mekonnen, Asaye Birhanu; Taye, Bineyam; Desta, Kassu; Tsegaye, Aster] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Fantahun, Mengistu; Gebreyohannes, Zenebe] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Mekonnen, Asaye Birhanu] Holy Cross Hosp, Minneapolis, MN USA; [Mekonnen, Asaye Birhanu] Walden Univ, Minneapolis, MN USA; [Taye, Bineyam] Colgate Univ, Hamilton, NY 13346 USA	Dilla University; Addis Ababa University; Walden University; Colgate University	Tsegaye, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia.	tsegayeaster@yahoo.com		Tsegaye, Aster/0000-0002-9026-4629				[Anonymous], 2011, SOCIOLINGUISTIC SURV; [Anonymous], 2011, LIT EARLY AM REPUBLI; Arani AS, 2008, REV I MED TROP, V50, P145, DOI 10.1590/S0036-46652008000300003; Bailey C, 2013, PATHOG GLOB HEALTH, V107, P52, DOI 10.1179/2047773213Y.0000000073; Chala B., 2013, EPIDEMIOL OPEN ACCES, V3, P2161, DOI DOI 10.4172/2161-1165.1000119; Coulibaly JT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-135; Gamboa MI, 2003, J HELMINTHOL, V77, P15, DOI 10.1079/JOH2002142; Giday M, 2001, CBM S SKRIFTSERIE, V3, P81; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jejaw Ayalew, 2014, BMC Res Notes, V7, P502, DOI 10.1186/1756-0500-7-502; Kheir A, 2017, KHARTOUM MED J, V10, P1368; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Legesse M, 2004, ETHIOP J HLTH DEV, V18, P32; Merid Y., 2001, Ethiopian Journal of Health Development, V15, P31; Midakso B, 2017, E AFRICAN J SOCIAL S, V2, P41; Moges F, 2006, JPN J INFECT DIS, V59, P400; Sures B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2001-3; Teklehaymanot T, 2009, ETHIOP J HEALTH DEV, V23, P57; Teklemariam Dejene, 2018, BMC Res Notes, V11, P146, DOI 10.1186/s13104-018-3248-2; Terefe A, 2011, ETHIOP J HEALTH DEV, V25, P46; World Health Organization, 2009, LIB CAT PUBL DAT NEG; World Health Organization, 2020, SOIL TRANSM HELM INF; World Health Organization (WHO), 2017, WHOHTMNTD201701	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240582	10.1371/journal.pone.0240582	http://dx.doi.org/10.1371/journal.pone.0240582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091025	Green Published, gold			2022-12-26	WOS:000586647200057
J	Marklund, E; Leach, S; Axelsson, H; Nystrom, K; Norder, H; Bemark, M; Angeletti, D; Lundgren, A; Nilsson, S; Andersson, LM; Yilmaz, A; Lindh, M; Liljeqvist, JA; Gisslen, M				Marklund, Emelie; Leach, Susannah; Axelsson, Hannes; Nystrom, Kristina; Norder, Helene; Bemark, Mats; Angeletti, Davide; Lundgren, Anna; Nilsson, Staffan; Andersson, Lars-Magnus; Yilmaz, Aylin; Lindh, Magnus; Liljeqvist, Jan-ake; Gisslen, Magnus			Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders	PLOS ONE			English	Article								Background To accurately interpret COVID-19 seroprevalence surveys, knowledge of serum-IgG responses to SARS-CoV-2 with a better understanding of patients who do not seroconvert, is imperative. This study aimed to describe serum-IgG responses to SARS-CoV-2 in a cohort of patients with both severe and mild COVID-19, including extended studies of patients who remained seronegative more than 90 days post symptom onset. Methods SARS-CoV-2-specific IgG antibody levels were quantified using two clinically validated and widely used commercial serological assays (Architect, Abbott Laboratories and iFlash 1800, YHLO), detecting antibodies against the spike and nucleocapsid proteins. Results Forty-seven patients (mean age 49 years, 38% female) were included. All (15/15) patients with severe symptoms and 29/32 (90.6%) patients with mild symptoms of COVID-19 developed SARS-CoV-2-specific IgG antibodies in serum. Time to seroconversion was significantly shorter (median 11 vs. 22 days, P= 0.04) in patients with severe compared to mild symptoms. Of the three patients without detectable IgG-responses after >90 days, all had detectable virus-neutralizing antibodies and in two, spike-protein receptor binding domain-specific IgG was detected with an in-house assay. Antibody titers were preserved during follow-up and all patients who seroconverted, irrespective of the severity of symptoms, still had detectable IgG levels >75 days post symptom onset. Conclusions Patients with severe COVID-19 both seroconvert earlier and develop higher concentrations of SARS-CoV-2-specific IgG than patients with mild symptoms. Of those patients who not develop detectable IgG antibodies, all have detectable virus-neutralizing antibodies, suggesting immunity. Our results showing that not all COVID-19 patients develop detectable IgG using two validated commercial clinical methods, even over time, are vital for the interpretation of COVID-19 seroprevalence surveys.	[Marklund, Emelie; Nystrom, Kristina; Norder, Helene; Andersson, Lars-Magnus; Yilmaz, Aylin; Lindh, Magnus; Liljeqvist, Jan-ake; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Marklund, Emelie; Andersson, Lars-Magnus; Yilmaz, Aylin; Gisslen, Magnus] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden; [Leach, Susannah; Axelsson, Hannes; Bemark, Mats; Angeletti, Davide; Lundgren, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [Leach, Susannah] Sahlgrens Univ Hosp, Dept Clin Pharmacol, Gothenburg, Sweden; [Norder, Helene; Lindh, Magnus; Liljeqvist, Jan-ake] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden; [Bemark, Mats; Lundgren, Anna] Sahlgrens Univ Hosp, Dept Clin Immunol & Transfus Med, Gothenburg, Sweden; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden; [Nilsson, Staffan] Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Chalmers University of Technology; University of Gothenburg	Gisslen, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden.; Gisslen, M (corresponding author), Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden.	magnus.gisslen@gu.se	Angeletti, Davide/H-7350-2019; Bemark, Mats/B-2578-2019; Leach, Susannah/ABE-4371-2021; Norder, Helene/GSD-5853-2022; Gisslen, Magnus/D-7454-2015	Angeletti, Davide/0000-0002-5256-1972; Bemark, Mats/0000-0001-7416-9819; Gisslen, Magnus/0000-0002-2357-1020; Nilsson, Staffan/0000-0003-4748-0446; Liljeqvist, Jan-Ake/0000-0002-1226-9870	Swedish State Support for Clinical Research [ALFGBG-717531, 679621]; SciLifeLab/KAWnational COVID-19 research program [V-2020-0250, 2020-0182]	Swedish State Support for Clinical Research; SciLifeLab/KAWnational COVID-19 research program	This work was supported by the Swedish State Support for Clinical Research (https://www.alfvastragotaland.se, ALFGBG-717531 (MG) and 679621 (SL)) and by SciLifeLab/KAWnational COVID-19 research program (https://www.scilifelab.se/covid-19#nationalprogram, V-2020-0250 (MG) and 2020-0182 (DA, MB, AL)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Evolved Universal Terrestrial Radio, 2010, 36 3GPP TS, pV9; Alshukairi AN, 2016, EMERG INFECT DIS, V22, P1113, DOI 10.3201/eid2206.160010; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Cervia C, 2020, BIORXIV; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Fafi-Kremer S, EBIOMEDICINE; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Liu W, 2006, J INFECT DIS, V193, P792, DOI 10.1086/500469; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Lou B, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00763-2020; Ma H, 2020, CELL MOL IMMUNOL, V17, P773, DOI 10.1038/s41423-020-0474-z; Marshall JC., 2020, LANCET INFECT DIS, V20, pe192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7]; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Sterlin D, 2020, IGA DOMINATES EARLY, DOI [10.20126532, 10.1101/2020.06.10.20126532, DOI 10.1101/2020.06.10.20126532]; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wajnberg A, 2020, SARS COV 2 INFECT IN; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xiao AT, 2020, J INFECTION, V81, P174, DOI 10.1016/j.jinf.2020.03.012; Yu HQ, 2020, EUR RESP J; Zeng FF, 2020, J MED VIROL, V92, P2050, DOI 10.1002/jmv.25989; Zhang GX, 2020, J INFECT DIS, V222, P183, DOI 10.1093/infdis/jiaa229; Zhao B, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.202002019; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	28	103	106	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241104	10.1371/journal.pone.0241104	http://dx.doi.org/10.1371/journal.pone.0241104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085715	Green Submitted, Green Published, gold			2022-12-26	WOS:000585943400035
J	Hashan, MR; Rabbi, MF; Haider, SS; Gupta, RD				Hashan, Mohammad Rashidul; Rabbi, Md Fazla; Haider, Shams Shabab; Das Gupta, Rajat			Prevalence and associated factors of underweight, overweight and obesity among women of reproductive age group in the Maldives: Evidence from a nationally representative study	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; CHILD UNDERNUTRITION; DOUBLE BURDEN; DUAL BURDEN; LOW-INCOME; MALNUTRITION; BANGLADESH; MIDDLE; HOUSEHOLD	Background Global epidemiological transition across various countries have documented the coexistence of undernutrition and overnutrition. South Asian countries are facing this public health hazard in remarkable manner. To enrich the evidence and relation with women's health in the Maldives, this study was undertaken to examine the prevalence and associated factors of underweight, overweight and obesity among reproductive age women. Methods This study was conducted utilizing data from the Maldives Demographic and Health Survey 2016-17. After presenting descriptive analyses, multivariable logistic regression analysis method was used to examine the prevalence and associations between different nutritional status categories. These were grouped based on the WHO recommended cut-off value and relevant socio-demographic determinants among reproductive age women. Results A total weighted sample of 6,634 reproductive age Maldivian women (15-49 years) were included in the analysis. The overall prevalence of overweight and obesity was 63%, while the underweight prevalence was 10%. The younger age group (15-24 years) had a higher prevalence of underweight (26%). On the other hand, an overweight and obesity prevalence of 82.6% was observed among the older age group (35-49 years). Regression analysis showed that residents of the North and Central Provinces, those in the higher quintiles of wealth index, married women and those with parity of more than two children, were all significantly negatively correlated to being underweight. Increased age, being married or separated/divorced/widowed and having more than three children was found to have a significant positive association with overweight and obesity. Conclusions Maldives is facing nutritional transition and a major public health hazard demonstrated by the high burden of overweight and obesity and persistence of chronic problem of undernutrition. Surveillance of vulnerable individuals with identified socio-demographic factors and cost-effective interventions are highly recommended to address the persistent underweight status and the emerging problem of overweight/obesity.	[Hashan, Mohammad Rashidul] Minist Hlth & Family Welf, Bangladesh Civil Serv, Dhaka, Bangladesh; [Rabbi, Md Fazla] Bangladesh Natl Nutr Council, Hlth Serv Div, Minist Hlth & Family Welf, Dhaka, Bangladesh; [Haider, Shams Shabab; Das Gupta, Rajat] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Sci Implementat & Scale Up, Dhaka, Bangladesh; [Das Gupta, Rajat] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, Dhaka, Bangladesh; [Das Gupta, Rajat] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of South Carolina System; University of South Carolina Columbia	Hashan, MR (corresponding author), Minist Hlth & Family Welf, Bangladesh Civil Serv, Dhaka, Bangladesh.	hasandmck66@gmail.com	Gupta, Rajat Das/E-5545-2018	Gupta, Rajat Das/0000-0002-7680-676X; Hashan, Mohammad Rashidul/0000-0002-1627-4976				Abrha S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3315-3; Ahmed M, 2020, J OBES, V2020, DOI 10.1155/2020/9173075; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Biswas RK, 2019, PUBLIC HEALTH NUTR, V22, P3163, DOI 10.1017/S1368980019002611; Biswas T, 2020, ADV NUTR, V11, P128, DOI 10.1093/advances/nmz078; Black RE, 2013, LANCET, V382, P372, DOI 10.1016/S0140-6736(13)60988-5; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bloom DE., 2012, GLOBAL EC BURDEN NON; Bloom DE, 2011, GLOBAL EC BURDEN NON; Caballero B, 2005, NEW ENGLAND J MED; Chowdhury MAB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018468; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doku DT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2033-6; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fanzo J., 2019, GLOBAL NUTR REPORT; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Garg C, 2010, OBES REV, V11, P105, DOI 10.1111/j.1467-789X.2009.00666.x; Golder AM, 2001, PUBLIC HEALTH NUTR, V4, P773, DOI 10.1079/PHN2000101; Gunderson EP, 2009, OBSTET GYN CLIN N AM, V36, P317, DOI 10.1016/j.ogc.2009.04.001; Haddad L, 2015, HEALTH POLICY PLANN, V30, P1193, DOI 10.1093/heapol/czu110; He Y, 2016, AM J PUBLIC HEALTH, V106, P2103, DOI 10.2105/AJPH.2016.303499; Hill B, 2017, OBES REV, V18, P755, DOI 10.1111/obr.12538; Hillemeier MM, 2011, J WOMENS HEAL; Janghorbani M, 2007, OBESITY, V15, P2797, DOI 10.1038/oby.2007.332; Jayawardena R, 2013, OBESITY FACTS, V6, P405, DOI 10.1159/000355598; Kabir A, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00952-4; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Khan MMH, 2009, SINGAP MED J, V50, P804; Khan MMH, 2011, B WORLD HEALTH ORGAN, V89, P583, DOI 10.2471/BLT.11.087429; Khan SH, 2013, OBES REV, V14, P126, DOI 10.1111/obr.12100; Lear SA, 2014, CAN MED ASSOC J, V186, P258, DOI 10.1503/cmaj.131090; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mamun AA, 2015, OBES RES CLIN PRACT, V9, P75, DOI 10.1016/j.orcp.2014.03.001; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Ministry of Health and Family-MOHF/Maldives and ICF Macro, 2010, MALD DEM HLTH SURV 2; Ministry of Health-MOH Maldives & ICF, 2018, MALD DEM HLTH SURV 2; Mistry SK, 2015, PUBLIC HEALTH, V129, P200, DOI 10.1016/j.puhe.2014.12.004; Monteiro CA, 2004, AM J PUBLIC HEALTH, V94, P433, DOI 10.2105/AJPH.94.3.433; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Oddo VM, 2012, AM J CLIN NUTR, V95, P951, DOI 10.3945/ajcn.111.026070; Okoh Mathew, 2013, Afr J Reprod Health, V17, P66; Papachatzi E, 2013, J Neonatal Perinatal Med, V6, P203, DOI 10.3233/NPM-1370313; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Prentice AM, 2018, ANN NUTR METAB, V72, P47, DOI 10.1159/000487383; Razak F, 2015, JAMA-J AM MED ASSOC, V314, P2164, DOI 10.1001/jama.2015.15666; Sarma Haribondhu, 2016, BMC Obes, V3, P13, DOI 10.1186/s40608-016-0093-5; Subramanian SV, 2009, AM J CLIN NUTR, V90, P369, DOI 10.3945/ajcn.2009.27487; Tanumihardjo SA, 2007, J AM DIET ASSOC, V107, P1966, DOI 10.1016/j.jada.2007.08.007; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; UNICEF, 2009, TRACK PROGR CHILD MA; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Voerman E, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002744; World Health Organization, 2000, WORLD HEAL ORGAN TEC, V2000, P894; World Health Organization, 2017, CARD DIS CVDS FACT S; World Health Organization, 2016, OB OV FACT SHEET	62	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241621	10.1371/journal.pone.0241621	http://dx.doi.org/10.1371/journal.pone.0241621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119696	Green Published, gold			2022-12-26	WOS:000600013600049
J	Janssen, N; Graovac, N; Vignjevic, G; Bogojevic, MS; Turic, N; Klobucar, A; Kavran, M; Petric, D; Cupina, AI; Fischer, S; Werner, D; Kampen, H; Merdic, E				Janssen, Nele; Graovac, Natasa; Vignjevic, Goran; Bogojevic, Mirta Sudaric; Turic, Natasa; Klobucar, Ana; Kavran, Mihaela; Petric, Dusan; Cupina, Aleksandra Ignjatovic; Fischer, Susanne; Werner, Doreen; Kampen, Helge; Merdic, Enrih			Rapid spread and population genetics of Aedes japonicus japonicus (Diptera: Culicidae) in southeastern Europe (Croatia, Bosnia and Herzegovina, Serbia)	PLOS ONE			English	Article							WEST NILE VIRUS; LA-CROSSE VIRUS; OCHLEROTATUS-JAPONICUS; APPALACHIAN REGION; VECTOR COMPETENCE; J. JAPONICUS; 1ST RECORD; MOSQUITO; ESTABLISHMENT; TRANSMISSION	The Asian bush mosquito, Aedes japonicus japonicus (Theobald, 1901), a potential vector of several pathogens, has recently established in North America and Central Europe. In 2013, it was found on the Slovenian-Croatian border, and during the following years, it emerged in more and more counties of northwestern Croatia. Surveillance of Ae. j. japonicus and other invasive mosquito species was subsequently extended both spatially and temporally in Croatia and neighbouring Bosnia and Herzegovina and Serbia. Mosquito collections were conducted in 2017 and 2018, based on adult trapping through dry ice-baited CDC traps and BG-Lure-baited BG-Sentinel traps, larval sampling through dippers and nets, and ovitrapping. Aedes j. japonicus specimens from collected samples were subjected to population genetic analysis by comparing microsatellite signatures and nad4 DNA sequences between sampled locations and with data previously obtained from more western European distribution areas. Aedes j. japonicus immature stages were found at 19 sites in Croatia, two sites in Bosnia and Herzegovina and one site in Serbia. In Croatia, four new counties were found colonised, two in the east and two in the south of the previously known distribution area. A spread of 250 km could thus be documented within five years. The findings in Bosnia and Herzegovina and Serbia represent the first records of Ae. j. japonicus in these countries. Genetic analysis suggests at least two introduction events into the surveyed area. Among the locations analysed, Orahovica can be considered a genetic border. The individuals collected west of this point were found to be similar to samples previously collected in the border regions of Southeast Germany/Austria and Austria/Slovenia, while the specimens from more eastern Croatian localities, together with those from Bosnia and Herzegovina and Serbia, were genetically different and could not be assigned to a probable origin. Thus, introduction from Central Europe, possibly by vehicular traffic, into the study area is likely, but other origins, transportation routes and modes of entry appear to contribute. Further dispersal of Ae. j. japonicus to other parts of southeastern Europe is anticipated.	[Janssen, Nele; Fischer, Susanne; Kampen, Helge] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Greifswald, Germany; [Graovac, Natasa; Vignjevic, Goran; Bogojevic, Mirta Sudaric; Turic, Natasa; Merdic, Enrih] Josip Juraj Strossmayer Univ, Dept Biol, Osijek, Croatia; [Klobucar, Ana] Andrija Stampar Teaching Inst Publ Hlth, Zagreb, Croatia; [Kavran, Mihaela; Petric, Dusan; Cupina, Aleksandra Ignjatovic] Univ Novi Sad, Fac Agr, Lab Med & Vet Entomol, Novi Sad, Serbia; [Werner, Doreen] Leibniz Ctr Agr Landscape Res, Muencheberg, Germany	Friedrich Loeffler Institute; University of JJ Strossmayer Osijek; University of Zagreb; University of Novi Sad; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Merdic, E (corresponding author), Josip Juraj Strossmayer Univ, Dept Biol, Osijek, Croatia.	enrih@biologija.unios.hr	Klobucar, Ana/AAB-4938-2022	Ignjatovic Cupina, Aleksandra/0000-0001-7045-6896; Klobucar, Ana/0000-0003-3464-6830	Josip Juraj Strossmayer University of Osijek [ZUP-2018-55]; Ministry of Education, Science and Technological Development of the Republic of Serbia [III43007, TR31084]; ECDC/EFSA (VectorNet project); Secretariat for Urbanism and Environment Protection of Vojvodina Province	Josip Juraj Strossmayer University of Osijek; Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); ECDC/EFSA (VectorNet project); Secretariat for Urbanism and Environment Protection of Vojvodina Province	EM Research in Croatia was supported by Josip Juraj Strossmayer University of Osijek (project ZUP-2018-55); DP in Serbia by the Ministry of Education, Science and Technological Development of the Republic of Serbia (projects III43007 and TR31084), ECDC/EFSA (VectorNet project) and the Secretariat for Urbanism and Environment Protection of Vojvodina Province	Andreadis TG, 2010, J MED ENTOMOL, V47, P43, DOI 10.1603/033.047.0106; [Anonymous], 2012, GUID SURV INV MOSQ E; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Bevins SN, 2007, J MED ENTOMOL, V44, P945, DOI 10.1603/0022-2585(2007)44[945:EAAOAR]2.0.CO;2; Capak K, 2017, P 29 SCI ED CROAT PE, P34; Capak K, P 30 SCI ED CROAT PE, P29; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P714; Chagin K. P., 1943, ME DITSINKAIA PARAZITOLOGIIA I PARAZITARNYE BOLEZNI [MED PARASITOL AND PARASITIC DIS], V12, P34; Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P433, DOI 10.1111/j.1467-842X.2004.tb00025.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ECDC, 2018, TRANSM W NIL VIR; ECDC, 2018, EP UPD W NIL VIR TRA; Egizi A, 2015, BIOL INVASIONS, V17, P123, DOI 10.1007/s10530-014-0710-5; Eritja R, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3317-y; Fielden MA, 2015, CAN ENTOMOL, V147, P737, DOI 10.4039/tce.2015.5; Fonseca DM, 2010, MOL ECOL, V19, P1559, DOI 10.1111/j.1365-294X.2010.04576.x; Fonseca DM, 2001, J MED ENTOMOL, V38, P135, DOI 10.1603/0022-2585-38.2.135; Gallitano S, 2005, J VECTOR ECOL, V30, P347; Gillani Waqar, 2018, NEWS SUNDAY 0603; Gjenero-Margan I, 2011, EUR COMMUN DIS B, V16; Gutsevich AV, 1971, FAMILY CULICIDAE, V4/3; Harris MC, 2015, EMERG INFECT DIS, V21, P646, DOI 10.3201/eid2104.140734; Huber K, 2012, J VECTOR ECOL, V37, P462, DOI 10.1111/j.1948-7134.2012.00252.x; Jackson M, 2016, J MED ENTOMOL, V53, P241, DOI 10.1093/jme/tjv164; Janssen N, 2019, PARASITOL RES, V118, P2475, DOI 10.1007/s00436-019-06376-w; Kalan K, 2017, J MED ENTOMOL, V54, P1510, DOI 10.1093/jme/tjx150; Kampen H., 2018, Mosquito-borne diseases: implications for public health, P41; Kampen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167948; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Klobuar A, 2019, MED VET ENTOMOL, V33, P161; Koban MB, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3349-3; Larish LB, 2005, J AM MOSQUITO CONTR, V21, P318, DOI 10.2987/8756-971X(2005)21[318:IAEOAF]2.0.CO;2; Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103; Merdic E, 2003, PERIOD BIOL, V105, P181; Merdic E, 2013, COLLEGIUM ANTROPOL, V37, P943; Munstermann LE., 1999, VECTOR ECOL NEWSL, V30, P7; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238; Pritchard JK, 2000, GENETICS, V155, P945; Riles MT, 2017, J AM MOSQUITO CONTR, V33, P340, DOI 10.2987/17-6696.1; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x; Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141; Scott JJ, 2001, J AM MOSQUITO CONTR, V17, P142; Scott JJ, 1999, VECTOR ECOL NEWSL, V30, P6; TAKASHIMA I, 1989, J MED ENTOMOL, V26, P454, DOI 10.1093/jmedent/26.5.454; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Turell MJ, 2013, J AM MOSQUITO CONTR, V29, P133, DOI 10.2987/12-6316r.1; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1; Wagner S, 2018, MED VET ENTOMOL, V32, P121, DOI 10.1111/mve.12273; Widdel AK, 2005, AM J TROP MED HYG, V73, P744, DOI 10.4269/ajtmh.2005.73.744; Yang F, 2018, EMERG INFECT DIS, V24, P553, DOI 10.3201/eid2403.161275; Zielke DE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1447-z; Zielke DE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0648-1; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	58	10	11	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241235	10.1371/journal.pone.0241235	http://dx.doi.org/10.1371/journal.pone.0241235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119650	gold, Green Published			2022-12-26	WOS:000600013600063
J	Nowling, RJ; Manke, KR; Emrich, SJ				Nowling, Ronald J.; Manke, Krystal R.; Emrich, Scott J.			Detecting inversions with PCA in the presence of population structure	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; CHROMOSOMAL INVERSIONS; GENOMIC DIVERGENCE; IDENTIFICATION; ASSOCIATION; BREAKPOINTS; ECOTYPES; ARRAY	Chromosomal inversions can lead to reproductive isolation and adaptation in insects such as Drosophila melanogaster and the non-model malaria vector Anopheles gambiae. Inversions can be detected and characterized using principal component analysis (PCA) of single nucleotide polymorphisms (SNPs). To aid in developing such methods, we formed a new benchmark derived from three publicly-available insect data. We then used this benchmark to perform an extended validation of our software for inversion analysis (Asaph). Through that process, we identified and characterized several problematic test cases liable to misinterpretation that can help guide PCA-based inversion detection. Lastly, we re-analyzed the 2R chromosome arm of 150 An. gambiae and coluzzii samples and observed two inversions (2Rc and 2Rd) that were previously known but not annotated in these particular individuals. The resulting benchmark data set and methods will be useful for future inversion detection based solely on SNP data.	[Nowling, Ronald J.] Milwaukee Sch Engn, Elect Engn & Comp Sci, Milwaukee, WI 53202 USA; [Manke, Krystal R.] Milwaukee Sch Engn, Phys & Chem, Milwaukee, WI USA; [Emrich, Scott J.] Univ Tennessee, Elect Engn & Comp Sci, Knoxville, TN USA	Milwaukee School Engineering; Milwaukee School Engineering; University of Tennessee System; University of Tennessee Knoxville	Nowling, RJ (corresponding author), Milwaukee Sch Engn, Elect Engn & Comp Sci, Milwaukee, WI 53202 USA.	nowling@msoe.edu		Emrich, Scott/0000-0002-5741-4517	National Science Foundation [1947257]	National Science Foundation(National Science Foundation (NSF))	RJN was supported by the National Science Foundation under Grant No. 1947257.	al Basatena NKS, 2013, GENETICS, V193, P243, DOI 10.1534/genetics.112.145599; Ayala D, 2019, MOL ECOL, V28, P1333, DOI 10.1111/mec.14880; Ayala D, 2017, EVOLUTION, V71, P686, DOI 10.1111/evo.13176; Bayoh MN, 2001, MED VET ENTOMOL, V15, P267, DOI 10.1046/j.0269-283x.2001.00298.x; Berg PR, 2017, HEREDITY, V119, P418, DOI 10.1038/hdy.2017.54; Berg PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23246; Caceres A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv073; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Caputo B, 2014, MOL ECOL, V23, P4574, DOI 10.1111/mec.12866; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Clucas GV, 2019, EVOL APPL, V12, P1971, DOI 10.1111/eva.12861; Corbett-Detig RB, 2019, GENETICS, V213, P1495, DOI 10.1534/genetics.119.302385; Corbett-Detig RB, 2012, GENETICS, V192, P131, DOI 10.1534/genetics.112.141622; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; da Silva VH, 2019, GENOME BIOL EVOL, V11, P1870, DOI 10.1093/gbe/evz106; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Fontaine MC, 2014, DATA EXTENSIVE INTRO; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Fuller ZL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007526; George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x; Giner-Delgado C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12173-x; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Huang K, 2020, MOL ECOL, V29, P2535, DOI 10.1111/mec.15428; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kess T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2461; Knief U, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1056-3; Lee C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S73; Lobo NF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-293; Love RR, 2020, G3-GENES GENOM GENET, V10, P3299, DOI 10.1534/g3.120.401418; Love RR, 2019, G3-GENES GENOM GENET, V9, P3249, DOI 10.1534/g3.119.400445; Love RR, 2016, MOL ECOL, V25, P5889, DOI 10.1111/mec.13888; Luu K, 2017, MOL ECOL RESOUR, V17, P67, DOI 10.1111/1755-0998.12592; Ma JZ, 2014, HUM GENET, V133, P967, DOI 10.1007/s00439-014-1437-1; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040224; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Main BJ, 2015, MOL ECOL, V24, P5145, DOI 10.1111/mec.13382; Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Noor MAF, 2007, GENETICS, V177, P1417, DOI 10.1534/genetics.107.070672; Nowling RJ, 2018, ACM-BCB'18: PROCEEDINGS OF THE 2018 ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, P270, DOI 10.1145/3233547.3233571; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; PREVOSTI A, 1988, P NATL ACAD SCI USA, V85, P5597, DOI 10.1073/pnas.85.15.5597; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PRIVE F, 2020, MOL BIOL EVOL; Puncher GN, 2019, FISH RES, V216, P29, DOI 10.1016/j.fishres.2019.03.020; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riehle MM, 2017, ELIFE, V6, DOI [10.7554/eLife.25813, 10.7554/elife.25813]; Rocca KAC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-147; Ruiz-Arenas C, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008203; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Sinclair-Waters M, 2018, MOL ECOL, V27, P339, DOI 10.1111/mec.14442; Sindi SS, 2010, J COMPUT BIOL, V17, P517, DOI 10.1089/cmb.2009.0185; Sodeland M, 2016, GENOME BIOL EVOL, V8, P1012, DOI 10.1093/gbe/evw057; Suzuki T, 2014, J HUM GENET, V59, P649, DOI 10.1038/jhg.2014.88; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zhu SL, 2018, IEEE INT C BIOINFORM, P254, DOI 10.1109/BIBM.2018.8621190; Zhu S, 2017, IEEE INT C BIOINFORM, P237	64	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240429	10.1371/journal.pone.0240429	http://dx.doi.org/10.1371/journal.pone.0240429			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119626	Green Submitted, gold, Green Published			2022-12-26	WOS:000600013600014
J	da Silva, WO; Rosa, CC; Pieczarka, JC; Ferguson-Smith, MA; O'Brien, PCM; Mendes-Oliveira, AC; Rossi, RV; Nagamachi, CY				Oliveira da Silva, Willam; Rosa, Celina Coelho; Pieczarka, Julio Cesar; Ferguson-Smith, Malcolm Andrew; O'Brien, Patricia Caroline Mary; Mendes-Oliveira, Ana Cristina; Rossi, Rogerio Vieira; Nagamachi, Cleusa Yoshiko			Karyotypic divergence reveals that diversity in the Oecomys paricola complex (Rodentia, Sigmodontinae) from eastern Amazonia is higher than previously thought	PLOS ONE			English	Article							CHROMOSOMAL REARRANGEMENTS; EVOLUTION; SPECIATION; MAMMALS; GENUS	The genus Oecomys (Rodentia, Sigmodontinae) is distributed from southern Central America to southeastern Brazil in South America. It currently comprises 18 species, but multidisciplinary approaches such as karyotypic, morphological and molecular studies have shown that there is a greater diversity within some lineages than others. In particular, it has been proposed that O. paricola constitutes a species complex with three evolutionary units, which have been called the northern, eastern and western clades. Aiming to clarify the taxonomic status of O. paricola and determine the relevant chromosomal rearrangements, we investigated the karyotypes of samples from eastern Amazonia by chromosomal banding and FISH with Hylaeamys megacephalus (HME) whole-chromosome probes. We detected three cytotypes for O. paricola: A (OPA-A; 2n = 72, FN = 75), B (OPA-B; 2n = 70, FN = 75) and C (OPA-C; 2n = 70, FN = 72). Comparative chromosome painting showed that fusions/fissions, translocations and pericentric inversions or centromeric repositioning were responsible for the karyotypic divergence. We also detected exclusive chromosomal signatures that can be used as phylogenetic markers. Our analysis of karyotypic and distribution information indicates that OPA-A, OPA-B and OPA-C are three distinct species that belong to the eastern clade, with sympatry occurring between two of them, and that the "paricola group" is more diverse than was previously thought.	[Oliveira da Silva, Willam; Rosa, Celina Coelho; Pieczarka, Julio Cesar; Nagamachi, Cleusa Yoshiko] Univ Fed Para UFPA, Inst Ciencias Biol, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil; [Ferguson-Smith, Malcolm Andrew; O'Brien, Patricia Caroline Mary] Univ Cambridge, Dept Vet Med, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Mendes-Oliveira, Ana Cristina] Univ Fed Para UFPA, Inst Ciencias Biol, Lab Ecol & Zool Vertebrados, Belem, Para, Brazil; [Rossi, Rogerio Vieira] Univ Fed Mato Grosso UFMT, Inst Biociencias, Dept Biol & Zool, Cuiaba, MG, Brazil	Universidade Federal do Para; University of Cambridge; Universidade Federal do Para; Universidade Federal de Mato Grosso do Sul	Nagamachi, CY (corresponding author), Univ Fed Para UFPA, Inst Ciencias Biol, Ctr Estudos Avancados Biodiversidade, Lab Citogenet, Belem, Para, Brazil.	cleusanagamachi@gmail.com	Nagamachi, Cleusa/AAV-8985-2021; Pieczarka, Julio C/E-7585-2016; Rossi, Rogerio V/I-2176-2015; de Oliveira, Ana Cristina Mendes/I-2680-2012	Pieczarka, Julio C/0000-0003-2951-8877; Oliveira da Silva, Willam/0000-0003-3125-1075; Vieira Rossi, Rogerio/0000-0003-2353-5000; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552032/2010-7, 305880/2017-9, 305876/2017-1]; Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA) [ICAAF 007/2011, 2010/110447]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [047/2012]; Banco Nacional de Desenvolvimento Economico e Social (BNDES) [2.318.697.0001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Banco Nacional de Desenvolvimento Economico e Social (BNDES)	CYN 552032/2010-7 Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq), www.cnpq.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CYN 305880/2017-9 Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq), www.cnpq.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CYN ICAAF 007/2011 Fundacao Amazonia Paraense de Amparo a Pesquisa (FAPESPA), http://www.fapespa.pa.gov.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CYN 047/2012 Coordenac comma ao de Aperfeic comma oamento de Pessoal de Ni ' vel Superior (CAPES), https://www.capes.gov.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript JCP 2010/110447 Fundac commaao Amazo<^> nia Paraense de Amparo a Pesquisa (FAPESPA), http://www.fapespa.pa.gov.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript JCP 2.318.697.0001 Banco Nacional de Desenvolvimento Econo<^>mico e Social (BNDES) https://www.bndes.gov.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript JCP 305876/2017-1 Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq), www.cnpq.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral D.D., 2009, B MUSEU PARAENSE EMI, V4, P231, DOI DOI 10.1590/S1981-81222009000200002; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Azevedo NF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-36; da Silva WO, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40593-8; da Silva WO, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1515-z; dos Santos M, 2015, ACTA AMAZON, V45, P187, DOI 10.1590/1809-4392201401953; Engelbrecht A, 2011, CYTOGENET GENOME RES, V133, P8, DOI 10.1159/000323416; FORD CE, 1956, STAIN TECHNOL, V31, P247, DOI 10.3109/10520295609113814; George TK., 1988, BRASIL FLORESTAL, V63, P33; Gilmour JSL, 1939, NATURE, V144, P333, DOI 10.1038/144333a0; Graphodatsky A, 2012, CYTOGENET GENOME RES, V137, P83, DOI 10.1159/000341502; Hijmans RJ, 2004, DIVA GIS VSN 50 GEOG; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Kasahara S., 2009, INTRODUCAO PESQUISA; KING M, 1987, HEREDITY, V59, P1, DOI 10.1038/hdy.1987.90; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Malcher SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181434; Mao XG, 2008, CHROMOSOME RES, V16, P155, DOI 10.1007/s10577-007-1206-2; MORIELLEVERSUTE E, 1995, BRAZ J GENET, V18, P503; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Oliveira da Silva W, 2020, INT J MOL SCI, V21, P2415, DOI 10.3390/ijms21072415; Pardinas UFJ, 2016, J MAMMAL, V97, P1177, DOI 10.1093/jmammal/gyw070; Patton J.L., 2015, RODENTS, V2, P384; PATTON JL, 1983, ANNU REV ECOL SYST, V14, P139, DOI 10.1146/annurev.es.14.110183.001035; Pereira AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146179; Perelman PL, 2012, CYTOGENET GENOME RES, V137, P174, DOI 10.1159/000341389; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rocchi M, 2012, HEREDITY, V108, P59, DOI 10.1038/hdy.2011.101; Rocha RG, 2014, ECOL EVOL, V4, P4598, DOI 10.1002/ece3.1336; Romanenko SA, 2012, CYTOGENET GENOME RES, V137, P233, DOI 10.1159/000339294; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184466; Rosa CC, 2012, J GENET, V91, P265, DOI 10.1007/s12041-012-0182-2; Saldanha J, 2019, MAMM BIOL, V97, P41, DOI 10.1016/j.mambio.2019.04.009; SCHERTHAN H, 1994, NAT GENET, V6, P342, DOI 10.1038/ng0494-342; Silva J.M.C., 2005, MEGADIVERSIDADE, V1, P124; Suarez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143482; Suarez-Villota EY, 2016, J MAMMAL, V97, P1177, DOI 10.1093/jmammal/gyw070; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Taylor PJ, 2000, J MAMMAL, V81, P317, DOI 10.1644/1545-1542(2000)081<0317:POCVIS>2.0.CO;2; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Tian Y, 2004, CHROMOSOME RES, V12, P55, DOI 10.1023/B:CHRO.0000009299.59969.fa; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241495	10.1371/journal.pone.0241495	http://dx.doi.org/10.1371/journal.pone.0241495			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119689	Green Published, gold			2022-12-26	WOS:000600013600018
J	Al-Khalil, O; Valeri, F; Senn, O; Rosemann, T; Di Gangi, S				Al-Khalil, Omar; Valeri, Fabio; Senn, Oliver; Rosemann, Thomas; Di Gangi, Stefania			Effects of a DRG-based hospital reimbursement on the health care utilization and costs in Swiss primary care: A retrospective "quasi-experimental" analysis	PLOS ONE			English	Article							PAYMENT; DESIGNS; SERIES	Introduction In Switzerland, a nationwide Swiss Diagnosis related Groups (Swiss DRG) system for hospital reimbursement was introduced in 2012. However, the impact of DRG systems on primary care is still unclear with respect to number of consultations and costs. The aim of this study was to investigate the effect of the implementation of DRG on costs and volumes in the primary care sector, on a nationwide basis in Switzerland. Methods The study retrospectively analysed yearly data, from 2008 to 2014, of almost 60 Swiss health insurers that covered almost all Swiss general practitioners, with a total number of patients which represented approximately 76% of the Swiss population. GP consultations, total numbers and rates, and the relative costs reimbursed (TARMED tariff values) in the Swiss federal states, cantons, which already introduced a DRG-like system before 2012 (AP-DRG), were compared to the GP consultations and costs reimbursed in the other cantons (DRG-naive). Regression discontinuity design analysis and mixed regression models, at cantonal level, were performed to evaluate the effect of the nationwide implementation of the Swiss DRG on health care demand and costs in the primary care setting. Change in outcome level and yearly trend pattern difference between groups (AP-DRG vs. DRG-naive) were examined. Results Overall, the total number of GP consultations and the relative TARMED values increased from 2008 to 2014. In the DRG naive, 15 cantons: in 2008, the number of GP consultations were 13,114,126, with a TARMED value of 1,194,957,157 CHF, and in 2014, the GP consultation were 13,752,511, with a TARMED value of 1,513,861,260 CHF. In the AP-DRG group, 11 cantons, the total number of GP consultations increased from 8,787,646, in 2008, to 9,347,168 in 2014 and the TARMED value increased from 896,673,657 CHF in 2008, to 1,100,203,508 CHF in 2014. The yearly trend pattern of GP consultations and TARMED values, in the AP-DRG group, were not significantly different from the respective trends in the DRG- naive and, overall, no significant change was detected in consultations and costs trends before and after 2012. Discussion/Conclusion This study found no evidence of any effect of the introduction of the SwissDRG on the yearly trend of primary care consultations and costs. Nevertheless, potential negative impacts on vulnerable patients, as chronically ill patients, could not be excluded and further investigation is required.	[Al-Khalil, Omar; Valeri, Fabio; Senn, Oliver; Rosemann, Thomas; Di Gangi, Stefania] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Al-Khalil, Omar; Valeri, Fabio; Senn, Oliver; Rosemann, Thomas; Di Gangi, Stefania] Univ Hosp Zurich, Zurich, Switzerland; [Al-Khalil, Omar] Univ Bern, Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Al-Khalil, O (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.; Al-Khalil, O (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.; Al-Khalil, O (corresponding author), Univ Bern, Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland.	omar.al-khalil@insel.ch		Di Gangi, Stefania/0000-0002-2847-6399				[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2010, EINFUHRUNG LEISTUNGS; [Anonymous], 2006, BER GES; Barnighausen T, 2017, J CLIN EPIDEMIOL, V89, P21, DOI 10.1016/j.jclinepi.2017.03.012; Bocking W, 2005, J PUBLIC HEALTH-HEID, V13, P128, DOI 10.1007/s10389-005-0103-4; Busato A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-31; Busse R., EUROPEAN OBSERVATORY; Busse R, 2013, BMJ BRIT MED J, V346, DOI 10.1136/bmj.f3197; Cassell A, 2018, BRIT J GEN PRACT, V68, pE245, DOI 10.3399/bjgp18X695465; Chanturidze T, 2016, HEALTH POLICY, V120, P987, DOI 10.1016/j.healthpol.2016.07.007; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; DESHARNAIS S, 1991, EVAL HEALTH PROF, V14, P228, DOI 10.1177/016327879101400206; Fassler M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14080; Fischer W, 2008, DRG FAMILIE CH 9116; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Imbens G, 2012, REV ECON STUD, V79, P933, DOI 10.1093/restud/rdr043; Insa K, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14575; 김성화, 2015, [JOURNAL OF THE KOREAN HOUSING ASSOCIATION, 한국주거학회논문집], V26, P1, DOI 10.6107/JKHA.2015.26.1.001; Kone I, 2019, INT J HEALTH PLAN M, V34, P56, DOI 10.1002/hpm.2669; Kutz A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.8332; Lee C, 2019, ASIA-PAC J PUBLIC HE, V31, P499, DOI 10.1177/1010539519872325; Leu A, 2018, HEALTH POLICY, V122, P577, DOI 10.1016/j.healthpol.2018.03.001; Moscoe E, 2015, J CLIN EPIDEMIOL, V68, P132, DOI 10.1016/j.jclinepi.2014.06.021; Mukhtar TK, 2018, BRIT J GEN PRACT, V68, pE370, DOI 10.3399/bjgp18X695981; OECD health statistics, 2018, OECD HLTH STAT HLTH; Or Z, 2014, HEALTH POLICY, V117, P146, DOI 10.1016/j.healthpol.2014.05.006; Rachamin Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227280; Thommen D, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13972; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wangmo T, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4220-0; Wasserfallen JB, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14097	33	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241179	10.1371/journal.pone.0241179	http://dx.doi.org/10.1371/journal.pone.0241179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108373	Green Accepted, Green Published, gold			2022-12-26	WOS:000588372400035
J	Frimer, JA; Skitka, LJ				Frimer, Jeremy A.; Skitka, Linda J.			Are politically diverse Thanksgiving dinners shorter than politically uniform ones?	PLOS ONE			English	Article							PARTISANSHIP; EXPOSURE	Americans on the political left and right are engaged in a Culture War with one another, one that is often characterized by mutual fear, antipathy, and avoidance. Are there safe havens from the socially straining effects of this Culture War, times and places where Americans of different political stripes gather and put aside their political differences? Previous research (Chen & Rohla, 2018) implied that there might not be insofar as even intimate family gatherings seem to be subject to Culture War tensions. They found that politically diverse Thanksgiving Dinners were 35-70 minutes shorter than politically uniform ones, representing a 14-27% reduction in overall dinner duration. Noting analytical and methodological limitations in the prior analysis, we conducted two pre-registered studies to test whether diverse dinners are shorter than uniform ones and to attempt to conceptually replicate and extend this prior analysis. Individual analyses yielded mixed results, with null models generally supported but effect estimates generally overlapping with those of Chen and Rohla (2018). A mega-analysis found that, when controlling for various covariates, politically diverse dinners were 24 minutes shorter than politically uniform ones, 95% confidence interval = [9, 39], representing a 6% decrease in the total dinner time [2%-10%]. This final result successfully replicates Chen and Rohla (2018) both in terms of effect overlap and direct-and-significance criteria while nonetheless favoring the conclusion that politics is not straining family ties as much as previously thought.	[Frimer, Jeremy A.] Univ Winnipeg, Dept Psychol, Winnipeg, MB, Canada; [Skitka, Linda J.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA	University of Winnipeg; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frimer, JA (corresponding author), Univ Winnipeg, Dept Psychol, Winnipeg, MB, Canada.	j.frimer@uwinniped.ca		Frimer, Jeremy/0000-0003-4811-0199	Social Sciences and Humanities Research Council of Canada (SSHRC) Insight Grant [IG 435-2018-1221]	Social Sciences and Humanities Research Council of Canada (SSHRC) Insight Grant(Social Sciences and Humanities Research Council of Canada (SSHRC))	Social Sciences and Humanities Research Council of Canada (SSHRC) Insight Grant (IG 435-2018-1221) to JAF. https://www.sshrccrsh.gc.ca/home-accueil-eng.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beyond Conflict, 2020, AM DIV MIND; Buchanan Patrick, 1992, 1992 REPUBLICAN NATL; Chen MK, 2018, SCIENCE, V360, P1020, DOI 10.1126/science.aaq1433; Clinical research, 2018, BMJ, V360, pk694; Dorison CA, 2019, COGNITION, V188, P98, DOI 10.1016/j.cognition.2019.02.010; Echterhoff G, 2009, PERSPECT PSYCHOL SCI, V4, P496, DOI 10.1111/j.1745-6924.2009.01161.x; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Frimer JA, 2020, J EXP SOC PSYCHOL, V86, DOI 10.1016/j.jesp.2019.103907; Frimer JA, 2018, J PERS SOC PSYCHOL, V115, P845, DOI 10.1037/pspi0000140; Frimer JA, 2017, J EXP SOC PSYCHOL, V72, P1, DOI 10.1016/j.jesp.2017.04.003; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; Hunter J. D., 1991, CULTURE WARS STRUGGL; Iyengar S, 2015, AM J POLIT SCI, V59, P690, DOI 10.1111/ajps.12152; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; McConnell C, 2018, AM J POLIT SCI, V62, P5, DOI 10.1111/ajps.12330; MILL JS, 1884, SYSTEM LOGIC RATIOCI; Motyl M, 2014, J EXP SOC PSYCHOL, V51, P1, DOI 10.1016/j.jesp.2013.10.010; Pew Research Center, 2016, PARTISANSHIP POLITIC; Pew Research Center, 2019, PART ANT MOR PERS; Reuters, 2018, REUTERS; Travis County, 2016, PREC RES TRAV COUNT; Wallace Gregory, 2016, VOTER TURNOUT 20 YEA; Webb TL, 2013, SOC PERSONAL PSYCHOL, V7, P794, DOI 10.1111/spc3.12071	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0239988	10.1371/journal.pone.0239988	http://dx.doi.org/10.1371/journal.pone.0239988			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108382	Green Published, gold			2022-12-26	WOS:000588372400021
J	Mekonnen, AG; Bayleyegn, AD; Aynalem, YA; Adane, TD; Muluneh, MA; Zeru, AB				Mekonnen, Alemayehu Gonie; Bayleyegn, Alebachew Demelash; Aynalem, Yared Asmare; Adane, Tigist Demssew; Muluneh, Mikyas Arega; Zeru, Abayneh Birlie			Determinants of knowledge, attitudes, and practices in relation to HIV/AIDS and other STIs among people with disabilities in North-Shewa zone, Ethiopia	PLOS ONE			English	Article							HEALTH; HIV	Introduction People with disabilities face socioeconomic disadvantages and they have limited access to sexual and reproductive health information. They are highly vulnerable to sexual abuse which places them at increased risk of HIV and STI infection. At present, however, little is known about the knowledge, attitude and practice of sexually transmitted diseases including HIV/AIDS and other STIs in Ethiopia. This study aimed to identify which individual factors best predict knowledge, attitudes, and practices in relation to HIV/AIDS and other STIs among people with disabilities in North-shewa zone, Ethiopia. Methods A cross-sectional study was conducted from June to October 2019. A total of 397 respondents were interviewed using a structured and pre-tested questionnaire. A systematic sampling technique was employed to select the respondents. Logistic regression was performed to analyze the data. A significant association was declared at a p-value of less than 0.05. Results Nearly half of the study participants were knowledgeable in relation to HIV/AIDS (47.3%) and STIs (46.9%). Sixty-two percent of respondents had good attitude towards evidence of HIV/AIDS while sixty-nine percent of participants had good attitude towards helpful facts of STIs. Twenty-three percent of study participants had been ever tested for HIV infections. Being married (AOR = 2.23; 95% CI = 1.92, 10.72) was associated with having good knowledge of STI. Males were 1.6 times more knowledgeable about HIV/AIDS than females (AOR = 1.60; 95% CI = 1.21, 9.12). Conclusions In this study, knowledge, attitudes, and practices of people with disabilities in relation to HIV/AIDS and other STIs were relatively low. This is clear evidence that HIV programs need to ensure that people with disabilities can access basic knowledge about HIV/AIDS and STIs.	[Mekonnen, Alemayehu Gonie; Bayleyegn, Alebachew Demelash; Aynalem, Yared Asmare; Adane, Tigist Demssew] Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Amhara Regional, Ethiopia; [Muluneh, Mikyas Arega] Debre Berhan Univ, Coll Hlth Sci, Dept Midwifery, Debre Berhan, Amhara Regional, Ethiopia; [Zeru, Abayneh Birlie] Debre Berhan Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Berhan, Amhara Regional, Ethiopia		Mekonnen, AG (corresponding author), Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Amhara Regional, Ethiopia.	alemayehugonie19@gmail.com		Adane, Tigist Demssew/0000-0003-2665-9703	Debre Berhan University, Ethiopia	Debre Berhan University, Ethiopia	The financial grants to carry out this study was obtained from Debre Berhan University, Ethiopia. The funding university does not have any role in the design of the study, data collection, analysis and interpretation of data, and in writing the manuscript.	Abdul R, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3138-1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alemu Tigist, 2011, Ethiop Med J, V49, P97; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2011, WORLD REP DIS; Baart J., 2018, DISABILITY CBR INCLU, V28, P26, DOI [10.5463/dcid.v28i4.656, DOI 10.5463/DCID.V28I4.656, DOI 10.5463/DCID.V29I4.656]; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; De Beaudrap P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008934; DeBeaudrap P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030417; Araujo AKF, 2015, REV RENE, V16, P738, DOI 10.15253/2175-6783.2015000500016; Frohmader C, 2014, ICPD INT C POP DEV 2; Gemeda TT, 2017, AFR J REPROD HEALTH, V21, P49, DOI 10.29063/ajrh2017/v21i3.4; Groce NE, 2013, SOC SCI MED, V77, P31, DOI 10.1016/j.socscimed.2012.10.024; Hanass-Hancock J, 2015, DISABIL REHABIL, V37, P2012, DOI 10.3109/09638288.2014.991455; Kassa TA, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0142-3; Kibret GD, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0594-9; Moono G., 2018, DISABIL REHABIL, P1; Ngilangwa DP, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.10922; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Obasi M, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.299.18546; Officer A, 2013, J POLICY PRACT INTEL, V10, P86, DOI 10.1111/jppi.12031; Oljira L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17349; Tun W, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20829; UNAIDS, 2012, UNAIDS STRAT INT DIS; Yousafzai AK, 2004, INT J REHABIL RES, V27, P247, DOI 10.1097/00004356-200409000-00012	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241312	10.1371/journal.pone.0241312	http://dx.doi.org/10.1371/journal.pone.0241312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108410	Green Published, gold			2022-12-26	WOS:000588372400032
J	Choe, MS; Kim, JS; Yeo, HC; Bae, CM; Han, HJ; Baek, K; Chang, W; Lim, KS; Yun, SP; Shin, IS; Lee, MY				Choe, Mu Seog; Kim, Joong Sun; Yeo, Han Cheol; Bae, Chang Min; Han, Ho Jae; Baek, Kyungmin; Chang, Woochul; Lim, Kyung Seob; Yun, Seung Pil; Shin, In-Sik; Lee, Min Young			A simple metastatic brain cancer model using human embryonic stem cell-derived cerebral organoids	FASEB JOURNAL			English	Article						brain metastasis; lung cancer; MBCCO model	EXTRACELLULAR-MATRIX; LUNG-CANCER; 3RD-DIMENSION; CULTURE; GAP	Every year, hundreds of thousands of people die because of metastatic brain cancer. Most metastatic cancer research uses 2D cell culture or animal models, but they have a few limitations, such as difficulty reproducing human tissue structures. This study developed a simple 3D in vitro model to better replicate brain metastasis using human cancer cells and human embryonic stem cell-derived cerebral organoids (metastatic brain cancer cerebral organoid [MBCCO]). The MBCCO model successfully reproduced metastatic cancer processes, including cell adhesion, proliferation, and migration, in addition to cell-cell interactions. Using the MBCCO model, we demonstrated that lung-specific X protein (LUNX) plays an important role in cell proliferation and migration or invasion. We also observed astrocyte accumulation around and their interaction with cancer cells through connexin 43 in the MBCCO model. We analyzed whether the MBCCO model can be used to screen drugs by measuring the effects of gefitinib, a well-known anticancer agent. We also examined the toxicity of gefitinib using normal cerebral organoids (COs). Therefore, the MBCCO model is a powerful tool for modeling human metastatic brain cancer in vitro and can also be used to screen drugs.	[Choe, Mu Seog; Yeo, Han Cheol; Bae, Chang Min; Lee, Min Young] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Coll Pharm, Vessel Organ Interact Res Ctr MRC, Daegu, South Korea; [Kim, Joong Sun] Korea Inst Oriental Med, K Herb Res Ctr, Daejeon, South Korea; [Han, Ho Jae] Seoul Natl Univ, Dept Vet Physiol, Coll Vet Med, Seoul, South Korea; [Baek, Kyungmin] Daegu Haany Univ, Dept Cardiovasc & Neurol Dis, Coll Oriental Med, Daegu, South Korea; [Chang, Woochul] Pusan Natl Univ, Dept Biol Educ, Coll Educ, Busan, South Korea; [Lim, Kyung Seob] Korea Res Inst Biosci & Biotechnol, Futurist Anim Resource & Res Ctr, Cheongju, South Korea; [Yun, Seung Pil] Gyeongsang Natl Univ, Sch Med, Dept Pharmacol, Jinju, South Korea; [Shin, In-Sik] Chonnam Natl Univ, Dept Vet Pharmacol, Coll Vet Med, BK21 Project Team, Gwangju, South Korea	Kyungpook National University; Korea Institute of Oriental Medicine (KIOM); Seoul National University (SNU); Daegu Haany University; Pusan National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Gyeongsang National University; Chonnam National University	Lee, MY (corresponding author), Kyungpook Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Daegu, South Korea.	vetmedic@knu.ac.kr		Chang, Woochul/0000-0001-7367-2586	National Research Foundation of Korea [2018R1D1A1A02044017, NRF-2020R1A5A2017323]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: 2018R1D1A1A02044017 and NRF-2020R1A5A2017323	Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Fan YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25062; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Heiland DH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10493-6; Hickman JA, 2014, BIOTECHNOL J, V9, P1115, DOI 10.1002/biot.201300492; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Laubli H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02120; Lee JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55150-6; Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017; Lin CM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00307; Lin J, 2015, ONCOLOGY-NY, V29, P250; Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; O'Brien ER, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00040; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; Placone AL, 2016, TUMOR BIOL, V37, P61, DOI 10.1007/s13277-015-4242-0; Qian XY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166074; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Shi L, 2014, LUNG CANCER, V83, P231, DOI 10.1016/j.lungcan.2013.11.016; Sutcliffe M, 2019, METHODS MOL BIOL, V1576, P1, DOI 10.1007/7651_2017_2; Theis M, 2012, BRAIN RES, V1487, P88, DOI 10.1016/j.brainres.2012.06.045; Tuveson D, 2019, SCIENCE, V364, P952, DOI 10.1126/science.aaw6985; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zheng XH, 2015, CANCER RES, V75, P1080, DOI 10.1158/0008-5472.CAN-14-1831	34	9	9	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16464	16475		10.1096/fj.202000372R	http://dx.doi.org/10.1096/fj.202000372R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33099835				2022-12-26	WOS:000583915500001
J	Chen, J; Xuan, ZF; Song, WF; Han, WL; Chen, H; Du, YH; Xie, HY; Zhao, YC; Zheng, SS; Song, PH				Chen, Jun; Xuan, Zefeng; Song, Wenfeng; Han, Weili; Chen, Hao; Du, Yehui; Xie, Haiyang; Zhao, Yongchao; Zheng, Shusen; Song, Penghong			EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation	ONCOGENE			English	Article							UBIQUITIN; ASTEMIZOLE; PATHWAY; INVOLVEMENT; PROGRESSION; EXPRESSION; CHANNELS	Ether-a-go-go-1 (EAG1), one of the potassium channels, is involved in various physiological processes and plays an important role in the tumorigenesis of many kinds of cancer. EAG1 is highly expressed in hepatocarcinoma cells and is closely related to clinical prognosis, but the molecular mechanism remains elusive. In this study, we verified that EAG1 promotes the proliferation of hepatocellular carcinoma (HCC) both in vitro and in vivo. It promotes cell cycle progression by inhibiting the ubiquitination of SKP2. In addition, EAG1 promotes the migration and invasion of HCC by promoting cell pseudopod formation. Furthermore, in a high-pressure plasmid-injected mouse liver orthotopic carcinoma model, astemizole, an EAG family blocker, can significantly inhibit the formation of liver cancer. Meanwhile, liver-specific EAG1 knockout mice show resistance to hepatocarcinogenesis. This research demonstrated that EAG1 plays an important role in the progression of HCC, and could be a potential therapeutic target for HCC.	[Chen, Jun; Xuan, Zefeng; Song, Wenfeng; Chen, Hao; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Zhejiang Univ, Sch Med, Div Hepatobiliary & Pancreat Surg, Dept Surg,Affiliated Hosp 1, Hangzhou, Peoples R China; [Chen, Jun; Xuan, Zefeng; Song, Wenfeng; Chen, Hao; Xie, Haiyang; Zhao, Yongchao; Zheng, Shusen; Song, Penghong] NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China; [Chen, Jun; Xuan, Zefeng; Song, Wenfeng; Chen, Hao; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Chinese Acad Med Sci, Key Lab Diag & Treatment Organ Transplantat, Res Unit Collaborat Diag & Treatment Hepatobiliar, 2019RU019, Hangzhou, Peoples R China; [Chen, Jun; Xuan, Zefeng; Song, Wenfeng; Chen, Hao; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Res Ctr Diag & Treatment Hepatobiliary Dis, Key Lab Organ Transplantat, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun; Han, Weili; Chen, Hao] Zhejiang Univ, Sch Med, Dept Lung Transplantat, Affiliated Hosp 1, Hangzhou, Peoples R China; [Xuan, Zefeng] Zhejiang Univ, Sch Med, Div Breast Surg, Dept Surg,Affiliated Hosp 1, Hangzhou, Peoples R China; [Du, Yehui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Thyroid Dis Diag & Treatment Ctr, Hangzhou, Peoples R China; [Zhao, Yongchao] Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310029, Peoples R China	Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS; Song, PH (corresponding author), Zhejiang Univ, Sch Med, Div Hepatobiliary & Pancreat Surg, Dept Surg,Affiliated Hosp 1, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), Chinese Acad Med Sci, Key Lab Diag & Treatment Organ Transplantat, Res Unit Collaborat Diag & Treatment Hepatobiliar, 2019RU019, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), Res Ctr Diag & Treatment Hepatobiliary Dis, Key Lab Organ Transplantat, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn; songpenghong@zju.edu.cn			National Natural Science Foundation of China [81272675, 81870434]; Key Research and Development Plan of Zhejiang Province [2020C04003]; National ST Major Project [2017ZX10203205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan of Zhejiang Province; National ST Major Project	This work was supported by the National Natural Science Foundation of China (81272675 and 81870434) to PS, the Key Research and Development Plan of Zhejiang Province (2020C04003) to PS, the National S&T Major Project (2017ZX10203205) to SZ.	Bertuccio P, 2017, J HEPATOL, V67, P302, DOI 10.1016/j.jhep.2017.03.011; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen TP, 2007, GYNECOL ONCOL, V104, P516, DOI 10.1016/j.ygyno.2006.09.015; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Chavez-Lopez MD, 2015, TUMOR BIOL, V36, P6149, DOI 10.1007/s13277-015-3299-0; Chavez-Lopez MD, 2014, INT J GYNECOL CANCER, V24, P824, DOI 10.1097/IGC.0000000000000151; Diaz L, 2009, CANCER RES, V69, P3300, DOI 10.1158/0008-5472.CAN-08-2036; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Garcia-Quiroz J, 2011, ANTI-CANCER AGENT ME, V11, P307, DOI 10.2174/187152011795347513; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Liu GX, 2015, INT J CLIN EXP PATHO, V8, P15093; Liu YT, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0462-3; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; Signoretti S, 2016, J CLIN INVEST, V126, P4387, DOI 10.1172/JCI90690; Stotz M, 2015, ANTICANCER RES, V35, P5737; Uddin S, 2016, SEMIN CANCER BIOL, V36, P18, DOI 10.1016/j.semcancer.2015.09.008; Vaiana SM, 2001, J BIOL PHYS, V27, P133, DOI 10.1023/A:1013146530021; Wang XZ, 2017, J MEMBRANE BIOL, V250, P123, DOI 10.1007/s00232-016-9944-8; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; Wickenden AD, 2002, PHARMACOL THERAPEUT, V94, P157, DOI 10.1016/S0163-7258(02)00201-2; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yoshida Y, 2012, ONCOGENE, V31, P4128, DOI 10.1038/onc.2011.570; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	34	5	5	3	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					163	176		10.1038/s41388-020-01522-6	http://dx.doi.org/10.1038/s41388-020-01522-6		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33097858				2022-12-26	WOS:000582109600001
J	Itani, N; Skeffington, KL; Beck, C; Niu, YG; Katzilieris-Petras, G; Smith, N; Giussani, DA				Itani, Nozomi; Skeffington, Katie L.; Beck, Christian; Niu, Youguo; Katzilieris-Petras, Georgios; Smith, Nicola; Giussani, Dino A.			Protective effects of pravastatin on the embryonic cardiovascular system during hypoxic development	FASEB JOURNAL			English	Article						cardiovascular disease; fetus; hypoxia; statins	SARCOPLASMIC-RETICULUM CA2+-ATPASE; OXIDATIVE STRESS; GROWTH RESTRICTION; MELATONIN SUPPLEMENTATION; GENE-EXPRESSION; DOWN-REGULATION; FETAL HYPOXIA; RAT MODEL; PREECLAMPSIA; PREGNANCY	The use of statins in complicated pregnancy is being considered, as they protect endothelial function in the mother and placenta. However, whether statins affect cardiovascular function in the fetus is completely unknown. Here, we have determined the effects of pravastatin and underlying mechanisms on the cardiovascular system of the hypoxic chicken embryo, a model system that permits the direct effects of pravastatin on the developing offspring to be isolated independently of additional effects on the mother and/or placenta. Chicken embryos were incubated under normoxia or hypoxia (14% O-2) from day 1 +/- pravastatin (1 mg/kg/d) from day 13 of incubation (term is 21 days). On day 19 of incubation, hearts and vessels were isolated to determine changes in the cardiovascular structure and function. The data show that pravastatin protected the hypoxic chicken embryo against impaired cardiovascular dysfunction. Mechanisms involved in this protection included reduced oxidative stress, enhanced NO bioavailability, restored antioxidant defenses and normalized protein expression of RhoA in the embryonic heart, and improved NO-dependent vasodilator mechanisms in the peripheral circulation. Therefore, we show that the treatment of the chronically hypoxic chicken embryo with pravastatin from day 13 of incubation, equivalent toca. 25 weeks of gestation in human pregnancy, has direct beneficial effects on the embryonic cardiovascular system. Therefore, pravastatin may be a candidate for human clinical translation to rescue fetal cardiovascular dysfunction in risky pregnancy.	[Itani, Nozomi; Skeffington, Katie L.; Beck, Christian; Niu, Youguo; Katzilieris-Petras, Georgios; Smith, Nicola; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England	University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	dag26@cam.ac.uk	Skeffington, Katie/AAJ-8756-2021	Katzilieris-Petras, Georgios/0000-0002-3037-464X; Smith, Nicola/0000-0002-5137-1384	British Heart Foundation (BHF) [PG/10/99/28656]	British Heart Foundation (BHF)(British Heart Foundation)	British Heart Foundation (BHF), Grant/Award Number: PG/10/99/28656	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Altimiras J, 2000, AM J PHYSIOL-REG I, V278, pR980, DOI 10.1152/ajpregu.2000.278.4.R980; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bilardo CM, 2017, ULTRASOUND OBST GYN, V50, P285, DOI 10.1002/uog.18815; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bourque SL, 2012, PLACENTA, V33, P449, DOI 10.1016/j.placenta.2012.01.012; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Carver AR, 2014, INT J DEV NEUROSCI, V33, P33, DOI 10.1016/j.ijdevneu.2013.11.004; Cetin I, 2020, HYPERTENSION, V75, P748, DOI 10.1161/HYPERTENSIONAHA.119.13727; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Costantine M, 2016, AM J OBSTET GYNECOL, V214, pS201, DOI 10.1016/j.ajog.2015.10.399; Costantine MM, 2013, OBSTET GYNECOL, V121, P349, DOI 10.1097/AOG.0b013e31827d8ad5; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Danson EJ, 2009, J MOL CELL CARDIOL, V46, P482, DOI 10.1016/j.yjmcc.2008.12.013; Darby JRT, 2020, THERIOGENOLOGY, V150, P84, DOI 10.1016/j.theriogenology.2020.01.080; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; Esteve-Valverde E, 2018, OBSTET GYNECOL SURV, V73, P40, DOI 10.1097/OGX.0000000000000522; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2016, J PHYSIOL-LONDON, V594, P1215, DOI 10.1113/JP271099; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; Guioli S, 2014, SEX DEV, V8, P227, DOI 10.1159/000358406; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Holm ACBS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12182; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Itani N, 2018, J PHYSIOL-LONDON, V596, P2991, DOI 10.1113/JP274111; Itani N, 2017, J PHYSIOL-LONDON, V595, P1563, DOI 10.1113/JP273393; Itani N, 2016, J PINEAL RES, V60, P16, DOI 10.1111/jpi.12283; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Karalis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002; Kendall G, 2005, EARLY HUM DEV, V81, P27, DOI 10.1016/j.earlhumdev.2004.10.012; Kobayashi N, 2002, CARDIOVASC RES, V55, P757, DOI 10.1016/S0008-6363(02)00457-1; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Lemley CO, 2012, AM J PHYSIOL-REG I, V302, pR454, DOI 10.1152/ajpregu.00407.2011; Li FQ, 1997, AM J PHYSIOL-REG I, V273, pR518, DOI 10.1152/ajpregu.1997.273.2.R518; Lindgren I, 2013, AM J PHYSIOL-REG I, V305, pR1093, DOI 10.1152/ajpregu.00320.2013; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; McDonnold M, 2014, AM J OBSTET GYNECOL, V210, pS354, DOI 10.1016/j.ajog.2013.10.756; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Munch G, 1998, J MOL MED-JMM, V76, P434, DOI 10.1007/s001090050235; Nanovskaya TN, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.038; Nuzzo AM, 2018, AM J PATHOL, V188, P2704, DOI 10.1016/j.ajpath.2018.07.027; OKAMURA K, 1990, J PERINAT MED, V18, P441, DOI 10.1515/jpme.1990.18.6.441; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761; PEDERSEN TR, 1994, LANCET, V344, P1383; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Phillips TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06300-1; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Ronkainen VP, 2011, J MOL CELL CARDIOL, V50, P1008, DOI 10.1016/j.yjmcc.2011.02.017; Shukla P, 2014, PLACENTA, V35, P461, DOI 10.1016/j.placenta.2014.04.007; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Sugishita Y, 2004, DEV BIOL, V273, P285, DOI 10.1016/j.ydbio.2004.05.036; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Thuc LC, 2010, APOPTOSIS, V15, P669, DOI 10.1007/s10495-010-0473-0; Tijsseling D, 2013, PEDIATR RES, V74, P639, DOI 10.1038/pr.2013.152; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Tong W, 2019, J DEV ORIG HLTH DIS, V10, P322, DOI 10.1017/S204017441900014X; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Umeji K, 2006, AM J PHYSIOL-HEART C, V291, pH2522, DOI 10.1152/ajpheart.01198.2005; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wyrwoll CS, 2016, P NATL ACAD SCI USA, V113, P6265, DOI 10.1073/pnas.1520356113; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhuang TF, 2014, NUTRIENTS, V6, P3968, DOI 10.3390/nu6093968	79	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16504	16515		10.1096/fj.202001743R	http://dx.doi.org/10.1096/fj.202001743R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094855	Green Submitted, hybrid			2022-12-26	WOS:000583912400001
J	Park, S; Park, K; Shim, JS; Youm, Y; Kim, J; Lee, E; Kim, HC				Park, Sungjong; Park, Kyungmee; Shim, Jee-Seon; Youm, Yoosik; Kim, Junsol; Lee, Eun; Kim, Hyeon Chang			Psychosocial factors affecting sleep misperception in middle-aged community-dwelling adults	PLOS ONE			English	Article							PRIMARY INSOMNIA; STATE MISPERCEPTION; SOCIAL NETWORKS; PSYCHOPHYSIOLOGICAL INSOMNIA; PSYCHOLOGICAL TREATMENT; LONG-TERM; METAANALYSIS; MARRIAGE; DURATION; HEALTH	Sleep misperception has long been a major issue in the field of insomnia research. Most studies of sleep misperception examine sleep underestimation by comparing the results of polysomnography conducted in a laboratory environment with patients' sleep diary entries. We aimed to investigate psychosocial characteristics of adults who underestimated or overestimated sleep time in a nonclinical, middle-aged community-dwelling population. We collected one week of sleep data with wrist-worn accelerometers. We used egocentric social network analysis to analyze the effects of psychosocial factors. Among 4,060 study participants, 922 completed the accelerometer substudy. Underestimation was defined as an accelerometer-measured sleep time >= 6 h and a subjective sleep time < 6 h. Overestimation was defined as an objective sleep time < 6 h and a subjective sleep time >= 6 h. Psychosocial characteristics of the sleep misperception group were evaluated using multivariate regression analysis. A total of 47 participants underestimated sleep time, and 420 overestimated sleep time. Regression analysis revealed that women, living with spouse, economic satisfaction, and bridging potential had protective effects against sleep underestimation. Blame from a spouse involved a 3.8-times higher risk of underestimation than the control group (p = 0.002). In men, discussing concerns with a spouse had a protective effect against underestimation (p < 0.001). Economic satisfaction, feeling social network-based intimacy, and support from a spouse were associated with overestimation in women. In men, feeling social network-based intimacy was also associated with overestimation (p < 0.001). We found that social relationship quality was related to sleep overestimation and underestimation. This association was marked in women. Good social relationships may have positive effects on sleep misperception via attenuation of negative emotional reactions and effects on emotional regulation.	[Park, Sungjong; Park, Kyungmee; Lee, Eun] Yonsei Univ, Severance Hosp, Dept Psychiat, Coll Med, Seoul, South Korea; [Park, Sungjong; Park, Kyungmee; Lee, Eun] Yonsei Univ, Severance Hosp, Inst Behav Sci Med, Coll Med, Seoul, South Korea; [Shim, Jee-Seon; Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Shim, Jee-Seon] Yonsei Univ, Cardiovasc & Metab Dis Etiol Res Ctr, Coll Med, Seoul, South Korea; [Youm, Yoosik; Kim, Junsol] Yonsei Univ, Dept Sociol, Coll Social Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Lee, E (corresponding author), Yonsei Univ, Severance Hosp, Dept Psychiat, Coll Med, Seoul, South Korea.; Lee, E (corresponding author), Yonsei Univ, Severance Hosp, Inst Behav Sci Med, Coll Med, Seoul, South Korea.	leeun@yuhs.ac	; Kim, Hyeon Chang/F-8796-2019	Kim, Junsol/0000-0003-1065-6479; Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Eun/0000-0002-7462-0144; Youm, Yoosik/0000-0003-3822-5777; Shim, Jee-Seon/0000-0002-8671-3153	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Science, ICT & Future Planning, Republic of Korea [2017R1A2B3008214]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare, Republic of Korea [HI13C0715]; National IT Industry Promotion Agency [A0602-19-1009]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National IT Industry Promotion Agency(National IT Industry Promotion Agency (NIPA), Republic of Korea)	This study was funded by the Basic Science Research Program through the National Research Foundation of Korea, the Ministry of Science, ICT & Future Planning, Republic of Korea (Grant number: 2017R1A2B3008214 to Eun Lee), the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, the Ministry of Health and Welfare, Republic of Korea (Grant number: HI13C0715 to Hyeon Chan Kim), and the Intelligence Information Expansion Support System for Private Organizations supervised by the National IT Industry Promotion Agency (Grant number: A0602-19-1009 to Eun Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien CH, 2014, PATHOL BIOL, V62, P241, DOI 10.1016/j.patbio.2014.07.003; Bastien Celyne H, 2004, Behav Sleep Med, V2, P50, DOI 10.1207/s15402010bsm0201_5; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Belle D, 1987, GENDER STRESS, P257; Bianchi MT, 2012, J CLIN SLEEP MED, V8, P547, DOI 10.5664/jcsm.2154; Butler EA, 2013, EMOT REV, V5, P202, DOI 10.1177/1754073912451630; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; CARSKADON MA, 1976, AM J PSYCHIAT, V133, P1382; Chunhua X, 2019, IMPAIRED EMOTIONAL M, V98; Clark DM, 1999, BEHAV RES THER, V37, pS5, DOI 10.1016/S0005-7967(99)00048-0; Cornwell B, 2011, J GERONTOL B-PSYCHOL, V66, P782, DOI 10.1093/geronb/gbr111; Cornwell B, 2009, J AGING HEALTH, V21, P129, DOI 10.1177/0898264308328649; Cunnington D, 2013, MED J AUSTRALIA, V199, pS36, DOI 10.5694/mja13.10718; Dittoni S, 2013, ACTA NEUROL SCAND, V128, P54, DOI 10.1111/ane.12078; Djomba JK, 2016, ZDRAV VARST, V55, P256, DOI 10.1515/sjph-2016-0035; Dollander M, 2002, ENCEPHALE, V28, P493; Dorsey CM, 1997, BIOL PSYCHIAT, V41, P209, DOI 10.1016/0006-3223(95)00659-1; EDINGER JD, 1995, SLEEP, V18, P232, DOI 10.1093/sleep/18.4.232; Edinger JD, 2003, SLEEP MED REV, V7, P203, DOI 10.1053/smrv.2002.0253; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; ESPIE CA, 1989, J BEHAV THER EXP PSY, V20, P143, DOI 10.1016/0005-7916(89)90047-5; Feige B, 2008, J SLEEP RES, V17, P180, DOI 10.1111/j.1365-2869.2008.00651.x; Fernandez-Mendoza J, 2011, PSYCHOSOM MED, V73, P88, DOI 10.1097/PSY.0b013e3181fe365a; FRANKEL BL, 1976, ARCH GEN PSYCHIAT, V33, P615; GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639; Green MJ, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-152; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Harvey AG, 2005, CLIN PSYCHOL REV, V25, P593, DOI 10.1016/j.cpr.2005.04.005; Harvey AG, 2012, PSYCHOL BULL, V138, P77, DOI 10.1037/a0025730; Hsieh YP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00848; Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006; Kappler C, 2003, EUR ARCH PSY CLIN N, V253, P49, DOI 10.1007/s00406-003-0406-9; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Krystal AD, 2002, SLEEP, V25, P630; Li LQ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1075-3; Liu J., 2004, INTRO SCH NETWORK AN; Lorant V, 2017, ADM POLICY MENT HLTH, V44, P877, DOI 10.1007/s10488-017-0800-7; [马绍奇 MA ShaoQi], 2011, [心理科学进展, Advances in Psychological Science], V19, P755; MANNE SL, 1989, J PERS SOC PSYCHOL, V56, P608, DOI 10.1037/0022-3514.56.4.608; Merrigan Jill M, 2013, JAMA, V309, P733, DOI 10.1001/jama.2013.524; Moon HJ, 2015, J CLIN NEUROL, V11, P358, DOI 10.3988/jcn.2015.11.4.358; Morgan K, 2003, BRIT J GEN PRACT, V53, P923; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; SALINPASCUAL RJ, 1992, AM J PSYCHIAT, V149, P904; Sarsour K, 2010, SLEEP MED, V11, P69, DOI 10.1016/j.sleep.2009.02.008; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Schepis D., 2011, SOCIAL NETWORK ANAL; Schirmer A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00058; Semler CN, 2005, BEHAV RES THER, V43, P843, DOI 10.1016/j.brat.2004.06.016; Seo MH, 2019, J OBES METAB SYNDR, V28, P143, DOI 10.7570/jomes.2019.28.2.143; Shim JS, 2019, YONSEI MED J, V60, P804, DOI 10.3349/ymj.2019.60.8.804; Sundermann O, 2014, SOC PSYCH PSYCH EPID, V49, P359, DOI 10.1007/s00127-013-0754-3; Suh S, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0940-9; Tang NKY, 2004, SLEEP, V27, P69, DOI 10.1093/sleep/27.1.69; Trajanovic NN, 2007, SLEEP MED, V8, P111, DOI 10.1016/j.sleep.2006.08.013; Troxel WM, 2007, SLEEP MED REV, V11, P389, DOI 10.1016/j.smrv.2007.05.002; Troxel WM, 2010, J PSYCHOSOM RES, V69, P459, DOI 10.1016/j.jpsychores.2010.04.003; Troxel WM, 2010, SLEEP, V33, P973, DOI 10.1093/sleep/33.7.973; Uecker JE, 2012, J HEALTH SOC BEHAV, V53, P67, DOI 10.1177/0022146511419206; van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533; van Hees VT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31266-z	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241237	10.1371/journal.pone.0241237	http://dx.doi.org/10.1371/journal.pone.0241237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095840	gold, Green Published			2022-12-26	WOS:000586649400064
J	Hopkins, KL; Hlongwane, KE; Otwombe, K; Dietrich, J; Jaffer, M; Cheyip, M; Olivier, J; van Rooyen, H; Wade, AN; Doherty, T; Gray, GE				Hopkins, Kathryn L.; Hlongwane, Khuthadzo E.; Otwombe, Kennedy; Dietrich, Janan; Jaffer, Maya; Cheyip, Mireille; Olivier, Jacobus; van Rooyen, Heidi; Wade, Alisha N.; Doherty, Tanya; Gray, Glenda E.			Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ADHERENCE; ART; RESILIENCE; ENGAGEMENT; MANAGEMENT; INITIATION; CONTINUUM	Introduction South Africa is the HIV epidemic epicentre; however, non-communicable diseases (NCDs) will be the most common cause of death by 2030. To improve identification and initiation of care for HIV and NCDs, we assessed proportion of clients referred and linked to care (LTC) for abnormal/positive screening results and time to LTC and treatment initiation from a HIV Testing Services (HTS) Centre before and after integrated testing for NCDs with optional peer-navigated linkage to care. Materials and methods This two-phase prospective study was conducted at an adult HTS Centre in Soweto, South Africa. Phase 1 (February-June 2018) utilised standard of care (SOC) HTS services (blood pressure [BP], HIV rapid diagnostic testing (RDT), sexually transmitted infections [STI]/Tuberculosis [TB] symptom screening) with passive referral for abnormal/positive results. Phase 2 (June 2018-March 2019) further integrated blood glucose/cholesterol/chlamydia RDT, with optional peer-navigated referral. Enrolled referred clients completed telephonic follow-up surveys confirming LTC/treatment initiation <= 3 months post-screening. Socio-demographics, screening results, time to LTC/treatment initiation, peer-navigated referral uptake were reported. Analysis included Fisher's exact, chi-squared, Kruskal Wallis, and Student's T-tests. Thematic analysis was conducted for open-ended survey responses. Results Of all 320 referrals, 40.0% were HIV-infections, 11.9% STIs, 6.6% TB, and 28.8% high/low BP. Of Phase 2-only referrals, 29.4% were for glucose and 23.5% cholesterol. Integrated NCD-HTS had significantly more clients LTC for HIV (76.7%[n = 66/86] vs 52.4%[n = 22/42], p = 0.0052) and within a shorter average time (6-8 days [Interquartile range (IQR):1-18.5] vs 8-13 days [IQR:2-32]) as compared to SOC HTS. Integrated NCD-HTS clients initiated HIV/STIs/BP treatment on average more quickly as compared to SOC HTS (5 days for STIs [IQR:1-21], 8 days for HIV/BP [IQR:5-17 and 2-13, respectively] vs 10 days for STIs [IQR: 4-32], 19.5 days for HIV [IQR:6.5-26.5], 8 days for BP [IQR:2-29)]. Participants chose passive over active referral (89.1% vs 10.9%; p<0.0001). Participants rejecting peer-navigated referral preferred to go alone (55.7% [n = 39/70]). Non-LTC was due to being busy (41.1% [n = 39/95]) and not being ready/refusing treatment (31.6% [n = 30/95]). Normalised results assessed at referral clinic (49.7% [n = 98/196]), prescribed lifestyle modification/monitoring (30.9% [n = 61/196]), and poor clinic flow/congestion and/or further testing required (10.7% [n = 21/196]) were associated with non-treatment initiation. Conclusion Same-day treatment initiation is not achieved across diseases, despite peer-navigated referral. There are psychosocial and health systems barriers at entry to care/treatment initiation. Additional research may identify best strategies for rapid treatment initiation.	[Hopkins, Kathryn L.; Hlongwane, Khuthadzo E.; Otwombe, Kennedy; Dietrich, Janan; Jaffer, Maya; Gray, Glenda E.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Hopkins, Kathryn L.; Otwombe, Kennedy; Wade, Alisha N.; Doherty, Tanya] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Dietrich, Janan; Doherty, Tanya] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Cheyip, Mireille; Olivier, Jacobus] Ctr Dis Control & Prevent, Pretoria, South Africa; [van Rooyen, Heidi] Human Sci Res Council, Human & Social Dev Programme, Pretoria, South Africa; [van Rooyen, Heidi; Gray, Glenda E.] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa; [Wade, Alisha N.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Doherty, Tanya] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Witwatersrand; University of the Western Cape; South African Medical Research Council	Hopkins, KL (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa.; Hopkins, KL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	HopkinsK@PHRU.co.za		Hopkins, Kathryn/0000-0003-2809-3686; Dietrich, Janan/0000-0002-1949-3138	South African Medical Research Council (SAMRC); National Research Foundation; SAMRC through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from South African National Treasury; CIPHER GROWING THE LEADERS OF TOMORROW grant from the International AIDS Society; President's Emergency Plan for AIDS Relief (PEPFAR) [1U2GPS001150]	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)South African Medical Research Council); National Research Foundation; SAMRC through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from South African National Treasury; CIPHER GROWING THE LEADERS OF TOMORROW grant from the International AIDS Society; President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	TD and GEG are funded by the South African Medical Research Council (SAMRC) and the National Research Foundation. The work reported herein for JD was made possible through funding by the SAMRC through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from funding received from the South African National Treasury as well as the CIPHER GROWING THE LEADERS OF TOMORROW grant from the International AIDS Society. The study was supported by the Cooperative Agreement to the SAMRC for Tuberculosis Control and HIV Prevention, Care, and Treatment Activities under the President's Emergency Plan for AIDS Relief (PEPFAR) (Cooperative Agreement Number: 1U2GPS001150). The funding was awarded to KLH. The study was reviewed in accordance with the Centers for Disease Control and Prevention (CDC) human research protection procedures and was determined to be research, but CDC investigators did not interact with human subjects or have access to identifiable data or specimens for research purposes (CGH 2018-017). The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the funding agencies.	Andrasik MP, 2008, J HEALTH CARE POOR U, V19, P912, DOI 10.1353/hpu.0.0037; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2012, MAPANA J SCI, V11, P65; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2016, POWDER INJECTION MOU, V10, P14; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; [Anonymous], 1994, PREVENTING AIDS THEO; [Anonymous], 2016, UN TEST TREAT GAM CH; CATT S, 1995, AIDS CARE, V7, P229, DOI 10.1080/09540129550126731; Dale S, 2014, AIDS PATIENT CARE ST, V28, P136, DOI 10.1089/apc.2013.0329; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Gold RS, 2001, AIDS CARE, V13, P693, DOI 10.1080/09540120120076869; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Human Sciences Research Council, 2017, S AFR NAT HIV PREV I; Hunt PW, 2017, CLIN INFECT DIS, V64, P132, DOI 10.1093/cid/ciw697; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Katz IT, 2015, AIDS BEHAV, V19, P704, DOI 10.1007/s10461-014-0920-y; Kotwani P, 2014, TROP MED INT HEALTH, V19, P459, DOI 10.1111/tmi.12273; Kouyoumdjian FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081044; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; McGowan JA, 2018, AIDS BEHAV, V22, P1688, DOI 10.1007/s10461-017-1980-6; Miller TA, 2016, PATIENT EDUC COUNS, V99, P1079, DOI 10.1016/j.pec.2016.01.020; Misener TR, 1998, WESTERN J NURS RES, V20, P431, DOI 10.1177/019394599802000403; Mugayero MJ, 2012, MEDSCAPE ED INTERNAL; Mujugira A, 2013, 7 IAS C HIV PATH TRE; Murrell D, 2017, MED NEWS TODAY; Nachega JB, 2014, CLIN INFECT DIS, V59, pS21, DOI 10.1093/cid/ciu299; Naik R, 2018, AIDS BEHAV, V22, P722, DOI 10.1007/s10461-017-1830-6; NIH Public Access Author Manuscript, 2011, J PHYS ACT HLTH, V8, pS257; Owusu KK, 2019, HIV AIDS-RES PALLIAT, V11, P321, DOI 10.2147/HIV.S216093; Philbin MM, 2014, AIDS BEHAV, V18, P1501, DOI 10.1007/s10461-013-0650-6; Rachlis B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5904-9; [Republic of South Africa Essential Drugs Programme. D.o. Health], 2018, STAND TREATM GUID ES; Ruria EC, AIDS S3, V31, pS253; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith LR, 2013, AIDS CARE, V25, P1485, DOI 10.1080/09540121.2013.775398; South African National Department of Health, 2016, REIMPL UN TEST TREAT; South African National Department of Health, 2018, TB CONTR PROGR 2018; South African National Department of Health, 2015, NAT HIV TEST SERV PO; Southern African Hypertenson Society, 2019, WHAT IS HYP; Staveteig S., 2013, DEMOGRAPHIC PATTERNS; The Heart and Stroke Foundation of South Africa, 2017, DIABETES; UNAIDS, 2014, 90 AMB TREATM TARG H; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; World Health Organization, 2015, CONS GUID HIV COUNS; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization Public Health Agency of Canada., PREV CHRON DIS VIT 2	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241014	10.1371/journal.pone.0241014	http://dx.doi.org/10.1371/journal.pone.0241014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091093	Green Published, gold			2022-12-26	WOS:000586647200028
J	Kok, RNU; Hebert, L; Huelsz-Prince, G; Goos, YJ; Zheng, X; Bozek, K; Stephens, GJ; Tans, SJ; van Zon, JS				Kok, Rutger N. U.; Hebert, Laetitia; Huelsz-Prince, Guizela; Goos, Yvonne J.; Zheng, Xuan; Bozek, Katarzyna; Stephens, Greg J.; Tans, Sander J.; van Zon, Jeroen S.			OrganoidTracker: Efficient cell tracking using machine learning and manual error correction	PLOS ONE			English	Article							SEGMENTATION; DISEASE	Time-lapse microscopy is routinely used to follow cells within organoids, allowing direct study of division and differentiation patterns. There is an increasing interest in cell tracking in organoids, which makes it possible to study their growth and homeostasis at the singlecell level. As tracking these cells by hand is prohibitively time consuming, automation using a computer program is required. Unfortunately, organoids have a high cell density and fast cell movement, which makes automated cell tracking difficult. In this work, a semi-automated cell tracker has been developed. To detect the nuclei, we use a machine learning approach based on a convolutional neural network. To form cell trajectories, we link detections at different time points together using a min-cost flow solver. The tracker raises warnings for situations with likely errors. Rapid changes in nucleus volume and position are reported for manual review, as well as cases where nuclei divide, appear and disappear. When the warning system is adjusted such that virtually error-free lineage trees can be obtained, still less than 2% of all detected nuclei positions are marked for manual analysis. This provides an enormous speed boost over manual cell tracking, while still providing tracking data of the same quality as manual tracking.	[Kok, Rutger N. U.; Huelsz-Prince, Guizela; Goos, Yvonne J.; Zheng, Xuan; Tans, Sander J.; van Zon, Jeroen S.] AMOLF, Amsterdam, Netherlands; [Hebert, Laetitia; Stephens, Greg J.] Okinawa Inst Sci & Technol Grad Univ OIST, Onna Son, Okinawa, Japan; [Bozek, Katarzyna] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne, Germany; [Stephens, Greg J.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands; [Tans, Sander J.] Delft Univ Technol, Kavli Inst Nanosci Delft, Bionanosci Dept, Delft, Netherlands	AMOLF; Okinawa Institute of Science & Technology Graduate University; University of Cologne; Vrije Universiteit Amsterdam; Delft University of Technology	Tans, SJ; van Zon, JS (corresponding author), AMOLF, Amsterdam, Netherlands.; Tans, SJ (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Bionanosci Dept, Delft, Netherlands.	s.j.tans@tudelft.nl; j.v.zon@amolf.nl	Tans, Sander/AAS-2901-2020	Zheng, Xuan/0000-0002-1700-9082; Kok, Rutger/0000-0002-6214-681X; Stephens, Greg/0000-0003-3135-3514	NWO Building Blocks of Life grant from the Dutch Research Council [737.016.009]; NWO Vidi grant from the Dutch Research Council [680-47-529]; OIST Graduate University	NWO Building Blocks of Life grant from the Dutch Research Council; NWO Vidi grant from the Dutch Research Council; OIST Graduate University	R.K. and X.Z were funded by an NWO Building Blocks of Life grant from the Dutch Research Council, number 737.016.009, https://www.nwo.nl/. G.H.P and J.S.v.Z were supported by an NWO Vidi grant from the Dutch Research Council, number 680-47-529, https://www.nwo.nl/. K.B., L.H. and G.J.S. were supported in the project by funds from OIST Graduate University, https://oist.jp/. Other authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; [Anonymous], 2019, PRION S1, V13, P1, DOI [10.1080/19336896.2019.1615197, DOI 10.1080/19336896.2019.1615197]; Artegiani B, 2018, HUM MOL GENET, V27, pR99, DOI 10.1093/hmg/ddy187; Ayachit U., 2015, PARAVIEW GUIDE PARAL, DOI 10.5555/2789330; Bradski G., 2008, LEARNING OPENCV COMP; Caicedo JC, 2019, NAT METHODS, V16, P1247, DOI 10.1038/s41592-019-0612-7; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Dunn KW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54244-5; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Haubold C, 2016, LECT NOTES COMPUT SC, V9911, P566, DOI 10.1007/978-3-319-46478-7_35; Ho DJ, 2019, 2019 IEEE EMBS INT C, P1; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Khan FA, 2019, VOLUMETRIC SEGMENTAT, DOI [10.1101/707257, DOI 10.1101/707257]; Liu R, 2018, ADV NEUR IN, V31; Matula P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144959; Montes-Olivas S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00873; Pan XP, 2018, WORLD WIDE WEB, V21, P1721, DOI 10.1007/s11280-017-0520-7; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Pennisi E, 2018, SCIENCE, V362, P1344, DOI 10.1126/science.362.6421.1344; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Skylaki S, 2016, NAT BIOTECHNOL, V34, P1137, DOI 10.1038/nbt.3713; Svensson CM, 2018, CYTOM PART A, V93A, P357, DOI 10.1002/cyto.a.23249; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Ulman V, 2017, NAT METHODS, V14, P1141, DOI 10.1038/nmeth.4473; US Foodlink, 2016, US FOODLINK, V12, P1, DOI DOI 10.1016/j.jalz.2016.03.001; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wallach TE, 2017, J PEDIATR GASTR NUTR, V64, P180, DOI 10.1097/MPG.0000000000001411; Winter M, 2011, NAT PROTOC, V6, P1942, DOI 10.1038/nprot.2011.422; Xie WD, 2018, COMP M BIO BIO E-IV, V6, P283, DOI 10.1080/21681163.2016.1149104; Xie YP, 2018, MED IMAGE ANAL, V44, P245, DOI 10.1016/j.media.2017.07.003; Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005; Zhu RK, 2017, IEEE INT C BIOINF BI, P51, DOI 10.1109/BIBE.2017.00016	38	13	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240802	10.1371/journal.pone.0240802	http://dx.doi.org/10.1371/journal.pone.0240802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091031	Green Submitted, Green Published, gold			2022-12-26	WOS:000586647200052
J	Nabbaale, J; Okello, E; Kibirige, D; Ssekitoleko, I; Isanga, J; Karungi, P; Sebatta, E; Zhu, ZW; Nakimuli, A; Omagino, J; Kayima, J				Nabbaale, Juliet; Okello, Emmy; Kibirige, Davis; Ssekitoleko, Isaac; Isanga, Joseph; Karungi, Patience; Sebatta, Elias; Zhu, Zhang Wan; Nakimuli, Annettee; Omagino, John; Kayima, James			Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; MORTALITY; FAILURE	Background Peripartum cardiomyopathy (PPCM) is an idiopathic cardiomyopathy presenting with acute heart failure during the peripartum period. It is common in patients of African ancestry. Currently, there is paucity of data on the burden, predictors and outcomes of PPCM in Uganda. This study aimed to investigate the prevalence, predictors and six-month outcomes of PPCM in an adult cohort attending a tertiary specialised cardiology centre in Kampala, Uganda. Methods This study consecutively enrolled 236 women presenting with features of acute heart failure in the peripartum period. Clinical evaluation and echocardiography were performed on all the enrolled women. PCCM was defined according to recommendations of the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Poor outcome at six months of follow-up was defined as presence of any of the following: death of a mother or her baby, New York Heart Association (NYHA) functional class III-IV or failure to achieve complete recovery of left ventricular function (left ventricular ejection fraction <= 55%). Results The median age, BMI and parity of the study participants was 31.5 (25.5-38.0) years, 28.3 (26.4-29.7) and 3 (2-4) respectively. The prevalence of PPCM was 17.4% (n = 41/236). Multiple pregnancy was the only predictor of PPCM in this study population (OR 4.3 95% CI 1.16-16.05, p = 0.029). Poor outcome at six-months was observed in about 54% of the patients with PPCM (n = 4, 9.8% in NYHA functional class III-IV and n = 22, 53.7% with LVEF <55%). No maternal or foetal mortality was documented. Conclusion PPCM is relatively common in Uganda and is associated with multiple pregnancy. Poor outcomes especially absence of complete recovery of left ventricular function are also common. Large studies to further investigate long-term maternal and foetal outcomes in Uganda are justified.	[Nabbaale, Juliet; Okello, Emmy; Sebatta, Elias; Zhu, Zhang Wan; Omagino, John; Kayima, James] Uganda Heart Inst, Div Adult Cardiol, Kampala, Uganda; [Kibirige, Davis] Uganda Martyrs Hosp Lubaga, Dept Med, Kampala, Uganda; [Ssekitoleko, Isaac] Uganda Virus Res Inst, Med Res Council, Stat Unit, Entebbe, Uganda; [Ssekitoleko, Isaac] London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda; [Isanga, Joseph] Case Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; [Karungi, Patience] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Nakimuli, Annettee] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Obstet & Gynaecol, Kampala, Uganda	Uganda Virus Research Institute; University of Limerick; Makerere University	Nabbaale, J (corresponding author), Uganda Heart Inst, Div Adult Cardiol, Kampala, Uganda.	jgnabbaale@gmail.com	Zhang, Wanzhu/HHZ-3159-2022	Zhang, Wanzhu/0000-0002-9164-1772; kibirige, Davis/0000-0001-5127-3031; NAKIMULI, ANNETTEE/0000-0003-2806-0243	NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (Office Of The Director, National Institutes of Health) [D43TW010132]; NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute of Dental and Craniofacial Research) [D43TW010132]; NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute Of Neurological Disorders And Stroke) [D43TW010132]; NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Heart, Lung, and Blood Institute) [D43TW010132]; NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (Forgarty International Centre) [D43TW010132]; NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute On Minority Health and Health Disparities) [D43TW010132]	NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (Office Of The Director, National Institutes of Health); NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute of Dental and Craniofacial Research); NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute Of Neurological Disorders And Stroke); NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Heart, Lung, and Blood Institute); NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (Forgarty International Centre); NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (National Institute On Minority Health and Health Disparities)	The study was funded by NURTURE Research Training and Mentoring Program for Career Development of Faculty at Makerere University College of Health Sciences, Uganda (Grant number D43TW010132 supported by the Office Of The Director, National Institutes of Health, National Institute of Dental and Craniofacial Research, National Institute Of Neurological Disorders And Stroke, National Heart, Lung, and Blood Institute, Forgarty International Centre, National Institute On Minority Health and Health Disparities).	[Anonymous], 2014, NAT REV UROL, V11, P364; Bauersachs J, 2019, EUR J HEART FAIL, V21, P827, DOI 10.1002/ejhf.1493; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Blauwet LA, 2013, HEART, V99, P308, DOI 10.1136/heartjnl-2012-302760; Brar SS, 2007, AM J CARDIOL, V100, P302, DOI 10.1016/j.amjcard.2007.02.092; DAVIDSON NM, 1974, B WORLD HEALTH ORGAN, V51, P203; DESAI D, 1995, TROP DOCT, V25, P118, DOI 10.1177/004947559502500310; Elkayam U, 2011, J AM COLL CARDIOL, V58, P659, DOI 10.1016/j.jacc.2011.03.047; Gambahaya ET, 2017, CARDIOVASC J AFR, V28, P8, DOI 10.5830/CVJA-2016-043; Gentry MB, 2010, J AM COLL CARDIOL, V55, P654, DOI 10.1016/j.jacc.2009.09.043; Greer IA, 2015, NEW ENGL J MED, V373, P540, DOI 10.1056/NEJMcp1407434; Hilfiker-Kleiner D, 2017, EUR J HEART FAIL, V19, P1723, DOI 10.1002/ejhf.808; Isezuo SA, 2007, ETHNIC DIS, V17, P228; Karaye KM, 2020, ESC HEART FAIL, V7, P236, DOI 10.1002/ehf2.12562; Karaye KM, 2011, INT J CARDIOL, V147, P342, DOI 10.1016/j.ijcard.2011.01.004; Karaye Kamilu M, 2016, Heart Views, V17, P55, DOI 10.4103/1995-705X.185114; Karaye KM, 2016, CARDIOVASC J AFR, V27, P66, DOI 10.5830/CVJA-2015-092; Karaye KM, 2015, INT J MOL SCI, V16, P7644, DOI 10.3390/ijms16047644; Karaye KM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-16; Karaye KM, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0204-8; Libhaber E, 2015, INT J CARDIOL, V190, P376, DOI 10.1016/j.ijcard.2015.04.081; Mwita JC, 2017, CARDIOVASC J AFR, V28, P112, DOI 10.5830/CVJA-2016-067; No authors listed Summaries for patients, 2012, ANN INTERN MED, V157, pI; Ntusi NBA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133466; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Raphael DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208931; Simeon Isezuo A, 2006, Indian Heart J, V58, P234; Sliwa K, 2017, EUR J HEART FAIL, V19, P1131, DOI 10.1002/ejhf.780; Sliwa K, 2014, HEART, V100, P1967, DOI 10.1136/heartjnl-2014-306199; Sliwa K, 2011, INT J CARDIOL, V147, P202, DOI 10.1016/j.ijcard.2009.08.022; Yameogo NV, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0856-7	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240837	10.1371/journal.pone.0240837	http://dx.doi.org/10.1371/journal.pone.0240837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085703	Green Published, gold			2022-12-26	WOS:000585943400017
J	Sazlina, SG; Sooryanarayana, R; Ho, BK; Omar, MA; Krishnapillai, AD; Tohit, NM; Abidin, SIZ; Ariaratnam, S; Ahmad, NA				Sazlina, Shariff Ghazali; Sooryanarayana, Rajini; Ho, Bee Kiau; Omar, Mohd. Azahadi; Krishnapillai, Ambigga Devi; Mohd Tohit, Noorlaili; Inche Zainal Abidin, Sheleaswani; Ariaratnam, Suthahar; Ahmad, Noor Ani			Cardiovascular disease risk factors among older people: Data from the National Health and Morbidity Survey 2015	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; BLOOD-PRESSURE; AGE	Study on cardiovascular disease (CVD) risk factors and their prevalence among the older people in Malaysia is limited. We aimed to determine the prevalence and factors associated with CVD risk factors using the non-laboratory Framingham Generalized 10-Year CVD risk score among older people in Malaysia. This was a population-based cross-sectional study using data of 3,375 participants aged >= 60 years from the National Health and Morbidity Survey 2015. Sociodemographic, health factors and clinical assessments (anthropometry and blood pressure) were included. Complex survey analysis was used to obtain prevalence with 95% confidence intervals (CI). We applied ordinal regression to determine the factors associated with CVD risk. The prevalence for the high 10-year CVD risk was 72.1%. Body mass index was higher among those aged 60-69 years in men (25.4kg/m(2), 95%CI 25.1-25.8) and women (26.7kg/m(2), 95%CI 26.3-27.1) than the other age groups. The factors associated with moderate and high 10-year CVD risk were Malay ethnicity (Odds Ratio(OR) 0.76, 95%CI 0.63-0.92, p = 0.004), unmarried status (OR 1.55, 95%CI 1.22-1.97, p<0.001) and physically inactive (OR 0.72, 95%CI 0.55-0.95, p = 0.020). There is a need for future study to evaluate preventive strategies to improve the health of older people in order to promote healthy ageing.	[Sazlina, Shariff Ghazali] Univ Putra Malaysia, Dept Family Med, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Sazlina, Shariff Ghazali] Univ Putra Malaysia, Malaysian Res Inst Ageing MyAgeing, Serdang, Selangor, Malaysia; [Sooryanarayana, Rajini] Minist Hlth Malaysia, Family Hlth Dev Div, Putrajaya, Wilayah Perseku, Malaysia; [Ho, Bee Kiau] Minist Hlth Malaysia, Klin Kesihatan Bandar Bot, Klang, Selangor, Malaysia; [Omar, Mohd. Azahadi] Minist Hlth Malaysia, Natl Inst Hlth, Shah Alam, Malaysia; [Krishnapillai, Ambigga Devi] Natl Def Univ Malaysia, Fac Med & Hlth, Dept Family Med, Kuala Lumpur, Malaysia; [Mohd Tohit, Noorlaili] Natl Univ Malaysia, Dept Family Med, Fac Med, Kuala Lumpur, Malaysia; [Inche Zainal Abidin, Sheleaswani] Minist Hlth, Elderly Hlth Sect, Family Hlth Dev Div, Putrajaya, Wilayah Perseku, Malaysia; [Ariaratnam, Suthahar] Univ Teknol MARA UiTM, Dept Psychiat, Fac Med, Selayang Campus, Batu Caves, Selangor, Malaysia; [Ahmad, Noor Ani] Minist Hlth Malaysia, Inst Publ Hlth, Natl Inst Hlth, Ctr Family Hlth Res, Shah Alam, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Universiti Pertahanan Nasional Malaysia; Universiti Kebangsaan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Sazlina, SG (corresponding author), Univ Putra Malaysia, Dept Family Med, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.; Sazlina, SG (corresponding author), Univ Putra Malaysia, Malaysian Res Inst Ageing MyAgeing, Serdang, Selangor, Malaysia.	sazlina@medic.upm.edu.my	Ariaratnam, Suthahar/ABA-6210-2021	Shariff-Ghazali, Sazlina/0000-0002-5737-7226	Ministry of Health Malaysia [NMRR-14-1064-21877]	Ministry of Health Malaysia	Ministry of Health Malaysia, Award number: NMRR-14-1064-21877, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific salary for this work.; The authors would like to thank the Director General, Ministry of Health Malaysia for his support and permission to publish this study. We also express our gratitude to the Deputy Director General of Health (Research and Technical Support) and Director, Institute for Public Health for their guidance and support for this publication.	Amarya S, 2014, J CLIN GERONTOL GERI, V5, P63, DOI 10.1016/j.jcgg.2014.01.004; Chiu Herng-Chia, 2004, Kaohsiung Journal of Medical Sciences, V20, P279, DOI 10.1016/S1607-551X(09)70119-6; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Department of Statistics, 2017, STAT CAUS DEATH MAL; Forsyth D R, 2009, Med J Malaysia, V64, P46; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; GREEN KG, 1989, INT J EPIDEMIOL, V18, P355, DOI 10.1093/ije/18.2.355; Ho B K, 2014, Malays Fam Physician, V9, P12; Institute for Public Health, 2015, NAT HLTH MORB SURV 2, VII; Institute for Public Health, 2015, NAT HLTH MORB SURV N, V1; Joshi Rajnish, 2013, J Cardiovasc Dis Res, V4, P140, DOI 10.1016/j.jcdr.2013.03.002; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Lee PY, 2013, ASIA-PAC J PUBLIC HE, V25, P316, DOI 10.1177/1010539511430521; Li CY, 2011, ASIAN NURS RES, V5, P164, DOI 10.1016/j.anr.2011.09.002; Lim KH, 2016, TOB INDUC DIS, V14, DOI 10.1186/s12971-016-0073-z; Liu L, 2016, MEDICINE BALTIMORE, V95; Miller TA, 2013, DIABET METAB SYND OB, V6, P421, DOI 10.2147/DMSO.S36368; Ministry of Health, 2004, MAN OB; Ministry of Health, 2010, COUNTR HLTH PLAN 10; Ministry of Health Malaysia, 2011, HLTH FACTS 2010 MIN; MITTELMARK MB, 1993, AM J EPIDEMIOL, V137, P311, DOI 10.1093/oxfordjournals.aje.a116678; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Samsudin S, 2016, INT J PUBLIC HLTH RE, V6, P741; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; WHO, 2017, WHO CARDIOVASCULAR D; Yang ZQ, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0686-y; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007; Zanchetti A, 2005, J HYPERTENS, V23, P2269, DOI 10.1097/01.hjh.0000194118.35098.43	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240826	10.1371/journal.pone.0240826	http://dx.doi.org/10.1371/journal.pone.0240826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085718	Green Published, Green Accepted, gold			2022-12-26	WOS:000585943400007
J	Feng, X; Xie, FY; Ou, XH; Ma, JY				Feng, Xie; Xie, Feng-Yun; Ou, Xiang-Hong; Ma, Jun-Yu			Cruciform DNA in mouse growing oocytes: Its dynamics and its relationship with DNA transcription	PLOS ONE			English	Article							ALPHA-AMANITIN; FOLLICULOGENESIS; TRANSLOCATIONS; PALINDROMES; MATURATION; FREQUENCY; REGION; AGE	Cruciform DNA is a causing factor of genome instability and chromosomal translocation, however, most studies about cruciform DNA in mammalian cells were based on palindromic sequences containing plasmids and reports about endogenous cruciform DNA are rare. In this study we observed the dynamics of endogenous cruciform DNA in mouse growing oocytes using immunofluorescence labeling method. We found cruciform DNA foci exist in transcription active growing oocytes but not in transcription inactive fully grown oocytes and colocalized with Parp1 but not with DNA damage marker gamma H2A.X. By analyzing the Genotype-Tissue Expression data, we found cruciform DNA-mediated chromosomal translocation in human spermatocytes is associated with the specific DNA transcription in testis. When inhibiting the transcription with alpha-amanitin in mouse oocytes, we found oocyte cruciform DNA foci decreased significantly. In summary, we observed the endogenous cruciform DNA in growing oocytes and our results showed that the cruciform DNA formation is transcription-dependent.	[Feng, Xie; Ou, Xiang-Hong] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China; [Feng, Xie; Xie, Feng-Yun; Ou, Xiang-Hong; Ma, Jun-Yu] Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangzhou, Peoples R China; [Ou, Xiang-Hong] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China	Southern Medical University - China; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory)	Ou, XH (corresponding author), Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China.; Ou, XH; Ma, JY (corresponding author), Guangdong Second Prov Gen Hosp, Reprod Med Ctr, Fertil Preservat Lab, Guangzhou, Peoples R China.; Ou, XH (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China.	ouxianghong2003@163.com; majy@gd2h.org.cn			Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2019GZR110104001]; Talent introduction fund of Guangdong Second Provincial General Hospital [YY2018-001]	Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Talent introduction fund of Guangdong Second Provincial General Hospital	This work was supported by the Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory to X.H.O. [2019GZR110104001] and the Talent introduction fund of Guangdong Second Provincial General Hospital to J.Y.M. [YY2018-001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, OFF J EUR UNION L, V15, P1; Baerwald AR, 2012, HUM REPROD UPDATE, V18, P73, DOI 10.1093/humupd/dmr039; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Cote AG, 2008, MOL CELL, V31, P800, DOI 10.1016/j.molcel.2008.08.025; Galindo CL, 2011, GENE CHROMOSOME CANC, V50, P275, DOI 10.1002/gcc.20853; Gotter AL, 2007, GENOME RES, V17, P470, DOI 10.1101/gr.6130907; Gougeon A, 2010, ANN ENDOCRINOL-PARIS, V71, P132, DOI 10.1016/j.ando.2010.02.021; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; HOAGE TR, 1976, ANAT REC, V184, P699, DOI 10.1002/ar.1091840409; Inagaki H, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00125; Inagaki H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2595; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; KASTROP PMM, 1991, MOL REPROD DEV, V28, P249, DOI 10.1002/mrd.1080280306; Kato T, 2007, FERTIL STERIL, V88, P1446, DOI 10.1016/j.fertnstert.2007.01.019; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Kurahashi H, 2006, DNA REPAIR, V5, P1136, DOI 10.1016/j.dnarep.2006.05.035; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma JY, 2019, HUM MOL GENET, V28, P3422, DOI 10.1093/hmg/ddz156; MEINECKE B, 1993, J REPROD FERTIL, V98, P195; Ohye T, 2014, PEDIATR INT, V56, P462, DOI 10.1111/ped.12437; Ohye T, 2010, EUR J HUM GENET, V18, P783, DOI 10.1038/ejhg.2010.20; Park Min-Woo, 2013, Dev Reprod, V17, P63, DOI 10.12717/DR.2013.17.1.063; Schoemaker MJ, 2019, INT J CANCER, V145, P1493, DOI 10.1002/ijc.32031; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Templado C, 2011, EUR J HUM GENET, V19, P145, DOI 10.1038/ejhg.2010.166; Witz G, 2010, NUCLEIC ACIDS RES, V38, P2119, DOI 10.1093/nar/gkp1161	32	3	3	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240844	10.1371/journal.pone.0240844	http://dx.doi.org/10.1371/journal.pone.0240844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079963	gold, Green Published			2022-12-26	WOS:000585940600018
J	Zhang, JX; Arif, M; Shen, HF; Hu, J; Sun, DY; Pu, XM; Yang, QY; Lin, BR				Zhang, Jingxin; Arif, Mohammad; Shen, Huifang; Hu, John; Sun, Dayuan; Pu, Xiaoming; Yang, Qiyun; Lin, Birun			Genomic divergence betweenDickeya zeaestrain EC2 isolated from rice and previously identified strains, suggests a different rice foot rot strain	PLOS ONE			English	Article							VI SECRETION; SP-NOV.; DICKEYA-ZEAE; EXTRACELLULAR POLYSACCHARIDE; FLAGELLIN GLYCOSYLATION; BIOFILM FORMATION; VIRULENCE; SYSTEM; PREDICTION; GENETICS	Rice foot rot caused byDickeya zeaeis an important bacterial disease of rice worldwide. In this study, we identified a new strain EC2 from rice in Guangdong province, China. This strain differed from the previously identified strain from rice in its biochemical characteristics, pathogenicity, and genomic constituents. To explore genomic discrepancies between EC2 and previously identified strains from rice, a complete genome sequence of EC2 was obtained and used for comparative genomic analyses. The complete genome sequence of EC2 is 4,575,125 bp in length. EC2 was phylogenetically closest to previously identifiedDickeyastrains from rice, but not within their subgroup. In terms of secretion systems, genomic comparisons revealed that EC2 harbored only type I (T1SS), typeII (T2SS), and type VI (T6SS) secretion systems. The flagella cluster of this strain possessed specific genomic characteristics like otherD.zeaestrains from Guangdong and from rice; within this locus, the genetic diversity among strains from rice was much lower than that of within strains from non-rice hosts. Unlike other strains from rice, EC2 lost the zeamine cluster, but retained the clustered regularly interspaced short palindromic repeats-1 (CRISPR-1) array. Compared to the otherD.zeaestrains containing both exopolysaccharide (EPS) and capsular polysaccharide (CPS) clusters, EC2 harbored only the CPS cluster, while the other strains from rice carried only the EPS cluster. Furthermore, we found strain MS1 from banana, carrying both EPS and CPS clusters, produced significantly more EPS than the strains from rice, and exhibited different biofilm-associated phenotypes. Comparative genomics analyses suggest EC2 likely evolved through a pathway different from the otherD.zeaestrains from rice, producing a new type of rice foot rot pathogen. These findings emphasize the emergence of a new type ofD.zeaestrain causing rice foot rot, an essential step in the early prevention of this rice bacterial disease.	[Zhang, Jingxin; Shen, Huifang; Sun, Dayuan; Pu, Xiaoming; Yang, Qiyun; Lin, Birun] Guangdong Acad Agr Sci, Inst Plant Protect, Key Lab New Tech Plant Protect Guangdong, Guangzhou, Peoples R China; [Arif, Mohammad; Hu, John] Univ Hawaii, Coll Trop Agr & Human Resources, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	Guangdong Academy of Agricultural Sciences; University of Hawaii System	Lin, BR (corresponding author), Guangdong Acad Agr Sci, Inst Plant Protect, Key Lab New Tech Plant Protect Guangdong, Guangzhou, Peoples R China.	linbr@126.com		Arif, Mohammad/0000-0002-5887-2050	Natural Science Foundation of Guangdong province [2015A030312002, 2016A030311017]; National Natural Science Foundation of China [31300118]; Science and Technology Project of Guangdong province [2016B020202003]; Science and Technology Project of Guangzhou city [201704030120]; Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science [R2017PY-QY004, R2018QD-056]	Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong province; Science and Technology Project of Guangzhou city; Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science	This research was supported by grants from the Natural Science Foundation of Guangdong province (2015A030312002, 2016A030311017) awarded to BL and QY, National Natural Science Foundation of China (31300118) awarded to JZ, Science and Technology Project of Guangdong province (2016B020202003) awarded to HS, the Science and Technology Project of Guangzhou city (201704030120) awarded to DS, and the Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science (R2017PY-QY004, R2018QD-056) awarded to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarjit Singh, 2009, Plant Disease Research (Ludhiana), V24, P135; ANDRO T, 1984, J BACTERIOL, V160, P1199, DOI 10.1128/JB.160.3.1199-1203.1984; BARRERE GC, 1986, INT J BIOL MACROMOL, V8, P372, DOI 10.1016/0141-8130(86)90058-9; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bellieny-Rabelo D, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02050-18; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319; Brady CL, 2012, INT J SYST EVOL MICR, V62, P1592, DOI 10.1099/ijs.0.035055-0; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Cheng YY, 2013, MOL PLANT MICROBE IN, V26, P1294, DOI 10.1094/MPMI-04-13-0098-R; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; De Maayer P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2735-x; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; GOTO M, 1979, PHYTOPATHOLOGY, V69, P213, DOI 10.1094/Phyto-69-213; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; Hong JM, 1983, J ZHEJIANG AGR U, V9, P339; Hu M, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1300-y; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Ichinose Y, 2013, J GEN PLANT PATHOL, V79, P359, DOI 10.1007/s10327-013-0464-4; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li HY, 2015, MICROB PATHOGENESIS, V85, P50, DOI 10.1016/j.micpath.2015.06.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu QiongGuang, 2004, Journal of South China Agricultural University, V25, P55; [刘琼光 Liu Qiongguang], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P2923; Long JT, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0037-5; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lv MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18578-2; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Oulghazi S, 2019, INT J SYST EVOL MICR, V69, P2440, DOI 10.1099/ijsem.0.003497; Parker CT, 2019, INT J SYST EVOL MICR, V69, pS7, DOI 10.1099/ijsem.0.000778; Parkinson N, 2014, INT J SYST EVOL MICR, V64, P2264, DOI 10.1099/ijs.0.058693-0; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; Pitman AR, 2010, EUR J PLANT PATHOL, V126, P423, DOI 10.1007/s10658-009-9551-y; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Prakasha A, 2017, BIOL CONTROL, V110, P107, DOI 10.1016/j.biocontrol.2017.04.012; Reverchon S, 2016, PROG MOL BIOL TRANSL, V142, P51, DOI 10.1016/bs.pmbts.2016.05.005; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Royet K, 2019, MOL PLANT PATHOL, V20, P287, DOI 10.1111/mpp.12754; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sleutel M, 2017, NAT CHEM BIOL, V13, P902, DOI 10.1038/nchembio.2413; Smith WPJ, 2020, PLOS BIOL, V18, DOI [10.1371/journal.pbio.3000720, 10.1371/journal.pbio.3000720.r001, 10.1371/journal.pbio.3000720.r002, 10.1371/journal.pbio.3000720.r003, 10.1371/journal.pbio.3000720.r004, 10.1371/journal.pbio.3000720.r005, 10.1371/journal.pbio.3000720.r006]; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tian YL, 2017, PHYTOPATHOLOGY, V107, P654, DOI [10.1094/PHYTO-11-16-0393-R, 10.1094/phyto-11-16-0393-r]; Tian YL, 2016, INT J SYST EVOL MICR, V66, P2831, DOI 10.1099/ijsem.0.001060; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0; Waleron M, 2002, MICROBIOL-SGM, V148, P583, DOI 10.1099/00221287-148-2-583; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang J. S., 1991, Acta Phytopathologica Sinica, V21, P181; Wang X, 2020, INT J SYST EVOL MICR, V70, P4171, DOI 10.1099/ijsem.0.004265; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; Yang SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002973; Zhang JX, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5154-3; Zhang LQ, 2012, J PLANT DIS PROTECT, V119, P125, DOI 10.1007/BF03356431; Zhang Q, 2018, J PLANT PATHOL, V100, P409, DOI 10.1007/s42161-018-0086-y; Zhou JN, 2016, MOL PLANT PATHOL, V17, P1398, DOI 10.1111/mpp.12376; Zhou JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1545-x; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087	82	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240908	10.1371/journal.pone.0240908	http://dx.doi.org/10.1371/journal.pone.0240908			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079956	Green Published, gold			2022-12-26	WOS:000585940600019
J	Rodriguez, NM; Casanova, F; Pages, G; Claure, L; Pedreira, M; Touchton, M; Knaul, F				Rodriguez, Natalia M.; Casanova, Felicia; Pages, Gabriela; Claure, Layla; Pedreira, Marian; Touchton, Michael; Knaul, Felicia			Community-based participatory design of a community health worker breast cancer training intervention for South Florida Latinx farmworkers	PLOS ONE			English	Article							PERSONAL PROTECTIVE EQUIPMENT; HISPANIC WOMEN; PESTICIDE EXPOSURE; ORANGE-COUNTY; IMMIGRANT; KNOWLEDGE; RISK; BEHAVIORS; DIAGNOSIS; CARE	Objective Community health worker (CHW)-led education is an important strategy to increase awareness and access to breast cancer screening in medically-underserved communities. This study aimed to develop a context-specific, culturally-appropriate training intervention for South Florida CHWs to educate Latinx immigrant farmworkers on breast cancer and early detection. Methods A community-based participatory research (CBPR) study, conducted 2017-2019, informed the design of a training curriculum for CHWs and educational dissemination materials. Twenty-two CHWs were trained and knowledge gains were measuring using a one-group pre-and post-test design. Triangulated evaluation consisted of field observations of CHW-client interactions, CHW self-reports, and rapid assessment surveys of community members. Results A community stakeholder-informed breast cancer training curriculum resulted in significant, sustained breast cancer knowledge gains among CHWs when comparing pre-, post-, and 4-6 month post-training follow-up test scores. Field observations of educational material dissemination, CHW self-reported evaluations, and community rapid assessment surveys at three health fairs demonstrated this was an effective strategy to engage female Latinx farmworkers in breast cancer education. Conclusions Community and key stakeholder participation in the development of a breast cancer educational intervention allowed for tailored design priorities around knowledge-based content, comprehensiveness, relevance, appropriateness, and ease of dissemination to community members. This model of participatory CHW training intervention design can enable future train-the-trainer approaches to disseminate and scale-up evidence-based health education interventions.	[Rodriguez, Natalia M.] Purdue Univ, Dept Publ Hlth, Coll Hlth & Human Sci, W Lafayette, IN 47907 USA; [Casanova, Felicia] Univ Miami, Coll Arts & Sci, Dept Sociol, Miami, FL USA; [Casanova, Felicia; Pages, Gabriela; Claure, Layla; Pedreira, Marian; Touchton, Michael; Knaul, Felicia] Univ Miami, Inst Adv Study Amer, Miami, FL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Miami; University of Miami	Rodriguez, NM (corresponding author), Purdue Univ, Dept Publ Hlth, Coll Hlth & Human Sci, W Lafayette, IN 47907 USA.	natalia@purdue.edu	Rodriguez, Natalia/AAP-8861-2021	Rodriguez, Natalia/0000-0002-2633-4397; Knaul, Felicia/0000-0002-0512-4788	Florida Breast Cancer Foundation; Miami Clinical and Translational Science Institute, from the National Center for Advancing Translational Sciences [UL1TR002736]; Miami Clinical and Translational Science Institute, from National Institute on Minority Health and Health Disparities [UL1TR002736]	Florida Breast Cancer Foundation; Miami Clinical and Translational Science Institute, from the National Center for Advancing Translational Sciences; Miami Clinical and Translational Science Institute, from National Institute on Minority Health and Health Disparities	This study was generously supported by the Florida Breast Cancer Foundation and by Grant Number UL1TR002736, Miami Clinical and Translational Science Institute, from the National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Schwartz NA, 2015, HEALTH PLACE, V32, P83, DOI 10.1016/j.healthplace.2014.12.016; [Anonymous], 2013, COMMUNITY HLTH WORKE; Arcury TA, 2001, ENVIRON HEALTH PERSP, V109, P429, DOI 10.2307/3434791; Arcury TA, 2016, ALCOHOL CLIN EXP RES, V40, P377, DOI 10.1111/acer.12969; Arnold TJ, 2019, PROG COMM HLTH PARTN, V13, P191, DOI 10.1353/cpr.2019.0019; Campbell K, 2017, WORKPLACE HEALTH SAF, V65, P313, DOI 10.1177/2165079916671955; Charmaz K, 2008, HDB CONSTRUCTIONIST, V1, P397, DOI DOI 10.1016/J.DESTUD.2004.08.003; Chavez LR, 2012, SOC SCI MED, V74, P887, DOI 10.1016/j.socscimed.2011.05.023; Chavez LR, 1997, INT MIGR REV, V31, P88, DOI 10.2307/2547259; Cosgrove S, 2014, HEALTH PROMOT PRACT, V15, P795, DOI 10.1177/1524839914541442; De Alba I, 2005, J GEN INTERN MED, V20, P290, DOI 10.1111/j.1525-1497.2005.40158.x; Earle-Richardson G, 2014, AM J IND MED, V57, P1053, DOI 10.1002/ajim.22352; Echeverria SE, 2006, MED CARE, V44, P788, DOI 10.1097/01.mlr.0000215863.24214.41; Engel LS, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1295; Engel LS, 2005, AM J EPIDEMIOL, V161, P121, DOI 10.1093/aje/kwi022; European Food Safety Authority (EFSA), 2005, EFSA J, V3, P235; Furgurson KF, 2019, J IMMIGR MINOR HEALT, V21, P515, DOI 10.1007/s10903-018-0771-0; Furgurson KF, 2019, HEALTH PROMOT PRACT, V20, P445, DOI 10.1177/1524839918764671; Guerrero N, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160036; Hugo G, 2013, MIGRATION POLICY I, V7, P1; Ingram M, 2015, HEALTH EXPECT, V18, P3007, DOI 10.1111/hex.12284; Israel B A, 2001, Educ Health (Abingdon), V14, P182; Joint Commitee For Guides In Metrology(JCGM), 2012, VIM3 INT VOCAB METRO, V3, P104; Keating NL, 2014, ONCOLOGIST, V19, P1091, DOI 10.1634/theoncologist.2014-0104; Kim K, 2016, AM J PUBLIC HEALTH, V106, pE3, DOI 10.2105/AJPH.2015.302987; Kim NJE, 2016, J AGROMEDICINE, V21, P154, DOI 10.1080/1059924X.2016.1143903; Knaul FM, 2010, DETECCION TEMPRANA C; Magana-Valladares L, 2018, J CANCER EDUC, V33, P160, DOI 10.1007/s13187-016-1065-7; Meade C D, 2001, Oncol Nurs Forum, V28, P1577; Mobley LR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050484; Montealegre JR, 2013, CANCER CAUSE CONTROL, V24, P1985, DOI 10.1007/s10552-013-0274-1; Palmer RC, 2005, HEALTH EDUC BEHAV, V32, P488, DOI 10.1177/1090198105276213; Payne J, 2017, J COMMUN HEALTH, V42, P983, DOI 10.1007/s10900-017-0345-4; Polat P, 2017, SOC WORK PUBLIC HLTH, V32, P166, DOI 10.1080/19371918.2015.1137525; Quandt SA, 2004, ENVIRON HEALTH PERSP, V112, P636, DOI 10.1289/ehp.6754; Quandt SA, 2013, HEALTH PROMOT PRACT, V14, P425, DOI 10.1177/1524839912459652; Remennick L, 2006, BREAST J, V12, pS103, DOI 10.1111/j.1075-122X.2006.00204.x; Salvatore AL, 2009, AM J PUBLIC HLTH S3, V99, pS578, DOI DOI 10.2105/AJPH.2008.149146; Scan 360, CANC DAT; Schlehofer MM, 2015, J COMMUN HEALTH NURS, V32, P71, DOI 10.1080/07370016.2015.1024541; Seay JS, 2015, PROG COMM HLTH PARTN, V9, P11, DOI 10.1353/cpr.2015.0029; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silver K, 2014, PROG COMM HLTH PARTN, V8, P501, DOI 10.1353/cpr.2014.0056; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Tovar-Aguilar JA, 2014, J AGROMEDICINE, V19, P107, DOI 10.1080/1059924X.2014.884397; Wadler BM, 2011, J ONCOL, V2011, DOI 10.1155/2011/150423; Widger K, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0085-8; Yarber L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1224-2; Zambrana RE, 1999, PREV MED, V29, P466, DOI 10.1006/pmed.1999.0566	49	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240827	10.1371/journal.pone.0240827	http://dx.doi.org/10.1371/journal.pone.0240827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IS	33075111	Green Published, gold			2022-12-26	WOS:000585920200013
J	Shiferaw, WS; Gatew, A; Afessa, G; Asebu, T; Petrucka, PM; Aynalem, YA				Shiferaw, Wondimeneh Shibabaw; Gatew, Abel; Afessa, Getnet; Asebu, Tsedale; Petrucka, Pammla Margaret; Aynalem, Yared Asmare			Assessment of knowledge and perceptions towards diabetes mellitus and its associated factors among people in Debre Berhan town, northeast Ethiopia	PLOS ONE			English	Article								Background Globally, diabetes is a major public health burden that results in more than 3.2 million adult deaths per year. Currently, diabetes is increasingly becoming a major threat to global public health, particularly in Sub-Saharan Africa. Although previous studies emphasized knowledge and health beliefs about diabetes among patients living with diabetes, there is minimal evidence about knowledge and perception of risk for developing diabetes at the community level. Objective This study aimed to assess the knowledge and perception of diabetes mellitus and its associated factors among people in Debre Berhan town, northeast Ethiopia. Methods A community-based cross-sectional study was conducted among 423 participants. The study was carried out from 25 February to 10 March 2019. Data were collected using a structured pretested questionnaire through face-to-face interviews. Data were entered into Epi data V 3.1 and exported to SPSS V 24 for analysis. A variable with p< 0.2 in bivariable analysis was entered into multivariable logistic regression. During multivariate analysis, variables with a p value of <= 0.05 were considered significantly associated. Result A total of 237 (56.02%) participants had good general knowledge about diabetes mellitus. In the multivariable analysis, participants who were single (AOR = 9.08, CI: 1.72-48), had a family history of diabetes (AOR = 2.83; CI: 1.10-7.24), and had exposure to health education (AOR = 3.27; CI: 2.02-5.31) were associated with good knowledge. In this study, few respondents (20.1%) felt that they had a higher risk of developing diabetes. Two-thirds of respondents (62.4%) saw diabetes is a serious disease. On the other hand, approximately 67% agreed to the perceived benefits of screening. Conclusion Almost half of the Debre Berhan community was found to have inadequate knowledge of diabetes mellitus. Married, higher educational status, exposure to health education, and family history of diabetes mellitus were significantly associated with good knowledge. The perceived risk of developing diabetes was low at the community level, although many respondents felt that behavior change is important in the prevention of diabetes. Therefore, policy makers, healthcare managers, and healthcare workers need to work cooperatively to foster community knowledge towards diabetes mellitus.	[Shiferaw, Wondimeneh Shibabaw; Asebu, Tsedale; Aynalem, Yared Asmare] Debre Berhan Univ, Inst Med & Hlth Sci, Coll Hlth Sci, Dept Nursing, Debre Berhan, Ethiopia; [Gatew, Abel; Afessa, Getnet] Debre Berhan Referral Hosp, Debre Berhan, Ethiopia; [Petrucka, Pammla Margaret] Univ Saskatchewan, Coll Nursing, Acad Borders, Saskatoon, SK, Canada	University of Saskatchewan	Shiferaw, WS (corresponding author), Debre Berhan Univ, Inst Med & Hlth Sci, Coll Hlth Sci, Dept Nursing, Debre Berhan, Ethiopia.	wshibabaw2015@gmail.com		Petrucka, Pammla/0000-0003-3174-3328				Abebe N, 2017, AFR J DIABETES MED, V25, P7; Abebe SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-97; Adejoh SO, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014539966; Al Shafaee MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-249; Al-Mutairi Reem L, 2015, Sultan Qaboos Univ Med J, V15, pe398, DOI 10.18295/squmj.2015.15.03.015; Aldasouqi SA, 2004, SAUDI MED J, V25, P1289; [Anonymous], 2013, DIABETES ATLAS; [Anonymous], 2018, ANN REPORT DEBRE BER; Asmamaw A, 2015, SCI J PUBLIC HLTH, V3, P199, DOI DOI 10.11648/J.SJPH.20150302.17; Balla SA, 2014, AM J HLTH RES, V2, P356, DOI DOI 10.11648/j.ajhr.20140206.16; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; FMOH, NAT STRAT ACT PLAN N; Glanz K., 2008, HLTH BEHAV HLTH ED T; Guariguata L., 2013, INT DIABETES FEDERAT; Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Kambinda DN, 2017, KNOWLEDGE ATTITUDES; Kassahun CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170040; Kassahun T, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0114-x; Maina WK, 2010, PAN AFR MED J, V7; Maina WK NZ, 2011, AFRICAN J DIABETES M; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mgbahurike A. A., 2017, WORLD J PHARM RES, P92, DOI [10.20959/wjpr201710-9388, DOI 10.20959/WJPR201710-9388]; Minhat H. S., 2014, World Journal of Medical Sciences, V11, P217; Moodley LM, 2007, S AFR FAM PRACT, V49, P16, DOI 10.1080/20786204.2007.10873652; Mukeshimana M, 2010, EXPLORING KNOWLEDGE; Mukeshimana MM, 2014, J CLIN NURS, V23, P541, DOI 10.1111/jocn.12199; Mukhopadhyay P, 2010, INT J DIABETES DEV C, V30, P143, DOI 10.4103/0973-3930.66510; Murugesan N SC, 2007, AWARENESS DIABETES I; National Comprehensive Cancer Network Dermatofibrosarcoma Protuberans and Merkel Cell Carcinoma, 2004, J Natl Compr Canc Netw, V2, P74; Peterson, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2; Pongmesa T SL, 2007, COMP DIABETES KNOWLE; Rani PK, 2008, RURAL REMOTE HEALTH, V8; Rasheed P, 2013, KUWAIT MED J, V45, P123; Sherwin RS, 2002, DIABETES CARE, V25, P742; Sristi S, 2015, INT J DIABETES DEV C, V35, P33, DOI 10.1007/s13410-014-0219-6; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thae Bo M, 2016, INT J PHYS MED REHAB, V04, P3; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Walter FM EJ, 2006, FAM PRACT; WHO, 2016, GLOB REP PSOR; Workie NW, 2013, HLTH EXTENSION PROGR	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240850	10.1371/journal.pone.0240850	http://dx.doi.org/10.1371/journal.pone.0240850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075078	Green Published, gold			2022-12-26	WOS:000585920200008
J	Asslander, L; Streuber, S				Asslaender, Lorenz; Streuber, Stephan			Virtual reality as a tool for balance research: Eyes open body sway is reproduced in photo-realistic, but not in abstract virtual scenes	PLOS ONE			English	Article							VISUAL CONTROL; MOTOR CONTROL; FALLS; POSTURE; ENVIRONMENTS; PREVENTION; RESPONSES; MOTION	Virtual reality (VR) technology is commonly used in balance research due to its ability to simulate real world experiences under controlled experimental conditions. However, several studies reported considerable differences in balance behavior in real world environments as compared to virtual environments presented in a head mounted display. Most of these studies were conducted more than a decade ago, at a time when VR was still struggling with major technical limitations (delays, limited field-of-view, etc.). In the meantime, VR technology has progressed considerably, enhancing its capacity to induce the feeling of presence and behavioural realism. In this study, we addressed two questions: Has VR technology now reached a point where balance is similar in real and virtual environments? And does the integration of visual cues for balance depend on the subjective experience of presence? We used a state-of-the-art head mounted VR system and a custom-made balance platform to compare balance when viewing (1) a real-world environment, (2) a photo-realistic virtual copy of the real-world environment, (3) an abstract virtual environment consisting of only spheres and bars (`low presence' VR condition), and, as reference, (4) a condition with eyes closed. Body sway of ten participants was measured in three different support surface conditions: (A) quiet stance, (B) stance on a sway referenced surface, and (C) surface tilting following a pseudo-random sequence. A 2-level repeated measures ANOVA and PostHoc analyses revealed no significant differences in body sway between viewing the real world environment and the photo-realistic virtual copy. In contrast, body sway was increased in the `low presence' abstract scene and further increased with eyes closed. Results were consistent across platform conditions. Our results support the hypothesis that state of the art VR reached a point of behavioural realism in which balance in photo-realistic VR is similar to balance in a real environment. Presence was lower in the abstract virtual condition as compared to the photo-realistic condition as measured by the IPQ presence questionnaire. Thus, our results indicate that spatial presence may be a moderating factor, but further research is required to confirm this notion. We conceive that virtual reality is a valid tool for balance research, but that the properties of the virtual environment affects results.	[Asslaender, Lorenz; Streuber, Stephan] Univ Konstanz, Constance, Germany; [Streuber, Stephan] Zukunftskolleg Univ Konstanz, Constance, Germany	University of Konstanz; University of Konstanz	Asslander, L (corresponding author), Univ Konstanz, Constance, Germany.	lorenz.asslaender@uni-konstanz.de	Assländer, Lorenz/ABG-4916-2021; Streuber, Stephan/ABG-1550-2021	Assländer, Lorenz/0000-0003-1394-9883; 	Zukunftskolleg "Cooperative Initiatives" Universitat Konstanz	Zukunftskolleg "Cooperative Initiatives" Universitat Konstanz	LA, SS Zukunftskolleg "Cooperative Initiatives" Universitat Konstanz; https://www.unikonstanz.de/zukunftskolleg/.	BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Breniere Y, 1996, J MOTOR BEHAV, V28, P291, DOI 10.1080/00222895.1996.10544598; BRONSTEIN AM, 1986, EXP BRAIN RES, V63, P655, DOI 10.1007/BF00237488; Carter ND, 2001, SPORTS MED, V31, P427, DOI 10.2165/00007256-200131060-00003; Chronicle of Higher Education, 2007, CHRONICLE HIGHER ED, V53, pB10; Cooper N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206218; Davies W.D.T., 1970, SYSTEM IDENTIFICATIO, Vfirst; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; Dokka K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000680; Horlings CGC, 2009, NEUROSCI LETT, V451, P227, DOI 10.1016/j.neulet.2008.12.057; JASP Team, 2019, JASP VERS 0 11 1 COM; Kang S.J., 2012, P 12 INT C CONSTR AP, P451; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kelly JW, 2008, PERCEPT PSYCHOPHYS, V70, P158, DOI 10.3758/PP.70.1.158; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kisker J, 2021, PSYCHOL RES-PSYCH FO, V85, P68, DOI 10.1007/s00426-019-01244-9; Logan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100418; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Menzies RJ, 2016, VIRTUAL REAL-LONDON, V20, P173, DOI 10.1007/s10055-016-0288-6; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; Nardone A, 2010, EUR J PHYS REHAB MED, V46, P221; NASHNER L, 1978, BRAIN RES, V150, P403, DOI 10.1016/0006-8993(78)90291-3; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pan XN, 2018, BRIT J PSYCHOL, V109, P395, DOI 10.1111/bjop.12290; Patton J, 2006, ASSIST TECHNOL, V18, P181, DOI 10.1080/10400435.2006.10131917; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pine DS, 2002, NEUROIMAGE, V15, P396, DOI 10.1006/nimg.2001.0988; Robert MT, 2016, GAIT POSTURE, V48, P261, DOI 10.1016/j.gaitpost.2016.06.010; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Sherman W. R., 2018, UNDERSTANDING VIRTUA; Slater M, 1997, PRESENCE-TELEOP VIRT, V6, P603, DOI 10.1162/pres.1997.6.6.603; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Streuber S, 2012, PRESENCE-TELEOP VIRT, V21, P281, DOI 10.1162/PRES_a_00113; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; van der Kooij H, 2005, J NEUROSCI METH, V145, P175, DOI 10.1016/j.jneumeth.2005.01.003; VANASTEN WNJC, 1988, EXP BRAIN RES, V73, P371, DOI 10.1007/BF00248230; Warren WH, 1996, J EXP PSYCHOL HUMAN, V22, P818, DOI 10.1037/0096-1523.22.4.818; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241479	10.1371/journal.pone.0241479	http://dx.doi.org/10.1371/journal.pone.0241479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119679	Green Published, gold			2022-12-26	WOS:000600013600060
J	Jin, X; Duan, YW; Bao, TF; Gu, JJ; Chen, YW; Li, YY; Mao, S; Chen, YF; Xie, W				Jin, Xin; Duan, Yongwei; Bao, Tengfei; Gu, Junjuan; Chen, Yawen; Li, Yuanyuan; Mao, Shi; Chen, Yongfeng; Xie, Wen			The values of coagulation function in COVID-19 patients	PLOS ONE			English	Article							THROMBOMODULIN	Objective To investigate the blood coagulation function in COVID-19 patients, and the correlation between coagulopathy and disease severity. Methods We retrospectively collected 147 clinically diagnosed COVID-19 patients at Wuhan Leishenshan Hospital of Hubei, China. We analyzed the coagulation function in COVID-19 patients through the data including thrombin-antithrombin complex (TAT), alpha 2-plasmininhibitor-plasmin Complex (PIC), thrombomodulin (TM), t-PA/PAI-1 Complex (t-PAIC), prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), fibrinogen (FIB), thrombin time (TT), D-Dimer (DD), and platelet (PLT). Result The levels of TAT, PIC, TM, t-PAIC, PT, INR, FIB, and DD in COVID-19 patients were higher than health controls (p<0.05), and also higher in the patients with thrombotic disease than without thrombotic disease (p<0.05). What's more, the patients with thrombotic disease had a higher case-fatality (p<0.05). TAT, PIC, TM, t-PAIC, PT, INR, APTT, FIB, DD, and PLT were also found correlated with disease severity. Meanwhile, we found that there were significant difference in TAT, TM, t-PAIC, PT, INR, APTT, DD, and PLT in the death and survival group. Further using univariate and multivariate logistic regression analysis also found that t-PAIC and DD were independent risk factors for death in patients and are excellent predicting the mortality risk of COVID-19. Conclusion Most COVID-19 patients with inordinate coagulation systems, dynamic monitoring of coagulation parameters might be a key in the control of COVID-19 death.	[Jin, Xin; Duan, Yongwei; Bao, Tengfei; Gu, Junjuan; Chen, Yawen; Xie, Wen] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Jin, Xin; Duan, Yongwei; Bao, Tengfei; Gu, Junjuan; Chen, Yawen; Xie, Wen] Wuhan Leishenshan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Li, Yuanyuan] Wuhan Hosp Tradit Chinese Med, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Mao, Shi] Wuhan Third Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Chen, Yongfeng] Wuhan Univ, Zhongnan Hosp, Med Management Dept, Wuhan, Hubei, Peoples R China; [Chen, Yongfeng] Wuhan Leishenshan Hosp, Med Management Dept, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Xie, W (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China.; Xie, W (corresponding author), Wuhan Leishenshan Hosp, Dept Lab Med, Wuhan, Hubei, Peoples R China.	whxw007@126.com						Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; [Anonymous], 2003, J PEDIATR SURG, DOI DOI 10.1016/S0022-3468(03)00270-7; [Anonymous], 2016, RINSHO KETSUEKI; [Anonymous], 2008, HAEMOPHILIA, DOI DOI 10.1111/J.1365-2516.2008.01834.X; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Fletcher-Sandersjoo A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00548; Fletcher-Sandersjoo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190365; Gong J., 2020, PREPRINT, DOI [DOI 10.1101/2020.02.25.20025643, 10.1101/2020.02.25.20025643, 10.1186/s12879-020-05681-5]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; HOEK JA, 1988, CLIN CHEM, V34, P2058; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; KAWAKAMI M, 1989, ARTHRITIS RHEUM, V32, P1427, DOI 10.1002/anr.1780321112; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Ozolina A, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-27; Pai VC, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0415-7; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Qiu H J, 2020, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V55, P569, DOI 10.3760/cma.j.cn115330-20200225-00128; Spanevello MM, 2012, LAB MED, V111, P8691; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Taylor Fletcher B Jr, 2002, Curr Hematol Rep, V1, P34; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wei YJ, 2018, MOL MED REP, V17, P1724, DOI 10.3892/mmr.2017.8070; World Health Organization, 15 WHO; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Zhou P, 2020, NATURE	27	36	37	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241329	10.1371/journal.pone.0241329	http://dx.doi.org/10.1371/journal.pone.0241329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119703	gold, Green Submitted, Green Published			2022-12-26	WOS:000600013600097
J	Salimi, Z; Ferguson-Pell, MW				Salimi, Zohreh; Ferguson-Pell, Martin William			Investigating the test-retest reliability of Illinois Agility Test for wheelchair users	PLOS ONE			English	Article							EFFICIENCY; TEAM	The Illinois Agility Test (IAT) is a standard agility course used to assess and train able-bodied athletes as well as wheelchair-sport athletes and rehabilitation of wheelchair users. It has been shown to be a reliable and valid tool to assess the able-bodied population, but the reliability of this test for assessing wheelchair propulsion has never been shown. The purpose of this study is to investigate the test-retest reliability of IAT to assess wheelchair propulsion. In this paper, the test-retest reliability of using IAT for wheelchair users is found for peak and average velocity, acceleration, tangential and total force of the push, each for the left and the right wheel. Each of these variables was found for thirty-two decisive points throughout the IAT path. The Intra-class Correlation Coefficient (ICC) was found to be very strong for 15 out of 16 variables. The average ICC was 89% and the average 95% confidence interval was [44% 96%]. In addition, thirty-seven other significant propulsion parameters were found that are clinically important, such as the number of pushes participants take to go around cones on the right, relative to turning around the cones on the left. Also, all thirty-seven variables were compared between the two sessions using four separate MANOVAs; the results showed no significant difference between IAT performed in the two sessions which were at least one week apart. This, in turn, backs the reliability of IAT for wheelchair users. These results are sufficient evidence to show that IAT is a reliable tool to test wheelchair agility for fifteen variables tested for non-wheelchair users. Since experienced wheelchair users are much more consistent in wheelchair propulsion compared to non-wheelchair-users, the results of this study show that IAT can be used as a reliable tool to assess and train wheelchair users, both for clinical and athletic applications.	[Salimi, Zohreh; Ferguson-Pell, Martin William] Univ Alberta, Fac Rehabil Med, Dept Rehabil Sci, Edmonton, AB, Canada; [Salimi, Zohreh] Hamedan Univ Med Sci, Autism Spectrum Disorders Res Ctr, Hamadan, Hamadan, Iran	University of Alberta	Ferguson-Pell, MW (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Rehabil Sci, Edmonton, AB, Canada.	martin.ferguson-pell@ualberta.ca		Salimi, Zohreh/0000-0001-5125-9512	Canadian Foundation for Innovation [CFI 30852]	Canadian Foundation for Innovation(Canada Foundation for Innovation)	The authors received no specific funding for this work. Canadian Foundation for Innovation (CFI 30852 Leading Edge Fund 2012) infrastructure grant provided the capital equipment for the project.	Amiri-Khorasani M, 2010, J STRENGTH COND RES, V24, P2698, DOI 10.1519/JSC.0b013e3181bf049c; ASATO KT, 1993, IEEE T BIO-MED ENG, V40, P1320, DOI 10.1109/10.250587; Cooper R., 1998, TEAM REHAB REP, V9, P35; Cowan RE, 2008, ARCH PHYS MED REHAB, V89, P260, DOI 10.1016/j.apmr.2007.08.141; de Groot S, 2004, AM J PHYS MED REHAB, V83, P640, DOI 10.1097/01.phm.0000133437.58810.c6; de Vries T. J. A., 1999, P INT BIOM WORKSH AP, P110; Ferguson-Pell M., 2017, DOI 10.1080/10400435.2017.1340360, Patent No. [WO 2017/059534 Al, 2017059534]; French CD, 2002, IEE CONF PUBL, P1, DOI 10.1049/cp:20020080; Gabbett TJ, 2002, J SPORT SCI, V20, P399, DOI 10.1080/026404102317366654; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Hachana Y, 2013, J STRENGTH COND RES, V27, P2752, DOI 10.1519/JSC.0b013e3182890ac3; Kulig K, 2001, CLIN BIOMECH, V16, P744, DOI 10.1016/S0268-0033(01)00066-3; Lam WN, 2001, P ANN INT IEEE EMBS, V23, P1441, DOI 10.1109/IEMBS.2001.1020474; Lenton JP, 2008, APPL PHYSIOL NUTR ME, V33, P870, DOI 10.1139/H08-072; Medola FO, 2014, IEEE T NEUR SYS REH, V22, P326, DOI 10.1109/TNSRE.2013.2289378; Qi L, 2015, SPINAL CORD, V53, P687, DOI 10.1038/sc.2015.30; Raya MA, 2013, J REHABIL RES DEV, V50, P951, DOI 10.1682/JRRD.2012.05.0096; Richter WM, 2001, MED ENG PHYS, V23, P707, DOI 10.1016/S1350-4533(01)00074-1; Robertson R. N., 1996, PUSHRIM FORCES JOINT, P856; Salimi Z., 15 BIOM ENG C BME PR, P73; Salimi Z., 2017, PHYS DISABILITY; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Shoukri M, 2014, STAT METHODS MED RES, V13, P251; SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Usma-alvarez C. C., 2014, SPORT TECHNOL, V3, P37; VANDERWOUDE LHV, 1995, J MED ENG TECHNOL, V19, P123, DOI 10.3109/03091909509012418; Vergouw D, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-63; Watanabe L., 2011, MOBILITY MANAGEMENT; Williams E.J., 2014, WHEELCHAIR BASKETBAL; Yang SY, 2016, 2016 INTERNATIONAL SYMPOSIUM ON COMPUTER, CONSUMER AND CONTROL (IS3C), P49, DOI 10.1109/IS3C.2016.23	31	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241412	10.1371/journal.pone.0241412	http://dx.doi.org/10.1371/journal.pone.0241412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119654	gold, Green Published			2022-12-26	WOS:000600013600027
J	Rattanathammethee, T; Tuitemwong, P; Thiennimitr, P; Sarichai, P; Pombejra, SN; Piriyakhuntorn, P; Hantrakool, S; Chai-Adisaksopha, C; Rattarittamrong, E; Tantiworawit, A; Norasetthada, L				Rattanathammethee, Thanawat; Tuitemwong, Pimchanok; Thiennimitr, Parameth; Sarichai, Phinitphong; Pombejra, Sarisa Na; Piriyakhuntorn, Pokpong; Hantrakool, Sasinee; Chai-Adisaksopha, Chatree; Rattarittamrong, Ekarat; Tantiworawit, Adisak; Norasetthada, Lalita			Gut microbiota profiles of treatment-naive adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy	PLOS ONE			English	Article							COLONIZATION; ANTIBIOTICS; DOMINATION; INFECTION; THERAPY	The intestinal bacterial flora of febrile neutropenic patients has been found to be significantly diverse. However, there are few reports of alterations of in adult acute myeloid leukemia (AML) patients. Stool samples of each treatment-naive AML patient were collected the day before initiation of induction chemotherapy (pretreatment), on the first date of neutropenic fever and first date of bone marrow recovery. Bacterial DNA was extracted from stool samples and bacterial 16s ribosomal RNA genes were sequenced by next-generation sequencing. Relative abundance, overall richness, Shannon's diversity index and Simpson's diversity index were calculated. No antimicrobial prophylaxis was in placed in all participants. Ten cases of AML patients (4 male and 6 female) were included with a median age of 39 years (range: 19-49) and all of patients developed febrile neutropenia. Firmicutes dominated during the period of neutropenic fever, subsequently declining after bone marrow recovery a pattern in contrast to that shown by Bacteroidetes and Proteobacteria. Enterococcus was more abundant in the febrile neutropenia period compared to pretreatment (mean difference +20.2; p < 0.0001) while Escherichia notably declined during the same period (mean difference -11.2; p = 0.0064). At the operational taxonomic unit (OTU) level, there was a significantly higher level of overall richness in the pretreatment period than in the febrile neutropenic episode (mean OTU of 203.1 vs. 131.7; p = 0.012). Both of the diversity indexes of Shannon and Simpson showed a significant decrease during the febrile neutropenic period. Adult AML patients with a first episode of febrile neutropenia after initial intensive chemotherapy demonstrated a significant decrease in gut microbiota diversity and the level of diversity remained constant despite recovery of bone marrow.	[Rattanathammethee, Thanawat; Piriyakhuntorn, Pokpong; Hantrakool, Sasinee; Chai-Adisaksopha, Chatree; Rattarittamrong, Ekarat; Tantiworawit, Adisak; Norasetthada, Lalita] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Hematol, Chiang Mai, Thailand; [Tuitemwong, Pimchanok] Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai, Thailand; [Thiennimitr, Parameth; Sarichai, Phinitphong] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Thiennimitr, Parameth] Chiang Mai Univ, Res Ctr Microbial Divers & Sustainable Utilizat, Chiang Mai, Thailand; [Pombejra, Sarisa Na] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chulalongkorn University	Rattanathammethee, T (corresponding author), Chiang Mai Univ, Fac Med, Dept Internal Med, Div Hematol, Chiang Mai, Thailand.	thanawat_r@outlook.com	Piriyakhuntorn, Pokpong/ABC-1664-2021; Thiennimitr, Parameth/AAA-3854-2021	Piriyakhuntorn, Pokpong/0000-0001-9730-8260; Rattanathammethee, Thanawat/0000-0003-2731-4889; Sarichai, Phinitphong/0000-0003-2892-0522; Na Pombejra, Sarisa/0000-0002-5472-0674	faculty of Medicine, Chiang Mai University, Thailand [MED-2559-03947]	faculty of Medicine, Chiang Mai University, Thailand	TR received the research grant from faculty of Medicine, Chiang Mai University, Thailand. (study code: MED-2559-03947) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2016, EVIDENCE, V8, pe1000; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; [Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; [Anonymous], 2009, EUROPEAN J ENDOVASCU, V37, pS1; [Anonymous], 2011, CLIN INFECT DIS S5, V52, pS397; [Anonymous], 2013, NUCLEIC ACIDS RES, V41, pD43; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Bai L, 2017, J MED MICROBIOL, V66, P1297, DOI 10.1099/jmm.0.000568; Bow EJ, 1997, J CLIN ONCOL, V15, P2254, DOI 10.1200/JCO.1997.15.6.2254; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EFSA (European Food Safety Authority), 2008, EFSA J, V6, p120r, DOI 10.2903/j.efsa.2008.120r; Galloway-Pena JR, 2016, CANCER-AM CANCER SOC, V122, P2186, DOI 10.1002/cncr.30039; Gaulke CA, 2018, NAT MED, V24, P1495, DOI 10.1038/s41591-018-0210-8; Hakim H, 2018, CLIN INFECT DIS, V67, P541, DOI 10.1093/cid/ciy153; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; James V. A., 2004, BEDE ROLL FRATERNITY, V39, pxiii; Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016; Khalil F, 2007, ARCH PATHOL LAB MED, V131, P1281; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Montassier E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0301-4; Nearing JT, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00028; Peled JU, 2020, NEW ENGL J MED, V382, P822, DOI 10.1056/NEJMoa1900623; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rashidi A, 2020, CANCER-AM CANCER SOC, V126, P1434, DOI 10.1002/cncr.32641; Ribosomal Database Project, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI [10.1093/nar/gkt124424288368, DOI 10.1093/NAR/GKT124424288368]; Schneider SM, 2000, EUR J NUTR, V39, P248, DOI 10.1007/s003940070003; Schwabkey ZI, 2020, ANNU REV MED, V71, P137, DOI 10.1146/annurev-med-052918-122440; Shannon CE, 1997, M D COMPUT, V14, P306; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song YJ, 2020, CURR TREAT OPTION ON, V21, DOI 10.1007/s11864-019-0693-7; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van der Velden WJFM, 2014, BRIT J HAEMATOL, V167, P441, DOI 10.1111/bjh.13113; van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346; Weber D, 2019, CLIN INFECT DIS, V68, P1303, DOI 10.1093/cid/ciy711; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; 2006, APPL ENV MICROBIOL, V72, P5069	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0236460	10.1371/journal.pone.0236460	http://dx.doi.org/10.1371/journal.pone.0236460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112882	Green Published, gold, Green Submitted			2022-12-26	WOS:000588374000029
J	Chen, L; Xu, MC; Wang, CX; Zheng, JS; Huang, GQ; Chen, F; Peng, DH; Sun, M				Chen, Ling; Xu, Mengci; Wang, Chunxiao; Zheng, Jinshui; Huang, Guoqiang; Chen, Feng; Peng, Donghai; Sun, Ming			Multi-copy alpha-amylase genes are crucial for Ditylenchus destructor to parasitize the plant host	PLOS ONE			English	Article							RNA INTERFERENCE; SWEET-POTATO; NEMATODE; ENZYMES; RESISTANCE; ALIGNMENT; PROTEINS; SEQUENCE; TISSUE	Ditylenchus destructor is a migratory plant-parasitic nematode that causes huge damage to global root and tuber production annually. The main plant hosts of D. destructor contain plenty of starch, which makes the parasitic environment of D. destructor to be different from those of most other plant-parasitic nematodes. It is speculated that D. destructor may harbor some unique pathogenesis-related genes to parasitize the starch-rich hosts. Herein, we focused on the multi-copy alpha-amylase genes in D. destructor, which encode a key starch-catalyzing enzyme. Our previously published D. destructor genome showed that it has three alpha-amylase encoding genes, Dd_02440, Dd_11154, and Dd_13225. Comparative analysis of alpha-amylases from different species demonstrated that the other plant-parasitic nematodes, even Ditylenchus dipsaci in the same genus, harbor only one or no alpha-amylase gene, and the three genes from D. destructor were closely clustered in the phylogenetic tree, indicating that there was a unique expansion of the alpha-amylase gene in D. destructor. The enzymatic activity of the three alpha-amylase proteins was verified by an enzyme assay. Quantitative real-time PCR assay showed that the expression of the three alpha-amylase genes in the post-hatching stage of D. destructor was found to be significantly higher than that in eggs. In the in situ hybridization assay, the expression of the genes was localized to the intestine, implying the association of these genes with nematode digestion. An infection assay in sweet potato demonstrated that RNA interference of any one alpha-amylase gene had no influence on the infectivity of D. destructor. Using the multi-target dsRNA cocktail method, it was found that silencing of two of the three genes inhibited nematode infection, and the infectivity of worms treated with three dsRNA simultaneously changed the most, which decreased by 76.6%. Thus, the multi-copy alpha-amylase genes in D. destructor are compensatory and crucial for nematodes to parasitize the plant host.	[Chen, Ling; Xu, Mengci; Wang, Chunxiao; Zheng, Jinshui; Huang, Guoqiang; Chen, Feng; Peng, Donghai; Sun, Ming] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Sun, M (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	m98sun@mail.hzau.edu.cn		Chen, Ling/0000-0001-7785-9305	National Key Research and Development Program of China [2017YFD0201201]; National Natural Science Foundation of China [31770116]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Research and Development Program of China (2017YFD0201201), the National Natural Science Foundation of China (31670085) and the National Natural Science Foundation of China (31770116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Duque LO, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00237; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elling AA, 2013, PHYTOPATHOLOGY, V103, P1092, DOI 10.1094/PHYTO-01-13-0019-RVW; Fan WJ, 2015, PHYTOPATHOLOGY, V105, P1458, DOI 10.1094/PHYTO-04-15-0087-R; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Hajihassani A, 2017, PLANT DIS, V101, P297, DOI 10.1094/PDIS-04-16-0479-RE; Janecek S, 2016, CELL MOL LIFE SCI, V73, P2707, DOI 10.1007/s00018-016-2246-6; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li Y, 2015, INT J BIOL SCI, V11, P1073, DOI 10.7150/ijbs.12065; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Liu GH, 2015, FOLIA MICROBIOL, V60, P443, DOI 10.1007/s12223-015-0380-4; Long H, 2006, EXP PARASITOL, V113, P106, DOI 10.1016/j.exppara.2005.12.010; Lopienska-Biernat E, 2008, J HELMINTHOL, V82, P45, DOI 10.1017/S0022149X0787355X; Mathew R, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9060671; Mccoy CJ, 2015, INT J PARASITOL, V45, P673, DOI 10.1016/j.ijpara.2015.05.003; Mills MK, 2017, J MED ENTOMOL, V54, P559, DOI 10.1093/jme/tjw225; Mizen KA, 2002, PLANT RESISTANCE PAR, P107; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Pandey A, 2000, BIOTECHNOL APPL BIOC, V31, P135, DOI 10.1042/BA19990073; Peng Huan, 2009, Journal of Agricultural Biotechnology, V17, P1035; Rehman S, 2009, PHYTOPATHOLOGY, V99, P194, DOI 10.1094/PHYTO-99-2-0194; Roderick H, 2018, PLANT BIOTECHNOL J, V16, P520, DOI 10.1111/pbi.12792; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vieira P, 2018, MOL PLANT PATHOL, V19, P1887, DOI 10.1111/mpp.12666; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x; Xu Z, 2015, NEMATOLOGY, V17, P117, DOI 10.1163/15685411-00002856; YOO YJ, 1987, BIOTECHNOL BIOENG, V30, P147, DOI 10.1002/bit.260300120; Zheng JS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0942; 2013, SURG OBES RELAT DIS, V9	39	2	3	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240805	10.1371/journal.pone.0240805	http://dx.doi.org/10.1371/journal.pone.0240805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104741	Green Published, gold			2022-12-26	WOS:000588370000045
J	Lin, CY; Lee, JA; Lin, PY; Hua, SC; Tsai, PY; Chen, BL; Lin, CE; Lee, TH; Chen, SM				Lin, Chia-Yu; Lee, Jen-Ai; Lin, Po-Yeh; Hua, Shih-Chun; Tsai, Pei-Yun; Chen, Bi-Li; Lin, Chia-En; Lee, Tzong-Huei; Chen, Shih-Ming			Utilizing methylglyoxal and D-lactate in urine to evaluate saikosaponin C treatment in mice with accelerated nephrotoxic serum nephritis	PLOS ONE			English	Article							MASUGI NEPHRITIS; EXPERIMENTAL GLOMERULONEPHRITIS; GLYOXALASE SYSTEM; ACID; MECHANISM; RAT; COMPLEMENT; BUPLEURUM; PATHOGENESIS; PHARMACOLOGY	The relationship between methylglyoxal (MGO) and D-lactate during saikosaponin C (SSC) treatment of mice with accelerated nephrotoxic serum (NTS) nephritis was investigated. NTS nephritis was induced by administration of anti-basement membrane antibodies to C57BL/6 mice and three dosages of SSC were administered for 14 days. Proteinuria, blood urea nitrogen, serum creatinine, renal histology, urinary MGO and d-lactate changes were examined. Compared to the NTS control group, the middle dosage (10 mg/kg/day) of SSC significantly alleviated the development of nephritis based on urine protein measurements (34.40 +/- 6.85 vs. 17.33 +/- 4.79 mg/day, p0.05). Pathological observation of the glomerular basement membrane (GBM) revealed monocyte infiltration, hypertrophy, and crescents were alleviated, and injury scoring also showed improved efficacy for the middle dose of SSC during nephritis (7.92 +/- 1.37 vs. 3.50 +/- 1.14, p0.05). Moreover, the significant decreases in urinary levels of MGO (24.71 +/- 3.46 vs. 16.72 +/- 2.36 mu g/mg, p0.05) and D-lactate (0.31 +/- 0.04 vs. 0.23 +/- 0.02 mu mol/mg, p0.05) were consistent with the biochemical and pathological examinations. This study demonstrates that MGO and D-lactate may reflect the extent of damage and the efficacy of SSC in NTS nephritis; further studies are required to enable clinical application.	[Lin, Chia-Yu; Lee, Jen-Ai; Lin, Po-Yeh; Hua, Shih-Chun; Tsai, Pei-Yun; Chen, Bi-Li; Lin, Chia-En; Chen, Shih-Ming] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Lin, Chia-Yu; Chen, Bi-Li] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; [Hua, Shih-Chun] Cathay Gen Hosp, Dept Pharm, Taipei, Taiwan; [Tsai, Pei-Yun] WanFang Hosp, Dept Pharm, Taipei, Taiwan; [Lee, Tzong-Huei] Natl Taiwan Univ, Inst Fisheries Sci, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Cathay General Hospital; Taipei Municipal WanFang Hospital; National Taiwan University	Chen, SM (corresponding author), Taipei Med Univ, Sch Pharm, Taipei, Taiwan.; Lee, TH (corresponding author), Natl Taiwan Univ, Inst Fisheries Sci, Taipei, Taiwan.	thlee1@ntu.edu.tw; smchen@tmu.edu.tw			Cathay General Hospital [108CGH-TMU-06]	Cathay General Hospital	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by Cathay General Hospital (108CGH-TMU-06).	[Anonymous], 2002, NEPHROL DIAL TRAN S4, V17, P34; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 1999, BEHAV GENET, V29, P103; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; [Anonymous], 2018, J ORTHOP TRAUMA, V32, pS141; [Anonymous], 2019, OPTICS EXPRESS, V27, pA581; [Anonymous], 2020, AM J PHYSIOL-CELL PH, V318, pC137; Ashour ML, 2011, J PHARM PHARMACOL, V63, P305, DOI 10.1111/j.2042-7158.2010.01170.x; BRUNETTI M, 1995, BLOOD, V86, P4199, DOI 10.1182/blood.V86.11.4199.bloodjournal86114199; Chalmers SA, 2015, J AUTOIMMUN, V57, P42, DOI 10.1016/j.jaut.2014.11.007; Chen RJY, 2010, ACTA PHARMACOL SIN, V31, P696, DOI 10.1038/aps.2010.61; Chen SM, 2008, J ETHNOPHARMACOL, V116, P397, DOI 10.1016/j.jep.2007.11.026; Chen SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227838; Chen SM, 2002, PHARMACOL RES, V45, P319, DOI 10.1006/phrs.2002.0948; Chiang LC, 2003, PLANTA MED, V69, P705, DOI 10.1055/s-2003-42797; Espinosa-Mansilla A, 2007, ANAL BIOCHEM, V371, P82, DOI 10.1016/j.ab.2007.07.028; ESTERBAUER H, 1982, BIOCHEM J, V208, P129, DOI 10.1042/bj2080129; Ewaschuk JB, 2005, J NUTR, V135, P1619, DOI 10.1093/jn/135.7.1619; Fan JH, 2007, BIOCHEM CELL BIOL, V85, P189, DOI 10.1139/O07-010; Fodelianaki G, 2019, EXP CELL RES, V377, P10, DOI 10.1016/j.yexcr.2019.02.023; FUJIMOTO T, 1964, ACTA PATHOL JAPON, V14, P275; Fukushima T, 2001, BIOMED CHROMATOGR, V15, P189, DOI 10.1002/bmc.60; HAMMER DK, 1963, J EXP MED, V117, P1019, DOI 10.1084/jem.117.6.1019; Hata Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59970-9; HATTORI T, 1991, FOLIA PHARMACOL JPN, V97, P13, DOI 10.1254/fpj.97.1_13; Hebert LA, 2013, AM J NEPHROL, V38, P253, DOI 10.1159/000354390; Hebert MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2799, DOI 10.1093/ndt/13.11.2799; Horio T, 2001, PATHOL INT, V51, P72, DOI 10.1046/j.1440-1827.2001.01165.x; Huang TC, 2014, LIFE SCI, V114, P4, DOI 10.1016/j.lfs.2014.07.034; Huang TC, 2013, BIOMED CHROMATOGR, V27, P1100, DOI 10.1002/bmc.2908; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0; Jin X, 2013, NEURAL REGEN RES, V8, P3241, DOI 10.3969/j.issn.1673-5374.2013.34.008; KONDO Y, 1976, LAB INVEST, V34, P363; KONDO Y, 1982, ACTA PATHOL JAPON, V32, P231; Kuppe C, 2017, J AM SOC NEPHROL, V28, P1408, DOI 10.1681/ASN.2016010060; KURIYAMA R, 1985, Bulletin of Tokyo Medical and Dental University, V32, P155; Lee JA, 2005, ANAL CHIM ACTA, V534, P185, DOI 10.1016/j.aca.2004.11.033; Li YC, 2013, TOXICOL LETT, V219, P85, DOI 10.1016/j.toxlet.2013.01.024; Li YC, 2012, BIOCHEM BIOPH RES CO, V423, P832, DOI 10.1016/j.bbrc.2012.06.049; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Lin MH, 2011, J CHROMATOGR B, V879, P3214, DOI 10.1016/j.jchromb.2011.02.015; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Ma Y, 2016, INFLAMMATION, V39, P1453, DOI 10.1007/s10753-016-0377-4; Meagher LC, 1996, J IMMUNOL, V156, P4422; Menzel S, 2011, PEDIATR NEPHROL, V26, P1775, DOI 10.1007/s00467-010-1725-5; Naik S., 2017, APPL ORGANOMET CHEM, V31, pe3549, DOI 10.1002/aoc.3549; Pan YC, 2019, INFLAMM RES, V68, P1025, DOI 10.1007/s00011-019-01284-2; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2014, BIOCHEM SOC T, V42, P413, DOI 10.1042/BST20140014; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Rosenkranz AR, 2000, KIDNEY INT, V58, P1055, DOI 10.1046/j.1523-1755.2000.00263.x; Silva MS, 2013, BIOCHEM J, V453, P1, DOI 10.1042/BJ20121743; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tipping PG, 2006, J AM SOC NEPHROL, V17, P1253, DOI 10.1681/ASN.2005091013; Tsai YC, 2003, ANAL BIOCHEM, V319, P34, DOI 10.1016/S0003-2697(03)00283-5; UNANUE E, 1964, J EXP MED, V119, P965, DOI 10.1084/jem.119.6.965; Ying ZL, 2014, EXP THER MED, V7, P1354, DOI 10.3892/etm.2014.1568	61	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241053	10.1371/journal.pone.0241053	http://dx.doi.org/10.1371/journal.pone.0241053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104740	Green Published, gold			2022-12-26	WOS:000588370000025
J	Ting, SW; Fan, PC; Lin, YS; Lin, MS; Lee, CC; Kuo, G; Chang, CH				Ting, Sze-Wen; Fan, Pei-Chun; Lin, Yu-Sheng; Lin, Ming-Shyan; Lee, Cheng-Chia; Kuo, George; Chang, Chih-Hsiang			Uremic pruritus and long-term morbidities in the dialysis population	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; INTERDIALYTIC WEIGHT-GAIN; ACUTE MYOCARDIAL-INFARCTION; PRACTICE PATTERNS; HEMODIALYSIS-PATIENTS; NATRIURETIC PEPTIDE; PARATHYROID-HORMONE; ISCHEMIC-STROKE; SKIN-CANCER; ASSOCIATION	Background Uremic pruritus (UP) is a multifactorial problem that contributes to low quality of life in dialysis patients. The long-term influences of UP on dialysis patients are still poorly understood. This study aims to elucidate the contribution of UP to long-term outcomes. Materials and method We used the Taiwan National Health Insurance Research Database to conduct this study. Patients on chronic dialysis were included and divided into UP and non-UP groups according to the long-term prescription of antihistamine in the absence of other indications. The outcomes include infection-related hospitalization, catheter-related infection, major adverse cardiac and cerebrovascular events (MACCE) and parathyroidectomy. Results After propensity score matching, 14,760 patients with UP and 29,520 patients without UP were eligible for analysis. After a mean follow-up of 5 years, we found that infection-related hospitalization, MACCE, catheter-related infection, heart failure and parathyroidectomy were all slightly higher in the UP than non-UP group (hazard ratio: 1.18 [1.16-1.21], 1.05 [1.01-1.09], 1.16 [1.12-1.21], 1.08 [1.01-1.16] and 1.10 [1.01-1.20], respectively). Subgroup analysis revealed that the increased risk of adverse events by UP was generally more apparent in younger patients and patients who underwent peritoneal dialysis. Conclusion UP may be significantly associated with an increased risk of long-term morbidities.	[Ting, Sze-Wen] Chang Gung Med Fdn, New Taipei City Tu Cheng Municipal Hosp, Dept Dermatol, Taoyuan, Taiwan; [Fan, Pei-Chun; Lee, Cheng-Chia; Kuo, George; Chang, Chih-Hsiang] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taoyuan, Taiwan; [Lin, Yu-Sheng; Lin, Ming-Shyan] Chiayi Chang Gung Mem Hosp, Dept Cardiol, Puzi City, Taiwan; [Lin, Yu-Sheng; Chang, Chih-Hsiang] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, CH (corresponding author), Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taoyuan, Taiwan.; Chang, CH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	sunchang@cgmh.org.tw	Kuo, George/AGE-0252-2022; Kuo, George/ABA-3641-2021	Kuo, George/0000-0002-5908-403X; Kuo, George/0000-0002-5908-403X; Lee, Cheng-Chia/0000-0002-6973-5908; Lin, Ming-shyan/0000-0001-9348-8153	Taiwan Ministry of Science and Technology [106-2314-B-182A-118-MY3]; Taiwan Clinical Trial Consortium [MOST 106-2321-B-182-002, 105-2314-B-002-045]	Taiwan Ministry of Science and Technology; Taiwan Clinical Trial Consortium	This work was supported by Taiwan Ministry of Science and Technology in the form of a grant awarded to CHC (106-2314-B-182A-118-MY3) and Taiwan Clinical Trial Consortium in the form of grants awarded to CHC (MOST 106-2321-B-182-002, 105-2314-B-002-045) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Amrein K, 2016, CLIN NUTR, V35, P514, DOI 10.1016/j.clnu.2015.03.020; [Anonymous], 2005, ESTUDOS BIOLOGIA CUR, V27, P19; [Anonymous], 2009, AM J KIDNEY DIS, V53, pS11; [Anonymous], 2018, DIABETES CARE, V40, pS1; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, MEDICINE, V95, pe3187; Austin PC, 2019, STAT MED, V38, P751, DOI 10.1002/sim.8008; Baron-Epel O, 2010, EUR J PUBLIC HEALTH, V20, P543, DOI 10.1093/eurpub/ckq052; Cabrera C, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0110-9; Chen YT, 2015, J EUR ACAD DERMATOL, V29, P1362, DOI 10.1111/jdv.12870; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cho YL, 1997, J AM ACAD DERMATOL, V36, P538, DOI 10.1016/S0190-9622(97)70240-8; Chou FF, 2000, J AM COLL SURGEONS, V190, P65, DOI 10.1016/S1072-7515(99)00212-4; Gangemi S, 2017, ALLERGY ASTHMA PROC, V38, P401, DOI 10.2500/aap.2017.38.4080; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Hung LC, 2017, J EPIDEMIOL, V27, P24, DOI 10.1016/j.je.2016.08.003; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kempker JA, 2019, CLIN INFECT DIS, V68, P1926, DOI 10.1093/cid/ciy794; Kiguchi N, 2016, J PHARMACOL EXP THER, V356, P596, DOI 10.1124/jpet.115.229997; Kimata N, 2014, HEMODIAL INT, V18, P657, DOI 10.1111/hdi.12158; Ko MJ, 2014, J AM ACAD DERMATOL, V71, P1151, DOI 10.1016/j.jaad.2014.08.004; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Lange N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.12.014; Lee MJ, 2014, AM J NEPHROL, V39, P427, DOI 10.1159/000362743; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; LONDON GM, 1987, KIDNEY INT, V32, P900, DOI 10.1038/ki.1987.293; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Mistik S, 2006, J EUR ACAD DERMATOL, V20, P672, DOI 10.1111/j.1468-3083.2006.01570.x; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Nochaiwong S, 2018, J EUR ACAD DERMATOL, V32, P1188, DOI 10.1111/jdv.14609; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Quirke M, 2017, BRIT J DERMATOL, V177, P382, DOI 10.1111/bjd.15186; Quraishi SA, 2013, AM J CLIN NUTR, V98, P952, DOI 10.3945/ajcn.113.058909; Saab G, 2012, J CLIN ENDOCR METAB, V97, P4414, DOI 10.1210/jc.2012-2001; Schoch D, 2017, J INVEST DERMATOL, V137, P2069, DOI 10.1016/j.jid.2017.05.020; Shimizu Y, 2014, INT J NEPHROL RENOV, V7, P329, DOI [10.1587/bplus.7.329, 10.2147/IJNRD.S65929]; Simonsen E, 2017, AM J KIDNEY DIS, V70, P638, DOI 10.1053/j.ajkd.2017.05.018; Sterling KA, 2012, NAT REV NEPHROL, V8, P403, DOI 10.1038/nrneph.2012.93; Ting SW, 2020, J AM ACAD DERMATOL, V83, P924, DOI 10.1016/j.jaad.2020.01.011; Tzanno-Martins C, 2000, NEPHRON, V84, P224, DOI 10.1159/000045581; Wang CC, 2016, BRIT J DERMATOL, V175, P1175, DOI 10.1111/bjd.14789; Wang CC, 2017, ACTA DERM-VENEREOL, V97, P1230, DOI 10.2340/00015555-2762; Weisshaar E, 2004, EXP DERMATOL, V13, P298, DOI 10.1111/j.0906-6705.2004.00184.x; Weng CH, 2018, KIDNEY BLOOD PRESS R, V43, P1000, DOI 10.1159/000490689; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Wong MMY, 2017, AM J KIDNEY DIS, V69, P367, DOI 10.1053/j.ajkd.2016.08.030; Xie B, 2019, J DERMATOL, V46, P177, DOI 10.1111/1346-8138.14749; Zucker I, 2003, J AM ACAD DERMATOL, V49, P842, DOI 10.1016/S0190-9622(03)02478-2; 2014, REG ANESTH PAIN MED, V9	55	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241088	10.1371/journal.pone.0241088	http://dx.doi.org/10.1371/journal.pone.0241088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104746	Green Published, gold			2022-12-26	WOS:000588370000002
J	Savino, M; Casula, A; Santhakumaran, S; Pitcher, D; Wong, E; Magadi, W; Evans, KM; Benoy-Deeney, F; Griffin, J; Plumb, L; Steenkamp, R; Nitsch, D; Medcalf, J				Savino, Manuela; Casula, Anna; Santhakumaran, Shalini; Pitcher, David; Wong, Esther; Magadi, Winnie; Evans, Katharine M.; Benoy-Deeney, Fran; Griffin, James; Plumb, Lucy; Steenkamp, Retha; Nitsch, Dorothea; Medcalf, James			Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis	PLOS ONE			English	Article							SURVIVAL; DIALYSIS; OUTCOMES; VINTAGE; IMPACT	Kidney disease is a recognised risk factor for poor COVID-19 outcomes. Up to 30 June 2020, the UK Renal Registry (UKRR) collected data for 2,385 in-centre haemodialysis (ICHD) patients with COVID-19 in England and Wales. Overall unadjusted survival at 1 week after date of positive COVID-19 test was 87.5% (95% CI 86.1-88.8%); mortality increased with age, treatment vintage and there was borderline evidence of Asian ethnicity (HR 1.16, 95% CI 0.94-1.44) being associated with higher mortality. Compared to the general population, the relative risk of mortality for ICHD patients with COVID-19 was 45.4 and highest in younger adults. This retrospective cohort study based on UKRR data supports efforts to protect this vulnerable patient group.	[Savino, Manuela; Casula, Anna; Santhakumaran, Shalini; Pitcher, David; Wong, Esther; Magadi, Winnie; Evans, Katharine M.; Benoy-Deeney, Fran; Griffin, James; Plumb, Lucy; Steenkamp, Retha; Nitsch, Dorothea; Medcalf, James] Renal Assoc, UK Renal Registry, Bristol, Avon, England; [Plumb, Lucy] Univ Bristol, Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Nitsch, Dorothea] London Sch Hyg & Trop Med, London, England; [Nitsch, Dorothea] Royal Free London NHS Fdn Trust, London, England; [Medcalf, James] Univ Leicester, Leicester, Leics, England; [Medcalf, James] Univ Hosp Leicester NHS Trust, Leicester, Leics, England	University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Royal Free London NHS Foundation Trust; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester	Savino, M (corresponding author), Renal Assoc, UK Renal Registry, Bristol, Avon, England.	Manuela.Savino@renalregistry.nhs.uk	savino, manuela/GNW-6853-2022; Evans, Katharine/L-1709-2013	savino, manuela/0000-0001-8712-8901; Nitsch, Dorothea/0000-0001-5767-248X; Evans, Katharine/0000-0002-9819-1049				Ali H, 2020, RENAL FAILURE, V42, P393, DOI 10.1080/0886022X.2020.1756323; Allon M, 2003, J AM SOC NEPHROL, V14, P1863, DOI 10.1097/01.ASN.0000074237.78764.D1; Chertow GM, 2000, KIDNEY INT, V57, P1176, DOI 10.1046/j.1523-1755.2000.00945.x; Dixon Anthony N, 2006, Diab Vasc Dis Res, V3, P22, DOI 10.3132/dvdr.2006.002; Goicoechea M, 2020, KIDNEY INT, V98, P27, DOI 10.1016/j.kint.2020.04.031; Intensive Care National Audit and Research Centre, ICNARC CAS MIX PROGR; Iseki K, 2003, NEPHROL DIAL TRANSPL, V18, P782, DOI 10.1093/ndt/gfg145; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Mather HM, 2018, DIABETIC MED, V15, P672; Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Office for National Statistics, 2020, WEEKL PROV FIG DEATH; Salim SA, 2018, J RENAL INJ PREV, V7, P206, DOI 10.15171/jrip.2018.48; Sumida K, 2016, NEPHROL DIAL TRANSPL, V31, P298, DOI 10.1093/ndt/gfv402; Udayaraj U, 2013, NEPHRON CLIN PRACT, V125, P111, DOI 10.1159/000360025; Wu C, 2020, JAMA INTER MED, DOI [10.1016/j.kint.2020.0994, DOI 10.1016/J.KINT.2020.0994]; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Xu JB, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020244; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	22	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241263	10.1371/journal.pone.0241263	http://dx.doi.org/10.1371/journal.pone.0241263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095841	gold, Green Published			2022-12-26	WOS:000586649400033
J	Kumar, A; Misra, S; Verma, V; Vishwakarma, RK; Kamal, VK; Nath, M; Prakash, K; Upadhyay, AD; Sahu, JK				Kumar, Amit; Misra, Shubham; Verma, Vivek; Vishwakarma, Ramesh K.; Kamal, Vineet Kumar; Nath, Manabesh; Prakash, Kiran; Upadhyay, Ashish Datt; Sahu, Jitendra Kumar			Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19	PLOS ONE			English	Article							HOST	The 2019-Coronavirus (COVID-19) pandemic has had a global impact. The effect of environmental temperature on transmissibility and fatality rate of COVID-19 and protective efficacy of Bacillus Calmette-Guerin (BCG) vaccination towards COVID-19 remains ambiguous. Therefore, we explored the global impact of environmental temperature and neonatal BCG vaccination coverage on transmissibility and fatality rate of COVID-19. The COVID-19 data for reported cases, deaths and global temperature were collected from 31(st)December 2020 to 3(rd)April 2020 for 67 countries. Temperature data were split into quartiles for all three categories (minimum temperature, maximum temperature and mean temperature). The impact of three types of temperature data and policy of BCG vaccination on COVID-19 infection was determined by applying the multivariable two-level negative binomial regression analysis keeping daily new cases and daily mortality as outcome. The highest number of cases fell in the temperature categories as following:mean temperature in the second quartile(6 degrees C to 10.5 degrees C), median 26, interquartile range (IQR) 237;minimum temperature in the first quartile(-26 degrees C to 1 degrees C), median 23, IQR 173;maximum temperature in the second quartile (10 degrees C to 16 degrees C), median 27.5, IQR 219.For the minimum temperature category, 28% statistically significant lower incidence was noted for new cases from the countries falling in the second quartile (2 degrees C to 6 degrees C) compared with countries falling in the first quartile (-26 degrees C to 1 degrees C) (incidence rate ratio [IRR] 0.72, 95% confidence interval [CI] 0.57 to 0.93). However, no statistically significant difference in incidence rate was observed for mean temperature categories in comparison to the first quartile. Countries with BCG vaccination policy had 58% less mortality as compared with countries without BCG coverage (IRR 0.42; 95% CI 0.18 to 0.95). Our exploratory study provides evidence that high temperature might not be associated with low transmissibility and countries having neonatal BCG vaccination policy had a low fatality rate of COVID-19.	[Kumar, Amit; Misra, Shubham; Verma, Vivek; Nath, Manabesh] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Vishwakarma, Ramesh K.] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Biostat & Bioinformat, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Kamal, Vineet Kumar] Indian Council Med Res, Natl Inst Epidemiol, Div Epidemiol & Biostat, Chennai, Tamil Nadu, India; [Prakash, Kiran] Govt Med Coll & Hosp, Dept Physiol, Chandigarh, India; [Upadhyay, Ashish Datt] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Sahu, Jitendra Kumar] Postgrad Inst Med Educ & Res, Pediat Neurol Unit, Chandigarh, India	All India Institute of Medical Sciences (AIIMS) New Delhi; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); All India Institute of Medical Sciences (AIIMS) New Delhi; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sahu, JK (corresponding author), Postgrad Inst Med Educ & Res, Pediat Neurol Unit, Chandigarh, India.	jsh2003@gmail.com	Nath, Manabesh/ABH-8405-2020; Upadhyay, Ashish Datt/GOJ-9023-2022; Misra, Shubham/AAA-6700-2021	Nath, Manabesh/0000-0001-5979-8377; Upadhyay, Ashish Datt/0000-0002-5957-5429; Misra, Shubham/0000-0002-4920-2573; Kamal, Vineet Kumar/0000-0002-7295-1644; Sahu, Jitendra/0000-0001-5194-9951; Vishwakarma, Ramesh/0000-0003-2458-2802; VERMA, VIVEK/0000-0003-2537-4431				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Adedokun KA, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00688-1; Binnicker MJ, 2020, CLIN CHEM, V66, P664, DOI 10.1093/clinchem/hvaa071; Biryukov J, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00441-20; Bukhari Q., 2020, WILL CORONAVIRUS PAN, DOI [10.2139/ssrn.3556998., DOI 10.2139/SSRN.3556998]; Cabeca TK, 2013, INFLUENZA OTHER RESP, V7, P1040, DOI 10.1111/irv.12101; Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004; COVID-19 Map, COVID 19 MAP; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Garcia LF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01441; Gursel M., 2020, MED HYPOTHESES, P109707, DOI [10.1016/j.mehy.2020.109707, DOI 10.1016/J.MEHY.2020.109707]; Huang ZW, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139487; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Li XG, 2020, J MED VIROL, V92, P602, DOI 10.1002/jmv.25731; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; Miller A., 2020, MEDRXIV, DOI 10.1101/2020.03.24.20042937; NOAA/NCEI, 2020, NAT CTR ENV INF CLIM; Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026; Sajadi Mohammad M, 2020, SSRN, P3550308, DOI 10.2139/ssrn.3550308; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Scafetta N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103493; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Shahzad F, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139115; Sharma AR, 2020, ALLERGOL IMMUNOPATH, V48, P507, DOI 10.1016/j.aller.2020.05.002; Verma BK, 2020, J EVAL CLIN PRACT, V26, P1592, DOI 10.1111/jep.13483; Verma V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233074; Wang J., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3551767, DOI 10.2139/SSRN.3551767]; Wang M., 2020, MEDRXIV, P1, DOI DOI 10.1101/2020.02.22.20025791; World Health Organization, PNEUM UNKN CAUS CHIN; Worldometer, CORONAVIRUS UPDATE L; Yao Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00517-2020; Zheng QT, 2020, J X-RAY SCI TECHNOL, V28, P391, DOI 10.3233/XST-200687	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240710	10.1371/journal.pone.0240710	http://dx.doi.org/10.1371/journal.pone.0240710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091086	Green Published, gold			2022-12-26	WOS:000586647200009
J	Meier, S; Karlsen, O; Le Goff, J; Sorensen, L; Sorhus, E; Pampanin, DM; Donald, CE; Fjelldal, PG; Dunaevskaya, E; Romano, M; Caliani, I; Casini, S; Bogevik, AS; Olsvik, PA; Myers, M; Grosvik, BE				Meier, Sonnich; Karlsen, Orjan; Le Goff, Jeremie; Sorensen, Lisbet; Sorhus, Elin; Pampanin, Daniela M.; Donald, Carey E.; Fjelldal, Per Gunnar; Dunaevskaya, Evgenia; Romano, Marta; Caliani, Ilaria; Casini, Silvia; Bogevik, Andre S.; Olsvik, Pal A.; Myers, Mark; Grosvik, Bjorn Einar			DNA damage and health effects in juvenile haddock (Melanogrammus aeglefinus) exposed to PAHs associated with oil-polluted sediment or produced water	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; COD BOREOGADUS-SAIDA; P-32 POSTLABELING ANALYSIS; SOLE PLEURONECTES-VETULUS; CANCER-RISK ASSESSMENT; MULLET LIZA-AURATA; ENGLISH SOLE; CRUDE-OIL; ADDUCT FORMATION; MASS-SPECTROMETRY	The research objective was to study the presence of DNA damages in haddock exposed to petrogenic or pyrogenic polyaromatic hydrocarbons (PAHs) from different sources: 1) extracts of oil produced water (PW), dominated by 2-ring PAHs; 2) distillation fractions of crude oil (representing oil-based drilling mud), dominated by 3-ring PAHs; 3) heavy pyrogenic PAHs, mixture of 4/5/6-ring PAHs. The biological effect of the different PAH sources was studied by feeding juvenile haddock with low doses of PAHs (0.3-0.7 mg PAH/kg fish/day) for two months, followed by a two-months recovery. In addition to the oral exposure, a group of fish was exposed to 12 single compounds of PAHs (4/5/6-ring) via intraperitoneal injection. The main endpoint was the analysis of hepatic and intestinal DNA adducts. In addition, PAH burden in liver, bile metabolites, gene and protein expression of CYP1A, GST activity, lipid peroxidation, skeletal deformities and histopathology of livers were evaluated. Juvenile haddock responded quickly to both intraperitoneal injection and oral exposure of 4/5/6-ring PAHs. High levels of DNA adducts were detected in livers three days after the dose of the single compound exposure. Fish had also high levels of DNA adducts in liver after being fed with extracts dominated by 2-ring PAHs (a PW exposure scenario) and 3-ring PAHs (simulating an oil exposure scenario). Elevated levels of DNA adducts were observed in the liver of all exposed groups after the 2 months of recovery. High levels of DNA adduct were found also in the intestines of individuals exposed to oil or heavy PAHs, but not in the PW or control groups. This suggests that the intestinal barrier is very important for detoxification of orally exposures of PAHs.	[Meier, Sonnich; Karlsen, Orjan; Sorensen, Lisbet; Sorhus, Elin; Donald, Carey E.; Fjelldal, Per Gunnar; Olsvik, Pal A.; Grosvik, Bjorn Einar] Inst Marine Res, Bergen, Norway; [Le Goff, Jeremie] Ctr Francois Baclesse, ADntox, Batiment Rech, Caen, France; [Sorensen, Lisbet] SINTEF Ocean AS, Environm & New Resources, Trondheim, Norway; [Pampanin, Daniela M.; Dunaevskaya, Evgenia] Univ Stavanger, Fac Sci & Technol, Dept Chem Biosci & Environm Engn, Stavanger, Norway; [Pampanin, Daniela M.] NORCE, Randaberg, Norway; [Romano, Marta; Caliani, Ilaria; Casini, Silvia] Univ Siena, Dept Phys Earth & Environm Sci, Siena, Italy; [Bogevik, Andre S.] Nofima AS, Norwegian Inst Food, Fisheries Aquaculture Res, Fyllingsdalen, Norway; [Olsvik, Pal A.] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Myers, Mark] Myers Ecotoxicol Serv LLC, Shoreline, WA, Australia	Institute of Marine Research - Norway; UNICANCER; Centre Francois Baclesse; SINTEF; Universitetet i Stavanger; Norwegian Research Centre (NORCE); University of Siena; Nofima; Nord University	Meier, S (corresponding author), Inst Marine Res, Bergen, Norway.	sonnich.meier@hi.no	Karlsen, Ørjan/K-6137-2012; Olsvik, Pål A/B-8232-2012	Karlsen, Ørjan/0000-0001-5801-4200; Olsvik, Pål A/0000-0002-5641-9420; Grosvik, Bjorn Einar/0000-0003-0794-2212; Sorhus, Elin/0000-0003-3542-4201; Donald, Carey/0000-0002-1246-2961; Bogevik, Andre S/0000-0002-5269-4329; Meier, Sonnich/0000-0001-8510-5669	water column monitoring program (Norwegian State Pollution Control Agency); Equinor ASA, Stavanger	water column monitoring program (Norwegian State Pollution Control Agency); Equinor ASA, Stavanger	This work was financed through the water column monitoring program (Norwegian State Pollution Control Agency), and is funded by the oil company, Statoil (now Equinor ASA, Forusbeen 50, 4035 Stavanger). The funders had no influence on the scientific design, data treatment or conclusion of the experiment. IMR is a Norwegian national research institute owned by the Ministry of Fisheries. It is a demand for all research funding that all data shall be publicly accessible, and that the institute is free to publish the results without interference from the funding sources. This was also made into contract with Statoil before the project started.	Aas E, 2000, AQUAT TOXICOL, V51, P241, DOI 10.1016/S0166-445X(00)00108-9; Aas E, 2000, BIOMARKERS, V5, P9, DOI 10.1080/135475000230505; Aas E, 2003, BIOMARKERS, V8, P445, DOI 10.1080/1354750032000158439; Akkineni LK, 2001, ARCH TOXICOL, V74, P720, DOI 10.1007/s002040000172; Amat A, 2006, ENVIRON CHEM LETT, V4, P93, DOI 10.1007/s10311-006-0040-7; [Anonymous], 2004, BLICKPUNKT KINO, V48, P12; [Anonymous], 2010, J CHINESE SOC POWER, V30, P224; Audebert M, 2012, TOXICOL APPL PHARM, V260, P58, DOI 10.1016/j.taap.2012.01.022; Bakke MJ, 2016, POLAR BIOL, V39, P1165, DOI 10.1007/s00300-015-1816-7; Bakke T, 2013, MAR ENVIRON RES, V92, P154, DOI 10.1016/j.marenvres.2013.09.012; Balbo S, 2014, ANAL CHEM, V86, P1744, DOI 10.1021/ac403565m; BENGTSSON BE, 1979, PHILOS T ROY SOC B, V286, P457, DOI 10.1098/rstb.1979.0040; Billiard SM, 2002, COMP BIOCHEM PHYS B, V133, P55, DOI 10.1016/S1096-4959(02)00105-7; Boglione C, 2006, ECOL INDIC, V6, P712, DOI 10.1016/j.ecolind.2005.08.032; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Boitsov S, 2013, MAR ENVIRON RES, V87-88, P73, DOI 10.1016/j.marenvres.2013.03.006; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bravo CF, 2011, ENVIRON TOXICOL CHEM, V30, P704, DOI 10.1002/etc.439; Brooks SJ, 2011, J TOXICOL ENV HEAL A, V74, P582, DOI 10.1080/15287394.2011.550566; Buesen R, 2003, CHEM-BIOL INTERACT, V142, P201, DOI 10.1016/S0009-2797(02)00076-5; Buesen R, 2002, TOXICOL APPL PHARM, V183, P168, DOI 10.1006/taap.2002.9484; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; CHRISTIANSEN JS, 1995, POLAR BIOL, V15, P277; Costa J, 2011, CHEMOSPHERE, V84, P1452, DOI 10.1016/j.chemosphere.2011.04.046; Danion M, 2011, ECOTOX ENVIRON SAFE, V74, P1888, DOI 10.1016/j.ecoenv.2011.07.027; de Gelder S, 2016, COMP BIOCHEM PHYS C, V185, P65, DOI 10.1016/j.cbpc.2016.03.003; Ducrotoy JP, 2000, MAR POLLUT BULL, V41, P5, DOI 10.1016/S0025-326X(00)00099-0; DUNN BP, 1987, CANCER RES, V47, P6543; Ericson G, 2000, MUTAT RES-FUND MOL M, V454, P11, DOI 10.1016/S0027-5107(00)00092-0; Ericson G, 1999, MUTAT RES-FUND MOL M, V427, P135, DOI 10.1016/S0027-5107(99)00088-3; Fang C, 2010, J PHARMACOL EXP THER, V334, P156, DOI 10.1124/jpet.110.167742; Flesher JW, 2016, TOXICOL MECH METHOD, V26, P151, DOI 10.3109/15376516.2015.1135223; GrOsvik BE, 2009, CONDITION MONITORING; GrOsvik BE, 2012, CONDITION MONITORING; GrOsvik BE, 2007, CONDITION MONITORING; Grung M, 2009, J TOXICOL ENV HEAL A, V72, P254, DOI 10.1080/15287390802539210; Gupta M, 2006, J BIOL CHEM, V281, P17552, DOI 10.1074/jbc.M600950200; Harvey JS, 1999, MUTAT RES-GEN TOX EN, V441, P103, DOI 10.1016/S1383-5718(99)00037-6; He CY, 2011, AQUAT TOXICOL, V101, P335, DOI 10.1016/j.aquatox.2010.11.008; HELLOU J, 1994, SCI TOTAL ENVIRON, V145, P71, DOI 10.1016/0048-9697(94)90298-4; HENDRICKS JD, 1985, JNCI-J NATL CANCER I, V74, P839; Henry LA, 2017, MAR ENVIRON RES, V129, P219, DOI 10.1016/j.marenvres.2017.05.008; Himmelstein MW, 2009, CRIT REV TOXICOL, V39, P679, DOI 10.1080/10408440903164163; HODDER VM, 1963, J FISH RES BOARD CAN, V20, P1465, DOI 10.1139/f63-100; Holth TF, 2009, ENVIRON SCI TECHNOL, V43, P3329, DOI 10.1021/es803479p; Hylland K, 2008, MAR POLLUT BULL, V56, P414, DOI 10.1016/j.marpolbul.2007.11.004; IARC, 2010, SOM NONH POL AR HYDR; ICES, 2011, REP STUD GROUP INT M; ICES, 2012, REP WORK GROUP BIOL; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Ingram AJ, 2000, J APPL TOXICOL, V20, P165, DOI 10.1002/(SICI)1099-1263(200005/06)20:3<165::AID-JAT625>3.0.CO;2-E; Jawad LA, 2018, J FISH DIS, V41, P1909, DOI 10.1111/jfd.12903; Kienzler A, 2013, AQUAT TOXICOL, V134, P47, DOI 10.1016/j.aquatox.2013.03.005; Kim SG, 2008, B ENVIRON CONTAM TOX, V81, P470, DOI 10.1007/s00128-008-9499-1; Klaene JJ, 2013, CANCER LETT, V334, P10, DOI 10.1016/j.canlet.2012.08.007; Le Goff J, 2006, AQUAT TOXICOL, V79, P55, DOI 10.1016/j.aquatox.2006.05.002; LEMAIRE P, 1992, ECOTOX ENVIRON SAFE, V23, P244, DOI 10.1016/0147-6513(92)90062-8; Lyons BP, 1997, MUTAT RES-GEN TOX EN, V390, P263, DOI 10.1016/S1383-5718(97)00024-7; Meador JP, 2006, CAN J FISH AQUAT SCI, V63, P2364, DOI 10.1139/F06-127; Milinkovitch T, 2011, AQUAT TOXICOL, V101, P155, DOI 10.1016/j.aquatox.2010.09.013; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Monien BH, 2015, ANAL CHEM, V87, P641, DOI 10.1021/ac503803m; Myers MS, 2003, HUM ECOL RISK ASSESS, V9, P67, DOI 10.1080/713609853; Myers MS, 1998, MAR ENVIRON RES, V45, P47, DOI 10.1016/S0141-1136(97)00021-4; Nagy E, 2004, ARCH TOXICOL, V78, P114, DOI 10.1007/s00204-003-0489-0; Nahrgang J, 2019, ECOTOX ENVIRON SAFE, V180, P53, DOI 10.1016/j.ecoenv.2019.04.082; Nahrgang J, 2010, MAR ENVIRON RES, V70, P120, DOI 10.1016/j.marenvres.2010.02.003; Nilsen B M, 1998, Methods Mol Biol, V107, P423; Olsvik PA, 2010, CHEMOSPHERE, V79, P905, DOI 10.1016/j.chemosphere.2010.03.026; Pampanin DM, 2017, MAR ENVIRON RES, V125, P49, DOI 10.1016/j.marenvres.2017.01.002; Phillips DH, 2013, CANCER LETT, V334, P5, DOI 10.1016/j.canlet.2012.11.027; Platt KL, 2008, MUTAT RES-GEN TOX EN, V650, P96, DOI 10.1016/j.mrgentox.2007.09.011; Pottenger Lynn H, 2009, Mutat Res, V678, P152, DOI 10.1016/j.mrgentox.2009.07.006; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; Saborido-Rey F, 2007, MAR ECOL PROG SER, V345, P271, DOI 10.3354/meps06961; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Singh R, 2006, CARCINOGENESIS, V27, P178, DOI 10.1093/carcin/bgi260; SLOOFF W, 1982, AQUAT TOXICOL, V2, P157, DOI 10.1016/0166-445X(82)90013-3; SORENSEN L, 2019, ENV POLLUTION; Sorensen L, 2016, RAPID COMMUN MASS SP, V30, P2052, DOI 10.1002/rcm.7688; Sorensen L, 2016, ANAL BIOANAL CHEM, V408, P1023, DOI 10.1007/s00216-015-9225-x; Sorhus E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31058; STEIN JE, 1994, ENVIRON HEALTH PERSP, V102, P19, DOI 10.1289/ehp.94102s1219; STEIN JE, 1993, CHEM-BIOL INTERACT, V88, P55, DOI 10.1016/0009-2797(93)90084-C; Sturve J, 2006, AQUAT TOXICOL, V78, pS73, DOI 10.1016/j.aquatox.2006.02.019; Suguitan Jr AL, 2011, PLOS ONE, V6; Sundt RC, 2012, MAR POLLUT BULL, V64, P144, DOI 10.1016/j.marpolbul.2011.10.005; Suzuki N, 2016, ZOOL SCI, V33, P407, DOI 10.2108/zs150211; Suzuki N, 2009, LIFE SCI, V84, P482, DOI 10.1016/j.lfs.2009.01.008; Tarantini A, 2011, TOXICOLOGY, V279, P36, DOI 10.1016/j.tox.2010.09.002; Torvanger I, 2018, J APPL ICHTHYOL, V34, P431, DOI 10.1111/jai.13666; Tretyakova N, 2013, CHEM REV, V113, P2395, DOI 10.1021/cr300391r; Trippel EA, 2004, CAN J FISH AQUAT SCI, V61, P2097, DOI [10.1139/f04-125, 10.1139/F04-125]; Uno S, 2004, MOL PHARMACOL, V65, P1225, DOI 10.1124/mol.65.5.1225; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Uno S, 2008, FREE RADICAL BIO MED, V44, P570, DOI 10.1016/j.freeradbiomed.2007.10.044; VanVeld PA, 1997, TOXICOL APPL PHARM, V142, P348, DOI 10.1006/taap.1996.8037; VARANASI U, 1989, CHEM-BIOL INTERACT, V69, P203, DOI 10.1016/0009-2797(89)90078-1; VARANASI U, 1986, CANCER RES, V46, P3817; Vethaak A.D., 2017, MAR ENVIRON RES, V124, P11, DOI DOI 10.1016/j.marenvres.2015.09.010; Vignet C, 2014, ENVIRON SCI POLLUT R, V21, P13877, DOI 10.1007/s11356-014-2585-5; Wolf JC, 2015, TOXICOL PATHOL, V43, P297, DOI 10.1177/0192623314540229; Wolrd Health Organization, 2010, WHO GUID IND AIR QUA; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; ZARB GA, 1990, J PROSTHET DENT, V64, P185, DOI 10.1016/0022-3913(90)90177-E	105	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240307	10.1371/journal.pone.0240307	http://dx.doi.org/10.1371/journal.pone.0240307			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091018	Green Published, gold			2022-12-26	WOS:000586647200019
J	Miyagawa, T; Sasaki, M; Yamaura, A				Miyagawa, Tadashi; Sasaki, Minami; Yamaura, Akira			Intracranial pressure based decision making: Prediction of suspected increased intracranial pressure with machine learning	PLOS ONE			English	Article							NERVE SHEATH DIAMETER; TRANSORBITAL ULTRASOUND MEASUREMENT; INVASIVELY MEASURED ICP; OPTIC-NERVE; SUBARACHNOID SPACE; HYPERTENSION; ONSD	Background Repeated invasive intracranial pressure (ICP) monitoring is desirable because many neurosurgical pathologies are associated with elevated ICP. On the other hand, it could become a risk for children to repeat sedation, anesthesia, or radiation exposure. As a non-invasive method, measurements of optic nerve sheath diameter (ONSD) has been revealed to accurately predict increased ICP. However, no studies have indicated a relationship among age, brain, and ventricular parameters in normal children, nor a prediction of increased ICP with artificial intelligence. Methods and findings This study enrolled 400 normal children for control and 75 children with signs of increased ICP between 2009 and 2019. Measurements of the parameters including ONSD on CT were obtained. A supervised machine learning was applied to predict suspected increased ICP based on CT measurements. A linear correlation was shown between ln(age) and mean ONSD (mONSD) in normal children, revealing mONSD = 0.36ln(age)+2.26 (R-2= 0.60). This study revealed a linear correlation of mONSD measured on CT with ln(age) and the width of the brain, not the width of the ventricles in 400 normal children based on the univariate analyses. Additionally, the multivariate analyses revealed minimum bicaudate nuclei distance was also associated with mONSD. The results of the group comparison between control and suspected increased ICP revealed a statistical significance in mONSD and the width of the ventricles. The study indicated that supervised machine learning application could be applied to predict suspected increased ICP in children, with an accuracy of 94% for training, 91% for test. Conclusions This study clarified three issues regarding ONSD and ICP. Mean ONSD measured on CT was correlated with ln(age) and the width of the brain, not the width of the ventricles in 400 normal children based on the univariate analyses. The multivariate analyses revealed minimum bicaudate nuclei distance was also associated with mONSD. Mean ONSD and the width of ventricles were statistically significant in children with signs of elevated ICP. Finally, the study showed that machine learning could be used to predict children with suspected increased ICP.	[Miyagawa, Tadashi] Matsudo City Gen Hosp, Dept Pediat Neurosurg, Matsudo, Chiba, Japan; [Sasaki, Minami; Yamaura, Akira] Matsudo City Gen Hosp, Dept Neurosurg, Matsudo, Chiba, Japan		Miyagawa, T (corresponding author), Matsudo City Gen Hosp, Dept Pediat Neurosurg, Matsudo, Chiba, Japan.	tadashi.miyagawa@gmail.com		Miyagawa, Tadashi/0000-0002-7532-155X				[Anonymous], 2020, JIANGSU J TRADITIONA, V52, P1; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Buchlak QD, 2019, NEUROSURGICAL REV, V17; Celtikci E, 2018, TURK NEUROSURG, V28, P167, DOI 10.5137/1019-5149.JTN.20059-17.1; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Kerscher SR, 2020, CHILD NERV SYST, V36, P107, DOI 10.1007/s00381-019-04336-4; Kerscher SR, 2020, CHILD NERV SYST, V36, P99, DOI 10.1007/s00381-019-04266-1; Killer HE, 2007, BRAIN, V130, P514, DOI 10.1093/brain/awl324; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lee HC, 2018, CLIN NEUROL NEUROSUR, V167, P31, DOI 10.1016/j.clineuro.2018.02.012; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Majeed Gohar, 2019, Surg Neurol Int, V10, P97, DOI 10.25259/SNI-120-2019; Mehrpour M, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/146059; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Padayachy LC, 2016, CHILD NERV SYST, V32, P1769, DOI 10.1007/s00381-016-3067-5; Padayachy LC, 2016, CHILD NERV SYST, V32, P1779, DOI 10.1007/s00381-016-3068-4; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rehman Siddiqui Naveed Ur, 2018, J Ayub Med Coll Abbottabad, V30, P495; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Senders JT, 2018, NEUROSURGERY, V83, P181, DOI 10.1093/neuros/nyx384; Senders JT, 2018, ACTA NEUROCHIR, V160, P29, DOI 10.1007/s00701-017-3385-8; Shofty B, 2012, AM J NEURORADIOL, V33, P366, DOI 10.3174/ajnr.A2779	23	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240845	10.1371/journal.pone.0240845	http://dx.doi.org/10.1371/journal.pone.0240845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085690	gold, Green Published			2022-12-26	WOS:000585943400042
J	Thomsen, H; Li, XJ; Sundquist, K; Sundquist, J; Forsti, A; Hemminki, K				Thomsen, Hauke; Li, Xinjun; Sundquist, Kristina; Sundquist, Jan; Foersti, Asta; Hemminki, Kari			Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases	PLOS ONE			English	Article							RISKS; EPIDEMIOLOGY; DATABASE	Autoimmune hepatitis (AH) and primary biliary cirrhosis (PBC) are autoimmune diseases (AIDs) targeting cellular components of the liver. Being rare diseases, limited data are available about familial risks among these AIDs (concordant) or between them and other AIDs (discordant). We aimed to carry out an unbiased study on these AIDs based on medically diagnosed patients. We collected data on patients diagnosed in Swedish hospitals with AH, PBC and other AIDs and calculated familial standardized incidence ratios (SIRs) for concordant and discordant familial relative risks. The number of AH patients was 6,269, of whom 43.0% were male; patient numbers for PBC were 4,269, with 17.8% males. AH accounted for 0.8% and 0.6% of all hospitalized AIDs in Sweden. For AH only the familial risk between siblings was significant (3.83). For PBC the risks for offspring of parents (9.05) and siblings (10.88) were high, but only risk for females was significant. Spousal risks were very high, 5.91 and 6.07 for AH. Risk for AH was 2.21 in families of PBC, and it was 2.47 for PBC in families of AH patients. Among other AIDs, 14 showed a significant association with AH, compared to 16 AIDs with PBC. The surprising finding in this nation-wide family study on medically diagnosed patients was the high risk for AH (6.0) between spouses, which exceed the risk between siblings, suggesting the existence of strong environmental risk factors. AH and PBC were associated with multiple other AIDs. The results call attention to environmental factors in AID etiology which should also be in focus in taking anamnestic data from patients.	[Thomsen, Hauke; Foersti, Asta; Hemminki, Kari] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Thomsen, Hauke; Li, Xinjun; Sundquist, Kristina; Sundquist, Jan; Foersti, Asta; Hemminki, Kari] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Thomsen, Hauke] GeneWerk GmbH, Heidelberg, Germany; [Sundquist, Kristina; Sundquist, Jan] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA; [Sundquist, Kristina; Sundquist, Jan] Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Sch Med, Dept Funct Pathol, Matsue, Shimane, Japan; [Foersti, Asta] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Foersti, Asta] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Div Pediat Neurooncol, Heidelberg, Germany; [Hemminki, Kari] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Hemminki, Kari] Charles Univ Prague, Fac Med, Plzen, Czech Republic; [Hemminki, Kari] Charles Univ Prague, Biomed Ctr Pilsen, Plzen, Czech Republic	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Icahn School of Medicine at Mount Sinai; Shimane University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Charles University Prague; Charles University Prague	Thomsen, H (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.; Thomsen, H (corresponding author), Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden.; Thomsen, H (corresponding author), GeneWerk GmbH, Heidelberg, Germany.	hauke.thomsen@genewerk.de	Thomsen, Hauke/M-6515-2017	Thomsen, Hauke/0000-0001-5951-3116; Sundquist, Jan/0000-0001-7228-5015	European Union's Horizon 2020 research and innovation programme [856620]	European Union's Horizon 2020 research and innovation programme	The study was supported by the European Union's Horizon 2020 research and innovation programme, grant No 856620. HT receives salary from GeneWerk GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, KARLOVACKI TJEDNIK, V64, P7; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Corrigan M, 2015, BRIT MED BULL, V114, P181, DOI 10.1093/bmb/ldv021; Czaja AJ, 2019, WORLD J GASTROENTERO, V25, P6579, DOI 10.3748/wjg.v25.i45.6579; Floreani A, 2018, J AUTOIMMUN, V95, P133, DOI 10.1016/j.jaut.2018.10.020; Galoosian A, 2020, J CLIN TRANSL HEPATO, V8, P49, DOI 10.14218/JCTH.2019.00049; Gonzalez Raul S, 2018, Surg Pathol Clin, V11, P329, DOI 10.1016/j.path.2018.02.010; Gronbaek L, 2020, LIVER INT, V40, P1634, DOI 10.1111/liv.14480; Gronbaek L, 2019, LIVER INT, V39, P205, DOI 10.1111/liv.13963; Gronbaek L, 2018, J HEPATOL, V69, P873, DOI 10.1016/j.jhep.2018.05.035; Hemminki K, 2007, CLIN EXP ALLERGY, V37, P1320, DOI 10.1111/j.1365-2222.2007.02737.x; Hemminki K, 2008, MUTAT RES-REV MUTAT, V658, P247, DOI 10.1016/j.mrrev.2008.01.002; Hemminki K, 2007, PAEDIATR PERINAT EP, V21, P235, DOI 10.1111/j.1365-3016.2007.00798.x; Hemminki K, 2010, AM J GASTROENTEROL, V105, P139, DOI 10.1038/ajg.2009.496; Hemminki K, 2009, NEUROGENETICS, V10, P111, DOI 10.1007/s10048-008-0164-y; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Manns MP, 2015, J HEPATOL, V62, pS100, DOI 10.1016/j.jhep.2015.03.005; Marschall HU, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47890-2; Mells George F, 2014, Clin Liver Dis (Hoboken), V3, P69, DOI 10.1002/cld.308; Mieli-Vergani G, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.17, 10.1038/nrdp.2018.18]; Ngu JH, 2013, HEPATOL INT, V7, P869, DOI 10.1007/s12072-013-9448-x; Ornolfsson KT, 2018, HEPATOLOGY, V68, P166, DOI 10.1002/hep.29675; Sahebjam F, 2015, FRONT MED-PRC, V9, P187, DOI 10.1007/s11684-015-0386-y; Tanaka A, 2019, CURR OPIN GASTROEN, V35, P93, DOI 10.1097/MOG.0000000000000507; Werner M, 2008, SCAND J GASTROENTERO, V43, P1232, DOI 10.1080/00365520802130183	25	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240794	10.1371/journal.pone.0240794	http://dx.doi.org/10.1371/journal.pone.0240794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079961	Green Published, gold			2022-12-26	WOS:000585940600013
J	Brockmann, M; Aupperle-Lellbach, H; Gentil, M; Heusinger, A; Muller, E; Marschang, RE; Pees, M				Brockmann, Maria; Aupperle-Lellbach, Heike; Gentil, Michaela; Heusinger, Anton; Mueller, Elisabeth; Marschang, Rachel E.; Pees, Michael			Challenges in microbiological identification of aerobic bacteria isolated from the skin of reptiles	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SCORE CUTOFF VALUES; CLINICAL MICROBIOLOGY; MALDI-TOF; SP-NOV.; GEN.-NOV.; DERMATITIS; LESIONS; IMPACT	Introduction Bacterial pathogens are often involved in dermatitis in reptiles. Exact identification of reptile-specific but otherwise uncommon bacterial species may be challenging. However, identification is crucial to evaluate the importance of the detected bacterial species. Objective The aim of this study was to assess the number of aerobic bacterial isolates cultured from skin-derived samples of reptiles which were not reliably identified by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS), and to determine their identity. Material and methods Routine bacterial diagnostics were performed on 235 skin samples, and 417 bacterial isolates were analysed by MALDI-TOF MS. The isolates were grouped into categories based on their first score: category I (>= 2.00), category II (>= 1.70 and < 2.00), and category III (< 1.70). Isolates from category III were further investigated by 16S rRNA gene sequencing and the following criteria were applied: query cover 100%, e-value rounded to 0.0 and sequence identity (%) > 98.00% for genus identification, and > 99.00% for species identification. Results The majority of bacterial isolates were in category I (85.1%) or category II (8.4%). In category III (6.5%) results achieved at first by MALDI-TOF MS corresponded to the results of the molecular analysis in 8.0% of isolates at the species level and in 24.0% at the genus level. Bacterial isolates classified as category III were heterogenic in genus (e.g.Chryseobacterium,Devriesea,Pseudomonas,Staphylococcus,Uruburuella), and some have only been described in reptiles so far. Conclusions Most of the aerobic bacterial isolates cultured from reptile skin achieved high scores by MALDI-TOF MS. However, in the majority of category III isolates MALDI-TOF MS results were different from those of the molecular analysis. This strengthens the need to carefully examine low-scored results for plausibility and to be familiar with the occurrence and morphology of relevant reptile-specific bacterial species (e.g.Devriesea agamarum) as well as with the limits of the database used.	[Brockmann, Maria; Aupperle-Lellbach, Heike; Gentil, Michaela; Heusinger, Anton; Mueller, Elisabeth; Marschang, Rachel E.] LABOKLIN GmbH & Co KG, Bad Kissingen, Germany; [Pees, Michael] Univ Leipzig, Clin Birds & Reptiles, Leipzig, Germany	LABOKLIN GmbH & Co. KG; Leipzig University	Brockmann, M (corresponding author), LABOKLIN GmbH & Co KG, Bad Kissingen, Germany.	brockmann@laboklin.com						[Anonymous], 2020, FAQ E VAL; [Anonymous], 2014, WATER RES, V62, P180; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; Barreto DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110128; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Boudewijns M, 2006, J CLIN MICROBIOL, V44, P3469, DOI 10.1128/JCM.01017-06; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Chung TH, 2017, VET MED-CZECH, V62, P169, DOI 10.17221/65/2016-VETMED; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Emami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038515; Garcia ME, 2008, VET J, V176, P254, DOI 10.1016/j.tvjl.2007.02.025; Gilbert MJ, 2015, INT J SYST EVOL MICR, V65, P975, DOI 10.1099/ijs.0.000048; Goodman G, 2007, IN PRACTICE, V29, P288; Hall T., 2011, GERF B BIOSCI, V2, P60; Heinritz SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154329; Hellebuyck T, 2009, VET MICROBIOL, V134, P267, DOI 10.1016/j.vetmic.2008.08.021; Hill AJ, 2018, ECOHEALTH, V15, P109, DOI 10.1007/s10393-017-1289-y; Hoppmann E, 2007, J EXOT PET MED, V16, P210, DOI 10.1053/j.jepm.2007.10.001; Keynan Y, 2007, J MED MICROBIOL, V56, P563, DOI 10.1099/jmm.0.46866-0; Kopcakova A, 2014, CHEM PAP, V68, P1435, DOI 10.2478/s11696-014-0612-0; Kuhnert P, 2015, INT J SYST EVOL MICR, V65, P1251, DOI 10.1099/ijs.0.000089; Ma Rong-rong, 2008, Zoological Research, V29, P253, DOI 10.3724/SP.J.1141.2008.00253; Martel A, 2008, INT J SYST EVOL MICR, V58, P2206, DOI 10.1099/ijs.0.65478-0; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Palmeiro Brian S., 2013, Veterinary Clinics of North America Exotic Animal Practice, V16, P523, DOI 10.1016/j.cvex.2013.05.003; Palmieri G, 2019, J BIOTECHNOL, V302, P101, DOI 10.1016/j.jbiotec.2019.07.002; Pasmans F, 2008, VET J, V175, P53, DOI 10.1016/j.tvjl.2006.12.009; Patel JB, 2001, MOL DIAGN, V6, P313, DOI 10.1054/modi.2001.29158; Plenz B, 2015, VET REC, V176, P285, DOI 10.1136/vr.102580; Randall LP, 2015, RES VET SCI, V101, P42, DOI 10.1016/j.rvsc.2015.05.018; Rau J, 2016, MALDI INTERNET PLATF; Richter C, 2012, J MED MICROBIOL, V61, P1409, DOI 10.1099/jmm.0.042606-0; Srinivasan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117617; Szabados F, 2012, EUR J CLIN MICROBIOL, V31, P1109, DOI 10.1007/s10096-011-1415-7; Tan KE, 2012, J CLIN MICROBIOL, V50, P3301, DOI 10.1128/JCM.01405-12; Tena D, 2014, EMERG INFECT DIS, V20, P2178, DOI 10.3201/eid2012.140493; Timperio AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181860; Tshikhudo P, 2013, AFR J BIOTECHNOL, V12, P5975, DOI DOI 10.5897/AJB2013.12057; Vela AI, 2005, INT J SYST EVOL MICR, V55, P643, DOI 10.1099/ijs.0.63346-0; Vishnivetskaya TA, 2009, EXTREMOPHILES, V13, P541, DOI 10.1007/s00792-009-0243-5; White SD, 2011, VET DERMATOL, V22, P150, DOI 10.1111/j.1365-3164.2010.00926.x; WOESE CR, 1985, SYST APPL MICROBIOL, V6, P143, DOI 10.1016/S0723-2020(85)80047-3; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x	45	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240085	10.1371/journal.pone.0240085	http://dx.doi.org/10.1371/journal.pone.0240085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075077	Green Published, gold			2022-12-26	WOS:000585920200022
J	Cathrine, CR; Lukose, B; Rani, P				Cathrine, C. Rani; Lukose, Bincy; Rani, P.			G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology	PLOS ONE			English	Article							GLYCATION ENDPRODUCTS RAGE; END-PRODUCTS RAGE; GLY82SER POLYMORPHISM; RECEPTOR; ASSOCIATION; GENE; PREDICTION	Receptor for advanced glycation end products (RAGE) has been implicated in the pathophysiology of Alzheimers disease(AD) due to its ability to bind amyloid-beta (A beta 42) and mediate inflammatory response. G82S RAGE polymorphism is associated with AD but the molecular mechanism for this association is not understood. Our previous in silico study indicated a higher binding affinity for mutated G82S RAGE, which could be caused due to changes in N linked glycosylation at residue N81. To confirm this hypothesis, in the present study molecular dynamics (MD) simulations were used to simulate the wild type (WT) and G82S glycosylated structures of RAGE to identify the global structural changes and to find the binding efficiency with A beta 42 peptide. Binding pocket analysis of the MD trajectory showed that cavity/binding pocket in mutant G82S glycosylated RAGE variants is more exposed and accessible to external ligands compared to WT RAGE, which can enhance the affinity of RAGE for A beta. To validate the above concept, an in vitro binding study was carried using SHSY5Y cell line expressing recombinant WT and mutated RAGE variant individually to which HiLyte Fluor labeled A beta 42 was incubated at different concentrations. Saturated binding kinetics method was adopted to determine the K-d values for A beta 42 binding to RAGE. The K-d value for A beta 42- WT and A beta 42-mutant RAGE binding were 92 +/- 40 nM (95% CI-52 to 152nM; R-2-0.92) and 45 +/- 20 nM (95% CI -29 to 64nM; R-2-0.93), respectively. The K-d value of <100nM observed for both variants implicates RAGE as a high-affinity receptor for A beta 42 and mutant RAGE has higher affinity compared to WT. The alteration in binding affinity is responsible for activation of the inflammatory pathway as implicated by enhanced expression of TNF alpha and IL6 in mutant RAGE expressing cell line which gives a mechanistic view for the G82S RAGE association with AD.	[Cathrine, C. Rani; Lukose, Bincy; Rani, P.] PSG Coll Technol, Dept Biotechnol, Coimbatore, Tamil Nadu, India	PSG College Technology	Rani, P (corresponding author), PSG Coll Technol, Dept Biotechnol, Coimbatore, Tamil Nadu, India.	rani.bio@psgtech.ac.in			Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi, India [SR/WOS-A/LS-1312/2014(G)]	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi, India	The work was supported by SR/WOS-A/LS-1312/2014 (G) (RCC) the Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; [Anonymous], 2015, CRIT CARE S1, V19, pP1; [Anonymous], 2007, CYBERJOURNAL PENTECO, V18, P1; Atac ZS, 2019, J CLIN NEUROSCI, V59, P197, DOI 10.1016/j.jocn.2018.10.072; BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Choi BR, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.147; Daborg J, 2010, J NEURAL TRANSM, V117, P861, DOI 10.1007/s00702-010-0437-0; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeLano WL, 2002, PYMOL MOL GRAPHICS S, V700, P5; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kankova K, 1999, DIABETES CARE, V22, P1745, DOI 10.2337/diacare.22.10.1745b; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumaramanickavel G, 2002, J DIABETES COMPLICAT, V16, P391, DOI 10.1016/S1056-8727(02)00187-3; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Miller MC, 2008, BRAIN RES, V1230, P273, DOI 10.1016/j.brainres.2008.06.124; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Park SJ, 2011, J BIOL CHEM, V286, P21384, DOI 10.1074/jbc.M111.241281; Prevost G, 2005, DIABETES METAB, V31, P35, DOI 10.1016/S1262-3636(07)70164-7; Priesnitz C, 2016, CYTOTECHNOLOGY, V68, P1647, DOI 10.1007/s10616-014-9821-1; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Woods R., 2005, GLYCOPROTEIN BUILDER; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0225487	10.1371/journal.pone.0225487	http://dx.doi.org/10.1371/journal.pone.0225487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119615	gold, Green Published			2022-12-26	WOS:000600013600119
J	Raick, X; Huby, A; Kurchevski, G; Godinho, AL; Parmentier, E				Raick, Xavier; Huby, Alessia; Kurchevski, Gregorio; Godinho, Alexandre Lima; Parmentier, Eric			Use of bioacoustics in species identification: Piranhas from genus Pygocentrus (Teleostei: Serrasalmidae) as a case study	PLOS ONE			English	Article							SOUND PRODUCTION; ACOUSTIC IDENTIFICATION; POMACENTRUS-PARTITUS; LEPTODACTYLIDAE; ANURA; MORPHOLOGY; DIVERSITY; VOCALIZATIONS; CHARACIFORMES; ECHOLOCATION	The genus Pygocentrus contains three valid piranha species (P. cariba, P. nattereri and P. piraya) that are allopatric in tropical and subtropical freshwater environments of South America. This study uses acoustic features to differentiate the three species. Sounds were recorded in P. cariba, two populations of P. nattereri (red- and yellow-bellied) and P. piraya; providing sound description for the first time in P. cariba and P. piraya. Calls of P. cariba were distinct from all the other studied populations. Red- and yellow-bellied P. nattereri calls were different from each other but yellow-bellied P. nattereri calls were similar to those of P. piraya. These observations can be explained by considering that the studied specimens of yellow-bellied P. nattereri have been wrongly identified and are actually a sub-population of P. piraya. Morphological examinations and recent fish field recordings in the Araguari River strongly support our hypothesis. This study shows for the first time that sounds can be used to discover identification errors in the teleost taxa.	[Raick, Xavier; Huby, Alessia; Parmentier, Eric] Univ Liege, Lab Funct & Evolutionary Morphol, Freshwater & Ocean Sci Unit Res, Liege, Belgium; [Kurchevski, Gregorio; Godinho, Alexandre Lima] Univ Fed Minas Gerais, Fish Passage Ctr, Belo Horizonte, MG, Brazil	University of Liege; Universidade Federal de Minas Gerais	Raick, X (corresponding author), Univ Liege, Lab Funct & Evolutionary Morphol, Freshwater & Ocean Sci Unit Res, Liege, Belgium.	xavier.raick@uliege.be	Parmentier, Eric/P-9733-2018	Raick, Xavier/0000-0002-1977-0289; Huby, Alessia/0000-0002-7547-0125	Fonds de la Recherche Scientifique [2018/V 3/5/199 - JG/MS -2718, 2018/V 3/5/200 - JG/MS 2717, 23625340]; King Leopold III Fund for Nature Exploration and Conservation [2018/1.12]	Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); King Leopold III Fund for Nature Exploration and Conservation	X.R.: Fonds de la Recherche Scientifique (2018/V 3/5/199 - JG/MS -2718) A.H.: Fonds de la Recherche Scientifique (2018/V 3/5/200 - JG/MS 2717) X.R. & A. H.: King Leopold III Fund for Nature Exploration and Conservation (2018/1.12.) E.P. & X.R.: Fonds de la Recherche Scientifique (PDR no. 23625340) https://www.frs-fnrs.be/fr/http://www.naturalsciences.be/LIII/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELEYE IA, 1992, J DIARRHOEAL DIS RES, V10, P93; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; Angulo A, 2003, HERPETOLOGICA, V59, P490, DOI 10.1655/20-104; Angulo A, 2008, ZOOL J LINN SOC-LOND, V152, P59, DOI 10.1111/j.1096-3642.2007.00338.x; [Anonymous], 1999, SOTTO IL VELAME, VI, P137; Belei Frederico, 2012, Check List, V8, P787; Bernstein SK, 2016, AM J PRIMATOL, V78, P937, DOI 10.1002/ajp.22564; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bignotto TS, 2020, BRAZ J BIOL, V80, P741, DOI 10.1590/1519-6984.219020; Borkin LY, 2004, ZOOL ZH, V83, P936; Brown RM, 2006, ZOOTAXA, P45; Casadevall M., 1996, Publicaciones Especiales Instituto Espanol de Oceanografia, V21, P45; Centro de TransposicAo de Peixes (Universidade Federal de Minas Gerais), 2008, UHE CAPIM BRANCO 1 P; Centro de TransposicAo de Peixes (Universidade Federal de Minas Gerais), 2007, UHE CAP BRANC 2 PROG; Chesmore E. D., 2001, Acta Horticulturae, P223; Colleye O, 2009, J FISH BIOL, V75, P908, DOI 10.1111/j.1095-8649.2009.02316.x; Cuervo AM, 2005, AUK, V122, P445, DOI 10.1642/0004-8038(2005)122[0445:SSANSO]2.0.CO;2; Di Iorio L, 2018, REMOTE SENS ECOL CON, V4, P248, DOI 10.1002/rse2.72; Eigenmann CH, 1915, ANN CARNEGIE MUSEUM, V9, P225; Feo TJ, 2015, AUK, V132, P248, DOI 10.1642/AUK-14-108.1; Feulner PGD, 2006, MOL PHYLOGENET EVOL, V39, P198, DOI 10.1016/j.ympev.2005.09.008; FINK WL, 1993, COPEIA, P665; Fink WL, 1997, COPEIA, P179; FISH MARIE POLAND, 1959, ZOOLOGICA [NEW YORK], V44, P71; Freeman BG, 2017, AUK, V134, P857, DOI 10.1642/AUK-17-63.1; Gebauer A, 2006, ZOOTAXA, P75; GERY J, 1987, REV SUISSE ZOOL, V94, P357, DOI 10.5962/bhl.part.79720; Henglmuller SM, 1999, J FISH BIOL, V54, P380, DOI 10.1006/jfbi.1998.0872; HENRY CS, 1994, TRENDS ECOL EVOL, V9, P388, DOI 10.1016/0169-5347(94)90061-2; HENRY CS, 1985, EVOLUTION, V39, P965, DOI 10.1111/j.1558-5646.1985.tb00441.x; Heyer W. Ronald, 1996, Amphibia-Reptilia, V17, P7, DOI 10.1163/156853896X00252; Hubert N, 2007, MOL ECOL, V16, P2115, DOI 10.1111/j.1365-294X.2007.03267.x; Huby A, 2019, BIOL J LINN SOC, V127, P722, DOI 10.1093/biolinnean/blz048; Jegu M., 2003, CHECK LIST FRESHWATE, P182, DOI DOI 10.5962/BHL.PART.80216; Johnson NK, 2001, AUK, V118, P334, DOI 10.1642/0004-8038(2001)118[0334:ANSOTT]2.0.CO;2; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Negret PJ, 2015, AUK, V132, P132, DOI 10.1642/AUK-14-183.1; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Kever L, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-34; Kolman MA, 2020, PHYLOGENOMICS PIRANH; Kwet A, 2009, STUD NEOTROP FAUNA E, V44, P93, DOI 10.1080/01650520902901659; Ladich F., 1992, Bioacoustics, V4, P131; Langeani F, 2014, GUIA ILUSTRADO PEIXE; Lin TH, 2014, OCEANS-IEEE; LITTLEJOHN MJ, 1968, SCIENCE, V162, P1003, DOI 10.1126/science.162.3857.1003; Machado VN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26550-x; Machado-Allison A, 1996, PECES CARIBES VENEZU; Martin B, 2014, OCEANS-IEEE; Martins I, 2015, BIOTA NEOTROP, V15, DOI 10.1590/1676-06032015006114; Mateussi NTB, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050371; Melotte G, 2019, BIOL J LINN SOC, V128, P403, DOI 10.1093/biolinnean/blz105; Melotte G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19812-1; Melotte G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36127; Millot S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-24; Millot S, 2011, J EXP BIOL, V214, P3613, DOI 10.1242/jeb.061218; Murray KL, 2001, J MAMMAL, V82, P728, DOI 10.1644/1545-1542(2001)082<0728:VISPCO>2.0.CO;2; Myrberg AA, 1997, B MAR SCI, V60, P1017; MYRBERG AA, 1993, J ACOUST SOC AM, V94, P3067, DOI 10.1121/1.407267; Nokman JR, 1928, P ZOOL SOC LONDON, V98, P781, DOI [10.1111/j.1469-7998.1928.tb07169.x, DOI 10.1111/J.1469-7998.1928.TB07169.X]; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Packert M, 2005, BIOL J LINN SOC, V86, P153, DOI 10.1111/j.1095-8312.2005.00529.x; Parkin DT, 2003, BIRD STUDY, V50, P223, DOI 10.1080/00063650309461316; Parmentier E, 2006, ACTA ZOOL-STOCKHOLM, V87, P113, DOI 10.1111/j.1463-6395.2006.00221.x; Parmentier E, 2018, ANIM CONSERV, V21, P211, DOI 10.1111/acv.12362; Parmentier E, 2018, J MORPHOL, V279, P864, DOI 10.1002/jmor.20816; Parmentier E, 2017, J EXP BIOL, V220, P186, DOI 10.1242/jeb.146514; Parmentier E, 2010, J EXP BIOL, V213, P3230, DOI 10.1242/jeb.044701; Raick X, 2020, J FISH BIOL, V97, P1676, DOI 10.1111/jfb.14529; Raick X, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.168948; Reichle S, 2001, J HERPETOL, V35, P21, DOI 10.2307/1566018; Renner SC, 2018, J ORNITHOL, V159, P63, DOI 10.1007/s10336-017-1493-0; Rountree RA, 2020, FRESHWATER BIOL, V65, P55, DOI 10.1111/fwb.13185; Shaw KL, 2000, ZOOL J LINN SOC-LOND, V129, P73, DOI 10.1111/j.1096-3642.2000.tb00009.x; Steindachner F, 1908, ANZEIGER KAIS AKAD W, V45, P359; Sunaga T, 1985, LIMNOL STUD RIO DOCE, P167; Sunaga T, 1987, LIMNOL STUD RIO DOCE, V2, P129; Thompson AW, 2014, MOL PHYLOGENET EVOL, V81, P242, DOI 10.1016/j.ympev.2014.06.018; Tubaro Pablo Luis, 1999, Etologia, V7, P19; Van Balen S, 2013, BIRD CONSERV INT, V23, P91, DOI 10.1017/S0959270911000360; Van Doren BM, 2018, WILSON J ORNITHOL, V130, P152, DOI 10.1676/16-126.1; Vono V, 2002, EFEITOS IMPLANTACAO; Walters CL, 2012, J APPL ECOL, V49, P1064, DOI 10.1111/j.1365-2664.2012.02182.x; Wang ZT, 2017, PEERJ, V5, DOI 10.7717/peerj.3924; White G, 1813, NATURAL HIST ANTIQUI; Xie J, 2018, APPL ACOUST, V131, P79, DOI 10.1016/j.apacoust.2017.10.024	88	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241316	10.1371/journal.pone.0241316	http://dx.doi.org/10.1371/journal.pone.0241316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119694	Green Published, gold			2022-12-26	WOS:000600013600118
J	del Paso, GAR; de la Coba, P				Reyes del Paso, Gustavo A.; de la Coba, Pablo			Reduced activity, reactivity and functionality of the sympathetic nervous system in fibromyalgia: An electrodermal study	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; HEART-RATE-VARIABILITY; LOW-BACK-PAIN; CARDIOVASCULAR REGULATION; BLOOD-FLOW; STIMULATION; SKIN; RESPONSES; TEMPERATURE; PATHOLOGY	Alterations in autonomic activity are well established in fibromyalgia syndrome (FMS). Previous studies found reduced parasympathetic activity and sympathetic reactivity to physical and stress manipulations. However, sympathetic activity at rest has not been well studied in FMS. Sweating is exclusively controlled by sympathetic mechanisms. In this study, skin conductance (SC), as an indirect measure of sweating, was analyzed in 45 women with FMS and 38 healthy women. Tonic SC levels were recorded during a 4-minute rest period, and a breathing maneuver consisting of deep breathing with posterior breath holding was used to evoke SC responses. Associations of tonic SC with state anxiety and body temperature, measured in the hand, were explored to determine sweat functionality. The results showed reduced tonic SC levels, with a less marked decrease in SC during the recording period, and blunted SC reactivity to the breathing manipulation in FMS patients relative to healthy participants. Positive associations of SC with state anxiety and body temperature were observed in healthy participants, but these associations were absent in FMS patients. These results indicate alterations of sweating in FMS, suggesting reduced tonic and reactivity sympathetic influences. Furthermore, the absence of associations between SC levels and state anxiety and body temperature in the patient sample suggested a loss of functionality of the autonomic nervous system in FMS. Diminished autonomic regulation in FMS would reduce the ability to cope with environmental demands, thus favoring increases in stress and pain levels. Finally, the observed reduction in sweating is in accordance with evidence of small nerve fiber neuropathy in FMS.	[Reyes del Paso, Gustavo A.; de la Coba, Pablo] Univ Jaen, Dept Psychol, Jaen, Spain	Universidad de Jaen	de la Coba, P (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	pcoba@ujaen.es	de la Coba, Pablo/G-5609-2019; Reyes del Paso, Gustavo A./G-4179-2011	de la Coba, Pablo/0000-0001-6469-3553; Reyes del Paso, Gustavo A./0000-0002-2188-8673	Spanish Ministry of Science, Innovation and Universities - FEDER funds [RTI2018-095830-B-I00]	Spanish Ministry of Science, Innovation and Universities - FEDER funds	This research was supported by a grant from the Spanish Ministry of Science, Innovation and Universities, co-financed by FEDER funds (Project RTI2018-095830-B-I00).	Albrecht PJ, 2016, REV ENVIRON HEALTH, V31, P281, DOI 10.1515/reveh-2015-0040; Albrecht PJ, 2013, PAIN MED, V14, P895, DOI 10.1111/pme.12139; [Anonymous], 2017, HDB PSYCHOPHYSIOLOGY; [Anonymous], 2015, OBSTET GYNECOL, V126, pe108; Berntson GG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P182, DOI 10.1017/CBO9780511546396.008; Bonnet A, 2004, INT J PSYCHOPHYSIOL, V53, P37, DOI 10.1016/j.ijpsycho.2004.01.004; Bulbena A., 2000, MEDICI N 150 NICA PS; Caro XJ, 2018, EUR J RHEUMATOL, V5, P104, DOI 10.5152/eurjrheum.2018.17109; Caro XJ, 2014, ARTHRITIS RHEUMATOL, V66, P1945, DOI 10.1002/art.38662; Clauw DJ, 2015, PAIN, V156, P2115, DOI 10.1097/j.pain.0000000000000311; Davydov DM, 2015, PHYSIOL BEHAV, V152, P203, DOI 10.1016/j.physbeh.2015.09.029; de la Coba P, 2018, PSYCHOSOM MED, V80, P573, DOI 10.1097/PSY.0000000000000599; Doppler K, 2015, PAIN, V156, P2319, DOI 10.1097/j.pain.0000000000000285; Evdokimov D, 2019, ANN NEUROL, V86, P504, DOI 10.1002/ana.25565; Farhad K, 2018, MUSCLE NERVE, V58, P611, DOI 10.1002/mus.26179; Furlan R, 2005, J RHEUMATOL, V32, P1787; Giannoccaro MP, 2014, MUSCLE NERVE, V49, P757, DOI 10.1002/mus.24156; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Jeschonneck M, 2000, RHEUMATOLOGY, V39, P917, DOI 10.1093/rheumatology/39.8.917; Kanbara K, 2004, APPL PSYCHOPHYS BIOF, V29, P255, DOI 10.1007/s10484-004-0386-1; Katz DL, 2007, MED HYPOTHESES, V69, P517, DOI 10.1016/j.mehy.2005.10.037; LAPOSSY E, 1994, CLIN RHEUMATOL, V13, P442, DOI 10.1007/BF02242940; Lawson VH, 2018, MUSCLE NERVE, V58, P625, DOI 10.1002/mus.26131; Lazaro C., 1994, EUR J PSYCHOL ASSESS, V10, P145; Lazarus R.S., 1984, EMOTION ADAPTATION; Martinez-Lavin Manuel, 2004, Curr Pain Headache Rep, V8, P385, DOI 10.1007/s11916-996-0012-4; Martinez-Lavin M, 2018, CLIN RHEUMATOL, V37, P3167, DOI 10.1007/s10067-018-4300-2; Meeus M, 2013, SEMIN ARTHRITIS RHEU, V43, P279, DOI 10.1016/j.semarthrit.2013.03.004; Mitani Y, 2006, APPL PSYCHOPHYS BIOF, V31, P217, DOI 10.1007/s10484-006-9020-8; Montoro CI, 2016, PAIN MED, V17, P2256, DOI 10.1093/pm/pnw082; Okifuji A, 2002, APPL PSYCHOPHYS BIOF, V27, P129, DOI 10.1023/A:1016243710507; PETRUZZELLO SJ, 1993, J SPORT EXERCISE PSY, V15, P63, DOI 10.1123/jsep.15.1.63; Pickering G, 2020, PAIN PRACT, V20, P348, DOI 10.1111/papr.12857; Pillemer SR, 1997, ARTHRITIS RHEUM-US, V40, P1928, DOI 10.1002/art.1780401103; QIAO ZG, 1991, J RHEUMATOL, V18, P1383; Raj SR, 2000, J RHEUMATOL, V27, P2660; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; del Paso GAR, 2015, PAIN MED, V16, P1835, DOI 10.1111/pme.12764; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; del Paso GAR, 2011, J PSYCHOSOM RES, V70, P125, DOI 10.1016/j.jpsychores.2010.09.012; del Paso GAR, 2010, PSYCHOSOM MED, V72, P462, DOI 10.1097/PSY.0b013e3181da91f1; Sandberg M, 2004, EUR J PAIN, V8, P163, DOI 10.1016/S1090-3801(03)00090-9; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; Spielberger C.D., 1982, CUESTIONARIO ANSIEDA; STERN RM, 1968, PSYCHOPHYSIOLOGY, V5, P132, DOI 10.1111/j.1469-8986.1968.tb02810.x; Sun W, 2012, BRAIN, V135, P359, DOI 10.1093/brain/awr345; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Thieme K, 2016, EUR J PAIN, V20, P1478, DOI 10.1002/ejp.872; Thieme K, 2006, J PSYCHOSOM RES, V61, P671, DOI 10.1016/j.jpsychores.2006.07.004; Thieme K, 2015, J PAIN, V16, P186, DOI 10.1016/j.jpain.2014.11.009; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; VAEROY H, 1989, J RHEUMATOL, V16, P1460; Van Houdenhove Boudewijn, 2005, Curr Rheumatol Rep, V7, P365; Watson NF, 2009, ARTHRITIS RHEUM-US, V60, P2839, DOI 10.1002/art.24772; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zamuner AR, 2015, CLIN EXP RHEUMATOL, V33, pS53	56	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241154	10.1371/journal.pone.0241154	http://dx.doi.org/10.1371/journal.pone.0241154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119628	gold, Green Published			2022-12-26	WOS:000600013600117
J	Nichols, TC; Levy, H; Merricks, EP; Raymer, RA; Lee, ML				Nichols, Timothy C.; Levy, Howard; Merricks, Elizabeth P.; Raymer, Robin A.; Lee, Martin L.			Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa	PLOS ONE			English	Article							SEVERE HEMOPHILIA-A; PROTEIN REPLACEMENT; CANINE MODELS; PROPHYLAXIS; THERAPY; MANAGEMENT; ADHERENCE; REGIMENS; DISEASE; IMPACT	Introduction The rapid clearance of factor IX necessitates frequent intravenous administrations to achieve effective prophylaxis for patients with hemophilia B. Subcutaneous administration has historically been limited by low bioavailability and potency. Dalcinonacog alfa was developed using a rational design approach to be a subcutaneously administered, next-generation coagulation prophylactic factor IX therapy. Aim This study aimed to investigate the pharmacokinetic, pharmacodynamic, and safety profile of dalcinonacog alfa administered subcutaneously in hemophilia B dogs. Methods Two hemophilia B dogs received single-dose daily subcutaneous dalcinonacog alfa injections for six days. Factor IX antigen and activity, whole blood clotting time, and activated partial thromboplastin time were measured at various time points. Additionally, safety assessments for clinical adverse events and evaluations of laboratory test results were conducted. Results There was an increase in plasma factor IX antigen with daily subcutaneous dalcinonacog alfa. Bioavailability of subcutaneous dalcinonacog alfa was 10.3% in hemophilia B dogs. Daily subcutaneous dosing of dalcinonacog alfa demonstrated the effects of bioavailability, time to maximal concentration, and half-life by reaching a steady-state activity sufficient to correct severe hemophilia to normal, after four days. Conclusion The increased potency of dalcinonacog alfa facilitated the initiation and completion of the Phase 1/2 subcutaneous dosing study in individuals with hemophilia B.	[Nichols, Timothy C.; Merricks, Elizabeth P.; Raymer, Robin A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Levy, Howard] Catalyst Biosci, San Francisco, CA 94080 USA; [Lee, Martin L.] UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles	Levy, H (corresponding author), Catalyst Biosci, San Francisco, CA 94080 USA.	hlevy@catbio.com			Catalyst Bioscience, Inc.; Catalyst Bioscience	Catalyst Bioscience, Inc.; Catalyst Bioscience	This study was supported by Catalyst Bioscience, Inc. The medical writing support was provided by Bronwyn Boyes and sponsored by Catalyst Bioscience. The funder provided support in the form of an institutional contract for authors [TCN, EPM, RAR], and did not have a role in data collection, but did have a role in the study design, and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. HL is an employee and MLL is a contractor of the funder.; MLL and HL analyzed the data. TCN, EPM, and RAR designed and executed the canine study. The medical writing support was provided by Bronwyn Boyes.	Andersson NG, 2017, BRIT J HAEMATOL, V179, P298, DOI 10.1111/bjh.14844; [Anonymous], 1996, TNT HONG KONG, V2, P28; [Anonymous], 2019, BENEFIX COAG FACT 9; Aznar JA, 2009, HAEMOPHILIA, V15, P665, DOI 10.1111/j.1365-2516.2009.02001.x; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Blanchette P, 2004, HAEMOPHILIA, V10, P679, DOI 10.1111/j.1365-2516.2004.01045.x; Blouse G, REDESIGNING FA UNPUB; BRINKHOUS KM, 1989, P NATL ACAD SCI USA, V86, P1382, DOI 10.1073/pnas.86.4.1382; De Moerloose P, 2008, HAEMOPHILIA, V14, P931, DOI 10.1111/j.1365-2516.2008.01843.x; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Dewhurst E, 2008, J SMALL ANIM PRACT, V49, P344, DOI 10.1111/j.1748-5827.2008.00583.x; Ettingshausen CE, 2019, RES PRACT THROMB HAE, V3, P268, DOI 10.1002/rth2.12192; EVANS JP, 1989, P NATL ACAD SCI USA, V86, P10095, DOI 10.1073/pnas.86.24.10095; Feng D, 2013, J THROMB HAEMOST, V11, P2176, DOI 10.1111/jth.12421; Fischer K, 2003, HAEMOPHILIA, V9, P376, DOI 10.1046/j.1365-2516.2003.00764.x; Giangrande P, 2005, EXPERT OPIN PHARMACO, V6, P1517, DOI 10.1517/14656566.6.9.1517; GRAY E, 1995, THROMB HAEMOSTASIS, V73, P675; Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Herzog RW, 2000, THROMB HAEMOSTASIS, V84, P352, DOI 10.1055/s-0037-1614021; Hong S-B, PHARMACOKINETI UNPUB; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; LEE ML, 1990, J LAB CLIN MED, V115, P745; Lee ML, 1997, 16 C INT SOC THROMB; Ljung RCR, 1999, THROMB HAEMOSTASIS, V82, P525; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; National Hemophilia Foundation, FAST FACTS; Nerich V, 2008, PHARM WORLD SCI, V30, P287, DOI 10.1007/s11096-007-9181-4; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nichols TC, 2016, J THROMB HAEMOST, V14, P894, DOI 10.1111/jth.13301; Nichols TC, 2009, ILAR J, V50, P144, DOI 10.1093/ilar.50.2.144; Nolte MW, 2012, J THROMB HAEMOST, V10, P1591, DOI 10.1111/j.1538-7836.2012.04826.x; Oldenburg J, 2015, HAEMOPHILIA, V21, P171, DOI 10.1111/hae.12539; Peyvandi F, 2016, LANCET, V388, P187, DOI 10.1016/S0140-6736(15)01123-X; Russell KE, 2003, BLOOD, V102, P4393, DOI 10.1182/blood-2003-05-1498; Santagostino E, 2010, HAEMOPHILIA, V16, P13, DOI 10.1111/j.1365-2516.2010.02301.x; Schulte S, 2009, THROMB RES, V124, pS6, DOI 10.1016/S0049-3848(09)70157-4; Stieltjes N, 2005, HAEMOPHILIA, V11, P452, DOI 10.1111/j.1365-2516.2005.01090.x; Stoner KL, 2015, PATIENT, V8, P145, DOI 10.1007/s40271-014-0075-y; Tagliaferri A, 2008, HAEMOPHILIA, V14, P945, DOI 10.1111/j.1365-2516.2008.01791.x; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Thornburg CD, 2017, PATIENT PREFER ADHER, V11, P1677, DOI 10.2147/PPA.S139851; Tischer B, 2018, PATIENT PREFER ADHER, V12, P431, DOI 10.2147/PPA.S151812; Treatment Guidelines Working Group on behalf of the World Federation of Hemophilia (WFH), 2012, GUIDELINES MANAGEMEN; Valentino LA, 2012, J THROMB HAEMOST, V10, P359, DOI 10.1111/j.1538-7836.2011.04611.x; White GC, 1997, THROMB HAEMOSTASIS, V77, P660; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Williams SC, 2020, HAEMOPHILIA, V26, P346, DOI 10.1111/hae.13949; Yen CT, 2016, THROMB J, V14, DOI 10.1186/s12959-016-0106-0; You CW, PHASE 1 2 TRIA UNPUB	50	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240896	10.1371/journal.pone.0240896	http://dx.doi.org/10.1371/journal.pone.0240896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112889	gold, Green Published			2022-12-26	WOS:000588374000053
J	Chan, GCK; Dor, FJ; Kit-Chung, NGJ; Chow, KM; Kwong, VWK; Pang, WF; Cheng, PMS; Law, MC; Leung, CB; Kam-Tao, LIP; Szeto, CC				Chan, Gordon Chun-Kau; Dor, Frank Jmf; Kit-Chung, Jack N. G.; Chow, Kai-Ming; Kwong, Vickie Wai-Ki; Pang, Wing-Fai; Cheng, Phyllis Mei-Shan; Law, Man-Ching; Leung, Chi-Bon; Kam-Tao, Philip L., I; Szeto, Cheuk Chun			Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; BIOIMPEDANCE SPECTROSCOPY; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; HEMODIALYSIS; ASSOCIATION; PREDICTOR; MORTALITY; SURVIVAL	Background Frailty and obesity contribute to the adverse clinical outcome of peritoneal dialysis (PD) patients, but the interaction between frailty and obesity remains uncertain. Objective To examine the interaction between frailty and obesity on the clinical outcome of PD patients. Design Single centre prospective observational cohort study. Patients 267 prevalent Chinese PD patients were recruited. Measurements Frailty was identified by a standard score. General and central obesity were determined by body mass index (BMI) and waist-hip ratio (WHR), respectively. Body composition was assessed by bioimpedance spectroscopy. All patients were followed for two years. Outcome measures included all-cause as well as cardiovascular mortality and hospitalization. Results Of the 267 patients, 120 (44.9%) were frail. Frail individuals were more likely to have central obesity (p < 0.001) but not general obesity. Although WHR did not predict patient survival, there was a significant interaction between WHR and frailty on patient survival and cardiovascular survival (p = 0.002 and p = 0.038, respectively). For patients without frailty, the two-year cardiovascular survival was 91.3% and 74.4% for those with and without central obesity, respectively (p = 0.002). For patients with frailty, however, the two-year cardiovascular survival was 64.6% and 66.7% for those with and without central obesity, respectively (p = 0.6). For patients without frailty, the number of hospital admission for cardiovascular disease over 2 years were 0.12 +/- 0.37 and 0.34 +/- 0.72 for those with and without central obesity, respectively (p = 0.03). For frail patients, however, the number of hospital admission was similar between those with and without central obesity. Conclusion There is a significant interaction between frailty and central obesity on the outcome of PD patients. The protective role of central obesity is only apparent in PD patients without frailty but not the frail ones, and there is a little prognostic value of general (non-central) obesity.	[Chan, Gordon Chun-Kau; Dor, Frank Jmf; Kit-Chung, Jack N. G.; Chow, Kai-Ming; Kwong, Vickie Wai-Ki; Pang, Wing-Fai; Cheng, Phyllis Mei-Shan; Law, Man-Ching; Leung, Chi-Bon; Kam-Tao, Philip L., I; Szeto, Cheuk Chun] Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Ming, Chow Kai/Y-5568-2019; Chan, Gordon Chun Kau/AHA-4072-2022	Ming, Chow Kai/0000-0001-5310-5197; Chan, Gordon Chun Kau/0000-0003-4681-7326	Chinese University of Hong Kong (CUHK) research	Chinese University of Hong Kong (CUHK) research	This study was supported by the Chinese University of Hong Kong (CUHK) research	Afsar B, 2006, PERITON DIALYSIS INT, V26, P705; Alfaadhel TA, 2015, CLIN J AM SOC NEPHRO, V10, P832, DOI 10.2215/CJN.07760814; [Anonymous], 2007, NEFROLOGIA, V27, pN3; [Anonymous], 2014, REV PRESCRIRE, V34, P171; [Anonymous], 2016, INT J SPECIALEDUCATI, V31, P1; [Anonymous], 2015, M2 PRESSWIRE, V32, P41; Avila-Carrasco L, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00630; Brown EA, 2020, PERITON DIALYSIS INT, V40, P327, DOI 10.1177/0896860819893558; Brown EA, 2017, KIDNEY INT, V91, P294, DOI 10.1016/j.kint.2016.08.026; Brown EA, 2010, NEPHROL DIAL TRANSPL, V25, P3755, DOI 10.1093/ndt/gfq212; Buch A, 2016, EXP GERONTOL, V76, P25, DOI 10.1016/j.exger.2016.01.008; Castro ACM, 2017, BRIT J NUTR, V117, P1299, DOI 10.1017/S0007114517001179; Chan GCK, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-01994-4; Choi SJ, 2011, PERITON DIALYSIS INT, V31, P67, DOI 10.3747/pdi.2009.00131; Clark AL, 2011, J CARD FAIL, V17, P374, DOI 10.1016/j.cardfail.2011.01.009; Cobo G, 2018, NEPHROL DIAL TRANSPL, V33, P35, DOI 10.1093/ndt/gfy175; Crow RS, 2019, J NUTR HEALTH AGING, V23, P138, DOI 10.1007/s12603-018-1138-x; Fitzpatrick J, 2019, NEPHROL DIAL TRANSPL, V34, P346, DOI 10.1093/ndt/gfy124; Franco Marcia Regina Gianotti, 2013, Braz. J. Nephrol., V35, P132, DOI 10.5935/0101-2800.20130022; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Guedes AM, 2019, PERITON DIALYSIS INT, V39, P201, DOI 10.3747/pdi.2018.00138; Horwich TB, 2018, PROG CARDIOVASC DIS, V61, P151, DOI 10.1016/j.pcad.2018.05.005; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Iyasere O, 2019, CLIN KIDNEY J, V12, P262, DOI 10.1093/ckj/sfy059; Iyasere O, 2019, PERITON DIALYSIS INT, V39, P112, DOI 10.3747/pdi.2018.00086; Jin Haifeng, 2015, Electrolyte Blood Press, V13, P22, DOI 10.5049/EBP.2015.13.1.22; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Johansen KL, 2015, CURR OPIN NEPHROL HY, V24, P268, DOI 10.1097/MNH.0000000000000120; Johansen KL, 2014, J AM SOC NEPHROL, V25, P381, DOI 10.1681/ASN.2013040431; Kiebalo T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061715; Kim JK, 2019, PERITON DIALYSIS INT, V39, P268, DOI 10.3747/pdi.2018.00164; Kwan BCH, 2014, PERITON DIALYSIS INT, V34, P409, DOI 10.3747/pdi.2013.00066; Kwong VWK, 2015, KIDNEY DIS-BASEL, V1, P147, DOI 10.1159/000439193; Lavie CJ, 2012, J AM COLL CARDIOL, V60, P1374, DOI 10.1016/j.jacc.2012.05.037; Lee MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077082; Lee SY, 2017, J RENAL NUTR, V27, P106, DOI 10.1053/j.jrn.2016.11.003; Li HF, 2011, AGING DIS, V2, P466; Li PKT, 2017, SEMIN NEPHROL, V37, P54, DOI 10.1016/j.semnephrol.2016.10.007; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Lyasere OU, 2016, CLIN J AM SOC NEPHRO, V11, P423, DOI 10.2215/CJN.01050115; McAdams-DeMarco MA, 2013, J AM GERIATR SOC, V61, P896, DOI 10.1111/jgs.12266; Ng JKC, 2016, KIDNEY BLOOD PRESS R, V41, P736, DOI 10.1159/000450563; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Obi Y, 2018, AM J KIDNEY DIS, V71, P802, DOI 10.1053/j.ajkd.2017.09.010; Pugh J, 2016, CLIN KIDNEY J, V9, P324, DOI 10.1093/ckj/sfv150; Sabatino A, 2017, CLIN NUTR, V36, P663, DOI 10.1016/j.clnu.2016.06.007; Su WS, 2010, INT J NEPHROL, V2010, DOI 10.4061/2010/831243; Szeto CC, 2001, J AM SOC NEPHROL, V12, P355, DOI 10.1681/ASN.V122355; Szeto CC, 2012, AM J NEPHROL, V35, P127, DOI 10.1159/000335580; Tang SCW, 2020, AM J KIDNEY DIS, V75, P772, DOI 10.1053/j.ajkd.2019.08.005; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wu CC, 2011, NEPHROL DIAL TRANSPL, V26, P3689, DOI 10.1093/ndt/gfr057	53	6	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241242	10.1371/journal.pone.0241242	http://dx.doi.org/10.1371/journal.pone.0241242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104712	Green Published, gold			2022-12-26	WOS:000588370000001
J	Hassan, L; Medenwald, D; Tiller, D; Kluttig, A; Ludwig-Kraus, B; Kraus, FB; Greiser, KH; Mikolajczyk, R				Hassan, Lamiaa; Medenwald, Daniel; Tiller, Daniel; Kluttig, Alexander; Ludwig-Kraus, Beatrice; Kraus, Frank Bernhard; Greiser, Karin H.; Mikolajczyk, Rafael			The association between change of soluble tumor necrosis factor receptor R1 (sTNF-R1) measurements and cardiovascular and all-cause mortality-Results from the population-based (Cardiovascular Disease, Living and Ageing in Halle) CARLA study 2002-2016	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; HEART-RATE-VARIABILITY; FACTOR RECEPTOR 1; INFLAMMATORY MARKERS; ELDERLY-PEOPLE; RISK-FACTORS; SHORT-TERM; DEATH; PREVALENCE	Aims Single measurements of higher levels of soluble tumor necrosis factor receptor I (sTNF-R1) have been shown to be associated with increased risk of mortality. However, up to date, little is known about the underlying temporal dynamics of sTNF-R1 concentrations and their relation with mortality. We aimed to characterize the effect of changes in sTNFR-1 levels on all-cause and cardiovascular mortality, independent from other established risk factors for mortality, including other inflammatory markers. Methods We used data of the population based cohort study CARLA and included 1408 subjects with sTNF-R1 measured at baseline (2002-2006) and first follow-up (2007-2010). Cox proportional hazard models were used to assess the association of baseline and follow-up sTNF-R1 measurements with all-cause and cardiovascular mortality during similar to 10 years since the first follow-up after adjusting for relevant confounders. Results Based on 211 deaths among 1408 subjects, per each doubling of the baseline sTNF-R1, the risk of all-cause mortality was increased by about 30% (Hazard ratio 1.28, 95% Confidence Interval 0.6-2.7), while per each doubling of the follow-up level of sTNF-R1 mortality was 3-fold (3.11, 1.5-6.5) higher in a model including both measurements and adjusting for confounders. The results were mainly related to the cardiovascular mortality (5.9, 2.1-16.8 per each doubling of follow up sTNF-R1 value). Conclusion Solely the follow-up value, rather than its change from baseline, predicted future mortality. Thus, while sTNF-R1 levels are associated with mortality, particularly cardiovascular, over a long-time period in the general population, if they change, the earlier measurements play no or little role.	[Hassan, Lamiaa; Medenwald, Daniel; Tiller, Daniel; Kluttig, Alexander; Mikolajczyk, Rafael] Martin Luther Univ Halle Wittenberg, Interdisciplinary Ctr Hlth Sci, Inst Med Epidemiol Biometr & Informat, Saxony Anhalt, Germany; [Medenwald, Daniel] Univ Hosp Halle, Dept Radiat Oncol, Halle, Saxony Anhalt, Germany; [Ludwig-Kraus, Beatrice; Kraus, Frank Bernhard] Univ Hosp Halle, Cent Lab, Halle, Saxony Anhalt, Germany; [Greiser, Karin H.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Baden Wurttembe, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Mikolajczyk, R (corresponding author), Martin Luther Univ Halle Wittenberg, Interdisciplinary Ctr Hlth Sci, Inst Med Epidemiol Biometr & Informat, Saxony Anhalt, Germany.	rafael.mikolajczyk@medizin.uni-halle.de	Mikolajczyk, Rafael/ABB-5259-2021; Ludwig-Kraus, Beatrice/D-2390-2013; Kraus, Bernhard/B-8172-2011	Kraus, Bernhard/0000-0003-4354-9952; Mikolajczyk, Rafael/0000-0003-1271-7204; Ludwig-Kraus, Beatrice/0000-0003-2660-4921	Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly-cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly-cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg; Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg; Ministry of Education and Cultural Affairs of Saxony-Anhalt; Federal Employment Office	The CARLA study was supported by a grant from the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Centre 598 'Heart failure in the elderly-cellular mechanisms and therapy' at the Medical Faculty of the Martin-Luther-University Halle-Wittenberg, by a grant from the Wilhelm-Roux Programme of the Martin-Luther-University Halle-Wittenberg, by the Ministry of Education and Cultural Affairs of Saxony-Anhalt, and by the Federal Employment Office.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alley DE, 2007, J AM GERIATR SOC, V55, P1801, DOI 10.1111/j.1532-5415.2007.01390.x; [Anonymous], 2010, LEGAL ED REV, V20, P87; [Anonymous], 2017, CMAJ, V189, pE1448; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Budiman V. A, 2016, MOMENTUM, V12, P49; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Carlsson AC, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0359-8; Carlsson AC, 2014, ATHEROSCLEROSIS, V237, P236, DOI 10.1016/j.atherosclerosis.2014.09.005; Doring AFB, 2000, KORA SURVEY 2000 MAN; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Giovannini S, 2011, J AM GERIATR SOC, V59, P1679, DOI 10.1111/j.1532-5415.2011.03570.x; Greiser Karin H, 2005, BMC Cardiovasc Disord, V5, P33, DOI 10.1186/1471-2261-5-33; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Jenny NS, 2012, J GERONTOL A-BIOL, V67, P970, DOI 10.1093/gerona/glr261; Jenny NS, 2007, AM J EPIDEMIOL, V165, P684, DOI 10.1093/aje/kwk057; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kizer JR, 2011, J GERONTOL A-BIOL, V66, P1100, DOI 10.1093/gerona/glr098; Lacruz ME, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000952; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luna JM, 2013, AGE AGEING, V42, P385, DOI 10.1093/ageing/afs175; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P3940, DOI 10.1002/art.23075; Medenwald D, 2017, EUROPACE, V19, P110, DOI 10.1093/europace/euv333; Ozenne B, 2017, R J, V9, P440, DOI 10.32614/RJ-2017-062; Parrinello CM, 2015, AM HEART J, V170, P380, DOI 10.1016/j.ahj.2015.04.017; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; R Core Team, 2018, R LANG ENV STAT COMP; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Saulnier PJ, 2014, DIABETES CARE, V37, P1425, DOI 10.2337/dc13-2580; Schumm-Drager PM, 2007, SCHILDDRUSENKRANKHEI, V2, P158; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Sung KC, 2014, EUR HEART J, V35, P1809, DOI 10.1093/eurheartj/ehu059; Tabak AG, 2010, EUR J ENDOCRINOL, V163, P89, DOI 10.1530/EJE-10-0277; Tiller D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059225; Tracy RP, 1999, ARTERIOSCL THROM VAS, V19, P1776, DOI 10.1161/01.ATV.19.7.1776; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; Verburg FA, 2017, NUKLEARMED-NUCL MED, V56, P9, DOI 10.3413/Nukmed-0852-16-10	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241213	10.1371/journal.pone.0241213	http://dx.doi.org/10.1371/journal.pone.0241213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104754	Green Published, gold			2022-12-26	WOS:000588370000033
J	Santymire, RM; Lavin, SR; Branvold-Faber, H; Kreeger, J; Che-Castaldo, J; Rafacz, M; Marinari, P				Santymire, Rachel M.; Lavin, Shana R.; Branvold-Faber, Heather; Kreeger, Julie; Che-Castaldo, Judy; Rafacz, Michelle; Marinari, Paul			Influence of vitamin E and carcass feeding supplementation on fecal glucocorticoid and androgen metabolites in male black-footed ferrets (Mustela nigripes)	PLOS ONE			English	Article							SEMEN QUALITY; OXIDATIVE STRESS; ORAL-HEALTH; ENRICHMENT; BEHAVIOR; SELENIUM; ANTIOXIDANTS; RESPONSES; ECOLOGY; BIOLOGY	In recent years, the ex situ population of the endangered black-footed ferret (Mustela nigripes; ferret) has experienced a decline in normal sperm morphology (from 50% to 20%), which may be linked to inbreeding depression and/or a dietary change. We examined the effects of adding carcass and vitamin E to the diet on stress and reproductive biomarkers in male ferrets (n = 42 males including 16 juveniles and 26 adults) housed at the U.S. Fish and Wildlife National Black-footed Ferret Conservation Center (Carr, CO, USA). Fecal samples (3x/week) were collected from November and December (pre-breeding season, no diet change), February through May (breeding season, diet change) and June (post-breeding season, diet change) and analyzed for fecal glucocorticoid metabolites (FGM) via a corticosterone enzyme immunoassay (EIA). A subset of samples from adult males (n = 15) were analyzed for fecal androgen metabolites (FAM) via a testosterone EIA. We first used a linear mixed effects model to identify the important fixed effects among meat treatment, vitamin E treatment, age class (juvenile or adult), and all possible interactions on each hormone. We then examined the important factor's effects across seasons using the non-parametric Friedman test. We found that age did not influence (p = 0.33) FGMs; however there was a significant effect of meat treatment on FGM (p = 0.04) and an effect of vitamin E on FAMs (p<0.10). When fed carcass, FGMs declined (p<0.001) from pre- to the during the breeding season time period, but was similar (p>0.05) between during and post-breeding season periods. Males that were not fed carcass had higher (p<0.05) FGMs during the breeding season compared to pre- and post-breeding season and FGMs were lower (p<0.05) in the post-breeding season compared to pre-breeding season. Males fed with carcass had lower (p<0.001) FGM than males that were not fed carcass during both the pre-breeding and the breeding season but not during the post-breeding season (p>0.05). Males supplemented with vitamin E had higher (p<0.001) FAM than non-supplemented males during the breeding season only. For both groups, FAM was highest (p<0.05) during the breeding season. In conclusion, adding carcass to the diet can reduce glucocorticoid production and adding vitamin E can increase testosterone during the breeding season, which may influence reproductive success.	[Santymire, Rachel M.; Lavin, Shana R.; Che-Castaldo, Judy; Rafacz, Michelle] Lincoln Pk Zoo, Conservat & Sci Dept, Chicago, IL 60614 USA; [Branvold-Faber, Heather; Kreeger, Julie; Marinari, Paul] US Fish & Wildlife Serv, Natl Black Footed Ferret Conservat Ctr, Carr, CO USA; [Marinari, Paul] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Lavin, Shana R.] Disneys Anim Kingdom, Anim Sci & Environm, Orlando, FL USA; [Branvold-Faber, Heather] Southside Anim Hosp, Anchorage, AK USA; [Rafacz, Michelle] Columbia Coll, Chicago, IL USA	United States Department of the Interior; US Fish & Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Walt Disney Company	Santymire, RM (corresponding author), Lincoln Pk Zoo, Conservat & Sci Dept, Chicago, IL 60614 USA.	rsantymire@lpzoo.org		Lavin, Shana/0000-0002-9557-0393; Santymire, Rachel/0000-0003-4102-9144	Davee Foundation	Davee Foundation	Funding was provided by The Davee Foundation.	Agarwal A, 2002, UROL CLIN N AM, V29, P817, DOI 10.1016/S0094-0143(02)00081-2; Akcali A, 2013, J ORAL REHABIL, V40, P60, DOI 10.1111/j.1365-2842.2012.02341.x; Altman Joanne D., 2005, Journal of Applied Animal Welfare Science, V8, P47, DOI 10.1207/s15327604jaws0801_4; [Anonymous], NLME LINEAR NONLINEA; Antonelli TS, 2016, CAN J ZOOL, V94, P15, DOI 10.1139/cjz-2015-0135; Bashaw MJ, 2003, ZOO BIOL, V22, P189, DOI 10.1002/zoo.10065; Behringer V, 2018, HORM BEHAV, V105, P66, DOI 10.1016/j.yhbeh.2018.07.011; Biggins DE, 2006, HABITAT PREFERENCES; BOND JC, 1990, APPL ANIM BEHAV SCI, V26, P373, DOI 10.1016/0168-1591(90)90036-D; Breivik T, 2001, J PERIODONTAL RES, V36, P295, DOI 10.1034/j.1600-0765.2001.360504.x; Brown JL, 1997, J WILDLIFE MANAGE, V61, P1428, DOI 10.2307/3802147; Chen HL, 2005, EXP GERONTOL, V40, P728, DOI 10.1016/j.exger.2005.06.004; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; COMBS GF, 1976, J NUTR, V106, P967, DOI 10.1093/jn/106.7.967; Contri A, 2011, THERIOGENOLOGY, V75, P1319, DOI 10.1016/j.theriogenology.2010.12.003; Echeverria-Alonzo S, 2009, J ANIM VET ADV, V8, P2311; Garelle D, 2018, BLACK FOOTED FERRET; Graves G, 2019, POPULATION ANAL BREE; Hilgert JB, 2006, J DENT RES, V85, P324, DOI 10.1177/154405910608500408; ICHIHARA I, 1967, Okajimas Folia Anatomica Japonica, V43, P203; Jenny S, 2002, ZOO BIOL, V21, P573, DOI 10.1002/zoo.10061; Keskes-Ammar L, 2003, ARCH ANDROLOGY, V49, P83, DOI 10.1080/713828100; Lamirande ED, 1992, J ANDROL, V13, P368; Law G., 1997, International Zoo Yearbook, V35, P197, DOI 10.1111/j.1748-1090.1997.tb01210.x; LINDBURG DG, 1988, ZOO BIOL, V7, P211, DOI 10.1002/zoo.1430070303; Litherland M., 1986, OVERSEAS MEMOIR BRIT, V9, P1; Lyons J, 1997, ZOO BIOL, V16, P71; Mancini A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6757154; Marinari P, 2019, N AM REGIONAL BLACK; Marinari PE, 2004, US GEOLOGICAL SURVEY, P23; MAZZARO LM, 1995, MAR MAMMAL SCI, V11, P545, DOI 10.1111/j.1748-7692.1995.tb00676.x; Meller CL, 2007, ZOO BIOL, V26, P51, DOI 10.1002/zoo.20119; Miller B., 1996, PRAIRIE NIGHT BLACK; Miller LJ, 2019, J APPL ANIM WELF SCI, V22, P188, DOI 10.1080/10888705.2018.1455582; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Muller DWH, 2011, P ROY SOC B-BIOL SCI, V278, P2076, DOI 10.1098/rspb.2010.2275; Oyarzun SE, 1995, EVALUATION NUTR ADEQ; Poessel SA, 2011, GEN COMP ENDOCR, V172, P526, DOI 10.1016/j.ygcen.2011.04.018; R Core Team, 2018, R LANG ENV STAT COMP; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; RICHARDSON L, 1987, AM MIDL NAT, V117, P225, DOI 10.2307/2425964; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ruskell AD, 2015, ZOO BIOL, V34, P170, DOI 10.1002/zoo.21192; Santymire R, BLACK FOOTED FERRET; Santymire RM, 2019, ANIM CONSERV, V22, P331, DOI 10.1111/acv.12466; Santymire RM, 2010, ZOO BIOL, V29, P289, DOI 10.1002/zoo.20248; Santymire RM, 2015, THERIOGENOLOGY, V84, P217, DOI 10.1016/j.theriogenology.2015.03.007; Santymire RM, 2014, ADV EXP MED BIOL, V753, P119, DOI 10.1007/978-1-4939-0820-2_7; Santymire RM, 2014, WILDL SOC 21 ANN C O; Santymire RM, 2018, COMMUNICATION; Santymire RM, 2004, DEFENDERS WILDLIFE C, P200; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sikka SC, 2004, J ANDROL, V25, P5; Sikka SC, 1995, J ANDROL, V16, P464; Skibiel AL, 2007, ZOO BIOL, V26, P371, DOI 10.1002/zoo.20147; Surai PF, 1998, BRIT POULTRY SCI, V39, P257, DOI 10.1080/00071669889222; UMEDA F, 1982, ENDOCRINOL JAPON, V29, P287; VAHL HA, 1987, J ANIM PHYSIOL AN N, V57, P204, DOI 10.1111/j.1439-0396.1987.tb00031.x; Wasser SK, 2010, GEN COMP ENDOCR, V168, P1, DOI 10.1016/j.ygcen.2010.04.004; WILLIAMS ES, 1991, ZOO BIOL, V10, P383, DOI 10.1002/zoo.1430100502; Wolf KN, 2000, BIOL REPROD, V63, P179, DOI 10.1095/biolreprod63.1.179; Yue DB, 2010, ANIM REPROD SCI, V118, P217, DOI 10.1016/j.anireprosci.2009.08.004	62	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241085	10.1371/journal.pone.0241085	http://dx.doi.org/10.1371/journal.pone.0241085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095820	Green Published, gold			2022-12-26	WOS:000586649400005
J	Zhen, H; Deng, HK; Song, Q; Zheng, MY; Yuan, ZQ; Cao, ZH; Pang, QX; Zhao, BS				Zhen, Hui; Deng, Hongkuan; Song, Qian; Zheng, Mingyue; Yuan, Zuoqing; Cao, Zhonghong; Pang, Qiuxiang; Zhao, Bosheng			The Wnt/Ca2+ signaling pathway is essential for the regeneration of GABAergic neurons in planarian Dugesia japonica	FASEB JOURNAL			English	Article						brain regeneration; function; GABAergic neuron; Wnt; Ca2+ signaling pathway	CONVERGENT EXTENSION MOVEMENTS; CENTRAL-NERVOUS-SYSTEM; ADULT ZEBRAFISH BRAIN; PROTEIN-KINASE-II; STEM-CELLS; DOPAMINERGIC-NEURONS; GABA(A) RECEPTORS; NEURAL-NETWORK; WNT; NEUROGENESIS	The growth and differentiation of neurons are critical events in the establishment of proper neuron connectivity and function. Planarians have a remarkable ability to completely regenerate a functional nervous system from a pluripotent stem cell population. Thus, planarians provide a powerful model to identify genes required for neuronal differentiation in vivo. The Wnt/Ca2+ signaling pathway is crucial for cancer development, arousing inflammatory responses, and neurodegeneration. We analyzed the expression patterns and RNAi phenotypes for members of the Wnt/Ca2+ signaling pathway in the planarian, Dugesia japonica. The expression of DjWnt5a, DjPLC-beta, DjCamKII, and DjCaln during regeneration was surprisingly similar and revealing in the regenerated brain. RNAi knockdown of DjWnt5a, DjPLC-beta, DjCamKII, and DjCaln led to defects in regenerated brains including brain partial deletions, incompact phenotypes at the posterior of the new brain, and lateral branches, which could not regenerate. Furthermore, the expressions of GAD and the number of GABAergic neurons decreased. Together, these results suggest that the Wnt/Ca2+ signaling pathway is required for GABAergic neuron regeneration.	[Zhen, Hui; Deng, Hongkuan; Song, Qian; Yuan, Zuoqing; Cao, Zhonghong; Zhao, Bosheng] Shandong Univ Technol, Lab Dev & Evolutionary Biol, 266 Xincun West Rd, Zibo 255000, Shandong, Peoples R China; [Deng, Hongkuan; Yuan, Zuoqing; Cao, Zhonghong; Pang, Qiuxiang] Shandong Univ Technol, Sch Life Sci, Zibo, Shandong, Peoples R China; [Zheng, Mingyue] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	Shandong University of Technology; Shandong University of Technology; Ocean University of China	Zhao, BS (corresponding author), Shandong Univ Technol, Lab Dev & Evolutionary Biol, 266 Xincun West Rd, Zibo 255000, Shandong, Peoples R China.	zhaobosheng@sdut.edu.cn	Zheng, Mingyue/HHZ-4062-2022	Zheng, Mingyue/0000-0002-3323-3092	National Natural Science Foundation of China [31970430, 31572263]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31970430 and 31572263	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Andersson ER, 2013, P NATL ACAD SCI USA, V110, pE602, DOI 10.1073/pnas.1208524110; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Brown DDR, 2018, DEV BIOL, V433, P374, DOI 10.1016/j.ydbio.2017.08.024; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Cajal S., 1928, DEGENERATION REGENER; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Coullery RP, 2016, NEUROTOXICOLOGY, V52, P150, DOI 10.1016/j.neuro.2015.12.004; Cowles MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004746; Cowles MW, 2013, DEVELOPMENT, V140, P4691, DOI 10.1242/dev.098616; Cowles MW, 2012, DEV DYNAM, V241, P901, DOI 10.1002/dvdy.23775; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Currie KW, 2016, ELIFE, V5, DOI 10.7554/eLife.19735; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GOTO S, 1986, ACTA NEUROPATHOL, V72, P150, DOI 10.1007/BF00685977; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GUPTA RC, 1985, CAN J PHYSIOL PHARM, V63, P1000, DOI 10.1139/y85-165; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Hill EM, 2015, DEVELOPMENT, V142, P4217, DOI 10.1242/dev.123612; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Houston CM, 2006, EUR J NEUROSCI, V24, P2504, DOI 10.1111/j.1460-9568.2006.05145.x; Houston CM, 2007, J BIOL CHEM, V282, P17855, DOI 10.1074/jbc.M611533200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; KARLS U, 1992, MOL CELL BIOL, V12, P3644, DOI 10.1128/MCB.12.8.3644; Kempermann G, 1998, NERVENARZT, V69, P851, DOI 10.1007/s001150050353; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; KING MM, 1984, J BIOL CHEM, V259, P8080; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Kury S, 2017, AM J HUM GENET, V101, P768, DOI 10.1016/j.ajhg.2017.10.003; Lauter G, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-43; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lu QQ, 2017, GENE, V615, P25, DOI 10.1016/j.gene.2017.03.017; Marsal M, 2003, GENE EXPR PATTERNS, V3, P489, DOI 10.1016/S1567-133X(03)00058-9; Martin C, 2007, NEUROENDOCRINOLOGY, V85, P257, DOI 10.1159/000103557; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Nishimura K, 2008, NEUROSCIENCE, V153, P1103, DOI 10.1016/j.neuroscience.2008.03.026; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nishimura K, 2011, J NEUROCHEM, V119, P1217, DOI 10.1111/j.1471-4159.2011.07518.x; Nishimura K, 2008, NEUROCHEM INT, V53, P184, DOI 10.1016/j.neuint.2008.09.006; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Qi YL, 2009, BIOCHEM BIOPH RES CO, V381, P129, DOI 10.1016/j.bbrc.2009.02.058; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; Stuckemann T, 2017, DEV CELL, V40, P248, DOI 10.1016/j.devcel.2016.12.024; Talabattula VAN, 2017, BIOCHEM BIOPH RES CO, V491, P40, DOI 10.1016/j.bbrc.2017.07.030; TANAKA O, 1994, NEUROSCI LETT, V182, P17, DOI 10.1016/0304-3940(94)90194-5; Tazaki A, 1999, BIOCHEM BIOPH RES CO, V260, P426, DOI 10.1006/bbrc.1999.0933; Umesono Y, 1999, DEV GENES EVOL, V209, P31, DOI 10.1007/s004270050224; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Zanardelli S, 2013, DEV BIOL, V384, P83, DOI 10.1016/j.ydbio.2013.09.017; Zeng A, 2018, CELL, V173, P1593, DOI 10.1016/j.cell.2018.05.006; Zhang XH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/758097; Zhen H, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111540	75	4	5	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16567	16580		10.1096/fj.201903040RR	http://dx.doi.org/10.1096/fj.201903040RR		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094857				2022-12-26	WOS:000586259000001
J	Alnajashi, H; Jabbad, R				Alnajashi, Hind; Jabbad, Razan			Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic	PLOS ONE			English	Article							ATTITUDES; RESIDENTS; KNOWLEDGE; HEALTH	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in late 2019 and Covid-19, a disease caused by SARS-CoV-2 became a pandemic in March 2020. As the pandemic still unfolds, uncertainty circles around the impact of SARS-CoV-2 infection on patients with chronic diseases, including autoimmune diseases such as multiple sclerosis (MS). To diminish the risk of SARS-CoV-2 infection and lessen the impact of the Covid-19 pandemic on the healthcare of MS patients, it is essential to understand knowledge, attitudes, and various behavioral practices related to Covid-19 among MS patients. Therefore, this study aimed to look at the behavioral practices related to Covid-19 among patients with MS. A total of 176 MS patients diagnosed at least one year before the survey were conveniently sampled online in Saudi Arabia and their data collected using a structured interview questionnaire in electronic Google form. We determined the reliability of the questionnaire by measuring its internal consistency in a pilot sample of 30 participants. Overall, more than 80% of participants had good knowledge and attitudes towards Covid-19. However, this did not correlate well with the impact on healthcare (r = 0.06). Our study revealed that 46% of participants were anxious about taking their medication, and 32% of participants missed their hospital appointments. Furthermore, 15% of the participants had a relapse but did not go to the hospital because of the pandemic, 15.9% stopped their DMTs, and 35.2% missed drug infusions or refills. Our study revealed overall good knowledge and attitudes related to Covid-19 among MS patients. However, the healthcare impact was considerable, as 32% of the participants missed their hospital appointments, and another 15% had a relapse. This highlights the significance of the impact of the Covid-19 pandemic on the healthcare of patients with MS. Measures to mitigate the effect of the pandemic on healthcare service delivery to patients with MS, such as telemedicine, should be strongly encouraged.	[Alnajashi, Hind; Jabbad, Razan] King Abdulaziz Univ, Div Neurol, Dept Med, Fac Med, Jeddah, Saudi Arabia	King Abdulaziz University	Alnajashi, H (corresponding author), King Abdulaziz Univ, Div Neurol, Dept Med, Fac Med, Jeddah, Saudi Arabia.	halnajashi@kau.edu.sa						Ahmed S., 2020, BMJ INNOV, V20, P44; Alkhamees AA, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152192; Amor S, 2020, ANN NEUROL, V87, P794, DOI 10.1002/ana.25770; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2020, BMJ-BRIT MED J, V369, pm2170, DOI 10.1136/bmj.m2170; [Anonymous], 2019, LANCET NEUROL; [Anonymous], 2020, J ULTRASOUND MED, V39, pE17; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Berger JR, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000761; Bonavita S., 2020, DIGITAL TRIAGE PEOPL, P9; Chen Emily, 2020, JMIR Public Health Surveill, V6, pe19273, DOI 10.2196/19273; Chudasama YV, 2020, DIABETES METAB SYND, V14, P965, DOI 10.1016/j.dsx.2020.06.042; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Ghajarzadeh M., 2020, ARE PATIENTS MULTIPL; Haeseleer M. D., 2020, FEASIBILITY REAL TIM, V22, P1; Heydarpour P, 2015, NEUROEPIDEMIOLOGY, V44, P232, DOI 10.1159/000431042; Hezima A, 2020, E MEDITERR HEALTH J, V26, P646, DOI 10.26719/emhj.20.076; Lavorgna L, 2018, MULT SCLER J, V24, P1657, DOI 10.1177/1352458518799629; Luna G, 2020, JAMA NEUROL, V77, P184, DOI 10.1001/jamaneurol.2019.3365; Mateen F. J., 2020, J NEUROL; Matthews PM, 2020, CURR OPIN NEUROL, V33, P271, DOI 10.1097/WCO.0000000000000823; Moccia M., 2020, ASSESSING DISABILITY; Mohn N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01059; Moghanibashi-Mansourieh A, 2020, ASIAN J PSYCHIATR, P51, DOI DOI 10.1016/j.ajp.2020.102076; multicenter collaboration group of Department of S Technology of Guangdong P Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p, 2020, ZHONGHUA JIE HE HE H, V43, pE019; multicenter collaboration group of Department of S Technology of Guangdong P Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus p, 2020, ZHONGHUA JIE HE HE H, V43, pE019; Ozamiz-Etxebarria N, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00054020, 10.1590/0102-311x00054020]; Parohan M, 2020, AGING MALE, V23, P1416, DOI 10.1080/13685538.2020.1774748; Repovic Pavle, 2019, Continuum (Minneap Minn), V25, P655, DOI 10.1212/CON.0000000000000739; Richez C, 2020, JOINT BONE SPINE, V87, P187, DOI 10.1016/j.jbspin.2020.03.010; Sahraian MA, 2020, MULT SCLER RELAT DIS, V42, DOI 10.1016/j.msard.2020.102193; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Timmis K, 2020, ENVIRON MICROBIOL, V22, P1986, DOI 10.1111/1462-2920.15029; Valentino L. A., 2020, OFFICIAL J WORLD FED; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Zheng C, 2020, CNS DRUGS, V34, P879, DOI 10.1007/s40263-020-00756-y; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241103	10.1371/journal.pone.0241103	http://dx.doi.org/10.1371/journal.pone.0241103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091088	Green Published, gold			2022-12-26	WOS:000586647200045
J	Ceriotti, S; Bullone, M; Leclere, M; Ferrucci, F; Lavoie, JP				Ceriotti, Serena; Bullone, Michela; Leclere, Mathilde; Ferrucci, Francesco; Lavoie, Jean-Pierre			Severe asthma is associated with a remodeling of the pulmonary arteries in horses	PLOS ONE			English	Article							BLOOD-FLOW DISTRIBUTION; VASCULAR ABNORMALITIES; AIRWAY INFLAMMATION; LUNG; HEAVES; HYPERTENSION; DISEASE; EXPOSURE; CELLS	Pulmonary hypertension andcor pulmonaleare complications of severe equine asthma, as a consequence of pulmonary hypoxic vasoconstriction. However, as pulmonary hypertension is only partially reversible by oxygen administration, other etiological factors are likely involved. In human chronic obstructive pulmonary disease, pulmonary artery remodeling contributes to the development of pulmonary hypertension. In rodent models, pulmonary vascular remodeling is present as a consequence of allergic airway inflammation. The present study investigated the presence of remodeling of the pulmonary arteries in severe equine asthma, its distribution throughout the lungs, and its reversibility following long-term antigen avoidance strategies and inhaled corticosteroid administration. Using histomorphometry, the total wall area of pulmonary arteries from different regions of the lungs of asthmatic horses and controls was measured. The smooth muscle mass of pulmonary arteries was also estimated on lung sections stained for alpha-smooth muscle actin. Reversibility of vascular changes in asthmatic horses was assessed after 1 year of antigen avoidance alone or treatment with inhaled fluticasone. Pulmonary arteries showed increased wall area in apical and caudodorsal lung regions of asthmatic horses in both exacerbation and remission. The pulmonary arteries smooth muscle mass was similarly increased. Both treatments reversed the increase in wall area. However, a trend for normalization of the vascular smooth muscle mass was observed only after treatment with antigen avoidance, but not with fluticasone. In conclusion, severe equine asthma is associated with remodeling of the pulmonary arteries consisting in an increased smooth muscle mass. The resulting narrowing of the artery lumen could enhance hypoxic vasoconstriction, contributing to pulmonary hypertension. In our study population, the antigen avoidance strategy appeared more promising than inhaled corticosteroids in controlling vascular remodeling. However, further studies are needed to support the reversibility of vascular smooth muscle mass remodeling after asthma treatment.	[Ceriotti, Serena; Bullone, Michela; Leclere, Mathilde; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ, Canada; [Ceriotti, Serena; Ferrucci, Francesco] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Ceriotti, Serena] Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL USA; [Bullone, Michela] Univ Torino, Dept Vet Sci, Grugliasco, Italy	Universite de Montreal; University of Milan; Auburn University System; Auburn University; University of Turin	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ, Canada.	jean-pierre.lavoie@umontreal.ca		Lavoie, Jean-Pierre/0000-0003-4655-2102; Ceriotti, Serena/0000-0002-6905-0538	Canadian Institutes of Health and Research [MIF79636]	Canadian Institutes of Health and Research(Canadian Institutes of Health Research (CIHR))	JPL was funded by the Canadian Institutes of Health and Research (grant number MIF79636; https://cihr-irsc.gc.ca/e/193.html). The funders had no role in study designs, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Cocuk Sagligi ve Hastaliklari Dergisi, V53, P258; [Anonymous], 2015, YAD VASHEM STUDIES, V43/2, P109; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Bullone M, 2018, EQUINE VET J, V50, P609, DOI 10.1111/evj.12806; Bullone M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09414-8; Bullone M, 2015, MOL IMMUNOL, V66, P97, DOI 10.1016/j.molimm.2014.12.005; Chandrasekar I, 2008, PEDIATR RES, V63, P67, DOI 10.1203/PDR.0b013e31815b43ee; Cook RC, 2004, J THORAC CARDIOV SUR, V127, P65, DOI 10.1016/S0022-5223(03)01024-9; Decloedt A, 2017, EQUINE VET J, V49, P603, DOI 10.1111/evj.12675; DIXON PM, 1978, EQUINE VET J, V10, P195, DOI 10.1111/j.2042-3306.1978.tb02260.x; FERNIE JM, 1985, J CLIN PATHOL, V38, P1374, DOI 10.1136/jcp.38.12.1374; FERNIE JM, 1985, J CLIN PATHOL, V38, P1380, DOI 10.1136/jcp.38.12.1380; Harkness LM, 2014, PULM PHARMACOL THER, V29, P144, DOI 10.1016/j.pupt.2014.09.003; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; Hlastala MP, 1996, J APPL PHYSIOL, V81, P1051, DOI 10.1152/jappl.1996.81.3.1051; Jean D, 1999, AM J VET RES, V60, P1341; Johansson AM, 2007, J VET INTERN MED, V21, P302, DOI 10.1892/0891-6640(2007)21[302:CEOAPO]2.0.CO;2; KAY JM, 1983, AM REV RESPIR DIS, V128, pS53; Lavoie JP, 2001, AM J RESP CRIT CARE, V164, P1410, DOI 10.1164/ajrccm.164.8.2012091; Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC; Leclere M, 2011, AM J RESP CELL MOL, V45, P181, DOI 10.1165/rcmb.2010-0300OC; Meconi DV, 2008, AUGUSTIN STUD, V39, P61, DOI 10.5840/augstudies20083917; No HK, 2007, J FOOD SCI, V72, pR87, DOI 10.1111/j.1750-3841.2007.00383.x; NYMAN G, 1991, EQUINE VET J, V23, P253, DOI 10.1111/j.2042-3306.1991.tb03713.x; Ochs M, 2013, AM J PHYSIOL-LUNG C, V305, pL15, DOI 10.1152/ajplung.00429.2012; Peinado VI, 1999, AM J RESP CRIT CARE, V159, P1605, DOI 10.1164/ajrccm.159.5.9807059; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908; Peinado VI, 2013, J HEART LUNG TRANSPL, V32, P1262, DOI 10.1016/j.healun.2013.09.007; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P676, DOI 10.1046/j.1365-2222.2003.01640.x; Relave F, 2008, VET SURG, V37, P232, DOI 10.1111/j.1532-950X.2008.00371.x; Robinson NE, 1996, BRIT VET J, V152, P283, DOI 10.1016/S0007-1935(96)80101-1; RUSSELL HK, 1972, ARCH PATHOL, V94, P187; Rydell-Tormanen K, 2009, INT ARCH ALLERGY IMM, V149, P251, DOI 10.1159/000199721; SAETTA M, 1991, AM REV RESPIR DIS, V143, P138, DOI 10.1164/ajrccm/143.1.138; Sage AM, 2006, J VET INTERN MED, V20, P694, DOI 10.1892/0891-6640(2006)20[694:EIAHWC]2.0.CO;2; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheikh AQ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9712; Sheikh AQ, 2014, CELL REP, V6, P809, DOI 10.1016/j.celrep.2014.01.042; Shimoda LA, 2013, J MOL MED, V91, P297, DOI 10.1007/s00109-013-0998-0; Singh I, 2016, AM J MED, V129, P366, DOI 10.1016/j.amjmed.2015.11.026; Sommer N, 2016, EUR RESPIR J, V47, P288, DOI 10.1183/13993003.00945-2015; Stack A, 2016, J APPL PHYSIOL, V120, P599, DOI 10.1152/japplphysiol.00975.2015; Stack A, 2014, J APPL PHYSIOL, V117, P370, DOI 10.1152/japplphysiol.00314.2014; Theodorou A, 1997, J APPL PHYSIOL, V83, P912, DOI 10.1152/jappl.1997.83.3.912; Tormanen KR, 2005, AM J RESP CRIT CARE, V171, P19, DOI 10.1164/rccm.200406-498OC; Veyssier-Belot C, 1999, CARDIOVASC RES, V44, P274, DOI 10.1016/S0008-6363(99)00230-8; Voelkel NF, 2003, EUR RESPIR J, V22, p28S, DOI 10.1183/09031936.03.00000503; Williams KJ, 2008, VET PATHOL, V45, P316, DOI 10.1354/vp.45-3-316; Williams KJ, 2013, J APPL PHYSIOL, V114, P869, DOI 10.1152/japplphysiol.01170.2012; Witzenrath M, 2006, EUR RESPIR J, V28, P370, DOI 10.1183/09031936.06.00080105; WRIGHT JL, 1992, LUNG, V170, P109	53	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0239561	10.1371/journal.pone.0239561	http://dx.doi.org/10.1371/journal.pone.0239561			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091038	Green Published, gold, Green Submitted			2022-12-26	WOS:000586647200004
J	Hicks, LL; Schwab, NA; Homyack, JA; Jones, JE; Maxell, BA; Burkholder, BO				Hicks, Lorin L.; Schwab, Nathan A.; Homyack, Jessica A.; Jones, Jay E.; Maxell, Bryce A.; Burkholder, Braden O.			A statistical approach to white-nose syndrome surveillance monitoring using acoustic data	PLOS ONE			English	Article							BAT ACTIVITY; WINTER; FOREST; FIRE	Traditional pathogen surveillance methods for white-nose syndrome (WNS), the most serious threat to hibernating North American bats, focus on fungal presence where large congregations of hibernating bats occur. However, in the western USA, WNS-susceptible bat species rarely assemble in large numbers and known winter roosts are uncommon features. WNS increases arousal frequency and activity of infected bats during hibernation. Our objective was to explore the effectiveness of acoustic monitoring as a surveillance tool for WNS. We propose a non-invasive approach to model pre-WNS baseline activity rates for comparison with future acoustic data after WNS is suspected to occur. We investigated relationships among bat activity, ambient temperatures, and season prior to presence of WNS across forested sites of Montana, USA where WNS was not known to occur. We used acoustic monitors to collect bat activity and ambient temperature data year-round on 41 sites, 2011-2019. We detected a diverse bat community across managed (n = 4) and unmanaged (n = 37) forest sites and recorded over 5.37 million passes from bats, including 13 identified species. Bats were active year-round, but positive associations between average of the nightly temperatures by month and bat activity were strongest in spring and fall. From these data, we developed site-specific prediction models for bat activity to account for seasonal and annual temperature variation prior to known occurrence of WNS. These prediction models can be used to monitor changes in bat activity that may signal potential presence of WNS, such as greater than expected activity in winter, or less than expected activity during summer. We propose this model-based method for future monitoring efforts that could be used to trigger targeted sampling of individual bats or hibernacula for WNS, in areas where traditional disease surveillance approaches are logistically difficult to implement or because of human-wildlife transmission concerns from COVID-19.	[Hicks, Lorin L.] Weyerhaeuser, Kalispell, MT USA; [Schwab, Nathan A.] Tetra Tech, Missoula, MT USA; [Homyack, Jessica A.] Weyerhaeuser, Centralia, WA 98531 USA; [Jones, Jay E.] Weyerhaeuser, Seattle, WA USA; [Maxell, Bryce A.; Burkholder, Braden O.] Montana Nat Heritage Program, Helena, MT USA		Homyack, JA (corresponding author), Weyerhaeuser, Centralia, WA 98531 USA.	jessica.homyack@weyerhaeuser.com			National Council for Air and Stream Improvement, Inc.; Plum Creek Timber; Weyerhaeuser; Stimson Lumber; F. H. Stoltze Land; Timber	National Council for Air and Stream Improvement, Inc.; Plum Creek Timber; Weyerhaeuser; Stimson Lumber; F. H. Stoltze Land; Timber	Funding was provided by National Council for Air and Stream Improvement, Inc., Plum Creek Timber, Weyerhaeuser, Stimson Lumber, F. H. Stoltze Land and Timber. Weyerhaeuser provided access and logistical support to collect empirical data and provided support in the form of salary for authors Lorin Hicks and Jessica Homyack. Weyerhaeuser also contracted with TetraTech for data collection and analysis, completed by author Nathan Schwab. The funder provided support in the form of salaries for authors [LH, JH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Plum Creek Timber, Stimson Lumber, F. H. Stoltze Land and Timber also provided funding and support in the form of salary for Lorin Hicks. Weyerhaeuser also contracted with TetraTech for data collection and analysis and Nathan Schwab received support in the form of salary. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2012, METHODS ECOL EVOL, V3, P992, DOI 10.1111/j.2041-210X.2012.00244.x; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Arno SF, 1979, FOREST REGIONS MONTA; Bachen D., 2020, DIRECTORY REPORTS LO; Bates PJ, 2019, NLME LINEAR NONLINEA; Bender MJ, 2015, FOREST ECOL MANAG, V336, P1, DOI 10.1016/j.foreco.2014.10.004; Bernard J, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.926.48741; Bernard RF, 2017, ECOL EVOL, V7, P1487, DOI 10.1002/ece3.2772; Bogan MA, 2003, W CREVICE CAVITY ROO; Boyles JG, 2006, MAMMAL REV, V36, P267, DOI 10.1111/j.1365-2907.2006.00095.x; Brigham RM, 2007, BATS FORESTS CONSERV; Burns LKL, 2019, FOREST ECOL MANAG, V446, P151, DOI 10.1016/j.foreco.2019.05.024; Cox MR, 2016, FOREST ECOL MANAG, V359, P221, DOI 10.1016/j.foreco.2015.09.048; Cryan PM, 2010, BMC BIOL, V125, P1; Darling JA, 2019, AQUAT ECOSYST HEALTH, P1; Department of Interior FaWS, 2014, WHIT NOS SYNDR DEV D; Dzal Y, 2011, BIOL LETTERS, V7, P392, DOI 10.1098/rsbl.2010.0859; Falxa Greg, 2007, Northwestern Naturalist, V88, P98, DOI 10.1898/1051-1733(2007)88[98:WFOSAC]2.0.CO;2; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gannon WL, 2003, WILDLIFE SOC B, V31, P45; Goerlitz HR, 2018, ECOL EVOL, V8, P5090, DOI 10.1002/ece3.4088; Gomes C, 2019, COMMUN ACM, V62, P56, DOI 10.1145/3339399; Government of Canada, 2020, BATS WHIT NOS SYNDR; Hahn G.J., 2011, STAT INTERVALS GUIDE, VVolume 92; Hammerson GA, 2017, BIOL CONSERV, V212, P144, DOI 10.1016/j.biocon.2017.05.025; Ingersoll TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065907; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Johnson JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049754; Knowles JE, MERTOOLS TOOLS ANAL; Lausen CL, 2006, CAN J ZOOL, V84, P1079, DOI 10.1139/Z06-093; Loeb S.C., 2015, SRS208; Maher SP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2301; Maxell B. A., 2015, MONTANA BAT WHITE NO; Montana Fish W & Parks., 2020, FUNGUS CAUSES WHITE; Neubaum DJ, 2018, J MAMMAL, V99, P1294, DOI 10.1093/jmammal/gyy120; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Pfister RD, 1977, FOREST HABITAT TYPES; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158; Rodhouse T. J., 2016, ECOSPHERE, V7, P1; Schwab Nathan A., 2014, Northwestern Naturalist, V95, P13; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; U.S. Fish and Wildlife Service [USFWS], 2016, FED REGISTER, V81, P1900; Verant ML, 2018, J APPL ECOL, V55, P820, DOI 10.1111/1365-2664.13070; Vindigni MA, 2009, FOREST ECOL MANAG, V258, P2056, DOI 10.1016/j.foreco.2009.07.058; Washington Department of Fish and Wildlife, 2019, BAT KILL DIS WHIT NO; 2014, REG ANESTH PAIN MED, V9	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241052	10.1371/journal.pone.0241052	http://dx.doi.org/10.1371/journal.pone.0241052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091068	gold, Green Published			2022-12-26	WOS:000586647200024
J	Scisciola, L; Rizzo, MR; Cataldo, V; Fontanella, RA; Balestrieri, ML; D'Onofrio, N; Marfella, R; Paolisso, G; Barbieri, M				Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela			Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications	FASEB JOURNAL			English	Article						atherosclerosis progression; DNA methylation; incretin based drugs; type 2 diabetes	EXTRACELLULAR-SUPEROXIDE DISMUTASE; DNA METHYLATION; RECEPTOR AGONIST; PLAQUE STABILITY; ATHEROSCLEROSIS; INHIBITION; EXPRESSION	The effect of GLP-1R agonists on DNA methylation levels ofNF-kappa BandSOD2genes in human aortic endothelial cells exposed to high glucose and in diabetic patients treated and not with incretin-based drugs, was evaluated. Methylation levels, mRNA and protein expression ofNF-kappa BandSOD2genes were measured in human endothelial cells exposed to high glucose for 7 days and treated with GLP-1R agonists. Methylation status ofNF-kappa BandSOD2promoter was also analyzed in 128 diabetics and 116 nondiabetics and correlated with intima media thickness (ITM), an early marker of atherosclerotic process. Cells exposed to high glucose showed lowerNF-kappa BandSOD2methylation levels, increased NF-kappa B and reduced SOD2 expression compared to normal glucose cells. Co-treatment with GLP-1 agonists prevented methylation and genes expression changes induced by high glucose. Both high glucose and incretins exposure increased DNA methyltransferases and demethylases levels. In diabetics, incretin treatment resulted a significant predictor ofNF-kappa BDNA methylation, independently of age, sex, body mass index (BMI), glucose and plasma lipid levels.NF-kappa BDNA methylation inversely correlated with IMT after adjusting for multiple covariates. Our results firstly provide new evidences of an additional mechanism by which incretin drugs could prevent vascular diabetic complications.	[Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Piazza Miraglia 2, I-80138 Naples, Italy; [Balestrieri, Maria Luisa; D'Onofrio, Nunzia] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Barbieri, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Piazza Miraglia 2, I-80138 Naples, Italy.	michelangela.barbieri@unicampania.it	Rizzo, Maria/HGD-6576-2022; D'Onofrio, Nunzia/M-2081-2019; Rizzo, Maria Rosaria/AHH-3649-2022; paolisso, giuseppe/AAP-8516-2020; Scisciola, Lucia/AEY-3523-2022; Barbieri, Michelangela/K-2192-2016	D'Onofrio, Nunzia/0000-0002-5300-9530; Rizzo, Maria Rosaria/0000-0002-1023-4260; paolisso, giuseppe/0000-0002-2137-455X; Scisciola, Lucia/0000-0003-3636-4298; Barbieri, Michelangela/0000-0002-9223-5792; marfella, raffaele/0000-0003-3960-9270; Balestrieri, Maria Luisa/0000-0001-6001-1789	Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica	Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica (grants PRIN 2015)	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS98, DOI 10.2337/dc20-S009; Barbieri M, 2017, J DIABETES COMPLICAT, V31, P295, DOI 10.1016/j.jdiacomp.2016.10.001; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Chen Z, 2017, ANNU REV BIOMED ENG, V19, P195, DOI 10.1146/annurev-bioeng-071516-044720; Dhliwayo N, 2014, DIABETES, V63, P3069, DOI 10.2337/db13-1916; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Fong DS, 2003, DIABETES CARE, V26, P226, DOI 10.2337/diacare.26.1.226; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gallego-Colon E, 2018, ATHEROSCLEROSIS, V278, P29, DOI 10.1016/j.atherosclerosis.2018.09.011; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Garczorz W, 2018, CARDIOVASC THER, V36, DOI 10.1111/1755-5922.12317; He J, 2019, ARTERIOSCL THROM VAS, V39, P1682, DOI 10.1161/ATVBAHA.119.312613; Jenkins AJ, 2018, CURR OPIN LIPIDOL, V29, P346, DOI 10.1097/MOL.0000000000000532; Jin JY, 2019, J MOL ENDOCRINOL, V63, pR103, DOI 10.1530/JME-19-0170; Jojima T, 2017, ATHEROSCLEROSIS, V261, P44, DOI 10.1016/j.atherosclerosis.2017.04.001; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Khullar M, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00237; Kowluru RA, 2016, LAB INVEST, V96, P1040, DOI 10.1038/labinvest.2016.78; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mishra M, 2015, INVEST OPHTH VIS SCI, V56, P5133, DOI 10.1167/iovs.15-16937; Muka T, 2016, NUTR METAB CARDIOVAS, V26, P553, DOI 10.1016/j.numecd.2016.04.002; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; Sommese L, 2017, EPIGENETICS-US, V12, P401, DOI 10.1080/15592294.2016.1278097; Sudo M, 2017, ATHEROSCLEROSIS, V265, P283, DOI 10.1016/j.atherosclerosis.2017.06.920; Tabaei S, 2019, ARTIF CELL NANOMED B, V47, P2031, DOI 10.1080/21691401.2019.1617724; Vincent AM, 2013, HAND CLINIC, V115, P591, DOI 10.1016/B978-0-444-52902-2.00034-5; Wei H, 2017, METHYLATION NF B ITS, DOI [10.5772/intechopen.72552, DOI 10.5772/INTECHOPEN.72552]; Yasuda H, 2016, J CLIN BIOCHEM NUTR, V59, P174, DOI 10.3164/jcbn.16-26; Yasuda H, 2016, J CLIN BIOCHEM NUTR, V58, P34, DOI 10.3164/jcbn.15-16; Yuan EF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0660-y; Zhang H, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160141; Ziyadeh FN, 2003, J AM SOC NEPHROL, V14, P1355, DOI 10.1097/01.ASN.0000065608.37756.58	34	10	10	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16489	16503		10.1096/fj.202000860RR	http://dx.doi.org/10.1096/fj.202000860RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090591				2022-12-26	WOS:000582261500001
J	Ting, NCH; El-Turk, N; Chou, MSH; Dobler, CC				Ting, Natasha C. H.; El-Turk, Nicole; Chou, Michael S. H.; Dobler, Claudia C.			Patient-perceived treatment burden of tuberculosis treatment	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH; COSTS; CARE	Background Treatment for tuberculosis lasts for a minimum of 6 months. The treatment burden experienced by patients in a low-incidence setting where directly observed therapy is the standard of care is not well-known. Methods Patients receiving tuberculosis treatment through the chest clinic at a tertiary hospital in Sydney, Australia, participated in a semi-structured interview. The interviews explored the treatment burden experienced by patients and possible solutions to ameliorate this burden. Interviews were conducted until data saturation was achieved. They were recorded, transcribed and analysed using NVivo 12 software. Results Twenty participants (80% male, mean age 40 years) with pulmonary (n = 13) and extra-pulmonary (n = 7) tuberculosis were interviewed. Participants experienced healthcare, financial, social and medication burdens along with lifestyle changes due to treatment. Medication intake was challenging due to the high number of pills, and 55% (n = 11) of patients experienced fatigue amongst other side effects. Patients found clinic-based directly observed therapy inconvenient, especially those working and/or studying. Suggestions to lessen treatment burden included reducing medication burden and better access to health services. Conclusion Tuberculosis treatment is associated with substantial treatment burden for patients. Measures to reduce treatment burden including alternative treatment delivery methods which are more accommodating to patients than clinic-based directly observed therapy, such as video directly observed therapy or partially self -administered treatment, should be considered on a case-by-case basis.	[Ting, Natasha C. H.; El-Turk, Nicole; Chou, Michael S. H.; Dobler, Claudia C.] Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia; [Ting, Natasha C. H.; El-Turk, Nicole; Chou, Michael S. H.; Dobler, Claudia C.] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Dobler, Claudia C.] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld, Australia; [Dobler, Claudia C.] Gold Coast Univ Hosp, Gold Coast, Qld, Australia	Liverpool Hospital; University of New South Wales Sydney; Bond University; Gold Coast University Hospital	Ting, NCH (corresponding author), Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia.; Ting, NCH (corresponding author), Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.	natashachting@gmail.com		Ting, Natasha/0000-0002-0540-0017; Dobler, Claudia/0000-0002-5460-0189; El-Turk, Nicole/0000-0003-1112-9670	South Western Sydney Local Health District (SWSLHD); Australian National Health and Medical Research Council [APP1123733]	South Western Sydney Local Health District (SWSLHD); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	There was no specific study sponsor. CCD was supported by an award from the South Western Sydney Local Health District (SWSLHD) and a fellowship of the Australian National Health and Medical Research Council (grant#APP1123733). These funders had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Agency of Clinical Innovation, 2018, DOTS UNIQUE CLIENT C; Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61; Craig GM, 2017, INT J INFECT DIS, V56, P90, DOI 10.1016/j.ijid.2016.10.011; Cremers AL, 2013, PUBLIC HEALTH ACTION, V3, P328, DOI 10.5588/pha.13.0038; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Dobler CC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4065; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Gallacher KI, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-017-0691-4; Garfein RS, 2019, J CLIN TUBER OTH MYC, V17, DOI 10.1016/j.jctube.2019.100098; Hansel NN, 2004, QUAL LIFE RES, V13, P639, DOI 10.1023/B:QURE.0000021317.12945.f0; Harb N, 2017, INT J CHRONIC OBSTR, V12, P1641, DOI 10.2147/COPD.S130353; Health Protection, 2014, HLTH PROTECTION PRIN; Hutchins V, 2011, CURR MED RES OPIN, V27, P1157, DOI 10.1185/03007995.2011.570745; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Khan MA, 2002, HEALTH POLICY PLANN, V17, P178, DOI 10.1093/heapol/17.2.178; Lee HK, 2016, PROC SINGAP HEALTHC, V25, P235, DOI 10.1177/2010105816652148; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; Marra Carlo A, 2004, Health Qual Life Outcomes, V2, P58, DOI 10.1186/1477-7525-2-58; Mirsaeidi M, 2015, EUR RESPIR J, V46, P871, DOI 10.1183/09031936.00011015; NSW Tuberculosis Program Communicable Diseases Branch, 2018, TUBERCULOSIS NSW SUR; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Tripathy SK, 2013, PUBLIC HEALTH ACTION, V3, P230, DOI 10.5588/pha.13.0043; World Health Organization Global Tuberculosis Programme, 2002, EXPANDED DOTS FRAMEW; World Health Organization (WHO), 2017, GUIDELINES TREATMENT; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5; 2010, TREATM TUB GUID 4 ED, P1	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241124	10.1371/journal.pone.0241124	http://dx.doi.org/10.1371/journal.pone.0241124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091084	gold, Green Published			2022-12-26	WOS:000586647200014
J	Tsuzuki, S; Akiyama, T; Matsunaga, N; Yahara, K; Shibayama, K; Sugai, M; Ohmagari, N				Tsuzuki, Shinya; Akiyama, Takayuki; Matsunaga, Nobuaki; Yahara, Koji; Shibayama, Keigo; Sugai, Motoyuki; Ohmagari, Norio			Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013-18	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIMICROBIAL RESISTANCE; PNEUMOCOCCAL PNEUMONIA; BURDEN; CHILDREN; DISEASE; TRENDS; IMPACT; SPAIN	Objectives To examine the association between penicillin susceptibility of Streptococcus pneumoniae and penicillin consumption in Japan. Methods We used Japan Nosocomial Infection Surveillance data on the susceptibility of S. pneumoniae and sales data obtained from IQVIA Services Japan K.K. for penicillin consumption. We analysed both sets of data by decomposing them into seasonality and chronological trend components. The cross-correlation function was checked using Spearman's rank correlation coefficient to examine the correlation between susceptibility and consumption. Results After adjusting for seasonality, the susceptibility of S. pneumoniae to penicillins gradually improved (55.7% in 2013 and 60.6% in 2018, respectively) and penicillin consumption increased during the same period (0.76 defined daily doses per 1,000 inhabitants per day [DID] in 2013, and 0.89 DID in 2018). The results showed positive cross-correlation (coefficient 0.801, p-value < 0.001). In contrast, cephalosporin consumption decreased (3.91 DID in 2013 and 3.19 DID in 2018) and showed negative cross-correlation with susceptibility of S. pneumoniae to penicillins (coefficient - 0.981, p-value < 0.001). Conclusions The rates of penicillin-susceptible S. pneumoniae isolates did not negatively correlate with penicillin consumption at the population level. Increased penicillin consumption might not impair the penicillin susceptibility of S. pneumoniae.	[Tsuzuki, Shinya; Akiyama, Takayuki; Matsunaga, Nobuaki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan; [Tsuzuki, Shinya] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [Yahara, Koji; Shibayama, Keigo; Sugai, Motoyuki] Natl Inst Infect Dis, Antimicrobial Resistance Res Ctr, Tokyo, Japan; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Antwerp; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Center for Global Health & Medicine - Japan	Tsuzuki, S; Matsunaga, N (corresponding author), Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan.; Tsuzuki, S (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium.	stsuzuki@hosp.ncgm.go.jp; nomatsunaga@hosp.ncgm.go.jp	Tsuzuki, Shinya/S-7286-2019; Ohmagari, Norio/GLN-5290-2022; Tsuzuki, Shinya/S-7286-2019	Tsuzuki, Shinya/0000-0002-8504-1244; Ohmagari, Norio/0000-0002-4622-8970; Tsuzuki, Shinya/0000-0001-5732-846X	Ministry of Health, Labour and Welfare [20HA2003]; Research Program on Emerging and Reemerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP19fk0108061]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Research Program on Emerging and Reemerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	Our study was supported by a grant from the Ministry of Health, Labour and Welfare (Grant number 20HA2003, changed from the previous one) and Research Program on Emerging and Reemerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) under grant number JP19fk0108061.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author received a salary from the funders.	Albanese BA, 2002, CLIN INFECT DIS, V34, P15, DOI 10.1086/323674; AMR Clinical Reference Center, 2020, ON HLTH PLATF; [Anonymous], 2016, CLIN RADIOL, V71, pe171; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, CLIN RADIOL, V71, pe171; [Anonymous], 2016, BIOL BLOOD MARROW TR, V22, pS1; [Anonymous], 2016, CLIN RADIOL, V71, pe171; Aspa J, 2008, EXPERT OPIN PHARMACO, V9, P229, DOI 10.1517/14656566.9.2.229 ; Baquero F, 1999, ANTIMICROB AGENTS CH, V43, P357, DOI 10.1128/AAC.43.2.357; Bishai W, 2002, J ANTIMICROB CHEMOTH, V49, P433, DOI 10.1093/jac/49.3.433; CDC, 2019, BIGG ANT THREATS US; Centers for Disease Control and Prevention, 2019, PNEUM DIS CLIN DIAGN; Chiou CCC, 2006, CURR OPIN CRIT CARE, V12, P470; Clinical and Laboratory Standard Institute, 2015, METH ANT DIL DISK SU, V3rd ed; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; European Commission, 2017, EUR COMM LAST VISIT; European Committee on Antimicrobial Susceptibility Testing, EUCAST CLIN BREAKP D; Feshchenko Y, 2016, J ANTIMICROB CHEMOTH, V71, P63, DOI 10.1093/jac/dkw068; Gu Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01576-z; Guy R, 2016, J ANTIMICROB CHEMOTH, V71, P1564, DOI 10.1093/jac/dkw018; Hsia YF, 2019, LANCET GLOB HEALTH, V7, pE861, DOI 10.1016/S2214-109X(19)30071-3; Jamsheer A, 2016, J ANTIMICROB CHEMOTH, V71, P45, DOI 10.1093/jac/dkw064; Kacou-Ndouba A, 2016, J ANTIMICROB CHEMOTH, V71, P21, DOI 10.1093/jac/dkw070; Karlowsky JA, 2018, J ANTIMICROB CHEMOTH, V73, P5, DOI 10.1093/jac/dky156; Kimura Y, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0223835, DOI 10.1371/J0URNAL.P0NE.022383531618258]; Marco F, 2000, J ANTIMICROB CHEMOTH, V46, P557, DOI 10.1093/jac/46.4.557; Ministry of Health Labour and Welfare Japan, 2012, REV MED FEES; Muraki Y, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05288-1; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; National Institute for Health and Care Excellence, 2019, REC PNEUM COMM ANT P; Norweigian Institute of Public Health, ATC DDD IND; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Martinez EP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221133; Peterson LR, 2006, CLIN INFECT DIS, V42, P224, DOI 10.1086/497594; Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P1700, DOI 10.1093/jac/dky031; Public Health England, 2018, ENGL SURV PROGR ANT, P163; R Core Team, 2018, R LANG ENV STAT COMP; Sharland M, 2018, LANCET INFECT DIS, V18, P18, DOI 10.1016/S1473-3099(17)30724-7; Smieszek T, 2018, J ANTIMICROB CHEMOTH, V73, P36, DOI 10.1093/jac/dkx500; Soyletir G, 2016, J ANTIMICROB CHEMOTH, V71, P71, DOI 10.1093/jac/dkw075; Su LH, 2009, J ANTIMICROB CHEMOTH, V64, P336, DOI 10.1093/jac/dkp209; Suda KJ, 2014, ANTIMICROB AGENTS CH, V58, P2763, DOI 10.1128/AAC.02239-13; The Government of Japan, 2016, NAT ACT PLAN ANT RES; Torumkuney D, 2020, J ANTIMICROB CHEMOTH, V75, P88, DOI 10.1093/jac/dkaa086; Torumkuney D, 2018, J ANTIMICROB CHEMOTH, V73, pV36, DOI 10.1093/jac/dky068; Torumkuney D, 2016, J Antimicrob Chemother, V71 Suppl 1, pi3, DOI 10.1093/jac/dkw073; Tsutsui A, 2019, J HOSP INFECT, V102, P226, DOI 10.1016/j.jhin.2018.10.005; Tsutsui A, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3604-x; Tsutsui A, 2018, J INFECT CHEMOTHER, V24, P414, DOI 10.1016/j.jiac.2018.01.003; Tsuzuki S, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-5021-1; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X	53	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240655	10.1371/journal.pone.0240655	http://dx.doi.org/10.1371/journal.pone.0240655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091045	Green Published, gold			2022-12-26	WOS:000586647200041
J	Wolday, D; Legesse, D; Kebede, Y; Siraj, DS; McBride, JA; Striker, R				Wolday, Dawit; Legesse, Dorsisa; Kebede, Yazezew; Siraj, Dawd S.; McBride, Joseph A.; Striker, Robert			Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia	PLOS ONE			English	Article							T-CELL-ACTIVATION; CD4/CD8 RATIO; INFECTED PATIENTS; CD4 COUNTS; HIV; NORMALIZATION; INDIVIDUALS; DETERMINANTS; PERCENTAGE; INITIATION	Background There is very little data on long-term immune recovery responses in patients on suppressive antiretroviral therapy (ART) in the setting of sub-Saharan Africa (SSA). Thus, we sought to determine CD4+ T-cell, CD8+ T-cell and CD4/CD8 ratio responses in a cohort of HIV infected individuals on sustained suppressive ART followed up for more than a decade. Methods The cohort comprised adult patients who started ART between 2001 and 2007 and followed for up to 14 years. Trends in median CD4+ T-cells, CD8+ T-cells and CD4/CD8 ratio were reviewed retrospectively. Poisson regression models were used to identify factors associated with achieving normalized T-cell biomarkers. Kaplan-Meier curves were used to estimate the probability of attaining normalized counts while on suppressive ART. Results A total of 227 patients with a median duration of follow-up on ART of 12 (IQR: 10.5-13.0) years were included. CD4 cell count increased from baseline median of 138 cells (IQR: 70-202) to 555 cells (IQR: 417-830). CD4 cell increased continuously up until 5 years, after which it plateaued up until 14 years of follow up. Only 69.6% normalized their CD4 cell count within a median of 6.5 (IQR: 3.0-10.5) years. In addition, only 15.9% of the cohort were able to achieve the median reference CD4+ T-cell threshold count in Ethiopians (approximate to 760 cells/mu L). CD8+ T-cell counts increased initially until year 1, after which continuous decrease was ascertained. CD4/CD8 ratio trend revealed continuous increase throughout the course of ART, and increased from a median baseline of 0.14 (IQR: 0.09-0.22) to a median of 0.70 (IQR: 0.42-0.95). However, only 12.3% normalized their ratio (>= 1.0) after a median of 11.5 years. In addition, only 8.8% of the cohort were able to achieve the median reference ratio of healthy Ethiopians. Conclusion Determination of both CD4+ and CD8+ T-cells, along with CD4/CD8 ratio is highly relevant in long-term follow-up of patients to assess immune recovery. Monitoring ratio levels may serve as a better biomarker risk for disease progression among patients on long-term ART. In addition, the findings emphasize the relevance of initiation of ART at the early stage of HIV-1 infection.	[Wolday, Dawit; Kebede, Yazezew] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Legesse, Dorsisa] Hayat Gen Hosp, Addis Ababa, Ethiopia; [Siraj, Dawd S.; McBride, Joseph A.; Striker, Robert] Univ Wisconsin, Div Infect Dis, Dept Med, Madison, WI USA	Mekelle University; University of Wisconsin System; University of Wisconsin Madison	Wolday, D (corresponding author), Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.	dawwol@gmail.com			Division of Infectious Diseases, Department of Medicine, University of Wisconsin, Madison, USA	Division of Infectious Diseases, Department of Medicine, University of Wisconsin, Madison, USA	The project was supported by the Division of Infectious Diseases, Department of Medicine, University of Wisconsin, Madison, USA.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2016, MEDICINE BALTIMORE, V95, pe3187; [Anonymous], 2012, DRUG DISCOV TODAY TE; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Caby F, 2016, CLIN INFECT DIS, V62, P1297, DOI 10.1093/cid/ciw076; Geltzeiler CB, 2020, DIS COLON RECTUM; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; Helleberg M, 2015, J INFECT DIS, V211, P1726, DOI 10.1093/infdis/jiu669; Hughes RA, 2018, AIDS, V32, P1361, DOI [10.1097/QAD.0000000000001848, 10.1097/qad.0000000000001848]; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kassu A, 2003, CLIN EXP IMMUNOL, V132, P113, DOI 10.1046/j.1365-2249.2003.02106.x; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Kroeze S, 2019, J INFECT DIS, V220, P1029, DOI 10.1093/infdis/jiz252; Kroeze S, 2018, AIDS, V32, P1043, DOI [10.1097/QAD.0000000000001801, 10.1097/qad.0000000000001801]; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Loutfy MR, 2010, JAIDS-J ACQ IMM DEF, V55, P451, DOI 10.1097/QAI.0b013e3181ec28ff; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mekonnen Y, 2005, J INFECT DIS, V192, P739, DOI 10.1086/432545; Ministry of Health (MoH). HIV/AIDS Prevention and Control Office, 2001, NAT GUID US ANT DRUG; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Mutoh Y, 2018, CLIN INFECT DIS, V67, P927, DOI 10.1093/cid/ciy176; Nakanjako D, 2016, AIDS, V30, P1913, DOI 10.1097/QAD.0000000000001085; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Ronsholt FF, 2012, JAIDS-J ACQ IMM DEF, V61, P270, DOI 10.1097/QAI.0b013e31825e7ac1; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Seng R, 2017, AIDS, V31, P1323, DOI 10.1097/QAD.0000000000001482; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Thornhill J, 2016, JAIDS-J ACQ IMM DEF, V73, P69, DOI 10.1097/QAI.0000000000001013; Tinago W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097011; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Trickey A, 2017, CLIN INFECT DIS, V65, P959, DOI 10.1093/cid/cix466; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; WHO, 2017, CONGUID UANT DRU; Wolday D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233049; Zhang XY, 2013, HIV CLIN TRIALS, V14, P61, DOI 10.1310/hct1402-61; 2014, REG ANESTH PAIN MED, V0009	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240880	10.1371/journal.pone.0240880	http://dx.doi.org/10.1371/journal.pone.0240880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091053	Green Published, gold			2022-12-26	WOS:000586647200030
J	Lacasa, L; Challen, R; Brooks-Pollock, E; Danon, L				Lacasa, Lucas; Challen, Robert; Brooks-Pollock, Ellen; Danon, Leon			A flexible method for optimising sharing of healthcare resources and demand in the context of the COVID-19 pandemic	PLOS ONE			English	Article								As the number of cases of COVID-19 continues to grow, local health services are at risk of being overwhelmed with patients requiring intensive care. We develop and implement an algorithm to provide optimal re-routing strategies to either transfer patients requiring Intensive Care Units (ICU) or ventilators, constrained by feasibility of transfer. We validate our approach with realistic data from the United Kingdom and Spain. In the UK, we consider the National Health Service at the level of trusts and define a 4-regular geometric graph which indicates the four nearest neighbours of any given trust. In Spain we coarse-grain the healthcare system at the level of autonomous communities, and extract similar contact networks. Through random search optimisation we identify the best load sharing strategy, where the cost function to minimise is based on the total number of ICU units above capacity. Our framework is general and flexible allowing for additional criteria, alternative cost functions, and can be extended to other resources beyond ICU units or ventilators. Assuming a uniform ICU demand, we show that it is possible to enable access to ICU for up to 1000 additional cases in the UK in a single step of the algorithm. Under a more realistic and heterogeneous demand, our method is able to balance about 600 beds per step in the Spanish system only using local sharing, and over 1300 using countrywide sharing, potentially saving a large percentage of these lives that would otherwise not have access to ICU.	[Lacasa, Lucas] Queen Mary Univ London, Sch Math Sci, London, England; [Lacasa, Lucas] CSIC, Inst Cross Disciplinary Phys & Complex Syst IFISC, Palma De Mallorca, Spain; [Challen, Robert] Univ Exeter, EPSRC Ctr Predict Modelling Healthcare, Exeter, Devon, England; [Challen, Robert] Taunton & Somerset NHS Fdn Trust, Taunton, Somerset, England; [Brooks-Pollock, Ellen] Univ Bristol, Bristol Med Sch Populat Hlth Sci, Bristol, Avon, England; [Danon, Leon] Univ Exeter, Coll Engn Math & Phys Sci, Data Sci Inst, Exeter, Devon, England; [Danon, Leon] British Lib, Alan Turing Inst, London, England	University of London; Queen Mary University London; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Exeter; University of Bristol; University of Exeter	Lacasa, L (corresponding author), Queen Mary Univ London, Sch Math Sci, London, England.; Lacasa, L (corresponding author), CSIC, Inst Cross Disciplinary Phys & Complex Syst IFISC, Palma De Mallorca, Spain.	l.lacasa@qmul.ac.uk	Danon, Leon/AFV-8758-2022	Danon, Leon/0000-0002-7076-1871; Challen, Robert/0000-0002-5504-7768; Brooks-Pollock, Ellen/0000-0002-5984-4932; Lacasa, Lucas/0000-0003-3057-0357	Engineering and Physical Sciences Research Council (EPSRC) [LL EP/P01660X/1, RCh EP/N014391/1, LD EP/N510129/1]; EPSRC [EP/N014391/1, EP/N510129/1, EP/P01660X/1] Funding Source: UKRI; MRC [MC_PC_19067] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors report three grants from Engineering and Physical Sciences Research Council (EPSRC) which contributed to the study: LL EP/P01660X/1 EPSRC, RCh EP/N014391/1 EPSRC, and LD EP/N510129/1 EPSRC.	Arabi YM, 2020, INTENS CARE MED, V46, P833, DOI 10.1007/s00134-020-05955-1; Arenas A, 2020, PHYS REV X, DOI DOI 10.1103/PHYSREVX.10.041055; Berenbrink P, 2019, INT PARALL DISTRIB P, P718, DOI 10.1109/IPDPS.2019.00080; Berenbrink P, 2015, J COMPUT SYST SCI, V81, P159, DOI 10.1016/j.jcss.2014.04.027; Chakrabarty D, 2009, ANN IEEE SYMP FOUND, P107, DOI 10.1109/FOCS.2009.51; Chu Jennifer, 2020, MIT NEWS OFFICE 0423; Danon L., 2020, SPATIAL MODEL COVID, DOI [10.1101/2020.02.12.20022566, DOI 10.1101/2020.02.12.20022566]; Deasy J, 2020, FORECASTING ULTRAEAR; DeLaurentis P-C Chen, 2009, THESIS; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lacasa L., POTENTIAL MONI UNPUB; Lamet J., 2020, EL MUNDO; Lofgren E, 2016, AAAI CONF ARTIF INTE, P35; Moulin HJ, 2003, FAIR DIVISION AND COLLECTIVE WELFARE, P1; NHS England, CRIT CAR BED CAP URG; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Siwicki Bill, 2020, HEALTHCAREITNEW 0515; Wooldridge, 2009, INTRO MULTIAGENT SYS; Xie JF, 2020, INTENS CARE MED, V46, P837, DOI 10.1007/s00134-020-05979-7; Yan D, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1307, DOI 10.1145/2736277.2741096; Young P., 1995, EQUITY	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241027	10.1371/journal.pone.0241027	http://dx.doi.org/10.1371/journal.pone.0241027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085729	Green Submitted, Green Published, gold			2022-12-26	WOS:000585943400033
J	Lee, YH; Sang, WG; Baek, JK; Kim, JH; Shin, P; Seo, MC; Cho, JI				Lee, Yun-Ho; Sang, Wan-Gyu; Baek, Jae-Kyeong; Kim, Jun-Hwan; Shin, Pyeong; Seo, Myung-Chul; Cho, Jung-Il			The effect of concurrent elevation in CO(2)and temperature on the growth, photosynthesis, and yield of potato crops	PLOS ONE			English	Article							SOLANUM-TUBEROSUM L.; AIR CO2 ENRICHMENT; CARBON-DIOXIDE; STOMATAL CONDUCTANCE; RESPONSES; OZONE; AMBIENT; IMPACT; TUBERIZATION; ACCLIMATION	Global climate change accompanied by continuous increases in atmospheric carbon dioxide (CO2) concentration and temperature affects the growth and yield of important crops. The present study investigated the effect of elevated temperature and CO(2)concentrations on the growth, yield, and photosynthesis of potato (Solanum tuberosumL. cv. Superior) crops using Korean Soil-Plant-Atmosphere-Research chambers that allow the regulation of temperature and CO(2)concentration under daylight conditions. Based on the average temperature from 1991 to 2010 in the Jeonju area, South Korea, potato plants were exposed to four different conditions: ambient weather (400 mu mol mol(-1), aCaT), elevated temperature (+4 degrees C, aCeT), elevated CO(2)concentration (800 mu mol mol(-1), eCaT), and concurrently elevated CO(2)concentration and temperature (eCeT). Under aCeT conditions, the temperature exceeded the optimal growth temperature range towards the late growth phase that decreased stomatal conductance and canopy net photosynthetic rate and subsequently reduced biomass and tuber yield. Stomatal conductance and chlorophyll concentration were lower under eCaT conditions than under aCaT conditions, whereas late-growth phase biomass and tuber yield were greater. Compared to other conditions, eCeT yielded a distinct increase in growth and development and canopy net photosynthetic rate during tuber initiation and bulking. Consequently, biomass and canopy net photosynthesis increased, and tuber yield increased by 20.3%, which could be attributed to the increased tuber size, rather than increased tuber number. Elevated CO(2)reduced chlorophyll, magnesium, and phosphorus concentrations; reducing nitrogen concentration (by approximately 39.7%) increased the C:N ratio. The data indicate that future climate conditions will likely change nutrient concentration and quality of crops. The present study shows that while elevated temperature may negatively influence the growth and yield of potato crops, especially towards the late-growth phase, the concurrent and appropriate elevation of CO(2)and temperature could promote balanced development of source and sink organs and positively effect potato productivity and quality.	[Lee, Yun-Ho; Sang, Wan-Gyu; Baek, Jae-Kyeong; Kim, Jun-Hwan; Shin, Pyeong; Seo, Myung-Chul; Cho, Jung-Il] Rural Dev Adm, Natl Inst Crop Sci, Crop Prod & Physiol Div, Wonju, Jeollabuk Do, South Korea	Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Seo, MC; Cho, JI (corresponding author), Rural Dev Adm, Natl Inst Crop Sci, Crop Prod & Physiol Div, Wonju, Jeollabuk Do, South Korea.	mcseo@korea.kr; jungilcho@korea.kr			"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ01357402]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01357402)" Rural Development Administration, Republic of Korea.	Ahmad Aien, 2011, American-Eurasian Journal of Agricultural & Environmental Sciences, V11, P633; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Baker JT, 2004, ENVIRON EXP BOT, V51, P103, DOI 10.1016/j.envexpbot.2003.08.001; Bartak M, 1998, ENVIRON EXP BOT, V39, P85, DOI 10.1016/S0098-8472(97)00027-0; Bunce JA, 2001, GLOBAL CHANGE BIOL, V7, P323, DOI 10.1046/j.1365-2486.2001.00406.x; Cao WX, 1997, J PLANT NUTR, V20, P871, DOI 10.1080/01904169709365302; CAO WX, 1994, J AM SOC HORTIC SCI, V119, P775, DOI 10.21273/JASHS.119.4.775; Chen CT, 2012, ENVIRON EXP BOT, V80, P27, DOI 10.1016/j.envexpbot.2012.02.003; Chen WR, 2012, RUSS J PLANT PHYSL+, V59, P732, DOI 10.1134/S1021443712060040; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Craigon J, 2002, EUR J AGRON, V17, P273, DOI 10.1016/S1161-0301(02)00066-7; Dong JL, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00924; Donnelly A, 2001, NEW PHYTOL, V149, P265, DOI 10.1046/j.1469-8137.2001.00015.x; Dusenge ME, 2019, NEW PHYTOL, V221, P32, DOI 10.1111/nph.15283; Fangmeier A, 2002, EUR J AGRON, V17, P353, DOI 10.1016/S1161-0301(02)00071-0; Finnan JM, 2005, J CROP IMPROV, V13, P91, DOI 10.1300/J411v13n01_06; Fleisher DH, 2009, T ASABE, V52, P1721, DOI 10.13031/2013.29134; Fleisher DH, 2008, AGR FOREST METEOROL, V148, P1109, DOI 10.1016/j.agrformet.2008.02.007; Fleisher DH, 2006, AGRON J, V98, P1442, DOI 10.2134/agronj2005.0322; Fleisher DH, 2006, AGR FOREST METEOROL, V139, P84, DOI 10.1016/j.agrformet.2006.06.002; Frank B, 2012, FUNDAMENTALS CHEM LA, V3 rd edition, P75; Gifford RM, 2000, PLANT SOIL, V224, P1, DOI 10.1023/A:1004790612630; Hacour A, 2002, EUR J AGRON, V17, P257, DOI 10.1016/S1161-0301(02)00065-5; HAMMES PS, 1990, POTATO RES, V33, P515, DOI 10.1007/BF02358030; Hansen TH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-12; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Heagle AS, 2003, J ENVIRON QUAL, V32, P1603, DOI 10.2134/jeq2003.1603; Hogy P, 2009, EUR J AGRON, V30, P78, DOI 10.1016/j.eja.2008.07.007; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jeffery SC, 2006, AGR ECOSYS ENV, V112, P49; Jorens, 2014, PROCEDURES RELATED G, P40; Kant S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00162; Kim YU, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00300; Kim YU, 2017, EUR J AGRON, V89, P46, DOI 10.1016/j.eja.2017.06.005; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Kumari S, 2015, ENVIRON EXP BOT, V109, P276, DOI 10.1016/j.envexpbot.2014.06.015; Kumari S, 2014, ECOTOX ENVIRON SAFE, V101, P146, DOI 10.1016/j.ecoenv.2013.12.021; Lahijani MJA, 2018, PLANT PHYSIOL BIOCH, V130, P303, DOI 10.1016/j.plaphy.2018.07.019; Lawson T, 2001, J PLANT PHYSIOL, V158, P309, DOI 10.1078/0176-1617-00105; Lawson T, 2001, ENVIRON POLLUT, V111, P479, DOI 10.1016/S0269-7491(00)00080-4; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Liu S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187724; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Marschner H, 1995, MINERAL NUTR HIGHER, P229, DOI DOI 10.1016/B978-012473542-2/50010-9; McGrath JM, 2013, PLANT CELL ENVIRON, V36, P697, DOI 10.1111/pce.12007; MENZEL CM, 1985, ANN BOT-LONDON, V55, P35, DOI 10.1093/oxfordjournals.aob.a086875; Miglietta F, 1998, GLOBAL CHANGE BIOL, V4, P163, DOI 10.1046/j.1365-2486.1998.00120.x; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; NASA, 2019, GLOBAL CLIMATE CHANG; Navarre R., 2014, POTATO BOT PRODUCTIO, P29; PRANGE RK, 1990, AM POTATO J, V67, P357, DOI 10.1007/BF02987277; PRASAD PVV, 2005, J CROP IMPROV, V0013, P00113, DOI DOI 10.1300/J411V13N01_07; Reddy AR, 2010, CURR SCI INDIA, V99, P46; Reddy K. Raja, 2001, Biotronics, V30, P27; ROGERS HH, 1993, VEGETATIO, V104, P117, DOI 10.1007/BF00048148; Rykaczewska K., 2013, American Journal of Plant Sciences, V4, P2386, DOI 10.4236/ajps.2013.412295; Schapendonk AHCM, 2000, AUST J PLANT PHYSIOL, V27, P1119, DOI 10.1071/PP99205; Sicher RC, 2001, PHYSIOL PLANTARUM, V112, P55, DOI 10.1034/j.1399-3054.2001.1120108.x; Tang RM, 2018, BOTANY, V96, P897, DOI 10.1139/cjb-2018-0125; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x; Taub DR, 2000, PLANT CELL ENVIRON, V23, P649, DOI 10.1046/j.1365-3040.2000.00574.x; Timlin D, 2006, AGRON J, V98, P1195, DOI 10.2134/agronj2005.0260; Wang WQ, 2019, FIELD CROP RES, V241, DOI 10.1016/j.fcr.2019.107564; Wheeler RM, 1999, ANN BOT-LONDON, V83, P243, DOI 10.1006/anbo.1998.0813; WHEELER RM, 1994, ADV SPACE RES, V14, P251, DOI 10.1016/0273-1177(94)90305-0; WOLF S, 1990, ANN BOT-LONDON, V65, P179, DOI 10.1093/oxfordjournals.aob.a087922; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; Xu ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00657; Xu ZZ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00701; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Yao YB, 2019, OPEN CHEM, V17, P728, DOI 10.1515/chem-2019-0085; Ziska L, 2016, IMPACTS CLIMATE CHAN, P190	74	14	15	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241081	10.1371/journal.pone.0241081	http://dx.doi.org/10.1371/journal.pone.0241081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085713	gold, Green Published			2022-12-26	WOS:000585943400002
J	Sorino, P; Caruso, MG; Misciagna, G; Bonfiglio, C; Campanella, A; Mirizzi, A; Franco, I; Bianco, A; Buongiorno, C; Liuzzi, R; Cisternino, AM; Notarnicola, M; Chiloiro, M; Pascoschi, G; Osella, AR				Sorino, Paolo; Caruso, Maria Gabriella; Misciagna, Giovanni; Bonfiglio, Caterina; Campanella, Angelo; Mirizzi, Antonella; Franco, Isabella; Bianco, Antonella; Buongiorno, Claudia; Liuzzi, Rosalba; Cisternino, Anna Maria; Notarnicola, Maria; Chiloiro, Marisa; Pascoschi, Giovanni; Osella, Alberto Ruben		MICOL Grp	Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study	PLOS ONE			English	Article							MODEL SELECTION; EPIDEMIOLOGY; INDEX; INFECTION	Background & aims Liver ultrasound scan (US) use in diagnosing Non-Alcoholic Fatty Liver Disease (NAFLD) causes costs and waiting lists overloads. We aimed to compare various Machine learning algorithms with a Meta learner approach to find the best of these as a predictor of NAFLD. Methods The study included 2970 subjects, 2920 constituting the training set and 50, randomly selected, used in the test phase, performing cross-validation. The best predictors were combined to create three models: 1) FLI plus GLUCOSE plus SEX plus AGE, 2) AVI plus GLUCOSE plus GGT plus SEX plus AGE, 3) BRI plus GLUCOSE plus GGT plus SEX plus AGE. Eight machine learning algorithms were trained with the predictors of each of the three models created. For these algorithms, the percent accuracy, variance and percent weight were compared. Results The SVM algorithm performed better with all models. Model 1 had 68% accuracy, with 1% variance and an algorithm weight of 27.35; Model 2 had 68% accuracy, with 1% variance and an algorithm weight of 33.62 and Model 3 had 77% accuracy, with 1% variance and an algorithm weight of 34.70. Model 2 was the most performing, composed of AVI plus GLUCOSE plus GGT plus SEX plus AGE, despite a lower percentage of accuracy. Conclusion A Machine Learning approach can support NAFLD diagnosis and reduce health costs. The SVM algorithm is easy to apply and the necessary parameters are easily retrieved in databases.	[Sorino, Paolo; Bonfiglio, Caterina; Campanella, Angelo; Mirizzi, Antonella; Franco, Isabella; Bianco, Antonella; Buongiorno, Claudia; Liuzzi, Rosalba; Osella, Alberto Ruben] S de Bellis Res Hosp, Natl Inst Gastroenterol, Lab Epidemiol & Biostat, Bari, Italy; [Caruso, Maria Gabriella; Notarnicola, Maria] S de Bellis Res Hosp, Natl Inst Gastroenterol, Lab Nutr Biochem, Bari, Italy; [Misciagna, Giovanni] Univ Bari, Polyclin Hosp, Sci & Eth Comm, Bari, Italy; [Cisternino, Anna Maria] S de Bellis Res Hosp, Natl Inst Gastroenterol, Clin Nutr Outpatient Clin, Bari, Italy; [Chiloiro, Marisa] San Giacomo Hosp Largo S Veneziani, Bari, Italy; [Pascoschi, Giovanni] Polytech Bari, Dept Elect & Informat Engn, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Politecnico di Bari	Osella, AR (corresponding author), S de Bellis Res Hosp, Natl Inst Gastroenterol, Lab Epidemiol & Biostat, Bari, Italy.	arosella@irccsdebellis.it		Sorino, Paolo/0000-0002-9081-2648	Ministry of Health, Italy (Progetto Finalizzato del Ministero della Salute) [ICS 160.2/RF 2003]; Apulia Region [1159]	Ministry of Health, Italy (Progetto Finalizzato del Ministero della Salute); Apulia Region	This work was funded by a grant from the Ministry of Health, Italy (Progetto Finalizzato del Ministero della Salute, ICS 160.2/RF 2003), 2004/2006) and by Apulia Region-D.G.R. n. 1159, 28/6/2018 and 2019.	Alexandros K., 2001, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V10, P525, DOI 10.1142/S0218213001000647; Bacopoulou F, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0366-z; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Biswas AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-273; Bro R, 2008, ANAL BIOANAL CHEM, V390, P1241, DOI 10.1007/s00216-007-1790-1; Canbay A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214436; Cozzolongo R, 2009, AM J GASTROENTEROL, V104, P2740, DOI 10.1038/ajg.2009.428; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Dagliati Arianna, 2018, J Diabetes Sci Technol, V12, P295, DOI 10.1177/1932296817706375; Du N, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, P100, DOI 10.1109/WI.2007.36; Fazel Y, 2016, METABOLISM, V65, P1017, DOI 10.1016/j.metabol.2016.01.012; Freedman DS, 2012, OBESITY, V20, P2438, DOI 10.1038/oby.2012.81; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Giovanni C, 2020, SUPER LEARNING MACHI; Guerrero-Romero F, 2003, ARCH MED RES, V34, P428, DOI 10.1016/S0188-4409(03)00073-0; James G, 2013, SPRINGER TEXTS STAT, V103, P203, DOI 10.1007/978-1-4614-7138-7_6; Karatzoglou A, 2006, J STAT SOFTW, V15; Khan Muhammad Badruddin, 2016, MACHINE LEARNING ALG; Kourou Konstantina, 2014, COMPUTATIONAL STRUCT, V13, DOI [10.1016/j.csbj.2014.11.005, DOI 10.1016/J.CSBJ.2014.11.00525750696]; Kukar M, 1999, ARTIF INTELL MED, V16, P25, DOI 10.1016/S0933-3657(98)00063-3; Larsen K., 2005, ACM SIGKDD EXPLOR NE, V7, P76, DOI DOI 10.1145/1089815.1089826; Lee DY, 2018, OBESITY, V26, P1096, DOI 10.1002/oby.22193; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Li J, 2009, DISCRETE DYN NAT SOC, V2009, DOI 10.1155/2009/673548; Lipshitz J, 2007, BLOOD, V110, p229B, DOI 10.1182/blood.V110.11.4625.4625; Mahana D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0297-9; Miles J., 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat06627, DOI 10.1002/9781118445112.STAT06627]; Napoli C, 2019, EUR HEART J CARDIOVA, DOI [10.1093/ehjcvp/pvz062, DOI 10.1093/EHJCVP/PVZ06231665258]; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Nevill AM, 2017, SCAND J MED SCI SPOR, V27, P1470, DOI 10.1111/sms.12780; Nuttall F. Q., 2015, NUTR TODAY, V50; Osella AR, 1997, J HEPATOL, V27, P30, DOI 10.1016/S0168-8278(97)80276-0; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Panda M, 2007, NETWORK INTRUSION DE, P7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Procino F, 2019, LIVER INT, V39, P187, DOI 10.1111/liv.13970; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Simmons SF, 2006, J AM MED DIR ASSOC, V7, P61, DOI 10.1016/j.jamda.2005.08.001; Stevens VL, 2015, AM J EPIDEMIOL, V182, P394, DOI 10.1093/aje/kwv073; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; Vrieze SI, 2012, PSYCHOL METHODS, V17, P228, DOI 10.1037/a0027127; Wu CC, 2016, APPL INTELL, V45, P673, DOI 10.1007/s10489-016-0785-z; Yip TCF, 2017, ALIMENT PHARM THER, V46, P447, DOI 10.1111/apt.14172; Younossi ZM, 2015, HEPATOLOGY, V62, p739A; Yu HF, 2011, MACH LEARN, V85, P41, DOI 10.1007/s10994-010-5221-8; Zuo WM, 2008, PATTERN ANAL APPL, V11, P247, DOI 10.1007/s10044-007-0100-z	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240867	10.1371/journal.pone.0240867	http://dx.doi.org/10.1371/journal.pone.0240867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079971	gold, Green Published			2022-12-26	WOS:000585940600017
J	Zegarra-Valdivia, JA; Pignatelli, J; de Sevilla, MEF; Fernandez, AM; Munive, V; Martinez-Rachadell, L; Nunez, A; Aleman, IT				Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Nunez, Angel; Torres Aleman, Ignacio			Insulin-like growth factor I modulates sleep through hypothalamic orexin neurons	FASEB JOURNAL			English	Article						IGF-I; orexin neurons; sleep	OREXIN/HYPOCRETIN NEURONS; HORMONE-SECRETION; HYPOCRETIN; BRAIN; IGF-1; RECEPTORS; AGE; SOMATOSTATIN; DEFICIENCY; METABOLISM	Although sleep disturbances are common co-morbidities of metabolic diseases, the underlying processes linking both are not yet fully defined. Changes in the duration of sleep are paralleled by changes in the levels of insulin-like growth factor-I (IGF-I), an anabolic hormone that shows a circadian pattern in the circulation and activity-dependent entrance in the brain. However, the specific role, if any, of IGF-I in this universal homeostatic process remains poorly understood. We now report that the activity of orexin neurons, a discrete cell population in the lateral hypothalamus that is involved in the circadian sleep/wake cycle and arousal, is modulated by IGF-I. Furthermore, mice with blunted IGF-I receptor activity in orexin neurons have lower levels of orexin in the hypothalamus, show altered electro-corticographic patterns with predominant slow wave activity, and reduced onset-sleep latency. Collectively, these results extend the role in the brain of this pleiotropic growth factor to shaping sleep architecture through the regulation of orexin neurons. We speculate that poor sleep quality associated to diverse conditions may be related to disturbed brain IGF-I input to orexin neurons.	[Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Torres Aleman, Ignacio] CSIC, Cajal Inst, Funct & Syst Neurobiol Dept, Madrid, Spain; [Zegarra-Valdivia, Jonathan A.; Pignatelli, Jaime; Fernandez de Sevilla, Maria Estrella; Fernandez, Ana M.; Munive, Victor; Martinez-Rachadell, Laura; Torres Aleman, Ignacio] CIBERNED, Madrid, Spain; [Zegarra-Valdivia, Jonathan A.] Univ Nacl San Agustin de Arequipa, Arequipa, Peru; [Nunez, Angel] UAM, Dept Anat Histol & Neurosci, Sch Med, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBERNED; Universidad Nacional de San Agustin de Arequipa; Autonomous University of Madrid	Aleman, IT (corresponding author), CSIC, Cajal Inst, Madrid 28002, Spain.	torres@cajal.csic.es	pignatelli, jaime/AAY-8734-2021; Zegarra-Valdivia, Jonathan Adrián/I-5382-2016; Nuñez, Angel/Y-9137-2019; Torres Aleman, Ignacio/A-1613-2008	pignatelli, jaime/0000-0002-8431-2241; Zegarra-Valdivia, Jonathan Adrián/0000-0003-0497-5270; Nuñez, Angel/0000-0002-8013-4812; Torres Aleman, Ignacio/0000-0001-8107-7947; Fernandez de Sevilla, Maria Estrella/0000-0002-2693-1861	Ministerio de Economia y Competitividad (MINECO) [SAF2016-76462]; Ciberned [CB06/05/0001]; National Council of Science, Technology and Technological Innovation	Ministerio de Economia y Competitividad (MINECO); Ciberned(Instituto de Salud Carlos III); National Council of Science, Technology and Technological Innovation	Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: SAF2016-76462; Ciberned, Grant/Award Number: CB06/05/0001; National Council of Science, Technology and Technological Innovation	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alam MN, 2002, J PHYSIOL-LONDON, V538, P619, DOI 10.1113/jphysiol.2001.012888; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arrigoni E, 2019, NEUROPHARMACOLOGY, V154, P34, DOI 10.1016/j.neuropharm.2018.11.017; Ashlin TG, 2018, CELL REP, V24, P1389, DOI 10.1016/j.celrep.2018.07.012; Bastianini S, 2012, J SLEEP RES, V21, P185, DOI 10.1111/j.1365-2869.2011.00945.x; Blair LAC, 1999, J NEUROSCI, V19, P1940; BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180; Breit A, 2018, J BIOL CHEM, V293, P17278, DOI 10.1074/jbc.RA118.004429; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; Carro E, 2000, J NEUROSCI, V20, P2926; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Chaudhari A, 2017, MOL BIOL CELL, V28, P834, DOI 10.1091/mbc.E16-08-0624; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen JC, 2016, ALZHEIMERS DEMENT, V12, P21, DOI 10.1016/j.jalz.2015.03.004; Chennaoui M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112439; Chennaoui M, 2016, APPL PHYSIOL NUTR ME, V41, P963, DOI 10.1139/apnm-2016-0110; Cipriani G, 2015, PSYCHOGERIATRICS, V15, P65, DOI 10.1111/psyg.12069; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; Date Y, 2000, MOL BRAIN RES, V76, P1, DOI 10.1016/S0169-328X(99)00317-4; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Franco C, 2017, MOL CELL NEUROSCI, V80, P100, DOI 10.1016/j.mcn.2017.02.008; Grubbs JJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000220; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Herrera CG, 2017, FRONT NEUROENDOCRIN, V44, P27, DOI 10.1016/j.yfrne.2016.11.002; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; Hung CM, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1623-0; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Karnani MM, 2020, PROG NEUROBIOL, V187, DOI 10.1016/j.pneurobio.2020.101771; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; KERN W, 1993, J CLIN ENDOCR METAB, V76, P1428, DOI 10.1210/jc.76.6.1428; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Kotz CM, 2006, PHYSIOL BEHAV, V88, P294, DOI 10.1016/j.physbeh.2006.05.031; Koyama Y, 2003, NEUROSCIENCE, V119, P1209, DOI 10.1016/S0306-4522(03)00173-8; Larsson SC, 2018, J ALZHEIMERS DIS, V66, P579, DOI 10.3233/JAD-180529; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Martinez-Rachadell L, 2019, GROWTH HORM IGF RES, V45, P25, DOI 10.1016/j.ghir.2019.02.003; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; McGregor R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178573; Metaxakis A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001824; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Monico-Neto M, 2017, GROWTH FACTORS, V35, P12, DOI 10.1080/08977194.2017.1314277; Monyak RE, 2017, MOL PSYCHIATR, V22, P1140, DOI 10.1038/mp.2016.51; Muller AP, 2012, MOL CELL NEUROSCI, V49, P9, DOI 10.1016/j.mcn.2011.07.008; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Obal F, 1999, BRAIN RES, V818, P267, DOI 10.1016/S0006-8993(98)01286-4; Peyron C, 1998, J NEUROSCI, V18, P9996; PRINZ PN, 1995, J GERONTOL A-BIOL, V50, pM222, DOI 10.1093/gerona/50A.4.M222; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; Sindi S, 2018, ALZHEIMERS DEMENT, V14, P1235, DOI 10.1016/j.jalz.2018.05.012; Skora S, 2018, CELL REP, V22, P953, DOI 10.1016/j.celrep.2017.12.091; Stanojlovic M, 2019, AM J PHYSIOL-REG I, V316, pR571, DOI 10.1152/ajpregu.00383.2018; STEIGER A, 1992, NEUROENDOCRINOLOGY, V56, P566, DOI 10.1159/000126275; SWAAB DF, 1985, BRAIN RES, V342, P37, DOI 10.1016/0006-8993(85)91350-2; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Tortorella S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00216; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; Tsuneki H, 2018, PHARMACOL THERAPEUT, V186, P25, DOI 10.1016/j.pharmthera.2017.12.010; Van Cauter E, 1998, SLEEP, V21, P553; van Oostrom SH, 2018, SLEEP MED, V41, P78, DOI 10.1016/j.sleep.2017.07.029; Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078; Wennberg A, 2019, ENDOCRINE, V66, P634, DOI 10.1007/s12020-019-02061-1; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Zegarra-Valdivia JA, 2019, J ALZHEIMERS DIS, V69, P979, DOI 10.3233/JAD-190241; Ziegenbein M, 2004, NEUROPSYCHOPHARMACOL, V29, P146, DOI 10.1038/sj.npp.1300298; Zink AN, 2018, INT J OBESITY, V42, P737, DOI 10.1038/ijo.2017.276	78	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15975	15990		10.1096/fj.202001281RR	http://dx.doi.org/10.1096/fj.202001281RR		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070417	Green Submitted			2022-12-26	WOS:000581148600001
J	Courter, JR; Perruci, RJ; McGinnis, KJ; Rainieri, JK				Courter, Jason R.; Perruci, Rebecca J.; McGinnis, Kelsey J.; Rainieri, Jacqueline K.			Black-capped chickadees (Poecile atricapillus) alter alarm call duration and peak frequency in response to traffic noise	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; CONVEY INFORMATION; SONG FREQUENCIES; MOBBING CALLS; AMBIENT NOISE; MASKING; FLEXIBILITY; ADJUSTMENT; BEHAVIOR; BIRDS	Anthropogenic noise is an often-overlooked byproduct of urbanization and affects the soundscape in which birds communicate. Previous studies assessing the impact of traffic noise have focused on bird song, with many studies demonstrating the ability of birds to raise song frequency in the presence of low-frequency traffic noise to avoid masking. Less is known about the impact of traffic noise on avian alarm calls, which is surprising given the degree to which predator information within alarm calls may impact fitness. The objective of this study was to assess the impacts of traffic noise on the Black-capped Chickadees (Poecile atricapillus), a small non-migratory songbird with a well-studied and information-rich alarm call. We studied birds at eight locations in Stark County, Ohio, from 15 January to 7 March 2016, and used a taxidermic mount of an Eastern Screech-Owl to elicit alarm calls. In half of the trials, a pre-recorded traffic noise track was also broadcasted at 50 decibels. In noise trials, chickadee calls contained more introductory notes (P < 0.001), more total notes (P < 0.001), were of longer duration (P < 0.001), and had lower introductory and D-note peak frequencies (P = 0.032 and P = 0.041, respectively). No differences were noted in the number of D-notes per call between noise and control trials. Modifying alarm call duration and frequency, without changing the number of D-notes, may be a strategy that chickadees use to convey predator information and to coordinate a threat-appropriate mobbing response when it is not possible to change call type. Our results add to the small, but growing, literature documenting the effects of anthropogenic noise on avian alarm calls, demonstrate the flexibility and complexity of chickadee calls given in response to predators, and may partially explain why chickadees adapt well to urban areas.	[Courter, Jason R.; Perruci, Rebecca J.; McGinnis, Kelsey J.; Rainieri, Jacqueline K.] Malone Univ, Dept Nat Sci, Canton, OH 44709 USA	Malone University	Courter, JR (corresponding author), Malone Univ, Dept Nat Sci, Canton, OH 44709 USA.	jcourter@malone.edu		Courter, Jason/0000-0001-9413-1455				Rios-Chelen AA, 2018, URBAN ECOSYST, V21, P15, DOI 10.1007/s11252-017-0690-1; Baker MC, 2002, WILSON BULL, V114, P510, DOI 10.1676/0043-5643(2002)114[0510:MCOBCC]2.0.CO;2; Billings AC, 2018, ANIM BEHAV, V138, P39, DOI 10.1016/j.anbehav.2018.02.001; Brumm H., 2013, ANIMAL COMMUNICATION, P187, DOI 10.1007/978-3-642-41494-7; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Brumm H, 2017, METHODS ECOL EVOL, V8, P1617, DOI 10.1111/2041-210X.12766; Brumm H, 2009, ANIM BEHAV, V78, P741, DOI 10.1016/j.anbehav.2009.07.004; Campbell KA, 2019, BEHAV PROCESS, V158, P53, DOI 10.1016/j.beproc.2018.10.015; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Courter JR, 2012, WILSON J ORNITHOL, V124, P626, DOI 10.1676/11-168.1; Courter JR, 2010, BEHAV ECOL, V21, P936, DOI 10.1093/beheco/arq086; Damsky J, 2017, CONDOR, V119, P26, DOI 10.1650/CONDOR-16-146.1; Dawson MRW, 2006, J ACOUST SOC AM, V119, P3161, DOI 10.1121/1.2189028; Tolentino VCD, 2018, ENVIRON POLLUT, V235, P983, DOI 10.1016/j.envpol.2018.01.045; Ditchkoff Stephen S., 2006, Urban Ecosystems, V9, P5, DOI 10.1007/s11252-006-3262-3; Dowling JL, 2012, BEHAV ECOL, V23, P201, DOI 10.1093/beheco/arr176; FICKEN MS, 1978, AUK, V95, P34, DOI 10.2307/4085493; Foote AD, 2004, NATURE, V428, P910, DOI 10.1038/428910a; Foote J. R., 2010, BIRDS N AM ONLINE; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Francis CD, 2011, P ROY SOC B-BIOL SCI, V278, P2025, DOI 10.1098/rspb.2010.1847; Goodwin SE, 2013, ANIM BEHAV, V85, P435, DOI 10.1016/j.anbehav.2012.12.003; Grace MK, 2015, BEHAV ECOL SOCIOBIOL, V69, P253, DOI 10.1007/s00265-014-1838-0; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Guo FY, 2016, BEHAV PROCESS, V129, P86, DOI 10.1016/j.beproc.2016.06.002; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; Hill SD, 2018, INTEGR ZOOL, V13, P194, DOI 10.1111/1749-4877.12284; Hu Y, 2010, ANIM BEHAV, V79, P863, DOI 10.1016/j.anbehav.2009.12.036; Jung H, 2020, ETHOLOGY, V126, P620, DOI 10.1111/eth.13013; KROODSMA DE, 1991, AM ZOOL, V31, P318; LaZerte SE, 2019, ETHOLOGY, V125, P516, DOI 10.1111/eth.12876; LaZerte SE, 2017, PEERJ, V5, DOI 10.7717/peerj.3257; LaZerte SE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1058; Leonard ML, 2008, BEHAV ECOL, V19, P502, DOI 10.1093/beheco/arm161; Lowry H, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030118; Luther DA, 2012, ANIM BEHAV, V83, P1059, DOI 10.1016/j.anbehav.2012.01.034; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Ortega Catherine P., 2012, Ornithological Monographs, V74, P6; Owens JL, 2013, THESIS; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Pohl NU, 2012, ANIM BEHAV, V83, P711, DOI 10.1016/j.anbehav.2011.12.019; Proppe DS, 2012, J AVIAN BIOL, V43, P325, DOI 10.1111/j.1600-048X.2012.05640.x; Proppe DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025413; Proppe DS, 2009, J EXP BIOL, V212, P3016, DOI 10.1242/jeb.031724; Radford AN, 2014, BEHAV ECOL, V25, P1022, DOI [10.1093/beheco/aru029, 10.1093/beheco/art102]; Rios-Chelen AA, 2012, J EVOLUTION BIOL, V25, P2171, DOI 10.1111/j.1420-9101.2012.02597.x; Rios-Chelen AA, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2243-7; Rios-Chelen AA, 2015, BEHAV ECOL SOCIOBIOL, V69, P1139, DOI 10.1007/s00265-015-1928-7; Ritchison G, 2017, BIRDS N AM ONLINE; Roca IT, 2016, BEHAV ECOL, V27, P1269, DOI 10.1093/beheco/arw060; Soard CM, 2009, ANIM BEHAV, V78, P1447, DOI 10.1016/j.anbehav.2009.09.026; Sturdy CB, 2000, J COMP PSYCHOL, V114, P357, DOI 10.1037/0735-7036.114.4.357; Sturdy Christopher B., 2007, P153; Templeton CN, 2016, CURR BIOL, V26, pR1173, DOI 10.1016/j.cub.2016.09.058; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Verzijden MN, 2010, J EXP BIOL, V213, P2575, DOI 10.1242/jeb.038299; Walters MJ, 2019, CONDOR, V121, DOI 10.1093/condor/duz002; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Zhou Y, 2019, FUNCT ECOL, V33, P1280, DOI 10.1111/1365-2435.13333	62	8	8	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241035	10.1371/journal.pone.0241035	http://dx.doi.org/10.1371/journal.pone.0241035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119633	Green Published, gold			2022-12-26	WOS:000600013600124
J	Nakamori, M; Hosomi, N; Nishi, H; Aoki, S; Nezu, T; Shiga, Y; Kinoshita, N; Ishikawa, K; Imamura, E; Shintani, T; Ohge, H; Kawaguchi, H; Kurihara, H; Wakabayashi, S; Maruyama, H				Nakamori, Masahiro; Hosomi, Naohisa; Nishi, Hiromi; Aoki, Shiro; Nezu, Tomohisa; Shiga, Yuji; Kinoshita, Naoto; Ishikawa, Kenichi; Imamura, Eiji; Shintani, Tomoaki; Ohge, Hiroki; Kawaguchi, Hiroyuki; Kurihara, Hidemi; Wakabayashi, Shinichi; Maruyama, Hirofumi			Serum IgG titers against periodontal pathogens are associated with cerebral hemorrhage growth and 3-month outcome	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ANTIBODY-LEVELS; STROKE; INFECTION; BACTERIA; MARKERS; DISEASE	To assess the influence of periodontal disease on cerebral hemorrhage and its clinical course, we examined the association of the serum IgG titer of periodontal pathogens with hemorrhage growth and 3-month outcome. We consecutively enrolled 115 patients with acute cerebral hemorrhage (44 females, aged 71.3 +/- 13.1 years) and used ELISA to evaluate the serum IgG titers of 9 periodontal pathogens: Porphyromonas gingivalis, Aggregatibacter (A.) actinomycetemcomitans, Prevotella intermedia, Prevotella nigrescens, Fusobacterium (F.) nucleatum, Treponema denticola, Tannerella forsythensis, Campylobacter rectus, and Eikenella corrodens. Significant hematoma growth was defined as an increase in the volume of >33% or an absolute increase in the volume of >12.5 mL. A poor outcome was defined as a 3 or higher on the modified Rankin Scale. We observed hemorrhage growth in 13 patients (11.3%). Multivariate analysis revealed that increased IgG titers of A. actinomycetemcomitans independently predicted the elevated hemorrhage growth (odds ratio 5.26, 95% confidence interval 1.52-18.25, p = 0.01). Notably, augmented IgG titers of F. nucleatum but not A. actinomycetemcomitans led to a poorer 3-month outcome (odds ratio 7.86, 95% confidence interval 1.08-57.08, p = 0.04). Thus, we demonstrate that elevated serum IgG titers of A. actinomycetemcomitans are an independent factor for predicting cerebral hemorrhage growth and that high serum IgG titers of F. nucleatum may predict a poor outcome in patients with this disease. Together, these novel data reveal how systemic periodontal pathogens may affect stroke patients, and, should, therefore, be taken into consideration in the management and treatment of these individuals.	[Nakamori, Masahiro; Hosomi, Naohisa; Aoki, Shiro; Nezu, Tomohisa; Shiga, Yuji; Kinoshita, Naoto; Ishikawa, Kenichi; Maruyama, Hirofumi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Hosomi, Naohisa] Chikamori Hosp, Dept Neurol, Kochi, Japan; [Hosomi, Naohisa] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan; [Nishi, Hiromi; Kawaguchi, Hiroyuki] Hiroshima Univ Hosp, Dept Gen Dent, Hiroshima, Japan; [Shintani, Tomoaki] Hiroshima Univ Hosp, Ctr Oral Examinat, Hiroshima, Japan; [Ohge, Hiroki] Hiroshima Univ Hosp, Dept Infect Dis, Hiroshima, Japan; [Kurihara, Hidemi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Periodontal Med, Hiroshima, Japan; [Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.; Hosomi, N (corresponding author), Chikamori Hosp, Dept Neurol, Kochi, Japan.; Hosomi, N (corresponding author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Maruyama, Hirofumi/B-9333-2011	Maruyama, Hirofumi/0000-0001-7613-8717; Aoki, Shiro/0000-0001-5348-5783; Nakamori, Masahiro/0000-0002-0944-5538	Japan Society for the Promotion of Science KAKENHI [17K17350, 17K17907, 18K10746]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Japan Society for the Promotion of Science KAKENHI (grant numbers 17K17350, 17K17907, and 18K10746) to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PRESCRIRE, V26, P857; [Anonymous], 2017, ETHICS INT AFF, V31, P19; [Anonymous], 2014, OFFICIAL J EUROPEA L, VL158, P35; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x; Feuille F, 1996, INFECT IMMUN, V64, P2095, DOI 10.1128/IAI.64.6.2094-2100.1996; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Heckmann JG, 2003, CAN J NEUROL SCI, V30, P266, DOI 10.1017/S0317167100002717; Huynh T, 2011, J ENDODONT, V37, P1531, DOI 10.1016/j.joen.2011.06.034; Kai A, 2008, J MED MICROBIOL, V57, P668, DOI 10.1099/jmm.0.47710-0; Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415; Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Murakami M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-557; Nakahara T, 2018, J GASTROENTEROL, V53, P269, DOI 10.1007/s00535-017-1368-4; Nishi H, 2020, CLIN EXP IMMUNOL, V200, P302, DOI 10.1111/cei.13430; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pussinen PJ, 2005, ARTERIOSCL THROM VAS, V25, P833, DOI 10.1161/01.ATV.0000157982.69663.59; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Sen S, 2018, STROKE, V49, P355, DOI 10.1161/STROKEAHA.117.018990; Simova P, 2012, APPL GEOGR, V34, P385, DOI 10.1016/j.apgeog.2012.01.003; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x; You ZY, 2009, ATHEROSCLEROSIS, V203, P615, DOI 10.1016/j.atherosclerosis.2008.07.037; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241205	10.1371/journal.pone.0241205	http://dx.doi.org/10.1371/journal.pone.0241205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112888	gold, Green Published			2022-12-26	WOS:000588374000007
J	Wang, Y; Lian, JY; Shen, H; Ni, YL; Zhang, RY; Guo, Y; Ye, WH				Wang, Yue; Lian, Juyu; Shen, Hao; Ni, Yunlong; Zhang, Ruyun; Guo, Yun; Ye, Wanhui			The effects of Bidens alba invasion on soil bacterial communities across different coastal ecosystem land-use types in southern China	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PHENOTYPIC PLASTICITY; NITROGEN ADDITION; PLANT; NETWORK; MODULARITY; DIVERSITY; RESPONSES; ALTERS; PILOSA	Environments in both biotic and abiotic ecosystems have been affected by the colonization of non-native flora. In this study, we examined the effect of Bidens alba invasion on different land-use types along a coastline in southern China. Bacterial communities in each site were determined using 16S rDNA sequencing, and soil physicochemical properties were analyzed using standard methods. Although our results indicated that B. alba invasion did not have a significant effect on the alpha diversity of bacteria, it caused significant differences in soil bacterial community composition between invaded and uninvaded soil across different land-use types. Beta diversity and several physicochemical properties in forest, orchard and waterfront environments were recorded to be more susceptible to B. alba invasion. A high proportion of the variation of bacterial communities can be explained by a combination of environmental variables, indicating that environmental selection rather than plant invasion is a more effective process in coastal microbial assemblages. By comparing topological roles of shared OTUs among invaded and uninvaded soil, keystone taxa in invaded soil were identified. Acidobacteria was the major phyla involved in the invasive process which could be driven by environmental selection. How key phyla react in our experiment should be verified by further studies.	[Wang, Yue; Lian, Juyu; Shen, Hao; Ni, Yunlong; Zhang, Ruyun; Guo, Yun; Ye, Wanhui] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Wang, Yue; Lian, Juyu; Shen, Hao; Ni, Yunlong; Zhang, Ruyun; Guo, Yun; Ye, Wanhui] Chinese Acad Sci, Ctr Plant Ecol, Core Bot Gardens, Guangzhou, Guangdong, Peoples R China; [Wang, Yue; Lian, Juyu; Shen, Hao; Ni, Yunlong; Zhang, Ruyun; Guo, Yun; Ye, Wanhui] Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China; [Wang, Yue; Lian, Juyu; Shen, Hao; Ni, Yunlong; Zhang, Ruyun; Guo, Yun; Ye, Wanhui] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Peoples R China; [Wang, Yue; Ni, Yunlong; Zhang, Ruyun; Guo, Yun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Hong Kong Branch of the Southern Marine Science & Engineering Guangdong Laboratory (Guangzhou); Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ni, YL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.; Ni, YL (corresponding author), Chinese Acad Sci, Ctr Plant Ecol, Core Bot Gardens, Guangzhou, Guangdong, Peoples R China.; Ni, YL (corresponding author), Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China.; Ni, YL (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Peoples R China.; Ni, YL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lianjy@scbg.ac.cn			National Key R&D Program of China [2017YFC0505802]; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) [GML2019ZD0408]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB31030000]; Guangdong Forestry Science & Technology Innovation Program [2019KJCX015]; GENE DENOVO (Guangzhou) Co., Ltd. (Guangzhou, P. R. China)	National Key R&D Program of China; Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Guangdong Forestry Science & Technology Innovation Program; GENE DENOVO (Guangzhou) Co., Ltd. (Guangzhou, P. R. China)	This work was supported by the National Key R&D Program of China (grant No. 2017YFC0505802), Key Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) (GML2019ZD0408), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB31030000) and Guangdong Forestry Science & Technology Innovation Program (2019KJCX015). GENE DENOVO (Guangzhou) Co., Ltd. (Guangzhou, P. R. China) provided support by sequencing PCR products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini A, 2016, PLANT SOIL, V400, P193, DOI 10.1007/s11104-015-2727-7; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2010, METROLOGY MEASUREMEN, V12, P233; Barberan A, 2014, ECOL LETT, V17, P794, DOI 10.1111/ele.12282; Barberan A, 2014, SCI TOTAL ENVIRON, V487, P187, DOI 10.1016/j.scitotenv.2014.04.030; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borcard D, 1994, ENVIRON ECOL STAT, V1, P37, DOI 10.1007/BF00714196; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; Campbell DE, 2009, ECOL ENG, V35, P463, DOI 10.1016/j.ecoleng.2008.07.022; Chen J, 2019, FOREST ECOL MANAG, V433, P228, DOI 10.1016/j.foreco.2018.11.005; Chen L, 2019, SCI TOTAL ENVIRON, V683, P202, DOI 10.1016/j.scitotenv.2019.05.220; Chen WB, 2019, WEED RES, V59, P49, DOI 10.1111/wre.12344; Chen XP, 2016, PEDOSPHERE, V26, P108, DOI 10.1016/S1002-0160(15)60027-3; Cheng JK, 2019, PLANT SOIL, V444, P443, DOI 10.1007/s11104-019-04297-2; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; El-Barougy RF, 2017, NEOBIOTA, P1, DOI 10.3897/neobiota.33.9968; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Huangfu CH, 2016, BIOL INVASIONS, V18, P3365, DOI 10.1007/s10530-016-1231-1; Jesse WAM, 2020, GLOBAL CHANGE BIOL, V26, P3294, DOI 10.1111/gcb.15091; Jiang XY, 2014, APPL SOIL ECOL, V80, P108, DOI 10.1016/j.apsoil.2014.04.002; Kong YH, 2017, J GEN APPL MICROBIOL, V63, P114, DOI 10.2323/jgam.2016.08.002; Kong ZY, 2019, ECOTOX ENVIRON SAFE, V183, DOI 10.1016/j.ecoenv.2019.109504; Kulmatiski A, 2006, J APPL ECOL, V43, P868, DOI 10.1111/j.1365-2664.2006.01192.x; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Liu YY, 2019, SCI TOTAL ENVIRON, V672, P634, DOI 10.1016/j.scitotenv.2019.04.024; Luo Ya-ting, 2019, Shengtaixue Zazhi, V38, P655, DOI 10.13292/j.1000-4890.201903.016; Makiola A, 2019, MOL ECOL, V28, P3786, DOI 10.1111/mec.15177; Mamet SD, 2019, ISME J, V13, P1988, DOI 10.1038/s41396-019-0407-y; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; Niu HB, 2007, PLANT SOIL, V294, P73, DOI 10.1007/s11104-007-9230-8; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pascault N, 2013, ECOSYSTEMS, V16, P810, DOI 10.1007/s10021-013-9650-7; Perez-Valera E, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv031; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Piper CL, 2015, J ECOL, V103, P386, DOI 10.1111/1365-2745.12356; Shen WS, 2016, ACTA AGR SCAND B-S P, V66, P97, DOI 10.1080/09064710.2015.1072234; Shi SJ, 2016, ECOL LETT, V19, P926, DOI 10.1111/ele.12630; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stefanowicz AM, 2019, SCI TOTAL ENVIRON, V677, P340, DOI 10.1016/j.scitotenv.2019.04.408; Stefanowicz AM, 2019, APPL SOIL ECOL, V136, P168, DOI 10.1016/j.apsoil.2019.01.004; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang CY, 2019, APPL SOIL ECOL, V144, P51, DOI 10.1016/j.apsoil.2019.07.008; Wang CY, 2018, AGR ECOSYST ENVIRON, V267, P15, DOI 10.1016/j.agee.2018.08.002; Wang CY, 2018, SCI TOTAL ENVIRON, V631-632, P702, DOI 10.1016/j.scitotenv.2018.03.061; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Xiang J, 2016, PHYSICA A, V443, P451, DOI 10.1016/j.physa.2015.09.093; [徐明锋 Xu Mingfeng], 2014, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V34, P91; Yang RH, 2019, FRONT MICROBIOL, V10, P12, DOI [10.3389/fmicb.2019.00012, DOI 10.3389/FMICB.2019.00012]; Zhang HY, 2020, SOIL BIOL BIOCHEM, V143, DOI 10.1016/j.soilbio.2020.107739; [张维理 Zhang Weili], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3214; Zheng Xin-ying, 2018, Shengtaixue Zazhi, V37, P580, DOI 10.13292/j.1000-4890.201802.029; Zhou Jizhong, 2010, mBio, V1, DOI 10.1128/mBio.00169-10	64	1	1	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0238478	10.1371/journal.pone.0238478	http://dx.doi.org/10.1371/journal.pone.0238478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112879	gold, Green Published			2022-12-26	WOS:000588374000022
J	Takayama, Y; Akagi, Y; Shibuya, Y; Kida, YS				Takayama, Yuzo; Akagi, Yuka; Shibuya, Yoichiro; Kida, Yasuyuki S.			Exposure to small molecule cocktails allows induction of neural crest lineage cells from human adipose-derived mesenchymal stem cells	PLOS ONE			English	Article							NEURONAL CELLS; DIFFERENTIATION; FIBROBLASTS; GENERATION; IDENTIFICATION; PROLIFERATION; MECHANISMS; EXPRESSION; ALZHEIMERS; CCR3	Neural crest cells (NCCs) are a promising source for cell therapy and regenerative medicine owing to their multipotency, self-renewability, and capability to secrete various trophic factors. However, isolating NCCs from adult organs is challenging, because NCCs are broadly distributed throughout the body. Hence, we attempted to directly induce NCCs from human adipose-derived mesenchymal stem cells (ADSCs), which can be isolated easily, using small molecule cocktails. We established a controlled induction protocol with two-step application of small molecule cocktails for 6 days. The induction efficiency was evaluated based on mRNA and protein expression of neural crest markers, such as nerve growth factor receptor (NGFR) and sex-determining region Y-box 10 (SOX10). We also found that various trophic factors were significantly upregulated following treatment with the small molecule cocktails. Therefore, we performed global profiling of cell surface makers and identified distinctly upregulated markers, including the neural crest-specific cell surface markers CD271 and CD57. These results indicate that our chemical treatment can direct human ADSCs to developing into the neural crest lineage. This offers a promising experimental platform to study human NCCs for applications in cell therapy and regenerative medicine.	[Takayama, Yuzo; Akagi, Yuka; Shibuya, Yoichiro; Kida, Yasuyuki S.] Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Tsukuba, Ibaraki, Japan; [Akagi, Yuka; Kida, Yasuyuki S.] Natl Inst Adv Ind Sci & Technol, Adv Photon & Biosensing Open Innovat Lab, Tsukuba, Ibaraki, Japan; [Shibuya, Yoichiro] Univ Tsukuba, Dept Plast & Reconstruct Surg, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Takayama, Y; Kida, YS (corresponding author), Natl Inst Adv Ind Sci & Technol, Cellular & Mol Biotechnol Res Inst, Tsukuba, Ibaraki, Japan.; Kida, YS (corresponding author), Natl Inst Adv Ind Sci & Technol, Adv Photon & Biosensing Open Innovat Lab, Tsukuba, Ibaraki, Japan.	yuzo-takayama@aist.go.jp; y-kida@aist.go.jp	kida, yasuyuki S/J-1718-2018; Takayama, Yuzo/L-5072-2018	kida, yasuyuki S/0000-0002-9972-293X; Takayama, Yuzo/0000-0002-6382-8767	Japan Society for the Promotion of Science (JSPS) [KAKENHI: 26702015]; JSPS [KAKENHI: 15K15649, KAKENHI: 18K19414]; BioMimetics Sympathies Inc.	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BioMimetics Sympathies Inc.	Funding was provided by a Grant-in-Aid for Young Scientists (A) (KAKENHI: 26702015) from Japan Society for the Promotion of Science (JSPS) to YT, Grant-in-Aid for Challenging Exploratory Research (KAKENHI: 15K15649) from JSPS to YT and YSK, and Grant-in-Aid for Challenging Exploratory Research (KAKENHI: 18K19414) from JSPS to YSK. Funding was also provided by BioMimetics Sympathies Inc. to YSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilleos A, 2012, CELL RES, V22, P288, DOI 10.1038/cr.2012.11; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2016, BIOMED RES INT, V3, P1; Bahm I, 2017, DEVELOPMENT, V144, P2456, DOI 10.1242/dev.147926; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Bogenmann E, 2011, GENESIS, V49, P862, DOI 10.1002/dvg.20747; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chen ZJ, 2017, CELL REP, V21, P707, DOI 10.1016/j.celrep.2017.09.037; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; de Almeida DC, 2016, STEM CELL REP, V6, P168, DOI 10.1016/j.stemcr.2016.01.003; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Hausmann OV, 2011, ALLERGY, V66, P85, DOI 10.1111/j.1398-9995.2010.02431.x; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Hu YF, 2010, STEM CELL REV REP, V6, P186, DOI 10.1007/s12015-010-9152-3; Jung DW, 2014, ACS CHEM BIOL, V9, P80, DOI 10.1021/cb400754f; Kamada M, 2014, BIOCHEM BIOPH RES CO, V453, P668, DOI 10.1016/j.bbrc.2014.10.009; Kawagishi-Hotta M, 2017, REGEN THER, V6, P29, DOI 10.1016/j.reth.2016.12.004; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim YJ, 2014, CELL STEM CELL, V15, P497, DOI 10.1016/j.stem.2014.07.013; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lim RG, 2017, NAT NEUROSCI, V20, P648, DOI 10.1038/nn.4532; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Ma XJ, 2017, PROTEIN CELL, V8, P328, DOI 10.1007/s13238-016-0362-6; Maruoka H, 2011, J BIOCHEM, V150, P473, DOI 10.1093/jb/mvr113; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Miller CT, 2007, DEV BIOL, V308, P144, DOI 10.1016/j.ydbio.2007.05.018; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MURPHY M, 1994, DEVELOPMENT, V120, P3519; Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77; Oh Y, 2016, CELL STEM CELL, V19, P95, DOI 10.1016/j.stem.2016.05.002; Ong WK, 2014, STEM CELL REP, V2, P171, DOI 10.1016/j.stemcr.2014.01.002; Pandamooz S, 2019, NEUROSCI LETT, V704, P8, DOI 10.1016/j.neulet.2019.03.033; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Sampaio TB, 2017, NEURAL REGEN RES, V12, P549, DOI 10.4103/1673-5374.205084; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Squillaro T., 2016, REV CLIN TRIALS MESE, V25, P829, DOI DOI 10.3727/096368915X689622; Suguitan Jr AL, 2011, PLOS ONE, V6; Takayama Y, 2017, FEBS LETT, V591, P590, DOI 10.1002/1873-3468.12572; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; Waddington C H, 1957, STRATEGY GENES DISCU; Wu LW, 2014, TRANSPL IMMUNOL, V30, P122, DOI 10.1016/j.trim.2014.03.001; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; 2014, REG ANESTH PAIN MED, V9	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241125	10.1371/journal.pone.0241125	http://dx.doi.org/10.1371/journal.pone.0241125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104750	Green Published, gold			2022-12-26	WOS:000588370000009
J	Roy, S; Ghosh, P				Roy, Satyaki; Ghosh, Preetam			Factors affecting COVID-19 infected and death rates inform lockdown-related policymaking	PLOS ONE			English	Article								Background After claiming nearly five hundred thousand lives globally, the COVID-19 pandemic is showing no signs of slowing down. While the UK, USA, Brazil and parts of Asia are bracing themselves for the second wave-or the extension of the first wave-it is imperative to identify the primary social, economic, environmental, demographic, ethnic, cultural and health factors contributing towards COVID-19 infection and mortality numbers to facilitate mitigation and control measures. Methods We process several open-access datasets on US states to create an integrated dataset of potential factors leading to the pandemic spread. We then apply several supervised machine learning approaches to reach a consensus as well as rank the key factors. We carry out regression analysis to pinpoint the key pre-lockdown factors that affect post-lockdown infection and mortality, informing future lockdown-related policy making. Findings Population density, testing numbers and airport traffic emerge as the most discriminatory factors, followed by higher age groups (above 40 and specifically 60+). Post-lockdown infected and death rates are highly influenced by their pre-lockdown counterparts, followed by population density and airport traffic. While healthcare index seems uncorrelated with mortality rate, principal component analysis on the key features show two groups: states (1) forming early epicenters and (2) experiencing strong second wave or peaking late in rate of infection and death. Finally, a small case study on New York City shows that days-to-peak for infection of neighboring boroughs correlate better with inter-zone mobility than the inter-zone distance. Interpretation States forming the early hotspots are regions with high airport or road traffic resulting in human interaction. US states with high population density and testing tend to exhibit consistently high infected and death numbers. Mortality rate seems to be driven by individual physiology, preexisting condition, age etc., rather than gender, healthcare facility or ethnic predisposition. Finally, policymaking on the timing of lockdowns should primarily consider the pre-lockdown infected numbers along with population density and airport traffic.	[Roy, Satyaki] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Ghosh, Preetam] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	University of North Carolina; University of North Carolina Chapel Hill; Virginia Commonwealth University	Roy, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	satyakir@unc.edu		Ghosh, Preetam/0000-0003-3880-5886; Roy, Satyaki/0000-0001-6767-266X	National Science Foundation [CBET-1802588]	National Science Foundation(National Science Foundation (NSF))	This work is partially supported by National Science Foundation (CBET-1802588).	A. Imlay Deseret News, 2020, DESERET NEWS; Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Agency for Healthcare Research and Quality, 2018, HLTH CAR QUAL DOES Y; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, CORONAVIRUS WORLD MA; [Anonymous], 2020, FIASCO MAKING CORONA; [Anonymous], 2020, CORONAVIRUS ITS TIME; [Anonymous], 2020, HOUSTON CHRONICLE; [Anonymous], 2020, XINHUANET; [Anonymous], 2020, 10 REASONS DOUBT COV; [Anonymous], 2020, CORONAVIRUS WHAT HAV; Baker Scott R, 2020, TECHNICAL REPORT; Barstugan M, 2020, ARXIV; Center for Disease Control and Prevention, 2020, COVID 19 TEST OV; Centers for Disease Control and Prevention (CDC), 2020, PREV US VIR TEST DAT; Cheng X, 2020, ARTIF INTELL; data.BetaNYC, 2020, NYC COVID19 BOR LEV; Golestaneh L, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100455; Gou JP, 2012, COMPUT J, V55, P1058, DOI 10.1093/comjnl/bxr131; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Hillyard V., 2020, NBC NEWS; Holmdahl I, 2020, NEW ENGL J MED, V383, P303, DOI 10.1056/NEJMp2016822; Hud Exchange, 2013, 2013 AH 1; Johns Hopkins Bloomberg School of Public Health, 2020, MAST, P2020; Kaggle, 2020, COVID19 US LOCKD DAT; KFF, 2018, POP DISTR RAC ETHN; KFF, 2017, POP DISTR GEND; Khan H., 2020, HOSSAIN COUNTRIES AR; Khan N., 2020, COVID 2019 WORLD EC; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Liu W., 2020, SCI FIGHT NOVEL CORO; Lush Tamara, 2020, 100 TEST POSITIVE CO; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; NYCOpenData, 2012, TRAFF VOL COUNTS; Paper D., 2020, HANDS ON SCIKIT LEAR, P165, DOI [10.1007/978-1-4842-5373-1_6, DOI 10.1007/978-1-4842-5373-1_6]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plagianakos V., 2013, ADV CONVEX ANAL GLOB, V54, P433; Pradhan Ashis, 2012, INT J EMERGING TECHN, V2, P82; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Raghav K., 2020, GUARDIAN; Randhawa GS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232391; Rish I., 2001, IJCAI 2001 WORKSH EM, V3, P41, DOI DOI 10.1039/B104835J; Rose A., 2020, COVID 19 CASES RISE; Ruder S., 2016, ARXIV; Sarfraz A., 2020, RANDOMIZED PLACEBO C; Scikit learn developers (BSD License), 2011, MULT LIN REGR; Scikit learn developers (BSD License), 2011, NAIV BAYES; Scikit learn developers (BSD License), 2011, SUPP VECT MACH; Scikit learn developers (BSD License), 2011, EXTR TREES; Scikit learn developers (BSD License), 2011, DEC TREES; Scikit learn developers (BSD License), 2011, STOCH GRAD DESC; Scikit learn developers (BSD License), 2019, SCIK LEARN PREPR KBI; Scikit learn developers (BSD License), 2011, NEAR CENTR; The News Tribune, 2020, NEWS TRIBUNE; United States Census, 2019, STAT POP CHAR 2010 2; United States Laboratory Testing, 2020, CDC COV DAT TRACK; US Department of Transportation, 2020, US INT AIR PASS FREI; US Historical Data, 2020, US HIST DAT; US Pharmacist, 2020, FACT AFF COV 19 TRAN; Wang PP, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110058; Wikipedia, 2019, LIST BUS AIRP US; Wikipedia, 2020, LIST GEOGR CTR US; World Population Review, 2020, GROSS DOM PROD; Worldometer, 2020, COVID 19 CAS; WTOC, 2020, DPH REP ALM 900 NEW; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zoabi Y., 2020, COVID 19 DIAGNOSIS P	68	42	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241165	10.1371/journal.pone.0241165	http://dx.doi.org/10.1371/journal.pone.0241165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095811	gold, Green Published			2022-12-26	WOS:000586649400001
J	Mohammed, S; Larsen-Reindorf, RE				Mohammed, Shamsudeen; Larsen-Reindorf, Roderick Emil			Menstrual knowledge, sociocultural restrictions, and barriers to menstrual hygiene management in Ghana: Evidence from a multi-method survey among adolescent schoolgirls and schoolboys	PLOS ONE			English	Article							GIRLS	On a daily basis, schoolgirls in low and middle-income countries discover blood on their clothing for the first time in school environments without toilets, water, or a supportive teacher, mentor, or role model to help them understand the changes happening in their bodies. This study aimed to examine the menstrual knowledge, sociocultural restrictions, and barriers to menstrual hygiene management in school environment among adolescent schoolgirls in a rural community. We collected quantitative data from 250 adolescent schoolgirls and qualitative data from thirty schoolboys and five schoolteachers in five Junior High Schools in the Kumbungu district of northern Ghana. Binary logistic regression models were fitted to determine the predictors of poor menstrual knowledge. Qualitative data were transcribed verbatim, coded, and organized into themes. Overall, 53.6% of the girls had poor knowledge about menstruation. Most of the boys had heard about menstruation and had an idea about what menstruation is with most of them describing it as "the flow of blood through the vagina of a female." The boys revealed that terms such as "Vodafone," "Red card," and "Palm oil" are used to describe menstruation in the schools and within the community. After adjusting for the effect of other sociodemographic factors, we found evidence that girls in their late adolescents were less likely to have poor menstrual knowledge compared to those aged 10-14 years (aOR 0.20, 95%CI 0.08-0.48). Maternal education was protective against poor menstrual knowledge. When compared to adolescents whose mothers were illiterates, those whose mothers had basic education (aOR 0.62, 95%CI 0.28-1.40) and those whose mothers had secondary or higher education (AOR 0.22, 95%CI 0.06-0.76) were less likely to have poor knowledge about menstruation. Adolescents from homes with no television and radio sets were more likely to have poor menstrual knowledge compared to those from homes with television and radio sets (aOR 2.42, 95%CI 1.41-4.15). Comfort, safety, and cost were the major factors that influenced their choice of sanitary products. Most of the teachers said the schools do not provide students with sanitary products, even in emergencies. We found that girls were not to prepare some local dishes (e.g.Wasawasa) during their periods and are forbidden from participating in religious activities (i.e. read the Holy Quran or pray in the mosque) during the period of menstruation. Open discussions about menstruation and its management are not encouraged and girls are considered unclean and impure during the period of menstruation. None of the schools had a regular supply of water in WASH facilities, a mirror for girls to check their uniforms for bloodstains or soap in the toilet facilities for handwashing. Menstrual education through the standard school curriculum, starting from primary school, could prepare girls for menarche, improve their knowledge on menstruation, and teach boys how to support girls and women during the period of menstruation. This could also eliminate the sociocultural misconceptions surrounding menstruation.	[Mohammed, Shamsudeen] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Kumasi, Ghana; [Mohammed, Shamsudeen] Coll Nursing & Midwifery, Populat & Reprod Hlth Resident, Nalerigu, Ghana; [Larsen-Reindorf, Roderick Emil] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Obstet & Gynaecol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Mohammed, S (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Kumasi, Ghana.; Mohammed, S (corresponding author), Coll Nursing & Midwifery, Populat & Reprod Hlth Resident, Nalerigu, Ghana.	deen0233@gmail.com		Mohammed, Shamsudeen/0000-0002-3771-8425				Abanyie SK, 2016, ENSURING AVAILABILIT, P1; Alberda H, 2018, MENSTRUAL HLTH TRAIN; Ameade Evans Paul Kwame, 2016, Adv Prev Med, V2016, P1056235, DOI 10.1155/2016/1056235; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; [Anonymous], 2013, C M L R, V2, P2; [Anonymous], 2015, GAIKO; Baumgarten N, 2012, STUD PRAGMAT, P1; Boosey R, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.253.5313; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Chang YT, 2012, J CLIN NURS, V21, P513, DOI 10.1111/j.1365-2702.2011.03700.x; Coast E, 2019, INT J PUBLIC HEALTH, V64, P293, DOI 10.1007/s00038-019-01209-0; Crofts T, 2012, FACT SHEET; Ghana Statistical Service (GSS), 2014, DISTR AN REP; Johnson L, 2016, SCH EXPERIENCE BOLIV; Kasiulevicius V, 2006, GERONTOLOGIJA, V7, P225, DOI DOI 10.1080/14636200601084014; Kennedy E, 2015, MENSTRUAL HYGIENE MA; Kgware M, 2016, MENSTRUATION MENSTRU; Kumar A, 2011, SOC WORK PUBLIC HLTH, V26, P594, DOI 10.1080/19371918.2010.525144; Lawan U M, 2010, Afr J Reprod Health, V14, P201; Mathiaud C, 2014, MENSTRUAL HYGIENE MA; Morrison J, 2018, ANAL MENSTRUAL HYGIE; Nanda G, 2016, MENSTRUAL HYGIENE MA; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Swedish International Development Cooperation Agency [Sida], 2016, HLTH BOTH PREREQUISI, P1; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; Ten VTA, 2007, MENSTRUAL HYGIENE NE, P1; Thakre SB, 2011, J CLIN DIAGN RES, V5, P1027; The World Bank, 2018, MENSTR HYG MAN EN WO; UNESCO, 2014, PUB ED MENSTR HYG MA; UNICEF, 2012, WAT SAN HYG WASH SCH, P3; UNICEF, 2008, MAIL GUARDIAN; UNICEF, 2016, SUPP RIGHTS GIRLS WO, P1; Upashe SP, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0245-7; WaterAid, 2009, EC GYNAECOL; World Anti-Doping Agency, 2020, WAST WAST RES CAS NA, P1; WSSCC and UN Women, 2014, MENSTR HYG MAN BEH P	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241106	10.1371/journal.pone.0241106	http://dx.doi.org/10.1371/journal.pone.0241106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091080	Green Published, gold, Green Accepted			2022-12-26	WOS:000586647200040
J	Armando, F; Ferrari, L; Arcari, ML; Azzali, G; Dallatana, D; Ferrari, M; Lombardi, G; Zanfabro, M; Di Lecce, R; Lunghi, P; Cameron, ER; Cantoni, AM; Corradi, A				Armando, Federico; Ferrari, Luca; Arcari, Maria Luisa; Azzali, Giacomo; Dallatana, Davide; Ferrari, Maura; Lombardi, Guerino; Zanfabro, Matteo; Di Lecce, Rosanna; Lunghi, Paolo; Cameron, Ewan R.; Cantoni, Anna M.; Corradi, Attilio			Endocanalicular transendothelial crossing (ETC): A novel intravasation mode used by HEK-EBNA293-VEGF-D cells during the metastatic process in a xenograft model	PLOS ONE			English	Article							CANCER-CELLS; LYMPHATIC VESSEL; TUMOR-CELLS; MIGRATION; VEGF; GROWTH; ENDOTHELIUM; LYMPHOCYTES; PASSAGE; EXTRAVASATION	In cancer metastasis, intravasation of the invasive tumor cell (TCi) represents one of the most relevant events. During the last years, models regarding cancer cell intravasation have been proposed, such as the "endocanalicular transendothelial crossing" (ETC) theory. This theory describes the interplay between two adjacent endothelial cells and the TCi or a leukocyte during intravasation. Two endothelial cells create a channel with their cell membranes, in which the cell fits in without involving endothelial cell intercellular junctions, reaching the lumen through a transendothelial passage. In the present study, ten SCID mice were subcutaneously xenotransplanted with the HEK-EBNA293-VEGF-D cell line and euthanized after 35 days. Post-mortem examinations were performed and proper specimens from tumors were collected. Routine histology and immunohistochemistry for Ki-67, pAKT, pERK, ZEB-1, TWIST-1, F-actin, E-cadherin and LYVE-1 were performed followed by ultrastructural serial sections analysis. A novel experimental approach involving Computed Tomography (CT) combined with 3D digital model reconstruction was employed. The analysis of activated transcription factors supports that tumor cells at the periphery potentially underwent an epithelial-to-mesenchymal transition (EMT)-like process. Topographical analysis of LYVE-1 immunolabeled lymphatics revealed a peritumoral localisation. TEM investigations of the lymphatic vessels combined with 3D digital modelling enhanced the understanding of the endotheliocytes behavior during TCi intravasation, clarifying the ETC theory. Serial ultrastructural analysis performed within tumor periphery revealed numerous cells during the ETC process. Furthermore, this study demonstrates that ETC is an intravasation mode more frequently used by the TCi than by leukocytes during intravasation in the HEK-EBNA293-VEGF-D xenograft model and lays down the potential basis for promising future studies regarding intravasation blocking therapy.	[Armando, Federico; Ferrari, Luca; Di Lecce, Rosanna; Cantoni, Anna M.; Corradi, Attilio] Univ Parma, Pathol Unit, Dept Vet Sci, Parma, Italy; [Arcari, Maria Luisa; Azzali, Giacomo; Dallatana, Davide] Univ Parma, Dept Med & Surg, Parma, Italy; [Ferrari, Maura; Lombardi, Guerino] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Unit Brescia, Brescia, Italy; [Zanfabro, Matteo] 3D Vet Printing Project, Parma, Italy; [Zanfabro, Matteo] Univ Parma, Diagnost Imaging Unit, Dept Vet Sci, Parma, Italy; [Lunghi, Paolo] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Lunghi, Paolo] Univ Parma, Ctr Mol & Translat Oncol, Parma, Italy; [Cameron, Ewan R.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland	University of Parma; University of Parma; IZS Lombardia e Emilia; University of Parma; University of Parma; University of Parma; University of Glasgow	Armando, F; Ferrari, L; Cantoni, AM (corresponding author), Univ Parma, Pathol Unit, Dept Vet Sci, Parma, Italy.	annamaria.cantoni@unipr.it; federico.armando@unipr.it; luca.ferrari@unipr.it	Armando, Federico/AAL-5748-2020; Ferrari, Luca/AAD-3223-2020; CORRADI, ATTILIO/GZB-1783-2022	Armando, Federico/0000-0002-2578-4409; Ferrari, Luca/0000-0002-5428-1595; CORRADI, ATTILIO/0000-0002-4511-9748; Lombardi, Guerino/0000-0003-0977-5761; Zanfabro, Matteo/0000-0002-4007-9871	National competitive research fund, MiUR-PRIN (Italy) [2002074251]	National competitive research fund, MiUR-PRIN (Italy)	A.C. (PI: Prof. Attilio Corradi -Prot. 2002074251). National competitive research fund, MiUR-PRIN (Italy), funding the research entitled "Lymphatic microcirculation and neoplastic metastasis" https://www.miur.gov.it/.The funder provided support in the form of materials and salary for the author (A.C.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these author is articulated in the `author contributions' section.	[Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; [Anonymous], **NON-TRADITIONAL**; Armando F, 2020, J CELL MOL MED, V24, P9332, DOI 10.1111/jcmm.15585; AZZALI G, 1990, J SUBMICR CYTOL PATH, V22, P273; AZZALI G, 1990, CELL TISSUE RES, V262, P191, DOI 10.1007/BF00327761; Azzali G, 2007, EUR J HISTOCHEM, V51, P73; AZZALI G, 1990, J SUBMICR CYTOL PATH, V22, P543; AZZALI G, 1982, LYMPHOLOGY, V15, P106; Azzali G, 2000, ANAT REC, V258, P71; Azzali G, 2007, AM J PATHOL, V170, P334, DOI 10.2353/ajpath.2007.060447; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bockhorn M, 2007, LANCET ONCOL, V8, P444, DOI 10.1016/S1470-2045(07)70140-7; Born G, 1883, ARCH MIKROSK ANAT, V22, P584, DOI 10.1007/bf02952679; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Davalli P, 2011, INT J ONCOL, V39, P1521, DOI 10.3892/ijo.2011.1136; Gasinska A, 2018, FOLIA HISTOCHEM CYTO, V56, P195, DOI 10.5603/FHC.a2018.0023; Girling JE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-84; Grzegrzolka J, 2015, ANTICANCER RES, V35, P3961; Heyder P, 2007, AUTOIMMUNITY, V40, P331, DOI 10.1080/08916930701356515; International Committee on Veterinary Gross Anatomical Nomenclature (ICVGAN), 2012, NOMINA ANATOMICA VET, V5th; Karnezis T, 2019, CANCER RES, V79, P1558, DOI 10.1158/0008-5472.CAN-18-1858; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lee TH, 2003, J BIOL CHEM, V278, P5277, DOI 10.1074/jbc.M210063200; Lee TH, 2002, J BIOL CHEM, V277, P10445, DOI 10.1074/jbc.M107348200; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Meirson T, 2018, DRUG RESIST UPDATE, V39, P1, DOI 10.1016/j.drup.2018.05.002; Mierke CT, 2008, J BIOPHYS, V2008; Miles FL, 2008, CLIN EXP METASTAS, V25, P305, DOI 10.1007/s10585-007-9098-2; Nath B, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081194; OGAWA K, 1993, ANAT REC, V237, P358, DOI 10.1002/ar.1092370309; OLAH I, 1985, POULTRY SCI, V64, P159, DOI 10.3382/ps.0640159; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Paquet-Fifield S, 2017, GROWTH FACTORS, V35, P61, DOI 10.1080/08977194.2017.1349765; Peng JM, 2018, HEPATOLOGY, V67, P2226, DOI 10.1002/hep.29678; Pignatelli J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37874; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Saba NF, 2017, CLIN LUNG CANCER, V18, pE203, DOI 10.1016/j.cllc.2016.12.005; Sage PT, 2009, FRONT BIOSCI-LANDMRK, V14, P5066, DOI 10.2741/3587; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Uchide K, 2007, ANN SURG ONCOL, V14, P862, DOI 10.1245/s10434-006-9225-3; Vestweber D, 2002, CURR OPIN CELL BIOL, V14, P587, DOI 10.1016/S0955-0674(02)00372-1; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Werner G, 1975, METHODENSAMMLUNG ELE, V7, P4; Wilmes LJ, 2007, MAGN RESON IMAGING, V25, P319, DOI 10.1016/j.mri.2006.09.041; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239932	10.1371/journal.pone.0239932	http://dx.doi.org/10.1371/journal.pone.0239932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085676	Green Accepted, Green Published, gold			2022-12-26	WOS:000585943400023
J	Stowers, KC; Marfo, NYA; Gurganus, EA; Gans, KM; Kumanyika, SK; Schwartz, MB				Cooksey Stowers, Kristen; Marfo, Nana Yaa A.; Gurganus, Eminet Abebe; Gans, Kim M.; Kumanyika, Shiriki K.; Schwartz, Marlene B.			The hunger-obesity paradox: Exploring food banking system characteristics and obesity inequities among food-insecure pantry clients	PLOS ONE			English	Article							NUTRITION ASSISTANCE PROGRAM; DIABETES SELF-MANAGEMENT; COPING STRATEGIES; DIETARY QUALITY; EMERGENCY FOOD; HEALTH; OVERWEIGHT; SECURITY; INTERVENTION; PREFERENCES	Purpose Heightened obesity risk among food-insecure food pantry clients is a health equity issue because the co-occurrence of obesity and hunger is deeply-rooted in systematic social disadvantage and historical oppression. This qualitative study examined key stakeholders' perspectives of the relationship between the U.S. food banking system and obesity disparities among food insecure clients. Methods We conducted in-depth, semi-structured interviews with 10 key stakeholders (e.g., food bank director, food bank board member, advocate) who are familiar with food bank operations. Data were transcribed verbatim, coded in NVivo [v11], and analyzed using thematic analysis. Results Multiple themes emerged drawing linkages betweenstructural characteristicsof the food banking system and disparities in the dual burden of food insecurity and obesity: [a] access to unhealthy food from donors; [b] federal emergency food policy and programming; [c] state-level emergency food policy and programming; [d] geography-based risk profiles; and [e] inadequate food supply versus client need. Interviewees also identifiedsocialchallenges between system leaders and clients that maintain disparities in obesity risk among individuals with very low food security including: [a] media representation and stereotypes about food pantry clients; [b] mistrust in communities of color; [c] lack of inclusion/representation among food bank system leaders; and [d] access to information. Conclusion Future efforts to alleviate obesity inequities among clients chronically burdened by food insecurity, especially among certain subpopulations of clients, should prioritize policy, systems, and environmental strategies to overcome thesestructuralandsocialchallenges within the food banking system.	[Cooksey Stowers, Kristen] Dept Allied Hlth Sci, Storrs, CT USA; [Cooksey Stowers, Kristen; Gans, Kim M.; Schwartz, Marlene B.] Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA; [Marfo, Nana Yaa A.] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA; [Gurganus, Eminet Abebe; Gans, Kim M.; Schwartz, Marlene B.] Univ Connecticut, Dept Human Dev & Family Sci, Storrs, CT USA; [Kumanyika, Shiriki K.] Drexel Univ, Dept Community Hlth & Prevent, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA	University of Connecticut; University of Connecticut; University of Connecticut; Drexel University	Stowers, KC (corresponding author), Dept Allied Hlth Sci, Storrs, CT USA.; Stowers, KC (corresponding author), Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA.	Kristen.cooksey@uconn.edu		Schwartz, Marlene/0000-0002-8939-1954; Cooksey Stowers, Kristen/0000-0001-7988-8011	 [170398]		KCS and MBS are Co-PIs on the grant Food Trust/Robert Wood Johnson Grant #170398 The Food Trust Center for Healthy Food Access The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2003, J NUTR, V133, P1070, DOI 10.1093/jn/133.4.1070; Alwood AT, 2014, FOOD INSECURITY HLTH; ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555; Babic M, 2015, PAYCHECK PANTRY HUNG; Bazerghi C, 2016, J COMMUN HEALTH, V41, P732, DOI 10.1007/s10900-015-0147-5; Bomberg EM, 2019, J HUNGER ENVIRON NUT, V14, P4, DOI 10.1080/19320248.2018.1512926; Braveman P, 2017, HLTH AFFAIRS BLOG, DOI DOI 10.1377/HBLOG20170622.060710/FULL/; Braveman P, 2009, PREV CHRONIC DIS, V6; Brewer Dawn P., 2010, Journal of Nutrition for the Elderly, V29, P150, DOI 10.1080/01639361003772343; Budig K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5335-7; Campbell E, 2009, FOOD BANK CENTRAL NE; Campbell E, 2015, NUTR FOCUSED FOOD BA; Campbell E, 2011, J HUNGER ENVIRON NUT, V6, P179, DOI 10.1080/19320248.2011.576589; Campbell EC, 2013, J HUNGER ENVIRON NUT, V8, P261, DOI 10.1080/19320248.2013.816991; Centers TNA of CH, 2017, COMM HLTH CTR FOOD O; Chhabra S, 2014, ECOL FOOD NUTR, V53, P678, DOI 10.1080/03670244.2014.933737; Chilton Mariana, 2009, Health Hum Rights, V11, P73; Coleman-Jensen A, 2016, US HOUSEHOLD FOOD SE, P57; Committee on Accelerating Progress in Obesity Prevention, 2012, ACCELERATING PROGR O; Cooksey-Stowers K, 2019, J HUNGER ENVIRON NUT, V14, P18, DOI 10.1080/19320248.2018.1512929; Cooksey-Stowers K, 2019, J HUNGER ENVIRON NUT, V14, P35, DOI 10.1080/19320248.2018.1512930; Crawford PB, 2011, AM J PREV MED, V40, P274, DOI 10.1016/j.amepre.2010.11.003; Dave JM, 2017, HEALTH PROMOT PRACT, V18, P221, DOI 10.1177/1524839916681732; De Marchis EH, 2019, ANN FAM MED, V17, P436, DOI 10.1370/afm.2412; DIETZ WH, 1995, PEDIATRICS, V95, P766; Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006; Douglas F, 2020, HEALTH SOC CARE COMM, V28, P404, DOI 10.1111/hsc.12872; Feldman M, 2018, TIPPING POINT LEVERA; Flynn MM, 2013, J HUNGER ENVIRON NUT, V8, P73, DOI 10.1080/19320248.2012.758066; Franklin B, 2012, J COMMUN HEALTH, V37, P253, DOI 10.1007/s10900-011-9420-4; Giancatarino Anthony, 2014, BUILDING CASE RACIAL; Gooding HC, 2012, OBESITY, V20, P1896, DOI 10.1038/oby.2011.233; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Handforth B, 2013, J ACAD NUTR DIET, V113, P411, DOI 10.1016/j.jand.2012.11.001; Hernandez DC, 2017, J ACAD NUTR DIET, V117, P1087, DOI 10.1016/j.jand.2017.01.014; Institute of Medicine Food, 2011, HUNG OB UND FOOD INS; Ippolito MM, 2017, PUBLIC HEALTH NUTR, V20, P183, DOI [10.1017/s1368980016001786, 10.1017/S1368980016001786]; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Jacobs A, 2015, FASEB J; Jilcott SB, 2011, J AM DIET ASSOC, V111, P1741, DOI 10.1016/j.jada.2011.08.004; Kaiser ML, 2018, SOC WORK PUBLIC HLTH, V33, P125, DOI 10.1080/19371918.2017.1415181; Kaur J, 2015, J ACAD NUTR DIET, V115, P751, DOI 10.1016/j.jand.2015.01.003; Kempson K, 2003, J NUTR EDUC BEHAV, V35, P179, DOI 10.1016/S1499-4046(06)60332-1; King AC, 2019, PREV MED, V119, P44, DOI 10.1016/j.ypmed.2018.12.016; Knoblock-Hahn A, 2017, J ACAD NUTR DIET, V117, P128, DOI 10.1016/j.jand.2016.04.011; Knowles M, 2015, HUM ORGAN, V74, P255, DOI 10.17730/0018-7259-74.3.255; Kumanyika S, 2017, CANC DISCOVERY, V7; Kumanyika S, 2018, PEDIAT OBESITY ETIOL, P695, DOI DOI 10.1007/978-3-319-68192-4_40; Kumanyika SK, 2019, AM J PUBLIC HEALTH, V109, P1350, DOI 10.2105/AJPH.2019.305221; Laraia B, 2015, OBESITY, V23, P1303, DOI 10.1002/oby.21075; Larson NI, 2011, AM J PREV MED, V40, P166, DOI 10.1016/j.amepre.2010.10.028; Martin K, 2012, PROG COMM HLTH PARTN, V6, P429, DOI 10.1353/cpr.2012.0056; Martin KS, 2007, J NUTR EDUC BEHAV, V39, P31, DOI 10.1016/j.jneb.2006.08.021; Martin KS, 2019, J HUNGER ENVIRON NUT, V14, P70, DOI 10.1080/19320248.2018.1512925; Martin KS, 2019, J ACAD NUTR DIET, V119, P553, DOI 10.1016/j.jand.2018.03.003; Martin MA, 2012, SOC SCI MED, V74, P1754, DOI 10.1016/j.socscimed.2011.11.013; Morales Mary E, 2016, Curr Nutr Rep, V5, P54, DOI 10.1007/s13668-016-0153-y; Natl Acad Sci Engn Med, 2017, COMMUNITIES IN ACTION: PATHWAYS TO HEALTH EQUITY, P1, DOI 10.17226/24624; Nettle D, 2017, BEHAV BRAIN SCI, V40, DOI [10.1017/S0140525X16002041, 10.1017/S0140525X16000947]; Nguyen BT, 2015, AM J PUBLIC HEALTH, V105, P1453, DOI 10.2105/AJPH.2015.302580; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pan LP, 2012, J ACAD NUTR DIET, V112, P1403, DOI 10.1016/j.jand.2012.06.011; Paynter S, 2011, PUBLIC ADMIN QUART, V35, P26; Remley DT, 2013, J HUNGER ENVIRON NUT, V8, P324, DOI 10.1080/19320248.2013.819475; Robaina KA, 2013, J NUTR EDUC BEHAV, V45, P159, DOI 10.1016/j.jneb.2012.07.001; Ross M, 2013, J HUNGER ENVIRON NUT, V8, P294, DOI 10.1080/19320248.2013.816992; Rowland B, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy057; Schwartz MB, 2020, HLTH EATING RES NUTR; Seligman HK, 2018, AM J PUBLIC HEALTH, V108, P1227, DOI 10.2105/AJPH.2018.304528; Seligman HK, 2015, HEALTH AFFAIR, V34, P1956, DOI 10.1377/hlthaff.2015.0641; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shimada T, 2013, J HUNGER ENVIRON NUT, V8, P281, DOI 10.1080/19320248.2013.821963; Simmet A, 2017, J ACAD NUTR DIET, V117, P563, DOI 10.1016/j.jand.2016.08.014; Smith TM, 2016, APPETITE, V97, P37, DOI 10.1016/j.appet.2015.11.009; Todd J, 2016, HOUSEHOLDS GET FOOD; United States Department of Agriculture, 2019, INT CHARTS HIGHL; United States Department of Agriculture F and NS, 2011, CIV RIGHTS TRAIN REQ; Verpy H, 2003, J NUTR EDUC BEHAV, V35, P6, DOI 10.1016/S1499-4046(06)60321-7; Wang ML, 2019, AM J PUBLIC HEALTH, V109, P1321, DOI 10.2105/AJPH.2019.305303; Warren M, 2019, STATE OBESITY BETTER; Webb K, 2017, DEV FOOD BANK NUTR P; Webb KL, 2013, J HUNGER ENVIRON NUT, V8, P257, DOI 10.1080/19320248.2013.817169; Weinfield N.S., 2014, HUNGER AM 2014 NATL; Wolfson JA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061648	84	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239778	10.1371/journal.pone.0239778	http://dx.doi.org/10.1371/journal.pone.0239778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085685	Green Published, gold			2022-12-26	WOS:000585943400024
J	Meireles, BM; Sampaio, VD; Monteiro, WM; Goncalves, MJF				Meireles, Bruna Martins; de Souza Sampaio, Vanderson; Monteiro, Wuelton Marcelo; Goncalves, Maria Jacirema Ferreira			Factors associated with malaria in indigenous populations: A retrospective study from 2007 to 2016	PLOS ONE			English	Article							WESTERN AMAZON REGION; BRAZILIAN AMAZON; EPIDEMIOLOGY; STATE	Background In Brazil malaria is most frequent in the Amazon region, mainly in the Amazonas state, where it is found the most proportion of indigenous people of the whole country. It is remarkable publications about malaria in the Amazon, although information on malaria in indigenous populations is still poorly explored. Objective Identify factors associated with malaria in indigenous populations. Methods Cross-sectional study of positive cases of malaria in the state of Amazonas, Brazil, from 2007 to 2016. Secondary data were obtained from the Epidemiological Surveillance Information System for Malaria and from the Mortality Information System, both from Brazil. To tackle with race missing data, cases with no race fulfilled were classified according to the probable location where infection occurred. This way, was imputed indigenous race for those which the probable infection location was indigenous village (aldeia). Variables tested with race were: sex, age, schooling, microscope surveillance slide type, parasitic infection species, parasitemia level, and timeliness of treatment. Multivariate logistic regression was used. Results A total of 1,055,852 cases of malaria were notified in the state of Amazonas. Among the factors that associate malaria and indigenous peoples, the most significant were sex, children and high levels of parasitemia. The magnitude ofPlasmodium vivaxinfection is higher thanPlasmodium falciparum, although this parasite was more frequent in indigenous than other races. In regards to mortality, 109 deaths were registered, most of them related toP.vivax. Conclusion The findings underscore the importance of look at indigenous people differently of other races. The associated factors highlight a profile of cases severity, because of highest parasitemia, many cases ofP.falciparumalthough high frequency ofP.vivax, and children. Furthermore, the mortality in indigenous, specially in older people is worrying	[Meireles, Bruna Martins; Goncalves, Maria Jacirema Ferreira] Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil; [de Souza Sampaio, Vanderson; Monteiro, Wuelton Marcelo] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [de Souza Sampaio, Vanderson; Monteiro, Wuelton Marcelo] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [de Souza Sampaio, Vanderson] Fundacao Vigilancia Saude Estado Amazonas, Manaus, Amazonas, Brazil; [Goncalves, Maria Jacirema Ferreira] Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Goncalves, Maria Jacirema Ferreira] Univ Fed Amazonas, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Universidade do Estado do Amazonas; Fundacao Oswaldo Cruz; Universidade Federal de Amazonas	Goncalves, MJF (corresponding author), Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil.; Goncalves, MJF (corresponding author), Fiocruz MS, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Goncalves, MJF (corresponding author), Univ Fed Amazonas, Manaus, Amazonas, Brazil.	jaciremagoncalves@gmail.com	Sampaio, Vanderson/M-4337-2015	Sampaio, Vanderson/0000-0001-7307-8851; Goncalves, Maria Jacirema/0000-0002-8460-8501	Amazonas State Research Support Foundation - Fundacao de Amparo a Pesquisa do Estado do Amazonas (PAPAC/FAPEAM)	Amazonas State Research Support Foundation - Fundacao de Amparo a Pesquisa do Estado do Amazonas (PAPAC/FAPEAM)	Program to support the scientific publication article by the Amazonas State Research Support Foundation - Fundacao de Amparo a Pesquisa do Estado do Amazonas (PAPAC/FAPEAM).	Almeida ACG, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2787-7; Baird JK, 2016, AM J TROP MED HYG, V95, P35, DOI 10.4269/ajtmh.16-0171; Braz RM, 2013, CAD SAUDE PUBLICA, V29, P935, DOI 10.1590/S0102-311X2013000500011; Camargo LMA, 1999, ACTA TROP, V72, P1, DOI 10.1016/S0001-706X(98)00082-5; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Carlos BC, 2019, PATHOG GLOB HEALTH, V113, P1, DOI 10.1080/20477724.2019.1581463; Costa KMD, 2010, REV PANAM SALUD PUBL, V28, P353, DOI 10.1590/S1020-49892010001100005; Duarte EC, 2014, REV SOC BRAS MED TRO, V47, P763, DOI 10.1590/0037-8682-0274-2014; Howes RE, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.16-0141; IBGE. Brazilian Institute of Geography and Statistics, 2012, IND BRAZ SOC DOM CHA; IBGE. Brazilian Institute of Geography and Statistics, 2010, DEM CENS 2010 BRAZ C; Lima Isac da S F, 2017, Rev Panam Salud Publica, V41, pe100; LOPEZANTUNANO FJ, 1992, MEM I OSWALDO CRUZ, V87, P105, DOI 10.1590/S0074-02761992000700016; Marcano TJ, 2004, MEM I OSWALDO CRUZ, V99, P369, DOI 10.1590/S0074-02762004000400005; Lapouble OMM, 2015, REV PANAM SALUD PUBL, V38, P300; Mesquita E, 2013, J MED INTERNET RES, V15; Ministerio da SaCide, 2015, B EPIDEMIOLOGICO; Maciel GBML, 2013, EPIDEMIOL SERV SAUDE, V22, P465, DOI 10.5123/S1679-49742013000300011; Terrazas WCM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0859-0; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olliaro PL, 2016, AM J TROP MED HYG, V95, P4, DOI 10.4269/ajtmh.16-0160; Parise EV, 2011, REV INST MED TROP SP, V53, P141, DOI 10.1590/S0036-46652011000300005; Peiter PC, 2013, CAD SAUDE PUBLICA, V29, P2497, DOI 10.1590/0102-311X00042213; Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6; Robinson LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001891; Rodrigues ED, 2011, REV LAT-AM ENFERM, V19, P1297, DOI 10.1590/S0104-11692011000600004; Santos IGD, 2011, REV PAN AMAZ SAUDE, V2, P31; Silva RSU, 2012, REV PAN-AMAZ SAUDE, V3, P45, DOI DOI 10.5123/S2176-62232012000100007; Simoes LR, 2014, CAD SAUDE PUBLICA, V30, P1403, DOI 10.1590/0102-311X00169312; Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204; Sousa JR, 2015, REV PAN AMAZ SAUDE, V6, P39; The Global Fund, 2019, TECHN BRIEF MAL GEND; Vianna João Jackson Bezerra, 2012, Psicol. Soc., V24, P94, DOI 10.1590/S0102-71822012000100011; Vitor-Silva S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1326-2; WHO. World Health Organization, 2019, MAL REP 2019	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240741	10.1371/journal.pone.0240741	http://dx.doi.org/10.1371/journal.pone.0240741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085704	gold, Green Published			2022-12-26	WOS:000585943400050
J	Djimeu, EW; Heard, A				Djimeu, Eric W.; Heard, Anna			Replication of influential studies on biomedical, social, behavioural and structural interventions for HIV prevention and treatment	PLOS ONE			English	Article								Replication is an important tool to promote high quality research and ensure policy makers can rely on studies in making guidelines or funding programs. By ensuring influential studies are replicable we provide assurance that the policies based on these studies are well-founded and the conclusions and recommendations are robust-to different estimation models or different choices. In this paper, we argue that replication is not only useful but necessary to ensure that an author's choice in how to analyse data is not the only factor that determines whether an intervention is effective or not. We also show that while most research is done well and provides robust results, small differences can lead to different interpretations and these differences need to be acknowledged. This special issue highlights 5 such replication studies, which are replications of influential studies on biomedical, social, behavioural and structural interventions for HIV prevention and treatment. We reflect on their findings. Four out of five studies, which conduct push button replication and pure replication, were able to reproduce the results of the original studies with minor differences, mainly due to minor typographical errors or rounding differences. The analysis of the measurement and estimation analyses conducted in these five studies reveals that the original results are not very robust to alternative analytical approaches, especially when these results rely on a small number of observations. In these cases, the original results are weakened. Furthermore, in contrast to the original papers, two of the five included replication studies conducted a theory of change analysis-to explore how or why the interventions work (or do not) not just whether the intervention works or not. These two analyses indicate that the estimated impacts of the interventions are drawn from few mediators. In addition, they demonstrate that, in some cases, a lack of effect may be related to lack of adequate exposure to the intervention rather than inefficacy of the interventionper se. However, overall, the included replication studies show that the results presented in the original papers are trustworthy and robust, especially when based on larger sample sizes. Replication studies can not only verify the results of a study, they can also provide additional insights on the published results, such as how and why an intervention was effective or less effective than expected. They can thus be a tool to inform the research community and/ or policymakers about whether and how interventions could be adopted, which need to be tested further, and which should be discontinued because of their ineffectiveness. Thus, publishing these replication studies in peer-reviewed journals makes the work public and publicized. The work advances knowledge, and publication should be encouraged, as it is for other types of research.	[Djimeu, Eric W.] Global Alliance Improved Nutr, Washington, DC 20036 USA; [Djimeu, Eric W.] Univ Yaounde II, CEREG, Yaounde, Cameroon; [Heard, Anna] Innovat Poverty Act, Washington, DC USA	Innovations for Poverty Action (IPA)	Djimeu, EW (corresponding author), Global Alliance Improved Nutr, Washington, DC 20036 USA.; Djimeu, EW (corresponding author), Univ Yaounde II, CEREG, Yaounde, Cameroon.	edjimeu@gainhealth.org			Bill & Melinda Gates Foundation [OPP1034373]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This research was funded by the Bill & Melinda Gates Foundation: OPP1034373; https://www.gatesfoundation.org/.AH and ED were employees of 3ie during the conduct of the replication studies. 3ie was the recipient of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	3ie, 2017, 3IE REPL CONTR NOT C; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Bekker LG, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007435; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Blum B., 2018, GEN; Brown AN, 2019, J DEV STUD, V55, P917, DOI 10.1080/00220388.2018.1506582; Brown AN, 2014, J DEV EFFECT, V6, P215, DOI 10.1080/19439342.2014.944555; Camerer CF., 2018, NAT HUM BEHAV, V2, P637, DOI [DOI 10.1038/s41562-018-0399-z, 10.1038/s41562-018-0399-z]; Chang A. C., 2015, FINANCE EC DISCUSSIO, DOI 10.17016/FEDS.2015.083; Chen BJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206677; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Djimeu EW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210327; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hein NA, 2012, PLOS ONE; Ortmann A., 2015, CONVERSATION; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Smith LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210405; Webb EL, 2012, LANCET, V380, P802, DOI 10.1016/S0140-6736(12)61442-1; WHO, 2013, TB HIV FACTS 2012 20; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Yu F, 2020, PLOS ONE	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240159	10.1371/journal.pone.0240159	http://dx.doi.org/10.1371/journal.pone.0240159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079927	Green Published, gold			2022-12-26	WOS:000585940600011
J	Song, LN; Liu, JY; Shi, TT; Zhang, YC; Xin, Z; Cao, X; Yang, JK				Song, Li-Ni; Liu, Jing-Yi; Shi, Ting-Ting; Zhang, Yi-Chen; Xin, Zhong; Cao, Xi; Yang, Jin-Kui			Angiotensin-(1-7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism	FASEB JOURNAL			English	Article						ACE2 | Ang-(1-7); glucose metabolism; hepatic steatosis; Mas; mitochondrial function	FATTY LIVER-DISEASE; OXIDATIVE STRESS; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; SIGNALING PATHWAYS; PHOSPHORYLATION; PATHOGENESIS; ASSOCIATION; DEFICIENCY; STEATOSIS	Nonalcoholic fatty liver disease (NAFLD) is the most general liver disease characterized by a continuum of liver abnormalities ranging from simple fatty liver to advanced stage of nonalcoholic steatohepatitis, cirrhosis, and even hepatocellular carcinoma. The pathological drivers of NAFLD are complex and largely undefined. It is increasingly identified that the imbalance between renin-angiotensin system and ACE2/Ang-(1-7)/Mas axis, as well as mitochondrial dysfunction associated with NAFLD. However, no known empirical research has focused on exploring the effect of the regulation of mitochondrial respiration chain activity by Ang-(1-7)/Mas on the prevention of NAFLD. Here, we evaluated the interaction and relevance of hepatic Ang-(1-7)/Mas-axis challenge with glucolipid metabolism and mitochondrial condition in vivo and in vitro. In this context, we found thatMasdeletion in mice contributed to the severe glucose intolerance, insulin resistance, and hepatic steatosis which accompanied by elevated levels of serum/ hepatic alanine aminotransferase, aspartate aminotransferase, and triglycerides, as well as the mitochondrial dysfunction. Whereas forced upregulation of Mas or Ang-(1-7) administration could significantly attenuate these consequences by downregulating the expression of hepatic lipogenic proteins and enzymes for gluconeogenesis. Furthermore, activation of Ang-(1-7)/Mas arm could improve the IRS-1/Akt/AMPK pathway and enhance the mitochondrial energy utilization. Considered together, it is becoming extremely hopeful to provide a new perspective for Ang-(1-7)/Mas axis for the therapeutics of NAFLD.	[Song, Li-Ni; Liu, Jing-Yi; Shi, Ting-Ting; Zhang, Yi-Chen; Xin, Zhong; Cao, Xi; Yang, Jin-Kui] Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care,Dept Endocrinol, Beijing 100730, Peoples R China	Capital Medical University	Cao, X; Yang, JK (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Diabet Inst, Beijing Key Lab Diabet Res & Care,Dept Endocrinol, Beijing 100730, Peoples R China.	tide005@126.com; jinkui.yang@gmail.com			National Natural Science Foundation of China [81670774, 81561128015]; Beijing Municipal Administration of Hospitals' Youth Program [QML20170205]; National Key R&D Program of China [2017YFC0909600]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201823]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals' Youth Program; National Key R&D Program of China; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support	This work was supported by grants from the National Natural Science Foundation of China (81670774, 81561128015), Beijing Municipal Administration of Hospitals' Youth Program (QML20170205), National Key R&D Program of China (2017YFC0909600), and Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201823)	Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bindom SM, 2009, MOL CELL ENDOCRINOL, V302, P193, DOI 10.1016/j.mce.2008.09.020; Braga JF, 2017, ENDOCR CONNECT, V6, P27, DOI 10.1530/EC-16-0098; Cao X, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3123; Cao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21592; Cao X, 2014, MOL CELL ENDOCRINOL, V393, P30, DOI 10.1016/j.mce.2014.05.024; Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025; Chen Z, 2019, TRENDS ENDOCRIN MET, V30, P903, DOI 10.1016/j.tem.2019.08.006; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Durik M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/536426; Duseja A, 2015, J CLIN EXP HEPATOL, V5, P51, DOI 10.1016/j.jceh.2015.02.006; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gao J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101366; Giani JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE262, DOI 10.1152/ajpendo.90678.2008; Han QA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27932-x; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Kido K, 2017, AM J PHYSIOL-REG I, V313, pR110, DOI 10.1152/ajpregu.00063.2017; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Li Y, 2019, J CELL BIOCHEM, V120, P8008, DOI 10.1002/jcb.28078; Li Y, 2019, GASTROENT RES PRACT, V2019, DOI 10.1155/2019/5647161; Liu C, 2012, ACTA DIABETOL, V49, P291, DOI 10.1007/s00592-011-0348-z; Liu DH, 2017, J MOL CELL CARDIOL, V105, P77, DOI 10.1016/j.yjmcc.2017.01.017; Lohr K, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12988; Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10; Lu Y, 2016, CHEMOSPHERE, V158, P143, DOI 10.1016/j.chemosphere.2016.05.071; Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613; Matsuda S, 2013, PPAR RES, V2013, DOI 10.1155/2013/256508; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Musso G, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001680; Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Serviddio G, 2013, FREE RADICAL BIO MED, V65, P952, DOI 10.1016/j.freeradbiomed.2013.08.174; Shi TT, 2018, BIOCHEM BIOPH RES CO, V495, P860, DOI 10.1016/j.bbrc.2017.11.055; Silva AR, 2013, AM J PHYSIOL-REG I, V305, pR1323, DOI 10.1152/ajpregu.00249.2013; Tan MJ, 2020, CELL DEATH DIFFER, V27, P2143, DOI 10.1038/s41418-020-0491-6; Tang AL, 2017, HEPATOL RES, V47, P116, DOI 10.1111/hepr.12707; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Tassone EJ, 2013, CARDIOVASC RES, V99, P129, DOI 10.1093/cvr/cvt065; Valbusa F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173398; Wei Y, 2008, J HEPATOL, V49, P417, DOI 10.1016/j.jhep.2008.03.018; Xu YZ, 2013, INTERNAL MED, V52, P855, DOI 10.2169/internalmedicine.52.8839; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	52	8	9	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16291	16306		10.1096/fj.202001639R	http://dx.doi.org/10.1096/fj.202001639R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078906	Bronze			2022-12-26	WOS:000581625200001
J	Ohlsson, C; Gustafsson, KL; Farman, HH; Henning, P; Lionikaite, V; Moverare-Skrtic, S; Sjogren, K; Tornqvist, AE; Andersson, A; Islander, U; Bernardi, AI; Poutanen, M; Chambon, P; Lagerquist, MK				Ohlsson, Claes; Gustafsson, Karin L.; Farman, Helen H.; Henning, Petra; Lionikaite, Vikte; Moverare-Skrtic, Sofia; Sjogren, Klara; Tornqvist, Anna E.; Andersson, Annica; Islander, Ulrika; Bernardi, Angelina I.; Poutanen, Matti; Chambon, Pierre; Lagerquist, Marie K.			Phosphorylation site S122 in estrogen receptor alpha has a tissue-dependent role in female mice	FASEB JOURNAL			English	Article						adipose tissue; bone; estrogen; posttranslational modifications	ADIPOSE-TISSUE; ER-ALPHA; INDEPENDENT ACTIVATION; PROMOTER INTERACTION; KINASE PATHWAY; SERINE 118; BONE; ESTRADIOL; SEX; EXPRESSION	Estrogen treatment increases bone mass and reduces fat mass but is associated with adverse effects in postmenopausal women. Knowledge regarding tissue-specific estrogen signaling is important to aid the development of new tissue-specific treatments. We hypothesized that the posttranslational modification phosphorylation in estrogen receptor alpha (ER alpha) may modulate ER alpha activity in a tissue-dependent manner. Phosphorylation of site S122 in ER alpha has been shown in vitro to affect ER alpha activity, but the tissue-specific role in vivo is unknown. We herein developed and phenotyped a novel mouse model with a point mutation at the phosphorylation site 122 in ER alpha (S122A). Female S122A mice had increased fat mass and serum insulin levels but unchanged serum sex steroid levels, uterus weight, bone mass, thymus weight, and lymphocyte maturation compared to WT mice. In conclusion, phosphorylation site S122 in ER alpha has a tissue-dependent role with an impact specifically on fat mass in female mice. This study is the first to demonstrate in vivo that a phosphorylation site in a transactivation domain in a nuclear steroid receptor modulates the receptor activity in a tissue-dependent manner.	[Ohlsson, Claes; Gustafsson, Karin L.; Farman, Helen H.; Henning, Petra; Lionikaite, Vikte; Moverare-Skrtic, Sofia; Sjogren, Klara; Tornqvist, Anna E.; Poutanen, Matti; Lagerquist, Marie K.] Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden; [Andersson, Annica; Islander, Ulrika; Bernardi, Angelina I.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Chambon, Pierre] Coll France, ULP, Natl Sante & Rech Med, CNRS,Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	University of Gothenburg; University of Gothenburg; University of Turku; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gustafsson, KL (corresponding author), Univ Gothenburg, Ctr Bone & Arthrit Res, Dept Internal Med & Clin Nutr, Inst Med,Sahlgrenska Acad,Klinfarmlab, Vita Straket 11, S-41345 Gothenburg, Sweden.	Karin.gustafsson.4@gu.se	Islander, Ulrika/S-4824-2019; Ohlsson, Claes/AGP-3544-2022; Lagerquist, Marie/A-9531-2010	Islander, Ulrika/0000-0002-8493-1739; Ohlsson, Claes/0000-0002-9633-2805; Lagerquist, Marie/0000-0002-9089-8605; Henning, Petra/0000-0002-9330-6265; Tornqvist, Anna/0000-0003-2621-9038; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; Swedish government [ALFGBG-721581]; Swedish county councils, the ALF-agreement [ALFGBG-721581]; Gustaf V 80-years fund; Swedish Rheumatism Association; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundations; Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF18OC0033898, NNF13OC0005785, NNF14OC0010513, NNF19OC0055250] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish government; Swedish county councils, the ALF-agreement; Gustaf V 80-years fund; Swedish Rheumatism Association; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundations; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The Swedish Research Council, the Swedish Foundation for Strategic Research, the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-721581), the Gustaf V 80-years fund, the Swedish Rheumatism Association, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundations, the Knut and Alice Wallenberg Foundation and the Novo Nordisk Foundation	Al-Dhaheri MH, 2007, MOL ENDOCRINOL, V21, P439, DOI 10.1210/me.2006-0059; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Barrett-Connor E, 2005, ANNU REV PUBL HEALTH, V26, P115, DOI 10.1146/annurev.publhealth.26.021304.144637; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Eaton SA, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010008; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; ETTINGER B, 1988, OBSTET GYNECOL, V72, pS1; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huderson BP, 2012, ENDOCRINOLOGY, V153, P4144, DOI 10.1210/en.2011-2001; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Iwaniec UT, 2016, J ENDOCRINOL, V230, pR115, DOI 10.1530/JOE-16-0089; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856; Kim TH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005537; KINCADE PW, 1994, IMMUNOL REV, V137, P119, DOI 10.1111/j.1600-065X.1994.tb00661.x; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LAUBER AH, 1991, ENDOCRINOLOGY, V129, P3180, DOI 10.1210/endo-129-6-3180; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lovre D, 2017, THER ADV CARDIO DIS, V11, P33, DOI 10.1177/1753944716649358; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ludwik KA, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107931; Maggi A, 2011, BBA-MOL BASIS DIS, V1812, P1054, DOI 10.1016/j.bbadis.2011.05.001; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Marjoribanks J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004143.pub5; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Miyagawa S, 2004, ONCOGENE, V23, P340, DOI 10.1038/sj.onc.1207207; Moverare-Skrtic S, 2014, NAT MED, V20, P1279, DOI 10.1038/nm.3654; Murphy LC, 2004, CLIN CANCER RES, V10, P5902, DOI 10.1158/1078-0432.CCR-04-0191; Murphy LC, 2011, ENDOCR-RELAT CANCER, V18, pR1, DOI 10.1677/ERC-10-0070; Murphy LC, 2009, J STEROID BIOCHEM, V114, P90, DOI 10.1016/j.jsbmb.2009.01.017; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Ohlsson C, 2000, BIOCHEM BIOPH RES CO, V278, P640, DOI 10.1006/bbrc.2000.3827; Panotopoulos G., 1997, Human Reproduction (Oxford), V12, P126; Patrone C, 1998, MOL ENDOCRINOL, V12, P835, DOI 10.1210/me.12.6.835; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Vazquez-Martinez ER, 2016, ENDOCRINE, V52, P618, DOI 10.1007/s12020-015-0825-1; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V36, P269; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shah YM, 2005, MOL ENDOCRINOL, V19, P732, DOI 10.1210/me.2004-0298; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tao ZP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0372-9; Turner RT, 1999, LUPUS, V8, P388, DOI 10.1177/096120339900800512; Ueda K, 2013, STEROIDS, V78, P589, DOI 10.1016/j.steroids.2012.12.006; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Vanderschueren D, 2014, ENDOCR REV, V35, P906, DOI 10.1210/er.2014-1024; Walker VR, 2004, ILAR J, V45, P455, DOI 10.1093/ilar.45.4.455; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Williams CC, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-36; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Xu SH, 2016, ACTA HISTOCHEM, V118, P317, DOI 10.1016/j.acthis.2016.01.008; Xu Y, 2018, MOL METAB, V15, P104, DOI 10.1016/j.molmet.2018.05.012; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	75	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15991	16002		10.1096/fj.201901376RR	http://dx.doi.org/10.1096/fj.201901376RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33067917	hybrid			2022-12-26	WOS:000581162300001
J	Bertacchini, F; Bilotta, E; Pantano, PS				Bertacchini, Francesca; Bilotta, Eleonora; Pantano, Pietro S.			On the temporal spreading of the SARS-CoV-2	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; MATHEMATICAL-THEORY; CHUA ATTRACTORS; ROYAL SOCIETY; ENDEMICITY; EPIDEMICS; GALLERY	The behaviour of SARS-CoV-2 virus is certainly one of the most challenging in contemporary world. Although the mathematical modelling of the virus has made relevant contributions, the unpredictable behaviour of the virus is still not fully understood. To identify some aspects of the virus elusive behaviour, we focused on the temporal characteristics of its course. We have analysed the latency trends the virus has realized worldwide, the outbreak of the hot spots, and the decreasing trends of the pandemic. We found that the spatio-temporal pandemic dynamics shows a complex behaviour. As with physical systems, these changes in the pandemic's course, which we have called transitional stages of contagion, highlight shared characteristics in many countries. The main results of this work is that the pandemic progression rhythms have been clearly identified for each country, providing the processes and the stages at which the virus develops, thus giving important information on the activation of containment and control measures.	[Bertacchini, Francesca] Univ Calabria, Dept Mech Energy & Management Engn, Arcavacata Di Rende, Cosenza, Italy; [Bilotta, Eleonora; Pantano, Pietro S.] Univ Calabria, Dept Phys, Arcavacata Di Rende, Cosenza, Italy	University of Calabria; University of Calabria	Bilotta, E (corresponding author), Univ Calabria, Dept Phys, Arcavacata Di Rende, Cosenza, Italy.	eleonora.bilotta@unical.it		Bilotta, Eleonora/0000-0002-1902-813X	Physics Department of the University of Calabria [2016.RIC.BILO. ATE001 FRS, 2016.RIC.PANT.ATE001 FRS]	Physics Department of the University of Calabria	With regard to the ex 60% fund, indicated in the funding statement as "funds of the Physics Department of the University of Calabria", we indicate that the funds are: For BE: 2016.RIC.BILO. ATE001 FRS, UNIVERSITY OF CALABRIA Modelling and Applications, University Projects. For PSP: 2016.RIC.PANT.ATE001 FRS UNIVERSITY OF CALABRIA, Modelling, University Projects. There was no additional external funding received for this study.	ANDERSON R M, 1991; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Arenas A, 2020, PHYS REV X, DOI DOI 10.1103/PHYSREVX.10.041055; Aron J.L., 1982, P139; Bernoulli D., 1760, MERCURE FRANCE, P173; Bilotta E, 2008, WORLD SCI SERIES NON; Bilotta E, 2007, INT J BIFURCAT CHAOS, V17, P1, DOI 10.1142/S0218127407017161; Bilotta E, 2007, INT J BIFURCAT CHAOS, V17, P293, DOI 10.1142/S0218127407017343; Blasius B, 2020, POWER LAW DISTRIBUTI; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Domingo E, 2020, VIRUS AS POPULATIONS: COMPOSITION, COMPLEXITY, QUASISPECIES, DYNAMICS, AND BIOLOGICAL IMPLICATIONS, 2ND EDITION, P225, DOI 10.1016/B978-0-12-816331-3.00007-6; Fang H, 2020, W26906 NBER; GROSSMAN Z, 1980, THEOR POPUL BIOL, V18, P204, DOI 10.1016/0040-5809(80)90050-7; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Holland LA, 2020, 81 BASE PAIR DELETIO; Holmes E., 2009, EVOLUTION EMERGENCE; KERMACK WO, 1991, B MATH BIOL, V53, P89, DOI 10.1007/BF02464425; KERMACK WO, 1991, B MATH BIOL, V53, P57, DOI 10.1016/S0092-8240(05)80041-2; Ma JL, 2020, INFECT DIS MODEL, V5, P129, DOI 10.1016/j.idm.2019.12.009; Materassi M., 2020, CHAOS SOLITON FRACT, VX; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Rehman SU, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030240; Ribeiro SP, 2020, SEVERE AIRPORT SANIT, DOI 10.1101/2020.03.26.20044370v2; Ross R., 1910, PREVENTION MALARIA; Schmidt M, 2002, CR PHYS, V3, P327, DOI 10.1016/S1631-0705(02)01326-9; Smith DL, 2005, PREV VET MED, V71, P225, DOI 10.1016/j.prevetmed.2005.07.009; Stroud P, J ARTIFICIAL SOC SOC, V10, P9; Verma M. K., 2020, T INDIAN NATL ACAD E, V5, P103, DOI [DOI 10.1101/2021.04.17.21255665(2021, 10.1101/2021.04.17.21255665(2021]; Wolfram S., 2017, ELEMENTARY INTRO WOL; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035; Ziff A. L., 2020, FRACTAL KINETICS COV	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240777	10.1371/journal.pone.0240777	http://dx.doi.org/10.1371/journal.pone.0240777			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119625	gold, Green Published, Green Submitted			2022-12-26	WOS:000600013600045
J	Girma, S; Agenagnew, L; Beressa, G; Tesfaye, Y; Alenko, A				Girma, Shimelis; Agenagnew, Liyew; Beressa, Girma; Tesfaye, Yonas; Alenko, Arefayne			Risk perception and precautionary health behavior toward COVID-19 among health professionals working in selected public university hospitals in Ethiopia	PLOS ONE			English	Article								Objective This study was designed to determine risk perception and precautionary health behavior toward coronavirus disease (COVID-19) among health professionals working in selected public university hospitals of Ethiopia. Methods A web-based cross-sectional survey was used with health professionals working in selected public university hospitals of Ethiopia. A structured survey questionnaire consisted of socio-demographic, risk perception, and behavioral response items were used. The survey questions were designed on Google form. All academic and clinical staff invited to participate in the online survey, which was carried out from May 1-14, 2020. Data analysis was done using the Statistical Package for Social Sciences version 24. Descriptive statistics computed and the result is presented by tables and figures. Results A total of 273 health professionals participated in this study. The mean (+/- SD) age of participants was 31.03 +/- 5.11. Study participants' overall mean score of perceived risk was 23.59 +/- 4.75. The study participants' mean score of perceived vulnerability (4.01 +/- 1.17) was higher than the human immunodeficiency virus, common cold, malaria, and tuberculosis. Regarding precautionary health behavior, the lowest mean score is for wearing gloves 1.82 +/- 1.15. Conclusion Participants mean score of perceived vulnerability of coronavirus disease was higher than some of the prevalent infectious disease in the area. Almost all participants applied recommended protective measures to the acceptable level, except for wearing mask and gloves. Therefore, there is a need to further intensification of more effective ways to support health professionals' adherence to major precautionary measure is important.	[Girma, Shimelis; Agenagnew, Liyew; Tesfaye, Yonas; Alenko, Arefayne] Jimma Univ, Inst Hlth, Dept Psychiat, Jimma, Ethiopia; [Beressa, Girma] Madda Walabu Univ, Sch Hlth Sci, Dept Publ Hlth, Goba, Ethiopia	Jimma University	Girma, S (corresponding author), Jimma Univ, Inst Hlth, Dept Psychiat, Jimma, Ethiopia.	shimelisgirma@gmail.com	Beressa, Girma/AAX-8368-2021	Beressa, Girma/0000-0001-5677-3692; Girma, Shimelis/0000-0001-6946-4020				Aro A, 2005, EUR J PUBLIC HEALTH, V15, P70; Bashirian S, 2020, J HOSP INFECT, V105, P430, DOI 10.1016/j.jhin.2020.04.035; Bhagavathula Akshaya Srikanth, 2020, JMIR Public Health Surveill, V6, pe19160, DOI 10.2196/19160; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Committee(IASC) I-AS, 2020, IASC INT BRIEF NOT A; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Mullet E, 2005, J RISK RES, V8, P19, DOI 10.1080/13669870210158571; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Vartti AM, 2009, INT J BEHAV MED, V16, P41, DOI 10.1007/s12529-008-9004-6; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Zhan SY, 2020, EMERG MICROBES INFEC, V9, P534, DOI 10.1080/22221751.2020.1732232	14	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241101	10.1371/journal.pone.0241101	http://dx.doi.org/10.1371/journal.pone.0241101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119644	Green Published, gold			2022-12-26	WOS:000600013600053
J	Sabu, S; Curioni, A; Vesper, C; Sebanz, N; Knoblich, G				Sabu, Simily; Curioni, Arianna; Vesper, Cordula; Sebanz, Natalie; Knoblich, Gunther			How does a partner's motor variability affect joint action?	PLOS ONE			English	Article							INFORMATION; STRATEGIES	Motor learning studies demonstrate that an individual's natural motor variability predicts the rate at which she learns a motor task. Individuals exhibiting higher variability learn motor tasks faster, presumably because variability fosters exploration of a wider space of motor parameters. However, it is unclear how individuals regulate variability while learning a motor task together with a partner who perturbs their movements. In the current study, we investigated whether and how variability affects performance and learning in such joint actions. Participants learned to jointly perform a sequence of movements with a confederate who was either highly variable or less variable in her movements. A haptic coupling between the actors led to translation of partner's movement variability into a force perturbation. We tested how the variability and predictability of force perturbations coming from a partner foster or hamper individual and joint performance. In experiment 1, the confederate produced more or less variable range of force perturbations that occurred in an unpredictable order. In experiment 2, the confederate produced more or less variable force perturbations in a predictable order. In experiment 3, the confederate produced more or less variable force perturbations in which the magnitude of force delivered was predictable whereas the direction of the force was unpredictable. We analysed individual performance, measured as movement accuracy and joint performance, measured as interpersonal asynchrony. Results indicated that in all three experiments, participants successfully regulated the variability of their own movements. However, individual performance was worse when partner produced highly variable force perturbations in an unpredictable order. Interestingly, predictability of force perturbations offset the detrimental effects of variability on individual performance. Furthermore, participants in the high variability condition achieved higher flexibility and resilience for a wide range of force perturbations, when the partner produced predictable movements. Participants improved their joint performance with a highly variable partner only when the partner produced partially predictable movements. Our results indicate that individuals involved in a joint action selectively rely on either their own or their partner's variability (or both) for benefitting individual and joint action performance, depending on the predictability of the partner' movements.	[Sabu, Simily; Curioni, Arianna; Sebanz, Natalie; Knoblich, Gunther] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Vesper, Cordula] Aarhus Univ, Dept Linguist Cognit Sci & Semiot, Aarhus, Denmark; [Vesper, Cordula] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark	Central European University; Aarhus University; Aarhus University	Sabu, S (corresponding author), Cent European Univ, Dept Cognit Sci, Budapest, Hungary.	sabu_simily@phd.ceu.edu	Sabu, Simily/ABD-9053-2020	Sabu, Simily/0000-0003-1610-3218; Vesper, Cordula/0000-0002-3434-4843; CURIONI, ARIANNA/0000-0003-4874-9320; Knoblich, Gunther/0000-0003-4463-5318; Sebanz, Natalie/0000-0003-1280-8974	European Research Council under the European Union's Seventh Framework Program (FP7/20072013)/ERC [609819]; ERC [616072]	European Research Council under the European Union's Seventh Framework Program (FP7/20072013)/ERC; ERC(European Research Council (ERC)European Commission)	This work was supported by the European Research Council under the European Union's Seventh Framework Program (FP7/20072013)/ERC grant agreement no 609819, SOMICS, and by ERC grant agreement no 616072, JAXPERTISE.	Murillo DB, 2017, J EXP PSYCHOL HUMAN, V43, P596, DOI 10.1037/xhp0000303; Cardis M, 2018, J NEUROPHYSIOL, V119, P39, DOI 10.1152/jn.00158.2017; Chang Y, 2013, STRUCT SAF, V41, P64, DOI 10.1016/j.strusafe.2012.11.002; Dhawale AK, 2017, ANNU REV NEUROSCI, V40, P479, DOI 10.1146/annurev-neuro-072116-031548; Gibb R, 2016, AVIATION VISUAL PERC; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Masumoto J, 2015, J NEUROPHYSIOL, V113, P3736, DOI 10.1152/jn.00313.2015; Masumoto J, 2013, J NEUROPHYSIOL, V109, P1307, DOI 10.1152/jn.00776.2012; Pacheco MM, 2018, ACTA PSYCHOL, V182, P9, DOI 10.1016/j.actpsy.2017.11.004; Pekny SE, 2015, J NEUROSCI, V35, P4015, DOI 10.1523/JNEUROSCI.3244-14.2015; Renart A, 2014, CURR OPIN NEUROBIOL, V25, P211, DOI 10.1016/j.conb.2014.02.013; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Schmidt MF, 2014, NEURON, V82, P6, DOI 10.1016/j.neuron.2014.03.010; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Takagi A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005971; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vesper C, 2013, P ANN M COGN SCI SOC, V35; Vesper C, 2016, COGNITION, V153, P118, DOI 10.1016/j.cognition.2016.05.002; Vesper C, 2011, EXP BRAIN RES, V211, P517, DOI 10.1007/s00221-011-2706-z; Wu HG, 2014, NAT NEUROSCI, V17, P312, DOI 10.1038/nn.3616	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241417	10.1371/journal.pone.0241417	http://dx.doi.org/10.1371/journal.pone.0241417			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119675	Green Published, gold			2022-12-26	WOS:000600013600110
J	Beltran, MI; Dijkerman, HC; Keizer, A				Beltran, Mercedes, I; Dijkerman, H. Chris; Keizer, Anouk			Affective touch experiences across the lifespan: Development of the Tactile Biography questionnaire and the mediating role of attachment style	PLOS ONE			English	Article							SELF-REPORT MEASURE; ADULT ATTACHMENT; PRETERM INFANTS; MATERNAL TOUCH; MENTAL-HEALTH; PERCEPTION; CONTACT; AFFERENTS; BEHAVIORS; PROMOTE	The sense of touch develops early in life and becomes a determinant aspect of our personal narratives, providing crucial information about the world around us and playing a prominent role in affective and social interactions. In this study we aimed to explore whether individual differences in touch experiences across the lifespan are related to adult attachment styles and to perceived touch deprivation. For this we first developed an instrument, namely the Tactile Biography, to quantify individual differences in affective touch experiences throughout life. Secondly, we performed a set of regressions models and a mediation analysis to investigate the role of attachment in relation to both the tactile history and perceived touch deprivation. We found that experiences of affective touch during childhood and adolescence seem to be closely associated with adult attachment styles and adult social touch experiences. Avoidant attachment appears to serve as a mediator in the relationship between earlier (childhood/adolescent) and later (adult) affective touch experiences, as well as between earlier affective touch experiences and perceived touch deprivation. These findings offer further support to existing literature, providing novel insights for the fields of social affective touch and attachment research.	[Beltran, Mercedes, I; Dijkerman, H. Chris; Keizer, Anouk] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands	Utrecht University	Beltran, MI; Keizer, A (corresponding author), Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands.	mercedesinesbeltran@gmail.com; a.keizer@uu.nl						Ackerley R, 2014, J NEUROSCI, V34, P2879, DOI 10.1523/JNEUROSCI.2847-13.2014; Ainsworth M., 1978, PATTERNS ATTACHMENT; ANISFELD E, 1990, CHILD DEV, V61, P1617, DOI 10.1111/j.1467-8624.1990.tb02888.x; [Anonymous], 2015, Cancer Discov, V5, pOF2, DOI 10.1158/2159-8290.CD-NB2014-188; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; [Anonymous], 2009, MSMR, V16, P10; [Anonymous], 2012, J MECH BEHAV BIOMED, V5, P231; [Anonymous], 2010, PRESCRIRE INT, V19, P109; [Anonymous], 2016, OJ L, V157, P1; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Anwyl-Irvine A, 2021, BEHAV RES METHODS, V53, P1407, DOI 10.3758/s13428-020-01501-5; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bowlby J, 1988, SECURE BASE CLIN APL; Brauer J, 2016, CEREB CORTEX, V26, P3544, DOI 10.1093/cercor/bhw137; Bremner AJ, 2017, ADV CHILD DEV BEHAV, V52, P227, DOI 10.1016/bs.acdb.2016.12.002; Cascio CJ, 2019, DEV COGN NEUROS-NETH, V35, P5, DOI 10.1016/j.dcn.2018.04.009; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chopik WJ, 2019, J PERS SOC PSYCHOL, V116, P598, DOI 10.1037/pspp0000167; Chopik WJ, 2014, J RES PERS, V53, P47, DOI 10.1016/j.jrp.2014.08.004; Chopik WJ, 2014, PERS INDIV DIFFER, V69, P212, DOI 10.1016/j.paid.2014.05.035; Croy I, 2016, PSYCHIAT RES, V245, P491, DOI 10.1016/j.psychres.2016.09.011; Croy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092975; Crucianelli L, 2016, PSYCHIAT RES, V239, P72, DOI 10.1016/j.psychres.2016.01.078; Ekeberg D, 2016, RELATIONSHIP INTERPE; Ellingsen DM, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01986; Feldman R, 2003, DEV MED CHILD NEUROL, V45, P274, DOI 10.1017/S0012162203000525; Feldman R, 2002, DEV PSYCHOL, V38, P194, DOI 10.1037//0012-1649.38.2.194; Feldman R, 2012, BIOL PSYCHIAT, V72, P175, DOI 10.1016/j.biopsych.2011.12.025; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Field A., 2018, DISCOVERING STAT USI, V5th, DOI DOI 10.1016/B978-012691360-6/50012-4; Field T, 2010, DEV REV, V30, P367, DOI 10.1016/j.dr.2011.01.001; Fraley RC, 2019, CURR OPIN PSYCHOL, V25, P26, DOI 10.1016/j.copsyc.2018.02.008; Fraley RC, 2003, DEV PSYCHOL, V39, P387, DOI 10.1037/0012-1649.39.3.387; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Fraley RC, 2000, JPSP, P19; George C., 1996, ADULT ATTACHME UNPUB; Girme YU, 2018, J PERS SOC PSYCHOL, V114, P397, DOI 10.1037/pspi0000115; Guedeney A, 2011, J PHYSIOL-PARIS, V105, P195, DOI 10.1016/j.jphysparis.2011.07.005; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Hertenstein MJ, 2006, GENET SOC GEN PSYCH, V132, P5, DOI 10.3200/MONO.132.1.5-94; Hertenstein MJ, 2002, HUM DEV, V45, P70, DOI 10.1159/000048154; Hielscher E, 2015, FRONT HUM NEUR C 12; Hudson NW, 2018, J PERS SOC PSYCHOL, V115, P688, DOI 10.1037/pspp0000215; Jakubiak BK, 2017, PERS SOC PSYCHOL REV, V21, P228, DOI 10.1177/1088868316650307; Jakubiak BK, 2016, SOC PSYCHOL PERS SCI, V7, P745, DOI 10.1177/1948550616646427; Jean ADL, 2012, INFANT BEHAV DEV, V35, P779, DOI 10.1016/j.infbeh.2012.07.023; Jean ADL, 2009, INFANT BEHAV DEV, V32, P123, DOI 10.1016/j.infbeh.2008.09.008; Jewitt C, 2019, INTERDISCIPLINARY IN, P57; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kanzawa-Lee GA, 2020, CANCER NURS, V43, pE207, DOI 10.1097/NCC.0000000000000687; Keizer A, 2019, DEV COGN NEUROS-NETH, V35, P104, DOI 10.1016/j.dcn.2017.09.004; Khan F, 2020, J PERS SOC PSYCHOL, V118, P1188, DOI 10.1037/pspi0000211; Kim KJ, 2018, J SOC PERS RELAT, V35, P1019, DOI 10.1177/0265407517702012; Kommers D, 2016, ACTA PAEDIATR, V105, P738, DOI 10.1111/apa.13254; Krahe C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0009; Loken LS, 2009, NAT NEUROSCI, V12, P547, DOI 10.1038/nn.2312; McCabe C, 2008, SOC COGN AFFECT NEUR, V3, P97, DOI 10.1093/scan/nsn005; Mercuri M, 2019, INFANT BEHAV DEV, V57, DOI 10.1016/j.infbeh.2019.101347; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Mikulincer M, 2012, WORLD PSYCHIATRY, V11, P11, DOI 10.1016/j.wpsyc.2012.01.003; Montagu A., 1971, TOUCHING HUMAN SIGNI; Morrison I, 2016, ADAPT HUM BEHAV PHYS, V2, P344, DOI 10.1007/s40750-016-0052-x; Morrison I, 2010, EXP BRAIN RES, V204, P305, DOI 10.1007/s00221-009-2007-y; Moszkowski RJ, 2009, INFANT BEHAV DEV, V32, P392, DOI 10.1016/j.infbeh.2009.06.006; Pieritz Karoline, 2015, Neuropsychiatr Dis Treat, V11, P2109, DOI 10.2147/NDT.S87703; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Punyanunt-Carter N.M., 2009, HUM COMMUN, V12, P67, DOI DOI 10.1037/T61074-000; Roche DN, 1999, J INTERPERS VIOLENCE, V14, P184, DOI 10.1177/088626099014002006; Sailer U, 2019, DEV COGN NEUROS-NETH, V35, P109, DOI 10.1016/j.dcn.2017.07.008; Samples-Steele CR, 2011, THESIS; Sehlstedt I, 2016, PSYCHOL AGING, V31, P176, DOI 10.1037/pag0000074; Sibley CG, 2005, PERS SOC PSYCHOL B, V31, P1524, DOI 10.1177/0146167205276865; Spitoni GF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66606-5; Strauss T, 2019, DEPRESS ANXIETY, V36, P635, DOI 10.1002/da.22914; Trotter PD, 2018, J NONVERBAL BEHAV, V42, P379, DOI 10.1007/s10919-018-0281-8; van Stralen HE, 2014, COGNITION, V131, P147, DOI 10.1016/j.cognition.2013.11.020; von Mohr M, 2018, SOC COGN AFFECT NEUR, V13, P1121, DOI 10.1093/scan/nsy085; Walker SC, 2013, NEUROPEPTIDES, V47, P379, DOI 10.1016/j.npep.2013.10.008; Weiss SJ, 2000, INFANT BEHAV DEV, V23, P91, DOI 10.1016/S0163-6383(00)00030-8; Weiss SJ, 2001, INFANT CHILD DEV, V10, P93, DOI 10.1002/icd.236; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	83	6	7	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241041	10.1371/journal.pone.0241041	http://dx.doi.org/10.1371/journal.pone.0241041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112898	gold, Green Published			2022-12-26	WOS:000588374000001
J	Bird, JJ; Barnes, CM; Premebida, C; Ekart, A; Faria, DR				Bird, Jordan J.; Barnes, Chloe M.; Premebida, Cristiano; Ekart, Aniko; Faria, Diego R.			Country-level pandemic risk and preparedness classification based on COVID-19 data: A machine learning approach	PLOS ONE			English	Article							ALGORITHMS	In this work we present a three-stage Machine Learning strategy to country-level risk classification based on countries that are reporting COVID-19 information. A K% binning discretisation (K = 25) is used to create four risk groups of countries based on the risk of transmission (coronavirus cases per million population), risk of mortality (coronavirus deaths per million population), and risk of inability to test (coronavirus tests per million population). The four risk groups produced by K% binning are labelled as 'low', 'medium-low', 'medium-high', and 'high'. Coronavirus-related data are then removed and the attributes for prediction of the three types of risk are given as the geopolitical and demographic data describing each country. Thus, the calculation of class label is based on coronavirus data but the input attributes are country-level information regardless of coronavirus data. The three four-class classification problems are then explored and benchmarked through leave-one-country-out cross validation to find the strongest model, producing a Stack of Gradient Boosting and Decision Tree algorithms for risk of transmission, a Stack of Support Vector Machine and Extra Trees for risk of mortality, and a Gradient Boosting algorithm for the risk of inability to test. It is noted that high risk for inability to test is often coupled with low risks for transmission and mortality, therefore the risk of inability to test should be interpreted first, before consideration is given to the predicted transmission and mortality risks. Finally, the approach is applied to more recent risk levels to data from September 2020 and weaker results are noted due to the growth of international collaboration detracting useful knowledge from country-level attributes which suggests that similar machine learning approaches are more useful prior to situations later unfolding.	[Bird, Jordan J.; Barnes, Chloe M.; Ekart, Aniko; Faria, Diego R.] Aston Univ, Sch Engn & Appl Sci, Aston Robot Vis & Intelligent Syst Lab ARVIS, Birmingham, W Midlands, England; [Premebida, Cristiano] Univ Coimbra, Inst Syst & Robot, Dept Elect & Comp Engn, Coimbra, Portugal	Aston University; Universidade de Coimbra	Bird, JJ (corresponding author), Aston Univ, Sch Engn & Appl Sci, Aston Robot Vis & Intelligent Syst Lab ARVIS, Birmingham, W Midlands, England.	birdj1@aston.ac.uk	Premebida, Cristiano/O-1673-2013; Bird, Jordan J./Z-4460-2019	Premebida, Cristiano/0000-0002-2168-2077; Bird, Jordan J./0000-0002-9858-1231; Barnes, Chloe/0000-0002-6782-1773; Ekart, Aniko/0000-0001-6967-5397				Agyeman AA, 2020, J MED VIROL, V92, P1373, DOI 10.1002/jmv.25780; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2015, LANCET ONCOL, V16, pe158; [Anonymous], 2021, WORLD FACTBOOK; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2000, ECONOMIST, V15, P61; ansen K, 2020, TIDSSKRIFT NORSKE LE; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bostrom M, 2008, CONSUM PUBLIC LIFE, P17; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Cawley GC, 2006, IEEE IJCNN, P1661; Chan AWS, 2020, J ASIAN PUBLIC POLIC, V13, P165, DOI 10.1080/17516234.2018.1503940; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Commar A., 2018, WHO global report on trends in prevalence of tobacco smoking 2000-2025; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DC T, 2020, NAT PROD COMMUN, V15, P1, DOI DOI 10.1080/15567249.2020.1729900; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Dzeroski S, 2004, MACH LEARN, V54, P255, DOI 10.1023/B.MAC.0000015881.36452.6e; Fayyad U., 1993, MULTIINTERVAL DISCRE; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fortin FA, 2012, J MACH LEARN RES, V13, P2171; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Hortacsu A., 2020, ESTIMATING FRACTION; Jacobson O, 2016, P 15 WORKSH BIOM NAT, P191; Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198; Krantz SG, 2020, INFECT CONT HOSP EP, V41, P857, DOI 10.1017/ice.2020.116; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lachmann A., 2020, CORRECTING REPORTED; Lau H, 2020, J MICROBIOL IMMUNOL, V53, P454, DOI 10.1016/j.jmii.2020.03.013; Li L, 2020, BIOMED CHROMATOGR, V34, DOI 10.1002/bmc.4905; Lighter J, 2020, CLIN INFECT DIS, P20181; Lloyd-Sherlock P, 2020, BEARING BRUNT COVID; M C W., 2020, BMJ-BRIT MED J, V368, pm544, DOI 10.1136/bmj.l6968; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marzuki Z., 2012, LUNG, V3, P57; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Olson RS, 2016, GECCO'16: PROCEEDINGS OF THE 2016 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P485, DOI 10.1145/2908812.2908918; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Ong Edison, 2020, bioRxiv, DOI 10.1101/2020.03.20.000141; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Picek S, 2018, CURSE CLASS IMBALANC; Platt J., 1998, ADV KERNEL METHODS S, P41, DOI [10.1109/iske.2008.4731075, DOI 10.1109/ISKE.2008.4731075]; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa030; The World Health Organisation, 2020, IS WHO RESP COVID 19; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Valcheva KS, 2020, PROCEEDINGDS, V3, P138; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; World Health Organization, 2017, PREV OB AD BMI 30; World Health Organization, 2013, GLOB HLTH WORKF STAT; Worldometers, 2020, CURRENT WORLD POPULA; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64	57	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241332	10.1371/journal.pone.0241332	http://dx.doi.org/10.1371/journal.pone.0241332			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112931	Green Accepted, gold, Green Published			2022-12-26	WOS:000588374000038
J	Tamiev, D; Furman, PE; Reuel, NF				Tamiev, Denis; Furman, Paige E.; Reuel, Nigel F.			Automated classification of bacterial cell sub-populations with convolutional neural networks	PLOS ONE			English	Article							IMAGE-ANALYSIS	Quantification of phenotypic heterogeneity present amongst bacterial cells can be a challenging task. Conventionally, classification and counting of bacteria sub-populations is achieved with manual microscopy, due to the lack of alternative, high-throughput, autonomous approaches. In this work, we apply classification-type convolutional neural networks (cCNN) to classify and enumerate bacterial cell sub-populations (B. subtilis clusters). Here, we demonstrate that the accuracy of the cCNN developed in this study can be as high as 86% when trained on a relatively small dataset (81 images). We also developed a new image preprocessing algorithm, specific to fluorescent microscope images, which increases the amount of training data available for the neural network by 72 times. By summing the classified cells together, the algorithm provides a total cell count which is on parity with manual counting, but is 10.2 times more consistent and 3.8 times faster. Finally, this work presents a complete solution framework for those wishing to learn and implement cCNN in their synthetic biology work.	[Tamiev, Denis; Furman, Paige E.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Reuel, Nigel F.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA	Iowa State University; Iowa State University	Reuel, NF (corresponding author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.	reuel@iastate.edu	Tameiv, Denis/GMW-4544-2022		Internal Iowa State University	Internal Iowa State University	Internal Iowa State University funding.	Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; [Anonymous], 2019, IMMUNE NETW, V19, pe34; [Anonymous], 2016, J NATL COMPR CANC NE, V14, pr34; Beaufort L, 2004, MAR MICROPALEONTOL, V51, P57, DOI 10.1016/j.marmicro.2003.09.003; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; Ferrari A, 2017, PATTERN RECOGN, V61, P629, DOI 10.1016/j.patcog.2016.07.016; Geron A., HANDS MACHINE LEARNI; Gertych A, 2019, SCI REP, V9, P1; Gonzalez LM, 2020, NAT CHEM BIOL, V16, P126, DOI 10.1038/s41589-019-0412-5; Hinton G. E., 2012, ARXIV12070580CS; Jha RK, 2020, ACS SYNTH BIOL, V9, P1234, DOI 10.1021/acssynbio.0c00025; Khan Aisha, 2016, Computer Vision - ECCV 2016. 14th European Conference: Workshops. Proceedings: LNCS 9913, P339, DOI 10.1007/978-3-319-46604-0_25; Khorshed RA, 2015, STEM CELL REP, V5, P139, DOI 10.1016/j.stemcr.2015.05.017; Kornilov AS, 2018, J IMAGING, V4, DOI 10.3390/jimaging4100123; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Leventhal DS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16602-0; Li C, 2019, ADV INTELL SYST COMP, V762, P3, DOI 10.1007/978-3-319-91211-0_1; Lin C, 2018, ANAL CHIM ACTA, V1041, P108, DOI 10.1016/j.aca.2018.08.053; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Nair V., 2010, ICML JAN; Ranzato M.A., 2007, IEEE C COMP VIS PATT, P1; Rawat W, 2017, NEURAL COMPUT, V29, P2352, DOI [10.1162/NECO_a_00990, 10.1162/neco_a_00990]; Rosenberg M., 2019, SCI REPORTS, V9, P1; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Siebert D, 2020, ACS SYNTH BIOL, V9, P1426, DOI 10.1021/acssynbio.0c00098; Sultana F., 2020, Intelligent Computing: Image Processing Based Applications. Advances in Intelligent Systems and Computing (AISC 1157), P1, DOI 10.1007/978-981-15-4288-6_1; Tamiev D, 2019, ACS SYNTH BIOL, V8, P2336, DOI 10.1021/acssynbio.9b00163; Wei SP, 2020, NAT CHEM BIOL, V16, P1143, DOI 10.1038/s41589-020-0579-9; Wiesmann V, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1591-2	32	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241200	10.1371/journal.pone.0241200	http://dx.doi.org/10.1371/journal.pone.0241200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104721	Green Published, Green Submitted, gold			2022-12-26	WOS:000588370000014
J	Augusto, AD; Iriemenam, NC; Kohatsu, L; de Sousa, L; Maueia, C; Hara, C; Mula, F; Cuamba, G; Chelene, I; Langa, Z; Lohman, N; Faife, F; Giles, D; Sabonete, AJ; Gudo, ES; Jani, I; Parekh, BS				Augusto, Angelo do Rosario; Iriemenam, Nnaemeka C.; Kohatsu, Luciana; de Sousa, Leonardo; Maueia, Cremildo; Hara, Christine; Mula, Flora; Cuamba, Gercio; Chelene, Imelda; Langa, Zainabo; Lohman, Nathaniel; Faife, Flavio; Giles, Denise; Sabonete, Acacio Jose; Gudo, Eduardo Samo; Jani, Ilesh; Parekh, Bharat S.			High level of HIV false positives using EIA-based algorithm in survey: Importance of confirmatory testing	PLOS ONE			English	Article							AG/AB COMBO ASSAY; ELISA; PERFORMANCE; ANTIBODIES; INFECTION; CUTOFF	The Mozambique Indicators of Immunization, Malaria and HIV/AIDS (IMASIDA) survey was conducted in 2015 and used a two Enzyme Immunoassay (EIA) (Vironostika HIV-1/2 and Murex HIV-1/2) based algorithm to determine the HIV status of the consented participants. The Mozambique Ministry of Health, with support from the US Centers for Disease Control and Prevention (US CDC), added Bio-Rad Geenius (TM) HIV-1/2 Supplemental Assay to the IMASIDA HIV testing algorithm to confirm all specimens that were found to be reactive on one or both EIAs. In total 11690 specimens were collected to estimate the proportion of HIV positive samples. Results indicate that the proportion of HIV positive samples based on the concordant positive results of two EIA assays was 21.5% (2518/11690). The addition of the Geenius assay to the IMASIDA HIV testing algorithm demonstrated that 792 (31.5%) of 2518 specimens were false-positive and reduced the proportion of HIV positive samples to 14.7% (1722/11690), demonstrating the importance of including a highly specific HIV test to confirm HIV diagnosis. HIV surveys exclusively based on EIA testing algorithm may result in misleading high prevalence results. Our results demonstrate that more specific confirmatory testing should be added to the EIA-based algorithms to ensure accurate HIV diagnosis and correct HIV prevalence estimate in cross-sectional surveys.	[Augusto, Angelo do Rosario; Maueia, Cremildo; Mula, Flora; Cuamba, Gercio; Chelene, Imelda; Langa, Zainabo; Sabonete, Acacio Jose; Gudo, Eduardo Samo; Jani, Ilesh] Inst Nacl Saude INS, EN1, Dist De Marracuene, Maputo, Mozambique; [Iriemenam, Nnaemeka C.; Kohatsu, Luciana; Parekh, Bharat S.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Int Lab Branch, Atlanta, GA 30333 USA; [Kohatsu, Luciana; de Sousa, Leonardo; Hara, Christine; Faife, Flavio; Giles, Denise] Ctr Dis Control & Prevent, Av Zedequias Manganhela, Maputo, Mozambique; [Lohman, Nathaniel] US Agcy Int Dev USAID, Maputo, Mozambique	Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID)	Iriemenam, NC; Parekh, BS (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Int Lab Branch, Atlanta, GA 30333 USA.	iqd4@cdc.gov; bsp1@cdc.gov		Kohatsu, Luciana/0000-0003-0170-570X; Iriemenam, Nnaemeka/0000-0003-2187-8894; PAREKH, BHARAT/0000-0002-1088-4263	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Strengthening the National Institute of Health in the Republic of Mozambique, CoAg [GH00080]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Strengthening the National Institute of Health in the Republic of Mozambique, CoAg	This Mozambique National Immunization, Malaria and HIV Indicator Survey, 2014 (IMASIDA) has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Strengthening the National Institute of Health in the Republic of Mozambique, CoAg #GH00080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	Alonso R, 2018, J CLIN VIROL, V103, P43, DOI 10.1016/j.jcv.2018.04.002; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 1999, SPENSER STUDIES, V13, P109; [Anonymous], 2014, ARTHRITIS RHEUM S, V66, pS690; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; CDC/APHL, 2014, LAB TEST DIAGN HIV I, DOI 10.15620/cdc.23447; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Chacon L, 2017, J CLIN VIROL, V92, P11, DOI 10.1016/j.jcv.2017.04.014; CHALLAKERE K, 1993, WESTERN J MED, V159, P214; Coleman SM, 2018, HIV CLIN TRIALS, V19, P15, DOI 10.1080/15284336.2018.1429846; Fearon Margaret, 2005, Can J Infect Dis Med Microbiol, V16, P26; McPhee CF, 2015, J CLIN VIROL, V63, P66, DOI 10.1016/j.jcv.2014.12.018; Fordan S, 2017, J CLIN VIROL, V91, P79, DOI 10.1016/j.jcv.2017.04.005; GHDx, 2007, MOZ POP HOUS CENS 20; Hill E., 2017, IMPORTANCE EXTERNAL; INS INE & ICF Macro, 2010, INQ NAC PREV RISC CO; Jensen TO, 2015, J CLIN MICROBIOL, V53, P1709, DOI 10.1128/JCM.03583-14; Kim S, 2010, CLIN VACCINE IMMUNOL, V17, P1642, DOI 10.1128/CVI.00258-10; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Lang R, 2017, J CLIN VIROL, V96, P84, DOI 10.1016/j.jcv.2017.10.005; Lavoie S, 2018, J CLIN VIROL, V104, P23, DOI 10.1016/j.jcv.2018.03.014; Lee CE, 2011, ANN ACAD MED SINGAP, V40, P448; Lindman J, 2019, J VIROL METHODS, V268, P42, DOI 10.1016/j.jviromet.2019.03.005; Montesinos I, 2014, J CLIN VIROL, V60, P399, DOI 10.1016/j.jcv.2014.04.025; Politis G., 1999, BOLET N ARQUEOLOG A, V14, P25; Serhir B, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.01398-18, 10.1128/jcm.01398-18]; Stefic K, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01645-19; Suguitan Jr AL, 2011, PLOS ONE, V6; USAID, 2016, PERF ENZ IMM HIV SER; Wai CT, 2002, AM J MED, V112, P737, DOI 10.1016/S0002-9343(02)01113-0; Weber B, 2006, EXPERT REV MOL DIAGN, V6, P399, DOI 10.1586/14737159.6.3.399; Willman JH, 2001, AM J CLIN PATHOL, V115, P764, DOI 10.1309/3F13-739A-NA7F-NV3X; Willman JH, 1999, CLIN DIAGN LAB IMMUN, V6, P615, DOI 10.1128/CDLI.6.4.615-616.1999; World Health Organization, CONS GUID US ANT DRU; 2016, CANC DISCOV, V6	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0239782	10.1371/journal.pone.0239782	http://dx.doi.org/10.1371/journal.pone.0239782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091019	gold, Green Published			2022-12-26	WOS:000586647200038
J	Li, JR; Yu, WZ; Zhao, ZX; Zhang, L; Gong, QY				Li, Jiangrong; Yu, Wenzhou; Zhao, Zhixian; Zhang, Lei; Gong, Qiongyu			Measles vaccination among children in border areas of Yunnan Province, Southwest China	PLOS ONE			English	Article							ELIMINATION; SURVEILLANCE; COVERAGE; PARENTS; EDUCATION; OUTBREAK; MYANMAR; SCHOOL	Background Border areas are at high risk of measles epidemics. This study aimed to evaluate the effectiveness of the implementation of the routine two-dose measles containing vaccine (MCV) program in border counties of Southwest China. Methods Data used in the study were derived from a cross-sectional survey among 1,467 children aged 8 to 84 months from five border counties of Yunnan Province, Southwest China in 2016. The participants were recruited using a multistage sampling method. Primary guardians of the children were interviewed to collect information on vaccination history, socio-economic status, and knowledge about immunization. Both coverage and timely coverage for the first (MCV1) and the second (MCV2) dose of MCV were calculated. The Kaplan-Meier method was performed to estimate the cumulative coverage of MCV, and Log-rank tests were adopted to compare the differences across counties and birth cohorts. Univariate and multivariate logistic regression models were used to investigate the predictors of delayed MCV1 vaccination. Results The coverage for MCV1 and MCV2 were 97.5% and 93.4%, respectively. However, only 63.8% and 84.0% of the children received MCV1 or MCV2 on time. Significant differences in the cumulative coverage were detected across counties and birth cohorts. Results of the multivariate logistic regression analysis indicated that children whose primary guardian knew the schedule of MCV were less likely to receive MCV1 late (OR = 0.63, P<0.01). For the guardians, doctors at vaccination units were the primary and also the most desired source of vaccination information. Conclusions Although the coverage for MCV is high in border areas of Southwest China, the timeliness of MCV vaccination seems suboptimal. Tailored information from local health professionals may help to reduce untimely vaccination.	[Li, Jiangrong; Zhao, Zhixian; Gong, Qiongyu] Yunnan Prov Ctr Dis Control & Prevent, Expanded Program Immunizat Dept, Kunming, Yunnan, Peoples R China; [Yu, Wenzhou] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Zhang, Lei] Zhaotong Vocat Coll Hlth, Zhaotong, Peoples R China	Chinese Center for Disease Control & Prevention	Gong, QY (corresponding author), Yunnan Prov Ctr Dis Control & Prevent, Expanded Program Immunizat Dept, Kunming, Yunnan, Peoples R China.	232442623@qq.com			Health Commission of Yunnan Province [2017NS096]; UNICEF	Health Commission of Yunnan Province; UNICEF	This study was funded by the Health Commission of Yunnan Province (Award Number: 2017NS096, Recipient: Qiongyu Gong) and UNICEF (Recipient: Jiangrong Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205147; [Anonymous], 2017, WANNACRY RANSOMWARE, V23, pvii, DOI 10.1080/13567888.2017.1335101; [Anonymous], 2016, B EPIDEMIOLOGICO COM, V22, P6; Bester JC, 2016, JAMA PEDIATR, V170, P1209, DOI 10.1001/jamapediatrics.2016.1787; Cao L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206566; Dua L, 2017, J MED PEST CONTROL, V33, P3; Dube E, 2018, VACCINE, V36, P545, DOI 10.1016/j.vaccine.2017.12.005; Expert Panel on Neurologic Imaging:, 2017, J Am Coll Radiol, V14, pS550, DOI 10.1016/j.jacr.2017.08.041; Gowda C, 2013, HUM VACC IMMUNOTHER, V9, P437, DOI 10.4161/hv.22821; Guerra FM, 2018, VACCINE, V36, P1248, DOI 10.1016/j.vaccine.2018.01.002; Han K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-203; Hao LX, 2016, VACCINE, V34, P6545, DOI 10.1016/j.vaccine.2016.02.005; Hu Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6226-7; Hu Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1998-5; Hu Y, 2015, INT J ENV RES PUB HE, V12, P3469, DOI 10.3390/ijerph120403469; Hu Y, 2013, INT J ENV RES PUB HE, V10, P2845, DOI 10.3390/ijerph10072845; Ismail SA, 2016, INT J INFECT DIS, V47, P15, DOI 10.1016/j.ijid.2016.05.011; Kaji A, 2016, J IMMIGR MINOR HEALT, V18, P1038, DOI 10.1007/s10903-015-0294-x; Lanini S, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.10.20735; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; [李倩 Li Qian], 2013, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V47, P504; Lin WY, 2014, HUM VACC IMMUNOTHER, V10, P3601, DOI 10.4161/21645515.2014.979687; Ma C, 2014, B WORLD HEALTH ORGAN, V92, P340, DOI 10.2471/BLT.13.130195; Ma C, 2011, J INFECT DIS, V204, pS447, DOI 10.1093/infdis/jir103; Ma R, 2016, VACCINE, V34, P1853, DOI 10.1016/j.vaccine.2015.11.006; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Moss WJ, 2017, LANCET, V390, P2490, DOI 10.1016/S0140-6736(17)31463-0; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; Nozaki I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6548-0; Orenstein WA, 2018, VACCINE, V36, pA1, DOI 10.1016/j.vaccine.2017.09.026; Pacheco FC, 2020, VACCINE, V38, P1881, DOI 10.1016/j.vaccine.2020.01.030; Rosso A, 2020, HUM VACC IMMUNOTHER, V16, P1969, DOI 10.1080/21645515.2019.1698901; Rosso A, 2019, VACCINE, V37, P1954, DOI 10.1016/j.vaccine.2019.02.049; Tang XY, 2016, TROP MED INT HEALTH, V21, P886, DOI 10.1111/tmi.12719; Wang HB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0745-y; Wichmann O, 2009, B WORLD HEALTH ORGAN, V87, P108, DOI 10.2471/BLT.07.050187; World Health Organization, 2012, WORLD HLTH STAT; Zaraket H, 2020, J INFECT PUBLIC HEAL, V13, P377, DOI 10.1016/j.jiph.2020.02.029; Zhuo JT, 2011, J INFECT DIS, V204, pS463, DOI 10.1093/infdis/jir064	39	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240733	10.1371/journal.pone.0240733	http://dx.doi.org/10.1371/journal.pone.0240733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085692	Green Published, gold			2022-12-26	WOS:000585943400029
J	Angel, I; Kerman, OP; Rousso-Noori, L; Friedmann-Morvinski, D				Angel, Inbar; Pilo Kerman, Ori; Rousso-Noori, Liat; Friedmann-Morvinski, Dinorah			Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma	ONCOGENE			English	Article							NF-KAPPA-B; STEM-CELLS; GLIOMA; ACTIVATION; DIFFERENTIATION; TRANSFORMATION; ANGIOGENESIS; INHIBITION; PROGNOSIS; RAS	Interconversion of transformed non-stem cells to cancer stem cells, termed cancer cell plasticity, contributes to intra-tumor heterogeneity and its molecular mechanisms are currently unknown. Here, we have identified Tenascin C (TNC) to be upregulated and secreted in mesenchymal glioblastoma (MES GBM) subtype with high NF-kappa B signaling activity. Silencing TNC decreases proliferation, migration and suppresses self-renewal of glioma stem cells. Loss of TNC in MES GBM compromises de-differentiation of transformed astrocytes and blocks the ability of glioma stem cells to differentiate into tumor derived endothelial cells (TDEC). Inhibition of NF-kappa B activity or TNC knockdown in tumor cells decreased their tumorigenic potential in vivo. Our results uncover a link between NF-kappa B activation in MES GBM and high levels of TNC in GBM extracellular matrix. We suggest that TNC plays an important role in the autocrine regulation of glioma cell plasticity and hence can be a potential molecular target for MES GBM.	[Angel, Inbar; Pilo Kerman, Ori; Rousso-Noori, Liat; Friedmann-Morvinski, Dinorah] Tel Aviv Univ, Sch Neurobiol Biochem & Biophys, George S Wise Fac Life Sci, Tel Aviv, Israel; [Friedmann-Morvinski, Dinorah] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Friedmann-Morvinski, D (corresponding author), Tel Aviv Univ, Sch Neurobiol Biochem & Biophys, George S Wise Fac Life Sci, Tel Aviv, Israel.; Friedmann-Morvinski, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	dino@tauex.tau.ac.il		Friedmann-Morvinski, Dinorah/0000-0002-6394-9876; Rousso Noori, Liat/0000-0001-7582-3165	Israel Science Foundation [1310/15]; Israel Cancer Research Fund (Research Career Development Award); EU-FP7 Marie Curie Actions (Career Integration Grant)	Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund (Research Career Development Award); EU-FP7 Marie Curie Actions (Career Integration Grant)	We thank Yifeng Xia and Eugene Ke for assistance in bioinformatic analysis, and Prof. Michal Baniyash for critically reading the manuscript. This research was supported by grants to DF-M from the Israel Science Foundation (Grant no. 1310/15), the Israel Cancer Research Fund (Research Career Development Award), and the EU-FP7 Marie Curie Actions (Career Integration Grant).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Brosicke N, 2015, CELL ADHES MIGR, V9, P131, DOI 10.1080/19336918.2014.1000071; Cabrera MC, 2015, WORLD J STEM CELLS, V7, P27, DOI 10.4252/wjsc.v7.i1.27; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chiquet-Ehrismann R, 2014, MATRIX BIOL, V37, P112, DOI 10.1016/j.matbio.2014.01.007; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Finco TS, 1997, J BIOL CHEM, V272, P24113, DOI 10.1074/jbc.272.39.24113; Friedmann-Morvinski D, 2016, ONCOGENE, V35, P608, DOI 10.1038/onc.2015.119; Friedmann-Morvinski D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501292; Friedmann-Morvinski Dinorah, 2014, Critical Reviews in Oncogenesis, V19, P327; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Langlois B, 2014, ONCOTARGET, V5, P10529, DOI 10.18632/oncotarget.2470; Lowy CM, 2015, CELL ADHES MIGR, V9, P112, DOI 10.1080/19336918.2015.1008331; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martiny-Baron G, 2010, ANGIOGENESIS, V13, P259, DOI 10.1007/s10456-010-9183-z; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Mettouchi A, 1997, MOL CELL BIOL, V17, P3202, DOI 10.1128/MCB.17.6.3202; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Miroshnikova YA, 2016, NAT CELL BIOL, V18, P1336, DOI 10.1038/ncb3429; Nie S, 2015, J PROTEOME RES, V14, P814, DOI 10.1021/pr5008653; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Poltavets V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00431; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rupp T, 2016, CELL REP, V17, P2607, DOI 10.1016/j.celrep.2016.11.012; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Sarkar S, 2017, CANCER RES, V77, P3231, DOI 10.1158/0008-5472.CAN-16-2171; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Yamini B, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090125; Yoshida T, 2015, CELL ADHES MIGR, V9, P96, DOI 10.1080/19336918.2015.1008332; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	51	17	18	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2020	39	46					6990	7004		10.1038/s41388-020-01506-6	http://dx.doi.org/10.1038/s41388-020-01506-6		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OQ9FF	33077835				2022-12-26	WOS:000579741400001
J	Hirai, N; Kasahara, K; Nakano, R; Ogawa, Y; Suzuki, Y; Ogawa, M; Hishiya, N; Nakano, A; Ichimura, S; Yano, H; Yoshikawa, M				Hirai, Nobuyasu; Kasahara, Kei; Nakano, Ryuichi; Ogawa, Yoshihiko; Suzuki, Yuki; Ogawa, Miho; Hishiya, Naokuni; Nakano, Akiyo; Ichimura, Sadahiro; Yano, Hisakazu; Yoshikawa, Masahide			Clinical characteristics and molecular epidemiology of invasiveStreptococcus agalactiaeinfections between 2007 and 2016 in Nara, Japan	PLOS ONE			English	Article							B STREPTOCOCCAL DISEASE; MACROLIDE RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; GENES; PNEUMONIAE; EMERGENCE; INFECTION; SEROTYPE; INFANTS; SYSTEM	InvasiveStreptococcus agalactiae(GBS) infections are increasingly common among neonates and the elderly. Therefore, GBS surveillance for better antibiotic treatment and prophylaxis strategies are needed. We retrospectively evaluated the clinical aspects of invasive infections and the phenotypic and genetic diversity of infectious isolates from Nara, Japan, collected between 2007 and 2016, by using information from hospital records. GBS strains collected from the blood and cerebrospinal fluid cultures were evaluated for capsular types, multi-locus sequence typing (MLST), antibiotic susceptibility, antibiotics resistance gene, and pulsed-field gel electrophoresis. Forty GBS isolates (10 from children and 30 from adults) were analyzed, and the distribution of molecular serotype and allelic profiles varied between children and adults. We found the rates of early-onset disease in neonates with birth complications to be higher than that of previous reports, indicating that there could be relevance between complications at birth and early-onset disease. Standard antibiotic prophylaxis strategies may need to be reconsidered in patients with birth complications. In adults, the mean age of the patients was 68 years (male: 63%). Primary bacteremia was the most common source of infection. In the neonates, six had early-onset diseases and four had late-onset diseases. The most frequently identified strains were molecular serotype Ia ST23 (40%) and molecular serotype Ib ST10 (20%) in children and molecular serotype Ib ST10 (17%), molecular serotype VI ST1 (13%), and molecular serotype V ST1 (13%) in adults. Levofloxacin-resistant molecular serotype Ib strains and molecular serotypes V and VI ST1 were common causes of GBS infection in adults but were rarely found in children. Furthermore, pulsed-field gel electrophoresis in our study showed that specific clone isolates, that tend to have antibiotics resistance were widespread horizontally for a decade. Continuous surveillance and molecular investigation are warranted to identify the transmission route and improve antibiotic treatment strategies.	[Hirai, Nobuyasu; Yoshikawa, Masahide] Nara Med Univ, Dept Pathogen Infect & Immun, Kashihara, Nara, Japan; [Hirai, Nobuyasu; Kasahara, Kei; Ogawa, Yoshihiko] Nara Med Univ, Ctr Infect Dis, Kashihara, Nara, Japan; [Hirai, Nobuyasu; Nakano, Ryuichi; Suzuki, Yuki; Hishiya, Naokuni; Nakano, Akiyo; Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Kashihara, Nara, Japan; [Ogawa, Miho; Ichimura, Sadahiro] BML Biomed Labs R&D Ctr Inc, Kawagoe, Saitama, Japan	Nara Medical University; Nara Medical University; Nara Medical University	Kasahara, K (corresponding author), Nara Med Univ, Ctr Infect Dis, Kashihara, Nara, Japan.	kassan@naramed-u.ac.jp		Nakano, Akiyo/0000-0003-1379-384X				Andrews JI, 2000, AM J OBSTET GYNECOL, V183, P859, DOI 10.1067/mob.2000.108839; [Anonymous], 2010, MMRW, V59, pRR; [Anonymous], 2016, EUR J ORAL IMPLAN S1, V9, pS173; [Anonymous], **NON-TRADITIONAL**; Arias B, 2019, MICROB DRUG RESIST, V25, P739, DOI 10.1089/mdr.2018.0246; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Furfaro LL, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00049-18; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Lee CC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49977-2; Lin HC, 2016, J MICROBIOL IMMUNOL, V49, P902, DOI 10.1016/j.jmii.2014.11.002; Maria-Marimon J, 2005, ANTIMICROB AGENTS CH, V49, P5069, DOI 10.1128/AAC.49.12.5069-5074.2005; Matsumoto A, 2007, JPN J INFECT DIS, V60, P10; Moroi H, 2019, EMERG MICROBES INFEC, V8, P2, DOI 10.1080/22221751.2018.1557987; Morozumi M, 2016, J CLIN MICROBIOL, V54, P2695, DOI 10.1128/JCM.01183-16; Mosleh MN, 2014, IRAN J BASIC MED SCI, V17, P595; Mukhopadhyay S, 2013, J PERINATOL, V33, P198, DOI 10.1038/jp.2012.96; Murayama SY, 2009, ANTIMICROB AGENTS CH, V53, P2650, DOI 10.1128/AAC.01716-08; Nagano N, 2019, INT J ANTIMICROB AG, V53, P203, DOI 10.1016/j.ijantimicag.2018.11.003; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Perez-Trallero E, 2007, ANTIMICROB AGENTS CH, V51, P1228, DOI 10.1128/AAC.01054-06; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Piccinelli G, 2015, ANTIMICROB AGENTS CH, V59, P2466, DOI 10.1128/AAC.05127-14; Pimentel BAS, 2016, EUR J CLIN MICROBIOL, V35, P927, DOI 10.1007/s10096-016-2617-9; Ryu H, 2014, J INFECT CHEMOTHER, V20, P509, DOI 10.1016/j.jiac.2014.03.005; Seki T, 2015, J ANTIMICROB CHEMOTH, V70, P2725, DOI 10.1093/jac/dkv203; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Sun Y, 2005, J CLIN MICROBIOL, V43, P4704, DOI 10.1128/JCM.43.9.4704-4707.2005; Targosz Rozmawial Kazimierz, 1998, PRZEKROJ, V11, P17; Wang NY, 2014, J INFECT DIS, V210, P982, DOI 10.1093/infdis/jiu151	34	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240590	10.1371/journal.pone.0240590	http://dx.doi.org/10.1371/journal.pone.0240590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075112	gold, Green Published, Green Submitted			2022-12-26	WOS:000585920200004
J	Zuilkoski, CM; Skibbens, RV				Zuilkoski, Caitlin M.; Skibbens, Robert V.			PCNA antagonizes cohesin-dependent roles in genomic stability	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DNA-REPLICATION; S-PHASE; BUDDING YEAST; CHROMOSOME CONDENSATION; TRANSCRIPTIONAL REGULATION; REMODELING COMPLEX; TELOMERE LENGTH; WAPL CONTROLS; ESTABLISHMENT	PCNA sliding clamp binds factors through which histone deposition, chromatin remodeling, and DNA repair are coupled to DNA replication. PCNA also directly binds Eco1/Ctf7 acetyltransferase, which in turn activates cohesins and establishes cohesion between nascent sister chromatids. While increased recruitment thus explains the mechanism through which elevated levels of chromatin-bound PCNA rescueeco1mutant cell growth, the mechanism through which PCNA instead worsens cohesin mutant cell growth remains unknown. Possibilities include that elevated levels of long-lived chromatin-bound PCNA reduce either cohesin deposition onto DNA or cohesin acetylation. Instead, our results reveal that PCNA increases the levels of both chromatin-bound cohesin and cohesin acetylation. Beyond sister chromatid cohesion, PCNA also plays a critical role in genomic stability such that high levels of chromatin-bound PCNA elevate genotoxic sensitivities and recombination rates. At a relatively modest increase of chromatin-bound PCNA, however, fork stability and progression appear normal in wildtype cells. Our results reveal that even a moderate increase of PCNA indeed sensitizes cohesin mutant cells to DNA damaging agents and in a process that involves the DNA damage response kinase Mec1(ATR), but not Tel1(ATM). These and other findings suggest that PCNA mis-regulation results in genome instabilities that normally are resolved by cohesin. Elevating levels of chromatin-bound PCNA may thus help target cohesinopathic cells linked that are linked to cancer.	[Zuilkoski, Caitlin M.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Zuilkoski, Caitlin M.] Indiana Univ, Dept Biol, Bloomington, IN USA	Lehigh University; Indiana University System; Indiana University Bloomington	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306; Zuilkoski, Caitlin/0000-0002-7793-5512	National Institutes of Health [R15GM110631]; Nemes Fellowship Research Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nemes Fellowship Research Award	This study was funded through an award from the National Institutes of Health [R15GM110631] to R.V.S. and a Nemes Fellowship Research Award to CMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, SIN INF, V78, P1; Baetz KK, 2004, MOL CELL BIOL, V24, P1232, DOI 10.1128/MCB.24.3.1232-1244.2003; Banerjee S, 2004, EUKARYOT CELL, V3, P1557, DOI 10.1128/EC.3.6.1557-1566.2004; Banerji R, 2017, BIOL OPEN, V6, P1802, DOI 10.1242/bio.026013; Banerji R, 2016, DEV DYNAM, V245, P7, DOI [10.1002/DVDY.24354, 10.1002/dvdy.24354]; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bender D, 2020, P NATL ACAD SCI USA, V117, P1081, DOI 10.1073/pnas.1911936117; Benedict B, 2020, DEV CELL, V52, P683, DOI 10.1016/j.devcel.2020.01.024; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Carvajal-Maldonado D, 2019, NUCLEIC ACIDS RES, V47, P1294, DOI 10.1093/nar/gky519; Cattoglio C, 2019, ELIFE, V8, DOI 10.7554/eLife.40164; Chakraborty U, 2018, GENETICS, V209, P439, DOI 10.1534/genetics.118.300923; Choe KN, 2017, MOL CELL, V65, P380, DOI 10.1016/j.molcel.2016.12.020; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dauban L, 2020, MOL CELL, V77, P1279, DOI 10.1016/j.molcel.2020.01.019; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; Delamarre A, 2020, MOL CELL, V77, P395, DOI 10.1016/j.molcel.2019.10.029; Devakumar LJPS, 2019, NUCLEIC ACIDS RES, V47, P6826, DOI 10.1093/nar/gkz441; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Faramarz A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0220348; Frattini C, 2017, MOL CELL, V68, P758, DOI 10.1016/j.molcel.2017.10.012; Fumasoni M, 2015, MOL CELL, V57, P812, DOI 10.1016/j.molcel.2014.12.038; Gassler J, 2017, EMBO J, V36, P3600, DOI 10.15252/embj.201798083; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Haarhuis JHI, 2017, CELL, V169, P693, DOI 10.1016/j.cell.2017.04.013; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Ivanov MP, 2018, EMBO J, V37, DOI 10.15252/embj.201797150; Johnson C, 2016, CELL REP, V16, P684, DOI 10.1016/j.celrep.2016.06.030; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kang MS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10376-w; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Kubota T, 2015, CELL REP, V12, P774, DOI 10.1016/j.celrep.2015.06.066; Kubota T, 2013, MOL CELL, V50, P273, DOI 10.1016/j.molcel.2013.02.012; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kulemzina I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002856; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Leung W, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010010; Li Q, 2012, BBA-GENE REGUL MECH, V1819, P238, DOI 10.1016/j.bbagrm.2011.06.013; Litwin I, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120581; Liu HW, 2020, MOL CELL, V78, P725, DOI 10.1016/j.molcel.2020.03.017; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; Lu S, 2014, EMBO REP, V15, P609, DOI 10.1002/embr.201337974; Maradeo ME, 2010, CELL CYCLE, V9, P4370, DOI 10.4161/cc.9.21.13634; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Marston AL, 2014, GENETICS, V196, P31, DOI 10.1534/genetics.112.145144; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; McAlear MA, 1996, GENETICS, V142, P65; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Morales C, 2020, J BIOL CHEM, V295, P146, DOI 10.1074/jbc.RA119.011099; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Myung Kyungjae, 2008, J Natl Cancer Inst Monogr, P12, DOI 10.1093/jncimonographs/lgn019; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; Nishiyama T, 2019, CURR OPIN CELL BIOL, V58, P8, DOI 10.1016/j.ceb.2018.11.006; Ohashi E, 2017, ADV EXP MED BIOL, V1042, P135, DOI 10.1007/978-981-10-6955-0_7; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Putnam CD, 2017, GENETICS, V206, P1187, DOI 10.1534/genetics.112.145805; Rao SSP, 2017, CELL, V171, P305, DOI 10.1016/j.cell.2017.09.026; Remeseiro S, 2012, EMBO J, V31, P2076, DOI 10.1038/emboj.2012.11; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075435; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Shen DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188739; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Sjogren C, 2010, EXP CELL RES, V316, P1445, DOI 10.1016/j.yexcr.2009.12.018; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Slade D, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080416; Smolikov S, 2004, P NATL ACAD SCI USA, V101, P1656, DOI 10.1073/pnas.0307796100; Song JH, 2012, J BIOL CHEM, V287, P34325, DOI 10.1074/jbc.M112.400192; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Sun HT, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007685; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tittel-Elmer M, 2012, MOL CELL, V48, P98, DOI 10.1016/j.molcel.2012.07.004; Tong K, 2015, P NATL ACAD SCI USA, V112, P7021, DOI 10.1073/pnas.1501369112; Tong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100470; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Ulrich HD, 2013, J MOL BIOL, V425, P4727, DOI 10.1016/j.jmb.2013.05.003; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Williams RM, 2020, CURR OPIN STRUC BIOL, V61, P98, DOI 10.1016/j.sbi.2019.12.010; Woodman J, 2015, MOL BIOL CELL, V26, P3754, DOI 10.1091/mbc.E15-03-0165; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Zhang JJ, 2017, EMBO REP, V18, P1294, DOI 10.15252/embr.201643807; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157; Zhang W, 2017, ELIFE, V6, DOI 10.7554/eLife.28231; Zheng G, 2018, ELIFE, V7, DOI 10.7554/eLife.33920; [No title captured]	122	3	3	18	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0235103	10.1371/journal.pone.0235103	http://dx.doi.org/10.1371/journal.pone.0235103			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075068	Green Submitted, gold, Green Published			2022-12-26	WOS:000585920200019
J	Mansor, N; Ahmad, N; Rahman, HA				Mansor, Norain; Ahmad, Norliza; Rahman, Hejar Abdul			Determinants of knowledge on sexually transmitted infections among students in public higher education institutions in Melaka state, Malaysia	PLOS ONE			English	Article								Introduction The increasing trend of sexually transmitted infections (STIs) among the young population is a significant public health problem. This study aimed to determine the level of knowledge on STIs among students in higher education institutions and its predicting factors, in Melaka. Methodology A cross-sectional study was conducted among 600 students from higher education institutions in Melaka aged between 18 to 30 years old. Multistage sampling of the institutions was performed. Valid and reliable self-administered questionnaire in the national language, Bahasa Malaysia, was used as to collect data on sociodemographic, personal background, knowledge on STIs and sources of information for STIs. Univariate, bivariate and multivariate analyses were conducted using IBM SPSS software version 25. Results The response rate for this study was 88%. The mean knowledge score was 24.1 +/- 5.1 out of 38. HIV was the most known STIs while gonorrhoea, trichomoniasis and chlamydial infections were among the least known STIs. Oral intercourse was the least known sexual activity that could transmit STIs. Higher proportion of respondents had correct knowledge on control and preventive measures of STIs (between 78% and 95%) compared to correct knowledge on sign and symptoms of STIs (between 8.5% and 67.8%). More than 90% of the respondents were unaware that a person infected with STIs could be symptom free. Four variables were identified as the determinants of the knowledge on STIs, which were level of education, place of stay, history of sexual and reproductive health education and involvement in STIs awareness programs (F (4,445) = 11.405, p <0.001, R-2 = 0.093). Conclusions The knowledge on STIs among students in higher education institutions was unsatisfactory. The existing sexual education programs can be strengthened by delivering more information on other STIs rather than focusing on HIV only. The future program should focus on students of diploma and/or skill certificate and staying off-campus.	[Mansor, Norain; Ahmad, Norliza; Rahman, Hejar Abdul] Univ Putra Malaysia, Fac Med & Hlth Sci, Community Hlth Dept, Serdang, Selangor, Malaysia; [Mansor, Norain] Minist Hlth Malaysia, Putrajaya, Malaysia	Universiti Putra Malaysia; Kementerian Kesihatan Malaysia	Ahmad, N (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Community Hlth Dept, Serdang, Selangor, Malaysia.	lizaahmad@upm.edu.my	Ahmad, Norliza/T-2302-2017	Ahmad, Norliza/0000-0001-6895-014X				Amu EO, 2015, J SEX TRANSM DIS, V2015, DOI [10.1155/2015/260126, DOI 10.1155/2015/26012626345225]; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; Anwar M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-47; Anwar M, 2010, MED PRIN PRACT, V19, P312, DOI 10.1159/000312719; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Ashcraft AM, 2017, PEDIATR CLIN N AM, V64, P305, DOI 10.1016/j.pcl.2016.11.002; Awang H, 2014, J BIOSOC SCI, V46, P214, DOI 10.1017/S0021932013000114; Barmania S, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0120-8; Centers for Disease Control and Prevention (CDC), 2017, SEX TRANSM DIS SURV; Centres for Disease Control and Prevention, 2016, SEX TRANSM INF PREV; Demis A., 2017, MOJ PUBLIC HLTH, V5, P142, DOI DOI 10.15406/MOJPH.2017.05.00140; Department of Statistic Malaysia, 2019, POP ETHN GROUP MEL, P2019; Drago F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040422; Eksi Z, 2014, PROCD SOC BEHV, V122, P465, DOI 10.1016/j.sbspro.2014.01.1374; Folasayo A. T., 2017, INT J ENV RES PUB HE, V14; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ihwani SS, J ADV REV SCI RES, V14, P12; Kumar Tarun, 2015, Indian J Sex Transm Dis AIDS, V36, P129, DOI 10.4103/0253-7184.167133; M.O.H, 2015, NAT STRAT PLAN END A; Malaysian Communications and Multimedia Commission (MCMC), 2018, HAND PHON US SURV 20; Malki BM, 2014, INT J MED SCI PUBLIC, V3, P342; MCMC, 2018, INT US SURV 2018; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Ministry of Health Malaysia, 2019, COUNTR PROGR REP HIV; Ministry of Health Malaysia (MOH), 2013, HLTH FACTS 2012; Ministry of Health Malaysia (MOH), 2018, HLTH FACTS 2017; MOH, 2013, HLTH FACTS 2013; Mokhtar MM, 2013, PROCD SOC BEHV, V85, P236, DOI 10.1016/j.sbspro.2013.08.355; National Population and Family Development Board (NPFDB), 2014, NAT POL REPR HLTH SO; Ngodji TK, 2017, INT J HEALTHCARE, P42; Norhayati MA, 2014, 3 MAL NAT AIDS C NAC; Nsuami MJ, 2010, AM J HEALTH EDUC, V41, P206, DOI 10.1080/19325037.2010.10599147; OpenDocs, 2020, I DEV STUD, V19, P1; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Qiu FF, 2017, ONCOTARGET, V8, P268, DOI 10.18632/oncotarget.13613; Rahmat Z, 2017, INT J PEPT RES THE, V216, P1; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Sharma B., 2016, ASIAN PACIFIC J HLTH, V3, P271, DOI [10.21276/apjhs.2016.3.4.43, DOI 10.21276/APJHS.2016.3.4.43]; Soleymani S, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0070-3; Svensson L, 2013, THESIS; Talib J, 2012, PROCD SOC BEHV, V59, P340, DOI 10.1016/j.sbspro.2012.09.284; United Nations Program in HIV/AIDS Asia Pacific (UNAIDSAP), 2018, ASEAN DEL SHAR INN P; World Health Organization, 2019, HIV ASS TUB ACH 2018; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2019, MORE 1 MILL NEW CUR	46	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240842	10.1371/journal.pone.0240842	http://dx.doi.org/10.1371/journal.pone.0240842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119620	gold, Green Published			2022-12-26	WOS:000600013600024
J	Mori, K; Ishikawa, K; Wada, I; Kubo, Y; Kobayashi, Y; Nakama, T; Haruta, M; Akiyama, M; Nakao, S; Yoshida, S; Sonoda, KH				Mori, Kenichiro; Ishikawa, Keijiro; Wada, Iori; Kubo, Yuki; Kobayashi, Yoshiyuki; Nakama, Takahito; Haruta, Masatoshi; Akiyama, Masato; Nakao, Shintaro; Yoshida, Shigeo; Sonoda, Koh-Hei			Changes in metamorphopsia after the treat-and-extend regimen of anti-VEGF therapy for macular edema associated with branch retinal vein occlusion	PLOS ONE			English	Article							RANIBIZUMAB	This study aims to investigate the changes in metamorphopsia after administering the treat-and-extend regimen of anti-vascular endothelial growth factor therapy for branch retinal vein occlusion-associated macular edema. We retrospectively examined 27 patients (27 eyes) with macula edema due to branch retinal vein occlusion who received intravitreal injections of anti-vascular endothelial growth factor agents using the treat-and-extend regimen for >= 18 months. We evaluated best-corrected visual acuity, central macular thickness, macular edema recurrence, and amount of metamorphopsia quantified by M-CHARTS. The best-corrected visual acuity (logarithm of minimum angle of resolution) and central macular thickness significantly improved at 18 months compared to baseline, the median value (interquartile range [IQR]), 0.30 (0.15-0.52) and 459 (373-542) mu m at baseline, and 0 (-0.08-0.16) and 267 (232-306) mu m at 18 months. The M-CHARTS score (the mean of vertical and horizontal scores) significantly decreased at 1, 6, and 12 months compared to baseline, but worsened at 18 month, the median value (IQR), 0.45 (0.250-0.925), 0.4 (0.15-0.70), 0.4 (0.150-0.625), 0.4 (0.225-0.550) and 0.45 (0.225-0.750) at baseline, 1 month, 6 months, 12 months and 18 months, respectively. The median cumulative number of macular edema recurrences was 2 (IQR, 0.5-3.0) at 18 months. Simple linear regression and multivariate analyses revealed that the change in the mean M-CHARTS score at 18 months was significantly correlated with the baseline score and the cumulative number of macular edema recurrences. Anti-vascular endothelial growth factor therapy using the treat-and-extend regimen improved metamorphopsia in branch retinal vein occlusion-related macular edema in the short to mid-term follow-up period, but not in the long term. Macular edema recurrence may be associated with persistent metamorphopsia.	[Mori, Kenichiro; Ishikawa, Keijiro; Wada, Iori; Kubo, Yuki; Kobayashi, Yoshiyuki; Nakama, Takahito; Akiyama, Masato; Nakao, Shintaro; Sonoda, Koh-Hei] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Haruta, Masatoshi; Yoshida, Shigeo] Kurume Univ, Grad Sch Med Sci, Dept Ophthalmol, Kurume, Fukuoka, Japan	Kyushu University; Kurume University	Ishikawa, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan.	keijishi@med.kyushu-u.ac.jp	Akiyama, Masato/AHC-2589-2022	Mori, Kenichiro/0000-0002-6615-7153	Japan Society for the Promotion of Science KAKENHI [17H05101]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Japan Society for the Promotion of Science KAKENHI grants 17H05101 (KI). (https://www.jsps.go.jp/j-grantsinaid/16_rule/rule.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Achiron A, 2015, ACTA OPHTHALMOL, V93, pE649, DOI 10.1111/aos.12735; Amoaku W, 2018, CLIN OPHTHALMOL, V12, P1731, DOI 10.2147/OPTH.S174560; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Clark WL, 2016, OPHTHALMOLOGY, V123, P330, DOI 10.1016/j.ophtha.2015.09.035; Guichard MM, 2018, OPHTHALMIC RES, V60, P29, DOI 10.1159/000487489; Iijima H, 2018, JPN J OPHTHALMOL, V62, P265, DOI 10.1007/s10384-018-0586-5; Lardenoye CWTA, 2000, INVEST OPHTH VIS SCI, V41, P4048; Matsumoto C, 2003, INVEST OPHTH VIS SCI, V44, P4012, DOI 10.1167/iovs.03-0117; Murakami T, 2007, AM J OPHTHALMOL, V143, P171, DOI 10.1016/j.ajo.2006.08.030; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sugiura Y, 2018, RETINA-J RET VIT DIS, V38, P1581, DOI 10.1097/IAE.0000000000001740; Tadayoni R, 2017, OPHTHALMOLOGY, V124, P1778, DOI 10.1016/j.ophtha.2017.06.027; Tanikawa A, 2018, JPN J OPHTHALMOL, V62, P280, DOI 10.1007/s10384-018-0581-x; Wada I, 2017, CLIN OPHTHALMOL, V11, P1719, DOI 10.2147/OPTH.S144981	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241343	10.1371/journal.pone.0241343	http://dx.doi.org/10.1371/journal.pone.0241343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112920	gold, Green Published			2022-12-26	WOS:000588374000057
J	Canitz, J; Kirschbaum, F; Tiedemann, R				Canitz, Julia; Kirschbaum, Frank; Tiedemann, Ralph			Transcriptome-wide single nucleotide polymorphisms related to electric organ discharge differentiation among African weakly electric fish species	PLOS ONE			English	Article							GENUS CAMPYLOMORMYRUS MORMYRIDAE; FACTOR-KAPPA-B; SKELETAL-MUSCLE; SEX-DIFFERENCES; EVOLUTION; NOTCH; MORPHOLOGY; COMMUNICATION; RECOGNITION; ANNOTATION	African weakly electric fish of the mormyrid genus Campylomormyrus generate pulse-type electric organ discharges (EODs) for orientation and communication. Their pulse durations are species-specific and elongated EODs are a derived trait. So far, differential gene expression among tissue-specific transcriptomes across species with different pulses and point mutations in single ion channel genes indicate a relation of pulse duration and electrocyte geometry/excitability. However, a comprehensive assessment of expressed Single Nucleotide Polymorphisms (SNPs) throughout the entire transcriptome of African weakly electric fish, with the potential to identify further genes influencing EOD duration, is still lacking. This is of particular value, as discharge duration is likely based on multiple cellular mechanisms and various genes. Here we provide the first transcriptome-wide SNP analysis of African weakly electric fish species (genus Campylomormyrus) differing by EOD duration to identify candidate genes and cellular mechanisms potentially involved in the determination of an elongated discharge of C. tshokwe. Non-synonymous substitutions specific to C. tshokwe were found in 27 candidate genes with inferred positive selection among Campylomormyrus species. These candidate genes had mainly functions linked to transcriptional regulation, cell proliferation and cell differentiation. Further, by comparing gene annotations between C. compressirostris (ancestral short EOD) and C. tshokwe (derived elongated EOD), we identified 27 GO terms and 2 KEGG pathway categories for which C. tshokwe significantly more frequently exhibited a species-specific expressed substitution than C. compressirostris. The results indicate that transcriptional regulation as well cell proliferation and differentiation take part in the determination of elongated pulse durations in C. tshokwe. Those cellular processes are pivotal for tissue morphogenesis and might determine the shape of electric organs supporting the observed correlation between electrocyte geometry/tissue structure and discharge duration. The inferred expressed SNPs and their functional implications are a valuable resource for future investigations on EOD durations.	[Canitz, Julia; Kirschbaum, Frank; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Kirschbaum, Frank] Humboldt Univ, Fac Life Sci, Dept Crop & Anim Sci, Berlin, Germany	University of Potsdam; Humboldt University of Berlin	Tiedemann, R (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany.	tiedeman@uni-potsdam.de		Tiedemann, Ralph/0000-0002-2604-6336; Canitz, Julia/0000-0003-0193-190X	University of Potsdam	University of Potsdam	JC and RT were funded by the University of Potsdam.; The authors would like to acknowledge Michael Lenhard and Christian Kappel, University of Potsdam, for providing an access to their computational server to perform bioinformatical analyses. We also want to thank Ina-Maria Schedina and Sofia Paraskevopoulou for their support solving bioinformatical problems. Financial support was provided by the University of Potsdam.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; AlvesGomes J, 1997, BRAIN BEHAV EVOLUT, V49, P324, DOI 10.1159/000113001; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; Assis CA, 2003, J FISH BIOL, V62, P1268, DOI 10.1046/j.1095-8649.2003.00106.x; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Bass A.H., 1986, P13; BASS AH, 1985, J COMP PHYSIOL A, V156, P587, DOI 10.1007/BF00619109; BASS AH, 1986, J COMP NEUROL, V244, P313, DOI 10.1002/cne.902440305; BASS AH, 1986, J COMP NEUROL, V254, P511, DOI 10.1002/cne.902540405; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bennett MVL, 1961, STUDIES MORPHOLOGY E, P113; Carlson BA, 2016, J EXP BIOL, V219, P31, DOI 10.1242/jeb.127720; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras-Cornejo H, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0025-2; DENIZOT JP, 1978, J NEUROCYTOL, V7, P165, DOI 10.1007/BF01217916; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Farber SA, 2003, GENOME RES, V13, P1082, DOI 10.1101/gr.479603; Fast MD, 2002, COMP BIOCHEM PHYS A, V132, P645, DOI 10.1016/S1095-6433(02)00109-5; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; FREEDMAN EG, 1989, J NEUROBIOL, V20, P619, DOI 10.1002/neu.480200703; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gallant JR, 2012, J EXP BIOL, V215, P2479, DOI 10.1242/jeb.063222; Gallant JR, 2011, J COMP PHYSIOL A, V197, P799, DOI 10.1007/s00359-011-0643-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gratten J, 2007, P ROY SOC B-BIOL SCI, V274, P619, DOI 10.1098/rspb.2006.3762; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Guth Robert, 2016, J Physiol Paris, V110, P233, DOI 10.1016/j.jphysparis.2016.11.005; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hassin S, 1999, BIOL REPROD, V61, P1608, DOI 10.1095/biolreprod61.6.1608; He HJ, 2011, MOL BIOL+, V45, P451, DOI 10.1134/S0026893311020099; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hofmann A, 2000, BIOCHEMISTRY-US, V39, P7712, DOI 10.1021/bi992359+; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Ishidate T, 2018, MOL CELL, V70, P639, DOI 10.1016/j.molcel.2018.04.009; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kirschbaum Frank, 2016, J Physiol Paris, V110, P281, DOI 10.1016/j.jphysparis.2017.01.003; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Korniienko Y, 2020, J COMP PHYSIOL A, V206, P571, DOI 10.1007/s00359-020-01425-7; KRAMER B, 1994, ANIM BEHAV, V48, P435, DOI 10.1006/anbe.1994.1257; Lamanna F, 2016, MOL PHYLOGENET EVOL, V101, P8, DOI 10.1016/j.ympev.2016.04.035; Lamanna F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1858-9; Lamanna F, 2014, MOL ECOL RESOUR, V14, P1222, DOI 10.1111/1755-0998.12260; LANDSMAN RE, 1988, EXPERIENTIA, V44, P900, DOI 10.1007/BF01941196; Lecat A, 2012, J BIOL CHEM, V287, P29213, DOI 10.1074/jbc.M112.355545; Li YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09288; Liao CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199990; Nguyen L, 2017, ENVIRON BIOL FISH, V100, P49, DOI 10.1007/s10641-016-0554-1; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Luo YL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2125-9; MacGrogan D, 2011, BIRTH DEFECTS RES A, V91, P449, DOI 10.1002/bdra.20815; Maqueen DJ, 2008, DEV GENES EVOL, V218, DOI [10.1007/s00427-007-0194-8, DOI 10.1007/S00427-007-0194-818074148]; Martin MD, 2016, ANIM BEHAV, V112, P179, DOI 10.1016/j.anbehav.2015.11.027; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; McCallum D, ALLTO MARKET RES; Meadows SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132580; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MOLLER P, 1970, ANIM BEHAV, V18, P768, DOI 10.1016/0003-3472(70)90026-6; Moriya Y, KAAS KEGG AUTOMATIC; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Nagel R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29132-z; Nagel R, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170443; Nagel R, 2017, J COMP PHYSIOL A, V203, P183, DOI 10.1007/s00359-017-1151-2; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Paul C, 2016, J MOL EVOL, V83, P61, DOI 10.1007/s00239-016-9754-8; Paul C, 2015, J COMP PHYSIOL A, V201, P357, DOI 10.1007/s00359-015-0995-6; Rohlfing K, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0597-0; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; SMITHVANIZ WF, 1995, MAR BIOL, V121, P573, DOI 10.1007/BF00349291; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Swapna I, 2018, CURR BIOL, V28, P2094, DOI 10.1016/j.cub.2018.05.012; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Tiedemann R, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P307, DOI 10.1007/978-3-642-12425-9_15; van Rijssel JC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2630; Wei YY, 2016, ONCOTARGET, V7, P70420, DOI 10.18632/oncotarget.11895; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zakon HH, 2009, INTEGR ZOOL, V4, P64, DOI 10.1111/j.1749-4877.2008.00136.x; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zhang JX, 2001, J VIROL, V75, P2946, DOI 10.1128/JVI.75.6.2946-2956.2001; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	89	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240812	10.1371/journal.pone.0240812	http://dx.doi.org/10.1371/journal.pone.0240812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108393	Green Published, gold			2022-12-26	WOS:000588372400039
J	Hein, NA; Bagenda, DS; Luo, JT				Hein, Nicholas A.; Bagenda, Danstan S.; Luo, Jiangtao			The President's Emergency Plan for AIDS Relief and adult mortality: A replication study of HIV development assistance effects in Sub-Saharan African countries	PLOS ONE			English	Article								The US budget for global health funding, which was by far the largest of similar funding in the world, increased from US $1.3 billion in 2001 to more than US $10 billion in recent years. More than 54% of this funding was allocated to the Global Fund to Fight HIV/AIDS through the US President's Emergency Plan for AIDS Relief (PEPFAR) in Africa. However, recent studies indicate contradictory results regarding the effectiveness of PEPFAR. One by Bendavid, Holmes, Bhattacharya, and Miller shows positive effects of PEPFAR in reducing adult mortality in Africa, while another by Duber, Coates, Szekeras, Kaji, and Lewis finds that there are no significant differences in reducing adult mortality in countries that received PEPFAR funding vs countries that did not. Due to their potential impact on policy decisions regarding critical global health funding, we wanted to assess why the results are discrepant. To do this, we replicated the Bendavid study. The replication provides verification that the study replicable and that the analytic choices of the authors are robust to different assumptions or restrictions. This allows us to assess the different choices and data available to the two research groups and draw some conclusions about why the results may be different. Then, focusing on two of the prominently discrepant studies, i.e., the Bendavid study (1998-2008) and the Duber study (2000-2006), we establish why the two studies are in disagreement. We apply appropriate individual-level and country-level analytical methodology as used by Bendavid over the analytical time period used for the Duber study (2000-2006), which originally focused on nationally aggregated data and differed in some key focus countries. For our first objective, we replicated the original Bendavid study findings and our findings support their conclusion that between 1998-2008 all-cause mortality decreased significantly more (OR = 0.84, CI, 0.72-0.99) in countries that implemented PEPFAR. For our second objective (Bendavid's data and methodology applied to Duber's study period), we found reduction in all cause adult mortality to be borderline insignificant (OR = 0.87 CI, 0.75-1.01, p = 0.06), most possibly reflecting the abbreviated fewer number of events and sample size over a shorter period. Therefore, our overall analyses are consistent with the conclusion of positive impact of the PEPFAR program in reducing adult mortality. We believe that the discrepancy observed in the original studies mainly a reflection of shortcomings in the analytical approach necessitated by the Duber study's nationally aggregated dataset or "may reflect a lack of data quality" in the Duber study (Duber, et al. 2010).	[Hein, Nicholas A.] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA; [Bagenda, Danstan S.] Univ Nebraska Med Ctr, Dept Anesthesiol, Coll Med, Omaha, NE USA; [Luo, Jiangtao] Eastern Virginia Med Sch, EVMS Sentara Healthcare Analyt & Delivery Sci Ins, Norfolk, VA 23501 USA; [Luo, Jiangtao] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Eastern Virginia Medical School; Eastern Virginia Medical School	Luo, JT (corresponding author), Eastern Virginia Med Sch, EVMS Sentara Healthcare Analyt & Delivery Sci Ins, Norfolk, VA 23501 USA.; Luo, JT (corresponding author), Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA.	luoj@evms.edu			International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation	International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The International Initiative for Impact Evaluation (3ie) to JL and The Bill & Melinda Gates Foundation helped fund this report. All content, errors and omissions are the sole responsibility of the authors and do not represent the opinions of 3ie, its donors or its Board of Commissioners.	[Anonymous], **NON-TRADITIONAL**; Bendavid E, 2014, JAMA INTERN MED, V174, P881, DOI 10.1001/jamainternmed.2014.292; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Brown AN, 2016, WHATS 1 REPLICATION; Dabiq, 2014, DABIQ, V6, P3; Duber HC, 2010, J INT AIDS SOC, P13, DOI [10.1186/1758-2652-13-13, DOI 10.1186/1758-2652-13-13]; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P2097, DOI 10.1001/jama.2012.4989; Fay MP, 1997, STAT MED, V16, P791; Glassman A., 2013, MORE HLTH MONEY PUTT; Hein N, 2018, PRESIDENTS EMERGENCY; Hein N, 2016, HIV DEV ASSISTANCE A; Hein N, 2017, HIV DEV ASSISTANCE A; Kaiser Family Foundation, US GLOB HLTH BUDG HI; Kaufmann D, 2011, HAGUE J RULE LAW, V3, P220, DOI 10.1017/S1876404511200046; Luo J, 2016, REPLICATION PLAN; Shelton JD, 2012, JAMA-J AM MED ASSOC, V308, P972, DOI 10.1001/jama.2012.9243; Valentine A, 2016, US GLOBAL HLTH BUDGE; **DATA OBJECT**	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0233948	10.1371/journal.pone.0233948	http://dx.doi.org/10.1371/journal.pone.0233948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104731	Green Published, gold			2022-12-26	WOS:000588370000031
J	Duggleby, RC; Tsang, HP; Strange, K; McWhinnie, A; Lamikanra, AA; Roberts, DJ; Hernandez, D; Madrigal, JA; Danby, RD				Duggleby, Richard C.; Tsang, Hoi Pat; Strange, Kathryn; McWhinnie, Alasdair; Lamikanra, Abigail A.; Roberts, David J.; Hernandez, Diana; Madrigal, J. Alejandro; Danby, Robert D.			Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR	PLOS ONE			English	Article							EXPRESSION; PREDICTION; POTENCY; GRAFTS; TREGS	Background Allogeneic haematopoietic cell transplantation (HCT) is a curative therapy for severe haematological disorders. However, it carries significant risk of morbidity and mortality. To improve patient outcomes, better graft selection strategies are needed, incorporating HLA matching with clinically important graft characteristics. Studies have shown that the cellular content of HCT grafts, specifically higher ratios of T regulatory (Tregs)/T cells, are important factors influencing outcomes when using adult peripheral blood mobilised grafts. So far, no equivalent study exists in umbilical cord blood (CB) transplantation due to the limitations of cryopreserved CB samples. Study design and methods To establish the most robust and efficient way to measure the Treg content of previously cryopreserved CB units, we compared the enumeration of Treg and CD3+ cells using flow cytometry and an epigenetic, DNA-based methodology. The two methods were assessed for their agreement, consistency and susceptibility to error when enumerating Treg and CD3+ cell numbers in both fresh and cryopreserved CB samples. Results Epigenetic enumeration gave consistent and comparable results in both fresh and frozen CB samples. By contrast, assessment of Tregs and CD3+ cells by flow cytometry was only possible in fresh samples due to significant cell death following cryopreservation and thawing. Conclusion Epigenetic assessment offers significant advantages over flow cytometry for analysing cryopreserved CB; similar cell numbers were observed both in fresh and frozen samples. Furthermore, multiple epigenetic assessments can be performed from DNA extracted from small cryopreserved CB segments; often the only CB sample available for clinical studies.	[Duggleby, Richard C.; Strange, Kathryn; McWhinnie, Alasdair; Hernandez, Diana; Madrigal, J. Alejandro; Danby, Robert D.] Anthony Nolan Res Inst, London, England; [Duggleby, Richard C.; Strange, Kathryn; Hernandez, Diana; Danby, Robert D.] UCL, UCL Canc Inst, London, England; [Tsang, Hoi Pat; Lamikanra, Abigail A.; Roberts, David J.] Natl Hlth Serv Blood & Transplant, Oxford, England; [Tsang, Hoi Pat; Lamikanra, Abigail A.; Roberts, David J.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Madrigal, J. Alejandro] Royal Free NHS Trust, UCL Canc Inst, London, England; [Danby, Robert D.] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England	University of London; University College London; NHS Blood & Transplant (NHSBT); University of Oxford; University of London; University College London; Oxford University Hospitals NHS Foundation Trust	Duggleby, RC (corresponding author), Anthony Nolan Res Inst, London, England.; Duggleby, RC (corresponding author), UCL, UCL Canc Inst, London, England.	Richard.Duggleby@anthonynolan.org	Hernandez, Diana/AAE-4613-2021; Danby, Robert/AAE-7955-2021; Duggleby, Richard/AAE-7134-2021	Hernandez, Diana/0000-0002-1353-2175; Danby, Robert/0000-0002-2985-7222	Anthony Nolan [803716/SC038827]; NHS Blood and Transplant intra mural funding	Anthony Nolan; NHS Blood and Transplant intra mural funding	The Anthony Nolan Research Institute is part of the Anthony Nolan, a registered charity (803716/SC038827). Authors Hoi Pat Tsang, Abigail A. Lamikanra, and David J. Roberts were supported by NHS Blood and Transplant intra mural funding.	Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Danby RD, 2016, BONE MARROW TRANSPL, V51, P110, DOI 10.1038/bmt.2015.215; Dawson NAJ, 2018, EUR J IMMUNOL, V48, P1415, DOI 10.1002/eji.201747407; De Vos J, 2014, PATHOL BIOL, V62, P218, DOI 10.1016/j.patbio.2014.05.005; Duggleby RC, 2012, TRANSFUSION, V52, P549, DOI 10.1111/j.1537-2995.2011.03305.x; Duggleby RC, 2014, METHODS MOL BIOL, V1109, P159, DOI 10.1007/978-1-4614-9437-9_10; Faivre L, 2017, BONE MARROW TRANSPL, V52, P1353, DOI 10.1038/bmt.2017.150; Figueroa-Tentori D, 2008, J IMMUNOL METHODS, V339, P228, DOI 10.1016/j.jim.2008.09.019; Fujimaki W, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/305859; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Lamikanra AA, 2017, CYTOTHERAPY, V19, P440, DOI 10.1016/j.jcyt.2016.12.004; Le Boedec K, 2016, VET CLIN PATH, V45, P648, DOI 10.1111/vcp.12390; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013267; Luciano AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095867; Querol S, 2010, BONE MARROW TRANSPL, V45, P970, DOI 10.1038/bmt.2010.7; Radke TF, 2013, STEMCELLS INT, V2013; Rodriguez L, 2004, VOX SANG, V87, P165, DOI 10.1111/j.1423-0410.2004.00550.x; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Sattui S, 2012, CYTOM PART B-CLIN CY, V82B, P54, DOI 10.1002/cyto.b.20621; Schwandt S, 2017, CYTOTHERAPY, V19, P962, DOI 10.1016/j.jcyt.2017.05.005; Seay HR, 2017, MOL THER-METH CLIN D, V4, P178, DOI 10.1016/j.omtm.2016.12.003; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sehouli J, 2011, EPIGENETICS-US, V6, P236, DOI 10.4161/epi.6.2.13755; Syrett CM, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03087; Tommasini A, 2002, CLIN EXP IMMUNOL, V130, P127, DOI 10.1046/j.1365-2249.2002.01940.x; Wang JL, 2016, P NATL ACAD SCI USA, V113, pE2029, DOI 10.1073/pnas.1520113113; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zhuo CH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-153	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240190	10.1371/journal.pone.0240190	http://dx.doi.org/10.1371/journal.pone.0240190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095809	Green Published, gold			2022-12-26	WOS:000586649400007
J	Wei, JY; Wang, L; Yang, X				Wei, Jinyu; Wang, Li; Yang, Xin			Game analysis on the evolution of COVID-19 epidemic under the prevention and control measures of the government	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA; RISK	In this paper, the interaction strategies and the evolutionary game analysis of the actions taken by the government and the public in the early days of the epidemic are incorporated into the natural transmission mechanism model of the epidemic, and then the transmission frequency equations of COVID-19 epidemic is established. According to the cumulative confirmed cases of COVID-19 in the UK and China, the upper limit of the spread of COVID-19 in different evolutionary scenarios is set. Using SPSS to perform logistic curve fitting, the frequency fitting equations of cumulative confirmed cases under different evolution scenarios are obtained respectively. The analysis result shows that the emergency response strategy adopted by the government in the early days of the epidemic can effectively control the spread of the epidemic. Combined with the transmission frequency equation of COVID-19 epidemic, measures taken by the government are analyzed. The influence of each measure on the frequency variable is judged and then the influence on the spread of the epidemic is obtained. Finally, based on the above analysis, the government is advised to adhere to the principles of scientific, initiative and flexibility when facing major epidemics.	[Wei, Jinyu; Wang, Li] Tianjin Univ Technol, Sch Management, Tianjin, Peoples R China; [Yang, Xin] Tianjin Univ Technol, Zhonghuan Informat Coll, Tianjin, Peoples R China	Tianjin University of Technology; Tianjin University of Technology	Yang, X (corresponding author), Tianjin Univ Technol, Zhonghuan Informat Coll, Tianjin, Peoples R China.	wing.lps@163.com			Tianjin Enterprise Science and Technology Commissioner Project [19JCTPJC59800]	Tianjin Enterprise Science and Technology Commissioner Project	This paper is supported by Tianjin Enterprise Science and Technology Commissioner Project (Project No: 19JCTPJC59800).	[Anonymous], 2014, ENTOMOL GEN, V35, P87; Balogova M, 2016, HERPETOZOA, V28, P167; Cao Zhi-dong, 2009, Fudan Xuebao Zirankexueban, V48, P793; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chen LJ, 2020, EMERG MICROBES INFEC, V9, P313, DOI 10.1080/22221751.2020.1725399; Cui B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4364-y; Endo A, 2018, ANN EPIDEMIOL, V28, P293, DOI 10.1016/j.annepidem.2018.02.011; Jin X, 2018, J DOMESTIC ANIMAL EC, V39, P69; Kleczkowski A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2336-7; Li L, 2009, J BIOL SYST, V17, P319, DOI 10.1142/S021833900900279X; Li Y., 2014, CHINESE J MANAGEMENT, V22, P74; [李仲来 Li Zhonglai], 2003, [遥感学报, Journal of Remote Sensing], V7, P345; Lv YJ, 2014, SE ASIAN STUDIES, P4; Maynard Smith J., 1982, pi; Mei S, 2016, MANAGE REV, V28, P158; Poletti Piero, 2011, PLoS One, V6, pe16460, DOI 10.1371/journal.pone.0016460; Qi X, 2009, J TIANJIN ADM CADRE, V25, P59; Ren YQ, 2015, WORLD HIST, P66; Santermans E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147172; Sega L, 2015, J BIOL DYNAM, V9, P229, DOI 10.1080/17513758.2015.1065351; Sethi R, 1998, GAME ECON BEHAV, V23, P284, DOI 10.1006/game.1997.0613; Taherkhani R, 2017, WORLD J HEPATOL, V9, P1040, DOI 10.4254/wjh.v9.i24.1040; [谈树萍 TAN Shuping], 2005, [生物数学学报, Journal of Biomathematics], V20, P392; Wessel L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S2; Yang YY, 2022, J CLIN NURS, V31, P1972, DOI 10.1111/jocn.15190; Zhang GQ, 2003, MANAGEMENT WORLD, P42; [张皓 Zhang Hao], 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P756; Zheng HE, 2016, J NANJING AGR U SOCI, V16, P9; Zhu YH, 2020, NEUROSCI BULL, V36, P299, DOI 10.1007/s12264-020-00476-9; [祖正虎 Zu Zhenghu], 2015, [系统工程理论与实践, Systems Engineering-Theory & Practice], V35, P2513	30	9	9	12	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240961	10.1371/journal.pone.0240961	http://dx.doi.org/10.1371/journal.pone.0240961			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095788	gold, Green Published			2022-12-26	WOS:000586649400026
J	Ahinkorah, BO				Ahinkorah, Bright Opoku			Individual and contextual factors associated with mistimed and unwanted pregnancies among adolescent girls and young women in selected high fertility countries in sub-Saharan Africa: A multilevel mixed effects analysis	PLOS ONE			English	Article							UNPLANNED PREGNANCY; HEALTH SURVEYS; TRANSITION; CHILDBEARING	Introduction Unintended pregnancies are associated with a number of risk factors such as malnutrition, mental illness, unsafe abortion, maternal mortality and horizontal transmission of HIV to children. These risks are predominant among adolescent girls and young women compared to older women. This study examined the individual and contextual factors associated with unintended pregnancy among adolescent girls and young women in selected high fertility countries in sub-Saharan Africa. Materials and methods Data for this study was obtained from recent Demographic and Health Surveys carried out between 2010 and 2018 in 10 countries in sub-Sahara Africa. The sample size for this study was made up of 6,791 adolescent girls and young women (aged 15-24), who were pregnant during the surveys and had complete responses on all the variables considered in the study. Unintended pregnancy was the outcome variable in this study. Descriptive and multilevel logistic regression analyses were performed and the fixed effect results of the multilevel logistic regression analysis were reported as adjusted odds ratios at 95% confidence interval. Results Unintended pregnancy in the selected countries was 22.4%, with Angola, recording the highest prevalence of 46.6% while Gambia had the lowest prevalence of 10.2%. The likelihood of unintended pregnancy was high among adolescent girls and young women aged 15-19 [aOR = 1.48; 95% CI = 1.26-1.73], those with primary [aOR = 1.99; 95% CI = 1.69-2.33] and secondary/higher [aOR = 2.30; 95% CI = 1.90-2.78] levels of education, single (never married/separated/divorced/widowed) adolescent girls and young women [aOR = 9.23; 95% CI = 7.55-11.28] and those who were cohabiting [aOR = 2.53; 95% CI = 2.16-2.96]. The odds of unintended pregnancy also increased with increasing birth order, with adolescent girls and young women having three or more births more likely to have unintended pregnancies compared to those with one birth [aOR = 1.99; 95% CI = 1.59-2.48]. Adolescent girls and young women who had ever used contraceptives (modern or traditional), had higher odds of unintended pregnancies compared to those who had never used contraceptives [aOR = 1.32; 95% CI = 1.12-1.54]. Finally, adolescent girls and young women who belonged to the rich wealth quintile were more likely to have unintended pregnancy compared to those in the poor wealth quintile [1.28; 95% CI = 1.08-1.51]. Conclusion The study found that age, marital status, level of education, parity, use of contraceptives and wealth quintile are associated with unintended pregnancy among adolescent girls and young women in high fertility sub-Saharan African countries. These findings call for the need for government and non-governmental organisations in high fertility sub-Saharan African countries to restructure sexual and reproductive health services, taking into consideration these individual and contextual level characteristics of adolescent girls and young women.	[Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Liverpool, Australia	University of Technology Sydney	Ahinkorah, BO (corresponding author), Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Liverpool, Australia.	brightahinkorah@gmail.com						Abajobir AA, 2016, J AFFECT DISORDERS, V192, P56, DOI 10.1016/j.jad.2015.12.008; Adeniyi OV, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2942-z; Ahinkorah BO, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100601; Ahinkorah BO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223389; Ajayi AI, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5522-6; Akella D, 2014, J HLTH DISPARITIES R, V8, P3; Akers R.L., 2004, CRIMINOLOGICAL THEOR, V4; Ameyaw EK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220970; Ameyaw Edward Kwabena, 2018, Matern Health Neonatol Perinatol, V4, P17, DOI 10.1186/s40748-018-0085-1; Amo-Adjei J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3842-y; [Anonymous], 2020, Cancer Discov, V10, pOF8, DOI 10.1158/2159-8290.CD-ND2020-008; [Anonymous], 2018, MED LETT DRUGS THER, V60, P1; [Anonymous], 2020, TOTAL FERTILITY RATE; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 1995, EUROPA ORIENTALIS, VXIV, P217; [Anonymous], 2015, UNINTENDED PREGNANCY; Austad K, 2016, GLOB HEALTH-SCI PRAC, V4, P342, DOI 10.9745/GHSP-D-16-00044; Bandura Albert, 1977, SOCIAL LEARNING THEO; Baschieri A, 2017, MATERN CHILD HLTH J, V21, P467, DOI 10.1007/s10995-016-2124-8; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Bellizzi S, 2020, CONTRACEPTION, V101, P26, DOI 10.1016/j.contraception.2019.09.006; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Bongaarts J, 1997, STUD FAMILY PLANN, V28, P267, DOI 10.2307/2137858; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; Bryant J, 2007, POPUL DEV REV, V33, P101, DOI 10.1111/j.1728-4457.2007.00160.x; Calvert C, 2013, J FAM PLAN REPROD H, V39, P1, DOI 10.1136/jfprhc-2012-100389; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Claridge AM, 2013, WOMEN HEALTH, V53, P777, DOI 10.1080/03630242.2013.831018; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Collins IJ, 2019, LANCET HIV, V6, pE105, DOI 10.1016/S2352-3018(18)30319-9; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Davis K, 1945, ANN AM ACAD POLIT SS, V237, P1, DOI 10.1177/000271624523700102; Decker Martha, 2011, Afr J Reprod Health, V15, P68; Divya V, 2013, PREGNANCY INTENTIONS; Eliason S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-261; Exavery A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-63; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Geda Y, 2019, CURR MED ISSUES, V17, P112, DOI [10.4103/cmi.cmi_12_19, DOI 10.4103/CMI.CMI_12_19]; Gottschalk LB, 2014, CONTRACEPTION, V90, P211, DOI 10.1016/j.contraception.2014.04.017; Habib MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1339-z; Huda TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211113; Kirk D, 1996, POP STUD-J DEMOG, V50, P361, DOI 10.1080/0032472031000149536; McNicoll G, 2009, POPUL DEV REV, V35, P777, DOI 10.1111/j.1728-4457.2009.00308.x; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Nations U., 2017, WORLD POP PROSP 2017; Notestein F., 1945, FOOD WORLD, P36; Palamuleni M. E., 2014, African Population Studies, V28, P551, DOI 10.11564/28-1-507; Potter Robert G., 1983, FERTILITY BIOL BEHAV; Ritchwood TD, 2015, CHILD YOUTH SERV REV, V52, P74, DOI 10.1016/j.childyouth.2015.03.005; ROSENTHAL DA, 1992, AUST PSYCHOL, V27, P166, DOI 10.1080/00050069208257605; Santhya KG, 2015, GLOB PUBLIC HEALTH, V10, P189, DOI 10.1080/17441692.2014.986169; Seidu AA, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2019.100459; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith T, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1469-8; Solanke BL, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0093-1; Tsui A, 1997, BUILDING SOLUTIONS, P130; Vazquez-Nava F, 2014, J URBAN HEALTH, V91, P176, DOI 10.1007/s11524-013-9819-6; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3	63	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241050	10.1371/journal.pone.0241050	http://dx.doi.org/10.1371/journal.pone.0241050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091050	Green Published, gold			2022-12-26	WOS:000586647200026
J	Lee, DY; Kyung, MG; Cho, YJ; Hwang, S; Kang, HW; Lee, DO				Lee, Dong Yeon; Kyung, Min Gyu; Cho, Yun Jae; Hwang, Seongjae; Kang, Ho Won; Lee, Dong-Oh			A modified transfibular technique of ankle arthrodesis using partial fibular resection and onlay bone graft	PLOS ONE			English	Article							CANCELLOUS-BONE; FOLLOW-UP; CONVERSION; FIXATION; SCREWS	The transfibular approach is a common procedure for tibiotalar fusion. However, this technique has several concerns: inadequate stability to resist rotational and shearing forces, a fibula is suboptimal for bone grafting, and an onlay fibular graft that might prevent impacting and cause distraction. We present a modified transfibular technique using partial fibular resection and onlay bone graft, which may address these potential problems. This study aimed to evaluate whether the ankle joint is well fused with neutral alignment and functionally improved at the final follow-up. For this study, 27 consecutive patients (mean age, 68.5 years; range, 58-83) who underwent tibiotalar fusion with a follow-up period of >1 year were retrospectively included. A modified transfibular lateral approach was performed, in which the distal anterior half fibula was resected and fixed as an onlay graft to achieve fusion between the tibia, fibula, talus, and fibular onlay graft simultaneously. Radiographic outcomes were assessed using computed tomography at 4 months after operation and serial follow-up radiographs. Functional outcomes were assessed using the American Orthopedic Foot and Ankle Society hindfoot scale and Foot and Ankle Outcome Score. The mean follow-up period was 17.3 (range, 12-32) months. Four months after operation, complete union was achieved in 13 patients, near-complete union in 8 patients, and partial union in the remaining 6 patients. At the final follow-up, all the patients achieved complete union and maintained neutral ankle alignment. The functional outcome showed a significant increase between the preoperative and postoperative periods. One minor complication occurred, in which medial side ankle pain was relieved after screw removal. This modified technique is safe and effective, and has several merits, including saving the soft tissue of the anterior ankle, saving the course of the peroneal tendons by leaving the posterior half of the fibula, resected fibula serving as a good bone stock, and reducing the likelihood of valgus deformity after fibulectomy.	[Lee, Dong Yeon; Kyung, Min Gyu; Hwang, Seongjae; Kang, Ho Won; Lee, Dong-Oh] Seoul Natl Univ Hosp, Dept Orthoped Surg, Seoul, South Korea; [Cho, Yun Jae] Hanil Gen Hosp, Dept Orthoped Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Lee, DY (corresponding author), Seoul Natl Univ Hosp, Dept Orthoped Surg, Seoul, South Korea.	leedy@snu.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science & ICT, Republic of Korea [NRF-2017M3A9E2063104]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science & ICT, Republic of Korea	This study was supported by a grant (NRF-2017M3A9E2063104) from the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2015, MINIMALLY INVASIVE S; Akra GA, 2010, J FOOT ANKLE SURG, V49, P508, DOI 10.1053/j.jfas.2010.07.004; Balaji SM, 2017, INDIAN J ORTHOP, V51, P75, DOI 10.4103/0019-5413.197549; Choi IH, 2011, J PEDIATR ORTHOPED, V31, P697, DOI 10.1097/BPO.0b013e318221ebce; Coester LM, 2001, J BONE JOINT SURG AM, V83A, P219, DOI 10.2106/00004623-200102000-00009; Colman AB, 2007, FOOT ANKLE INT, V28, P303, DOI 10.3113/FAI.2007.0303; Fragomen AT, 2012, CLIN ORTHOP RELAT R, V470, P2864, DOI 10.1007/s11999-012-2470-9; FREY C, 1994, FOOT ANKLE INT, V15, P581, DOI 10.1177/107110079401501102; Fuchs S, 2003, J BONE JOINT SURG BR, V85B, P994, DOI 10.1302/0301-620X.85B7.13984; Fujimori J, 1999, FOOT ANKLE INT, V20, P485, DOI 10.1177/107110079902000804; Greisberg J, 2004, CLIN ORTHOP RELAT R, P80, DOI 10.1097/01.blo.0000132460.27102.d6; HELM R, 1990, J BONE JOINT SURG BR, V72, P141, DOI 10.1302/0301-620X.72B1.2298774; Hintermann B, 2009, J BONE JOINT SURG AM, V91A, P850, DOI 10.2106/JBJS.H.00229; Horwitz T., 1942, AM J SURG, V55, P550, DOI [10.1016/S0002-9610(42)90921-8, DOI 10.1016/S0002-9610(42)90921-8]; Kennedy JG, 2006, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000203480.04174.0e; Kim JG, 2018, CLIN ORTHOP SURG, V10, P368, DOI 10.4055/cios.2018.10.3.368; KIRKPATRICK JS, 1991, CLIN ORTHOP RELAT R, P29; LANCE EM, 1979, CLIN ORTHOP RELAT R, P146; Lawton CD, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0576-1; Lee HJ, 2016, J ORTHOP SURG-HONG K, V24, P101, DOI 10.1177/230949901602400123; MANN RA, 1991, CLIN ORTHOP RELAT R, P49; MYERSON MS, 1991, CLIN ORTHOP RELAT R, P84; Nihal Aneel, 2008, Foot Ankle Surg, V14, P1, DOI 10.1016/j.fas.2007.08.004; Pellegrini MJ, 2015, J BONE JOINT SURG AM, V97A, P2004, DOI 10.2106/JBJS.O.00396; Rowan R, 1999, J BONE JOINT SURG BR, V81B, P113, DOI 10.1302/0301-620X.81B1.8999; Sandberg OH, 2016, ACTA ORTHOP, V87, P459, DOI 10.1080/17453674.2016.1205172; Schuberth John M, 2005, J Foot Ankle Surg, V44, P125, DOI 10.1053/j.jfas.2005.01.012; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith JT, 2013, FOOT ANKLE INT, V34, P557, DOI 10.1177/1071100713477617; SWARD L, 1992, J BONE JOINT SURG BR, V74, P752, DOI 10.1302/0301-620X.74B5.1527128; Takakura Y, 1999, CLIN ORTHOP RELAT R, P178; THORDARSON DB, 1990, J BONE JOINT SURG AM, V72A, P1359, DOI 10.2106/00004623-199072090-00013; Zwipp H, 2010, CLIN ORTHOP RELAT R, V468, P958, DOI 10.1007/s11999-009-1074-5	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241141	10.1371/journal.pone.0241141	http://dx.doi.org/10.1371/journal.pone.0241141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091091	gold, Green Published			2022-12-26	WOS:000586647200037
J	Pineda, RC; Krampe, RT; Vanlandewijck, Y; Van Biesen, D				Pineda, Roi Charles; Krampe, Ralf Th; Vanlandewijck, Yves; Van Biesen, Debbie			Reliability of center of pressure excursion as a measure of postural control in bipedal stance of individuals with intellectual disability: A pilot study	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; LOW-BACK-PAIN; INTRASESSION RELIABILITY; TASK PRIORITIZATION; HEALTHY-YOUNG; RISK-FACTORS; STABILITY; BALANCE; ADULTS; STEADINESS	The high prevalence of postural instability in individuals with intellectual disability (ID) warrants the need for reliable and practical postural control assessments. Stabilometry is a postural control assessment that has been widely used for clinical populations. However, the scant systematic knowledge about the reliability of stabilometric protocols for adults with ID renders results questionable and limits its value for clinicians and researchers. The study's purpose was to develop a stabilometric protocol for adults with and without ID based on optimal combinations of shortest necessary trial durations and the least number of trial repetitions that guarantee sufficient reliability. Participants performed six trials of bipedal standing in 2 vision (eyes open vs eyes closed) x 2 surface (solid vs compliant) conditions on a force platform. Several parameters were calculated from the first 10-, 20-, and 30-s interval of every center-of-pressure (COP) trial data. For different trial durations, we identified the number of trials that yielded acceptable relative (intraclass correlation coefficient >= 0.70) and absolute (standard error of measurement < 20%) reliability using the Spearman-Brown prophecy formula. To determine the optimal combination of trial duration and number of repetition for each COP parameter, we implemented a two-step process: 1) identify the largest number of repetition for each of the three trial durations and then 2) select the trial duration with the lowest number of repetition. For both ID- and non-ID groups, we observed a trend whereby shorter trial durations required more repetitions and vice versa. The phase plane and ellipse area were the most and least reliable center-of-pressure parameter, respectively. To achieve acceptable reliability, four 30-s trials of each experimental condition appeared to be optimal for testing participants with and without ID alike. The results of this research can inform stabilometric test protocols of future postural control studies of adults with ID.	[Pineda, Roi Charles; Vanlandewijck, Yves; Van Biesen, Debbie] Katholieke Univ Leuven, Fac Movement & Rehabil Sci, Dept Rehabil Sci, Leuven, Belgium; [Krampe, Ralf Th] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Brain & Cognit Grp, Leuven, Belgium	KU Leuven; KU Leuven	Pineda, RC (corresponding author), Katholieke Univ Leuven, Fac Movement & Rehabil Sci, Dept Rehabil Sci, Leuven, Belgium.	roicharles.pineda@kuleuven.be		Pineda, Roi Charles/0000-0002-8224-8725; Vanlandewijck, Yves/0000-0003-2982-0849	Research Foundation - Flanders [G0C6817N]	Research Foundation - Flanders(FWO)	The work of RCP was supported by Project Grant No. G0C6817N awarded to YV by the Research Foundation - Flanders, https://www.fwo.be/en/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association on Intellectual and Developmental Disabilities, 2010, INTELLECTUAL DISABIL, V11th.; [Anonymous], 1998, CERCETARI ISTORICE, V17, P101; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; Bauer C, 2008, ARCH PHYS MED REHAB, V89, P1977, DOI 10.1016/j.apmr.2008.02.033; Blomqvist S, 2013, RES DEV DISABIL, V34, P198, DOI 10.1016/j.ridd.2012.07.008; Borji R, 2017, J MOTOR BEHAV, V49, P407, DOI 10.1080/00222895.2016.1219309; Borji R, 2013, RES DEV DISABIL, V34, P4477, DOI 10.1016/j.ridd.2013.09.025; Burns J, 2015, INT REV SPORT EXER P, V8, P251, DOI 10.1080/1750984X.2015.1068830; Cooper SA, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0329-3; Coppieters Michel, 2002, Physiother Res Int, V7, P146; Cox CR, 2010, J INTELL DISABIL RES, V54, P1045, DOI 10.1111/j.1365-2788.2010.01333.x; Cumming G., 2013, UNDERSTANDING NEW ST; Dellavia C, 2009, PERCEPT MOTOR SKILL, V108, P608, DOI 10.2466/PMS.108.2.608-622; Doumas M, 2008, EXP BRAIN RES, V187, P275, DOI 10.1007/s00221-008-1302-3; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Enkelaar L, 2012, RES DEV DISABIL, V33, P291, DOI 10.1016/j.ridd.2011.08.028; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; Hadian MR, 2008, J APPL SCI, V8, P3019, DOI DOI 10.3923/jas.2008.3019.3025; Hale L, 2007, J INTELL DISABIL RES, V51, P260, DOI 10.1111/j.1365-2788.2006.00873.x; Harringe ML, 2008, GAIT POSTURE, V28, P38, DOI 10.1016/j.gaitpost.2007.09.011; Horner-Johnson W, 2013, J POLICY PRACT INTEL, V10, P260, DOI 10.1111/jppi.12048; Howarth SJ, 2009, J ELECTROMYOGR KINES, V19, P875, DOI 10.1016/j.jelekin.2008.03.010; Hsieh K, 2012, AJIDD-AM J INTELLECT, V117, P442, DOI 10.1352/1944-7558-117.6.442; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Lahtinen U, 2007, ADAPT PHYS ACT Q, V24, P125, DOI 10.1123/apaq.24.2.125; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; LETZ R, 1995, NEUROTOXICOL TERATOL, V17, P611, DOI 10.1016/0892-0362(95)00023-2; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; Payne V. G., 2012, HUMAN MOTOR DEV LIFE; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Prioli AC, 2006, HUM MOVEMENT SCI, V25, P435, DOI 10.1016/j.humov.2006.03.003; Qiu H, 2015, INT J IND ERGONOM, V47, P37, DOI 10.1016/j.ergon.2015.02.004; Rapp MA, 2006, AM J GERIAT PSYCHIAT, V14, P52, DOI 10.1097/01.JGP.0000192490.43179.e7; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rey MCB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00162; RILEY PO, 1995, J REHABIL RES DEV, V32, P227; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simonoff E, 2007, J AM ACAD CHILD PSY, V46, P591, DOI 10.1097/chi.0b013e3180323330; Speedtsberg MB, 2017, GAIT POSTURE, V51, P1, DOI 10.1016/j.gaitpost.2016.09.019; Stratford PW, 1997, PHYS THER, V77, P745, DOI 10.1093/ptj/77.7.745; SUOMI R, 1994, ARCH PHYS MED REHAB, V75, P205; Takala EP, 1997, CLIN BIOMECH, V12, P429, DOI 10.1016/S0268-0033(97)00033-8; Terra MB, 2018, PHYSIOTHER THEORY PR, DOI 10.1080/09593985.2018.1508261; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Wang Deli, 2002, Inj Control Saf Promot, V9, P107, DOI 10.1076/icsp.9.2.107.8703; Wechsler D, 1999, WERCHSLER ABBREVIATE; Winter D, 2005, BIOMECHANICS MOTOR C; Yim-Chiplis P K, 2000, Biol Res Nurs, V1, P321	56	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240702	10.1371/journal.pone.0240702	http://dx.doi.org/10.1371/journal.pone.0240702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085708	gold, Green Published			2022-12-26	WOS:000585943400010
J	Braam, JF; Hetem, DJ; Vergunst, CE; Wessel, SK; van Rooijen, MS; Nijhuis, RHT; van der Loeff, MFS; van Dam, AP; Bruisten, SM				Braam, Joyce F.; Hetem, David J.; Vergunst, Clarissa E.; Kuizenga Wessel, Sophie; van Rooijen, Martijn S.; Nijhuis, Roel H. T.; Schim van der Loeff, Maarten F.; van Dam, Alje P.; Bruisten, Sylvia M.			Evaluating the prevalence and risk factors for macrolide resistance inMycoplasma genitaliumusing a newly developed qPCR assay	PLOS ONE			English	Article							REAL-TIME PCR; MYCOPLASMA-GENITALIUM; TRICHOMONAS-VAGINALIS; CLINICAL SPECIMENS; DISEASE; URETHRITIS; INFECTION	Mycoplasma genitalium(MG) is a sexually transmitted bacterium in which macrolide resistance is rapidly increasing, limiting treatment options. We validated a new assay to detect the presence of macrolide resistance-associated mutations in MG (MG-MRAM). In 2018, symptomatic and asymptomatic clients visiting sexually transmitted infections (STI) clinics in Amsterdam or The Hague were tested for MG using transcription mediated amplification (TMA) assays. The sensitivity to detect MG of the newly developed MG-MRAM qPCR was compared to the MgPa qPCR, both in relation to the TMA assay. For the sensitivity and specificity to detect relevant mutations the MG-MRAM qPCR was compared to 23SrRNA sequencing analysis. The qPCR was subsequently used to determine the presence of MG-MRAM at different anatomical locations and to identify risk factors for MG-MRAM. MG-positive clients (402) providing 493 MG-positive samples were included. In total 309/493 (62.7%) samples from 291 (72.4%) clients were successfully typed with the MG-MRAM qPCR. The MG-MRAM qPCR had a sensitivity of 98.6% (95%CI 91.1%-99.9%) and specificity of 94.1% (95%CI 78.9%-99.0%) to detect MG-MRAM compared to sequencing analysis. Infection with MG-MRAM was detected in 193/291 (66.3%) clients: in 129/178 (72.5%) men and 64/113 (56.6%) women (p = 0.005). Prevalence of MG-MRAM was significantly higher in men, clients with a higher education, HIV-positive clients and clients with >10 sexual partners in the previous six months, but in multivariable analysis no factor was significantly associated with MG-MRAM presence. Since MG-MRAM prevalence was very high, testing for MG-MRAM is essential if treatment for MG is considered, and can be performed with this sensitive and specific qPCR test in routine diagnostics.	[Braam, Joyce F.; Vergunst, Clarissa E.; van Rooijen, Martijn S.; Schim van der Loeff, Maarten F.; van Dam, Alje P.; Bruisten, Sylvia M.] Publ Hlth Serv GGD Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Hetem, David J.; Nijhuis, Roel H. T.] Haaglanden Med Ctr, Dept Med Microbiol, The Hague, Netherlands; [Vergunst, Clarissa E.] NWZ Den Helder, Dept Dermatol, Den Helder, Netherlands; [Kuizenga Wessel, Sophie] Publ Hlth Serv, Dept Infect Dis, The Hague, Netherlands; [Nijhuis, Roel H. T.] Meander Med Ctr, Lab Med Microbiol & Immunol, Amersfoort, Netherlands; [Schim van der Loeff, Maarten F.] Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst AI&II, Dept Internal Med, Amsterdam, Netherlands; [van Dam, Alje P.; Bruisten, Sylvia M.] Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst AI&II, Dept Med Microbiol, Amsterdam, Netherlands	Public Health Service Amsterdam; Haaglanden Medical Center; Meander Medisch Centrum	Braam, JF (corresponding author), Publ Hlth Serv GGD Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.	jbraam@ggd.amsterdam.nl		Van Dam, Alje/0000-0003-3967-550X; Braam, Joyce/0000-0002-5043-3424				[Anonymous], 2018, VOX             0919; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Braam JF, 2018, EUR J CLIN MICROBIOL, V37, P2137, DOI 10.1007/s10096-018-3350-3; Braam JF, 2017, J ANTIMICROB CHEMOTH, V72, P1529, DOI 10.1093/jac/dkw584; de Jong AS, 2016, INT J STD AIDS, V27, P856, DOI 10.1177/0956462415596496; De Vries HJC, 2014, TIJDSCHRIFT INFECTIE, V9, P9; Geraats-Peters CWM, 2005, J CLIN MICROBIOL, V43, P5653, DOI 10.1128/JCM.43.11.5653-5659.2005; Horner P, 2015, SEX TRANSM INFECT, V91, pA10, DOI 10.1136/sextrans-2015-052126.28; Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Le Roy C, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01478-19; Le Roy C, 2017, J CLIN MICROBIOL, V55, P3194, DOI 10.1128/JCM.00579-17; Lis R, 2015, CLIN INFECT DIS, V61, P418, DOI 10.1093/cid/civ312; Martens L, 2019, EMERG INFECT DIS, V25, P1297, DOI 10.3201/eid2507.181556; Nafa K, 2016, METHODS MOL BIOL, V1392, P71, DOI 10.1007/978-1-4939-3360-0_8; Netherlands Association of Dermatology and Venereology, MULT GUID DIAGN TREA; Nijhuis RHT, 2015, J ANTIMICROB CHEMOTH, V70, P2515, DOI 10.1093/jac/dkv136; Read TRH, 2017, CLIN INFECT DIS, V64, P250, DOI 10.1093/cid/ciw719; Tabrizi SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156740; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Thellin O, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4424-2; Touati A, 2014, J CLIN MICROBIOL, V52, P1549, DOI 10.1128/JCM.03318-13; Unemo M, 2018, CLIN MICROBIOL INFEC, V24, P533, DOI 10.1016/j.cmi.2017.09.006; van der Veer C, 2016, SEX TRANSM INFECT, V92, P83, DOI 10.1136/sextrans-2015-052118; Zou SH, 2019, CASE REP INFECT DIS, V2019, DOI 10.1155/2019/2180567	26	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240836	10.1371/journal.pone.0240836	http://dx.doi.org/10.1371/journal.pone.0240836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079948	gold, Green Published			2022-12-26	WOS:000585940600030
J	Tovissode, CF; Lokonon, BE; Kakai, RG				Tovissode, Chenangnon Frederic; Lokonon, Bruno Enagnon; Glele Kakai, Romain			On the use of growth models to understand epidemic outbreaks with application to COVID-19 data	PLOS ONE			English	Article							CHARACTERIZE	The initial phase dynamics of an epidemic without containment measures is commonly well modelled using exponential growth models. However, in the presence of containment measures, the exponential model becomes less appropriate. Under the implementation of an isolation measure for detected infectives, we propose to model epidemic dynamics by fitting a flexible growth model curve to reported positive cases, and to infer the overall epidemic dynamics by introducing information on the detection/testing effort and recovery and death rates. The resulting modelling approach is close to the Susceptible-Infectious-Quarantined-Recovered model framework. We focused on predicting the peaks (time and size) in positive cases, active cases and new infections. We applied the approach to data from the COVID-19 outbreak in Italy. Fits on limited data before the observed peaks illustrate the ability of the flexible growth model to approach the estimates from the whole data.	[Tovissode, Chenangnon Frederic; Lokonon, Bruno Enagnon; Glele Kakai, Romain] Univ Abomey Calavi, Fac Sci Agron, Lab Biomath & Estimat Forestieres, Abomey Calavi, Benin	University of Abomey Calavi	Kakai, RG (corresponding author), Univ Abomey Calavi, Fac Sci Agron, Lab Biomath & Estimat Forestieres, Abomey Calavi, Benin.	romain.glelekakai@fsa.uac.bj		Glele Kakai, Romain/0000-0002-6965-4331; Tovissode, Chenangnon Frederic/0000-0002-3685-3043	African German Network of Excellence in Sciences (AGNES)	African German Network of Excellence in Sciences (AGNES)	The authors are grateful to an anonymous reviewer for drawing their attention on models based on fractal-wavelet for modelling the COVID-19 pandemic. RGK acknowledges the support from the African German Network of Excellence in Sciences (AGNES).	Agosto A, 2020, POISSON AUTOREGRESSI; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2016, MATLAB VERS 9 0 0 R2; Bianca C, 2013, AIP CONF PROC, V1558, P1797, DOI 10.1063/1.4825874; Bianca C, 2011, AIP CONF PROC, V1389, P945, DOI 10.1063/1.3637764; Casella F, 2021, IEEE CONTR SYST LETT, V5, P1079, DOI 10.1109/LCSYS.2020.3009912; Chowell G, 2020, EPIDEMICS-NETH, V30, DOI 10.1016/j.epidem.2019.100379; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Chowell Gerardo, 2016, Infect Dis Model, V1, P71, DOI 10.1016/j.idm.2016.07.004; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Golinski A, 2020, MODELING COVID 19 EP, DOI [10.1101/2020.06.01.20118612, DOI 10.1101/2020.06.01.20118612]; Guariglia E, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21030304; Guariglia E, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18030084; Hethcote H, 2002, MATH BIOSCI, V180, P141, DOI 10.1016/S0025-5564(02)00111-6; Kosmidis K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237304; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Materassi M, 2019, CHAOS SOLITONS FR 10, V4, P1696; Pcurar CM, 2020, CHAOS SOLITONS FRACT, V139, P1; Pedersen MG, 2020, QUANTIFYING UNDETECT, V10; R Core Team, 2021, R LANG ENV STAT; TURNER ME, 1976, MATH BIOSCI, V29, P367, DOI 10.1016/0025-5564(76)90112-7; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; World Health Organization, 2020, 208 WHO	28	9	9	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240578	10.1371/journal.pone.0240578	http://dx.doi.org/10.1371/journal.pone.0240578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079964	gold, Green Published			2022-12-26	WOS:000585940600006
J	Xia, XJ; Fu, XN; Du, J; Wu, BB; Zhao, XG; Zhu, JS; Zhao, ZW				Xia, Xiju; Fu, Xiaonan; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhu, Jinsong; Zhao, Zhangwu			Regulation of circadian rhythm and sleep by miR-375-timeless interaction in Drosophila	FASEB JOURNAL			English	Article						CLEAR-CLIP; circadian rhythm; miRNAs; miR-375; sleep	MIRNA-TARGET INTERACTIONS; MOLECULAR OSCILLATIONS; INTEGRATIVE ANALYSIS; EMERGING ROLES; MICRORNA; PERIOD; CLOCK; IDENTIFICATION; TRANSCRIPTION; BEHAVIOR	MicroRNAs are important coordinators of circadian regulation that mediate the fine-tuning of gene expression. Although many studies have shown the effects of individual miRNAs on the circadian clock, the global functional miRNA-mRNA interaction network involved in the circadian system remains poorly understood. Here, we used CLEAR (Covalent Ligation of Endogenous Argonaute-bound RNAs)-CLIP (Cross-Linking and Immuno-Precipitation) to explore the regulatory functions of miRNAs in the circadian system by comparing the miRNA-mRNA interactions betweenDrosophilawild-type strainW(1118)and a mutant of the key circadian transcriptional regulator Clock (Clk(jrk)). This experimental approach unambiguously identified tens of thousands of miRNA-mRNA interactions in both the head and body. The miRNA-mRNA interactome showed dramatic changes in theClk(jrk)flies. Particularly, among similar to 300 miRNA-mRNA circadian relevant interactions, multiple interactions involving core clock genespdp1,tim,andvridisplayed distinct changes as a result of theClkmutation. Based on the CLEAR-CLIP analysis, we found a novel regulation of the circadian rhythm and sleep by themiR-375-timelessinteraction. The results indicated thatClkdisruption abolished normal rhythmic expression ofmiR-375and the functional regulation occurred in the l-LNv neurons, wheremiR-375modulated the circadian rhythm and sleep via targetingtimeless. This work provides the first global view of miRNA regulation in the circadian rhythm.	[Xia, Xiju; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhao, Zhangwu] China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing 100193, Peoples R China; [Xia, Xiju; Du, Juan; Wu, Binbin; Zhao, Xianguo; Zhao, Zhangwu] China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China; [Fu, Xiaonan] Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA USA; [Zhu, Jinsong] Virginia Tech, Dept Biochem, 340 West Campus Dr, Blacksburg, VA 24061 USA	China Agricultural University; China Agricultural University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhao, ZW (corresponding author), China Agr Univ, Coll Plant Protect, Dept Entomol, Beijing 100193, Peoples R China.; Zhao, ZW (corresponding author), China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing 100193, Peoples R China.; Zhu, JS (corresponding author), Virginia Tech, Dept Biochem, 340 West Campus Dr, Blacksburg, VA 24061 USA.	zhujin@vt.edu; zhaozw@cau.edu.cn		Wu, Binbin/0000-0002-0879-4904; Zhu, Jinsong/0000-0002-1587-753X	National Natural Science Foundation of China (NSFC) [31730076, 31970458]; Foundation for the National Institutes of Health (FNIH) [R01 AI122743]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Foundation for the National Institutes of Health (FNIH)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31730076 and 31970458; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: R01 AI122743	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Chen X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14707; Chen X, 2016, P NATL ACAD SCI USA, V113, pE2965, DOI 10.1073/pnas.1605837113; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cusumano P, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007500; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan X, 2015, BRIEF BIOINFORM, V16, P780, DOI 10.1093/bib/bbu044; Flores O, 2014, NUCLEIC ACIDS RES, V42, P4629, DOI 10.1093/nar/gkt1393; Garaulet DL, 2016, J NEUROSCI, V36, P3414, DOI 10.1523/JNEUROSCI.3287-15.2016; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Goodwin PR, 2018, CELL REP, V23, P3776, DOI 10.1016/j.celrep.2018.05.078; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Hafner A, 2017, NAT STRUCT MOL BIOL, V24, P840, DOI 10.1038/nsmb.3452; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helwak A, 2014, NAT PROTOC, V9, P711, DOI 10.1038/nprot.2014.043; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lerner I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8056; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Scheel TKH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07880-8; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Ueda M, 2018, GENES CELLS, V23, P80, DOI 10.1111/gtc.12555; Vodala S, 2012, CELL METAB, V16, P601, DOI 10.1016/j.cmet.2012.10.002; Xue YB, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0401-8; Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; You S, 2018, GENETICS, V208, P1195, DOI 10.1534/genetics.117.300342; Zhang Y, 2016, J NEUROSCI, V36, P2007, DOI 10.1523/JNEUROSCI.3286-15.2016; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	58	4	4	1	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16536	16551		10.1096/fj.202001107R	http://dx.doi.org/10.1096/fj.202001107R		OCT 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078445	Green Accepted			2022-12-26	WOS:000581624500001
J	Zhou, Y; Yang, DC; Chen, H; Zheng, CF; Jiang, HC; Liu, XY; Huang, XZ; Ye, SM; Song, SS; Jiang, N; Zhao, ZY; Ma, SQ; Ma, J; Huang, K; Chen, CS; Fan, XF; Gong, YS; Wang, XC; Fan, JM; Liu, R; Shentu, YP				Zhou, Ying; Yang, Dichen; Chen, Hao; Zheng, Chenfei; Jiang, Huanchang; Liu, Xiaoyuan; Huang, Xingzhou; Ye, Simin; Song, Shuangshuang; Jiang, Nan; Zhao, Zhongyuan; Ma, Shuqing; Ma, Jun; Huang, Kate; Chen, Chaosheng; Fan, Xiaofang; Gong, Yongsheng; Wang, Xiaochuan; Fan, Junming; Liu, Rong; Shentu, Yangping			Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice	FASEB JOURNAL			English	Article						cancerous inhibitor of PP2A (CIP2A); cognitive impairments; polyphyllin I (PPI)	PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; MEMORY DEFICITS; TAU; PP2A; PHOSPHORYLATION; INHIBITION; METHYLTRANSFERASE; DEPHOSPHORYLATION; BRAIN	Polyphyllin I (PPI) is a natural phytochemical drug isolated from plants which can inhibit the proliferation of cancer cells. One of the PPI tumor-inhibitory effects is through downregulating the expression of Cancerous Inhibitor of PP2A (CIP2A), the latter, is found upregulated in Alzheimer's disease (AD) brains and participates in the development of AD. In this study, we explored the application of PPI in experimental AD treatment in CIP2A-overexpressed cells and 3XTg-AD mice. In CIP2A-overexpressed HEK293 cells or primary neurons, PPI effectively reduced CIP2A level, activated PP2A, and decreased the phosphorylation of tau/APP and the level of A beta. Furthermore, synaptic protein levels were restored by PPI in primary neurons overexpressing CIP2A. Animal experiments in 3XTg-AD mice revealed that PPI treatment resulted in decreased CIP2A expression and PP2A re-activation. With the modification of CIP2A-PP2A signaling, the hyperphosphorylation of tau/APP and A beta overproduction were prevented, and the cognitive impairments of 3XTg-AD mice were rescued. In summary, PPI ameliorated AD-like pathology and cognitive impairment through modulating CIP2A-PP2A signaling pathway. It may be a potential drug candidate for the treatment of AD.	[Zhou, Ying; Zheng, Chenfei; Chen, Chaosheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Nephrol, Wenzhou, Peoples R China; [Zhou, Ying; Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou, Peoples R China; [Yang, Dichen; Chen, Hao; Jiang, Huanchang; Liu, Xiaoyuan; Ye, Simin; Song, Shuangshuang; Jiang, Nan; Zhao, Zhongyuan; Ma, Shuqing] Wenzhou Med Univ, Wenzhou, Peoples R China; [Huang, Xingzhou] Wenzhou Med Univ, Affiliated Hosp 1, Cent Lab, Wenzhou, Peoples R China; [Ma, Jun; Huang, Kate; Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Fanhai West Rd 1, Wenzhou 325035, Peoples R China; [Fan, Xiaofang; Gong, Yongsheng; Fan, Junming] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou, Peoples R China; [Wang, Xiaochuan; Liu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Disorders, Sch Basic Med,Dept Pathophysiol,Key Lab, Hangkong Rd 13, Wuhan 430030, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Huazhong University of Science & Technology	Shentu, YP (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Fanhai West Rd 1, Wenzhou 325035, Peoples R China.; Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ Neurol Disorders, Sch Basic Med,Dept Pathophysiol,Key Lab, Hangkong Rd 13, Wuhan 430030, Peoples R China.	rong.liu@hust.edu.cn; styp@wmu.edu.cn		Liu, Rong/0000-0001-7477-6520	National Natural Science Foundation of China [31900685, 31771189]; Natural Science Foundation of Zhejiang Province [LQ19H050002]; Wenzhou Municipal Science and Technology Bureau [Y20201001, ZS2017008, Y20180159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau	National Natural Science Foundation of China, Grant/Award Number: 31900685 and 31771189; Natural Science Foundation of Zhejiang Province, Grant/Award Number: LQ19H050002; Wenzhou Municipal Science and Technology Bureau, Grant/Award Number: Y20201001, ZS2017008 and Y20180159	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], 2017, INT J CLIN PHARM TOX; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Chen YZ, 2014, ANTI-CANCER DRUG, V25, P983, DOI 10.1097/CAD.0000000000000127; Cheng Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00195-1; Clark AR, 2019, PHARMACOL THERAPEUT, V201, P181, DOI 10.1016/j.pharmthera.2019.05.016; Dal Pra I, 2014, CURR NEUROPHARMACOL, V12, P353, DOI 10.2174/1570159X12666140828214701; Forny-Germano L, 2014, J NEUROSCI, V34, P13629, DOI 10.1523/JNEUROSCI.1353-14.2014; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hefter D, 2020, NEUROSCIENTIST, V26, P231, DOI 10.1177/1073858419882619; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; IQBAL K, 1986, LANCET, V2, P421; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janus C, 2001, Curr Neurol Neurosci Rep, V1, P451, DOI 10.1007/s11910-001-0105-8; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kilian JG, 2017, NEUROSCIENCE, V348, P191, DOI 10.1016/j.neuroscience.2017.02.011; Li DX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00133; Li GB, 2017, ONCOTARGET, V8, P10359, DOI 10.18632/oncotarget.14413; Li JL, 2020, ARCH BIOCHEM BIOPHYS, V687, DOI 10.1016/j.abb.2020.108363; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu GP, 2013, MOL THER, V21, P2247, DOI 10.1038/mt.2013.189; Liu XW, 2018, INT J ONCOL, V53, P1279, DOI 10.3892/ijo.2018.4464; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Naseri NN, 2019, NEUROSCI LETT, V705, P183, DOI 10.1016/j.neulet.2019.04.022; Negi JS, 2014, ANTI-CANCER AGENT ME, V14, P833, DOI 10.2174/1871520614666140611101040; Panza F, 2016, IMMUNOTHERAPY-UK, V8, P1119, DOI 10.2217/imt-2016-0019; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174; Shentu YP, 2018, CELL REP, V24, P713, DOI 10.1016/j.celrep.2018.06.009; Shi QQ, 2017, MOL IMMUNOL, V88, P79, DOI 10.1016/j.molimm.2017.06.017; Shi YM, 2015, PHYTOMEDICINE, V22, P1139, DOI 10.1016/j.phymed.2015.08.014; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sun BL, 2018, NEUROSCI BULL, V34, P1111, DOI 10.1007/s12264-018-0249-z; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Sun XY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.329; Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222; Tian Y, 2020, CHEM-BIOL INTERACT, V316, DOI 10.1016/j.cbi.2019.108936; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Yu F.L., 2018, EUR J DRUG METAB PH, V3, P1; Yue GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065164; Zhang YL, 2018, GLOB ENV HLTH SAF, V2, P2, DOI DOI 10.1155/2018/2540681; Zheng HY, 2018, CURR MED SCI, V38, P115, DOI 10.1007/s11596-018-1854-9	53	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16414	16431		10.1096/fj.202001499R	http://dx.doi.org/10.1096/fj.202001499R		OCT 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070372	hybrid			2022-12-26	WOS:000581165700001
J	Murai, A; Ebara, S; Sasaki, S; Ohashi, T; Miyazaki, T; Nomura, T; Araki, S				Murai, Aiko; Ebara, Shunsuke; Sasaki, Satoshi; Ohashi, Tomohiro; Miyazaki, Tohru; Nomura, Toshiyuki; Araki, Shinsuke			Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors	PLOS ONE			English	Article							MCL-1; PROTEIN; POTENT; KINASE	Emerging evidence indicates that alternative splicing plays a critical role in cancer progression through abnormal expression or mutation of splicing factors. Small-molecule splicing modulators have recently attracted considerable attention as a novel class of cancer therapeutics. CDC-like kinases (CLKs) are central to exon recognition in mRNA splicing and CLK inhibitors exhibit anti-tumour activities. Most importantly, molecular mechanism-based combination strategies for cancer therapy must be considered. However, it remains unclear whether CLK inhibitors modulate expression and splicing of apoptosis-related genes, and whether CLK inhibitors enhance cytotoxicity in combination with apoptosis inducers. Here we report an appropriate mechanism-based drug combination approach. Unexpectedly, we found that the CLK inhibitor T3 rapidly induced apoptosis in A2780 cells and G2/M cell cycle arrest in HCT116 cells. Regardless of the different phenotypes of the two cancer cell types, T3 decreased the levels of anti-apoptotic proteins (cIAP1, cIAP2, XIAP, cFLIP and Mcl-1) for a short period of exposure and altered the splicing of the anti-apoptotic MCL1L and CFLAR isoform in A2780 and HCT116 cells. In contrast, other members of the Bcl-2 family (i.e., Bcl-xL and Bcl-2) were resistant to T3-induced expression and splicing modulation. T3 and a Bcl-xL/Bcl-2 inhibitor synergistically induced apoptosis. Taken together, the use of a CLK inhibitor is a novel therapeutic approach to sensitise cancer cells to Bcl-xL/Bcl-2 inhibitors.	[Murai, Aiko; Ebara, Shunsuke; Sasaki, Satoshi; Ohashi, Tomohiro; Miyazaki, Tohru; Nomura, Toshiyuki; Araki, Shinsuke] Takeda Pharmaceut Co Ltd, Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Murai, A; Araki, S (corresponding author), Takeda Pharmaceut Co Ltd, Res, Fujisawa, Kanagawa, Japan.	aiko.murai@takeda.com; shinsuke.araki@takeda.com	; Araki, Shinsuke/M-3983-2018	Ohashi, Tomohiro/0000-0002-2761-5940; Araki, Shinsuke/0000-0002-9936-1417				Agrawal AA, 2018, CURR OPIN GENET DEV, V48, P67, DOI 10.1016/j.gde.2017.10.010; Aird D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08150-5; [Anonymous], 2003, J STUDY JUDAISM, V34, P160; [Anonymous], 2013, BMC P S6, V7, pO1; Araki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116929; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dominguez D, 2016, ELIFE, V5, DOI 10.7554/eLife.10288; Elgendy M, 2017, J CLIN INVEST, V127, P153, DOI 10.1172/JCI84386; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Funnell T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-016-0008-7; Gallego-Paez LM, 2017, HUM GENET, V136, P1015, DOI 10.1007/s00439-017-1790-y; Gloaguen C, 2015, J MED CHEM, V58, P1644, DOI 10.1021/jm500672y; Greaves G, 2019, CELL DEATH DIFFER, V26, P1037, DOI 10.1038/s41418-018-0183-7; Iwai K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708289; Koo JH, 2015, MOL CELL BIOL, V35, P2344, DOI 10.1128/MCB.01525-14; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Larrayoz M, 2016, LEUKEMIA, V30, P351, DOI 10.1038/leu.2015.286; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Martin AP, 2009, CANCER BIOL THER, V8, P2084; Montes M, 2019, TRENDS GENET, V35, P68, DOI 10.1016/j.tig.2018.10.002; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Seiler M, 2018, NAT MED, V24, P497, DOI 10.1038/nm.4493; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Teng T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15522; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yoshida T, 2015, CANCER RES, V75, P1516, DOI 10.1158/0008-5472.CAN-14-2443; Yoshimoto R, 2017, RNA, V23, P47, DOI 10.1261/rna.058065.116; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240718	10.1371/journal.pone.0240718	http://dx.doi.org/10.1371/journal.pone.0240718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064779	gold, Green Published			2022-12-26	WOS:000585918300030
J	Christensen, KA; Rondeau, EB; Minkley, DR; Sakhrani, D; Biagi, CA; Flores, AM; Withler, RE; Pavey, SA; Beacham, TD; Godin, T; Taylor, EB; Russello, MA; Devlin, RH; Koop, B				Christensen, Kris A.; Rondeau, Eric B.; Minkley, David R.; Sakhrani, Dionne; Biagi, Carlo A.; Flores, Anne-Marie; Withler, Ruth E.; Pavey, Scott A.; Beacham, Terry D.; Godin, Theresa; Taylor, Eric B.; Russello, Michael A.; Devlin, Robert H.; Koop, Ben F.			The sockeye salmon genome, transcriptome, and analyses identifying population defining regions of the genome	PLOS ONE			English	Article							SEX-DETERMINING LOCUS; VARIANT CALL FORMAT; ONCORHYNCHUS-NERKA; PACIFIC SALMON; RAINBOW-TROUT; WIDE ASSOCIATION; GENETIC-EVIDENCE; LINKAGE; CHROMOSOMES; ATLANTIC	Sockeye salmon (Oncorhynchus nerka) is a commercially and culturally important species to the people that live along the northern Pacific Ocean coast. There are two main sockeye salmon ecotypes-the ocean-going (anadromous) ecotype and the fresh-water ecotype known as kokanee. The goal of this study was to better understand the population structure of sockeye salmon and identify possible genomic differences among populations and between the two ecotypes. In pursuit of this goal, we generated the first reference sockeye salmon genome assembly and an RNA-seq transcriptome data set to better annotate features of the assembly. Resequenced whole-genomes of 140 sockeye salmon and kokanee were analyzed to understand population structure and identify genomic differences between ecotypes. Three distinct geographic and genetic groups were identified from analyses of the resequencing data. Nucleotide variants in an immunoglobulin heavy chain variable gene cluster on chromosome 26 were found to differentiate the northwestern group from the southern and upper Columbia River groups. Several candidate genes were found to be associated with the kokanee ecotype. Many of these genes were related to ammonia tolerance or vision. Finally, the sex chromosomes of this species were better characterized, and an alternative sex-determination mechanism was identified in a subset of upper Columbia River kokanee.	[Christensen, Kris A.; Rondeau, Eric B.; Minkley, David R.; Sakhrani, Dionne; Biagi, Carlo A.; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Christensen, Kris A.; Rondeau, Eric B.; Minkley, David R.; Flores, Anne-Marie; Koop, Ben F.] Univ Victoria, Victoria, BC, Canada; [Rondeau, Eric B.; Withler, Ruth E.; Beacham, Terry D.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Pavey, Scott A.] Univ New Brunswick, Biol Sci, St John, NB, Canada; [Godin, Theresa] Freshwater Fisheries Soc British Columbia, Vancouver, BC, Canada; [Taylor, Eric B.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada; [Taylor, Eric B.] Univ British Columbia, Beaty Biodivers Museum, Vancouver, BC, Canada; [Russello, Michael A.] Univ British Columbia, Okanagan, BC, Canada	Fisheries & Oceans Canada; University of Victoria; Fisheries & Oceans Canada; University of New Brunswick; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia Okanagan	Christensen, KA (corresponding author), Fisheries & Oceans Canada, W Vancouver, BC, Canada.; Christensen, KA; Koop, B (corresponding author), Univ Victoria, Victoria, BC, Canada.	kris.christensen@wsu.edu; bkoop@uvic.ca	Koop, Ben F./A-8151-2008; Biagi, Carlo/AAN-2030-2020	Koop, Ben F./0000-0003-0045-5200; Biagi, Carlo/0000-0002-6345-9674; Christensen, Kristen/0000-0003-0021-0326	Fisheries and Oceans Canada under the Canadian Regulatory System for Biotechnology; Natural Sciences and Engineering Research Council of Canada	Fisheries and Oceans Canada under the Canadian Regulatory System for Biotechnology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this study was provided by Fisheries and Oceans Canada (https://www.dfompo.gc.ca/index-eng.htm) under the Canadian Regulatory System for Biotechnology to RHD. BFK's, MAR's, and EBT's research is supported by the Natural Sciences and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/index_eng.asp) (EBT -Discovery and Equipment grants programs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allendorf F.W., 1984, P1; Andrews S, 2016, FASTQC; [Anonymous], 2009, KRITIKA, V10, P1; [Anonymous], 2015, CORSALUD; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Avramopoulos D, 2018, AM J MED GENET B, V177, P257, DOI 10.1002/ajmg.b.32552; Ayllon F, 2020, BIORXIV; Beacham TD, 2006, T AM FISH SOC, V135, P174, DOI 10.1577/T05-149.1; Beacham TD, 2006, T AM FISH SOC, V135, P1604, DOI 10.1577/T06-071.1; Beacham TD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183713; Beacham TD, 2009, FISH B-NOAA, V107, P244; Beamish RJ, 2018, OCEAN ECOLOGY PACIFI, P1147; Becker R.A., 2018, MAPS DRAW GEOGRAPHIC; Behnke R, 2002, TROUT SALMON N AM, P384; Beltran JF, 2020, FISH PHYSIOL BIOCHEM, V46, P1825, DOI 10.1007/s10695-020-00829-1; Lissabet JFB, 2020, COMP BIOCHEM PHYS A, V241, DOI 10.1016/j.cbpa.2019.110633; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bertho S, 2018, P NATL ACAD SCI USA, V115, P12781, DOI 10.1073/pnas.1803826115; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Morgan S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66406-x; Chen GB, 2016, HEREDITY, V117, P51, DOI 10.1038/hdy.2016.25; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Christensen KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204076; Christensen KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195461; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Crosbie RH, 1999, J CELL BIOL, V145, P153, DOI 10.1083/jcb.145.1.153; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; De Tomasi L, 2017, AM J HUM GENET, V101, P803, DOI 10.1016/j.ajhg.2017.09.026; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Debrand E, 2009, FEBS J, V276, P1610, DOI 10.1111/j.1742-4658.2009.06893.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DEVLIN RH, 1993, CAN J FISH AQUAT SCI, V50, P1738, DOI 10.1139/f93-195; DFO, 2018, 2018052 DFO CAN SCI; Duggan DJ, 1997, NEUROGENETICS, V1, P49, DOI 10.1007/s100480050008; Eddy FB, 2005, J FISH BIOL, V67, P1495, DOI 10.1111/j.1095-8649.2005.00930.x; Eisbrenner WS, 2014, HEREDITY, V113, P86, DOI 10.1038/hdy.2013.55; Everett MV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-521; Faber-Hammond J, 2012, CYTOGENET GENOME RES, V136, P69, DOI 10.1159/000334583; Faber-Hammond JJ, 2015, GENOME BIOL EVOL, V7, P1972, DOI 10.1093/gbe/evv123; FOOTE CJ, 1992, CAN J FISH AQUAT SCI, V49, P99, DOI 10.1139/f92-012; Fort P, 2005, NEUROSCI RES, V53, P25, DOI 10.1016/j.neures.2005.05.007; gc5k/GEAR [Internet], GC5K GEAR; Gleason LU, 2015, ECOLOGICAL GENOMICS; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Godmann M, 2008, DEV BIOL, V315, P552, DOI 10.1016/j.ydbio.2007.12.018; Guo Y, 2014, BRIEF BIOINFORM, V15, P879, DOI 10.1093/bib/bbt069; Gutierrez AP, 2016, MAR GENOM, V26, P41, DOI 10.1016/j.margen.2015.12.007; Iribarne M, 2019, VIS IMP BLINDN; Jackman SD, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2425-6; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kijas J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23984-1; Knaus BJ, 2017, MOL ECOL RESOUR, V17, P44, DOI 10.1111/1755-0998.12549; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Koren S, 2019, SKOREN ARROWGRID; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larson WA, 2019, MOL ECOL, V28, P2254, DOI 10.1111/mec.15082; Larson WA, 2017, MOL ECOL, V26, P554, DOI 10.1111/mec.13933; Larson WA, 2016, J HERED, V107, P559, DOI 10.1093/jhered/esw043; Larson WA, 2016, J HERED, V107, P122, DOI 10.1093/jhered/esv099; Larson WA, 2014, MOL ECOL, V23, P5448, DOI 10.1111/mec.12949; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Lemay MA, 2015, MOL ECOL, V24, P798, DOI 10.1111/mec.13066; Lemay MA, 2012, N AM J FISH MANAGE, V32, P282, DOI 10.1080/02755947.2012.676383; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2019, LH3 SEQTK; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XL, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00634-0; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Limborg MT, 2015, G3-GENES GENOM GENET, V5, P2463, DOI 10.1534/g3.115.020222; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Lubieniecki KP, 2015, G3-GENES GENOM GENET, V5, P2513, DOI 10.1534/g3.115.020115; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKinney G, 2020, G3-GENES GENOM GENET, V10, P1553, DOI 10.1534/g3.119.400972; McKinney GJ, 2015, MOL ECOL, V24, P1792, DOI 10.1111/mec.13143; McPhail J.D., 1986, P615; Media Matters, 2007, MEDIA MATTERS, V21, P1; Micheletti SJ, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1255-5; Moore JW, 2016, MAR ECOL PROG SER, V559, P201, DOI 10.3354/meps11933; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Nadin BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060831; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; NELSON JS, 1968, J FISH RES BOARD CAN, V25, P409, DOI 10.1139/f68-032; Nichols KM, 2016, EVOL APPL, V9, P1285, DOI 10.1111/eva.12412; Northcote T.C., 1973, 2 GREAT LAK FISH COM; PacificBiosciences/GenomicConsensus [Internet], 2019, PACIFICBIOSCIENCES G; Pearse DE, 2019, NAT ECOL EVOL, V3, P1731, DOI 10.1038/s41559-019-1044-6; Perez-Ortiz AC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215480; Phillips RB, 2013, CYTOGENET GENOME RES, V141, P177, DOI 10.1159/000355149; Phillips RB, 2001, GENETICA, V111, P119, DOI 10.1023/A:1013743431738; Podlesnykh AV, 2017, J HERED, V108, P328, DOI 10.1093/jhered/esx001; Prince DJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603198; Pritchard VL, 2018, MOL ECOL, V27, P2560, DOI 10.1111/mec.14705; Quinn TP, 2016, CAN J FISH AQUAT SCI, V73, P1015, DOI 10.1139/cjfas-2015-0345; R Core Team, 2021, R LANGUAGE ENV STAT; Rialdi A, 2017, CELL, V169, P679, DOI 10.1016/j.cell.2017.04.021; Rondeau EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102089; Russello M, 2017, 20162017 U BRIT COL; S BE, 2018, J CROHNS COLITIS, V12, pS049; Salmela L, 2014, BIOINFORMATICS, V30, P3506, DOI 10.1093/bioinformatics/btu538; Samuels DC, 2016, GENETICS, V204, P893, DOI 10.1534/genetics.116.189936; Sanna-Cherchi S, 2017, AM J HUM GENET, V101, P789, DOI 10.1016/j.ajhg.2017.09.018; Schaschl H, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-019-1575-0; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Sievert C, INTERACTIVE WEB BASE; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Stefansson Sigurd O., 2008, P639; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tarakci H, 2016, FRONT BIOSCI-LANDMRK, V21, P744, DOI 10.2741/4418; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; TAYLOR EB, 1994, CAN J FISH AQUAT SCI, V51, P1430, DOI 10.1139/f94-143; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; THORGAARD GH, 1978, CAN J GENET CYTOL, V20, P349, DOI 10.1139/g78-039; THORGAARD GH, 1977, SCIENCE, V196, P900, DOI 10.1126/science.860122; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tiedje C, 2015, RNA, V21, P262, DOI 10.1261/rna.048090.114; VARNAVSKAYA NV, 1992, CAN J ZOOL, V70, P2115, DOI 10.1139/z92-284; Veale Andrew J, 2017, Genome Biol Evol, V9, P2921, DOI 10.1093/gbe/evx215; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winans GA, 1996, T AM FISH SOC, V125, P645, DOI 10.1577/1548-8659(1996)125&lt;0645:AVONIT&gt;2.3.CO;2; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; WOOD CC, 1994, CAN J FISH AQUAT SCI, V51, P114, DOI 10.1139/f94-299; Wood CC, 2008, EVOL APPL, V1, P207, DOI 10.1111/j.1752-4571.2008.00028.x; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; Xu GC, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy157; Xu TF, 2019, AQUACULTURE, V512, DOI 10.1016/j.aquaculture.2019.734332; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yasuike M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-486; Yeo S, 2018, BIOINFORMATICS, V34, P725, DOI 10.1093/bioinformatics/btx675; 2019, AM J PHYSL RENAL PHY, V316, pE1071; 2015, DTSCH ARZTEBL, V112, pE786	146	13	13	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240935	10.1371/journal.pone.0240935	http://dx.doi.org/10.1371/journal.pone.0240935			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119641	gold, Green Published			2022-12-26	WOS:000600013600071
J	Yun, JH; Kim, JM; Jeon, HJ; Oh, T; Choi, HJ; Kim, BJ				Yun, Jun Ho; Kim, Jeong-Min; Jeon, Hyun Jeong; Oh, Taekeun; Choi, Hyung Jin; Kim, Bong-Jo			Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients	PLOS ONE			English	Article							PLASMA ASYMMETRIC DIMETHYLARGININE; KYNURENINE PATHWAY; NITRIC-OXIDE; METABOLITES	Diabetic retinopathy (DR) is a common complication of diabetes, and it is the consequence of microvascular retinal changes due to high glucose levels over a long time. Metabolomics profiling is a rapidly evolving method used to identify the metabolites in biological fluids and investigate disease progression. In this study, we used a targeted metabolomics approach to quantify the serum metabolites in type 2 diabetes (T2D) patients. Diabetes patients were divided into three groups based on the status of their complications: non-DR (NDR, n = 143), non-proliferative DR (NPDR, n = 123), and proliferative DR (PDR, n = 51) groups. Multiple logistic regression analysis and multiple testing corrections were performed to identify the significant differences in the metabolomics profiles of the different analysis groups. The concentrations of 62 metabolites of the NDR versus DR group, 53 metabolites of the NDR versus NPDR group, and 30 metabolites of the NDR versus PDR group were found to be significantly different. Finally, sixteen metabolites were selected as specific metabolites common to NPDR and PDR. Among them, three metabolites including total DMA, tryptophan, and kynurenine were potential makers of DR progression in T2D patients. Additionally, several metabolites such as carnitines, several amino acids, and phosphatidylcholines also showed a marker potential. The metabolite signatures identified in this study will provide insight into the mechanisms underlying DR development and progression in T2D patients in future studies.	[Yun, Jun Ho; Kim, Jeong-Min; Kim, Bong-Jo] Korea Natl Inst Hlth, Ctr Genome Sci, Div Genome Res, Cheongju, Chungbuk, South Korea; [Yun, Jun Ho] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Jeon, Hyun Jeong; Oh, Taekeun] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, Chungbuk, South Korea; [Choi, Hyung Jin] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Dept Biomed Sci, Seoul, South Korea; [Choi, Hyung Jin] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Dept Anat & Cell Biol, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Chungbuk National University; Chungbuk National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Korea Natl Inst Hlth, Ctr Genome Sci, Div Genome Res, Cheongju, Chungbuk, South Korea.; Choi, HJ (corresponding author), Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Dept Biomed Sci, Seoul, South Korea.; Choi, HJ (corresponding author), Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Dept Anat & Cell Biol, Seoul, South Korea.	kbj6181@cdc.go.kr; hjchoi@snu.ac.kr		Kim, Jeong-Min/0000-0002-4305-5162	Korea National Institute of Health [2013-NG73001-00, 2019-NG-053-00]; Korea Centers for Disease Control and Prevention, Republic of Korea [4851-307, 4851-302, 4845-301]	Korea National Institute of Health; Korea Centers for Disease Control and Prevention, Republic of Korea	This study was supported by intramural grants from the Korea National Institute of Health (Nos. 2013-NG73001-00 & 2019-NG-053-00). Biospecimens and data were provided by the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and the Korea Biobank Projects (4851-307), which were supported by the Korea Centers for Disease Control and Prevention, Republic of Korea.	Abhary S, 2009, DIABETES CARE, V32, P2084, DOI 10.2337/dc09-0816; Andrzejewska-Buczko J, 2001, Med Sci Monit, V7, P742; [Anonymous], 2004, DIABETES CARE S1, V27, pS5; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barba I, 2010, INVEST OPHTH VIS SCI, V51, P4416, DOI 10.1167/iovs.10-5348; Cabrera AP, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010216; Ceriello Antonio, 2006, Endocr Pract, V12 Suppl 1, P60; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Cho H, 2013, RETINA-J RET VIT DIS, V33, P542, DOI 10.1097/IAE.0b013e3182753b6f; Fiedorowicz M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01254; Haines NR, 2018, J PROTEOME RES, V17, P2421, DOI 10.1021/acs.jproteome.8b00169; Hemminki V, 2007, METABOLISM, V56, P1305, DOI 10.1016/j.metabol.2007.05.012; Hsieh YT, 2018, JAMA OPHTHALMOL, V136, P68, DOI 10.1001/jamaophthalmol.2017.5202; KLEIN R, 1992, DIABETES CARE, V15, P1875, DOI 10.2337/diacare.15.12.1875; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Liew G, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0939-3; Malecki MT, 2007, DIABETES CARE, V30, P2899, DOI 10.2337/dc07-1138; Matsuyama K, 2008, MOL VIS, V14, P992; Munipally PK, 2011, ARCH PHYSIOL BIOCHEM, V117, P254, DOI 10.3109/13813455.2011.623705; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Opatrilova R, 2018, ACTA OPHTHALMOL, V96, P222, DOI 10.1111/aos.13384; Paris LP, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0877-5; Park HC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220506; Raddino R, 2007, HEART INT, V3, P18, DOI 10.4081/hi.2007.18; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Sumarriva K, 2019, INVEST OPHTH VIS SCI, V60, P3119, DOI 10.1167/iovs.19-27321; Veras L, 2016, ASIA PAC J CLIN ONCO, V12, pe196, DOI 10.1111/ajco.12129; Young SP, 2009, MOL VIS, V15, P1210; Yun JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224274; Zhu XR, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0358-3	31	13	13	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241365	10.1371/journal.pone.0241365	http://dx.doi.org/10.1371/journal.pone.0241365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119699	Green Published, gold			2022-12-26	WOS:000600013600011
J	Kwon, OJ; Zhang, L; Jia, DY; Xin, L				Kwon, Oh-Joon; Zhang, Li; Jia, Deyong; Xin, Li			Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1(+) prostate luminal cells	ONCOGENE			English	Article							LINEAGE PLASTICITY; CANCER; MOUSE; METASTASIS; MODEL; EXPRESSION; RESISTANCE; PHENOTYPE; CARCINOMA; PATTERNS	Prostate adenocarcinoma undergoes neuroendocrine differentiation to acquire resistance toward antihormonal therapies. The underlying mechanisms have been investigated extensively, among which Sox2 has been shown to play a critical role. However, genetic evidence in mouse models for prostate cancer to support the crucial role of Sox2 is missing. The adult mouse prostate luminal cells contain both castration-resistant Sox2-expressing Sca-1(+) cells and castration-responsive Sca-1(-) cells. We show that both types of the luminal cell are susceptible to oncogenic transformation induced by loss of function of the tumor suppressor Pten. The tumors derived from the Sca-1(+) cells are castration resistant and are more inclined to develop castration-induced neuroendocrine differentiation. Genetic ablation of Sox2 suppresses neuroendocrine differentiation but does not impact the castration-resistant property. This study provides direct genetic evidence that Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation of Pten null prostate adenocarcinoma, corroborates that the lineage status of the prostate cancer cells is a determinant for its propensity to exhibit lineage plasticity, and supports that the intrinsic features of cell-of-origin for prostate cancers can dictate their clinical behaviors.	[Kwon, Oh-Joon; Zhang, Li; Jia, Deyong; Xin, Li] Univ Washington, Dept Urol, Seattle, WA 98109 USA; [Xin, Li] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xin, L (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98109 USA.; Xin, L (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA.	xin18@uw.edu	Jia, Deyong/GQP-9611-2022; Jia, Deyong/GSJ-0327-2022	Jia, Deyong/0000-0003-2034-0363; Kwon, Oh-Joon/0000-0001-9067-0240; Xin, Li/0000-0002-7138-0042	 [R01CA190378]		This work is supported by R01CA190378 (LX).	Backman SA, 2004, P NATL ACAD SCI USA, V101, P1725, DOI 10.1073/pnas.0308217100; Beltran H, 2019, CLIN CANCER RES, V25, P43, DOI 10.1158/1078-0432.CCR-18-1912; Berger A, 2019, J CLIN INVEST, V129, P3924, DOI 10.1172/JCI127961; Bishop JL, 2017, CANCER DISCOV, V7, P54, DOI 10.1158/2159-8290.CD-15-1263; Crowell PD, 2019, CELL REP, V28, P1499, DOI 10.1016/j.celrep.2019.07.007; Davies AH, 2018, NAT REV UROL, V15, P271, DOI 10.1038/nrurol.2018.22; Fine SW, 2012, ADV ANAT PATHOL, V19, P204, DOI 10.1097/PAP.0b013e31825c6b92; Goldstein NS, 2002, AM J CLIN PATHOL, V117, P471, DOI 10.1309/G6PR-Y774-X738-FG2K; Guo WX, 2020, NAT GENET, V52, P908, DOI 10.1038/s41588-020-0642-1; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hsu EC, 2020, P NATL ACAD SCI USA, V117, P2032, DOI 10.1073/pnas.1905384117; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kregel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053701; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Kwon OJ, 2020, ONCOGENE, V39, P7142, DOI 10.1038/s41388-020-01487-6; Kwon OJ, 2020, STEM CELLS, V38, P1479, DOI 10.1002/stem.3253; Kwon OJ, 2016, STEM CELLS, V34, P191, DOI 10.1002/stem.2217; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Lee AR, 2018, EBIOMEDICINE, V35, P167, DOI 10.1016/j.ebiom.2018.08.011; Lee TK, 2010, PATHOLOGY, V42, P319, DOI 10.3109/00313021003767314; Li HY, 2020, LAB INVEST, V100, P570, DOI 10.1038/s41374-019-0343-5; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Liu TT, 2016, CHINESE J CANCER RES, V28, P50, DOI 10.3978/j.issn.1000-9604.2016.02.02; Lovnicki J, 2020, J CLIN INVEST, V130, P5338, DOI 10.1172/JCI135373; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Masumori N, 2001, CANCER RES, V61, P2239; McAuley E, 2019, STEM CELLS, V37, P690, DOI 10.1002/stem.2987; Metz EP, 2019, J CELL PHYSIOL, V234, P19298, DOI 10.1002/jcp.28610; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Quintanal-Villalonga A, 2020, NAT REV CLIN ONCOL, V17, P360, DOI 10.1038/s41571-020-0340-z; Schaefer T, 2020, ONCOGENE, V39, P278, DOI 10.1038/s41388-019-0997-x; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wei X, 2019, CELL STEM CELL, V24, P753, DOI 10.1016/j.stem.2019.03.010; Won OJ, 2016, J CLIN INVEST, V126, P2626, DOI 10.1172/JCI84637; Xin L, 2019, ADV EXP MED BIOL, V1210, P67, DOI 10.1007/978-3-030-32656-2_4; Yu X, 2014, PROSTATE CANCER P D, V17, P301, DOI 10.1038/pcan.2014.29; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Zhang DX, 2018, STEM CELL REP, V10, P228, DOI 10.1016/j.stemcr.2017.11.016; Zhang L, 2012, TRANSGENIC RES, V21, P1117, DOI 10.1007/s11248-012-9598-y; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zou M, 2017, CANCER DISCOV, V7, P736, DOI 10.1158/2159-8290.CD-16-1174	45	13	13	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					203	214		10.1038/s41388-020-01526-2	http://dx.doi.org/10.1038/s41388-020-01526-2		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33110232	Green Accepted			2022-12-26	WOS:000582768100003
J	Lei, GK; Fu, YG; Wu, WJ				Lei, Gaoke; Fu, Yueguan; Wu, Wei-Jian			Type and distribution of sensilla in the antennae of Euplatypus parallelus (F.) (Coleoptera: Curculionidea, Platypodinae)	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; FINE-STRUCTURE; CLICK BEETLE; PINE-BEETLE; ULTRASTRUCTURE; PHEROMONE; LEPIDOPTERA; ODOR; SCOLYTINAE; RECEPTORS	Euplatypus parallelus (F.) (Coleoptera: Curculionidea) is the most destructive cosmopolitan insect pest of the Platypodinae. Pheromone-based luring agents are used currently in controlling bark beetle. Antennae are the primary insect organs sensing volatiles of host trees and pheromones of pioneer males. We studied the external morphology of antennae and the type, distribution, and the number of the beetle sensilla. Our results show E. parallelus have a geniculate antenna composed of 6 segments, namely the scape, 4-segmented funicle and club. Ninety-seven percent of the antennal sensors were distributed in the club, and 3% were distributed in the scape and funicle. 6 types of sensilla on the antennae were found, including sensilla trichodea (subtypes: STI, STII and STIII), sensilla basiconica (subtypes: SBI, SBII, SBIII and SBIV), sensilla chaetica (subtypes: SChI, SChII and SChIII), as well as sensilla coeloconica, sensilla campaniform and sensilla furcatea. There was no significant difference in the type, distribution and number of sensilla in males and females. No significant difference in the shape and distribution of antennae was found between sexes, but the length of antennae and the number of SChI, SChII, STI, SBI, SBIII and SBIV were significantly larger in females than males. We revealed the external cuticular structure of the antennae in E. parallelus, which can be used to guide future electrophysiological investigations to understand the ability of this beetle to detect semiochemicals.	[Lei, Gaoke; Wu, Wei-Jian] South China Agr Univ, Lab Insect Ecol, Guangzhou, Peoples R China; [Fu, Yueguan] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences	Wu, WJ (corresponding author), South China Agr Univ, Lab Insect Ecol, Guangzhou, Peoples R China.	weijwu@scau.edu.cn			Special Fund for Agro-scientific Research in the Public Interest of China [201103026-4]; Earmarked Fund for China Agriculture Research System [CARS-34-BC2]	Special Fund for Agro-scientific Research in the Public Interest of China; Earmarked Fund for China Agriculture Research System	This study was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (201103026-4) and the Earmarked Fund for China Agriculture Research System (CARS-34-BC2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; [Anonymous], 1997, Healthc Demand Dis Manag, V3, P127; [Anonymous], 2016, CROSSACCENT, V24, P33; Atkinson TH, 2000, 321 IFAS; Audino PG, 2005, J ECON ENTOMOL, V98, P1506, DOI 10.1603/0022-0493-98.5.1506; Beaver Roger A., 2013, Entomologist's Monthly Magazine, V149, P143; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; BORDEN JH, 1966, ANN ENTOMOL SOC AM, V59, P253, DOI 10.1093/aesa/59.2.253; BORG TK, 1971, Z ZELLFORSCH MIK ANA, V113, P13, DOI 10.1007/BF00331198; Bumrungsri Sara, 2008, Songklanakarin Journal of Science and Technology, V30, P579; Chen HB, 2010, MICRON, V41, P735, DOI 10.1016/j.micron.2010.06.007; Chen L, 2008, MICRON, V39, P517, DOI 10.1016/j.micron.2007.08.002; Dethiee VG, 1963, PHYSL INSECT SENSES; DICKENS JC, 1993, J INSECT PHYSIOL, V39, P503, DOI 10.1016/0022-1910(93)90083-4; DICKENS JC, 1977, J INSECT PHYSIOL, V23, P481, DOI 10.1016/0022-1910(77)90258-X; DICKENS JC, 1985, J CHEM ECOL, V11, P1359, DOI 10.1007/BF01012137; DICKENS JC, 1978, INT J INSECT MORPHOL, V7, P251, DOI 10.1016/0020-7322(78)90007-7; DYER LJ, 1978, J CHEM ECOL, V4, P199, DOI 10.1007/BF00988055; Lopez MF, 2018, CAN ENTOMOL, V150, P471, DOI 10.4039/tce.2018.25; Lopez MF, 2014, ANN ENTOMOL SOC AM, V107, P1130, DOI 10.1603/AN14069; Gillett Conrad P. D. T., 2017, Proceedings of the Hawaiian Entomological Society, V49, P51; Gillett CPDT, 2014, MOL BIOL EVOL, V31, P2223, DOI 10.1093/molbev/msu154; Girardi GS, 2006, NEOTROP ENTOMOL, V35, P864, DOI 10.1590/S1519-566X2006000600023; Gumus E. M., 2015, Bulletin OEPP, V45, P112, DOI 10.1111/epp.12190; HALLBERG E, 1994, TISSUE CELL, V26, P489, DOI 10.1016/0040-8166(94)90002-7; HALLBERG E, 1982, PROTOPLASMA, V111, P206, DOI 10.1007/BF01281968; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Jordal BH, 2015, MOL PHYLOGENET EVOL, V92, P294, DOI 10.1016/j.ympev.2015.05.028; Kamata N, 2008, J FOREST RES-JPN, V13, P122, DOI 10.1007/s10310-007-0053-5; Keil T.A., 1984, P477; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Lee JS, 2011, ENVIRON ENTOMOL, V40, P1363, DOI 10.1603/EN11138; Lei GK, 2020, MICRON, V130, DOI 10.1016/j.micron.2019.102815; Li Y, 2018, FLA ENTOMOL, V101, P141, DOI 10.1653/024.101.0127; Li ZB, 2014, ACTA ZOOL-STOCKHOLM, V95, P73, DOI 10.1111/azo.12010; [李宗波 Li Zongbo], 2013, [西北林学院学报, Journal of Northwest Forestry College], V28, P138; Lu Shidong, 2019, Journal of Southwest Forestry University, V39, P86; Lucia A, 2014, P S DES TEST INT PAC, P1, DOI DOI 10.1109/DTIP.2014.7056678; MacKay CA, 2014, ARTHROPOD STRUCT DEV, V43, P469, DOI 10.1016/j.asd.2014.04.005; Merivee E, 1997, INT J INSECT MORPHOL, V26, P75, DOI 10.1016/S0020-7322(97)00013-5; Merivee E, 1999, INT J INSECT MORPHOL, V28, P41, DOI 10.1016/S0020-7322(98)00032-4; MOECK HA, 1968, CAN J ZOOLOG, V46, P521, DOI 10.1139/z68-072; Palma R, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13301; PAYNE T L, 1973, International Journal of Insect Morphology and Embryology, V2, P177, DOI 10.1016/0020-7322(73)90027-5; Prestwich G.D., 1987, P473; Ranger CM, 2017, ANN ENTOMOL SOC AM, V110, P172, DOI 10.1093/aesa/saw069; Reinhart, 2004, CHEMOSENSE, V6, P1; Ren LL, 2012, MICRON, V43, P921, DOI 10.1016/j.micron.2012.03.005; Said I, 2003, J INSECT PHYSIOL, V49, P857, DOI 10.1016/S0022-1910(03)00137-9; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHNEIDER D, 1964, Z VERGL PHYSIOL, V48, P632, DOI 10.1007/BF00333745; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Silva JCP, 2013, P 3 C BRAS HEV, P24; SKILBECK CA, 1994, INT J INSECT MORPHOL, V23, P319, DOI 10.1016/0020-7322(94)90028-0; [孙世伟 Sun Shiwei], 2017, [热带作物学报, Chinese Journal of Tropical Crops], V38, P695; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; TAYLOR TR, 1981, EXPERIENTIA, V37, P729, DOI 10.1007/BF01967948; Tittiger C, 2017, CURR OPIN INSECT SCI, V24, P68, DOI 10.1016/j.cois.2017.09.005; Vipin AV, 2017, BIOMED PHARMACOTHER, V91, P415, DOI 10.1016/j.biopha.2017.04.107; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wang PY, 2012, MICROSC RES TECHNIQ, V75, P1672, DOI 10.1002/jemt.22115; Wang QuanPo, 2013, Journal of Northwest A & F University - Natural Science Edition, V41, P87; [王涛 Wang Tao], 2017, [植物保护, Plant Protection], V43, P112; Wang Y, 2020, ZOOL ANZ, V286, P11, DOI 10.1016/j.jcz.2020.03.001; WHITEHEAD AT, 1981, INT J INSECT MORPHOL, V10, P19, DOI 10.1016/0020-7322(81)90010-6; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; WOOD SL, 1993, GREAT BASIN NAT, V53, P259; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P1; Yang H, 2009, MICRON, V40, P231, DOI 10.1016/j.micron.2008.08.002; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; Zhang XH, 2014, CELL MOL BIOL, V60, P29	73	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241275	10.1371/journal.pone.0241275	http://dx.doi.org/10.1371/journal.pone.0241275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108376	Green Published, gold			2022-12-26	WOS:000588372400023
J	Liu, CD; Zhou, XH; Long, Q; Zeng, HY; Sun, QC; Chen, YT; Wu, DH; Liu, L				Liu, Chengdong; Zhou, Xiaohan; Long, Qian; Zeng, Hanyi; Sun, Qingcan; Chen, Yuting; Wu, Dehua; Liu, Li			Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene	ONCOGENE			English	Article							THERAPEUTIC STRATEGY; EXOSOMES; CELLS; PROLIFERATION; METASTASIS; SECRETION; RELEASE; STRESS	Cancer cells under hypoxic, endoplasmic reticulum, and reactive oxygen species stress secrete copious amounts of small extracellular vesicles (sEVs) to promote tumor metastasis. The effects of blocking stress-induced sEV release on tumor metastasis remain unknown. We found that miR-30a-3p was selectively sorted into sEVs by hepatocellular carcinoma (HCC) cells under the influence of multiple stressors. miR-30a-3p removal from cancer cells through sEVs promoted HCC cell migration and invasion, whereas exogenous overexpression of miR-30a-3p could inhibit migration, invasion, and sEV release by directly targeting SNAP23. HCC cells efficiently absorbed hepatic stellate cell (HSC) sEVs, providing an advantage in the treatment of HCC using HSC sEVs. Treatment with HSC sEVs rich in miR-30a-3p cargo effectively attenuated HCC migration, invasion, and metastasis. Overall, sEVs containing miR-30a-3p decreased sEV secretion as well as the migration, invasion, and metastasis of HCC by directly targeting SNAP23, thereby providing an effective strategy to attenuate metastasis of HCC.	[Liu, Chengdong; Long, Qian; Zeng, Hanyi; Sun, Qingcan; Liu, Li] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China; [Zhou, Xiaohan; Chen, Yuting; Wu, Dehua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liu, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China.; Wu, DH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China.	18602062748@163.com; liuli@i.smu.edu.cn		Wu, De-Hua/0000-0003-0560-0016	National Nature Science Foundation of China [81773008, 81672756, 81872399, 81972897]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Natural Science Foundation of Guangdong Province [2017A030311023]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Guangzhou Technology Project [201804010044]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program; Guangzhou Technology Project	This work was supported by the National Nature Science Foundation of China [grant numbers 81773008, 81672756, 81872399, 81972897], the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2015), the Natural Science Foundation of Guangdong Province [grant number 2017A030311023], the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program: 2017BT01S131 and the Guangzhou Technology Project [grant number 201804010044].	An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; Atienzar-Aroca S, 2016, J CELL MOL MED, V20, P1457, DOI 10.1111/jcmm.12834; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hou J, 2018, J ORAL PATHOL MED, V47, P144, DOI 10.1111/jop.12654; Hu JL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1019-x; Huang TT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0967-5; Im EJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09387-4; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kanlikilicer P, 2016, CANCER RES, V76, P7194, DOI 10.1158/0008-5472.CAN-16-0714; Keklikoglou I, 2019, NAT CELL BIOL, V21, P190, DOI 10.1038/s41556-018-0256-3; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Li L, 2017, HEPATOLOGY, V65, P501, DOI 10.1002/hep.28735; Liu JT, 2019, HEPATOLOGY, V70, P241, DOI 10.1002/hep.30607; Lucchetti D, 2020, CANCERS, V12, DOI 10.3390/cancers12020260; Meng WR, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0982-6; Merchant ML, 2017, NAT REV NEPHROL, V13, P731, DOI 10.1038/nrneph.2017.148; Nishida-Aoki N, 2017, MOL THER, V25, P181, DOI 10.1016/j.ymthe.2016.10.009; O'Neill CP, 2019, CANCERS, V11, DOI 10.3390/cancers11020136; Pavlyukov MS, 2018, CANCER CELL, V34, P119, DOI 10.1016/j.ccell.2018.05.012; Peng DY, 2018, LEUKEMIA, V32, P1180, DOI 10.1038/s41375-018-0015-2; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Qiao Y, 2018, ONCOGENE, V37, P873, DOI 10.1038/onc.2017.387; Spychalski P, 2019, RADIOTHER ONCOL, V132, P127, DOI 10.1016/j.radonc.2018.12.012; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; Wang F, 2018, HEPATOLOGY, V67, P940, DOI 10.1002/hep.29586; Wang W, 2014, EJSO-EUR J SURG ONC, V40, P1586, DOI 10.1016/j.ejso.2013.11.008; Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841; Wang XH, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0468-y; Wei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14041; Wu XG, 2019, ANGIOGENESIS, V22, P397, DOI 10.1007/s10456-019-09665-1; Xie Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0984-4; Yang L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0990-6; Zeng ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07810-w; Zhan CN, 2020, ORAL DIS, V26, P865, DOI 10.1111/odi.13172; Zhang X, 2019, CANCER MANAG RES, V11, P1653, DOI 10.2147/CMAR.S188248; Zhang XN, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0959-5; Zhang ZC, 2017, CANCER LETT, V397, P33, DOI 10.1016/j.canlet.2017.03.004	44	16	16	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					233	245		10.1038/s41388-020-01521-7	http://dx.doi.org/10.1038/s41388-020-01521-7		OCT 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33110233				2022-12-26	WOS:000582768100001
J	Shoari, N; Ezzati, M; Baumgartner, J; Malacarne, D; Fecht, D				Shoari, Niloofar; Ezzati, Majid; Baumgartner, Jill; Malacarne, Diego; Fecht, Daniela			Accessibility and allocation of public parks and gardens in England and Wales: A COVID-19 social distancing perspective	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GREEN SPACE; ACCESS; ATTRIBUTES; PROXIMITY; QUALITY; HEALTH	Visiting parks and gardens supports physical and mental health. We quantified access to public parks and gardens in urban areas of England and Wales, and the potential for park crowdedness during periods of high use. We combined data from the Office for National Statistics and Ordnance Survey to quantify (i) the number of parks within 500 and 1,000 metres of urban postcodes (i.e., availability), (ii) the distance of postcodes to the nearest park (i.e., accessibility), and (iii) per-capita space in each park for people living within 1,000m. We examined variability by city and share of flats. Around 25.4 million people (similar to 87%) can access public parks or gardens within a ten-minute walk, while 3.8 million residents (similar to 13%) live farther away; of these 21% are children and 13% are elderly. Areas with a higher share of flats on average are closer to a park but people living in these areas visit parks that are potentially overcrowded during periods of high use. Such disparity in urban areas of England and Wales becomes particularly evident during COVID-19 pandemic and lockdown when local parks, the only available out-of-home space option, hinder social distancing requirements. Cities aiming to facilitate social distancing while keeping public green spaces safe might require implementing measures such as dedicated park times for different age groups or entry allocation systems that, combined with smartphone apps or drones, can monitor and manage the total number of people using the park.	[Shoari, Niloofar; Ezzati, Majid; Malacarne, Diego; Fecht, Daniela] Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ezzati, Majid] Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England; [Ezzati, Majid] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana; [Baumgartner, Jill] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada; [Baumgartner, Jill] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Imperial College London; Imperial College London; University of Ghana; McGill University; McGill University	Fecht, D (corresponding author), Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	d.fecht@imperial.ac.uk		Shoari, Niloofar/0000-0002-3658-6563	Wellcome Trust [209376/Z/17/Z]; MRC [MR/L01341X/1, MR/S019669/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Pathways to Equitable Healthy Cities grant from the Wellcome Trust [209376/Z/17/Z]. Infrastructure support for the Department of Epidemiology and Biostatistics was provided by the NIHR Imperial Biomedical Research Centre (BRC). The funders did not have any input in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publications. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Ajjan RA, 2019, DIABETES VASC DIS RE, V16, P3, DOI 10.1177/1479164118795252; Bergo I, 2020, PARIS CLOSES ALL PAR; Blackall M, 2020, LOCKDOWN UK THERE AR; Clay JM, 2020, LANCET PUBLIC HEALTH, V5, pE259, DOI 10.1016/S2468-2667(20)30088-8; Dennett A, 2018, MODELLING POPULATION; Diaz J., 2020, CITIES CLOSE STREETS; Duncan P, 2020, GUARDIAN; Friedman WN, 2020, WASHINGTON POST; Gomez LF, 2010, AM J PREV MED, V38, P592, DOI 10.1016/j.amepre.2010.02.005; Grazuleviciene R, 2015, INT J HYG ENVIR HEAL, V218, P358, DOI 10.1016/j.ijheh.2015.02.004; Ingle S, 2020, GUARDIAN; Kaczynski AT, 2008, AM J PUBLIC HEALTH, V98, P1451, DOI 10.2105/AJPH.2007.129064; Kondo MC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030445; Mayor of London, 2020, LONDON PARKS GREEN S; McCormick R, 2017, J PEDIATR NURS, V37, P3, DOI 10.1016/j.pedn.2017.08.027; Mears M, 2019, ISPRS INT J GEO-INF, V8, DOI 10.3390/ijgi8060286; Mingoya C, 2020, OPINION PANDEMIC WE; Murphy-Bates Sebastian, 2020, MAIL ONLINE; National Parks, 2020, NATL PARK COVID 19 I; Natural England, MONITOR ENGAGEMENT N; Office for National Statistics, 2011, BUILT AREAS DECEMBER; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Rigolon A, 2018, ENVIRON PLAN B-URBAN, V45, P275, DOI 10.1177/0265813516672212; Rigolon A, 2017, LANDSCAPE URBAN PLAN, V165, P73, DOI 10.1016/j.landurbplan.2017.05.007; Schipperijn J, 2017, URBAN FOR URBAN GREE, V27, P253, DOI 10.1016/j.ufug.2017.08.010; Smith G, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0090-z; Townsend M., 2020, GUARDIAN; Van Cauwenberg J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020192; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; Vanaken GJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122668; Veitch J, 2017, LANDSCAPE URBAN PLAN, V161, P52, DOI 10.1016/j.landurbplan.2016.12.004; Walawalkar Aaron., 2020, GUARDIAN; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Wood L, 2017, HEALTH PLACE, V48, P63, DOI 10.1016/j.healthplace.2017.09.002; Yeo NL, 2020, GERONTOLOGIST, V60, pE184, DOI 10.1093/geront/gnz019; Zhang XY, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-31; 2014, REG ANESTH PAIN MED, V9	37	47	47	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241102	10.1371/journal.pone.0241102	http://dx.doi.org/10.1371/journal.pone.0241102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095838	gold, Green Submitted, Green Published			2022-12-26	WOS:000586649400042
J	Kalinauskaite, G; Senger, C; Kluge, A; Furth, C; Kufeld, M; Tinhofer, I; Budach, V; Beck, M; Hochreiter, A; Grun, A; Stromberger, C				Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Furth, Christian; Kufeld, Markus; Tinhofer, Ingeborg; Budach, Volker; Beck, Marcus; Hochreiter, Alexandra; Gruen, Arne; Stromberger, Carmen			68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cance	PLOS ONE			English	Article							GA-68-PSMA LIGAND PET/CT; RADIATION-THERAPY; BIOCHEMICAL RECURRENCE; MEMBRANE ANTIGEN; DIAGNOSIS; EFFICACY	Background Androgen deprivation therapy (ADT) remains the standard therapy for patients with oligometastatic prostate cancer (OMPC). Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT)-based stereotactic body radiotherapy (SBRT) is emerging as an alternative option to postpone starting ADT and its associated side effects including the development of drug resistance. The aim of this study was to determine progression free-survival (PFS) and treatment failure free-survival (TFFS) after PSMA-PET/CT-based SBRT in OMPC patients. The efficacy and safety of single fraction radiosurgery (SFRS) and ADT delay were investigated. Methods Patients with <= 5 metastases from OMPC, with/without ADT treated with PSMA-PET/CT-based SBRT were retrospectively analyzed. PFS and TFFS were primary endpoints. Secondary endpoints were local control (LC), overall survival (OS) and ADT-free survival (ADTFS). Results Fifty patients with a total of 75 metastases detected by PSMA-PET/CT were analyzed. At the time of SBRT, 70% of patients were castration-sensitive. Overall, 80% of metastases were treated with SFRS (median dose 20 Gy, range: 16-25). After median follow-up of 34 months (range: 5-70) median PFS and TFFS were 12 months (range: 2-63) and 14 months (range: 2-70), respectively. Thirty-two (64%) patients had repeat oligometastatic disease. Twenty-four (48%) patients with progression underwent second SBRT course. Two-year LC after SFRS was 96%. Grade 1 and 2 toxicity occurred in 3 (6%) and 1 (2%) patients, respectively. ADTFS and OS rates at 2-years were 60.5% and 100%, respectively. In multivariate analysis, TFFS significantly improved in patients with time to first metastasis (TTM) >36 months (p = 0.01) and PSA before SBRT <= 1 ng/ml (p = 0.03). Conclusion For patients with OMPC, SBRT might be used as an alternative to ADT. This way, the start/escalation of palliative ADT and its side effects can be deferred. Metastases treated with PSMA-PET/CT-based SFRS reached excellent LC with minimal toxicity. Low PSA levels and longer TTM predict elongated TFFS.	[Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Furth, Christian; Tinhofer, Ingeborg; Budach, Volker; Beck, Marcus; Hochreiter, Alexandra; Gruen, Arne; Stromberger, Carmen] Charite Univ Med Berlin, Berlin, Germany; [Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Furth, Christian; Tinhofer, Ingeborg; Budach, Volker; Beck, Marcus; Hochreiter, Alexandra; Gruen, Arne; Stromberger, Carmen] Free Univ Berlin, Berlin, Germany; [Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Furth, Christian; Tinhofer, Ingeborg; Budach, Volker; Beck, Marcus; Hochreiter, Alexandra; Gruen, Arne; Stromberger, Carmen] Humboldt Univ, Berlin, Germany; [Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Tinhofer, Ingeborg; Budach, Volker; Beck, Marcus; Hochreiter, Alexandra; Gruen, Arne; Stromberger, Carmen] Berlin Inst Hlth, Dept Radiat Oncol & Radiotherapy, Berlin, Germany; [Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Kufeld, Markus; Budach, Volker; Beck, Marcus; Gruen, Arne; Stromberger, Carmen] Charite Univ Med Berlin, Charite CyberKnife Ctr, Dept Radiat Oncol, Berlin, Germany; [Kalinauskaite, Goda; Senger, Carolin; Kluge, Anne; Kufeld, Markus; Budach, Volker; Beck, Marcus; Gruen, Arne; Stromberger, Carmen] Charite Univ Med Berlin, Charite CyberKnife Ctr, Dept Neurosurg, Berlin, Germany; [Furth, Christian] Berlin Inst Hlth, Dept Nucl Med, Berlin, Germany; [Tinhofer, Ingeborg] Charite Univ Med Berlin, Translat Radiooncol & Radiobiol Res Lab, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kalinauskaite, G (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Kalinauskaite, G (corresponding author), Free Univ Berlin, Berlin, Germany.; Kalinauskaite, G (corresponding author), Humboldt Univ, Berlin, Germany.; Kalinauskaite, G (corresponding author), Berlin Inst Hlth, Dept Radiat Oncol & Radiotherapy, Berlin, Germany.; Kalinauskaite, G (corresponding author), Charite Univ Med Berlin, Charite CyberKnife Ctr, Dept Radiat Oncol, Berlin, Germany.; Kalinauskaite, G (corresponding author), Charite Univ Med Berlin, Charite CyberKnife Ctr, Dept Neurosurg, Berlin, Germany.	goda.kalinauskaite@charite.de	Grün, Arne/AAE-2369-2022	Stromberger, Carmen/0000-0001-6165-1729; Hochreiter, Alexandra/0000-0003-4526-6091; Furth, Christian/0000-0001-7302-7886; Tinhofer, Ingeborg/0000-0002-0512-549X; Kalinauskaite, Goda/0000-0003-3798-1546; Grun, Arne/0000-0002-3868-2719; Budach, Volker/0000-0002-2191-9871	Berliner Krebsgesellschaft das Ernst von Leyden-Stipendium	Berliner Krebsgesellschaft das Ernst von Leyden-Stipendium	Award was received by GK. Funder: Berliner Krebsgesellschaft das Ernst von Leyden-Stipendium URL: https://www.berlinerkrebsgesellschaft.de/krebsforschung/ernst-von-leyden-stipendium/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P11, DOI 10.1007/s00259-013-2525-5; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; [Anonymous], 2018, J NUCL MED, V59, p9N; Asokendaran ME, 2019, WORLD J NUCL MED, V18, P232, DOI 10.4103/wjnm.WJNM_59_18; Bluemel C, 2016, CLIN NUCL MED, V41, P515, DOI 10.1097/RLU.0000000000001197; Bowden P, 2020, INT J CANCER, V146, P161, DOI 10.1002/ijc.32509; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Decaestecker K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-135; Eiber M, 2015, J NUCL MED, V56, P668, DOI 10.2967/jnumed.115.154153; Einspieler I, 2017, J NUCL MED, V58, P1081, DOI 10.2967/jnumed.116.184457; Franzese C, 2019, J CANCER RES CLIN, V145, P2469, DOI 10.1007/s00432-019-03007-w; Grubmuller B, 2018, EUR J NUCL MED MOL I, V45, P235, DOI 10.1007/s00259-017-3858-2; Guckenberger M, 2020, LANCET ONCOL, V21, pE18, DOI 10.1016/S1470-2045(19)30718-1; Guler OC, 2018, CLIN TRANSL ONCOL, V20, P484, DOI 10.1007/s12094-017-1736-9; Gupta SK, 2017, INT J RADIAT ONCOL, V99, P701, DOI 10.1016/j.ijrobp.2017.06.2448; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hong JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195149; Hurmuz P, 2020, STRAHLENTHER ONKOL, V196, P1034, DOI 10.1007/s00066-020-01660-6; Jadvar H, 2018, J NUCL MED, V59, P1338, DOI 10.2967/jnumed.118.213470; Morigi JJ, 2015, J NUCL MED, V56, P1185, DOI 10.2967/jnumed.115.160382; Muldermans JL, 2016, INT J RADIAT ONCOL, V95, P696, DOI 10.1016/j.ijrobp.2016.01.032; Nicosia L, 2020, STRAHLENTHER ONKOL, V196, P213, DOI 10.1007/s00066-019-01523-9; Oehus AK, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06883-5; Ong WL, 2019, BJU INT, V124, P19, DOI 10.1111/bju.14886; Ost P, 2018, J CLIN ONCOL, V36, P446, DOI 10.1200/JCO.2017.75.4853; Ost P, 2016, EUR UROL, V69, P9, DOI 10.1016/j.eururo.2015.07.004; Parker C, 2015, ANN ONCOL, V26, pV69, DOI 10.1093/annonc/mdv222; Pasqualetti F, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0586-x; Patel PH, 2019, WORLD J UROL, V37, P2615, DOI 10.1007/s00345-019-02873-w; Pfister D, 2016, EUR J NUCL MED MOL I, V43, P1410, DOI 10.1007/s00259-016-3366-9; Phillips R, 2020, JAMA ONCOL, V6, P650, DOI 10.1001/jamaoncol.2020.0147; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rao Arpit, 2019, Am Soc Clin Oncol Educ Book, V39, P309, DOI 10.1200/EDBK_239041; Siva S, 2018, EUR UROL, V74, P455, DOI 10.1016/j.eururo.2018.06.004; Slaoui A, 2019, WORLD J UROL, V37, P2343, DOI 10.1007/s00345-019-02652-7; Sterzing F, 2016, EUR J NUCL MED MOL I, V43, P34, DOI 10.1007/s00259-015-3188-1; Triggiani L, 2017, BRIT J CANCER, V116, P1520, DOI 10.1038/bjc.2017.103; Valeriani M, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1414-x	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240892	10.1371/journal.pone.0240892	http://dx.doi.org/10.1371/journal.pone.0240892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085712	gold, Green Published			2022-12-26	WOS:000585943400037
J	Xu, YS; Moller, J; Wang, R; Liang, YJ				Xu, Yongshi; Moller, Jette; Wang, Rui; Liang, Yajun			Life-course blood pressure trajectories and cardiovascular diseases: A population-based cohort study in China	PLOS ONE			English	Article							RISK; HYPERTENSION; ASSOCIATION; ADULTHOOD; CHILDHOOD; GROWTH; STROKE; IMPACT	Background The patterns of blood pressure trajectory (i.e., change over time) over life-course remain to be explored. In this study, we aim to determine the trajectories of systolic blood pressure (SBP) from adulthood to late life and to assess its impact on the risk of cardiovascular diseases (CVDs). Methods Based on the China Health and Nutrition Survey, a total of 3566 participants aged 20-50 years at baseline (1989) with at least three SBP measurements during 1989-2011 were included. SBP was measured through physical examination, and socio-demographic factors, lifestyles, medications, and CVDs were based on self-reported questionnaire. Latent class growth modeling was performed to examine SBP trajectory. Odds ratio (OR) and 95% confidence interval (CI) from logistic regression was used to determine the association between SBP trajectory and CVDs. Results Five trajectory groups of SBP were identified: Class 1: rapid increase (n = 113, 3.2%); Class 2: slight increase (n = 1958, 54.9%); Class 3: stable (n = 614, 17.2%); Class 4: increase (n = 800, 22.4%); Class 5: fluctuant (n = 81, 2.3%). After adjustment of demographic factors, baseline SBP, and lifestyles, compared with the "slight increase" group, the OR (95% CI) of CVDs was 0.65 (0.32, 1.28) for "stable" group, 2.24 (1.40, 3.58) for "increase" group, 3.95 (1.81, 8.62) for "rapid increase" group, and 4.32 (1.76, 10.57) for "fluctuant" group. After stratified by use of antihypertensive drugs, the association was only significant for "rapid increase" group among those using antihypertensive drugs with OR (95% CI) of 2.81 (1.01, 7.77). Conclusions Having a rapidly increasing SBP over life-course is associated with a higher risk of CVDs. This implies the importance of monitoring lifetime change of blood pressure for the prevention of CVDs.	[Xu, Yongshi; Moller, Jette; Liang, Yajun] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Wang, Rui] GIH, Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Wang, Rui] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden; [Wang, Rui] Stockholm Univ, Stockholm, Sweden; [Wang, Rui] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA	Karolinska Institutet; Swedish School of Sport & Health Sciences; Karolinska Institutet; Stockholm University; University of Wisconsin System; University of Wisconsin Madison	Liang, YJ (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	yajun.liang@ki.se	Wang, Rui/HGE-4083-2022	Wang, Rui/0000-0001-7209-741X	National Institutes of Health (NIH) [P01-HD28076, HD30880]; NIH [HD39183]; Carolina Population Center (CPC); Ford Foundation; National Science Foundation [INT-9215399]; National Institute of Nutrition and Food Safety; Chinese Centers for Disease Control and Prevention; Karolinska Institutet, Sweden [2018-01590]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolina Population Center (CPC); Ford Foundation; National Science Foundation(National Science Foundation (NSF)); National Institute of Nutrition and Food Safety; Chinese Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Karolinska Institutet, Sweden(Karolinska Institutet)	The China Health and Nutrition Survey (CHNS) was funded by a number of organizations. Main funding for the survey and data dissemination from 1991 to 2004 came from the National Institutes of Health (NIH) (P01-HD28076 and HD30880). Additional funding has come from NIH (HD39183), the Carolina Population Center (CPC) (in particular, CPC funded CHNS 1989), the Ford Foundation, the National Science Foundation (INT-9215399), the National Institute of Nutrition and Food Safety (formerly named Institute of Nutrition and Food Hygiene), and the Chinese Centers for Disease Control and Prevention (formerly named Chinese Academy of Preventive Medicine). This work was supported in part by the Karolinska Institutet, Sweden (2018-01590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, CIRCULATION, V125, P37, DOI 10.1161/CIRCULATIONAHA.110.002774; Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Batis C, 2013, EPIDEMIOLOGY, V24, P410, DOI 10.1097/EDE.0b013e318289e047; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Food and Nutrition Board: Institute of Medicine, 2002, DIET REF INT EN CARB; Fuchs FD, 2020, HYPERTENSION, V75, P285, DOI 10.1161/HYPERTENSIONAHA.119.14240; Hao G, 2017, HYPERTENSION, V69, P435, DOI 10.1161/HYPERTENSIONAHA.116.08312; He J, 1999, J HYPERTENS, V17, pS7; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; Kagura J, 2016, HYPERTENSION, V68, P1123, DOI 10.1161/HYPERTENSIONAHA.116.08046; Li WJ, 2017, HYPERTENSION, V70, P508, DOI [10.1161/hypertensionaha.117.09479, 10.1161/HYPERTENSIONAHA.117.09479]; Li YP, 2016, J AM COLL CARDIOL, V68, P818, DOI 10.1016/j.jacc.2016.06.011; Liang YJ, 2014, INT J CARDIOL, V175, P96, DOI 10.1016/j.ijcard.2014.04.258; Mattace-Raso FUS, 2004, J AM GERIATR SOC, V52, P1538, DOI 10.1111/j.1532-5415.2004.52419.x; Mosley WJ, 2007, HYPERTENSION, V49, P1256, DOI 10.1161/HYPERTENSIONAHA.106.083592; Portegies MLP, 2016, HYPERTENSION, V67, P1126, DOI 10.1161/HYPERTENSIONAHA.116.07098; SHIMIZU Y, 1984, STROKE, V15, P839, DOI 10.1161/01.STR.15.5.839; Smitson CC, 2017, AM J HYPERTENS, V30, P587, DOI 10.1093/ajh/hpx028; Theodore RF, 2015, HYPERTENSION, V66, P1108, DOI 10.1161/HYPERTENSIONAHA.115.05831; Tielemans SMAJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001378; Vasan RS, 2002, CIRCULATION, V105, P48, DOI 10.1161/hc0102.101774; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wills AK, 2012, EPIDEMIOLOGY, V23, P203, DOI 10.1097/EDE.0b013e3182456567	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240804	10.1371/journal.pone.0240804	http://dx.doi.org/10.1371/journal.pone.0240804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085698	gold, Green Published			2022-12-26	WOS:000585943400039
J	Kobayashi, F; Saraya, T; Oda, M; Sakuma, S; Watanabe, M; Takata, S; Tamura, M; Takakura, H; Nakamoto, K; Honda, K; Ohkuma, K; Mikura, S; Inoue, M; Hirata, A; Kurokawa, N; Shirai, T; Aso, K; Noda, A; Miyaoka, C; Yoshida, Y; Ishikawa, N; Morita, K; Ieki, E; Nakajima, H; Ishii, H; Takizawa, H				Kobayashi, Fumi; Saraya, Takeshi; Oda, Miku; Sakuma, Sho; Watanabe, Masato; Takata, Saori; Tamura, Masaki; Takakura, Hiroki; Nakamoto, Keitaro; Honda, Kojiro; Ohkuma, Kosuke; Mikura, Sunao; Inoue, Manami; Hirata, Aya; Kurokawa, Nozomi; Shirai, Tatsuya; Aso, Kaori; Noda, Akinari; Miyaoka, Chika; Yoshida, Yuki; Ishikawa, Narishige; Morita, Kikuko; Ieki, Eriko; Nakajima, Hiromi; Ishii, Haruyuki; Takizawa, Hajime			Novel predictive factors for patient discomfort and severe cough during bronchoscopy: A prospective questionnaire analysis	PLOS ONE			English	Article								During bronchoscopy, discomfort is mainly caused by an unavoidable cough; however, there are no reports of any predictive factors for strong cough during bronchoscopy identified before the procedure. To clarify the factors underlying the discomfort status and predictive factors for strong cough during bronchoscopy, we prospectively evaluated patients who underwent bronchoscopy at Kyorin University Hospital between March 2018 and July 2019. Before and after bronchoscopy, the enrolled patients answered a questionnaire regarding the procedure. At the same time, bronchoscopists evaluated cough severity using a four-grade cough scale. We evaluated patient characteristics and predictive factors associated with bronchoscopy from the perspective of discomfort and strong cough. A total of 172 patients were ultimately enrolled in this study. On multivariate logistic regression analysis, comparison of the subjective data between the discomfort and comfort groups revealed that factors that were more common in the former group were younger age (OR = 0.96,p= 0.002), less experienced bronchoscopist (OR = 2.08,p= 0.047), and elevation of cough score per 1 point (OR = 1.69,p< 0.001). Furthermore, the predictive factors for strong cough prior to performing bronchoscopy were female sex (OR = 2.57,p= 0.009), EBUS-TBNA (OR = 2.95,p= 0.004), and prolonged examination time of more than 36 min (OR = 2.32,p= 0.022). Regarding patients' discomfort,younger age, less experienced bronchoscopist, and the elevation of cough score per 1 point were important factors for discomfort in bronchoscopy. On the other hand, female sex, EBUS-TBNA, and prolonged examination time were crucial factors for strong cough.	[Kobayashi, Fumi; Saraya, Takeshi; Oda, Miku; Sakuma, Sho; Watanabe, Masato; Takata, Saori; Tamura, Masaki; Takakura, Hiroki; Nakamoto, Keitaro; Honda, Kojiro; Ohkuma, Kosuke; Mikura, Sunao; Inoue, Manami; Hirata, Aya; Kurokawa, Nozomi; Shirai, Tatsuya; Aso, Kaori; Noda, Akinari; Miyaoka, Chika; Yoshida, Yuki; Ishikawa, Narishige; Morita, Kikuko; Ieki, Eriko; Nakajima, Hiromi; Ishii, Haruyuki; Takizawa, Hajime] Kyorin Univ, Dept Resp Med, Sch Med, Mitaka, Tokyo, Japan	Kyorin University	Saraya, T (corresponding author), Kyorin Univ, Dept Resp Med, Sch Med, Mitaka, Tokyo, Japan.	sara@yd5.so-net.ne.jp		Nakamoto, Keitaro/0000-0002-7140-6273; Saraya, Takeshi/0000-0003-0502-8128				Fujimoto K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208495; Fujisawa TKN, 2011, J JPN SOC RESP ENDOS, V33, P3; Hadzri Hm, 2010, JRSM Short Rep, V1, P35, DOI 10.1258/shorts.2010.010044; Jeyabalan A, 2014, RESPIRATION, V88, P244, DOI 10.1159/000363063; Kage H, 2019, CANCER SCI, V110, P2652, DOI 10.1111/cas.14112; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kastelik JA, 2002, AM J RESP CRIT CARE, V166, P961, DOI 10.1164/rccm.2109061; Mitsumune T, 2005, RESPIROLOGY, V10, P92, DOI 10.1111/j.1440-1843.2005.00642.x; Tsunoda A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5773-3; Yildirim F, 2017, J PAIN RES, V10, P775, DOI 10.2147/JPR.S118047	10	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240485	10.1371/journal.pone.0240485	http://dx.doi.org/10.1371/journal.pone.0240485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075060	Green Published, gold			2022-12-26	WOS:000585920200031
J	Rudolph, JL; Stapel, JC; Selen, LPJ; Medendorp, WP				Rudolph, Judith L.; Stapel, Janny C.; Selen, Luc P. J.; Medendorp, W. Pieter			Single versus dual-rate learning when exposed to Coriolis forces during reaching movements	PLOS ONE			English	Article							MOTOR; ADAPTATION; DYNAMICS; MEMORY	When we reach for an object during a passive whole body rotation, a tangential Coriolis force is generated on the arm. Yet, within a few trials, the brain adapts to this force so it does not disrupt the reach. Is this adaptation governed by a single-rate or dual-rate learning process? Here, guided by state-space modeling, we studied human reach adaptation in a fully-enclosed rotating room. After 90 pre-rotation reaches (baseline), participants were trained to make 240 to-and-fro reaches while the room rotated at 10 rpm (block A), then performed 6 reaches under opposite room rotation (block B), and subsequently made 100 post-rotation reaches (washout). A control group performed the same paradigm, but without the reaches during rotation block B. Single-rate and dual-rate models can be best dissociated if there would be full un-learning of compensation A during block B, but minimal learning of B. From the perspective of a dual-rate model, the un-learning observed in block B would mainly be caused by the faster state, such that the washout reaches would show retention effects of the slower state, called spontaneous recovery. Alternatively, following a single-rate model, the same state would govern the learning in block A and un-learning in block B, such that the washout reaches mimic the baseline reaches. Our results do not provide clear signs of spontaneous recovery in the washout reaches. Model fits further show that a single-rate process outperformed a dual-rate process. We suggest that a single-rate process underlies Coriolis force reach adaptation, perhaps because these forces relate to familiar body dynamics and are assigned to an internal cause.	[Rudolph, Judith L.; Selen, Luc P. J.; Medendorp, W. Pieter] Radboud Univ Nijmegen, Donders Ctr Cognit, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Stapel, Janny C.] Uppsala Univ, Dept Psychol, Uppsala, Sweden	Radboud University Nijmegen; Uppsala University	Medendorp, WP (corresponding author), Radboud Univ Nijmegen, Donders Ctr Cognit, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	p.medendorp@donders.ru.nl		Medendorp, W. Pieter/0000-0001-9615-4220	Swedish Research Council [2016-01725]; Donders Centre for Cognition	Swedish Research Council(Swedish Research CouncilEuropean Commission); Donders Centre for Cognition	This work was supported by a grant of the Swedish Research Council (JCS, grant nr. 2016-01725) and an internal grant from the Donders Centre for Cognition (WPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ST, 2018, J NEUROPHYSIOL, V119, P1367, DOI 10.1152/jn.00197.2017; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Berniker M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002210; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Cluff T, 2013, J NEUROSCI, V33, P15903, DOI 10.1523/JNEUROSCI.0263-13.2013; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Howard IS, 2013, J NEUROPHYSIOL, V109, P2632, DOI 10.1152/jn.00773.2012; Howard IS, 2009, J NEUROSCI METH, V181, P199, DOI 10.1016/j.jneumeth.2009.05.005; Ingram JN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002196; Inoue M, 2015, J NEUROPHYSIOL, V113, P328, DOI 10.1152/jn.00803.2013; Joiner WM, 2008, J NEUROPHYSIOL, V100, P2948, DOI 10.1152/jn.90706.2008; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002312; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142963; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Pigeon P, 2013, J NEUROPHYSIOL, V110, P1370, DOI 10.1152/jn.00104.2012; Sarwary AME, 2013, J NEUROPHYSIOL, V110, P1269, DOI 10.1152/jn.00914.2012; Sarwary AME, 2018, J NEUROPHYSIOL, V120, P2011, DOI 10.1152/jn.00488.2018; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Trewartha KM, 2017, COGNITION, V163, P121, DOI 10.1016/j.cognition.2017.02.014; Trewartha KM, 2014, J NEUROSCI, V34, P13411, DOI 10.1523/JNEUROSCI.1489-14.2014; van der Kooij K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117901	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240666	10.1371/journal.pone.0240666	http://dx.doi.org/10.1371/journal.pone.0240666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075104	Green Published, gold			2022-12-26	WOS:000585920200024
J	Boddapati, S; Gilmore, J; Boone, K; Bushey, J; Ross, J; Gfeller, B; Mcfee, W; Rao, R; Corrigan, G; Chen, A; Clarke, H; Valliere-Douglass, J; Bhargava, S				Boddapati, Shanta; Gilmore, Jason; Boone, Kyle; Bushey, John; Ross, Jonathan; Gfeller, Brian; Mcfee, William; Rao, Romesh; Corrigan, Greg; Chen, Aaron; Clarke, Howard; Valliere-Douglass, John; Bhargava, Swapnil			Evidence for co-translational misincorporation of non-canonical amino acid hydroxyproline in recombinant antibodies produced in Chinese Hamster Ovary (CHO) cell lines	PLOS ONE			English	Article							PROTEIN; QUALITY; STRESS; DESIGN; SERINE	With the advent of highly sensitive technologies such as tandem mass spectrometry and next-generation sequencing, recombinant antibodies are now routinely analyzed for the presence of low-level sequence variants including amino acid misincorporations. During mAb cell culture process development, we found that proline was replaced with the non-canonical amino acid, hydroxyproline, in the protein sequence. We investigated the relationship between proline content in the cell culture media and proline sequence variants and found that the proline concentration was inversely correlated with the amount of sequence variants detected in the protein sequence. Hydroxyproline incorporation has been previously reported in recombinant proteins produced in mammalian expression systems as a post-translational modification. Given the dependency on proline levels, the mechanism was then investigated. To address the possibility of co-translational misincorporation of hydroxyproline, we used tandem mass spectrometry to measure incorporation of stable-isotope labelled hydroxyproline added to the feed of a production bioreactor. We discovered co-translational misincorporation of labelled hydroxyproline in the recombinant antibody. These findings are significant, since they underscore the need to track non-canonical amino acid incorporation as a co-translational event in CHO cells. Understanding the mechanism of hydroxyproline incorporation is crucial in developing an appropriate control strategy during biologics production.	[Boddapati, Shanta; Gilmore, Jason; Boone, Kyle; Bushey, John; Ross, Jonathan; Gfeller, Brian; Mcfee, William; Rao, Romesh; Chen, Aaron; Clarke, Howard; Valliere-Douglass, John; Bhargava, Swapnil] Seattle Genet Inc, Proc Sci, Bothell, WA 98021 USA; [Corrigan, Greg] Seattle Genet Inc, Upstream Mfg, Bothell, WA USA	Seattle Genetics; Seattle Genetics	Boddapati, S (corresponding author), Seattle Genet Inc, Proc Sci, Bothell, WA 98021 USA.	sboddapati@seagen.com		Gfeller, Brian/0000-0003-3492-3105				Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; AVERYHARTFULLARD V, 1988, P NATL ACAD SCI USA, V85, P1082, DOI 10.1073/pnas.85.4.1082; Bandaranayake AD, 2014, FEBS LETT, V588, P253, DOI 10.1016/j.febslet.2013.11.035; BAUM BJ, 1975, J BIOL CHEM, V250, P1464; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; Biermann M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-116; BOGOSIAN G, 1989, J BIOL CHEM, V264, P531; Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200; CASTRO PML, 1992, APPL MICROBIOL BIOT, V38, P84; Dunlop RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075376; Feeney L, 2013, BIOTECHNOL BIOENG, V110, P1087, DOI 10.1002/bit.24759; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo DL, 2010, BIOTECHNOL BIOENG, V107, P163, DOI 10.1002/bit.22780; Harris RP, 2014, CURR OPIN BIOTECH, V30, P45, DOI 10.1016/j.copbio.2014.05.003; Ho SCL, 2016, J BIOSCI BIOENG, V122, P499, DOI 10.1016/j.jbiosc.2016.03.003; HONG JC, 1994, PLANT PHYSIOL, V104, P793, DOI 10.1104/pp.104.2.793; Kapur M, 2018, TRENDS GENET, V34, P218, DOI 10.1016/j.tig.2017.12.007; Khetan A, 2010, BIOTECHNOL BIOENG, V107, P116, DOI 10.1002/bit.22771; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Lin TJ, 2019, MABS-AUSTIN, V11, P1, DOI 10.1080/19420862.2018.1531965; Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Nunn PR, 2010, NAT PROD COMMUN, V5, P485; Rathore AS, 2009, NAT BIOTECHNOL, V27, P26, DOI 10.1038/nbt0109-26; Reitz C, 2018, CURR OPIN BIOTECH, V53, P248, DOI 10.1016/j.copbio.2018.05.003; Ren DY, 2011, J CHROMATOGR B, V879, P2877, DOI 10.1016/j.jchromb.2011.08.015; Rodgers KJ, 2008, INT J BIOCHEM CELL B, V40, P1452, DOI 10.1016/j.biocel.2008.01.009; Rodgers KJ, 2014, EXP NEUROL, V253, P192, DOI 10.1016/j.expneurol.2013.12.010; Rubenstein E, 2008, J NEUROPATH EXP NEUR, V67, P1035, DOI 10.1097/NEN.0b013e31818add4a; Salazar A, 2016, AMINO ACIDS, V48, P1161, DOI 10.1007/s00726-016-2181-8; Schwartz MH, 2017, CRIT REV BIOCHEM MOL, V52, P205, DOI 10.1080/10409238.2016.1274284; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Soini J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-30; Song YX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00304-1; Spahr C, 2017, MABS-AUSTIN, V9, P812, DOI 10.1080/19420862.2017.1325556; Tyshchuk O, 2019, MABS-AUSTIN, V11, P1219, DOI 10.1080/19420862.2019.1635865; Valliere-Douglass John, 2019, PDA J Pharm Sci Technol, V73, P622, DOI 10.5731/pdajpst.2019.010009; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; Wang XY, 2016, ADV NUTR, V7, p773S, DOI 10.3945/an.115.010991; Wen DY, 2009, J BIOL CHEM, V284, P32686, DOI 10.1074/jbc.M109.059360; Wong HE, 2018, BIOCHEMISTRY-US, V57, P6767, DOI 10.1021/acs.biochem.8b00976; Yang Y, 2010, OXID MED CELL LONGEV, V3, P392, DOI 10.4161/oxim.3.6.14786; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; Zhang ZQ, 2013, BIOCHEMISTRY-US, V52, P8165, DOI 10.1021/bi401002c	45	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241250	10.1371/journal.pone.0241250	http://dx.doi.org/10.1371/journal.pone.0241250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QC1YS	33119652	Green Published, gold			2022-12-26	WOS:000614631900001
J	Abshiru, NA; Sikora, JW; Camarillo, JM; Morris, JA; Compton, PD; Lee, T; Neelamraju, Y; Haddox, S; Sheridan, C; Carroll, M; Cripe, LD; Tallman, MS; Paietta, EM; Melnick, AM; Thomas, PM; Garrett-Bakelman, FE; Kelleher, NL				Abshiru, Nebiyu A.; Sikora, Jacek W.; Camarillo, Jeannie M.; Morris, Juliette A.; Compton, Philip D.; Lee, Tak; Neelamraju, Yaseswini; Haddox, Samuel; Sheridan, Caroline; Carroll, Martin; Cripe, Larry D.; Tallman, Martin S.; Paietta, Elisabeth M.; Melnick, Ari M.; Thomas, Paul M.; Garrett-Bakelman, Francine E.; Kelleher, Neil L.			Targeted detection and quantitation of histone modifications from 1,000 cells	PLOS ONE			English	Article							MODIFICATIONS PREDICT PROGNOSIS; MASS-SPECTROMETRY REVEALS; CANCER; ACETYLATION; METHYLATION; CHROMATIN; H3; QUANTIFICATION; PROTEINS; PATTERNS	Histone post-translational modifications (PTMs) create a powerful regulatory mechanism for maintaining chromosomal integrity in cells. Histone acetylation and methylation, the most widely studied histone PTMs, act in concert with chromatin-associated proteins to control access to genetic information during transcription. Alterations in cellular histone PTMs have been linked to disease states and have crucial biomarker and therapeutic potential. Traditional bottom-up mass spectrometry of histones requires large numbers of cells, typically one million or more. However, for some cell subtype-specific studies, it is difficult or impossible to obtain such large numbers of cells and quantification of rare histone PTMs is often unachievable. An established targeted LC-MS/MS method was used to quantify the abundance of histone PTMs from cell lines and primary human specimens. Sample preparation was modified by omitting nuclear isolation and reducing the rounds of histone derivatization to improve detection of histone peptides down to 1,000 cells. In the current study, we developed and validated a quantitative LC-MS/MS approach tailored for a targeted histone assay of 75 histone peptides with as few as 10,000 cells. Furthermore, we were able to detect and quantify 61 histone peptides from just 1,000 primary human stem cells. Detection of 37 histone peptides was possible from 1,000 acute myeloid leukemia patient cells. We anticipate that this revised method can be used in many applications where achieving large cell numbers is challenging, including rare human cell populations.	[Abshiru, Nebiyu A.; Sikora, Jacek W.; Camarillo, Jeannie M.; Morris, Juliette A.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60201 USA; [Abshiru, Nebiyu A.; Sikora, Jacek W.; Camarillo, Jeannie M.; Morris, Juliette A.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60201 USA; [Abshiru, Nebiyu A.; Sikora, Jacek W.; Camarillo, Jeannie M.; Morris, Juliette A.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL 60201 USA; [Lee, Tak; Sheridan, Caroline; Melnick, Ari M.; Garrett-Bakelman, Francine E.] Weill Cornell Med, Div Hematol Oncol, Dept Med, New York, NY 10065 USA; [Neelamraju, Yaseswini; Haddox, Samuel; Garrett-Bakelman, Francine E.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22904 USA; [Carroll, Martin] Univ Penn, Div Hematol & Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cripe, Larry D.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Paietta, Elisabeth M.] Montefiore Med Ctr, Moses Campus, Bronx, NY USA; [Garrett-Bakelman, Francine E.] Univ Virginia, Dept Med, Div Hematol Med Oncol, Charlottesville, VA 22904 USA	Northwestern University; Northwestern University; Northwestern University; Cornell University; University of Virginia; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Virginia	Kelleher, NL (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60201 USA.; Kelleher, NL (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60201 USA.; Kelleher, NL (corresponding author), Northwestern Univ, Prote Ctr Excellence, Evanston, IL 60201 USA.; Garrett-Bakelman, FE (corresponding author), Weill Cornell Med, Div Hematol Oncol, Dept Med, New York, NY 10065 USA.; Garrett-Bakelman, FE (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22904 USA.; Garrett-Bakelman, FE (corresponding author), Univ Virginia, Dept Med, Div Hematol Med Oncol, Charlottesville, VA 22904 USA.	fg5q@virginia.edu; n-kelleher@northwestern.edu	Compton, Philip/A-9921-2013; Compton, Philip/AAK-9633-2021; Neelamraju, Yaseswini/AIA-0734-2022	Compton, Philip/0000-0001-5212-7175; Compton, Philip/0000-0001-5212-7175; 	Paul G. Allen Family Foundation [11715]; NCI [CCSG P30CA060553, K08CA169055]; UVA Cancer Center through the NCI Cancer Center Support Grant [P30CA44579]; University of Virginia; American Society of Hematology under the ASH-AMFDP [ASHAMFDP-20121]; Robert Wood Johnson Foundation; National Cancer Institute of the National Institutes of Health [CA180827, CA180820, CA233290, CA189859, CA233321, CA233270]; National Resource for Translational and Developmental Proteomics [P41GM108569]	Paul G. Allen Family Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UVA Cancer Center through the NCI Cancer Center Support Grant; University of Virginia; American Society of Hematology under the ASH-AMFDP; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Resource for Translational and Developmental Proteomics	This work was carried out with a financial support from The Paul G. Allen Family Foundation (Award #11715), NCI CCSG P30CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center, and the National Resource for Translational and Developmental Proteomics supported by P41GM108569 to NLK. We would also like to acknowledge funding from NCI K08CA169055, UVA Cancer Center through the NCI Cancer Center Support Grant P30CA44579, the University of Virginia and the American Society of Hematology (ASHAMFDP-20121) under the ASH-AMFDP partnership with The Robert Wood Johnson Foundation to FEG-B. This study was conducted by the ECOG-ACRIN Cancer Research Group (Peter J. O'Dwyer, MD and Mitchell D. Schnall, MD, PhD, Group Co-Chairs) and supported by the National Cancer Institute of the National Institutes of Health under the following award numbers: CA180827, CA180820, CA233290, CA189859, CA233321, CA233270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, REV PRESCRIRE, V28, P468; [Anonymous], 2014, J VISUAL COMMUNICATI; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bock I, 2011, EPIGENETICS-US, V6, P256, DOI 10.4161/epi.6.2.13837; Chopra M, 2015, CANCER GENET-NY, V208, P192, DOI 10.1016/j.cancergen.2014.10.005; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Ding J, 2020, NAT BIOTECHNOL, V38, P737, DOI 10.1038/s41587-020-0465-8; Feng JX, 2019, ANAL CHEM, V91, P5613, DOI 10.1021/acs.analchem.8b05226; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Guo Q, 2018, J PROTEOME RES, V17, P234, DOI 10.1021/acs.jproteome.7b00544; James R, 2019, HAEMATOLOGICA, V105, P2273; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Luo X, 2017, ANAL CHEM, V89, P11664, DOI 10.1021/acs.analchem.7b03100; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Muller-Tidow C, 2010, BLOOD, V116, P3564, DOI 10.1182/blood-2009-09-240978; Noberini R, 2019, METHODS; Noberini R, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0369-8; Peach SE, 2012, MOL CELL PROTEOMICS, V11, P128, DOI 10.1074/mcp.M111.015941; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piunti A, 2017, NAT MED, V23, P493, DOI 10.1038/nm.4296; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sidoli S, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0139-z; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Su XD, 2007, EXPERT REV PROTEOMIC, V4, P211, DOI 10.1586/14789450.4.2.211; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Waki M, 2014, BIOCHIMIE, V107, P73, DOI 10.1016/j.biochi.2014.10.003; Wouters BJ, 2016, BLOOD, V127, P42, DOI 10.1182/blood-2015-07-604512; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zheng YP, 2016, MOL CELL PROTEOMICS, V15, P776, DOI 10.1074/mcp.M115.053819; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203; Zheng YP, 2012, P NATL ACAD SCI USA, V109, P13549, DOI 10.1073/pnas.1205707109	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240829	10.1371/journal.pone.0240829	http://dx.doi.org/10.1371/journal.pone.0240829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104722	Green Published, gold			2022-12-26	WOS:000588370000017
J	Heer, H; Streib, L; Schafer, RB; Ruzika, S				Heer, Henriette; Streib, Lucas; Schaefer, Ralf B.; Ruzika, Stefan			Maximising the clustering coefficient of networks and the effects on habitat network robustness	PLOS ONE			English	Article							LANDSCAPE CONNECTIVITY; COMPLEX NETWORKS; BIODIVERSITY SCENARIOS; CONSERVATION; VULNERABILITY; GRAPHS	The robustness of networks against node failure and the response of networks to node removal has been studied extensively for networks such as transportation networks, power grids, and food webs. In many cases, a network's clustering coefficient was identified as a good indicator for network robustness. In ecology, habitat networks constitute a powerful tool to represent metapopulations or -communities, where nodes represent habitat patches and links indicate how these are connected. Current climate and land-use changes result in decline of habitat area and its connectivity and are thus the main drivers for the ongoing biodiversity loss. Conservation efforts are therefore needed to improve the connectivity and mitigate effects of habitat loss. Habitat loss can easily be modelled with the help of habitat networks and the question arises how to modify networks to obtain higher robustness. Here, we develop tools to identify which links should be added to a network to increase the robustness. We introduce two different heuristics, Greedy and Lazy Greedy, to maximize the clustering coefficient if multiple links can be added. We test these approaches and compare the results to the optimal solution for different generic networks including a variety of standard networks as well as spatially explicit landscape based habitat networks. In a last step, we simulate the robustness of habitat networks before and after adding multiple links and investigate the increase in robustness depending on both the number of added links and the heuristic used. We found that using our heuristics to add links to sparse networks such as habitat networks has a greater impact on the clustering coefficient compared to randomly adding links. The Greedy algorithm delivered optimal results in almost all cases when adding two links to the network. Furthermore, the robustness of networks increased with the number of additional links added using the Greedy or Lazy Greedy algorithm.	[Heer, Henriette; Streib, Lucas; Schaefer, Ralf B.] Univ Koblenz Landau, iES Landau, Dept Quantitat Landscape Ecol, Landau, Germany; [Ruzika, Stefan] Univ Kaiserslautern, Dept Math, Kaiserslautern, Germany	University of Koblenz & Landau; University of Kaiserslautern	Heer, H (corresponding author), Univ Koblenz Landau, iES Landau, Dept Quantitat Landscape Ecol, Landau, Germany.	heer@uni-koblenz.de	Schaefer, Ralf/E-1926-2011	Schaefer, Ralf/0000-0003-3510-1701	B-M-U Graduate Academy of the University of Koblenz-Landau	B-M-U Graduate Academy of the University of Koblenz-Landau	H.H. and L.S. have been supported by the B-M-U Graduate Academy of the University of Koblenz-Landau https://www.uni-koblenz-landau.de/de/graduiertenakademie/graduiertenakademie The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albet R, 2001, NATURE, V409, P542, DOI 10.1038/35054111; Almpanidou V, 2014, ECOL MODEL, V286, P37, DOI 10.1016/j.ecolmodel.2014.04.024; Ash J, 2007, PHYSICA A, V380, P673, DOI 10.1016/j.physa.2006.12.058; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berche B, 2009, EUR PHYS J B, V71, P125, DOI 10.1140/epjb/e2009-00291-3; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cuadra L, 2015, ENERGIES, V8, P9211, DOI 10.3390/en8099211; Dale MRT, 2010, ANNU REV ECOL EVOL S, V41, P21, DOI 10.1146/annurev-ecolsys-102209-144718; DeAngelis DL, 2017, ECOSYSTEMS, V20, P284, DOI 10.1007/s10021-016-0066-z; Dilts TE, 2016, ECOL APPL, V26, P1223, DOI 10.1890/15-0925; ERDOS P, 1960, B INT STATIST INST, V38, P343; Eros T, 2012, LANDSCAPE ECOL, V27, P303, DOI 10.1007/s10980-011-9659-2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fox RJ, 2014, FUNCT ECOL, V28, P642, DOI 10.1111/1365-2435.12190; Galpern P, 2011, BIOL CONSERV, V144, P44, DOI 10.1016/j.biocon.2010.09.002; Green O, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P321, DOI 10.1109/SocialCom.2013.51; Hagberg A, 2008, LAUR085495 LANL; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; Heer H, ECOLOGICAL INDICATOR; HOARE CAR, 1962, COMPUT J, V5, P10, DOI 10.1093/comjnl/5.1.10; Holland MD, 2008, NATURE, V456, P792, DOI 10.1038/nature07395; Keller D, 2012, FRESHWATER BIOL, V57, P1373, DOI 10.1111/j.1365-2427.2012.02797.x; Kindlmann P, 2008, LANDSCAPE ECOL, V23, P879, DOI 10.1007/s10980-008-9245-4; Krumke SO, 2009, GRAPHENTHEORETISCHE; Kun A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47497-7; Lechner AM, 2017, LANDSCAPE ECOL, V32, P99, DOI 10.1007/s10980-016-0431-5; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Martensen AC, 2017, METHODS ECOL EVOL, V8, P1253, DOI 10.1111/2041-210X.12799; Mazaris AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059640; Newman M, 2006, NETWORKS INTRO; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Ottmann T, 2017, ALGORITHMEN DATENSTR; Perry GLW, 2019, OIKOS, V128, P1277, DOI 10.1111/oik.06052; Petsas P, 2020, LANDSCAPE ECOL, V35, P561, DOI 10.1007/s10980-020-00981-2; Pietsch M, 2018, ECOL INDIC, V94, P116, DOI 10.1016/j.ecolind.2017.05.052; Prima MC, 2019, FUNCT ECOL, V33, P1663, DOI 10.1111/1365-2435.13380; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Streib L, 2020, ECOL MODEL, V416, DOI 10.1016/j.ecolmodel.2019.108909; Thompson PL, 2014, EVOL ECOL RES, V16, P445; Titeux N, 2016, GLOBAL CHANGE BIOL, V22, P2505, DOI 10.1111/gcb.13272; Turner MG, 1988, LANDSCAPE ECOL, V1, P241, DOI 10.1007/BF00157696; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219	51	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240940	10.1371/journal.pone.0240940	http://dx.doi.org/10.1371/journal.pone.0240940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079943	Green Published, gold			2022-12-26	WOS:000585940600024
J	Cai, HJ; Zhang, YY; Liu, X; Jiang, WZ; Chen, ZF; Li, SF; Guan, GX				Cai, Huajun; Zhang, Yiyi; Liu, Xing; Jiang, Weizhong; Chen, Zhifen; Li, Shoufeng; Guan, Guoxian			Association of age and cause-special mortality in patients with stage I/II colon cancer: A population-based competing risk analysis	PLOS ONE			English	Article								Purpose This study aimed to determine the probability and prognostic factors of colon cancer-specific mortality (CCSM) and noncancer-specific mortality (NCSM) for patients with stage I/II colon cancer and evaluate the association of age on cause-specific mortality. Materials and methods From Surveillance, Epidemiology, and End Results (SEER) database, we identified 33152 patients with stage I/II colon cancer undergoing surgery between 2004 and 2011. The cumulative incidence of CCSM and NCSM was calculated, and competing risk analysis was performed to investigate prognostic factors for cause-specific mortality. Results In patients <50, 50-75, and >75 years of age, 5-year cumulative incidence of CCSM was 5.7%, 7.8%, and 16.1%, respectively (overall, 10.6%); 5-year cumulative incidence of NCSM was 2.2%, 7.1%, and 26.9%, respectively (overall, 13.8%). The probability of CCSM and NCSM increased with advanced age. The 5-year cumulative incidence of CCSM was higher than NCSM in patients <50 years of age, whereas lower in patients >75 years of age. The probability of CCSM and NCSM was similar in patients 50-75 years of age. Competing-risk multivariable analysis demonstrated that increasing age was a strong predictor of CCSM (per year increase, SHR 1.03,95% confidence interval [CI]: 1.03-1.04). Age was most predictive of NCSM: (per year increase, SHR 1.08, 95% CI: 1.08-1.08). Conclusion Age was significantly associated with an increased cumulative incidence of CCSM and NCSM of patients with stage I/II colon cancer underwent surgery. NCSM was a significant competing event and should be adequately considered when performing survival analysis.	[Cai, Huajun; Zhang, Yiyi; Liu, Xing; Li, Shoufeng; Guan, Guoxian] Fujian Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Fuzhou, Peoples R China; [Jiang, Weizhong; Chen, Zhifen] Fujian Med Univ, Union Hosp, Dept Colorectal Surg, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University	Guan, GX (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Fuzhou, Peoples R China.	fjxhggx@163.com	陈, 致奋/AAB-5063-2021	陈, 致奋/0000-0001-7199-7061; Guan, Guoxian/0000-0001-9883-3139	Special Financial Foundation of Fujian Provincial [2015-1297]; Young and middle-aged backbone training project in the health system of Fujian province [2016-ZQN-26]; Startup Fund for Scientific Research, Fujian Medical University [2018QH2027]; Professor Development Foundation of Fujian Medical University [JS11006]	Special Financial Foundation of Fujian Provincial; Young and middle-aged backbone training project in the health system of Fujian province; Startup Fund for Scientific Research, Fujian Medical University; Professor Development Foundation of Fujian Medical University	This study was supported by the Special Financial Foundation of Fujian Provincial (No.2015-1297), Young and middle-aged backbone training project in the health system of Fujian province (2016-ZQN-26), the Startup Fund for Scientific Research, Fujian Medical University (2018QH2027) and Professor Development Foundation of Fujian Medical University (No.JS11006).	[Anonymous], 2017, AEROSPACE CHINA, V18, P23; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2017, AM U L REV, V67, P177; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Briganti A, 2013, EUR UROL, V63, P693, DOI 10.1016/j.eururo.2012.08.054; Burdett N, 2018, JNCI-J NATL CANCER I, V110, P825, DOI 10.1093/jnci/djy111; Carmona R, 2016, J CLIN ONCOL, V34, P1270, DOI 10.1200/JCO.2015.65.0739; Chan KK, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-82; Dasgupta P, 2013, CANCER CAUSE CONTROL, V24, P897, DOI 10.1007/s10552-013-0166-4; de Glas NA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv366; Devoto L, 2017, INT J COLORECTAL DIS, V32, P1237, DOI 10.1007/s00384-017-2848-y; Doat S, 2014, EUR J CANCER, V50, P1276, DOI 10.1016/j.ejca.2013.12.026; Doll KM, 2018, JAMA SURG, V153, P588, DOI 10.1001/jamasurg.2018.0501; Donoghoe MW, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0327-3; Eguchi T, 2017, J CLIN ONCOL, V35, P281, DOI 10.1200/JCO.2016.69.0834; Fine J P, 2001, Biostatistics, V2, P85, DOI 10.1093/biostatistics/2.1.85; Gabriel E, 2018, J GASTROINTEST ONCOL, V9, P96, DOI 10.21037/jgo.2017.11.13; Huang XD, 2018, RADIOTHER ONCOL, V129, P389, DOI 10.1016/j.radonc.2018.09.004; Imanguli M, 2017, ANN SURG ONCOL, V24, P2069, DOI 10.1245/s10434-017-5862-y; Kneuertz PJ, 2015, JAMA SURG, V150, P402, DOI 10.1001/jamasurg.2014.3572; McLaughlin C, 2019, RADIOTHER ONCOL, V133, P50, DOI 10.1016/j.radonc.2018.11.026; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Patel SS, 2013, CANCER-AM CANCER SOC, V119, P739, DOI 10.1002/cncr.27753; Rho YS, 2017, CLIN COLORECTAL CANC, V16, P334, DOI 10.1016/j.clcc.2017.03.008; Rodriguez L, 2018, CLIN COLORECTAL CANC, V17, pE651, DOI 10.1016/j.clcc.2018.06.007	25	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240715	10.1371/journal.pone.0240715	http://dx.doi.org/10.1371/journal.pone.0240715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064784	Green Published, gold			2022-12-26	WOS:000585918300031
J	Gelippi, M; Popp, B; Gauger, MFW; Caraveo-Patino, J				Gelippi, Michelle; Popp, Brian; Gauger, Marco F. W.; Caraveo-Patino, Javier			Tracing gestation and lactation in free ranging gray whales using the stable isotopic composition of epidermis layers	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; CARBON ISOTOPES; NITROGEN; TURNOVER; RATIOS; DIET; VALUES; MILK; SKIN; DISCRIMINATION	The isotopic composition of baleen whales' epidermis structural layers can give information about dietary change over time. This study investigated if epidermis layers integrated isotopic values that record physiological changes from gestation to lactation. Epidermis tissues (n = 43) were collected from free ranging lactating female gray whale and calves during the beginning of three breeding seasons. Modelling of delta C-13 and delta N-15 values show intra- and inter-individual differences based on epidermal layers, age class and year of sampling. The isotopic composition of mother-calf pairs is correlated, and the estimates of the maximum mother-to-calf isotopic difference was similar to 1.4 parts per thousand for delta C-13 and between 1 and 1.5 parts per thousand for delta N-15 values. Change in delta N-15 values among epidermal layers in calves was associated with the transition from fetus to consumption of maternal milk. It is here proposed when lactation influences calf epidermis, delta N-15 values decrease consistently from the outermost to the innermost layer. However, if a calf was born only few days before collection, epidermis integrates more variable delta N-15 patterns because gestation still affects the isotopic composition of the layers. The possibility of calculating mother-to-calf nitrogen isotope fractionation, and the regularity of changes between calf layer delta N-15 values, allowed results of an isotopic clock model to predict the age of each calf when sampled with its mother. This model has the potential to be a straightforward method to estimate the beginning of lactation, therefore calf birth date when direct observations are not feasible. The non-lethal remote collection of epidermis appears to be an effective tool for the study of the physiology of reproduction of baleen whales. The parallel study of the three epidermal structural layers highlighted the importance of considering the unique mother-calf pair physiological status at the time of sampling time when stable isotope results are interpreted.	[Gelippi, Michelle; Gauger, Marco F. W.; Caraveo-Patino, Javier] Ctr Inves Biol Noroeste, La Paz, Bcs, Mexico; [Popp, Brian] Univ Hawaii Manoa, Dept Earth Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Caraveo-Patino, J (corresponding author), Ctr Inves Biol Noroeste, La Paz, Bcs, Mexico.	jcaraveo04@cibnor.mx		Caraveo-Patino, Javier/0000-0002-9268-4707; Popp, Brian/0000-0001-7021-5478	NSF award [1137336]; CONACYT [779462/616369]	NSF award(National Science Foundation (NSF)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MG received the "research in residence" NSF award #1137336, for inter-university training in continental-scale ecology, University of Utah. MG received the CONACYT grant #779462/616369) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092288; [Anonymous], 2020, LANCET PSYCHIAT, V7, P1, DOI 10.1016/S2215-0366(19)30483-3; Arregui M, 2017, RAPID COMMUN MASS SP, V31, P1551, DOI 10.1002/rcm.7936; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bates D, FITTING LINEAR MIXED; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Borrell A, 2016, PHYSIOL BIOCHEM ZOOL, V89, P41, DOI 10.1086/684632; Busquets-Vass G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177880; Calambokidis J., 2012, UPDATED ANAL ABUNDAN; Caraveo-Patino J, 2005, HYDROBIOLOGIA, V539, P99, DOI 10.1007/s10750-004-3370-0; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Cherel Y, 2015, RAPID COMMUN MASS SP, V29, P1485, DOI 10.1002/rcm.7243; Clark CT, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow050; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Ducatez S, 2008, MAR BIOL, V155, P413, DOI 10.1007/s00227-008-1039-3; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gimenez J, 2016, J EXP MAR BIOL ECOL, V475, P54, DOI 10.1016/j.jembe.2015.11.001; Habran S, 2019, RAPID COMMUN MASS SP, V33, P176, DOI 10.1002/rcm.8308; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Horstmann-Dehn L, 2012, MAR MAMMAL SCI, V28, pE173, DOI 10.1111/j.1748-7692.2011.00503.x; Huang SL, 2011, MAR MAMMAL SCI, V27, P182, DOI 10.1111/j.1748-7692.2010.00392.x; Iverson SJ, 1997, CAN J ZOOL, V75, P188, DOI 10.1139/z97-026; Jenkins SG, 2001, OECOLOGIA, V129, P336, DOI 10.1007/s004420100755; Jones M. Lou, 2009, ENCY MARINE MAMMALS, V36, P1352; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; Ko AR, 2016, OCEAN SCI J, V51, P397, DOI 10.1007/s12601-016-0036-6; Lang AR, 2014, MAR MAMMAL SCI, V30, P1473, DOI 10.1111/mms.12129; Lesage V, 2010, MAR ECOL PROG SER, V419, P249, DOI 10.3354/meps08825; Lowther AD, 2011, MAR MAMMAL SCI, V27, P567, DOI 10.1111/j.1748-7692.2010.00425.x; Lubcker N, 2020, CONSERV PHYSIOL, V8, DOI 10.1093/conphys/coaa060; Madigan DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049220; Mann J, 1999, MAR MAMMAL SCI, V15, P102, DOI 10.1111/j.1748-7692.1999.tb00784.x; Martinez-Aguilar S, 2019, GRAY WHALE ESCHRICHT; McCue Marshall D., 2012, P103; Moore SE, 2007, MAR MAMMAL SCI, V23, P419, DOI 10.1111/j.1748-7692.2007.00102.x; Morales-Guerrero B, 2017, VET DERMATOL, V28, P213, DOI 10.1111/vde.12392; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Perryman Wayne L., 2002, Journal of Cetacean Research and Management, V4, P155; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Reeb D, 2006, MAR MAMMAL SCI, V22, P206, DOI 10.1111/j.1748-7692.2006.00015.x; Reeb D, 2007, ANAT REC, V290, P596, DOI 10.1002/ar.20535; Ryan C, 2012, RAPID COMMUN MASS SP, V26, P2745, DOI 10.1002/rcm.6394; Sharp JA, 2005, J DAIRY RES, V72, P81, DOI 10.1017/S0022029905001251; Sokolov V.E., 1982, MAMMAL SKIN; STAUBIN DJ, 1990, CAN J ZOOL, V68, P359, DOI 10.1139/z90-051; Stevens Jr DL, 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat07571, DOI 10.1002/9781118445112.STAT07571]; Stricker CA, 2015, MAR ECOL PROG SER, V523, P255, DOI 10.3354/meps11205; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Urban R. J., 2003, Journal of Cetacean Research and Management, V5, P281; Wild LA, 2018, RAPID COMMUN MASS SP, V32, P1425, DOI 10.1002/rcm.8168; Yablokov A, 1974, JPRS TRANSL, P62150	58	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240171	10.1371/journal.pone.0240171	http://dx.doi.org/10.1371/journal.pone.0240171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119639	gold, Green Published			2022-12-26	WOS:000600013600103
J	Meyer, VMC; Siqueira, MM; Costa, PFBM; Caetano, BC; Lopes, JCO; Folescu, TW; Motta, FD				Correa Meyer, Viviane Mauro; Siqueira, Marilda Mendonca; Barreto Machado Costa, Patricia Fernandes; Caetano, Braulia Costa; Oliveira Lopes, Jonathan Christian; Folescu, Tania Wrobel; Motta, Fernando do Couto			Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis	PLOS ONE			English	Article							SYNCYTIAL VIRUS; VIRAL-INFECTIONS; TRACT INFECTIONS; YOUNG-CHILDREN; RHINOVIRUS; PATHOGENS; DIAGNOSIS; GROWTH	Backgrounds Cystic Fibrosis (CF) is a genetic, multisystemic, progressive illness that causes chronic suppurative lung disease. A major cause of morbimortality in this condition are pulmonary exacerbations. Although classically attributed to bacterial infections, respiratory virus have been increasingly recognized in its ethiopathogeny. Methods Nasopharyngeal swab samples were collected from children < 18 years old with CF in Rio de Janeiro, Brazil, with pulmonary exacerbation criteria. Samples were submitted to RT-PCR for Adenovirus, Influenza A and B, Parainfluenza Virus, Respiratory Syncytial Virus (RSV), Metapneumovirus and Rhinovirus. Virus positive and virus negative groups were compared in regards to clinical presentation, severity of exacerbation and bacterial colonization. Results Out of 70 samples collected from 48 patients, 35.7% were positive for respiratory viruses. Rhinovirus were the most common (28% of all positive samples), followed by RSV. The virus positive group was associated with change in sinus discharge (p = 0.03). Considering only patients younger than five years old, positive virus detection was also associated with fever (p = 0.01). There was no significant difference in clinical severity or in bacterial colonization between virus positive and negative groups. Conclusions Prospective studies are still needed to assess the long term impact of viral infections in patients with CF, and their interaction with the bacterial microbiome in these patients.	[Correa Meyer, Viviane Mauro; Siqueira, Marilda Mendonca; Caetano, Braulia Costa; Oliveira Lopes, Jonathan Christian; Motta, Fernando do Couto] Oswaldo Cruz Inst IOC FIOCRUZ, Resp Virus & Measles Lab, Rio De Janeiro, Brazil; [Barreto Machado Costa, Patricia Fernandes; Folescu, Tania Wrobel] Natl Inst Women Children & Adolescents Hlth Ferna, Pulmonol Dept, Rio De Janeiro, Brazil; [Barreto Machado Costa, Patricia Fernandes] Fed Univ State Rio de Janeiro UNIRIO, Pediat Dept, Rio De Janeiro, Brazil; [Correa Meyer, Viviane Mauro] Hosp Israelita Albert Einstein, Pediat Emergency Dept, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro; Hospital Israelita Albert Einstein	Meyer, VMC (corresponding author), Oswaldo Cruz Inst IOC FIOCRUZ, Resp Virus & Measles Lab, Rio De Janeiro, Brazil.; Meyer, VMC (corresponding author), Hosp Israelita Albert Einstein, Pediat Emergency Dept, Sao Paulo, Brazil.	vivianecorreameyer@gmail.com	Motta, Fernando/AAJ-2647-2021		Brazilian Ministry of Health; Fundacao Oswaldo Cruz - FIOCRUZ [25030.000964/2014, 25030.000932/2017-82]; Fundacao Oswaldo Cruz - FIOCRUZ (National Health Foundation)	Brazilian Ministry of Health; Fundacao Oswaldo Cruz - FIOCRUZ; Fundacao Oswaldo Cruz - FIOCRUZ (National Health Foundation)	This study was supported by the Brazilian Ministry of Health and Fundacao Oswaldo Cruz - FIOCRUZ (projects 25030.000964/2014 and 25030.000932/2017-82; National Health Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAT REV DRUG DISCOV, V11, P433; Bellinghausen C, 2016, J GEN VIROL, V97, P3089, DOI 10.1099/jgv.0.000627; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Burns JL, 2012, INFLUENZA OTHER RESP, V6, P218, DOI 10.1111/j.1750-2659.2011.00292.x; Chattoraj SS, 2011, THORAX, V66, P333, DOI 10.1136/thx.2010.151431; Chin M, 2015, J CYST FIBROS, V14, P482, DOI 10.1016/j.jcf.2014.11.009; Colasurdo GN, 2006, J MED VIROL, V78, P651, DOI 10.1002/jmv.20589; Collinson J, 1996, THORAX, V51, P1115, DOI 10.1136/thx.51.11.1115; Cousin M, 2016, INFLUENZA OTHER RESP, V10, P109, DOI 10.1111/irv.12353; Cutting GR, 2012, KENDIG CHERNICKS DIS, P753; de Almeida MB, 2010, EMERG INFECT DIS, V16, P996, DOI 10.3201/eid1606.100063; Emerson J, 2013, J PEDIATR INFECT DIS, V2, P345, DOI 10.1093/jpids/pit039; Esther CR, 2014, PEDIATR PULM, V49, P926, DOI 10.1002/ppul.22917; Etherington C, 2014, J CYST FIBROS, V13, P49, DOI 10.1016/j.jcf.2013.06.004; Flight WG, 2014, THORAX, V69, P247, DOI 10.1136/thoraxjnl-2013-204000; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goffard A, 2014, J CLIN VIROL, V60, P147, DOI 10.1016/j.jcv.2014.02.005; Hendricks MR, 2016, P NATL ACAD SCI USA, V113, P1642, DOI 10.1073/pnas.1516979113; Hoek RAS, 2013, SCAND J INFECT DIS, V45, P65, DOI 10.3109/00365548.2012.708942; Jones AM, 2011, EUR RESPIR J, V38, P1486, DOI 10.1183/09031936.00061711; Kanga J, 1999, CLIN THER, V21, P1343, DOI 10.1016/S0149-2918(99)80035-6; Korten I, 2018, THORAX, V73, P13, DOI 10.1136/thoraxjnl-2016-209553; PETERSEN NT, 1981, ACTA PAEDIATR SCAND, V70, P623, DOI 10.1111/j.1651-2227.1981.tb05757.x; Ramirez Ixsy A, 2014, Ann Am Thorac Soc, V11, P554, DOI 10.1513/AnnalsATS.201310-346OC; SHWACHMAN H, 1958, AMA J DIS CHILD, V96, P6, DOI 10.1001/archpedi.1958.02060060008002; Somayaji R, 2017, CLIN INFECT DIS, V64, P1760, DOI 10.1093/cid/cix203; Stelzer-Braid S, 2017, J MED VIROL, V89, P1494, DOI 10.1002/jmv.24794; van Ewijk BE, 2008, PEDIATRICS, V122, P1171, DOI 10.1542/peds.2007-3139; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; 2014, REG ANESTH PAIN MED, V9	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240452	10.1371/journal.pone.0240452	http://dx.doi.org/10.1371/journal.pone.0240452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112873	gold, Green Published			2022-12-26	WOS:000588374000058
J	He, KJ; Liu, G; Zhao, JF; Li, JX				He, Kejun; Liu, Ge; Zhao, Junfang; Li, Jingxin			Co-variability of the summer NDVIs on the eastern Tibetan Plateau and in the Lake Baikal region: Associated climate factors and atmospheric circulation	PLOS ONE			English	Article							DIFFERENCE VEGETATION INDEX; AIR-SEA INTERACTION; SURFACE-TEMPERATURE; LOWER REACHES; RAINFALL; TRENDS; PREDICTION; OSCILLATION; ANOMALIES; LATITUDE	The Tibetan Plateau and Siberia are both crucial regions in which the vegetation dynamics are sensitive to climate change. The variabilities in the normalized difference vegetation index (NDVI) over the two regions have been explored previously, but there have been few studies on the relationship of the NDVI in the two regions. Using the GIMMS-NDVI, GHCN-CAMS and NCEP reanalysis datasets and statistical and physical diagnostic methods, we show that the summer (June, July and August) NDVI over the eastern Tibetan Plateau and Lake Baikal and its adjacent eastern region of Siberia have an in-phase co-variability, especially on an interannual timescale (with a correlation coefficient of 0.69 during the time period 1982-2014). Further analyses show that precipitation and the related cloud cover and solar radiation are responsible for the variability in the NDVI over the eastern Tibetan Plateau, whereas temperature has the more important role in modulating the variability in the NDVI over the Lake Baikal region. A dipole pattern prevails over the Tibetan Plateau-Lake Baikal region and reflects the anomalies in the intensity and location of the South Asian high and the northeast Asian blocking high. This dipole pattern simultaneously modulates precipitation over the eastern Tibetan Plateau and the temperature over the Lake Baikal region and leads to the co-variability of the NDVI between the two regions. A synergistic sea surface temperature index, which reflects sea surface temperature anomalies in the eastern tropical Pacific Ocean, the northwest Pacific Ocean, the northern Indian Ocean and the subtropical north Atlantic Ocean, appears to adjust this Tibetan Plateau-Lake Baikal dipole pattern and is therefore closely related to the co-variability of the NDVI between the eastern Tibetan Plateau and the Lake Baikal region. Our results suggest that vegetation dynamics may not be only a local phenomenon in some areas, but are also likely to remotely link with variations in vegetation over other regions.	[He, Kejun; Liu, Ge; Zhao, Junfang; Li, Jingxin] Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China; [Liu, Ge] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Forecast & Evaluat Meteoro, Nanjing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Nanjing University of Information Science & Technology	Liu, G; Zhao, JF (corresponding author), Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China.; Liu, G (corresponding author), Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Forecast & Evaluat Meteoro, Nanjing, Peoples R China.	liuge@cma.gov.cn; zhaojfcams@163.com	Li, Jing/GYU-5036-2022		National Key Research and Development Program of China [2018YFC1505706]; Second Tibetan Plateau Scientific Expedition and Research (STEP) program [2019QZKK0105]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20100300]; National Science Foundation of China [91637312, 41775084]; Science and Technology Development Fund of CAMS [2019KJ022]; Basic Research Fund of CAMS [2019Z008]	National Key Research and Development Program of China; Second Tibetan Plateau Scientific Expedition and Research (STEP) program; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund of CAMS; Basic Research Fund of CAMS	The National Key Research and Development Program of China (2018YFC1505706) is replaced with the Second Tibetan Plateau Scientific Expedition and Research (STEP) program (2019QZKK0105) This research is funded by the National Key Research and Development Program of China (2018YFC1505706), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA20100300), the National Science Foundation of China (91637312 and 41775084), the Science and Technology Development Fund of CAMS (2019KJ022), and the Basic Research Fund of CAMS (2019Z008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2008, CANC S8, V113, pi; [Anonymous], 2002, J GEOPHYS RES, V107, P8; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Chu D, 2007, ARCT ANTARCT ALP RES, V39, P635, DOI 10.1657/1523-0430(07-501)[CHU]2.0.CO;2; DESER C, 1990, J CLIMATE, V3, P1254, DOI 10.1175/1520-0442(1990)003<1254:LSACFO>2.0.CO;2; Ding MJ, 2007, J GEOGR SCI, V17, P259, DOI 10.1007/s11442-007-0259-7; Ding Y.H., 2007, ADV CLIM CHANG RES, V3, P1; Du JQ, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4818-4; Duan AM, 2017, ADV ATMOS SCI, V34, P157, DOI 10.1007/s00376-016-6008-z; [段安民 Duan Anmin], 2016, [气候变化研究进展, Progressus Inquisitiones de Mutatione Climatis], V12, P374; Duan AM, 2013, J CLIMATE, V26, P261, DOI 10.1175/JCLI-D-11-00669.1; Gao QZ, 2016, SCI TOTAL ENVIRON, V554, P34, DOI 10.1016/j.scitotenv.2016.02.131; [龚道溢 Gong Daoyi], 2002, [地理学报, Acta Geographica Sinica], V57, P505; Gong DY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002193; Guo Y, 2017, J APPL METEOROL CLIM, V56, P2275, DOI 10.1175/JAMC-D-16-0376.1; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; [韩熠哲 Han Yizhe], 2018, [气象学报, Acta Meteorologica Sinica], V76, P920; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Hong XW, 2016, J CLIMATE, V29, P3753, DOI 10.1175/JCLI-D-15-0541.1; Hua T, 2018, ADV ATMOS SCI, V35, P1337, DOI 10.1007/s00376-018-7064-3; Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1; Huang K, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8100876; Ibrahim YZ, 2015, REMOTE SENS-BASEL, V7, P5471, DOI 10.3390/rs70505471; Ichii K, 2001, INT GEOSCIENCE REMOT, DOI 10.1109/IGARSS.2001.977082; Jeyaseelan AT, 2007, INT J REMOTE SENS, V28, P4927, DOI 10.1080/01431160701253279; Jin JX, 2010, 2010 18TH INTERNATIONAL CONFERENCE ON GEOINFORMATICS; Jury MR, 1997, THEOR APPL CLIMATOL, V57, P155, DOI 10.1007/BF00863610; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Law & Regulatory Practice, 2002, ADM L REV, V54, P44; Li RQ, 2018, SCI COLD ARID REG, V10, P482, DOI 10.3724/SP.J.1226.2018.00482; Liebmann B, 1996, B AM METEOROL SOC, V77, P1275; Liu G, 2017, J CLIMATE, V30, P9965, DOI [10.1175/JCLI-D-17-0079.1, 10.1175/jcli-d-17-0079.1]; Liu G, 2017, INT J CLIMATOL, V37, P3478, DOI 10.1002/joc.4932; [刘少华 Liu Shaohua], 2014, [干旱区地理, Arid Land Geography], V37, P480; Liu WB, 2016, CLIM DYNAM, V46, P3481, DOI 10.1007/s00382-015-2782-z; Liu YM, 2012, CLIM DYNAM, V39, P1183, DOI 10.1007/s00382-012-1335-y; Mao JF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014010; [孟梦 Meng Meng], 2018, [水土保持研究, Research of Soil and Water Conservation], V25, P360; Meng W., 2000, CHINESE J ATMOSPHERI, V24, P15; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Obukhov A. M., 1947, USPEHI MAT NAUK, V2, P196; Oku Y, 2006, J CLIMATE, V19, P2995, DOI 10.1175/JCLI3811.1; Pang GJ, 2017, QUATERN INT, V444, P87, DOI 10.1016/j.quaint.2016.08.038; Park HS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012752; Pearson K, 1902, MAG, V2, P559; Pinzon JE, 2004, H HUANG TRANSFORM 2; Rasmussen MS, 1997, INT J REMOTE SENS, V18, P1059, DOI 10.1080/014311697218575; Ren HL, 2020, J METEOROL RES-PRC, V34, P43, DOI 10.1007/s13351-020-9155-1; Schneider U., 2011, GPCC FULL DATA REANA, DOI [10.5676/DWD_GPCC/FD_M_V7_050, DOI 10.5676/DWD_GPCC/FD_M_V7_050]; Sobrino JA, 2011, INT J REMOTE SENS, V32, P4267, DOI 10.1080/01431161.2010.486414; [宋怡 SONG Yi], 2008, [遥感学报, Journal of Remote Sensing], V12, P499; Sun J, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-5177-x; Sun J, 2013, REMOTE SENS-BASEL, V5, P1894, DOI 10.3390/rs5041894; Suzuki R, 2000, INT J CLIMATOL, V20, P955, DOI 10.1002/1097-0088(200007)20:9&lt;955::AID-JOC512&gt;3.0.CO;2-1; Tateishi R, 2004, INT J REMOTE SENS, V25, P2287, DOI 10.1080/01431160310001618455; Tian LD, 2008, EARTH SCI, V38, P986; Trenberth KE, 2000, J CLIMATE, V13, P4358, DOI 10.1175/1520-0442(2000)013<4358:TSORSL>2.0.CO;2; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; van Eijl H, 2002, J GEN VIROL, V83, P195, DOI 10.1099/0022-1317-83-1-195; VERMOTE E, 1995, INT J REMOTE SENS, V16, P2317, DOI 10.1080/01431169508954561; Wang B, 2000, J CLIMATE, V13, P1517, DOI 10.1175/1520-0442(2000)013<1517:PEATHD>2.0.CO;2; Wang B, 2009, J CLIMATE, V22, P3864, DOI 10.1175/2009JCLI2850.1; Wang HS, 2015, INT J CLIMATOL, V35, P687, DOI 10.1002/joc.4013; Wang HM, 2017, INT J CLIMATOL, V37, P4631, DOI 10.1002/joc.5111; [王青霞 Wang Qingxia], 2014, [高原气象, Plateau Meteorology], V33, P301; Wang XJ, 2018, INT J CLIMATOL, V38, P1116, DOI 10.1002/joc.5246; [韦志刚 WeiZhigang], 2003, [大气科学, Chinese Journal of Atmospheric Sciences], V27, P157; Wilks DS., 2006, STAT METHODS ATMOSPH, V3, P133; Wu GX, 2007, J HYDROMETEOROL, V8, P770, DOI 10.1175/JHM609.1; Wu GX, 1998, SCI ATMOSPHERICA SIN, V22, P470, DOI 10.1007/s00376-999-0032-1; Wu GX, 1997, MOMORIAL VOLUME PROF; Wu RG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015779; [谢力 Xie Li], 2002, [气象学报, Acta Meteorologica Sinica], V60, P181; Xu YM, 2017, REG ENVIRON CHANGE, V17, P2339, DOI 10.1007/s10113-017-1163-z; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yan H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1297; Zhang JY, 2011, J GEOPHYS RES, V116, DOI [10.1029/2011JD016458, DOI 10.1029/2011JD016458]; Zhang L, 2013, J APPL REMOTE SENS, V7, DOI 10.1117/1.JRS.7.073572; [张人禾 Zhang Renhe], 2015, [科学通报, Chinese Science Bulletin], V60, P3036; Zhang WJ, 2016, GEOPHYS RES LETT, V43, P11375, DOI 10.1002/2016GL071190; Zhang WJ, 2016, J CLIMATE, V29, P4347, DOI 10.1175/JCLI-D-15-0104.1; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x; Zhao P, 2008, ACTA METEOROL SIN, V22, P455; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; [周婷 Zhou Ting], 2015, [冰川冻土, Journal of Glaciology and Geocryology], V37, P58; [卓嘎 ZhuoGa], 2007, [气象科学, Scientia Meteorologlca Sinica], V27, P488; Zuo JQ, 2013, ADV ATMOS SCI, V30, P1173, DOI 10.1007/s00376-012-2125-5	90	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239465	10.1371/journal.pone.0239465	http://dx.doi.org/10.1371/journal.pone.0239465			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112880	Green Published, gold			2022-12-26	WOS:000588374000067
J	Rehman, R; Zafar, A; Ali, AA; Baig, M; Alam, F				Rehman, Rehana; Zafar, Amara; Ali, Arzina Aziz; Baig, Mukhtiar; Alam, Faiza			Impact of serum and follicular fluid kisspeptin and estradiol on oocyte maturity and endometrial thickness among unexplained infertile females during ICSI	PLOS ONE			English	Article							OVARIAN HYPERSTIMULATION SYNDROME; HIGH-RISK; MATURATION; WOMEN; HORMONES	Objective To relate serum and follicular fluid (FF) kisspeptin and estradiol levels in different stages of stimulation during Intracytoplasmic Sperm Injection (ICSI) with oocyte maturity and endometrial thickness among unexplained infertile females. Methods This cross-sectional study was carried out at the Australian Concept Infertility Medical Centre from March 2017 till March 2018. Fifty unexplained infertile females, booked for ICSI, were included in the study. Serum kisspeptin and estradiol were estimated by Enzyme-Linked Immunosorbent Assay in all four stages; 1: follicular stimulation, 2: ovulation induction, 3: oocyte pickup, and 4: embryo transfer. FF was aspirated during oocyte retrieval (stage 3) for the analysis of KP and estradiol. Pregnancy outcomes were categorized as non-pregnant, preclinical abortion, and clinical pregnancy. Results The age of the study subjects was 32.04 +/- 2.29 (Mean +/- SD) years, with mean BMI of 28.51 +/- 4.15 (Mean +/- SD) kg/m(2). Mean serum kisspeptin and estradiol levels increased in all subjects as the stimulation proceeded stages 1-3; however, the mean dropped after retrieval of the oocytes (stage 4). Out of 27 female subjects who completed the cycle, 17 remained non-pregnant, 4 had preclinical abortion, and 6 acquired clinical pregnancy. The FF kisspeptin concentration was significantly higher than serum concentrations and positively correlated with serum and FF estradiol concentrations. FF-kisspeptin correlated with serum kisspeptin in Stage 3 (r = 0.930, p<0.001), maturity of oocyte (r = 0.511, p = 0.006) and endometrial thickness (r = 0.522, p = 0.005). Kisspeptin in stage 3 was also found to correlate with endometrial thickness (r = 0.527, p = 0.005) and with estradiol (r = 0.624, p = 0.001) independently. Conclusion Increase in serum and FF-kisspeptin and estradiol levels from stages 1 to 3, resulted in an optimum endometrial thickness, probability of fertilization of oocytes and chances of clinical pregnancy in Assisted Reproductive Techniques /ICSI cycles of unexplained infertile females.	[Rehman, Rehana] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Zafar, Amara; Ali, Arzina Aziz] Aga Khan Univ, Med Coll, Karachi, Pakistan; [Baig, Mukhtiar] King Abdulaziz Univ, Fac Med, Jeddah, Saudi Arabia; [Alam, Faiza] Univ Karachi, Dept Physiol, Karachi, Pakistan	Aga Khan University; Aga Khan University; King Abdulaziz University; University of Karachi	Alam, F (corresponding author), Univ Karachi, Dept Physiol, Karachi, Pakistan.	faiza.orakzai@gmil.com	Alam, Faiza/P-4978-2016; Alam, Faiza/AAG-5297-2022; Alam, Faiza/AFK-6964-2022	Alam, Faiza/0000-0002-4131-129X	Pakistan Health Research Council [4-22-27/15/RDC/AKU]	Pakistan Health Research Council	Rr received grant from Pakistan Health Research Council for the support of funds; Grant#4-22-27/15/RDC/AKU. URL: http://phrc.org.pk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara A, 2018, ENDOCR REV, V39, P593, DOI 10.1210/er.2017-00236; Abbara A, 2017, HUM REPROD, V32, P1915, DOI 10.1093/humrep/dex253; Abbara A, 2015, J CLIN ENDOCR METAB, V100, P3322, DOI 10.1210/jc.2015-2332; [Anonymous], 2017, AKUSHERSTVO GINECOLO, V11, P99; Bodis J, 2019, J INT MED RES, DOI 10.1177/0300060519879330; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Gaytan F, 2009, AM J PHYSIOL-ENDOC M, V296, pE520, DOI 10.1152/ajpendo.90895.2008; Gunn DD, 2016, FERTIL STERIL, V105, DOI 10.1016/j.fertnstert.2016.02.001; Hanson B, 2017, J ASSIST REPROD GEN, V34, P167, DOI 10.1007/s10815-016-0836-8; Hu KL, 2019, HUM REPROD UPDATE, V25, P326, DOI 10.1093/humupd/dmy046; Hu KL, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00365; Jamil Z, 2017, REPROD BIOMED ONLINE, V34, P147, DOI 10.1016/j.rbmo.2016.11.004; Jayasena CN, 2014, J CLIN INVEST, V124, P3667, DOI 10.1172/JCI75730; Kamath MS, 2016, CURR MED ISSUES, V14, P94; Katagiri F, 2015, BIOCHEM BIOPH RES CO, V458, P663, DOI 10.1016/j.bbrc.2015.02.021; Latif R, 2015, NETH J MED, V73, P175; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Nejad SZ, 2017, INT J ENDOCRINOL MET, V15, DOI 10.5812/ijem.44337; Petean CC, 2008, FERTIL STERIL, V90, P2080, DOI 10.1016/j.fertnstert.2007.10.072; Rehman R, 2018, J PAK MED ASSOC, V68, P1451; Rehman R, 2018, PAK J MED SCI, V34, P342, DOI 10.12669/pjms.342.14078; Rehman R, 2017, PAK J MED SCI, V33, P182, DOI 10.12669/pjms.331.11692; Rehman R, 2014, PAK J MED SCI, V30, P986, DOI 10.12669/pjms.305.5175; Rehnnan R, 2015, J PAK MED ASSOC, V65, P448; Taniguchi Y, 2017, REPROD MED BIOL, V16, P380, DOI 10.1002/rmb2.12056; Trevisan CM, 2018, CELL PHYSIOL BIOCHEM, V49, P1259, DOI 10.1159/000493406; Wang LH, 2020, NEUROENDOCRINOLOGY, V110, P172, DOI 10.1159/000503006; Yu HL, 2019, REPROD BIOMED ONLINE, V38, P465, DOI 10.1016/j.rbmo.2018.11.014	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239142	10.1371/journal.pone.0239142	http://dx.doi.org/10.1371/journal.pone.0239142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112855	gold, Green Published			2022-12-26	WOS:000588374000049
J	van Niekerk, JM; Vos, MC; Stein, A; Braakman-Jansen, LMA; in't Holt, AFV; Van Gemert-Pijnen, JEWC				van Niekerk, J. M.; Vos, M. C.; Stein, A.; Braakman-Jansen, L. M. A.; in't Holt, A. F. Voor; Van Gemert-Pijnen, J. E. W. C.			Risk factors for surgical site infections using a data-driven approach	PLOS ONE			English	Article							HOSPITAL-ACQUIRED INFECTIONS; CARDIAC-SURGERY; WOUND-INFECTION; PREVENTION; ALGORITHM; RESECTION; RATES	Objective The objective of this study was to identify risk factors for surgical site infection from digestive, thoracic and orthopaedic system surgeries using clinical and data-driven cut-off values. A second objective was to compare the identified risk factors in this study to risk factors identified in literature. Summary background data Retrospective data of 3 250 surgical procedures performed in large tertiary care hospital in The Netherlands during January 2013 to June 2014 were used. Methods Potential risk factors were identified using a literature scan and univariate analysis. A multivariate forward-step logistic regression model was used to identify risk factors. Standard medical cut-off values were compared with cut-offs determined from the data. Results For digestive, orthopaedic and thoracic system surgical procedures, the risk factors identified were preoperative temperature of >= 38 degrees C and antibiotics used at the time of surgery. C-reactive protein and the duration of the surgery were identified as a risk factors for digestive surgical procedures. Being an adult (age >= 18) was identified as a protective effect for thoracic surgical procedures. Data-driven cut-off values were identified for temperature, age and CRP which can explain the SSI outcome up to 19.5% better than generic cut-off values. Conclusions This study identified risk factors for digestive, orthopaedic and thoracic system surgical procedures and illustrated how data-driven cut-offs can add value in the process. Future studies should investigate if data-driven cut-offs can add value to explain the outcome being modelled and not solely rely on standard medical cut-off values to identify risk factors.	[van Niekerk, J. M.; Braakman-Jansen, L. M. A.; Van Gemert-Pijnen, J. E. W. C.] Univ Twente, Fac Behav Sci, Ctr eHlth Res & Dis Management, Dept Psychol Hlth & Technol, Enschede, Netherlands; [van Niekerk, J. M.; Stein, A.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Dept Earth Observat Sci, Enschede, Netherlands; [van Niekerk, J. M.; Vos, M. C.; in't Holt, A. F. Voor] Erasmus MC Univ Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	University of Twente; University of Twente; Erasmus University Rotterdam; Erasmus MC	Braakman-Jansen, LMA (corresponding author), Univ Twente, Fac Behav Sci, Ctr eHlth Res & Dis Management, Dept Psychol Hlth & Technol, Enschede, Netherlands.	l.m.a.braakman-jansen@utwente.nl		van Niekerk, Johan Magnus/0000-0002-4737-5809	INTERREG V A - European Commission [202085]; Dutch Ministry of Health, Welfare and Sport; Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North RhineWestphalia; Ministry for National and European Affairs and Regional Development of Lower Saxony	INTERREG V A - European Commission; Dutch Ministry of Health, Welfare and Sport; Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North RhineWestphalia; Ministry for National and European Affairs and Regional Development of Lower Saxony	This research was supported by the INTERREG V A (202085) funded project EurHealth1Health (http://www.eurhealth1health.eu), part of a Dutch-German cross-border network supported by the European Commission, the Dutch Ministry of Health, Welfare and Sport, the Ministry of Economy, Innovation, Digitalisation and Energy of the German Federal State of North RhineWestphalia and the Ministry for National and European Affairs and Regional Development of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzaid Ahmed Abdulaziz, 2015, Heart Views, V16, P79, DOI 10.4103/1995-705X.164457; Aldiabat KM, 2018, QUAL REP, V23, P245; [Anonymous], 2015, J PAIN OFF J AM PAIN, V16, P769; [Anonymous], 2017, MEDICINE, V96, pe6504; [Anonymous], 2011, BANKERS LETT LAW, V45, p[1, 1], DOI DOI 10.18637/JSS.V045.I07; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Araki T, 2014, SURG TODAY, V44, P1072, DOI 10.1007/s00595-013-0809-9; Asendorpf JB, 2014, INT J BEHAV DEV, V38, P453, DOI 10.1177/0165025414542713; Ben-Ami E, 2008, J HOSP INFECT, V70, P335, DOI 10.1016/j.jhin.2008.08.010; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Chen LF, 2012, AM J INFECT CONTROL, V40, P963, DOI 10.1016/j.ajic.2012.01.012; Cheng KP, 2015, PATIENT PREFER ADHER, V9, P1171, DOI [10.2147/PPA.S66153, 10.2147/PPA.S86153]; Di Gennaro F, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000370; Ejaz A, 2017, J SURG RES, V217, P153, DOI 10.1016/j.jss.2017.05.018; European Centre for Disease Prevention and Control, 2018, HEALTHCARE ASS INFEC; Fiorini N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005343; Fukuda H, 2016, J HOSP INFECT, V93, P347, DOI 10.1016/j.jhin.2016.04.005; Giri S, 2013, SURG INFECT, V14, P313, DOI 10.1089/sur.2012.108; Hastie T, 2009, ELEMENTS, V27, P337, DOI DOI 10.1007/B94608; Hijas-Gomez AI, 2017, SPINE, V42, P748, DOI 10.1097/BRS.0000000000001916; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; In Lee K, 2007, COMMUN STAT-SIMUL C, V26, P559; Isik O, 2015, CHIRURGIA-BUCHAREST, V110, P457; Isik O, 2015, SURG INFECT, V16, P281, DOI 10.1089/sur.2013.195; Jolivet S, 2018, CLIN MICROBIOL INFEC, V24, P283, DOI 10.1016/j.cmi.2017.07.004; Kokudo T, 2015, WORLD J SURG, V39, P1185, DOI 10.1007/s00268-014-2922-3; Kunutsor SK, 2017, EPIDEMIOL INFECT, V145, P1738, DOI 10.1017/S0950268817000486; Leaper DJ, 2017, J HOSP INFECT, V95, P135, DOI 10.1016/j.jhin.2016.12.016; Lola I, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-151; Martin EM, 2016, INFECT CONT HOSP EP, V37, P1; Mehta PA, 2000, PEDIATR INFECT DIS J, V19, P1000, DOI 10.1097/00006454-200010000-00012; Moreno E-O A, 2012, NATL SURG QUALITY IM, V14, P136, DOI DOI 10.1111/j.1477-2574.2011.00417.x; Morikane K, 2016, INFECT CONT HOSP EP, V37, P1167, DOI 10.1017/ice.2016.155; Perkins JD, 2007, LIVER TRANSPLANT, V13, P767; R Core Team, 2020, R LANG ENV STAT COMP; Rafiq G, 2013, IEEE VEH TECHNOL MAG, V8, P45, DOI 10.1109/MVT.2013.2281660; Roy S, 2014, SURG INFECT, V15, P266, DOI 10.1089/sur.2012.163; Schimmel JJP, 2010, EUR SPINE J, V19, P1711, DOI 10.1007/s00586-010-1421-y; Silvestri M, 2018, SURG TODAY, V48, P338, DOI 10.1007/s00595-017-1590-y; Stancu SM, 2019, SURG INFECT, V20, P39, DOI 10.1089/sur.2018.146; Streefkerk RHRA, 2014, INFECT CONT HOSP EP, V35, P886, DOI 10.1086/676868; Streefkerk RHRA, 2014, INFECT CONT HOSP EP, V35, P888, DOI 10.1086/676869; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Takahashi Y, 2018, J INFECT CHEMOTHER, V24, P739, DOI 10.1016/j.jiac.2018.05.007; Triantafyllopoulos Georgios, 2015, ScientificWorldJournal, V2015, P979560, DOI 10.1155/2015/979560; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Werkgroep infectiepreventie, 2011, PREV VAN POST WOND, P1; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; World Health Organization, 2020, GUID ATC CLASS DDD A; Xing D, 2013, EUR SPINE J, V22, P605, DOI 10.1007/s00586-012-2514-6; Zarb P, 2012, EUROSURVEILLANCE, V17, P4; 2018, M TWAIN J, V56, P124; 2018, COMPUT BIOL MED, V99, P24	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240995	10.1371/journal.pone.0240995	http://dx.doi.org/10.1371/journal.pone.0240995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112893	gold, Green Published			2022-12-26	WOS:000588374000008
J	Zhang, T; Ahn, K; Emerick, B; Modarai, SR; Opdenaker, LM; Palazzo, J; Schleiniger, G; Fields, JZ; Boman, BM				Zhang, Tao; Ahn, Koree; Emerick, Brooks; Modarai, Shirin R.; Opdenaker, Lynn M.; Palazzo, Juan; Schleiniger, Gilberto; Fields, Jeremy Z.; Boman, Bruce M.			APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH plus stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development	PLOS ONE			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; ALDEHYDE DEHYDROGENASE-ACTIVITY; COLORECTAL-CANCER; ENDOCRINE-CELLS; PHENOTYPIC CHARACTERIZATION; PROMYELOCYTIC LEUKEMIA; INTESTINAL EPITHELIUM; TUMOR-GROWTH; IN-VITRO; MOUSE	APC mutations drive human colorectal cancer (CRC) development. A major contributing factor is colonic stem cell (SC) overpopulation. But, the mechanism has not been fully identified. A possible mechanism is the dysregulation of neuroendocrine cell (NEC) maturation by APC mutations because SCs and NECs both reside together in the colonic crypt SC niche where SCs mature into NECs. So, we hypothesized that sequential inactivation of APC alleles in human colonic crypts leads to progressively delayed maturation of SCs into NECs and overpopulation of SCs. Accordingly, we used quantitative immunohistochemical mapping to measure indices and proportions of SCs and NECs in human colon tissues (normal, adenomatous, malignant), which have different APC-zygosity states. In normal crypts, many cells staining for the colonic SC marker ALDH1 co-stained for chromogranin-A (CGA) and other NEC markers. In contrast, in APC-mutant tissues from familial adenomatous polyposis (FAP) patients, the proportion of ALDH+ SCs progressively increased while NECs markedly decreased. To explain how these cell populations change in FAP tissues, we used mathematical modelling to identify kinetic mechanisms. Computational analyses indicated that APC mutations lead to: 1) decreased maturation of ALDH+ SCs into progenitor NECs (not progenitor NECs into mature NECs); 2) diminished feedback signaling by mature NECs. Biological experiments using human CRC cell lines to test model predictions showed that mature GLP-2R+ and SSTR1+ NECs produce, via their signaling peptides, opposing effects on rates of NEC maturation via feedback regulation of progenitor NECs. However, decrease in this feedback signaling wouldn't explain the delayed maturation because both progenitor and mature NECs are depleted in CRCs. So the mechanism for delayed maturation must explain how APC mutation causes the ALDH+ SCs to remain immature. Given that ALDH is a key component of the retinoic acid (RA) signaling pathway, that other components of the RA pathway are selectively expressed in ALDH+ SCs, and that exogenous RA ligands can induce ALDH+ cancer SCs to mature into NECs, RA signaling must be attenuated in ALDH+ SCs in CRC. Thus, attenuation of RA signaling explains why ALDH+ SCs remain immature in APC mutant tissues. Since APC mutation causes increased WNT signaling in FAP and we found that sequential inactivation of APC in FAP patient tissues leads to progressively delayed maturation of colonic ALDH+ SCs, the hypothesis is developed that human CRC evolves due to an imbalance between WNT and RA signaling.	[Zhang, Tao; Ahn, Koree; Modarai, Shirin R.; Opdenaker, Lynn M.; Boman, Bruce M.] Helen F Graham Canc Ctr & Res Inst, Cawley Ctr Translat Canc Res, Newark, DE 19713 USA; [Zhang, Tao; Ahn, Koree; Modarai, Shirin R.; Opdenaker, Lynn M.; Boman, Bruce M.] Univ Delaware, Newark, DE USA; [Zhang, Tao; Ahn, Koree; Palazzo, Juan; Boman, Bruce M.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Emerick, Brooks; Schleiniger, Gilberto; Boman, Bruce M.] Univ Delaware, Dept Math Sci, Ctr Applicat Math Med, Newark, DE 19716 USA; [Fields, Jeremy Z.] CATX Inc, Princeton, NJ USA	Helen F. Graham Cancer Center & Research Institute; University of Delaware; Jefferson University; University of Delaware	Boman, BM (corresponding author), Helen F Graham Canc Ctr & Res Inst, Cawley Ctr Translat Canc Res, Newark, DE 19713 USA.; Boman, BM (corresponding author), Thomas Jefferson Univ, Philadelphia, PA 19107 USA.; Boman, BM (corresponding author), Univ Delaware, Dept Math Sci, Ctr Applicat Math Med, Newark, DE 19716 USA.	brboman@udel.edu		Emerick, Brooks/0000-0003-0469-7258	Lisa Dean Moseley Foundation; NIH [5R21DK62146]; University of Delaware from the Department of Mathematical Sciences; University of Delaware from the Department of Biological Sciences Graduate Scholars Award; Hamline University; Cancer B. Ware Foundation; Cawley Center for Translational Cancer Research Funds; Delaware INBRE NIH/NIGMS [GM103446]	Lisa Dean Moseley Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Delaware from the Department of Mathematical Sciences; University of Delaware from the Department of Biological Sciences Graduate Scholars Award; Hamline University; Cancer B. Ware Foundation; Cawley Center for Translational Cancer Research Funds; Delaware INBRE NIH/NIGMS	This study was supported in part by The Lisa Dean Moseley Foundation (BB), NIH Grant 5R21DK62146 (BB), University of Delaware awards for a graduate fellowship stipend from the Department of Mathematical Sciences (BE) and Department of Biological Sciences Graduate Scholars Award (SM)., a Hamline University Summer Student Fellowship Award (KA), Cancer B. Ware Foundation funding (BB, SM, LO), and Cawley Center for Translational Cancer Research Funds (BB, SM, LO). Additional support for the Bioimaging Core Facility was made possible through funding from Delaware INBRE NIH/NIGMS GM103446 (BB, SM, LO). No funding was provided by CATX, Inc. CATX Inc did not provide any support in the form of salaries for Dr Fields or other authors, or provide any other financial backing to the study. Dr Fields has no ownership in CATX, Inc. CATX Inc holds no intellectual property or any commercial interests in the study.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahlman H, 2001, ANN ONCOL, V12, pS63, DOI 10.1093/annonc/12.suppl_2.S63; Allahverdiyev AM, 2012, DEHYDROGENASES, DOI [10.5772/48591, DOI 10.5772/48591]; [Anonymous], 2012, KIDNEY INT S, V2, P11; [Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 2017, INT J MOL SCI, V18, pE961; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Augenlicht L, 1989, CELL MOL BIOL COLON, P1; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BARRETT P, 1995, HISTOCHEM J, V27, P482; Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Benatti P, 2005, CLIN CANCER RES, V11, P8332, DOI 10.1158/1078-0432.CCR-05-1030; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Black WJ, 2009, PHARMACOGENET GENOM, V19, P893, DOI 10.1097/FPC.0b013e3283329023; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Boman BM, 2004, AM J PATHOL, V165, P1489, DOI 10.1016/S0002-9440(10)63407-4; Boman BM, 2001, CANCER RES, V61, P8408; Boman B, 2009, MOL CARCINOGEN, V48, P821, DOI 10.1002/mc.20526; Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; BUFFA R, 1978, CELL TISSUE RES, V192, P227; Bulow S, 2003, GUT, V52, P742, DOI 10.1136/gut.52.5.742; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Cappelli G, 2008, CUAD FILOL ITAL, V15, P73; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; Chuang JH, 2015, WORLD J STEM CELLS, V7, P437, DOI 10.4252/wjsc.v7.i2.437; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Clark DW, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.82; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Cojoc M, 2015, CANCER RES, V75, P1482, DOI 10.1158/0008-5472.CAN-14-1924; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; DESCHNER EE, 1966, EXP CELL RES, V43, P661, DOI 10.1016/0014-4827(66)90038-3; Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033; Drucker DJ, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P161; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Emerick B, 2018, J MATH BIOL, V76, P1797, DOI 10.1007/s00285-017-1204-8; Emerick B, 2017, J MATH BIOL, V75, P1171, DOI 10.1007/s00285-017-1112-y; Engberg N, 2010, STEM CELLS, V28, P1498, DOI 10.1002/stem.479; EVANS GS, 1988, VIRCHOWS ARCH B, V56, P191, DOI 10.1007/BF02890017; Fang J, 2002, CANCER BIOL THER, V1, P614, DOI 10.4161/cbt.308; Fearnhead NS, 2002, BRIT MED BULL, V64, P27, DOI 10.1093/bmb/64.1.27; Federal Court, 2005, MALAYAN LAW J, V1, P197; Feng HL, 2018, BRIT J CANCER, V118, P224, DOI 10.1038/bjc.2017.363; Gagliardi G, 2012, J CANCER RES THER, P1, DOI [10.4103/0973-1482.95165, DOI 10.4103/0973-1482.95165]; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; GRODEN J, 1995, CANCER RES, V55, P1531; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hatano Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071446; Hayakawa Y, 2019, GASTROENTEROLOGY, V156, P1066, DOI 10.1053/j.gastro.2018.11.024; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ichii Shigetoshi, 1992, Human Molecular Genetics, V1, P387, DOI 10.1093/hmg/1.6.387; Idres N, 2001, CANCER RES, V61, P700; Ishihara K, 2017, METHODS MOL BIOL, V1597, P43, DOI 10.1007/978-1-4939-6949-4_4; Jang GB, 2015, CANCER RES, V75, P1691, DOI 10.1158/0008-5472.CAN-14-2041; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim JY, 2016, ONCOTARGET, V7, P20395, DOI 10.18632/oncotarget.7954; Kim JY, 2019, ANTICANCER RES, V39, P3661, DOI 10.21873/anticanres.13514; Kim RJ, 2013, CANCER LETT, V333, P18, DOI 10.1016/j.canlet.2012.11.026; Kirkland SC, 2001, J CELL SCI, V114, P2055; Kleist B, 2015, WORLD J GASTROENTERO, V21, P11740, DOI 10.3748/wjg.v21.i41.11740; Kozovska Z, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4572-6; Lamlum H, 2000, P NATL ACAD SCI USA, V97, P2225, DOI 10.1073/pnas.040564697; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; LEVY DB, 1994, CANCER RES, V54, P5953; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Lloyd-Lewis B, 2013, WIRES SYST BIOL MED, V5, P391, DOI 10.1002/wsbm.1221; LORENZSONN V, 1968, GASTROENTEROLOGY, V55, P88; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; MASKENS AP, 1979, GASTROENTEROLOGY, V77, P1245; Mayr U, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176727; Modarai Shirin R, 2018, Oncotarget, V9, P34658, DOI 10.18632/oncotarget.26157; Modarai SR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2969-7; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Moran Gordon W, 2008, Therap Adv Gastroenterol, V1, P51, DOI 10.1177/1756283X08093943; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; Nakata Y, 2012, J BIOL DYNAM, V6, P2, DOI 10.1080/17513758.2011.558214; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nicke B, 1999, GUT, V45, P51, DOI 10.1136/gut.45.1.51; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Opdenaker Lynn M, 2015, Cancer Stud Mol Med, V2, P87, DOI 10.17140/CSMMOJ-2-113; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Patel YC, 1997, TRENDS ENDOCRIN MET, V8, P398, DOI 10.1016/S1043-2760(97)00168-9; Philpott A, 2014, CURR OPIN CELL BIOL, V31, P39, DOI 10.1016/j.ceb.2014.07.002; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; POTTEN CS, 1992, GUT, V33, P524, DOI 10.1136/gut.33.4.524; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Radford IR, 2006, CELL PROLIFERAT, V39, P403, DOI 10.1111/j.1365-2184.2006.00396.x; Re RN, 2006, REGUL PEPTIDES, V133, P1, DOI 10.1016/j.regpep.2005.09.012; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rindi G, 2004, ANN NY ACAD SCI, V1014, P1, DOI 10.1196/annals.1294.001; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Russo J E, 1989, Prog Clin Biol Res, V290, P65; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sasaki N, P NATL ACAD SCI US, V13, pE5399; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sei Y, 2011, AM J PHYSIOL-GASTR L, V300, pG345, DOI 10.1152/ajpgi.00278.2010; Serra D, 2019, NATURE, V569, P66, DOI 10.1038/s41586-019-1146-y; SHAMSUDDIN AKM, 1986, J SUBMICR CYTOL PATH, V18, P761; SHAMSUDDIN AM, 1982, HUM PATHOL, V13, P790, DOI 10.1016/S0046-8177(82)80075-0; Shenoy Anitha, 2012, Methods Mol Biol, V916, P373, DOI 10.1007/978-1-61779-980-8_27; Shenoy AK, 2012, CANCER RES, V72, P5091, DOI 10.1158/0008-5472.CAN-12-1806; Shia J, 2002, AM J SURG PATHOL, V26, P863, DOI 10.1097/00000478-200207000-00004; Shroyer NF, 2010, PEDIAT GASTROINTESTI, P1; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Suwala Abigail Kora, 2018, Oncotarget, V9, P22703, DOI 10.18632/oncotarget.25210; Toledo-Guzman ME, 2019, CURR STEM CELL RES T, V14, P375, DOI 10.2174/1574888X13666180810120012; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Tonge PD, 2010, DIFFERENTIATION, V80, P20, DOI 10.1016/j.diff.2010.04.001; van Es JH, 2019, P NATL ACAD SCI USA, V116, P26599, DOI 10.1073/pnas.1801888117; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Viswanathan V, 2008, CANCER RES, V77, P3778; Wang ZH, 2016, GENETICS, V203, P269, DOI 10.1534/genetics.115.183244; Wasan HS, 1998, J PATHOL, V185, P246; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yan KS, 2017, CELL STEM CELL, V21, P78, DOI 10.1016/j.stem.2017.06.014; Zhang T, 2010, AM J PATHOL, V177, P2816, DOI 10.2353/ajpath.2010.100047; ZHU J, 1995, LEUKEMIA, V9, P302; Zhuang XF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-549	145	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239601	10.1371/journal.pone.0239601	http://dx.doi.org/10.1371/journal.pone.0239601			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112876	Green Published, gold			2022-12-26	WOS:000588374000021
J	Dahmani, Z; Addou-Klouche, L; Gizard, F; Dahou, S; Messaoud, A; Djebri, NC; Benaissti, MI; Mostefaoui, M; Terbeche, H; Nouari, W; Miliani, M; Lefranc, G; Fernandez, A; Lamb, NJ; Aribi, M				Dahmani, Zoheir; Addou-Klouche, Lynda; Gizard, Florence; Dahou, Sara; Messaoud, Aida; Djebri, Nihel Chahinez; Benaissti, Mahmoud Idris; Mostefaoui, Meriem; Terbeche, Hadjer; Nouari, Wafa; Miliani, Marwa; Lefranc, Gerard; Fernandez, Anne; Lamb, Ned J.; Aribi, Mourad			Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2(+) breast cancer cells on biomarkers of monocyte antitumor activity	PLOS ONE			English	Article							SIGNALING PATHWAY; NITRIC-OXIDE; MACROPHAGE; PLASTICITY; CULTURE; GROWTH; INTERLEUKIN-10; EXPRESSION; IMPACT; GAMMA	Background Immune activities of monocytes (MOs) can be altered within the microenvironment of solid malignancies, including breast cancer. Metformin (1,1-dimethylbiguanide hydrochloride, MET), has been shown to decrease tumor cell proliferation, but its effects have yet to be explored with respect to MOs (monocytes) activity during their crosstalk with breast cancer cells. Here, we investigated the effects of MET on overall phenotypic functional activities, including cellular immunometabolism and protective redox signaling based-biomarkers, intracellular free calcium ions (Ca-if(2+)), phagocytosis and co-operative cytokines (IFN-gamma and IL-10) of autologous MOs before and during their interplay with primary ER-/PR-/HER2(+) breast cancer cells. Methods Human primary breast cancer cells were either cultured alone or co-cultured with autologous MOs before treatment with MET. Results MET downregulated breast cancer cell proliferation and phagocytosis, while having no significant effect on the ratio of phosphorylated Akt (p-Akt) to total Akt. Additionally, we observed that, in the absence of MET treatment, the levels of lactate dehydrogenase (LDH)-based cytotoxicity, catalase, Ca-if(2+), IL-10 and arginase activity were significantly reduced in co-cultures compared to levels in MOs cultured alone whereas levels of inducible nitric oxide synthase (iNOS) activity were significantly increased. In contrast, MET treatment reduced the effects measured in co-culture on the levels of LDH-based cytotoxicity, arginase activity, catalase, Ca-if(2+), and IFN-gamma. MET also induced upregulation of both iNOS and arginase in MO cells, although the increase did not reach significant difference for iNOS activity. Moreover, MET induced a robust increase of superoxide dismutase (SOD) activity in MOs, but not in MOs co-cultured with breast cancer cells. Furthermore, MET markedly upregulated the levels of IFN-gamma production and downregulated those of IL-10 in isolated MOs, while inducing a slight opposing up-regulation of IL-10 production in co-cultures. Conclusions Our results show that the biomarkers of phenotypic functional activities of MOs are modified after co-culturing with primary human breast cancer cells. Treatment of co-cultures with MET resulted in increased release of antitumor cytokine IFN-gamma and Ca-if(2+), and increased cell necrosis during breast cancer cells-MOs crosstalk.	[Dahmani, Zoheir; Addou-Klouche, Lynda; Dahou, Sara; Messaoud, Aida; Djebri, Nihel Chahinez; Benaissti, Mahmoud Idris; Mostefaoui, Meriem; Terbeche, Hadjer; Nouari, Wafa; Miliani, Marwa; Aribi, Mourad] Univ Tlemcen, Lab Appl Mol Biol & Immunol, W0414100, Tilimsen, Algeria; [Gizard, Florence; Fernandez, Anne; Lamb, Ned J.] Univ Montpellier, Cell Biol Unit, IGH CNRS, UMR 9002, Montpellier, France; [Lefranc, Gerard] Univ Montpellier, IGH, CNRS, UMR 9002, Montpellier, France	Universite Abou Bekr Belkaid; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Aribi, M (corresponding author), Univ Tlemcen, Lab Appl Mol Biol & Immunol, W0414100, Tilimsen, Algeria.; Lamb, NJ (corresponding author), Univ Montpellier, Cell Biol Unit, IGH CNRS, UMR 9002, Montpellier, France.	ned.lamb@igh.cnrs.fr; mourad.aribi@univ-tlemcen.dz		Aribi, Mourad/0000-0002-6522-7252	Thematic Research Agency ATRBSA (Algeria); Thematic Research Agency ATRSS (Algeria); Directorate General of Scientific Researche and Technological Development (DGRSDT, Direction Generale de la Recherche Scientifique et du Developpement Technologique, MESRS, Algeria); CNRS; AFD (Association Francaise pour la Diabete) [1546]	Thematic Research Agency ATRBSA (Algeria); Thematic Research Agency ATRSS (Algeria); Directorate General of Scientific Researche and Technological Development (DGRSDT, Direction Generale de la Recherche Scientifique et du Developpement Technologique, MESRS, Algeria); CNRS(Centre National de la Recherche Scientifique (CNRS)); AFD (Association Francaise pour la Diabete)	This work was funded by the Thematic Research Agencies ATRBSA and ATRSS (Algeria) and the Directorate General of Scientific Research and Technological Development (DGRSDT, Direction Ge ' ne ' rale de la Recherche ' Scientifique et du De ' veloppement Technologique, MESRS, Algeria) for financial support to ZD, LA-K, SD, AM, NC-D, MI-B, MM, HT, WN, MMand MA. FG, GL, AF and NL were supported by CNRS core funding and AFD (Association Francaise pour la Diabete) grant 1546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dubayee MS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00537; Al-Zaidan L, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00277; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; [Anonymous], 2015, EUR HEART J S, V17, pD2; [Anonymous], 2002, J CLIN DENSITOM; Aribi M, 2018, METHODS MOL BIOL, V1784, P135, DOI 10.1007/978-1-4939-7837-3_14; Aribi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135515; Avtandilyan N, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8696923; Baskic Dejan, 2003, Med Pregl, V56 Suppl 1, P103; Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312; Blond D, 2000, J VIROL, V74, P8904, DOI 10.1128/JVI.74.19.8904-8912.2000; Bravo-Santano N, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00374-18; Brown DM, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-29; Buldak L, 2014, PHARMACOL REP, V66, P418, DOI 10.1016/j.pharep.2013.11.008; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cassetta L, 2016, CELL RES, V26, P3, DOI 10.1038/cr.2015.144; Chiang CF, 2017, ONCOTARGET, V8, P20706, DOI 10.18632/oncotarget.14982; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI 10.1097/CCO.0000000000000006; Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541; Doseff A, TUMOR MICROENVIRONME, DOI [10.5772/32615, DOI 10.5772/32615]; Eroglu Z, 2014, ONCOLOGIST, V19, P135, DOI 10.1634/theoncologist.2013-0283; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Fan C, 2015, INT J MOL MED, V36, P204, DOI 10.3892/ijmm.2015.2217; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; FELLER WF, 1972, J NATL CANCER I, V48, P1117; Ferret Pierre-Jacques, 2002, BMC Immunol, V3, P3; Gao ZY, 2016, EXP THER MED, V11, P1700, DOI 10.3892/etm.2016.3143; Garofalo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083832; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Gingras I, 2015, CLIN ADV HEMATOL ONC, V13, P372; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Honorio-Franca AC, 2016, ONCOTARGETS THER, V9, P617, DOI 10.2147/OTT.S99839; Ibberson M, 2013, CLIN CANCER RES, V19, P3439, DOI 10.1158/1078-0432.CCR-12-3181; Idzkowska E, 2015, SCAND J IMMUNOL, V82, P163, DOI 10.1111/sji.12314; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jones JCR, 2008, CSH PROTOC, V2008, DOI 10.1101/pdb.prot4478; Kahl BC, 2000, INFECT IMMUN, V68, P5385, DOI 10.1128/IAI.68.9.5385-5392.2000; Kato Y, 2010, HORM METAB RES, V42, P632, DOI 10.1055/s-0030-1255033; Kavoosi Gholamreza, 2006, Korean Journal of Parasitology, V44, P35, DOI 10.3347/kjp.2006.44.1.35; Keshet R, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033332; Liu BL, 2011, CELL CYCLE, V10, P2959, DOI 10.4161/cc.10.17.16359; Marinello PC, 2016, TUMOR BIOL, V37, P5337, DOI 10.1007/s13277-015-4395-x; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Mitchell AJ, 2014, CELL IMMUNOL, V291, P22, DOI 10.1016/j.cellimm.2014.05.010; Mohamed MM, 2010, CELL PHYSIOL BIOCHEM, V25, P315, DOI 10.1159/000276564; Mojic M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010089; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Muhammad Siti Nur Hasyila, 2016, Asian Pac J Cancer Prev, V17, P3223; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Mutlu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32541; Nouari W, 2016, INT IMMUNOPHARMACOL, V30, P94, DOI 10.1016/j.intimp.2015.11.033; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Olingy CE, 2019, J LEUKOCYTE BIOL, V106, P309, DOI 10.1002/JLB.4RI0818-311R; Pabst MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-13; Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Sadeghi N, 2012, FUTURE MED CHEM, V4, P1153, DOI [10.4155/FMC.12.56, 10.4155/fmc.12.56]; Sarvaiya HA, 2016, DATA BRIEF, V9, P579, DOI 10.1016/j.dib.2016.09.025; Soliman H, 2013, CANCER CONTROL, V20, P17, DOI 10.1177/107327481302000104; Speirs V, 1998, BRIT J CANCER, V78, P1421, DOI 10.1038/bjc.1998.702; Stephen J, 2013, J IMMUNOL, V191, P5677, DOI 10.4049/jimmunol.1301250; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Szewczyk M, 2012, ANTICANCER RES, V32, P2133; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Takano S, 2012, ANAL CHEM INSIGHTS, V7, P23, DOI 10.4137/ACI.S9681; Herrera MT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2705-1; Turrini R, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1303585; Wahl Larry M, 2006, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0706as70; Walton PA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00108; Xin WX, 2018, MOL CLIN ONCOL, V8, P483, DOI 10.3892/mco.2017.1541; Xu T, 2017, J CANCER, V8, P3838, DOI 10.7150/jca.21051; Yanagawa Y, 2009, IMMUNOLOGY, V127, P345, DOI 10.1111/j.1365-2567.2008.02986.x; Zahzeh MR, 2015, J BLOOD MED, V6, P99, DOI 10.2147/JBM.S78759; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343	80	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240982	10.1371/journal.pone.0240982	http://dx.doi.org/10.1371/journal.pone.0240982			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108409	Green Published, gold			2022-12-26	WOS:000588372400033
J	Mann, JP; Carter, P; Armstrong, MJ; Abdelaziz, HK; Uppal, H; Patel, B; Chandran, S; More, R; Newsome, PN; Potluri, R				Mann, Jake P.; Carter, Paul; Armstrong, Matthew J.; Abdelaziz, Hesham K.; Uppal, Hardeep; Patel, Billal; Chandran, Suresh; More, Ranjit; Newsome, Philip N.; Potluri, Rahul			Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors	PLOS ONE			English	Article							FIBROSIS STAGE; HEART-FAILURE; FOLLOW-UP; NAFLD; CIRRHOSIS; STEATOHEPATITIS; PREDICTOR	Non-alcoholic fatty liver disease (NAFLD) is common and strongly associated with the metabolic syndrome. Though NAFLD may progress to end-stage liver disease, the top cause of mortality in NAFLD is cardiovascular disease (CVD). Most of the data on liver-related mortality in NAFLD derives from specialist liver centres. It is not clear if the higher reported mortality rates in individuals with non-cirrhotic NAFLD are entirely accounted for by complications of atherosclerosis and diabetes. Therefore, we aimed to describe the CVD burden and mortality in NAFLD when adjusting for metabolic risk factors using a 'real world' cohort. We performed a retrospective study of patients followed-up after an admission to non-specialist hospitals with a NAFLD-spectrum diagnosis. Non-cirrhotic NAFLD and NAFLD-cirrhosis patients were defined by ICD-10 codes. Cases were age-/sex-matched with non-NAFLD hospitalised patients. All-cause mortality over 14-years follow-up after discharge was compared between groups using Cox proportional hazard models adjusted for demographics, CVD, and metabolic syndrome components. We identified 1,802 patients with NAFLD-diagnoses: 1,091 with non-cirrhotic NAFLD and 711 with NAFLD-cirrhosis, matched to 24,737 controls. There was an increasing burden of CVD with progression of NAFLD: for congestive heart failure 3.5% control, 4.2% non-cirrhotic NAFLD, 6.6% NAFLD-cirrhosis; and for atrial fibrillation 4.7% control, 5.9% non-cirrhotic NAFLD, 12.1% NAFLD-cirrhosis. Over 14-years follow-up, crude mortality rates were 14.7% control, 13.7% non-cirrhotic NAFLD, and 40.5% NAFLD-cirrhosis. However, after adjusting for demographics, non-cirrhotic NAFLD (HR 1.3 (95% CI 1.1-1.5)) as well as NAFLD-cirrhosis (HR 3.7 (95% CI 3.0-4.5)) patients had higher mortality compared to controls. These differences remained after adjusting for CVD and metabolic syndrome components: non-cirrhotic NAFLD (HR 1.2 (95% CI 1.0-1.4)) and NAFLD-cirrhosis (HR 3.4 (95% CI 2.8-4.2)). In conclusion, from a large non-specialist registry of hospitalised patients, those with non-cirrhotic NAFLD had increased overall mortality compared to controls even after adjusting for CVD.	[Mann, Jake P.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Mann, Jake P.] Univ Cambridge, Dept Paediat, Cambridge, England; [Mann, Jake P.; Carter, Paul; Uppal, Hardeep; Potluri, Rahul] Aston Univ, ACALM Study Unit Collaborat, Aston Med Sch, Birmingham, W Midlands, England; [Carter, Paul] Univ Cambridge, Dept Med, Div Cardiovasc Med, Cambridge, England; [Armstrong, Matthew J.] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England; [Abdelaziz, Hesham K.; Patel, Billal; More, Ranjit] Blackpool Victoria Hosp, Lancashire Cardiac Ctr, Blackpool, England; [Abdelaziz, Hesham K.] Ain Shams Univ Hosp, Dept Cardiovasc Med, Cairo, Egypt; [Chandran, Suresh] Pennine Acute Hosp NHS Trust, Dept Med, Manchester, Lancs, England; [Newsome, Philip N.] Univ Hosp Birmingham NHS Fdn Trust, Res Liver Biomed Res Unit, Natl Inst Hlth, Birmingham, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Birmingham, W Midlands, England; [Newsome, Philip N.] Univ Birmingham, Ctr Liver Res, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Cambridge; University of Cambridge; Aston University; University of Cambridge; University of Birmingham; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Birmingham; University of Birmingham; University of Birmingham	Mann, JP (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.; Mann, JP (corresponding author), Univ Cambridge, Dept Paediat, Cambridge, England.; Mann, JP (corresponding author), Aston Univ, ACALM Study Unit Collaborat, Aston Med Sch, Birmingham, W Midlands, England.	jm2032@cam.ac.uk	Newsome, Philip N/D-4495-2018; Hesham K Abdelaziz, Abdelaziz HK/I-9302-2019	Newsome, Philip N/0000-0001-6085-3652; Hesham K Abdelaziz, Abdelaziz HK/0000-0002-5165-9919; Mann, Jake/0000-0002-4711-9215	Wellcome Trust Fellowship [216329/Z/19/Z]	Wellcome Trust Fellowship(Wellcome Trust)	JPM is supported by a Wellcome Trust Fellowship (216329/Z/19/Z, https://wellcome.ac.uk).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194153; Alexander M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5367; Angelico F, 2017, ATHEROSCLEROSIS, V262, P179, DOI 10.1016/j.atherosclerosis.2017.03.038; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Athyros VG, 2020, CURR VASC PHARMACOL, V18, P172, DOI 10.2174/1570161117666190405164313; Athyros VG, 2017, METABOLISM, V71, P17, DOI 10.1016/j.metabol.2017.02.014; Athyros VG, 2015, WORLD J GASTROENTERO, V21, P6820, DOI 10.3748/wjg.v21.i22.6820; Baratta F, 2020, CLIN GASTROENTEROL H, V18, P2324, DOI 10.1016/j.cgh.2019.12.026; Carter P, 2014, INT J CARDIOL, V173, P573, DOI 10.1016/j.ijcard.2014.03.116; Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Gokce S, 2013, PEDIATR CARDIOL, V34, P308, DOI 10.1007/s00246-012-0447-9; Hagstrom H, 2019, LIVER INT, V39, P197, DOI 10.1111/liv.13973; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Henson JB, 2020, ALIMENT PHARM THER, V51, P728, DOI 10.1111/apt.15660; Katsiki N, 2019, METABOLISM, V98, pIII, DOI 10.1016/j.metabol.2019.07.009; Kilaru SM, 2017, GASTROENTEROLOGY, V152, pS688, DOI 10.1016/S0016-5085(17)32415-0; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Labenz C, 2018, ALIMENT PHARM THER, V48, P1109, DOI 10.1111/apt.14976; Liu ZP, 2020, J HEPATOL, V73, P263, DOI 10.1016/j.jhep.2020.03.006; Molnar MZ, 2019, LIVER TRANSPLANT, V25, P399, DOI 10.1002/lt.25367; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Noureddin M, 2020, GASTROENTEROLOGY, V159, P422, DOI 10.1053/j.gastro.2020.04.039; O'Leary JG, 2019, GASTROENTEROLOGY, V157, P34, DOI 10.1053/j.gastro.2019.03.070; Paik J, 2019, LIVER INT, V39, P342, DOI 10.1111/liv.13992; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Potluri R, 2014, INT J CARDIOL, V176, P760, DOI 10.1016/j.ijcard.2014.07.097; Properzi C, 2018, HEPATOLOGY, V68, P1741, DOI 10.1002/hep.30076; Ratziu V, 2018, LANCET GASTROENTEROL, V3, P8, DOI 10.1016/S2468-1253(17)30365-5; Rowe IA, 2018, LANCET GASTROENTEROL, V3, P66, DOI 10.1016/S2468-1253(17)30142-5; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sanders FWB, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1439-8; Sangha J, 2015, INT J NEUROSCI, V125, P256, DOI 10.3109/00207454.2014.930463; Sherwood P, 2001, BRIT MED J, V322, P276, DOI 10.1136/bmj.322.7281.276; Stahl EP, 2019, J AM COLL CARDIOL, V73, P948, DOI 10.1016/j.jacc.2018.11.050; Stefan N, 2019, LANCET DIABETES ENDO, V7, P313, DOI 10.1016/S2213-8587(18)30154-2; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Uppal H, 2015, J INTELL DISABIL RES, V59, P873, DOI 10.1111/jir.12196; Valbusa F, 2018, INT J CARDIOL, V265, P162, DOI 10.1016/j.ijcard.2018.04.129; Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014; Wijarnpreecha K, 2018, DIGEST LIVER DIS, V50, P1166, DOI 10.1016/j.dld.2018.09.004; Wild SH, 2018, DIABETES CARE, V41, P341, DOI 10.2337/dc17-1590; WU SQ, 2016, SCI REP-UK, V6, DOI DOI 10.1038/SREP3338627633274; Younossi ZM, 2019, TRANSPLANTATION, V103, P22, DOI 10.1097/TP.0000000000002484; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Ziaei F, 2016, INT J CARDIOL, V214, P411, DOI 10.1016/j.ijcard.2016.03.198; Ziff OJ, 2018, INT J CARDIOL, V252, P117, DOI 10.1016/j.ijcard.2017.06.033	56	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241357	10.1371/journal.pone.0241357	http://dx.doi.org/10.1371/journal.pone.0241357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108366	Green Published, Green Submitted, gold			2022-12-26	WOS:000588372400031
J	Gilles, G; McCulloch, AD; Brakebusch, CH; Herum, KM				Gilles, George; McCulloch, Andrew D.; Brakebusch, Cord H.; Herum, Kate M.			Maintaining resting cardiac fibroblasts in vitro by disrupting mechanotransduction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MYOCARDIAL-INFARCTION; MYOFIBROBLAST; FIBROSIS; DIFFERENTIATION; ACTIVATION; INTEGRINS; ACTIN	Mechanical cues activate cardiac fibroblasts and induce differentiation into myofibroblasts, which are key steps for development of cardiac fibrosis. In vitro, the high stiffness of plastic culturing conditions will also induce these changes. It is therefore challenging to study resting cardiac fibroblasts and their activation in vitro. Here we investigate the extent to which disrupting mechanotransduction by culturing cardiac fibroblasts on soft hydrogels or in the presence of biochemical inhibitors can be used to maintain resting cardiac fibroblasts in vitro. Primary cardiac fibroblasts were isolated from adult mice and cultured on plastic or soft (4.5 kPa) polyacrylamide hydrogels. Myofibroblast marker gene expression and smooth muscle alpha-actin (SMA) fibers were quantified by real-time PCR and immunostaining, respectively. Myofibroblast differentiation was prevented on soft hydrogels for 9 days, but had occurred after 15 days on hydrogels. Transferring myofibroblasts to soft hydrogels reduced expression of myofibroblast-associated genes, albeit SMA fibers remained present. Inhibitors of transforming growth factor beta receptor I (TGF beta RI) and Rho-associated protein kinase (ROCK) were effective in preventing and reversing myofibroblast gene expression. SMA fibers were also reduced by blocker treatment although cell morphology did not change. Reversed cardiac fibroblasts maintained the ability to re-differentiate after the removal of blockers, suggesting that these are functionally similar to resting cardiac fibroblasts. However, actin alpha 2 smooth muscle (Acta2), lysyl oxidase (Lox) and periostin (Postn) were no longer sensitive to substrate stiffness, suggesting that transient treatment with mechanotransduction inhibitors changes the mechanosensitivity of some fibrosis-related genes. In summary, our results bring novel insight regarding the relative importance of specific mechanical signaling pathways in regulating different myofibroblast-associated genes. Furthermore, combining blocker treatment with the use of soft hydrogels has not been tested previously and revealed that only some genes remain mechano-sensitive after phenotypic reversion. This is important information for researchers using inhibitors to maintain a "resting" cardiac fibroblast phenotype in vitro as well as for our current understanding of mechanosensitive gene regulation.	[Gilles, George; McCulloch, Andrew D.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [McCulloch, Andrew D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Brakebusch, Cord H.; Herum, Kate M.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Copenhagen	Herum, KM (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark.	kate.herum@bric.ku.dk		Brakebusch, Cord/0000-0002-9342-1634	European Union [795390]; NIH [1 R01 HL137100-01, U01 H127654, 1 U01 HL126273]	European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.M.H. has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 795390. https://ec.europa.eu/programmes/horizon2020/en/The project was supported in part by NIH grants 1 R01 HL137100-01, U01 H127654 and 1 U01 HL126273. https://www.nih.gov/grants-funding The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, ONCOGENESIS, V6, pe345; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Dorn LE, 2018, J MOL CELL CARDIOL, V121, P205, DOI 10.1016/j.yjmcc.2018.07.130; Driesen RB, 2014, CARDIOVASC RES, V101, P411, DOI 10.1093/cvr/cvt338; Frangogiannis NG, 2019, J AM COLL CARDIOL, V73, P2283, DOI 10.1016/j.jacc.2018.10.094; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Herum KM, 2017, MOL BIOL CELL; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Lu M, 2019, IUBMB LIFE, V71, P1729, DOI 10.1002/iub.2112; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; MUKHERJEE D, 1990, CIRC RES, V67, P1474, DOI 10.1161/01.RES.67.6.1474; Nagaraju CK, 2019, J AM COLL CARDIOL, V73, P2267, DOI 10.1016/j.jacc.2019.02.049; Ohashi K, 2017, J BIOCHEM, V161, P245, DOI 10.1093/jb/mvw082; Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053; Shinde AV, 2017, BBA-MOL BASIS DIS, V1863, P298, DOI 10.1016/j.bbadis.2016.11.006; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Stempien-Otero A, 2016, J MOL CELL CARDIOL, V97, P153, DOI 10.1016/j.yjmcc.2016.05.002; Sullivan KE, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt403; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; van Putten S, 2016, J MOL CELL CARDIOL, V93, P133, DOI 10.1016/j.yjmcc.2015.11.025; Venugopal B, 2018, BIOMATER SCI-UK, V6, P1109, DOI 10.1039/c7bm00853h; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710	28	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241390	10.1371/journal.pone.0241390	http://dx.doi.org/10.1371/journal.pone.0241390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104742	gold, Green Published			2022-12-26	WOS:000588370000049
J	Basar, S; Ali, M; Ochoa-Ruiz, G; Zareei, M; Waheed, A; Adnan, A				Basar, Sadia; Ali, Mushtaq; Ochoa-Ruiz, Gilberto; Zareei, Mahdi; Waheed, Abdul; Adnan, Awais			Unsupervised color image segmentation: A case of RGB histogram based K-means clustering initialization	PLOS ONE			English	Article							ALGORITHM; SEARCH; MODEL	Color-based image segmentation classifies pixels of digital images in numerous groups for further analysis in computer vision, pattern recognition, image understanding, and image processing applications. Various algorithms have been developed for image segmentation, but clustering algorithms play an important role in the segmentation of digital images. This paper presents a novel and adaptive initialization approach to determine the number of clusters and find the initial central points of clusters for the standard K-means algorithm to solve the segmentation problem of color images. The presented scheme uses a scanning procedure of the paired Red, Green, and Blue (RGB) color-channel histograms for determining the most salient modes in every histogram. Next, the histogram thresholding is applied and a search in every histogram mode is performed to accomplish RGB pairs. These RGB pairs are used as the initial cluster centers and cluster numbers that clustered each pixel into the appropriate region for generating the homogeneous regions. The proposed technique determines the best initialization parameters for the conventional K-means clustering technique. In this paper, the proposed approach was compared with various unsupervised image segmentation techniques on various image segmentation benchmarks. Furthermore, we made use of a ranking approach inspired by the Evaluation Based on Distance from Average Solution (EDAS) method to account for segmentation integrity. The experimental results show that the proposed technique outperforms the other existing clustering techniques by optimizing the segmentation quality and possibly reducing the classification error.	[Basar, Sadia; Ali, Mushtaq; Waheed, Abdul] Hazara Univ, Dept Informat Technol, Mansehra, Pakistan; [Basar, Sadia] Abbottabad Univ Sci & Technol, Dept Comp Sci, Abbottabad, Pakistan; [Ochoa-Ruiz, Gilberto; Zareei, Mahdi] Sch Engn & Sci, Tecnol Monterrey, Zapopan, Mexico; [Waheed, Abdul] Seoul Natl Univ, Sch Elect & Comp Engn, Seoul, South Korea; [Adnan, Awais] Inst Management Sci, Dept Comp Sci, Peshawar, Pakistan	Hazara University; Tecnologico de Monterrey; Seoul National University (SNU)	Basar, S (corresponding author), Hazara Univ, Dept Informat Technol, Mansehra, Pakistan.; Basar, S (corresponding author), Abbottabad Univ Sci & Technol, Dept Comp Sci, Abbottabad, Pakistan.	sadiaa.khancs@gmail.com	Zareei, Mahdi/D-8043-2013; Waheed, Abdul/AAW-5832-2020	Zareei, Mahdi/0000-0001-6623-1758; Waheed, Abdul/0000-0002-0974-6154; Ochoa-Ruiz, Gilberto/0000-0002-9896-8727				Ahamad M. V, 2017, INT J ADV RES SCI EN, V6, P1110; Akhtar N, 2015, INT CONF COMM SYST, P1124, DOI 10.1109/CSNT.2015.164; Akthar N, 2016, 2016 SECOND INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE & COMMUNICATION TECHNOLOGY (CICT), P192, DOI 10.1109/CICT.2016.46; Al Aghbari Z, 2006, IMAGE VISION COMPUT, V24, P894, DOI 10.1016/j.imavis.2006.02.013; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 1994, NIH TECHNOL ASSESS S; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Badawi A, 2019, J IMAGING, V5, DOI 10.3390/jimaging5030038; Cheng HD, 2003, PATTERN RECOGN, V36, P1545, DOI 10.1016/S0031-3203(02)00293-5; Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7; Chin-Wei B., 2010, INT ADV SOFT COMPUTI, V2, P40; COLORNI A, 1992, FROM ANIM ANIMAT, P134; de la Fuente-Tomas L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210314; Dhanachandra N, 2015, PROCEDIA COMPUT SCI, V54, P764, DOI 10.1016/j.procs.2015.06.090; Elbalaoui A., 2013, INT J ADV COMPUTER S, P15; Fan JP, 2019, IEEE ACCESS, V7, P58974, DOI 10.1109/ACCESS.2019.2915345; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Han CY, 2017, CLUSTER COMPUT, V20, P1017, DOI 10.1007/s10586-017-0792-9; HARALICK RM, 1985, COMPUT VISION GRAPH, V29, P100, DOI 10.1016/S0734-189X(85)90153-7; Hartigan J., 1975, CLUSTERING ALGORITHM; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hojjatoleslami SA, 1998, IEEE T IMAGE PROCESS, V7, P1079, DOI 10.1109/83.701170; Ilieva G, 2018, COMPUT APPL MATH, V37, P5650, DOI 10.1007/s40314-018-0652-0; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kandwal Rohan, 2014, INT J ADV RES COMPUT, V4, P2277; Keshavarz Ghorabaee M, 2015, INFORMATICA-LITHUAN, V26, P435, DOI 10.15388/Informatica.2015.57; Kucukkulahli E, 2016, NEURAL COMPUT APPL, V27, P1445, DOI 10.1007/s00521-016-2287-7; Kumar V, 2014, ENG APPL ARTIF INTEL, V29, P93, DOI 10.1016/j.engappai.2013.11.008; Li M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226345; Li YY, 2019, ARAB J SCI ENG, V44, P2737, DOI 10.1007/s13369-018-3487-5; Liang WZ, 2018, IEEE ACCESS, V6, P65747, DOI 10.1109/ACCESS.2018.2878747; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mehmood G, 2020, IEEE ACCESS, V8, P131397, DOI 10.1109/ACCESS.2020.3007405; Meinel G., 2004, INT ARCH PHOTOGRAM B, V35, P1097, DOI DOI 10.3390/RS6042912; Moftah Hossam M., 2010, Proceedings 10th International Conference on Intelligent Systems Design and Applications (ISDA 2010), P320, DOI 10.1109/ISDA.2010.5687244; Moftah HM, 2014, NEURAL COMPUT APPL, V24, P1917, DOI 10.1007/s00521-013-1437-4; Narayanan BN, 2019, PATTERN ANAL APPL, V22, P559, DOI 10.1007/s10044-017-0653-4; Niknam T, 2010, APPL SOFT COMPUT, V10, P183, DOI 10.1016/j.asoc.2009.07.001; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; Peng XD, 2017, J INTELL FUZZY SYST, V32, P955, DOI 10.3233/JIFS-161548; Peng YH, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9142808; Qian W., 2012, ELECT DES ENG, V20, P21, DOI 10.14022/j.cnki.dzsjgc.2012.07.034; Qingxue Zhang, 2015, 2015 IEEE Biomedical Circuits and Systems Conference (BioCAS), P1, DOI 10.1109/BioCAS.2015.7348384; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Singh M, 2013, INT J ELECT COMPUT S, V2, P933; Song JH, 2019, INFORMATION, V10, DOI 10.3390/info10020074; Soumya D., 2013, INT J SCI ENG RES, V4, P937; Steinbach M., 2000, COMP DOCUMENT CLUSTE; Stevic Z, 2019, TRANSPORT-VILNIUS, V34, P52, DOI 10.3846/transport.2019.7275; Wang HG, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201802993; Wang JH, 2017, ENG COMPUTATION, V34, P174, DOI 10.1108/EC-10-2015-0315; Xie DH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210411; Yang W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229651; Yu ZD, 2010, PATTERN RECOGN, V43, P1889, DOI 10.1016/j.patcog.2009.11.015; Yuan C., 2019, THE J, V2, P226, DOI [DOI 10.3390/J2020016, 10.3390/j2020016]; Zhang CC, 2014, SENSORS-BASEL, V14, P16128, DOI 10.3390/s140916128; Zhang H, 2008, COMPUT VIS IMAGE UND, V110, P260, DOI 10.1016/j.cviu.2007.08.003; ZHANG YJ, 2002, INT J IMAGE GRAPHICS, V02, P441; Zheng C, 2017, IEEE T GEOSCI REMOTE, V55, P3015, DOI 10.1109/TGRS.2017.2658731; Zheng YH, 2015, J INTELL FUZZY SYST, V28, P961, DOI 10.3233/IFS-141378; Zhimao Lu, 2012, ICIC Express Letters, V6, P3125	66	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240015	10.1371/journal.pone.0240015	http://dx.doi.org/10.1371/journal.pone.0240015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091007	gold, Green Published			2022-12-26	WOS:000586647200042
J	Barbaree, BA; Reiter, ME; Hickey, CM; Strum, KM; Isola, JE; Jennings, S; Tarjan, LM; Strong, CM; Stenzel, LE; Shuford, WD				Barbaree, Blake A.; Reiter, Matthew E.; Hickey, Catherine M.; Strum, Khara M.; Isola, Jennifer E.; Jennings, Scott; Tarjan, L. Max; Strong, Cheryl M.; Stenzel, Lynne E.; Shuford, W. David			Effects of drought on the abundance and distribution of non-breeding shorebirds in central California, USA	PLOS ONE			English	Article							DUNLIN CALIDRIS-ALPINA; WINTERING DUNLIN; HABITAT AVAILABILITY; CARRYING-CAPACITY; EXTREME DROUGHT; PACIFIC COAST; RICE FIELDS; MANAGEMENT; MOVEMENTS; PATTERNS	Conservation of migratory species requires anticipating the potential impacts of extreme climatic events, such as extreme drought. During drought, reduced habitat availability for shorebirds creates the potential for changes in their abundance and distribution, in part because many species are highly mobile and rely on networks of interior and coastal habitats. Understanding how shorebirds responded to a recent drought cycle that peaked from 2013 to 2015 in central California, USA, will help optimize management of wetlands and fresh water for wildlife. In the Central Valley, a vast interior region that is characterized by a mosaic of wetlands and agricultural lands, we found 22% and 29% decreases in the annual abundance of shorebirds during periods of 3-year drought (2013-2015) and 2-year extreme drought (2014-2015), respectively, when compared to non-drought years. Lower abundance of shorebirds coincided with significant decreases in the mean proportion flooded of survey units (7% and 9%, respectively) that were reliant on fresh water. Drought was associated with lower abundance within both the interior Central Valley and coastal San Francisco Bay for greater and lesser yellowlegs (Tringa melanoleuca and T.flavipes) and long- and short-billed dowitchers (Limnodromus scolopaceus and L.griseus). Only dunlins (Calidris alpina) had patterns of abundance that suggested substantial shifts in distribution between the Central Valley and coastal regions of San Francisco Bay and Point Reyes. Our results indicate that drought has the potential to reduce, at least temporally, shorebird populations and flooded habitat in the Central Valley, and the ability to respond to drought by taking advantage of nearby coastal habitats may limit the long-term effects of drought on some species. Successful conservation strategies must balance the impacts of reduced habitat availability at interior sites with the ability of some migratory shorebirds to adapt rapidly to shifting distributions of resources.	[Barbaree, Blake A.; Reiter, Matthew E.; Hickey, Catherine M.; Stenzel, Lynne E.; Shuford, W. David] Point Blue Conservat Sci, Petaluma, CA USA; [Strum, Khara M.] Audubon Calif, Sacramento, CA USA; [Isola, Jennifer E.] US Fish & Wildlife Serv, Sacramento Natl Wildlife Refuge Complex, Willows, CA USA; [Jennings, Scott] Audubon Canyon Ranch, Marshall, CA USA; [Tarjan, L. Max] San Francisco Bay Bird Observ, Milpitas, CA USA; [Strong, Cheryl M.] US Fish & Wildlife Serv, Newport Field Off, Newport, OR USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Barbaree, BA (corresponding author), Point Blue Conservat Sci, Petaluma, CA USA.	bbarbaree@pointblue.org		Barbaree, Blake/0000-0002-5912-8768	David and Lucile Packard Foundation; S. D. Bechtel, Jr. Foundation; United States Forest Service International Programs	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); S. D. Bechtel, Jr. Foundation; United States Forest Service International Programs(United States Department of Agriculture (USDA)United States Forest Service)	Funding for this research was provided to Point Blue Conservation Science for the Migratory Shorebird Project and Pacific Flyway Shorebird Survey by the David and Lucile Packard Foundation http://packard.org/and United States Forest Service International Programs https://www.fs.usda.gov/about-agency/international-programs, and to the Migratory Bird Conservation Partnership (Point Blue Conservation Science, Audubon California, The Nature Conservancy) by the S. D. Bechtel, Jr. Foundation http://sdbjrfoundation.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2006, J WILDLIFE MANAGE, V70, P965, DOI 10.2193/0022-541X(2006)70[965:SUBWGW]2.0.CO;2; Adams William M., 2014, BIODIVERSITY-OTTAWA, V15, P101, DOI 10.1080/14888386.2014.931822; Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; [Anonymous], 2017, CLIN GENITOURIN CANC; Barbaree BA, 2018, LANDSCAPE ECOL, V33, P829, DOI 10.1007/s10980-018-0638-8; Barbaree BA, 2016, J WILDLIFE MANAGE, V80, P256, DOI 10.1002/jwmg.1006; Barbaree BA, 2015, WATERBIRDS, V38, P40, DOI 10.1675/063.038.0106; Bennett JM, 2014, DIVERS DISTRIB, V20, P1321, DOI 10.1111/ddi.12230; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Brand LA, 2014, WATERBIRDS, V37, P52, DOI 10.1675/063.037.0108; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Cady SM, 2019, GLOBAL CHANGE BIOL, V25, P2691, DOI 10.1111/gcb.14668; Central Valley Joint Venture, 2006, CENTR VALL JOINT VEN; Chambers LE, 2006, INT J BIOMETEOROL, V50, P292, DOI 10.1007/s00484-005-0019-2; DETTINGER M, 2014, SAN FRANC ESTUARY WA, V12; Dodd SL, 1998, WILSON BULL, V110, P182; Duncan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051490; Dybala K., 2017, SAN FRANCISCO ESTUAR, V15, P1; Elphick CS, 1998, J APPL ECOL, V35, P95, DOI 10.1046/j.1365-2664.1998.00274.x; Fleskes JP, 2012, WETLANDS CENTRAL VAL; Galbraith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108899; Golet GH, 2018, ECOL APPL, V28, P409, DOI 10.1002/eap.1658; GOSSCUSTARD JD, 1995, J APPL ECOL, V32, P337, DOI 10.2307/2405100; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Kelly John P., 2001, Western Birds, V32, P145; Kelly JP, 2014, WETLANDS, V34, P893, DOI 10.1007/s13157-014-0551-0; Kingsford RT, 2010, MAR FRESHWATER RES, V61, P875, DOI 10.1071/MF09088; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; Lund J, 2018, J WATER RES PLAN MAN, V144, DOI 10.1061/(ASCE)WR.1943-5452.0000984; Maron M, 2015, DIVERS DISTRIB, V21, P731, DOI 10.1111/ddi.12339; Marron JS, 2015, STAT SCI, V30, P468, DOI 10.1214/15-STS524; Matchett EL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169780; Maxwell SL, 2019, DIVERS DISTRIB, V25, P613, DOI 10.1111/ddi.12878; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Page GW, 1999, CONDOR, V101, P461, DOI 10.2307/1370176; Pandolfino, 2018, STUDIES W BIRDS, P215, DOI [DOI 10.21199/SWB3.12, 10.21199/SWB3.12]; Petrie MJ, 2016, J FISH WILDL MANAG, V7, P408, DOI 10.3996/082015-JFWM-082; Pitelka FA, 1950, GEOGRAPHIC VARIATION; Popovic I, 2019, CONDOR, V121, DOI 10.1093/condor/duz036; Prugh LR, 2018, NAT CLIM CHANGE, V8, P819, DOI 10.1038/s41558-018-0255-1; Reiter ME, 2020, AVIAN CONSERV ECOL, V15, DOI 10.5751/ACE-01620-150207; Reiter ME, 2018, PEERJ, V6, DOI 10.7717/peerj.5147; Robinson JA, 1996, J FIELD ORNITHOL, V67, P307; Sanzenbacher PM, 2002, CONDOR, V104, P271, DOI 10.1650/0010-5422(2002)104[0271:RAMPOW]2.0.CO;2; Schaffer-Smith D, 2018, ECOL APPL, V28, P1534, DOI 10.1002/eap.1732; Shepherd PCF, 2004, J WILDLIFE MANAGE, V68, P61, DOI 10.2193/0022-541X(2004)068[0061:MAAHPO]2.0.CO;2; SHUFORD W D, 1989, Western Birds, V20, P137; Shuford W. David, 2020, Western Birds, V51, P190, DOI 10.21199/WB51.3.2; Shuford WD, 1998, CONDOR, V100, P227, DOI 10.2307/1370264; Stanley TR, 2007, J WILDLIFE MANAGE, V71, P2556, DOI 10.2193/2007-023; Steen V, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2095; Stenzel L.E., 2018, W FIELD ORNITHOLOGIS, P236, DOI [10.21199/SWB3.13, DOI 10.21199/SWB3.13]; Stenzel Lynne E., 2002, Western Birds, V33, P69; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Strum KM, 2013, AGR ECOSYST ENVIRON, V179, P116, DOI 10.1016/j.agee.2013.08.003; Swain DL, 2018, NAT CLIM CHANGE, V8, P427, DOI 10.1038/s41558-018-0140-y; Taft OW, 2008, IBIS, V150, P541, DOI 10.1111/j.1474-919X.2008.00816.x; Taft OW, 2002, J APPL ECOL, V39, P987, DOI 10.1046/j.1365-2664.2002.00763.x; Takekawa JY, 2002, WATERBIRDS, V25, P93; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; U.S. Shorebird Conservation Plan Partnership, 2016, US SHOR CONS CONC 20; WARNOCK N, 1995, WILSON BULL, V107, P131; Wen L, 2016, ECOL EVOL, V6, P6672, DOI 10.1002/ece3.2091; Williams AP, 2020, SCIENCE, V368, P314, DOI 10.1126/science.aaz9600; Zameroski D, 2006, IEEE INT CONF ROBOT, P1997, DOI 10.1109/ROBOT.2006.1641998; Zuur Alain F., 2009, P1	66	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240931	10.1371/journal.pone.0240931	http://dx.doi.org/10.1371/journal.pone.0240931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085697	gold, Green Published			2022-12-26	WOS:000585943400028
J	Yeemin, W; Kemarat, S; Theanthong, A				Yeemin, Wichai; Kemarat, Supatcharin; Theanthong, Apiluk			The effects of post activation potentiation warm-up and pre-shot routine programs on driving performance in amateur golfers	PLOS ONE			English	Article							ACCURACY; SPEED	The purpose of this study was to assess the effects of three different programs, i.e. active dynamic warm-up program plus functional resistance warm-up using Theraband plus pre-shot routine program (AFPR); pre-shot routine program (PR); and active dynamic warm-up program plus functional resistance warm-up using Theraband (AF) on driver club head speed, driving distance, and driving accuracy in the amateur golfers. Fifteen amateur golfers with an average age of 19.67 +/- 0.89 years and 4.87 +/- 1.77 points of average handicap were assigned to participate in either AFPR, PR or AF program. All participants in the three programs practiced three sessions on non-consecutive days per week during the intervention phase. Each participant's performance was assessed before and after six weeks of the program through hitting ten maximal drives with the ball flight and swing analyzed using the P3ProSwing Golf Simulator and recorded for the driver club head speed, driving distance, and driving accuracy. Multivariate analysis of variance showed no statistically significant differences (P < .05) of the performances of the golfers participated in the 3 programs (club head speed: F = 1.02, P = 0.33; accuracy: F = 0.32, P = 0.72; distance: F = 0.18, P = 0.83). Furthermore, a paired t-tests also showed no statistically significant (P < .05) improvement occurred in the 3 programs after the six-week training. Although the effect of the 3 programs did not show statistically significant increase in the performance of the amateur golfers, however, the three parameters of the performance, i.e. the driver club head speed, the driving distance and the driving accuracy showed certain improvements. The 3 training programs may have benefit to the amateur golfers with certain increases of their performance.	[Yeemin, Wichai; Kemarat, Supatcharin; Theanthong, Apiluk] Thammasat Univ, Fac Allied Hlth Sci, Bangkok, Thailand	Thammasat University	Yeemin, W (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Bangkok, Thailand.	wichai.yee@allied.tu.ac.th		Yeemin, Wichai/0000-0002-4619-0335	Faculty of Allied Health Sciences, Thammasat University	Faculty of Allied Health Sciences, Thammasat University	This study was supported by a research grant from the Faculty of Allied Health Sciences, Thammasat University. The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anthi X., 2014, J PHYS ED SPORT, V14, P134, DOI [10.7752/jpes.2014.02021I, DOI 10.7752/JPES.2014.02021]; Beauchamp PH, 1996, SPORT PSYCHOL, V10, P157, DOI 10.1123/tsp.10.2.157; Boutcher S. H., 1992, ADV SPORT PSYCHOL, P251; BOUTCHER SH, 1987, INT J SPORT PSYCHOL, V18, P30; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Cohn P.J., 1990, SPORT PSYCHOL, V4, P33, DOI [https://doi.org/10.1123/tsp.4.1.33, DOI 10.1123/TSP.4.1.33]; Cotterill S., 2010, INT REV SPORT EXER P, V3, P132, DOI [10.1080/1750984X.2010.488269, DOI 10.1080/1750984X.2010.488269]; Cotterill ST, 2011, J SPORT PSYCHOL ACTI, V2, P81, DOI 10.1080/21520704.2011.584245; Cotterill ST, 2010, J APPL SPORT PSYCHOL, V22, P51, DOI 10.1080/10413200903403216; CREWS DJ, 1986, PERCEPT MOTOR SKILL, V62, P291, DOI 10.2466/pms.1986.62.1.291; Fradkin AJ, 2004, BRIT J SPORT MED, V38, P762, DOI 10.1136/bjsm.2003.009399; Gergley JC, 2009, J STRENGTH COND RES, V23, P863, DOI 10.1519/JSC.0b013e3181a00c67; Gordon BS, 2009, J STRENGTH COND RES, V23, P1606, DOI 10.1519/JSC.0b013e3181a3c39d; Gryc T., 2015, J PHYS ED SPORT, V15, P781; Hazell J, 2014, EUR J SPORT SCI, V14, P603, DOI 10.1080/17461391.2014.888484; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Lee S, 2015, PERCEPT MOTOR SKILL, V120, P673, DOI 10.2466/30.25.PMS.120v14x5; Lephart SM, 2007, J STRENGTH COND RES, V21, P860; Lobmeyer D.A.L., 1986, J SPORT BEHAV, V9, P70; Marshall Kelsey J, 2017, Int J Exerc Sci, V10, P954; *McCann P., 2001, EUR J SPORT SCI, V1, P1, DOI [10.1080/17461390100071503, DOI 10.1080/17461390100071503, https://doi.org/10.1080/17461390100071503]; Mesagno C, 2008, SPORT PSYCHOL, V22, P439, DOI 10.1123/tsp.22.4.439; Mesagno C, 2015, PSYCHOL SPORT EXERC, V19, P85, DOI 10.1016/j.psychsport.2015.03.005; Perkins-Ceccato N, 2003, J SPORT SCI, V21, P593, DOI 10.1080/0264041031000101980; Pochai P, 2015, J SPORTS SCI TECHNOL, V15, P123; Rixon KP, 2007, J STRENGTH COND RES, V21, P500, DOI 10.1519/00124278-200705000-00037; Singer R.N., 1988, SPORT PSYCHOL, P49, DOI [10.1123/tsp.2.1.49, DOI 10.1123/TSP.2.1.49]; Sommer M, 2009, J SPORT SCI MED, V8, P648; Tanaka Y, 2010, RES Q EXERCISE SPORT, V81, P416; Tilley NR, 2012, INT J SPORTS PHYS TH, V7, P388; Wen HY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152766; Wergin VV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228012; Xenofondos A., 2010, CITIUS ALTIUS FORTIU, V28, P32; Zois J, 2011, J SCI MED SPORT, V14, P522, DOI 10.1016/j.jsams.2011.03.012	34	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240881	10.1371/journal.pone.0240881	http://dx.doi.org/10.1371/journal.pone.0240881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3QJ	33079942	Green Published, gold			2022-12-26	WOS:000585940600027
J	Yuan, YJ; Ye, Z; Yu, H; Chen, Y; Wang, YW; Zhao, JH; Sun, JF; Xu, LM				Yuan, Ya-Jing; Ye, Zhi; Yu, Hao; Chen, Yang; Wang, Yu-Wen; Zhao, Jun-Hua; Sun, Ji-Feng; Xu, Li-Ming			Shrm4 contributes to autophagy inhibition and neuroprotection following ischemic stroke by mediating GABA(B)receptor activation	FASEB JOURNAL			English	Article						autophagy; baclofen; gamma-aminobutyric acid; gamma-aminobutyric acid receptor; ischemic stroke; middle cerebral artery occlusion; Shrm4	RECEPTOR AGONISTS; GABA; TRANSPORTERS; RECOVERY; PATHWAY; CELLS	Acute ischemic stroke is one of the leading causes of death in developed countries and the most common cause of disability in adults worldwide. Despite advances in the understanding of stroke pathophysiology, therapeutic options remain limited. In this study, we explored the interaction of Shrm4 and the metabotropic gamma-aminobutyric acid (GABA) receptors (GABA(B)) in ischemic stroke. A transient middle cerebral artery occlusion (MCAO) model was induced by filament insertion in Shrm4+/+ and wild-type C57BL/6J mice, followed by reperfusion for up to 7 days. Baclofen was administered was used to activate GABA(B)in vivo during reperfusion. Neurological deficits, motor and memory functions, and infarct volume were determined in the various mouse groups. Furthermore, we also developed an oxygen-glucose deprivation (OGD) cell model in primary neurons to test Shrm4/GABA(B)interactions in vitro. Shrm4 was observed to decrease infarct volume and neuronal cell loss in penumbra, and rescue neurological deficits in MCAO mice. Notably, Shrm4 also increased pole climbing speed, reduced foot faults, and increased escape latency in the Morris water maze test, while reducing neuron autophagy through an interaction with GABA(B)receptors. GABA(B)activation using baclofen further reduced OGD-induced neuron damage in culture and stroke outcomes of MCAO, relative to Shrm4 alone. Taken together, Shrm4-mediated GABA(B)activation confers neuroprotection by reducing neuronal autophagy in acute ischemic stroke.	[Yuan, Ya-Jing] Tianjin Med Univ Canc Inst & Hosp, Dept Anesthesia, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy,Tianjins Clin Res, Tianjin, Peoples R China; [Ye, Zhi] Ctr South Univ, Affiliated Xiangya Hosp, Dept Anesthesia, Changsha, Peoples R China; [Yu, Hao; Chen, Yang] Tianjin Med Univ Canc Inst & Hosp, Dept Radiotherapy, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 24 West Huan Hu Rd, Tianjin 300060, Peoples R China; [Wang, Yu-Wen; Zhao, Jun-Hua; Sun, Ji-Feng; Xu, Li-Ming] Tianjin Med Univ, Canc Hosp, Airport Hosp, Dept Radiotherapy, Tianjin, Peoples R China; [Xu, Li-Ming] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp,Key Lab Breast, Key Lab Canc Prevent & Therapy,Tianjins Clin Res, Dept Radiotherapy,Natl Clin Res Ctr Canc,Minist E, Tianjin, Peoples R China	Tianjin Medical University; Central South University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Xu, LM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Radiotherapy, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 24 West Huan Hu Rd, Tianjin 300060, Peoples R China.	limingxu2013@yeah.net	Ye, zhi/HGD-4616-2022		National Natural Science Foundation of China [81501140, 81502656]; Tianjin Health Bureau Fund [2012KZ072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Health Bureau Fund	This study was supported by the National Natural Science Foundation of China (No. 81501140 & No.81502656) and Tianjin Health Bureau Fund (2012KZ072).	Asadi H, 2015, INTERN MED J, V45, P798, DOI 10.1111/imj.12652; Badhiwala JH, 2015, JAMA-J AM MED ASSOC, V314, P1832, DOI 10.1001/jama.2015.13767; Baudel MASMA, 2017, J NEUROCHEM, V140, P195, DOI 10.1111/jnc.13901; Bishop BM, 2016, ANN PHARMACOTHER, V50, P219, DOI 10.1177/1060028015620199; Bowery NG, 2006, CURR OPIN PHARMACOL, V6, P37, DOI 10.1016/j.coph.2005.10.002; Brohan J, 2017, CNS DRUGS, V31, P845, DOI 10.1007/s40263-017-0463-7; Bush CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147287; Chen K, 2005, BRAIN RES BULL, V67, P310, DOI 10.1016/j.brainresbull.2005.07.004; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Hodor A, 2014, ANN CLIN TRANSL NEUR, V1, P765, DOI 10.1002/acn3.115; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jiang YJ, 2016, MOL MED REP, V13, P2060, DOI 10.3892/mmr.2016.4773; Khoshnam SE, 2017, NEUROL SCI, V38, P1167, DOI 10.1007/s10072-017-2938-1; Kokinovic B, 2018, J PHYSIOL-LONDON, V596, P1949, DOI 10.1113/JP275690; Li L, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0144219, 10.1371/journal.pone.0150898]; Lie MEK, 2017, ADV NEUROBIOL, V16, P137, DOI 10.1007/978-3-319-55769-4_7; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14474; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Onwuekwe IO, 2012, ANN MED HEALTH SCI R, V2, P186, DOI 10.4103/2141-9248.105669; Shehadah A, 2016, NEUROLOGY, V87, P450, DOI 10.1212/WNL.0000000000002925; Tian RH, 2020, MOL CELL BIOCHEM, V463, P115, DOI 10.1007/s11010-019-03634-4; Wang HB, 2019, RESTOR NEUROL NEUROS, V37, P315, DOI 10.3233/RNN-180827; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan HL, 2016, NEUROSCIENCE, V337, P191, DOI 10.1016/j.neuroscience.2016.09.017; Yoder M, 2007, CELL MOTIL CYTOSKEL, V64, P49, DOI 10.1002/cm.20167; Zapata J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14536; Zhang J, 2019, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001928.PUB3; Zhu XQ, 2015, MOL MED REP, V12, P5957, DOI 10.3892/mmr.2015.4207	30	6	7	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15837	15848		10.1096/fj.202000458RR	http://dx.doi.org/10.1096/fj.202000458RR		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33079458				2022-12-26	WOS:000581626000001
J	Oleszczuk, JD; Catalano, MI; Dalaison, L; Di Rienzo, JA; Pecci, MDG; Carpane, P				Oleszczuk, Jose Dario; Catalano, Maria Ines; Dalaison, Lucia; Di Rienzo, Julio Alejandro; Gimenez Pecci, Maria de la Paz; Carpane, Pablo			Characterization of components of resistance to Corn Stunt disease	PLOS ONE			English	Article							NEPHOTETTIX-VIRESCENS HOMOPTERA; SOGATELLA-FURCIFERA HOMOPTERA; HEMIPTERA CICADELLIDAE; WHITEBACKED PLANTHOPPER; SPIROPLASMA-KUNKELII; GREEN LEAFHOPPER; RICE VARIETIES; TUNGRO DISEASE; WILD-RICE; MAIZE	Corn Stunt is an important disease in the Americas due to it high prevalence and the yield reductions that can cause when present. However, changes in the presence of this disease across years hampers the effective identification of resistant genotypes to this disease. To avoid the limitations of phenotypic selection under natural pressure, this research aimed to devise an effective strategy to screen disease-resistant genotypes in the absence of high and constant natural pressures. To do so, we investigated the presence of antixenosis and antibiosis as components of resistance to the vectorDalbulus maidisas well as resistance to the pathogenSpiroplasma kunkeliiunder artificial inoculation conditions in four maize hybrids. The hybrids shown differences in their levels of resistance and target organisms, either the insect vector or the pathogen. Antixenosis and antibiosis toD.maidiswere observed in DK72-10. Resistance toS.kunkeliiby DK79-10 was seen as a delayed onset of symptoms, and DKB390 showed antixenosis toD.maidisand resistance toS.kunkelii. An association between symptom severity and yield reduction was found, but not between accumulation of pathogenS.kunkeliiand symptom severity nor yield. In conclusion, the proposed methodology was efficacious and can aid in the screening of resistant genotypes in breeding programs to reduce the impact of Corn Stunt disease, ensuring that hybrids with good resistance level will be planted by farmers whenever disease occurs.	[Oleszczuk, Jose Dario; Carpane, Pablo] Bayer Argentina, Fontezuela, Buenos Aires, Argentina; [Catalano, Maria Ines; Dalaison, Lucia] Ctr Invest Biol CEBIO, Pergamino, Buenos Aires, Argentina; [Di Rienzo, Julio Alejandro] Univ Nacl Cordoba, Fac Ciencias Agr, Catedra Estadist & Biometria, Cordoba, Argentina; [Gimenez Pecci, Maria de la Paz] Inst Patol Vegetal IPAVE, Inst Nacl Tecnol Agr INTA, Cordoba, Argentina	National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Carpane, P (corresponding author), Bayer Argentina, Fontezuela, Buenos Aires, Argentina.	pablo.carpane@bayer.com		Catalano, Maria Ines/0000-0002-8382-7403	Bayer CropScience Argentina	Bayer CropScience Argentina(Bayer AG)	Bayer CropScience Argentina provided support for this study in the form of salaries fro JO and PC and the expenses related directly to implement the experiments (supplies, mobility, meals, etc.). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIVIZATOS AS, 1986, ANN APPL BIOL, V108, P535, DOI 10.1111/j.1744-7348.1986.tb01992.x; Altstatt George E, 1945, PLANT DIS REPORTER, V29, P533; [Anonymous], 2003, ALLEGORIA, Vxv, p[65, 72]; [Anonymous], 2003, AIR SPACE LAW, V28, P280; Azzam O, 2002, PLANT DIS, V86, P88, DOI 10.1094/PDIS.2002.86.2.88; BAJET NB, 1989, PLANT DIS, V73, P926, DOI 10.1094/PD-73-0926; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BRADFUTE OE, 1981, PLANT DIS, V65, P837, DOI 10.1094/PD-65-837; Carloni E, 2013, J ECON ENTOMOL, V106, P1574, DOI 10.1603/EC12323; Carloni E, 2011, J ECON ENTOMOL, V104, P1793, DOI 10.1603/EC11156; Carloni E, 2010, THESIS; Caro LA, 2009, P 13 JORN FIT ARG 20, P12; Caro LA, 2008, P 1 C ARG FIT 2008 M, P336; Carpane P, 2006, MAYDICA, V51, P461; Carpane P, 2007, THESIS; Carpane P, 2013, PHYTOPATHOLOGY, V103, P129, DOI 10.1094/PHYTO-07-12-0158-R; CHENG CH, 1972, J ECON ENTOMOL, V65, P1148, DOI 10.1093/jee/65.4.1148; Costamagna AC, 2005, J ECON ENTOMOL, V98, P1374, DOI 10.1603/0022-0493-98.4.1374; De Oliveira CM, 2013, FLA ENTOMOL, V96, P1470, DOI 10.1653/024.096.0427; de Oliveira E, 2003, PESQUI AGROPECU BRAS, V38, P19, DOI 10.1590/S0100-204X2003000100003; Di Rienzo JA, 2002, J AGRIC BIOL ENVIR S, V7, P129, DOI 10.1198/10857110260141193; Frazier Norman W., 1945, PLANT DIS REPORTER, V29, P212; GAMEZ R, 1973, ANN APPL BIOL, V73, P285, DOI 10.1111/j.1744-7348.1973.tb00935.x; Gimenez Pecci MP, 2014, ESCUELA MATEMATICA A, P46; Gimenez PM, 2002, REV FACULTAD AGRONOM, V105, P1; Gomez LG, 2012, ENFERMEDADES MAIZ PR, P25; GUSSIE JS, 1995, PHYTOPATHOLOGY, V85, P1093, DOI 10.1094/Phyto-85-1093; HAO GTF, 1970, J ECON ENTOMOL, V63, P924, DOI 10.1093/jee/63.3.924; HEINRICHS EA, 1983, ENVIRON ENTOMOL, V12, P201, DOI 10.1093/ee/12.1.201; HEINRICHS EA, 1983, ENVIRON ENTOMOL, V12, P1793, DOI 10.1093/ee/12.6.1793; HIBINO H, 1987, PHYTOPATHOLOGY, V77, P871, DOI 10.1094/Phyto-77-871; Hidalgo H., 1998, Agronomia Mesoamericana, V9, P119; HOGENBOOM NG, 1993, CURR PLANT SCI BIOT, V18, P5; Hruska AJ, 1997, J ECON ENTOMOL, V90, P604, DOI 10.1093/jee/90.2.604; Hruska Allan J., 1996, American Entomologist, V42, P248; KARIM ANMR, 1991, J ECON ENTOMOL, V84, P1208, DOI 10.1093/jee/84.4.1208; KAWABE S, 1985, JARQ-JPN AGR RES Q, V19, P115; KHAN ZR, 1985, J ECON ENTOMOL, V78, P1280, DOI 10.1093/jee/78.6.1280; KUNKEL LO, 1946, P NATL ACAD SCI USA, V32, P246, DOI 10.1073/pnas.32.9.246; Laguna I., 2004, B SANIDAD VEGETAL PL, V30, P257; LENARDON SL, 1993, PLANT DIS, V77, P100, DOI 10.1094/PD-77-0100C; Massola Junior Nelson S., 1999, Fitopatologia Brasileira, V24, P571; Massola Nelson S. Jr., 1999, Summa Phytopathologica, V25, P356; Mendoza-Elos Mariano, 2002, Revista Mexicana de Fitopatologia, V20, P13; NAULT LR, 1990, MAYDICA, V35, P165; NAULT LR, 1980, PHYTOPATHOLOGY, V70, P659, DOI 10.1094/Phyto-70-659; Okuda M, 2019, PHYTOPATHOLOGY, V109, P701, DOI 10.1094/PHYTO-07-18-0277-R; Oliveira E, 2002, REV BRASILEIRA MILHO, V1, P53; Oliveira Elizabeth, 1998, Fitopatologia Brasileira, V23, P45; Paradell Susana L., 2001, Boletin de Sanidad Vegetal Plagas, V27, P465; R Core Team, 2020, R LANG ENV STAT COMP; Robledo C., 2018, INFOSTAT VERSION 201; Rodriguez EA, 1988, P 1 REUN CIENT AGR A, P17; SAXENA RC, 1987, INSECT SCI APPL, V8, P731, DOI 10.1017/S1742758400022840; Scott G, 1977, CROP SCI, V14, P758; SCOTT GE, 1977, AGRON J, V69, P92, DOI 10.2134/agronj1977.00021962006900010024x; Shibata Y, 2007, PLANT DIS, V91, P1386, DOI 10.1094/PDIS-91-11-1386; SOGAWA K, 1970, Applied Entomology and Zoology, V5, P145; SUTULA CL, 1986, PLANT DIS, V70, P722, DOI 10.1094/PD-70-722; Venables WN., 2002, MODERN APPL STAT S, V4; Virla E., 1992, Revista de la Facultad de Agronomia Universidad Nacional de La Plata, V66-67, P23; Virla E.G., 2003, Boletin de Sanidad Vegetal Plagas, V29, P17; YE ZH, 1990, CROP SCI, V30, P1178, DOI 10.2135/cropsci1990.0011183X003000060003x	63	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0234454	10.1371/journal.pone.0234454	http://dx.doi.org/10.1371/journal.pone.0234454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075073	Green Published, gold, Green Submitted			2022-12-26	WOS:000585920200018
J	Huang, CW; Su, WC; Yin, TC; Chen, PJ; Chang, TK; Chen, YC; Li, CC; Hsieh, YC; Tsai, HL; Wang, JY				Huang, Ching-Wen; Su, Wei-Chih; Yin, Tzu-Chieh; Chen, Po-Jung; Chang, Tsung-Kun; Chen, Yen-Cheng; Li, Ching-Chun; Hsieh, Yi-Chien; Tsai, Hsiang-Lin; Wang, Jaw-Yuan			Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I-III rectal cancer undergoing preoperative chemoradiotherapy	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; NEOADJUVANT CHEMORADIOTHERAPY; SHORT-TERM; POSTOPERATIVE CHEMORADIOTHERAPY; GERMAN CAO/ARO/AIO-04; RANDOMIZED-TRIAL; LOCAL RECURRENCE; OPEN-LABEL; CHEMORADIATION	Background This aim of this study was to evaluate the effects of time interval between the completion of radiotherapy and robotic-assisted surgery on the outcomes among patients with rectal cancer undergoing preoperative concurrent chemoradiotherapy (CCRT). Methods In total, 116 patients with stage I-III rectal cancer who underwent preoperative CCRT and robotic-assisted surgery between September 2013 and February 2019 were enrolled. Patients were categorized into two groups based on the time interval: group A (10-12 weeks) and group B (>= 12 weeks). Results Among the 116 enrolled patients, 98 (84.5%) had middle and lower rectal cancers. Two (1.7%) patients underwent abdominoperineal resection with a sphincter preservation rate of 98.3%. Thirty-seven (31.9%) patients had a pathologic complete response (pCR). The circumferential resection margin and distal resection margin were positive in 2 (1.7%) and 1 (0.9%) patients, respectively. Therefore, the R0 resection rate was 97.4%. A total of 24 (22.4%) patients experienced postoperative relapse and 12 (10.3%) patients died; these were slightly more common in group B than in group A (28.8% vs 15.8% and 15.3% vs 5.3%, respectively; bothP> 0.05); however, this difference was nonsignificant. Three-year disease-free survival (DFS) and overall survival (OS) were 75% and 89%, respectively, among all patients. Non-significant trend of favorable 3-year DFS, 3-year OS, 3-year locoregional control rate and 3-year distant metastasis control rate were observed in group A compared with group B (allP> 0.05). Conclusion Robotic-assisted surgery after a longer interval is safe and feasible for patients with rectal cancer undergoing preoperative CCRT. The present study's results suggested that the time interval of 10-12 weeks can be considered because comparable clinical and perioperative outcomes and preferable oncological outcomes were observed for interval of this length. However, future prospective randomized clinical trials are required to verify the present finding.	[Huang, Ching-Wen; Su, Wei-Chih; Yin, Tzu-Chieh; Chen, Po-Jung; Chang, Tsung-Kun; Chen, Yen-Cheng; Li, Ching-Chun; Hsieh, Yi-Chien; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Surg,Fac Med, Kaohsiung, Taiwan; [Yin, Tzu-Chieh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gen & Digest Surg, Kaohsiung, Taiwan; [Yin, Tzu-Chieh] Kaohsiung Med Univ, Kaohsiung Municipal Tatung Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Po-Jung] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Taipei Med Univ, Sch Pharm, Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Taipei Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Dept Surg,Fac Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Sch Pharm, Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan.	cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Chang, Tsung-Kun/0000-0001-9760-5070	Ministry of Science and Technology [MOST108-2321-B-037-001, MOST107-2321-B-037-003, MOST107-2314-B-037-116, MOST107-2314-B-037-022-MY2, MOST107-2314-B-037-023-MY2]; Ministry of Health and Welfare - Health and welfare surcharge of tobacco products [MOHW107-TDU-B-212-123006, MOHW107-TDU-B-212-114026B, MOHW108-TDU-B-212-133006, MOHW108-TDU-B-212-124026]; Kaohsiung Medical University Hospital [KMUH106-6M29, KMUH107-7R28, KMUH108-8R34, KMUH108-8R35, KMUH108-8M33, KMUH108-8M35, KMUH108-8M36, KMUHS10801, KMUHS10804, KMUHS10807, KMUH-DK109005similar to3]; Center for Cancer Research, Kaohsiung Medical University [KMU-TC108A04]; Grant of Taiwan Precision Medicine Initiative, Academia Sinica, Taiwan, R.O.C	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare - Health and welfare surcharge of tobacco products; Kaohsiung Medical University Hospital; Center for Cancer Research, Kaohsiung Medical University; Grant of Taiwan Precision Medicine Initiative, Academia Sinica, Taiwan, R.O.C	This study was supported by grants through funding from the Ministry of Science and Technology (MOST108-2321-B-037-001, MOST107-2321-B-037-003, MOST107-2314-B-037-116, MOST107-2314-B-037-022-MY2, MOST107-2314-B-037-023-MY2) and the Ministry of Health and Welfare (MOHW107-TDU-B-212-123006, MOHW107-TDU-B-212-114026B, MOHW108-TDU-B-212-133006, MOHW108-TDU-B-212-124026), which are funded by the Health and welfare surcharge of tobacco products, as well as the Kaohsiung Medical University Hospital (KMUH106-6M29, KMUH107-7R28, KMUH108-8R34, KMUH108-8R35, KMUH108-8M33, KMUH108-8M35, KMUH108-8M36, KMUHS10801, KMUHS10804, KMUHS10807, KMUH-DK109005 similar to 3) and the Center for Cancer Research, Kaohsiung Medical University (KMU-TC108A04). In addition, this study was supported by the Grant of Taiwan Precision Medicine Initiative, Academia Sinica, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002102.pub3; [Anonymous], 2006, CHEM ENG PROCESSING, V32, P162; Baek JH, 2011, SURG ENDOSC, V25, P521, DOI 10.1007/s00464-010-1204-x; BOSSE, 2005, J CLIN ONCOL, V0023, P05620, DOI DOI 10.1200/JCO.2005.02.113; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Chen YT, 2020, BMC SURG, V20, DOI 10.1186/s12893-020-0687-1; Deng YH, 2016, J CLIN ONCOL, V34, P3300, DOI 10.1200/JCO.2016.66.6198; Dolinsky CM, 2007, J SURG ONCOL, V96, P207, DOI 10.1002/jso.20815; Du DL, 2018, CLIN COLORECTAL CANC, V17, P13, DOI 10.1016/j.clcc.2017.10.012; Edge SB., 2010, AJCC CANC STAGING MA, P143; Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396; Fu XL, 2017, ONCOTARGET, V8, P34340, DOI 10.18632/oncotarget.16127; Garcia-Aguilar J, 2003, DIS COLON RECTUM, V46, P298, DOI 10.1007/s10350-004-6545-x; Garcia-Aguilar J, 2015, LANCET ONCOL, V16, P957, DOI 10.1016/S1470-2045(15)00004-2; Garcia-Aguilar J, 2011, ANN SURG, V254, P97, DOI 10.1097/SLA.0b013e3182196e1f; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hellan M, 2015, ANN SURG ONCOL, V22, P2151, DOI 10.1245/s10434-014-4278-1; Huang CW, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0315-x; Huang CM, 2016, THER ADV GASTROENTER, V9, P702, DOI 10.1177/1756283X16656690; Huang MY, 2020, KAOHSIUNG J MED SCI, V36, P152, DOI 10.1002/kjm2.12161; Huh JW, 2008, WORLD J SURG, V32, P1116, DOI 10.1007/s00268-008-9520-1; Jayne D, 2017, JAMA-J AM MED ASSOC, V318, P1569, DOI 10.1001/jama.2017.7219; Jones K, 2018, WORLD J GASTRO ONCOL, V10, P449, DOI 10.4251/wjgo.v10.i11.449; Kane C, 2019, CANCER TREAT REV, V81, DOI 10.1016/j.ctrv.2019.101908; Kim JY, 2012, ANN SURG ONCOL, V19, P2485, DOI 10.1245/s10434-012-2262-1; Law WL, 2017, SURG ENDOSC, V31, P2798, DOI 10.1007/s00464-016-5289-8; Lefevre JH, 2019, ANN SURG, V270, P747, DOI 10.1097/SLA.0000000000003530; Lefevre JH, 2016, J CLIN ONCOL, V34, P3773, DOI 10.1200/JCO.2016.67.6049; Lichthardt S, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6538-8; Lim DR, 2017, SURG ENDOSC, V31, P1728, DOI 10.1007/s00464-016-5165-6; Lim SB, 2008, ANN SURG, V248, P243, DOI 10.1097/SLA.0b013e31817fc2a0; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Mace AG, 2015, DIS COLON RECTUM, V58, P32, DOI 10.1097/DCR.0000000000000266; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; Petrelli F, 2016, ANN SURG, V263, P458, DOI 10.1097/SLA.0000000000000368; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Rodel C, 2015, LANCET ONCOL, V16, P979, DOI 10.1016/S1470-2045(15)00159-X; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Rouanet P, 2018, ANN SURG ONCOL, V25, P3572, DOI 10.1245/s10434-018-6738-5; Roxburgh CSD, 2019, ANN SURG ONCOL, V26, P2019, DOI 10.1245/s10434-019-07340-9; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Sloothaak DAM, 2013, BRIT J SURG, V100, P933, DOI 10.1002/bjs.9112; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Yang YJ, 2016, ONCOTARGET, V7, P45513, DOI 10.18632/oncotarget.9995	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240742	10.1371/journal.pone.0240742	http://dx.doi.org/10.1371/journal.pone.0240742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064768	gold, Green Published			2022-12-26	WOS:000585918300042
J	Jiao, J; Hu, XL; Huang, YH; Hu, JY; Hsing, C; Lai, ZQ; Wong, C; Xin, JH				Jiao, Jiao; Hu, Xiaoling; Huang, Yanhuan; Hu, Junyan; Hsing, Chihchia; Lai, Zhangqi; Wong, Calvin; Xin, John H.			Neuro-perceptive discrimination on fabric tactile stimulation by Electroencephalographic (EEG) spectra	PLOS ONE			English	Article							GAMMA-BAND; SYNCHRONIZATION	The precise evaluation of sensory perceptions during fabric-skin interactions is still poorly understood in neuroscience. This study aims to investigate the cortical sensory response to fabric stimuli with different textiles by Electroencephalographic (EEG) spectral intensities, and evaluate the relationships between EEG frequency bands, traditional subjective questionnaires, and the materials' physical properties. Twelve healthy adult participants were recruited to test three fabrics with different textile compositions of 1) cotton, 2) nylon, and 3) polyester and wool. The physical properties of the fabrics were quantitatively evaluated by a Fabric Touch Tester (FTT). Subjects were invited to rate the sensory perception of the fabric samples via a subjective questionnaire and objective EEG recording. Significant differences in the EEG relative spectral power of Theta and Gamma bands were acquired in response to the different fabric stimuli (P0.05). The Theta and Gamma powers demonstrated a significant correlation with the most of the subjective sensations evaluated by questionnaire and the fabrics' physical properties by FTT (P0.05). The EEG spectral analysis could feasibly be used for the discrimination of fabric stimuli with different textile compositions and further indicates sensory perceptions during fabric stimulation. This finding may provide evidence for further exploratory research of sensory perceptions via EEG spectral analysis, which could be applied to the study of brain generators of skin tactility in future prostheses and the automatic detection of sensory perception in industries.	[Jiao, Jiao; Hu, Junyan; Wong, Calvin; Xin, John H.] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Peoples R China; [Hu, Xiaoling; Huang, Yanhuan; Hsing, Chihchia; Lai, Zhangqi] Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China; [Jiao, Jiao] Hong Kong Baptist Univ, Dr Stephen Hui Res Ctr Phys Recreat & Wellness, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong Baptist University	Xin, JH (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Peoples R China.	john.xin@polyu.edu.hk		XIN, John Haozhong/0000-0001-9965-7421; Hu, Xiaoling/0000-0003-3188-3005	PolyU Central Fund from Department of Biomedical Engineering [BME-1-ZE4R, NSFC 81771959]; Institute of Textiles and Clothing of Hong Kong Polytechnic University [ITC-4-ZZFS]	PolyU Central Fund from Department of Biomedical Engineering; Institute of Textiles and Clothing of Hong Kong Polytechnic University	Funding: This work was supported by the PolyU Central Fund from Department of Biomedical Engineering [grant number: BME-1-ZE4R, NSFC 81771959] and Institute of Textiles and Clothing [grant number: ITC-4-ZZFS] of The Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EP5 FABR HAND GUID S; Asayesh A, 2018, J TEXT I, V109, P32, DOI 10.1080/00405000.2017.1320817; Caliandro P, 2017, NEUROREHAB NEURAL RE, V31, P81, DOI 10.1177/1545968316662525; Chand GB, 2017, NEUROIMAGE, V152, P381, DOI 10.1016/j.neuroimage.2017.03.014; Collins IJ, 2019, LANCET HIV, V6, pE105, DOI 10.1016/S2352-3018(18)30319-9; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Hauck M, 2007, J NEUROSCI, V27, P9270, DOI 10.1523/JNEUROSCI.2283-07.2007; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hoefer D, 2016, SKIN RES TECHNOL, V22, P470, DOI 10.1111/srt.12288; Hu JY, 2006, POLYM TEST, V25, P1081, DOI 10.1016/j.polymertesting.2006.07.008; Im CH, 2018, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-981-13-0908-3; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Lee KH, 2003, BRAIN RES REV, V41, P57, DOI 10.1016/S0165-0173(02)00220-5; Liao X, 2016, J SENS STUD, V31, P181, DOI 10.1111/joss.12189; Liao X, 2014, FIBER POLYM, V15, P1548, DOI 10.1007/s12221-014-1548-2; Luck SJ, 2017, PSYCHOPHYSIOLOGY, V54, P146, DOI 10.1111/psyp.12639; Michail G, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00182; Nuwer MR, 1999, ELECTROENCEPHALOGR S; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Quantification Pan N., 2006, INT J DESIGN NATURE, V1, P48, DOI [10.1136/bmj.323.7326.1389, DOI 10.1136/BMJ.323.7326.1389]; Respiratory care committee of Chinese Thoracic Society, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V17, pE020, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Romo R, 2013, PROG NEUROBIOL, V103, P41, DOI 10.1016/j.pneurobio.2012.03.007; Singh H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00893; Song WG, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00064; Tozum MS, 2016, J TEXT I, V107, P1203, DOI 10.1080/00405000.2015.1099374; Wang YY, 2014, FIBRES TEXT EAST EUR, V22, P102; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Yin J., 1998, GEOTECH ENG, V29, P29	28	1	1	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241378	10.1371/journal.pone.0241378	http://dx.doi.org/10.1371/journal.pone.0241378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112925	gold, Green Published			2022-12-26	WOS:000588374000033
J	Garg, PK; Putegnat, B; Truong, L; Reynolds, C; Sanchez, I; Nedrelow, JK; Uffman, J; Lokitz, SJ; Nazih, R; Garg, S; Thornton, PS				Garg, Pradeep K.; Putegnat, Burton; Truong, Lisa; Reynolds, Courtney; Sanchez, Irene; Nedrelow, Jonathan K.; Uffman, John; Lokitz, Stephen J.; Nazih, Rachid; Garg, Sudha; Thornton, Paul S.			Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BETA-CELL HYPERPLASIA; SURGICAL-MANAGEMENT; HYPOGLYCEMIA; INFANCY; PANCREATECTOMY; DIAGNOSIS; LOCALIZATION; OCTREOTIDE; TERM	Introduction Congenital hyperinsulinism is characterized by abnormal regulation of insulin secretion from the pancreas causing profound hypoketotic hypoglycemia and is the leading cause of persistent hypoglycemia in infants and children. The main objective of this study is to highlight the different mechanisms to interpret the F-18-DOPA PET scans and how this can influence outcomes. Materials and methods After F-18-Fluoro-L-DOPA was injected intravenously into 50 subjects' arm at a dose of 2.96-5.92 MBq/kg, three to four single-bed position PET scans were acquired at 20, 30, 40 and 50-minute post injection. The radiologist interpreted the scans for focal and diffuse hyperinsulinism using a visual interpretation method, as well as determining the Standard Uptake Value ratios with varying cut-offs. Results Visual interpretation had the combination of the best sensitivity and positive prediction values. Conclusions In patients with focal disease, SUV ratios are not as accurate in identifying the focal lesion as visual inspection, and cases of focal disease may be missed by those relying on SUV ratios, thereby denying the patients a chance of cure. We recommend treating patients with diazoxide-resistant hyperinsulinism in centers with dedicated multidisciplinary team comprising of at least a pediatric endocrinologist with a special interest in hyperinsulinism, a radiologist experienced in interpretation of F-18-Fluoro-L-DOPA PET/CT scans, a histopathologist with experience in frozen section analysis of the pancreas and a pancreatic surgeon experienced in partial pancreatectomies in patients with hyperinsulinism.	[Garg, Pradeep K.; Lokitz, Stephen J.; Nazih, Rachid; Garg, Sudha] Biomed Res Fdn, Ctr Mol Imaging & Therapy, Shreveport, LA 71103 USA; [Putegnat, Burton; Truong, Lisa; Reynolds, Courtney; Sanchez, Irene; Nedrelow, Jonathan K.; Uffman, John; Thornton, Paul S.] Cook Childrens Med Ctr, Ft Worth, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Cook Children's Medical Center	Garg, PK (corresponding author), Biomed Res Fdn, Ctr Mol Imaging & Therapy, Shreveport, LA 71103 USA.	Pradeep.Garg@cmitla.org		Reynolds, Courtney/0000-0001-9487-2667; Garg, Pradeep/0000-0002-8874-7082	Center for Molecular Imaging and Therapy, the Biomedical Research Foundation of Northwest Louisiana [CMIT-2016.1]; Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism	Center for Molecular Imaging and Therapy, the Biomedical Research Foundation of Northwest Louisiana; Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism	The Center for Molecular Imaging and Therapy, the Biomedical Research Foundation of Northwest Louisiana (CMIT-2016.1) to PKG.The Cook Children's Health Care System, Fort Worth, TX Endowed Chair for Hyperinsulinism (PT). The funders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adzick NS, 2004, J PEDIATR SURG, V39, P270, DOI 10.1016/j.jpedsurg.2003.11.019; Arnoux JB, 2010, EARLY HUM DEV, V86, P287, DOI 10.1016/j.earlhumdev.2010.05.003; Barthlen W, 2008, J CLIN ENDOCR METAB, V93, P869, DOI 10.1210/jc.2007-2036; Barthlen W, 2011, HORM RES PAEDIAT, V75, P304, DOI 10.1159/000323532; Becherer A, 2004, J NUCL MED, V45, P1161; Beltrand J, 2012, DIABETES CARE, V35, P198, DOI 10.2337/dc11-1296; Blomberg BA, 2013, MOL IMAGING BIOL, V15, P1, DOI 10.1007/s11307-012-0593-8; Borelli MI, 1997, DIABETES METAB, V23, P161; Cherian MP, 2005, J PEDIATR ENDOCR MET, V18, P1441; Christiansen CD, 2018, EUR J NUCL MED MOL I, V45, P250, DOI 10.1007/s00259-017-3867-1; Cretolle C, 2002, J PEDIATR SURG, V37, P155, DOI 10.1053/jpsu.2002.30241; de Lonlay-Debeney P, 1999, NEW ENGL J MED, V340, P1169, DOI 10.1056/NEJM199904153401505; Doyle ME, 2003, PHARMACOL REV, V55, P105, DOI 10.1124/pr.55.1.7; DUBOIS J, 1995, PEDIATR RADIOL, V25, P512, DOI 10.1007/BF02015782; Fekete N, 2004, J PEDIATR SURG, V39, P267, DOI 10.1016/j.jpedsurg.2003.11.004; Garg PK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186340; GLASER B, 1993, J PEDIATR-US, V123, P644, DOI 10.1016/S0022-3476(05)80970-9; Hardy OT, 2007, J CLIN ENDOCR METAB, V92, P4706, DOI 10.1210/jc.2007-1637; Hardy OT, 2007, J PEDIATR-US, V150, P140, DOI 10.1016/j.jpeds.2006.08.028; Huang Q, 2007, ENDOCRINOLOGY, V148, P81, DOI 10.1210/en.2006-0738; Hussain Khalid, 2004, Pediatr Endocrinol Rev, V2 Suppl 1, P163; Iatrou M, 2004, IEEE NUCL SCI CONF R, P2493; Jakoby BW, 2011, PHYS MED BIOL, V56, P2375, DOI 10.1088/0031-9155/56/8/004; Kauhanen S, 2008, J CLIN ONCOL, V26, P5307, DOI 10.1200/JCO.2008.18.8581; Kauhanen S, 2007, J CLIN ENDOCR METAB, V92, P1237, DOI 10.1210/jc.2006-1479; Laje P, 2013, J PEDIATR SURG, V48, P388, DOI 10.1016/j.jpedsurg.2012.11.025; LINDSTROM P, 1986, BIOCHIM BIOPHYS ACTA, V884, P276, DOI 10.1016/0304-4165(86)90174-1; McMahon AW, 2017, PHARMACOEPIDEM DR S, V26, P26, DOI 10.1002/pds.4144; Mohnike K, 2008, HORM RES, V70, P65, DOI 10.1159/000137655; Otonkoski T, 2006, DIABETES, V55, P13, DOI 10.2337/diabetes.55.01.06.db05-1128; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; PANTEN U, 1989, BIOCHEM PHARMACOL, V38, P1217, DOI 10.1016/0006-2952(89)90327-4; Pierro A, 2011, SEMIN PEDIATR SURG, V20, P50, DOI 10.1053/j.sempedsurg.2010.10.009; RAHIER J, 1984, DIABETOLOGIA, V26, P282; Rahier J, 1998, HISTOPATHOLOGY, V32, P15; Ribeiro MJ, 2007, EUR J NUCL MED MOL I, V34, P2120, DOI 10.1007/s00259-007-0498-y; Shilyansky J, 1997, J PEDIATR SURG, V32, P342, DOI 10.1016/S0022-3468(97)90207-4; Souza F, 2006, CURR MED CHEM, V13, P2761, DOI 10.2174/092986706778521940; Stanley CA, 2004, J CLIN ENDOCR METAB, V89, P288, DOI 10.1210/jc.2003-030965; Suchi M, 2003, PEDIATR DEVEL PATHOL, V6, P322, DOI 10.1007/s10024-002-0026-9; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; Thornton P, 2019, HORM RES PAEDIAT, V91, P25, DOI 10.1159/000497458; THORNTON PS, 1993, J PEDIATR-US, V123, P637, DOI 10.1016/S0022-3476(05)80969-2; von Rohden L, 2011, SEMIN PEDIATR SURG, V20, P28, DOI 10.1053/j.sempedsurg.2010.10.011; Wagner FM, 2009, J NUCL MED, V50, P1724, DOI 10.2967/jnumed.109.063297	45	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241243	10.1371/journal.pone.0241243	http://dx.doi.org/10.1371/journal.pone.0241243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108363	gold, Green Published			2022-12-26	WOS:000588372400012
J	Egorova, MA; Akimov, AG; Khorunzhii, GD; Ehret, G				Egorova, Marina A.; Akimov, Alexander G.; Khorunzhii, Gleb D.; Ehret, Guenter			Frequency response areas of neurons in the mouse inferior colliculus. III. Time-domain responses: Constancy, dynamics, and precision in relation to spectral resolution, and perception in the time domain	PLOS ONE			English	Article							AUDITORY MIDBRAIN; CENTRAL NUCLEUS; INTRINSIC-PROPERTIES; GAP DETECTION; HOUSE MOUSE; DURATION DISCRIMINATION; COMMUNICATION CALLS; DISCHARGE PATTERNS; IDENTIFIED NEURONS; SPEECH-PERCEPTION	The auditory midbrain (central nucleus of inferior colliculus, ICC) receives multiple brainstem projections and recodes auditory information for perception in higher centers. Many neural response characteristics are represented in gradients (maps) in the three-dimensional ICC space. Map overlap suggests that neurons, depending on their ICC location, encode information in several domains simultaneously by different aspects of their responses. Thus, interdependence of coding, e.g. in spectral and temporal domains, seems to be a general ICC principle. Studies on covariation of response properties and possible impact on sound perception are, however, rare. Here, we evaluated tone-evoked single neuron activity from the mouse ICC and compared shapes of excitatory frequency-response areas (including strength and shape of inhibition within and around the excitatory area; classes I, II, III) with types of temporal response patterns and first-spike response latencies. Analyses showed covariation of sharpness of frequency tuning with constancy and precision of responding to tone onsets. Highest precision (first-spike latency jitter < 1 ms) and stable phasic responses throughout frequency-response areas were the quality mainly of class III neurons with broad frequency tuning, least influenced by inhibition. Class II neurons with narrow frequency tuning and dominating inhibitory influence were unsuitable for time domain coding with high precision. The ICC center seems specialized rather for high spectral resolution (class II presence), lateral parts for constantly precise responding to sound onsets (class III presence). Further, the variation of tone-response latencies in the frequency-response areas of individual neurons with phasic, tonic, phasic-tonic, or pauser responses gave rise to the definition of a core area, which represented a time window of about 20 ms from tone onset for tone-onset responding of the whole ICC. This time window corresponds to the roughly 20 ms shortest time interval that was found critical in several auditory perceptual tasks in humans and mice.	[Egorova, Marina A.; Akimov, Alexander G.; Khorunzhii, Gleb D.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia; [Ehret, Guenter] Univ Ulm, Inst Neurobiol, Ulm, Germany	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Ulm University	Ehret, G (corresponding author), Univ Ulm, Inst Neurobiol, Ulm, Germany.	guenter.ehret@uni-ulm.de		Egorova, Marina/0000-0002-4216-6469; Ehret, Gunter/0000-0002-1201-4878	Russian Foundation for Basic Research [06-0448616, 18-015-00188]; VW foundation [I/69589]; Deutsche Forschungsgemeinschaft [EH 53/16-1, EH 53/22-1];  [AAAA-A18-118013090245-6]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); VW foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This study was supported by the Russian Foundation for Basic Research (projects 06-0448616 and 18-015-00188), by the state budget for state orders for 2018-2020 (state registration #AAAA-A18-118013090245-6). It was also supported by grants of the VW foundation (I/69589), and by the Deutsche Forschungsgemeinschaft to GE: EH 53/16-1, 22-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL SM, 1972, J ACOUST SOC AM, V51, P1219, DOI 10.1121/1.1912963; AITKIN LM, 1985, J NEUROPHYSIOL, V53, P43, DOI 10.1152/jn.1985.53.1.43; Akimov AG, 2017, EUR J NEUROSCI, V45, P440, DOI 10.1111/ejn.13488; [Anonymous], 1997, Healthc Demand Dis Manag, V3, P135; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.10.001; Bal R, 2002, NEUROSCI LETT, V317, P42, DOI 10.1016/S0304-3940(01)02425-9; Basta D, 2003, BRAIN RES, V968, P171, DOI 10.1016/S0006-8993(03)02233-9; Baumann S, 2011, NAT NEUROSCI, V14, P423, DOI 10.1038/nn.2771; BOCK GR, 1972, J NEUROPHYSIOL, V35, P265, DOI 10.1152/jn.1972.35.2.265; Brand A, 2000, J NEUROPHYSIOL, V84, P1790, DOI 10.1152/jn.2000.84.4.1790; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Cant NB, 2006, J COMP NEUROL, V495, P511, DOI 10.1002/cne.20888; Casseday JH, 2002, SPR HDB AUD, V15, P238; Casseday JH, 2000, J NEUROPHYSIOL, V84, P1475, DOI 10.1152/jn.2000.84.3.1475; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chen C, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2005861; COVEY E, 1991, J NEUROSCI, V11, P3456; DARWIN CJ, 1984, Q J EXP PSYCHOL-A, V36, P193, DOI 10.1080/14640748408402155; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Egorova M, 2001, EXP BRAIN RES, V140, P145, DOI 10.1007/s002210100786; Egorova MA, 2018, J EVOL BIOCHEM PHYS+, V54, P482, DOI 10.1134/S002209301806008X; Egorova M, 2008, EUR J NEUROSCI, V28, P675, DOI 10.1111/j.1460-9568.2008.06376.x; Ehret G, 2005, AUDITORY SIGNAL PROCESSINGP: PHYSIOLOGY, PSYCHOACOUSTICS, AND MODELS, P162, DOI 10.1007/0-387-27045-0_20; EHRET G, 1985, J COMP PHYSIOL A, V156, P619, DOI 10.1007/BF00619111; Ehret G, 2005, INFERIOR COLLICULUS, P312, DOI 10.1007/0-387-27083-3_11; Ehret G, 2003, NEUROREPORT, V14, P1365, DOI 10.1097/01.wnr.0000078545.07662.85; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; EHRET G, 1988, BRAIN RES REV, V13, P139, DOI 10.1016/0165-0173(88)90018-5; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Ehret G, 1997, CENTRAL AUDITORY SYS, P259; Ehret G, 1987, CATEGORICAL PERCEPTI, P301; Ehret G, 2010, HBK BEHAV NEUROSCI, V19, P125, DOI 10.1016/B978-0-12-374593-4.00013-9; Ferragamo MJ, 1998, J COMP PHYSIOL A, V182, P65; FITZGIBBONS PJ, 1983, J ACOUST SOC AM, V74, P67, DOI 10.1121/1.389619; FRENCH NR, 1947, J ACOUST SOC AM, V19, P90, DOI 10.1121/1.1916407; Fu ZY, 2013, NEUROSCI BULL, V29, P541, DOI 10.1007/s12264-013-1346-7; Geissler DB, 2002, P NATL ACAD SCI USA, V99, P9021, DOI 10.1073/pnas.122606499; Gershuni G, 1969, NEIROFIZIOLOGIYA, V1, P105; Gersuni GV, 1971, SENSORY PROCESSES NE, P157; GIRAUDI D, 1980, J ACOUST SOC AM, V68, P802, DOI 10.1121/1.384818; Grimsley CA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00174; Hage SR, 2003, EUR J NEUROSCI, V18, P2301, DOI 10.1046/j.1460-9568.2003.02945.x; Hanafin Patrick, 1996, Eur J Health Law, V3, P179, DOI 10.1163/157180996X00077; Hattori T, 1997, J COMP PHYSIOL A, V180, P271, DOI 10.1007/s003590050047; Heil P, 1997, J NEUROPHYSIOL, V78, P2438, DOI 10.1152/jn.1997.78.5.2438; Hernandez O, 2005, NEUROSCIENCE, V132, P203, DOI 10.1016/j.neuroscience.2005.01.001; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; HORIKAWA J, 1988, P JPN ACAD B-PHYS, V64, P181, DOI 10.2183/pjab.64.181; Hurley LM, 2005, J NEUROSCI, V25, P7876, DOI 10.1523/JNEUROSCI.1178-05.2005; IRWIN RJ, 1981, AUDIOLOGY, V20, P234; Ito T, 2018, SPRINGER HANDB AUDIT, V65, P127, DOI 10.1007/978-3-319-71798-2_6; Khorunzhii GD, 2014, J EVOL BIOCHEM PHYS+, V50, P357, DOI 10.1134/S0022093014040097; Klink KB, 2004, J COMP PHYSIOL A, V190, P1039, DOI 10.1007/s00359-004-0561-0; Klug A, 2000, HEARING RES, V148, P107, DOI 10.1016/S0378-5955(00)00146-5; Koch U, 2003, J NEUROPHYSIOL, V90, P3679, DOI 10.1152/jn.00375.2003; Kudo M, 1988, AUDITORY PATHWAY STR, P171; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; Kuwada S, 1997, J NEUROSCI, V17, P7565; Langner G, 2002, HEARING RES, V168, P110, DOI 10.1016/S0378-5955(02)00367-2; LeBeau FEN, 2001, J NEUROSCI, V21, P7303, DOI 10.1523/JNEUROSCI.21-18-07303.2001; Lee J, 2019, J NEUROSCI, V39, P6905, DOI 10.1523/JNEUROSCI.0659-19.2019; Liang FX, 2011, BRAIN RES, V1369, P46, DOI 10.1016/j.brainres.2010.11.011; Loftus WC, 2010, J NEUROSCI, V30, P13396, DOI 10.1523/JNEUROSCI.0338-10.2010; Malinina E S, 2016, Dokl Biol Sci, V470, P209; Malmierca MS, 2012, MOUSE NERVOUS SYSTEM, P607, DOI 10.1016/B978-0-12-369497-3.10024-X; MILLER JD, 1976, J ACOUST SOC AM, V60, P410, DOI 10.1121/1.381097; Murphy BA, 2003, ANN EMERG MED, V41, P123, DOI 10.1067/mem.2003.13; Neff WD, 1975, HDB SENSORY PHYSIOLO, P307; Oliver DL, 1997, J COMP NEUROL, V382, P215, DOI 10.1002/(SICI)1096-9861(19970602)382:2<215::AID-CNE6>3.0.CO;2-6; Ono M, 2017, J NEUROSCI, V37, P8952, DOI 10.1523/JNEUROSCI.0745-17.2017; Ono M, 2014, J PHYSIOL-LONDON, V592, P3647, DOI 10.1113/jphysiol.2014.275446; Palmer AR, 2013, J PHYSIOL-LONDON, V591, P4003, DOI 10.1113/jphysiol.2013.255943; Perez CA, 2013, CEREB CORTEX, V23, P670, DOI 10.1093/cercor/bhs045; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; Peruzzi D, 2000, NEUROSCIENCE, V101, P403, DOI 10.1016/S0306-4522(00)00382-1; PISONI DB, 1977, J ACOUST SOC AM, V61, P1352, DOI 10.1121/1.381409; PISONI DB, 1974, J ACOUST SOC AM, V55, P328, DOI 10.1121/1.1914506; Pollak GD, 2011, HEARING RES, V274, P27, DOI 10.1016/j.heares.2010.05.010; Portfors CV, 2011, NEUROSCIENCE, V193, P429, DOI 10.1016/j.neuroscience.2011.07.025; Recio-Spinoso A, 2014, J NEUROPHYSIOL, V111, P817, DOI 10.1152/jn.00971.2011; Rees A, 1997, J NEUROPHYSIOL, V77, P2945, DOI 10.1152/jn.1997.77.6.2945; Reetz G, 1999, BRAIN RES, V816, P527, DOI 10.1016/S0006-8993(98)01230-X; Rodriguez FA, 2010, J NEUROPHYSIOL, V103, P887, DOI 10.1152/jn.00813.2009; ROMAND R, 1990, DEV BRAIN RES, V54, P221, DOI 10.1016/0165-3806(90)90145-O; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Rouiller EM, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P33, DOI 10.1007/978-1-4419-8712-9_3; Sachs L, 1999, ANGEW STAT, V9th; SCHREINER CE, 1988, J NEUROPHYSIOL, V60, P1823, DOI 10.1152/jn.1988.60.6.1823; Schreiner CE, 1997, NATURE, V388, P383, DOI 10.1038/41106; Schreiner CE, 1988, AUDITORY FUNCTION, P337; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; Seshagiri CV, 2007, J NEUROPHYSIOL, V98, P2058, DOI 10.1152/jn.01317.2006; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Sivaramakrishnan S, 2004, J NEUROSCI, V24, P5031, DOI 10.1523/JNEUROSCI.0357-04.2004; Sivaramakrishnan S, 2001, J NEUROSCI, V21, P2861, DOI 10.1523/JNEUROSCI.21-08-02861.2001; STEVENS KN, 1974, J ACOUST SOC AM, V55, P653, DOI 10.1121/1.1914578; STIEBLER I, 1986, NEUROSCI LETT, V65, P336, DOI 10.1016/0304-3940(86)90285-5; STIEBLER I, 1985, J COMP NEUROL, V238, P65, DOI 10.1002/cne.902380106; Stiebler I., 1987, FREQUENZREPRASENTATI, V173; Straka MM, 2014, J NEUROPHYSIOL, V112, P981, DOI 10.1152/jn.00008.2014; Tan ML, 2007, J NEUROPHYSIOL, V98, P454, DOI 10.1152/jn.00174.2007; Tan XD, 2008, HEARING RES, V235, P90, DOI 10.1016/j.heares.2007.10.002; Voytenko SV, 2008, NEUROSCIENCE, V155, P923, DOI 10.1016/j.neuroscience.2008.06.031; WAGNER T, 1994, NEUROREPORT, V6, P89, DOI 10.1097/00001756-199412300-00024; Wallace MN, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00055; Walton JP, 1998, J NEUROSCI, V18, P2764; Walton JP, 1997, J COMP PHYSIOL A, V181, P161, DOI 10.1007/s003590050103; Winer JA, 2005, INFERIOR COLLICULUS, P1, DOI 10.1007/0-387-27083-3_1; Xie R, 2008, NEUROSCIENCE, V154, P245, DOI 10.1016/j.neuroscience.2008.02.039; Yassin L, 2016, HEARING RES, V341, P79, DOI 10.1016/j.heares.2016.08.005; Zwicker E., 1967, OHR ALS NACHRICHTENE	112	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240853	10.1371/journal.pone.0240853	http://dx.doi.org/10.1371/journal.pone.0240853			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104718	Green Published, gold			2022-12-26	WOS:000588370000040
J	Kline, JM; Arriaga-Gomez, E; Yangdon, T; Boo, B; Landry, J; Saldias-Montivero, M; Neamonitaki, N; Mengistu, H; Silverio, S; Zacheis, H; Pasha, D; Martinov, T; Fife, BT; Chatterjea, D				Kline, Jaclyn M.; Arriaga-Gomez, Erica; Yangdon, Tenzin; Boo, Beebie; Landry, Jasmine; Saldias-Montivero, Marietta; Neamonitaki, Nefeli; Mengistu, Hanna; Silverio, Sayira; Zacheis, Hayley; Pasha, Dogukan; Martinov, Tijana; Fife, Brian T.; Chatterjea, Devavani			Repeated dermal application of the common preservative methylisothiazolinone triggers local inflammation, T cell influx, and prolonged mast cell-dependent tactile sensitivity in mice	PLOS ONE			English	Article							ALLERGIC CONTACT-DERMATITIS; TUMOR-NECROSIS-FACTOR; RECRUITMENT; RECEPTOR; MODEL; RISK	Occupational exposure to toxic chemicals increases the risk of developing localized provoked vulvodynia-a prevalent, yet poorly understood, chronic condition characterized by sensitivity to touch and pressure, and accumulation of mast cells in painful tissues. Here, we topically sensitized female ND4 Swiss mice to the common household and industrial preservative methylisothiazolinone (MI) and subsequently challenged them daily with MI or acetone and olive oil vehicle on the labiar skin. MI-challenged mice developed significant, persistent tactile sensitivity and long-lasting local accumulation of mast cells alongside early, transient increases in CD4(+) and CD8(+) T cells, eosinophils, neutrophils, and increases in pro-inflammatory cytokines. Therapeutic administration of imatinib, a c-Kit inhibitor known to inhibit mast cell survival, led to reduced mast cell accumulation and alleviated tactile genital pain. We provide the first pre-clinical evidence of dermal MI-induced mast-cell dependent pain and lay the groundwork for detailed understanding of these intersections between MI-driven immunomodulation and chronic pain.	[Kline, Jaclyn M.; Arriaga-Gomez, Erica; Yangdon, Tenzin; Boo, Beebie; Landry, Jasmine; Saldias-Montivero, Marietta; Neamonitaki, Nefeli; Mengistu, Hanna; Silverio, Sayira; Zacheis, Hayley; Pasha, Dogukan; Chatterjea, Devavani] Macalester Coll, Biol Dept, St Paul, MN 55105 USA; [Martinov, Tijana; Fife, Brian T.] Univ Minnesota, Dept Med, Ctr Immunol, Med Sch, Box 736 UMHC, Minneapolis, MN 55455 USA	Macalester College; University of Minnesota System; University of Minnesota Twin Cities	Chatterjea, D (corresponding author), Macalester Coll, Biol Dept, St Paul, MN 55105 USA.	chatterjead@macalester.edu	Martinov, Tijana/AFU-5047-2022; Fife, Brian/D-2042-2013	Kline, Jaclyn/0000-0002-6897-5520; Fife, Brian/0000-0001-9826-5637	National Institutes of Health [1R15AI113620-01A1]; Howard Hughes Medical Institute Foundation; Arnold and Mabel Beckman Foundation; Macalester College	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Foundation(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation; Macalester College	This work was funded by National Institutes of Health 1R15AI113620-01A1 to D.C (https://www.nih.gov).JK, EAG, TY and SS were supported by summer stipends from an education grant from the Howard Hughes Medical Institute Foundation to Macalester College (https://www.hhmi.org).BB was supported by a Beckman Scholar Award to Macalester College from the Arnold and Mabel Beckman Foundation (https://www.beckman-foundation.org).JK, EAG, TY, BB, JL, MS-M, NN, HM, SS, HZ, DP were additionally supported by intramural summer research awards from Macalester College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2012, J PHARM HLTH SERV RE, V3, P229; Arriaga-Gomez E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215361; Benck CJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53638; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077; Bomstein J, 2008, INT J GYNECOL PATHOL, V27, P136, DOI 10.1097/pgp.0b013e318140021b; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Castanedo-Tardana MP, 2013, DERMATITIS, V24, P2, DOI 10.1097/DER.0b013e31827edc73; Cerny-Reiterer S, 2015, ONCOTARGET, V6, P3071, DOI 10.18632/oncotarget.3074; Devos FC, 2015, TOXICOL LETT, V235, P179, DOI 10.1016/j.toxlet.2015.04.009; Falsetta ML, 2018, J LOW GENIT TRACT DI, V22, P52, DOI 10.1097/LGT.0000000000000364; Foster DC, 1997, OBSTET GYNECOL, V89, P291, DOI 10.1016/S0029-7844(96)00447-4; GALLI SJ, 1993, AM J PATHOL, V142, P965; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Harlow BL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.033; Harlow BL, 2009, ANN EPIDEMIOL, V19, P771, DOI 10.1016/j.annepidem.2009.06.006; Hashimoto T., 2018, ITCH, V3, pe17, DOI [10.1097/itx.0000000000000017, DOI 10.1097/ITX.0000000000000017]; IEMURA A, 1994, AM J PATHOL, V144, P321; Jones TG, 2010, J IMMUNOL, V185, P1804, DOI 10.4049/jimmunol.1001146; Juurikivi A, 2005, ANN RHEUM DIS, V64, P1126, DOI 10.1136/ard.2004.029835; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Kumamoto Y, 2012, CURR OPIN IMMUNOL, V24, P411, DOI 10.1016/j.coi.2012.05.006; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Leclair CML, 2014, J LOW GENIT TRACT DI, V18, P195, DOI 10.1097/LGT.0b013e3182a55591; Lee E, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundov MD, 2011, BRIT J DERMATOL, V165, P1178, DOI 10.1111/j.1365-2133.2011.10523.x; Lundov MD, 2013, CONTACT DERMATITIS, V69, P271, DOI 10.1111/cod.12149; Martinov T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078673; Nhu QM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00128; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Pukall CF, 2016, J SEX MED, V13, P291, DOI 10.1016/j.jsxm.2015.12.021; Reed BD, 2019, J WOMENS HEALTH, V28, P69, DOI 10.1089/jwh.2018.7188; Schwensen JF, 2015, CONTACT DERMATITIS, V72, P127, DOI 10.1111/cod.12322; Walsh CM, 2019, ELIFE, V8, DOI [10.7554/elife.48448, 10.7554/eLife.48448]; Wood SN, 2016, J STAT SOFTW, V75, P1, DOI 10.18637/jss.v075.i07; Yazar K, 2015, BRIT J DERMATOL, V173, P115, DOI 10.1111/bjd.13751; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; 2019, HUM REPROD, V34, pe102	44	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241218	10.1371/journal.pone.0241218	http://dx.doi.org/10.1371/journal.pone.0241218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104726	Green Published, gold			2022-12-26	WOS:000588370000047
J	Mugenyi, L; Nankabirwa, JI; Arinaitwe, E; Rek, J; Hens, N; Kamya, M; Dorsey, G				Mugenyi, Levicatus; Nankabirwa, Joaniter, I; Arinaitwe, Emmanuel; Rek, John; Hens, Niel; Kamya, Moses; Dorsey, Grant			Estimating the optimal interval between rounds of indoor residual spraying of insecticide using malaria incidence data from cohort studies	PLOS ONE			English	Article								Background Indoor residual spraying (IRS) reduces vector densities and malaria transmission, however, the most effective spraying intervals for IRS have not been well established. We estimated the optimal timing interval for IRS using a statistical approach. Methods Six rounds of IRS were implemented in Tororo District, a historically high malaria transmission setting in Uganda, during the study period (3 rounds with bendiocarb active ingredient (Ficam (R)): December 2014 to December 2015, and 3 rounds with pirimiphos methyl active ingredient (Actellic 300 (R) CS): June 2016 to July 2018). A generalized additive model was used to estimate the optimal timing interval for IRS based on the predicted malaria incidence. The model was fitted to clinical incidence data from a cohort of children aged 0.5-10 years from selected households observed throughout the study period. Results 494 children, 67% aged less than 5 years at enrolment were analysed. Six-months period incidence of malaria decreased from 2.96 per person-years at the baseline to 1.74 following the first round of IRS and then to 0.02 after 6 rounds of IRS. The optimal time interval for IRS differed between bendiocarb and pirimiphos methyl and by IRS round. To retain an optimum impact, bendiocarb would require respraying 17 (95% CI: 14.2-21.0) weeks after application whereas pirimiphos methyl could remain impactful for 40 (95% CI: 37.0-42.8) weeks, although in the final year this estimates 36 (95% CI: 32.7-37.7) weeks. However, we could not estimate from the data the optimal time after the second and third rounds of bendiocarb and after the second round of pirimiphos methyl. Neither the amount of rainfall nor the EIR nor the distribution of nets were found to be statistically significant for determining the time period between spray rounds. Conclusion In our setting, the effect of the two IRS products was distinct. Statistically, pirimiphos methyl provided a longer window of protection than bendiocarb, although impact varied between different spray rounds and years which was not explained by rainfall or EIR or distribution of nets in our statistical approach. Understanding the effectiveness of IRS and how long it lasts can help for planning campaigns, but one should consider the financial cost and insecticide resistance. Monitoring the timing of spray campaigns using clinical incidence could be repeated in future programs to help determine the average period of protectivity of these products.	[Mugenyi, Levicatus; Nankabirwa, Joaniter, I; Kamya, Moses] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Mugenyi, Levicatus] Aids Support Org, Kampala, Uganda; [Nankabirwa, Joaniter, I; Arinaitwe, Emmanuel; Rek, John; Kamya, Moses] Infect Dis Res Collaborat, Kampala, Uganda; [Hens, Niel] Hasselt Univ, Data Sci Inst, I Biostat, Hasselt, Belgium; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Makerere University; Hasselt University; University of Antwerp; University of California System; University of California San Francisco	Mugenyi, L (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Mugenyi, L (corresponding author), Aids Support Org, Kampala, Uganda.	lmugenyi005@gmail.com	; Hens, Niel/M-4445-2017	C. Rek, John/0000-0003-4063-0763; Mugenyi, Levi/0000-0002-9423-2472; Hens, Niel/0000-0003-1881-0637	National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Centers of Excellence in Malaria Research (ICEMR) program [U19AI089674]; Fogarty International Center of the National Institutes of Health [D43TW010526]; Fogarty International Center (Emerging Global Leader Award) [K43TW010365]	National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Centers of Excellence in Malaria Research (ICEMR) program; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Fogarty International Center (Emerging Global Leader Award)	This research report is supported by the National Institute of Allergy and Infectious Diseases (NIAID) as part of the International Centers of Excellence in Malaria Research (ICEMR) program (U19AI089674) and the Fogarty International Center of the National Institutes of Health under Award Number D43TW010526. JIN is supported by the Fogarty International Center (Emerging Global Leader Award grant number K43TW010365.	Aikpon R, 2014, PARASITES VECTORS; Brumback BA, 1998, J AM STAT ASS; Haji KA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1239-x; Kamya MR, 2015, AM J TROP MED HYG; Katureebe A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002167; Mabaso MLH, 2004, TROPICAL MED INT HLT; Monitor, 2016, MONITOR; Mpofu SM, 1991, J AM MOSQ CONTROL AS; Nankabirwa JI, 2020, AM J TROP MED HYG; Nankabirwa JI, 2019, J INFECT DIS; O'Meara WP, 2010, LANCET INFECT DIS; Okullo AE, 2017, MALAR J; OpenDocs, 2020, I DEV STUD, V19, P1; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Randriamaherijaona S, 2017, J MED ENTOMOL; Raouf S, 2017, CLIN INFECT DIS; Reinsch C, 1967, NUMER MATH, V24; Sherrard-Smith E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07357-w; Steinhardt LC, 2013, AM J TROP MED HYG; Syngenta, 2013, LONG LAST CONTR PYR; Tanser FC, 2007, COCHRANE DATABASE SY; Torabi M, 2011, J APPL STAT; Tukei BB, 2017, MALAR J; Wahba G., 1990, SPLINE MODELS OBSERV; West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630; WHO, 2015, OP MAN IND RES SPRAY	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241033	10.1371/journal.pone.0241033	http://dx.doi.org/10.1371/journal.pone.0241033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095812	gold, Green Published			2022-12-26	WOS:000586649400056
J	Al-Ghouti, MA; Khan, M; Nasser, MS; Al Saad, K; Heng, OONE				Al-Ghouti, Mohammad A.; Khan, Mariam; Nasser, Mustafa S.; Al Saad, Khalid; Heng, O. O. N. Ee			Physiochemical characterization and systematic investigation of metals extraction from fly and bottom ashes produced from municipal solid waste	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; SEQUENTIAL EXTRACTION; HEAVY-METALS; COAL; REMOVAL; OPTIMIZATION; COMBUSTION; SEDIMENTS; MOBILITY; SLUDGE	Incineration has emerged as one of the acceptable ways to treat municipal solid waste (MSW) due to its potential in reducing the mass and volume of the waste. However, it produces two major by-product residues, namely MSW-bottom ash (MSW-BA) and MSW-fly ash (MSW-FA). These residues have gained great attention to their hazardous nature and potential to be reused and recycled. In this paper, the physicochemical characterizations of the MSW-BA and the MSW-FA were performed, followed by a systematic investigation of metals extraction from MSW-BA and MSW-FA. Various extracting agents were used to investigate the possibility to extract 21 metals including cadmium (Cd), vanadium (V), chromium (Cr), and lead (Pb). It was revealed that some metals were present in a high amount in the MSW-BA while other metals were higher in the MSW-FA. Moreover, the energy-dispersive X-ray spectroscopy results revealed that the MSW-BA was dominated by oxygen (O) 55.4 +/- 0.6 wt%, silicon (Si) 22.5 +/- 0.3 wt%, and calcium (Ca) 18.5 +/- 0.2 wt%. On the other hand, the MSW-FA was enriched with Ca 45.2 +/- 0.5 wt%, and O 40.3 +/- 0.4 wt%. From the scanning electron microscopy, the MSW-BA was observed as flaky with an irregular surface that consisted of large pores, while, the MSW-FA was present as agglomerated particles and had a bimodal distribution. Moreover, Fourier transform infrared spectroscopy revealed that Al-Fe-OH, Al-Al-OH, Si-O, C-O, and C-H were some of the major functional groups present in the ashes. The F-tests concluded that the metal extraction from the MSW-BA and MSW-FA were significantly affected by the acid type. it is concluded that nitric acid and phosphoric acid were the best-suited acid for the MSW-BA while sulfuric acid and phosphoric acid for the MSW-FA. More than 11 wt% of Cd and 9 wt% of Cu were extracted from MSW-BA while 6 wt% of Pb and 4.5 wt% of V were extracted from the MSW-FA. The present methodology is an interesting development in metal extraction from the MSW-BA and the MSW-FA, which can develop in a cost-effective and sustainable option to utilize MSW.	[Al-Ghouti, Mohammad A.; Khan, Mariam] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, State Of Qatar, Qatar; [Nasser, Mustafa S.] Qatar Univ, Coll Engn, Gas Proc Ctr, Doha, State Of Qatar, Qatar; [Al Saad, Khalid] Qatar Univ, Coll Arts & Sci, Dept Chem & Earth Sci, Doha, State Of Qatar, Qatar; [Heng, O. O. N. Ee] Domest Solid Waste Management Ctr DSWMC, Doha, State Of Qatar, Qatar	Qatar University; Qatar University; Qatar University	Al-Ghouti, MA (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, State Of Qatar, Qatar.	mohammad.al-ghouti@qu.edu.qa		Al-Ghouti, Mohammad/0000-0002-9943-1091	Qatar University [QUCG-CAS-2018/2019-2]; Domestic Solid Waste Management Centre of Doha, State of Qatar - Qatar National Library	Qatar University(Qatar National Research Fund (QNRF)); Domestic Solid Waste Management Centre of Doha, State of Qatar - Qatar National Library	This study was funded by a grant from Qatar University (grant #QUCG-CAS-2018/2019-2). The Domestic Solid Waste Management Centre of Doha, State of Qatar provided material support, and support in the form of salary for author OEH. The publication of this article was funded by the Qatar National Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov S, 2018, WASTE MANAGE, V79, P735, DOI 10.1016/j.wasman.2018.08.010; Al Bakri Abdullah Mohd Mustafa, 2014, Applied Mechanics and Materials, V679, P20, DOI 10.4028/www.scientific.net/AMM.679.20; Al-Abed SR, 2006, SCI TOTAL ENVIRON, V364, P14, DOI 10.1016/j.scitotenv.2005.10.021; Al-Ghouti MA, 2016, WASTE MANAGE, V49, P238, DOI 10.1016/j.wasman.2015.12.013; Al-Ghouti MA, 2011, CHEM ENG J, V173, P191, DOI 10.1016/j.cej.2011.07.080; Al-Maaded M, 2012, J POLYM ENVIRON, V20, P186, DOI 10.1007/s10924-011-0332-2; Alam Q, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.124985; Alam Q, 2019, WASTE MANAGE, V87, P1, DOI 10.1016/j.wasman.2019.01.031; [Anonymous], 2017, CMAJ, V189, pE1448; [Anonymous], 2015, REV MAR SCI AGRON VE, V3, P71; [Anonymous], 2020, CONV US DOLL QAT RIY; Arena U, 2012, WASTE MANAGE, V32, P625, DOI 10.1016/j.wasman.2011.09.025; Assi A, 2020, WASTE MANAGE, V116, P147, DOI 10.1016/j.wasman.2020.07.031; Bertolini L, 2004, CEMENT CONCRETE RES, V34, P1899, DOI 10.1016/j.cemconres.2004.02.001; Calabro E, 2015, PETROL SCI TECHNOL, V33, P1676, DOI 10.1080/10916466.2015.1089282; Caraballo MA, 2018, J HAZARD MATER, V360, P587, DOI 10.1016/j.jhazmat.2018.08.046; Chand V, 2013, MICROCHEM J, V111, P53, DOI 10.1016/j.microc.2012.11.007; Chandaliya VK, 2018, FUEL, V212, P422, DOI 10.1016/j.fuel.2017.10.029; Chang FY, 2006, J HAZARD MATER, V138, P594, DOI 10.1016/j.jhazmat.2006.05.099; Chaspoul FR, 2008, WASTE MANAGE, V28, P1324, DOI 10.1016/j.wasman.2007.07.005; Dahl O, 2009, FUEL PROCESS TECHNOL, V90, P871, DOI 10.1016/j.fuproc.2009.04.013; Dhir RK, 2018, WOOD PUBL SER CIVIL, P1; Fan Y, 2008, J HAZARD MATER, V159, P313, DOI 10.1016/j.jhazmat.2008.02.020; Fedje KK, 2010, J HAZARD MATER, V173, P310, DOI 10.1016/j.jhazmat.2009.08.094; Ferreira C, 2003, J HAZARD MATER, V96, P201, DOI 10.1016/S0304-3894(02)00201-7; Gabarron M, 2019, CHEMOSPHERE, V218, P266, DOI 10.1016/j.chemosphere.2018.11.114; Gao X, 2017, J CLEAN PROD, V164, P410, DOI 10.1016/j.jclepro.2017.06.218; Haynes RJ, 2009, J ENVIRON MANAGE, V90, P43, DOI 10.1016/j.jenvman.2008.07.003; Herman AP, 2016, PROCEDIA ENGINEER, V148, P432, DOI 10.1016/j.proeng.2016.06.447; Hong KJ, 2000, J HAZARD MATER, V75, P57, DOI 10.1016/S0304-3894(00)00171-0; Hu HY, 2016, J MATER CYCLES WASTE, V18, P340, DOI 10.1007/s10163-014-0341-z; Huang SJ, 2007, J HAZARD MATER, V149, P180, DOI 10.1016/j.jhazmat.2007.03.067; Huber F, 2020, WASTE MANAGE, V102, P677, DOI 10.1016/j.wasman.2019.11.036; Hussain M, 2019, MATER TODAY-PROC, V16, P1886, DOI 10.1016/j.matpr.2019.06.065; King JF, 2018, INT J COAL GEOL, V195, P75, DOI 10.1016/j.coal.2018.05.009; Koukouzas N, 2007, FUEL, V86, P2186, DOI 10.1016/j.fuel.2007.03.036; Kowalski PR, 2016, ENRGY PROCED, V97, P31, DOI 10.1016/j.egypro.2016.10.013; Lam Charles H. K., 2010, Sustainability, V2, P1943, DOI 10.3390/su2071943; Leermakers M, 2019, TALANTA, V199, P80, DOI 10.1016/j.talanta.2019.02.053; Lide D.R, 2006, CRC HDB CHEM PHYS, V87th; Lin RH, 2018, FUEL, V232, P124, DOI 10.1016/j.fuel.2018.05.141; Lynn C.J., 2017, INTERJ PAVE RES TECH, V10, P185, DOI [10.1016/j.ijprt.2016.12.003, DOI 10.1016/J.IJPRT.2016.12.003]; Mahmoud D., 2014, J ADV SCI ENG RES, V4, P148; Mojid MA, 2012, J SOIL SCI PLANT NUT, V12, P655, DOI 10.4067/S0718-95162013005000010; Nikku M, 2019, FUEL, V254, DOI 10.1016/j.fuel.2019.115690; Pagnanelli F, 2004, ENVIRON POLLUT, V132, P189, DOI 10.1016/j.envpol.2004.05.002; Pandey SK, 2019, ENVIRON TECHNOL INNO, V13, P373, DOI 10.1016/j.eti.2016.10.004; Park YJ, 2002, J HAZARD MATER, V91, P83, DOI 10.1016/S0304-3894(01)00362-4; Patra S, 2017, ENRGY PROCED, V143, P454, DOI 10.1016/j.egypro.2017.12.710; Rambaldi E, 2010, CERAM INT, V36, P2469, DOI 10.1016/j.ceramint.2010.08.005; Remond S, 2002, CEMENT CONCRETE RES, V32, P303, DOI 10.1016/S0008-8846(01)00674-3; Rumky J, 2018, SCI TOTAL ENVIRON, V645, P573, DOI 10.1016/j.scitotenv.2018.07.125; SCHWARZENBACH G, 1945, HELV CHIM ACTA, V28, P1133, DOI 10.1002/hlca.194502801158; Tang JF, 2016, WASTE MANAGE, V48, P315, DOI 10.1016/j.wasman.2015.10.003; US EPA, 1996, 3050B USEPA; Wongsa A, 2017, J CLEAN PROD, V148, P49, DOI 10.1016/j.jclepro.2017.01.147; Wu HN, 2018, WASTE MANAGE, V78, P164, DOI 10.1016/j.wasman.2018.05.032; Yakubu Y, 2018, J ENVIRON MANAGE, V207, P243, DOI 10.1016/j.jenvman.2017.11.042; Yang ZZ, 2018, WASTE MANAGE, V78, P841, DOI 10.1016/j.wasman.2018.07.002; Zhang HY, 2010, PROCESS SAF ENVIRON, V88, P269, DOI 10.1016/j.psep.2010.03.004; Zhang L, 2014, ENVIRON SCI POLLUT R, V21, P12767, DOI 10.1007/s11356-014-3241-9	61	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0239412	10.1371/journal.pone.0239412	http://dx.doi.org/10.1371/journal.pone.0239412			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091005	Green Published, gold			2022-12-26	WOS:000586647200034
J	Brown, HE; Evans, TA				Brown, Haley E.; Evans, Timothy A.			Minimal structural elements required for midline repulsive signaling and regulation ofDrosophilaRobo1	PLOS ONE			English	Article							VIVO FUNCTIONAL-ANALYSIS; CONTROL AXON REPULSION; DROSOPHILA ROBO1; ROUNDABOUT RECEPTOR; GUIDANCE; SLIT; BINDING; ROLES; COMMISSURELESS; NETRIN-1	The Roundabout (Robo) family of axon guidance receptors has a conserved ectodomain arrangement of five immunoglobulin-like (Ig) domains plus three fibronectin type III (Fn) repeats. Based on the strong evolutionary conservation of this domain structure among Robo receptors, as well asin vitrostructural and domain-domain interaction studies of Robo family members, this ectodomain arrangement is predicted to be important for Robo receptor signaling in response to Slit ligands. Here, we define the minimal ectodomain structure required for Slit binding and midline repulsive signalingin vivobyDrosophilaRobo1. We find that the majority of the Robo1 ectodomain is dispensable for both Slit binding and repulsive signaling. We show that a significant level of midline repulsive signaling activity is retained when all Robo1 ectodomain elements apart from Ig1 are deleted, and that the combination of Ig1 plus one additional ectodomain element (Ig2, Ig5, or Fn3) is sufficient to restore midline repulsion to wild type levels. Further, we find that deleting four out of five Robo1 Ig domains (Delta Ig2-5) does not affect negative regulation of Robo1 by Commissureless (Comm) or Robo2, while variants lacking all three fibronectin repeats (Delta Fn1-3 and Delta Ig2-Fn3) are insensitive to regulation by both Comm and Robo2, signifying a novel regulatory role for Robo1's Fn repeats. Our results provide anin vivoperspective on the importance of the conserved 5+3 ectodomain structure of Robo receptors, and suggest that specific biochemical properties and/or ectodomain structural conformations observedin vitrofor domains other than Ig1 may have limited significance forin vivosignaling in the context of midline repulsion.	[Brown, Haley E.; Evans, Timothy A.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Brown, Haley E.] Indiana Univ, Dept Biol, Bloomington, IN USA	University of Arkansas System; University of Arkansas Fayetteville; Indiana University System; Indiana University Bloomington	Evans, TA (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	evanst@uark.edu		Brown, Haley/0000-0003-4566-5236; Evans, Timothy/0000-0002-2756-8064	National Institutes of Health [R15 NS098406]; National Institutes of Health (NIH) [P40 OD-018537]; Drosophila Genomics Resource Center [NIH 2P40OD010949]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drosophila Genomics Resource Center	This work was supported by National Institutes of Health Grant R15 NS098406 to TAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Stocks obtained from the Bloomington Drosophila Stock Center [National Institutes of Health (NIH) grant P40 OD-018537) and cultured cells obtained from the Drosophila Genomics Resource Center (NIH 2P40OD010949) were used in this study. Monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, created by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH and maintained at The Department of Biology, University of Iowa, Iowa City, IA 52242.	Aleksandrova N, 2018, STRUCTURE, V26, P320, DOI 10.1016/j.str.2017.12.003; [Anonymous], 2016, J NATL COMPR CANC NE, V14, pr34; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; [Anonymous], 2018, DEVELOPMENT, V145, pe0201; Barak R, 2019, CELL, V177, P272, DOI 10.1016/j.cell.2019.02.004; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown HE, 2018, G3-GENES GENOM GENET, V8, P621, DOI 10.1534/g3.117.300418; Brown HE, 2015, G3-GENES GENOM GENET, V5, P2429, DOI 10.1534/g3.115.022327; Cebria F, 2007, DEV BIOL, V307, P394, DOI 10.1016/j.ydbio.2007.05.006; Cebria F, 2007, DEVELOPMENT, V134, P833, DOI 10.1242/dev.02794; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Coleman HA, 2010, DEVELOPMENT, V137, P2417, DOI 10.1242/dev.047993; Dascenco D, 2015, CELL; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Evans TA, 2015, ELIFE, V4, DOI 10.7554/eLife.08407; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Fukuhara N, 2008, J BIOL CHEM, V283, P16226, DOI 10.1074/jbc.M800688200; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Georgiou M, 2002, DEVELOPMENT, V129, P2947; Gilestro GF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003798; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Li XT, 2016, GENE, V577, P215, DOI 10.1016/j.gene.2015.11.044; Liu Y, 2018, NEURON, V97, P1261, DOI 10.1016/j.neuron.2018.02.010; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Pak JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15211-1; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Programa UBACyT, 2002, REV ARGENTINA PSICOL, VXXXIV, P119; Pugliese Giovanni, 2010, B ARTE, VVII, pV; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Reichert MC, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0071-0; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Yom-Tov G, 2017, J MOL BIOL, V429, P3606, DOI 10.1016/j.jmb.2017.10.002; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zheng W, 2012, CEREB CORTEX, V22, P2587, DOI 10.1093/cercor/bhr330	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241150	10.1371/journal.pone.0241150	http://dx.doi.org/10.1371/journal.pone.0241150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091076	Green Published, gold, Green Submitted			2022-12-26	WOS:000586647200061
J	Kim, SW; Han, SJ; Han, JY; Kim, H; Ku, SY; Suh, CS				Kim, Sung Woo; Han, Soo Jin; Han, Ji Yeon; Kim, Hoon; Ku, Seung-Yup; Suh, Chang Suk			Predictor for supraphysiologic serum estradiol elevation on hCG triggering day of controlled ovarian stimulation using letrozole and gonadotropins in women with estrogen-dependent cancers	PLOS ONE			English	Article							BREAST-CANCER; FERTILITY PRESERVATION; EMBRYO CRYOPRESERVATION; YOUNG-WOMEN; IVF	The objective of this study was to evaluate predicting factors for supraphysiologic serum estradiol elevation during controlled ovarian stimulation (COS) with administration of letrozole and gonadotropins in patients with estrogen-dependent cancer. Use of aromatase inhibitors is recommended to prevent the potential effects of elevated serum estradiol levels and recurrence of tumor in patients with estrogen-dependent cancers during COS. Although previous studies reported that letrozole have shown an effective lowering of peak estrogen levels, a part of patients shows supraphysiologic levels of estrogen associated with ovarian stimulation despite the administration of letrozole. From January 2009 to December 2019, patients with estrogen-dependent cancer who underwent COS with antagonist protocol using a letrozole (5 mg/ day) to keep estrogen levels low were included in this study. Early monitoring serum estradiol was measured in all patients on the 4-6th day of stimulation. Subjects were classified into two groups according to the serum estradiol level on hCG triggering day, physiologic estradiol group (<= 400 pg/mL) and supraphysiologic estradiol group (>400 pg/mL). A total of 96 COS cycles were retrospectively analyzed. Supraphysiologic level of serum estradiol was found in 21.9% of the patients. Mean age, AMH, duration of stimulation, total dose of gonadotropins administered were not different between the two groups. However, early monitoring serum estradiol level was significantly higher in the supraphysiologic estradiol group (67.1 +/- 47.9 vs. 115.6 +/- 78.1, p = 0.001) and was associated with the occurrence of supraphysiologic elevation of serum estradiol on hCG triggering day. Patients with early monitoring serum estradiol >= 84.5 pg/mL had an odds ratio of 5.376 [95% CI, 1.613-17.913] for supraphysiologic elevation of serum estradiol compared to those with early monitoring serum estradiol below 84.5 pg/mL. In conclusion, early monitoring serum estradiol is an independent predicting factor for supraphysiologic level of serum estradiol on hCG triggering day in the COS cycles using letrozole and gonadotropins.	[Kim, Sung Woo; Han, Soo Jin; Han, Ji Yeon; Kim, Hoon; Ku, Seung-Yup; Suh, Chang Suk] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Hoon; Ku, Seung-Yup; Suh, Chang Suk] Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Ku, SY (corresponding author), Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea.; Ku, SY (corresponding author), Seoul Natl Univ, Inst Reprod Med & Populat, Med Res Ctr, Seoul, South Korea.	jyhsyk@snu.ac.kr		Han, Jiyeon/0000-0002-1007-3188	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1A2C1010293]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2020R1A2C1010293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI S, 1980, ENDOCRINOL JAPON, V27, P709; Azim A, 2007, FERTIL STERIL, V88, P657, DOI 10.1016/j.fertnstert.2006.12.068; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Azim AA, 2007, J CLIN ENDOCR METAB, V92, P2197, DOI 10.1210/jc.2007-0247; Cahill DJ, 2000, HUM REPROD, V15, P1909, DOI 10.1093/humrep/15.9.1909; Cakmak H, 2013, FERTIL STERIL, V100, P1673, DOI 10.1016/j.fertnstert.2013.07.1992; Cobo A, 2014, FERTIL STERIL, V102, P1006, DOI 10.1016/j.fertnstert.2014.06.019; de Pedro M, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.503; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Dixon JM, 2001, BREAST CANCER RES TR, V66, P191, DOI 10.1023/A:1010669403283; Dowsett M, 1995, CLIN CANCER RES, V1, P1511; Frattarelli JL, 2000, FERTIL STERIL, V74, P518, DOI 10.1016/S0015-0282(00)00693-2; Gadducci A, 2007, GYNECOL ENDOCRINOL, V23, P625, DOI 10.1080/09513590701582406; Goncalves V, 2014, HUM REPROD UPDATE, V20, P279, DOI 10.1093/humupd/dmt039; Gupta PB, 2006, J STEROID BIOCHEM, V102, P71, DOI 10.1016/j.jsbmb.2006.09.025; Holzer H, 2006, FERTIL STERIL, V85, P277, DOI 10.1016/j.fertnstert.2005.05.078; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Kim YJ, 2010, ARCH GYNECOL OBSTET, V282, P199, DOI 10.1007/s00404-010-1401-9; Ku SY, 2003, EUR J OBSTET GYN R B, V109, P55, DOI 10.1016/S0301-2115(02)00476-1; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Munoz E, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.504; Oehninger S, 2000, MOL CELL ENDOCRINOL, V169, P73, DOI 10.1016/S0303-7207(00)00355-5; Oktay K, 2003, HUM REPROD, V18, P90, DOI 10.1093/humrep/deg045; Oktay K, 2005, J CLIN ONCOL, V23, P4347, DOI 10.1200/JCO.2005.05.037; Oktay K, 2006, J CLIN ENDOCR METAB, V91, P3885, DOI 10.1210/jc.2006-0962; Oktay K, 2015, J CLIN ONCOL, V33, P2424, DOI 10.1200/JCO.2014.59.3723; Papageorgiou T, 2002, HUM REPROD, V17, P2846, DOI 10.1093/humrep/17.11.2846; Pereira N, 2016, GYNECOL ENDOCRINOL, V32, P823, DOI 10.1080/09513590.2016.1177013; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sonmezer M, 2006, ONCOLOGIST, V11, P422, DOI 10.1634/theoncologist.11-5-422; Tal R, 2017, AM J OBSTET GYNECOL, V217, P129, DOI 10.1016/j.ajog.2017.02.027; Taylan E, 2017, WORLD J CLIN ONCOL, V8, P241, DOI 10.5306/wjco.v8.i3.241	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240870	10.1371/journal.pone.0240870	http://dx.doi.org/10.1371/journal.pone.0240870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085706	gold, Green Published			2022-12-26	WOS:000585943400004
J	Akgun, E; Tuzuner, MB; Sahin, B; Kilercik, M; Kulah, C; Cakiroglu, HN; Serteser, M; Unsal, I; Baykal, AT				Akgun, Emel; Tuzuner, Mete Bora; Sahin, Betul; Kilercik, Meltem; Kulah, Canan; Cakiroglu, Hacer Nur; Serteser, Mustafa; Unsal, Ibrahim; Baykal, Ahmet Tarik			Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients	PLOS ONE			English	Article							CATHEPSIN-G; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; ACTIVATION; EXPRESSION; INNATE; MICE	COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared throughout the World and currently affected more than 9 million people and caused the death of around 470,000 patients. The novel strain of the coronavirus disease is transmittable at a devastating rate with a high rate of severe hospitalization even more so for the elderly population. Naso-oro-pharyngeal swab samples as the first step towards detecting suspected infection of SARS-CoV-2 provides a non-invasive method for PCR testing at a high confidence rate. Furthermore, proteomics analysis of PCR positive and negative naso-oropharyngeal samples provides information on the molecular level which highlights disease pathology. Samples from 15 PCR positive cases and 15 PCR negative cases were analyzed with nanoLC-MS/MS to identify the differentially expressed proteins. Proteomic analyses identified 207 proteins across the sample set and 17 of them were statistically significant. Protein-protein interaction analyses emphasized pathways like Neutrophil degranulation, Innate Immune System, Antimicrobial Peptides. Neutrophil Elastase (ELANE), Azurocidin (AZU1), Myeloperoxidase (MPO), Myeloblastin (PRTN3), Cathepsin G (CTSG) and Transcobalamine-1 (TCN1) were found to be significantly altered in naso-oropharyngeal samples of SARS-CoV-2 patients. The identified proteins are linked to alteration in the innate immune system specifically via neutrophil degranulation and NETosis.	[Akgun, Emel; Kilercik, Meltem; Serteser, Mustafa; Baykal, Ahmet Tarik] Acibadem Univ, Fac Med, Dept Med Biochem, Istanbul, Turkey; [Akgun, Emel; Tuzuner, Mete Bora; Sahin, Betul; Kilercik, Meltem; Kulah, Canan; Cakiroglu, Hacer Nur; Serteser, Mustafa; Unsal, Ibrahim; Baykal, Ahmet Tarik] Acibadem Labmed Clin Labs, Istanbul, Turkey	Acibadem University; Acibadem Hastaneleri; Acibadem Hospitals Group	Baykal, AT (corresponding author), Acibadem Univ, Fac Med, Dept Med Biochem, Istanbul, Turkey.; Baykal, AT (corresponding author), Acibadem Labmed Clin Labs, Istanbul, Turkey.	ahmet.baykal@acibadem.edu.tr	Baykal, Ahmet T/C-3948-2013; akgun, emel/GRR-2111-2022; Serteser, Mustafa/F-9130-2015	Baykal, Ahmet T/0000-0002-8814-7351; akgun, emel/0000-0002-2750-6939; Tuzuner, Mete Bora/0000-0001-8924-4850; Serteser, Mustafa/0000-0001-7868-7613	Acibadem Labmed Clinical Laboratory	Acibadem Labmed Clinical Laboratory	Acibadem Labmed Clinical Laboratory provided support for this study in the form of salaries for MBT, BS, CK, HNC, and IU. The specific roles of these authors are articulated in the 'author contributions' section. Data acquisition was also conducted in Acibadem Labmed Clinical Laboratory's proteomics facility. The funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Almansa Raquel, 2012, BMC Res Notes, V5, P401, DOI 10.1186/1756-0500-5-401; [Anonymous], 2010, ROAD TRAVEL, V22, P1; Belouzard S, 2010, J BIOL CHEM, V285, P22756, DOI 10.1074/jbc.M110.103275; Bracke K, 2005, INT ARCH ALLERGY IMM, V138, P169, DOI 10.1159/000088439; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550; Cazzola M, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0073-2019; Conti P, 2020, J BIOL REGUL HOMEOST, V34, P10; Di Stefano A, 2004, CLIN EXP ALLERGY, V34, P1156, DOI 10.1111/j.1365-2222.2004.02030.x; DORING G, 1995, J IMMUNOL, V154, P4842; Drescher B, 2013, VIRUS RES, V171, P1, DOI 10.1016/j.virusres.2012.11.002; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Gurel B, 2019, CURR ALZHEIMER RES, V16, P613, DOI 10.2174/1567205016666190730155926; Jean-Louis V, 2008, MECH VENT, P503; JOINER KA, 1989, J CELL BIOL, V109, P2771, DOI 10.1083/jcb.109.6.2771; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; LAFUMA C, 1991, EUR RESPIR J, V4, P1004; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Lawson MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-87; Luksch H, 2013, HUM MUTAT, V34, P122, DOI 10.1002/humu.22169; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martin KR, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14056; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Moseley MA, 2018, J PROTEOME RES, V17, P770, DOI 10.1021/acs.jproteome.7b00464; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Panigrahy D, 2020, CANCER METAST REV, V39, P337, DOI 10.1007/s10555-020-09889-4; Pourbagheri-Sigaroodi A, 2020, CLIN CHIM ACTA, V510, P475, DOI [10.1016/j.cca.2020.08.019, 10.1016/j.caa.2020.08.019]; SENGELOV H, 1993, J IMMUNOL, V150, P1535; Son ED, 2009, J DERMATOL SCI, V53, P150, DOI 10.1016/j.jdermsci.2008.08.006; Srinivasan L, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a022459; Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x; Tacnet-Delorme P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00818; Wang J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02063	39	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240012	10.1371/journal.pone.0240012	http://dx.doi.org/10.1371/journal.pone.0240012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079950	gold, Green Published			2022-12-26	WOS:000585940600016
J	Brandao, APME; Yamaguchi, LF; Tepe, EJ; Salatino, A; Kato, MJ				Egydio Brandao, Anary P. M.; Yamaguchi, Lydia F.; Tepe, Eric J.; Salatino, Antonio; Kato, Massuo J.			Evaluation of DNA markers for molecular identification of threePiperspecies from Brazilian Atlantic Rainforest	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SPECIES IDENTIFICATION; MICROSATELLITE MARKERS; ANTIFUNGAL ACTIVITY; GENETIC DIVERSITY; BARCODE REGIONS; BENZOIC-ACID; SSR MARKERS; PIPER; TRANSFERABILITY	Piperis one of two large genera in the Piperaceae, and with ca. 2600 species, is one of the largest plant genera in the world. Species delimitation and evaluation of genetic diversity among populations are important requisites for conservation and adequate exploitation of economically important species. DNA barcoding has been used as a powerful tool and a practical method for species characterization and delimitation. The present work aims to evaluate molecular markers for barcoding threePiperspecies native to Brazil:P.gaudichaudianum("jaborandi" or "pariparoba"),P.malacophyllum("pariparoba-murta") andP.regnellii("caapeba" or "pariparoba"). A reference DNA barcode library was developed using sequences of three candidate regions: ITS2,trnH-psbAandrbcL. Transferability of the microsatellite (SSR) primers Psol 3, Psol 6 and Psol 10, designed originally forPiper solmsianum, to the threePiperspecies was also evaluated. The discriminatory power of the markers was based on the determination of inter- and intraspecific distances, phylogenetic reconstruction, and clustering analysis, as well as BLASTn comparison. Sequences of ITS2 enabled efficient species identification by means of the BLASTn procedure. Based on these sequences, intraspecific divergence was lower than interspecific variation. Maximum Parsimony analyses based on ITS2 sequences provided three resolved clades, each corresponding to one of the three analysed species. Sequences oftrnH-psbAandrbcLhad lower discriminatory value. Analyses combining sequences of these regions were less effective toward the attainment of resolved and strongly supported clades of all species. In summary, robustly supported clades ofP.regnelliiwere obtained in most of the analyses, based either on isolated or combined sequences. The SSRs primers Psol 3, Psol 6 and Psol 10 were shown to be transferable toP.gaudichaudianumandP.regnellii, but not toP.malacophyllum. Preliminary cluster analyses based on the polymorphism of the amplified products suggested that Psol 3 has lower potential than Psol 6 and Psol 10 for discrimination ofPiperspecies.	[Egydio Brandao, Anary P. M.; Salatino, Antonio] Univ Sao Paulo, Dept Bot, Sao Paulo, Brazil; [Yamaguchi, Lydia F.; Kato, Massuo J.] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil; [Tepe, Eric J.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University System of Ohio; University of Cincinnati	Brandao, APME (corresponding author), Univ Sao Paulo, Dept Bot, Sao Paulo, Brazil.	anaryegydio@gmail.com.br	Kato, Massuo/AAF-8096-2021; Yamaguchi, Lydia/AAE-4791-2021; Kato, Massuo Jorge/C-1631-2014	Kato, Massuo/0000-0002-3315-2129; Kato, Massuo Jorge/0000-0002-3315-2129	FAPESP FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2009/51850-9, 2014/50316-7 - FAPESP APMEB - 2013/19398-4]; CNPq (Conselho Nacional do Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2009/51850-9, 2013/19398-4, 2014/50316-7]; US National Science Foundation [DEB-1442075]	FAPESP FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional do Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); US National Science Foundation(National Science Foundation (NSF))	MJK - 2009/51850-9; 2014/50316-7 - FAPESP APMEB - 2013/19398-4 -FAPESP FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) - www.fapesp.br CNPq (Conselho Nacional do Desenvolvimento Cientifico e Tecnologico) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; grants 2009/51850-9, 2013/19398-4 and 2014/50316-7) US National Science Foundation (DEB-1442075).	AKKAYA MS, 1992, GENETICS, V132, P1131; Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bafeel SO, 2012, GENET MOL RES, V11, P1934, DOI 10.4238/2012.July.19.12; Benevides PJC, 1999, PHYTOCHEMISTRY, V52, P339, DOI 10.1016/S0031-9422(99)00177-6; Bosmali I, 2012, FOOD RES INT, V46, P141, DOI 10.1016/j.foodres.2011.12.013; Callejas Posada R., 2020, FLORA MESOAMERICANA, V2, pi; Chaveerach A, 2016, PHYTOKEYS, P1, DOI 10.3897/phytokeys.70.6766; Christ JA, 2018, ACTA BOT BRAS, V32, P511, DOI 10.1590/0102-33062017abb0268; Di Stasi L.C., 2002, PLANTAS MED AMAZONIA; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ganie Showkat Hussain, 2015, Plant Gene, V4, P83, DOI 10.1016/j.plgene.2015.10.002; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Garcia FP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/940531; Ghebru B, 2002, THEOR APPL GENET, V105, P229, DOI 10.1007/s00122-002-0929-x; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Guo ZH, 2016, CR BIOL, V339, P60, DOI 10.1016/j.crvi.2015.12.004; Hall B.G., 2016, PHYLOGENETIC TREES M; Hayashi K, 2004, THEOR APPL GENET, V108, P1212, DOI 10.1007/s00122-003-1553-0; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hon CC, 2003, ACTA PHARMACOL SIN, V24, P841; Huang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156633; Jaramillo MA, 2008, SYST BOT, V33, P647, DOI 10.1600/036364408786500244; Joy N, 2011, GENETICA, V139, P1033, DOI 10.1007/s10709-011-9605-x; Kang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13057-0; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2017, J SYST EVOL, V55, P291, DOI 10.1111/jse.12254; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuleung C, 2004, THEOR APPL GENET, V108, P1147, DOI 10.1007/s00122-003-1532-5; Lago JHG, 2004, J NAT PROD, V67, P1783, DOI 10.1021/np030530j; Lago JHG, 2005, J BRAZIL CHEM SOC, V16, P153, DOI 10.1590/S0103-50532005000200005; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Liao PC, 2009, CONSERV GENET, V10, P1911, DOI 10.1007/s10592-009-9852-x; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Menezes IC, 2009, CONSERV GENET RESOUR, V1, P209, DOI 10.1007/s12686-009-9051-6; Morandim-Giannetti AD, 2010, J MED PLANTS RES, V4, P1810; Nazareno AG, 2009, GENET MOL BIOL, V32, P568, DOI 10.1590/S1415-47572009005000056; Ooi SL, 2018, J ALTERN COMPLEM MED, V24, P770, DOI 10.1089/acm.2018.0001; Parvathy VA, 2018, INDIAN J BIOTECHNOL, V17, P346; Pessini GL, 2005, J BRAZIL CHEM SOC, V16, P1130, DOI 10.1590/S0103-50532005000700007; Pirie MD, 2006, J BIOGEOGR, V33, P31, DOI 10.1111/j.1365-2699.2005.01388.x; Quijano-Abril MA, 2006, J BIOGEOGR, V33, P1266, DOI 10.1111/j.1365-2699.2006.01501.x; Ramos CS, 2009, CHEMOECOLOGY, V19, P73, DOI 10.1007/s00049-009-0011-0; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tepe EJ, 2014, PHYTOKEYS, V34, P19, DOI 10.3897/phytokeys.34.6376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandenbroucke H, 2015, GENOME, V58, P1, DOI 10.1139/gen-2014-0166; Vijayan K, 2010, CURR SCI INDIA, V99, P1530; Wanke S, 2006, PLANT BIOLOGY, V8, P93, DOI 10.1055/s-2005-873060; Yoshida NC, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1300092; Yu N, 2016, MOLECULES, V21, DOI 10.3390/molecules21091221	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0239056	10.1371/journal.pone.0239056	http://dx.doi.org/10.1371/journal.pone.0239056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075070	Green Published, gold			2022-12-26	WOS:000585920200021
J	Gayacharan; Rani, U; Singh, S; Basandrai, AK; Rathee, VK; Tripathi, K; Singh, N; Dixit, GP; Rana, JC; Pandey, S; Kumar, A; Singh, K				Gayacharan; Rani, Upasana; Singh, Sarvjeet; Basandrai, Ashwani K.; Rathee, Virender K.; Tripathi, Kuldeep; Singh, Neeta; Dixit, Girish P.; Rana, Jai C.; Pandey, Sushil; Kumar, Ashok; Singh, Kuldeep			Identification of novel resistant sources for ascochyta blight (Ascochyta rabiei) in chickpea	PLOS ONE			English	Article							CICER-ARIETINUM L.; GERMPLASM; INHERITANCE; PATHOGENICITY; ACCESSIONS; COLLECTION; SEQUENCE; GENETICS	Chickpea (Cicer arietinumL.) is the second largest pulse crop grown worldwide and ascochyta blight caused byAscochyta rabiei(Pass.) Labr. is the most devastating disease of the crop in all chickpea growing areas across the continents. The pathogenA.rabieiis highly variable. The resistant sources available are not sufficient and new sources needs to be identified from time to time as resistance breakdown in existing chickpea varieties is very frequent due to fast evolution of new pathotypes of the pathogen. Therefore, this work was undertaken to evaluate the existing chickpea germplasm diversity conserved in Indian National Genebank against the disease under artificial epiphytotic conditions. An artificial standard inoculation procedure was followed for uniform spread of the pathogen. During the last fivewinterseasons from 2014-15 to 2018-19, a total of 1,970 accessions have been screened against the disease and promising accessions were identified and validated. Screening has resulted in identification of some promising chickpea accessions such as IC275447, IC117744, EC267301, IC248147 and EC220109 which have shown the disease resistance (disease severity score <= 3) in multiple seasons and locations. Promising accessions can serve as the potential donors in chickpea improvement programs. The frequency of resistant and moderately resistant type accessions was comparatively higher in accessions originated from Southwest Asian countries particularly Iran and Syria than the accessions originated from Indian sub-continent. Further large scale screening of chickpea germplasm originated from Southwest Asia may result in identifying new resistant sources for the disease.	[Gayacharan; Tripathi, Kuldeep; Singh, Neeta; Pandey, Sushil; Kumar, Ashok; Singh, Kuldeep] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Rani, Upasana; Singh, Sarvjeet] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India; [Basandrai, Ashwani K.] CSKHPKV, Rice & Wheat Res Ctr, Malan, Himachal Prades, India; [Rathee, Virender K.] CSKHPKV, Hill Agr Res & Extens Ctr, Dhaulakuan, Himachal Prades, India; [Dixit, Girish P.] ICAR Indian Inst Pulses Res, Kanpur, Uttar Pradesh, India; [Rana, Jai C.] NASC, Biovers Int, India Off, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Punjab Agricultural University; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; Alliance; Bioversity International	Gayacharan (corresponding author), ICAR Natl Bur Plant Genet Resources, New Delhi, India.	gayacharan@icar.gov.in	Tripathi, Kuldeep/ABG-3393-2021; Singh, Sarvjeet/ABA-4385-2021	, Gayacharan/0000-0002-3582-6422; Singh, Kuldeep/0000-0001-5239-6586	ICAR-Consortia Research Platform on Agrobiodiversity, NBPGR	ICAR-Consortia Research Platform on Agrobiodiversity, NBPGR	Funder: ICAR-Consortia Research Platform on Agrobiodiversity, NBPGR The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akem C, 1999, INT J PEST MANAGE, V45, P131, DOI 10.1080/096708799227923; Baite MS, 2017, RES J BIOTECHNOL, V12, P29; Baite MS, 2018, PHYSIOL MOL PLANT P, V102, P122, DOI 10.1016/j.pmpp.2018.01.001; Benzohra I. E., 2013, World Applied Sciences Journal, V21, P873; Bokhari A. A., 2011, Pakistan Journal of Phytopathology, V23, P5; Butler EJ., 1973, FUNGI DIS PLANTS, P547; Chandora R, 2020, CHICKPEA: CROP WILD RELATIVES FOR ENHANCING GENETIC GAINS, P37, DOI 10.1016/B978-0-12-818299-4.00003-8; Chen W, 2004, PLANT PATHOL, V53, P759, DOI 10.1111/j.1365-3059.2004.01103.x; Chongo G, 2001, CAN J PLANT PATHOL, V23, P358; Collard BCY, 2003, THEOR APPL GENET, V107, P719, DOI 10.1007/s00122-003-1297-x; Collard BCY, 2001, AUSTRALAS PLANT PATH, V30, P271, DOI 10.1071/AP01036; DEY SK, 1993, EUPHYTICA, V68, P147, DOI 10.1007/BF00024163; Flandez-Galvez H, 2003, THEOR APPL GENET, V107, P1257, DOI 10.1007/s00122-003-1371-4; Gan YT, 2006, FIELD CROP RES, V97, P121, DOI 10.1016/j.fcr.2005.10.002; Garg T, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2125-3; Gurdip Singh, 1990, Indian Phytopathology, V43, P48; Harveson R. M., 2002, Plant Disease, V86, P698, DOI 10.1094/PDIS.2002.86.6.698B; JAN H, 1991, PLANT DIS, V75, P904, DOI 10.1094/PD-75-0904; Kanouni H., 2011, International Journal of Plant Breeding and Genetics, V5, P1, DOI 10.3923/ijpbg.2011.1.22; Kaur L, 2013, PHYTOPATHOL MEDITERR, V52, P157; Labdi M, 2013, PLANT BREEDING, V132, P197, DOI 10.1111/pbr.12038; Mohammdi WAD, 2019, ACTA SCI AGR, V3, P105; Nasir M, 2000, AUSTRALAS PLANT PATH, V29, P102, DOI 10.1071/AP00018; Nene Y. L., 1987, The Chickpea., P233; NENE YL, 1982, TROP PEST MANAGE, V28, P61, DOI 10.1080/09670878209370675; Pande S, 2005, AUST J AGR RES, V56, P317, DOI 10.1071/AR04143; Pande S, 2011, AUSTRALAS PLANT PATH, V40, P149, DOI 10.1007/s13313-010-0024-8; Reddy M. V., 1990, Phytopathologia Mediterranea, V24, P32; REDDY MV, 1984, PLANT DIS, V68, P900, DOI 10.1094/PD-69-900; Santra DK, 2000, CROP SCI, V40, P1606, DOI 10.2135/cropsci2000.4061606x; Sattar A, 1933, ANN APPL BIOL, V20, P612, DOI 10.1111/j.1744-7348.1933.tb07448.x; Singh K.B., 1987, CHICKPEA, P11, DOI DOI 10.1016/J.YMPEV.2021.107235; SINGH KB, 1984, PLANT DIS, V68, P782, DOI 10.1094/PD-69-782; SINGH KB, 1989, CROP SCI, V29, P657, DOI 10.2135/cropsci1989.0011183X002900030022x; SINGH KB, 1993, CROP SCI, V33, P186, DOI 10.2135/cropsci1993.0011183X003300010033x; Sun SL, 2016, PLANT DIS, V100, P1494, DOI 10.1094/PDIS-12-15-1406-PDN; Tadesse M., 2017, PLANT SCI, V5, P22; Tar'an B, 2007, GENOME, V50, P26, DOI 10.1139/G06-137; Tekeoglu M, 2000, CROP SCI, V40, P1251, DOI 10.2135/cropsci2000.4051251x; TEWARI SK, 1986, EUPHYTICA, V35, P211, DOI 10.1007/BF00028559; Trapero-Casas A, 2000, PLANT DIS, V84, DOI [10.1094/PDIS.2000.84.4.488B, 10.1094/PDIS.2000.84.1.102C]; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; VIR S, 1975, EUPHYTICA, V24, P209, DOI 10.1007/BF00147187; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	44	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240589	10.1371/journal.pone.0240589	http://dx.doi.org/10.1371/journal.pone.0240589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075085	Green Published, gold			2022-12-26	WOS:000585920200025
J	Camp, AA; Williams, WC; Eitzer, BD; Koethe, RW; Lehmann, DM				Camp, Allison A.; Williams, Wanda C.; Eitzer, Brian D.; Koethe, Robert W.; Lehmann, David M.			Effects of the neonicotinoid acetamiprid in syrup on Bombus impatiens (Hymenoptera: Apidae) microcolony development	PLOS ONE			English	Article							BUMBLE BEES BOMBUS; APIS-MELLIFERA HYMENOPTERA; SYSTEMIC INSECTICIDES; HONEY-BEES; POLLEN; RESIDUES; POLLINATOR; DECLINE; NECTAR; BLUEBERRY	Worldwide, many pollinator populations are in decline. Population reductions have been documented for the agriculturally important honey bee (Apis mellifera), and other bee species such as bumble bees that are also critical for pollinating crops and natural landscapes. A variety of factors contribute to the observed population reductions, including exposure to agrochemicals. In recent decades, neonicotinoid pesticide use has dramatically increased, as have concerns regarding the safety of these chemicals for pollinator health. Here we assessed the toxicity of the neonicotinoid acetamiprid to the bumble bee Bombus impatiens, a species commercially available for use in agricultural settings in North America. Using the microcolony model, we examined nest growth, development and subsequent nest productivity as measured by drone production. We found that high concentrations of acetamiprid in syrup (11,300 mu g/L) significantly impacted nest growth and development, and ultimately drone production, and exposure to 1,130 mu g/L acetamiprid also significantly decreased drone production. The no observable adverse effect level was 113 mu g/L. Overall, acetamiprid delivered in syrup can negatively impact B. impatiens nest development and productivity, however only at concentrations above which would be expected in the environment when used according to label rates.	[Camp, Allison A.] Oak Ridge Associated Univ, Res Triangle Pk, NC USA; [Williams, Wanda C.] US EPA, Publ Hlth & Integrated Toxicol Program, Cardiopulm & Immunotoxicol Branch, Ctr Publ Hlth & Environm Assessment CPHEA, Res Triangle Pk, NC 27711 USA; [Eitzer, Brian D.] Connecticut Agr Expt Stn, New Haven, CT 06504 USA; [Koethe, Robert W.] US EPA, Reg Off 1, Land Chem & Redev Div RCRA, Waste Management & Pesticides Sect, Boston, MA USA; [Lehmann, David M.] US EPA, Publ Hlth & Environm Syst Div, Exposure Indicators Branch, Ctr Publ Hlth & Environm Assessment CPHEA, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; Connecticut Agricultural Experiment Station; United States Environmental Protection Agency; United States Environmental Protection Agency	Lehmann, DM (corresponding author), US EPA, Publ Hlth & Environm Syst Div, Exposure Indicators Branch, Ctr Publ Hlth & Environm Assessment CPHEA, Res Triangle Pk, NC 27711 USA.	Lehmann.david@epa.gov		Lehmann, David/0000-0003-0174-344X				Belsky JE, 2020, INSECTS, V11, DOI 10.3390/insects11080506; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bohme F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199995; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Calatayud-Vernich P, 2018, ENVIRON POLLUT, V241, P106, DOI 10.1016/j.envpol.2018.05.062; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Camp AA, EFFECTS NEONIC UNPUB; Campan AS, 2019, EUR PROC SOC BEHAV, V63, P1, DOI 10.15405/epsbs.2019.06.1; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; De Luca PA, 2013, CURR OPIN PLANT BIOL, V16, P429, DOI 10.1016/j.pbi.2013.05.002; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gradish AE, 2012, CAN ENTOMOL, V144, P478, DOI 10.4039/tce.2012.40; Gradish AE, 2019, ENVIRON ENTOMOL, V48, P12, DOI 10.1093/ee/nvy168; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Klinger EG, 2019, ENVIRON ENTOMOL, V48, P1249, DOI 10.1093/ee/nvz117; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Livesey JS, 2019, ECOL ENTOMOL, V44, P601, DOI 10.1111/een.12736; Lozier JD, 2011, MOL ECOL, V20, P4870, DOI 10.1111/j.1365-294X.2011.05314.x; Mach BM, 2018, ENVIRON TOXICOL CHEM, V37, P860, DOI 10.1002/etc.4021; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Morandin LA, 2001, J ECON ENTOMOL, V94, P462, DOI 10.1603/0022-0493-94.2.462; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OECD, 2014, GUID DOC HON BEE AP; Orfali K, 2012, AM J BIOETHICS, V12, P54, DOI 10.1080/15265161.2012.680544; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Scholer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091573; SHIPP JL, 1994, SCI HORTIC-AMSTERDAM, V57, P29, DOI 10.1016/0304-4238(94)90032-9; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Tong Z, 2016, MOLECULES, V21, DOI 10.3390/molecules21121652; USEPA, 2002, PEST FACT SHEET AC; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; WILLMER PG, 1994, ECOL ENTOMOL, V19, P271, DOI 10.1111/j.1365-2311.1994.tb00419.x; Wood TJ, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2697	53	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241111	10.1371/journal.pone.0241111	http://dx.doi.org/10.1371/journal.pone.0241111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119659	gold, Green Published			2022-12-26	WOS:000600013600068
J	O'Regan, A; Bengoechea, EG; Clifford, AM; Casey, M; Gallagher, S; Glynn, L; Doyle, C; Woods, C				O'Regan, Andrew; Garcia Bengoechea, Enrique; Clifford, Amanda M.; Casey, Monica; Gallagher, Stephen; Glynn, Liam; Doyle, Ciaran; Woods, Catherine			How to improve recruitment, sustainability and scalability in physical activity programmes for adults aged 50 years and older: A qualitative study of key stakeholder perspectives	PLOS ONE			English	Article							ACTIVITY INTERVENTIONS; PUBLIC-HEALTH; PARTICIPATION; MAINTENANCE; INTERVIEWS; INACTIVITY; COMPONENT; BENEFITS; INCREASE; PEOPLE	Introduction Physical inactivity among adults aged 50 years and over is a worldwide health concern. The objectives of the study were to investigate the perspectives of those involved with existing physical activity programmes on optimising recruitment, sustainability and scalability of physical activity programmes for adults aged 50 years and over. Methods The study was conducted in Ireland's Midwest region, where community-based physical activity programmes are delivered to groups by state-funded Local Sports Partnerships. Programme attendees, physical activity professionals and community advocates were recruited. One-to-one interviews and focus groups were conducted in 2018, recorded, transcribed and analysed by an interdisciplinary team experienced in qualitative research. Over a series of meetings, a thematic approach was used to code and analyse the transcripts, categorising data into higher order codes, themes and overarching themes with the purpose of making meaning of the data. Twenty-nine people participated in four focus groups and 18 participated in one-to-one interviews. Findings Data analysis produced three overarching themes. "Age appropriate" explains how communication and the environment should be adapted to the needs of adults aged 50 years and older. "Culture and connection" refer to the interplay of individual and social factors that influence participation, including individual fears and insecurities, group cohesion and added value beyond the physical gains in these programmes. "Roles and partnerships" outlines how key collaborations may be identified and managed and how local ownership is key to success and scalability. Conclusion Successful recruitment, sustainability and scalability require an understanding that the target population has unique needs that must be catered for when planning interventions, communicating messages and choosing personnel. The findings of this study can inform the development of community-based programmes to increase physical activity in adults aged 50 years and older.	[O'Regan, Andrew; Casey, Monica; Glynn, Liam] Univ Limerick, Grad Entry Med Sch, Hlth Res Inst, Limerick, Ireland; [Garcia Bengoechea, Enrique; Doyle, Ciaran; Woods, Catherine] Univ Limerick, Phys Act Hlth Res Cluster, Hlth Res Inst, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Clifford, Amanda M.] Univ Limerick, Hlth Res Inst, Sch Allied Hlth, Limerick, Ireland; [Gallagher, Stephen] Univ Limerick, Hlth Res Inst, Dept Psychol, Limerick, Ireland; [Glynn, Liam] Hlth Res Board Primary Care Clin Trial Network, Galway, Ireland	University of Limerick; University of Limerick; University of Limerick; University of Limerick	O'Regan, A (corresponding author), Univ Limerick, Grad Entry Med Sch, Hlth Res Inst, Limerick, Ireland.	andrew.oregan@ul.ie		Woods, Catherine/0000-0002-0892-6591; Glynn, Liam/0000-0002-6153-9363; O'Regan, Andrew/0000-0001-8470-2736	Health and Positive Aging Initiative (HaPAI)	Health and Positive Aging Initiative (HaPAI)	The Move for Life research project is funded under the Health and Positive Aging Initiative (HaPAI), led by the Department of Health and is a joint national programme with the Health Service Executive and Atlantic Philanthropies.; The authors wish to acknowledge the contribution of each participant who gave willingly of their time and shared their experiences and perspectives so generously. We also acknowledge the support of the Local Sports Partnership coordinators Phelim Macken and John Sweeney, who facilitated the recruitment of participants, Mo Foley Walsh (Limerick City and County Council) Geraldine Quinn (Health Service Executive) and Mary Harkin (Age and Opportunity) and researchers Nollaig O'Sullivan, Gearoid Balfry.	[Anonymous], 2012, DRUG DISCOV TODAY TE; [Anonymous], 2019, HLTH IR SURV SUMM RE; [Anonymous], 2016, COMP MIGRATION STUDI, V4, P4; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bennie JA, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0797-2; Blanchet S, 2018, GERIATR PSYCHOL NEUR, V16, P197, DOI 10.1684/pnv.2018.0734; Bredland EL, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5517-3; Burton E, 2018, J SPORT SCI, V36, P666, DOI 10.1080/02640414.2017.1329549; Burton E, 2017, CLIN INTERV AGING, V12, P585, DOI 10.2147/CIA.S128324; Casey M, 2014, BRIT J GEN PRACT, V64, pE500, DOI 10.3399/bjgp14X680989; Chatters R, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2482-1; Cleland CL, 2012, PREV MED, V54, P371, DOI 10.1016/j.ypmed.2012.04.004; de Labra C, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0155-4; Deci E.L., 2002, HDB SELF DETERMINATI; Department of Health, 2013, NAT POS AG STRAT; Department of Health UK, 2011, START ACT STAY ACT; Ekelund U, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4570; Estabrooks PA, 2008, ANN BEHAV MED, V36, P1, DOI 10.1007/s12160-008-9040-0; Farley TA, 2007, AM J PUBLIC HEALTH, V97, P1625, DOI 10.2105/AJPH.2006.092692; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; Glasgow RE, 2012, CTS-CLIN TRANSL SCI, V5, P48, DOI 10.1111/j.1752-8062.2011.00383.x; Grant G, 2017, HEALTH SOC CARE COMM, V25, P1218, DOI 10.1111/hsc.12424; Hawley-Hague H, 2016, J AGING PHYS ACTIV, V24, P119, DOI 10.1123/japa.2014-0108; Hunter A, 2002, QUAL HEALTH RES, V12, P388, DOI 10.1177/104973202129119964; Kendrick D, 2018, PUBLIC HEALTH, V164, P118, DOI 10.1016/j.puhe.2018.08.003; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Leask Calum F, 2019, Res Involv Engagem, V5, P2, DOI 10.1186/s40900-018-0136-9; Lofland J, 2006, ANAL SOCIAL SETTINGS, V4th; Martinson BC, 2010, J PHYS ACT HEALTH, V7, P127, DOI 10.1123/jpah.7.1.127; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Morgan GS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6624-5; Murtagh EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118293; Namey E, 2005, QUALITATIVE RES METH; National Institute for Health Research: Themed review, 2019, MEDICATIONS OPIOID U, P1, DOI 10.3310/themedreview-03898; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; O'Regan A, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0473-y; Olanrewaju O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168614; Oldridge NB, 2008, EUR J CARDIOV PREV R, V15, P130, DOI 10.1097/HJR.0b013e3282f19d42; Patzelt C, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0374-3; Pluye P, 2004, EVAL PROGRAM PLANN, V27, P121, DOI 10.1016/j.evalprogplan.2004.01.001; Reis RS, 2016, LANCET, V388, P1337, DOI 10.1016/S0140-6736(16)30728-0; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Shelton RC, 2018, ANNU REV PUBL HEALTH, V39, P55, DOI 10.1146/annurev-publhealth-040617-014731; Taylor-Robinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029536; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Watson KB, 2016, MMWR-MORBID MORTAL W, V65, P954, DOI 10.15585/mmwr.mm6536a3; Whitty CJM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0544-8; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH; Zubala A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180902	53	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240974	10.1371/journal.pone.0240974	http://dx.doi.org/10.1371/journal.pone.0240974			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119669	Green Published, gold			2022-12-26	WOS:000600013600104
J	Gil, A; Hernandez, CS; Perez-Merino, P; Rubio, M; Velarde, G; Abellanas-Lodares, M; Roman-Daza, A; Alejandre, N; Jimenez-Alfaro, I; Casares, I; Dave, SR; Lim, D; Lage, E				Gil, Andrea; Hernandez, Carlos S.; Perez-Merino, Pablo; Rubio, Marcos; Velarde, Gonzalo; Abellanas-Lodares, Maria; Roman-Daza, Angeles; Alejandre, Nicolas; Jimenez-Alfaro, Ignacio; Casares, Ignacio; Dave, Shivang R.; Lim, Daryl; Lage, Eduardo			Assesment of the QuickSee wavefront autorefractor for characterizing refractive errors in school-age children	PLOS ONE			English	Article							CLINICAL-EVALUATION; VISUAL IMPAIRMENT; VISION IMPAIRMENT; MAGNITUDE; BLINDNESS	Purpose To assess the performance of an open-view binocular handheld aberrometer (QuickSee) for diagnosing refractive errors in children. Methods 123 school-age children (9.9 +/- 3.3 years) with moderate refractive error underwent autorefraction (AR) with a standard desktop device and subjective refraction (SR), with or without cycloplegia to determine their eyeglass prescription. Measurements with QuickSee (QS) were taken in 62 of these patients without cycloplegia (NC), and in 61 under cycloplegia (C). Differences in refraction values (AR vs SR vs QS) as well as the visual acuity (VA) achieved by the patients with each method (QS vs SR) were used to evaluate the performance of the device in measuring refractive error. Results The spherical equivalent refraction obtained by QS agreed within 0.5 D of the SR in 71% (NC) and 70% (C) of the cases. Agreement between the desktop autorefractor and SR for the same threshold was of 61% (NC) and 77% (C). VA resulting from QS refractions was equal to or better than that achieved by SR procedure in 77% (NC) and 74% (C) of the patients. Average improvement in VA with the QS refractions was of 8.6 and 13.4 optotypes for the NC and C groups respectively, while the SR procedure provided average improvements of 8.9 (NC) and 14.8 (C) optotypes. Conclusions The high level of agreement between QuickSee and subjective refraction together with the VA improvement achieved in both study groups using QuickSee refractions suggest that the device is a useful autorefraction tool for school-age children.	[Gil, Andrea; Hernandez, Carlos S.; Rubio, Marcos; Casares, Ignacio; Lage, Eduardo] Univ Autonoma Madrid, Dept Elect & Commun Technol, Madrid, Spain; [Gil, Andrea; Hernandez, Carlos S.; Perez-Merino, Pablo; Lim, Daryl; Lage, Eduardo] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain; [Hernandez, Carlos S.; Rubio, Marcos; Casares, Ignacio; Dave, Shivang R.; Lage, Eduardo] PlenOptika Inc, Boston, MA 02215 USA; [Velarde, Gonzalo] Hosp Ruber Juan Bravo, Madrid, Spain; [Abellanas-Lodares, Maria; Roman-Daza, Angeles; Alejandre, Nicolas; Jimenez-Alfaro, Ignacio] Hosp Univ Fdn Jimenez Diaz, Dept Ophthalmol, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz	Lage, E (corresponding author), Univ Autonoma Madrid, Dept Elect & Commun Technol, Madrid, Spain.; Lage, E (corresponding author), Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain.; Lage, E (corresponding author), PlenOptika Inc, Boston, MA 02215 USA.	eduardo.lage@uam.es	Lage, Eduardo/AAL-2813-2021; Morote, Ignacio Jimenez-Alfaro/ABH-3590-2020	Lage, Eduardo/0000-0003-0011-2451; Morote, Ignacio Jimenez-Alfaro/0000-0002-4285-4659; Gil Ruiz, Andrea/0000-0003-0022-8446	Spanish Ministry of Economy, Industry and Competitivity [RYC-2016-21125, FJCI-2015-27101]; Madrid Regional Government [IND2019/TIC-17116]	Spanish Ministry of Economy, Industry and Competitivity(Spanish Government); Madrid Regional Government	Eduardo Lage is funded by the Ramon y Cajal program from the Spanish Ministry of Economy, Industry and Competitivity (RYC-2016-21125). Pablo Perez-Merino was funded by the Juan de la Cierva program from the same Ministry (FJCI-2015-27101). Carlos S. Hernandez and Andrea Gil are funded by the Madrid Regional Government through IND2019/TIC-17116 grant. PlenOptika Inc. provided support in the form of salaries for authors AG, MR, CSH, IC, SD, and DL, but did not have any additional role in the study design, data collection and decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219501; Alswailmi FK, 2018, PAK J MED SCI, V34, P751, DOI 10.12669/pjms.343.14510; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Benjamin WJ., 2006, BORISHS CLIN REFRACT; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Burnett AM, 2018, B WORLD HEALTH ORGAN, V96, P682, DOI 10.2471/BLT.18.212332; Chat SWS, 2001, OPHTHAL PHYSL OPT, V21, P87, DOI 10.1016/S0275-5408(00)00048-X; Choong YF, 2006, AM J OPHTHALMOL, V142, P68, DOI 10.1016/j.ajo.2006.01.084; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Durr NJ, 2015, OPTOMETRY VISION SCI, V92, P1140, DOI 10.1097/OPX.0000000000000732; Fast D. K., 2019, EARLY CHILDHOOD ED; Harrington SC, 2019, BRIT J OPHTHALMOL, V103, P1112, DOI 10.1136/bjophthalmol-2018-312573; Hunt OA, 2003, BRIT J OPHTHALMOL, V87, P1504, DOI 10.1136/bjo.87.12.1504; Jmir Editorial Office, 2018, JMIR Public Health Surveill, V4, pe53, DOI 10.2196/publichealth.9932; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Lin HZ, 2013, TZU CHI MED J, V25, P43, DOI 10.1016/j.tcmj.2013.01.006; Mayro EL, 2018, J AAPOS, V22, P214, DOI 10.1016/j.jaapos.2018.01.011; Naidoo KS, 2016, OPTOMETRY VISION SCI, V93, P227, DOI 10.1097/OPX.0000000000000796; Nguyen MT, 2017, OPTOMETRY VISION SCI, V94, P886, DOI 10.1097/OPX.0000000000001107; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rubio M, 2019, OPTOMETRY VISION SCI, V96, P726, DOI 10.1097/OPX.0000000000001427; Varma R, 2017, JAMA OPHTHALMOL, V135, P610, DOI 10.1001/jamaophthalmol.2017.1021; Wan Xiu-hua, 2012, Zhonghua Yan Ke Za Zhi, V48, P519; Zhang X.R., 2008, BIOMATER SCI, V6, P418	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240933	10.1371/journal.pone.0240933	http://dx.doi.org/10.1371/journal.pone.0240933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112912	Green Published, gold			2022-12-26	WOS:000588374000074
J	Ramos-Sono, D; Laureano, R; Rueda, D; Gilman, RH; La Rosa, A; Ruiz, J; Leon, R; Sheen, P; Zimic, M				Ramos-Sono, Daniel; Laureano, Raul; Rueda, Daniel; Gilman, Robert H.; La Rosa, Adolfo; Ruiz, Jesus; Leon, Raul; Sheen, Patricia; Zimic, Mirko			An electrochemical biosensor for the detection of Mycobacterium tuberculosis DNA from sputum and urine samples	PLOS ONE			English	Article							DIAGNOSIS	Tuberculosis (TB) is a major global public health problem with high mortality and morbidity. In low-middle income countries (LMIC) a large number of respiratory symptomatic cases that require TB screening per year demands more accurate, fast and affordable testing for TB diagnostics. Sputum smear is the initial screening test in LMICs, however, its sensitivity is limited in patients with low sputum bacilli load. The same limitation is observed in the currently available molecular tests. We designed, standardized and evaluated an electrochemical biosensor that detects the highly specific DNA insertion element 6110 (IS6110). A PCR amplified DNA product is hybridized on the surface of the working electrode built on FTO-Glass with immobilized specific DNA probes, after which cyclic voltammetry is performed with an Ag/AgCl reference electrode and a platinum counter electrode. The response of the sensor was measured by the ratio (cathodic peak current of the hybridized sensor) / (cathodic peak current of the non-hybridized sensor). We tested the biosensor, using positive hybridization control sequences, genomic DNA extracted from M. tuberculosis strains and sputum of TB patients, and extracted DNA from the urine of healthy controls spiked with M. tuberculosis DNA. This biosensor was effective for the detection of M. tuberculosis DNA with a detection limit of 16 fM in sputum sample and 1 fM in spiked urine samples. The low cost and the relatively brief duration of the assay make this an important TB screening tool in the fight against tuberculosis.	[Ramos-Sono, Daniel; Laureano, Raul; Rueda, Daniel; Sheen, Patricia; Zimic, Mirko] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Bioinformat & Biol Mol, Labs Invest & Desarrollo, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [La Rosa, Adolfo] Univ Nacl Ingn, Fac Ciencias, Lab Electroquim, Lima, Peru; [Ruiz, Jesus; Leon, Raul] NDT Innovat Inc, Lab Met & Ciencias Mat, Lima, Peru	Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University Nacional de Ingenieria Lima	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Bioinformat & Biol Mol, Labs Invest & Desarrollo, Lima, Peru.	mirko.zimic@upch.pe		Ramos, daniel/0000-0002-2405-2724	Wellcome Trust [99805/Z/12/Z]; Grand Challenge Canada GCC [0687-01-10]; ERANET LAC [ELAC2014/HID-0352]; NIH [R25 TW009720-01]; Google LATAM award 2016; MRC [MR/K007467/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Grand Challenge Canada GCC; ERANET LAC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Google LATAM award 2016(Google Incorporated); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust (Ref: 99805/Z/12/Z (https://wellcome.ac.uk/grant-funding) awarded to PS, and partly by the Grand Challenge Canada GCC Number 0687-01-10 (https://www.grandchallenges.ca) awarded to PS. This study was also supported by the ERANET LAC ELAC2014/HID-0352 (https://www.era-learn.eu/network-information/networks) awarded to MZ, NIH Grant R25 TW009720-01 awarded to MZ, and Google LATAM award 2016 awarded to MZ. NDT Innovations Inc, provided the salary of JR and RL. he specific roles of these authors are articulated in the `author contributions' section. NDT Innovations also provided access to the electron microscopy equipment but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Salah KM, 2015, SENSORS-BASEL, V15, P14539, DOI 10.3390/s150614539; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2013, BMC P S6, V7, pO1; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bordelon H, 2017, J MICROBIOL METH, V136, P65, DOI 10.1016/j.mimet.2017.02.010; Botezatu I, 2000, GENETIC ANAL DNA EXC, V1084, P1078; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Dunn JJ, 2016, J CLIN MICROBIOL, V54, P1434, DOI 10.1128/JCM.03043-15; Fan WQ, 2014, CRYSTENGCOMM, V16, P820, DOI 10.1039/c3ce42001a; Freeman RG, 1995, SERS SUBSTRATES, P267; Frei HACSR, 2005, COMP BACT ALERT 3D L, P499; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Kr S, 2015, XPERT R MTB RIF ASSA; Lewandowski Clare M., 2015, EFFECTS BRIEF MINDFU, V1, P1689, DOI [10.1017/CB09781107415324.004, DOI 10.1017/CB09781107415324.004]; Lubin AA, 2010, ACCOUNTS CHEM RES, V43, P496, DOI 10.1021/ar900165x; Lubin AA, 2009, ANAL CHEM, V81, P2150, DOI 10.1021/ac802317k; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; Mir M, 2007, THESIS; Niu LM, 2018, ARAB J CHEM, V11, P655, DOI 10.1016/j.arabjc.2015.03.009; Parker CO, 2009, ANAL CHEM, V81, P5291, DOI 10.1021/ac900511e; Patel S, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/3130469; Patel Y, 2018, MATER RELIG, V14, P1, DOI 10.1080/17432200.2017.1417215; Peng HP, 2015, SENSOR ACTUAT B-CHEM, V207, P269, DOI 10.1016/j.snb.2014.10.059; Prabhakar N, 2016, ANAL CHIM ACTA, V939, P108, DOI 10.1016/j.aca.2016.08.015; Rajesh, 2012, MATER CHEM PHYS, V132, P22, DOI 10.1016/j.matchemphys.2011.10.024; Ryu YJ, 2015, TUBERC RESPIR DIS, V78, P64, DOI 10.4046/trd.2015.78.2.64; Samra Z, 2000, COMP STUDY 3 CULTURE, P750; Sin MLY, 2014, EXPERT REV MOL DIAGN, V14, P225, DOI 10.1586/14737159.2014.888313; Srivastava SK, 2016, RSC ADV, V6, P17759, DOI 10.1039/c5ra15269k; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Torati R, 2016, BIOSENS BIOELECTRON, V78, P483, DOI 10.1016/j.bios.2015.11.098; Tosar JP, 2010, BIOSENS BIOELECTRON, V26, P1205, DOI 10.1016/j.bios.2010.08.053; Wei D, 2009, 2009 LASERS & ELECTRO-OPTICS & THE PACIFIC RIM CONFERENCE ON LASERS AND ELECTRO-OPTICS, VOLS 1 AND 2, P1233; Zhou LX, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/193963	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241067	10.1371/journal.pone.0241067	http://dx.doi.org/10.1371/journal.pone.0241067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112923	gold, Green Published			2022-12-26	WOS:000588374000060
J	Storari, AP; Rodrigues, T; Saraiva, AAF; Salles, FF				Storari, Arianny P.; Rodrigues, Taissa; Saraiva, Antonio A. F.; Salles, Frederico F.			Unmasking a gap: A new oligoneuriid fossil (Ephemeroptera: Insecta) from the Crato Formation (upper Aptian), Araripe Basin, NE Brazil, with comments on Colocrus McCafferty	PLOS ONE			English	Article							CLASSIFICATION; PHYLOGENY; EVOLUTION	The Crato Formation (Araripe Basin) preserves one of the most diverse entomofaunas of the Cretaceous. Among the groups of insects, mayflies stand out in abundance, but among them oligoneuriids are especially rare. A newly discovered adult oligoneuriid from this unit is here described as Incogemina nubila gen. et sp. nov. and new subfamily Incogemininae. A phylogenetic analysis recovered the new taxon as the sister group to the species-rich and cosmopolitan Oligoneuriinae. The paratype of Colocrus indivicum, described as an "oligoneuriid" from the same unit, is here reviewed and considered as belonging to the family Hexagenitidae. The biogeographical and taxonomic implications of this discovery and the phylogenetic position of Incogemina nubila are discussed. Incogemina bridge an important morphological gap between the Oligoneuriinae and the extant Chromarcys. Also, it demonstrates that the divergence between Oligoneuriinae and Incogemininae probably occurred in South America.	[Storari, Arianny P.; Rodrigues, Taissa] Univ Fed Espirito Santo, Ctr Ciencias Humanas & Nat, Dept Ciencias Biol, Lab Paleontol, Vitoria, ES, Brazil; [Saraiva, Antonio A. F.] Univ Reg Cariri, Ctr Ciencias Biol & Saude, Lab Paleontol URCA LPU, Crato, CE, Brazil; [Salles, Frederico F.] Univ Fed Vicosa, Dept Entomol, Museu Entomol, Vicosa, MG, Brazil	Universidade Federal do Espirito Santo; Universidade Regional do Cariri; Universidade Federal de Vicosa	Storari, AP (corresponding author), Univ Fed Espirito Santo, Ctr Ciencias Humanas & Nat, Dept Ciencias Biol, Lab Paleontol, Vitoria, ES, Brazil.	ariannystorari@gmail.com	Rodrigues, Taissa/H-1220-2012; Salles, Frederico Falcão/C-3439-2013; Storari, Arianny/AAE-1808-2022	Rodrigues, Taissa/0000-0001-7918-1358; Salles, Frederico Falcão/0000-0001-8331-5929; Storari, Arianny/0000-0002-3645-3015	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309666/2019-8]; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico [BP3-013900202.01.00/18]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (https://capes.gov.br/) Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) - 309666/2019-8 to TR and 309666/2019-8 to FFS, and by the Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (https://funcap.ce.gov.br/) to AAFS (#BP3-013900202.01.00/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Andrade Marco Brandalise, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P323; DEMOULIN G, 1971, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique, V47, P1; EDMUNDS GF, 1972, ANNU REV ENTOMOL, V17, P21, DOI 10.1146/annurev.en.17.010172.000321; Edmunds GF, 1979, P 2 INT C EPH PANSTW, P11; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hubbard M.D., 1984, Monographiae Biologicae, V57, P257; Kluge NJ, 2004, PHYLOGENETIC SYSTEM, P1, DOI [10.1007/978-94-007-0872-3, DOI 10.1007/978-94-007-0872-3]; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Martill DM, 2007, CRATO FOSSIL BEDS BR, P8, DOI DOI 10.1017/CBO9780511535512.003; Martins Neto Rafael Gioia, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P471; Martins-Neto Rafael Gioia, 1996, Revista Espanola de Paleontologia, V11, P177; Massariol FC, 2019, ZOOL J LINN SOC-LOND, V187, P378, DOI 10.1093/zoolinnean/zlz031; Massariol FC, 2015, ZOOTAXA, V4007, P242, DOI 10.11646/zootaxa.4007.2.6; McCafferty W.P., 1991, P87; McCafferty W.P., 1990, B AM MUS NAT HIST, V195, P20; MCCAFFERTY WP, 1979, ANN ENTOMOL SOC AM, V72, P5, DOI 10.1093/aesa/72.1.5; McCafferty WP, 1999, P S NAT CONS ENT 21, P1; Neumann VH, 1999, B RESUMOS S CRETACEO, V5, P279; Ogden TH, 2009, SYST ENTOMOL, V34, P616, DOI 10.1111/j.1365-3113.2009.00488.x; Ogden TH, 2005, MOL PHYLOGENET EVOL, V37, P625, DOI 10.1016/j.ympev.2005.08.008; Polegatto CM, 2001, ACTA GEOLOGICA LEOPO, V24, P145; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; Salles FF, 2016, ZOOKEYS, P45, DOI 10.3897/zookeys.625.9874; Sinitshenkova N.D., 1987, Trudy Paleontologicheskogo Instituta, V221, P1; Sinitshenkova ND, 2002, PALEONTOL J, V35, P270; Sinitshenkova ND., 1974, ENTOMOL REV, V53, P130; Sroka P, 2019, ZOOKEYS, P101, DOI 10.3897/zookeys.872.36098; Staniczek AH, 2007, CRATO FOSSIL BEDS BR, P163	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240365	10.1371/journal.pone.0240365	http://dx.doi.org/10.1371/journal.pone.0240365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112866	Green Published, gold			2022-12-26	WOS:000588374000036
J	Rubenstein, E; Ehrenthal, DB; Mallinson, DC; Bishop, L; Kuo, HH; Durkin, M				Rubenstein, Eric; Ehrenthal, Deborah B.; Mallinson, David C.; Bishop, Lauren; Kuo, Hsiang-Huo; Durkin, Maureen			Pregnancy complications and maternal birth outcomes in women with intellectual and developmental disabilities in Wisconsin Medicaid	PLOS ONE			English	Article							US WOMEN; PEOPLE; HEALTH; SEXUALITY; AUTISM	Background Women with intellectual and developmental disabilities (IDD) may face greater risk for poor pregnancy outcomes. Our objective was to examine risk of maternal pregnancy complications and birth outcomes in women with IDD compared to women without IDD in Wisconsin Medicaid, from 2007-2016. Methods Data were from the Big Data for Little Kids project, a data linkage that creates an administrative data based cohort of mothers and children in Wisconsin. Women with >= 1 IDD claim the year before delivery were classified as having IDD. Common pregnancy complications and maternal birth outcomes were identified from the birth record. We calculated risk ratios (RR) using log-linear regression clustered by mother. We examined outcomes grouped by IDD-type and explored interaction by race. Results Of 177,691 women with live births, 1,032 (0.58%) had an IDD claim. Of 274,865 deliveries, 1,757 were to mothers with IDD (0.64%). Women with IDD were at greater risk for gestational diabetes (RR: 1.28, 95% CI: 1.0, 1.6), gestational hypertension (RR: 1.22, 95% CI: 1.0, 1.5), and caesarean delivery (RR 1.32, 95% CI: 1.2, 1.4) compared to other women. Adjustment for demographic covariates did not change estimates. Women with intellectual disability were at highest risk of gestational hypertension. Black women with IDD were at higher risk of gestational hypertension than expected under a multiplicative model. Conclusions Women with IDD have increased risk of pregnancy complications and adverse outcomes in Wisconsin Medicaid. Results were robust to adjustment. Unique patterns by IDD types and Black race warrant further exploration.	[Rubenstein, Eric; Bishop, Lauren; Durkin, Maureen] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Rubenstein, Eric] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Ehrenthal, Deborah B.; Mallinson, David C.; Durkin, Maureen] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Ehrenthal, Deborah B.; Kuo, Hsiang-Huo] Univ Wisconsin, Dept Obstet & Gynecol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Mallinson, David C.] Univ Wisconsin, Ctr Demog & Ecol, Madison, WI 53706 USA; [Bishop, Lauren] Univ Wisconsin, Sandra Rosesnbaum Sch Social Work, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Boston University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rubenstein, E (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.; Rubenstein, E (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA.	erubens@bu.edu	Bishop, Lauren/AGD-8686-2022	Bishop, Lauren/0000-0003-1269-4129; Rubenstein, Eric/0000-0002-9146-4497; Mallinson, David/0000-0003-1069-6040	Eunice Kennedy Shriver National Institute for Child Health and Human Development [R03HD099619, T32 HD007014-42]; University of Wisconsin-Madison Clinical and Translational Science Award programme through the National Institutes of Health National Center for Advancing Translational Sciences [UL1TR00427, KL2 TR002374]; University of Wisconsin-Madison School of Medicine and Public Health's Wisconsin Partnership Program; University of Wisconsin-Madison Institute for Research on Poverty; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54 HD090256]	Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Wisconsin-Madison Clinical and Translational Science Award programme through the National Institutes of Health National Center for Advancing Translational Sciences; University of Wisconsin-Madison School of Medicine and Public Health's Wisconsin Partnership Program; University of Wisconsin-Madison Institute for Research on Poverty; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development (R03HD099619-ER; T32 HD007014-42-DM; https://connections.spectrumnews.org/) and the University of Wisconsin-Madison Clinical and Translational Science Award programme through the National Institutes of Health National Center for Advancing Translational Sciences (UL1TR00427-LB, KL2 TR002374-LB; https://ictr.wisc.edu/), by the University of Wisconsin-Madison School of Medicine and Public Health's Wisconsin Partnership Program (DE; https://www.med.wisc.edu/wisconsin-partnership-program/), and by the University of Wisconsin-Madison Institute for Research on Poverty (DE; https://www.irp.wisc.edu/).This study was supported in part by a core grant to the Waisman Center from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD090256-ER, LB, DM; nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to public, or preparation of the manuscript.	Abells D, 2016, CURR OPIN OBSTET GYN, V28, P350, DOI 10.1097/GCO.0000000000000299; Addlakha R, 2017, REPROD HEALTH MATTER, V25, P4, DOI 10.1080/09688080.2017.1336375; Akobirshoev I, 2019, J INTELL DISABIL RES, V63, P313, DOI 10.1111/jir.12577; Akobirshoev I, 2017, DISABIL HEALTH J, V10, P406, DOI 10.1016/j.dhjo.2017.02.010; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beadle-Brown J, 2007, CURR OPIN PSYCHIATR, V20, P437, DOI 10.1097/YCO.0b013e32827b14ab; Brault M. W., 2012, CURRENT POPULATION R, P70; Brown HK, 2020, AM J OBSTET GYNECOL, V222, P189, DOI 10.1016/j.ajog.2019.10.096; Brown HK, 2016, CAN J PSYCHIAT, V61, P714, DOI 10.1177/0706743716649188; Christensen Deborah L, 2018, MMWR Surveill Summ, V65, P1, DOI [10.15585/mmwr.ss6503a1, 10.15585/mmwr.ss6513a1]; Courtney-Long EA, 2017, J RACIAL ETHN HEALTH, V4, P213, DOI 10.1007/s40615-016-0220-5; Darney BG, 2017, WOMEN HEALTH ISS, V27, P336, DOI 10.1016/j.whi.2016.12.007; Durkin M, 2020, EPIDEMIOLOGY INTELLE; Greenwood Nechama W, 2013, Int J Family Med, V2013, P642472, DOI 10.1155/2013/642472; Holmes LG, 2014, J DEV BEHAV PEDIATR, V35, P172, DOI 10.1097/DBP.0000000000000030; Horner-Johnson W, 2017, DISABIL HEALTH J, V10, P376, DOI 10.1016/j.dhjo.2017.02.009; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Kjerulff KH, 2018, WOMEN HEALTH ISS, V28, P82, DOI 10.1016/j.whi.2017.10.005; Larson A, 2019, J COMMUN HEALTH, V44, P32, DOI 10.1007/s10900-018-0550-9; Little SE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.023; Luke B, 2018, EPIDEMIOLOGY, V29, pE31, DOI 10.1097/EDE.0000000000000828; Mallinson DC, 2020, HEALTH SERV RES, V55, P82, DOI 10.1111/1475-6773.13239; Mallinson DC, 2019, PUBLIC HEALTH REP, V134, P542, DOI 10.1177/0033354919860503; Martin JA, 2019, 13 NAT CTR HLTH STAT; McDermott S, 2019, DISABIL HEALTH J, V12, P535, DOI 10.1016/j.dhjo.2019.07.001; McDermott S, 2018, AJIDD-AM J INTELLECT, V123, P371, DOI 10.1352/1944-7558-123.4.371; Mitra M, 2018, AJIDD-AM J INTELLECT, V123, P399, DOI 10.1352/1944-7558-123.5.399; Mitra M, 2018, MATERN CHILD HLTH J, V22, P1492, DOI 10.1007/s10995-018-2546-6; Parish SL, 2015, AJIDD-AM J INTELLECT, V120, P433, DOI 10.1352/1944-7558-120.5.433; Reppermund S, 2016, CURR OPIN PSYCHIATR, V29, P149, DOI 10.1097/YCO.0000000000000228; Roy A, 2012, J ROY SOC MED, V105, P384, DOI 10.1258/jrsm.2012.110303; Rubenstein E, 2019, AUTISM RES, V12, P1541, DOI 10.1002/aur.2173; Salvador-Carulla L, 2016, CURR OPIN PSYCHIATR, V29, P89, DOI 10.1097/YCO.0000000000000237; Sundelin HEK, 2020, ACTA OBSTET GYN SCAN, V99, P518, DOI 10.1111/aogs.13773; Tarasoff LA, 2020, AM J OBSTET GYNECOL, V222, P27, DOI 10.1016/j.ajog.2019.07.015	35	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241298	10.1371/journal.pone.0241298	http://dx.doi.org/10.1371/journal.pone.0241298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108397	Green Published, gold			2022-12-26	WOS:000588372400036
J	Taylor, NJ; Gaynanova, I; Eschrich, SA; Welsh, EA; Garrett, TJ; Beecher, C; Sharma, R; Koomen, JM; Smalley, KSM; Messina, JL; Kanetsky, PA				Taylor, Nicholas J.; Gaynanova, Irina; Eschrich, Steven A.; Welsh, Eric A.; Garrett, Timothy J.; Beecher, Chris; Sharma, Ritin; Koomen, John M.; Smalley, Keiran S. M.; Messina, Jane L.; Kanetsky, Peter A.			Metabolomics of primary cutaneous melanoma and matched adjacent extratumoral microenvironment	PLOS ONE			English	Article							MALIGNANT-MELANOMA; EXPRESSION; METABOANALYST; FIBROBLASTS; RECEPTOR; PATTERNS; ACID; MITOCHONDRIA; METABOLISM; CAVEOLIN-1	Background Melanoma causes the vast majority of deaths attributable to skin cancer, largely due to its propensity for metastasis. To date, few studies have examined molecular changes between primary cutaneous melanoma and adjacent putatively normal skin. To broaden temporal inferences related to initiation of disease, we performed a metabolomics investigation of primary melanoma and matched extratumoral microenvironment (EM) tissues; and, to make inferences about progressive disease, we also compared unmatched metastatic melanoma tissues to EM tissues. Methods Ultra-high performance liquid chromatography-mass spectrometry-based metabolic profiling was performed on frozen human tissues. Results We observed 824 metabolites as differentially abundant among 33 matched tissue samples, and 1,118 metabolites as differentially abundant between metastatic melanoma (n = 46) and EM (n = 34) after false discovery rate (FDR) adjustment (p<0.01). No significant differences in metabolite abundances were noted comparing primary and metastatic melanoma tissues. Conclusions Overall, pathway-based results significantly distinguished melanoma tissues from EM in the metabolism of: ascorbate and aldarate, propanoate, tryptophan, histidine, and pyrimidine. Within pathways, the majority of individual metabolite abundances observed in comparisons of primary melanoma vs. EM and metastatic melanoma vs. EM were directionally consistent. This observed concordance suggests most identified compounds are implicated in the initiation or maintenance of melanoma.	[Taylor, Nicholas J.] Texas A&M Univ, Dept Epidemiol & Biostat, College Stn, TX 77843 USA; [Gaynanova, Irina] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Eschrich, Steven A.; Welsh, Eric A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Garrett, Timothy J.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Beecher, Chris] IROA Technol, Chapel Hill, NC USA; [Sharma, Ritin; Koomen, John M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Smalley, Keiran S. M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL USA; [Smalley, Keiran S. M.; Messina, Jane L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Kanetsky, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Sharma, Ritin] Translat Genom Res Inst, Collaborat Ctr Translat Mass Spectrometry, Phoenix, AZ USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Translational Genomics Research Institute	Taylor, NJ (corresponding author), Texas A&M Univ, Dept Epidemiol & Biostat, College Stn, TX 77843 USA.	ntaylor@tamu.edu	Eschrich, Steven/K-6848-2013; Sharma, Ritin/AAB-4693-2021; Taylor, Nicholas/B-7960-2018	Eschrich, Steven/0000-0002-9833-2788; Sharma, Ritin/0000-0001-8365-9916; Taylor, Nicholas/0000-0003-4811-8529; Gaynanova, Irina/0000-0002-4116-0268	NIH [P50 CA168536, U24-DK097209]; National Cancer Institute [R25 CA147832, T32 CA147832]; National Cancer Institutes-Cancer Center [P30-CA076292]; Moffitt Foundation; Moffitt Core facilities; Collaborative Data Services Core; Biostatistics and Bioinformatics Shared Resource; Tissue Core; Metabolomics Core at Moffitt	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institutes-Cancer Center; Moffitt Foundation; Moffitt Core facilities; Collaborative Data Services Core; Biostatistics and Bioinformatics Shared Resource; Tissue Core; Metabolomics Core at Moffitt	H. Lee Moffitt Cancer Center & Research Institute (Moffitt) Skin Cancer SPORE is funded through NIH grant P50 CA168536. NJT was supported by National Cancer Institute grants: R25 CA147832, T32 CA147832. National Cancer Institutes-Cancer Center Support Grant supports Moffitt Core facilities through P30-CA076292; Moffitt Core facilities are also supported in part by the Moffitt Foundation. Southeastern Center for Integrated Metabolomics (SECIM) is funded by the NIH through U24-DK097209. The funders provided support in the form of salaries for authors [JK, KSMS, PAK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Support for this work was also contributed by Moffitt Core facilities, including the Collaborative Data Services Core, the Biostatistics and Bioinformatics Shared Resource, the Tissue Core, and the Metabolomics Core at Moffitt.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; [Anonymous], 2010, EUR J CARDIO-THORAC, V38, pS1; [Anonymous], 2010, EUR J CARDIO-THORAC, V38, pS1; [Anonymous], 2017, PLOS MED, V14, P11; Avagliano A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00722; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Benjamini Y, 2001, ANN STAT, V29, P1165; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; Bindels LB, 2017, BRIT J CANCER, V117, P1336, DOI 10.1038/bjc.2017.307; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Chiavarina B, 2012, CELL CYCLE, V11, P3280, DOI 10.4161/cc.21643; Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057; Chong J, 2018, BIOINFORMATICS, V34, P4313, DOI 10.1093/bioinformatics/bty528; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Curry J, 2017, LARYNGOSCOPE, V127, P1808, DOI 10.1002/lary.26489; Danhier P, 2017, BBA-BIOENERGETICS, V1858, P556, DOI 10.1016/j.bbabio.2017.02.001; de Souza AV, 2003, J PINEAL RES, V34, P242, DOI 10.1034/j.1600-079X.2003.02928.x; Dutta S, 2013, SAUDI PHARM J, V21, P337, DOI 10.1016/j.jsps.2012.12.007; Ellsworth DL, 2004, BREAST CANCER RES TR, V88, P131, DOI 10.1007/s10549-004-1424-7; Ellsworth DL, 2004, ANN SURG ONCOL, V11, P861, DOI 10.1245/ASO.2004.03.024; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hong H, 2014, CELL CYCLE, V13, P3112, DOI 10.4161/15384101.2014.949527; Huang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20567; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Mal M, 2012, ANAL BIOANAL CHEM, V403, P483, DOI 10.1007/s00216-012-5870-5; Mameri H, 2017, CLIN CANCER RES, V23, P2116, DOI 10.1158/1078-0432.CCR-16-0626; Marshall AG, 1990, FOURIER TRANSFORMS N; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; Martins SF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2566-9; Matei V, 2016, INVEST OPHTH VIS SCI, V57; Pan P, 2018, INT J CANCER, V143, P886, DOI 10.1002/ijc.31366; Pan P, 2017, CARCINOGENESIS, V38, P86, DOI 10.1093/carcin/bgw122; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; PricewaterhouseCoopers, 2011, TAXTALK ELECT B AUST, V131, P14; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Serkova Natalie J., 2009, V520, P273, DOI 10.1007/978-1-60327-811-9_20; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stupp GS, 2013, ANAL CHEM, V85, P11858, DOI 10.1021/ac4025413; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tang Y, 2011, CELL DEATH DIFFER, V18, P602, DOI 10.1038/cdd.2010.117; Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; Ulmer Candice Z, 2015, J Proteomics Bioinform, V8, P126; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wasinger C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24709-0; Wilde L, 2017, SEMIN ONCOL, V44, P198, DOI 10.1053/j.seminoncol.2017.10.004; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Wu DJ, 2017, SEMIN CELL DEV BIOL, V64, P125, DOI 10.1016/j.semcdb.2016.11.003; Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039; Wu KN, 2011, CELL CYCLE, V10, P4250, DOI 10.4161/cc.10.24.18551; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yu ZH, 2018, CLIN MASS SPECTROM, V10, P16, DOI 10.1016/j.clinms.2018.08.001	64	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240849	10.1371/journal.pone.0240849	http://dx.doi.org/10.1371/journal.pone.0240849			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108391	Green Published, gold			2022-12-26	WOS:000588372400015
J	Waite, CCD; da Silva, GOA; Bitencourt, JAP; Chequer, LPT; Pennafirme, S; Jurelevicius, DD; Seldin, L; Crapez, MAC				da Costa Waite, Carolina Coelho; Andrade da Silva, Guilherme Oliveira; Pires Bitencourt, Jose Augusto; Torres Chequer, Luciana Pereira; Pennafirme, Simone; Jurelevicius, Diogo de Azevedo; Seldin, Lucy; Carlos Crapez, Mirian Araujo			Potential application of Pseudomonas stutzeri W228 for removal of copper and lead from marine environments	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SOIL; RESISTANCE; BIOREMEDIATION; MANIPULATION; REDUCTION; TOXICITY; METALS	High concentrations of metals in the environment alter bacterial diversity, selecting resistant and tolerant species. The study evaluated the selection of a potential bacterial strain from Sepetiba Bay-Rio de Janeiro, Brazil marine sediments to remove Cu and Pb. The bacterial strain isolated from the sediments was used in three different bioassays: (1) Cu at concentrations of 0 (control), 6 and 50 mu g.mL(-1); (2) Pb at concentrations of 0 (control), 6 and 50 mu g.mL(-1); (3) Cu + Pb in concentrations of 3 mu g.mL(-1) Cu + 3 mu g.mL(-1) Pb (6 mu g.mL(-1)) and 25 mu g.mL(-1) Cu + 25 mu g.mL(-1) Pb (50 mu g.mL(-1)). The number of cells and the enzymatic activities of dehydrogenases and esterases were quantified. Results of taxonomic identification indicated the selection of the Pseudomonas stutzeri W228 strain, showing a greater degree of similarity (+/- 73%) with the database used. There was no significant variation in the number of cells, 10(8) cells.mL(-1), which represents a high biomass production in the presence of stressors. However, we observed a reduction in dehydrogenase activity at all tested concentrations of Cu, Pb and Cu + Pb. The activity of esterase increased, indicating a higher energy demand to complete the bacterial life cycle. The study showed significant results for the absorption of Pb by the extracellular polymeric substances (EPS) and the efflux of Cu. The capacity of Pb absorption by EPS can be considered a resistance mechanism, as well as the efflux of Cu, so that the available EPS sites could be occupied by the most toxic ions demonstrating that Pseudomonas stutzeri is resistant to Pb and Cu.	[da Costa Waite, Carolina Coelho; Andrade da Silva, Guilherme Oliveira; Torres Chequer, Luciana Pereira; Pennafirme, Simone; Carlos Crapez, Mirian Araujo] Univ Fed Fluminense, Inst Biol, Programa Biol Marinha & Ambientes Costeiros, Niteroi, RJ, Brazil; [Pires Bitencourt, Jose Augusto] Inst Tecnol Vale Desenvolvimento Sustentavel, Belem, Para, Brazil; [Jurelevicius, Diogo de Azevedo; Seldin, Lucy] Univ Fed Rio de Janeiro, Ctr Ciencias Saude CCS Ilha Fundao, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal do Rio de Janeiro	Waite, CCD (corresponding author), Univ Fed Fluminense, Inst Biol, Programa Biol Marinha & Ambientes Costeiros, Niteroi, RJ, Brazil.	carolccwaite@gmail.com	Pennafirme, Simone/ABG-8270-2020; Bitencourt, Jose/AAW-3586-2021; Jurelevicius, Diogo A/I-8235-2014	Bitencourt, Jose/0000-0002-3571-5183; Jurelevicius, Diogo A/0000-0002-5719-5713; Chequer, Luciana/0000-0002-4928-0504; Oliveira Andrade da Silva, Guilherme/0000-0003-2625-1089	Coordination for the Improvement of Higher Education Personnel (CAPES); PhD ship for C. C. C. Waite	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PhD ship for C. C. C. Waite	This work was funded by the Coordination for the Improvement of Higher Education Personnel (CAPES) by a PhD ship for C. C. C. Waite.	Abhijit Gupta, 2016, Journal of Microbial and Biochemical Technology, V8, P364; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abuchacra PFF, 2015, MAR POLLUT BULL, V100, P414, DOI 10.1016/j.marpolbul.2015.08.012; Alboghobeish H, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-44; Anderson TH, 2010, SOIL BIOL BIOCHEM, V42, P2039, DOI 10.1016/j.soilbio.2010.06.026; Baptista-Neto J. A., 2004, J COASTAL RES, V20, P749; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; BLOEM J, 1986, APPL ENVIRON MICROB, V52, P1266, DOI 10.1128/AEM.52.6.1266-1272.1986; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brasil, 2016, AT SAUD DOS TRAB EXP; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Brons JK, 2008, APPL ENVIRON MICROB, V74, P2717, DOI 10.1128/AEM.02195-07; Pineda GAC, 2019, BRAZ J CHEM ENG, V36, P681, DOI 10.1590/0104-6632.20190362s20180294; Chandrangsu P, 2017, NAT REV MICROBIOL, V15, P338, DOI 10.1038/nrmicro.2017.15; Chequer L, 2017, LAT AM J AQUAT RES, V45, P814, DOI 10.3856/vol45-issue4-fulltext-17; Crapez M., 2003, ANU I GEOCIENC, V26, P60; D'Acunto B., AM SOC CIVIL ENG, DOI DOI 10.1061/(ASCE)EE.1943-7870.0001052; da C F Pinto Pedro Henrique, 2016, Surg Neurol Int, V7, pS785; Waite CCD, 2016, MAR POLLUT BULL, V109, P386, DOI 10.1016/j.marpolbul.2016.05.044; da Fonseca EM, 2009, J COASTAL RES, P802; Das S, 2016, APPL MICROBIOL BIOT, V100, P2967, DOI 10.1007/s00253-016-7364-4; de Mora AP, 2005, APPL SOIL ECOL, V28, P125, DOI 10.1016/j.apsoil.2004.07.006; Expert Panel on Neurologic Imaging:, 2017, J Am Coll Radiol, V14, pS550, DOI 10.1016/j.jacr.2017.08.041; Field A, 2013, DISCOVERING STAT USI; Fonseca EF, 2013, ENVIRON EARTH SCI, V70, P643, DOI 10.1007/s12665-012-2148-3; Green M. R., 2012, MOL CLONING 4, V633; Gupta Pratima, 2017, Biotechnol Rep (Amst), V13, P58, DOI 10.1016/j.btre.2016.12.006; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Hartig E, 1999, J BACTERIOL, V181, P3658; Heuer H., 1997, Modern soil microbiology., P353; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Irha N, 2003, ENVIRON INT, V28, P779, DOI 10.1016/S0160-4120(02)00124-1; Isildar A, 2019, J HAZARD MATER, V362, P467, DOI 10.1016/j.jhazmat.2018.08.050; Jaroslawiecka A, 2014, MICROBIOL-SGM, V160, P12, DOI 10.1099/mic.0.070284-0; Joo J. H., 2009, ANN 9 INT C E SE AS, P450; Jung A, 2015, APPL ENVIRON MICROB, V81, P736, DOI 10.1128/AEM.03104-14; Kasai Y, 2002, ENVIRON MICROBIOL, V4, P141, DOI 10.1046/j.1462-2920.2002.00275.x; Kenarova A, 2014, ECOTOX ENVIRON SAFE, V100, P226, DOI 10.1016/j.ecoenv.2013.11.012; KEPNER RL, 1994, MICROBIOL REV, V58, P603, DOI 10.1128/MMBR.58.4.603-615.1994; Kizilkaya R, 2004, EUR J SOIL BIOL, V40, P95, DOI 10.1016/j.ejsobi.2004.10.002; Krepsky N., 2007, Braz. J. Biol., V67, P117, DOI 10.1590/S1519-69842007000100016; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Maalej H, 2015, J APPL MICROBIOL, V118, P356, DOI 10.1111/jam.12688; Madigan M.T., 2003, BIOL MICROORGANISMOS; MATTUSCHKA B, 1994, BIOMETALS, V7, P201; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Neto JAB, 2000, ENVIRON POLLUT, V109, P1; Niti C, 2013, RES J CHEM ENVIRON, V17, P88; Oksanen J., 2016, R PACKAG; Paraquetti HHM, 2004, WATER RES, V38, P1439, DOI 10.1016/j.watres.2003.11.039; Parthipan P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00193; Pontel LB, 2014, MICROBIOL-SGM, V160, P1659, DOI 10.1099/mic.0.080473-0; R Core Team, 2013, R LANG ENV STAT COMP; Rademacher C, 2012, MICROBIOL-SGM, V158, P2451, DOI 10.1099/mic.0.058487-0; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sabadini-Santos E, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1949-2; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Sambrook J, 2001, MOL CLONING 3, V3rd; Semple KT, 2004, ENVIRON SCI TECHNOL, V38, p228A, DOI 10.1021/es040548w; SHEN G Q, 2005, ENV CHEM, V61, P1175; Pinto AFS, 2019, J SEDIMENT ENVIRON, V4, P108, DOI 10.12957/jse.2019.40992; STUBBERFIELD LCF, 1990, J MICROBIOL METH, V12, P151, DOI 10.1016/0167-7012(90)90026-3; Sunilkumar Channarayapatna-Ramesh, 2017, Journal of Applied Biology & Biotechnology, V5, P37, DOI 10.7324/JABB.2017.50406; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wuana RA, 2011, ISRN ECOL, V2011, P1, DOI [10.5402/2011/402647, DOI 10.5402/2011/402647]; Yazdankhah Siamak, 2018, Microbial Ecology in Health and Disease, V29, P1548248, DOI 10.1080/16512235.2018.1548248	68	3	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240486	10.1371/journal.pone.0240486	http://dx.doi.org/10.1371/journal.pone.0240486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104697	Green Published, gold			2022-12-26	WOS:000588370000035
J	Malyshev, AV; Flynn, PT; Cox, R; Duarte, C; Quijon, PA				Malyshev, Andrey, V; Flynn, Paula Tummon; Cox, Ruth; Duarte, Cristian; Quijon, Pedro A.			Community disruption in small biogenic habitats: A coastal invader overcomes habitat complexity to alter community structure	PLOS ONE			English	Article							CRAB CARCINUS-MAENAS; INTERTIDAL MUSSEL BEDS; INVASIVE GREEN CRAB; MYTILUS-EDULIS; SOFT-BOTTOM; ECOSYSTEM ENGINEERS; SPATIAL STRUCTURE; PREDATORS; IMPACTS; SEDIMENT	Non-indigenous species are often identified as threats to native species and communities. Yet, the mechanisms that enable many of these invaders to thrive and alter their newly invaded habitats are still not fully understood. This applies to habitats such as widespread sedimentary shorelines characterized by the presence of scattered biogenic clumps of blue mussels (Mytilus edulis) structurally more complex than bare sediments. In Atlantic Canada, some of these shorelines are numerically dominated by native mud crabs (Dyspanopeus sayi) but have been gradually invaded by the European green crab (Carcinus maenas). This study describes between-habitat (mussel clump vs. bare sediment) differences in density and diversity of invertebrates. It also tests the impact of juvenile green crabs in comparison to native mud crabs using two approaches: First, measuring habitat-related differences in these crabs' feeding rates on a common prey (soft-shell clams, Mya arenaria). Second, measuring their influence on invertebrate communities associated with mussel clumps. The results show that mussel clumps hold higher invertebrate density and diversity than surrounding sedimentary bottoms. In the laboratory, the feeding rates of native mud crabs were dependent on the type of habitat (sand flat > mussel clump), whereas those of green crabs were significantly higher and unrelated to the habitat in which predation occurred. In field experiments, juvenile green crabs were also the only predators that changed community structure in the mussel clump habitat. These results indicate that green crabs can cause a significant impact on native species and communities. Moreover, they suggest that the ability of this species to overcome the refuge provided by complex biogenic habitats for prey may represent an unexplored mechanism to explain this invader's expansion here and elsewhere.	[Malyshev, Andrey, V] Greifswald Univ, Inst Bot & Landscape Ecol, Greifswald, Germany; [Flynn, Paula Tummon; Quijon, Pedro A.] Univ Prince Edward Isl, Dept Biol, Charlottetown, PE, Canada; [Cox, Ruth] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Duarte, Cristian] Univ Andres Bello, Fac Ciencias Vida, Santiago, Chile; [Duarte, Cristian] Univ Andres Bello, Ctr Invest Marina Quintay, CIMARQ, Santiago, Chile	University of Prince Edward Island; University of Prince Edward Island; Universidad Andres Bello; Universidad Andres Bello	Quijon, PA (corresponding author), Univ Prince Edward Isl, Dept Biol, Charlottetown, PE, Canada.	pquijon@upei.ca		Quijon, Pedro/0000-0002-7980-0654	Natural Sciences and Engineering Research Council, Canada (NSERC) [5261]	Natural Sciences and Engineering Research Council, Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council, Canada (NSERC) through a Discovery Grant (5261) to PAQ.	Agardy T, 2000, ICES J MAR SCI, V57, P761, DOI 10.1006/jmsc.2000.0721; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; ALBRECHT A, 1994, HELGOLANDER MEERESUN, V48, P243, DOI 10.1007/BF02367039; AMBROSE WG, 1984, MAR ECOL PROG SER, V17, P109, DOI 10.3354/meps017109; Annex XV, 2014, OFFICIAL J EUROPEA L, V161, P1948; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2011, ANUARIO MUSICAL, VLXVI, P181; Appy TD, 1980, FISH MAR SERV TECH R, V920, P124; Audet D, 2003, J SHELLFISH RES, V22, P255; BAX Nicholas, 2003, MARINE POLICY, V27, P313; Bertness MD, 2013, ECOLOGY, V94, P1937, DOI 10.1890/12-2150.1; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Byers JE, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P227; Chunhua, 2008, GUGONG BOWUYUAN YUAN, V4, P75; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; COHEN AN, 1995, MAR BIOL, V122, P225; Commito J. A., 2001, V151, P39; Commito JA, 2005, J EXP MAR BIOL ECOL, V316, P133, DOI 10.1016/j.jembe.2004.10.010; Commito JA, 2006, J EXP MAR BIOL ECOL, V330, P27, DOI 10.1016/j.jembe.2005.12.015; COMMITO JA, 1989, J EXP MAR BIOL ECOL, V125, P33, DOI 10.1016/0022-0981(89)90214-1; Commito JA, 2000, J EXP MAR BIOL ECOL, V255, P133, DOI 10.1016/S0022-0981(00)00285-9; COMMITO JA, 1987, ESTUAR COAST SHELF S, V25, P599, DOI 10.1016/0272-7714(87)90117-X; Commito JA, 2018, J EXP MAR BIOL ECOL, V506, P30, DOI 10.1016/j.jembe.2018.05.004; Commito JA, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00200.1; Commito JA, 2008, J EXP MAR BIOL ECOL, V366, P70, DOI 10.1016/j.jembe.2008.07.010; Cordero MLH, 2014, J EXP MAR BIOL ECOL, V460, P100, DOI 10.1016/j.jembe.2014.06.012; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Crawford TW, 2006, LANDSCAPE ECOL, V21, P1033, DOI 10.1007/s10980-006-0003-1; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; CUNNINGHAM PN, 1984, MAR ECOL PROG SER, V16, P21, DOI 10.3354/meps016021; Davis RC, 1998, RESTOR ECOL, V6, P297, DOI 10.1046/j.1526-100X.1998.00634.x; DITTMANN S, 1990, HELGOLANDER MEERESUN, V44, P335, DOI 10.1007/BF02365471; Edelist D, 2013, DIVERS DISTRIB, V19, P69, DOI 10.1111/ddi.12002; Ellis JC, 2012, J EXP MAR BIOL ECOL, V416, P84, DOI 10.1016/j.jembe.2012.02.014; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Elton C., 1958; Flynn PST, 2015, J SEA RES, V103, P113, DOI 10.1016/j.seares.2015.07.002; Flynn PT, 2019, ICES J MAR SCI, V76, P2338, DOI 10.1093/icesjms/fsz130; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Fresard M., 2006, Agricultural and Resource Economics Review, V35, P78; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; Gehrels H, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2927-6; Griffen BD, 2006, J ANIM ECOL, V75, P959, DOI 10.1111/j.1365-2656.2006.01115.x; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; Hill JM, 2013, MAR ECOL PROG SER, V488, P209, DOI 10.3354/meps10386; Borthagaray AI, 2007, ACTA OECOL, V31, P243, DOI 10.1016/j.actao.2006.10.008; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Katsanevakis S, 2016, DIVERS DISTRIB, V22, P694, DOI 10.1111/ddi.12429; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; Lutz-Collins V, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2947-2; Malyshev A, 2011, ICES J MAR SCI, V68, P1852, DOI 10.1093/icesjms/fsr126; Mascaro M, 2001, HYDROBIOLOGIA, V449, P159, DOI 10.1023/A:1017569809818; Matheson K, 2016, MAR ECOL PROG SER, V548, P31, DOI 10.3354/meps11674; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MYERS N, 1989, BIOSCIENCE, V39, P506, DOI 10.1093/bioscience/39.8.506; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; OLAFSSON EB, 1994, OCEANOGR MAR BIOL, V32, P65; Pace ML, 2001, COM ECO SYS, P157; Palacios KC, 2003, J SHELLFISH RES, V22, P865; Paolucci EM, 2013, DIVERS DISTRIB, V19, P988, DOI 10.1111/ddi.12073; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Peterson C. H., 1979, ECOL PROCESS, P233; Petraitis PS, 2015, ECOLOGY, V96, P3186, DOI 10.1890/14-2107.1; Pickering TR, 2017, MAR ENVIRON RES, V127, P24, DOI 10.1016/j.marenvres.2017.03.002; Poirier LA, 2017, HELGOLAND MAR RES, V71, DOI 10.1186/s10152-017-0493-z; Quijon PA, 2005, OECOLOGIA, V144, P125, DOI 10.1007/s00442-005-0017-4; Quijon PA, 2005, MAR ECOL PROG SER, V285, P137, DOI 10.3354/meps285137; Quijon PA, 2017, MAR POLLUT BULL, V116, P538, DOI 10.1016/j.marpolbul.2017.01.020; Quijon PA, 2008, MAR ECOL PROG SER, V371, P85, DOI 10.3354/meps07691; Quinn BK, 2012, J EXP MAR BIOL ECOL, V412, P117, DOI 10.1016/j.jembe.2011.11.012; Reise K, 1995, ECOLOGICAL STUDIES, V54; Rossong KA, 2006, AGONISTIC INTERACTIO, V329, P281; Rossong MA, 2012, BIOL INVASIONS, V14, P659, DOI 10.1007/s10530-011-0107-7; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Seed R, 1996, J MAR BIOL ASSOC UK, V76, P203, DOI 10.1017/S0025315400029131; Smallegange IM, 2006, OIKOS, V113, P157, DOI 10.1111/j.0030-1299.2006.14172.x; Snover ML, 1998, J EXP MAR BIOL ECOL, V223, P53, DOI 10.1016/S0022-0981(97)00148-2; Sorte CJB, 2017, GLOBAL CHANGE BIOL, V23, P341, DOI 10.1111/gcb.13425; Sorte CJB, 2011, J EXP MAR BIOL ECOL, V400, P209, DOI 10.1016/j.jembe.2011.02.009; Steele MA, 1996, J EXP MAR BIOL ECOL, V198, P249, DOI 10.1016/0022-0981(96)00011-1; Stephens D.W., 1986, pi; Subhan Md Abdus, 2017, Nano-Structures & Nano-Objects, V10, P30, DOI 10.1016/j.nanoso.2017.03.001; Sun YF, 2017, AQUACULTURE, V479, P638, DOI 10.1016/j.aquaculture.2017.07.008; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thiel M, 2002, HELGOLAND MAR RES, V56, P21, DOI 10.1007/s10152-001-0098-3; THIEL M, 1994, HELGOLANDER MEERESUN, V48, P321, DOI 10.1007/BF02367044; Thomsen MS, 2014, MAR ECOL PROG SER, V495, P39, DOI 10.3354/meps10566; Thrush SE, 1999, AUST J ECOL, V24, P344, DOI 10.1046/j.1442-9993.1999.00981.x; TOKESHI M, 1995, MAR ECOL PROG SER, V119, P167, DOI 10.3354/meps119167; Waser AM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00437.1; WILSON WH, 1990, ANNU REV ECOL SYST, V21, P221, DOI 10.1146/annurev.ecolsys.21.1.221; Wong MC, 2014, ESTUAR COAST, V37, P1004, DOI 10.1007/s12237-013-9728-7	95	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241116	10.1371/journal.pone.0241116	http://dx.doi.org/10.1371/journal.pone.0241116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104744	gold, Green Published			2022-12-26	WOS:000588370000052
J	Mashkour, N; Jones, K; Kophamel, S; Hipolito, T; Ahasan, S; Walker, G; Jakob-Hoff, R; Whittaker, M; Hamann, M; Bell, I; Elliman, J; Owens, L; Saladin, C; Crespo-Picazo, JL; Gardner, B; Loganathan, AL; Bowater, R; Young, E; Robinson, D; Baverstock, W; Blyde, D; March, D; Eghbali, M; Mohammadi, M; Freggi, D; Giliam, J; Hale, M; Nicolle, N; Spiby, K; Wrobel, D; Parga, M; Mobaraki, A; Rajakaruna, R; Hyland, KP; Read, M; Ariel, E				Mashkour, Narges; Jones, Karina; Kophamel, Sara; Hipolito, Teresa; Ahasan, Shamim; Walker, Grant; Jakob-Hoff, Richard; Whittaker, Maxine; Hamann, Mark; Bell, Ian; Elliman, Jennifer; Owens, Leigh; Saladin, Claire; Crespo-Picazo, Jose Luis; Gardner, Brett; Loganathan, Aswini Leela; Bowater, Rachel; Young, Erina; Robinson, David; Baverstock, Warren; Blyde, David; March, Duan; Eghbali, Maryam; Mohammadi, Maryam; Freggi, Daniela; Giliam, Jane; Hale, Mike; Nicolle, Nicholas; Spiby, Kevin; Wrobel, Daphne; Parga, Mariluz; Mobaraki, Asghar; Rajakaruna, Rupika; Hyland, Kevin P.; Read, Mark; Ariel, Ellen			Disease risk analysis in sea turtles: A baseline study to inform conservation efforts	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; CLIMATE-CHANGE; GREEN TURTLES; INFECTIOUS-DISEASES; ANTIBIOTIC-RESISTANCE; ENVIRONMENTAL DNA; LOGGERHEAD TURTLE; LONG-TERM; FIBROPAPILLOMATOSIS	The impact of a range of different threats has resulted in the listing of six out of seven sea turtle species on the IUCN Red List of endangered species. Disease risk analysis (DRA) tools are designed to provide objective, repeatable and documented assessment of the disease risks for a population and measures to reduce these risks through management options. To the best of our knowledge, DRAs have not previously been published for sea turtles, although disease is reported to contribute to sea turtle population decline. Here, a comprehensive list of health hazards is provided for all seven species of sea turtles. The possible risk these hazards pose to the health of sea turtles were assessed and "One Health" aspects of interacting with sea turtles were also investigated. The risk assessment was undertaken in collaboration with more than 30 experts in the field including veterinarians, microbiologists, social scientists, epidemiologists and stakeholders, in the form of two international workshops and one local workshop. The general finding of the DRA was the distinct lack of knowledge regarding a link between the presence of pathogens and diseases manifestation in sea turtles. A higher rate of disease in immunocompromised individuals was repeatedly reported and a possible link between immunosuppression and environmental contaminants as a result of anthropogenic influences was suggested. Society based conservation initiatives and as a result the cultural and social aspect of interacting with sea turtles appeared to need more attention and research. A risk management workshop was carried out to acquire the insights of local policy makers about management options for the risks relevant to Queensland and the options were evaluated considering their feasibility and effectiveness. The sea turtle DRA presented here, is a structured guide for future risk assessments to be used in specific scenarios such as translocation and head-starting programs.	[Mashkour, Narges; Jones, Karina; Kophamel, Sara; Hipolito, Teresa; Ahasan, Shamim; Whittaker, Maxine; Elliman, Jennifer; Owens, Leigh; Bowater, Rachel; Ariel, Ellen] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Jones, Karina] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Ahasan, Shamim] Hajee Mohammad Danesh Sci & Technol Univ, Fac Vet & Anim Sci, Dinjapur, Rangpur, Bangladesh; [Walker, Grant] North East Sea Turtles, Charlotteville, Tobago, Trinidad Tobago; [Walker, Grant] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Jakob-Hoff, Richard] Auckland Zoo, New Zealand Ctr Conservat Med, Auckland, New Zealand; [Jakob-Hoff, Richard] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA, Australia; [Hamann, Mark] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Bell, Ian] Univ Queensland, Fac Hlth & Behav Sci, Brisbane, Qld, Australia; [Saladin, Claire] Reserve Nat St Barthelemy, Gustavia, St Barthelemy; [Saladin, Claire] FWI Reserve Nat St Martin, St Martin Dheres, France; [Crespo-Picazo, Jose Luis] Fdn Oceanograf, Vet Serv & Res Dept, Avanqua Oceanograf Agora, Valencia, Spain; [Gardner, Brett] Australia Zoo Wildlife Hosp, Beerwah, Beerwah, Qld, Australia; [Gardner, Brett; Nicolle, Nicholas; Spiby, Kevin] Two Oceans Aquarium, Cape Town, South Africa; [Loganathan, Aswini Leela] Univ Malaysia, Biotechnol Res Inst, Kota Kinabalu, Sabah, Malaysia; [Young, Erina] Murdoch Univ, Conservat Med Program Sch Vet & Life Sci, Coll Vet Med, Perth, WA, Australia; [Robinson, David; Baverstock, Warren] Aquarium & Dubai Turtle Rehabil Project, Burj Al Arab, Dubai, U Arab Emirates; [Blyde, David] Sea World, Gold Coast, Qld, Australia; [March, Duan] Southern Cross Univ, Natl Marine Sci Ctr, Sch Environm Sci & Engn, Coffs Harbour, NSW, Australia; [March, Duan] Southern Cross Univ, Ctr Coastal Biogeochem Res, Sch Environm Sci & Engn, Coffs Harbour, NSW, Australia; [March, Duan] Dolphin Marine Rescue Anim Rehab Trust, Coffs Harbour, NSW, Australia; [Eghbali, Maryam] Ideh Doostdar E Hormozgan Ecotourism & NGO Grp, Kish, Iran; [Mohammadi, Maryam] Dept Environm, Kish, Iran; [Freggi, Daniela] Sea Turtle Rescue Ctr, Lampedusa, Italy; [Giliam, Jane] Ark Anim Hosp, Yarrawonga, NT, Australia; [Hale, Mike] Yuku Baja Muliku Ranger Base, Archer Point, Australia; [Wrobel, Daphne] Fundacao ProTAMAR, Rua Prof Ademir Francisco S-N, Florianopolis, SC, Brazil; [Parga, Mariluz] SUBMON Marine Environm Serv, Barcelona, Spain; [Mobaraki, Asghar] Wildlife & Aquat Affairs Bur, Dept Environm, Tehran, Iran; [Rajakaruna, Rupika] Univ Peradeniya, Peradeniya, Sri Lanka; [Hyland, Kevin P.] Wildlife Protect Off, Dubai, U Arab Emirates; [Read, Mark] Great Barrier Reef Marine Pk Author, Field Management Unit, Mackay, Qld, Australia	James Cook University; James Cook University; University of Glasgow; Murdoch University; James Cook University; University of Queensland; Murdoch University; Southern Cross University; Southern Cross University; University of Peradeniya	Mashkour, N (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	narges.mashkour@my.jcu.edu.au	mashkour, narges/K-6977-2019; Kophamel, Sara/AAD-8510-2022; Whittaker, Maxine/H-1990-2011; Ariel, Ellen/B-7015-2012	mashkour, narges/0000-0002-4101-0737; Whittaker, Maxine/0000-0002-1677-2991; Ariel, Ellen/0000-0002-3171-1679; Crespo Picazo, Jose Luis/0000-0002-5216-044X; Gardner, Brett/0000-0003-2968-1850; Loganathan, Aswini Leela/0000-0003-2311-8792	James Cook University higher degree by research enhancement scheme	James Cook University higher degree by research enhancement scheme	The international workshops and the publication fee is supported by James Cook University higher degree by research enhancement scheme. The first author has applied for this grant and was awarded the grant to carry out the research.	Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; Ahasan MS, 2017, MAR POLLUT BULL, V120, P18, DOI 10.1016/j.marpolbul.2017.04.046; Alfaro A, 2008, 27 ANN S SEA TURTL B; Ambrose E, 2016, SEA TURTLE MORTALITY; [Anonymous], 2018, J VASC INTERV RADIOL, V29, pS105; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2020, GUARDIAN; [Anonymous], 2018, ENV LAND WATER PLAST; [Anonymous], 2019, IMMUNE NETW, V19, pe34; Ariel E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-100; Armstrong D., 2003, ANIMAL MOVEMENTS DIS; Association AVM, 2008, ONE HLTH NEW PROFESS; Authorities) GGBRMP, 2018, TRADITIONAL USE MARI; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Barrios-Garrido H, 2019, OCEAN COAST MANAGE, V171, P19, DOI 10.1016/j.ocecoaman.2019.01.003; Beng KC, 2020, BIODIVERS CONSERV, V29, P2089, DOI 10.1007/s10531-020-01980-0; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brodie J., 2014, ECOSYST RES; Bruckner G, 2010, HDB IMPORT RISK ANAL; Buller N. B, 2014, BACTERIA FUNGI FISH; Camedda A, 2014, MAR ENVIRON RES, V100, P25, DOI 10.1016/j.marenvres.2013.12.004; Campbell L, 2010, CONSERV SOC, V8, P1; Campbell RS, 1990, SURVEY DISEASES MARI; Cardenas DM, 2019, J WILDLIFE DIS, V55, P169, DOI 10.7589/2017-12-295; Baez JC, 2019, FISH RES, V212, P21, DOI 10.1016/j.fishres.2018.11.032; CARR A, 1987, MAR POLLUT BULL, V18, P352, DOI 10.1016/S0025-326X(87)80025-5; Casale P, 2010, AQUAT CONSERV, V20, P611, DOI 10.1002/aqc.1133; Casey RN, 1997, DIS AQUAT ORGAN, V31, P1, DOI 10.3354/dao031001; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chapman PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149962; Coberley SS, 2002, J VIROL, V76, P10553, DOI 10.1128/JVI.76.20.10553-10558.2002; Coberley SS, 2001, J CLIN MICROBIOL, V39, P3572, DOI 10.1128/JCM.39.10.3572-3577.2001; Committee EaCR, 2016, TOXIC TIDE THREAT MA; Cosgrove MJ, 2012, TURTLES ANATOMY ECOL; Crane O., 2013, MARINE TURTLE HLTH A; Cribb TH, 2017, INT J PARASITOL, V47, P61, DOI 10.1016/j.ijpara.2016.11.002; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Curry SS, 2000, J WILDLIFE DIS, V36, P792, DOI 10.7589/0090-3558-36.4.792; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Santos MRD, 2015, DIS AQUAT ORGAN, V115, P193, DOI 10.3354/dao02883; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Denkinger J, 2013, OCEAN COAST MANAGE, V80, P29, DOI 10.1016/j.ocecoaman.2013.03.005; Dobbs K., 2001, MARINE TURTLES GREAT; Donlan CJ, 2010, CONSERV BIOL, V24, P1586, DOI 10.1111/j.1523-1739.2010.01541.x; Donnelly K, 2015, DIS AQUAT ORGAN, V113, P257, DOI 10.3354/dao02843; Duncan EM, 2019, GLOBAL CHANGE BIOL, V25, P744, DOI 10.1111/gcb.14519; Fauquier DA, 2013, J ZOO WILDLIFE MED, V44, P364, DOI 10.1638/2012-0164R.1; Fichi G, 2016, VET MICROBIOL, V185, P56, DOI 10.1016/j.vetmic.2016.02.003; Flint J, 2013, BIGOTRY, FOOTBALL AND SCOTLAND, P3; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Foley AM, 2019, J WILDLIFE MANAGE, V83, P1057, DOI 10.1002/jwmg.21665; Foster RL, 2012, J SPEC PEDIATR NURS, V17, P1, DOI 10.1111/j.1744-6155.2011.00319.x; Garcia-Parraga D, 2014, DIS AQUAT ORGAN, V111, P191, DOI 10.3354/dao02790; George RH, 1997, BIOL SEA TURTLE; Gilman E, 2006, FISH FISH, V7, P2, DOI 10.1111/j.1467-2979.2006.00196.x; GLAZEBROOK JS, 1990, DIS AQUAT ORGAN, V9, P97, DOI 10.3354/dao009097; Godley Brendan J., 2009, Endangered Species Research, V7, P85, DOI 10.3354/esr00203; Greiner EC, 2013, BIOL SEA TURTLES, V3; HAINES H, 1978, US NMFS MAR FISH REV, V40, P33; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M, 2013, CRC MAR BIOL SER, P353; Harper KJ, 2020, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00810; Hartley M, 2017, ECOHEALTH, V14, pS16, DOI 10.1007/s10393-016-1134-8; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00432; Heppell SS, 1996, ECOL APPL, V6, P556, DOI 10.2307/2269391; Herbst L, 1999, INFECT DISEASES MARI; Herbst LH., 2002, BIOL SEA TURTLES, V2, P385; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; Jakob-Hoff RM, 2014, ORIGINAL MANUAL PROC; Jensen M. P, 2010, ASSESSING COMPOSITIO; Jones AG, 2004, CURR BIOL, V14, pR842, DOI 10.1016/j.cub.2004.09.038; Jones K, 2016, VET J, V212, P48, DOI 10.1016/j.tvjl.2015.10.041; Ventura RJ, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.1.003, 10.5365/wpsar.2015.6.1.003]; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Kirchgessner M., 2009, MANUAL EXOTIC PET PR, P207, DOI [10.1016/B978-141600119-5.50012-3, DOI 10.1016/B978-141600119-5.50012-3]; Kumar V, 2018, 38TH ANN S SEA TURTL; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; LESTER RJG, 1980, AUST J MAR FRESH RES, V31, P713; Lewbart GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096487; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Limpus C.J., 2009, BIOLOGICAL REV AUSTR; Manire CA., 2017, SEA TURTLE HLTH REHA; Manire CA, 2008, VET MICROBIOL, V130, P227, DOI 10.1016/j.vetmic.2008.01.013; Marschang R, 2014, CURRENT THERAPY REPT, P368; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Mashkour N, 2018, J VIROL METHODS, V258, P13, DOI 10.1016/j.jviromet.2018.04.004; Musick John A., 1997, P137; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Norton T., 2014, SEA TURTLE PHYS EX 2; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2004, VET J, V167, P202, DOI 10.1016/S1090-0233(03)00111-4; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Pacioni C, 2015, ECOL MANAG RESTOR, V16, P142, DOI 10.1111/emr.12155; Pavlin B, 2015, WPSAR, V6, P1; Phillott A. D., 2004, Memoirs of the Queensland Museum, V49, P701; Phillott AD, 2001, AUST J ZOOL, V49, P713, DOI 10.1071/ZO00051; Phillott AD, 2014, HERPETOL CONSERV BIO, V9, P297; Quackenbush SL, 1998, VIROLOGY, V246, P392, DOI 10.1006/viro.1998.9207; Raidal SR, 1998, AUST VET J, V76, P415, DOI 10.1111/j.1751-0813.1998.tb12392.x; Ranaivoson G., 1994, Archives de l'Institut Pasteur de Madagascar, V61, P84; Tomillo PS, 2015, GLOBAL CHANGE BIOL, V21, P2980, DOI 10.1111/gcb.12918; Santoro M, 2006, J PARASITOL, V92, P1202, DOI 10.1645/GE-866R.1; Santoro Mario, 2009, V86, P507, DOI 10.1007/978-1-4020-8278-8_48; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Senko J, 2011, OCEAN COAST MANAGE, V54, P148, DOI 10.1016/j.ocecoaman.2010.10.030; Shaver DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173920; Shimada T, 2017, OCEAN COAST MANAGE, V142, P163, DOI 10.1016/j.ocecoaman.2017.03.028; Shimada T, 2016, MAR ECOL PROG SER, V562, P163, DOI 10.3354/meps11972; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stahelin GD, 2012, MARINE TURTLE NEWSLE, V117, P3; Stamper MA, 2009, J ZOO WILDLIFE MED, V40, P196, DOI 10.1638/2007-0101.1; Stevenson MA, 2015, AUSTR EPIDEMIOLOGIST, V22, P35; SWINGLAND IR, 1978, J ZOOL, V186, P285; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tisdell C, 2002, BIODIVERS CONSERV, V11, P1521, DOI 10.1023/A:1016833300425; Torrent A, 2002, J WILDLIFE DIS, V38, P221, DOI 10.7589/0090-3558-38.1.221; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Valdivia A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210164; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Villanueva JAE, 2018, 38 ANN S SEA TURT BI; Wallace BP, 2011, GLOBAL CONSERVATION; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Warwick Clifford, 2013, JRSM Short Rep, V4, P8, DOI 10.1177/2042533313475574; Webb SJ, 2014, ENVIRON SCI TECHNOL, V48, P14728, DOI 10.1021/es504182e; White EM, 2018, ENVIRON SCI TECHNOL, V52, P10307, DOI 10.1021/acs.est.8b02776; Williams SR, 2012, J ZOO WILDLIFE MED, V43, P402, DOI 10.1638/2011-0102.1; Work PA, 2010, J EXP MAR BIOL ECOL, V393, P168, DOI 10.1016/j.jembe.2010.07.019; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Yetsko K., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.04.932632, DOI 10.1101/2020.02.04.932632]; Zavala-Norzagaray AA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00635; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003; Zinsstag J, 2015, ONE HLTH THEORY PRAC	142	8	8	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0230760	10.1371/journal.pone.0230760	http://dx.doi.org/10.1371/journal.pone.0230760			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095793	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000586649400030
J	Xue, XL; Zhou, DS; Zhou, CJ				Xue, Xianglian; Zhou, Dongsheng; Zhou, Changjun			New insights into the existing image encryption algorithms based on DNA coding	PLOS ONE			English	Article							SEQUENCE OPERATION; CHAOS THEORY; CRYPTANALYSIS; PERMUTATION; SYSTEM; SECURE	Because a DNA nucleotide sequence has the characteristics of large storage capacity, high parallelism, and low energy consumption, DNA cryptography is favored by information security researchers. Image encryption algorithms based on DNA coding have become a research hotspot in the field of image encryption and security. In this study, based on a comprehensive review of the existing studies and their results, we present new insights into the existing image encryption algorithms based on DNA coding. First, the existing algorithms were summarized and classified into five types, depending on the type of DNA coding: DNA fixed coding, DNA dynamic coding, different types of base complement operation, different DNA sequence algebraic operations, and combinations of multiple DNA operations. Second, we analyzed and studied each classification algorithm using simulation and obtained their advantages and disadvantages. Third, the DNA coding mechanisms, DNA algebraic operations, and DNA algebraic combination operations were compared and discussed. Then, a new scheme was proposed by combining the optimal coding mechanism with the optimal DNA coding operation. Finally, we revealed the shortcomings of the existing studies and the future direction for improving image encryption methods based on DNA coding.	[Xue, Xianglian] Shaanxi Univ Chinese Med, Sect Comp Teaching & Res, Xianyang, Peoples R China; [Xue, Xianglian] Xian Univ Technol, Lab Network Comp & Secur Technol Shaanxi Prov, Xian, Peoples R China; [Zhou, Dongsheng] Dalian Univ, Key Lab Adv Design & Intelligent Comp, Minist Educ, Dalian, Peoples R China; [Zhou, Changjun] Zhejiang Normal Univ, Coll Math & Comp Sci, Jinhua, Zhejiang, Peoples R China	Shaanxi University of Chinese Medicine; Xi'an University of Technology; Dalian University; Zhejiang Normal University	Xue, XL (corresponding author), Shaanxi Univ Chinese Med, Sect Comp Teaching & Res, Xianyang, Peoples R China.; Xue, XL (corresponding author), Xian Univ Technol, Lab Network Comp & Secur Technol Shaanxi Prov, Xian, Peoples R China.	xuexianglian0419@126.com		Xue, Xianglian/0000-0001-7149-5774	National Natural Science Foundation of China [61672121]; program for the Liaoning Distinguished Professor; Science and Technology Innovation Fund of Dalian [2018J12GX036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for the Liaoning Distinguished Professor; Science and Technology Innovation Fund of Dalian	Changjun Zhou 61672121 the National Natural Science Foundation of China Yes Dongsheng Zhou in part by program for the Liaoning Distinguished Professor, the Science and Technology Innovation Fund of Dalian (No.2018J12GX036). Yes There was no additional external funding received for this study.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Ahadpour ZAS, 2019, MULTIMEDIA TOOLS APP, DOI [10.1016/j.optlaseng.2019.105851, DOI 10.1016/J.OPTLASENG.2019.105851]; Akhavan A, 2017, OPT LASER TECHNOL, V95, P94, DOI 10.1016/j.optlastec.2017.04.022; Alghafis A, 2020, MATH COMPUT SIMULAT, V177, P441, DOI 10.1016/j.matcom.2020.05.016; Alghafis A, 2020, WIREL NETW, DOI 10.1007/s11276-020-02363-7; Alghafis A, 2020, PHYSICA A, V554, DOI 10.1016/j.physa.2019.123908; Ali KM, 2019, MULTIMED TOOLS APPL, V78, P32585, DOI 10.1007/s11042-019-07866-w; Ali KM, 2019, INT J THEOR PHYS, V58, P3091, DOI 10.1007/s10773-019-04188-3; [Anonymous], 2012, COMPUTER ELECT ENG, V38, P1240; [Anonymous], 2018, REGIONAL EC MANAGEME, V53, P117; [Anonymous], 2017, COMPLEXITY; Arshad U, 2020, PHYSICA A, V546, DOI 10.1016/j.physa.2019.123458; Babaei M, 2013, NAT COMPUT, V12, P101, DOI 10.1007/s11047-012-9334-9; Belazi A, 2019, IEEE ACCESS, V7, P36667, DOI 10.1109/ACCESS.2019.2906292; Belazi A, 2014, NONLINEAR DYNAM, V76, P1989, DOI 10.1007/s11071-014-1263-y; Chai XL, 2019, SIGNAL PROCESS, V155, P44, DOI 10.1016/j.sigpro.2018.09.029; Chai XL, 2017, SIGNAL PROCESS-IMAGE, V52, P6, DOI 10.1016/j.image.2016.12.007; Chai XL, 2017, OPT LASER ENG, V88, P197, DOI 10.1016/j.optlaseng.2016.08.009; Chen JX, 2018, SIGNAL PROCESS, V142, P340, DOI 10.1016/j.sigpro.2017.07.034; Dagadu J.C., 2019, INT J NETWORK SECURI, V21, P83; Dou YQ, 2017, OPTIK, V145, P456, DOI 10.1016/j.ijleo.2017.08.050; Enayatifar R, 2014, OPT LASER ENG, V56, P83, DOI 10.1016/j.optlaseng.2013.12.003; Hermassi H, 2014, MULTIMED TOOLS APPL, V72, P2211, DOI 10.1007/s11042-013-1533-6; Huang XL, 2014, MULTIMED TOOLS APPL, V72, P57, DOI 10.1007/s11042-012-1331-6; Jain A, 2016, MULTIMED TOOLS APPL, V75, P5455, DOI 10.1007/s11042-015-2515-7; Kalpana J, 2015, OPTIK, V126, P5703, DOI 10.1016/j.ijleo.2015.09.091; Khan M, 2019, NEURAL COMPUTING APP; Khan M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225031; Khan M, 2019, INT J THEOR PHYS, V58, P4293, DOI 10.1007/s10773-019-04301-6; Khan M, 2019, MULTIMED TOOLS APPL, V78, P26203, DOI 10.1007/s11042-019-07818-4; Khan M, 2019, WIRELESS PERS COMMUN, V109, P849, DOI 10.1007/s11277-019-06594-6; Khan M, 2019, INT J THEOR PHYS, V58, P2720, DOI 10.1007/s10773-019-04162-z; Kumar M, 2016, SIGNAL PROCESS, V125, P187, DOI 10.1016/j.sigpro.2016.01.017; Li X, IEEE T NANOBIOSCIENC, DOI [10.1109/TNB.2020.297164, DOI 10.1109/TNB.2020.297164]; Li X, 2016, OPTIK, V127, P2558, DOI 10.1016/j.ijleo.2015.11.221; Li X, 2017, J BIOMED NANOTECHNOL, V13, P747, DOI 10.1166/jbn.2017.2383; Liu YS, 2014, OPT LASER TECHNOL, V60, P111, DOI 10.1016/j.optlastec.2014.01.015; Mondal B, 2017, J KING SAUD UNIV-COM, V29, P499, DOI 10.1016/j.jksuci.2016.02.003; Munir N, 2020, WIREL NETW, DOI 10.1007/s11276-020-02361-9; Ozkaynak F, 2014, NONLINEAR DYNAM, V78, P1311, DOI 10.1007/s11071-014-1517-8; Rehman AU, 2018, OPTIK, V159, P348, DOI 10.1016/j.ijleo.2018.01.064; Rhouma R, 2009, CHAOS SOLITON FRACT, V40, P309, DOI 10.1016/j.chaos.2007.07.083; Shah T, WIRELESS PERSONAL CO; Shi XL, 2016, NANOSCALE, V8, P14785, DOI 10.1039/c6nr02695h; Shi XL, 2015, SOFT MATTER, V11, P8484, DOI 10.1039/c5sm00796h; Song T., 2017, ONCOTAGET, P5, DOI [10.18632/oncotarget.23733, DOI 10.18632/ONCOTARGET.23733]; Suryadi M. T., 2018, P INT C MATH PUR APP, P1; Wang B, 2020, IEEE T NANOBIOSCI, V19, P127, DOI 10.1109/TNB.2019.2942036; Wang B, 2018, IEEE ACM T COMPUT BI, V15, P999, DOI 10.1109/TCBB.2017.2679004; Wang XY, 2015, OPT LASER ENG, V73, P53, DOI 10.1016/j.optlaseng.2015.03.022; Wang XY, 2020, OPT LASER ENG, V125, DOI 10.1016/j.optlaseng.2019.105851; Wang XY, 2018, IEEE ACCESS, V6, P62272, DOI 10.1109/ACCESS.2018.2875676; Wang Y, 2015, COMPUT ELECTR ENG, V46, P433, DOI 10.1016/j.compeleceng.2015.03.011; Waseem HM, 2020, IEEE ACCESS, V8, P71821, DOI 10.1109/ACCESS.2020.2987097; Waseem HM, 2019, APPL PHYS B-LASERS O, V125, DOI 10.1007/s00340-019-7142-y; Wei XP, 2012, J SYST SOFTWARE, V85, P290, DOI 10.1016/j.jss.2011.08.017; Wu XJ, 2018, MULTIMED TOOLS APPL, V77, P12349, DOI 10.1007/s11042-017-4885-5; Wu XJ, 2018, SIGNAL PROCESS, V148, P272, DOI 10.1016/j.sigpro.2018.02.028; Wu XJ, 2015, APPL SOFT COMPUT, V37, P24, DOI 10.1016/j.asoc.2015.08.008; Wu Y, 2013, INFORM SCIENCES, V222, P323, DOI 10.1016/j.ins.2012.07.049; Xie T, 2014, OPTIK, V125, P7166, DOI 10.1016/j.ijleo.2014.07.111; Xu Guangxian, 2014, Journal of Computer Applications, V34, P3177, DOI 10.11772/j.issn.1001-9081.2014.11.3177; Xu GX, 2014, J COMPUTER APPL, V34, P3177; Xue XL, 2010, NEURAL NETW WORLD, V20, P285; Xue XL, 2010, J COMPUT THEOR NANOS, V7, P397, DOI 10.1166/jctn.2010.1372; Yang YG, 2019, OPT LASER TECHNOL, V119, DOI 10.1016/j.optlastec.2019.105661; Yin Q, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062191; Zeng L, 2015, OPTIK, V126, P5022, DOI 10.1016/j.ijleo.2015.09.219; Zhang J, 2014, MATH PROBLEMS ENG, V60, P111; Zhang J, 2016, MATH PROBL ENG, V126, P1, DOI [10.1155/2016/6408741, DOI 10.1155/2016/6408741]; Zhang LL, 2017, CHINESE PHYS B, V26, DOI 10.1088/1674-1056/26/6/064209; Zhang Q, 2013, IETE TECH REV, V30, P404, DOI 10.4103/0256-4602.123123; Zhang Q, 2013, OPTIK, V124, P6276, DOI 10.1016/j.ijleo.2013.05.009; Zhang Q, 2013, OPTIK, V124, P3596, DOI 10.1016/j.ijleo.2012.11.018; Zhang Q, 2010, MATH COMPUT MODEL, V52, P2028, DOI 10.1016/j.mcm.2010.06.005; Zhang S, 2016, MULTIMED TOOLS APPL, V75, P17157, DOI 10.1007/s11042-015-2982-x; Zhang T.T., 2018, IOP C SERIES J PHYS, V1004, DOI [10.1088/1742-6596/1004/1/012023, DOI 10.1088/1742-6596/1004/1/012023]; Zhang XC, 2017, COMPUTATIONAL INTELL, V2016, P1; Zhang YQ, 2016, OPT LASER ENG, V82, P95, DOI 10.1016/j.optlaseng.2016.02.002; Zhang Y, 2015, OPTIK, V126, P223, DOI 10.1016/j.ijleo.2014.08.129; Zhang YS, 2014, OPTIK, V125, P1562, DOI 10.1016/j.ijleo.2013.09.018; Zhen P, 2016, MULTIMED TOOLS APPL, V75, P6303, DOI 10.1007/s11042-015-2573-x; Zhou SH, 2013, COMPUTER APPL SOFTWA, V30, P318; ZHU S Q, 2017, COMPUTER APPL RES, V34, P3090; [No title captured]	86	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241184	10.1371/journal.pone.0241184	http://dx.doi.org/10.1371/journal.pone.0241184			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095816	gold, Green Published			2022-12-26	WOS:000586649400035
J	Wu, SS; Xue, LP; Legido-Quigley, H; Khan, M; Wu, H; Peng, XX; Li, XW; Li, P				Wu, Shishi; Xue, Lanping; Legido-Quigley, Helena; Khan, Mishal; Wu, Hua; Peng, Xiaoxiang; Li, Xuewen; Li, Ping			Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital	PLOS ONE			English	Article							WUHAN	As a novel concept of responding to disease epidemics, Fangcang shelter hospitals were deployed to expand the health system's capacity and provide medical services for non-severe COVID-19 patients during the outbreak in Wuhan. To give insights on patient management within Fangcang hospitals, we conducted a retrospective analysis to: 1) describe the characteristics of the patients admitted to Fangcang hospitals and 2) explore risk factors for longer length of stay (LOS). We enrolled 136 confirmed COVID-19 patients, including asymptomatic patients and those with mild symptoms, who were hospitalized in the Wuti Fangcang Hospital. 58 patients completed the treatment and discharged before 1 March 2020. After describing patients' demographic and clinical characteristics, exposure history, treatment received and time course of the disease, we conducted linear regression analysis to identify factors influencing LOS. We found that patients having fever before admission were hospitalized 3.5 days (95%CI 1.39 to 5.63, p = 0.002) longer than those without fever and that patients having bilateral pneumonia were hospitalized 3.4 days (95%CI 0.49 to 6.25, p = 0.023) longer than those with normal CT scan results. We also found weak evidence suggesting that patients with diabetes were hospitalized 3.2 days longer than those without diabetes (95%CI -0.2 to 6.56, p = 0.065). However, we observed no significant differences in LOS between symptomatic and asymptomatic patients and between patients who received treatment and those without treatment. Longer duration of hospitalization among non-severe COVID-19 patients is associated with having fever, bilateral pneumonia on CT scan and diabetes. However, being asymptomatic and using supportive medications at the early stage of infection do not have significant influences on LOS. Our study is a single-centered study with relatively small sample size. The findings provide evidence for predicting hospital bed demand in a novel response scenario and may help decision-makers in preparing for ramping up the health system capacity.	[Wu, Shishi; Legido-Quigley, Helena] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Xue, Lanping] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Neurol, Taiyuan, Shanxi, Peoples R China; [Legido-Quigley, Helena; Khan, Mishal] London Sch Hyg Trop Med, Fac Publ Hlth & Policy, London, England; [Wu, Hua] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Orthoped, Taiyuan, Shanxi, Peoples R China; [Peng, Xiaoxiang] Third Peoples Hosp Hubei Prov, Dept Neurol, Wuhan, Hubei, Peoples R China; [Li, Xuewen] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Cardiovasc Med, Taiyuan, Shanxi, Peoples R China; [Li, Ping] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Resp & Crit Care Med, Taiyuan, Shanxi, Peoples R China	National University of Singapore; University of London; London School of Hygiene & Tropical Medicine	Peng, XX (corresponding author), Third Peoples Hosp Hubei Prov, Dept Neurol, Wuhan, Hubei, Peoples R China.; Li, P (corresponding author), Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Resp & Crit Care Med, Taiyuan, Shanxi, Peoples R China.	lpys812@163.com; pengxiaoxiang@163.com			Singapore Population Health Improvement Centre (SPHERiC) - Singapore National Medical Research Council [NMRC/CG/CO26/2017_NUHS]; research project "Clinical Observation and Research on Treatment of Pneumonia with Traditional Chinese Medicine in the Qiaokou District Fangcang Hospital" - National Administration of Traditional Chinese Medicine [2020ZYLCYJ03-3]	Singapore Population Health Improvement Centre (SPHERiC) - Singapore National Medical Research Council; research project "Clinical Observation and Research on Treatment of Pneumonia with Traditional Chinese Medicine in the Qiaokou District Fangcang Hospital" - National Administration of Traditional Chinese Medicine	This study received support from the Singapore Population Health Improvement Centre (SPHERiC) (NMRC/CG/CO26/2017_NUHS), which is funded by the Singapore National Medical Research Council. This study also received support from the research project "Clinical Observation and Research on Treatment of Pneumonia with Traditional Chinese Medicine in the Qiaokou District Fangcang Hospital"(2020ZYLCYJ03-3), which is funded by National Administration of Traditional Chinese Medicine.	Ali I, 2020, DISASTER MED PUBLIC, V14, pE16, DOI 10.1017/dmp.2020.149; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Figueiredo A.M., 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.256701, DOI 10.2471/BLT.20.256701]; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Guo A, 2020, RISK FACTORS ADM ASS; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Guzzetta G, 2020, ARXIV200412338; Hou W, INFECT DIS, V2020, P1; Hu K, 2021, PHYTOMEDICINE, V85, DOI 10.1016/j.phymed.2020.153242; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hulme KD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00861; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Ji JS, 2020, SURVIVAL ANAL HOSP L; Ji W, 2020, COMP SEVERE NONSEVER; Kiernan K, 2018, IMMUNITY, V49, P6, DOI 10.1016/j.immuni.2018.06.013; Kumar A, 2020, DIABETES METAB SYND, V14, P535, DOI 10.1016/j.dsx.2020.04.044; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lopez L, 2020, NAT HUM BEHAV, V4, P746, DOI 10.1038/s41562-020-0908-8; Luo Y, 2019, AM J CHINESE MED, V47, P1223, DOI 10.1142/S0192415X19500629; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; National Health Commission, 2020, COVID 19 DIAGN TREAT; Qian YJ, 2020, INFECTION, V48, P929, DOI 10.1007/s15010-020-01508-2; Rees EM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01726-3; Schett G, 2020, NAT REV IMMUNOL, V20, P271, DOI 10.1038/s41577-020-0312-7; Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280; Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Tong ZD, 2020, EMERG INFECT DIS, V26, P1052, DOI 10.3201/eid2605.200198; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang X, 2020, CLIN MICROBIOL INFEC, V26, P1063, DOI 10.1016/j.cmi.2020.03.032; Wang ZW, 2020, BIOSCI TRENDS, V14, P64, DOI 10.5582/bst.2020.01030; Xie HS, 2020, LIVER INT, V40, P1321, DOI 10.1111/liv.14449; XU B, 2020, J INFECTION, V81, pE51, DOI 10.1016/j.jinf.2020.04.012; Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X; Yamashita T, 2007, COMMUN STAT-THEOR M, V36, P2395, DOI 10.1080/03610920701215639; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhao W, 2020, CLIN CHARACTERISTICS; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	47	25	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240959	10.1371/journal.pone.0240959	http://dx.doi.org/10.1371/journal.pone.0240959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085709	Green Accepted, Green Published, gold			2022-12-26	WOS:000585943400016
J	Brooks, MB; Mitnick, CD; Manjourides, J				Brooks, Meredith B.; Mitnick, Carole D.; Manjourides, Justin			Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; INVERSE PROBABILITY; RECURRENCE; SURVIVAL	Objective Observational tuberculosis cohort studies are often limited by a lack of long-term data characterizing survival beyond the initial treatment outcome. Though Cox proportional hazards models are often applied to these data, differential risk of long-term survival, dependent on the initial treatment outcome, can lead to violations of model assumptions. We evaluate the performance of two alternate censoring approaches on reducing bias in treatment effect estimates. Design We simulate a typical multidrug-resistant tuberculosis cohort study and use Cox proportional hazards models to assess the relationship of an aggressive treatment regimen with hazard of death. We compare three assumptions regarding censored observations to determine which produces least biased treatment effect estimates: conventional non-informative censoring, an extension of short-term survival informed by literature, and incorporation of predicted long-term vital status. Results The treatment regimen's protective effect on death is consistently underestimated by the conventional censoring method, up to 7.6%. Models using the two alternative censoring techniques produce treatment effect estimates consistently stronger and less biased than the conventional method, underestimating the treatment effect by less than 2.4% across all scenarios. Conclusions When model assumptions are violated, alternative censoring techniques can more accurately estimate associations between treatment and long-term survival. In multidrug-resistant tuberculosis cohort analyses, this bias reduction may yield more accurate and, larger effect estimates. This bias reduction can be achieved through use of standard statistical procedures with a simple re-coding of the censoring indicator.	[Brooks, Meredith B.; Mitnick, Carole D.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Brooks, Meredith B.; Manjourides, Justin] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Northeastern University	Brooks, MB (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Brooks, MB (corresponding author), Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA.	Meredith_Brooks@hms.harvard.edu	Mitnick, Carole/GRO-1991-2022	Mitnick, Carole/0000-0002-3455-658X; Brooks, Meredith/0000-0001-8431-5517	Northeastern University, Department of Health Sciences, Population Heath Doctoral Program	Northeastern University, Department of Health Sciences, Population Heath Doctoral Program	This work was supported by the Northeastern University, Department of Health Sciences, Population Heath Doctoral Program to M.B.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Centers for Disease Control and Prevention, CLIN GROWTH CHARTS; Centers of Disease Control and Prevention, 2014, MULT RES TUB FACT SH; Collett, 2003, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Franke MF, 2013, CLIN INFECT DIS, V56, P770, DOI 10.1093/cid/cis1008; Gelmanova IY, 2015, INT J TUBERC LUNG D, V19, P399, DOI 10.5588/ijtld.14.0415; Gelmanova IY, 2012, INT UN TUB LUNG DIS; Griffin BA, 2012, STAT MED, V31, P3320, DOI 10.1002/sim.5347; Howe CJ, 2011, AM J EPIDEMIOL, V173, P569, DOI 10.1093/aje/kwq385; Jackson D, 2014, STAT MED, V33, P4681, DOI 10.1002/sim.6274; Kwak N, 2016, AM J INFECT CONTROL, V44, P843, DOI 10.1016/j.ajic.2016.01.012; Lakemedelsverket, 2010, INFORM LAKEMEDELSVER, V21, P13; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Migliori GB, 2002, INT J TUBERC LUNG D, V6, P858; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mitnick CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058664; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; s NA, 2018, LANCET INFECT DIS, V18, pe228; Scharfstein DO, 2002, BIOMETRIKA, V89, P617, DOI 10.1093/biomet/89.3.617; Shin SS, 2006, EMERG INFECT DIS, V12, P687, DOI 10.3201/eid1204.041256; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Tierney DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108035; World Health Organization, 2001, 2 DEC IMPR AD HLTH D; World Health Organization, 2017, TUB FACT SHEET; Yoshida M, 2007, CLIN TRIALS, V4, P318, DOI 10.1177/1740774507081224	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240297	10.1371/journal.pone.0240297	http://dx.doi.org/10.1371/journal.pone.0240297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075072	Green Published, gold			2022-12-26	WOS:000585920200011
J	Cennamo, G; Solari, D; Montorio, D; Scala, MR; Melenzane, A; Fossataro, F; Somma, T; Tranfa, F; Cavallo, LM				Cennamo, Gilda; Solari, Domenico; Montorio, Daniela; Scala, Maria Rosaria; Melenzane, Antonietta; Fossataro, Federica; Somma, Teresa; Tranfa, Fausto; Cavallo, Luigi Maria			Early vascular modifications after endoscopic endonasal pituitary surgery: The role of OCT-angiography	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; RADIAL PERIPAPILLARY CAPILLARIES; VISUAL-FIELD RECOVERY; TRANSSPHENOIDAL SURGERY; DIABETIC-RETINOPATHY; TIME-COURSE; ADENOMAS; FEATURES; DENSITY	Purpose The aim of the present study is to analyze the changes in retinal vessel density (VD), using Optical Coherence Tomography Angiography (OCT-A), in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing optic chiasm. Methods We evaluated the VD in Superficial Capillary Plexus (SCP), Deep Capillary Plexus (DCP), Radial Peripapillary Capillary (RPC) and the Foveal Avascular Zone (FAZ) area in a series of fourteen patients (7 males, 7 females, mean age 56 +/- 13 years), as compared to healthy controls. We also detected the structural Spectral Domain (SD)-OCT parameters: Ganglion Cell Complex (GCC), Retinal Nerve Fiber Layer (RNFL), visual field parameters (Mean Deviation, Pattern Standard Deviation) and Best Corrected Visual Acuity (BCVA). These measurements were performed prior than surgery and 48 hours after. Results The patients showed a significant decrease in VD of the macular and papillary regions, a significant increase in FAZ area, a significant impairment in SD-OCT, VF parameters and BCVA respect to 14 eyes of 14 healthy controls (p<0.05), at pre-op evaluation. In patients group the VD in SCP, DCP and RPC increased after surgery respect to baseline but the difference turned to be out statistically significant only in RPC (p = 0.003). Also the BCVA (p = 0.040) and the Mean Deviation at visual field (p = 0.015) significantly improved after surgery. While there was a reduction in structural OCT parameters but it was statistically significant only in GCC (p = 0.039). A positive correlation was found between the preoperative VD of the RPC, Mean Deviation, BCVA and the postoperative Mean Deviation (r = 0.426 p = 0.027; r = 0.624 p = 0.001; r = 0.515 p = 0.006). Conclusion OCT-A allows to detect the early changes occurring within 48 hours after surgery showing that the improvement in retinal vessel density could occur before the recovery of the structural OCT parameters and can be a positive predictive factor for the functional recovery.	[Cennamo, Gilda] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Solari, Domenico; Scala, Maria Rosaria; Somma, Teresa; Cavallo, Luigi Maria] Univ Naples Federico II, Div Neurosurg, Dept Neurosci Reprod Sci & Dent, Naples, Italy; [Montorio, Daniela; Melenzane, Antonietta; Fossataro, Federica; Tranfa, Fausto] Univ Naples Federico II, Eye Clin, Dept Neurosci Reprod Sci & Dent, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Cennamo, G (corresponding author), Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.	xgilda@hotmail.com	Fossataro, Federica/AAU-9316-2021; Somma, Teresa/HGT-8889-2022; Montorio, Daniela/AAJ-8687-2020	Fossataro, Federica/0000-0001-5798-1899; CENNAMO, Gilda/0000-0003-4253-1929				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al-Louzi O, 2018, CURR OPIN ENDOCRINOL, V25, P274, DOI 10.1097/MED.0000000000000415; Bressanutti S, 2020, J CLIN MED, V9; Cappabianca P, 2014, WORLD NEUROSURG, V82, pS3, DOI 10.1016/j.wneu.2014.07.019; Cappabianca P, 2015, J NEUROSURG, V122, P473, DOI 10.3171/2014.8.JNS141716; Cavallo LM, 2019, WORLD NEUROSURG, V127, P686, DOI 10.1016/j.wneu.2019.03.048; Cavallo LM, 2019, WORLD NEUROSURG, V126, P439, DOI 10.1016/j.wneu.2019.03.125; Cennamo G, 2020, PHOTODIAGN PHOTODYN, V30, DOI 10.1016/j.pdpdt.2020.101702; Cicinelli MV, 2018, BRIT J OPHTHALMOL, V102, P1192, DOI 10.1136/bjophthalmol-2017-311317; Dallorto L, 2020, ACTA OPHTHALMOL, V98, pE585, DOI 10.1111/aos.14322; Danesh-Meyer HV, 2008, INVEST OPHTH VIS SCI, V49, P1879, DOI 10.1167/iovs.07-1127; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; Danesh-Meyer HV, 2015, J CLIN NEUROSCI, V22, P1098, DOI 10.1016/j.jocn.2015.02.001; de Carlo TE, 2015, OSLI RETINA, V46, P611, DOI 10.3928/23258160-20150610-03; de Notaris M, 2012, J NEUROSURG, V116, P622, DOI 10.3171/2011.11.JNS111162; Durbin MK, 2017, JAMA OPHTHALMOL, V135, P370, DOI 10.1001/jamaophthalmol.2017.0080; Gnanalingham KK, 2005, J NEUROL NEUROSUR PS, V76, P415, DOI 10.1136/jnnp.2004.035576; HENKIND P, 1973, BRIT J OPHTHALMOL, V57, P595, DOI 10.1136/bjo.57.8.595; HENKIND P, 1967, BRIT J OPHTHALMOL, V51, P115, DOI 10.1136/bjo.51.2.115; Higashiyama T, 2016, OSLI RETINA, V47, P724, DOI 10.3928/23258160-20160808-05; Huang D, 2016, DEV OPHTHALMOL, V56, P6, DOI 10.1159/000442770; Huang YP, 2014, OSLI RETINA, V45, P382, DOI 10.3928/23258160-20140909-08; Ishibazawa A, 2015, AM J OPHTHALMOL, V160, P35, DOI 10.1016/j.ajo.2015.04.021; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kane EJ, 2019, J NEURO-OPHTHALMOL, V39, P333, DOI 10.1097/WNO.0000000000000763; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; KORNZWEIG AL, 1968, ARCH OPHTHALMOL-CHIC, V80, P696; Lake MG, 2013, AM FAM PHYSICIAN, V88, P319; Lee S, 2013, BRIT J NEUROSURG, V27, P425, DOI 10.3109/02688697.2013.767316; M I., 1954, RETINAL CIRCULATION; Mansoori T, 2018, INT OPHTHALMOL, V38, P967, DOI 10.1007/s10792-017-0544-0; Mansoori T, 2017, J GLAUCOMA, V26, P241, DOI 10.1097/IJG.0000000000000594; Mase T, 2016, INVEST OPHTH VIS SCI, V57, pOCT504, DOI 10.1167/iovs.15-18877; McIlwaine GG, 2005, J NEURO-OPHTHALMOL, V25, P40, DOI 10.1097/00041327-200503000-00011; Mejico LJ, 2004, AM J OPHTHALMOL, V137, P908, DOI 10.1016/j.ajo.2003.12.038; Miura M, 2015, AM J OPHTHALMOL, V159, P528, DOI 10.1016/j.ajo.2014.12.002; Moein HR, 2018, RETINA-J RET VIT DIS, V38, P2277, DOI 10.1097/IAE.0000000000001902; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P7966, DOI 10.1167/iovs.11-7450; Ogra S, 2014, J CLIN NEUROSCI, V21, P735, DOI 10.1016/j.jocn.2014.01.005; Ohkubo S, 2012, JPN J OPHTHALMOL, V56, P68, DOI 10.1007/s10384-011-0093-4; Parodi MB, 2017, BRIT J OPHTHALMOL, V101, P428, DOI 10.1136/bjophthalmol-2016-308925; Parodi MB, 2018, AM J OPHTHALMOL, V187, P61, DOI 10.1016/j.ajo.2017.12.013; Parodi MB, 2018, RETINA-J RET VIT DIS, V38, P237, DOI 10.1097/IAE.0000000000001539; Parodi MB, 2017, BRIT J OPHTHALMOL, V101, P780, DOI 10.1136/bjophthalmol-2016-308869; Prieto R, 2015, WORLD NEUROSURG, V83, P500, DOI 10.1016/j.wneu.2014.10.002; Rabiolo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205773; Rao HL, 2016, AM J OPHTHALMOL, V171, P75, DOI 10.1016/j.ajo.2016.08.030; Samara WA, 2017, OPHTHALMOLOGY, V124, P235, DOI 10.1016/j.ophtha.2016.10.008; Samara WA, 2016, AM J OPHTHALMOL, V166, P76, DOI 10.1016/j.ajo.2016.03.033; Savino PJ, 2009, J NEURO-OPHTHALMOL, V29, P245, DOI 10.1097/WNO.0b013e3181b1b3d7; Schwartz DM, 2014, OPHTHALMOLOGY, V121, P180, DOI 10.1016/j.ophtha.2013.09.002; Scoles D, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-9; Solari Domenico, 2022, J Neurosurg Sci, V66, P362, DOI 10.23736/S0390-5616.19.04687-3; Solari D, 2014, HAND CLINIC, V124, P291, DOI 10.1016/B978-0-444-59602-4.00019-8; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Tan PEZ, 2015, INVEST OPHTH VIS SCI, V56, P3989, DOI 10.1167/iovs.14-15879; Yu PK, 2014, EXP EYE RES, V129, P83, DOI 10.1016/j.exer.2014.10.020; Yu SY, 2018, J CELL MOL MED, V22, P2023, DOI 10.1111/jcmm.13445; Zabel P, 2019, INVEST OPHTH VIS SCI, V60, P3447, DOI 10.1167/iovs.19-27028; Zhang L, 2012, ARCH OPHTHALMOL-CHIC, V130, P913, DOI 10.1001/archophthalmol.2011.1567	61	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241295	10.1371/journal.pone.0241295	http://dx.doi.org/10.1371/journal.pone.0241295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119707	Green Published, gold			2022-12-26	WOS:000600013600088
J	De Alencastro, L; Locatelli, I; Clair, C; Ebell, MH; Senn, N				De Alencastro, Lionel; Locatelli, Isabella; Clair, Carole; Ebell, Mark H.; Senn, Nicolas			Correlation of clinical decision-making with probability of disease: A web-based study among general practitioners	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; ALVARADO SCORE; APPENDICITIS; DIAGNOSIS; GUIDELINES; MANAGEMENT	Background Medical decision-making relies partly on the probability of disease. Current recommendations for the management of common diseases are based increasingly on scores that use arbitrary probability thresholds. Objective To assess decision-making in pharyngitis and appendicitis using a set of clinical vignettes, and the extent to which management is congruent with the true probability of having the disease. Design We developed twenty-four clinical vignettes with clinical presentations corresponding to specific probabilities of having disease defined by McIsaac (pharyngitis) or Alvarado (appendicitis) scores. Each participant answered four randomly selected web-based vignettes. Participants General practitioners (GP) working in primary care structures in Switzerland and the USA. Main measures A comparison between the GP's management decision according to the true probability of having the disease and to the GP's estimated probability, investigating the GP's ability to estimate probability of disease. Key results The mean age of the GPs was 48 years (SD 12) and 66% were men. The correlation between the GP's clinical management decision based on the vignette and the recommendations was stronger for appendicitis than pharyngitis (k(w) = 0.74, 95% CI 0.70-0.78 vs. k(w) = 0.66, 95% CI 0.62-0.71). On the other hand, the association between the clinical management decision and the probability of disease estimated by GPs was more congruent with recommendations for pharyngitis than appendicitis (k(w) = 0.70, 95% CI 0.660.73 vs. 0.61, 95% CI 0.56-0.66). Only a minority of GPs correctly estimated the probability of disease (29% for appendicitis and 39% for pharyngitis). Conclusions Despite the fact that general practitioners often misestimate the probability of disease, their management decisions are usually in line with recommendations. This means that they use other approaches, perhaps more subjective, to make decisions, such as clinical judgment or reasoning that integrate factors other than just the risk of the disease.	[De Alencastro, Lionel; Locatelli, Isabella; Clair, Carole; Senn, Nicolas] Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland; [Ebell, Mark H.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia	De Alencastro, L (corresponding author), Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland.	Lionel.De-Alencastro@unisante.ch	Clair, Carole/D-9786-2014; Clair, Carole/AAF-6675-2021	Clair, Carole/0000-0001-5281-0943; Clair, Carole/0000-0001-5281-0943				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; [Anonymous], 1994, J Dent Educ, V58, P648; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; CDC, 1995, NAT AMB MED CAR SURV; Chang AM, 2007, ACAD EMERG MED, V14, P599, DOI 10.1197/j.aem.2007.03.1355; Chen EH, 2008, ACAD EMERG MED, V15, P414, DOI 10.1111/j.1553-2712.2008.00100.x; Cherry Donald K, 2002, Adv Data, P1; Coward S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165161; Ebell MH, 2018, BRIT J GEN PRACT, V68, pE765, DOI 10.3399/bjgp18X699545; Ebell Mark H, 2015, Evid Based Med, V20, P41, DOI 10.1136/ebmed-2014-110140; Ebell MH, 2014, ANN EMERG MED, V64, P365, DOI 10.1016/j.annemergmed.2014.02.025; EISENBERG JM, 1983, MED DECIS MAKING, V3, P155, DOI 10.1177/0272989X8300300203; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Tan WJ, 2015, J AM COLL SURGEONS, V220, P218, DOI 10.1016/j.jamcollsurg.2014.10.010; Tan WJ, 2013, ANZ J SURG, V83, P748, DOI 10.1111/ans.12076; Tsugawa Y, 2017, JAMA INTERN MED, V177, P206, DOI 10.1001/jamainternmed.2016.7875; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241210	10.1371/journal.pone.0241210	http://dx.doi.org/10.1371/journal.pone.0241210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119623	gold, Green Published			2022-12-26	WOS:000600013600096
J	Dempsey, G; Hungerford, D; McHale, P; McGarey, L; Benison, E; Morton, B				Dempsey, Ged; Hungerford, Dan; McHale, Phil; McGarey, Lauren; Benison, Edward; Morton, Ben			Long term outcomes for elderly patients after emergency intensive care admission: A cohort study	PLOS ONE			English	Article							MORTALITY; ICU; FRAILTY; TRIAGE; IMPACT; OLDER	Background Elderly patients (>= 80 years of age) surviving an episode of critical illness suffer long-term morbidity and risk of mortality. Identifying high risk groups could assist in informing discussions with patients and families. Aim To determine factors associated with long-term survival following ICU admission. Design A cohort study of patients aged >= 80 years of age admitted to the ICU as an emergency. Methods Patients admitted from January 2010 to December 2018 were included in the study. Primary outcome was five year survival. Mortality was assessed using a multivariable flexible parametric survival analysis adjusted for demographics, and clinically relevant covariates. Results There were 828 patients. Mean age was 84 years (SD 3.2) and 419 (51%) were male. Patients were categorised into medical (423 (51%)) and surgical (405 (49%)) admissions. Adjusted hazard ratios (aHR) for mortality were highest for serum lactate (>8 mmol/l aHR 2.56 (C.I. 1.79-3.67)), lowest systolic blood pressure (< 70 mmHg aHR 2.04 (C.I. 1.36-3.05)) and pH (< 7.05 aHR 4.70 (C.I 2.67-8.21)). There were no survivors beyond one year with severe abnormalities of pH and lactate (< 7.05 and > 8 mmol/l respectively). Relative survival for medical patients was below that expected for the general population for the duration of the study. Conclusion Overall five-year survival was 27%. For medical and surgical patients it was 19% and 35% respectively. Survival at 30 days and one year was 61% and 46%. The presence of features of circulatory shock predicted poor short and long term survival.	[Dempsey, Ged; McGarey, Lauren; Benison, Edward; Morton, Ben] Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Hungerford, Dan] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [McHale, Phil] Univ Liverpool, Inst Populat Hlth Sci, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Morton, Ben] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Morton, Ben] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre, Malawi	University of Liverpool; University of Liverpool; Liverpool School of Tropical Medicine; University of Malawi	Dempsey, G (corresponding author), Liverpool Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England.	ged.dempsey@aintree.nhs.uk		Hungerford, Daniel/0000-0002-9770-0163; Benison, Edward/0000-0001-6986-7153; Morton, Ben/0000-0002-6164-2854				Andersen FH, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0053-0; Anderson F, 1996, J PALLIAT CARE, V12, P5, DOI 10.1177/082585979601200102; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Atramont A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3215; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Boumendil A, 2005, J AM GERIATR SOC, V53, P88, DOI 10.1111/j.1532-5415.2005.53016.x; Chin-Yee N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1689-y; de Rooij SE, 2006, INTENS CARE MED, V32, P1039, DOI 10.1007/s00134-006-0171-0; de Rooij SE, 2007, CRIT CARE, V11, DOI 10.1186/cc5716; Dickman PW, 2015, STATA J, V15, P186, DOI 10.1177/1536867X1501500112; Flaatten H, 2017, INTENS CARE MED, V43, P1319, DOI 10.1007/s00134-017-4718-z; Flaatten H, 2017, INTENS CARE MED, V43, P1820, DOI 10.1007/s00134-017-4940-8; Fuchs L, 2012, INTENS CARE MED, V38, P1654, DOI 10.1007/s00134-012-2629-6; Groll DL, 2006, AM J PHYS MED REHAB, V85, P574, DOI 10.1097/01.phm.0000223220.91914.61; Guidet B, 2017, JAMA-J AM MED ASSOC, V318, P1450, DOI 10.1001/jama.2017.13889; Guidet B, 2014, J CRIT CARE, V29, P896, DOI 10.1016/j.jcrc.2014.08.004; Haas LEM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1061-z; Heyland DK, 2016, CRIT CARE MED, V44, P1718, DOI 10.1097/CCM.0000000000001762; Heyland DK, 2013, JAMA INTERN MED, V173, P778, DOI 10.1001/jamainternmed.2013.180; Jones A, 2020, CRIT CARE MED, V48; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lown DJ, 2013, CRIT CARE RESUSC, V15, P49; Muscedere J, 2017, INTENS CARE MED, V43, P1105, DOI 10.1007/s00134-017-4867-0; Nielsson MS, 2014, ACTA ANAESTH SCAND, V58, P19, DOI 10.1111/aas.12211; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Philippart F, 2013, INTENS CARE MED, V39, P1565, DOI 10.1007/s00134-013-2976-y; Pietilainen L, 2018, INTENS CARE MED, V44, P1221, DOI 10.1007/s00134-018-5273-y; Roch A, 2011, CRIT CARE, V15, DOI 10.1186/cc9984; Sprung CL, 2012, CRIT CARE MED, V40, P132, DOI 10.1097/CCM.0b013e318232d6b0	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241244	10.1371/journal.pone.0241244	http://dx.doi.org/10.1371/journal.pone.0241244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119649	Green Published, Green Accepted, gold			2022-12-26	WOS:000600013600012
J	Gu, JJ; Hoj, J; Rouse, C; Pendergast, AM				Gu, Jing Jin; Hoj, Jacob; Rouse, Clay; Pendergast, Ann Marie			Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells	PLOS ONE			English	Article							TUMOR-STROMA RATIO; MATRIX METALLOPROTEINASES; ABL KINASES; GROWTH; MICROENVIRONMENT; PROGRESSION; RESISTANCE; SURVIVAL	Mesenchymal stem cells (MSCs) are recruited and activated by solid tumors and play a role in tumor progression and metastasis. Here we show that MSCs promote metastasis in a panel of non-small cell lung cancer (NSCLC) cells. MSCs elicit transcriptional alterations in lung cancer cells leading to increased expression of factors implicated in the epithelial-to-mesenchymal transition (EMT) and secreted proteins including matrix metalloproteinase-9 (MMP9). MSCs enhance secretion of enzymatically active MMP9 in a panel of lung adenocarcinoma cells. High expression of MMP9 is linked to low survival rates in lung adenocarcinoma patients. Notably, we found that ABL tyrosine kinases are activated in MSC-primed lung cancer cells and functional ABL kinases are required for MSC-induced MMP9 expression, secretion and proteolytic activity. Importantly, ABL kinases are required for MSC-induced NSCLC metastasis. These data reveal an actionable target for inhibiting MSC-induced metastatic activity of lung adenocarcinoma cells through disruption of an ABL kinase-MMP9 signaling axis activated in MSC-primed lung cancer cells.	[Gu, Jing Jin; Hoj, Jacob; Pendergast, Ann Marie] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Rouse, Clay] Duke Univ, Sch Med, Div Lab Anim Resources, Durham, NC USA	Duke University; Duke University	Pendergast, AM (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	ann.pendergast@duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	NIH NCI [R01CA195549, F31CA22496001, F99CA245732-01, 5T32GM007105-44]; Lung Cancer Research Foundation; Duke SPORE in Brain Cancer grant [P50CA190991]; Emerson Collective	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Research Foundation; Duke SPORE in Brain Cancer grant; Emerson Collective	This work was supported by NIH NCI grants R01CA195549 (A.M.P.), F31CA22496001 (J.P.H.), F99CA245732-01 (J.P.H.), and 5T32GM007105-44 (J.P.H.), the Lung Cancer Research Foundation Free to Breathe Metastasis Research Grant (A.M.P.), the Emerson Collective, and the Duke SPORE in Brain Cancer grant (P50CA190991).	[Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2019, CIRCULATION, V2019; Boire A, 2017, CELL, V168, P1101, DOI 10.1016/j.cell.2017.02.025; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Cheng B, 2020, J THORAC DIS, V12, P1056, DOI 10.21037/jtd.2020.03.11; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Fregni G, 2018, EBIOMEDICINE, V29, P128, DOI 10.1016/j.ebiom.2018.02.017; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hoj JP, 2019, CELL REP, V29, P3421, DOI 10.1016/j.celrep.2019.11.018; Hrustanovic G, 2013, CANCER BIOL THER, V14, P304, DOI 10.4161/cbt.23627; Hughes TP, 2019, NEW ENGL J MED, V381, P2315, DOI 10.1056/NEJMoa1902328; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Liu RW, 2014, CANCER LETT, V353, P145, DOI 10.1016/j.canlet.2014.07.047; Martin FT, 2010, BREAST CANCER RES TR, V124, P317, DOI 10.1007/s10549-010-0734-1; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Melzer C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0143-0; Miller KD, 2004, CLIN CANCER RES, V10, P1971, DOI 10.1158/1078-0432.CCR-03-0968; Minamoto H, 2003, HISTOPATHOLOGY, V43, P427, DOI 10.1046/j.1365-2559.2003.01704.x; Neel DS, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0007-0; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Owyong M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800226; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Ridge SM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0597-8; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Simpson MA, 2015, J BIOL CHEM, V290, P8360, DOI 10.1074/jbc.M115.638874; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Sun B, 2009, CYTOTHERAPY, V11, P289, DOI 10.1080/14653240902807026; Takigawa H, 2017, NEOPLASIA, V19, P429, DOI 10.1016/j.neo.2017.02.010; Tamura T, 2015, MOL CLIN ONCOL, V3, P217, DOI 10.3892/mco.2014.410; Trivanovic D, 2018, DEV DYNAM, V247, P359, DOI 10.1002/dvdy.24583; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wang J, 2015, TRENDS CANCER, V1, P110, DOI 10.1016/j.trecan.2015.07.004; Wang J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad3210; Wylie AA, 2017, NATURE, V543, P733, DOI 10.1038/nature21702; Xi KX, 2017, J THORAC DIS, V9, P4017, DOI 10.21037/jtd.2017.09.29; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yousef EM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-609; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang K, 2018, MOL BIOL CELL, V29, P2863, DOI 10.1091/mbc.E18-01-0044; Zhang TH, 2015, INT J CLIN EXP PATHO, V8, P11348	48	16	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241423	10.1371/journal.pone.0241423	http://dx.doi.org/10.1371/journal.pone.0241423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119681	gold, Green Published			2022-12-26	WOS:000600013600106
J	Afaya, RA; Bam, V; Azongo, TB; Afaya, A				Afaya, Richard Adongo; Bam, Victoria; Azongo, Thomas Bavo; Afaya, Agani			Knowledge of chronic complications of diabetes among persons living with type 2 diabetes mellitus in northern Ghana	PLOS ONE			English	Article							COMPLEXITY; ADULTS	Introduction Diabetes mellitus is a complex disease that affects many organ systems, leading to concerns about deteriorating population health status and ever-increasing healthcare expenditure. Many people with diabetes do not achieve optimal glycaemic control and other metabolic indices, leading to a heightened risk of developing complications. Adequate knowledge of diabetes complications is a prerequisite for risk-factor reduction and prevention of the consequences of the disease. Therefore, this study aimed to evaluate the knowledge of chronic complications of diabetes among persons living with type 2 diabetes mellitus in northern Ghana. Method A descriptive cross-sectional study was conducted among 320 patients with type 2 diabetes mellitus in northern Ghana. The consecutive sampling technique was employed to recruit participants from September to November 2018. Data analysis was performed using IBM statistical package for social science version 23. Descriptive statistics such as frequencies and percentages were used. Both bivariate and multivariate logistic regression analysis were employed to determine associations between knowledge of diabetes complications and demographic/clinical characteristics of participants, at 95% confidence interval with statistical significance at P0.05. Results The majority of participants (54.1%) had inadequate knowledge and 45.9% had adequate knowledge of diabetes complications. The factors associated with inadequate level of knowledge were female gender [AOR = 0.29 (95%CI: 0.14-0.56), p<0.001], older age [AOR = 0.45 (95%CI:0.20-0.99), p = 0.049], primary education [AOR = 0.13 (95%CI: 0.03-0.51), p = 0.004], no formal education [AOR = 0.16 (95%CI: 0.05-0.50), p = 0.002], rural dwellers [AOR = 0.50 (95%CI: 0.27-0.95), p = 0.033] and unknown family history diabetes [AOR = 0.38 (95%CI: 0.17-0.82), p = 0.014]. Conclusion More than half of the studied population had inadequate knowledge of diabetes complications. Female gender, rural dwellers, and low education level were factors positively associated with inadequate knowledge of diabetes complications. A multisectoral approach is needed, where the government of Ghana together with other sectors of the economy such as the health, education and local government sectors work collaboratively in the development of locally tailored diabetes education programmes to promote healthy self-care behaviours relevant for the prevention of diabetes and its complications.	[Afaya, Richard Adongo] Tamale West Hosp, Dept Surg, Tamale, Ghana; [Afaya, Richard Adongo; Bam, Victoria] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana; [Azongo, Thomas Bavo] Univ Dev Studies, Sch Allied Hlth Sci, Dept Publ Hlth, Tamale, Ghana; [Afaya, Agani] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Dept Nursing, Ho, Ghana; [Afaya, Agani] Yonsei Univ, Coll Nursing, Seoul, South Korea	Kwame Nkrumah University Science & Technology; University for Development Studies; Yonsei University; Yonsei University Health System	Afaya, RA (corresponding author), Tamale West Hosp, Dept Surg, Tamale, Ghana.; Afaya, RA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana.	afayarich@gmail.com						Almetwazi M, 2019, SAUDI PHARM J, V27, P384, DOI 10.1016/j.jsps.2018.12.007; Amissah I., 2014, INT J SCI RES, V3, P2104; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; [Anonymous], 2014, NYU ENVTL LJ, V21; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2018, IEEE T SYSTEMS MAN C, P1, DOI DOI 10.2861/86313; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; [Anonymous], 2019, MONTHLY NEWSLETTER M; [Anonymous], 2018, J HIST MODERN THEOLO, V25, p[1, 21]; Blaum CS, 2010, MED CARE, V48, P327, DOI 10.1097/MLR.0b013e3181ca4035; Bos M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-387; Cook-Huynh M, 2012, ETHNIC DIS, V22, P347; de-Graft Aikins Ama, 2007, Ghana Med J, V41, P154; DEEPALI BS, 2017, INT J COMMUNITY MED, V4, P2428, DOI DOI 10.18203/2194-6040.IJCMPH20172836; Desalu O O, 2011, Ghana Med J, V45, P60; Doherty ML, 2014, BMC PUBLIC HEALTH, V14, P1; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Gatimu SM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3845-8; Global Health Estimates, 2016, DIS BURD CAUS AG SEX; Gulabani Michell, 2008, Indian J Community Med, V33, P204, DOI 10.4103/0970-0218.42068; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; International Diabetes Federation, 2015, IDF DIABETES ATLAS; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Konduru S, 2017, INDIAN J PHARM PRACT, V10, P32, DOI [10.5530/ijopp.10.1.8, DOI 10.5530/IJOPP.10.1.8]; Kuruvatti J, 2002, PRACT DIABETES INT, V19, P160; Malik S, 2013, MED CARE, V51, P180, DOI 10.1097/MLR.0b013e318273119b; Mao WH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6569-8; Ministry of Health, 2015, PHARM COUNC GHAN; Mogre V, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0169-3; Murugesan N, 2007, DIABETES RES CLIN PR, V77, P433, DOI 10.1016/j.diabres.2007.01.004; Nisar N, 2008, PAK J MED SCI, V24, P667; Nowakowska M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1373-y; Obirikorang Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3311-7; que MA., 2009, J MED, V10, P90; Roglic G., 2016, INT J NONCOMMUN DIS, V1, P3, DOI [10.4103/2468-8827.184853, DOI 10.4103/2468-8827.184853]; Sabri Ahmad Ayaz, 2007, Mcgill J Med, V10, P87; Saleh F, 2012, BMC PUBLIC HEALTH, V12, P1; Sarfo IA, 2016, EUR J MED, V13, P73; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Tracey ML, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2818-2; Yamane T, 1967, STAT INTRO ANAL	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241424	10.1371/journal.pone.0241424	http://dx.doi.org/10.1371/journal.pone.0241424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112906	Green Published, gold			2022-12-26	WOS:000588374000054
J	Furbeyre, H; Labussiere, E				Furbeyre, Hauteclaire; Labussiere, Etienne			A minimally invasive catheterization of the external jugular vein in suckling piglets using ultrasound guidance	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; INFLAMMATORY CYTOKINES; PLACEMENT; FEATURES; GROWTH	There is a growing interest for minimally invasive surgical procedures to improve experimental animal welfare. Minimally invasive catheterization procedures in pigs have been already developed using Seldinger technique but reproducibility is low, especially in young pigs. A novel method for a minimally invasive catheterization of external jugular vein was evaluated in suckling piglets of 21 days of age. Growth performance and haptoglobin concentration in plasma were measured throughout a four-week study in a group of seven catheterized piglets and a group of seven non-catheterized piglets. Catheterization was performed using Seldinger technique under continuous ultrasound monitoring for vein detection and needle insertion. The surgical procedure was quick and showed a great reproducibility. All catheters remained functional during the first week after catheterization. Catheterization in piglets did not significantly affect body weight (BW) and feed intake during four weeks after the surgical intervention compared to non-catheterized piglets (P > 0.10). Haptoglobin concentration in plasma was greater in catheterized piglets compared with non-catheterized piglets, with a significant increase over two weeks after catheter insertion (P < 0.05), suggesting the development of a chronic inflammation in catheterized piglets. This method can be easily performed in piglets with minimal effect on growth and feeding behaviour. Transposition to heavier pigs should be considered.	[Furbeyre, Hauteclaire; Labussiere, Etienne] INRAE, Inst Agro, PEGASE, St Gilles, France	INRAE; Institut Agro	Labussiere, E (corresponding author), INRAE, Inst Agro, PEGASE, St Gilles, France.	etienne.labussiere@inrae.fr		Furbeyre, Hauteclaire/0000-0002-7428-5489	public organism France Agri Mer	public organism France Agri Mer	This work was financially supported by the public organism France Agri Mer (https://www.franceagrimer.fr).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, LUMIERE VIE CAHIER B, V44, P24; [Anonymous], 1999, INV DEALERS DIG, V65, P29; Bain S A, 1991, J Invest Surg, V4, P103; Bomba L, 2014, FUNCT INTEGR GENOMIC, V14, P657, DOI 10.1007/s10142-014-0396-x; Castillo M, 2006, J ANIM SCI, V84, P2725, DOI 10.2527/jas.2004-556; de Jong IC, 2000, CAN J ANIM SCI, V80, P273, DOI 10.4141/A99-085; Epstein ME, 2014, HDB VET PAIN MANAGEM, P161; Flournoy WS, 2009, LAB ANIM-UK, V43, P344, DOI 10.1258/la.2009.0080092; Forauer AR, 2006, RADIOLOGY, V240, P427, DOI 10.1148/radiol.2402031129; Fudge M, 2002, CONTEMP TOP LAB ANIM, V41, P38; Gasthuys E, 2017, LAB ANIM-UK, V51, P498, DOI 10.1177/0023677217692372; Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023; GREENFELD JI, 1995, CRIT CARE MED, V23, P894, DOI 10.1097/00003246-199505000-00018; Johnson RW, 1997, J ANIM SCI, V75, P1244; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Kohler TR, 1998, J VASC SURG, V28, P59, DOI 10.1016/S0741-5214(98)70200-9; Larsson N, 2015, LAB ANIM-UK, V49, P215, DOI 10.1177/0023677215575222; Lombardo Carlo, 2010, Acta Biomed, V81, P101; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Matte JJ, 1999, LAB ANIM, V33, P258, DOI 10.1258/002367799780578101; Miller AH, 2002, ACAD EMERG MED, V9, P800, DOI 10.1111/j.1553-2712.2002.tb02168.x; National Research Council, 2010, REC ALL PAIN LAB AN, P71; NOBLET J, 1989, J ANIM SCI, V67, P3352; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Sauerwein H, 2005, REDOX REP, V10, P295, DOI 10.1179/135100005X83725; Skok J, 2007, ACTA AGR SCAND A-AN, V57, P129, DOI 10.1080/09064700801907089; Spinka M, 1997, J ANIM SCI, V75, P1223; Sun YN, 2017, ASIAN AUSTRAL J ANIM, V30, P267, DOI 10.5713/ajas.16.0215; TAKKEN A, 1981, AUST VET J, V57, P17, DOI 10.1111/j.1751-0813.1981.tb07078.x; Tan RHH, 2003, AUST VET J, V81, P136, DOI 10.1111/j.1751-0813.2003.tb11074.x; Usvald D, 2008, VET MED-CZECH, V53, P365, DOI 10.17221/1992-VETMED; Vesely TM, 2003, J VASC INTERV RADIOL, V14, P527, DOI 10.1097/01.RVI.0000071097.76348.72	32	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241444	10.1371/journal.pone.0241444	http://dx.doi.org/10.1371/journal.pone.0241444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112934	Green Published, gold			2022-12-26	WOS:000588374000011
J	Muwonge, TR; Nsubuga, R; Brown, C; Nakyanzi, A; Bagaya, M; Bambia, F; Katabira, E; Kyambadde, P; Baeten, JM; Heffron, R; Celum, C; Mujugira, A; Haberer, JE				Muwonge, Timothy R.; Nsubuga, Rogers; Brown, Charles; Nakyanzi, Agnes; Bagaya, Monica; Bambia, Felix; Katabira, Elly; Kyambadde, Peter; Baeten, Jared M.; Heffron, Renee; Celum, Connie; Mujugira, Andrew; Haberer, Jessica E.			Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; ADHERENCE; ACCEPTABILITY; TRIALS	Background Scale-up of oral pre-exposure prophylaxis (PrEP) for HIV prevention in Uganda began with serodiscordant couples (SDC) and has expanded to other most at-risk populations (MARPs). We explored knowledge, acceptability, barriers and facilitators of PrEP use among potential PrEP users in four MARPs (SDC; men who have sex with men [MSM]; female sex workers [FSW], and fisher folk). Methods We administered quantitative surveys to potential PrEP users in multiple settings in Central Uganda at baseline and approximately 9 months after healthcare worker (HCW) training on PrEP. Results The survey was completed by 250 potential PrEP users at baseline and 125 after HCW training; 55 completed both surveys. For these 250 participants, mean age was 28.5 years (SD 6.9), 47% were male and 6% were transgender women, with approximately even distribution across MARPs and recruitment locations (urban, peri-urban, and rural). Most (65%) had not heard about PrEP. After HCW training, 24% of those sampled were aware of PrEP, and the proportion of those who accurately described PrEP as "antiretrovirals to be used before HIV exposure" increased from 54% in the baseline survey to 74% in the second survey (p<0.001). The proportion of participants who reported HCW as a source of PrEP information increased after training (59% vs 91%, p<0.001). In both surveys, nearly all participants indicated they were willing to take PrEP if offered. The most common anticipated barriers to PrEP were stigma, transportation, accessibility, busy schedules, and forgetfulness. Closeness to home was a common facilitator for all participant categories. Conclusions Initial awareness of PrEP was low, but PrEP knowledge and interest increased among diverse MARPs after HCW training. Demand creation and HCW training will be critical for increasing PrEP awareness among key populations, with support to overcome barriers to PrEP use. These findings should encourage the acceleration of PrEP rollout in Uganda.	[Muwonge, Timothy R.; Nsubuga, Rogers; Brown, Charles; Nakyanzi, Agnes; Bagaya, Monica; Bambia, Felix; Mujugira, Andrew] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Kyambadde, Peter] Most At Risk Populat Initiat, Kampala, Uganda; [Kyambadde, Peter] Minist Hlth, STD AIDS Control Program, Kampala, Uganda; [Baeten, Jared M.; Heffron, Renee; Celum, Connie] Univ Washington, Dept Global Hlth Med & Epidemiol, Seattle, WA 98195 USA; [Haberer, Jessica E.] Massachusetts Gen Hosp Global Hlth, Dept Gen Internal Med, Boston, MA USA	Makerere University; Makerere University; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital	Muwonge, TR (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	tmuwonge@idi.co.ug		Mujugira, Andrew/0000-0001-6646-6733; Nsubuga, Rogers/0000-0002-2674-7052	National Institute of Mental Health [R01 MH098744, K24MH114732]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported through a research grant from the National Institute of Mental Health (grant number R01 MH098744 to JEH). JEH was additionally supported by K24MH114732. The authors designed and executed the study, had full access to the raw data, performed all analyses, wrote the manuscript, and had final responsibility for the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, **DROPPED REF**, V13, pE40; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Chou R, 2019, JAMA-J AM MED ASSOC, V321, P2214, DOI 10.1001/jama.2019.2591; de Mendoza C, 2019, AIDS REV, V21, P170; Djomand G, 2020, MMWR-MORBID MORTAL W, V69, P212, DOI 10.15585/mmwr.mm6908a3; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Haberer JE, 2016, CURR OPIN HIV AIDS, V11, P10, DOI 10.1097/COH.0000000000000220; Heffron Renee, 2017, Gates Open Res, V1, P3, DOI 10.12688/gatesopenres.12752.2; Hodges-Mameletzis I, 2019, DRUGS, V79, P1263, DOI 10.1007/s40265-019-01143-8; Huang XJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00799; Kay ES, 2020, AM J PUBLIC HEALTH, V110, P61, DOI 10.2105/AJPH.2019.305389; Koenig LJ, 2013, AM J PREV MED, V44, pS91, DOI 10.1016/j.amepre.2012.09.047; Krakower DS, 2016, CURR OPIN HIV AIDS, V11, P41, DOI 10.1097/COH.0000000000000206; McCormack SM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21103; Minisrty of Health Uganda, 2016, TECHN GUID PREEXP PR; Ministry of Health Uganda, 2017, UG POP BAS HIV IMP A; Ministry of Health Uganda, 2016, CONS GUID PREV TREAT; MOH, 2018, CONS GUID PREV TREAT; PEPFAR, 2018, UG COUNTR OP PLAN CO; President's Emergency Plan for AIDS Relief (PEPFAR), 2019, UG COUNTR OP PLAN CO; Sidebottom D, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3463-4; Timothy RM, 2020, 15 INT C HIV TREATM; Uganda AIDS. Commission, 2015, EXTENDED ZIMBABWE NA; Uganda MoH, 2010, NAT IMPL GUID HIV CO; UNAIDS, 2014, FAST TRACK END AIDS; United States Agency for International Development, 2019, TARG SETT PREP PREP; Van der Elst EM, 2013, AIDS BEHAV, V17, P2162, DOI 10.1007/s10461-012-0317-8; World Health Organization, 2018, UPD REC 1 LIN 2 LIN	29	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241399	10.1371/journal.pone.0241399	http://dx.doi.org/10.1371/journal.pone.0241399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112907	Green Published, gold			2022-12-26	WOS:000588374000071
J	Bradshaw, DJ; Dickens, NJ; Trefry, JH; McCarthy, PJ				Bradshaw, David J., II; Dickens, Nicholas J.; Trefry, John H.; McCarthy, Peter J.			Defining the sediment prokaryotic communities of the Indian River Lagoon, FL, USA, an Estuary of National Significance	PLOS ONE			English	Article							ST-LUCIE ESTUARY; HEAVY-METALS; GEN. NOV.; MICROBIAL COMMUNITIES; SOUTH FLORIDA; WATER; CONTAMINATION; SOLUBILITY; COASTAL	The Indian River Lagoon, located on the east coast of Florida, USA, is an Estuary of National Significance and an important economic and ecological resource. The Indian River Lagoon faces several environmental pressures, including freshwater discharges through the St. Lucie Estuary; accumulation of anoxic, fine-grained, organic-rich sediment; and metal contamination from agriculture and marinas. Although the Indian River Lagoon has been well-studied, little is known about its microbial communities; thus, a two-year 16S amplicon sequencing study was conducted to assess the spatiotemporal changes of the sediment bacterial and archaeal groups. In general, the Indian River Lagoon exhibited a prokaryotic community that was consistent with other estuarine studies. Statistically different communities were found between the Indian River Lagoon and St. Lucie Estuary due to changes in porewater salinity causing microbes that require salts for growth to be higher in the Indian River Lagoon. The St. Lucie Estuary exhibited more obvious prokaryotic seasonality, such as a higher relative abundance of Betaproteobacteriales in wet season and a higher relative abundance of Flavobacteriales in dry season samples. Distance-based linear models revealed these communities were more affected by changes in total organic matter and copper than changes in temperature. Anaerobic prokaryotes, such as Campylobacterales, were more associated with high total organic matter and copper samples while aerobic prokaryotes, such as Nitrosopumilales, were more associated with low total organic matter and copper samples. This initial study fills the knowledge gap on the Indian River Lagoon bacterial and archaeal communities and serves as important data for future studies to compare to determine possible future changes due to human impacts or environmental changes.	[Bradshaw, David J., II; Dickens, Nicholas J.; McCarthy, Peter J.] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Dept Biol Sci, Ft Pierce, FL 34946 USA; [Trefry, John H.] Florida Inst Technol, Dept Ocean Engn & Marine Sci, Melbourne, FL 32901 USA	Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; Florida Institute of Technology	Bradshaw, DJ (corresponding author), Florida Atlantic Univ, Harbor Branch Oceanog Inst, Dept Biol Sci, Ft Pierce, FL 34946 USA.	dbradshaw2015@fau.edu	Bradshaw, David/GRS-5224-2022; Dickens, Nicholas/G-1445-2013	Dickens, Nicholas/0000-0003-0492-5855; Bradshaw, David/0000-0002-7295-2962	Harbor Branch Oceanographic Institute (HBOI) Foundation; Everglades Foundation; Save Our Seas Specialty License Plate through the HBOI Foundation	Harbor Branch Oceanographic Institute (HBOI) Foundation; Everglades Foundation; Save Our Seas Specialty License Plate through the HBOI Foundation	This research was supported by the following organizations and agencies: the Harbor Branch Oceanographic Institute (HBOI) Foundation (https://hboifoundation.org/) (DJB, NJD), the Everglades Foundation (https://evergladesfoundation.org/) (DJB), and the Save Our Seas Specialty License Plate which are granted through the HBOI Foundation (https://myfloridaspecialtyplate.com/save-our-seas.html) (PJM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A., 2017, MSYSTEMS, V2, DOI [DOI 10.1128/MSYSTEMS.00191-16, 10.1128/mSystems.00191-16]; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2012, ACTA OBSTET GYNAECOL, V64, P1029; Australian and New Zealand Environment and Conservation Council [ANZECC], 2000, AUSTR NZ GUID FERSH; Badylak S, 2004, J PLANKTON RES, DOI [10.1093/plankt/fbh073, DOI 10.1093/PLANKT/FBH07321258622]; Behera P, 2017, SCI TOTAL ENVIRON, DOI [10.1016/j.scitotenv.2017.03.271, DOI 10.1016/J.SCITOTENV.2017.03.27128395262]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besaury L, 2014, MAR BIOTECHNOL, DOI [10.1007/s10126-013-9542-z, DOI 10.1007/S10126-013-9542-Z24072336]; Bolyen E, 2019, NAT BIOTECHNOL, DOI [10.1038/s41587-019-0209-9, DOI 10.1038/S41587-019-0209-931341288]; Bondoso J, 2015, SYST APPL MICROBIOL, DOI [10.1016/j.syapm.2014.10.004, DOI 10.1016/J.SYAPM.2014.10.00425487949]; Bradshaw DJ, 2020, PRJNA594146; Bradshaw DJ, 2020, GENERAL 16S AMPLICON; Brenner DJ, 2005, BERGEYS MANUAL SYSTE, V2, DOI [10.1007/0-387-29298-5, DOI 10.1007/0-387-28021-9, 10.1007/0-387-28021-9]; Campbell BJ, 2011, P NATL ACAD SCI USA, DOI [10.1073/pnas.1101405108, DOI 10.1073/PNAS.110140510821768380]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Clarke K. R., 2015, PRIMER V7 USER MANUA, P296; Cornall A, 2016, ENVIRON TOXICOL CHEM, V35, P468, DOI 10.1002/etc.3205; Cornall AM, 2013, GEOMICROBIOL J, V30, P48, DOI 10.1080/01490451.2011.653083; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; Davis K, 2020, SHORELINE POLYGON WA; Dell'Anno A, 2012, ENVIRON POLLUT, DOI [10.1016/j.envpol.2012.03.043, DOI 10.1016/J.ENVPOL.2012.03.04322542785]; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Du ZJ, 2016, INT J SYST EVOL MICR, DOI [10.1099/ijsem.0.000683, DOI 10.1099/IJSEM.0.00068326474827]; Earth Microbiome Project (EMP), 2020, 16S RRNA AMPL PROT; East Central Florida Regional Planning Council [ECFRPC] Treasure Coast Regional Planning Council [TCRPC], 2016, IND RIV LAG EC VAL; Elliott AC, 2011, COMPUT METH PROG BIO, DOI [10.1016/j.cmpb.2010.11.002, DOI 10.1016/J.CMPB.2010.11.00221146248]; Fernandez-Cadena JC, 2020, MAR POLLUT BULL, V150, DOI 10.1016/j.marpolbul.2019.110701; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gaidos E, 2011, ENVIRON MICROBIOL, DOI [10.1111/j.1462-2920.2010.02392.x, DOI 10.1111/J.1462-2920.2010.02392.X21176054]; GARLAND JL, 1995, B MAR SCI, V57, P79; Gillan DC, 2005, APPL ENVIRON MICROB, V71, P679, DOI 10.1128/AEM.71.2.679-690.2005; Gooch JW, 2011, ENCY DICT POLYM, DOI DOI 10.1007/978-1-4419-6247-8_15277; Gutierrez NL, 2018, REV MEX BIODIVERS, DOI [10.22201/ib.20078706e.2018.3.2409, DOI 10.22201/IB.20078706E.2018.3.2409]; Guttman DS, 2014, NAT REV GENET, DOI [10.1038/nrg3748, DOI 10.1038/NRG374825266034]; Harbor Branch Oceanographic Institute [HBOI], 2020, FAU HARB BRANCH IND; He ZL, 2006, ENVIRON GEOL, V50, P250, DOI 10.1007/s00254-006-0205-5; Hou D, 2019, J ENVIRON MANAGE, DOI [10.1016/j.jenvman.2019.109542, DOI 10.1016/J.JENVMAN.2019.10954231569024]; Hunter EM, 2006, APPL ENVIRON MICROB, DOI [10.1128/AEM.03007-05, DOI 10.1128/AEM.03007-0516957183]; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Indian River Lagoon National Estuary Program [IRLNEP], 2019, IND RIV LAG COMPR CO; Indian River Lagoon National Estuary Program [IRLNEP] St. Johns Water Management District [SJRWMD], 2007, IND RIV LAG INTR NAT; Johnson JM, 2015, FEMS MICROBIOL ECOL, DOI [10.1093/femsec/fiu035, DOI 10.1093/FEMSEC/FIU03525764556]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Krieg NR, 2011, BERGEYS, DOI [10.1007/978-0-387-68572-4, DOI 10.1007/978-0-387-68572-4]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; MagalhAes CM, 2011, FEMS MICROBIOL ECOL, DOI [10.1111/j.1574-6941.2011.01107.x, DOI 10.1111/J.1574-6941.2011.01107.X21470256]; Mahmoudi N, 2015, FEMS MICROBIOL ECOL, P91, DOI [10.1093/femsec/fiu013, DOI 10.1093/FEMSEC/FIU01325764536]; McIlroy SJ, 2017, FRONT MICROBIOL, DOI [10.3389/fmicb.2017.01134, DOI 10.3389/FMICB.2017.0113428690595]; McKeon CS, 2015, PEERJ, V3, DOI 10.7717/peerj.1348; McKight P.E, 2010, CORSINI ENCYCLO PSYC, P1, DOI [DOI 10.1002/9780470479216.CORPSY0491, 10.1002/9780470479216.corpsy0491]; MCMAHON PJT, 1989, WATER SCI TECHNOL, V21, P39, DOI 10.2166/wst.1989.0025; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mohit V, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv038; Mohr KI, 2012, INT J SYST EVOL MICR, V62, P1191, DOI 10.1099/ijs.0.033696-0; Munksgaard NC, 2001, MAR CHEM, V75, P165, DOI 10.1016/S0304-4203(01)00033-0; Mussmann M, 2017, ISME J, V11, P1276, DOI 10.1038/ismej.2016.185; National Weather Service [NWS], 2020, NOWDATA NOAA ONL WEA; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Ogle D.H., 2019, FSA FISHERIES STOCK; Oni OE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01290; OPPENHEIMER CH, 1960, GEOCHIM COSMOCHIM AC, V19, P244, DOI 10.1016/0016-7037(60)90032-6; Park S, 2012, INT J SYST EVOL MICR, V62, P1784, DOI 10.1099/ijs.0.031443-0; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; QIIME 2 Development Team, 2020, MOV PICT TUT; Quero GM, 2017, MOL ECOL, DOI [10.1111/mec.14363, DOI 10.1111/MEC.1436328926207]; R Core Team, 2021, R LANGUAGE ENV STAT; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rstudio T, 2020, RSTUDIO INT DEV R; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; Sime P, 2005, WETLANDS, V25, P898, DOI 10.1672/0277-5212(2005)025[0898:SLEAIR]2.0.CO;2; Soule DF, 1991, MARINE STUDIES S 20F; South Florida Water Management District [SFWMD], 2020, DBHYDRO; Spring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00281; St. Johns River Water Management District [SJRWMD], 2020, EAU GALL RIV ELB CRE; St. Johns Water Management District [SJRWMD], 2020, CONT SENS BAS WAT QU; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Trefry JH, 2008, TOXIC SUBSTANCES IND; Trefry JH, 1992, FLORIDA SCI, P160; Trefry John H., 2011, Florida Scientist, V74, P43; Trim galore Krueger F, 2015, WRAPPER TOOL CUTADAP, V516, P517; United States Gelogical Service [USGS], 2020, CURR COND FLOR STREA; USEPA, 2001, NAT MAN MEAS GUID CO; Vishnivetskaya TA, 2011, APPL ENVIRON MICROB, V77, P302, DOI 10.1128/AEM.01715-10; Waite DW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00682; Ward L, 2017, ISME J, DOI [10.1038/ismej.2016.193, DOI 10.1038/ISMEJ.2016.19328072418]; WICKHAM H, 2017, R PACKAGE VERSION, V1, P1, DOI DOI 10.1590/S0100-204X2017000300003; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wickham H, 2007, J STAT SOFTW, V21, P1; Yang YG, 2013, AGR WATER MANAGE, V118, P38, DOI 10.1016/j.agwat.2012.12.001; Zhang MK, 2003, ENVIRON GEOL, V44, P1, DOI 10.1007/s00254-002-0728-3; Ziegler M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14213	95	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0236305	10.1371/journal.pone.0236305	http://dx.doi.org/10.1371/journal.pone.0236305			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33105476	gold, Green Submitted, Green Published			2022-12-26	WOS:000588370000037
J	Nishida, Y; Hosomi, S; Yamagami, H; Fujimoto, K; Nakata, R; Itani, S; Nadatani, Y; Fukunaga, S; Otani, K; Tanaka, F; Nagami, Y; Taira, K; Kamata, N; Watanabe, T; Iseki, Y; Fukuoka, T; Shibutani, M; Nagahara, H; Ohfuji, S; Fujiwara, Y				Nishida, Yu; Hosomi, Shuhei; Yamagami, Hirokazu; Fujimoto, Koji; Nakata, Rieko; Itani, Shigehiro; Nadatani, Yuji; Fukunaga, Shusei; Otani, Koji; Tanaka, Fumio; Nagami, Yasuaki; Taira, Koichi; Kamata, Noriko; Watanabe, Toshio; Iseki, Yasuhito; Fukuoka, Tatsunari; Shibutani, Masatsune; Nagahara, Hisashi; Ohfuji, Satoko; Fujiwara, Yasuhiro			Novel prognostic biomarkers of pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: Neutrophil-to-lymphocyte ratio	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; INFLAMMATORY BOWEL-DISEASE; IMMATURE PLASMA-CELLS; DOUBLE-BLIND; POOR SURVIVAL; PREDICTS; RISK; COMPLICATIONS; COLECTOMY; DIAGNOSIS	Objectives Pouchitis is a major complication after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC). Although there have been many investigations of the neutrophil-to-lymphocyte ratio (NLR) in various diseases, its role in predicting the development of pouchitis remains unclear. We aimed to evaluate the clinical utility of the NLR for predicting the development of pouchitis after IPAA in UC patients. Materials and methods UC patients who underwent IPAA at Osaka City University Hospital between May 2006 and March 2019 were included. The incidence of pouchitis was estimated using the Kaplan-Meier method. Potential preoperative, intraoperative, and postoperative predictors for pouchitis, including various demographic and clinical variables, were analyzed. The combined impact of the NLR and other known prognostic factors were investigated using Cox proportional hazard regression with inverse probability of treatment weighting (IPTW). Results Forty-nine patients with UC who underwent IPAA were included. The median follow-up period was 18.3 months (interquartile range: 10.7-47.2 months). Eighteen patients (36.7%) developed pouchitis. The incidence of pouchitis was 19.2%, 32.6%, and 45.9% at 1, 2, and 5 years, respectively. NLR was significantly associated with the development of pouchitis in the univariate Cox regression analysis (hazard ratio (HR), 1.14; 95% confidence interval (CI), 1.01-1.28; P = 0.03). The NLR cutoff value of 2.15 was predictive of the development of pouchitis according to receiver operating characteristic analysis (specificity: 67.7%, sensitivity: 72.2%). The incidence of pouchitis was significantly lower in the low NLR group than that in the high NLR group (P = 0.01, log-rank test). Cox regression analyses using IPTW also identified NLR as a prognostic factor for the development of pouchitis by statistically adjusting for background factors (HR, 3.60; 95% CI, 1.31-9.89; P = 0.01). Conclusions NLR may be a novel and useful indicator for predicting the development of pouchitis after IPAA in UC and should be introduced in clinical practice.	[Nishida, Yu; Hosomi, Shuhei; Fujimoto, Koji; Nakata, Rieko; Itani, Shigehiro; Nadatani, Yuji; Fukunaga, Shusei; Otani, Koji; Tanaka, Fumio; Nagami, Yasuaki; Taira, Koichi; Kamata, Noriko; Watanabe, Toshio; Fujiwara, Yasuhiro] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Osaka, Japan; [Yamagami, Hirokazu] Ishikiri Seiki Hosp, Dept Gastroenterol, Higashiosaka, Osaka, Japan; [Iseki, Yasuhito; Fukuoka, Tatsunari; Shibutani, Masatsune; Nagahara, Hisashi] Osaka City Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan; [Ohfuji, Satoko] Osaka City Univ, Dept Publ Hlth, Grad Sch Med, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Hosomi, S (corresponding author), Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Osaka, Japan.	m1265271@med.osaka-cu.ac.jp	Tanaka, Fumio/HCI-5442-2022; Ohfuji, Satoko/AHB-4998-2022	Tanaka, Fumio/0000-0002-9186-1249; 				AISENBERG J, 1995, DIGEST DIS SCI, V40, P1866, DOI 10.1007/BF02208648; [Anonymous], 2002, COMMUN ACM, V45, P30; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1371/JOURNAL.PONE.0169845]; Bertani L, 2020, INFLAMM BOWEL DIS, V26, P1579, DOI 10.1093/ibd/izaa062; Carter MJ, 2001, GASTROENTEROLOGY, V121, P805, DOI 10.1053/gast.2001.28017; Chandrashekara S, 2015, REUMATISMO, V67, P109, DOI 10.4081/reumatismo.2015.838; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.067; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; Demir AK, 2015, KAOHSIUNG J MED SCI, V31, P585, DOI 10.1016/j.kjms.2015.10.001; FAZIO VW, 1995, ANN SURG, V222, P120, DOI 10.1097/00000658-199508000-00003; Fleshner PR, 2001, GUT, V49, P671, DOI 10.1136/gut.49.5.671; Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9; HERMANOWICZ A, 1985, CLIN SCI, V69, P241, DOI 10.1042/cs0690241; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Hirata N, 2008, INFLAMM BOWEL DIS, V14, P1084, DOI 10.1002/ibd.20447; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Hurst RD, 1996, ARCH SURG-CHICAGO, V131, P497; Isaacs KL, 2007, INFLAMM BOWEL DIS, V13, P1250, DOI 10.1002/ibd.20187; Jinno Y, 2006, VIRCHOWS ARCH, V448, P412, DOI 10.1007/s00428-005-0136-7; Johnson MW, 2008, EUR J GASTROEN HEPAT, V20, P174, DOI 10.1097/MEG.0b013e3282f1c9a7; Koike Y, 2019, J SURG RES, V238, P72, DOI 10.1016/j.jss.2019.01.022; Lagunas-Rangel FA, 2020, J MED VIROL, V92, P1733, DOI 10.1002/jmv.25819; LOHMULLER JL, 1990, ANN SURG, V211, P622; LUUKKONEN P, 1994, GUT, V35, P243, DOI 10.1136/gut.35.2.243; Mahadevan U, 2003, GASTROENTEROLOGY, V124, P1636, DOI 10.1016/S0016-5085(03)00325-1; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; Mor IJ, 2008, DIS COLON RECTUM, V51, P1202, DOI 10.1007/s10350-008-9364-7; Nishida Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213505; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; ROCHE JK, 1982, CLIN IMMUNOL IMMUNOP, V25, P362, DOI 10.1016/0090-1229(82)90201-X; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; SANDBORN WJ, 1995, AM J GASTROENTEROL, V90, P740; Schmidt CM, 1998, ANN SURG, V227, P654, DOI 10.1097/00000658-199805000-00006; Shen B, 2005, AM J GASTROENTEROL, V100, P93, DOI 10.1111/j.1572-0241.2005.40778.x; Shen B, 2003, DIS COLON RECTUM, V46, P748, DOI 10.1007/s10350-004-6652-8; Shibutani M, 2013, ANTICANCER RES, V33, P3291; Shimada H, 2010, GASTRIC CANCER, V13, P170, DOI 10.1007/s10120-010-0554-3; Stahlberg D, 1996, DIS COLON RECTUM, V39, P1012, DOI 10.1007/BF02054692; Sugihara M, 2010, PHARM STAT, V9, P21, DOI 10.1002/pst.365; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Torun S, 2012, CLIN RES HEPATOL GAS, V36, P491, DOI 10.1016/j.clinre.2012.06.004; Uchida K, 2013, SURG TODAY, V43, P1219, DOI 10.1007/s00595-012-0434-z; Uo M, 2013, GUT, V62, P1734, DOI 10.1136/gutjnl-2012-303063	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241322	10.1371/journal.pone.0241322	http://dx.doi.org/10.1371/journal.pone.0241322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104762	Green Published, gold			2022-12-26	WOS:000588370000012
J	Wenndt, A; Sudini, HK; Pingali, P; Nelson, R				Wenndt, Anthony; Sudini, Hari Kishan; Pingali, Prabhu; Nelson, Rebecca			Exploring aflatoxin contamination and household-level exposure risk in diverse Indian food systems	PLOS ONE			English	Article							FUMONISIN CONTAMINATION; ASPERGILLUS-FLAVUS; STORAGE PRACTICES; DIETARY EXPOSURE; MAIZE; MYCOTOXINS; B-1; CONSUMPTION; CHILDREN; SORGHUM	The present study sought to identify household risk factors associated with aflatoxin contamination within and across diverse Indian food systems and to evaluate their utility in risk modeling. Samples (n = 595) of cereals, pulses, and oil seeds were collected from 160 households across four diverse districts of India and analyzed for aflatoxin B1 using enzyme-linked immunosorbent assay (ELISA). Demographic information, food and cropping systems, food management behaviors, and storage environments were profiled for each household. An aflatoxin detection risk index was developed based on household-level features and validated using a repeated 5-fold cross-validation approach. Across districts, between 30-80% of households yielded at least one contaminated sample. Aflatoxin B1 detection rates and mean contamination levels were highest in groundnut and maize, respectively, and lower in other crops. Landholding had a positive univariate effect on household aflatoxin detection, while storage conditions, product source, and the number of protective behaviors used by households did not show significant effects. Presence of groundnut, post-harvest grain washing, use of sack-based storage systems, and cultivation status (farming or non-farming) were identified as the most contributive variables in stepwise logistic regression and were used to generate a household-level risk index. The index had moderate classification accuracy (68% sensitivity and 62% specificity) and significantly correlated with village-wise aflatoxin detection rates. Spatial analysis revealed utility of the index for identifying at-risk localities and households. This study identified several key features associated with aflatoxin contamination in Indian food systems and demonstrated that household characteristics are substantially predictive of aflatoxin risk.	[Wenndt, Anthony; Nelson, Rebecca] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA; [Wenndt, Anthony; Pingali, Prabhu] Cornell Univ, Tata Cornell Inst Agr & Nutr, Ithaca, NY 14850 USA; [Sudini, Hari Kishan] Int Crops Res Inst Semi Arid Trop, Patancheru, Telangana, India; [Pingali, Prabhu] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	Cornell University; Cornell University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Cornell University	Wenndt, A (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA.; Wenndt, A (corresponding author), Cornell Univ, Tata Cornell Inst Agr & Nutr, Ithaca, NY 14850 USA.	ajw258@cornell.edu		Wenndt, Anthony/0000-0002-6496-3557	Technical Assistance and Research for Indian Nutrition and Agriculture (TARINA) program of the Tata Cornell Institute for Agriculture and Nutrition; Bill & Melinda Gates Foundation [OPP1137807]	Technical Assistance and Research for Indian Nutrition and Agriculture (TARINA) program of the Tata Cornell Institute for Agriculture and Nutrition; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the Technical Assistance and Research for Indian Nutrition and Agriculture (TARINA) program (tarina.tci.cornell.edu) of the Tata Cornell Institute for Agriculture and Nutrition (tci.cornell.edu). TARINA is funded by the Bill & Melinda Gates Foundation (Grant No. OPP1137807 to PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abinash Panda., 2004, GLOB BUS REV, V5, P27, DOI [DOI 10.1177/097215090400500103, 10.1177/097215090400500103]; Anitha S, 2019, TOXINS, V11, DOI 10.3390/toxins11120716; [Anonymous], 2010, SCI WORKS HIST DEP Z, V28, P435; [Anonymous], 2007, SPINE J S, V7, p1S; [Anonymous], 2014, APPROPRIATE TECHNOLO, V41, P52; Aurino E, 2017, ECON HUM BIOL, V25, P99, DOI 10.1016/j.ehb.2016.10.007; Bandyopadhyay R, 2007, FOOD ADDIT CONTAM A, V24, P1109, DOI 10.1080/02652030701553251; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battilani P, 2013, COMPUT ELECTRON AGR, V94, P38, DOI 10.1016/j.compag.2013.03.005; Bhaskar AVV, 2017, FOOD SECUR, V9, P981, DOI 10.1007/s12571-017-0721-z; Bhat RV, 1997, J TOXICOL-CLIN TOXIC, V35, P249, DOI 10.3109/15563659709001208; Bhatnagar-Mathur P, 2015, PLANT SCI, V234, P119, DOI 10.1016/j.plantsci.2015.02.009; Chauhan YS, 2008, AUST J EXP AGR, V48, P358, DOI 10.1071/EA06101; Chu X, 2017, BIOSYST ENG, V157, P13, DOI 10.1016/j.biosystemseng.2017.02.005; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; Craufurd PQ, 2006, FIELD CROP RES, V98, P20, DOI 10.1016/j.fcr.2005.12.001; Desai M., 2004, J OBSTET GYN INDIA, V54, P483; Dhaliwal RK, 2010, INDIAN J TRADIT KNOW, V9, P526; Egal S, 2005, INT J FOOD MICROBIOL, V104, P215, DOI 10.1016/j.ijfoodmicro.2005.03.004; Elzupir AO, 2015, TOXIN REV, V34, P37, DOI 10.3109/15569543.2014.984229; Fox J., 2018, R COMPANION APPL REG, VThird; Gebauer A, 2019, GEODERMA, V354, DOI 10.1016/j.geoderma.2019.07.004; Hell K, 2000, J STORED PROD RES, V36, P365, DOI 10.1016/S0022-474X(99)00056-9; Hoffmann V, 2013, MARKET LEMONS MAIZE; Iida H, 2012, MATERN CHILD HLTH J, V16, P1164, DOI 10.1007/s10995-011-0894-6; Jabir Ali, 2015, International Journal of Vegetable Science, V21, P9, DOI 10.1080/19315260.2013.813891; Jolly P, 2006, INT J HYG ENVIR HEAL, V209, P345, DOI 10.1016/j.ijheh.2006.02.002; Joshi P. K., 2004, Economic and Political Weekly, V39, P2457; Kahle D, 2013, R J, V5, P144; Kamala A, 2018, WORLD MYCOTOXIN J, V11, P447, DOI 10.3920/WMJ2017.2234; Krishi Vigyan Kendra, 2013, KRISHI VIGYAN KENDRA; Kumari A, 2018, INT J CURR MICROBIOL, V7, P733, DOI [10.20546/ijcmas.2018.707.090, DOI 10.20546/IJCMAS.2018.707.090]; Larroza A, 2017, EUR J RADIOL, V92, P78, DOI 10.1016/j.ejrad.2017.04.024; Leroy JL, 2015, SOC SCI MED, V146, P104, DOI 10.1016/j.socscimed.2015.10.039; Magan N, 2007, INT J FOOD MICROBIOL, V119, P131, DOI 10.1016/j.ijfoodmicro.2007.07.034; Mahuku G, 2019, FOOD CONTROL, V96, P219, DOI 10.1016/j.foodcont.2018.08.032; Manjula K, 2009, TOXIN REV, V28, P63, DOI 10.1080/15569540802462214; Mardia L. K., 2016, AM J FOOD NUTR, V4, P169, DOI [10.12691/ajfn-4-6-5, DOI 10.12691/AJFN-4-6-5]; Matumba L, 2017, MYCOTOXIN RES, V33, P129, DOI 10.1007/s12550-017-0272-3; Matumba L, 2011, FOOD CONTROL, V22, P266, DOI 10.1016/j.foodcont.2010.07.008; Mutegi C. K., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P1779; Mutiga SK, 2015, PHYTOPATHOLOGY, V105, P1250, DOI 10.1094/PHYTO-10-14-0269-R; Mutiga SK, 2014, PHYTOPATHOLOGY, V104, P1221, DOI 10.1094/PHYTO-01-14-0006-R; Ohno T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157269; Overmars KP, 2005, INT J GEOGR INF SCI, V19, P125, DOI 10.1080/13658810410001713380; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Patil VS, 2019, IRRIG DRAIN, V68, P140, DOI 10.1002/ird.2291; Pingali P, 2017, GLOB FOOD SECUR-AGR, V15, P77, DOI 10.1016/j.gfs.2017.05.002; Pretari A, 2019, J STORED PROD RES, V82, P31, DOI 10.1016/j.jspr.2019.03.001; Reddy SV, 2001, FOOD ADDIT CONTAM, V18, P553, DOI 10.1080/02652030010025383; Rindfuss RR, 2004, PEOPLE ENV APPROCHES, P1, DOI [10.1007/0-306-48130-8, DOI 10.1007/0-306-48130-8_1]; Sales AC, 2005, FOOD ADDIT CONTAM A, V22, P429, DOI 10.1080/02652030500058387; Sarkar S., 2014, EUR ACAD RES, V2, P8307; SASHIDHAR RB, 1992, J STORED PROD RES, V28, P257, DOI 10.1016/0022-474X(92)90006-C; Shephard GS, 2008, FOOD ADDIT CONTAM A, V25, P146, DOI 10.1080/02652030701567442; Shiva V, 2004, FUTURES, V36, P715, DOI 10.1016/j.futures.2003.12.014; Shuaib F M B, 2012, Ghana Med J, V46, P179; SINHA KK, 1992, J STORED PROD RES, V28, P211, DOI 10.1016/0022-474X(92)90043-P; Smith L. E., 2016, African Journal of Food, Agriculture, Nutrition and Development, V16, P11086, DOI 10.18697/ajfand.75.ILRI09; Soler LD, 2010, REG ENVIRON CHANGE, V10, P371, DOI 10.1007/s10113-009-0107-7; Sowley E. N. K., 2016, African Journal of Biotechnology, V15, P1864; Sudini H, 2015, J STORED PROD RES, V64, P133, DOI 10.1016/j.jspr.2014.09.002; Tedihou E, 2012, TROP PLANT PATHOL, V37, P25, DOI 10.1590/S1982-56762012000100003; Thompson C, 2000, J WILDLIFE DIS, V36, P172, DOI 10.7589/0090-3558-36.1.172; Torres AM, 2014, FOOD RES INT, V62, P11, DOI 10.1016/j.foodres.2014.02.023; Tripathi BM, 2010, AIDS BEHAV, V14, P94, DOI 10.1007/s10461-010-9730-z; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; UBANI ON, 1993, FOOD CHEM, V47, P7, DOI 10.1016/0308-8146(93)90294-P; Unnevehr L, 2013, AFLATOXINS FINDING S; Ved R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000681; Venables WN., 2002, MODERN APPL STAT S, V4; Waliyar F., 2008, Mycotoxins: detection methods, management, public health and agricultural trade, P209, DOI 10.1079/9781845930820.0209; Waliyar F, 2012, INT CROPS RES I SEMI; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wojnacki Jose, 2014, Small GTPases, V5, pe28430; Wu F, 2010, FOOD ADDIT CONTAM A, V27, P658, DOI 10.1080/19440041003639582; Xu Y, 2017, J FOOD PROTECT, V80, P44, DOI [10.4315/0362-028x.jfp-16-152, 10.4315/0362-028X.JFP-16-152]; Yadav S, 2016, INT CONF ADV COMPU, P78, DOI 10.1109/IACC.2016.25; Yao H, 2010, FOOD ADDIT CONTAM A, V27, P701, DOI 10.1080/19440040903527368	79	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240565	10.1371/journal.pone.0240565	http://dx.doi.org/10.1371/journal.pone.0240565			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104713	Green Published, gold, Green Accepted			2022-12-26	WOS:000588370000030
J	von Felden, J; Craig, AJ; Garcia-Lezana, T; Labgaa, I; Haber, PK; D'Avola, D; Asgharpour, A; Dieterich, D; Bonaccorso, A; Torres-Martin, M; Sia, D; Sung, MW; Tabrizian, P; Schwartz, M; Llovet, JM; Villanueva, A				von Felden, Johann; Craig, Amanda J.; Garcia-Lezana, Teresa; Labgaa, Ismail; Haber, Philipp K.; D'Avola, Delia; Asgharpour, Amon; Dieterich, Douglas; Bonaccorso, Antoinette; Torres-Martin, Miguel; Sia, Daniela; Sung, Max W.; Tabrizian, Parissa; Schwartz, Myron; Llovet, Josep M.; Villanueva, Augusto			Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma	ONCOGENE			English	Article							LIQUID BIOPSY; DOUBLE-BLIND; SORAFENIB; IDENTIFICATION; TARGETS	Little is known about the mutational landscape of advanced hepatocellular carcinoma (HCC), and predictive biomarkers of response to systemic therapies are lacking. We aimed to describe the mutational landscape of advanced HCC and to identify predictors of primary resistance to systemic therapies using circulating tumor DNA (ctDNA). We prospectively enrolled 121 patients between October 2015 and January 2019. We performed targeted ultra-deep sequencing of 25 genes and Digital Droplet PCR of TERT promoter, including sequential samples throughout treatment. Primary endpoint was progression-free survival (PFS) stratified by mutation profiles in ctDNA. Secondary endpoints were overall survival and objective response rate. The most frequent mutations in ctDNA of advanced HCC were TERT promoter (51%), TP53 (32%), CTNNB1 (17%), PTEN (8%), AXIN1, ARID2, KMT2D, and TSC2 (each 6%). TP53 and CTNNB1 mutations were mutually exclusive. Patients with mutations in the PI3K/MTOR pathway had significantly shorter PFS than those without these mutations after tyrosine kinase inhibitors (2.1 vs 3.7 months, p < 0.001), but not after immune checkpoint inhibition (CPI). WNT pathway mutations were not associated with PFS, overall survival, or objective response after CPI. Serial profiling of ctDNA in a subset correlated with treatment response. Mutation profiling of ctDNA in advanced HCC shows similar mutation frequencies for known HCC drivers compared to early stages and identifies predictive biomarkers of response to systemic therapies.	[von Felden, Johann] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [von Felden, Johann; Craig, Amanda J.; Garcia-Lezana, Teresa; Labgaa, Ismail; Haber, Philipp K.; D'Avola, Delia; Asgharpour, Amon; Dieterich, Douglas; Torres-Martin, Miguel; Sia, Daniela; Llovet, Josep M.; Villanueva, Augusto] Icahn Sch Med Mt Sinai, Liver Canc Program, Div Liver Dis, Tisch Canc Inst,Dept Med, New York, NY 10029 USA; [Labgaa, Ismail] Lausanne Univ Hosp CHUV, Dept Visceral Surg, Lausanne, Switzerland; [D'Avola, Delia] Clin Univ Navarra, Liver Unit, Pamplona, Spain; [D'Avola, Delia] Clin Univ Navarra, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain; [Bonaccorso, Antoinette; Tabrizian, Parissa; Schwartz, Myron] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA; [Sung, Max W.; Villanueva, Augusto] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA; [Llovet, Josep M.] Univ Barcelona, Liver Canc Translat Res Lab, Hosp Clin, IDIBAPS, Catalonia, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain	University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Villanueva, A (corresponding author), Icahn Sch Med Mt Sinai, Liver Canc Program, Div Liver Dis, Tisch Canc Inst,Dept Med, New York, NY 10029 USA.; Villanueva, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA.	augusto.villanueva@mssm.edu	Llovet, Josep M/D-4340-2014; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Llovet, Josep M/0000-0003-0547-2667; Torres Martin, Miguel/0000-0003-1589-8936; Craig, Amanda/0000-0001-8987-019X; Labgaa, Ismail/0000-0003-4286-2170; von Felden, Johann/0000-0003-2839-5174; Sia, Daniela/0000-0002-9000-611X	German Research Foundation [HA8754/1-1, FE1746/1-1]; National Cancer Institute Ruth L. Kirschstein NRSA Institutional Research Training Grant [CA078207]; Swiss National Science Foundation; Foundation Roberto Gianna Gonella; Foundation SICPA; Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH); Nuovo Soldati Foundation; European Commission (EC)/Horizon 2020 Program (HEPCAR) [667273-2]; U.S. Department of Defense [CA150272P3]; Accelerator Award (CRUCK, AECC, AIRC) [C9380/A26813]; National Cancer Institute, Tisch Cancer Institute [P30-CA196521]; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF2016-76390]; Generalitat de Catalunya/AGAUR [SGR-1358]	German Research Foundation(German Research Foundation (DFG)); National Cancer Institute Ruth L. Kirschstein NRSA Institutional Research Training Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Roberto Gianna Gonella; Foundation SICPA; Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH); Nuovo Soldati Foundation; European Commission (EC)/Horizon 2020 Program (HEPCAR)(European Commission); U.S. Department of Defense(United States Department of Defense); Accelerator Award (CRUCK, AECC, AIRC)(Fondazione AIRC per la ricerca sul cancro); National Cancer Institute, Tisch Cancer Institute; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Generalitat de Catalunya/AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	JvF is supported by the German Research Foundation (FE1746/1-1). AJC is supported by the National Cancer Institute Ruth L. Kirschstein NRSA Institutional Research Training Grant (CA078207). IL is supported by a grant from the Swiss National Science Foundation, from Foundation Roberto & Gianna Gonella and Foundation SICPA. PKH is supported by the German Research Foundation (HA8754/1-1). DD is supported by the Grant for Studies Broadening from the Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH) and the Cancer Research Grant from Nuovo Soldati Foundation. JML is supported by the European Commission (EC)/Horizon 2020 Program (HEPCAR, Ref. 667273-2), U.S. Department of Defense (CA150272P3), an Accelerator Award (CRUCK, AECC, AIRC) (HUNTER, Ref. C9380/A26813), National Cancer Institute, Tisch Cancer Institute (P30-CA196521), Samuel Waxman Cancer Research Foundation, Spanish National Health Institute (SAF2016-76390) and the Generalitat de Catalunya/AGAUR (SGR-1358). AV is supported by the U.S. Department of Defense (CA150272P3).	Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; [Anonymous], 2018, IARC DATA; [Anonymous], 2018, CDC LIVER CANC REPOR; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Brunner SF, 2019, NATURE, V574, P538, DOI 10.1038/s41586-019-1670-9; Craig AJ, 2020, NAT REV GASTRO HEPAT, V17, P139, DOI 10.1038/s41575-019-0229-4; de Galarreta MR, 2019, CANCER DISCOV, V9, P1124, DOI 10.1158/2159-8290.CD-19-0074; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Finn RS, 2020, J CLIN ONCOL, V38, P193, DOI 10.1200/JCO.19.01307; Goodall J, 2017, CANCER DISCOV, V7, P1006, DOI 10.1158/2159-8290.CD-17-0261; Harding JJ, 2019, CLIN CANCER RES, V25, P2116, DOI 10.1158/1078-0432.CCR-18-2293; Howell J, 2019, EUR J CANCER, V116, P56, DOI 10.1016/j.ejca.2019.04.014; Huang A, 2017, J HEPATOL, V67, P293, DOI 10.1016/j.jhep.2017.03.005; Jiang PY, 2019, J HEPATOL, V71, P409, DOI 10.1016/j.jhep.2019.04.003; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Labgaa I, 2018, ONCOGENE, V37, P3740, DOI 10.1038/s41388-018-0206-3; Labgaa I, 2015, DISCOV MED, V19, P263; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2019, J HEPATOL, V70, P1262, DOI 10.1016/j.jhep.2019.01.028; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; Mansukhani S, 2018, CLIN CHEM, V64, P1626, DOI 10.1373/clinchem.2018.289629; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Nault JC, 2020, HEPATOLOGY, V71, P164, DOI 10.1002/hep.30811; Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3; Ng CKY, 2018, ANN ONCOL, V29, P1286, DOI 10.1093/annonc/mdy083; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothwell DG, 2019, NAT MED, V25, P738, DOI 10.1038/s41591-019-0380-z; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; von Felden J, 2020, GUT, V69, P2025, DOI 10.1136/gutjnl-2019-320282; von Felden J, 2020, CURR OPIN GASTROEN, V36, P177, DOI 10.1097/MOG.0000000000000626; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; YAU T, 2019, ANN ONCOL, V30, P29; Zhang H, 2018, ONCOL LETT, V15, P9377, DOI 10.3892/ol.2018.8536; Zhu AX, 2019, LANCET ONCOL, V20, P282, DOI 10.1016/S1470-2045(18)30937-9; Zhu AX, 2018, LANCET ONCOL, V19, P940, DOI 10.1016/S1470-2045(18)30351-6; Zhu M, 2019, CELL, V177, P608, DOI 10.1016/j.cell.2019.03.026	45	42	43	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					140	151		10.1038/s41388-020-01519-1	http://dx.doi.org/10.1038/s41388-020-01519-1		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33097857				2022-12-26	WOS:000582109700001
J	Edwards, NJ; Hwang, C; Marini, S; Pagani, CA; Spreadborough, PJ; Rowe, CJ; Yu, PE; Mei, AN; Visser, N; Li, SL; Hespe, GE; Huber, AK; Strong, AL; Shelef, MA; Knight, JS; Davis, TA; Levi, B				Edwards, Nicole J.; Hwang, Charles; Marini, Simone; Pagani, Chase A.; Spreadborough, Philip J.; Rowe, Cassie J.; Yu, Pauline; Mei, Annie; Visser, Noelle; Li, Shuli; Hespe, Geoffrey E.; Huber, Amanda K.; Strong, Amy L.; Shelef, Miriam A.; Knight, Jason S.; Davis, Thomas A.; Levi, Benjamin			The role of neutrophil extracellular traps and TLR signaling in skeletal muscle ischemia reperfusion injury	FASEB JOURNAL			English	Article						extracellular signal-regulated kinases (ERK) 1; 2; hydroxychloroquine; inflammation; muscle fibrosis	PEPTIDYLARGININE DEIMINASE INHIBITION; SLE PATIENTS; MYOPATHY; FIBROSIS; PAD4; ACTIVATION; SUFFICIENT; APOPTOSIS; AUTOPHAGY; PATHWAY	Ischemia reperfusion (IR) injury results in devastating skeletal muscle fibrosis. Here, we recapitulate this injury with a mouse model of hindlimb IR injury which leads to skeletal muscle fibrosis. Injury resulted in extensive immune infiltration with robust neutrophil extracellular trap (NET) formation in the skeletal muscle, however, direct targeting of NETs via the peptidylarginine deiminase 4 (PAD4) mechanism was insufficient to reduce muscle fibrosis. Circulating levels of IL-10 and TNF alpha were significantly elevated post injury, indicating toll-like receptor (TLR) signaling may be involved in muscle injury. Administration of hydroxychloroquine (HCQ), a small molecule inhibitor of TLR7/8/9, following injury reduced NET formation, IL-10, and TNF alpha levels and ultimately mitigated muscle fibrosis and improved myofiber regeneration following IR injury. HCQ treatment decreased fibroadipogenic progenitor cell proliferation and partially inhibited ERK1/2 phosphorylation in the injured tissue, suggesting it may act through a combination of TLR7/8/9 and ERK signaling mechanisms. We demonstrate that treatment with FDA-approved HCQ leads to decreased muscle fibrosis and increased myofiber regeneration following IR injury, suggesting short-term HCQ treatment may be a viable treatment to prevent muscle fibrosis in ischemia reperfusion and traumatic extremity injury.	[Edwards, Nicole J.; Hwang, Charles; Marini, Simone; Pagani, Chase A.; Yu, Pauline; Mei, Annie; Visser, Noelle; Li, Shuli; Hespe, Geoffrey E.; Huber, Amanda K.; Strong, Amy L.; Levi, Benjamin] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Spreadborough, Philip J.; Rowe, Cassie J.; Davis, Thomas A.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Shelef, Miriam A.] Univ Wisconsin, Div Rheumatol, Madison, WI USA; [Shelef, Miriam A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Knight, Jason S.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Levi, Benjamin] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Michigan System; University of Michigan; University of Texas System; University of Texas Southwestern Medical Center Dallas	Levi, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Gen Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Levi, B (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Organogenesis & Trauma, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	benjamin.levi@UTSouthwestern.edu		Visser, Noelle/0000-0002-9025-6020; Pagani, Chase/0000-0001-9834-2516; Marini, Simone/0000-0002-5704-3533; Edwards, Nicole/0000-0002-2622-1544	Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship [T32-HD007505]; Howard Hughes Medical Institute Medical Research Fellowship; National Institutes of Health NIAMS [K08 AR065500]; National Institutes of Health (NIH) [R01GM123069, R01AR071379]; American College of Surgeons Clowes Award; US Department of Defense [W81XWH-18-1-0653, OR170174, W81XWH-17-1-0655, OR160105]	Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Clowes Award; US Department of Defense(United States Department of Defense)	NJE was supported by a Ruth L. Kirschstein Institutional National Research Service Award Postdoctoral fellowship (T32-HD007505). CH was supported by a Howard Hughes Medical Institute Medical Research Fellowship. MS was supported by National Institutes of Health NIAMS K08 AR065500. BL was supported or partially supported by National Institutes of Health (NIH) R01GM123069, R01AR071379, American College of Surgeons Clowes Award, US Department of Defense Grants W81XWH-18-1-0653 (OR170174) and W81XWH-17-1-0655 (OR160105).	Agarwal S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02148; Albadawi H, 2016, J VASC SURG, V64, P484, DOI 10.1016/j.jvs.2015.01.031; Allen C, 2012, J IMMUNOL, V189, P381, DOI 10.4049/jimmunol.1200409; Andrikopoulos P, 2019, J AM SOC NEPHROL, V30, P33, DOI 10.1681/ASN.2018020209; AVINAZUBIETA JA, 1995, BRIT J RHEUMATOL, V34, P166; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai YJ, 2018, BIOMED PHARMACOTHER, V105, P1318, DOI 10.1016/j.biopha.2018.06.091; de Oliveira THC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01917; Carmona-Rivera C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag3358; Casado E, 2006, ANN RHEUM DIS, V65, P385, DOI 10.1136/ard.2004.023200; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cepika AM, 2012, CELL IMMUNOL, V276, P196, DOI 10.1016/j.cellimm.2012.05.009; Chen YP, 2017, EUR J PHARMACOL, V796, P90, DOI 10.1016/j.ejphar.2016.11.053; Choi DE, 2017, SURGERY, V161, P444, DOI 10.1016/j.surg.2016.07.028; Cholok D, 2017, J TRAUMA ACUTE CARE, V82, P174, DOI 10.1097/TA.0000000000001290; Chowdhury CS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4579; Collier JB, 2016, J BIOL CHEM, V291, P26850, DOI 10.1074/jbc.M116.754762; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Feng J, 2017, DRUG DES DEV THER, V11, P1989, DOI 10.2147/DDDT.S136792; Foglia B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112700; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gillani S, 2012, INJURY, V43, P670, DOI 10.1016/j.injury.2011.03.008; Godsell J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34604; Guimaraes-Costa AB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00523; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Honda M, 2013, TRANSPLANTATION, V95, P551, DOI 10.1097/TP.0b013e31827d62b5; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Itagaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120549; Jang CH, 2006, RHEUMATOLOGY, V45, P703, DOI 10.1093/rheumatology/kei282; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kenny EF, 2017, ELIFE, V6, DOI [10.7554/elife.24437, 10.7554/eLife.24437]; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Khosa S, 2018, NEUROPATHOLOGY, V38, P646, DOI 10.1111/neup.12520; Kim JG, 2009, PHYSIOL MEAS, V30, P529, DOI 10.1088/0967-3334/30/7/001; Kim JY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215299; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Kusunoki Y, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00227; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leffler J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0726-y; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lindau D, 2014, ANN RHEUM DIS, V73, P2199, DOI 10.1136/annrheumdis-2012-203041; Liu L, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12579; Mallavia B, 2020, AM J RESP CELL MOL, V62, P364, DOI 10.1165/rcmb.2019-0140OC; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; McIlroy DJ, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.07.013; Muchir A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-17; Nie M, 2019, CLIN CANCER RES, V25, P1867, DOI 10.1158/1078-0432.CCR-18-1226; Okada M, 2018, SURG TODAY, V48, P1089, DOI 10.1007/s00595-018-1696-x; Oklu R, 2013, J VASC SURG, V58, P1627, DOI 10.1016/j.jvs.2013.02.241; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Patel R, 2012, AM J SURG, V203, P488, DOI 10.1016/j.amjsurg.2011.05.005; Ramser B, 2009, J INVEST DERMATOL, V129, P2419, DOI 10.1038/jid.2009.80; Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266; Sorensen OE, 2016, J CLIN INVEST, V126, P1612, DOI 10.1172/JCI84538; Stepien DM, 2020, J IMMUNOL, V204, P2203, DOI 10.4049/jimmunol.1900814; Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004; Thomas MM, 2014, FASEB J, V28, P2098, DOI 10.1096/fj.13-238972; Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Walters TJ, 2008, APPL PHYSIOL NUTR ME, V33, P272, DOI 10.1139/H07-180; Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Willis R, 2012, LUPUS, V21, P830, DOI 10.1177/0961203312437270; Willis VC, 2017, CLIN EXP IMMUNOL, V188, P263, DOI 10.1111/cei.12932; Wong SL, 2018, FASEB J, V32, P6358, DOI 10.1096/fj.201800691R; Wosczyna MN, 2018, DEV CELL, V46, P135, DOI 10.1016/j.devcel.2018.06.018; XU S, 2017, SCI REP UK, V7; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zhong W, 2009, HEPATOLOGY, V50, P1524, DOI 10.1002/hep.23189; Zhou QL, 2018, EXP CELL RES, V370, P506, DOI 10.1016/j.yexcr.2018.07.016; Zhu BL, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/5701719	80	8	10	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15753	15770		10.1096/fj.202000994RR	http://dx.doi.org/10.1096/fj.202000994RR		OCT 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089917	Green Accepted, Bronze, Green Published			2022-12-26	WOS:000582261400001
J	Koenig, MR; Razo, E; Mitzey, A; Newman, CM; Dudley, DM; BreitbachID, ME; Semler, MR; Stewart, LM; Weiler, AM; Rybarczyk, S; Bach, KM; Mohns, MS; Simmons, HA; Mejia, A; Fritsch, M; Dennis, M; Teixeira, LBC; Schotzko, ML; Nork, TM; Rasmussen, CA; Katz, A; Nair, V; Hou, JC; Hartman, A; Ver Hoeve, J; Kim, C; Schneider, ML; Ausderau, K; Kohn, S; Jaeger, AS; Aliota, MT; Hayes, JM; Schultz-Darken, N; Eickhoff, J; Antony, KM; Noguchi, K; Zeng, XK; Permar, S; Prabhakaran, V; Capuano, S; Friedrich, TC; Golos, TG; O'Connor, DH; Mohr, EL				Koenig, Michelle R.; Razo, Elaina; Mitzey, Ann; Newman, Christina M.; Dudley, Dawn M.; BreitbachID, Meghan E.; Semler, Matthew R.; Stewart, Laurel M.; Weiler, Andrea M.; Rybarczyk, Sierra; Bach, Kathryn M.; Mohns, Mariel S.; Simmons, Heather A.; Mejia, Andres; Fritsch, Michael; Dennis, Maria; Teixeira, Leandro B. C.; Schotzko, Michele L.; Nork, T. Michael; Rasmussen, Carol A.; Katz, Alex; Nair, Veena; Hou, Jiancheng; Hartman, Amy; Ver Hoeve, James; Kim, Charlene; Schneider, Mary L.; Ausderau, Karla; Kohn, Sarah; Jaeger, Anna S.; Aliota, Matthew T.; Hayes, Jennifer M.; Schultz-Darken, Nancy; Eickhoff, Jens; Antony, Kathleen M.; Noguchi, Kevin; Zeng, Xiankun; Permar, Sallie; Prabhakaran, Vivek; Capuano, Saverio, III; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.; Mohr, Emma L.			Quantitative definition of neurobehavior, vision, hearing and brain volumes in macaques congenitally exposed to Zika virus	PLOS ONE			English	Article							PRENATAL STRESS; RHESUS; INFECTION; INFANTS; SEGMENTATION; LESIONS; IMPACT; MODEL	Congenital Zika virus (ZIKV) exposure results in a spectrum of disease ranging from severe birth defects to delayed onset neurodevelopmental deficits. ZIKV-related neuropathogenesis, predictors of birth defects, and neurodevelopmental deficits are not well defined in people. Here we assess the methodological and statistical feasibility of a congenital ZIKV exposure macaque model for identifying infant neurobehavior and brain abnormalities that may underlie neurodevelopmental deficits. We inoculated five pregnant macaques with ZIKV and mock-inoculated one macaque in the first trimester. Following birth, growth, ocular structure/function, brain structure, hearing, histopathology, and neurobehavior were quantitatively assessed during the first week of life. We identified the typical pregnancy outcomes of congenital ZIKV infection, with fetal demise and placental abnormalities. We estimated sample sizes needed to define differences between groups and demonstrated that future studies quantifying brain region volumes, retinal structure, hearing, and visual pathway function require a sample size of 14 animals per group (14 ZIKV, 14 control) to detect statistically significant differences in at least half of the infant exam parameters. Establishing the parameters for future studies of neurodevelopmental outcomes following congenital ZIKV exposure in macaques is essential for robust and rigorous experimental design.	[Koenig, Michelle R.; Newman, Christina M.; Dudley, Dawn M.; BreitbachID, Meghan E.; Semler, Matthew R.; Stewart, Laurel M.; Mohns, Mariel S.; Fritsch, Michael; O'Connor, David H.] UW Madison, Dept Pathol & Lab Med, Madison, WI USA; [Koenig, Michelle R.; Mitzey, Ann; Golos, Thaddeus G.] UW Madison, Dept Comparat Biosci, Madison, WI USA; [Razo, Elaina; Mohr, Emma L.] UW Madison, Dept Pediat, Madison, WI 53706 USA; [Weiler, Andrea M.; Rybarczyk, Sierra; Simmons, Heather A.; Mejia, Andres; Schotzko, Michele L.; Hayes, Jennifer M.; Schultz-Darken, Nancy; Capuano, Saverio, III; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.] UW Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Bach, Kathryn M.; Schneider, Mary L.; Ausderau, Karla] UW Madison, Dept Kinesiol, Madison, WI USA; [Dennis, Maria; Permar, Sallie] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Teixeira, Leandro B. C.; Friedrich, Thomas C.] UW Madison, Dept Pathobiol Sci, Madison, WI USA; [Nork, T. Michael; Rasmussen, Carol A.; Katz, Alex; Ver Hoeve, James; Kim, Charlene] UW Madison, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Nair, Veena; Hou, Jiancheng; Kohn, Sarah; Prabhakaran, Vivek] UW Madison, Dept Radiol, Madison, WI USA; [Hartman, Amy] UW Madison, Dept Commun Sci & Disorders, Madison, WI USA; [Jaeger, Anna S.; Aliota, Matthew T.] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN USA; [Eickhoff, Jens] UW Madison, Biostat & Med Informat, Madison, WI USA; [Antony, Kathleen M.; Golos, Thaddeus G.] UW Madison, Dept Obstet & Gynecol, Madison, WI USA; [Noguchi, Kevin] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zeng, Xiankun] US Army, Med Res Inst Infect Dis, Frederick, MD USA; [Aliota, Matthew T.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Duke University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Mohr, EL (corresponding author), UW Madison, Dept Pediat, Madison, WI 53706 USA.	emohr2@wisc.edu	de Lima, Antonio Marcos Oliveira/AAT-2148-2021; Teixeira, Leandro/AAU-6094-2021; Aliota, Matthew/AAS-6376-2021	Teixeira, Leandro/0000-0001-9960-678X; Aliota, Matthew/0000-0002-6902-9149; Breitbach, Meghan/0000-0001-5974-8353; Zeng, Xiankun (Kevin)/0000-0003-3526-8755; Semler, Matthew/0000-0001-7754-6392	National Institutes of Health [P01 AI132132, R01 AI138647, R01 AI116382-01A1S1, K08 AI139341, R01 AI132563]; Pediatric Infectious Diseases Society; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002373-02, TL1002375-02]; NIH [P30 EY016665]; McPherson Eye Research Institute's Retina Research Foundation Kathryn & Latimer Murfee Chair; Research to Prevent Blindness; Sanofi Pasteur	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Infectious Diseases Society; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McPherson Eye Research Institute's Retina Research Foundation Kathryn & Latimer Murfee Chair; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Sanofi Pasteur	This study was supported by the National Institutes of Health (P01 AI132132 (DHO), R01 AI138647 (DHO), R01 AI116382-01A1S1 (DHO), K08 AI139341 (ELM), R01 AI132563 (MTA and TCF)) and the Pediatric Infectious Diseases Society funded by Stanley A. Plotkin and Sanofi Pasteur (www.pids.org) (ELM). This study was also supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR002373-02 and TL1002375-02 (ELM). This study was supported in part by the Core Grant for Vision Research from the NIH to the University of Wisconsin-Madison (P30 EY016665) (PI: Curtis Brandt), McPherson Eye Research Institute's Retina Research Foundation Kathryn & Latimer Murfee Chair (TMN), and an unrestricted grant from Research to Prevent Blindness to the University of Wisconsin Department of Ophthalmology and Visual Sciences (TMN). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1; Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2018, MMWR-MORBID MORTAL W, V67, P858; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BRAZELTON T B, 1973, Clinical Obstetrics and Gynecology, V16, P361, DOI 10.1097/00003081-197303000-00020; BUNTON TE, 1986, VET PATHOL, V23, P431, DOI 10.1177/030098588602300413; Coe CL, 2010, DEV PSYCHOBIOL, V52, P625, DOI 10.1002/dev.20489; Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6; Conway BR, 2018, ANNU REV VIS SCI, V4, P381, DOI 10.1146/annurev-vision-091517-034202; de Carvalho Leal Mariana, 2019, Top Magn Reson Imaging, V28, P19, DOI 10.1097/RMR.0000000000000191; de Fatima Viana Vasco Aragao Maria, 2019, Top Magn Reson Imaging, V28, P29, DOI 10.1097/RMR.0000000000000194; Barbosa MHD, 2019, BRAZ J OTORHINOLAR, V85, P642, DOI 10.1016/j.bjorl.2019.05.002; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Vianna RAD, 2019, J TROP PEDIATRICS, V65, P592, DOI 10.1093/tropej/fmz019; DOYLE WJ, 1983, ELECTROEN CLIN NEURO, V56, P210, DOI 10.1016/0013-4694(83)90075-5; Dudley DM, 2019, ANNU REV VIROL, V6, P481, DOI [10.1146/annurev-virology-092818-015732, 10.1146/annurev-virology-092818- 015732]; Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Fouda Genevieve G, 2018, Immunohorizons, V2, P14, DOI 10.4049/immunohorizons.1700057; Gerzson LR, 2020, J CHILD NEUROL, V35, P278, DOI 10.1177/0883073819892128; Hall J. W., 2006, NEW HDB AUDITORY EVO; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Huang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082922; Huber HF, 2020, J DEV ORIG HLTH DIS, V11, P297, DOI 10.1017/S2040174419000539; Johnson H., 2007, INSIGHT JOUR, P2, DOI [10.54294/hmb052, DOI 10.54294/HMB052]; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laughlin NK, 1999, NEUROTOXICOL TERATOL, V21, P627, DOI 10.1016/S0892-0362(99)00036-7; Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354; LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503; Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; Miyake Y., 2013, RETINA-J RET VIT DIS, P202; Moreira ME., VERTICAL EXPOSURE ZI; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; MYERS RE, 1972, J REPROD MED, V9, P171; Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1; Pecanha PM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229434; Prastawa M, 2003, ACAD RADIOL, V10, P1341, DOI 10.1016/S1076-6332(03)00506-3; Rajadhyaksha Viraj, 2010, Perspect Clin Res, V1, P106; Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098; Robson AG, 2018, DOC OPHTHALMOL, V136, P1, DOI 10.1007/s10633-017-9621-y; Rojas MA, NEURODEVELOPMENT OUT; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Schmitt Carl, 2014, NANJING U LAW J, V1, P15; SCHNEIDER ML, 1992, INFANT BEHAV DEV, V15, P155, DOI 10.1016/0163-6383(92)80021-L; Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6; Schneider ML, 1999, CHILD DEV, V70, P263, DOI 10.1111/1467-8624.00020; Shi YD, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00617; Society for Maternal-Fetal Medicine (SMFM) Publications Committee, 2017, AM J OBSTET GYNECOL, V216, pB8; Steinbach RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227676; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Syggelou A, 2011, J CHEMOTHERAPY, V23, P123, DOI 10.1179/joc.2011.23.3.123; Tarantal A.F., 2005, ULTRASOUND IMAGING R; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Wong Chee Wai, 2019, Retin Cases Brief Rep, V13, P171, DOI 10.1097/ICB.0000000000000552; Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561; 2015, PLAST RECONSTR SURG, V136, pS1	65	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0235877	10.1371/journal.pone.0235877	http://dx.doi.org/10.1371/journal.pone.0235877			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091010	Green Published, gold			2022-12-26	WOS:000586647200075
J	Tong, JY; He, R; Tang, XT; Li, MZ; Wan, JL				Tong, Jiayun; He, Rui; Tang, Xiaoting; Li, Mingzhi; Wan, Jinglin			Transcriptomic analysis of seed germination improvement ofAndrographis paniculataresponding to air plasma treatment	PLOS ONE			English	Article							ABSCISIC-ACID; GENE-EXPRESSION; LEPIDIUM-SATIVUM; DORMANCY RELEASE; LOW-TEMPERATURE; EARLY GROWTH; ARABIDOPSIS; GIBBERELLIN; ETHYLENE; ROLES	The plasma seed treatment is effective for promoting seed germination in many crops. However, the biological mechanism remains unclear. Therefore, mRNA sequencing was used to screen differentially expressed genes in the germination process ofAndrographis paniculataseeds treated with air plasma (power density = 8.99 J/cm(3)). Following plasma treatment, the germination percentages were significantly higher than those of the control, they were 3.5 +/- 0.6%vs. 0 at 28 hours after sowing (HAS) and 50.3 +/- 2.6%vs. 37.3 +/- 1.7% at 48 HAS. After unigenes were assembled and annotated, 125 differentially expressed genes (DEGs) were detected at 28 HAS, compared with nine DEGs at 48 HAS, but no DEGs were detected at 0 HAS, indicating that air plasma treatment mainly changed the gene expression ofA.paniculataseeds at 28 HAS. TheNCED5expression level of the treated group was less than one-fifth of the control, and the expressions of three ethylene response factors were significantly higher than the control at 28 HAS, indicating that lower abscisic acid levels play an important role and ethylene signal transduction also participates in radicle protrusion.ACO,NRT1andPRP3expressions were significantly higher than in the control at 48 HAS, suggesting that higher ethylene levels cause the endosperm cap to weaken and start to grow root hairs and lateral roots earlier. These findings reveal that plasma promotes seed germination mainly by regulating the expression of hormone-related genes. And the possible signal transduction of related hormones was discussed.	[Tong, Jiayun] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [He, Rui; Tang, Xiaoting] Guangzhou Univ Chinese Med, Res Ctr Chinese Herbal Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Li, Mingzhi] Genepioneer Biotechnol Co Ltd, Nanjing, Jiangsu, Peoples R China; [Wan, Jinglin] Nanjing Suman Plasma Technol Co Ltd Corona Lab, Nanjing, Jiangsu, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Tong, JY (corresponding author), Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; He, R (corresponding author), Guangzhou Univ Chinese Med, Res Ctr Chinese Herbal Resource Sci & Engn, Guangzhou, Guangdong, Peoples R China.	tong-jiayun@hotmail.com; rayhe618@hotmail.com		Tong, Jiayun/0000-0001-5273-7803	National Natural Science Foundation of China [31401277]; Special Subsidies for Public Health Services of TCM "the National Survey of TCM Resources" (DSS) from National Administration of Traditional Chinese Medicine of People's Republic of China [MOF. 66/2017]; National Natural Science Foundation of China; National Administration of Traditional Chinese Medicine of People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Subsidies for Public Health Services of TCM "the National Survey of TCM Resources" (DSS) from National Administration of Traditional Chinese Medicine of People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Administration of Traditional Chinese Medicine of People's Republic of China	This work was supported by the National Natural Science Foundation of China (Jiayun Tong received the funding, Grant No. 31401277), and the Special Subsidies for Public Health Services of TCM "the National Survey of TCM Resources" (DSS, MOF. 66/2017) from National Administration of Traditional Chinese Medicine of People's Republic of China. The authors Ming-zhi Li and Jing-lin Wan are employed by commercial companies Genepioneer Biotechnologies Co. Ltd., and Nanjing Suman Plasma Technology Co., Ltd.. The specific roles of these authors are articulated in the `author contributions' section. The funding organizations the National Natural Science Foundation of China and the National Administration of Traditional Chinese Medicine of People's Republic of China did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries (Xiao-Ting Tang) and research materials.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2009, TANZAN J HLTH RES, V11, piii; [Anonymous], 2019, JBL NEWS, V9, P12, DOI DOI 10.5923/J.EP.20190901.02; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Barba-Espin G, 2012, PLANT PHYSIOL BIOCH, V59, P30, DOI 10.1016/j.plaphy.2011.12.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhardt C, 2000, PLANT PHYSIOL, V122, P705, DOI 10.1104/pp.122.3.705; Bethke PC, 2007, PLANT PHYSIOL, V143, P1173, DOI 10.1104/pp.106.093435; da Silva ARM, 2017, COLLOID SURFACE B, V157, P280, DOI 10.1016/j.colsurfb.2017.05.063; Dai Y, 2019, ELECT POWER SYSTEM E, V17, P36; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Frey A, 2012, PLANT J, V70, P501, DOI 10.1111/j.1365-313X.2011.04887.x; Goktas A., 2011, METODOLOSKI ZVEZKI, V8, P17, DOI DOI 10.5897/SRE11.1283; Gonzalez-Astorga J, 2000, PLANT ECOL, V151, P253, DOI 10.1023/A:1026570623406; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; International Seed Testing Association (ISTA), 2008, INT RUL SEED TEST, P31; Ishibashi Y, 2013, ANN BOT-LONDON, V111, P95, DOI 10.1093/aob/mcs240; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; Nakano R, 2016, PLASMA MED, V6, DOI [10.1615/plasmaMed.2016019093, DOI 10.1615/PLASMAMED.2016019093]; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pipa AV, 2019, ATOMS, V7, DOI 10.3390/atoms7010014; Potokina E, 2002, FUNCT INTEGR GENOMIC, V2, P28, DOI 10.1007/s10142-002-0050-x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Saberi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30200-7; Satyanti A, 2019, OECOLOGIA, V189, P407, DOI 10.1007/s00442-018-04328-2; Seol YB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00480-6; Sera B, 2010, IEEE T PLASMA SCI, V38, P2963, DOI 10.1109/TPS.2010.2060728; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Sun XZ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15758; Talei D., 2012, Journal of Medicinal Plants Research, V6, P2170; [汤小婷 Tang Xiaoting], 2017, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V28, P383; Tong JY, 2019, J PLANT GROWTH REGUL, V38, P273, DOI 10.1007/s00344-018-9839-2; Tong JY, 2014, PLASMA SCI TECHNOL, V16, P260, DOI 10.1088/1009-0630/16/3/16; Tong JiaYun, 2011, Seed, V30, P1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002; Voegele A, 2011, J EXP BOT, V62, P5131, DOI 10.1093/jxb/err214; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Yin MQ, 2005, PLASMA SCI TECHNOL, V7, P3143, DOI 10.1088/1009-0630/7/6/017; Zivkovic S, 2004, SEED SCI TECHNOL, V32, P693	53	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240939	10.1371/journal.pone.0240939	http://dx.doi.org/10.1371/journal.pone.0240939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091041	gold, Green Published			2022-12-26	WOS:000586647200074
J	Wei, LX; Cao, P; Xu, C; Zhong, HJ; Wang, XK; Bai, MZ; Hu, B; Wang, RZ; Liu, N; Tian, Y; Chen, HJ; Li, JS; Yuan, W				Wei, Leixin; Cao, Peng; Xu, Chen; Zhong, Huajian; Wang, Xiukun; Bai, Meizhu; Hu, Bo; Wang, Ruizhe; Liu, Ning; Tian, Ye; Chen, Huajiang; Li, Jinsong; Yuan, Wen			Chondroitin synthase-3 regulates nucleus pulposus degeneration through actin-induced YAP signaling	FASEB JOURNAL			English	Article						chondroitin sulfate; intervertebral disc degeneration; nucleus pulposus; Yap	INTERVERTEBRAL DISC DEGENERATION; MOLECULAR-CLONING; SULFATE GLUCURONOSYLTRANSFERASE; POLYMERIZING FACTOR; N-ACETYLGALACTOSAMINYLTRANSFERASE; CONTACT INHIBITION; NEEDLE PUNCTURE; MODIFIED MICE; EXPRESSION; CELL	Loss of chondroitin sulfate (CS) has been reported to play a key role during intervertebral disc degeneration (IDD). However, the detailed mechanism of CS and its synthases have not been elucidated. Since CS is mainly synthesized by chondroitin synthases 3 (Chsy3), here, the Chsy3 knockout mice are generated by using CRISPR-Cas9 and semi-cloning technology to study its mechanism during IDD. We find that CS and Chsy3 expression are decreased during IDD both in human and mice nucleus pulposus (NP) tissue, and knockout of Chsy3 shows that spontaneous IDD phenotype resembles that of human samples in theChsy3(-/-)mice. Taking advantage of RNA-Seq data, we confirm increased catabolic and decreased anabolic changes inChsy3(-/-)NP cells. By using bioinformatic analysis and validation, we find that Hippo signaling pathway is significantly downregulated, and the activation of Yap1 is mainly affected inChsy3(-/-)NP cells. Furthermore, functional analyses have shown that Chsy3 could regulate NP cell degeneration by Actin tension mediated activation of Yap1, which is independent of Hippo/Lats signaling. In summary, our findings reveal a novel mechanism that depletion of CS-related Chsy3 can cause spontaneous intervertebral disc degeneration by mediating Yap activation through CS-related actin-tension in NP cells.	[Wei, Leixin; Cao, Peng; Xu, Chen; Zhong, Huajian; Hu, Bo; Wang, Ruizhe; Liu, Ning; Tian, Ye; Chen, Huajiang; Yuan, Wen] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China; [Wei, Leixin; Wang, Xiukun; Bai, Meizhu; Li, Jinsong] Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, Shanghai 200031, Peoples R China	Naval Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yuan, W (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China.; Li, JS (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Shanghai Key Lab Mol Andr, Shanghai 200031, Peoples R China.	jsli@sibcb.ac.cn; yuanwenspine@smmu.edu.cn	Li, Jin/GYQ-5363-2022; Xu, Chen/AAQ-5514-2020	Xu, Chen/0000-0001-8068-2109; Bai, Meizhu/0000-0001-8208-4073	National Nature Science Foundation of China [82002335, 81972088, 82072471, 81672211, 81871802, 81772376, 81601928, 81702149, 31971109, 31471390]; Shanghai Municipal Commission of Health and Family Planning [17140901500, 18ZR1438900, 20QA1409200, 20184Y0181]; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program [17CG36]; Shanghai "Rising Stars of Medical Talent" Youth Development Program	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program; Shanghai "Rising Stars of Medical Talent" Youth Development Program	National Nature Science Foundation of China, Grant/Award Number: 82002335, 81972088, 82072471, 81672211, 81871802, 81772376, 81601928, 81702149, 31971109 and 31471390; Shanghai Municipal Commission of Health and Family Planning, Grant/Award Number: 17140901500, 18ZR1438900, 20QA1409200 and 20184Y0181; Shanghai Education Development Foundation; Shanghai Municipal Education Commission "Chen Guang" Program, Grant/Award Number: 17CG36; Shanghai "Rising Stars of Medical Talent" Youth Development Program	Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Choi H, 2018, MATRIX BIOL, V70, P102, DOI 10.1016/j.matbio.2018.03.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Gu YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136042; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hu B, 2018, J CELL BIOCHEM, V119, P566, DOI 10.1002/jcb.26215; Hu B, 2017, ONCOTARGET, V8, P49303, DOI 10.18632/oncotarget.17571; Hutton WC, 1997, J SPINAL DISORD, V10, P47; Ishimaru D, 2014, OSTEOARTHR CARTILAGE, V22, P250, DOI 10.1016/j.joca.2013.11.010; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Lei T, 2017, AM J TRANSL RES, V9, P900; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Moreno-Vicente R, 2018, CELL REP, V25, P1622, DOI 10.1016/j.celrep.2018.10.024; Nishiyama H, 1985, Nihon Seikeigeka Gakkai Zasshi, V59, P1119; Ogawa H, 2010, J BIOL CHEM, V285, P34155, DOI 10.1074/jbc.M110.109553; Oichi T, 2018, SPINE, V43, pE557, DOI 10.1097/BRS.0000000000002427; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Sivan SS, 2014, BBA-GEN SUBJECTS, V1840, P3181, DOI 10.1016/j.bbagen.2014.07.013; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; van Meurs JBJ, 2017, OSTEOARTHR CARTILAGE, V25, P181, DOI 10.1016/j.joca.2016.11.011; Wang S, 2014, CELL PROLIFERAT, V47, P381, DOI 10.1111/cpr.12121; Wang WJ, 2015, CLIN CHIM ACTA, V448, P238, DOI 10.1016/j.cca.2015.06.023; Watanabe Y, 2010, BIOCHEM J, V432, P47, DOI 10.1042/BJ20100847; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002; Zhang C, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12492; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhong CQ, 2017, METHODS MOL BIOL, V1498, P121, DOI 10.1007/978-1-4939-6472-7_8; Zhong CQ, 2015, CELL STEM CELL, V17, P221, DOI 10.1016/j.stem.2015.06.005	40	6	6	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16581	16600		10.1096/fj.202001021R	http://dx.doi.org/10.1096/fj.202001021R		OCT 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089528	hybrid			2022-12-26	WOS:000582261300001
J	Baird, ME; Green, R; Lowe, R; Mongin, M; Bougeot, E				Baird, Mark Edward; Green, Rebecca; Lowe, Ryan; Mongin, Mathieu; Bougeot, Elodie			Optimising cool-water injections to reduce thermal stress on coral reefs of the Great Barrier Reef	PLOS ONE			English	Review							MODEL; TIME; AGE	Coral bleaching driven by ocean warming is one of the most visible ecological impacts of climate change and perhaps the greatest threat to the persistence of reefs in the coming decades. In the absence of returning atmospheric greenhouse gas concentrations to those compatible with ocean temperatures below the mass coral bleaching temperature thresholds, the most straightforward means to reduce thermal-stress induced bleaching is to cool water at the seabed. The feasibility of reducing the seabed temperature through cool-water injections is considered first by analysing the feasibility of doing so on 19 reefs with differing physical environments using a simple residence time metric in 200 m resolution hydrodynamic model configurations. We then concentrate on the reefs around Lizard Island, the most promising candidate of the 19 locations, and develop a 40 m hydrodynamic model to investigate the effect of the injection of cool water at differing volumetric rates. Injecting 27 degrees C seawater at a rate of 5 m(3)s(-1)at 4 sites in early 2017 cooled 97 ha of the reef by 0.15 degrees C or more. The power required to pump 5 m(3)s(-1)through a set of pipes over a distance of 3 km from a nearby channel is similar to 466 kW. This power applied at 4 sites for 3 months achieves a 2 Degree Heating Weeks (DHWs) reduction on 97 ha of reef. A more precise energy costing will require further expert engineering design of the pumping equipment and energy sources. Even for the most physically favourable reefs, cool-water transported through pipes and injected at a reef site is energy expensive and cannot be scaled up to any meaningful fraction of the 3,100 reefs of the GBR. Should priority be given to reducing thermal stress on one or a few high value reefs, this paper provides a framework to identify the most promising sites.	[Baird, Mark Edward; Mongin, Mathieu; Bougeot, Elodie] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Green, Rebecca; Lowe, Ryan] Univ Western Australia, Ocean Grad Sch, UWA Oceans Inst, Perth, WA, Australia; [Green, Rebecca; Lowe, Ryan] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, Perth, WA, Australia; [Bougeot, Elodie] Ecole Natl Super Ingn Limoges, Limoges, France	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Western Australia; Ecole d'Ingenieurs de l'Universite de Limoges (ENSIL-ENSCI)	Baird, ME (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.	mark.baird@csiro.au	Baird, Mark/GLU-2397-2022; mongin, mathieu/G-4169-2015; Baird, Mark E/D-7172-2015; Lowe, Ryan/A-5032-2012	Baird, Mark/0000-0003-4955-2298; mongin, mathieu/0000-0001-9647-0530; Baird, Mark E/0000-0003-4955-2298; Green, Rebecca/0000-0002-3377-1886; Lowe, Ryan/0000-0002-7080-8406	Australian Government	Australian Government(Australian GovernmentCGIAR)	The work is supported by a grant from the Australian Government to the Reef Restoration and Adaptation Program (https://www.gbrrestoration.org).The funding body played no role in the writing of this paper. Opinions expressed in the paper is that of the authors in their individual capacity.	Allen Coral Atlas, 2020, ZENODO; Anthony K, PLOS ONE; Anthony K, 2017, NAT ECOL EVOL, V1, P1420, DOI 10.1038/s41559-017-0313-5; Baird ME, 2018, ECOL MODEL, V386, P20, DOI 10.1016/j.ecolmodel.2018.07.013; Baird ME, 2004, CORAL REEFS, V23, P386, DOI 10.1007/s00338-004-0404-z; Beaman R.G., 2018, SSSI HYDR COMM SEM 0, DOI [10.4225/25/5a207b36022d2, DOI 10.4225/25/5A207B36022D2]; Deleersnijder E, 2001, J MARINE SYST, V28, P229, DOI 10.1016/S0924-7963(01)00026-4; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Green RH, 2019, CORAL REEFS, V38, P759, DOI 10.1007/s00338-019-01771-2; HAALAND SE, 1983, J FLUID ENG-T ASME, V105, P89, DOI 10.1115/1.3240948; Herzfeld M, 2015, OCEAN MODEL, V90, P1, DOI 10.1016/j.ocemod.2015.04.001; Herzfeld M, 2015, OCEAN MODEL, V89, P71, DOI 10.1016/j.ocemod.2015.02.004; Herzfeld M., 2016, EREEFS MARINE MODELL; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2018, ECOLOGY, V99, P501, DOI 10.1002/ecy.2092; Hughes TP, 2019, NAT CLIM CHANGE, V9, P40, DOI 10.1038/s41558-018-0351-2; Incropera F. P., 1990, FUNDAMENTALS HEAT MA; Kays W.M., 1980, CONVECTIVE HEAT MASS; Latham J, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0053; Lesser GR, 2004, COAST ENG, V51, P883, DOI 10.1016/j.coastaleng.2004.07.014; Lowe RJ, 2015, ANNU REV MAR SCI, V7, P43, DOI 10.1146/annurev-marine-010814-015834; Martyr-Koller RC, 2017, ESTUAR COAST SHELF S, V192, P86, DOI 10.1016/j.ecss.2017.04.024; Matz MV, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007220; Maxwell W., 1968, ATLAS GREAT BARRIER; Mongin M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034023; Monsen NE, 2002, LIMNOL OCEANOGR, V47, P1545, DOI 10.4319/lo.2002.47.5.1545; National Academies of Sciences Engineering and Medicine, 2019, RES REV INT INCR PER; Pan YW, 2016, SCI CHINA EARTH SCI, V59, P236, DOI 10.1007/s11430-015-5195-2; Reid EC, 2019, LIMNOL OCEANOGR, V64, P1949, DOI 10.1002/lno.11162; Roberts P. J., 2010, MARINE WASTEWATER OU; Schiller A, 2014, B AM METEOROL SOC, V95, P23, DOI 10.1175/BAMS-D-12-00202.1; Schulz KG, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00636; Skirving W, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010018; Steven ADL, 2019, J OPER OCEANOGR, V12, pS12, DOI 10.1080/1755876X.2019.1650589; Stjern CW, 2018, ATMOS CHEM PHYS, V18, P621, DOI 10.5194/acp-18-621-2018; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x	36	7	7	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0239978	10.1371/journal.pone.0239978	http://dx.doi.org/10.1371/journal.pone.0239978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079939	gold, Green Published			2022-12-26	WOS:000585940600031
J	Robinson, KA; Dunn, M; Hussey, SP; Fritz-Laylin, LK				Robinson, Kristyn A.; Dunn, Mallory; Hussey, Shane P.; Fritz-Laylin, Lillian K.			Identification of antibiotics for use in selection of the chytrid fungi Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans	PLOS ONE			English	Article							DEAMINASE GENE BSD; SELECTABLE MARKER; CHLAMYDOMONAS-REINHARDTII; HYGROMYCIN-RESISTANCE; INDUCIBLE EXPRESSION; TRANSFORMATION; NEOMYCIN; CELLS; ACTIVATION; ECOSYSTEMS	Global amphibian populations are being decimated by chytridiomycosis, a deadly skin infection caused by the fungal pathogensBatrachochytrium dendrobatidis(Bd) andB.salamandrivorans(Bsal). Although ongoing efforts are attempting to limit the spread of these infections, targeted treatments are necessary to manage the disease. Currently, no tools for genetic manipulation are available to identify and test specific drug targets in these fungi. To facilitate the development of genetic tools in Bd and Bsal, we have tested five commonly used antibiotics with available resistance genes: Hygromycin, Blasticidin, Puromycin, Zeocin, and Neomycin. We have identified effective concentrations of each for selection in both liquid culture and on solid media. These concentrations are within the range of concentrations used for selecting genetically modified cells from a variety of other eukaryotic species.	[Robinson, Kristyn A.; Dunn, Mallory; Hussey, Shane P.; Fritz-Laylin, Lillian K.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Fritz-Laylin, LK (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	lfritzlaylin@umass.edu		Fritz-Laylin, Lillian/0000-0002-9237-9403	National Science Foundation [IOS 1827257]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (IOS 1827257), awarded to Lillian K Fritz-Laylin (LFL). https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505480 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, Mayo Clin Health Lett, V16, P4; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Bellard C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2454; Benko Z, 2011, BIOTECHNIQUES, V51, P57, DOI 10.2144/000113706; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Brooks DR, 2000, FEMS MICROBIOL LETT, V186, P287, DOI 10.1111/j.1574-6968.2000.tb09119.x; Brown S, 2016, BIOPROTOC, V6; BUCHSCHACHER GL, 1992, J VIROL, V66, P2731, DOI 10.1128/JVI.66.5.2731-2739.1992; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Bureik M, 2005, FEMS YEAST RES, V5, P627, DOI 10.1016/j.femsyr.2004.12.007; Cary GA, 2014, YEAST, V31, P167, DOI 10.1002/yea.3007; Chankova SG, 2007, RADIAT ENVIRON BIOPH, V46, P409, DOI 10.1007/s00411-007-0123-2; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Chow MZY, 2013, STEM CELLS DEV, V22, P2678, DOI 10.1089/scd.2013.0125; CULLEN D, 1987, GENE, V57, P21, DOI 10.1016/0378-1119(87)90172-7; Dong Y, 2014, MAR DRUGS, V12, P4326, DOI 10.3390/md12084326; Drobinskaya I, 2008, STEM CELLS, V26, P2245, DOI 10.1634/stemcells.2008-0387; EGELHOFF TT, 1989, MOL CELL BIOL, V9, P1965, DOI 10.1128/MCB.9.5.1965; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Fritz-Laylin LK, 2017, J CELL BIOL, V216, P1673, DOI 10.1083/jcb.201701074; Fukuda H, 1999, NEW TRANSFORMATION S, V3; Gleason FH, 2011, MAR FRESHWATER RES, V62, P383, DOI 10.1071/MF10294; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grossart HP, 2016, FUNGAL ECOL, V19, P28, DOI 10.1016/j.funeco.2015.06.004; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Han GM, 2018, J MICROBIOL, V56, P356, DOI 10.1007/s12275-018-7349-3; Harrison SJ, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-19; HASNAIN SE, 1985, MOL CELL BIOL, V5, P3647, DOI 10.1128/MCB.5.12.3647; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Jin QW, 2008, J GEN VIROL, V89, P2611, DOI 10.1099/vir.0.2008/003624-0; Kagami M, 2014, FRONT MICROBIOL, V5; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Li G, 2019, DICTYOSTELIUM, V9; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lopez-Paz C, 2017, PLANT J, V92, P1232, DOI 10.1111/tpj.13731; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Medinal EM, 2020, ELIFE, V9, DOI 10.7554/eLife.52741; Mehta R, 2003, CURR MICROBIOL, V47, P237, DOI 10.1007/s00284-002-3945-9; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Moore JC, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt23; Nicolussi A, 2018, J BIOL CHEM, V293, P1330, DOI 10.1074/jbc.RA117.000463; Niemirowicz GT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205527; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Rashid A, 2017, J CELL SCI MUTAT, V1, P1; Robinson KA, 2020, DIS AQUAT ORGAN, V140, P1, DOI 10.3354/dao03488; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Sato M, 2012, REPROD DOMEST ANIM, V47, P759, DOI 10.1111/j.1439-0531.2011.01964.x; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; SHIMMA Y, 1990, J GEN MICROBIOL, V136, P1753, DOI 10.1099/00221287-136-9-1753; SMITH HO, 1981, ANNU REV BIOCHEM, V50, P41, DOI 10.1146/annurev.bi.50.070181.000353; Stepanenko AA, 2017, MUTAT RES-REV MUTAT, V773, P91, DOI 10.1016/j.mrrev.2017.05.002; Svidritskiy E, 2013, P NATL ACAD SCI USA, V110, P12283, DOI 10.1073/pnas.1304922110; Swafford AJM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71618-2; Tam JP, 2002, J BIOL CHEM, V277, P50450, DOI 10.1074/jbc.M208429200; Tamura K, 1995, BIOSCI BIOTECH BIOCH, V59, P2336, DOI 10.1271/bbb.59.2336; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; Ukekawa R, 2007, GENES CELLS, V12, P397, DOI 10.1111/j.1365-2443.2007.01057.x; Van Hove J, 2011, BIOCHEM BIOPH RES CO, V414, P101, DOI 10.1016/j.bbrc.2011.09.031; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Zhang XR, 2018, G3-GENES GENOM GENET, V8, P2067, DOI 10.1534/g3.118.200164	67	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240480	10.1371/journal.pone.0240480	http://dx.doi.org/10.1371/journal.pone.0240480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079945	gold, Green Published, Green Submitted			2022-12-26	WOS:000585940600020
J	Chon, D; Shin, J; Kim, JH				Chon, Doukyoung; Shin, Jaeyong; Kim, Jae-Hyun			Consideration of body mass index (BMI) in the association between hand grip strength and hypertension: Korean Longitudinal Study of Ageing (KLoSA)	PLOS ONE			English	Article							MUSCLE STRENGTH; ADULTS; OLDER; DISEASES; HEALTH; WOMEN	Objective The purpose of this study was to investigate the association between grip strength and hypertension in the Korean population aged 65 years or older. Furthermore, individual differences in BMI were taken into account to examine whether grip strength or a relative grip strength predicted hypertension better. Methods Data from the Korean Longitudinal Study of Ageing from 2006 to 2016 were assessed, and a total of 3,383 participants were analyzed in our study (Male: 1,527, Female: 1,856). Using the generalized estimating equation model, the association between grip strength and hypertension, assessed by the response to the question 'have you ever been diagnosed with hypertension from your doctor?', over the follow-up period was analyzed. The relative grip strength, calculated by dividing the mean grip strength by BMI, was also analyzed in association of hypertension. Results Both grip strength and relative grip strength were significantly associated with hypertension in our sample. However, the results were more significant in the total sample when relative grip strength was used. In terms of grip strength, as the High group as reference: Low (Odds Ratio (OR): 1.238, 95% Confidence Interval (CI): 1.096, 1.397), Middle Low (OR: 1.104, 95% CI: 0.990, 1.231), and Middle high (OR: 1.024, 95% CI: 0.934, 1.122). In the analysis using relative grip strength, as High group as reference: Low (OR: 1.393, 95% CI: 1.234, 1.573), Middle low (OR: 1.232, 95% CI: 1.104, 1.374), and Middle high (OR:1.104, 95% CI: 1.009, 1.209). Furthermore, the lower QIC measure in the model with relative grip strength (QIC: 25,251) compared with the one using grip strength (QIC: 25,266) indicated a better model fit in the former. Conclusions The results of the current study strengthen the previous findings in regards to hand grip strength and health. Furthermore, the results of our study shines light on the necessity of considering individual differences in BMI, when using a physical measure as a study variable.	[Chon, Doukyoung] Korea Univ, Dept Prevent Med, Sch Med, Seoul, South Korea; [Shin, Jaeyong] Ajou Univ, Sch Med, Dept Prevent Med, Suwon, Gyeonggi Do, South Korea; [Kim, Jae-Hyun] Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea	Korea University; Korea University Medicine (KU Medicine); Ajou University; Dankook University	Shin, J (corresponding author), Ajou Univ, Sch Med, Dept Prevent Med, Suwon, Gyeonggi Do, South Korea.; Kim, JH (corresponding author), Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea.	drshin@ajou.ac.kr; kjh930529@gmail.com	Shin, Jaeyong/AAA-5394-2022	Shin, Jaeyong/0000-0002-2955-6382; Kim, Jae-Hyun/0000-0002-3531-489X				Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2015, HLTH AT A GLANC, V15, P2016; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Choquette S, 2010, J NUTR HEALTH AGING, V14, P190, DOI 10.1007/s12603-010-0047-4; Dong B, 2016, HYPERTENS RES, V39, P919, DOI 10.1038/hr.2016.84; Fowles J, 2014, HEALTH REP, V25, P13; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gubelmann C, 2017, EUR J PREV CARDIOL, V24, P514, DOI 10.1177/2047487316680695; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Ji C, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0734-4; Lawman HG, 2016, AM J PREV MED, V50, P677, DOI 10.1016/j.amepre.2015.10.022; Lee J-A., 2017, J KOREAN ACAD KINESI, V19, P53, DOI [10.15758/jkak.2017.19.3.53, DOI 10.15758/JKAK.2017.19.3.53]; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Liu LJ, 2013, AM J CARDIOL, V112, P694, DOI 10.1016/j.amjcard.2013.04.050; Mainous AG, 2015, AM J PREV MED, V49, P850, DOI 10.1016/j.amepre.2015.05.025; McGowan CL, 2006, AM J PHYSIOL-HEART C, V291, pH1797, DOI 10.1152/ajpheart.01113.2005; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sharman JE, 2009, J SCI MED SPORT, V12, P252, DOI 10.1016/j.jsams.2008.10.009; Silventoinen K, 2009, INT J EPIDEMIOL, V38, P110, DOI 10.1093/ije/dyn231; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Statistics Korea, 2019, POP STAT; Wall HK, 2014, JAMA-J AM MED ASSOC, V312, P1973, DOI 10.1001/jama.2014.15388	26	9	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241360	10.1371/journal.pone.0241360	http://dx.doi.org/10.1371/journal.pone.0241360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119673	Green Published, gold			2022-12-26	WOS:000600013600003
J	Gedeborg, R; Garmo, H; Robinson, D; Stattin, P				Gedeborg, Rolf; Garmo, Hans; Robinson, David; Stattin, Par			Prescription-based prediction of baseline mortality risk among older men	PLOS ONE			English	Article							MEDICATION REGIMEN COMPLEXITY; CHRONIC DISEASE SCORE; REGISTER; PEOPLE; SWEDEN	Background Understanding the association between patients' history of prescribed medications and mortality rate could optimize characterization of baseline risk when the Charlson Comorbidity Index is insufficient. Methods Using a Swedish cohort of men selected randomly as controls to men with prostate cancer diagnosed 2007-2013, we estimated the association between medications prescribed during the previous year and mortality rates, using Cox regression stratified for age. Results Among the 326,450 older men with median age of 69 years included in this study, 73% were categorized as free of comorbidity according to the Charlson Comorbidity Index; however, 84% had received at least one prescription during the year preceding the follow-up. This was associated with a 60% overall increase in mortality rate (hazard ratio [HR] = 1.60, 95% confidence interval [CI] 1.56 to 1.64). Some drugs that were unexpectedly associated with mortality included locally acting antacids (HR = 4.7, 95% CI 4.4 to 5.1), propulsives (HR = 4.7, 95% CI 4.4 to 5.0), vitamin A and D (HR = 4.6, 95% CI 4.3 to 4.9), and loop diuretics, for example furosemide (HR = 3.7; 95% CI 3.6 to 3.8). Thiazide diuretics, however, were only weakly associated with a mortality risk (HR = 1.5; 95% CI 1.4 to 1.5). Surprisingly, only weak associations with mortality were seen for major cardiovascular drug classes. Conclusions A majority of older men had a history of prescribed medications and many drug classes were associated with mortality rate, including drug classes not directly indicated for a specific comorbidity represented in commonly used comorbidity measures. Prescription history can improve baseline risk assessment but some associations might be context-sensitive.	[Gedeborg, Rolf] Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden; [Garmo, Hans; Stattin, Par] Uppsala Univ, Dept Surg Sci, Urol, Uppsala, Sweden; [Garmo, Hans] Kings Coll London, Sch Canc & Pharmaceut Sci, Guys Hosp, Translat Oncol & Urol Res TOUR, London, England; [Garmo, Hans] Uppsala Univ Hosp, Reg Canc Ctr Uppsala Orebro, Uppsala, Sweden; [Robinson, David] Ryhov Hosp, Dept Urol, Jonkoping, Sweden	Uppsala University; Uppsala University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Uppsala University; Uppsala University Hospital	Gedeborg, R (corresponding author), Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care, Uppsala, Sweden.	rolf.gedeborg@surgsci.uu.se	Gedeborg, Rolf/AAV-6702-2020	Gedeborg, Rolf/0000-0002-8850-7863; Robinson, David/0000-0002-3433-8873	Swedish Cancer Society [17-0474]; Swedish Research Council [17-00847]; Clinical Cancer Research Foundation in Jonkoping, Sweden	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Clinical Cancer Research Foundation in Jonkoping, Sweden	Par Stattin received funding from the Swedish Cancer Society 17-0474 and the Swedish Research Council 17-00847. David Robinson received funding from the Clinical Cancer Research Foundation in Jonkoping, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, NATURWISSENSCHAFTLIC, V40, P373; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Hagel E, 2009, SCAND J UROL NEPHROL, V43, P342, DOI 10.3109/00365590903024577; Huang SP, 2019, DRUG SAFETY, V42, P67, DOI 10.1007/s40264-018-0720-9; Johnson ML, 2006, MED CARE, V44, P793, DOI 10.1097/01.mlr.0000218804.41758.ef; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Masclee GMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204746; Pratt NL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021122; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Schink T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203362; Sonnebring G, 2014, PCBASESWEDEN PLATFOR; Sylvestre E, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0586-x; Van Hemelrijck M, 2016, INT J EPIDEMIOL, V45, P73, DOI 10.1093/ije/dyv305; Vitry A, 2009, AUST NZ J PUBL HEAL, V33, P126, DOI 10.1111/j.1753-6405.2009.00357.x; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Wallerstedt SM, 2016, BASIC CLIN PHARMACOL, V119, P464, DOI 10.1111/bcpt.12613; Wimmer BC, 2016, ANN PHARMACOTHER, V50, P89, DOI 10.1177/1060028015621071; Wimmer BC, 2016, J GERONTOL A-BIOL, V71, P831, DOI 10.1093/gerona/glv219	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241439	10.1371/journal.pone.0241439	http://dx.doi.org/10.1371/journal.pone.0241439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119680	Green Published, gold			2022-12-26	WOS:000600013600083
J	Su, WC; Culotta, M; Mueller, J; Tsuzuki, D; Pelphrey, K; Bhat, A				Su, Wan-Chun; Culotta, McKenzie; Mueller, Jessica; Tsuzuki, Daisuke; Pelphrey, Kevin; Bhat, Anjana			Differences in cortical activation patterns during action observation, action execution, and interpersonal synchrony between children with or without autism spectrum disorder (ASD): An fNIRS pilot study	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; NEAR-INFRARED SPECTROSCOPY; FUNCTIONAL CONNECTIVITY; IMITATION NETWORK; ALE METAANALYSIS; MOTOR; PERCEPTION; FMRI; ADOLESCENTS; MECHANISMS	Engaging in socially embedded actions such as imitation and interpersonal synchrony facilitates relationships with peers and caregivers. Imitation and interpersonal synchrony impairments of children with Autism Spectrum Disorder (ASD) might contribute to their difficulties in connecting and learning from others. Previous fMRI studies investigated cortical activation in children with ASD during finger/hand movement imitation; however, we do not know whether these findings generalize to naturalistic face-to-face imitation/interpersonal synchrony tasks. Using functional near infrared spectroscopy (fNIRS), the current study assessed the cortical activation of children with and without ASD during a face-to-face interpersonal synchrony task. Fourteen children with ASD and 17 typically developing (TD) children completed three conditions: a) Watch-observed an adult clean up blocks; b) Do-cleaned up the blocks on their own; and c) Together-synchronized their block clean up actions to that of an adult. Children with ASD showed lower spatial and temporal synchrony accuracies but intact motor accuracy during the Together/interpersonal synchrony condition. In terms of cortical activation, children with ASD had hypoactivation in the middle and inferior frontal gyri (MIFG) as well as middle and superior temporal gyri (MSTG) while showing hyperactivation in the inferior parietal cortices/lobule (IPL) compared to the TD children. During the Together condition, the TD children showed bilaterally symmetrical activation whereas children with ASD showed more left-lateralized activation over MIFG and right-lateralized activation over MSTG. Additionally, using ADOS scores, in children with ASD greater social affect impairment was associated with lower activation in the left MIFG and more repetitive behavior impairment was associated with greater activation over bilateral MSTG. In children with ASD better communication performance on the VABS was associated with greater MIFG and/or MSTG activation. We identified objective neural biomarkers that could be utilized as outcome predictors or treatment response indicators in future intervention studies.	[Su, Wan-Chun; Culotta, McKenzie; Bhat, Anjana] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Su, Wan-Chun; Culotta, McKenzie; Bhat, Anjana] Univ Delaware, Biomech & Movement Sci Program, Newark, DE 19716 USA; [Mueller, Jessica] AI du Pont Nemours Hosp Children, Swank Autism Ctr, Dept Behav Hlth, Wilmington, DE USA; [Tsuzuki, Daisuke] Tokyo Metropolitan Univ, Dept Language Sci, Tokyo, Japan; [Pelphrey, Kevin] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Bhat, Anjana] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA	University of Delaware; University of Delaware; Tokyo Metropolitan University; University of Virginia; University of Delaware	Bhat, A (corresponding author), Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA.; Bhat, A (corresponding author), Univ Delaware, Biomech & Movement Sci Program, Newark, DE 19716 USA.; Bhat, A (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	abhat@udel.edu	Bhat, Anjana/AAX-8869-2021; Su, Wan-Chun/GXF-9816-2022	Bhat, Anjana/0000-0002-0771-0967; 	National Institutes of Health [1S10OD021534-01]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [U54-GM104941, P20 GM103446]; Dana foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); Dana foundation	This work was supported by the National Institutes of Health through a shared instrumentation grant awarded to the University of Delaware (Grant #: 1S10OD021534-01, PI: Bhat) and pilot award funding through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (U54-GM104941, PI: Binder-Macleod; P20 GM103446, PI: Stanhope). AB also thanks the Dana foundation for their support of this fNIRS-based research through a Clinical Neuroscience Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Bhat AN, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00431; Bhat AN, 2011, PHYS THER, V91, P1116, DOI 10.2522/ptj.20100294; Brihmat N, 2018, BRAIN IMAGING BEHAV, V12, P1363, DOI 10.1007/s11682-017-9804-x; Cacioppo S, 2014, NEUROSCIENCE, V277, P842, DOI 10.1016/j.neuroscience.2014.07.051; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Chita-Tegmark M, 2016, RES DEV DISABIL, V48, P79, DOI 10.1016/j.ridd.2015.10.011; Cook JL, 2013, BRAIN, V136, P2816, DOI 10.1093/brain/awt208; COREN S, 1993, B PSYCHONOMIC SOC, V31, P1, DOI 10.3758/bf03334122; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dawson G, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-11; Del Casale A, 2016, WORLD J BIOL PSYCHIA, V17, P378, DOI 10.3109/15622975.2015.1102323; Dona O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190081; Dougherty CC, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0089-5; Edwards LA, 2014, AUTISM RES, V7, P363, DOI 10.1002/aur.1379; Egetemeir J, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00095; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Fairhurst MT, 2014, NEUROIMAGE, V84, P688, DOI 10.1016/j.neuroimage.2013.09.027; Fan YT, 2010, J CHILD PSYCHOL PSYC, V51, P981, DOI 10.1111/j.1469-7610.2010.02269.x; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fishman I, 2015, ANN NEUROL, V78, P958, DOI 10.1002/ana.24533; Fitzpatrick P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01323; Fournier KA, 2010, J AUTISM DEV DISORD, V40, P1227, DOI 10.1007/s10803-010-0981-3; Franchini M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178859; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Gatti R, 2017, BRAIN IMAGING BEHAV, V11, P565, DOI 10.1007/s11682-016-9536-3; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Haberling IS, 2016, CORTEX, V82, P72, DOI 10.1016/j.cortex.2016.06.003; Hamzei F, 2016, CEREB CORTEX, V26, P2215, DOI 10.1093/cercor/bhv066; Herringshaw AJ, 2016, AUTISM RES, V9, P1046, DOI 10.1002/aur.1599; Hill EL, 2004, DEV REV, V24, P189, DOI 10.1016/j.dr.2004.01.001; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Hu XS, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.12.126003; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Iacoboni M, 2009, CURR OPIN NEUROBIOL, V19, P661, DOI 10.1016/j.conb.2009.09.008; Ikeda T, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.3.035008; Jack A, 2014, DEV COGN NEUROS-NETH, V10, P77, DOI 10.1016/j.dcn.2014.08.001; Jack A, 2011, NEUROPSYCHOLOGIA, V49, P3689, DOI 10.1016/j.neuropsychologia.2011.09.024; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kaur M, 2019, PHYS THER, V99, P1520, DOI 10.1093/ptj/pzz115; Kaur M, 2018, RES DEV DISABIL, V72, P79, DOI 10.1016/j.ridd.2017.10.025; Kawasaki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14508-4; Keith JM, 2019, J ABNORM CHILD PSYCH, V47, P741, DOI 10.1007/s10802-018-0455-1; Kim SY, 2015, PSYCHIAT INVEST, V12, P37, DOI 10.4306/pi.2015.12.1.37; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koehler S, 2012, NEUROSCI LETT, V508, P73, DOI 10.1016/j.neulet.2011.12.021; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Lenroot RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00733; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lim YH, 2017, J AUTISM DEV DISORD, V47, P2238, DOI 10.1007/s10803-017-3144-y; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Lord C., 2012, AUTISM DIAGNOSTIC OB; Marsh AA, 2010, SOC COGN AFFECT NEUR, V5, P392, DOI 10.1093/scan/nsq004; Marsh KL, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00004; Martineau J, 2010, BRAIN RES, V1320, P168, DOI 10.1016/j.brainres.2010.01.035; McKenna R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00154; Menz MM, 2009, HUM BRAIN MAPP, V30, P3339, DOI 10.1002/hbm.20756; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Mogan R, 2017, J EXP SOC PSYCHOL, V72, P13, DOI 10.1016/j.jesp.2017.03.009; Molenberghs P, 2010, HUM BRAIN MAPP, V31, P1316, DOI 10.1002/hbm.20938; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Mottron L, 2003, J CHILD PSYCHOL PSYC, V44, P904, DOI 10.1111/1469-7610.00174; Muhlau M, 2005, NEUROPSYCHOLOGIA, V43, P1086, DOI 10.1016/j.neuropsychologia.2004.10.004; Nebel MB, 2016, BIOL PSYCHIAT, V79, P633, DOI 10.1016/j.biopsych.2015.08.029; Nicholson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169700; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Philip RCM, 2012, NEUROSCI BIOBEHAV R, V36, P901, DOI 10.1016/j.neubiorev.2011.10.008; Phillips-Silver J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00026; Pineda Jaime A., 2009, P135, DOI 10.1007/978-1-59745-479-7_7; Pokorny JJ, 2015, AUTISM RES, V8, P284, DOI 10.1002/aur.1445; Poulin-Lord MP, 2014, NEUROIMAGE-CLIN, V4, P444, DOI 10.1016/j.nicl.2014.02.008; Powers M.D., 2014, HDB AUTISM PERVASIVE, V4th; Rane P, 2015, HARVARD REV PSYCHIAT, V23, P223, DOI 10.1097/HRP.0000000000000072; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Reynolds JE, 2015, INT J DEV NEUROSCI, V47, P309, DOI 10.1016/j.ijdevneu.2015.10.003; Richardson MJ, 2007, J EXP PSYCHOL HUMAN, V33, P845, DOI 10.1037/0096-1523.33.4.845; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Roid G. H., 2003, STANFORD BINET INTEL; Rutter M., 2003, SOCIAL COMMUNICATION; Sato H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1960907; Semin G, 2009, MIRROR NEURON SYSTEM; Semrud-Clikeman M, 2011, NEUROPSYCHOBIOLOGY, V64, P47, DOI 10.1159/000325075; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Somogyi E, 2013, RES DEV DISABIL, V34, P3822, DOI 10.1016/j.ridd.2013.07.039; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, Vsecond; Srinivasan Sudha M, 2015, Autism Res Treat, V2015, P736516, DOI 10.1155/2015/736516; Srinivasan SM, 2016, RES AUTISM SPECT DIS, V27, P73, DOI 10.1016/j.rasd.2016.04.001; Su WC, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00057; Sutoko S, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.010801; Tachibana A, 2011, NEUROSCI LETT, V503, P125, DOI 10.1016/j.neulet.2011.08.023; Tsuzuki D, 2012, NEUROSCI RES, V72, P163, DOI 10.1016/j.neures.2011.10.008; Turella L, 2009, BRAIN LANG, V108, P10, DOI 10.1016/j.bandl.2007.11.002; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Vicaria IM, 2016, J NONVERBAL BEHAV, V40, P335, DOI 10.1007/s10919-016-0238-8; Vrticka P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00095; Wadsworth HM, 2017, NEUROSCIENCE, V343, P147, DOI 10.1016/j.neuroscience.2016.12.001; Whyatt C, 2013, RES AUTISM SPECT DIS, V7, P613, DOI 10.1016/j.rasd.2013.01.003; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Yang J, 2016, BRAIN IMAGING BEHAV, V10, P960, DOI 10.1007/s11682-015-9456-7; Zheng R, 2019, MOTOR CONTROL, V23, P398, DOI 10.1123/mc.2017-0084	114	16	18	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240301	10.1371/journal.pone.0240301	http://dx.doi.org/10.1371/journal.pone.0240301			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119704	Green Published, gold			2022-12-26	WOS:000600013600061
J	Belyayev, A; Jandova, M; Josefiova, J; Kalendar, R; Mahelka, V; Mandak, B; Krak, K				Belyayev, Alexander; Jandova, Michaela; Josefiova, Jirina; Kalendar, Ruslan; Mahelka, Vaclav; Mandak, Bohumil; Krak, Karol			The major satellite DNA families of the diploid Chenopodium album aggregate species: Arguments for and against the "library hypothesis"	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; EVOLUTION; SEQUENCE; HETEROCHROMATIN; ORGANIZATION	Satellite DNA (satDNA) is one of the major fractions of the eukaryotic nuclear genome. Highly variable satDNA is involved in various genome functions, and a clear link between satellites and phenotypes exists in a wide range of organisms. However, little is known about the origin and temporal dynamics of satDNA. The "library hypothesis" indicates that the rapid evolutionary changes experienced by satDNAs are mostly quantitative. Although this hypothesis has received some confirmation, a number of its aspects are still controversial. A recently developed next-generation sequencing (NGS) method allows the determination of the satDNA landscape and could shed light on unresolved issues. Here, we explore low-coverage NGS data to infer satDNA evolution in the phylogenetic context of the diploid species of the Chenopodium album aggregate. The application of the Illumina read assembly algorithm in combination with Oxford Nanopore sequencing and fluorescent in situ hybridization allowed the estimation of eight satDNA families within the studied group, six of which were newly described. The obtained set of satDNA families of different origins can be divided into several categories, namely group-specific, lineage-specific and species-specific. In the process of evolution, satDNA families can be transmitted vertically and can be eliminated over time. Moreover, transposable element-derived satDNA families may appear repeatedly in the satellitome, creating an illusion of family conservation. Thus, the obtained data refute the "library hypothesis", rather than confirming it, and in our opinion, it is more appropriate to speak about "the library of the mechanisms of origin".	[Belyayev, Alexander; Jandova, Michaela; Josefiova, Jirina; Mahelka, Vaclav; Mandak, Bohumil; Krak, Karol] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Kalendar, Ruslan] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Kalendar, Ruslan] Nazarbayev Univ, Natl Lab Astana, Nur Sultan, Kazakhstan; [Mandak, Bohumil; Krak, Karol] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Suchdol, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Helsinki; Nazarbayev University; Czech University of Life Sciences Prague	Belyayev, A (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.	alexander.belyayev@ibot.cas.cz	Belyayev, Alexander/G-1611-2014; Kalendar, Ruslan/D-9751-2012; Mahelka, Václav/H-1608-2014	Belyayev, Alexander/0000-0002-8933-6197; Kalendar, Ruslan/0000-0003-3986-2460; Mahelka, Václav/0000-0003-1922-0540; Mandak, Bohumil/0000-0002-9545-7497; Krak, Karol/0000-0002-0340-2086	Czech Science Foundation [20-20286S, RVO 67985939]; Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan [AP08855353]	Czech Science Foundation(Grant Agency of the Czech Republic); Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by the Czech Science Foundation (grant No 20-20286S) for KK and as part of the long-term research development project RVO 67985939 for AB, and the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (AP08855353) for RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyayev A, 2014, J EVOLUTION BIOL, V27, P2573, DOI 10.1111/jeb.12513; Belyayev A, 2020, MOBILE DNA-UK, V11, DOI 10.1186/s13100-020-00219-7; Belyayev A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051201; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Garrido-Ramos MA, 2015, CYTOGENET GENOME RES, V146, P153, DOI 10.1159/000437008; Heitkam T, 2020, PLANT J, V103, P32, DOI 10.1111/tpj.14705; Kalendar R, 2017, GENOMICS, V109, P312, DOI 10.1016/j.ygeno.2017.05.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIT S, 1961, J MOL BIOL, V3, P711, DOI 10.1016/S0022-2836(61)80075-2; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lower SS, 2018, CURR OPIN GENET DEV, V49, P70, DOI 10.1016/j.gde.2018.03.003; Mandak B, 2018, MOL PHYLOGENET EVOL, V129, P189, DOI 10.1016/j.ympev.2018.08.016; Mandak B, 2016, PERSPECT PLANT ECOL, V23, P18, DOI 10.1016/j.ppees.2016.09.004; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Mestrovic N, 2015, CHROMOSOME RES, V23, P583, DOI 10.1007/s10577-015-9483-7; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Palacios-Gimenez OM, 2020, GENOME BIOL EVOL, V12, P88, DOI 10.1093/gbe/evaa018; Plohl M, 2012, GENOME DYNAM, V7, P126, DOI 10.1159/000337122; Plohl M, 2010, HEREDITY, V104, P543, DOI 10.1038/hdy.2009.141; Ruiz-Ruano FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28333; SALSER W, 1976, FED PROC, V35, P23; SOUTHERN EM, 1970, NATURE, V227, P794, DOI 10.1038/227794a0; Sultana N, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050527; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wei KHC, 2018, MOL BIOL EVOL, V35, P925, DOI 10.1093/molbev/msy005	30	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241206	10.1371/journal.pone.0241206	http://dx.doi.org/10.1371/journal.pone.0241206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108401	Green Published, gold			2022-12-26	WOS:000588372400001
J	Hattori, K; Wakatsuki, H; Sakauchi, C; Furutani, S; Sugawara, S; Hatta, T; Natsume, T; Ichijo, H				Hattori, Kazuki; Wakatsuki, Hiroaki; Sakauchi, Chihiro; Furutani, Shotaro; Sugawara, Sho; Hatta, Tomohisa; Natsume, Tohru; Ichijo, Hidenori			beta-adrenergic receptor signaling evokes the PKA-ASK axis in mature brown adipocytes	PLOS ONE			English	Article							REGULATING KINASE 1; ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MAP KINASE; C-JUN; APOPTOSIS; PHOSPHORYLATION; OBESITY	Boosting energy expenditure by harnessing the activity of brown adipocytes is a promising strategy for combatting the global epidemic of obesity. Many studies have revealed that the beta(3)-adrenergic receptor agonist is a potent activator of brown adipocytes, even in humans, and PKA and p38 MAPK have been demonstrated for regulating the transcription of a wide range of critical genes such as Ucp1. We previously revealed that the PKA-ASK1-p38 axis is activated in immature brown adipocytes and contributes to functional maturation. However, the downstream mechanisms of PKA that initiate the p38 MAPK cascade are still mostly unknown in mature brown adipocytes. Here, we identified the ASK family as a crucial signaling molecule bridging PKA and MAPK in mature brown adipocytes. Mechanistically, the phosphorylation of ASK1 at threonine 99 and serine 993 is critical in PKA-dependent ASK1 activation. Additionally, PKA also activates ASK2, which contributes to MAPK regulation. These lines of evidence provide new details for tailoring a beta AR-dependent brown adipocyte activation strategy.	[Hattori, Kazuki; Wakatsuki, Hiroaki; Sakauchi, Chihiro; Furutani, Shotaro; Sugawara, Sho; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Hatta, Tomohisa; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Tokyo, Japan; [Hattori, Kazuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Hattori, K; Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan.	kzkhattori@13.alumni.u-tokyo.ac.jp; ichijo@mol.f.u-tokyo.ac.jp	Hattori, Kazuki/J-9477-2019	Hattori, Kazuki/0000-0002-5592-4257; Sugawara, Sho/0000-0003-0010-7409	Japan Society for the Promotion of Science (JSPS) [JP18H03995, JP25221302, JP16K18872, JP25893036]; Japan Agency for Medical Research and Development (AMED) [JP19gm5010001]; Kowa Life Science Foundation [2016 A-2]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kowa Life Science Foundation	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS; grant numbers JP18H03995 and JP25221302 to H.I., JP16K18872 and JP25893036 to K.H., see https://kaken.nii.ac.jp/for details), Project for Elucidating and Controlling Mechanisms of Aging and Longevity from Japan Agency for Medical Research and Development (AMED; grant number JP19gm5010001 to H.I.), and the Kowa Life Science Foundation (2016 A-2 to K.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; [Anonymous], 2020, OV OB; [Anonymous], 2020, OB OV; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Baskin AS, 2018, DIABETES, V67, P2113, DOI 10.2337/db18-0462; Betz MJ, 2018, NAT REV ENDOCRINOL, V14, P77, DOI 10.1038/nrendo.2017.132; Bian L, 2010, DIABETES, V59, P1276, DOI 10.2337/db09-1700; Bonora M, 2012, PURINERG SIGNAL, V8, P343, DOI 10.1007/s11302-012-9305-8; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Challa TD, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810124; Cheng R, 2018, BBA-GEN SUBJECTS, V1862, P2271, DOI 10.1016/j.bbagen.2018.07.015; Chino H, 2019, MOL CELL, V74, P909, DOI 10.1016/j.molcel.2019.03.033; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; deSouza CJ, 1997, DIABETES, V46, P1257, DOI 10.2337/diabetes.46.8.1257; Federspiel JD, 2016, MOL CELL PROTEOMICS, V15, P1947, DOI 10.1074/mcp.M115.057364; Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892; Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510; Fujisawa T, 2016, HUM MOL GENET, V25, P245, DOI 10.1093/hmg/ddv467; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Hattori K, 2018, CELL CYCLE, V17, P5, DOI 10.1080/15384101.2017.1397330; Hattori K, 2017, EMBO REP, V18, P2067, DOI 10.15252/embr.201744228; Hattori K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11158; Hotamisligil GS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a006072; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Imamura K, 2018, P NATL ACAD SCI USA, V115, P3646, DOI 10.1073/pnas.1719298115; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kamiyama M, 2017, CELL DEATH DIFFER, V24, P2066, DOI 10.1038/cdd.2017.114; Keshwani MM, 2012, P NATL ACAD SCI USA, V109, pE1221, DOI 10.1073/pnas.1202741109; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Naguro I, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2283; Nishida Takuto, 2017, Advances in Biological Regulation, V66, P2, DOI 10.1016/j.jbior.2017.05.004; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; O'Mara AE, 2020, J CLIN INVEST, V130, P2209, DOI 10.1172/JCI131126; Okazaki T, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1883; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pepin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112714; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sakauchi C, 2017, BBA-GEN SUBJECTS, V1861, P3030, DOI 10.1016/j.bbagen.2016.09.028; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Takeda K, 2007, J BIOL CHEM, V282, P7522, DOI 10.1074/jbc.M607177200; Tholey A, 2001, BIOCHEMISTRY-US, V40, P225, DOI 10.1021/bi0021277; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Torres-Quesada O, 2017, CELL SIGNAL, V37, P1, DOI 10.1016/j.cellsig.2017.05.012; Trevelyan SJ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay6318; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Watanabe T, 2015, J BIOL CHEM, V290, P10791, DOI 10.1074/jbc.M114.623280; Xiang M, 2016, J HEPATOL, V64, P1365, DOI 10.1016/j.jhep.2016.02.002; Yamamoto E, 2008, HYPERTENSION, V52, P573, DOI 10.1161/HYPERTENSIONAHA.108.112292; Yi D, 2019, CELL REP, V29, P2621, DOI 10.1016/j.celrep.2019.10.099; Yubero P, 1998, MOL ENDOCRINOL, V12, P1023, DOI 10.1210/me.12.7.1023; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang SJ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004225; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zhou XY, 2016, BBA-GEN SUBJECTS, V1860, P2037, DOI 10.1016/j.bbagen.2016.05.032	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e023264	10.1371/journal.pone.0232645	http://dx.doi.org/10.1371/journal.pone.0232645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108364	Green Published, gold, Green Submitted			2022-12-26	WOS:000588372400037
J	de Pedro, I; Galan-Vidal, J; Freije, A; de Diego, E; Gandarillas, A				de Pedro, Isabel; Galan-Vidal, Jesus; Freije, Ana; de Diego, Ernesto; Gandarillas, Alberto			p21CIP1 controls the squamous differentiation response to replication stress	ONCOGENE			English	Article							CELL-CYCLE EXIT; HUMAN KERATINOCYTES; DNA-REPLICATION; P21 EXPRESSION; MITOTIC EXIT; C-MYC; P53; P21(WAF1/CIP1); CANCER; SKIN	The control of cell fate is critical to homeostasis and cancer. Cell cycle cdk inhibitor p21CIP1 has a central and paradoxical role in the regulatory crossroads leading to senescence, apoptosis, or differentiation. p21 is an essential target of tumor suppressor p53, but it also is regulated independently. In squamous self-renewal epithelia continuously exposed to mutagenesis, p21 controls cell fate by mechanisms still intriguing. We previously identified a novel epidermoid DNA damage-differentiation response. We here show that p21 intervenes in the mitosis block that is required for the squamous differentiation response to cell cycle deregulation and replication stress. The inactivation of endogenous p21 in human primary keratinocytes alleviated the differentiation response to oncogenic loss of p53 or overexpression of the DNA replication major regulator Cyclin E. The bypass of p21-induced mitotic block involving upregulation of Cyclin B allowed DNA damaged cells to escape differentiation and continue to proliferate. In addition, loss of p21 drove keratinocytes from differentiation to apoptosis upon moderate UV irradiation. The results show that p21 is required to drive keratinocytes towards differentiation in response to genomic stress and shed light into its dual and paradoxical role in carcinogenesis.	[de Pedro, Isabel; Galan-Vidal, Jesus; Freije, Ana; de Diego, Ernesto; Gandarillas, Alberto] Inst Res Marques de Valdecilla IDIVAL, Cell Cycle Stem Cell Fate & Canc Lab France Suppl, Santander 39011, Spain; [de Diego, Ernesto] Hosp Univ Marques de Valdecilla, Paediat Surg, Santander 39008, Spain; [Gandarillas, Alberto] INSERM, Languedoc Roussillon, F-34394 Montpellier, France	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Institut National de la Sante et de la Recherche Medicale (Inserm)	Gandarillas, A (corresponding author), Inst Res Marques de Valdecilla IDIVAL, Cell Cycle Stem Cell Fate & Canc Lab France Suppl, Santander 39011, Spain.; Gandarillas, A (corresponding author), INSERM, Languedoc Roussillon, F-34394 Montpellier, France.	agandarillas@idival.org	Vidal, Jesús Galán/AAN-3015-2021	Galan Vidal, Jesus/0000-0001-9105-2401	Instituto de Salud Carlos III/FEDER (AG; Spain) [PI14/00900, PI17/01307]; ISCIII-FEDER [PI1400900]; IFC (Industrial Farmaceutica Cantabria); Asociacion Espanola Contra el Cancer (AECC; Spain) [PRDCA19003GALA]	Instituto de Salud Carlos III/FEDER (AG; Spain); ISCIII-FEDER(Spanish Government); IFC (Industrial Farmaceutica Cantabria); Asociacion Espanola Contra el Cancer (AECC; Spain)	This work was funded by Instituto de Salud Carlos III/FEDER (AG; Spain), grants PI14/00900 and PI17/01307. IdP was in part supported by lab resources, by ISCIII-FEDER PI1400900 and by a scholarship from IFC (Industrial Farmaceutica Cantabria, currently Cantabria Labs; Spain). JG is recipient of a predoctoral scholarship from Asociacion Espanola Contra el Cancer (AECC; Spain), PRDCA19003GALA. We thank Jeannette G. Cook for the doxycycline-inducible Cyclin E construct.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alonso-Lecue P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.259; ANDREASSEN PR, 1994, J CELL BIOL, V127, P789, DOI 10.1083/jcb.127.3.789; Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Borowiec AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077507; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; de Pedro I, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1130-8; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; El-Deiry WS, 2016, CANCER RES, V76, P5189, DOI 10.1158/0008-5472.CAN-16-2055; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Freije A, 2012, ONCOGENE, V31, P5180, DOI 10.1038/onc.2012.22; Freije A, 2020, METHODS MOL BIOL, V2109, P113, DOI 10.1007/7651_2019_238; Freije A, 2014, CELL REP, V9, P1349, DOI 10.1016/j.celrep.2014.10.012; Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gandarillas A, 2012, CELL CYCLE, V11, P4507, DOI 10.4161/cc.22529; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harvat BL, 1998, J CELL SCI, V111, P1185; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Kreis NN, 2015, ONCOGENE, V34, P1758, DOI 10.1038/onc.2014.133; Kumar MG, 1999, ARCH DERMATOL RES, V291, P37, DOI 10.1007/s004030050381; le Pelletier F, 2001, J INVEST DERMATOL, V117, P1324; Liu M, 1999, J INVEST DERMATOL, V113, P283, DOI 10.1046/j.1523-1747.1999.00657.x; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Matson JP, 2017, ELIFE, V6, DOI 10.7554/eLife.30473; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Molinuevo R, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001063; Mullers E, 2014, CELL CYCLE, V13, P2733, DOI 10.4161/15384101.2015.945831; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Ren ZP, 1997, AM J PATHOL, V150, P1791; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Ritchie A, 2009, CELL DEATH DIFFER, V16, P838, DOI 10.1038/cdd.2009.13; Sanz-Gomez N, 2020, METHODS MOL BIOL, V2109, P83, DOI 10.1007/7651_2019_237; Sanz-Gomez N, 2020, CELL DEATH DIFFER, V27, P2451, DOI 10.1038/s41418-020-0515-2; Sanz-Gomez N, 2018, HEAD NECK-J SCI SPEC, V40, P2487, DOI 10.1002/hed.25376; SHEA CR, 1992, AM J PATHOL, V141, P25; Teixeira LK, 2017, ADV EXP MED BIOL, V1042, P527, DOI 10.1007/978-981-10-6955-0_22; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yook JI, 1998, ORAL ONCOL, V34, P198, DOI 10.1016/S1368-8375(97)00091-2; Zanet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015701; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	51	2	2	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					152	162		10.1038/s41388-020-01520-8	http://dx.doi.org/10.1038/s41388-020-01520-8		OCT 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33097856				2022-12-26	WOS:000582109700002
J	Khajah, MA; EL-Hashim, AZ; Orabi, KY; Hawai, S; Sary, HG				Khajah, Maitham A.; EL-Hashim, Ahmed Z.; Orabi, Khaled Y.; Hawai, Sanaa; Sary, Hanan G.			Onion bulb extract can both reverse and prevent colitis in mice via inhibition of pro-inflammatory signaling molecules and neutrophil activity	PLOS ONE			English	Article							BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; PATHOGENESIS; CYTOKINES; SAFETY; RISK; CONSUMPTION; TARGET; RATS	Background Onion is one of the most commonly used plants in the traditional medicine for the treatment of various diseases. We recently demonstrated the anti-inflammatory properties of onion bulb extract (OBE) in reducing colitis severity in mice when administered at the same time of colitis induction. However, whether onion can reverse established colitis or even prevent its development has not been investigated. Hypothesis To test 1. whether OBE can reduce colitis severity when given either before (preventative approach) or after (treatment approach) colitis induction and if so, 2. what are the mechanisms by which onion can achieve these effects. Methods Colitis was induced by dextran sulfate sodium (DSS) administration using treatment and preventative approaches. The severity of the inflammation was determined by the gross and histological assessments. The colonic level/activity of pro-inflammatory molecules and immune cell markers was assessed by immunofluorescence and western blotting analysis. In vitro neutrophil superoxide release and survival was assessed by chemilumenecense and Annexin-V/7AAD assays respectively. Results OBE treatment significantly reduced colitis severity in both approaches, the colonic expression/activity profile of pro-inflammatory molecules, inhibited WKYMVm-induced superoxide release, and increased spontaneous apoptosis of neutrophils in vitro. Conclusions OBE can be used as an effective option in the prevention and/or the treatment of established colitis.	[Khajah, Maitham A.; EL-Hashim, Ahmed Z.; Hawai, Sanaa] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait; [Orabi, Khaled Y.; Sary, Hanan G.] Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait	Kuwait University; Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait.	maitham@hsc.edu.kw		Orabi, Khaled/0000-0003-0262-4637	Kuwait Foundation for the Advancement of Sciences (KFAS) [P11613PT01];  [SRUL02/13]	Kuwait Foundation for the Advancement of Sciences (KFAS)(Kuwait Foundation for the Advancement of Sciences (KFAS)); 	This work was supported by Kuwait Foundation for the Advancement of Sciences (KFAS) (grant number: P11613PT01). Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University. We would like to thank Dr. Ananthalakshmi KV for the technical help, the histology unit in the faculty of Allied Health, and the animal unit in Health Science Center, Kuwait University.	[Anonymous], 2020, NAT MED, V26, P1, DOI 10.1038/s41591-019-0740-8; [Anonymous], 2016, CHILD NEUROPSYCHOL, V13, P1; [Anonymous], 2015, FUEL CELLS B, V2015, P3, DOI [10.1016/S1464-2859(15)30109-7, DOI 10.1016/S1464-2859(15)30109-7]; [Anonymous], 2017, MEDICINE, V96, pe6504; Avila-Roman J, 2016, BRIT J NUTR, V116, P2044, DOI 10.1017/S0007114516004189; Ballini A, 2019, ENDOCR METAB IMMUNE, V19, P373, DOI 10.2174/1871530319666181221150352; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Benninghoff AD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020544; Bhattacharyya Sumit, 2017, Nutr Healthy Aging, V4, P181, DOI 10.3233/NHA-170023; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Bonovas S, 2018, BEST PRACT RES CL GA, V32-33, P43, DOI 10.1016/j.bpg.2018.05.005; Borisova MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020445; Bruell V, 2015, BRIT J NUTR, V114, P1263, DOI 10.1017/S0007114515002950; Castro-Lopez J, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1486-0; Chiu HF, 2016, PHYTOTHER RES, V30, P380, DOI 10.1002/ptr.5537; Dodda D, 2014, INDIAN J PHARMACOL, V46, P286, DOI 10.4103/0253-7613.132160; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Emamat H, 2018, INDIAN J CLIN BIOCHE, V33, P75, DOI 10.1007/s12291-017-0636-7; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gabbani T, 2016, EXPERT OPIN DRUG SAF, V15, P1427, DOI 10.1080/14740338.2016.1218468; Gao Y, 2019, J CELL PHYSIOL, V234, P10625, DOI 10.1002/jcp.27739; Ge J, 2015, TURK J GASTROENTEROL, V26, P492, DOI 10.5152/tjg.2015.0106; Gong ZZ, 2018, MOL IMMUNOL, V104, P11, DOI 10.1016/j.molimm.2018.09.004; Gormaz JG, 2015, CURR TOP MED CHEM, V15, P1735, DOI 10.2174/1568026615666150427124357; Hagan M, 2015, EXPERT OPIN DRUG SAF, V14, P1473, DOI 10.1517/14740338.2015.1063612; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang XL, 2011, INFLAMM RES, V60, P727, DOI 10.1007/s00011-011-0325-6; Hussain MT, 2019, DNA CELL BIOL, V38, P1025, DOI 10.1089/dna.2019.5024; Jang J, 2019, INT IMMUNOPHARMACOL, V72, P124, DOI 10.1016/j.intimp.2019.03.062; Joo M, 2015, KOREAN J PHYSIOL PHA, V19, P43, DOI 10.4196/kjpp.2015.19.1.43; Leon AJ, 2006, MED CLIN-BARCELONA, V127, P145, DOI 10.1157/13090382; Khajah M, 2013, J IMMUNOL, V190, P2208, DOI 10.4049/jimmunol.1200322; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Khajah MA, 2019, J ETHNOPHARMACOL, V241, DOI 10.1016/j.jep.2019.112008; Khajah MA, 2017, DEV COMP IMMUNOL, V74, P200, DOI 10.1016/j.dci.2017.05.005; Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861; Khalili H, 2018, NAT REV GASTRO HEPAT, V15, P525, DOI 10.1038/s41575-018-0022-9; Khan HMW, 2015, CLIN EXP GASTROENTER, V8, P293, DOI 10.2147/CEG.S57248; Li F, 2015, EUR J GASTROEN HEPAT, V27, P623, DOI 10.1097/MEG.0000000000000330; Lieber JG, 2004, BLOOD, V103, P852, DOI 10.1182/blood-2003-04-1030; Lin XJ, 2018, MUCOSAL IMMUNOL, V11, P1663, DOI 10.1038/s41385-018-0018-3; Makhezer N, 2019, MUCOSAL IMMUNOL, V12, P117, DOI 10.1038/s41385-018-0086-4; Miranda PM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0433-4; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Nelson SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179143; Oliveira TT, 2015, DARU, V23, DOI 10.1186/s40199-015-0098-5; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Plevy SE, 1997, J IMMUNOL, V159, P6276; Rhodes Jesse H., 2020, P NUTR SOC, P1; Rogler G, 2014, CANCER LETT, V345, P235, DOI 10.1016/j.canlet.2013.07.032; Romero M, 2017, FOOD FUNCT, V8, P2702, DOI [10.1039/c7fo00755h, 10.1039/C7FO00755H]; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sturniolo GC, 2001, INFLAMM BOWEL DIS, V7, P94, DOI 10.1097/00054725-200105000-00003; Tang GY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080857; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; Toh JY, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0368-y; Wang DD, 2019, INT J BIOL MACROMOL, V125, P572, DOI 10.1016/j.ijbiomac.2018.12.092; Wang F, 2017, CLIN NUTR, V36, P1259, DOI 10.1016/j.clnu.2016.10.009; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41	66	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0233938	10.1371/journal.pone.0233938	http://dx.doi.org/10.1371/journal.pone.0233938			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095803	Green Published, gold			2022-12-26	WOS:000586649400010
J	Means, SA; Blasche, C; Laing, CR				Means, Shawn A.; Blasche, Christian; Laing, Carlo R.			A permutation method for network assembly	PLOS ONE			English	Article							RANDOM GRAPHS; SYSTEM; WEB	We present a method for assembling directed networks given a prescribed bi-degree (in- and out-degree) sequence. This method utilises permutations of initial adjacency matrix assemblies that conform to the prescribed in-degree sequence, yet violate the given out-degree sequence. It combines directed edge-swapping and constrained Monte-Carlo edge-mixing for improving approximations to the given out-degree sequence until it is exactly matched. Our method permits inclusion or exclusion of 'multi-edges', allowing assembly of weighted or binary networks. It further allows prescribing the overall percentage of such multiple connections-permitting exploration of a weighted synthetic network space unlike any other method currently available for comparison of real-world networks with controlled multi-edge proportion null spaces. The graph space is sampled by the method non-uniformly, yet the algorithm provides weightings for the sample space across all possible realisations allowing computation of statistical averages of network metrics as if they were sampled uniformly. Given a sequence of in- and out- degrees, the method can also produce simple graphs for sequences that satisfy conditions of graphicality. Our method successfully builds networks with order O(10(7)) edges on the scale of minutes with a laptop running Matlab. We provide our implementation of the method on the GitHub repository for immediate use by the research community, and demonstrate its application to three real-world networks for null-space comparisons as well as the study of dynamics of neuronal networks.	[Means, Shawn A.; Blasche, Christian; Laing, Carlo R.] Massey Univ, Sch Nat & Computat Sci, Auckland, New Zealand	Massey University	Means, SA (corresponding author), Massey Univ, Sch Nat & Computat Sci, Auckland, New Zealand.	S.Means@massey.ac.nz			Marsden Fund Council from Government funding by Royal Society Te Aparangi [MAU1719]	Marsden Fund Council from Government funding by Royal Society Te Aparangi	This work is fully supported by the Marsden Fund Council from Government funding, managed by Royal Society Te Aparangi (MAU1719) to CRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ANSTEE RP, 1982, CAN J MATH, V34, P438, DOI 10.4153/CJM-1982-029-3; Bayati M, 2010, ALGORITHMICA, V58, P860, DOI 10.1007/s00453-009-9340-1; Blasche C, 2020, J COMPUT DYNAM, V7, P401, DOI 10.3934/jcd.2020016; Blitzstein J, 2011, INTERNET MATH, V6, P489, DOI 10.1080/15427951.2010.557277; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; Burstein D, 2017, SIAM J DISCRETE MATH, V31, P50, DOI 10.1137/15M102527X; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cimini G, 2019, NAT REV PHYS, V1, P58, DOI 10.1038/s42254-018-0002-6; Conaco C, 2012, P NATL ACAD SCI USA, V109, P10612, DOI 10.1073/pnas.1201890109; Del Genio CI, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010012, 10.1371/journal.pone.0015369]; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Erdo P., 1960, MAT LAPOK, V11, P264; ERMENTROUT GB, 1986, SIAM J APPL MATH, V46, P233, DOI 10.1137/0146017; Fosdick BK, 2018, SIAM REV, V60, P315, DOI 10.1137/16M1087175; Gotelli NJ, 2001, OECOLOGIA, V129, P281, DOI 10.1007/s004420100717; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jmir Editorial Office, 2018, JMIR Public Health Surveill, V4, pe53, DOI 10.2196/publichealth.9932; Kim H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023012; Kim H, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/39/392001; Kleitman D. J., 1973, Discrete Mathematics, V6, P79, DOI 10.1016/0012-365X(73)90037-X; KOREN M, 1976, J COMB THEORY B, V21, P235, DOI 10.1016/S0095-8956(76)80007-X; LaMar MD, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046206; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; MCKAY BD, 1990, EUR J COMBIN, V11, P565, DOI 10.1016/S0195-6698(13)80042-X; Means SA, 2020, PERMUTEA; Newman M., 1999, MONTE CARLO METHODS; Newman Mark, 2018, NETWORKS; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Pichler G, 2012, ARCH DIS CHILD-FETAL, V97, pF444, DOI 10.1136/archdischild-2011-300578; Sanderson JG, 1998, OECOLOGIA, V116, P275, DOI 10.1007/s004420050589; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Squartini T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083001; Steger A, 1999, COMB PROBAB COMPUT, V8, P377, DOI 10.1017/S0963548399003867; Tinhofer G, 1990, COMPUTATIONAL GRAP S, V7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zamora-Lopez G, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224006	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240888	10.1371/journal.pone.0240888	http://dx.doi.org/10.1371/journal.pone.0240888			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095802	Green Published, gold			2022-12-26	WOS:000586649400053
J	Rothe, K; Spinner, CD; Waschulzik, B; Janke, C; Schneider, J; Schneider, H; Braitsch, K; Smith, C; Schmid, RM; Busch, DH; Katchanov, J				Rothe, Kathrin; Spinner, Christoph D.; Waschulzik, Birgit; Janke, Christian; Schneider, Jochen; Schneider, Heike; Braitsch, Krischan; Smith, Christopher; Schmid, Roland M.; Busch, Dirk H.; Katchanov, Juri			A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The "Triple F" approach supported by Procalcitonin and paired blood and urine cultures	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; ASYMPTOMATIC BACTERIURIA; ACUTE PYELONEPHRITIS; SEPTIC SHOCK; MANAGEMENT; EPIDEMIOLOGY; PREVALENCE; BACTEREMIA; SEPSIS; WOMEN	For acute medicine physicians, distinguishing between asymptomatic bacteriuria (ABU) and clinically relevant urinary tract infections (UTI) is challenging, resulting in overtreatment of ABU and under-recognition of urinary-source bacteraemia without genitourinary symptoms (USB). We conducted a retrospective analysis of ED encounters in a university hospital between October 2013 and September 2018 who met the following inclusion criteria: Suspected UTI with simultaneous collection of paired urinary cultures and blood cultures (PUB) and determination of Procalcitonin (PCT). We sought to develop a simple algorithm based on clinical signs and PCT for the management of suspected UTI. Individual patient presentations were retrospectively evaluated by a clinical "triple F" algorithm (F1 ="fever", F2 ="failure", F3 ="focus") supported by PCT and PUB. We identified 183 ED patients meeting the inclusion criteria. We introduced the term UTI with systemic involvement (SUTI) with three degrees of diagnostic certainty: bacteremic UTI (24.0%; 44/183), probable SUTI (14.2%; 26/183) and possible SUTI (27.9%; 51/183). In bacteremic UTI, half of patients (54.5%; 24/44) presented without genitourinary symptoms. Discordant bacteraemia was diagnosed in 16 patients (24.6% of all bacteremic patients). An alternative focus was identified in 67 patients, five patients presented withS.aureusbacteremia. 62 patients were diagnosed with possible UTI (n = 20) or ABU (n = 42). Using the proposed "triple F" algorithm, dichotomised PCT of < 0.25 pg/ml had a negative predictive value of 88.7% and 96.2% for bacteraemia und accordant bacteraemia respectively. The application of the algorithm to our cohort could have resulted in 33.3% reduction of BCs. Using the diagnostic categories "possible" or "probable" SUTI as a trigger for initiation of antimicrobial treatment would have reduced or streamlined antimicrobial use in 30.6% and 58.5% of cases, respectively. In conclusion, the "3F" algorithm supported by PCT and PUB is a promising diagnostic and antimicrobial stewardship tool.	[Rothe, Kathrin; Busch, Dirk H.] Tech Univ Munich, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Spinner, Christoph D.; Schneider, Jochen; Schmid, Roland M.; Katchanov, Juri] Tech Univ Munich, Sch Med, Dept Internal Med 2, Munich, Germany; [Waschulzik, Birgit] Tech Univ Munich, Sch Med, Inst Med Informat Stat & Epidemiol, Munich, Germany; [Janke, Christian] Ludwig Maximilians Univ Munchen, Div Infect Dis & Trop Med, Univ Hosp, Munich, Germany; [Schneider, Heike] Tech Univ Munich, Sch Med, Dept Clin Chem & Pathobiochem, Munich, Germany; [Braitsch, Krischan] Tech Univ Munich, Sch Med, Dept Internal Med 3, Munich, Germany; [Smith, Christopher] Nagasaki Univ, Sch Trop Med & Global Hlth TMGH, Nagasaki, Japan; [Smith, Christopher] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Busch, Dirk H.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Nagasaki University; University of London; London School of Hygiene & Tropical Medicine; German Center for Infection Research	Rothe, K (corresponding author), Tech Univ Munich, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany.	kathrin.rothe@turn.de		Schneider, Jochen/0000-0002-0300-0159; Spinner, Christoph/0000-0002-3875-5367; Smith, Chris/0000-0001-9238-3202				Committee to Advise on Tropical Medicine and Travel (CATMAT), 2007, Can Commun Dis Rep, V33, P1; [Anonymous], 2019, Cancer Discov, V9, pOF3, DOI 10.1158/2159-8290.CD-NB2018-158; Aspevall O, 2001, CLIN MICROBIOL INFEC, V7, P173, DOI 10.1046/j.1198-743x.2001.00237.x; Barros M, 2009, BRAZ J INFECT DIS, V13, P294, DOI 10.1590/S1413-86702009000400011; Brown P, 2005, PHARMACOECONOMICS, V23, P1123, DOI 10.2165/00019053-200523110-00005; Cai T, 2015, CLIN INFECT DIS, V61, P1655, DOI 10.1093/cid/civ696; Covino M, 2020, INTERN EMERG MED, V15, P119, DOI 10.1007/s11739-019-02212-2; Dubbs SB, 2019, EMERG MED CLIN N AM, V37, P707, DOI 10.1016/j.emc.2019.07.007; Eisinger RP, 1997, CLIN NEPHROL, V47, P50; Finucane TE, 2017, J AM GERIATR SOC, V65, P1650, DOI 10.1111/jgs.14907; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Geerlings SE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0002-2012; Johnson JR, 2018, NEW ENGL J MED, V378, P48, DOI 10.1056/NEJMcp1702758; Jones GR, 1996, QJM-MON J ASSOC PHYS, V89, P515; Kelly AM, 1998, J ACCID EMERG MED, V15, P254; Kim Y, 2017, INFECT CHEMOTHER, V49, P22, DOI 10.3947/ic.2017.49.1.22; Ko YH, 2016, INT BRAZ J UROL, V42, P270, DOI 10.1590/S1677-5538.IBJU.2014.0465; Kobo O, 2017, EPIDEMIOL INFECT, V145, P3065, DOI 10.1017/S0950268817001807; Kwiecien R, 2011, DTSCH ARZTEBL INT, V108, P515, DOI 10.3238/arztebl.2011.0515; Lafon T, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4106-0; Lemiale V, 2007, EUR UROL, V51, P1394, DOI 10.1016/j.eururo.2006.12.018; Levine AR, 2018, AM J EMERG MED, V36, P1993, DOI 10.1016/j.ajem.2018.03.001; Lin E, 2012, ARCH INTERN MED, V172, P33, DOI 10.1001/archinternmed.2011.565; Long B, 2018, EMERG MED CLIN N AM, V36, P685, DOI 10.1016/j.emc.2018.06.003; Marschall J, 2012, CLIN INFECT DIS, V54, P1692, DOI 10.1093/cid/cis252; Mountain D, 2006, EUR J EMERG MED, V13, P76, DOI 10.1097/01.mej.0000188231.45109.ec; Park SY, 2010, J INFECTION, V61, P492, DOI 10.1016/j.jinf.2010.08.014; Pescatore R, 2019, WEST J EMERG MED, V20, P573, DOI 10.5811/westjem.2019.5.42096; Rowe TA, 2014, INFECT DIS CLIN N AM, V28, P75, DOI 10.1016/j.idc.2013.10.004; Sager R, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0795-7; Schuetz P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub3; Schuetz P, 2015, ANN EMERG MED, V66, P318, DOI 10.1016/j.annemergmed.2015.03.029; Schulz L, 2016, J EMERG MED, V51, P25, DOI 10.1016/j.jemermed.2016.02.009; Shaikh N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009185.pub2; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Shenep JL, 2000, INT J ANTIMICROB AG, V14, P129, DOI 10.1016/S0924-8579(99)00172-7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stalenhoef JE, 2015, CURR OPIN INFECT DIS, V28, P106, DOI 10.1097/QCO.0000000000000121; Stalenhoef JE, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3789-6; Stokes W, 2019, CLIN INFECT DIS, V69, P963, DOI 10.1093/cid/ciy1000; Swaminathan Subramanian, 2010, Curr Infect Dis Rep, V12, P455, DOI 10.1007/s11908-010-0138-8; Tandogdu Z, 2016, CURR OPIN INFECT DIS, V29, P73, DOI 10.1097/QCO.0000000000000228; Thanassi M, 1997, ACAD EMERG MED, V4, P797, DOI 10.1111/j.1553-2712.1997.tb03788.x; Tilahun B, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.4106; Trevino SE, 2016, INFECT CONT HOSP EP, V37, P749, DOI 10.1017/ice.2016.56; Tunkel AR, 2002, CLIN INFECT DIS, V34, P1524, DOI 10.1086/340402; van Nieuwkoop C, 2010, CRIT CARE, V14, DOI 10.1186/cc9328; van Nieuwkoop C, 2010, CLIN INFECT DIS, V50, pE69, DOI 10.1086/652657; Wagenlehner FME, 2017, CURR OPIN UROL, V27, P133, DOI 10.1097/MOU.0000000000000364; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240981	10.1371/journal.pone.0240981	http://dx.doi.org/10.1371/journal.pone.0240981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091046	Green Published, gold			2022-12-26	WOS:000586647200071
J	Nagler, RH; Vogel, RI; Gollust, SE; Rothman, AJ; Fowler, EF; Yzer, MC				Nagler, Rebekah H.; Vogel, Rachel I.; Gollust, Sarah E.; Rothman, Alexander J.; Fowler, Erika Franklin; Yzer, Marco C.			Public perceptions of conflicting information surrounding COVID-19: Results from a nationally representative survey of US adults	PLOS ONE			English	Article							HEALTH INFORMATION; EXPOSURE	Conflicting information surrounding COVID-19 abounds, from disagreement over the effectiveness of face masks in preventing viral transmission to competing claims about the promise of certain treatments. Despite the potential for conflicting information about COVID-19 to produce adverse public health effects, little is known about whether the U.S. public notices this information, and whether certain population subgroups are particularly likely to do so. To address these questions, we fielded a nationally representative survey of U.S. adults in late April 2020 (N= 1,007). Results showed substantial self-reported exposure to conflicting information about COVID-19, with nearly 75% of participants reporting having recently heard such information from health experts, politicians, and/or others. Participants perceived disagreement across a range of COVID-19-related issues, though from politicians more than health experts. Factors including political affiliation, information source use, and personal experience with COVID-19 were associated with perceptions of disagreement. Future research should consider potential cognitive and behavioral consequences of such perceptions.	[Nagler, Rebekah H.; Yzer, Marco C.] Univ Minnesota, Hubbard Sch Journalism & Mass Commun, Minneapolis, MN 55455 USA; [Vogel, Rachel I.] Univ Minnesota, Sch Med, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA; [Gollust, Sarah E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Rothman, Alexander J.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Fowler, Erika Franklin] Wesleyan Univ, Dept Govt, Middletown, CT USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wesleyan University	Nagler, RH (corresponding author), Univ Minnesota, Hubbard Sch Journalism & Mass Commun, Minneapolis, MN 55455 USA.	nagle026@umn.edu		Vogel, Rachel/0000-0003-0149-8464; Nagler, Rebekah/0000-0003-1479-4115	COVID-19 Rapid Response Grant from the Office of the Vice President for Research at the University of Minnesota (OVPR COVID19) [05]; National Cancer Institute [5R21CA218054-02]	COVID-19 Rapid Response Grant from the Office of the Vice President for Research at the University of Minnesota (OVPR COVID19); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a COVID-19 Rapid Response Grant from the Office of the Vice President for Research at the University of Minnesota (OVPR COVID19 #05; PI: RHN). Additional support was provided by a grant from the National Cancer Institute (5R21CA218054-02; PI: RHN). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder URLs: https://research.umn.edu/funding-awards/ovprfunding/covid-19-rapid-response-grants and https://cancercontrol.cancer.gov/brp/	Almaguer M, 2020, NBC TODAY       0609; [Anonymous], 2014, VASCULAR MED UK, V19, P67; Azjenman N, 2020, MORE WORDS LEADERS S, DOI 10.2139/ssrn.3582908; Baker P, 2020, NY TIMES; Board TE, 2020, LOS ANGELES TIMES; Brennen J.S., 2020, THESIS U OXFORD; Breslow J, 2020, FAUCI MIXED MESSAGIN; Carpenter DM, 2016, HEALTH EXPECT, V19, P1173, DOI 10.1111/hex.12438; Chang CC, 2015, SCI COMMUN, V37, P602, DOI 10.1177/1075547015597914; Chang CC, 2013, J HEALTH COMMUN, V18, P1326, DOI 10.1080/10810730.2013.778363; Collins K, 2020, WHITE HOUSE CONTINUE; Fowler EF, 2015, ANN AM ACAD POLIT SS, V658, P155, DOI 10.1177/0002716214555505; Gollust SE, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106278; Gollust SE, 2020, J HEALTH POLIT POLIC, V45, DOI 10.1215/03616878-8543210; Gollust SE, 2020, J HEALTH POLIT POLIC, V45, P967, DOI 10.1215/03616878-8641506; GREEN DP, 1993, PUBLIC OPIN QUART, V57, P503, DOI 10.1086/269393; Harvard T.H. Chan School of Public Health, 2020, COVID 19 PATH FORWAR; Jamieson K. H., 2020, HARVARD KENNEDY SCH, DOI [10.37016/mr-2020-012, DOI 10.37016/MR-2020-012]; Jurecic Q, 2020, ATLANTIC; Jurkowitz M, 2020, AM WHO PRIMARILY GET; Kiviniemi MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-899; Koerth M, 2020, FIVETHIRTYEIGHT 0406; Lee CJ, 2018, HEALTH COMMUN, V33, P453, DOI 10.1080/10410236.2016.1278495; Mandavilli A., 2020, NEW YORK TIMES; Matsa KE, 2018, FEWER AM RELY TV NEW; Motta M, 2020, CAN J POLIT SCI, V53, P335, DOI 10.1017/S0008423920000396; Nagler R.H., 2018, ENCY HLTH RISK MESSA, P353, DOI [10.1093/acrefore/9780190228613.013.292, DOI 10.1093/ACREFORE/9780190228613.013.292]; Nagler RH, 2019, ANN BEHAV MED, V53, P896, DOI 10.1093/abm/kay098; Nagler RH, 2012, COMMUN METHODS MEAS, V6, P56, DOI 10.1080/19312458.2011.651348; NORC, 2020, AMERISPEAK OMN SURV; Pennycook G, 2020, PSYCHOL SCI, V31, P770, DOI 10.1177/0956797620939054; Pew Research Center, 2020, AM NEWS PATHW PROJ; Sandman PM, 2003, RISK COMMUNICATION R; Saulsberry L, 2019, VACCINE, V37, P5121, DOI 10.1016/j.vaccine.2019.05.062; Schumaker E, 2020, ABC NEWS; Schwitzer G, 2018, TSUNAMI NOT READ FOR; Shoemaker PJ, 1996, MEDIATING MESSAGE TH; Sonmez F, 2020, WASHINGTON POST; Southwell BG, 2018, Informat Austin, P1; Stephenson J, 2020, JAMA HLTH FORUM 0602; Szabo L., 2020, KAISER HLTH NEWS; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Tan ASL, 2015, PREV MED, V81, P268, DOI 10.1016/j.ypmed.2015.09.009; Viswanath K, 2005, NAT REV CANCER, V5, P828, DOI 10.1038/nrc1718; Vraga EK, 2020, MEDIA COMMUN-LISBON, V8, P475, DOI 10.17645/mac.v8i2.3200; Wallace-Wells D, 2020, NEW YORK MAGAZINE; Yong E, 2020, ATLANTIC; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	48	43	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240776	10.1371/journal.pone.0240776	http://dx.doi.org/10.1371/journal.pone.0240776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085719	Green Published, gold			2022-12-26	WOS:000585943400031
J	Wikramanayake, E; Or, C; Costa, F; Wen, XJ; Cheung, F; Shapiro, A				Wikramanayake, Eric; Or, Carmen; Costa, Felipe; Wen, Xianji; Cheung, Fion; Shapiro, Aurelie			A climate adaptation strategy for Mai Po Inner Deep Bay Ramsar site: Steppingstone to climate proofing the East Asian-Australasian Flyway	PLOS ONE			English	Article							SEA-LEVEL RISE; ASSESSING COASTAL SQUEEZE; PEARL RIVER DELTA; MIGRATORY BIRDS; CONSERVATION; WETLANDS; SHOREBIRDS; CHALLENGES; IMPACTS; FUTURE	The ecological functionality of the East Asian-Australasian Flyway is threatened by the loss of wetlands which provide staging and wintering sites for migrating waterbirds. The disappearance of wetland ecosystems due to coastal development prevents birds from completing their migrations, resulting in population declines, and even an eventual collapse of the migration phenomenon. Coastal wetlands are also under threat from global climate change and its consequences, notably sea level rise (SLR), extreme storm events, and accompanying wave and tidal surges. The impacts of SLR are compounded by coastal subsidence and decreasing sedimentation, which can result from coastal development. Thus, important wetlands along the flyway should be assessed for the impacts of climate change and coastal subsidence to plan and implement proactive climate adaptation strategies that include habitat migration and possibility of coastal squeeze. We modelled the impacts of climate change and decreasing sedimentation rates on important bird habitats in the Mai Po Inner Deep Bay Ramsar site to support a climate adaptation strategy that will continue to host migratory birds. Located in the Inner Deep Bay of the Pearl River estuary, Mai Po's tidal flats, coastal mangroves, marshes, and fishponds provide habitat for over 80,000 wintering and passage waterbirds. We applied the Sea Level Affecting Marshes Model (SLAMM) to simulate habitat conversion under two SLR scenarios (1.5m and 2.0m) for 2050, 2075, and 2100 for four accretion rates (2mm/yr, 4 mm/yr, 8 mm/yr, 15 mm/yr). The results showed no discernible impact to habitats until after 2075, but projections for 2100 show that the mangroves, marshes and tidal flats could be impacted in almost all scenarios of SLR and accretion. Under a 1.5m SLR scenario, even at low tide, if accretion levels decrease to 4 mm/yr, the tidal flats will be inundated and with a 2 mm/yr accretion the mangroves will also be inundated. Thus, important shorebird habitats will be lost. During high tide the ponds inside the nature reserve, which are intensively managed to provide high tide roosting sites and other habitats for waterbirds, will also be inundated. Thus, with a 1.5m SLR and declining sedimentation the migratory shorebirds will lose habitat, including the high tide roosting habitats inside the nature reserve. The model also indicates that the fishponds further inland in the Ramsar site will be less impacted. Most fishponds are privately owned and could be developed in the future, including into high rise apartments; thus, securing them for conservation should be an important climate change adaptation strategy for Mai Po, since they provide essential habitats for birds under future climate change scenarios. But Mai Po is only one steppingstone along the EAAF, and hundreds of other wetlands are also threatened by encroaching infrastructure and climate change. Thus, similar analyses for the other wetlands are recommended to develop a flyway-wide climate-adaptation conservation strategy before available options become lost to wetland conversion.	[Wikramanayake, Eric; Or, Carmen; Wen, Xianji; Cheung, Fion] WWF Hong Kong, Hong Kong, Peoples R China; [Costa, Felipe; Shapiro, Aurelie] WWF Germany Space Sci, Berlin, Germany; [Shapiro, Aurelie] Here There Mapping Solut, Berlin, Germany	World Wildlife Fund	Wikramanayake, E (corresponding author), WWF Hong Kong, Hong Kong, Peoples R China.	ericw@wwf.org.hk		Shapiro, Aurelie/0000-0001-9693-9394; Wikramanayake, Eric/0000-0002-1373-6952	general Mai Po Nature Reserve management fund; WWF Hong Kong	general Mai Po Nature Reserve management fund; WWF Hong Kong	The analysis was supported by the general Mai Po Nature Reserve management fund, which is capitalized from multiple sources and managed by WWF Hong Kong. The salaries of EW, CO, XW, FC are supported by WWF Hong Kong (but not from the Mai Po Nature Reserve management fun). Authors FC and AS were provided with a consultancy by WWF HK, through Here+There Mapping Solutions to conduct the analysis. The funder (WWF Hong Kong) provided support in the form of salaries for authors [EW, CO, XW, FC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. FC and AS received a consultancy from WWF Hong Kong through Here+There Mapping Solutions, to run the SLAMM model.	ADB, 2017, REG RISK HUM DIM CLI, P131; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2019, INT J GYNECOL CANC, V29(Suppl4, pA1; Bamber JL, 2019, P NATL ACAD SCI USA, V116, P11195, DOI 10.1073/pnas.1817205116; Bamford M, 2008, MIGRATORY SHOREBIRDS, P237; Bao KS, 2015, J COASTAL RES, V31, pIV, DOI 10.2112/JCOASTRES-D-14-00190.1; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Bellio M, 2017, MAR FRESHWATER RES, V68, P999, DOI 10.1071/MF15240; Borchert SM, 2018, J APPL ECOL, V55, P2876, DOI 10.1111/1365-2664.13169; Bosello F, 2012, CLIMATIC CHANGE, V112, P63, DOI 10.1007/s10584-011-0340-1; Chan FKS, 2012, ENVIRON URBAN ASIA, V3, P41, DOI 10.1177/097542531200300103; Clough J, 2016, TECHNICAL DOCUMENTAT; Clough J, 2016, ENVIRON MODELL SOFTW, V84, P349, DOI 10.1016/j.envsoft.2016.06.023; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Dawson D, 2016, J TRANSP GEOGR, V51, P97, DOI 10.1016/j.jtrangeo.2015.11.009; Doody JP, 2013, OCEAN COAST MANAGE, V79, P34, DOI 10.1016/j.ocecoaman.2012.05.008; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; Fernandez-Nunez M, 2019, RESOURCES-BASEL, V8, DOI 10.3390/resources8010050; Gallo-Cajiao E, 2020, BIOL CONSERV, V246, DOI 10.1016/j.biocon.2020.108582; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Hansen L, 2010, CONSERV BIOL, V24, P63, DOI 10.1111/j.1523-1739.2009.01404.x; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; He YH, 2016, INT J CLIMATOL, V36, P3237, DOI 10.1002/joc.4551; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Horton BP, 2019, AGUFM; Hua N, 2015, BIRD CONSERV INT, V25, P38, DOI 10.1017/S0959270914000380; Iwamura T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0325; Jackson MV, 2020, BIOL CONSERV, V247, DOI 10.1016/j.biocon.2020.108591; Jackson MV, 2019, ECOL EVOL, V9, P2505, DOI 10.1002/ece3.4895; Jones KR, 2016, BIOL CONSERV, V194, P121, DOI 10.1016/j.biocon.2015.12.008; 문보라, 2017, [JOUNAL OF FISHERIES AND MARINE SCIENCES EDUCATION, 수산해양교육연구], V29, P627, DOI 10.13000/JFMSE.2017.29.3.627; Lee BY, 2010, HKIE CIV DIV C, P12; Li J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210552; Liu F, 2019, J HYDROL, V573, P194, DOI 10.1016/j.jhydrol.2019.03.063; Luo SX, 2018, OCEAN COAST MANAGE, V153, P193, DOI 10.1016/j.ocecoaman.2017.12.018; MacKinnon J, 2012, OCCASIONAL PAPER IUC, V47; Macusi E.D., 2011, THE J, V9, P13; Melville DS, 2016, EMU, V116, P100, DOI 10.1071/MU15045; Melville DS, 1997, SHOREBIRD CONSERVATI, P15; Melvin AM, 2017, P NATL ACAD SCI USA, V114, pE122, DOI 10.1073/pnas.1611056113; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Morelli TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159909; Murray NJ, 2019, NATURE, V565, P222, DOI 10.1038/s41586-018-0805-8; Murray NJ, 2015, AUSTRAL ECOL, V40, P472, DOI 10.1111/aec.12211; Murray NJ, 2014, FRONT ECOL ENVIRON, V12, P267, DOI 10.1890/130260; Narayan S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09269-z; Neumann JE, 2015, CLIMATIC CHANGE, V131, P97, DOI 10.1007/s10584-013-1037-4; Nicholls RJ, 2018, RESILIENCE: THE SCIENCE OF ADAPTATION TO CLIMATE CHANGE, P13, DOI 10.1016/B978-0-12-811891-7.00002-5; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Propato M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200368; Ranasinghe R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45442-2; Rosenzweig C, 2011, CLIMATIC CHANGE, V106, P93, DOI 10.1007/s10584-010-0002-8; Runge CA, 2015, SCIENCE, V350, P1255, DOI 10.1126/science.aac9180; Rydge J, 2015, CONTRIBUTING PAPER S, P20; Schuerch M, 2018, NATURE, V561, P231, DOI 10.1038/s41586-018-0476-5; Scott D.A., 1989, DIRECTORY ASIAN WETL; Smolders S, 2015, NAT HAZARD EARTH SYS, V15, P1659, DOI 10.5194/nhess-15-1659-2015; Studds CE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14895; Sun FL, 2020, P NATL ACAD SCI USA, V117, P5719, DOI 10.1073/pnas.1915169117; Sung YH, 2018, BIRD CONSERV INT, V28, P157, DOI 10.1017/S0959270917000016; Szabo JK, 2016, EMU, V116, P95, DOI 10.1071/MUv116n2_ED; Titus JG, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044008; Torio DD, 2013, J COASTAL RES, V29, P1049, DOI 10.2112/JCOASTRES-D-12-00162.1; Wang H, 2014, ECOL ENG, V71, P346, DOI 10.1016/j.ecoleng.2014.07.058; Wang J, 2012, CLIMATIC CHANGE, V115, P537, DOI 10.1007/s10584-012-0468-7; Whetter D, 2017, FIDDLEHEAD, P72; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; WONG SH, 1990, ENVIRON GEOL WATER S, V15, P111, DOI 10.1007/BF01705098; Wong TE, 2017, CLIMATIC CHANGE, V144, P347, DOI 10.1007/s10584-017-2039-4; Wu WT, 2017, OCEAN COAST MANAGE, V138, P1, DOI 10.1016/j.ocecoaman.2017.01.005; Wu ZY, 2018, GEOMORPHOLOGY, V314, P42, DOI 10.1016/j.geomorph.2018.05.001; Yang L, 2015, REG ENVIRON CHANGE, V15, P379, DOI 10.1007/s10113-014-0651-7; Yong DL, 2018, CONSERV BIOL, V32, P740, DOI 10.1111/cobi.13041; Zhang JX, 2009, HUM ECOL RISK ASSESS, V15, P671, DOI 10.1080/10807030903050749	78	3	3	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239945	10.1371/journal.pone.0239945	http://dx.doi.org/10.1371/journal.pone.0239945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085699	gold, Green Published			2022-12-26	WOS:000585943400041
J	Korhonen, L; Cohen, J; Gregoricus, N; Farley, MM; Perlmutter, R; Holzbauer, SM; Dumyati, G; Beldavs, Z; Paulick, A; Vinje, J; Limbago, BM; Lessa, FC; Guh, AY				Korhonen, Lauren; Cohen, Jessica; Gregoricus, Nicole; Farley, Monica M.; Perlmutter, Rebecca; Holzbauer, Stacy M.; Dumyati, Ghinwa; Beldavs, Zintars; Paulick, Ashley; Vinje, Jan; Limbago, Brandi M.; Lessa, Fernanda C.; Guh, Alice Y.			Evaluation of viral co-infections among patients with community-associatedClostridioides difficileinfection	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; ACUTE GASTROENTERITIS; MULTICENTER; NOROVIRUS; ETIOLOGY; PANEL	We assessed viral co-infections in 155 patients with community-associatedClostridioides difficileinfection in five U.S. sites during December 2012-February 2013. Eighteen patients (12%) tested positive for norovirus (n = 10), adenovirus (n = 4), rotavirus (n = 3), or sapovirus (n = 1). Co-infected patients were more likely than non-co-infected patients to have nausea or vomiting (56% vs 31%; p = 0.04), suggesting that viral co-pathogens contributed to symptoms in some patients. There were no significant differences in prior healthcare or medication exposures or in CDI complications.	[Korhonen, Lauren; Cohen, Jessica; Paulick, Ashley; Limbago, Brandi M.; Lessa, Fernanda C.; Guh, Alice Y.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Cohen, Jessica] Atlanta Res & Educ Fdn, Atlanta, GA USA; [Gregoricus, Nicole; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Farley, Monica M.] Emory Univ, Sch Med, Atlanta, GA USA; [Farley, Monica M.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Perlmutter, Rebecca] Maryland Dept Hlth, Baltimore, MD USA; [Holzbauer, Stacy M.] Minnesota Dept Hlth, St Paul, MN USA; [Holzbauer, Stacy M.] Ctr Dis Control & Prevent, Career Epidemiol Field Officer Program, Atlanta, GA USA; [Dumyati, Ghinwa] New York Emerging Infect Program, Rochester, NY USA; [Dumyati, Ghinwa] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Beldavs, Zintars] Oregon Hlth Author, Portland, OR USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; University of Rochester	Guh, AY (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	ggt4@cdc.gov		Vinje, Jan/0000-0002-1530-3675; Paulick, Ashley/0000-0001-6796-4355	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the Centers for Disease Control and Prevention, which had a role in study design, date collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2009, CLIN INFECT DIS S2, V48, pS197; [Anonymous], 2015, BROWN J WORLD AFFAIR, V21, P179; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Buss SN, 2015, J CLIN MICROBIOL, V53, P915, DOI 10.1128/JCM.02674-14; Centers for Disease Control and Prevention, CLOSTR DIFF INF CDI; Chitnis AS, 2013, JAMA INTERN MED, V173, P1359, DOI 10.1001/jamainternmed.2013.7056; El Feghaly RE, 2013, J PEDIATR GASTR NUTR, V57, P813, DOI 10.1097/MPG.0b013e3182a3202f; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; Ludwig A, 2013, EPIDEMIOL INFECT, V141, P1598, DOI 10.1017/S0950268813000241; Nicholson MR, 2016, J PEDIATR-US, V176, P50, DOI 10.1016/j.jpeds.2016.05.068; Pijnacker R, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.11.029; Shafiq M, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-00348-7; Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007; Stokely JN, 2016, CLIN EPIDEMIOL, V8, P253, DOI 10.2147/CLEP.S106495; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Valenzuela C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207850; Weng MK, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819000372	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240549	10.1371/journal.pone.0240549	http://dx.doi.org/10.1371/journal.pone.0240549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075113	Green Published, gold			2022-12-26	WOS:000585920200016
J	Rivera, SR; Jhamb, SK; Abdel-Hamid, HZ; Acsadi, G; Brandsema, J; Ciafaloni, E; Darras, BT; Iannaccone, ST; Konersman, CG; Kuntz, NL; McDonald, CM; Parsons, JA; Rocha, CT; Zaidman, CM; Butterfield, RJ; Connolly, AM; Mathews, KD				Rivera, Sarah R.; Jhamb, Sumit K.; Abdel-Hamid, Hoda Z.; Acsadi, Gyula; Brandsema, John; Ciafaloni, Emma; Darras, Basil T.; Iannaccone, Susan T.; Konersman, Chamindra G.; Kuntz, Nancy L.; McDonald, Craig M.; Parsons, Julie A.; Tesi Rocha, Carolina; Zaidman, Craig M.; Butterfield, Russell J.; Connolly, Anne M.; Mathews, Katherine D.			Medical management of muscle weakness in Duchenne muscular dystrophy	PLOS ONE			English	Article							DIAGNOSIS; LIFE	Introduction Duchenne muscular dystrophy (DMD) is a childhood onset muscular dystrophy leading to shortened life expectancy. There are gaps in published DMD care guidelines regarding recently approved DMD medications and alternative steroid dosing regimens. Methods A list of statements about use of currently available therapies for DMD in the United States was developed based on a systematic literature review and expert panel feedback. Panelists' responses were collected using a modified Delphi approach. Results Among corticosteroid regimens, either deflazacort or prednisone weekend dosing was preferred when payer requirements do not dictate choice. Most patients with exon 51 skip-amenable mutations should be offered eteplirsen, before or with a corticosteroid. Discussion The options available for medical management of the motor symptoms of DMD are expanding rapidly. The choice of medical therapies should balance expected benefit with side effects.	[Rivera, Sarah R.] Optum Lifesci Wolfeboro, Dept Clin Serv, Wolfeboro, NH 03894 USA; [Jhamb, Sumit K.] Optum Global Solut, Dept Clin Serv, Noida, Uttar Pradesh, India; [Abdel-Hamid, Hoda Z.] Childrens Hosp Pittsburgh UPMC, Div Child Neurol, Pittsburgh, PA USA; [Acsadi, Gyula] Connecticut Childrens Med Ctr, Dept Neurol, Farmington, CT USA; [Brandsema, John] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Neurol, Philadelphia, PA 19104 USA; [Ciafaloni, Emma] Univ Rochester, Med Ctr, Dept Pediat Neuromuscular Med, Rochester, NY 14642 USA; [Darras, Basil T.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Darras, Basil T.] Harvard Med Sch, Boston, MA 02115 USA; [Iannaccone, Susan T.] UT Southwestern, Dept Pediat, Dallas, TX USA; [Konersman, Chamindra G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Kuntz, Nancy L.] Ann & Robert H Lurie Childrens Hosp, Dept Pediat, Chicago, IL USA; [McDonald, Craig M.] UC Davis Hlth, Dept Phys Med & Rehabil, Sacramento, CA USA; [Parsons, Julie A.] Univ Colorado, Dept Pediat & Neurol, Sch Med, Aurora, CO USA; [Tesi Rocha, Carolina] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Zaidman, Craig M.] Washington Univ, Div Child Neurol & Neuromuscular, Dept Neurol, Sch Med, St Louis, MO 63110 USA; [Butterfield, Russell J.] Univ Utah, Dept Neurol & Pediat, Salt Lake City, UT USA; [Connolly, Anne M.] Nationwide Childrens Hosp, Dept Neurol, Columbus, OH USA; [Mathews, Katherine D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	Optum; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Connecticut Children's Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Rochester; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Washington University (WUSTL); Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Iowa	Rivera, SR (corresponding author), Optum Lifesci Wolfeboro, Dept Clin Serv, Wolfeboro, NH 03894 USA.	riverapharmd@gmail.com	Connolly, Anne/GYD-3128-2022	Tesi Rocha, Carolina/0000-0002-7224-0754	Sarepta	Sarepta	Sarepta funded this study. The funder Optum provided support in the form of salaries for authors SRR and SKJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alfano L.N., 2017, INT ANN C WORLD MUS; [Anonymous], 2019, SAR THER ANN FDA APP; [Anonymous], 2020, WHAT IS DUCH MUSC DY; [Anonymous], 2016, PRESCR INF EX 51; Birnkrant DJ, 2018, LANCET NEUROL, V17, P347, DOI 10.1016/S1474-4422(18)30025-5; Birnkrant DJ, 2018, LANCET NEUROL, V17, P445, DOI 10.1016/S1474-4422(18)30026-7; Birnkrant DJ, 2018, LANCET NEUROL, V17, P251, DOI 10.1016/S1474-4422(18)30024-3; Bowden SA, 2019, J NEUROMUSCULAR DIS, V6, P31, DOI 10.3233/JND-180346; Connolly AM, 2015, MUSCLE NERVE, V51, P522, DOI 10.1002/mus.24346; FDA, 2020, VY 53 ACC APPR; Frank DE, 2020, NEUROLOGY, V94, pE2270, DOI 10.1212/WNL.0000000000009233; Gloss D, 2016, NEUROLOGY, V86, P465, DOI 10.1212/WNL.0000000000002337; Iff J, 2019, MUSC DYSTR ASS CLIN; Kinane T Bernard, 2018, J Neuromuscul Dis, V5, P47, DOI 10.3233/JND-170272; Landfeldt E, 2014, NEUROLOGY, V83, P529, DOI 10.1212/WNL.0000000000000669; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; McNally EM, 2017, CIRCULATION, V136, P979, DOI 10.1161/CIRCULATIONAHA.117.028382; Passamano Luigia, 2012, Acta Myol, V31, P121; Sarepta Therapeutics, JP MORG HEALTH C	19	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240687	10.1371/journal.pone.0240687	http://dx.doi.org/10.1371/journal.pone.0240687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075081	gold, Green Published			2022-12-26	WOS:000585920200027
J	Clark, J; Dickinson, DL				Clark, Jeremy; Dickinson, David L.			The effect of sleep on public good contributions and punishment: Experimental evidence	PLOS ONE			English	Article							PREFRONTAL CORTEX; DEPRIVATION; COOPERATION; PROVISION; SANCTIONS; RESTRICTION; MONETARY; BEHAVIOR	We investigate the effect of a full week of sleep restriction (SR) vs. well-restedness (WR) on contributions in a common public good experiment, the voluntary contributions mechanism (VCM). We examine the effect of sleep manipulation on decisions regarding both contributions and punishment of non-contributors. Actigraphy devices are used to confirm that our random assignment to sleep condition generates significant differences in objective nightly sleep duration and sleepiness. We find that when punishment is unavailable public good contributions do not differ by SR/WR assignment. When punishment is available, we find evidence that SR subjects contribute more than WR subjects, respond more to the availability of punishment than do WR subjects, and that the availability of punishment significantly increases the contributions of SR but not WR subjects. Yet SR subjects do not punish others more or less than WR subjects. Our main findings are robust when considering compliance and sample selection. However, some findings are not robust to an alternative but less objective sleep control measure that is based partly on participants' self-identified optimal sleep levels.	[Clark, Jeremy] Univ Canterbury, Dept Econ & Finance, Christchurch, New Zealand; [Dickinson, David L.] Appalachian State Univ, Dept Econ, Boone, NC 28608 USA; [Dickinson, David L.] Appalachian State Univ, CERPA, Boone, NC 28608 USA; [Dickinson, David L.] IZA Inst Lab Econ, Bonn, Germany; [Dickinson, David L.] Chapman Univ, Econ Sci Inst, Orange, CA USA	University of Canterbury; University of North Carolina; Appalachian State University; University of North Carolina; Appalachian State University; IZA Institute Labor Economics; Chapman University System; Chapman University	Clark, J (corresponding author), Univ Canterbury, Dept Econ & Finance, Christchurch, New Zealand.	jeremy.clark@canterbury.ac.nz		Dickinson, David/0000-0003-3899-0276; Clark, Jeremy/0000-0002-2622-1683	United States National Science Foundation BCS [1229067, SES-1734137]	United States National Science Foundation BCS	This research was funded by the United States National Science Foundation BCS grant number 1229067 and SES-1734137, awarded to Prof. David Dickinson. This division of the granting agency's website is https://www.nsf.gov/div/index.jsp?div=BCS The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; Aguir M., 2009, INCREASE LEISURE INE; Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356; Anderson C, 2010, J SLEEP RES, V19, P54, DOI 10.1111/j.1365-2869.2009.00767.x; Anderson CM, 2006, GAME ECON BEHAV, V54, P1, DOI 10.1016/j.geb.2004.08.007; ANDREONI J, 1988, J PUBLIC ECON, V35, P57, DOI 10.1016/0047-2727(88)90061-8; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Bouwmeester S, 2017, PERSPECT PSYCHOL SCI, V12, P527, DOI 10.1177/1745691617693624; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Costa-Font J, 2017, CEP DISCUSSION PAPER; Dickinson DL, 2017, EUR ECON REV, V97, P57, DOI 10.1016/j.euroecorev.2017.05.002; Dickinson DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174367; Dickinson DL, 2016, BEHAV SLEEP MED, V14, P501, DOI 10.1080/15402002.2015.1028064; Dickinson DL, 2015, J PUBLIC ECON, V122, P55, DOI 10.1016/j.jpubeco.2014.10.008; Dinges DF, 1997, SLEEP, V20, P267; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Engelmann D, 2015, SOC CHOICE WELFARE, V45, P561, DOI 10.1007/s00355-015-0884-5; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Ferrara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120029; Ford ES, 2015, SLEEP, V38, P829, DOI 10.5665/sleep.4684; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gordon AM, 2014, SOC PSYCHOL PERS SCI, V5, P168, DOI 10.1177/1948550613488952; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hafner M., 2016, 1791 RAND EUR; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hoffman E, 1996, AM ECON REV, V86, P653; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; ISAAC RM, 1985, J PUBLIC ECON, V26, P51; Krajbich I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8455; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Noussair C, 2005, ECON INQ, V43, P649, DOI 10.1093/ei/cbi045; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Palmer CA, 2017, SLEEP MED REV, V31, P6, DOI 10.1016/j.smrv.2015.12.006; Primi C, 2016, J BEHAV DECIS MAKING, V29, P453, DOI 10.1002/bdm.1883; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Robinson JPM.William, 2010, ELECT INT J TIME USE, V7, P61; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Williams JM, 2020, BEHAV SLEEP MED, V18, P91, DOI 10.1080/15402002.2018.1545653	52	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240324	10.1371/journal.pone.0240324	http://dx.doi.org/10.1371/journal.pone.0240324			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119643	Green Published, gold			2022-12-26	WOS:000600013600025
J	Panta, M; Kump, AJ; Dalloul, JM; Schwab, KR; Ahmad, SM				Panta, Manoj; Kump, Andrew J.; Dalloul, John M.; Schwab, Kristopher R.; Ahmad, Shaad M.			Three distinct mechanisms, Notch instructive, permissive, and independent, regulate the expression of two different pericardial genes to specify cardiac cell subtypes	PLOS ONE			English	Article							SPLIT COMPLEX GENES; TRANSCRIPTION FACTOR; TRANSGENIC RNAI; DROSOPHILA; SUPPRESSOR; HAIRLESS; PROTEIN; ENHANCER; MESODERM; PATHWAY	The development of a complex organ involves the specification and differentiation of diverse cell types constituting that organ. Two major cell subtypes, contractile cardial cells (CCs) and nephrocytic pericardial cells (PCs), comprise the Drosophila heart. Binding sites for Suppressor of Hairless [Su(H)], an integral transcription factor in the Notch signaling pathway, are enriched in the enhancers of PC-specific genes. Here we show three distinct mechanisms regulating the expression of two different PC-specific genes, Holes in muscle (Him), and Zn finger homeodomain 1 (zfh1). Him transcription is activated in PCs in a permissive manner by Notch signaling: in the absence of Notch signaling, Su(H) forms a repressor complex with co-repressors and binds to the Him enhancer, repressing its transcription; upon alleviation of this repression by Notch signaling, Him transcription is activated. In contrast, zfh1 is transcribed by a Notch-instructive mechanism in most PCs, where mere alleviation of repression by preventing the binding of Su(H)-co-repressor complex is not sufficient to activate transcription. Our results suggest that upon activation of Notch signaling, the Notch intracellular domain associates with Su(H) to form an activator complex that binds to the zfh1 enhancer, and that this activator complex is necessary for bringing about zfh1 transcription in these PCs. Finally, a third, Notch-independent mechanism activates zfh1 transcription in the remaining, even skipped-expressing, PCs. Collectively, our data show how the same feature, enrichment of Su(H) binding sites in PC-specific gene enhancers, is utilized by two very distinct mechanisms, one permissive, the other instructive, to contribute to the same overall goal: the specification and differentiation of a cardiac cell subtype by activation of the pericardial gene program. Furthermore, our results demonstrate that the zfh1 enhancer drives expression in two different domains using distinct Notch-instructive and Notch-independent mechanisms.	[Panta, Manoj; Kump, Andrew J.; Schwab, Kristopher R.; Ahmad, Shaad M.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Panta, Manoj; Kump, Andrew J.; Dalloul, John M.; Schwab, Kristopher R.; Ahmad, Shaad M.] Indiana State Univ, Ctr Genom Advocacy, Terre Haute, IN 47809 USA; [Dalloul, John M.] Terre Haute South Vigo High Sch, Terre Haute, IN USA; [Dalloul, John M.] Stanford Univ, Stanford, CA 94305 USA	Indiana State University; Indiana State University; Stanford University	Ahmad, SM (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.; Ahmad, SM (corresponding author), Indiana State Univ, Ctr Genom Advocacy, Terre Haute, IN 47809 USA.	Shaad.Ahmad@indstate.edu		Kump, Andrew/0000-0001-6396-5086; Ahmad, Shaad/0000-0001-5373-1710; Schwab, Kristopher/0000-0001-8056-1817; Dalloul, John/0000-0003-0753-2504	American Heart Association [16SDG31390005]; Bloomington Drosophila Stock Center (NIH) [P4OOD018537]	American Heart Association(American Heart Association); Bloomington Drosophila Stock Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Scientist Development Grant 16SDG31390005 from the American Heart Association (https://www.heart.org) to SMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank B. Paterson, J. Jacobs, J. Skeath, D. Kosman, J. Reinitz, M. Halfon, Z. Han, the Transgenic RNAi Project (TRiP) at Harvard Medical School, the Bloomington Drosophila Stock Center (NIH P4OOD018537), and the Vienna Drosophila Resource Center for providing antibodies and fly strains; E. Johnson, A. Banse, and J. Stapleton at SNPsaurus for sequencing pWattB-nlacZ; S. Gisselbrecht for annotating the pWattB-nlacZ sequence and identifying putative Pnt, Pdp1, Eve, and Grn transcription factor binding sites on the enhancer sequences; and S. Wafzig and C. Kennedy from the Office of Information Technology-Academia Media Services at Indiana State University for illustrating our models.	Ahmad SM, 2016, DEVELOPMENT, V143, P306, DOI 10.1242/dev.122952; Ahmad SM, 2014, DEVELOPMENT, V141, P878, DOI 10.1242/dev.101709; Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; [Anonymous], 2015, NATL ASSEMBLY PAKIST, V2, P2; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Busser BW, 2015, NUCLEIC ACIDS RES, V43, P1726, DOI 10.1093/nar/gkv011; Busser BW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002531; Busser BW, 2012, DEVELOPMENT, V139, P1164, DOI 10.1242/dev.077362; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chartier A, 2002, DEVELOPMENT, V129, P3241; Davidson E, 2006, DEV EVOLUTION; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Elwell JA, 2015, DEV BIOL, V400, P266, DOI 10.1016/j.ydbio.2015.02.005; Falo-Sanjuan J, 2020, DEV GROWTH DIFFER, V62, P4, DOI 10.1111/dgd.12644; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Gajewski M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-21; Garces A, 2006, DEVELOPMENT, V133, P1445, DOI 10.1242/dev.02321; Gilbert S.F., 2016, DEV BIOL, V11th ed.; Gomez-Lamarca MJ, 2018, DEV CELL, V44, P611, DOI 10.1016/j.devcel.2018.01.020; Grigorian M, 2011, DEV BIOL, V353, P105, DOI 10.1016/j.ydbio.2011.02.024; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; HARTENSTEIN AY, 1992, DEVELOPMENT, V116, P1203; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Jagla K, 1997, DEVELOPMENT, V124, P3471; Klein T, 1998, DEVELOPMENT, V125, P2951; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liotta D, 2007, CURR BIOL, V17, P1409, DOI 10.1016/j.cub.2007.07.039; Lonfat N, 2014, SCIENCE, V346, P1004, DOI 10.1126/science.1257493; Lovato TL, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020018; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Morel V, 2001, CURR BIOL, V11, P789, DOI 10.1016/S0960-9822(01)00224-X; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Poelmann RE, 2019, DEV DYNAM, V248, P634, DOI 10.1002/dvdy.45; Preger-Ben Noon E, 2018, CELL REP, V22, P3021, DOI 10.1016/j.celrep.2018.02.073; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Rebeiz M, 2011, DEVELOPMENT, V138, P215, DOI 10.1242/dev.050161; Rosenthal N., 2010, HEART DEV REGENERATI, P47, DOI DOI 10.1016/B978-0-12-381332-9.00002-5; Rotstein B, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3020015; Shokri L, 2019, CELL REP, V27, P955, DOI 10.1016/j.celrep.2019.03.071; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Su MT, 1999, DEVELOPMENT, V126, P3241; Tian XL, 2004, DEVELOPMENT, V131, P5807, DOI 10.1242/dev.01459; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vanderploeg J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-8; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yin ZZ, 1997, DEVELOPMENT, V124, P4971; Zhu XM, 2012, DEVELOPMENT, V139, P1457, DOI 10.1242/dev.069005; 2016, P NATL ACAD SCI US, V0113, pE7720; 2002, ESTUD AV, V0016, P00209	69	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241191	10.1371/journal.pone.0241191	http://dx.doi.org/10.1371/journal.pone.0241191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108408	Green Published, gold			2022-12-26	WOS:000588372400027
J	Baek, YJ; Lee, T; Cho, Y; Hyun, JH; Kim, MH; Sohn, Y; Kim, JH; Ahn, JY; Jeong, SJ; Ku, NS; Yeom, JS; Lee, J; Choi, JY				Baek, Yae Jee; Lee, Taeyong; Cho, Yunsuk; Hyun, Jong Hoon; Kim, Moo Hyun; Sohn, Yujin; Kim, Jung Ho; Ahn, Jin Young; Jeong, Su Jin; Ku, Nam Su; Yeom, Joon-Sup; Lee, Jeehyun; Choi, Jun Yong			A mathematical model of COVID-19 transmission in a tertiary hospital and assessment of the effects of different intervention strategies	PLOS ONE			English	Article							OUTBREAK	Novel coronavirus (named SARS-CoV-2) can spread widely in confined settings including hospitals, cruise ships, prisons, and places of worship. In particular, a healthcare-associated outbreak could become the epicenter of coronavirus disease (COVID-19). This study aimed to evaluate the effects of different intervention strategies on the hospital outbreak within a tertiary hospital. A mathematical model was developed for the COVID-19 transmission within a 2500-bed tertiary hospital of South Korea. The SEIR (susceptible-exposed-infectious-recovered) model with a compartment of doctor, nurse, patient, and caregiver was constructed. The effects of different intervention strategies such as front door screening, quarantine unit for newly admitted patients, early testing of suspected infected people, and personal protective equipment for both medical staff and visitors were evaluated. The model suggested that the early testing (within eight hours) of infected cases and monitoring the quarantine ward for newly hospitalized patients are effective measures for decreasing the incidence of COVID-19 within a hospital (81.3% and 70% decrease of number of incident cases, respectively, during 60 days). Front door screening for detecting suspected cases had only 42% effectiveness. Screening for prohibiting the admission of COVID-19 patients was more effective than the measures for patients before emergency room or outpatient clinic. This model suggests that under the assumed conditions, some effective measures have a great influence on the incidence of COVID-19 within a hospital. The implementation of the preventive measures could reduce the size of a hospital outbreak.	[Baek, Yae Jee; Cho, Yunsuk; Hyun, Jong Hoon; Kim, Moo Hyun; Sohn, Yujin; Kim, Jung Ho; Ahn, Jin Young; Jeong, Su Jin; Ku, Nam Su; Yeom, Joon-Sup; Choi, Jun Yong] Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Taeyong; Lee, Jeehyun] Yonsei Univ, Dept Math, Seoul, South Korea; [Lee, Jeehyun] Yonsei Univ, Dept Computat Sci & Engn, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Choi, JY (corresponding author), Yonsei Univ, Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea.	seran@yuhs.ac	Yeom, Joon Sup/Q-5559-2019; Taha, Samy/N-4620-2019	Yeom, Joon Sup/0000-0001-8940-7170; Taha, Samy/0000-0003-0284-7806; Lee, Taeyong/0000-0002-1940-0210; Choi, Jun Yong/0000-0002-2775-3315; Ku, Nam Su/0000-0002-9717-4327; Kim, Jung Ho/0000-0002-5033-3482; Hyun, JongHoon/0000-0002-9621-0250; Ahn, Jin Young/0000-0002-3740-2826; Jeong, Su Jin/0000-0003-4025-4542	Korea Centers for Disease Control and Prevention [2019-ER5408-00]; research grants for deriving the major clinical and epidemiological indicators of people with HIV [Korea HIV/AIDS Cohort Study] [2019-ER5101-00]; Ministry of Health AMP; Welfare, Republic of Korea [HI14C1324]; National Research Foundation of Korea [2020R1A2C1A0101077511]; Korea Health Industry Development Institute [HG20C0003030020]	Korea Centers for Disease Control and Prevention; research grants for deriving the major clinical and epidemiological indicators of people with HIV [Korea HIV/AIDS Cohort Study]; Ministry of Health AMP; Welfare, Republic of Korea; National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work of Jun Yong Choi was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention [2019-ER5408-00], research grants for deriving the major clinical and epidemiological indicators of people with HIV [Korea HIV/AIDS Cohort Study, 2019-ER5101-00], and a grant from the Ministry of Health & Welfare, Republic of Korea [grant number: HI14C1324] The work of Jeehyun Lee was supported by National Research Foundation of Korea [grant number: 2020R1A2C1A0101077511] and Korea Health Industry Development Institute [grant number: HG20C0003030020].	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Backer JA, 2020, CHINA EURO SURVEILL, V25, P5, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750; Guan W-J, 2020, NEW ENGLAND J MED; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hens N., 2012, MODELING INFECT DIS; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Kang D, 2020, INT J INFECT DIS, V94, P96, DOI 10.1016/j.ijid.2020.03.076; Klompas M, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006372; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lee IK, 2020, J HOSP INFECT, V105, P102, DOI 10.1016/j.jhin.2020.02.022; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liang KH, 2020, INFECT GENET EVOL, V82, DOI 10.1016/j.meegid.2020.104306; Liu T., 2020, LANCET, DOI [DOI 10.1101/2020.01.25.919787, 10.1101/2020.01.25.919787]; Mizumoto K, 2020, INFECT DIS MODEL, V5, P264, DOI 10.1016/j.idm.2020.02.003; Nadim SS, 2020, ARXIV200308150; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Organization WH, 2020, TRANSM SARS COV 2 IM; Rey AMD, 2017, REV ESP QUIM, V30, P443; Schunemann H.J., 2020, LANCET; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Xiao S, 2018, EPIDEMIOL INFECT, V146, P1114, DOI [10.1017/S0950268818001012, 10.1017/s0950268818001012]	29	8	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241169	10.1371/journal.pone.0241169	http://dx.doi.org/10.1371/journal.pone.0241169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104736	Green Published, gold			2022-12-26	WOS:000588370000010
J	Ivanov, DK; Bostelmann, G; Lan-Leung, B; Williams, J; Partridge, L; Escott-Price, V; Thornton, JM				Ivanov, Dobril K.; Bostelmann, Gerrit; Lan-Leung, Benoit; Williams, Julie; Partridge, Linda; Escott-Price, Valentina; Thornton, Janet M.			A novel computational approach for predicting complex phenotypes in Drosophila (starvation-sensitive and sterile) by deriving their gene expression signatures from public data	PLOS ONE			English	Article								Many research teams perform numerous genetic, transcriptomic, proteomic and other types of omic experiments to understand molecular, cellular and physiological mechanisms of disease and health. Often (but not always), the results of these experiments are deposited in publicly available repository databases. These data records often include phenotypic characteristics following genetic and environmental perturbations, with the aim of discovering underlying molecular mechanisms leading to the phenotypic responses. A constrained set of phenotypic characteristics is usually recorded and these are mostly hypothesis driven of possible to record within financial or practical constraints. We present a novel proof-of-principal computational approach for combining publicly available gene-expression data from control/mutant animal experiments that exhibit a particular phenotype, and we use this approach to predict unobserved phenotypic characteristics in new experiments (data derived from EBI's ArrayExpress and ExpressionAtlas respectively). We utilised available microarray gene-expression data for two phenotypes (starvation-sensitive and sterile) in Drosophila. The data were combined using a linear-mixed effects model with the inclusion of consecutive principal components to account for variability between experiments in conjunction with Gene Ontology enrichment analysis. We present how available data can be ranked in accordance to a phenotypic likelihood of exhibiting these two phenotypes using random forest. The results from our study show that it is possible to integrate seemingly different gene-expression microarray data and predict a potential phenotypic manifestation with a relatively high degree of confidence (>80% AUC). This provides thus far unexplored opportunities for inferring unknown and unbiased phenotypic characteristics from already performed experiments, in order to identify studies for future analyses. Molecular mechanisms associated with gene and environment perturbations are intrinsically linked and give rise to a variety of phenotypic manifestations. Therefore, unravelling the phenotypic spectrum can help to gain insights into disease mechanisms associated with gene and environmental perturbations. Our approach uses public data that are set to increase in volume, thus providing value for money.	[Ivanov, Dobril K.; Bostelmann, Gerrit; Thornton, Janet M.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Ivanov, Dobril K.; Lan-Leung, Benoit; Williams, Julie; Escott-Price, Valentina] Cardiff Univ, Coll Biomed & Life Sci, UK Dementia Res Inst Cardiff UKDRI, Cardiff, Wales; [Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany; [Partridge, Linda] UCL, Inst Hlth Ageing, London, England; [Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England	European Molecular Biology Laboratory (EMBL); Cardiff University; Max Planck Society; University of London; University College London; University of London; University College London	Ivanov, DK (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.; Ivanov, DK (corresponding author), Cardiff Univ, Coll Biomed & Life Sci, UK Dementia Res Inst Cardiff UKDRI, Cardiff, Wales.	IvanovD1@cardiff.ac.uk		Thornton, Janet/0000-0003-0824-4096; Escott-Price, Valentina/0000-0003-1784-5483; Williams, Julie/0000-0002-4069-0259; Ivanov, Dobril/0000-0001-6271-6301; Lan-Leung, Benoit/0000-0002-2201-7917; Bostelmann, Gerrit/0000-0002-1690-6347	UK Dementia Research Institute from DRI Ltd; UK Medical Research Council; Alzheimer's Society; Alzheimer's Research UK; European Regional Development Fund through the Welsh Government [CU-147]; Wellcome Trust [098565/Z/12/Z]; MRC [UKDRI-3003, MR/T04604X/1, MR/L023784/2] Funding Source: UKRI	UK Dementia Research Institute from DRI Ltd; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); European Regional Development Fund through the Welsh Government; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK. The project was also part-funded by the European Regional Development Fund through the Welsh Government (CU-147; Dr Dobril Ivanov and Dr Benoit Lan-Leung) and by the Wellcome Trust Strategic Award (098565/Z/12/Z; Prof Linda Partridge).	[Anonymous], 2012, REGEN MED S3, V7, pS14; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719; Crow M, 2019, P NATL ACAD SCI USA, V116, P6491, DOI 10.1073/pnas.1802973116; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giordan M, 2014, STAT BIOSCI, V6, P73, DOI 10.1007/s12561-013-9081-1; Kucerova L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2383-1; Li ZC, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00126; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; See LLC, 2005, PEDIATR CRIT CARE ME, V6, pS42; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Vartiainen S, 2014, DIS MODEL MECH, V7, P635, DOI 10.1242/dmm.016527; Zarringhalam K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19635-0; 2014, REG ANESTH PAIN MED, V9	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240824	10.1371/journal.pone.0240824	http://dx.doi.org/10.1371/journal.pone.0240824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104720	gold, Green Published, Green Accepted			2022-12-26	WOS:000588370000020
J	Dewar, B; Anderson, JE; Kwok, ESH; Ramsay, T; Dowlatshahi, D; Fahed, R; Dyason, C; Shamy, M				Dewar, Brian; Anderson, Joanna E.; Kwok, Edmund S. H.; Ramsay, Tim; Dowlatshahi, Dar; Fahed, Robert; Dyason, Claire; Shamy, Michel			Physician preparedness for resource allocation decisions under pandemic conditions: A cross-sectional survey of Canadian physicians, April 2020	PLOS ONE			English	Article								Background Under the pandemic conditions created by the novel coronavirus of 2019 (COVID-19), physicians have faced difficult choices allocating scarce resources, including but not limited to critical care beds and ventilators. Past experiences with severe acute respiratory syndrome (SARS) and current reports suggest that making these decisions carries a heavy emotional toll for physicians around the world. We sought to explore Canadian physicians' preparedness and attitudes regarding resource allocation decisions. Methods From April 3 to April 13, 2020, we conducted an 8-question online survey of physicians practicing in the region of Ottawa, Ontario, Canada, organized around 4 themes: physician preparedness for resource rationing, physician preparedness to offer palliative care, attitudes towards resource allocation policy, and approaches to resource allocation decision-making. Results We collected 219 responses, of which 165 were used for analysis. The majority (78%) of respondents felt "somewhat" or "a little prepared" to make resource allocation decisions, and 13% felt "not at all prepared." A majority of respondents (63%) expected the provision of palliative care to be "very" or "somewhat difficult." Most respondents (83%) either strongly or somewhat agreed that there should be policy to guide resource allocation. Physicians overwhelmingly agreed on certain factors that would be important in resource allocation, including whether patients were likely to survive, and whether they had dementia and other significant comorbidities. Respondents generally did not feel confident that they would have the social support they needed at the time of making resource allocation decisions. Interpretation This rapidly implemented survey suggests that a sample of Canadian physicians feel underprepared to make resource allocation decisions, and desire both more emotional support and clear, transparent, evidence-based policy.	[Dewar, Brian; Ramsay, Tim; Dowlatshahi, Dar; Fahed, Robert; Shamy, Michel] Ottawa Hosp Res Inst, Dept Neurol, Ottawa, ON, Canada; [Anderson, Joanna E.] Carleton Univ, Dept Psychol, Ottawa, ON, Canada; [Kwok, Edmund S. H.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Dowlatshahi, Dar; Fahed, Robert; Dyason, Claire; Shamy, Michel] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Carleton University; University of Ottawa; University of Ottawa	Shamy, M (corresponding author), Ottawa Hosp Res Inst, Dept Neurol, Ottawa, ON, Canada.; Shamy, M (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	mshamy@toh.ca			University of Ottawa Department of Medicine Special Pandemic Agile Research Competition (SPARC) Grant	University of Ottawa Department of Medicine Special Pandemic Agile Research Competition (SPARC) Grant	The project was funded by University of Ottawa Department of Medicine Special Pandemic Agile Research Competition (SPARC) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], QUALTR XM EXP MAN SO; [Anonymous], 2020, BMJ, V369, pm2170, DOI 10.1136/bmj.m2170; [Anonymous], 2004, OBESITY RES S2, p51S; Barrett K, 2020, CAN MED ASSOC J, V192, pE640, DOI 10.1503/cmaj.200715; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Ferraresi M, CORONAVIRUS CAUTIONA; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Law T, TIME; Ontario Health, 2020, CLIN TRIAG GUID MAJ; Persad G, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009666; Phua GC, 2008, CLIN CHEST MED, V29, P323, DOI 10.1016/j.ccm.2008.01.001; Schmidt H, NY TIMES; Shoukat A, 2020, CAN MED ASSOC J, V192, pE489, DOI 10.1503/cmaj.200457; Thompson AK, 2006, BMC MED ETHICS, V7, P12, DOI [10.1186/1472-6939-7-12, DOI 10.1186/1472-6939-7-12]; Truog RD, 2020, NEW ENGL J MED, V382, P1973, DOI 10.1056/NEJMp2005689; White DB, 2009, ANN INTERN MED, V150, P132, DOI 10.7326/0003-4819-150-2-200901200-00011; Wu PE, 2020, CMAJ	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0238842	10.1371/journal.pone.0238842	http://dx.doi.org/10.1371/journal.pone.0238842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091015	gold, Green Published			2022-12-26	WOS:000586647200033
J	Lina, TT; Johnson, SJ; Wagner, RD				Lina, Taslima T.; Johnson, Shemedia J.; Wagner, R. Doug			Intravaginal poly-(D, L-lactic-co-glycolic acid)-(polyethylene glycol) drug-delivery nanoparticles induce pro-inflammatory responses withCandida albicansinfection in a mouse model	PLOS ONE			English	Article							DENDRITIC CELLS; AUTOPHAGY; HALLMARK; IMMUNITY	In a recent study, using an in vitro model to study intravaginal nanoparticle exposure during yeast infections, we demonstrated thatC.albicansexposure suppressed apoptotic gene expression and induced oxidative stress and pyroptosis in vaginal epithelial cells. The mucous-penetrating drug delivery nanoparticles made from poly-(D, L-lactic-co-glycolic acid)-(polyethylene glycol) induced cytotoxicity by activating apoptosis, endoplasmic reticulum (ER) stress, oxidative stress, and DNA damage repair responses alone and, in some cases withC.albicans. In the current study we evaluated the effects of fluorescently-labelled nanoparticles in CBA/J mice challenged intravaginally for two hours followed by intravaginal challenge withC.albicansfor 18 hours. Nanoparticle treatment increased systemic translocation ofC.albicansthreefold in the heart.C.albicansalso increased systemic distribution of the nanoparticles fivefold in the heart. Flow cytometric assays showed co-localization of the nanoparticles with epithelial cells, macrophages and dendritic cells. Nanoparticle-treated,C.albicans-infected mice exhibited induction of autophagy, ER stress, apoptosis, and inflammatory serum cytokines.C.albicansinfection was associated with pyroptosis and suppressed expression of ER stress and apoptosis-related genes. Induction of apoptosis during nanoparticle treatment and in nanoparticle-treated-C.albicansinfected mice was observed as DNA damage responses, mitochondrial depolarization and (Poly [ADP-Ribose] Polymerase) cleavage.C.albicansinfection was associated with increased mRNA expression of anti-apoptotic genes. BothC.albicansinfection and nanoparticle treatment showed enhanced chemoattraction of dendritic cells and polymorphonuclear cells to factors in vaginal washings in a chemotaxis assay. This study shows that both intravaginal treatment of mice with the nanoparticles and infection withC.albicansinduce cytotoxic and inflammatory responses.C.albicansalso suppressed cell apoptosis. These results clarify our understanding of how nanoparticles modulate host cellular responses duringC.albicansinfection and will be applicable for future research and development of intravaginal nanomedicines.	[Lina, Taslima T.; Johnson, Shemedia J.; Wagner, R. Doug] US FDA, Microbiol Div, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Lina, Taslima T.] US FDA, Off Regulatory & Risk Management, Natl Ctr Toxicol Res, Jefferson, AR USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Wagner, RD (corresponding author), US FDA, Microbiol Div, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	doug.wagner@fda.hhs.gov			FDA Office of Women's Health	FDA Office of Women's Health	RDW received funding from the FDA Office of Women's Health. TTL was supported in part by an appointment to the ORISE Research Participation Program at the National Center for Toxicological Research, U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA/NCTR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 1997, OFFICIAL J C, V236, P1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2007, 19 CENTURY GENDER ST, V3, P2; [Anonymous], 2017, REGNO DOCUMENTI, V7, P230; [Anonymous], 2015, EL CUADERNO, V66, P1; Barillet S, 2019, NANOTOXICOLOGY, V13, P606, DOI 10.1080/17435390.2018.1564078; Cook MT, 2018, J CONTROL RELEASE, V270, P145, DOI 10.1016/j.jconrel.2017.12.004; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Elsabahy M, 2013, CHEM SOC REV, V42, P5552, DOI 10.1039/c3cs60064e; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Liang GF, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-447; Lin MH, 2018, J BIOMED NANOTECHNOL, V14, P66, DOI 10.1166/jbn.2018.2459; Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Machado A, 2016, ACTA BIOMATER, V44, P332, DOI 10.1016/j.actbio.2016.08.018; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Matsuzawa-Ishimoto Y, 2018, ANNU REV IMMUNOL, V36, P73, DOI 10.1146/annurev-immunol-042617-053253; MCWILLIAM AS, 1994, J EXP MED, V179, P1331, DOI 10.1084/jem.179.4.1331; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Motulsky H., 1995, INTUITIVE BIOSTATIST; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592; Rahman Durdana, 2012, Methods Mol Biol, V845, P527, DOI 10.1007/978-1-61779-539-8_38; Rosati D, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8020144; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006; Wong TW, 2014, EXPERT OPIN DRUG DEL, V11, P1419, DOI 10.1517/17425247.2014.924499; Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10; Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131; Yu L, 2009, SMALL, V5, P2784, DOI 10.1002/smll.200901714; Zhang T, 2011, EUR J PHARM BIOPHARM, V79, P526, DOI 10.1016/j.ejpb.2011.06.007; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240789	10.1371/journal.pone.0240789	http://dx.doi.org/10.1371/journal.pone.0240789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091017	gold, Green Published			2022-12-26	WOS:000586647200021
J	Bajaru, S; Pal, S; Prabhu, M; Patel, P; Khot, R; Apte, D				Bajaru, Sameer; Pal, Saunak; Prabhu, Mrugank; Patel, Pinal; Khot, Rahul; Apte, Deepak			A multi-species occupancy modeling approach to access the impacts of land use and land cover on terrestrial vertebrates in the Mumbai Metropolitan Region (MMR), Western Ghats, India	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; HUMAN-POPULATION; URBAN EXPANSION; UTTARA KANNADA; HABITAT; BIRDS; CONSERVATION; FRAGMENTATION; DEFORESTATION; BIODIVERSITY	Urbanization is one of the main drivers in the conversion of natural habitats into different land use and land cover types (LULC) which threaten the local as well as global biodiversity. This impact is particularly alarming in tropical countries like India, where similar to 18% of the world's population live, and its ever-growing economy (i.e., industrial development) expanded urban areas by several folds. We undertook this study to examine the impacts of urbanization (i.e., LULC) on terrestrial vertebrates (mammals, birds, reptiles, and amphibians) in the Mumbai Metropolitan Region (MMR), Western Ghats, India. We sampled different habitats ranged from highly disturbed urban areas to less disturbed forested areas. Multiple sampling methods such as quadrat sampling, line transect, point count, and camera trapping were used to quantify the target taxa. We used multi-species occupancy modeling in the Bayesian framework to estimate detection probability and occupancy and to assess the effect of various LULC on different species. All four groups showed a significant negative impact of increasing anthropogenic habitat cover on occupancy. Out of 213 species detected in this study, 96% of mammals, 85% of birds, 93.75% of amphibians, and 69.43% of reptiles showed a negative effect of anthropogenic habitat cover. Evidence suggests that historical and recent human disturbances could have played an important role in transforming this area from semi-evergreen and moist deciduous forest to open, scrubby, dry deciduous, and fire-prone landscape. This might be the reason for the high occupancy of open and degraded forest habitat preferring species in our study area. We recommend species-rich areas in the MMR, e.g., Karnala Bird Sanctuary (KBS) and Prabalgad-Matheran-Malanggad Hill Range (PMMHR), must be conserved through habitat restoration, ecotourism, public awareness, and policymaking.	[Bajaru, Sameer; Pal, Saunak; Prabhu, Mrugank; Khot, Rahul] Bombay Nat Hist Soc, Nat Hist Collect Dept, Mumbai, Maharashtra, India; [Patel, Pinal] Ctr Environm Res & Educ CERE, Mumbai, Maharashtra, India; [Apte, Deepak] Bombay Nat Hist Soc, Mumbai, Maharashtra, India		Bajaru, S (corresponding author), Bombay Nat Hist Soc, Nat Hist Collect Dept, Mumbai, Maharashtra, India.	s.bajaru@bnhs.org	Pal, Saunak/AAE-6408-2021	Pal, Saunak/0000-0002-8267-4708; Apte, Deepak/0000-0001-5565-4659; Khot, Rahul/0000-0001-6215-6965	City and Industrial Development Corporation of Maharashtra (CIDCO)	City and Industrial Development Corporation of Maharashtra (CIDCO)	Fund for this research was provided by the City and Industrial Development Corporation of Maharashtra (CIDCO; https://cidco.maharashtra.gov.in/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar AG, 2003, CITIES, V20, P3, DOI 10.1016/S0264-2751(02)00092-6; Aiyaduraj Ambika, 2006, Journal of the Bombay Natural History Society, V103, P5; Ali S., 2002, BOOK INDIAN BIRDS; Ali S., 1983, HDB BIRDS INDIA PAKI; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BEEHLER BM, 1987, IBIS, V129, P197, DOI 10.1111/j.1474-919X.1987.tb03201.x; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Biju S.D., 2014, Ceylon Journal of Science Biological Sciences, V43, P37; Borges Renee M., 2015, P483; Broms KM, 2016, ECOLOGY, V97, P1759, DOI 10.1890/15-1471.1; Carrillo-Rubio E, 2014, CONSERV BIOL, V28, P1034, DOI 10.1111/cobi.12261; Chamberlain DE, 2007, J ORNITHOL, V148, P453, DOI 10.1007/s10336-007-0165-x; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Dahanukar N, 2004, J BIOGEOGR, V31, P123, DOI 10.1046/j.0305-0270.2003.01016.x; Daniel, 2002, BOOK INDIAN REPTILES; Daniels RJR, 1995, J APPL ECOL, V32, P866, DOI 10.2307/2404826; DANIELS RJR, 1992, P NATL ACAD SCI USA, V89, P5311, DOI 10.1073/pnas.89.12.5311; DANIELS RJR, 1990, P INDIAN AS-ANIM SCI, V99, P79, DOI 10.1007/BF03186376; DAYAN T, 1990, AM NAT, V136, P39, DOI 10.1086/285081; Dechner A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195311; Denwood MJ, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i09; Dibner RR, 2017, ECOL EVOL, V7, P5692, DOI 10.1002/ece3.3131; DINERSTEIN E, 1989, BIOTROPICA, V21, P214, DOI 10.2307/2388646; Dinesh KP., 2019, CHECKLIST AMPHIBIANS; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Ganesh S.R., 2018, CHECKLIST REPTILES I; Ganesh T, 2002, ASSESSMENT BIODIVERS; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Heatwole H, 1982, US Fish and Wildlife Service Wildlife Research Report, V13, P1; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Ieno E.N., 2015, BEGINNERS GUIDE DATA; Ishwar N. M., 2003, CONSERVATION SOC, V1, P69; Ishwar NM, 2001, CURR SCI INDIA, V80, P413; Ishwar NM, 1998, NAT RES SEM WILDL CO; Jha CS, 2000, CURR SCI INDIA, V79, P231; Joshi Kamal, 2011, Indian Birds, V7, P33; Kalle R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079295; Kamdar S, 2014, 1 WORK GROUP M ENV I; KATTAN GH, 1994, CONSERV BIOL, V8, P138, DOI 10.1046/j.1523-1739.1994.08010138.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2015, APPL HIERARCHICAL MO, V1, DOI DOI 10.1016/C2015-0-04070-9; Kleppel GS, 2006, CHANGING LAND USE PA; Krishnan M., 1972, Journal of the Bombay Natural History Society, V69, P469; Leston LFV, 2006, BIOL CONSERV, V131, P566, DOI 10.1016/j.biocon.2006.03.003; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manakadan Ranjit, 1999, Journal of the Bombay Natural History Society, V96, P221; Mathai J, 2013, RAFFLES B ZOOL, P9; Midway SR, 2014, T AM FISH SOC, V143, P1348, DOI 10.1080/00028487.2014.931745; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagendra H, 2012, LANDSCAPE URBAN PLAN, V105, P400, DOI 10.1016/j.landurbplan.2012.01.014; Naniwadekar R, 2007, J BIOGEOGR, V34, P842, DOI 10.1111/j.1365-2699.2006.01648.x; Nayar TS., 2014, FLOWERING PLANTS W G; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Northrup JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192819; Pereira AB, 1935, BRAGANCA PORTUGUESES; PLUMMER MV, 1981, J HERPETOL, V15, P425, DOI 10.2307/1563532; Prater S.H., 1971, BOOK INDIAN ANIMALS, V3rd; Rajashekara S., 2015, Zoos' Print, V30, P6; Raman TRS, 2006, BIODIVERS CONSERV, V15, P1577, DOI 10.1007/s10531-005-2352-5; Raman TRS, 2003, IBIS, V145, P9, DOI 10.1046/j.1474-919X.2003.00105.x; Raman TRS, 2002, ANIM CONSERV, V5, P201, DOI 10.1017/S1367943002002251; Reddy CS, 2013, CURR SCI INDIA, V105, P1492; Roberts T.J, 1997, MAMMALS PAKISTAN; Robin VV, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0882-6; Roonwal M. L., 1977, PRIMATES S ASIA ECOL; Royle J. A., 2008, HIERARCHICAL MODELIN; SABNIS J H, 1981, Journal of the Bombay Natural History Society, V78, P513; Sawant Nitin S., 2010, Journal of Threatened Taxa, V2, P1199; Seto K. C, 2013, URBANIZATION BIODIVE, P1, DOI [10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1_1]; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Shyam R, 1966, THESIS; Sidhu Swati, 2010, Journal of the Bombay Natural History Society, V107, P91; Simon D, 2004, ENVIRON URBAN, V16, P235, DOI 10.1177/095624780401600214; Smith MA, 1935, FAUNA BRIT INDIA REP, VII; Somaweera R, 2009, LIZARDS SRI LANKA A; Soul?, 1980, CONSERVATION BIOL EV, P119; United Nations, 2018, WORLDS CIT 2018; United Nations Department of Economic and Social Affairs Population Division, 2019, A421 STESASER; Whitaker R., 2004, SNAKES INDIA FIELD G; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	90	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240989	10.1371/journal.pone.0240989	http://dx.doi.org/10.1371/journal.pone.0240989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085696	gold, Green Published			2022-12-26	WOS:000585943400009
J	Lee, HW; Ha, HI; Park, SY; Lim, HK				Lee, Hye-Won; Ha, Hong Il; Park, Sun-Young; Lim, Hyun Kyung			Reliability of 3D image analysis and influence of contrast medium administration on measurement of Hounsfield unit values of the proximal femur	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FEMORAL-NECK; BLOOD-FLOW; CT; SEGMENTATION; OSTEOPOROSIS; ATTENUATION; ACCURACY; ANATOMY; VOLUME	Purpose To evaluate the reliability of 3D image analysis and the effect of an iodine contrast agent on the computed tomography (CT) Hounsfield unit (HU) values of the proximal femur. Materials and methods Fifty female patients (mean age, 61.3 years; age range, 50-79 years) who underwent both pre- and post-enhancement abdominopelvic CT scans were included in this retrospective study. Whole 3D volumes of the left proximal femur from the head to the lesser trochanter were extracted using the regional growth technique with commercial 3D software. Total volume, mean HU, and HU histogram analysis (HUHA) values of the extracted femur were calculated. HUHA distribution was classified into HUHA(fat)for the assumed fatty marrow (percentage of negative HU values) and HUHA(dense-bone)(percentage of HU values >= 126 HU). Reliability was assessed by calculating intra- and interobserver correlation coefficients (ICCs) and by drawing Bland-Altman plots. The effect of contrast medium administration was evaluated by the pairedt-test. Results All intra- and interobserver ICCs of 3D volume measurements showed excellent reproducibility (all ICCs > 0.90). On Bland-Altman analysis of two observers' 3D volume measurements, the differences in the mean total volume, HUHA(fat), HUHA(dense-bone), and mean HU were 2.4 cm(3), 0.17%, 0.6%, and 1.9 HU, respectively. The mean difference in HU after contrast agent administration (-2.2 HU) was not significant (P= 0.27). The mean difference in HUHA(fat)and HUHA(dense-bone)after contrast agent administration were -1.1% and -2.2%, respectively, on the Bland-Altman plot. HUHA(fat)and HUHA(dense-bone)showed significant differences (P< 0.05). The 95% limits of agreement for HUHA(fat), HUHA(dense-bone), and mean HU were -3.6% to 1.3%, -6.5% to 2.1%, and -30.0 to 25.5 HU, respectively. Conclusion Image analysis based on 3D volume measurement of the proximal femur showed excellent reliability, with the contrast agent administration showing negligible influence on the mean HU.	[Lee, Hye-Won; Ha, Hong Il; Park, Sun-Young] Hallym Univ, Dept Radiol, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea; [Lim, Hyun Kyung] Soonchunhyang Univ, Dept Radiol, Seoul Hosp, Seoul, South Korea	Hallym University; Soonchunhyang University	Ha, HI (corresponding author), Hallym Univ, Dept Radiol, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea.	ha.hongil@gmail.com	Park, Sun/GSD-9620-2022					Baum T, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0066-z; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Bousson V, 2004, J BONE MINER RES, V19, P794, DOI 10.1359/JBMR.040124; Buerke B, 2010, AM J ROENTGENOL, V195, P979, DOI 10.2214/AJR.10.4010; Cw P, 2010, CURR OPIN BIOTECH, V21, P627; Fujii M, 2016, RADIOLOGY, V281, P933, DOI 10.1148/radiol.2016151657; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Guo HY, 2018, INT J COMPUT ASS RAD, V13, P1549, DOI 10.1007/s11548-018-1804-9; Kalra MK, 2015, RADIOGRAPHICS, V35, P1706, DOI 10.1148/rg.2015150118; Kim G, 2012, J DIGIT IMAGING, V25, P486, DOI 10.1007/s10278-012-9458-6; Kubo T, 2001, ANN NUCL MED, V15, P231, DOI 10.1007/BF02987837; LAHTINEN T, 1981, J NUCL MED, V22, P966; Lim HK, 2019, EUR RADIOL, V29, P1831, DOI 10.1007/s00330-018-5728-0; Lindner C, 2013, IEEE T MED IMAGING, V32, P1462, DOI 10.1109/TMI.2013.2258030; Liu G, 1997, OSTEOPOROSIS INT, V7, P564, DOI 10.1007/BF02652563; Lu YG, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-130; Maki DD, 1999, RADIOLOGY, V213, P468, DOI 10.1148/radiology.213.2.r99nv33468; Park JE, 2017, KOREAN J RADIOL, V18, P888, DOI 10.3348/kjr.2017.18.6.888; Pickhardt PJ, 2016, OSTEOPOROSIS INT, V27, P147, DOI 10.1007/s00198-015-3224-9; Pompe E, 2015, EUR RADIOL, V25, P283, DOI 10.1007/s00330-014-3408-2; Poole KES, 2017, BONE, V94, P124, DOI 10.1016/j.bone.2016.10.020; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Preda L, 2007, EUR RADIOL, V17, P2096, DOI 10.1007/s00330-006-0573-y; Prisby RD, 2007, J BONE MINER RES, V22, P1280, DOI 10.1359/JBMR.070415; RATCLIFFE JF, 1980, J ANAT, V131, P57; Sharma N, 2010, J MED PHYS, V35, P3, DOI 10.4103/0971-6203.58777; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; Wormanns D, 2004, EUR RADIOL, V14, P86, DOI 10.1007/s00330-003-2132-0; Zhang J, 2010, COMPUT BIOL MED, V40, P231, DOI 10.1016/j.compbiomed.2009.11.020	30	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241012	10.1371/journal.pone.0241012	http://dx.doi.org/10.1371/journal.pone.0241012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085702	gold, Green Published, Green Submitted			2022-12-26	WOS:000585943400015
J	Nikovics, K; Morin, H; Riccobono, D; Bendahmane, A; Favier, AL				Nikovics, Krisztina; Morin, Halima; Riccobono, Diane; Bendahmane, Abdelhafid; Favier, Anne-Laure			Hybridization-chain-reaction is a relevant method for in situ detection of M2d-like macrophages in a mini-pig model	FASEB JOURNAL			English	Article						adipose tissue-derived stem cells; cytokines and muscle regeneration	MESSENGER-RNA; STEM-CELLS; ANGIOGENESIS; POLARIZATION; GENERATION; ACTIN	Macrophages are a heterogeneous population of cells with an important role in innate immunity and tissue regeneration. Based on in vitro experiments, macrophages have been subdivided into five distinct subtypes named M1, M2a, M2b, M2c, and M2d, depending on the means of their activation and the cell surface markers they display. Whether all subtypes can be detected in vivo is still unclear. The identification of macrophages in vivo in the regenerating muscle could be used as a new diagnostic tool to monitor therapeutic strategies for tissue repair. The use of classical immunolabeling techniques is unable to discriminate between different M2 macrophages and a functional characterization of these macrophages is lacking. Using in situ hybridization coupled with hybridization-chain-reaction detection (HCR), we achieved the identification of M2d-like macrophages within regenerating muscle and applied this technique to understand the role of M2 macrophages in the regeneration of irradiated pig-muscle after adipose tissue stem cell treatment. Our work highlights the limits of immunolabeling and the usefulness of HCR analysis to provide valuable information for macrophage characterization.	[Nikovics, Krisztina; Favier, Anne-Laure] French Armed Forces Biomed Res Inst, Dept Platforms & Technol Res, Imagery Unit, 1,Pl Gen Valerie Andre,BP73, F-91223 Bretigny Sur Orge, France; [Morin, Halima; Bendahmane, Abdelhafid] Univ Evry, Univ Paris Saclay, CNRS, Inst Plant Sci Paris Saclay IPS2,INRAE, Orsay, France; [Riccobono, Diane] French Armed Forces Biomed Res Inst, Dept NRBC Defens, Radiobiol Unit, Bretigny Sur Orge, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Nikovics, K (corresponding author), French Armed Forces Biomed Res Inst, Dept Platforms & Technol Res, Imagery Unit, 1,Pl Gen Valerie Andre,BP73, F-91223 Bretigny Sur Orge, France.	krisztina.nikovics@intradef.gouv.fr		Bendahmane, Abdelhafid/0000-0003-3246-868X	Delegation Generale de l Armement [PDH2-NRBC-4-NR-4306]	Delegation Generale de l Armement	Delegation Generale de l Armement, Grant/Award Number: PDH2-NRBC-4-NR-4306	Abdelaziz MH, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02251-w; Arora S, 2018, IMMUNOBIOLOGY, V223, P383, DOI 10.1016/j.imbio.2017.11.001; Ballara SC, 1999, INT J EXP PATHOL, V80, P235, DOI 10.1046/j.1365-2613.1999.00129.x; Bonnardel J, 2018, CURR OPIN IMMUNOL, V50, P64, DOI 10.1016/j.coi.2017.12.001; Chistiakov DA, 2017, IMMUNOBIOLOGY, V223, P101, DOI 10.1016/j.imbio.2017.10.005; Choi HMT, 2016, DEVELOPMENT, V143, P3632, DOI 10.1242/dev.140137; Choi HMT, 2014, ACS NANO, V8, P4284, DOI 10.1021/nn405717p; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; GAN FY, 1994, J HISTOTECHNOL, V17, P313, DOI 10.1179/his.1994.17.4.313; Gharib SA, 2019, J ALLERGY CLIN IMMUN, V143, P1536, DOI 10.1016/j.jaci.2018.10.046; HOOCK TC, 1991, J CELL BIOL, V112, P653, DOI 10.1083/jcb.112.4.653; Hou LQ, 2016, AM J PHYSIOL-HEART C, V310, pH455, DOI 10.1152/ajpheart.00726.2015; Huang X, 2018, METHODS MOL BIOL, V1784, P119, DOI 10.1007/978-1-4939-7837-3_12; Jain N, 2019, ANNU REV BIOMED ENG, V21, P267, DOI 10.1146/annurev-bioeng-062117-121224; King A, 2014, ADV WOUND CARE, V3, P614, DOI 10.1089/wound.2013.0497; Lemos DR, 2015, BONE, V80, P19, DOI 10.1016/j.bone.2015.06.013; Linard C, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1051-6; Linard C, 2018, STEM CELL TRANSL MED, V7, P569, DOI 10.1002/sctm.17-0267; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Pajarinen J, 2019, BIOMATERIALS, V196, P80, DOI 10.1016/j.biomaterials.2017.12.025; Perandini LA, 2018, FEBS J, V285, P1973, DOI 10.1111/febs.14417; Riccobono D, 2018, HEALTH PHYS, V115, P37, DOI 10.1097/HP.0000000000000822; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Snyder RJ, 2016, WOUND REPAIR REGEN, V24, P613, DOI 10.1111/wrr.12444; Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019; TANEJA KL, 1990, J CELL BIOCHEM, V44, P241, DOI 10.1002/jcb.240440406; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Viniegra A, 2018, J DENT RES, V97, P1160, DOI 10.1177/0022034518777973; Wermuth PJ, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0047-4; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu JJ, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1303-0; Zhao B, 2018, PEERJ, V6, DOI 10.7717/peerj.5400	41	7	7	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15675	15686		10.1096/fj.202001496R	http://dx.doi.org/10.1096/fj.202001496R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078886				2022-12-26	WOS:000581625700001
J	Zarei, M; Giannikou, K; Du, H; Liu, HJ; Duarte, M; Johnson, S; Nassar, AH; Widlund, HR; Henske, EP; Long, HW; Kwiatkowski, DJ				Zarei, Mahsa; Giannikou, Krinio; Du, Heng; Liu, Heng-Jia; Duarte, Melissa; Johnson, Sneha; Nassar, Amin H.; Widlund, Hans R.; Henske, Elizabeth P.; Long, Henry W.; Kwiatkowski, David J.			MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61	ONCOGENE			English	Article							TUBEROUS SCLEROSIS COMPLEX; CELL-GROWTH; MICROPHTHALMIA; GENE; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; TUMORIGENESIS; ACTIVATION; EXPRESSION	Tuberous sclerosis complex (TSC) is an autosomal dominant tumor suppressor syndrome, characterized by tumor development in multiple organs, including renal angiomyolipoma. Biallelic loss of TSC1 or TSC2 is a known genetic driver of angiomyolipoma development, however, whether an altered transcriptional repertoire contributes to TSC-associated tumorigenesis is unknown. RNA-seq analyses showed that MITF A isoform (MITF-A) was consistently highly expressed in angiomyolipoma, immunohistochemistry showed microphthalmia-associated transcription factor nuclear localization, and Chromatin immuno-Precipitation Sequencing analysis showed that the MITF-A transcriptional start site was highly enriched with H3K27ac marks. Using the angiomyolipoma cell line 621-101, MITF knockout (MITF.KO) and MITF-A overexpressing (MITF.OE) cell lines were generated. MITF.KO cells showed markedly reduced growth and invasion in vitro, and were unable to form xenografted tumors. In contrast, MITF.OE cells grew faster in vitro and as xenografted tumors compared to control cells. RNA-Seq analysis showed that both ID2 and Cysteine-rich angiogenic inducer 61 (CYR61) expression levels were increased in the MITF.OE cells and reduced in the MITF.KO cells, and luciferase assays showed this was due to transcriptional effects. Importantly, CYR61 overexpression rescued MITF.KO cell growth in vitro and tumor growth in vivo. These findings suggest that MITF-A is a transcriptional oncogenic driver of angiomyolipoma tumor development, acting through regulation of CYR61.	[Zarei, Mahsa; Giannikou, Krinio; Du, Heng; Nassar, Amin H.; Kwiatkowski, David J.] Brigham & Womens Hosp, Dept Med, Canc Genet Lab, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Zarei, Mahsa; Giannikou, Krinio; Du, Heng; Liu, Heng-Jia; Duarte, Melissa; Nassar, Amin H.; Widlund, Hans R.; Henske, Elizabeth P.; Long, Henry W.; Kwiatkowski, David J.] Harvard Med Sch, Boston, MA 02115 USA; [Zarei, Mahsa; Johnson, Sneha] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Giannikou, Krinio; Duarte, Melissa; Long, Henry W.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Liu, Heng-Jia; Henske, Elizabeth P.] Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Widlund, Hans R.] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Texas A&M University System; Texas A&M University College Station; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Kwiatkowski, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Canc Genet Lab, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.; Kwiatkowski, DJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu	Giannikou, Krinio/AAC-9214-2022	Nassar, Amin/0000-0002-8084-9105; Zarei, Mahsa/0000-0002-0554-6163; Du, Heng/0000-0001-9067-0910	Engles Fund for TSC and LAM; University of Pennsylvania Orphan Disease Center; LAM Foundation; NIH NCI [1P01CA120964];  [DOD-18-1-0592];  [DOD-17-1-0205]	Engles Fund for TSC and LAM; University of Pennsylvania Orphan Disease Center; LAM Foundation; NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	This work was supported by the Engles Fund for TSC and LAM; the University of Pennsylvania Orphan Disease Center in partnership with the LAM Foundation; DOD-18-1-0592 (MZ), DOD-17-1-0205 (KG), and the NIH NCI 1P01CA120964 (DJK).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Badri KR, 2013, AM J RESP CRIT CARE, V187, P663, DOI 10.1164/ajrccm.187.6.663; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; BONETTI F, 1993, AM J SURG PATHOL, V17, P1092, DOI 10.1097/00000478-199311000-00002; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dhar A., 2010, Experimental Oncology, V32, P2; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gery S, 2005, CLIN CANCER RES, V11, P7243, DOI 10.1158/1078-0432.CCR-05-0231; Giannikou K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006242; Harbst K, 2012, CLIN CANCER RES, V18, P4026, DOI 10.1158/1078-0432.CCR-12-0343; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Henske EP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.35; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Huang YT, 2016, ONCOTARGET, V7, P1663, DOI 10.18632/oncotarget.6411; Johansson CH, 2013, MELANOMA RES, V23, P360, DOI 10.1097/CMR.0b013e328362f9cd; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Li CG, 2014, J EXP MED, V211, P15, DOI 10.1084/jem.20131080; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816; Mayer S, 2017, ONCOL LETT, V14, P2334, DOI 10.3892/ol.2017.6406; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; NELLIST M, 1993, CELL, V75, P1305; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Zarei M, 2019, J EXP MED, V216, P2635, DOI 10.1084/jem.20190251; Zarei M, 2017, CANCER RES, V77, P4460, DOI 10.1158/0008-5472.CAN-17-0015; Zavala-Pompa A, 2001, AM J SURG PATHOL, V25, P65, DOI 10.1097/00000478-200101000-00007; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	46	6	6	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					112	126		10.1038/s41388-020-01504-8	http://dx.doi.org/10.1038/s41388-020-01504-8		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33082558	Green Accepted			2022-12-26	WOS:000582339900001
J	Buckley, SJ; Davies, MR; McMillan, DJ				Buckley, Sean J.; Davies, Mark R.; McMillan, David J.			In silicocharacterisation of stand-alone response regulators ofStreptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; MULTIPLE GENE REGULATOR; EMM TYPES; GENOME SEQUENCE; VIRULENCE GENES; PEROXIDE STRESS; EXPRESSION; PEPTIDE; SEROTYPE; MGA	Bacterial "stand-alone" response regulators (RRs) are pivotal to the control of gene transcription in response to changing cytosolic and extracellular microenvironments during infection. The genome of group AStreptococcus(GAS) encodes more than 30 stand-alone RRs that orchestrate the expression of virulence factors involved in infecting multiple tissues, so causing an array of potentially lethal human diseases. Here, we analysed the molecular epidemiology and biological associations in the coding sequences (CDSs) and upstream intergenic regions (IGRs) of 35 stand-alone RRs from a collection of global GAS genomes. Of the 944 genomes analysed, 97% encoded 32 or more of the 35 tested RRs. The length of RR CDSs ranged from 297 to 1587 nucleotides with an average nucleotide diversity (pi) of 0.012, while the IGRs ranged from 51 to 666 nucleotides with average pi of 0.017. We present new evidence of recombination in multiple RRs includingmga, leading tomga-2switching,emm-switching andemm-like gene chimerization, and the first instance of an isolate that encodes bothmga-1andmga-2. Recombination was also evident inrofA/nraandmsmRloci with 15emm-types represented in multiple FCT (fibronectin-binding, collagen-binding, T-antigen)-types, including novelemm-type/FCT-type pairings. Strong associations were observed between concatenated RR allele types, andemm-type, MLST-type, core genome phylogroup, and country of sampling. No strong associations were observed between individual loci and disease outcome. We propose that 11 RRs may form part of future refinement of GAS typing systems that reflect core genome evolutionary associations. This subgenomic analysis revealed allelic traits that were informative to the biological function, GAS strain definition, and regional outbreak detection.	[Buckley, Sean J.; McMillan, David J.] Univ Sunshine Coast, Sch Hlth & Sports Sci, Sippy Downs, Qld, Australia; [Davies, Mark R.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	University of the Sunshine Coast; University of Melbourne	Buckley, SJ (corresponding author), Univ Sunshine Coast, Sch Hlth & Sports Sci, Sippy Downs, Qld, Australia.	sean.buckley@research.usc.edu.au	Davies, Mark R/J-2128-2014	Davies, Mark R/0000-0001-6141-5179; Buckley, Sean J/0000-0001-5539-077X	Australian Government PhD scholarship	Australian Government PhD scholarship(Australian Government)	SJB received funding for this work in the form of an Australian Government PhD scholarship, which was conducted at the University of the Sunshine Coast.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2018, LANCET GLOB HEALTH, V6, pE593, DOI 10.1016/S2214-109X(18)30239-0; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2019, CANCER DISCOV, V10, pOF5; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Athey TBT, 2014, J CLIN MICROBIOL, V52, P1871, DOI 10.1128/JCM.00029-14; Bao YJ, 2016, MICROBIOL-SGM, V162, P1346, DOI 10.1099/mic.0.000326; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Beall B, 2000, MICROBIOL-SGM, V146, P1195, DOI 10.1099/00221287-146-5-1195; Ben Zakour NL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15877; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; Bessen DE., 2016, STREPTOCOCCUS PYOGEN; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Beyer-Sehlmeyer G, 2005, INT J MED MICROBIOL, V295, P161, DOI 10.1016/j.ijmm.2005.02.010; Cao TN, 2014, INFECT IMMUN, V82, P1744, DOI 10.1128/IAI.01639-13; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Chochua S, 2017, MBIO, V8, DOI [10.1128/mBio.01422-17, 10.1128/mbio.01422-17]; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028640; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davies MR, 2019, NAT GENET, V51, P1035, DOI 10.1038/s41588-019-0417-8; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; DebRoy S, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000235; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Dmitriev AV, 2008, FEMS MICROBIOL LETT, V284, P43, DOI 10.1111/j.1574-6968.2008.01171.x; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Do H, 2017, P NATL ACAD SCI USA, V114, pE8498, DOI 10.1073/pnas.1705972114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efstratiou A, 2017, STREPTOCOCCUS PYOGEN; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Falaleeva M, 2014, INFECT IMMUN, V82, P5293, DOI 10.1128/IAI.02035-14; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Flores AR, 2019, J PEDIAT INF DIS SOC, V8, P244, DOI 10.1093/jpids/piy053; Flores AR, 2013, INFECT IMMUN, V81, P4128, DOI 10.1128/IAI.00405-13; Flores AR, 2012, MBIO, V3, DOI 10.1128/mBio.00413-12; FRANK C, 1995, MED MICROBIOL IMMUN, V184, P139; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Galloway-Pena J, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw042; Gherardi G, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00059; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Grifantini R, 2011, J BACTERIOLOGY; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hand RM., 2020, HUNTERS TROPICAL MED, P429, DOI DOI 10.1016/B978-0-323-55512-8.00040-5; HELMANN JD, 2002, BACILLUS SUBTILIS IT, P289; Hollands A, 2010, J INFECT DIS, V202, P11, DOI 10.1086/653124; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hondorp ER, 2013, MOL MICROBIOL, V88, P1176, DOI 10.1111/mmi.12250; Huang CY, 2014, J CLIN MICROBIOL, V52, P508, DOI 10.1128/JCM.02383-13; Hynes W, 2016, SECRETED EXTRACELLUL; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86, DOI DOI 10.1016/S2468-2667(19)30246-4; Johnson DR, 2006, J MED MICROBIOL, V55, P157, DOI 10.1099/jmm.0.46224-0; Kalia A, 2002, INFECT IMMUN, V70, P1971, DOI 10.1128/IAI.70.4.1971-1983.2002; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; LaRock CN, 2015, BBA-BIOMEMBRANES, V1848, P3047, DOI 10.1016/j.bbamem.2015.02.010; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; Lees JA, 2019, GENOME RES, V29, P304, DOI 10.1101/gr.241455.118; Lees JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12797; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lei BF, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00080-18; Li Y, 2020, LANCET INFECT DIS, V20, P538, DOI 10.1016/S1473-3099(20)30279-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu DY, 2005, RES MICROBIOL, V156, P564, DOI 10.1016/j.resmic.2005.01.010; Lu BH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01052; Luo F, 2008, INFECT IMMUN, V76, P2490, DOI 10.1128/IAI.01567-07; Makthal N, 2016, MOL MICROBIOL, V99, P1119, DOI 10.1111/mmi.13294; Makthal N, 2013, J BIOL CHEM, V288, P18311, DOI 10.1074/jbc.M113.456590; Manetti AGO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013864; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McDowell EJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-114; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McIver KS, 1997, J BACTERIOL, V179, P5178, DOI 10.1128/jb.179.16.5178-5187.1997; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Miller EW, 2015, MOL MICROBIOL, V98, P473, DOI 10.1111/mmi.13136; Mintzer V, 2019, CLIN MICROBIOL INFEC, V25, P1086, DOI 10.1016/j.cmi.2019.04.019; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nithyanand P, 2010, CURR MICROBIOL, V60, P454, DOI 10.1007/s00284-009-9564-y; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ong CLY, 2014, J INFECT DIS, V209, P1500, DOI 10.1093/infdis/jiu053; Opdyke JA, 2001, MOL MICROBIOL, V42, P495, DOI 10.1046/j.1365-2958.2001.02657.x; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Rossen JWA, 2018, CLIN MICROBIOL INFEC, V24, P355, DOI 10.1016/j.cmi.2017.11.001; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Sanson M, 2015, INFECT IMMUN, V83, P2382, DOI 10.1128/IAI.03023-14; Sanson M, 2015, AM J PATHOL, V185, P462, DOI 10.1016/j.ajpath.2014.10.018; Sarkar P, 2017, MOL MICROBIOL, V103, P576, DOI 10.1111/mmi.13584; Schwengers O, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007134; Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; Siemens N, 2012, J BACTERIOLOGY; Silva-Costa C, 2015, EXPERT REV ANTI-INFE, V13, P615, DOI 10.1586/14787210.2015.1023292; Sitkiewicz I, 2017, POL J MICROBIOL, V66, P17, DOI 10.5604/17331331.1234989; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tokajian S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00358-14; Toukoki C, 2010, MOL MICROBIOL, V76, P971, DOI 10.1111/j.1365-2958.2010.07157.x; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Turner CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08914-x; Vega LA, 2016, VIRULENCE RELATED TR; Vega LA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00925-16; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Wang HB, 2013, BIOMED ENVIRON SCI, V26, P782, DOI 10.3967/0895-3988.2013.09.012; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wilkening RV, 2017, TRENDS MICROBIOL, V25, P563, DOI 10.1016/j.tim.2017.01.007; Wilkening RV, 2017, J BIOL CHEM, VM117; Woodbury R, 2003, BIOCHEM BIOPH RES CO, V302, P722, DOI 10.1016/S0006-291X(03)00254-7; Woodbury RL, 2006, RES MICROBIOL, V157, P851, DOI 10.1016/j.resmic.2006.07.002; Xavier BB, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100769; You YH, 2018, EBIOMEDICINE, V28, P128, DOI 10.1016/j.ebiom.2018.01.010; Young CA, 2015, J BACTERIOL, V197, P2580, DOI 10.1128/JB.00127-15	128	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240834	10.1371/journal.pone.0240834	http://dx.doi.org/10.1371/journal.pone.0240834			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075055	gold, Green Published			2022-12-26	WOS:000585920200039
J	Gupta, H; Galatas, B; Chidimatembue, A; Huijben, S; Cistero, P; Matambisso, G; Nhamussua, L; Simone, W; Bassat, Q; Menard, D; Ringwald, P; Rabinovich, NR; Alonso, PL; Saute, F; Aide, P; Mayor, A				Gupta, Himanshu; Galatas, Beatriz; Chidimatembue, Arlindo; Huijben, Silvie; Cistero, Pau; Matambisso, Gloria; Nhamussua, Lidia; Simone, Wilson; Bassat, Quique; Menard, Didier; Ringwald, Pascal; Rabinovich, N. Regina; Alonso, Pedro L.; Saute, Francisco; Aide, Pedro; Mayor, Alfredo			Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ARTEMISININ RESISTANCE; IMPACT; CHEMOPREVENTION; ELIMINATION; SELECTION; PROVINCE; CAMBODIA; MYANMAR; FAILURE	Background Mass drug administration (MDA) can rapidly reduce the burden ofPlasmodium falciparum(Pf). However, concerns remain about its contribution to select for antimalarial drug resistance. Methods We used Sanger sequencing and real-time PCR to determine the proportion of molecular markers associated with antimalarial resistance (k13,pfpm2,pfmdr1 and pfcrt) inPfisolates collected before (n = 99) and after (n = 112) the implementation of two monthly MDA rounds with dihydroartemisinin-piperaquine (DHAp) for two consecutive years in Magude district of Southern Mozambique. Results None of thek13polymorphisms associated with artemisinin resistance were observed in thePfisolates analyzed. The proportion ofPfisolates with multiple copies ofpfpm2, an amplification associated with piperaquine resistance, was similar in pre- (4.9%) and post-MDA groups (3.4%; p = 1.000). No statistically significant differences were observed between pre- and post-MDA groups in the proportion ofPfisolates neither with mutations inpfcrtandpfmdr1genes, nor with the carriage ofpfmdr1multiple copies (p>0.05). Conclusions This study does not show any evidence of increased frequency of molecular makers of antimalarial resistance after MDA with DHAp in southern Mozambique where markers of antimalarial resistance were absent or low at the beginning of the intervention.	[Gupta, Himanshu; Cistero, Pau; Matambisso, Gloria; Bassat, Quique; Rabinovich, N. Regina; Alonso, Pedro L.; Mayor, Alfredo] Hosp Clin Univ Barcelona, Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain; [Galatas, Beatriz; Chidimatembue, Arlindo; Matambisso, Gloria; Nhamussua, Lidia; Simone, Wilson; Bassat, Quique; Alonso, Pedro L.; Saute, Francisco; Aide, Pedro; Mayor, Alfredo] Ctr Invest Saude Manhica, Manhica, Mozambique; [Bassat, Quique; Mayor, Alfredo] Pg Lluis Co, ICREA, Barcelona, Spain; [Bassat, Quique] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Bassat, Quique] Univ Barcelona, Hosp St Joan Deu, Pediat Dept, Pediat Infect Dis Unit, Barcelona, Spain; [Menard, Didier] Inst Pasteur, Paris, France; [Menard, Didier] INSERM, U1201, Paris, France; [Menard, Didier] CNRS, ERL9195, Paris, France; [Ringwald, Pascal] World Hlth Org WHO, Global Malaria Programme, Geneva, Switzerland; [Rabinovich, N. Regina] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Aide, Pedro] Minist Hlth, Natl Inst Hlth, Manhica, Mozambique; [Gupta, Himanshu] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Infect Biol, London, England; [Huijben, Silvie] Arizona State Univ, Sch Life Sci, Ctr Evolut & Med, Tempe, AZ USA; [Alonso, Pedro L.] WHO, Global Malaria Program, Geneva, Switzerland	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Arizona State University; Arizona State University-Tempe; World Health Organization	Mayor, A (corresponding author), Hosp Clin Univ Barcelona, Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain.; Mayor, A (corresponding author), Ctr Invest Saude Manhica, Manhica, Mozambique.; Mayor, A (corresponding author), Pg Lluis Co, ICREA, Barcelona, Spain.	alfredo.mayor@isglobal.org	Galatas, Beatriz/AAP-4362-2020; Bassat, Quique/P-2341-2016; Cisteró, Pau/H-2468-2017; Menard, Didier/O-3294-2013; Gupta, Himanshu/G-8834-2015	Bassat, Quique/0000-0003-0875-7596; Cisteró, Pau/0000-0001-7225-4331; Menard, Didier/0000-0003-1357-4495; Gupta, Himanshu/0000-0003-1391-8358; Huijben, Silvie/0000-0002-3537-1915; Galatas, PhD, Beatriz/0000-0002-9546-6385	La Caixa Foundation [INV-008483/OPP1115265]; Bill and Melinda Gates Foundation [INV-008483/OPP1115265]; Departament d'Universitats i Recerca de la Generalitat de Catalunya, Agencia de Gestiod'Ajuts Universitaris i de Recerca [2017SGR664]; Science and Engineering Research Board (SERB), Department of Science & Technology, Government of India [SB/OS/PDF043/201516]; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program [CEX2018-000806-S]; Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development Cooperation (AECID); Fundacion Ramon Areces; Mozambican National Malaria Control Program; Ministry of Health	La Caixa Foundation(La Caixa Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Departament d'Universitats i Recerca de la Generalitat de Catalunya, Agencia de Gestiod'Ajuts Universitaris i de Recerca; Science and Engineering Research Board (SERB), Department of Science & Technology, Government of India; Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program; Generalitat de Catalunya through the CERCA Program; Government of Mozambique; Spanish Agency for International Development Cooperation (AECID); Fundacion Ramon Areces; Mozambican National Malaria Control Program; Ministry of Health	We would like to thank La Caixa and Bill and Melinda Gates Foundations for providing the funds for this study (grant number INV-008483/OPP1115265). A.M. is supported by the Departament d'Universitats i Recerca de la Generalitat de Catalunya, Agencia de Gestiod'Ajuts Universitaris i de Recerca (2017SGR664). HG was supported (January 2017-January 2019) by the Science and Engineering Research Board (SERB), Department of Science & Technology, Government of India (Overseas Postdoctoral Fellowship, SB/OS/PDF043/201516). We acknowledge support from the Spanish Ministry of Science and Innovation through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. The Centro de Investigacao em Saude de Manhica (CISM) is supported by the Government of Mozambique and the Spanish Agency for International Development Cooperation (AECID). This research is part of ISGlobal's Program on the Molecular Mechanisms of Malaria, which is partially supported by the Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to the community of Magude and the district authorities, for allowing this project to take place and for greatly contributing to its successful implementation and evaluation. We would also like to thank all the field workers, the staff of the Hospitals, clinical officers, field supervisors, data manager and those who worked in the lab for their contribution to the collection and organization of samples shipment. We thank the Mozambican National Malaria Control Program and the Ministry of Health for supporting and providing guidance throughout the project. P.R. and P.L.A are staff members of the World Health Organization. Authors alone are responsible for the views expressed in this publication, and these do not necessarily represent the decisions, policy, or views of the World Health Organization.	Agrawal S, 2017, J INFECT DIS, V216, P468, DOI 10.1093/infdis/jix334; Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2019, IMMUNE NETW, V19, pe34; [Anonymous], 2017, EPLASTY, V17, pic25; [Anonymous], 2015, BMJ, V2015, ph1887; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Phuc BQ, 2017, EMERG INFECT DIS, V23, P715, DOI 10.3201/eid2304.161872; Cairns ME, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003214; Deng CS, 2018, CLIN INFECT DIS, V67, P1670, DOI 10.1093/cid/ciy364; Dhingra SK, 2017, MBIO, V8, DOI [10.1128/mBio.00303-17, 10.1128/mbio.00303-17]; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eisele TP, 2020, AM J TROP MED HYG, V103, P7, DOI 10.4269/ajtmh.19-0659; Eisele TP, 2016, J INFECT DIS, V214, P1831, DOI 10.1093/infdis/jiw416; Gadalla AAH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166699; Galatas B, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003227; Goodman CD, 2016, SCIENCE, V352, P349, DOI 10.1126/science.aad9279; Gupta H, 2018, EMERG INFECT DIS, V24, P40, DOI 10.3201/eid2401.170864; Imwong M, 2020, LANCET INFECT DIS, V20, P1470, DOI 10.1016/S1473-3099(20)30228-0; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Kim J, 2019, NATURE, V576, P315, DOI 10.1038/s41586-019-1795-x; Landier J, 2018, LANCET, V391, P1916, DOI [10.1016/S0140-6736(18)30792-X, 10.1016/s0140-6736(18)30792-x]; Landier Jordi, 2017, Wellcome Open Res, V2, P81, DOI 10.12688/wellcomeopenres.12240.1; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-380; Mayor A, 2015, NEW ENGL J MED, V373, P1607, DOI 10.1056/NEJMoa1406459; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Mitja O, 2018, LANCET, V391, P1599, DOI 10.1016/S0140-6736(18)30204-6; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Pongvongsa T, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2541-9; Rono MK, 2018, NAT ECOL EVOL, V2, P377, DOI 10.1038/s41559-017-0419-9; Ross LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05652-0; Schwab AE, 2006, PARASITOLOGY, V133, P589, DOI 10.1017/S003118200600076X; Scott N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2418-y; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Some AF, 2014, ANTIMICROB AGENTS CH, V58, P3660, DOI 10.1128/AAC.02406-14; Taylor SM, 2014, J CLIN MICROBIOL, V52, P2144, DOI 10.1128/JCM.00565-14; Tripura R, 2018, CLIN INFECT DIS, V67, P817, DOI 10.1093/cid/ciy196; Tun KM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1240-7; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; von Seidlein L, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002745; Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434; West SK, 2014, J INFECT DIS, V210, P65, DOI 10.1093/infdis/jiu046; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/s1473-3099(16)30415-7, 10.1016/S1473-3099(16)30415-7]; World Health Organization, 2017, ART ART BAS COMB THE; Zongo I, 2015, ANTIMICROB AGENTS CH, V59, P4387, DOI 10.1128/AAC.04923-14; Zuber JA, 2018, INFECT DRUG RESIST, V11, P299, DOI 10.2147/IDR.S123887; [No title captured]	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240174	10.1371/journal.pone.0240174	http://dx.doi.org/10.1371/journal.pone.0240174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075062	Green Published, gold			2022-12-26	WOS:000585920200001
J	Kortje, M; Baumann, U; Stover, T; Weissgerber, T				Koertje, Monika; Baumann, Uwe; Stoever, Timo; Weissgerber, Tobias			Sensitivity to interaural time differences and localization accuracy in cochlear implant users with combined electric-acoustic stimulation	PLOS ONE			English	Article							SOUND SOURCE LOCALIZATION; TEMPORAL-FINE-STRUCTURE; SPEECH-PERCEPTION; AUDITORY-SYSTEM; NORMAL-HEARING; NOISE; CUES; LISTENERS; RESPONSES; ENVELOPE	Objectives In this study, localization accuracy and sensitivity to acoustic interaural time differences (ITDs) in subjects using cochlear implants with combined electric-acoustic stimulation (EAS) were assessed and compared with the results of a normal hearing control group. Methods Eight CI users with EAS (2 bilaterally implanted, 6 unilaterally implanted) and symmetric binaural acoustic hearing and 24 normal hearing subjects participated in the study. The first experiment determined mean localization error (MLE) for different angles of sound incidence between +/- 60 degrees (frontal and dorsal presentation). The stimuli were either low-pass, high-pass or broadband noise bursts. In a second experiment, just noticeable differences (JND) of ITDs were measured for pure tones of 125 Hz, 250 Hz and 500 Hz (headphone presentation). Results Experiment 1: MLE of EAS subjects was 8.5 degrees, 14.3 degrees and 14.7 degrees, (low-, high-pass and broadband stimuli respectively). In the control group, MLE was 1.8 degrees (broadband stimuli). In the differentiation between sound incidence from front and back, EAS subjects performed on chance level. Experiment 2: The JND-ITDs were 88.7 mu s for 125 Hz, 48.8 mu s for 250 Hz and 52.9 mu s for 500 Hz (EAS subjects). Compared to the control group, JND-ITD for 125 Hz was on the same level of performance. No statistically significant correlation was found between MLE and JND-ITD in the EAS cohort. Conclusions Near to normal ITD sensitivity in the lower frequency acoustic hearing was demonstrated in a cohort of EAS users. However, in an acoustic localization task, the majority of the subjects did not reached the level of accuracy of normal hearing. Presumably, signal processing time delay differences between devices used on both sides are deteriorating the transfer of precise binaural timing cues.	[Koertje, Monika; Baumann, Uwe; Weissgerber, Tobias] Goethe Univ Frankfurt, Univ Hosp Frankfurt, ENT Dept, Audiol Acoust, Frankfurt, Germany; [Stoever, Timo] Goethe Univ Frankfurt, Univ Hosp Frankfurt, ENT Dept, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kortje, M (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, ENT Dept, Audiol Acoust, Frankfurt, Germany.	monika.koertje@kgu.de	Weissgerber, Tobias/AAN-3688-2021; Koertje, Monika/AAC-4615-2022	Weissgerber, Tobias/0000-0002-0327-1274; Koertje, Monika/0000-0003-2432-7609; Baumann, Uwe/0000-0002-1295-2661	German Research Foundation [337436298]	German Research Foundation(German Research Foundation (DFG))	The study was funded by the German Research Foundation (Project Number 337436298). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff JM, 2010, J ACOUST SOC AM, V127, pEL87, DOI 10.1121/1.3298451; Baumann U, 2009, HNO, V57, P542, DOI 10.1007/s00106-009-1923-2; Bernstein JGW, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518765514; Blauert J., 1997, SPATIAL HEARING PSYC; Dietz M, 2013, P NATL ACAD SCI USA, V110, P15151, DOI 10.1073/pnas.1309712110; Dillon H., 2003, HEAR J, V56, P30; Doge J, 2017, OTOL NEUROTOL, V38, pE563, DOI 10.1097/MAO.0000000000001520; Dunn CC, 2010, J AM ACAD AUDIOL, V21, P44, DOI 10.3766/jaaa.21.1.6; Francart T, 2009, JARO-J ASSOC RES OTO, V10, P131, DOI 10.1007/s10162-008-0145-8; Fullgrabe C, 2013, AM J AUDIOL, V22, P313, DOI 10.1044/1059-0889(2013/12-0070); Gifford RH, 2020, HEARING RES, V390, DOI 10.1016/j.heares.2020.107929; Gifford RH, 2017, EAR HEARING, V38, P539, DOI 10.1097/AUD.0000000000000418; Gifford RH, 2014, HEARING RES, V312, P28, DOI 10.1016/j.heares.2014.02.007; Gifford RH, 2013, EAR HEARING, V34, P413, DOI 10.1097/AUD.0b013e31827e8163; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; HAHLBROCK K H, 1953, Arch Ohren Nasen Kehlkopfheilkd, V162, P394, DOI 10.1007/BF02105664; Helbig S, 2016, OTOL NEUROTOL, V37, pE353, DOI 10.1097/MAO.0000000000001066; Hildebrandt KJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002096; Jones H, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514554574; Killan C, 2019, EAR HEARING, V40, P870, DOI 10.1097/AUD.0000000000000666; Lammers MJW, 2014, OTOL NEUROTOL, V35, P1433, DOI 10.1097/MAO.0000000000000433; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Loiselle LH, 2016, J SPEECH LANG HEAR R, V59, P810, DOI 10.1044/2015_JSLHR-H-14-0355; Loiselle LH, 2015, AUDIOL NEURO-OTOL, V20, P166, DOI 10.1159/000367883; Moore, 2013, INTRO PSYCHOL HEARIN; Moore BCJ, 2018, J ACOUST SOC AM, V143, P1287, DOI 10.1121/1.5025845; Mueller Martin F, 2014, Cochlear Implants Int, V15, P36, DOI 10.1179/1754762813Y.0000000040; Ochi A, 2016, ADV EXP MED BIOL, V894, P19, DOI 10.1007/978-3-319-25474-6_3; Ozmeral EJ, 2016, J NEUROPHYSIOL, V116, P2720, DOI 10.1152/jn.00560.2016; Papesh MA, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00124; Plant K, 2016, INT J AUDIOL, V55, pS31, DOI 10.3109/14992027.2016.1150609; Rader T, 2015, HNO, V63, P85, DOI 10.1007/s00106-014-2943-0; Risoud M, 2020, EUR ANN OTORHINOLARY, V137, P21, DOI 10.1016/j.anorl.2019.09.007; Ross B, 2007, J NEUROSCI, V27, P11172, DOI 10.1523/JNEUROSCI.1813-07.2007; Seebacher J, 2019, HEARING RES, V371, P19, DOI 10.1016/j.heares.2018.10.015; Seeber B, 2002, ACTA ACUST UNITED AC, V88, P446; Seeber BU, 2008, J ACOUST SOC AM, V123, P1030, DOI 10.1121/1.2821965; Spencer NJ, 2016, J ACOUST SOC AM, V140, P1783, DOI 10.1121/1.4962444; Veugen LCE, 2016, HEARING RES, V336, P72, DOI 10.1016/j.heares.2016.04.008; von Ilberg C, 1999, ORL J OTO-RHINO-LARY, V61, P334, DOI 10.1159/000027695; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Weissgerber T, 2014, DGA 2014; Yost WA, 2017, J ACOUST SOC AM, V142, P173, DOI 10.1121/1.4990656; Zirn S, 2015, HEARING RES, V328, P148, DOI 10.1016/j.heares.2015.08.010; Zirn S, 2018, J ACOUST SOC AM, V143, P1939, DOI [10.1121/1.5036343, DOI 10.1121/1.5036343]; Zirn S, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519843876	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0241015	10.1371/journal.pone.0241015	http://dx.doi.org/10.1371/journal.pone.0241015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075114	Green Published, gold			2022-12-26	WOS:000585920200029
J	Leandersson, P; Akesson, A; Hedenfalk, I; Malander, S; Borgfeldt, C				Leandersson, Pia; Akesson, Anna; Hedenfalk, Ingrid; Malander, Susanne; Borgfeldt, Christer			A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients	PLOS ONE			English	Article							MALIGNANCY ALGORITHM ROMA; LONG-TERM SURVIVAL; SUBJECTIVE ASSESSMENT; NO IMPROVEMENT; INDEX RMI; CANCER; RISK; WOMEN; ULTRASOUND; CARCINOMAS	Objective Survival in epithelial ovarian cancer (EOC) remains poor. Most patients are diagnosed in late stages. Early diagnosis increases the chance of survival. We used the proximity extension assay from Olink Proteomics to search for new protein biomarkers with the potential to improve the diagnostic performance of CA125 and HE4 in patients with ovarian tumors. Material and methods Plasma samples were obtained from 180 women with ovarian tumors; 30 cases of benign tumor, 28 cases with borderline tumors, 25 early EOC cases (FIGO stage I) and 97 advanced EOC cases (FIGO stages II-IV). Proteins were measured using the Olink (R) Oncology II and Inflammation panels. For statistical analyses, patients were categorized into benign tumors versus cancer and benign tumors versus borderline + cancer, respectively. Results We analyzed 177 biomarkers. Thirty-four proteins had ROC AUC > 0.7 for discrimination between benign tumors and cancer. Fifteen proteins had ROC AUC > 0.7 for discrimination between benign tumors and borderline tumors + cancer. HE4 ranked highest for both comparisons. A reference model with HE4, CA125 and age (AUC 0.838 for benign tumors vs. cancer and AUC 0.770 for benign tumors vs. borderline tumors + cancer) was compared to the reference model with the addition of each of the remaining proteins with AUC > 0.7. ITGAV was the only individual biomarker found to improve diagnostic performance of the reference model, to AUC 0.874 for benign tumors vs. cancer and AUC 0.818 for benign tumors vs. borderline tumors + cancer (p < 0.05). Cross-validation and LASSO regression was combined to select multiple biomarker combinations. The best performing model for discrimination between benign tumors and borderline tumors + cancer was a 6-biomarker combination (HE4, CA125, ITGAV, CXCL1, CEACAM1, IL-10RB) and age (AUC 0.868, sensitivity 0.86 and specificity 0.82, p = 0.016 for comparison with the reference model). Conclusion HE4 was the best performing individual biomarker for discrimination between benign ovarian tumors and EOC including borderline tumors. The addition of other carcinogenesis-related biomarkers in a multiplex biomarker panel can improve the diagnostic performance of the established biomarkers HE4 and CA125.	[Leandersson, Pia] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci Obstet & Gynecol, Reprod Med Ctr, Malmo, Sweden; [Akesson, Anna] Skane Univ Hosp Lund, Clin Studies Sweden Forum South, Lund, Sweden; [Hedenfalk, Ingrid] Lund Univ, Dept Clin Sci Oncol & Pathol, Lund, Sweden; [Malander, Susanne] Lund Univ, Skane Univ Hosp Lund, Dept Clin Sci Oncol & Pathol, Lund, Sweden; [Borgfeldt, Christer] Lund Univ, Skane Univ Hosp Lund, Dept Clin Sci Obstet & Gynecol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Leandersson, P (corresponding author), Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci Obstet & Gynecol, Reprod Med Ctr, Malmo, Sweden.	pia.leandersson@med.lu.se		Hedenfalk, Ingrid/0000-0002-6840-3397; Borgfeldt, Christer/0000-0003-2267-8325; Leandersson, Pia/0000-0002-6180-0111	Swedish Cancer Society; Southern Health Care Region of Sweden	Swedish Cancer Society(Swedish Cancer Society); Southern Health Care Region of Sweden	This project was financially supported by the Swedish Cancer Society https://www.cancerfonden.se (IH and CB) and the Southern Health Care Region of Sweden https://sodrasjukvardsregionen.se (PL and IH). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Boylan KLM, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9169-6; Braicu EI, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-49; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Dankner M, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1328336; De Carvalho VP, 2019, TRANSL RES, V206, P71, DOI 10.1016/j.trsl.2018.11.001; Elzek MA, 2015, CANCER METAST REV, V34, P83, DOI 10.1007/s10555-014-9547-8; Engel J, 2002, EUR J CANCER, V38, P2435, DOI 10.1016/S0959-8049(02)00495-1; Enroth S, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0464-9; Enroth S, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-018-9216-y; Goldberg I, 2001, CLIN CANCER RES, V7, P4073; Henic E, 2008, CLIN CANCER RES, V14, P5785, DOI 10.1158/1078-0432.CCR-08-0096; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; JACOBS I, 1989, HUM REPROD, V4, P1; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Kalapotharakos G, 2016, ACTA OBSTET GYN SCAN, V95, P473, DOI 10.1111/aogs.12846; Karlsen MA, 2015, GYNECOL ONCOL, V138, P640, DOI 10.1016/j.ygyno.2015.06.021; Karlsen MA, 2012, GYNECOL ONCOL, V127, P379, DOI 10.1016/j.ygyno.2012.07.106; Khare V, 2015, CANCER IMMUNOL RES, V3, P1227, DOI 10.1158/2326-6066.CIR-15-0031; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kotowicz B, 2015, EUR J OBSTET GYN R B, V194, P141, DOI 10.1016/j.ejogrb.2015.09.008; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Leandersson P, 2016, ANTICANCER RES, V36, P957; Lennox GK, 2015, INT J GYNECOL CANCER, V25, P809, DOI 10.1097/IGC.0000000000000442; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; Meys EMJ, 2016, EUR J CANCER, V58, P17, DOI 10.1016/j.ejca.2016.01.007; Moore RG, 2012, AM J OBSTET GYNECOL, V206, DOI DOI 10.1016/J.AJOG.2011.12.029; Moore RG, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.043; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morice P, 2003, HUM REPROD UPDATE, V9, P185, DOI 10.1093/humupd/dmg006; Mustea A, 2006, ANTICANCER RES, V26, P1715; Nolen BM, 2013, MOL DIAGN THER, V17, P139, DOI 10.1007/s40291-013-0027-6; NORDCAN, 2019, NORDCAN CANC INC MOR; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Rainczuk A, 2012, REPRODUCTION, V144, P303, DOI 10.1530/REP-12-0153; Skubitz APN, 2019, CANCER PREV RES, V12, P171, DOI 10.1158/1940-6207.CAPR-18-0221; Terry KL, 2016, CLIN CANCER RES, V22, P4664, DOI 10.1158/1078-0432.CCR-16-0316; Tian Y, 2011, PROTEOMICS, V11, P4677, DOI 10.1002/pmic.201000811; Timmermans M, 2018, EUR J CANCER, V88, P31, DOI 10.1016/j.ejca.2017.10.030; van Baal JOAM, 2018, J HISTOCHEM CYTOCHEM, V66, DOI 10.1369/0022155417742897; Van Gorp T, 2012, EUR J CANCER, V48, P1649, DOI 10.1016/j.ejca.2011.12.003; Wang Q, 2011, INT J BIOL MARKER, V26, P262, DOI 10.5301/JBM.2011.8616; Wei HX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01315; Wilbers RHP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186317; Wolk K, 2005, GENES IMMUN, V6, P8, DOI 10.1038/sj.gene.6364144; Yanaranop M, 2017, GYNECOL OBSTET INVES, V82, P47, DOI 10.1159/000446238; Yang WL, 2017, EXPERT REV MOL DIAGN, V17, P577, DOI 10.1080/14737159.2017.1326820	53	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240418	10.1371/journal.pone.0240418	http://dx.doi.org/10.1371/journal.pone.0240418			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075095	gold, Green Published			2022-12-26	WOS:000585920200035
J	Miller, M; Rogers, JC; Badham, MA; Cadenas, L; Brightwell, E; Adams, J; Tyler, C; Sebahar, PR; Haussener, TJ; Reddy, HRK; Looper, RE; Williams, DL				Miller, Mariel; Rogers, Jeffery C.; Badham, Marissa A.; Cadenas, Lousili; Brightwell, Eian; Adams, Jacob; Tyler, Cole; Sebahar, Paul R.; Haussener, Travis J.; Reddy, Hariprasada Reddy Kanna; Looper, Ryan E.; Williams, Dustin L.			Examination of a first-in-class bis-dialkylnorspermidine-terphenyl antibiotic in topical formulation against mono and polymicrobial biofilms	PLOS ONE			English	Article							DIABETIC FOOT OSTEOMYELITIS; STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; MUPIROCIN RESISTANCE; INFECTIOUS-DISEASES; MANAGEMENT; SPECIMENS; CULTURE; GROWTH	Biofilm-impaired tissue is a significant factor in chronic wounds such as diabetic foot ulcers. Most, if not all, anti-biotics in clinical use have been optimized against planktonic phenotypes. In this study, anin vitroassessment was performed to determine the potential efficacy of a first-in-class series of antibiofilm antibiotics and compare outcomes to current clinical standards of care. The agent, CZ-01179, was formulated into a hydrogel and tested against mature biofilms of a clinical isolate of methicillin-resistantStaphylococcus aureusandPseudomonas aeruginosaATCC 27853 using two separate methods. In the first method, biofilms were grown on cellulose discs on an agar surface. Topical agents were spread on gauze and placed over the biofilms for 24 h. Biofilms were quantified and imaged with confocal and scanning electron microscopy. In the second method, biofilms were grown on bioabsorbable collagen coupons in a modified CDC biofilm reactor. Coupons were immersed in treatment for 24 h. The first method was limited in its ability to assess efficacy. Efficacy profiles against biofilms grown on collagen were more definitive, with CZ-01179 gel eradicating well-established biofilms to a greater degree compared to clinical standards. In conclusion, CZ-01179 may be a promising topical agent that targets the biofilm phenotype. Pre-clinical work is currently being performed to determine the translatable potential of CZ-01179 gel.	[Miller, Mariel; Rogers, Jeffery C.; Badham, Marissa A.; Cadenas, Lousili; Brightwell, Eian; Adams, Jacob; Tyler, Cole; Williams, Dustin L.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Miller, Mariel; Rogers, Jeffery C.; Badham, Marissa A.; Cadenas, Lousili; Brightwell, Eian; Adams, Jacob; Tyler, Cole; Williams, Dustin L.] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Sebahar, Paul R.; Haussener, Travis J.; Reddy, Hariprasada Reddy Kanna; Looper, Ryan E.; Williams, Dustin L.] Curza Global LLC, Provo, UT 84604 USA; [Sebahar, Paul R.; Haussener, Travis J.; Reddy, Hariprasada Reddy Kanna; Looper, Ryan E.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Uniformed Services University of the Health Sciences - USA	Williams, DL (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA.; Williams, DL (corresponding author), Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Curza Global LLC, Provo, UT 84604 USA.; Williams, DL (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA.	dustin.williams@utah.edu	; Kanna Reddy, Hariprasada Reddy/ABH-4895-2020	Miller, Mariel/0000-0001-8539-2864; Kanna Reddy, Hariprasada Reddy/0000-0001-5580-1292; Williams, Dustin/0000-0001-5275-1365	Department of Veterans Affairs [1I01RX002287-01]	Department of Veterans Affairs(US Department of Veterans Affairs)	DLW received a Merit Review award from the Department of Veterans Affairs that supported this work. Award number is 1I01RX002287-01. The grant submission was peer reviewed, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Curza Global) provided support in the form of salaries for authors (REL, PRS, HRKR, JCR, TJH, DLW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Authors DLW, PRS, REL and TJH have financial interest in Curza Global, LLC.	Aragon-Sanchez FJ, 2008, DIABETOLOGIA, V51, P1962, DOI 10.1007/s00125-008-1131-8; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Ashton NN, 2019, ACTA BIOMATER; Barequet IS, 2004, ANTIMICROB AGENTS CH, V48, P1681, DOI 10.1128/AAC.48.5.1681-1687.2004; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44; CDC U, 2013, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention (CDC), 2011, PUBL HLTH ACT PLAN C; CHEN WYJ, 1992, J INVEST DERMATOL, V99, P559, DOI 10.1111/1523-1747.ep12667378; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Duarte B, 2017, INT WOUND J, V14, P918, DOI 10.1111/iwj.12728; FDA, 2019, NOV DRUG APPR 2019; FDA, 2010, NOV DRUG APPR 2010; FDA, 2015, NOV DRUG APPR 2015; FDA, 2011, NOV DRUG APPR 2011; FDA, 2013, NOV DRUG APPR 2013; FDA, 2016, NOVEL DRUG APPROVALS; FDA, 2017, NOV DRUG APPR 2017; FDA, 2009, NOV DRUG APPR 2009; FDA, 2014, NOV DRUG APPR 2014; FDA, 2012, NOV DRUG APPR 2012; FIELD CK, 1994, AM J SURG, V167, pS2, DOI 10.1016/0002-9610(94)90002-7; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; GlaxoSmithKline, 2015, BACTR 2 CREAM OINTM; Greer N, 2013, ANN INTERN MED, V159, P532, DOI 10.7326/0003-4819-159-8-201310150-00006; Hammond AA, 2011, BURNS, V37, P312, DOI 10.1016/j.burns.2010.09.017; Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P19890, DOI 10.1073/pnas.0606756104; Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Katsu T, 2002, ANTIMICROB AGENTS CH, V46, P1073, DOI 10.1128/AAC.46.4.1073-1079.2002; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Lesens O, 2011, CLIN MICROBIOL INFEC, V17, P285, DOI 10.1111/j.1469-0691.2010.03194.x; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Mangum LC, 2018, INJURY, V49, P1763, DOI 10.1016/j.injury.2018.08.004; MANSITO TB, 1987, MICROBIOS, V49, P55; MAPLE PAC, 1989, LANCET, V1, P537; Mombelli A, 2004, INT DENT J, V54, P3, DOI 10.1111/j.1875-595X.2004.tb00246.x; NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Peters NK, 2008, J INFECT DIS, V197, P1087, DOI 10.1086/533451; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Senneville E, 2006, CLIN INFECT DIS, V42, P57, DOI 10.1086/498112; USFaD A., 2018, NOVEL DRUG APPROVALS; Vandeplassche E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187540; Vasquez JE, 2000, INFECT CONT HOSP EP, V21, P459, DOI 10.1086/501788; Voggu L, 2006, J BACTERIOL, V188, P8079, DOI 10.1128/JB.00858-06; WHEAT J, 1985, AM J MED, V78, P218, DOI 10.1016/0002-9343(85)90388-2; Williams DL, 2020, BIOFILM, P2; Williams DL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206774; Williams DL, 2012, BIOMATERIALS, V33, P8641, DOI 10.1016/j.biomaterials.2012.08.003; Williams DL, 2012, J BIOMED MATER RES A, V100A, P1888, DOI 10.1002/jbm.a.34123; Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709; World Health Organization, 2016, GLOB ANT RES SURV SY	60	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0234832	10.1371/journal.pone.0234832	http://dx.doi.org/10.1371/journal.pone.0234832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075071	Green Submitted, gold, Green Published			2022-12-26	WOS:000585920200012
J	Egerman, MA; Wong, JS; Runxia, T; Mosoyan, G; Chauhan, K; Reyes-Bahamonde, J; Anandakrishnan, N; Wong, NJ; Bagiella, E; Salem, F; Meliambro, K; Li, H; Azeloglu, EU; Coca, SG; Campbell, KN; Raij, L				Egerman, Marc A.; Wong, Jenny S.; Runxia, Tian; Mosoyan, Gohar; Chauhan, Kinsuk; Reyes-Bahamonde, Joselyn; Anandakrishnan, Nanditha; Wong, Nicholas J.; Bagiella, Emilia; Salem, Fadi; Meliambro, Kristin; Li, Hong; Azeloglu, Evren U.; Coca, Steven G.; Campbell, Kirk N.; Raij, Leopoldo			Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease	FASEB JOURNAL			English	Article						amiloride; edema; eGFR; glomerular; plasminogen; podocytes	URINARY SERINE PROTEASES; FILTRATION-RATE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RENAL OUTCOMES; PROTEINURIA; PLASMIN; ACTIVATION; NEPHRIN; ENAC	Urinary plasminogen/plasmin, or plasmin (ogen) uria, has been demonstrated in proteinuric patients and exposure of cultured podocytes to plasminogen results in injury via oxidative stress pathways. A causative role for plasmin (ogen) as a "second hit" in kidney disease progression has yet to have been demonstrated in vivo. Additionally, association between plasmin (ogen) uria and kidney function in glomerular diseases remains unclear. We performed comparative studies in a puromycin aminonucleoside (PAN) nephropathy rat model treated with amiloride, an inhibitor of plasminogen activation, and measured changes in plasmin (ogen) uria. In a glomerular disease biorepository cohort (n = 128), we measured time-of-biopsy albuminuria, proteinuria, and plasmin (ogen) uria for correlations with kidney outcomes. In cultured human podocytes, plasminogen treatment was associated with decreased focal adhesion marker expression with rescue by amiloride. Increased glomerular plasmin (ogen) was found in PAN rats and focal segmental glomerulosclerosis (FSGS) patients. PAN nephropathy was associated with increases in plasmin (ogen) uria and proteinuria. Amiloride was protective against PAN-induced glomerular injury, reducing CD36 scavenger receptor expression and oxidative stress. In patients, we found associations between plasmin (ogen) uria and edema status as well as eGFR. Our study demonstrates a role for plasmin (ogen)-induced podocyte injury in the PAN nephropathy model, with amiloride having podocyte-protective properties. In one of the largest glomerular disease cohorts to study plasminogen, we validated previous findings while suggesting a potentially novel relationship between plasmin (ogen) uria and estimated glomerular filtration rate (eGFR). Together, these findings suggest a role for plasmin (ogen) in mediating glomerular injury and as a viable targetable biomarker for podocyte-sparing treatments.	[Egerman, Marc A.; Wong, Jenny S.; Mosoyan, Gohar; Chauhan, Kinsuk; Reyes-Bahamonde, Joselyn; Anandakrishnan, Nanditha; Wong, Nicholas J.; Meliambro, Kristin; Azeloglu, Evren U.; Coca, Steven G.; Campbell, Kirk N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, 1 Gustave Levy Pl,Box 1243, New York, NY 10029 USA; [Runxia, Tian; Raij, Leopoldo] Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, 1120 NW 14th St,Suite 809, Miami, FL 33136 USA; [Bagiella, Emilia] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Ctr Biostat, New York, NY 10029 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Li, Hong] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Azeloglu, Evren U.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Miami; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai	Campbell, KN (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, 1 Gustave Levy Pl,Box 1243, New York, NY 10029 USA.; Raij, L (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Katz Family Div Nephrol & Hypertens, 1120 NW 14th St,Suite 809, Miami, FL 33136 USA.	kirk.campbell@mssm.edu; lraij@med.miami.edu	Anandakrishnan, Nanditha/AAI-7298-2021; Chauhan, Kinsuk/P-9985-2019	Anandakrishnan, Nanditha/0000-0003-2452-2527; Chauhan, Kinsuk/0000-0002-1198-3562; Li, Hong/0000-0001-5731-5335; Salem, Fadi/0000-0002-2603-2778	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK103022, DK122807, R01DK112258, U01DK10692, R01DK115562, R01DK103022]; HHS | CDC | National Institute for Occupational Safety and Health (NIOSH) [U01OH011326]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL85757]; Department of the Army [PR191906P1]; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH [NS046593, 1S10OD025047-01]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | CDC | National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Department of the Army; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK103022, DK122807, R01DK112258, U01DK10692, R01DK115562 and R01DK103022; HHS | CDC | National Institute for Occupational Safety and Health (NIOSH), Grant/Award Number: U01OH011326; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL85757; Department of the Army, Grant/Award Number: PR191906P1; South Florida Veterans Affairs Foundation For Research and Education (SFVAFRE); NIH, Grant/Award Number: NS046593 and 1S10OD025047-01	Andersen H, 2015, NEPHROL DIAL TRANSPL, V30, P781, DOI 10.1093/ndt/gfu402; Artunc F, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13249; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Bello AK, 2011, CLIN J AM SOC NEPHRO, V6, P1418, DOI 10.2215/CJN.09741110; Buhl KB, 2014, J HYPERTENS, V32, P1672, DOI 10.1097/HJH.0000000000000216; Buhl KB, 2012, HYPERTENSION, V60, P1346, DOI 10.1161/HYPERTENSIONAHA.112.198879; Calizo RC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09936-x; Chen JL, 2019, AM J NEPHROL, V50, P92, DOI 10.1159/000501059; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Culleton BF, 2000, AM J MED, V109, P1, DOI 10.1016/S0002-9343(00)00444-7; Currie G, 2014, INT J NEPHROL RENOV, V7, P13, DOI 10.2147/IJNRD.S40522; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Fukuda A, 2010, NEPHROLOGY, V15, P321, DOI 10.1111/j.1440-1797.2009.01256.x; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Ge XH, 2020, J AM SOC NEPHROL, V31, P2372, DOI 10.1681/ASN.2019121261; Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; He Chaosheng, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1654; Hinrichs GR, 2018, AM J PHYSIOL-RENAL, V315, pF151, DOI 10.1152/ajprenal.00545.2017; Inoue T, 2006, HYPERTENS RES, V29, P687, DOI 10.1291/hypres.29.687; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kakizoe Y, 2009, J HYPERTENS, V27, P1679, DOI 10.1097/HJH.0b013e32832c7d23; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kopp JB, 2012, J AM SOC NEPHROL, V23, P1273, DOI 10.1681/ASN.2012060618; Liu H, 2001, AM J PHYSIOL-RENAL, V280, pF88, DOI 10.1152/ajprenal.2001.280.1.F88; Mann JFE, 2004, KIDNEY INT, V66, pS59, DOI 10.1111/j.1523-1755.2004.09215.x; Marshall CB, 2006, KIDNEY INT, V70, P1962, DOI 10.1038/sj.ki.5001965; Matsusaka T, 2011, AM J PHYSIOL-RENAL, V300, pF792, DOI 10.1152/ajprenal.00570.2010; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehrotra R, 2017, J AM SOC NEPHROL, V28, P395, DOI 10.1681/ASN.2016070769; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Min KJ, 2003, BIOCHEM BIOPH RES CO, V312, P969, DOI 10.1016/j.bbrc.2003.11.010; Morigi M, 2005, AM J PATHOL, V166, P1309, DOI 10.1016/S0002-9440(10)62350-4; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Muroya Y, 2016, CLIN EXP NEPHROL, V20, P862, DOI 10.1007/s10157-016-1253-0; Oxlund CS, 2014, J AM SOC HYPERTENS, V8, P872, DOI 10.1016/j.jash.2014.09.019; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Philippe A, 2008, J AM SOC NEPHROL, V19, P1871, DOI 10.1681/ASN.2008010059; Qin L, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1959-y; Raij L, 2016, AM J PHYSIOL-RENAL, V311, pF1308, DOI 10.1152/ajprenal.00162.2016; Ray EC, 2018, KIDNEY INT REP, V3, P1434, DOI 10.1016/j.ekir.2018.06.007; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Rincon J, 2004, INT J EXP PATHOL, V85, P25, DOI 10.1111/j.0959-9673.2004.0368.x; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schork A, 2016, CLIN J AM SOC NEPHRO, V11, P761, DOI 10.2215/CJN.12261115; Staehr M, 2015, AM J PHYSIOL-RENAL, V309, pF235, DOI 10.1152/ajprenal.00138.2015; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Svenningsen P, 2017, PFLUG ARCH EUR J PHY, V469, P1415, DOI 10.1007/s00424-017-2014-y; Svenningsen P, 2015, PFLUG ARCH EUR J PHY, V467, P531, DOI 10.1007/s00424-014-1661-5; Svenningsen P, 2012, CLIN EXP PHARMACOL P, V39, P117, DOI 10.1111/j.1440-1681.2011.05524.x; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Wickman L, 2013, J AM SOC NEPHROL, V24, P2081, DOI 10.1681/ASN.2013020173; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x; Zhang B, 2012, NEPHROL DIAL TRANSPL, V27, P1746, DOI 10.1093/ndt/gfr612	67	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16191	16204		10.1096/fj.202000413R	http://dx.doi.org/10.1096/fj.202000413R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070369	Green Submitted, Green Accepted			2022-12-26	WOS:000581164200001
J	Alrefaei, AF				Alrefaei, Abdulwahed Fahad			Molecular detection and genetic characterization of Trichomonas gallinae in falcons in Saudi Arabia	PLOS ONE			English	Article							FINCH EPIDEMIC STRAIN; BIRDS; PREVALENCE; INFECTION; GENOTYPE; PIGEON	Avian trichomonosis is primarily caused by Trichomonas gallinae, a flagellated protozoan parasite that especially infects the upper digestive tract of columbid bird species and their avian predators. However, this parasite has recently been found to be distributed worldwide in various other avian species. This parasitic disease is common in captive falcons in Saudi Arabia and the Middle East. This study aimed to examine and identify the genetic variation of T. gallinae obtained from three species of falcons in Saudi Arabia via the sequencing analysis of the internal transcribed spacer (ITS) region. Swab samples from 97 saker falcons (Falco cherrug), 24 peregrine falcons (Falco peregrinus) and 37 gyrfalcons (Falco rusticolus) were cultured and analysed for infection between 2018 and 2019. The overall prevalence of infection by T. gallinae was 26.58% (n = 42), of which 35 (83.33%) were collected from Riyadh region and seven (16.67%) were collected from Qassim region. The results indicate the presence of four genotypes of T. gallinae in Saudi falcons: A, C, II, and KSA11. This study reports for the first time genetic diversity of T. gallinae in these falcons in Saudi Arabia.	[Alrefaei, Abdulwahed Fahad] King Saud Univ, Dept Zool, Coll Sci, Riyadh, Saudi Arabia	King Saud University	Alrefaei, AF (corresponding author), King Saud Univ, Dept Zool, Coll Sci, Riyadh, Saudi Arabia.	afrefaei@ksu.edu.sa	Alrefaei, Abdulwahed Fahad/AAX-7443-2021	Alrefaei, Abdulwahed Fahad/0000-0002-3761-6656	King Saud University, Riyadh, Saudi Arabia [RSP-2020/218]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project was supported by Researchers Supporting Project (RSP-2020/218), King Saud University, Riyadh, Saudi Arabia.	Albeshr MF, 2020, SAUDI ARABIA AVIAN D, DOI [10.1637/0005-2086-64.2.130, DOI 10.1637/0005-2086-64.2.130]; Alrefaei AF, 2019, GENOME BIOL EVOL, V11, P2391, DOI 10.1093/gbe/evz164; Amin A, 2014, PARASITOLOGY, V141, P733, DOI 10.1017/S0031182013002096; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; Arabkhazaeli F, 2020, AVIAN PATHOL, V49, P47, DOI 10.1080/03079457.2019.1662369; Arfin S, 2019, J ADV VET ANIM RES, V6, P549, DOI 10.5455/javar.2019.f381; Bailey TC, 1997, EMIRATES ABU DHABI D; Bunbury N, 2008, BIOL CONSERV, V141, P153, DOI 10.1016/j.biocon.2007.09.008; Bunbury N, 2007, J WILDLIFE DIS, V43, P399, DOI 10.7589/0090-3558-43.3.399; Chi JF, 2013, PARASITOLOGY, V140, P1234, DOI 10.1017/S0031182013000930; da Silva DG, 2007, INFECT GENET EVOL, V7, P433, DOI [10.1016/j.meegid.2006.01.002, 10.1016/j.meegid.2007.01.002]; Duboucher C, 2006, J CLIN MICROBIOL, V44, P1165, DOI 10.1128/JCM.44.3.1165-1168.2006; Ermgassen EKHJZ, 2016, PARASITOLOGY, V143, P1294, DOI 10.1017/S0031182016000780; Farooq HA, 2018, PARASITOLOGY, V145, P1548, DOI [10.1017/S0031182018000513, 10.1017/s0031182018000513]; Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212; Gerhold RW, 2013, AVIAN DIS, V57, P681, DOI 10.1637/10518-022213-ResNote.1; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Girard YA, 2014, INFECT GENET EVOL, V24, P146, DOI 10.1016/j.meegid.2014.03.002; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; Grunenwald C, 2018, AVIAN DIS, V62, P117, DOI 10.1637/11742-080817-Reg.1; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lawson B, 2011, INFECT GENET EVOL, V11, P1638, DOI 10.1016/j.meegid.2011.06.007; Martinez-Herrero MC, 2014, AVIAN PATHOL, V43, P535, DOI 10.1080/03079457.2014.967660; Mcburney S, 2015, PARASITOLOGY, V142, P1053, DOI 10.1017/S0031182015000281; McKeon T, 1997, AUST VET J, V75, P652, DOI 10.1111/j.1751-0813.1997.tb15363.x; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Samour J, 1996, P ANN C ASS AV VET; Samour JH, 2000, J AVIAN MED SURG, V14, P113, DOI 10.1647/1082-6742(2000)014[0113:PASAAS]2.0.CO;2; Sansano-Maestre J, 2009, AVIAN PATHOL, V38, P201, DOI 10.1080/03079450902912135; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; Stockdale JE, 2015, PARASITOLOGY, V142, P490, DOI 10.1017/S0031182014001474; Zadravec M, 2017, VET PARASITOL, V239, P90, DOI 10.1016/j.vetpar.2017.04.001	33	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241411	10.1371/journal.pone.0241411	http://dx.doi.org/10.1371/journal.pone.0241411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119695	Green Published, gold			2022-12-26	WOS:000600013600028
J	Franz, M; Schmidt, B; Hecht, H; Naumann, E; Miltner, WHR				Franz, Marcel; Schmidt, Barbara; Hecht, Holger; Naumann, Ewald; Miltner, Wolfgang H. R.			Suggested deafness during hypnosis and simulation of hypnosis compared to a distraction and control condition: A study on subjective experience and cortical brain responses	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HARVARD GROUP SCALE; INTRACEREBRAL POTENTIALS; HYPNOTIC DEAFNESS; VISUAL-STIMULI; RARE TARGET; NEURAL GENERATORS; P300; PAIN; ATTENTION	Hypnosis is a powerful tool to affect the processing and perception of stimuli. Here, we investigated the effects of hypnosis on the processing of auditory stimuli, the time course of event-related-potentials (ERP; N1 and P3b amplitudes) and the activity of cortical sources of the P3b component. Forty-eight participants completed an auditory oddball paradigm composed of standard, distractor, and target stimuli during a hypnosis (HYP), a simulation of hypnosis (SIM), a distraction (DIS), and a control (CON) condition. During HYP, participants were suggested that an earplug would obstruct the perception of tones and during SIM they should pretend being hypnotized and obstructed to hear the tones. During DIS, participants' attention was withdrawn from the tones by focusing participants' attention onto a film. In each condition, subjects were asked to press a key whenever a target stimulus was presented. Behavioral data show that target hit rates and response time became significantly reduced during HYP and SIM and loudness ratings of tones were only reduced during HYP. Distraction from stimuli by the film was less effective in reducing target hit rate and tone loudness. Although, the N1 amplitude was not affected by the experimental conditions, the P3b amplitude was significantly reduced in HYP and SIM compared to CON and DIS. In addition, source localization results indicate that only a small number of neural sources organize the differences of tone processing between the control condition and the distraction, hypnosis, and simulation of hypnosis conditions. These sources belong to brain areas that control the focus of attention, the discrimination of auditory stimuli, and the organization of behavioral responses to targets. Our data confirm that deafness suggestions significantly change auditory processing and perception but complete deafness is hard to achieve during HYP. Therefore, the term 'deafness' may be misleading and should better be replaced by 'hypoacusis'.	[Franz, Marcel; Schmidt, Barbara; Hecht, Holger; Miltner, Wolfgang H. R.] Friedrich Schiller Univ Jena, Inst Psychol, Jena, Germany; [Naumann, Ewald] Univ Trier, Inst Psychol, Trier, Germany; [Miltner, Wolfgang H. R.] Friedrich Schiller Univ Jena, Med Fac, Jena, Germany	Friedrich Schiller University of Jena; Universitat Trier; Friedrich Schiller University of Jena	Franz, M (corresponding author), Friedrich Schiller Univ Jena, Inst Psychol, Jena, Germany.	wolfgang.miltner@uni-jena.de	Schmidt, Barbara/AAH-4517-2020	Schmidt, Barbara/0000-0002-6828-5546	Deutsche Forschungsgemeinschaft (DFG) [MI 265/15-1, NA 482/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Grant number: MI 265/15-1 awarded to Miltner, Wolfgang H.R. NA 482/5-1 awarded to Naumann, Ewald. Name of funder: Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi MC, 2009, J BEHAV MED, V32, P328, DOI 10.1007/s10865-009-9207-6; Barabasz A, 1999, INT J CLIN EXP HYP, V47, P5, DOI 10.1080/00207149908410019; BARBER T X, 1972, American Journal of Clinical Hypnosis, V15, P112; BARBER TX, 1963, J ABNORM PSYCHOL, V67, P557, DOI 10.1037/h0047040; BARBER TX, 1965, PSYCHOL REP, V16, P809, DOI 10.2466/pr0.1965.16.3.809; BARBER TX, 1964, BRIT J PSYCHOL, V55, P439, DOI 10.1111/j.2044-8295.1964.tb00930.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; BECK EC, 1965, J NERV MENT DIS, V140, P154, DOI 10.1097/00005053-196502000-00005; Bigdely-Shamlo N, 2013, IEEE ENG MED BIO, P5845, DOI 10.1109/EMBC.2013.6610881; Blundon EG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173237; BONGARTZ W, 1985, INT J CLIN EXP HYP, V33, P131, DOI 10.1080/00207148508406643; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen XF, 2018, J PAIN RES, V11, P1921, DOI 10.2147/JPR.S174490; Clarke JM, 1999, CLIN NEUROPHYSIOL, V110, P1226, DOI 10.1016/S1388-2457(99)00064-4; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cox RE, 2008, ADV HYPNOSIS RES MET, P311; CRAWFORD HJ, 1979, AM J PSYCHOL, V92, P193, DOI 10.2307/1421920; De Angelis V, 2018, NEUROIMAGE, V180, P291, DOI 10.1016/j.neuroimage.2017.11.020; De Pascalis V, 2000, INT J CLIN EXP HYP, V48, P44, DOI 10.1080/00207140008410360; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Dynes JB, 1932, J ABNORM SOC PSYCH, V27, P79, DOI 10.1037/h0073199; Erickson MH, 1939, J GEN PSYCHOL, V20, P61, DOI 10.1080/00221309.1939.9709999; Erickson MH, 1938, J GEN PSYCHOL, V19, P151, DOI 10.1080/00221309.1938.9711192; FIELD PETER B., 1965, INT J CLIN EXP HYPN, V13, P238, DOI 10.1080/00207146508412946; Fischli P, 1987, LAUF DINGE; Franz M, SUGGESTED BLINDNESS; Friederich M, 2001, PSYCHOPHYSIOLOGY, V38, P768, DOI 10.1017/S0048577201000221; Glaesmer H, 2015, PATIENT EDUC COUNS, V98, P1112, DOI 10.1016/j.pec.2015.05.007; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hof W. J. op ' t, 1993, ZWOLS HIST TIJDSCHRI, V10, P22; Jegindo EME, 2013, INT J PSYCHOL RELIG, V23, P171, DOI 10.1080/10508619.2012.759065; Jensen MP, 2017, NEUROSCI CONSCIOUS, V3, DOI 10.1093/nc/nix004; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Katayama J, 1996, INT J PSYCHOPHYSIOL, V23, P33, DOI 10.1016/0167-8760(96)00030-X; Katayama J, 1996, EVOKED POTENTIAL, V100, P555, DOI 10.1016/S0168-5597(96)95171-0; Kiehl KA, 2001, J PSYCHOPHYSIOL, V15, P221, DOI 10.1027//0269-8803.15.4.221; Kiehl KA, 2001, PSYCHOPHYSIOLOGY, V38, P133, DOI 10.1111/1469-8986.3810133; Kihlstrom J.F., 2012, OXFORD HDB HYPNOSIS, P21, DOI [DOI 10.1093/OXFORDHB/9780198570097.013.0002, 10.1093/oxfordhb/9780198570097.013.0002]; Kihlstrom JF, 2003, INT J CLIN EXP HYP, V51, P166, DOI 10.1076/iceh.51.2.166.14611; Kihlstrom JF, 2013, CORTEX, V49, P365, DOI 10.1016/j.cortex.2012.05.016; Kirsch I, 1997, APPL PREV PSYCHOL, V6, P69, DOI 10.1016/S0962-1849(05)80012-5; Kiss G, 2011, ANAESTH INTENS CARE, V39, P1139, DOI 10.1177/0310057X1103900626; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kolassa IT, 2007, COGNITION EMOTION, V21, P1721, DOI 10.1080/02699930701229189; Kolassa IT, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-38; Kolassa IT, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-59; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kosslyn SM, 2000, AM J PSYCHIAT, V157, P1279, DOI 10.1176/appi.ajp.157.8.1279; Kujala T, 2010, PROG NEUROBIOL, V91, P55, DOI 10.1016/j.pneurobio.2010.01.006; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Larbig W, 2013, ALLGEMEINARZT, V35, P60; Larbig W, 2015, PSYCHOPHYSIOLOGY EXZ, P279; Lima CF, 2016, TRENDS NEUROSCI, V39, P527, DOI 10.1016/j.tins.2016.06.003; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Lynn S., 2012, OXFORD HDB HYPNOSIS, P111, DOI DOI 10.1093/OXFORDHB/9780198570097.013.0005; Lynn SJ, 2012, SOCIAL COGNITIVE THE, P111; MEIER W, 1993, PAIN, V53, P175, DOI 10.1016/0304-3959(93)90078-4; MILTNER W, 1989, PAIN, V38, P303, DOI 10.1016/0304-3959(89)90217-0; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Miltner WHR, 2006, PROGR PSYCHOL SCI WO; Moerel M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00225; Montenegro G, 2017, AM J CLIN HYPN, V59, P414, DOI 10.1080/00029157.2016.1172057; ORNE M, 1971, INT J CLIN EXP HYP, V19, P183, DOI 10.1080/00207147108407167; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Plakke B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00199; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; R Core Team, 2021, R LANGUAGE ENV STAT; Riegel B, 2018, VERHALTENSTHERAPIE, V28, P44, DOI 10.1159/000464339; Sarbin T.R., 1972, HYPNOSIS SOCIAL PSYC; SCHEIBE KE, 1968, INT J CLIN EXP HYP, V16, P158, DOI 10.1080/00207146808410587; Schmidt B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05195-2; Schuler G, 1996, HYPN KOGN, V13, P79; Shadish WR, 2003, EXPT QUASIEXPERIMENT, DOI [10.1111/j.1752-0606.2003.tb01694.x, DOI 10.1111/J.1752-0606.2003.TB01694.X]; SPANOS NP, 1992, J ABNORM PSYCHOL, V101, P192, DOI 10.1037/0021-843X.101.1.192; SPANOS NP, 1974, AM PSYCHOL, V29, P500, DOI 10.1037/h0036795; SPANOS NP, 1982, J ABNORM PSYCHOL, V91, P75, DOI 10.1037/0021-843X.91.1.75; Tervaniemi M, 1997, NEUROREPORT, V8, P2571, DOI 10.1097/00001756-199707280-00030; Trippe RH, 2004, ANASTH INTENSIVMED, V45, P642; Verleger R, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13542; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Willford AC, 2018, PAC AFF, V91, P644; Wronka E, 2012, ACTA NEUROBIOL EXP, V72, P51	92	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240832	10.1371/journal.pone.0240832	http://dx.doi.org/10.1371/journal.pone.0240832			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119665	Green Published, gold			2022-12-26	WOS:000600013600006
J	Thomas, E; Gerster, S; Mugabo, L; Jean, H; Oates, T				Thomas, Evan; Gerster, Sally; Mugabo, Lambert; Jean, Huguens; Oates, Tim			Computer vision supported pedestrian tracking: A demonstration on trail bridges in rural Rwanda	PLOS ONE			English	Article								Trail bridges can improve access to critical services such as health care, schools, and markets. In order to evaluate the impact of trail bridges in rural Rwanda, it is helpful to objectively know how and when they are being used. In this study, we deployed motion-activated digital cameras across several trail bridges installed by the non-profit Bridges to Prosperity. We conducted and validated manual counting of bridge use to establish a ground truth. We adapted an open source computer vision algorithm to identify and count bridge use reflected in the digital images. We found a reliable correlation with less than 3% error bias of bridge crossings per hour between manual counting and those sites at which the cameras logged short video clips. We applied this algorithm across 186 total days of observation at four sites in fall 2019, and observed a total of 33,800 daily bridge crossings ranging from about 20 to over 1,100 individual uses per day, with no apparent correlation between daily or total weekly rainfall and bridge use, potentially indicating that transportation behaviors, after a bridge is installed, are no longer impacted by rainfall conditions. Higher bridge use was observed in the late afternoons, on market and church days, and roughly equal use of the bridge crossings in each direction. These trends are consistent with the design-intent of these bridges.	[Thomas, Evan; Gerster, Sally] Univ Colorado, Mortenson Ctr Global Engn, Boulder, CO 80309 USA; [Mugabo, Lambert] Amazi Yego Ltd, Kigali, Rwanda; [Jean, Huguens; Oates, Tim] Synaptiq Inc, Portland, OR USA; [Oates, Tim] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA	University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland Baltimore County	Thomas, E (corresponding author), Univ Colorado, Mortenson Ctr Global Engn, Boulder, CO 80309 USA.	evan.thomas@colorado.edu		Thomas, Evan/0000-0003-3095-8407; Mugabo, Lambert/0000-0001-9214-5394	Autodesk Foundation	Autodesk Foundation	Funding for this work was provided by the Autodesk Foundation. The funder provided support in the form of contracted services through the University of Colorado Boulder for authors ET and SG. Synaptiq provided support for the study in the form of a salaries for HJ and TO. Amazi Yego Ltd. provided support for the study in the form of a salary for LM. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brooks W, 2019, ECONOMETRICA; Cherrett T, 2000, TRANSPORT RES REC, P112, DOI 10.3141/1719-14; Crouzil A, 2016, J ELECTRON IMAGING, V25, DOI 10.1117/1.JEI.25.5.051207; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Girshick R., 2015, P IEEE INT C COMP VI, P1440, DOI DOI 10.1109/ICCV.2015.169; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; Gollin D, 2014, Q J ECON, V129, P939, DOI 10.1093/qje/qjt056; Greene-Roesel R, 2008, TRB 2008 ANN M; Kaiming He, 2020, IEEE Transactions on Pattern Analysis and Machine Intelligence, V42, P386, DOI 10.1109/TPAMI.2018.2844175; King DE, 2009, J MACH LEARN RES, V10, P1755; Li JA, 2010, TRANSPORT RES REC, P83, DOI 10.3141/2198-10; Liu L, 2020, INT J COMPUT VISION, V128, P261, DOI 10.1007/s11263-019-01247-4; Ma Z, 2016, IEEE T CIRC SYST VID, V26, P1955, DOI 10.1109/TCSVT.2015.2489418; O'Reilly K, 2015, J WATER SANIT HYG DE, V5, P426, DOI 10.2166/washdev.2015.155; Redmon J., 2013, DARKNET OPEN SOURCE; REDMON J, 2017, PROC CVPR IEEE, DOI [DOI 10.1109/CVPR.2017.690, 10.1109/CVPR.2017.690]; Redmon J., 2016, PROC CVPR IEEE, DOI [10.1109/CVPR.2016.91, DOI 10.1109/CVPR.2016.91]; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Schasberger MG, 2012, AM J PREV MED, DOI [10.1016/j.amepre.2012.06.029, DOI 10.1016/J.AMEPRE.2012.06.02923079274]; Schneider RJ, 2009, TRANSP RES RECORD, P1, DOI 10.3141/2140-01; Sinha A, 2016, AM J TROP MED HYG, V95, P720, DOI 10.4269/ajtmh.16-0102; The World Bank, TRANSPORT; Turman-Bryant N, 2018, CRITICAL REV MONITOR; Wojke N, 2018, P INT C IM PROC ICIP	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241379	10.1371/journal.pone.0241379	http://dx.doi.org/10.1371/journal.pone.0241379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104747	Green Published, gold			2022-12-26	WOS:000588370000032
J	Barbanera, Y; Arcioni, F; Lancioni, H; La Starza, R; Cardinali, I; Matteucci, C; Nofrini, V; Roetto, A; Piga, A; Grammatico, P; Caniglia, M; Mecucci, C; Gorello, P				Barbanera, Ylenia; Arcioni, Francesco; Lancioni, Hovirag; La Starza, Roberta; Cardinali, Irene; Matteucci, Caterina; Nofrini, Valeria; Roetto, Antonella; Piga, Antonio; Grammatico, Paola; Caniglia, Maurizio; Mecucci, Cristina; Gorello, Paolo			Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; SICKLE-CELL-ANEMIA; FETAL-HEMOGLOBIN; THALASSEMIA; ASSOCIATION; POLYMORPHISM; HAPLOTYPES; MUTATIONS; BCL11A; GENE	Author summary Worldwide most frequent genetic diseases are represented by a very heterogeneous group of congenital hemolytic anaemias which include beta-thalassemia and sickle cell anaemia. They are deeply geographically structured and characterized by high complexity of the genetic background associated with variable clinical severities. Due to this heterogeneity we investigated the nuclear and mitochondrial DNA marker variations in patients with hemoglobinopathies in order to provide the first comprehensive genetic stratification of these hereditary disease. This study contributes to detail the multifaceted picture of hemoglobin disorders. The hemoglobin disorders are the most common single gene disorders in the world. Previous studies have suggested that they are deeply geographically structured and a variety of genetic determinants influences different clinical phenotypes between patients inheriting identical beta-globin gene mutations. In order to get new insights into the heterogeneity of hemoglobin disorders, we investigated the molecular variations on nuclear genes (i.e.HBB,HBG2,BCL11A,HBS1LandMYB)and mitochondrial DNA control region. This pilot study was carried out on 53 patients belonging to different continents and molecularly classified in 4 subgroup: beta-thalassemia (beta(+)/beta(+),beta(0)/beta(0)and beta(+)/beta(0))(15), sickle cell disease(HbS/HbS)(20), sickle cell/beta-thalassemia (HbS/beta(+)or HBS/beta(0))(10), and non-thalassemic compound heterozygous (HbS/HbC,HbO-Arab/HbC)(8). This comprehensive phylogenetic analysis provided a clear separation between African and European patients either in nuclear or mitochondrial variations. Notably, informing on the phylogeographic structure of affected individuals, this accurate genetic stratification, could help to optimize the diagnostic algorithm for patients with uncertain or unknown origin.	[Barbanera, Ylenia; La Starza, Roberta; Matteucci, Caterina; Nofrini, Valeria; Mecucci, Cristina; Gorello, Paolo] Univ Perugia, Dept Med, Hematol, Perugia, Italy; [Arcioni, Francesco; Caniglia, Maurizio] Hosp Santa Maria Misericordia, Pediat Oncohematol, Perugia, Italy; [Lancioni, Hovirag; Cardinali, Irene] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy; [Roetto, Antonella; Piga, Antonio] Univ Turin, Hosp San Luigi Gonzaga, Dept Clin & Biol Sci, Turin, Italy; [Grammatico, Paola] Sapienza Univ, San Camillo Forlanini Hosp, Dept Mol Med, Lab Med Genet, Rome, Italy	University of Perugia; Hospital Santa Maria della Misericordia; University of Perugia; University of Turin; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome	Gorello, P (corresponding author), Univ Perugia, Dept Med, Hematol, Perugia, Italy.	paolo.gorello@unipg.it	La Starza, Roberta/ABD-0836-2022; Roetto, Antonella/K-4731-2016	Matteucci, Caterina/0000-0002-9553-4819; Cardinali, Irene/0000-0003-0632-9993				Adam MP, 2011, GENEREVIEWS; Al-Allawi N, 2019, INT J LAB HEMATOL, V41, P87, DOI 10.1111/ijlh.12927; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P217; [Anonymous], 2014, NUCL ACIDS RES, V42, pD7; [Anonymous], 2012, REGEN MED S3, V7, pS14; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bernaudin F, 2018, BLOOD ADV, V2, P626, DOI 10.1182/bloodadvances.2017014555; Bianchi N, 2016, MOL DIAGN THER, V20, P161, DOI 10.1007/s40291-016-0187-2; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Chaouch L, 2016, HEMATOLOGY, V21, P425, DOI 10.1080/10245332.2015.1107275; CHEN YS, 1995, AM J HUM GENET, V57, P133; Dadheech S, 2014, MOL BIOL REP, V41, P3331, DOI 10.1007/s11033-014-3195-5; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; GILMAN JG, 1985, BLOOD, V66, P783; Gorello P, 2016, HEMOGLOBIN, V40, P371, DOI 10.1080/03630269.2017.1289101; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Jamali L, 2016, MITOCHONDRIAL DNA A, V27, P1693, DOI 10.3109/19401736.2014.958730; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Lai YL, 2017, BLOOD CELL MOL DIS, V63, P52, DOI 10.1016/j.bcmd.2017.01.011; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Li CK, 2017, BEST PRACT RES CL OB, V39, P16, DOI 10.1016/j.bpobgyn.2016.10.013; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mejri A, 2016, HEMOGLOBIN, V40, P411, DOI 10.1080/03630269.2016.1252386; Menzel S, 2019, MOL DIAGN THER, V23, P235, DOI 10.1007/s40291-018-0370-8; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagel RL, 2004, CELL MOL BIOL, V50, P5; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Pakdee N, 2014, BLOOD CELL MOL DIS, V53, P11, DOI 10.1016/j.bcmd.2014.02.005; Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435; Pereira C, 2015, BLOOD CELL MOL DIS, V54, P315, DOI 10.1016/j.bcmd.2015.02.001; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sankaran VG, 2015, NAT MED, V21, P221, DOI 10.1038/nm.3814; Sebastiani P, 2015, BLOOD CELL MOL DIS, V54, P224, DOI 10.1016/j.bcmd.2015.01.001; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Sherva R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-51; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stadhouders R, 2014, J CLIN INVEST, V124, P1699, DOI 10.1172/JCI71520; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thein SL, 2013, HEMATOL-AM SOC HEMAT, P354, DOI 10.1182/asheducation-2013.1.354; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2015, CELL, V163, P33, DOI 10.1016/j.cell.2015.08.067; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Weatherall DJ, 2010, ANN NY ACAD SCI, V1202, P17, DOI 10.1111/j.1749-6632.2010.05546.x	51	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240632	10.1371/journal.pone.0240632	http://dx.doi.org/10.1371/journal.pone.0240632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091040	Green Published, gold			2022-12-26	WOS:000586647200010
J	Schulz, K; Stevens, PW; Hill, JE; Trotter, AA; Ritch, JL; Tuckett, QM; Patterson, JT				Schulz, Kailee; Stevens, Philip W.; Hill, Jeffrey E.; Trotter, Alexis A.; Ritch, Jared L.; Tuckett, Quenton M.; Patterson, Joshua T.			Coastal restoration evaluated using dominant habitat characteristics and associated fish communities	PLOS ONE			English	Article							COMMON SNOOK; ECOSYSTEM SERVICES; SPECIES-DIVERSITY; MANGROVE FORESTS; CLIMATE-CHANGE; LIFE-HISTORY; SALT-MARSHES; TAMPA BAY; COMPLEXITY; ESTUARINE	Increasing coastal populations and urban development have led to the loss of estuarine habitats for fish and wildlife. Specifically, a decline in complexity and heterogeneity of tidal marshes and creeks is thought to negatively impact fish communities by altering the function of nursery grounds, including predator refuge and prey resources. To offset these impacts, numerous agencies are restoring degraded habitats while also creating new ones where habitat has been lost. To improve understanding of what contributes to a successful restoration, six quarterly sampling events using two gear types to collect small- and large-bodied fishes were conducted to compare the fish community structure and habitat characteristics at three natural, three restored, and three impacted (i.e. ditched) areas along the coast of Tampa Bay, Florida. Overall, impacted sites had significantly lower small-bodied and juvenile fish diversity than natural and restored areas, while restored sites harbored a greater number of fish species than impacted sites for both large- and small-bodied fish. Habitat features such as shoreline slope differentiated impacted and restored from natural areas. Although we did not find a direct correlation, habitat heterogeneity likely played a role in structuring fish communities. These findings provide guidance for future coastal restoration or modification of existing projects. Specifically, the habitat mosaic approach of creating a geographically compact network of heterogenous habitat characteristics is likely to support fish diversity, while decreasing shoreline slope in a greater amount of area within coastal wetland restorations would more closely mimic natural areas.	[Schulz, Kailee; Hill, Jeffrey E.; Tuckett, Quenton M.; Patterson, Joshua T.] Univ Florida, Sch Forest Resources & Conservat, Program Fisheries & Aquat Sci, Gainesville, FL 32611 USA; [Stevens, Philip W.; Trotter, Alexis A.; Ritch, Jared L.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [Hill, Jeffrey E.; Tuckett, Quenton M.] Univ Florida, Trop Aquaculture Lab, Ruskin, FL USA; [Patterson, Joshua T.] Florida Aquarium, Ctr Conservat, Apollo Beach, FL USA; [Schulz, Kailee] US Fish & Wildlife Serv, Delta Juvenile Fish Monitoring Program, Enhanced Delta Smelt Monitoring Program, Dept Interior, Lodi, CA 95240 USA	State University System of Florida; University of Florida; Florida Fish & Wildlife Conservation Commission; State University System of Florida; University of Florida; United States Department of the Interior; US Fish & Wildlife Service	Schulz, K (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Program Fisheries & Aquat Sci, Gainesville, FL 32611 USA.; Schulz, K (corresponding author), US Fish & Wildlife Serv, Delta Juvenile Fish Monitoring Program, Enhanced Delta Smelt Monitoring Program, Dept Interior, Lodi, CA 95240 USA.	ka.schulz@ufl.edu			Tampa Bay Environmental Restoration Fund	Tampa Bay Environmental Restoration Fund	This project was funded by the Tampa Bay Environmental Restoration Fund (https://www.tbep.org/).Logistical support was provided by the Tropical Aquaculture Laboratory and the School of Forest Resources and Conservation at the University of Florida. Additional staff support for field sampling and laboratory work was provided by State of Florida Saltwater Fishing License sales, U.S. Department of the Interior, U.S. Fish and Wildlife Service, and Federal Aid for Sport Fish Restoration to the Florida Fish and Wildlife Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P346; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 1975, P 2 ANN C REST COAST; [Anonymous], 2011, FIELD GUIDE COASTAL; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Beach D., 2002, COASTAL SPRAWL EFFEC, P1; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Boucek RE, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00355; Brame AB, 2014, MAR ECOL PROG SER, V509, P255, DOI 10.3354/meps10902; Cicchetti G, 2011, ESTUAR COAST, V34, P1278, DOI 10.1007/s12237-011-9408-4; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; Clavero M, 2013, FRESHWATER BIOL, V58, P1190, DOI 10.1111/fwb.12120; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dance MA, 2015, ESTUAR COAST SHELF S, V167, P447, DOI 10.1016/j.ecss.2015.10.025; Dauvin JC, 2007, MAR POLLUT BULL, V55, P271, DOI 10.1016/j.marpolbul.2006.08.017; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Ding BQ, 2015, HYDROBIOLOGIA, V748, P133, DOI 10.1007/s10750-014-1932-3; Drexler M, 2014, ESTUAR COAST, V37, P962, DOI 10.1007/s12237-013-9727-8; Everitt JH, 2010, J COASTAL RES, V26, P649, DOI 10.2112/JCOASTRES-D-09-00133.1; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Gratwicke B, 2005, J Fish Biol, V66, P650; Green BC, 2012, MAR ECOL PROG SER, V466, P177, DOI 10.3354/meps09791; Greening H, 2014, ESTUAR COAST SHELF S, V151, pA1, DOI 10.1016/j.ecss.2014.10.003; Greening H. S., 2011, Ecological Restoration, V29, P82, DOI 10.3368/er.29.1-2.82; Harrison TD, 2004, J FISH BIOL, V65, P683, DOI 10.1111/j.0022-1112.2004.00477.x; Heck Kenneth L., 1980, ESTUARINE PERSPECTIV, DOI [10.1016/b978-0-12-404060-1.50043-5, DOI 10.1016/B978-0-12-404060-1.50043-5, 10.1016/B978-0-12-404060-1.50043-5]; Henningson BF, 2015, BAY AREA SCI INFORM, P17; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Krebs JM, 2014, ESTUAR COAST, V37, P832, DOI 10.1007/s12237-013-9724-y; Lewis III RR, 1988, ECOLOGY TAMPA BAY FL, V85, P1; Lewis III RR, 1998, MARINE POLLUTION B, V37, P486; Lewis IIIRR, 1977, P 2 ANN C COAST SOC, P31; LEWIS RR, 1992, STEMMING TIDE COASTA, P169; Madrid EN, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00503; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Munsch SH, 2016, MAR ECOL PROG SER, V557, P1, DOI 10.3354/meps11862; Munsch SH, 2014, N AM J FISH MANAGE, V34, P814, DOI 10.1080/02755947.2014.910579; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Neahr TA, 2010, FISHERIES MANAG ECOL, V17, P404, DOI 10.1111/j.1365-2400.2010.00733.x; Newman SP, 2015, J ANIM ECOL, V84, P1678, DOI 10.1111/1365-2656.12429; Osland MJ, 2019, ESTUAR COAST, V42, P1084, DOI 10.1007/s12237-019-00533-1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Pardo I, 2012, SCI TOTAL ENVIRON, V420, P33, DOI 10.1016/j.scitotenv.2012.01.026; Peters KM, 1998, B MAR SCI, V62, P509; Pierre JI, 2014, Ecosphere, V5, P1; Plunket J, 2005, B MAR SCI, V77, P155; Poulakis Gregg R., 2003, Gulf of Mexico Science, V21, P171; Poulakis Gregg R., 2002, Wetlands Ecology and Management, V10, P51, DOI 10.1023/A:1014305310291; Romanach SS, 2018, OCEAN COAST MANAGE, V154, P72, DOI 10.1016/j.ocecoaman.2018.01.009; Ryer CH, 2010, MAR ECOL PROG SER, V415, P275, DOI 10.3354/meps08732; Schaberg SJ, 2019, RESTOR ECOL, V27, P54, DOI 10.1111/rec.12712; Schulz K, 2020, RESTOR ECOL, V28, P1283, DOI 10.1111/rec.13215; Sheaves M, 2015, ESTUAR COAST, V38, P401, DOI 10.1007/s12237-014-9846-x; Sherwood ET, 2014, ENVIRON MANAGE, V53, P401, DOI 10.1007/s00267-013-0179-5; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snyder D, 2016, MARINE FISHES FLORID; Southwest Florida Water Management District, DISTR DED 1 PHAS TER; Stevens Philip W., 2006, Wetlands Ecology and Management, V14, P435, DOI 10.1007/s11273-006-0006-3; Stevens PW, 2007, B MAR SCI, V80, P93; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Torio DD, 2013, J COASTAL RES, V29, P1049, DOI 10.2112/JCOASTRES-D-12-00162.1; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P301, DOI 10.1001/archpsyc.62.3.301; Walters DM, 2003, FRESHWATER BIOL, V48, P1950, DOI 10.1046/j.1365-2427.2003.01137.x; Whitman R.L, 1993, COMP EVALUATION FISH; Winner BL, 2010, T AM FISH SOC, V139, P62, DOI 10.1577/T08-215.1; Wolanski E., 2016, ESTUARINE ECOHYDROLO, DOI DOI 10.1016/B978-0-444-63398-9.00007-6; Yates KK, 2011, US GEOLOGICAL SURVEY, V1348, P1; Zhang JC, 2012, J COASTAL RES, V28, P1279, DOI 10.2112/JCOASTRES-D-11-00211.1; [No title captured]	79	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240623	10.1371/journal.pone.0240623	http://dx.doi.org/10.1371/journal.pone.0240623			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091008	Green Published, gold			2022-12-26	WOS:000586647200063
J	Sendall, MC; Brodie, A				Sendall, Marguerite C.; Brodie, Alison			Postgraduate health promotion students' perceptions of at-risk populations: Those who smoke tobacco, are overweight or obese or drink alcohol at hazardous levels	PLOS ONE			English	Article							ATTITUDES; DOCTORS	Perceptions acquired during tertiary health promotion education can influence students' interactions with their future service-users. Reflective practice can highlight these perceptions. Here we describe the findings of a reflective exercise conducted with postgraduate health promotion students as part of a learning activity. Students (n = 44) reflected on their understandings of at-risk populations in three priority areas-tobacco, obesity and alcohol. The activity aimed to deconstruct students' understandings of these populations and identify understandings juxtaposed to the philosophical underpinnings of health promotion, for addressing through teaching and learning. Thematic analysis revealed students' understanding of all three at-risk populations fit within five themes: apathy/lack of altruism, complexity/choice, pressure/control, escaping /excuses, and environmental contexts. Students also have varying levels of tolerance to at-risk populations, expressing greatest tolerance towards those whose addiction undermines choice and self-control, and least towards those who are overweight/obese or whose behaviour causes risk to others. Our findings show reflective practice is a valuable tool to help educators understand students' attitudes and values and implement changes to support their future role in the community.	[Sendall, Marguerite C.; Brodie, Alison] Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia; [Sendall, Marguerite C.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Sendall, MC (corresponding author), Queensland Univ Technol, Fac Hlth, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.; Sendall, MC (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	m.sendall@qut.edu.au		Brodie, Alison/0000-0003-2786-8152				[Anonymous], 2011, GEORGE WASHINGTON J, V2, P2; Bakhshi S, 2014, INT J ENV RES PUB HE, V11, P218, DOI 10.3390/ijerph110100218; Cronin M, 2007, HEALTH EDUC J, V66, P286, DOI 10.1177/0017896907080136; Duaso MJ, 2014, ADDICTION, V109, P1811, DOI 10.1111/add.12680; Hall C, 2014, DEV COMPETENT GLOBAL; Henriquez PC, 2008, REV LAT-AM ENFERM, V16, P621, DOI 10.1590/S0104-11692008000700019; Hernandez RA, 2013, MED TEACH, V35, pE1082, DOI 10.3109/0142159X.2012.733453; Hojat M., 2016, EMPATHY HLTH PROFESS, DOI [DOI 10.1007/978-3-319-27625-0, 10.1007/978-3-319-27625-0]; Kempenaar LE, 2018, MED TEACH, V40, P969, DOI 10.1080/0142159X.2017.1403575; Lee B K, 2011, Educ Health (Abingdon), V24, P509; Liveng A, 2018, SCAND J PUBLIC HEALT, V46, P66, DOI 10.1177/1403494817743899; Mann K, 2009, ADV HEALTH SCI EDUC, V14, P595, DOI 10.1007/s10459-007-9090-2; McKay FH, 2015, REFLECT PRACT, V16, P242, DOI 10.1080/14623943.2015.1005588; National Health and Medical Research Council, 2014, ETHICAL CONSIDERATIO; O'Brien KS, 2010, OBESITY, V18, P2138, DOI 10.1038/oby.2010.79; Okonkwo O, 2010, HEALTH EDUC J, V69, P192, DOI 10.1177/0017896910363147; Paton M, 2012, P AUSTR C SCI MATH E; Rote AE, 2017, PEDAGOGY HLTH PROMOT, V4, P200; Van Winkle LJ, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00339; Werkhoven T, 2018, EUR PHYS EDUC REV, V24, P181, DOI 10.1177/1356336X16675774; While AE, 2015, LONDON J PRIM CARE, V7, P112, DOI 10.1080/17571472.2015.1113716; Zhu DQ, 2011, OBES REV, V12, P459, DOI 10.1111/j.1467-789X.2010.00821.x	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241076	10.1371/journal.pone.0241076	http://dx.doi.org/10.1371/journal.pone.0241076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091087	gold, Green Published			2022-12-26	WOS:000586647200058
J	Philippon, M; Cornee, JJ; Munch, P; van Hinsbergen, DJJ; BouDagher-Fadel, M; Gailler, L; Boschman, LM; Quillevere, F; Montheil, L; Gay, A; Lebrun, JF; Lallemand, S; Marivaux, L; Antoine, PO				Philippon, Melody; Cornee, Jean-Jacques; Munch, Philippe; van Hinsbergen, Douwe J. J.; BouDagher-Fadel, Marcelle; Gailler, Lydie; Boschman, Lydian M.; Quillevere, Frederic; Montheil, Leny; Gay, Aurelien; Lebrun, Jean Frederic; Lallemand, Serge; Marivaux, Laurent; Antoine, Pierre-Olivier		GARANTI Team	Eocene intra-plate shortening responsible for the rise of a faunal pathway in the northeastern Caribbean realm	PLOS ONE			English	Article							LESSER ANTILLES ARC; CENOZOIC EVOLUTION; CRUSTAL STRUCTURE; RECONSTRUCTION; PLATE; ISLAND; MODEL	Intriguing latest Eocene land-faunal dispersals between South America and the Greater Antilles (northern Caribbean) has inspired the hypothesis of the GAARlandia (Greater Antilles Aves Ridge) land bridge. This landbridge, however, should have crossed the Caribbean oceanic plate, and the geological evolution of its rise and demise, or its geodynamic forcing, remain unknown. Here we present the results of a land-sea survey from the northeast Caribbean plate, combined with chronostratigraphic data, revealing a regional episode of mid to late Eocene, trench-normal, E-W shortening and crustal thickening by similar to 25%. This shortening led to a regional late Eocene-early Oligocene hiatus in the sedimentary record revealing the location of an emerged land (the Greater Antilles-Northern Lesser Antilles, or GrANoLA, landmass), consistent with the GAARlandia hypothesis. Subsequent submergence is explained by combined trench-parallel extension and thermal relaxation following a shift of arc magmatism, expressed by a regional early Miocene transgression. We tentatively link the NE Caribbean intra-plate shortening to a well-known absolute and relative North American and Caribbean plate motion change, which may provide focus for the search of the remaining connection between 'GrANoLA' land and South America, through the Aves Ridge or Lesser Antilles island arc. Our study highlights the how regional geodynamic evolution may have driven paleogeographic change that is still reflected in current biology.	[Philippon, Melody; Lebrun, Jean Frederic] Univ Antilles, CNRS, Univ Montpellier, Geosci Montpellier, Pointe A Pitre, France; [Cornee, Jean-Jacques; Munch, Philippe; Montheil, Leny; Gay, Aurelien; Lebrun, Jean Frederic; Lallemand, Serge] Univ Antilles, CNRS, Univ Montpellier, Geosci Montpellier, Montpellier, France; [van Hinsbergen, Douwe J. J.] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [BouDagher-Fadel, Marcelle] UCL, Off Vice Provost Res, London, England; [Gailler, Lydie] Univ Jean Monnet, Inst Rech Dev, Clermont Ferrand, France; [Boschman, Lydian M.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Quillevere, Frederic] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, UMR 5276,LGL TPE, Villeurbanne, France; [Marivaux, Laurent; Antoine, Pierre-Olivier] UM, IRD, EPHE,UMR 5554, CNRS,Lab Paleontol,Inst Sci Evolut Montpellier IS, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Utrecht University; University of London; University College London; Institut de Recherche pour le Developpement (IRD); Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Philippon, M (corresponding author), Univ Antilles, CNRS, Univ Montpellier, Geosci Montpellier, Pointe A Pitre, France.	melody.philippon@univ-antilles.fr	Gay, Aurélien/D-2192-2013; Lallemand, Serge/D-5469-2011	Gay, Aurélien/0000-0003-2003-6679; Lallemand, Serge/0000-0003-1924-9423; Boudagher-Fadel, Marcelle/0000-0002-2339-2444; cornee, jean-jacques/0000-0003-0542-098X; Quillevere, Frederic/0000-0002-6248-0447	INSU TelluSYSTER; Netherlands Organization for Scientific Research (NWO) Vici grant [865.17.001]; GAARAnti project [ANR-17-CE31-0009]	INSU TelluSYSTER(Centre National de la Recherche Scientifique (CNRS)); Netherlands Organization for Scientific Research (NWO) Vici grant(Netherlands Organization for Scientific Research (NWO)); GAARAnti project	Financial support has been provided by INSU TelluSYSTER and GAARAnti project (ANR-17-CE31-0009). DJJvH acknowledges Netherlands Organization for Scientific Research (NWO) Vici grant 865.17.001.	Aitken T, 2011, MAR PETROL GEOL, V28, P235, DOI 10.1016/j.marpetgeo.2009.10.003; Ali JR, 2012, J BIOGEOGR, V39, P431, DOI 10.1111/j.1365-2699.2011.02674.x; Allen RW, 2019, GEOLOGY, V47, P891, DOI 10.1130/G46708.1; Alonso R, 2012, J BIOGEOGR, V39, P434, DOI 10.1111/j.1365-2699.2011.02594.x; Arnaiz-Rodriguez MS, 2016, REV MEX CIENC GEOL, V33, P286; Blackburn DC, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0947; Boschman LM, 2019, J GEOPHYS RES-SOL EA, V124, P6243, DOI 10.1029/2018JB016369; Boschman LM, 2014, EARTH-SCI REV, V138, P102, DOI 10.1016/j.earscirev.2014.08.007; BouDagher-Fadel M.K., 2018, EVOLUTION GEOLOGICAL; BouDagher-Fadel M.K., 2015, BIOSTRAT GRAPHIC GEO, V2nd; BouDagher-Fadel M.K., 2018, PROFESSIONAL PAPERS, P1; BOUYSSE P, 1988, TECTONOPHYSICS, V149, P121, DOI 10.1016/0040-1951(88)90122-9; BOUYSSE P, 1990, TECTONOPHYSICS, V175, P349, DOI 10.1016/0040-1951(90)90180-G; BURKE K, 1988, ANNU REV EARTH PL SC, V16, P201, DOI 10.1146/annurev.ea.16.050188.001221; Chamberland L, 2007, J BIOGEOGR, V45, P2442; Church AK, 2014, SEARCH DISCOVERY, V10076, P58; Cornee JJ, 2020, NEWSLETTERS STRATIGR; Darwin C., 1860, NATURALISTS VOYAGE R, V11th ed.; Delsuc F, 2019, CURR BIOL, V29, P2031, DOI 10.1016/j.cub.2019.05.043; Doubrovine PV, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009072; Feuillet N, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000308; Gaina C, 2019, TECTONOPHYSICS, V760, P136, DOI 10.1016/j.tecto.2018.08.010; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hulsey CD, 2011, MOL PHYLOGENET EVOL, V58, P124, DOI 10.1016/j.ympev.2010.11.016; Iturralde-Vinent M, 1999, B AM NATURAL HIST MU, V328, P1234; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; JANY I, 1990, MAR GEOPHYS RES, V12, P173, DOI 10.1007/BF02266712; Kerr A., 1997, GEOPH MONOG SERIES, P123; Lao-Davila DA, 2014, J S AM EARTH SCI, V54, P1, DOI 10.1016/j.jsames.2014.04.009; Lebrun J.-F., 2017, GARANTI CRUISE RV LA, DOI [10.17600/17001200, DOI 10.17600/17001200]; Legendre L, 2018, TECTONICS, V37, P2777, DOI 10.1029/2017TC004921; Legendre L, 2018, THESIS; Leroy S, 2000, GEOPHYS J INT, V141, P539, DOI 10.1046/j.1365-246x.2000.00059.x; MACPHEE RDE, 1989, QUATERNARY RES, V31, P94, DOI 10.1016/0033-5894(89)90088-4; Mann P, 1997, GEOLOGY, V25, P211, DOI 10.1130/0091-7613(1997)025<0211:MFTFOL>2.3.CO;2; Gomez-Garcia AM, 2019, GEOCHEM GEOPHY GEOSY, V20, P5371, DOI 10.1029/2019GC008340; Marivaux L, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2806; Melekhova E, 2019, EARTH PLANET SC LETT, V516, P12, DOI 10.1016/j.epsl.2019.03.030; Montes C, 2019, EARTH-SCI REV, V198, DOI 10.1016/j.earscirev.2019.102903; Neill I, 2010, LITHOS, V120, P407, DOI 10.1016/j.lithos.2010.08.026; Philippon M, 2020, TECTONOPHYSICS, V777, DOI 10.1016/j.tecto.2020.228323; PINDELL J, 1982, TECTONICS, V1, P179, DOI 10.1029/TC001i002p00179; Presslee S, 2019, NAT ECOL EVOL, V3, P1121, DOI 10.1038/s41559-019-0909-z; Rican O, 2011, SYST BIOL, V61, P543; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Schlaphorst D, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180764; Spakman W, 2018, NAT GEOSCI, V11, P211, DOI 10.1038/s41561-018-0066-z; Speed R, 1991, J GEOPHYS RES SOLID, V96, pno b3; Stanek K, 2009, ORIGIN EVOLUTION CAR, P0; van Benthem S, 2014, TECTONICS, V33, P850, DOI 10.1002/2013TC003402; van Hinsbergen DJJ, 2009, J STRUCT GEOL, V31, P1130, DOI 10.1016/j.jsg.2009.06.007; Velez-Juarbe J, 2014, J VERTEBR PALEONTOL, V34, P157, DOI 10.1080/02724634.2013.789039	52	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0241000	10.1371/journal.pone.0241000	http://dx.doi.org/10.1371/journal.pone.0241000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079958	Green Submitted, gold, Green Published			2022-12-26	WOS:000585940600001
J	Ryals, RC; Patel, S; Acosta, C; McKinney, M; Pennesi, ME; Sahay, G				Ryals, Renee C.; Patel, Siddharth; Acosta, Chris; McKinney, Madison; Pennesi, Mark E.; Sahay, Gaurav			The effects of PEGylation on LNP based mRNA delivery to the eye	PLOS ONE			English	Article							GENE; NANOPARTICLES; THERAPY; RETINA	Gene therapy is now an effective approach to treat many forms of retinal degeneration. Delivery agents that are cell-specific, allow for multiple dosing regimens, and have low immunogenicity are needed to expand the utility of gene therapy for the retina. We generated eight novel lipid nanoparticles (LNPs) ranging in size from 50 nm to 150 nm by changing the PEG content from 5% to 0.5%, respectively. Subretinal injections of LNP-mRNA encoding luciferase revealed that 0.5% PEG content within nanoparticles elicits the highest expression. Similar injections of LNP delivered cre mRNA into Ai9 mice revealed cell-specific protein expression in the retinal pigment epithelium (RPE), confirmed by fundus photography and immunohistochemistry of whole globe cross-sections. To investigate mechanisms of LNP delivery to the eye, we injected mCherry mRNA using the subretinal approach in apoE(-/-) and Mertk(-/-) mice. RPE transfection was observed in both mouse models suggesting that LNP intracellular delivery is not solely dependent on apolipoprotein adsorption or phagocytosis. To investigate LNP penetration, particles were delivered to the vitreous chamber via an intravitreal injection. The 0.5% PEG particles mediated the highest luciferase activity and expression was observed in the Muller glia, the optic nerve head and the trabecular meshwork, but failed to reach the RPE. Overall, particles containing less PEG (similar to 150 nm in size) mediated the highest expression in the eye. Thus far, these particles successfully transfect RPE, Muller cells, the optic nerve head and the trabecular meshwork based on route of administration which can expand the utility of LNP-mediated gene therapies for the eye.	[Ryals, Renee C.; Pennesi, Mark E.; Sahay, Gaurav] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA; [Patel, Siddharth; Acosta, Chris; McKinney, Madison; Sahay, Gaurav] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Portland, OR 97204 USA	Oregon Health & Science University; Oregon State University	Sahay, G (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.; Sahay, G (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Portland, OR 97204 USA.	sahay@ohsu.edu		Sahay, Gaurav/0000-0003-1071-0500	Medical Research Foundation of Oregon; OSU Startup funds; National Eye Institute [1R21EY031066-01A1]; Research to Prevent Blindness; National Institutes of Health [P30 EY010572]	Medical Research Foundation of Oregon; OSU Startup funds; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Medical Research Foundation of Oregon (G.S), OSU Startup funds (G.S), National Eye Institute 1R21EY031066-01A1 (G.S), unrestricted departmental funding from Research to Prevent Blindness (M.P) and grant P30 EY010572 from the National Institutes of Health (M.P).	Adams D., 2018, REV NEUROL, V174, pS37; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Ameri H, 2018, J CURR OPHTHALMOL, V30, P1, DOI 10.1016/j.joco.2018.01.006; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Apaolaza PS, 2016, BIOMATERIALS, V90, P40, DOI 10.1016/j.biomaterials.2016.03.004; Bao YJ, 2013, PHARM RES-DORDR, V30, P342, DOI 10.1007/s11095-012-0874-6; Behzadi S, 2017, CHEM SOC REV, V46, P4218, DOI 10.1039/c6cs00636a; Borras T, 2017, ASIA-PAC J OPHTHALMO, V6, P80, DOI 10.22608/APO.2016126; Cullis PR, 2017, MOL THER, V25, P1467, DOI 10.1016/j.ymthe.2017.03.013; del Amo EM, 2017, PROG RETIN EYE RES, V57, P134, DOI 10.1016/j.preteyeres.2016.12.001; Duncan JL, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.6; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Grzybowski A, 2018, OPHTHALMOLOGICA, V239, P181, DOI 10.1159/000486145; HEEGAARD S, 1986, GRAEF ARCH CLIN EXP, V224, P355, DOI 10.1007/BF02150029; Hoy SM, 2018, DRUGS, V78, P1625, DOI 10.1007/s40265-018-0983-6; Huang XN, 2019, DRUG DISCOV TODAY, V24, P1510, DOI 10.1016/j.drudis.2019.05.005; Kay C, 2019, RETINAL PHYS, V16, P36; Kulkarni JA, 2018, NUCLEIC ACID THER, V28, P146, DOI 10.1089/nat.2018.0721; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Patel S, 2019, J CONTROL RELEASE, V303, P91, DOI 10.1016/j.jconrel.2019.04.015; Patel SK, 2011, INT J CHEM REACT ENG, V9; Patel U., 2016, VORETIGENE NEPARVOVE; Peeters L, 2005, INVEST OPHTH VIS SCI, V46, P3553, DOI 10.1167/iovs.05-0165; Peng YQ, 2017, OPHTHALMIC RES, V58, P217, DOI 10.1159/000479157; Puras G, 2014, J CONTROL RELEASE, V174, P27, DOI 10.1016/j.jconrel.2013.11.004; Roska B, 2018, NATURE, V557, P359, DOI 10.1038/s41586-018-0076-4; Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638; Sanders NN, 2007, J CONTROL RELEASE, V122, P226, DOI 10.1016/j.jconrel.2007.05.004; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Shen JK, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba1606; Song LY, 2002, BBA-BIOMEMBRANES, V1558, P1, DOI 10.1016/S0005-2736(01)00399-6; Stower H, 2018, NAT MED, V24, P1303, DOI 10.1038/s41591-018-0192-6; Tai LY, 2017, INT J PHARMACEUT, V529, P347, DOI 10.1016/j.ijpharm.2017.06.090; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014	39	36	36	16	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241006	10.1371/journal.pone.0241006	http://dx.doi.org/10.1371/journal.pone.0241006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119640	gold, Green Published			2022-12-26	WOS:000600013600010
J	Vucinic, N; Teofilovski-Parapid, G; Eric, M; Tubbs, RS; Radosevic, D; Jovancevic, B				Vucinic, Nikola; Teofilovski-Parapid, Gordana; Eric, Mirela; Tubbs, R. Shane; Radosevic, Dragana; Jovancevic, Bojana			Morphometric analysis of the patterns of calcaneal facets for the talus in Serbian population	PLOS ONE			English	Article							SEX	Literature describes different patterns of calcaneal facets for the talus in terms of whether some calcaneal facets are connected or separated from each other or completely absent. The aim of this study was to establish the patterns of calcaneal facets for the talus, to calculate their total area, and to analyse the data with respect to gender. The study involved 59 calcanei which were photographed. The patterns of calcaneal facets noted in this study were compared with the patterns from the literature. ImageJ program was used to measure different parameters on calcanei. The pattern 1 was the most commonly found in the study sample (45.76%), then the pattern 2 (40.68%), and finally the pattern 3 (13.56%). That order of frequencies is the same in both sexes. The patterns 1 and 2 have a larger contact surface for the talus in comparison to the pattern 3. Male bones have a larger contact surface for the talus than female bones. The sum of the pattern 1 and pattern 3 frequencies was high. Knowing the frequency of different patterns of calcaneal facets for the talus in a certain population is important for orthopaedic surgeons when performing foot osteotomy.	[Vucinic, Nikola; Eric, Mirela; Radosevic, Dragana] Univ Novi Sad, Dept Anat, Fac Med, Novi Sad, Serbia; [Teofilovski-Parapid, Gordana] Univ Belgrade, Fac Med, Belgrade, Serbia; [Tubbs, R. Shane] Tulane Univ, Sch Med, Tulane Ctr Clin Neurosci, Dept Neurosurg, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Tubbs, R. Shane] St Georges Univ, Dept Anat Sci, St Georges, Grenada; [Tubbs, R. Shane] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Jovancevic, Bojana] Univ Novi Sad, Fac Med, Novi Sad, Serbia	University of Novi Sad; University of Belgrade; Tulane University; Tulane University; University of Novi Sad	Vucinic, N (corresponding author), Univ Novi Sad, Dept Anat, Fac Med, Novi Sad, Serbia.	nikola.vucinic@mf.uns.ac.rs		Vucinic, Nikola/0000-0003-4419-6255	Ministry of Education, Science and Technological Development, Republic of Serbia [172041]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was financially supported by the Ministry of Education, Science and Technological Development, Republic of Serbia [Project no. 172041]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, J IND ECOL, V22, P23; Aydingoz U, 2016, AM J ROENTGENOL, V207, P846, DOI 10.2214/AJR.16.16056; Barbaix E, 2000, ERGONOMICS, V43, P1718, DOI 10.1080/001401300750004122; Best A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190553; BRUCKNER J, 1987, Journal of Orthopaedic and Sports Physical Therapy, V8, P489; BUNNING PSC, 1965, J ANAT, V99, P71; Chavan S. K., 2014, IOSRJ DENT MED SCI, V13, P16; Dayal MR, 2008, HOMO, V59, P209, DOI 10.1016/j.jchb.2007.01.001; DRAYERVERHAGEN F, 1993, J ANAT, V183, P631; Garg R., 2013, INDIAN J BASIC APPL, V2, P643; Greer Richardson E., 1998, CAMPBELLS OPERATIVE, V9th, P1720; Gualdi-Russo E, 2007, FORENSIC SCI INT, V171, P151, DOI 10.1016/j.forsciint.2006.10.014; GUPTA SC, 1977, J ANAT, V124, P651; Kim DI, 2013, FORENSIC SCI INT, V228, DOI 10.1016/j.forsciint.2013.03.012; Muthukumaravel N, 2011, J CLIN DIAGN RES, V5, P791; Nozaki S, 2020, CLIN ANAT, V33, P751, DOI 10.1002/ca.23501; Saadeh FA, 2000, J ANAT SOC INDIA, V49, P6; Snell R., 2012, CLIN ANATOMY REGIONS; Standring S., 2020, GRAYS ANATOMY; STEELE DG, 1976, AM J PHYS ANTHROPOL, V45, P581, DOI 10.1002/ajpa.1330450323; Stoica IC, 2017, ROM J MORPHOL EMBRYO, V58, P689; Tahir M, 2008, P SZPGMI, V22, P91; Ukoha UU, 2017, REV ARGENT ANAT, V8, P29	23	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240818	10.1371/journal.pone.0240818	http://dx.doi.org/10.1371/journal.pone.0240818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119596	Green Published, gold			2022-12-26	WOS:000600013600069
J	Xiong, ZQ; Lin, MH; Lin, Z; Sun, T; Yang, GY; Wang, ZX				Xiong, Zhengqiang; Lin, Manhui; Lin, Zhen; Sun, Tao; Yang, Guangyi; Wang, Zhengxing			Single image super-resolution via Image Quality Assessment-Guided Deep Learning Network	PLOS ONE			English	Article							INFORMATION; EFFICIENT	In recent years, deep learning (DL) networks have been widely used in super-resolution (SR) and exhibit improved performance. In this paper, an image quality assessment (IQA)-guided single image super-resolution (SISR) method is proposed in DL architecture, in order to achieve a nice tradeoff between perceptual quality and distortion measure of the SR result. Unlike existing DL-based SR algorithms, an IQA net is introduced to extract perception features from SR results, calculate corresponding loss fused with original absolute pixel loss, and guide the adjustment of SR net parameters. To solve the problem of heterogeneous datasets used by IQA and SR networks, an interactive training model is established via cascaded network. We also propose a pairwise ranking hinge loss method to overcome the shortcomings of insufficient samples during training process. The performance comparison between our proposed method with recent SISR methods shows that the former achieves a better tradeoff between perceptual quality and distortion measure than the latter. Extensive benchmark experiments and analyses also prove that our method provides a promising and opening architecture for SISR, which is not confined to a specific network model.	[Xiong, Zhengqiang; Sun, Tao; Yang, Guangyi] Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China; [Lin, Manhui] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Peoples R China; [Lin, Zhen] Wuhan Univ, Comp & Sci Sch, Wuhan, Peoples R China; [Wang, Zhengxing] State Key Lab Bridge Struct Hlth & Safety, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Sun, T (corresponding author), Wuhan Univ, Elect Informat Sch, Wuhan, Peoples R China.	suntao@whu.edu.cn		Sun, Tao/0000-0001-6006-2762; Lin, Manhui/0000-0002-6933-9788	Science and Technology on Near-Surface Detection Laboratory Foundation of China [614241409041317]; Project of Technical Innovation of Hubei Province [2018AAA029]	Science and Technology on Near-Surface Detection Laboratory Foundation of China; Project of Technical Innovation of Hubei Province	This work was supported in part by the Science and Technology on Near-Surface Detection Laboratory Foundation of China (614241409041317), and in part by the Project of Technical Innovation of Hubei Province (2018AAA029).	Agustsson E, 2017, IEEE COMPUT SOC CONF, P1122, DOI 10.1109/CVPRW.2017.150; Ali M, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, COMMUNICATIONS AND COMPUTING (ICSPCC), P184, DOI 10.1109/ICSPCC.2014.6986179; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2019, IEEE T IND ELECT; Bevilacqua M, 2012, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2012, DOI 10.5244/C.26.135; Blau Y, 2019, LECT NOTES COMPUT SC, V11133, P334, DOI 10.1007/978-3-030-11021-5_21; Blau Y, 2018, PROC CVPR IEEE, P6228, DOI 10.1109/CVPR.2018.00652; BOOR CD, 1962, J MATH PHYS CAMB, V41, P212; Cao FL, 2019, NEUROCOMPUTING, V358, P424, DOI 10.1016/j.neucom.2019.05.066; Chen MJ, 2011, J REAL-TIME IMAGE PR, V6, P281, DOI 10.1007/s11554-010-0170-9; Dong C, 2016, LECT NOTES COMPUT SC, V9906, P391, DOI 10.1007/978-3-319-46475-6_25; Dong C, 2016, IEEE T PATTERN ANAL, V38, P295, DOI 10.1109/TPAMI.2015.2439281; Fang Y., 2019, IEEE T CIRCUITS SYST; FINNEY D J, 1971, P333; Gao F, 2018, PATTERN RECOGN, V81, P432, DOI 10.1016/j.patcog.2018.04.016; Gatys L., 2015, TEXTURE SYNTHESIS US, P262; Getreuer P, 2009, VISUAL COMMUNICATION, V7257, P725718; Guo T., 2019, ARXIV190410082; Hosu V., 2019, ARXIVCSCV191006180; HUANG JB, 2015, PROC CVPR IEEE, P5197, DOI DOI 10.1109/CVPR.2015.7299156; Johnson J, 2016, LECT NOTES COMPUT SC, V9906, P694, DOI 10.1007/978-3-319-46475-6_43; Kim J, 2016, PROC CVPR IEEE, P1646, DOI [10.1109/CVPR.2016.181, 10.1109/CVPR.2016.182]; Kim J, 2017, IEEE IMAGE PROC, P3180; Kim J, 2017, IEEE SIGNAL PROC MAG, V34, P130, DOI 10.1109/MSP.2017.2736018; Ledig C, 2017, PROC CVPR IEEE, P105, DOI 10.1109/CVPR.2017.19; Lim B, 2017, IEEE COMPUT SOC CONF, P1132, DOI 10.1109/CVPRW.2017.151; Lin KY, 2018, PROC CVPR IEEE, P732, DOI 10.1109/CVPR.2018.00083; Liu SY, 2020, IEEE T IMAGE PROCESS, V29, P7697, DOI 10.1109/TIP.2020.2992079; Liu XL, 2017, IEEE I CONF COMP VIS, P1040, DOI 10.1109/ICCV.2017.118; Ma C, 2017, COMPUT VIS IMAGE UND, V158, P1, DOI 10.1016/j.cviu.2016.12.009; Ma KD, 2017, IEEE T IMAGE PROCESS, V26, P3951, DOI 10.1109/TIP.2017.2708503; Ma Y, 2019, IEEE ACCESS, V7, P146893, DOI 10.1109/ACCESS.2019.2942625; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Mittal A, 2013, IEEE SIGNAL PROC LET, V20, P209, DOI 10.1109/LSP.2012.2227726; Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050; Moorthy AK, 2010, IEEE SIGNAL PROC LET, V17, P513, DOI 10.1109/LSP.2010.2043888; Nafchi HZ, 2016, IEEE ACCESS, V4, P5579, DOI 10.1109/ACCESS.2016.2604042; Nasrollahi K, 2014, MACH VISION APPL, V25, P1423, DOI 10.1007/s00138-014-0623-4; Ponomarenko N, 2015, SIGNAL PROCESS-IMAGE, V30, P57, DOI 10.1016/j.image.2014.10.009; Saad MA, 2012, IEEE T IMAGE PROCESS, V21, P3339, DOI 10.1109/TIP.2012.2191563; Sajjadi M.S., 2017, P IEEECVF INT C COMP, P4491, DOI DOI 10.1109/CVPR.2019.00817; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P430, DOI 10.1109/TIP.2005.859378; Sheikh HR, 2005, IEEE T IMAGE PROCESS, V14, P2117, DOI 10.1109/TIP.2005.859389; Shi WZ, 2016, PROC CVPR IEEE, P1874, DOI 10.1109/CVPR.2016.207; Tai Y, 2017, PROC CVPR IEEE, P2790, DOI 10.1109/CVPR.2017.298; Vasu S., 2018, EUR C COMP VIS ECCV; Wang LG, 2019, PROC CVPR IEEE, P12242, DOI 10.1109/CVPR.2019.01253; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZW, 2015, IEEE I CONF COMP VIS, P370, DOI 10.1109/ICCV.2015.50; Wang Z, 2011, IEEE T IMAGE PROCESS, V20, P1185, DOI 10.1109/TIP.2010.2092435; Xu B., 2015, ARXIV150500853, V1505, P853; Yang CY, 2014, LECT NOTES COMPUT SC, V8692, P372, DOI 10.1007/978-3-319-10593-2_25; Yang WM, 2019, IEEE T MULTIMEDIA, V21, P3106, DOI 10.1109/TMM.2019.2919431; Zeyde R., 2010, INT C CURVES SURFACE, P711, DOI DOI 10.1007/978-3-642-27413-8_47; Zhang KB, 2017, IEEE T NEUR NET LEAR, V28, P1109, DOI 10.1109/TNNLS.2015.2511069; Zhang KB, 2015, IEEE T IMAGE PROCESS, V24, P846, DOI 10.1109/TIP.2015.2389629; Zhang KB, 2012, IEEE T IMAGE PROCESS, V21, P4544, DOI 10.1109/TIP.2012.2208977; Zhang L, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2426416; Zhang YL, 2018, LECT NOTES COMPUT SC, V11211, P294, DOI [10.1007/978-3-030-01234-2_18, 10.1007/978-3-030-01240-3_22]	60	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241313	10.1371/journal.pone.0241313	http://dx.doi.org/10.1371/journal.pone.0241313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119656	gold, Green Published			2022-12-26	WOS:000600013600120
J	Franca, MM; Funari, MFA; Lerario, AM; Santos, MG; Nishi, MY; Domenice, S; Moraes, DR; Costalonga, EF; Maciel, GAR; Maciel-Guerra, AT; Guerra, G; Mendonca, BB				Franca, Monica M.; Funari, Mariana F. A.; Lerario, Antonio M.; Santos, Mariza G.; Nishi, Mirian Y.; Domenice, Sorahia; Moraes, Daniela R.; Costalonga, Everlayny F.; Maciel, Gustavo A. R.; Maciel-Guerra, Andrea T.; Guerra-Junior, Gil; Mendonca, Berenice B.			Screening of targeted panel genes in Brazilian patients with primary ovarian insufficiency	PLOS ONE			English	Article							HOMOZYGOUS 1-BP DELETION; UBIQUITIN LIGASE; MUTATIONS; GENETICS; VARIANTS; GENOMICS; FAILURE; PROTEIN; GROWTH; MOUSE	Primary ovarian insufficiency (POI) is a heterogeneous disorder associated with several genes. The majority of cases are still unsolved. Our aim was to identify the molecular diagnosis of a Brazilian cohort with POI. Genetic analysis was performed using a customized panel of targeted massively parallel sequencing (TMPS) and the candidate variants were confirmed by Sanger sequencing. Additional copy number variation (CNV) analysis of TMPS samples was performed by CONTRA. Fifty women with POI (29 primary amenorrhea and 21 secondary amenorrhea) of unknown molecular diagnosis were included in this study, which was conducted in a tertiary referral center of clinical endocrinology. A genetic defect was obtained in 70% women with POI using the customized TMPS panel. Twenty-four pathogenic variants and two CNVs were found in 48% of POI women. Of these variants, 16 genes were identified as BMP8B, CPEB1, INSL3, MCM9, GDF9, UBR2, ATM, STAG3, BMP15, BMPR2, DAZL, PRDM1, FSHR, EIF4ENIF1, NOBOX, and GATA4. Moreover, a microdeletion and microduplication in the CPEB1 and SYCE1 genes, respectively, were also identified in two distinct patients. The genetic analysis of eleven patients was classified as variants of uncertain clinical significance whereas this group of patients harbored at least two variants in different genes. Thirteen patients had benign or no rare variants, and therefore the genetic etiology remained unclear. In conclusion, next-generation sequencing (NGS) is a highly effective approach to identify the genetic diagnoses of heterogenous disorders, such as POI. A molecular etiology allowed us to improve the disease knowledge, guide decisions about prevention or treatment, and allow familial counseling avoiding future comorbidities.	[Franca, Monica M.; Funari, Mariana F. A.; Santos, Mariza G.; Nishi, Mirian Y.; Domenice, Sorahia; Moraes, Daniela R.; Mendonca, Berenice B.] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Unidade Endocrinol Desenvolvimento,Lab Hormonios, Sao Paulo, SP, Brazil; [Lerario, Antonio M.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Nishi, Mirian Y.; Mendonca, Berenice B.] Univ Sao Paulo FMUSP, Lab Sequenciamento Larga Escala SELA, Fac Med, Sao Paulo, SP, Brazil; [Costalonga, Everlayny F.] Univ Fed Espirito Santo, Dept Clin Med, Fac Med, Vitoria, ES, Brazil; [Maciel, Gustavo A. R.] Univ Sao Paulo, Dept Obstet & Ginecol, Fac Med, Disciplina Ginecol,Hosp Clin HCFMUSP, Sao Paulo, SP, Brazil; [Maciel-Guerra, Andrea T.] Univ Estadual Campinas, Fac Ciencias Med, Dept Genet Med & Med Genom, Campinas, SP, Brazil; [Guerra-Junior, Gil] Univ Estadual Campinas, Fac Ciencias Med, Dept Pediat, Campinas, SP, Brazil; [Franca, Monica M.] Univ Chicago, Dept Med, Sect Endocrinol, 5841 S Maryland Ave, Chicago, IL 60637 USA	Universidade de Sao Paulo; University of Michigan System; University of Michigan; Universidade de Sao Paulo; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); University of Chicago	Franca, MM (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Unidade Endocrinol Desenvolvimento,Lab Hormonios, Sao Paulo, SP, Brazil.; Franca, MM (corresponding author), Univ Chicago, Dept Med, Sect Endocrinol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mmfrancabr@gmail.com	Maciel, Gustavo A/D-2291-2009; Mendonca, Berenice/AAS-3742-2021; Maciel-Guerra, Andrea/E-9130-2016	Maciel, Gustavo A/0000-0001-9097-8528; Mendonca, Berenice/0000-0003-1762-1084; Franca, Monica M/0000-0002-6020-3200; Maciel-Guerra, Andrea/0000-0002-4850-8079	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/14231-0, 2013/02162-8, 2014/50137-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303002/2016-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors received the following funding in support of this study: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2014/14231-0 to Dr. MonicaM Franca; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2013/02162-8 to Berenice B. Mendonca; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 303002/2016-6 to Berenice B. Mendonca; and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2014/50137-5.	Adelman CA, 2013, NATURE, V502, P381, DOI 10.1038/nature12565; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Bennett-Toomey J, 2018, VITAM HORM, V107, P193, DOI 10.1016/bs.vh.2018.01.014; Bertini V, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2010.02.013; Bestetti I, 2019, HUM REPROD, V34, P574, DOI 10.1093/humrep/dey389; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Bouilly J, 2016, J CLIN ENDOCR METAB, V101, P4541, DOI 10.1210/jc.2016-2152; Bouilly J, 2011, HUM MUTAT, V32, P1108, DOI 10.1002/humu.21543; Caburet S, 2014, NEW ENGL J MED, V370, P943, DOI 10.1056/NEJMoa1309635; Patino LC, 2017, SYST BIOL REPROD MED, V63, P145, DOI 10.1080/19396368.2017.1291767; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; de Vries L, 2014, J CLIN ENDOCR METAB, V99, pE2129, DOI 10.1210/jc.2014-1268; Desai S, 2017, J CLIN ENDOCR METAB, V102, P576, DOI 10.1210/jc.2016-2565; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Eggers S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1105-y; Franca MM, 2018, CLIN GENET, V93, P408, DOI 10.1111/cge.13156; Franca MM, 2019, EUR J MED GENET, V62, P186, DOI 10.1016/j.ejmg.2018.07.008; Franca MM, 2017, ENDOCRINE, V58, P442, DOI 10.1007/s12020-017-1459-2; Franca MM, 2017, SEX DEV, V11, P137, DOI 10.1159/000477193; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Garcia-Rivas G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0440-5; Huhtaniemi I, 2018, TRENDS ENDOCRIN MET, V29, P400, DOI 10.1016/j.tem.2018.03.010; Ivell R, 2018, HUM REPROD UPDATE, V24, P639, DOI 10.1093/humupd/dmy029; Jaillard S, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0272-5; Fonseca DJ, 2015, FERTIL STERIL, V104, P154, DOI 10.1016/j.fertnstert.2015.04.016; Jiao X, 2018, TRENDS ENDOCRIN MET, V29, P795, DOI 10.1016/j.tem.2018.07.002; Jung DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15680; Kasippillai T, 2013, J CLIN ENDOCR METAB, V98, pE1534, DOI 10.1210/jc.2013-1102; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Laissue P, 2018, MOL CELL ENDOCRINOL, V460, P170, DOI 10.1016/j.mce.2017.07.021; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004; de LaPiscina IM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00142; McGuire MM, 2011, FERTIL STERIL, V95, P1595, DOI 10.1016/j.fertnstert.2010.12.052; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsuiko O, 2016, HUM REPROD, V31, P1913, DOI 10.1093/humrep/dew142; Tucker EJ, 2016, ENDOCR REV, V37, P609, DOI 10.1210/er.2016-1047; Tung JY, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-40; Villaescusa JC, 2006, GENE, V367, P101, DOI 10.1016/j.gene.2005.09.026; Vincent SD, 2014, HUM MOL GENET, V23, P5087, DOI 10.1093/hmg/ddu232; Wang WT, 2015, REPROD BIOMED ONLINE, V31, P573, DOI 10.1016/j.rbmo.2015.06.012; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027; Wood-Trageser MA, 2014, AM J HUM GENET, V95, P754, DOI 10.1016/j.ajhg.2014.11.002; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101; Zhang W, 2018, REPROD BIOMED ONLINE, V36, P206, DOI 10.1016/j.rbmo.2017.10.104; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240795	10.1371/journal.pone.0240795	http://dx.doi.org/10.1371/journal.pone.0240795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095795	Green Published, gold			2022-12-26	WOS:000586649400012
J	Peace, A; Pattemore, D; Broussard, M; Fonseka, D; Tomer, N; Bosque-Perez, NA; Crowder, D; Shaw, AK; Jesson, L; Howlett, BG; Jochym, M; Li, J				Peace, Angela; Pattemore, David; Broussard, Melissa; Fonseka, Dilini; Tomer, Nathan; Bosque-Perez, Nilsa A.; Crowder, David; Shaw, Allison K.; Jesson, Linley; Howlett, Brad G.; Jochym, Mateusz; Li, Jing			Orchard layout and plant traits influence fruit yield more strongly than pollinator behaviour and density in a dioecious crop	PLOS ONE			English	Article							HONEY-BEES; KIWIFRUIT POLLINATION; GROWTH MODELS; DYNAMICS; SET; MANAGEMENT; SYSTEMS; POLLEN; NUMBER; WIND	Mutualistic plant-pollinator interactions are critical for the functioning of both non-managed and agricultural systems. Mathematical models of plant-pollinator interactions can help understand key determinants in pollination success. However, most previous models have not addressed pollinator behavior and plant biology combined. Information generated from such a model can inform optimal design of crop orchards and effective utilization of managed pollinators like western honey bees (Apis mellifera), and help generate hypotheses about the effects of management practices and cultivar selection. We expect that the number of honey bees per flower and male to female flower ratio will influence fruit yield. To test the relative importance of these effects, both singly and simultaneously, we utilized a delay differential equation model combined with Latin hypercube sampling for sensitivity analysis. Empirical data obtained from historical records and collected in kiwifruit (Actinidia chinensis) orchards in New Zealand were used to parameterize the model. We found that, at realistic bee densities, the optimal orchard had 65-75% female flowers, and the most benefit was gained from the first 6-8 bees/1000 flowers, with diminishing returns thereafter. While bee density significantly impacted fruit production, plant-based parameters-flower density and male:female flower ratio-were the most influential. The predictive model provides strategies for improving crop management, such as choosing cultivars which have their peak bloom on the same day, increasing the number of flowers with approximately 70% female flowers in the orchard, and placing enough hives to maintain more than 6 bees per 1000 flowers to optimize yield.	[Peace, Angela; Fonseka, Dilini] Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA; [Pattemore, David; Broussard, Melissa; Tomer, Nathan; Jochym, Mateusz] New Zealand Inst Plant & Food Res, Hamilton, New Zealand; [Pattemore, David] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Bosque-Perez, Nilsa A.] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID USA; [Crowder, David] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Shaw, Allison K.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN USA; [Jesson, Linley] New Zealand Inst Plant & Food Res, Havelock North, New Zealand; [Howlett, Brad G.] New Zealand Inst Plant & Food Res, Lincoln, New Zealand; [Li, Jing] Calif State Univ Northridge, Dept Math, Northridge, CA 91330 USA	Texas Tech University System; Texas Tech University; New Zealand Institute for Plant & Food Research Ltd; University of Auckland; Idaho; University of Idaho; Washington State University; University of Minnesota System; University of Minnesota Twin Cities; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; California State University System; California State University Northridge	Peace, A (corresponding author), Texas Tech Univ, Dept Math & Stat, Lubbock, TX 79409 USA.	a.peace@ttu.edu	Peace, Angela/AFR-4935-2022; Jochym, Mateusz/F-3401-2018; Jesson, Linley/G-3285-2018; Tomer, Nathan/C-3041-2019; Shaw, Allison/E-7161-2010	Jochym, Mateusz/0000-0003-2794-1671; Crowder, David/0000-0002-3720-1581; Peace, Angela/0000-0001-8200-8839; Jesson, Linley/0000-0003-4969-160X; Tomer, Nathan/0000-0001-5280-1262; Shaw, Allison/0000-0001-7969-8365	Plant & Food Research Discovery Science [DS 14-65]	Plant & Food Research Discovery Science	This work was supported by Plant & Food Research Discovery Science grant DS 14-65. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajcz AW, 2017, ECOL MODEL, V361, P80, DOI 10.1016/j.ecolmodel.2017.07.026; Broussard MA, 2020, USING AGENT BASED MO; BRUNDELL D J, 1975, New Zealand Journal of Botany, V13, P485; Cangi R., 2006, Zahradnictvi (Horticultural Science), V33, P23; CLINCH PG, 1984, NEW ZEAL J EXP AGR, V12, P29, DOI 10.1080/03015521.1984.10427785; COSTA G, 1993, NEW ZEAL J CROP HORT, V21, P189, DOI 10.1080/01140671.1993.9513767; Costa G., 2010, 7 INT S KIW, V913, P337; Dumont Y, 2018, MATH METHOD APPL SCI, V41, P8545, DOI 10.1002/mma.4858; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Geber M.A., 2006, ECOLOGY EVOLUTION FL, P102; Gonzalez MV, 1998, ANN APPL BIOL, V132, P349, DOI 10.1111/j.1744-7348.1998.tb05210.x; GONZALEZ MV, 1995, J AM SOC HORTIC SCI, V120, P199, DOI 10.21273/JASHS.120.2.199; GONZALEZ MV, 1994, J HORTIC SCI BIOTECH, V69, P697, DOI 10.1080/14620316.1994.11516502; Goodwin M., 2012, POLLINATION CROPS AU; Goodwin RM, 2013, NEW ZEAL J BOT, V51, P229, DOI 10.1080/0028825X.2013.806934; GOODWIN RM, 1993, NEW ZEAL J CROP HORT, V21, P17, DOI 10.1080/01140671.1993.9513741; Goodwin RM, 1999, NEW ZEAL J CROP HORT, V27, P63, DOI 10.1080/01140671.1999.9514081; Goodwin RM., 1987, ECOLOGY HONEY BEE AP; Goodwin RM, 1987, THESIS U AUCKLAND; Goodwin RM., 1995, NZ KIWIFRUIT J, V111, P5; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Hopping M.E., 1990, KIWIFRUIT SCI MANAGE, P71; Howlett B. G., 2017, New Zealand Plant Protection, V70, P52, DOI 10.30843/nzpp.2017.70.27; Howpage D., 1999, THESIS; Jang SRJ, 2002, J MATH BIOL, V44, P129, DOI 10.1007/s002850100117; JAY D, 1984, BEE WORLD, V65, P155; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lescourret F, 1998, AGR SYST, V56, P91, DOI 10.1016/S0308-521X(97)00043-7; Lescourret F, 1998, AGR SYST, V56, P67, DOI 10.1016/S0308-521X(97)00042-5; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Macfarlane RP, 1983, 1980 1982 KIWIFRUIT; Manning R, 2001, BEE WORLD, V82, P60, DOI 10.1080/0005772X.2001.11099504; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; McKay SA., 1978, POLLINATION OTHER FA; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; PALMER-JONES T, 1976, New Zealand Journal of Experimental Agriculture, V4, P255; Pomeroy Nelson, 2002, New Zealand Entomologist, V25, P41; Ramos-Jiliberto R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33265-6; Schmid R, 1978, REPROD ANATOMY ACTIN; Shaw AK, 2017, ECOLOGY, V98, P2145, DOI 10.1002/ecy.1907; SOBERON JM, 1981, J THEOR BIOL, V91, P363, DOI 10.1016/0022-5193(81)90238-1; Steven D, 1988, NZ KIWIFRUIT, V15; Steven D., 1988, NZ KIWIFRUIT, V1988, P12; TESTOLIN R, 1990, J AM SOC HORTIC SCI, V115, P704, DOI 10.21273/JASHS.115.5.704; TESTOLIN R, 1991, SCI HORTIC-AMSTERDAM, V48, P41, DOI 10.1016/0304-4238(91)90151-N; Thomson J, 2003, AM NAT, V162, pS1, DOI 10.1086/378683; Vaissiere BE, 1996, J ECON ENTOMOL, V89, P453, DOI 10.1093/jee/89.2.453; Walklate PJ, 2004, P ROY SOC B-BIOL SCI, V271, P441, DOI 10.1098/rspb.2003.2578; Woodward TJ, 2012, NEW ZEAL J CROP HORT, V40, P187, DOI 10.1080/01140671.2011.639377; Yang L, 1990, APICULTURE CHINA, V1, P2	52	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0231120	10.1371/journal.pone.0231120	http://dx.doi.org/10.1371/journal.pone.0231120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095783	Green Submitted, gold, Green Published			2022-12-26	WOS:000586649400021
J	Taylor, SS; Coyle, JR; White, EP; Hurlbert, AH				Taylor, Sara Snell; Coyle, Jessica R.; White, Ethan P.; Hurlbert, Allen H.			A simulation study of the use of temporal occupancy for identifying core and transient species	PLOS ONE			English	Article							RICHNESS; ABUNDANCE; HETEROGENEITY	Transient species, which do not maintain self-sustaining populations in a system where they are observed, are ubiquitous in nature and their presence often impacts the interpretation of ecological patterns and processes. Identifying transient species from temporal occupancy, the proportion of time a species is observed at a given site over a time series, is subject to classification errors as a result of imperfect detection and source-sink dynamics. We use a simulation-based approach to assess how often errors in detection or classification occur in order to validate the use of temporal occupancy as a metric for inferring whether a species is a core or transient member of a community. We found that low detection increases error in the classification of core species, while high habitat heterogeneity and high detection increase error in classification of transient species. These findings confirm that temporal occupancy is a valid metric for inferring whether a species can maintain a self-sustaining population, but imperfect detection, low abundance, and highly heterogeneous landscapes may yield high misclassification rates.	[Taylor, Sara Snell; Hurlbert, Allen H.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Coyle, Jessica R.] St Marys Coll Calif, Dept Biol, Moraga, CA USA; [White, Ethan P.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [White, Ethan P.] Univ Florida, Informat Inst, Gainesville, FL USA; [Hurlbert, Allen H.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Saint Mary's College of California; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill	Taylor, SS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	ssnell6@gmail.com		Hurlbert, Allen/0000-0002-5678-9907; Coyle, Jessica/0000-0001-5428-8669; White, Ethan/0000-0001-6728-7745; Snell Taylor, Sara/0000-0002-0353-9613	National Science Foundation [DEB-1354563]; Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative [GBMF4563]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative	This research was supported the National Science Foundation through grant DEB-1354563 to A. H. Hurlbert and E. P. White and by the Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative through Grant GBMF4563 to E. P. White. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, Med Lett Drugs Ther, V50, P63; [Anonymous], 2015, RIV STORICA ITAL, V6, P1, DOI DOI 10.3389/fpls.2015.00951; [Anonymous], 1985, ALTERN LAB ANIM ATLA, V12, P1; Belmaker J, 2009, GLOBAL ECOL BIOGEOGR, V18, P426, DOI 10.1111/j.1466-8238.2009.00456.x; Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.2307/176597; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cody M. L., 1975, ECOLOGY EVOLUTION CO; Costello MJ, 1996, J EXP MAR BIOL ECOL, V202, P49, DOI 10.1016/0022-0981(96)00030-5; Coyle JR, 2013, AM NAT, V181, pE83, DOI 10.1086/669903; Cunningham RB, 1999, AUST J ECOL, V24, P270, DOI 10.1046/j.1442-9993.1999.00971.x; Guillera-Arroita G, 2019, ECOL EVOL, V9, P780, DOI 10.1002/ece3.4821; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Jenkins MF, 2018, PEERJ, V6, DOI 10.7717/peerj.6019; Johnston A, 2014, BIRD STUDY, V61, P340, DOI 10.1080/00063657.2014.941787; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kery M, 2008, J APPL ECOL, V45, P589, DOI 10.1111/j.1365-2664.2007.01441.x; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Taylor SS, 2020, GLOBAL ECOL BIOGEOGR, V29, P736, DOI 10.1111/geb.13064; Taylor SJS, 2018, ECOLOGY, V99, P1825, DOI 10.1002/ecy.2398; Umana MN, 2017, ECOL LETT, V20, P619, DOI 10.1111/ele.12760; Wintle BA, 2004, ECOL APPL, V14, P703, DOI 10.1890/02-5166	27	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241198	10.1371/journal.pone.0241198	http://dx.doi.org/10.1371/journal.pone.0241198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095844	Green Published, Green Submitted, gold			2022-12-26	WOS:000586649400055
J	Pandey, D; Bansal, S; Goyal, S; Garg, A; Sethi, N; Pothiyill, DI; Sreelakshmi, ES; Sayyad, MG; Sethi, R				Pandey, Deeksha; Bansal, Suvrati; Goyal, Shubham; Garg, Akanksha; Sethi, Nikita; Pothiyill, Dan Isaac; Sreelakshmi, Edavana Santhosh; Sayyad, Mehmood Gulab; Sethi, Rishi			Psychological impact of mass quarantine on population during pandemics-The COVID-19 Lock-Down (COLD) study	PLOS ONE			English	Article							MENTAL-HEALTH; OUTBREAK	Background Quarantine often is an unpleasant experience. The aim of this study is to explore the degree of psychological distress in terms of-Depression, Anxiety and Stress among the adult population in India during the strict 21 days mandatory lockdown. We hypothesize that quantification of psychological impact of current situation will help us to modify the policies and implementation strategies. This assessment might also help in future to keep targeted services in place, to cope up with the psychological distress of the quarantined population. Method A cross sectional survey design was adopted to assess the psychological state of general population in India, during the COVID-19 mandatory lockdown period, with the help of a validated questionnaire. Findings The reported prevalence of depression was around 30.5%, which was the highest among the variables of psychological health. Anxiety was reported by 22.4%, followed by stress which was seen in 10.8% of respondents. In the third week the incidence of depression (37.8% versus 23.4%; p<0.001), anxiety (26.6% versus 18.2%; p<0.001) and stress (12.2% versus 9.3%; p<0.045) was reported to be significantly higher as compared to second week. Interpretation Our results suggest a progressively detrimental impact of lockdown on various aspects of psychological health. We noticed around eight to ten fold increase in the prevalence of depression (30.5%) and anxiety (22.4%) during lockdown, as compared to baseline statistics in Indian population (3 center dot 1-3 center dot 6% for depressive disorders and 3 center dot 0-3 center dot 5% for anxiety disorders).	[Pandey, Deeksha; Bansal, Suvrati; Goyal, Shubham; Garg, Akanksha; Pothiyill, Dan Isaac; Sreelakshmi, Edavana Santhosh] Manipal Acad Higher Educ MAHE, KMC Manipal, Manipal, India; [Sethi, Nikita] Ashoka Univ, Sonipat, India; [Sayyad, Mehmood Gulab] Abeda Inamdar Coll, Pune, Maharashtra, India; [Sethi, Rishi] King Georges Med Univ KGMU, Lucknow, Uttar Pradesh, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; King George's Medical University	Pandey, D (corresponding author), Manipal Acad Higher Educ MAHE, KMC Manipal, Manipal, India.	deekshiiiobg@gmail.com		Bansal, Suvrati/0000-0002-3129-3104; sethi, rishi/0000-0002-6745-6235				Anjum S, 2020, PSYCHIAT DANUB, V32, P245, DOI 10.24869/psyd.2020.245; [Anonymous], 2020, LANCET INFECT DIS, V20, P511; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Azim D, 2020, INFECT CONT HOSP EP, V41, P989, DOI 10.1017/ice.2020.127; Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114095; Tran BX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103577; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Ghosal S, 2020, DIABETES METAB SYND, V14, P311, DOI 10.1016/j.dsx.2020.03.017; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Ho CSH, 2020, ANN ACAD MED SINGAP, V49, P155; Huang YE, 2021, PSYCHOL HEALTH MED, V26, P23, DOI 10.1080/13548506.2020.1754438; Inchausti F, 2020, J CONTEMP PSYCHOTHER, V50, P243, DOI 10.1007/s10879-020-09460-w; Jung SJ, 2020, YONSEI MED J, V61, P271, DOI 10.3349/ymj.2020.61.4.271; Kaufman KR, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.25; Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron; Le HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124377; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120; Losada-Baltar A, 2021, J GERONTOL B-PSYCHOL, V76, pE10, DOI 10.1093/geronb/gbaa048; Monteith LL, 2021, J RURAL HEALTH, V37, P179, DOI 10.1111/jrh.12448; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rubin GJ, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m313; Sagar R, 2020, LANCET PSYCHIAT, V7, P148, DOI 10.1016/S2215-0366(19)30475-4; Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; Wang C, 2020, BRAIN BEHAV IMM 0413; Wang Cuiyan, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17051729; Xiao CF, 2020, PSYCHIAT INVEST, V17, P175, DOI 10.30773/pi.2020.0047; Yao H, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102015; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381	31	51	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240501	10.1371/journal.pone.0240501	http://dx.doi.org/10.1371/journal.pone.0240501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091020	gold, Green Published			2022-12-26	WOS:000586647200066
J	Thakur, M; Singh, A; Joshi, BD; Ghosh, A; Singh, SK; Singh, N; Sharma, LK; Chandra, K				Thakur, Mukesh; Singh, Abhishek; Joshi, Bheem Dutt; Ghosh, Avijit; Singh, Sujeet Kumar; Singh, Neha; Sharma, Lalit Kumar; Chandra, Kailash			Time-lapse sentinel surveillance of SARS-CoV-2 spread in India	PLOS ONE			English	Article							WEB SERVER; POPULATION-GROWTH; CORONAVIRUS	The novel coronavirus 2019 (COVID-19) global pandemic has drastically affected the world economy, raised public anxiety, and placed a substantial psychological burden on the governments and healthcare professionals by affecting over 4.7 million people worldwide. As a preventive measure to minimise the risk of community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in India, a nationwide lockdown was imposed initially for 21 days to limit the movement of 1.3 billion people. These restrictions continue in most areas, with a conditional relaxation occurring in a few Indian states. In an attempt to assess the emerging mutants of SARS-CoV-2 and determine their spread in India, we analysed 112 complete genomes of SARS-CoV-2 in a time-lapse manner. We found 72 distinct SARS-CoV-2 haplotypes, defined by 143 polymorphic sites and high haplotype diversity, suggesting that this virus possesses a high evolutionary potential. We also demonstrated that early introduction of SARS-CoV-2 into India was from China, Italy and Iran and observed signs of community spread of the virus following its rapid demographic expansion since its first outbreak in the country. Additionally, we identified 18 mutations in the SARS-CoV-2 spike glycoprotein and a few selected mutations showed to increase stability, binding affinity, and molecular flexibility in the overall tertiary structure of the protein that may facilitate interaction between the receptor binding domain (RBD) of spike protein and the human angiotensin-converting enzyme 2 (ACE2) receptor. The study provides a pragmatic view of haplotype-dependent spread of SARS-CoV-2 in India which could be important in tailoring the pharmacologic treatments to be more effective for those infected with the most common haplotypes. The findings based on the time-lapse sentinel surveillance of SARS-CoV-2 will aid in the development of a real-time practical framework to tackle the ongoing, fast-evolving epidemic challenges in the country.	[Thakur, Mukesh; Singh, Abhishek; Joshi, Bheem Dutt; Ghosh, Avijit; Singh, Sujeet Kumar; Sharma, Lalit Kumar; Chandra, Kailash] Zool Survey India, Kolkata, W Bengal, India; [Singh, Abhishek] Gujarat Forens Sci Univ, Gandhinagar, Gujarat, India; [Singh, Neha] Smithsonian Conservat Biol Inst, Front Royal, VA USA	Zoological survey of India; National Forensic Sciences University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Thakur, M (corresponding author), Zool Survey India, Kolkata, W Bengal, India.	thamukesh@gmail.com	Singh, Sujeet Kumar/ABC-2594-2020	Singh, Sujeet Kumar/0000-0002-3671-1328; Joshi, Bheem Dutt/0000-0002-6534-1119; Sharma, Lalit Kumar/0000-0003-1214-7416; Thakur, Mukesh/0000-0003-2609-7579; singh, Abhishek/0000-0002-2202-3719				Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banerjee AK, 2020, MUTATION HOT SPOTS S, P2020040281; Bhattacharya D, 2016, NUCLEIC ACIDS RES, V44, pW406, DOI 10.1093/nar/gkw336; BIOvIA D. S, 2015, DS DISC STUD MOD ENV; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Brufsky A, 2020, J MED VIROL, V92, P1386, DOI [10.1002/jmv.25902, 10.1002/jmv.25980]; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Cleemput S, 2020, BIOINFORMATICS, V36, P3552, DOI 10.1093/bioinformatics/btaa145; Eden JS, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa027; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Fu YX, 1997, GENETICS, V147, P915; Jia Y, 2020, 034942 BIORXIV; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai AL, 2020, J MED VIROL, V92, P675, DOI 10.1002/jmv.25723; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matsuda T, 2020, 08802V2 ARXIV, p08802v2; Mavian C, 2020, 020594 ARXIV, P0401020594; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; TAJIMA F, 1989, GENETICS, V123, P585; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Xue LC, 2016, BIOINFORMATICS, V32, P3676, DOI 10.1093/bioinformatics/btw514; Yadav PD, 2020, INDIAN J MED RES, V151, P200, DOI 10.4103/ijmr.IJMR_663_20; Yu WB, 2020, ZOOL RES, V41, P247, DOI 10.24272/j.issn.2095-8137.2020.022; Zehender G, 2020, J MED VIROL, V92, P1637, DOI 10.1002/jmv.25794; Zhang YZ, 2020, CELL, V181, P223, DOI 10.1016/j.cell.2020.03.035; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241172	10.1371/journal.pone.0241172	http://dx.doi.org/10.1371/journal.pone.0241172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091066	Green Published, gold			2022-12-26	WOS:000586647200025
J	Mumah, JN; Mulupi, S; Wado, YD; Ushie, BA; Nai, D; Kabiru, CW; Izugbara, CO				Mumah, Joyce N.; Mulupi, Stephen; Wado, Yohannes D.; Ushie, Boniface A.; Nai, Deladem; Kabiru, Caroline W.; Izugbara, Chimaraoke O.			Adolescents' narratives of coping with unintended pregnancy in Nairobi's informal settlements	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ABORTION; WOMEN; SOUTH; RISK; KENYA; BIRTH; AGE	Aim This study explored adolescent experiences and coping strategies for unintended pregnancy in two informal settlements-Viwandani and Korogocho-in Nairobi, Kenya. Methods Forty-nine in-depth-interviews and eight focus group discussions were conducted with male and female adolescents aged 15-19 years from households in two informal settlements. Participants were purposively selected to include adolescents of varying socio-demographic characteristics, including the married and unmarried, and adolescents who had never/ever been pregnant. Data were transcribed, translated verbatim and analyzed thematically. Results Adolescents attributed unintended pregnancy to poverty, sexual violence and inconsistent contraceptive use. Lack of parental support and guidance, as well as household conflicts also exposed girls to early sexual debut and risky sexual behavior. Decisions about pregnancy management centered on carrying the pregnancy to term or terminating it. Deciding to terminate a pregnancy was not always straightforward and was motivated by concerns about stigma or shame, and school disruption. Participants reiterated that carrying an unintended pregnancy to term disrupts adolescents' schooling, with few girls returning to school after childbirth. Upon deciding to carry a pregnancy to term, adolescents used several coping strategies such as relocating from usual residence, hiding until delivery and planning to put up the child for adoption upon delivery. Conclusions Early interventions to provide adolescents with comprehensive pregnancy prevention information and to address sexual violence and poverty can prevent unintended pregnancy in adolescents. Efforts to support adolescents to positively cope with unintended pregnancy and facilitate re-entry to school are also warranted.	[Mumah, Joyce N.; Mulupi, Stephen; Wado, Yohannes D.; Ushie, Boniface A.; Kabiru, Caroline W.] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Nai, Deladem] Populat Council, Accra, Ghana; [Kabiru, Caroline W.; Izugbara, Chimaraoke O.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Izugbara, Chimaraoke O.] Int Ctr Res Women ICRW, Washington, DC USA	African Population & Health Research Centre; University of Witwatersrand	Wado, YD (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	ywado@aphrc.org		Wado, Yohannes Dibaba/0000-0002-7200-6116	Department for International Development (DFID) through Population Council for the `STEP UP' (Strengthening Evidence for Programming for Unintended Pregnancy"project [SR1109D-6]	Department for International Development (DFID) through Population Council for the `STEP UP' (Strengthening Evidence for Programming for Unintended Pregnancy"project	The study was funded by the Department for International Development (DFID) through a subaward from the Population Council for the `STEP UP' (Strengthening Evidence for Programming for Unintended Pregnancy"project (grant number SR1109D-6). The STEP UP project was carried out in the Nairobi Urban Health and Demographic Surveillance System (NUHDSS) in collaboration with the London School of Hygiene and Tropical Medicine (LSHTM), icddr,B, and Population Council.	African Population and Health Research Center, 2014, POP HLTH DYN NAIR IN; African Population and Health Research Center, 2002, POP HLTH DYN NAIR IN; African Population and Health Research Center Ministry of Health (MOH) K Ipas Institute G, 2013, INCIDENCE COMPLICATI; Beguy D, 2015, INT J EPIDEMIOLOGY; Beguy D, 2013, STATUS REPORT SEXUAL; Birungi H, 2015, ED SECTOR RESPONSE E; Chung HW, 2018, J ADOLESCENCE, V69, P180, DOI 10.1016/j.adolescence.2018.10.007; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Darroch JE, 2016, ADDING IT COSTS BENE; Diamond I, 1999, J ROY STAT SOC A STA, V162, P273, DOI 10.1111/1467-985X.00135; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; Gueye A, 2015, INT PERSPECT SEX R H, V41, P191, DOI 10.1363/4119115; Izugbara C, 2014, INT J SEX HEALTH, V26, P100, DOI 10.1080/19317611.2013.831965; Kearney M, 2012, NATL BUREAU EC RES; Kearney MS, 2012, J ECON PERSPECT, V26, P141, DOI 10.1257/jep.26.2.141; Kearney S, NBER WORKING PAPER S; Kenya National Bureau of Statistics, 2015, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics (KNBS) and ICF Micro, 2014, KENYA DEMOGRAPHIC HL; Kilburn K, 2018, AIDS, V32, P1669, DOI 10.1097/QAD.0000000000001866; Lince-Deroche N, 2015, AFR J REPROD HEALTH, V19, P73; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Merrick T. W., 2015, MAKING CASE INVESTIN; Muganda-Onyando R, 2008, DRAIN COUNTING COST; Mumah J, 2014, STEP RES REPORT NAIR; Mumah JN, 2015, STUD FAMILY PLANN, V46, P369, DOI 10.1111/j.1728-4465.2015.00038.x; Omwancha KM, 2012, IMPLEMENTATION ED RE, DOI [10.1016/j.ijpharm.2012.11.022, DOI 10.1016/J.IJPHARM.2012.11.02223200955]; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Population Council, 2015, CONC MEAS UN PREGN B; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Shah IH, 2012, REPROD HEALTH MATTER, V20, P169, DOI 10.1016/S0968-8080(12)39598-0; Singh S, 2012, ADDING IT COSTS BENE; Stoebenau Kirsten, 2011, Global Health, V7, P34, DOI 10.1186/1744-8603-7-34; Undie C.-C., 2015, KNOWL COMMONS, DOI [10.31899/rh4.1040, DOI 10.31899/RH4.1040]; Uren Zoe, 2007, Health Stat Q, P34; Ushie BA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0521-4; Vikat A, 2002, J EPIDEMIOL COMMUN H, V56, P659, DOI 10.1136/jech.56.9.659; WHO, 2014, SUMM TABL DALYS YLLS; World Health Organization, 2014, HLTH WORLDS AD; World Health Organization (WHO), AD PREGN FACT SHEET; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933; 2015, SEWAGE DISPOSAL CLOV, V15	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240797	10.1371/journal.pone.0240797	http://dx.doi.org/10.1371/journal.pone.0240797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119610	Green Published, gold			2022-12-26	WOS:000600013600009
J	Griffiths, CA; Wright, SR; Silva, JF; Ellis, JR; Righton, DA; Phillips, SRM				Griffiths, Christopher A.; Wright, Serena R.; Silva, Joana F.; Ellis, Jim R.; Righton, David A.; Phillips, Sophy R. McCully			Horizontal and vertical movements of starry smooth-hound Mustelus asterias in the northeast Atlantic	PLOS ONE			English	Article							EUROPEAN CONTINENTAL-SHELF; FREE-RANGING FISH; ENGLISH-CHANNEL; ENVIRONMENTAL VARIABLES; DICENTRARCHUS-LABRAX; POPULATION-STRUCTURE; GENETIC-STRUCTURE; PRIONACE-GLAUCA; DIEL VARIATION; CLIMATE-CHANGE	Commercial landings of starry smooth-hound Mustelus asterias in northern European seas are increasing, whilst our knowledge of their ecology, behaviour and population structure remains limited. M. asterias is a widely distributed demersal shark, occupying the waters of the southern North Sea and Irish Sea in the north, to at least the southern Bay of Biscay in the south, and is seasonally abundant in UK waters. There are no species-specific management measures for the northeast Atlantic stock, and the complexity of its population structure is not yet fully understood. To address this issue, we deployed both mark-recapture and electronic tags on M. asterias to gain novel insights into its horizontal and vertical movements. Our data suggest that the habitat use of M. asterias changes on a seasonal basis, with associated changes in geographical distribution, depth utilisation and experienced temperature. We report the first direct evidence of philopatry for this species, and also provide initial evidence of sex-biased dispersal and potential metapopulation-like stock structuring either side of the UK continental shelf. Investigations of finer-scale vertical movements revealed clear diel variation in vertical activity. The illustrated patterns of seasonal space-use and behaviour will provide important information to support the stock assessment process and will help inform any future management options.	[Griffiths, Christopher A.; Wright, Serena R.; Silva, Joana F.; Ellis, Jim R.; Righton, David A.; Phillips, Sophy R. McCully] Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England; [Griffiths, Christopher A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England	Centre for Environment Fisheries & Aquaculture Science; University of Sheffield	Griffiths, CA (corresponding author), Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England.; Griffiths, CA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England.	c.a.griffiths@sheffield.ac.uk		McCully Phillips, Sophy/0000-0003-3110-5916; Fernandes da Silva, Joana/0000-0002-2897-1410; Wright, Serena/0000-0003-4912-1455; Righton, David/0000-0001-8643-3672; Griffiths, Christopher/0000-0001-7203-0426	European Maritime and Fisheries Fund [ENG 1395]; Defra; Cefas' science development scheme	European Maritime and Fisheries Fund; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Cefas' science development scheme	This work was funded by the European Maritime and Fisheries Fund project ENG 1395, Defra and Cefas' science development scheme. The funders provided support for consumables, field work and staff time for all authors (CAG, SRW, JFS, JRE, DAR and SMP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; [Anonymous], 2009, CARDIOVASCULAR THERA, V8, pS4; [Anonymous], 2011, BR J DIABETES VASC D, V11, P159; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2007, QOS EN IP NETW ASS M, V345, P1, DOI DOI 10.3354/MEPS07140; [Anonymous], 2019, LANCET DIGITAL HLTH; [Anonymous], 2009, STUDIES CULTURE ART, V02, P53; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2008, AM J HEALTH-SYST PH, V65, P2367; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Benoit HP, 2003, ICES J MAR SCI, V60, P1298, DOI 10.1016/S1054-3139(03)00124-3; Bird C, 2020, J MAR BIOL ASSOC UK, V100, P121, DOI 10.1017/S0025315419000997; Boulcott P, 2007, ICES J MAR SCI, V64, P369, DOI 10.1093/icesjms/fsl033; Breve NWP, 2016, J FISH BIOL, V89, P1158, DOI 10.1111/jfb.12994; Burt G, 2006, SCI SERIES TECHNICAL, V135; Burt G, 2013, SUMMARY RESULTS OPPO; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Coiraton C, 2020, MAR BIOL, V167, DOI 10.1007/s00227-020-3668-0; Compagno LJV, 1984, FAO SPECIES CATALOGU, V4, P125; Couch J, 1862, HIST FISHES BRIT ISL, V1; de Pontual H, 2019, ICES J MAR SCI, V76, P501, DOI 10.1093/icesjms/fsy086; Dean MJ, 2014, ICES J MAR SCI, V71, P1474, DOI 10.1093/icesjms/fsu040; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Ellis J.R., 2005, J NW ATL FISH SCI, V37, P195, DOI [10.2960/J.v35.m485, DOI 10.2960/J.V35.M485]; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Escatel-Luna E, 2015, J HERED, V106, P355, DOI 10.1093/jhered/esv030; Farrell E, 2015, FISH ATLAS CELTIC SE, P76; Farrell ED, 2010, J FISH BIOL, V77, P1505, DOI 10.1111/j.1095-8649.2010.02771.x; FRANCIS MP, 1988, NEW ZEAL J MAR FRESH, V22, P259, DOI 10.1080/00288330.1988.9516298; GEBCO, 2017, GEN BATH CHART OC; Griffiths CA, 2018, ECOL EVOL, V8, P7031, DOI 10.1002/ece3.4223; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hobson VJ, 2007, MAR ECOL PROG SER, V347, P101, DOI 10.3354/meps07047; Hobson VJ, 2009, AQUAT BIOL, V5, P133, DOI 10.3354/ab00144; Hoffmayer ER, 2013, B MAR SCI, V89, P551, DOI 10.5343/bms.2012.1048; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hunter E, 2004, MAR ECOL PROG SER, V279, P261, DOI 10.3354/meps279261; Hunter E, 2004, MAR BIOL, V144, P787, DOI 10.1007/s00227-003-1242-1; Hunter E, 2004, J ANIM ECOL, V73, P377, DOI 10.1111/j.0021-8790.2004.00801.x; Hunter E, 2003, MAR BIOL, V142, P601, DOI 10.1007/s00227-002-0984-5; ICES, 2019, SMOOTH HOUND MUST SP; Kerr LA, 2017, ICES J MAR SCI, V74, P1708, DOI 10.1093/icesjms/fsw188; King JR, 2010, FISH RES, V101, P50, DOI 10.1016/j.fishres.2009.09.006; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Kovach AI, 2010, MAR ECOL PROG SER, V410, P177, DOI 10.3354/meps08612; Le Danois E, 1913, CONTRIBUTION ETUDE S; Lindegren M, 2010, MAR ECOL PROG SER, V402, P239, DOI 10.3354/meps08454; Macleod CD, 2009, J MAR BIOL ASSOC UK, V89, P1059, DOI 10.1017/S0025315408002828; Martin CS, 2012, J EXP MAR BIOL ECOL, V418, P91, DOI 10.1016/j.jembe.2012.03.010; McCully Phillips SR, 2019, C7246 CEFAS; McMillan MN, 2019, ICES J MAR SCI, V76, P1083, DOI 10.1093/icesjms/fsy181; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Michalsen K, 1996, ICES J MAR SCI, V53, P389, DOI 10.1006/jmsc.1996.0054; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Pawson MG, 2007, ICES J MAR SCI, V64, P332, DOI 10.1093/icesjms/fsl035; PAWSON MG, 1987, J MAR BIOL ASSOC UK, V67, P183, DOI 10.1017/S0025315400026448; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Phillips SRM, 2015, J FISH BIOL, V87, P1411, DOI 10.1111/jfb.12826; Phillips SRM, 2020, J FISH BIOL, V96, P590, DOI 10.1111/jfb.14245; Portnoy DS, 2015, MOL ECOL, V24, P5877, DOI 10.1111/mec.13441; Queero JC, 2003, GUIDE POISSONS LATLA; Quero JC, 1998, ITAL J ZOOL, V65, P493, DOI 10.1080/11250009809386873; R Core Team, 2019, LANG ENV STAT COMP; Raby GD, 2020, J APPL ECOL, V57, P181, DOI 10.1111/1365-2664.13522; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Righton D, 2007, J MAR BIOL ASSOC UK, V87, P599, DOI 10.1017/S0025315407054641; Robichaud D, 2001, CAN J FISH AQUAT SCI, V58, P2325, DOI 10.1139/cjfas-58-12-2325; Sandoval-Castillo J, 2015, MAR ECOL PROG SER, V533, P191, DOI 10.3354/meps11395; Saulquin B, 2010, INT J REMOTE SENS, V31, P4069, DOI 10.1080/01431160903199155; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Sefick S., 2016, STREAM METABOLISM PA; Shiffman DS, 2012, MAR FRESHWATER RES, V63, P635, DOI 10.1071/MF11235; Skjaeraasen JE, 2012, P NATL ACAD SCI USA, V109, P8995, DOI 10.1073/pnas.1200223109; Stebbing ARD, 2002, J MAR BIOL ASSOC UK, V82, P177, DOI 10.1017/S0025315402005325; Stephenson RL, 1999, FISH RES, V43, P247, DOI 10.1016/S0165-7836(99)00076-4; Sulikowski JA, 2010, MAR ECOL PROG SER, V418, P249, DOI 10.3354/meps08821; TAYLOR AH, 1983, OCEANOL ACTA, V6, P63; The Lancet HIV, 2017, LANCET HIV, V4, pe51; The Mathworks Inc, 2011, MATLAB; van Aken HM, 2008, J SEA RES, V60, P227, DOI 10.1016/j.seares.2008.09.001; Vandeperre F, 2014, FISH RES, V153, P89, DOI 10.1016/j.fishres.2014.01.006; VAS P, 1990, ENVIRON BIOL FISH, V29, P209, DOI 10.1007/BF00002221; Wearmouth VJ, 2009, J EXP MAR BIOL ECOL, V380, P77, DOI 10.1016/j.jembe.2009.07.035; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	90	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239480	10.1371/journal.pone.0239480	http://dx.doi.org/10.1371/journal.pone.0239480			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112858	Green Accepted, Green Published, gold			2022-12-26	WOS:000588374000003
J	Hailu, D; Belay, A				Hailu, Demelash; Belay, Abera			Melissopalynology and antioxidant properties used to differentiate Schefflera abyssinica and polyfloral honey	PLOS ONE			English	Article							HARENNA FOREST HONEY; PHYSICOCHEMICAL PROPERTIES; BOTANICAL ORIGIN; PHENOLIC CONTENT; ANTIMICROBIAL ACTIVITY; CLASSIFICATION; SAMPLES; COLOR; ANTIBACTERIAL; PROFILES	Honey can be categorized as monofloral and polyfloral honey. There is a strong interest in science and commerce, to further differentiate honey. In the present study, Schefflera abyssinica and polyfloral honey from Sheka Forest, Ethiopia was investigated. Botanical origin was determined based on Melissopalynology. Refractive index, moisture, sugars, ash, pH, free acidity, hydroxymethylfurfural, optical density, diastase activity, protein, and color were determined based on the standard method of the international honey commission (IHC) and AOAC. Antioxidant activity and Antioxidant content were determined using UV- visible spectroscopy. The level of pollen dominancy for monofloral honey (Schefflera abyssinica) ranged from 76.2 to 85.8%. The polyfloral honey stuffed with a variety of pollen grain ranged from 2.2% (Coffea arabica) to 23.2% (Schefflera abyssinica). Schefflera abyssinica honey contained more total phenolic compounds (75.08 +/- 2.40 mg GAE/100g), and total flavonoids (42.03 +/- 1.49 mg QE/100 g), as well as had stronger DPPH (44.43 +/- 0.97%) and hydrogen peroxide (78.00 +/- 4.82%) scavenging activity. The principal component analysis revealed that Schefflera abyssinica honey associated with the antioxidant properties of total phenolic, total flavonoids, DPPH, and H2O2., which revealed that floral honey sources can essentially differentiated by antioxidant patterns. The higher electrical conductivity (0.42 +/- 0.02 mS/cm), ash (0.41 +/- 0.05 g/100g), pH (4.01 +/- 0.08), optical density (0.26 +/- 0.03) and diastase activity (5.21 +/- 0.17 Schade units) were recorded in polyfloral honey. Schefflera abyssinica and polyfloral honey satisfy the requirement of national and international standards. The pollen analysis in combination with antioxidant properties distinguishes Schefflera abyssinica from polyfloral honeys.	[Hailu, Demelash; Belay, Abera] Addis Ababa Sci & Technol Univ, Dept Food Sci & Appl Nutr, Addis Ababa, Ethiopia	Addis Ababa University	Belay, A (corresponding author), Addis Ababa Sci & Technol Univ, Dept Food Sci & Appl Nutr, Addis Ababa, Ethiopia.	ab.berabelay@gmail.com						Abdulkhaliq A, 2017, INT J FOOD PROP, V20, P447, DOI 10.1080/10942912.2016.1166128; Alvarez-Suarez JM, 2012, FOOD CHEM TOXICOL, V50, P1508, DOI 10.1016/j.fct.2012.01.042; Anklam E, 1998, FOOD CHEM, V63, P549, DOI 10.1016/S0308-8146(98)00057-0; [Anonymous], 2020, NAT REV EARTH ENV, V1, P1, DOI 10.1038/s43017-019-0017-2; [Anonymous], 2011, INT J CYBER BEHAV PS, V1, P36; [Anonymous], 2013, N 1, V17, DOI DOI 10.1093/NDT/GFV100; [Anonymous], 2019, HOLOS UKRAJINY; [Anonymous], 2013, J LIFE SCI; [Anonymous], 2019, ARCHITEKTURA MURATOR; [Anonymous], 1999, AUGUSTINIAN STUDIES, V30, P57; [Anonymous], 2018, BIZNES, V10-11, P6; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; [Anonymous], 2018, DIAB PRAKT, V4, P1, DOI DOI 10.1186/s40798-017-0116-x; [Anonymous], 1985, NIH CONSENSUS STATEM, V5, P1; Anupama D, 2003, FOOD RES INT, V36, P183, DOI 10.1016/S0963-9969(02)00135-7; AOAC, 2000, OFFICIAL METHODS ANA, V17th, P17; de Sousa JMB, 2016, LWT-FOOD SCI TECHNOL, V65, P645, DOI 10.1016/j.lwt.2015.08.058; Belay A, 2017, J FOOD SCI TECH MYS, V54, P2769, DOI 10.1007/s13197-017-2713-6; Belay A, 2017, LWT-FOOD SCI TECHNOL, V75, P393, DOI 10.1016/j.lwt.2016.09.021; Belay A, 2015, FOOD CHEM, V167, P213, DOI 10.1016/j.foodchem.2014.06.080; Belay A, 2013, FOOD CHEM, V141, P3386, DOI 10.1016/j.foodchem.2013.06.035; Ben Sghaier M, 2011, ENVIRON TOXICOL PHAR, V32, P336, DOI 10.1016/j.etap.2011.07.003; Bertoncelj J, 2007, FOOD CHEM, V105, P822, DOI 10.1016/j.foodchem.2007.01.060; Bogdanov, 2009, HARMONIZED METHOD IN, P1; Chakir A, 2016, ARAB J CHEM, V9, pS946, DOI 10.1016/j.arabjc.2011.10.013; Chakrabarty D, 2018, HIST THEORY, V57, P5, DOI 10.1111/hith.12044; Ciappini M, 2016, INT J FOOD PROP, V19, P111, DOI 10.1080/10942912.2015.1020436; Consonni R, 2015, RSC ADV, V5, P59696, DOI 10.1039/c5ra05828g; da Silva PM, 2016, FOOD CHEM, V196, P309, DOI 10.1016/j.foodchem.2015.09.051; do Nascimento KS, 2018, LWT-FOOD SCI TECHNOL, V91, P85, DOI [10.1016/.j.lwt.2018.01.016, 10.1016/j.lwt.2018.01.016]; Dobre I, 2012, FOOD RES INT, V49, P126, DOI 10.1016/j.foodres.2012.08.009; El-Borai AM, 2018, EGYPT J BOT, V58, P97, DOI 10.21608/ejbo.2018.1015.1088; EL-Metwally AAE, 2015, THESIS, V1, P133; El-Sohaimy S. A., 2015, Annals of Agricultural Science (Cairo), V60, P279, DOI 10.1016/j.aoas.2015.10.015; ESA, 2013, COMP ETH STAND DRINK; Escuredo O, 2013, FOOD CHEM, V138, P851, DOI 10.1016/j.foodchem.2012.11.015; Estevinho LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162206; EU Council, 2002, OFF J EUR COMMUNITIE, V10, P47; Ferreira ICFR, 2009, FOOD CHEM, V114, P1438, DOI 10.1016/j.foodchem.2008.11.028; Fichtl R, 1994, HONEYBEE FLORA ETHIO, V1994; Fisher DA, 2013, GASTROINTEST ENDOSC, V78, P8, DOI 10.1016/j.gie.2013.04.163; Gomes S, 2010, FOOD CHEM TOXICOL, V48, P544, DOI 10.1016/j.fct.2009.11.029; Goslinski M, 2020, J FOOD SCI TECH MYS, V57, P1269, DOI 10.1007/s13197-019-04159-w; Gulfraz M, 2011, INT J FOOD SCI TECH, V46, P263, DOI 10.1111/j.1365-2621.2010.02488.x; Habib HM, 2014, FOOD CHEM, V153, P35, DOI 10.1016/j.foodchem.2013.12.048; Nguyen HTL, 2018, FOOD CHEM, V241, P143, DOI 10.1016/j.foodchem.2017.08.070; Islam A, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-177; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kamal A., 2002, J BIOL SCI, V2, P626; Kamal MA, 2011, SAUDI J BIOL SCI, V18, P17, DOI 10.1016/j.sjbs.2010.09.003; Karabagias IK, 2014, FOOD CHEM, V146, P548, DOI 10.1016/j.foodchem.2013.09.105; Karabournioti S., 2017, J BOT SCI RES REV, V6, P32; Khalil MI, 2012, MOLECULES, V17, P11199, DOI 10.3390/molecules170911199; Kifle TB, 2014, AM J AGR FOR, V2, P278, DOI DOI 10.11648/J.AJAF.20140206.18; Kishore RK, 2011, NUTR RES, V31, P322, DOI 10.1016/j.nutres.2011.03.001; Kivrak S, 2017, FOOD SCI TECH-BRAZIL, V37, P80, DOI [10.1590/1678-457X.07916, 10.1590/1678-457x.07916]; Kortesniemi M, 2018, FOOD CHEM, V246, P351, DOI 10.1016/j.foodchem.2017.10.069; Kowalski S, 2013, FOOD CHEM, V141, P1378, DOI 10.1016/j.foodchem.2013.04.025; Kruczek A, 2015, ACTA BIOLOGICA, V22, P120; Leontowicz Hanna, 2007, Medycyna Weterynaryjna, V63, P1434; Liza A-Rahaman N., 2013, AGR SCI, V4, P46, DOI DOI 10.4236/AS.2013.45B009; Marghitas LA, 2009, FOOD CHEM, V112, P863, DOI 10.1016/j.foodchem.2008.06.055; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moniruzzaman M, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-43; Munuera Giner M., 1994, Alimentaria, V31, P37; Nestle, 2007, NUTRIPRO NESTLE PROF, V1, P1; Oroian M, 2017, J FOOD MEAS CHARACT, V11, P719, DOI 10.1007/s11694-016-9441-x; Ouchemoukh S, 2007, FOOD CONTROL, V18, P52, DOI 10.1016/j.foodcont.2005.08.007; Owayss A. A., 2005, EGYPT J APPL SCI, V20, P247; Pontis JA, 2014, FOOD SCI TECH-BRAZIL, V34, P69, DOI 10.1590/S0101-20612014005000015; RUCH RJ, 1989, CARCINOGENESIS, V10, P1003, DOI 10.1093/carcin/10.6.1003; Ruiz-Navajas Y, 2011, INT J FOOD PROP, V14, P459, DOI 10.1080/10942910903249480; Ruoff K, 2007, APIDOLOGIE, V38, P438, DOI 10.1051/apido:2007027; Serem JC, 2012, FOOD CHEM, V133, P1544, DOI 10.1016/j.foodchem.2012.02.047; Sime D, 2015, B CHEM SOC ETHIOPIA, V29, P163, DOI 10.4314/bcse.v29i2.1; Stagos D, 2018, INT J MOL MED, V42, P726, DOI 10.3892/ijmm.2018.3656; Sumitra Maurya, 2014, Indian Journal of Natural Products and Resources, V5, P9; Szczesna T, 2011, J APIC SCI, V55, P111; Temizer Ilginc Kizilpinar, 2016, HACETTEPE JOURNAL OF BIOLOGY AND CHEMISTRY, V44, P209, DOI 10.15671/HJBC.20164420563; Thrasyvoulou A, 2018, J APICULT RES, V57, P88, DOI 10.1080/00218839.2017.1411181; Tornuk F, 2013, IND CROP PROD, V46, P124, DOI 10.1016/j.indcrop.2012.12.042; Turbay CV Gabrig, 2013, GEOL USP SER CIENT, V13, P2, DOI [10.5327/Z1519-874X201300040002, DOI 10.5327/Z1519-874X201300040002]; Vit P., 2009, J APIPRODUCT APIMEDI, V1, P72; Wilczynska Aleksandra, 2010, Polish Journal of Food and Nutrition Sciences, V60, P309; Zhou JH, 2014, FOOD CHEM, V145, P941, DOI 10.1016/j.foodchem.2013.08.117; 2001, 121981 CODEX STAN, V11, P1	86	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240868	10.1371/journal.pone.0240868	http://dx.doi.org/10.1371/journal.pone.0240868			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112916	gold, Green Published			2022-12-26	WOS:000588374000017
J	Kakehashi, E; Muramatsu, K; Hibino, H				Kakehashi, Erina; Muramatsu, Keiichi; Hibino, Haruo			Perceptual holistic color combination analysis of Papilionidae butterflies as aesthetic objects	PLOS ONE			English	Article							IMAGE	In this study, we clarified the holistic color combination rules of human-preferred Papilionidae butterflies by examining the hue, lightness, and chroma. A set of 118 Papilionidae butterfly images used in our previous study was analyzed. These images were classified via hierarchical density-based spatial clustering based on perceptual similarities of colors that were obtained from a subjective image classification experiment. The color combinations of the clustered images were determined based on representative colors that were analyzed by a Gaussian mixture model with minimum message length and the color combination types defined in our previous study. Consequently, we obtained the following holistic color combination rules for Papilionidae: 1) contrasting lightness, similar chroma, and similar hue, 2) contrasting lightness, contrasting chroma, and similar hue, 3) similar lightness, similar chroma, and complementary hue, and 4) similar lightness, similar chroma, and similar hue. These rules suggest that minority color harmony theories are valid under particular conditions.	[Kakehashi, Erina] Keio Univ, Global Res Inst, Tokyo, Japan; [Muramatsu, Keiichi] Waseda Univ, Global Educ Ctr, Tokyo, Japan; [Hibino, Haruo] Chiba Univ, Grad Sch Engn, Chiba, Japan	Keio University; Waseda University; Chiba University	Kakehashi, E (corresponding author), Keio Univ, Global Res Inst, Tokyo, Japan.	kakehashi@keio.jp		Kakehashi, Erina/0000-0002-1762-7542				[Anonymous], 2008, J COLOR SCI ASS JAPA; [Anonymous], 1997, OFF J BASIC DES ART; [Anonymous], 2011, NEUROCHEM RES, V36, P355; [Anonymous], 2008, COSTUME TEXTILE; Beldade P, 2002, NAT REV GENET, V3, P442, DOI 10.1038/nrg818; Blanchard CE., 2005, US patent, Patent No. [6,870,544, 6870544]; Breuer GB, 2015, INT J SCI EDUC, V37, P2664, DOI 10.1080/09500693.2015.1099171; Campello Ricardo J. G. B., 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P160, DOI 10.1007/978-3-642-37456-2_14; Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7; Chuang MC, 2001, COLOR RES APPL, V26, P29, DOI 10.1002/1520-6378(200102)26:1<29::AID-COL4>3.0.CO;2-B; Commission Internationale De L'Eclairage (CIE), 2004, CIE PUB, V3rd; Design Seeds, 2009, ALL WHO LOV COL; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Hsiao SW, 2015, COLOR RES APPL, V40, P612, DOI 10.1002/col.21929; Kakehashi E, 2020, COLOR RES APPL, V45, P65, DOI 10.1002/col.22454; Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007; Kobayasi M, 1999, P INT S MULT IM COL, P139; Konstantinidis K, 2005, OPT COMMUN, V248, P375, DOI 10.1016/j.optcom.2004.12.029; Layberry R, 1998, BUTTERFLIES CANADA, V77; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Matsuka M, 1998, AJIA KONCHU SHIGEN I; Ou LC, 2006, COLOR RES APPL, V31, P191, DOI 10.1002/col.20208; Ou LC, 2018, COLOR RES APPL, V43, P736, DOI 10.1002/col.22243; Rogowitz BE, 1998, P SOC PHOTO-OPT INS, V3299, P576, DOI 10.1117/12.320148; Shipley NJ, 2017, ANTHROZOOS, V30, P357, DOI 10.1080/08927936.2017.1335083; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Szabo F, 2010, COLOR RES APPL, V35, P34, DOI 10.1002/col.20558; Tan KS, 2011, PATTERN RECOGN, V44, P1, DOI 10.1016/j.patcog.2010.07.013; Wu YM, 2003, ICICS-PCM 2003, VOLS 1-3, PROCEEDINGS, P541; 2015, PEDIAT DERMATOL, V32	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240356	10.1371/journal.pone.0240356	http://dx.doi.org/10.1371/journal.pone.0240356			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112869	Green Published, gold			2022-12-26	WOS:000588374000010
J	Perlejewski, K; Bukowska-Osko, I; Rydzanicz, M; Dzieciatkowski, T; Zakrzewska-Pniewska, B; Podlecka-Pietowska, A; Filipiak, A; Barc, K; Cortes, KC; Pawelczyk, A; Radkowski, M; Laskus, T				Perlejewski, Karol; Bukowska-Osko, Iwona; Rydzanicz, Malgorzata; Dzieciatkowski, Tomasz; Zakrzewska-Pniewska, Beata; Podlecka-Pietowska, Aleksandra; Filipiak, Agata; Barc, Krzysztof; Cortes, Kamila Caraballo; Pawelczyk, Agnieszka; Radkowski, Marek; Laskus, Tomasz			Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics	PLOS ONE			English	Article							ACUTE DISSEMINATED ENCEPHALOMYELITIS; ENVIRONMENTAL RISK-FACTORS; HUMAN HERPESVIRUS-6; DISEASE-ACTIVITY; INFECTION; VIRUS; ENCEPHALITIS; PATHOGENESIS; PROTEIN; HHV-6	Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system of unclear etiology, but there is some evidence that viral infections could be responsible for triggering autoimmune mechanisms against myelin. We searched for viral RNA and DNA in cerebrospinal fluid (CSF) of 34 MS patients and 13 controls using RT-PCR/PCR against common neurotropic viruses. In addition, shotgun DNA- and RNA-based metagenomics were done in 13 MS patients and 4 controls. Specific quantitative real-time RT-PCR/PCR testing revealed the presence of viral nucleic acid in seven (20.59%) MS patients and in one (7.69%) control patient. In MS patients the most frequently detected was human herpesvirus type 6 (HHV-6; 3 cases; 8.82%); followed by Epstein-Barr virus (EBV; 2 cases; 5.88%), varicella zoster virus (VZV; 1 case; 2.94%) and Enterovirus (EV; 1 case; 2.94%). The single identified virus among controls was EBV (7.69%). DNA and RNA metagenomic assays did not identify any known eukaryotic viruses even though three of the analyzed samples were low-level positive by specific quantitative real-time PCR. In conclusion, we detected the presence of Herpesviridae and occasionally Enteroviridae in CSF from patients with MS but their prevalence was not significantly higher than among controls. Metagenomic analysis seems to be less sensitive than real-time RT-PCR/PCR and it did not detect any potential viral pathogens.	[Perlejewski, Karol; Bukowska-Osko, Iwona; Cortes, Kamila Caraballo; Pawelczyk, Agnieszka; Radkowski, Marek] Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland; [Rydzanicz, Malgorzata] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Dzieciatkowski, Tomasz] Med Univ Warsaw, Dept Microbiol, Warsaw, Poland; [Zakrzewska-Pniewska, Beata; Podlecka-Pietowska, Aleksandra] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Filipiak, Agata; Barc, Krzysztof] Med Univ Warsaw, Univ Clin Ctr, Warsaw, Poland; [Laskus, Tomasz] Med Univ Warsaw, Dept Adult Infect Dis, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Perlejewski, K (corresponding author), Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland.	kperlejewski@wum.edu.pl	Dzieciatkowski, Tomasz/AAG-5382-2021; Barć, Krzysztof/AAD-4916-2019; Perlejewski, Karol/V-3854-2018; Pawelczyk, Agnieszka/M-4934-2018; Bukowska-Osko, Iwona/V-3859-2018	Barć, Krzysztof/0000-0001-9668-6446; Perlejewski, Karol/0000-0002-3782-6442; Podlecka-Pietowska, Aleksandra/0000-0003-3940-4662; Pawelczyk, Agnieszka/0000-0001-9336-8258; Filipiak-Duliban, Aleksandra/0000-0002-8118-8468; Bukowska-Osko, Iwona/0000-0002-0216-7184	National Science Center, Poland [2017/25/B/NZ6/01463]; Medical University of Warsaw, Poland [1M24/PM1/17]; Research Development Foundation in Hospital for Infectious Diseases, Warsaw, Poland	National Science Center, Poland(National Science Centre, Poland); Medical University of Warsaw, Poland; Research Development Foundation in Hospital for Infectious Diseases, Warsaw, Poland	This study was supported by Grant (TL); 2017/25/B/NZ6/01463 from the National Science Center, Poland (https://www.ncn.gov.pl/), Grant (KP); 1M24/PM1/17 from Medical University of Warsaw, Poland (http://www.wum.edu.pl/), and Grant (TL) from The Research Development Foundation in Hospital for Infectious Diseases, Warsaw, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi DV, 1998, MULT SCLER, V4, P490, DOI 10.1177/135245859800400606; Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Agin H, 2010, NEUROSCIENCES, V15, P46; Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; [Anonymous], 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1494; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2014, MULT SCLER MAN MULT; [Anonymous], 2019, CANCER DISCOV, V10, pOF5; [Anonymous], 2016, OBSTET GYNECOL; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bukowska-Osko I, 2017, ADV EXP MED BIOL, V944, P53, DOI 10.1007/5584_2016_42; Croxford J. Ludovic, 2002, Autoimmunity Reviews, V1, P251, DOI 10.1016/S1568-9972(02)00080-0; Dzieciqtkowski Tomasz, 2008, Medycyna Doswiadczalna i Mikrobiologia, V60, P259; Farrell RA, 2009, NEUROLOGY, V73, P32, DOI 10.1212/WNL.0b013e3181aa29fe; Gustafsson R, 2014, J MICROBIOL IMMUNOL, V47, P418, DOI 10.1016/j.jmii.2013.03.009; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; Jie JS, 2010, NANO TODAY, V5, P313, DOI 10.1016/j.nantod.2010.06.009; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kierat Szymon, 2012, Medycyna Doswiadczalna i Mikrobiologia, V64, P139; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Kuusisto H, 2008, MULT SCLER J, V14, P54, DOI 10.1177/1352458507080063; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leibovitch EC, 2014, CURR OPIN VIROL, V9, P127, DOI 10.1016/j.coviro.2014.09.016; Les Katarzyna, 2010, Medycyna Doswiadczalna i Mikrobiologia, V62, P245; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lipowski D, 2017, J INFECT DIS, V215, P896, DOI 10.1093/infdis/jix040; Loma I, 2011, CURR NEUROPHARMACOL, V9, P409, DOI 10.2174/157015911796557911; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; MUTINELLI F, 1989, ACTA NEUROPATHOL, V77, P333, DOI 10.1007/BF00687587; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; O'Gorman C, 2012, INT J MOL SCI, V13, P11718, DOI 10.3390/ijms130911718; Perlejewski K, 2016, ADV EXP MED BIOL, V935, P89, DOI 10.1007/5584_2016_25; Perlejewski K, 2015, J VIROL METHODS, V226, P1, DOI 10.1016/j.jviromet.2015.09.010; Pierrot-Deseilligny C, 2013, THER ADV NEUROL DISO, V6, P81, DOI 10.1177/1756285612473513; Pillai S, 2015, EUR J PAEDIATR NEURO, V19, P266, DOI 10.1016/j.ejpn.2014.12.015; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rynans S, 2015, ARCH IMMUNOL THER EX, V63, P79, DOI 10.1007/s00005-014-0320-z; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Smits SL, 2013, EMERG INFECT DIS, V19, P1511, DOI 10.3201/eid1909.130404; Sotelo J, 2014, CLIN NEUROL NEUROSUR, V119, P44, DOI 10.1016/j.clineuro.2013.12.020; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Tejada-Simon MV, 2002, J VIROL, V76, P6147, DOI 10.1128/JVI.76.12.6147-6154.2002; Thacker EL, 2006, ANN NEUROL, V59, P499, DOI 10.1002/ana.20820; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Virtanen JO, 2007, J NEUROVIROL, V13, P347, DOI 10.1080/13550280701381332; Virtanen JO, 2012, CNS NEUROL DISORD-DR, V11, P528; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Wingerchuk DM, 2012, THER ADV NEUROL DISO, V5, P13, DOI 10.1177/1756285611425694; Ysrraelit MC, 2019, IMMUNOLOGY, V156, P9, DOI 10.1111/imm.13004	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240601	10.1371/journal.pone.0240601	http://dx.doi.org/10.1371/journal.pone.0240601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112911	Green Published, gold			2022-12-26	WOS:000588374000031
J	Akamine, S; Okuzono, S; Yamamoto, H; Setoyama, D; Sagata, N; Ohgidani, M; Kato, TA; Ishitani, T; Kato, H; Masuda, K; Matsushita, Y; Ono, H; Ishizaki, Y; Sanefuji, M; Saitsu, H; Matsumoto, N; Kang, D; Kanba, S; Nakabeppu, Y; Sakai, Y; Ohga, S				Akamine, Satoshi; Okuzono, Sayaka; Yamamoto, Hiroyuki; Setoyama, Daiki; Sagata, Noriaki; Ohgidani, Masahiro; Kato, Takahiro A.; Ishitani, Tohru; Kato, Hiroki; Masuda, Keiji; Matsushita, Yuki; Ono, Hiroaki; Ishizaki, Yoshito; Sanefuji, Masafumi; Saitsu, Hirotomo; Matsumoto, Naomichi; Kang, Dongchon; Kanba, Shigenobu; Nakabeppu, Yusaku; Sakai, Yasunari; Ohga, Shouichi			GNAO1 organizes the cytoskeletal remodeling and firing of developing neurons	FASEB JOURNAL			English	Article						cytoskeleton; developmental and epileptic encephalopathy; G protein subunit alpha O1 (GNAO1); organoid; spectrin alpha; non&#8208; erythrocytic 1 (SPTAN1)	AXON INITIAL SEGMENT; ALPHA-II SPECTRIN; DE-NOVO MUTATIONS; INFANTILE EPILEPTIC ENCEPHALOPATHY; CEREBRAL ORGANOIDS; MOVEMENT-DISORDER; BRAIN-DEVELOPMENT; STEM-CELLS; ANKYRIN-G; ACTIVATION	Developmental and epileptic encephalopathy (DEE) represents a group of neurodevelopmental disorders characterized by infantile-onset intractable seizures and unfavorable prognosis of psychomotor development. To date, hundreds of genes have been linked to the onset of DEE. GNAO1 is a DEE-associated gene encoding the alpha-O1 subunit of guanine nucleotide-binding protein (G alpha(O)). Despite the increasing number of reported children with GNAO1 encephalopathy, the molecular mechanisms underlying their neurodevelopmental phenotypes remain elusive. We herein present that co-immunoprecipitation and mass spectrometry analyses identified another DEE-associated protein, SPTAN1, as an interacting partner of G alpha(O). Silencing of endogenous Gnao1 attenuated the neurite outgrowth and calcium-dependent signaling. Inactivation of GNAO1 in human-induced pluripotent stem cells gave rise to anomalous brain organoids that only weakly expressed SPTAN1 and Ankyrin-G. Furthermore, GNAO1-deficient organoids failed to conduct synchronized firing to adjacent neurons. These data indicate that G alpha(O) and other DEE-associated proteins organize the cytoskeletal remodeling and functional polarity of neurons in the developing brain.	[Akamine, Satoshi; Okuzono, Sayaka; Yamamoto, Hiroyuki; Matsushita, Yuki; Ono, Hiroaki; Ishizaki, Yoshito; Sanefuji, Masafumi; Sakai, Yasunari; Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan; [Setoyama, Daiki; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka, Japan; [Sagata, Noriaki; Ohgidani, Masahiro; Kato, Takahiro A.; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka, Japan; [Ishitani, Tohru] Gunma Univ, Inst Mol & Cellular Regulat, Div Integrated Signaling Syst, Maebashi, Gumma, Japan; [Ishitani, Tohru] Osaka Univ, Div Cellular & Mol Biol, Dept Homeostat Regulat, Res Inst Microbial Dis, Suita, Osaka, Japan; [Kato, Hiroki] Kyushu Univ, Grad Sch Dent Sci, Dept Mol Cell Biol & Oral Anat, Div Oral Biol Sci, Fukuoka, Japan; [Masuda, Keiji] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Oral Med Children, Fukuoka, Japan; [Saitsu, Hirotomo] Hamamatsu Univ, Dept Biochem, Sch Med, Hamamatsu, Shizuoka, Japan; [Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Gunma University; Osaka University; Kyushu University; Kyushu University; Hamamatsu University School of Medicine; Yokohama City University; Kyushu University	Sakai, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka 8128582, Japan.	ysakai22q13@gmail.com	Sanefuji, Masafumi/GRO-5252-2022; Saitsu, Hirotomo/AAM-7131-2021; Nakabeppu, Yusaku/A-8902-2011	Sanefuji, Masafumi/0000-0001-6036-5528; Kato, Hiroki/0000-0002-6529-659X; Nakabeppu, Yusaku/0000-0002-6739-242X	JSPS KAKENHI [JP19K08281, JP17H01539]; AMED [JP19ek0109411, JP19ek0109280, JP19ek0109348, JP18kk020501]; Health and Labour Sciences Research Grant; Ministry of Health, Labour and Welfare of Japan; Life Science Foundation of Japan; Takeda Science Foundation; The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Health and Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	JSPS KAKENHI, Grant/Award Number: JP19K08281 and JP17H01539; AMED, Grant/Award Number: JP19ek0109411, JP19ek0109280, JP19ek0109348 and JP18kk020501; Health and Labour Sciences Research Grant; Ministry of Health, Labour and Welfare of Japan; Life Science Foundation of Japan; Takeda Science Foundation; The Mother and Child Health Foundation; The Japan Epilepsy Research Foundation; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics	Ackermann A, 2019, J ONCOL, V2019, DOI 10.1155/2019/7079604; Akamine Satoshi, 2018, Epilepsia Open, V3, P81, DOI 10.1002/epi4.12085; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; Baldwin PR, 2016, AUTISM RES, V9, P553, DOI 10.1002/aur.1559; COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x; Danti FR, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000143; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Feng HJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211066; Feng HJ, 2018, NEUROBIOL DIS, V116, P131, DOI 10.1016/j.nbd.2018.05.005; Feng HJ, 2017, NEUROLOGY, V89, P762, DOI 10.1212/WNL.0000000000004262; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gerald B, 2018, SEMIN PEDIATR NEUROL, V26, P28, DOI 10.1016/j.spen.2017.08.008; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamdan FF, 2017, AM J HUM GENET, V101, P664, DOI 10.1016/j.ajhg.2017.09.008; Hillenbrand M, 2015, P NATL ACAD SCI USA, V112, pE1181, DOI 10.1073/pnas.1417573112; Huang CYM, 2017, J NEUROSCI, V37, P11311, DOI 10.1523/JNEUROSCI.2112-17.2017; Nguyen HTN, 2019, BIOCHEM BIOPH RES CO, V513, P1048, DOI 10.1016/j.bbrc.2019.04.084; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kato H, 2017, CELL STRUCT FUNCT, V42, P105, DOI 10.1247/csf.17012; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; Kurian MA, 2010, BRAIN, V133, P2964, DOI 10.1093/brain/awq238; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lau BYC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221052; Leterrier C, 2016, CURR TOP MEMBR, V77, P185, DOI 10.1016/bs.ctm.2015.10.005; Leterrier C, 2014, SEMIN CELL DEV BIOL, V27, P44, DOI 10.1016/j.semcdb.2013.11.001; LOMBROSO CT, 1990, J CLIN NEUROPHYSIOL, V7, P380, DOI 10.1097/00004691-199007000-00005; Luchtenborg AM, 2014, DEVELOPMENT, V141, P3399, DOI 10.1242/dev.106773; MATSUSHITA Y, 2016, SCI REP UK, V6; McCartney CSE, 2018, BBA-MOL CELL RES, V1865, P221, DOI 10.1016/j.bbamcr.2017.10.013; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Ohkubo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13191; OHTAHARA S, 1987, BRAIN DEV-JPN, V9, P371, DOI 10.1016/S0387-7604(87)80110-9; Pearson TS, 2017, NEUROLOGY, V89, P754, DOI 10.1212/WNL.0000000000004277; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Raucher D, 2001, J CELL SCI, V114, P3759; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sagata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14440-7; Saitsu H, 2016, EUR J HUM GENET, V24, P129, DOI 10.1038/ejhg.2015.92; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Sakaguchi H, 2019, STEM CELL REP, V13, P458, DOI 10.1016/j.stemcr.2019.05.029; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Schorling DC, 2017, NEUROPEDIATRICS, V48, P371, DOI 10.1055/s-0037-1603977; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Syrbe S, 2017, BRAIN, V140, P2322, DOI 10.1093/brain/awx195; Takata A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10482-9; Tanaka Y, 2020, CELL REP, V30, P1682, DOI 10.1016/j.celrep.2020.01.038; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tyagarajan SK, 2013, J BIOL CHEM, V288, P9634, DOI 10.1074/jbc.M112.442616; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Veeranna, 2004, AM J PATHOL, V165, P795, DOI 10.1016/S0002-9440(10)63342-1; Wang Y, 2018, J CLIN INVEST, V128, P760, DOI 10.1172/JCI95743; Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou RB, 2019, SCIENCE, V365, P929, DOI 10.1126/science.aaw5937	68	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16601	16621		10.1096/fj.202001113R	http://dx.doi.org/10.1096/fj.202001113R		OCT 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33107105	Green Published, hybrid			2022-12-26	WOS:000586269000001
J	Hjortbak, MV; Gronnebaek, TS; Jespersen, NR; Lassen, TR; Seefeldt, JM; Tonnesen, PT; Jensen, RV; Koch, LG; Britton, SL; Pedersen, M; Jessen, N; Botker, HE				Hjortbak, Marie Vognstoft; Gronnebaek, Thomas Skjorlund; Jespersen, Nichlas Riise; Lassen, Thomas Ravn; Seefeldt, Jacob Marthinsen; Tonnesen, Pernille Tilma; Jensen, Rebekka Vibjerg; Koch, Lauren Gerard; Britton, Steven L.; Pedersen, Michael; Jessen, Niels; Botker, Hans Erik			Differences in intrinsic aerobic capacity alters sensitivity to ischemia-reperfusion injury but not cardioprotective capacity by ischemic preconditioning in rats	PLOS ONE			English	Article							REDUCES INFARCT SIZE; ARTIFICIAL SELECTION; EXERCISE CAPACITY; RISK-FACTORS; HEART; MORTALITY; MODELS; RESISTANCE; OUTCOMES; PROTECT	Introduction Aerobic capacity is a strong predictor of cardiovascular mortality. Whether aerobic capacity influences myocardial ischemia and reperfusion (IR) injury is unknown. Purpose To investigate the impact of intrinsic differences in aerobic capacity and the cardioprotective potential on IR injury. Methods We studied hearts from rats developed by selective breeding for high (HCR) or low (LCR) capacity for treadmill running. The rats were randomized to: (1) control, (2) local ischemic preconditioning (IPC) or (3) remote ischemic preconditioning (RIC) followed by 30 minutes of ischemia and 120 minutes of reperfusion in an isolated perfused heart model. The primary endpoint was infarct size. Secondary endpoints included uptake of labelled glucose, content of selected mitochondrial proteins in skeletal and cardiac muscle, and activation of AMP-activated kinase (AMPK). Results At baseline, running distance was 203 +/- 7 m in LCR vs 1905 +/- 51 m in HCR rats (p<0.01). Infarct size was significantly lower in LCR than in HCR controls (49 +/- 5% vs 68 +/- 5%, p = 0.04). IPC reduced infarct size by 47% in LCR (p<0.01) and by 31% in HCR rats (p = 0.01). RIC did not modulate infarct size (LCR: 52 +/- 5, p>0.99; HCR: 69 +/- 6%, p>0.99, respectively). Phosphorylaion of AMPK did not differ between LCR and HCR controls. IPC did not modulate cardiac phosphorylation of AMPK. Glucose uptake during reperfusion was similar in LCR and HCR rats. IPC increased glucose uptake during reperfusion in LCR animals (p = 0.02). Mitochondrial protein content in skeletal muscle was lower in LCR than in HCR (0.77 +/- 0.10 arbitrary units (AU) vs 1.09 +/- 0.07 AU, p = 0.02), but not in cardiac muscle. Conclusion Aerobic capacity is associated with altered myocardial sensitivity to IR injury, but the cardioprotective effect of IPC is not. Glucose uptake, AMPK activation immediately prior to ischemia and basal mitochondrial protein content in the heart seem to be of minor importance as underlying mechanisms for the cardioprotective effects.	[Hjortbak, Marie Vognstoft; Jespersen, Nichlas Riise; Lassen, Thomas Ravn; Seefeldt, Jacob Marthinsen; Tonnesen, Pernille Tilma; Jensen, Rebekka Vibjerg; Botker, Hans Erik] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Hjortbak, Marie Vognstoft; Jespersen, Nichlas Riise; Lassen, Thomas Ravn; Seefeldt, Jacob Marthinsen; Tonnesen, Pernille Tilma; Jensen, Rebekka Vibjerg; Pedersen, Michael; Botker, Hans Erik] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Gronnebaek, Thomas Skjorlund] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Koch, Lauren Gerard] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Britton, Steven L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Jessen, Niels] Aahus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark; [Jessen, Niels] Aarhus Univ Hosp, Dept Clin Pharmacol, Aarhus, Denmark; [Jessen, Niels] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Aarhus University; Aarhus University; Aarhus University	Hjortbak, MV (corresponding author), Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark.; Hjortbak, MV (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	hjortbak@clin.au.dk	Seefeldt, Jacob/ABD-6276-2021; Jessen, Niels/E-1731-2011	Seefeldt, Jacob/0000-0002-0633-5878; Botker, Hans Erik/0000-0001-6358-8962; Jespersen, Nichlas Riise/0000-0003-2502-2102; Jessen, Niels/0000-0001-5613-7274	National Institutes of Health, U.S.A [P40ODO21331]; Independent Research Fund Denmark [11-115818]; Aarhus University Graduate School; Danish Council for Strategic Research [11-108354]; Novo Nordisk Foundation (Conditioning Based Intervention Strategies ConBis); Trygfonden; COST (European Cooperation in Science and Technology) [CA16225]	National Institutes of Health, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Independent Research Fund Denmark; Aarhus University Graduate School; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation (Conditioning Based Intervention Strategies ConBis); Trygfonden; COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	The LCR-HCR rat models are funded by the Office of Infrastructure Programs grant P40ODO21331 (to L.G.K and S.L.B) from the National Institutes of Health, U.S.A. These rat models for low and high intrinsic exercise capacity are maintained as an international resource with support from the Department of Physiology & Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH. Contact L. G.K(Lauren.Koch2@UToledo.edu) or S.L.B (brittons@umich.edu) for information on the rat models. Other sources of funding: MVH and HEB were funded by The Independent Research Fund Denmark (11-115818), Aarhus University Graduate School, The Danish Council for Strategic Research (11-108354), Novo Nordisk Foundation (Conditioning Based Intervention Strategies ConBis) and Trygfonden. This article is based on the work of COST Action EU-CARDIOPROTECTION (CA16225) and supported by COST (European Cooperation in Science and Technology).	Barboza CA, 2016, INT J SPORTS MED, V37, P421, DOI 10.1055/s-0035-1565136; Behmenburg F, 2017, J CARDIOTHOR VASC AN, V31, P1223, DOI 10.1053/j.jvca.2016.07.005; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; BOWLES DK, 1992, AM J PHYSIOL, V263, pH804, DOI 10.1152/ajpheart.1992.263.3.H804; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Brown DA, 2003, J APPL PHYSIOL, V95, P2510, DOI 10.1152/japplphysiol.00487.2003; Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; Davidson SM, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0704-z; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; Fiuza-Luces C, 2018, NAT REV CARDIOL, V15, P731, DOI 10.1038/s41569-018-0065-1; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Hauerslev M, 2018, AM J PHYSIOL-HEART C, V315, pH150, DOI 10.1152/ajpheart.00114.2018; Hausenloy DJ, 2019, CARDIOVASC RES, V115, pE161, DOI 10.1093/cvr/cvz242; Hausenloy DJ, 2017, CARDIOVASC RES, V113, P564, DOI 10.1093/cvr/cvx049; Hausenloy DJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0588-8; Hayward R, 1997, EUR J PHARMACOL, V334, P157, DOI 10.1016/S0014-2999(97)01149-7; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Hjortbak MV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192981; Hoydal MA, 2013, J APPL PHYSIOL, V115, P1788, DOI 10.1152/japplphysiol.00312.2013; Hunter CJ, 2008, FRONT BIOSCI-LANDMRK, V13, P347, DOI 10.2741/2684; Hussain SO, 2001, AM J PHYSIOL-REG I, V281, pR1787, DOI 10.1152/ajpregu.2001.281.6.R1787; Jessen N, 2014, DRUG DISCOV TODAY, V19, P999, DOI 10.1016/j.drudis.2014.03.009; Ji LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069910; KATZ J, 1967, BIOCHEMISTRY-US, V6, P1, DOI 10.1021/bi00853a001; Koch LG, 2019, METHODS MOL BIOL, V2018, P309, DOI 10.1007/978-1-4939-9581-3_15; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; Kristiansen SB, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0872-7; Michelsen MM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0260-x; Moller AB, 2019, J CANCER RES CLIN, V145, P1449, DOI 10.1007/s00432-019-02911-5; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Penna C, 2020, ANTIOXID REDOX SIGN, V32, P1115, DOI 10.1089/ars.2019.8009; Povlsen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064093; Rahbek SK, 2015, AMINO ACIDS, V47, P767, DOI 10.1007/s00726-014-1907-8; Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256; Ren YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056950; Rossello X, 2018, CARDIOVASC DRUG THER, V32, P127, DOI 10.1007/s10557-018-6788-8; Schwarzer M, 2010, BASIC RES CARDIOL, V105, P357, DOI 10.1007/s00395-010-0087-2; Solskov L, 2012, MOL CELL BIOCHEM, V360, P353, DOI 10.1007/s11010-011-1075-z; Souza RWA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35728-2; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Stottrup NB, 2006, CLIN EXP PHARMACOL P, V33, P1099, DOI 10.1111/j.1440-1681.2006.04497.x; Stottrup NB, 2010, CARDIOVASC RES, V88, P257, DOI 10.1093/cvr/cvq205; THOMASSEN A, 1988, AM J CARDIOL, V62, P686, DOI 10.1016/0002-9149(88)91203-9; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Wever KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142021; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240866	10.1371/journal.pone.0240866	http://dx.doi.org/10.1371/journal.pone.0240866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108389	Green Published, gold			2022-12-26	WOS:000588372400019
J	Han, YR; Yun, CC				Han, Yiran; Yun, C. Chris			Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity	FASEB JOURNAL			English	Article						deubiquitinating enzyme; diarrhea; Na+; H+ exchange; ubiquitination	NA+/H+ EXCHANGER NHE3; FUNCTIONAL PROTEOMICS; ACTIVATES P53; TRAFFICKING; TRANSPORT; PROTEIN; PATHOPHYSIOLOGY; INHIBITION; ABSORPTION; MECHANISMS	Na+/H+ exchanger NHE3 of human or primates differs from NHE3 of other animals by having a PY motif, which mediates interaction with the E3 ubiquitin (Ub) ligase Nedd4-2. Ub-conjugation of human NHE3 by Nedd4-2 regulates endocytosis of NHE3 but does not affect its cellular expression. Because Ub-conjugation is a reversible process, the aim of this study is to identify deubiquitinating enzyme (DUB) regulating the post-endosomal fate of human NHE3. Using an activity-based chemical screening, we identified ubiquitin specific protease-7 (USP7) and USP10 that bind NHE3. The roles of DUBs in regulation of NHE3 were studied by determining the effects of silencing of USP7 and USP10. Knockdown of USP7 or USP10 resulted in increased NHE3 ubiquitination and decreased NHE3 expression at the surface membrane and cellular level. The endocytic retrieval of NHE3 was promoted by depletion of USP7 or USP10, with increased association of NHE3 with Rab5a and Rab7. Inhibition of USP7 and USP10 by chemical inhibitors or knockdown had an additive effect on NHE3. In addition, NHE3 half-life was reduced accounting for decreased NHE3 protein abundance. NHE3 is inhibited by protein kinase A. Activation of PKA by forskolin decreased the binding of USP7 and USP10 to NHE3, while increasing ubiquitination of NHE3. Knockdown of USP10 had an additive effect on PKA-dependent inhibition of NHE3. These findings demonstrate that USP7 and USP10 are DUBs that regulate NHE3 ubiquitination and expression, and reveal a new mechanism of NHE3 inhibition involving DUBs.	[Han, Yiran; Yun, C. Chris] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA; [Han, Yiran; Yun, C. Chris] Atlanta VA Med Ctr, Gastroenterol Res, Decatur, GA USA; [Yun, C. Chris] Emory Univ, Sch Med, Winship Canc Inst, Cell & Mol Biol Res Program, Atlanta, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA.	ccyun@emory.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK107719]; U.S. Department of Veterans Affairs (VA) [I01BX004459]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: DK107719; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX004459	Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Bhattacharya S, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0012-y; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Cavet ME, 2001, AM J PHYSIOL-CELL PH, V281, pC2039, DOI 10.1152/ajpcell.2001.281.6.C2039; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Di Sole F, 2011, KIDNEY INT, V80, P822, DOI 10.1038/ki.2011.229; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Guo J, 2020, J CELL MOL MED, V24, P4324, DOI 10.1111/jcmm.15093; Gurney MA, 2017, CELL MOL GASTROENTER, V3, P27, DOI 10.1016/j.jcmgh.2016.09.010; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Kee Y, 2016, MOL CELL BIOL, V36, P524, DOI 10.1128/MCB.00847-15; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maher MM, 1997, GASTROENTEROLOGY, V112, P174, DOI 10.1016/S0016-5085(97)70232-4; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; No YR, 2014, J BIOL CHEM, V289, P18360, DOI 10.1074/jbc.M113.541706; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Sadler JBA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40596-5; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Singh V, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218610; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Yoo BK, 2012, AM J PHYSIOL-GASTR L, V303, pG180, DOI 10.1152/ajpgi.00069.2012; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978	44	6	6	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16476	16488		10.1096/fj.202001875R	http://dx.doi.org/10.1096/fj.202001875R		OCT 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33095475	Green Accepted			2022-12-26	WOS:000583914500001
J	Neto, SRM; Castiglione, RC; da Silva, TCB; Paes, LD; Pontes, A; Oliveira, DF; Ferraz, EB; Caldas, CCA; Nascimento, JHM; Bouskela, E				Marques Neto, Silvio R.; Castiglione, Raquel C.; da Silva, Teresa C. B.; Paes, Lorena da S.; Pontes, Aiza; Oliveira, Dahienne F.; Ferraz, Emanuelle B.; Ade Caldas, Carla Christina; Nascimento, Jose Hamilton M.; Bouskela, Eliete			Effects of high intensity interval training on neuro-cardiovascular dynamic changes and mitochondrial dysfunction induced by high-fat diet in rats	PLOS ONE			English	Article							ANAEROBIC THRESHOLD; INSULIN-RESISTANCE; BLOOD-PRESSURE; HEART-RATE; EXERCISE; OBESITY; ASSOCIATION; IMPACT	Background and aims Mitochondrial swelling is involved in the pathogenesis of many human diseases associated with oxidative stress including obesity. One of the strategies for prevention of deleterious effects related to obesity and overweight is engaging in regular physical activity, of which high intensity interval training (HIIT) is efficient in promoting biogenesis and improving the function of mitochondria. Therefore, our aims were to investigate the effects of HIIT on metabolic and neuro-cardiovascular dynamic control and mitochondrial swelling induced by high-fat diet (HFD). Methods and results Twenty-three male Wistar rats (60 - 80g) were divided into 4 subgroups: control (C), HIIT, HFD and HFD+HIIT. The whole experimentation period lasted for 22 weeks and HIIT sessions were performed 5 days a week during the last 4 weeks. At the end of the experiments, fasting glucose and insulin tolerance tests were performed. Cerebral microcirculation was analyzed using cortical intravital microscopy for capillary diameter and functional density. Cardiac function and ergoespirometric parameters were also investigated. Mitochondrial swelling was evaluated on brain and heart extracts. HFD promoted an increase on body adiposity (p<0.001), fasting glucose levels (p<0.001), insulin resistance index (p<0.05), cardiac hypertrophy index (p<0.05) and diastolic blood pressure (p<0.05), along with worsened cardiac function (p<0.05), reduced functional cerebral capillary density (p<0.05) and its diameter (p<0.01), and heart and brain mitochondrial function (p<0.001). HFD did not affect any ergoespirometric parameter. After 4 weeks of training, HIIT was able to improve cardiac hypertrophy index, diastolic blood pressure, cerebral functional capillary density (p<0.01) and heart and brain mitochondrial swelling (p<0.001). Conclusion In animals subjected to HFD, HIIT ameliorated both cerebral mitochondrial swelling and functional capillary density, but it did not improve cardiovascular function suggesting that the cardiovascular dysfunction elicited by HFD was not due to heart mitochondrial swelling.	[Marques Neto, Silvio R.; Castiglione, Raquel C.; da Silva, Teresa C. B.; Paes, Lorena da S.; Pontes, Aiza; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil; [Marques Neto, Silvio R.; Ade Caldas, Carla Christina] Salgado Oliveira Univ UNIVERSO, Phys Act Sci Lab LACAF, Phys Act Sci Postgrad Program, Niteroi, RJ, Brazil; [Marques Neto, Silvio R.] Univ Estacio Sa, Sch Phys Educ, Exercise Physiol Lab, Rio De Janeiro, RJ, Brazil; [Marques Neto, Silvio R.; da Silva, Teresa C. B.] Univ Grande Rio, Hlth Sci Sch, Duque De Caxias, RJ, Brazil; [Oliveira, Dahienne F.; Ferraz, Emanuelle B.; Nascimento, Jose Hamilton M.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Cardiac Electrophysiol Lab, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Salgado de Oliveira; Universidade Estacio de Sa; Universidade do Grande Rio; Universidade Federal do Rio de Janeiro	Neto, SRM (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil.; Neto, SRM (corresponding author), Salgado Oliveira Univ UNIVERSO, Phys Act Sci Lab LACAF, Phys Act Sci Postgrad Program, Niteroi, RJ, Brazil.; Neto, SRM (corresponding author), Univ Estacio Sa, Sch Phys Educ, Exercise Physiol Lab, Rio De Janeiro, RJ, Brazil.; Neto, SRM (corresponding author), Univ Grande Rio, Hlth Sci Sch, Duque De Caxias, RJ, Brazil.	marquesilvio@gmail.com	Nascimento, Jose Hamilton/L-3722-2018	Nascimento, Jose Hamilton/0000-0001-7052-254X; Ferreira de Oliveira, Dahienne/0000-0002-8104-9476; Marques-Neto, Silvio/0000-0001-5742-4646	Brazilian National Council for Scientific and Technologic Development (CNPq) [474116/2008-5]; Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [E-26/111.732/2011]	Brazilian National Council for Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This research was supported by the Brazilian National Council for Scientific and Technologic Development (CNPq) (Grant number: 474116/2008-5) and Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) (Grant number: E-26/111.732/2011), both received by Eliete Bouskela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert MA, 2018, PROG CARDIOVASC DIS, V61, P114, DOI 10.1016/j.pcad.2018.07.012; [Anonymous], 2018, LANCET GLOB HEALTH, V6, pE593, DOI 10.1016/S2214-109X(18)30239-0; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Bellar D, 2015, BIOL SPORT, V32, P315, DOI 10.5604/20831862.1174771; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Camm AJ, 1996, CIRCULATION, V93, P1043; Cassidy S, 2017, DIABETOLOGIA, V60, P7, DOI 10.1007/s00125-016-4106-1; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Chianese R, 2018, CURR NEUROPHARMACOL, V16, P1059, DOI 10.2174/1570159X15666171017102547; Chrois KM, 2020, EUR J SPORT SCI, V20, P135, DOI 10.1080/17461391.2019.1615556; Coetsee C, 2017, EUR J APPL PHYSIOL, V117, P1617, DOI 10.1007/s00421-017-3651-8; de Abreu RM, 2019, BRAZ J PHYS THER, V23, P279, DOI 10.1016/j.bjpt.2018.09.010; De Boer MP, 2012, MICROCIRCULATION, V19, P5, DOI 10.1111/j.1549-8719.2011.00130.x; Dimova R, 2020, HORM METAB RES, V52, P39, DOI 10.1055/a-0972-1302; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Fernandes RA, 2011, J PEDIATR-US, V158, P634, DOI 10.1016/j.jpeds.2010.10.007; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Giannoni A, 2017, EUR J HEART FAIL, V19, P1701, DOI 10.1002/ejhf.782; Granata C, 2019, HIGH INTENSITY INTER; Guarino D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00665; Huertas JR, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7058350; Jimenez-Maldonado A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00839; Kalaivani A, 2019, ARCH PHYSIOL BIOCHEM, V125, P228, DOI 10.1080/13813455.2018.1452036; Keating SE, 2017, OBES REV, V18, P943, DOI 10.1111/obr.12536; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kwok SY, 2013, ARCH DIS CHILD, V98, P287, DOI 10.1136/archdischild-2012-302794; LANDSBERG L, 1986, Q J MED, V61, P1081; Leopoldo AS, 2010, CAN J CARDIOL, V26, P423, DOI 10.1016/S0828-282X(10)70440-2; Liu F, 2018, AGING DIS, V9, P924, DOI 10.14336/AD.2017.1126; Lopes WA, 2019, AUTON NEUROSCI-BASIC, V216, P87, DOI 10.1016/j.autneu.2018.11.003; Maranhao PA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-32; Marques-Neto SR, 2012, J STRENGTH COND RES, V26, P1967, DOI 10.1519/JSC.0b013e318234eb5d; Marques-Neto SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148402; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Nascimento AF, 2011, LIFE SCI, V88, P1031, DOI 10.1016/j.lfs.2011.03.015; Pereira-Junior PP, 2006, EUR J APPL PHYSIOL, V96, P487, DOI 10.1007/s00421-005-0111-7; Plourde B, 2014, EXPERT REV CARDIOVAS, V12, P1099, DOI 10.1586/14779072.2014.952283; Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z; Rowell L, 1993, HUMAN CARDIOVASCULAR; Satoh H, 2004, J CLIN INVEST, V114, P224, DOI 10.1172/JCI200420785; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Sieck G, 2014, PHYSIOLOGY, V29, P302, DOI 10.1152/physiol.00036.2014; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Tofolo LP, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00170; Torma Ferenc, 2019, Sports Med Health Sci, V1, P24, DOI 10.1016/j.smhs.2019.08.003; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; van Raalte DH, 2013, DIABETOLOGIA, V56, P2383, DOI 10.1007/s00125-013-3016-8; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Zhao RY, 2011, DIABETES METAB SYNDR, V4, P61, DOI 10.2147/DMSO.S15510	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240060	10.1371/journal.pone.0240060	http://dx.doi.org/10.1371/journal.pone.0240060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095799	Green Published, gold			2022-12-26	WOS:000586649400058
J	Pan, D; Yang, JQ; Zhou, GZ; Kong, FB				Pan, Dan; Yang, Jiaqing; Zhou, Guzhen; Kong, Fanbin			The influence of COVID-19 on agricultural economy and emergency mitigation measures in China: A text mining analysis	PLOS ONE			English	Article								Understanding the influence of COVID-19 on China's agricultural economy and the Chinese government's emergency measures to ease the economic impacts of viral spread can offer urgently-needed lessons while this virus continues to spread across the globe. Thus, this study collected over 750,000 words upon the topic of COVID-19 and agriculture from the largest two media channels in China: WeChat and Sina Weibo, and employed web crawler technology and text mining method to explore the influence of COVID-19 on agricultural economy and mitigation measures in China. The results show that: (1) the impact of COVID-19 on China's agricultural economy at the very first phase is mainly reflected in eight aspects as crop production, agricultural products supply, livestock production, farmers' income and employment, economic crop development, agricultural products sales model, leisure agriculture development, and agricultural products trade. (2) The government's immediate countermeasures include resuming agricultural production and farmers' work, providing financial support, stabilizing agricultural production and products supply, promoting agricultural products sale, providing subsidies, providing agricultural technology guidance and field management, and providing assistance to poor farmers to reduce poverty. (3) The order of government's immediate countermeasures is not all in line with the order of impact aspects, which indicates that more-tailored policies should be implemented to mitigate the strikes of COVID-19 on China's agricultural economy in the future.	[Pan, Dan; Yang, Jiaqing; Zhou, Guzhen] Jiangxi Univ Finance & Econ, Sch Econ, Nanchang, Jiangxi, Peoples R China; [Kong, Fanbin] Zhejiang A&F Univ, Sch Econ & Management, Hangzhou, Zhejiang, Peoples R China	Jiangxi University of Finance & Economics; Zhejiang A&F University	Pan, D (corresponding author), Jiangxi Univ Finance & Econ, Sch Econ, Nanchang, Jiangxi, Peoples R China.; Kong, FB (corresponding author), Zhejiang A&F Univ, Sch Econ & Management, Hangzhou, Zhejiang, Peoples R China.	pandan@jxufe.edu.cn; kongfanbin@aliyun.com			National Youth Talent Support Program; National Natural Science Foundation of China [71863016, 71673123]; Outstanding Youth of Natural Science Foundation in Jiangxi Province [2018ACB21004]; Science and Technology Research Foundation of Jiangxi Province [GJJ170349]	National Youth Talent Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth of Natural Science Foundation in Jiangxi Province; Science and Technology Research Foundation of Jiangxi Province	We would like to thank the financial support from the National Youth Talent Support Program, the National Natural Science Foundation of China (No. 71863016; No. 71673123), the Outstanding Youth of Natural Science Foundation in Jiangxi Province (No. 2018ACB21004), and the Science and Technology Research Foundation of Jiangxi Province (No. GJJ170349).	Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bridges, 2019, BRIDGES R APPL CHIEF; Chu Z.Y., 2020, RURAL FINANCE RES, V5, P9; Elahi E, 2020, LAND USE POLICY, V90, DOI 10.1016/j.landusepol.2019.104324; Elahi E, 2019, J CLEAN PROD, V238, DOI 10.1016/j.jclepro.2019.117900; Elahi E, 2019, ENERGY, V183, P191, DOI 10.1016/j.energy.2019.06.084; Elahi E, 2019, LAND USE POLICY, V83, P461, DOI 10.1016/j.landusepol.2019.02.023; Fan SG, 2020, CHINA AGR ECON REV, V12, P471, DOI 10.1108/CAER-04-2020-0065; Hou ZP, 2019, TOURISM MANAGE, V74, P276, DOI 10.1016/j.tourman.2019.03.009; Jiang H.Y., 2020, REFORM, V3, P5; Liu W, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072304; Liu XJ, 2019, SUSTAIN CITIES SOC, V44, P550, DOI 10.1016/j.scs.2018.10.047; Luo QJ, 2017, TOURISM MANAGE, V62, P159, DOI 10.1016/j.tourman.2017.04.007; Pan D, 2018, ECOL ECON, V148, P77, DOI 10.1016/j.ecolecon.2018.02.004; Rozelle S, 2020, INVISIBLE CHINA URBA, DOI [10.7208/9780226740515/html, DOI 10.7208/9780226740515/HTML]; Shi L.J., 2020, J FISH CHINA, V1, P1; Wang Y, 2019, J CLEAN PROD, V238, DOI 10.1016/j.jclepro.2019.117926; Yang F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132374; Ye X.Q., 2020, AGR EC, V41, P4, DOI 10.13246/j.cnki.iae.2020.03.001; Zhang H., 2020, FARMERS DAILY; Zhang X., 2020, CHINESE LIVESTOCK FA; Zhang YM, 2020, CHINA AGR ECON REV, V12, P387, DOI 10.1108/CAER-04-2020-0063; Zhu X.K., 2020, FARMERS DAILY   0305	23	38	38	18	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241167	10.1371/journal.pone.0241167	http://dx.doi.org/10.1371/journal.pone.0241167			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095814	gold, Green Published			2022-12-26	WOS:000586649400017
J	Elelu, N; Bankole, AA; Musa, RJ; Odetokun, IA; Rabiu, M; Biobaku, KT; Aremu, A; Ahmed, AO; Ghali, MI; Raji, MA; Ogo, NI; Cutler, SJ; Ogundipe, GAT				Elelu, Nusirat; Bankole, Adefolake Ayinke; Musa, Ramat Jummai; Odetokun, Ismail Ayoade; Rabiu, Musa; Biobaku, Khalid Talha; Aremu, Abdulfatai; Ahmed, Akeem Olayiwola; Ghali, Mohammed Ibraheem; Raji, Mashood Abiola; Ogo, Ndudim Isaac; Cutler, Sally Jane; Ogundipe, Gabriel Adetunji Taiwo			Serospatial epidemiology of zoonoticCoxiella burnetiiin a cross section of cattle and small ruminants in northern Nigeria	PLOS ONE			English	Article							COXIELLA-BURNETII; Q-FEVER; SEROLOGICAL SURVEY; INFECTION; LIVESTOCK; ANIMALS; TICKS; SHEEP; BRUCELLOSIS; PREVALENCE	The persistent and highly transmissibleCoxiella burnetiiis a neglected infection that negatively affects reproductive parameters of livestock. It is also of zoonotic importance and has been reported to cause devastating human infections globally. Domestic ruminants represent the most frequent source of human infection. Data from Nigeria are very few and outdated. There is a significant gap in up-to-date information on the exposure, spatial distribution and risk factors of infection of this important disease. The exposure toC.burnetiiwas determined using sensitive serological assays in cattle and small ruminants. A total of 538 animals made up of 268 cattle and 270 small ruminants were sampled from three northern Nigerian states. The proportion of cattle sampled that were seropositive from the study locations were: Kwara 14/90 (15.6%; 95% CI: 8.8-24.7); Plateau 10/106 (9.43%; 95% CI: 4.6-16.7) and Borno 4/72 (5.56%; 95% CI: 1.5-13.6) states. Lower seroprevalence was recorded among the small ruminants sampled, with positives recorded from sheep and goat sampled from only Kwara state 6/184 (3.3%; 95% CI: 1.2-7.0); while none of the small ruminants sampled from Plateau were seropositive. The results of the bivariate analysis showed that none of the tested independent variables (village, age group, sex, breed of cattle, presence of ticks, reproductive status, and management system) were statistically significant factors associated with seropositivity of cattle for antibodies toC.burnetii. Stakeholders involved in animal husbandry should be duly educated on proper disposal of birth products as well as bodily fluids in order to reduce environmental contamination, persistence and human infection.	[Elelu, Nusirat; Musa, Ramat Jummai; Odetokun, Ismail Ayoade; Rabiu, Musa; Biobaku, Khalid Talha; Aremu, Abdulfatai; Ahmed, Akeem Olayiwola; Ghali, Mohammed Ibraheem; Raji, Mashood Abiola] Univ Ilorin, Fac Vet Med, Ilorin, Nigeria; [Bankole, Adefolake Ayinke; Cutler, Sally Jane] Univ East London, Sch Hlth Sport & Biosci, London, England; [Ogo, Ndudim Isaac] Natl Vet Res Inst, Vom, Nigeria; [Ogundipe, Gabriel Adetunji Taiwo] Univ Ibadan, Fac Vet Med, Ibadan, Nigeria	University of Ilorin; University of East London; University of Ibadan	Elelu, N (corresponding author), Univ Ilorin, Fac Vet Med, Ilorin, Nigeria.	nusyelelu@yahoo.com	Mashood, Raji/AAG-9654-2021; Odetokun, Ismail Ayoade/A-5431-2018	Odetokun, Ismail Ayoade/0000-0002-5171-1895; Elelu, Nusirat/0000-0003-1255-4572; Bankole, adefolake/0000-0003-2621-9302; Aremu, Akinloluwa/0000-0003-3100-0612	University of Ilorin, Nigeria; International Foundation for Science (IFS) [I-3-B-6114-1]	University of Ilorin, Nigeria; International Foundation for Science (IFS)(International Foundation for Science)	Resources for staff support and field work was provided by University of Ilorin, Nigeria. Additional funding for field sampling and laboratory analysis was provided by the International Foundation for Science (IFS) grant number (I-3-B-6114-1) awarded to NE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDO PB, 1977, REV ELEV MED VET PAY, V30, P359, DOI 10.19182/remvt.8073; ADESIYUN AA, 1985, INT J ZOONOSES, V12, P1; ADESIYUN AA, 1984, INT J ZOONOSES, V11, P155; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; [Anonymous], 2013, SMU SCI TECH L REV, V16, P43; Barlozzari G, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268819002115; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; Blench R., 1995, CAHIERS SCI HUMAINES, V37, P787; BLONDEAU J, 1990, ANN NY ACAD SCI, V590, P281, DOI 10.1111/j.1749-6632.1990.tb42233.x; Clark NJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3135-4; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; editorial Journal, 2014, NETW SECUR, V7, P1; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Elelu N., 2016, PARASIT VECTORS, V9, P1; Georgiev M, 2013, EUROSURVEILLANCE, V18, P13; Halajian A, 2016, TICKS TICK-BORNE DIS, V7, P361, DOI 10.1016/j.ttbdis.2015.12.008; HILBINK F, 1993, INT J EPIDEMIOL, V22, P945, DOI 10.1093/ije/22.5.945; Honarmand H, 2012, INTERDISCIP PERSPECT; Kanoute YB, 2017, ACTA TROP, V165, P66, DOI 10.1016/j.actatropica.2016.02.012; Keay R. W. J., 1959, OUTLINE NIGERIAN VEG; Klaasen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085424; Klemmer J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192188; Lambton SL, 2016, EPIDEMIOL INFECT, V144, P19, DOI 10.1017/S0950268815000874; Larson PS, 2019, ZOONOSES PUBLIC HLTH, V66, P316, DOI 10.1111/zph.12567; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; McCaughey C, 2010, EPIDEMIOL INFECT, V138, P21, DOI 10.1017/S0950268809002854; Meadows S, 2015, PREV VET MED, V121, P199, DOI 10.1016/j.prevetmed.2015.06.014; Nusinovici S, 2017, TRANSBOUND EMERG DIS, V64, P585, DOI 10.1111/tbed.12423; Nyifi A. S., 2018, Savannah Veterinary Journal, V1, P14, DOI 10.36759/svj.2017.005; Ogo NI, 2013, VET WORLD, V6, P818, DOI 10.14202/vetworld.2013.818-822; OP026, 2016, J CROHNS COLITIS, V10, pS21; Rahman A, 2016, VET MED INT, P7; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reye AL, 2012, APPL ENVIRON MICROB, V78, P2562, DOI 10.1128/AEM.06686-11; Ryan E, 2011, VET REC, V169, p280B, DOI 10.1136/vr.d5208; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tissot-Dupont H, 1999, AM J EPIDEMIOL, V150, P67, DOI 10.1093/oxfordjournals.aje.a009920; Tissot-Dupont H, 2008, INFECT DIS CLIN N AM, V22, P505, DOI 10.1016/j.idc.2008.03.002; Valergakis GE, 2012, VET REC, V171, DOI 10.1136/vr.100908; Vanderburg S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002787	41	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240249	10.1371/journal.pone.0240249	http://dx.doi.org/10.1371/journal.pone.0240249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075103	Green Published, gold			2022-12-26	WOS:000585920200026
J	Bar-Sela, G; Cohen, I; Avisar, A; Loven, D; Aharon, A				Bar-Sela, Gil; Cohen, Idan; Avisar, Adva; Loven, David; Aharon, Anat			Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients	PLOS ONE			English	Article							ANGIOSTATIN; MICROPARTICLES; MICROVESICLES; ACTIVATION; THROMBOSIS; APOPTOSIS; SURFACE; CELLS; BINDS	Extracellular vesicles (EVs) are subcellular membrane blebs that include exosomes and microparticles, which represent a potential source for cancer biomarker discovery. We assess EVs characteristics as a tool to evaluate the endothelial and anti-tumor treatment injury during adjuvant chemotherapy in breast (BC) and colon cancer (CC) patients. Blood samples were taken from 29 BC and 25 CC patients before and after chemotherapy, as well as from healthy control donors (HC). Circulating blood EVs were isolated and characterized by size/concentration, membrane antigens for cell origin, thrombogenicity, and protein content. We observed higher EVs concentration and particle size in CC patients after chemotherapy compared with HC. Higher levels of endothelial EVs (CD144-positive) and vascular endothelial growth factor receptor 1 (VEGFR1), apparently as an indication of endothelial dysfunction, were found in all cancer patients, regardless of a given treatment, compared to HC. Levels of EVs labeled CD62E, CD34(+)41(-), the lymphocyte markers CD11(+) and CD-14(+), Annexin-V, and the coagulation proteins TF and TFPI, however, sometimes demonstrate significant differences between patients, although HC did not show significant differences between patients pre- and post-chemotherapy. Most importantly, increasing levels of EVs encapsulated Angiostatin were found in patients with CC, while chemotherapy treatment leads to its notable rise in circulating blood EVs. Our results demonstrate the potential of EVs encapsulated Angiostatin as a tool to evaluate endothelial damage during adjuvant chemotherapy in BC and CC patients.	[Bar-Sela, Gil; Aharon, Anat] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel; [Bar-Sela, Gil; Cohen, Idan; Loven, David] Emek Med Ctr, Canc Ctr, Afula, Israel; [Avisar, Adva] Univ Haifa, Haifa, Israel; [Aharon, Anat] Sourasky Med Ctr, Hematol & Bone Marrow Transplantat, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Emek Medical Center; University of Haifa; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Bar-Sela, G (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel.; Bar-Sela, G (corresponding author), Emek Med Ctr, Canc Ctr, Afula, Israel.	gil_ba@clalit.org.il	Cohen‬, ‪Idan/AAD-6997-2021	Cohen‬, ‪Idan/0000-0001-6933-9385; Bar-Sela, Gil/0000-0001-6579-1841	Israel Science Foundation (ISF) [1413/21]; Rappaport Family Institute [2012-2014]	Israel Science Foundation (ISF)(Israel Science Foundation); Rappaport Family Institute	This work was funded by the: Israel Science Foundation (ISF), grant No 1413/21, and Rappaport Family Institute Grant 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2009, BEST PRACT RES CL HA, V22, P61, DOI 10.1016/j.beha.2008.11.002; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2015, PEDIATRICS, V135, pe1097; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2013, J CROHNS COLITIS, V7, P769; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Aubertin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35376; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cameron AC, 2016, CAN J CARDIOL, V32, P852, DOI 10.1016/j.cjca.2015.12.023; Chi SL, 2006, CANCER RES, V66, P875, DOI 10.1158/0008-5472.CAN-05-2806; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Geddings JE, 2016, J THROMB HAEMOST, V14, P153, DOI 10.1111/jth.13181; Gupta N, 2001, EMBO REP, V2, P536, DOI 10.1093/embo-reports/kve115; Helal O, 2011, NUTR METAB CARDIOVAS, V21, P665, DOI 10.1016/j.numecd.2010.01.004; Ida M, 2004, J BIOCHEM, V135, P583, DOI 10.1093/jb/mvh071; Iii APO, 2012, MICROPARTICLES HEMOS, V108, P1284; Lima LG, 2013, BIOSCIENCE REP, V33, P701, DOI 10.1042/BSR20130057; Lucas R, 1998, BLOOD, V92, P4730; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Nestle, 2007, NUTRIPRO NESTLE PROF, V1, P1; Nurgali K, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00245; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Razak NBA, 2018, CANCERS, V10, DOI 10.3390/cancers10100380; Rider P, 2017, J IMMUNOL, V198, P1395, DOI 10.4049/jimmunol.1601342; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Stortecky S, 2010, CURR OPIN ONCOL, V22, P312, DOI 10.1097/CCO.0b013e32833ab6f1; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tripisciano C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03262-2; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Zheng XZ, 2007, BLOOD, V109, P1003, DOI 10.1182/blood-2006-06-032086; Zhu TJ, 2016, INT J CLIN EXP MED, V9, P5233	38	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240994	10.1371/journal.pone.0240994	http://dx.doi.org/10.1371/journal.pone.0240994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108394	Green Published, gold			2022-12-26	WOS:000588372400007
J	Liu, L; Wang, R; Ding, HH; Tian, L; Gao, T; Bao, CD				Liu, Li; Wang, Ran; Ding, Huihua; Tian, Lei; Gao, Ting; Bao, Chunde			The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DISEASE-ACTIVITY; ACTIVITY INDEX; KIDNEY INJURY; CYSTATIN-C; ERYTHEMATOSUS; CLASSIFICATION; CHILDREN; VCAM-1	Given the urgent need for non-invasive biomarkers of LN, we aim to identify novel urinary biomarkers that facilitate diagnosis, assessment of disease activity and prediction of treatment response in a retrospective SLE cohort. A total of 154 SLE patients and 55 healthy controls were enrolled, among whom 73 were active LN patients. We measured renal activity by renal SLEDAI. The treatment response of the active LN patients who finished 6-month induction therapy was assessed based on the American College of Rheumatology response criteria. The expression levels of 10 urinary biomarkers (UBMs): beta 2-MG, calbindin D, cystatin C, IL-18, KIM-1, MCP-1, nephrin, NGAL, VCAM-1, and VDBP were tested using Luminex high-throughput proteomics technology. All but urinary nephrin levels were significantly increased in active LN compared to healthy controls. uCystatinC, uMCP-1, uKIM-1 levels were significantly higher in active LN group compared to inactive LN group. Correlation analysis revealed positive correlation between uCystatinC, uKIM-1, uMCP-1, uNGAL, uVDBP and RSLEDAI score. In renal pathology, uCystatinC, uKIM-1, uVCAM-1, and uVDBP positively correlated with activity index (AI) while uVCAM-1 positively correlated with chronicity index (CI). Moreover, the combination of uVCAM-1, uCystatinC, uKIM-1 discriminated proliferative LN from membranous LN with an AUC of 0.80 (95%CI: 0.69-0.90). Most importantly, baseline uNGAL demonstrated good prediction ability to discriminate responders from non-responders in active LN patients after 6-month induction therapy. Using a multiplex bead technique, we have identified the combination of uVCAM-1, uCystatinC, uKIM-1 as a biomarker panel to reflect renal pathology and NGAL as a promising urinary biomarker to both reflect disease activity and predict treatment response.	[Liu, Li; Tian, Lei; Gao, Ting] Shanghai Jiao Tong Univ, Renji Hosp, Dept Emergency Med, Sch Med, Shanghai, Peoples R China; [Wang, Ran; Ding, Huihua; Bao, Chunde] Shanghai Jiao Tong Univ, Renji Hosp, Dept Rheumatol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, CD (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Rheumatol, Sch Med, Shanghai, Peoples R China.	baochunde_1678@126.com			National Natural Science Foundation of China [81771733]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant no.: 81771733) received by CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elkareem MI, 2010, CLIN EXP NEPHROL, V14, P548, DOI 10.1007/s10157-010-0322-z; Adhya Z, 2019, LUPUS, V28, P713, DOI 10.1177/0961203319845487; Almaani S, 2017, CLIN J AM SOC NEPHRO, V12, P825, DOI 10.2215/CJN.05780616; Almaani S, 2017, J AM SOC NEPHROL, V28, P1394, DOI 10.1681/ASN.2016080886; [Anonymous], 2012, J MED INTERNET RES, V14, pe128; Bajema IM, 2018, KIDNEY INT, V93, P789, DOI 10.1016/j.kint.2017.11.023; Bennett MR, 2017, PEDIATR RHEUMATOL, V15, DOI 10.1186/s12969-017-0202-0; Brunner HI, 2019, PEDIATR NEPHROL, V34, P117, DOI 10.1007/s00467-018-4049-5; Brunner HI, 2017, J RHEUMATOL, V44, P1239, DOI 10.3899/jrheum.161128; Brunner HI, 2016, ARTHRIT CARE RES, V68, P1003, DOI 10.1002/acr.22762; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Ding Y, 2018, LUPUS, V27, P1778, DOI 10.1177/0961203318788167; Dong XW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010343; Elewa EA, 2015, LUPUS, V24, P138, DOI 10.1177/0961203314550225; Gasparin AA, 2019, LUPUS, V28, P265, DOI 10.1177/0961203319826695; Gladman DD, 2002, J RHEUMATOL, V29, P288; Go DJ, 2018, LUPUS, V27, P1600, DOI 10.1177/0961203318778774; Gomez-Puerta JA, 2018, LUPUS, V27, P637, DOI 10.1177/0961203317738226; Gulati G, 2017, LUPUS, V26, P927, DOI 10.1177/0961203316684212; Gupta R, 2016, CLIN RHEUMATOL, V35, P2707, DOI 10.1007/s10067-016-3404-9; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kasitanon N, 2006, MEDICINE, V85, P147, DOI 10.1097/01.md.0000224709.70133.f7; Kazama JJ, 2002, NEPHRON, V91, P13, DOI 10.1159/000057599; Kiani AN, 2012, J RHEUMATOL, V39, P1231, DOI 10.3899/jrheum.111470; Landolt-Marticorena C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1120-0; Lee YH, 2017, Z RHEUMATOL, V76, P357, DOI 10.1007/s00393-016-0109-z; Liang MH, 2006, ARTHRITIS RHEUM-US, V54, P421, DOI 10.1002/art.21625; Liu G, 2019, LUPUS, V28, P283, DOI 10.1177/0961203319826703; Manderson D, 2016, LAW CULT HUMANIT, V12, P221, DOI 10.1177/1743872112446046; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Nozaki Y, 2014, LUPUS, V23, P769, DOI 10.1177/0961203314526292; Parodis I, LUPUS SCI MED 2020, V7, pe000389; Peixoto L, 2015, ACTA MEDICA PORT, V28, P333, DOI 10.20344/amp.5770; Polidori N, 2020, J PEDIATR ENDOCR MET, V33, P1183, DOI 10.1515/jpem-2020-0138; Rubinstein T, 2010, RHEUMATOLOGY, V49, P960, DOI 10.1093/rheumatology/kep468; Satirapoj B, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0678-3; Smith EMD, 2017, PEDIATR NEPHROL, V32, P283, DOI 10.1007/s00467-016-3485-3; Soliman S, 2017, INT J RHEUM DIS, V20, P1714, DOI 10.1111/1756-185X.13197; Suttichet TB, 2019, LUPUS SCI MED, V6, DOI 10.1136/lupus-2018-000298; Wang P, 2015, EXP BIOL MED, V240, P169, DOI 10.1177/1535370214548995; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Williams P, 2018, CRIT CARE RESUSC, V20, P6; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166	45	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240942	10.1371/journal.pone.0240942	http://dx.doi.org/10.1371/journal.pone.0240942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108403	Green Published, gold			2022-12-26	WOS:000588372400028
J	de Melo, AC; Thuler, LCS; da Silva, JL; de Albuquerque, LZ; Pecego, AC; Rodrigues, LDR; da Conceicao, MS; Garrido, MM; Mendes, GLQ; Pereira, ACPM; Soares, MA; Viola, JPB				de Melo, Andreia C.; Thuler, Luiz C. S.; da Silva, Jesse L.; de Albuquerque, Lucas Z.; Pecego, Ana C.; Rodrigues, Luciana de O. R.; da Conceicao, Magda S.; Garrido, Marianne M.; Quintella Mendes, Gelcio L.; Mendes Pereira, Ana Cristina P.; Soares, Marcelo A.; Viola, Joao P. B.		Brazilian Natl Canc Inst COVID-19	Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute	PLOS ONE			English	Article								Objective This study aimed to describe the demographic and clinical characteristics of cancer inpatients with COVID-19 exploring clinical outcomes. Methods A retrospective search in the electronic medical records of cancer inpatients admitted to the Brazilian National Cancer Institute from April 30, 2020 to May 26, 2020 granted identification of 181 patients with COVID-19 confirmed by RT-PCR. Results The mean age was 55.3 years (SD +/- 21.1). Comorbidities were present in 110 (60.8%) cases. The most prevalent solid tumors were breast (40 [22.1%]), gastrointestinal (24 [13.3%]), and gynecological (22 [12.2%]). Among hematological malignancies, lymphoma (20 [11%]) and leukemia (10 [5.5%]) predominated. Metastatic disease accounted for 90 (49.7%) cases. In total, 63 (34.8%) had recently received cytotoxic chemotherapy. The most common complications were respiratory failure (70 [38.7%]), septic shock (40 [22.1%]) and acute kidney injury (33 [18.2%]). A total of 60 (33.1%) patients died due to COVID-19 complications. For solid tumors, the COVID-19-specific mortality rate was 37.7% (52 out of 138 patients) and for hematological malignancies, 23.5% (8 out of 34). According to the univariate analysis COVID-19-specific mortality was significantly associated with age over 75 years (P = .002), metastatic cancer (p <0.001), two or more sites of metastases (P < .001), the presence of lung (P < .001) or bone metastases (P = .001), non-curative treatment or best supportive care intent (P < .001), higher C-reactive protein levels (P = .002), admission due to COVID-19 (P = .009), and antibiotics use (P = .02). After multivariate analysis, cases with admission due to symptoms of COVID-19 (P = .027) and with two or more metastatic sites (P < .001) showed a higher risk of COVID-19-specific death. Conclusion This is the first Brazilian cohort of cancer patients with COVID-19. The rates of complications and COVID-19-specific death were significantly high.	[de Melo, Andreia C.; Thuler, Luiz C. S.; da Silva, Jesse L.; de Albuquerque, Lucas Z.] Brazilian Natl Canc Inst, Div Clin Res & Technol Dev, Rio De Janeiro, RJ, Brazil; [Pecego, Ana C.; Rodrigues, Luciana de O. R.; da Conceicao, Magda S.; Garrido, Marianne M.] Brazilian Natl Canc Inst, Hosp Infect Control Comm, Rio De Janeiro, RJ, Brazil; [Quintella Mendes, Gelcio L.] Brazilian Natl Canc Inst, Sect Clin Oncol, Rio De Janeiro, RJ, Brazil; [Mendes Pereira, Ana Cristina P.] Brazilian Natl Canc Inst, Sect Anesthesiol, Rio De Janeiro, RJ, Brazil; [Soares, Marcelo A.] Brazilian Natl Canc Inst, Program Oncovirol, Rio De Janeiro, RJ, Brazil; [Viola, Joao P. B.] Brazilian Natl Canc Inst, Program Immunol & Tumor Biol, Rio De Janeiro, RJ, Brazil	National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca)	de Melo, AC (corresponding author), Brazilian Natl Canc Inst, Div Clin Res & Technol Dev, Rio De Janeiro, RJ, Brazil.	andreia.melo@inca.gov.br	Soares, Marcelo A/G-5662-2010; de Melo, Andreia/C-8133-2019; Gomes, Renan/ABF-6345-2021	de Melo, Andreia/0000-0002-1201-4333; Gomes, Renan/0000-0002-0897-469X; da Silva, Jesse Lopes/0000-0002-0790-9917; Viola, Joao/0000-0002-0698-3146	CNPq [306798/2019-0, 305765/2015-9, 307042/2017-0]; FAPERJ [202.640/2019, 211.562/2019, 010.000162/2020, E-26/202.894/2017]; PIBIC/CNPq fellowship	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PIBIC/CNPq fellowship	Yes. This work was supported by grants to LCST from CNPq (306798/2019-0), to MAS from CNPq (305765/2015-9) and FAPERJ (E-26/202.894/2017) and to JPBV from CNPq (307042/2017-0) and FAPERJ (202.640/2019, 211.562/2019 and 010.000162/2020). LZA was supported by a PIBIC/CNPq fellowship.	[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, COR BRAS; [Anonymous], 2020, COVID 19 BRAZ HAS 43; CDCP, 2020, CDC 2019 NOV COR 201; Dai M, 2020, CANC DISCOV, DOI 10.1158/2159-8290.CD-20-0422; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lee LY, 2020, LANCET; Malard F, 2020, BONE MARROW TRANSPL, V55, P2180, DOI 10.1038/s41409-020-0931-4; Mehta V, 2020, CANC DISCOV, DOI 10.1158/2159-8290.CD-20-0516; Tian J, 2020, ANN SURG ONCOL, V27, P4307, DOI 10.1245/s10434-020-08700-6; Vuagnat P, 2020, COVID 19 BREAST CANC, DOI 10.1186/s13058-020-01293-8; World Health Organization, 2022, WEEKL OP UPD COVID 1; World Health Organization, 2020, WHO DIR GEN OP REM M, DOI DOI 10.1093/ANNONC/MDY517; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu XC, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020126; Yang K, 2020, CELL ONCOL, V43, P1175, DOI 10.1007/s13402-020-00550-4; Zhang L, 2020, ANN ONCOL, V31, P894, DOI 10.1016/j.annonc.2020.03.296	18	28	28	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241261	10.1371/journal.pone.0241261	http://dx.doi.org/10.1371/journal.pone.0241261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104715	Green Published, gold, Green Submitted			2022-12-26	WOS:000588370000038
J	Hu, FP; Liao, CC; Chen, TL; Yeh, CC; Shi, LW; Shih, CC				Hu, Feng-Ping; Liao, Chien-Chan; Chen, Ta-Liang; Yeh, Chun-Chieh; Shi, Luwen; Shih, Chun-Chuan			Prevalence, expenditures, and associated factors of purchasing non-prescribed Chinese herbal medicine in Taiwan	PLOS ONE			English	Article							ACUPUNCTURE USE; UNITED-STATES; DRUGS; OUTPATIENTS	Background and aims Purchasing Chinese herbal medicine (CHM) without a physician's prescription may have adverse effects on health. However, the recent status of purchasing non-prescribed CHM and the associated factors are not completely understood. We aimed to report the prevalence of purchasing CHM and associated factors. Methods Using data from the 2017 Taiwan Survey of Family Income and Expenditure, we identified 16,528 individuals (householders) aged 18 years and older. Sociodemographic factors, expenditures on medical services and health behaviours were compared between people with and without a history of purchasing non-prescribed CHM by calculating adjusted odds ratios (ORs) and 95% confidence intervals (CIs) in a multiple logistic regression analysis. Results The one-year prevalence of purchasing non-prescribed CHM was 74.8% in Taiwan. In addition to sociodemographics, marital status (OR 2.14, 95% CI 1.88-2.44), the use of traditional Chinese medicine (OR 3.62, 95% CI 3.30-3.97), the purchasing of non-prescribed biochemical medications (OR 3.09, 95% CI 2.75-3.48), the purchasing of health foods (OR 2.59, 95% CI 2.33-2.86), the use of folk therapy (OR 2.27, 95% CI 1.95-2.64), and a high level of expenditure on alcohol (OR 3.79, 95% CI 3.29-4.36) were strongly correlated with purchasing non-prescribed CHM. Conclusion The one-year prevalence of purchasing non-prescribed CHM is very high in Taiwan and is correlated with sociodemographics, health behaviours, and the utilization of medical care. The interaction of non-prescribed CHM with physician-prescribed herbal medicine and biomedical medications requires more attention.	[Hu, Feng-Ping; Shi, Luwen] Peking Univ, Sch Pharmaceut Sci, Beijing, Peoples R China; [Liao, Chien-Chan] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chan; Chen, Ta-Liang] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Liao, Chien-Chan; Chen, Ta-Liang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chan] Taipei Med Univ, Wan Fang Hosp, Res Ctr Big Data & Meta Anal, Taipei, Taiwan; [Liao, Chien-Chan] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Ta-Liang] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Shih, Chun-Chuan] I Shou Univ, Coll Med, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, Coll Pharm, PhD Program Clin Drug Dev Herbal Med, Taipei, Taiwan	Peking University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; I Shou University; Taipei Medical University	Shih, CC (corresponding author), I Shou Univ, Coll Med, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.; Shih, CC (corresponding author), Taipei Med Univ, Coll Pharm, PhD Program Clin Drug Dev Herbal Med, Taipei, Taiwan.	hwathai@seed.net.tw			Taiwan's Ministry of Health and Welfare [MOHW108-NRICM-M-114-000003]; Taiwan's Ministry of Science and Technology [MOST108-2320-B-214-003-MY3, MOST106-2314-B-038-036-MY3]	Taiwan's Ministry of Health and Welfare; Taiwan's Ministry of Science and Technology	This study is based on data obtained from Health and Welfare Information Science Center, Ministry of Health and Welfare, Taiwan. Our study was supported by the Taiwan's Ministry of Health and Welfare (MOHW108-NRICM-M-114-000003); and by the Taiwan's Ministry of Science and Technology (MOST108-2320-B-214-003-MY3; MOST106-2314-B-038-036-MY3).	Al-Ramahi R, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0764-7; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2010, J OIL GAS KAZAKHTAN, V4, P69; Blenkinsopp A, 1996, BRIT MED J, V312, P629; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Chang CC, 2016, J ETHNOPHARMACOL, V177, P46, DOI 10.1016/j.jep.2015.11.028; Chen KC, 2015, COMPUT METH PROG BIO, V122, P462, DOI 10.1016/j.cmpb.2015.09.006; Clarke Tainya C, 2015, Natl Health Stat Report, P1; He YH, 2020, JAMA ONCOL, V6, P271, DOI 10.1001/jamaoncol.2019.5233; Hequet D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1658-0; Hori S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-14; Huang CW, 2019, J CHIN MED ASSOC, V82, P665, DOI 10.1097/JCMA.0000000000000131; Husain I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1887; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Kemppainen LM, 2018, SCAND J PUBLIC HEALT, V46, P448, DOI 10.1177/1403494817733869; Kim JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-336; Liao HL, 2008, J ALTERN COMPLEM MED, V14, P741, DOI 10.1089/acm.2007.7111; Liu CY, 2010, ASIA-PAC J PUBLIC HE, V22, P51, DOI 10.1177/1010539509352024; Lu WD, 2020, ONCOLOGIST, V25, P310, DOI 10.1634/theoncologist.2019-0489; Nahin Richard L, 2016, Natl Health Stat Report, P1; Shih CC, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1679-2; Upchurch DM, 2014, J ALTERN COMPLEM MED, V20, P32, DOI 10.1089/acm.2012.0120; Wang SJ, 2012, ALLERGY, V67, P583, DOI 10.1111/j.1398-9995.2012.02806.x; Yang L, 2017, ACUPUNCT MED, V35, P189, DOI 10.1136/acupmed-2016-011179; Zhong LLD, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-016-0099-4	25	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240311	10.1371/journal.pone.0240311	http://dx.doi.org/10.1371/journal.pone.0240311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104738	Green Published, gold			2022-12-26	WOS:000588370000011
J	Samarth, DP; Kwon, YM				Samarth, Deepti Pranay; Kwon, Young Min			Horizontal genetic exchange of chromosomally encoded markers between Campylobacter jejuni cells	PLOS ONE			English	Article							NATURAL TRANSFORMATION; ANTIBIOTIC-RESISTANCE; NEISSERIA-GONORRHOEAE; IV SECRETION; TETRACYCLINE RESISTANCE; EXTRACELLULAR DNA; FLAGELLIN LOCUS; FREE-RANGE; DIVERSITY; RECOMBINATION	Many epidemiological studies provide us with the evidence of horizontal gene transfer (HGT) contributing to the bacterial genomic diversity that benefits the bacterial populations with increased ability to adapt to the dynamic environments. Campylobacter jejuni, a major cause of acute enteritis in the U.S., often linked with severe post-infection neuropathies, has been reported to exhibit a non-clonal population structure and comparatively higher strain-level genetic variation. In this study, we provide evidence of the HGT of chromosomally encoded genetic markers between C. jejuni cells in the biphasic MH medium. We used two C. jejuni NCTC-11168 mutants harbouring distinct antibiotic-resistance genes [chloramphenicol (Cm) and kanamycin (Km)] present at two different neutral genomic loci. Cultures of both marker strains were mixed together and incubated for 5 hrs, then plated on MH agar plates supplemented with both antibiotics. The recombinant cells with double antibiotic markers were generated at the frequency of 0.02811 +/- 0.0035% of the parental strains. PCR assays using locus-specific primers confirmed that transfer of the antibiotic-resistance genes was through homologous recombination. Also, the addition of chicken cecal content increased the recombination efficiency approximately up to 10-fold as compared to the biphasic MH medium (control) at P < 0.05. Furthermore, treating the co-culture with DNase I decreased the available DNA, which in turn significantly reduced recombination efficiency by 99.92% (P < 0.05). We used the cell-free supernatant of 16 hrs-culture of Wild-type C. jejuni as a template for PCR and found DNA sequences from six different genomic regions were easily amplified, indicating the presence of released chromosomal DNA in the culture supernatant. Our findings suggest that HGT in C. jejuni is facilitated in the chicken gut environment contributing to in vivo genomic diversity. Additionally, C. jejuni might have an active mechanism to release its chromosomal DNA into the extracellular environment, further expediting HGT in C. jejuni populations.	[Samarth, Deepti Pranay; Kwon, Young Min] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Kwon, Young Min] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Samarth, DP (corresponding author), Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.	Samarth.deepti@gmail.com		Samarth, Deepti/0000-0001-6647-8558				[Anonymous], 2003, ARCH HOSP, V1, P137; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2010, NEPHROL THER, V6, pS27; [Anonymous], 2017, DTSCH ZRZTEBLATT JG, V114, pA741; [Anonymous], 2012, REGEN MED S3, V7, pS14; Avrain L, 2004, J APPL MICROBIOL, V97, P134, DOI 10.1111/j.1365-2672.2004.02306.x; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Blokesch M, 2017, CURR OPIN MICROBIOL, V38, P22, DOI 10.1016/j.mib.2017.04.001; Brito PH, 2018, GENOME BIOL EVOL, V10, P108, DOI 10.1093/gbe/evx270; Brown HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00699; Butzler J, 2018, CLIN ASPECTS CAMPYLO, P21; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Crespo MD, 2016, PLASMID, V86, P32, DOI 10.1016/j.plasmid.2016.06.001; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Ducey TF, 2002, RAPID IDENTIFICATION; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Dworkin J, 1997, J BACTERIOL, V179, P7523, DOI 10.1128/jb.179.23.7523-7529.1997; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gardner SP, 2012, ADV APPL MICROBIOL, V79, P19, DOI 10.1016/B978-0-12-394318-7.00002-4; Gibreel A, 2004, ANTIMICROB AGENTS CH, V48, P3442, DOI 10.1128/AAC.48.9.3442-3450.2004; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Griggs DJ, 2005, ANTIMICROB AGENTS CH, V49, P699, DOI 10.1128/AAC.49.2.699-707.2005; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; GUERRY P, 1994, INFECT IMMUN, V62, P426, DOI 10.1128/IAI.62.2.426-432.1994; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Halpin RW, 2018, JEWISH DOCTORS AND THE HOLOCAUST: THE ANATOMY OF SURVIVAL IN AUSCHWITZ, P1; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hanninen ML, 1999, APPL ENVIRON MICROB, V65, P2272; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; Harrington CS, 1997, J CLIN MICROBIOL, V35, P2386, DOI 10.1128/JCM.35.9.2386-2392.1997; Heinemann JA, 2006, REV CELL BIOL MOL ME; Hermans D, 2012, CRIT REV MICROBIOL, V38, P17, DOI 10.3109/1040841X.2011.615298; Holt JP, 2012, APPL ENV MICROBIOL; Huang HM, 2014, VIROLOGY, V468, P274, DOI 10.1016/j.virol.2014.07.029; de Aldecoa ALI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01390; Iglesias-Torrens Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01676; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jeon B, 2008, ANTIMICROB AGENTS CH, V52, P2699, DOI 10.1128/AAC.01607-07; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Koraimann G, 2004, BACTERIAL CONJUGATIO, P111; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Korolik V, 1998, VET MICROBIOL, V60, P239, DOI 10.1016/S0378-1135(98)00145-X; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lastovica AJ, 2008, CAMPYLOBACTER, 3RD EDITION, P123; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Liou LS, 2016, J NEUROL SCI, V369, P159, DOI 10.1016/j.jns.2016.08.014; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Mandal RK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4032-8; Marder EP, 2017, MMWR-MORBID MORTAL W, V66, P397, DOI 10.15585/mmwr.mm6615a1; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mell JC, 2014, J BACTERIOL, P1293; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Nachamkin I., 1998, CLIN MICROBIOLOGY RE, V11, P3; Nuijten PJM, 2000, INFECT IMMUN, V68, P7137, DOI 10.1128/IAI.68.12.7137-7140.2000; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Owens J, 2013, VET MICROBIOL, V162, P144, DOI 10.1016/j.vetmic.2012.08.017; Oyarzabal OA, 2007, J CLIN MICROBIOL, V45, P402, DOI 10.1128/JCM.01456-06; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Pratt A, 2005, J ANTIMICROB CHEMOTH, V55, P452, DOI 10.1093/jac/dki040; Ramsey ME, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00061; Rivoal K, 2005, APPL ENVIRON MICROB, V71, P6216, DOI 10.1128/AEM.71.10.6216-6227.2005; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schouls LM, 2003, J CLIN MICROBIOL, V41, P15, DOI 10.1128/JCM.41.1.15-26.2003; SHADOWEN RD, 1989, J CLIN MICROBIOL, V27, P1744, DOI 10.1128/JCM.27.8.1744-1747.1989; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Singh P, 2013, POULTRY SCI, V92, P2135, DOI 10.3382/ps.2012-02615; SINHA RP, 1971, BIOCHIM BIOPHYS ACTA, V232, P61, DOI 10.1016/0005-2787(71)90491-6; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Solomon JM, 1996, TRENDS GENET, V12, P150, DOI 10.1016/0168-9525(96)10014-7; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Suerbaum S, 2001, J BACTERIOL, V183, P2553, DOI 10.1128/JB.183.8.2553-2559.2001; Suguitan Jr AL, 2011, PLOS ONE, V6; Taboada EN, 2004, J CLIN MICROBIOL, V42, P4566, DOI 10.1128/JCM.42.10.4566-4576.2004; TAYLOR DE, 1992, ANNU REV MICROBIOL, V46, P35, DOI 10.1146/annurev.micro.46.1.35; TAYLOR DE, 1981, ANTIMICROB AGENTS CH, V19, P831, DOI 10.1128/AAC.19.5.831; Taylor F, 2018, PERSPECT ASIAN TOUR, P87, DOI 10.1007/978-981-10-5909-4_6; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Van Vliet AHM, 1998, METHOD MICROBIOL, V27, P407; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; Vidal AB, 2016, APPL ENVIRON MICROB, V82, P2347, DOI 10.1128/AEM.03693-15; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; WASSENAAR TM, 1993, GENE, V132, P131, DOI 10.1016/0378-1119(93)90525-8; WASSENAAR TM, 1995, MICROBIOL-UK, V141, P95, DOI 10.1099/00221287-141-1-95; Wassenaar TM, 1998, APPL ENVIRON MICROB, V64, P1816; Wassenaar TM, 2002, INT J INFECT DIS, V6, pS22; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wiesner RS, 2008, CAMPYLOBACTER, 3RD EDITION, P559; Wiesner RS, 2003, J BACTERIOL, V185, P5408, DOI 10.1128/JB.185.18.5408-5418.2003; Wiesner RS, 2006, PHYSL GENETIC BIOCH; Willison HJ, 1999, J NEUROIMMUNOL, V100, P3, DOI 10.1016/S0165-5728(99)00213-1; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0; Xu Fuzhou, 2010, J Bacteriol, V192, P4425, DOI 10.1128/JB.00478-10; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Zeng X, 2015, APPL ENV MICROBIOL; Zeng XM, 2009, INFECT IMMUN, V77, P5437, DOI 10.1128/IAI.00666-09; Zhang Y., 2008, PLOS ONE, V3, pe3933; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a	113	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241058	10.1371/journal.pone.0241058	http://dx.doi.org/10.1371/journal.pone.0241058			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104745	Green Published, gold			2022-12-26	WOS:000588370000034
J	Tian, J; Zhang, CT; Wang, Q				Tian, Jie; Zhang, Chuntao; Wang, Qun			Analysis of craniocerebral injury in facial collision accidents	PLOS ONE			English	Article							LOGIT MODEL; SEVERITY; HEAD; IMPACT	Considering that the Pc-Crash multibody dynamics software can reproduce the accident process accurately and obtain the collision parameters of pedestrian heads at the moment of head landing, the finite element analysis method can accurately analyze the injury of the pedestrian head when the boundary conditions are known. This paper combines the accident reconstruction method with the finite element analysis method to study the injury mechanism of pedestrian head impact on the ground in vehicle pedestrian collision accidents to provide a theoretical basis for pedestrian protection and the improvement of vehicle shapes. First, a real-life vehicle pedestrian collision is reproduced by Pc-Crash. The simulation results show that the rigid multibody model can accurately simulate the scene of the accident, then the speed and angle of the pedestrian head landing moment can be obtained at the same time. Second, the finite element model of human heads with a detailed facial structure is established and verified. Finally, the collision parameters obtained from the accident reconstruction are used as the boundary conditions to analyze the collision between the pedestrian head and the ground, and the biomechanical parameters, such as intracranial pressure, von Mises stress, shear stress and strain, can be determined. The results show that the stress wave will propagate inside and outside the skull and cause stress concentration in the skull and the brain tissue to varying degrees after the pedestrian head strikes the ground. When the stress exceeds a certain limit, it will cause different degrees of brain tissue injury.	[Tian, Jie; Zhang, Chuntao; Wang, Qun] Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing, Jaingsu, Peoples R China	Nanjing Forestry University	Tian, J (corresponding author), Nanjing Forestry Univ, Coll Automobile & Traff Engn, Nanjing, Jaingsu, Peoples R China.	njtianjie@163.com	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	National Natural Science Foundation of China [51975299]; High Level Talent Fund of Nanjing Forestry University [GXL2018004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Level Talent Fund of Nanjing Forestry University	This study was supported by the National Natural Science Foundation of China in the form of a grant awarded to JT (51975299) and the High Level Talent Fund of Nanjing Forestry University in the form of a grant awarded to JT (GXL2018004).	Anderson R.W.G., 1999, P INT IRCOBI C BIOM, P107; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baumgartner D, 2005, SOLID MECH APPL, V124, P195; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Cociu S., 2020, MEDESPERA INT MEDICA, V8, P301; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; Elliott JR, 2012, ACCIDENT ANAL PREV, V45, P342, DOI 10.1016/j.aap.2011.07.022; Eluru N, 2008, ACCIDENT ANAL PREV, V40, P1033, DOI 10.1016/j.aap.2007.11.010; Gupta Vishal, 2013, Stapp Car Crash J, V57, P139; He LM, 2005, CHIN J NEUROMEDICINE, V4, P874; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; National Bureau of statistics of the people's Republic of China, 2020, STAT B NAT EC SOC DE; Peng HR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176170; Sun SS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235323; Sun SS, 2019, ENG FAIL ANAL, V102, P395, DOI 10.1016/j.engfailanal.2019.04.050; Sze NN, 2007, ACCIDENT ANAL PREV, V39, P1267, DOI 10.1016/j.aap.2007.03.017; Tamura A., 2015, INT J VEH SAF, V8, P85; Wang C., 2015, STUDY MEMBERSHIP FUN; Ward C, 1980, P 24 STAPP CAR CRASH, P161, DOI [10.2307/44632636, DOI 10.2307/446326]; World Health Organisation, 2018, GLOB STAT REP ROAD S; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, ACCIDENT ANAL PREV, V127, P87, DOI 10.1016/j.aap.2019.02.029; Zeng Q, 2016, J SAFETY RES, V59, P105, DOI 10.1016/j.jsr.2016.10.005	26	5	5	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240359	10.1371/journal.pone.0240359	http://dx.doi.org/10.1371/journal.pone.0240359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104724	Green Published, gold			2022-12-26	WOS:000588370000004
J	Baillet, H; Leroy, D; Verin, E; Delpouve, C; Boulanger, J; Benguigui, N; Komar, J; Thouvarecq, R				Baillet, Heloise; Leroy, David; Verin, Eric; Delpouve, Claire; Boulanger, Jeremie; Benguigui, Nicolas; Komar, John; Thouvarecq, Regis			Effects of practice on a mechanical horse with an online feedback on performing a sitting postural coordination	PLOS ONE			English	Article							BIMANUAL COORDINATION; MUSCLE-ACTIVITY; DYNAMICS; ADJUSTMENTS; PATTERNS; PERTURBATIONS; MODES	The present research aims at quantifying the impact of practicing a new coordination pattern with an online visual feedback on the postural coordination performed on a mechanical horse. Forty-four voluntary participants were recruited in this study. They were randomly assigned to four practice groups based on i) with or without feedback (i.e., group 1, control, did not receive the feedback; group 2, 3 and 4 received an online feedback during practice) and ii) the specific trunk/horse coordination to target during practice (group 1, target coordination = 180 degrees (without feedback); group 2, target coordination = 0 degrees; group 3, target coordination = 90 degrees; group 4, target coordination = 180 degrees). All participants performed pre-, practice, post- and retention sessions. The pre-, post- and retention sessions consisted of four trials, with one trial corresponding to one specific target coordination to maintain between their own oscillations and the horse oscillations (spontaneous, 0 degrees, 90 degrees, and 180 degrees). The practice phase was composed of three different sessions during which participants received an online feedback about the coordination between their own oscillations and the horse oscillations. Results showed a significant change with practice in the trunk/horse coordination patterns which persisted even after one month (retention-test). However, all the groups did not show the same nature of change, evidenced by a high postural variability during post-test for 0 degrees and 90 degrees target coordination groups, in opposition to the 180 degrees and spontaneous groups who showed a decrease in coordination variability for the 180 degrees group. The coordination in anti-phase was characterized as spontaneously adopted by participants on the mechanical horse, explaining the ease of performing this coordination (compared to the 0 degrees and 90 degrees target coordination). The effect of online visual feedback appeared not only on the coordination pattern itself, but most importantly on its variability during practice, including concerning initially stable coordination patterns.	[Baillet, Heloise; Leroy, David; Thouvarecq, Regis] Normandie Univ, CETAPS, UNIROUEN, Rouen, France; [Verin, Eric] Normandie Univ, UNIROUEN, Rouen, France; [Verin, Eric] Rouen Univ Hosp, Rouen, France; [Delpouve, Claire] CRMPR Herbiers Rehabil Ctr, Bois Guillaume, France; [Boulanger, Jeremie] Lille 1 Univ, Villeneuve Dascq, France; [Benguigui, Nicolas] Normandie Univ, CESAMS, UNICAEN, Caen, France; [Komar, John] Nanyang Technol Univ, Natl Inst Educ, Singapore, Singapore	CHU de Rouen; Universite de Lille - ISITE; Universite de Lille; Universite de Caen Normandie; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Baillet, H (corresponding author), Normandie Univ, CETAPS, UNIROUEN, Rouen, France.	bailletheloise@gmail.com	Komar, John/ABD-4094-2020	Komar, John/0000-0002-2063-4065	CPER-FEDER Q7 project; Institut Francais du Cheval et de l'Equitation (IFCE)	CPER-FEDER Q7 project; Institut Francais du Cheval et de l'Equitation (IFCE)	The research reported here was supported by the CPER-FEDER Q7 project [Axe: Masses de Donnees et Contenus Intelligents, project: Data science: methodologies et applications (DAISI)] and the Institut Francais du Cheval et de l'Equitation (IFCE).	[Anonymous], 2019, CANC DISCOV, V10, pOF5; Baillet H, 2017, J MOTOR BEHAV, V49, P441, DOI 10.1080/00222895.2016.1241743; Bardy BG, 2006, MOTOR CONTROL AND LEARNING, P77, DOI 10.1007/0-387-28287-4_7; Bardy BG, 1999, J EXP PSYCHOL HUMAN, V25, P1284, DOI 10.1037/0096-1523.25.5.1284; Bardy BG, 2002, J EXP PSYCHOL HUMAN, V28, P499, DOI 10.1037//0096-1523.28.3.499; Bardy BG, 2004, UND COM SYS, P103; Batschelet E., 1978, ANIMAL MIGRATION NAV, P3, DOI DOI 10.1007/978-3-662-11147-5_1; Bernstein N, 1967, COORDINATION REGULAT; Brogren E, 1996, DEV MED CHILD NEUROL, V38, P379; Carlberg Eva Brogren, 2005, Neural Plast, V12, P221, DOI 10.1155/NP.2005.221; Delignieres D, 1998, HUM MOVEMENT SCI, V17, P221, DOI 10.1016/S0167-9457(97)00031-6; Delignieres D., 2009, B PSYCHOL, V502, P327; Faugloire E, 2005, NEUROSCI LETT, V374, P136, DOI 10.1016/j.neulet.2004.10.043; Faugloire E, 2003, STUD PERCEPT ACTION, V7, P109; Faugloire E, 2006, J MOTOR BEHAV, V38, P299, DOI 10.3200/JMBR.38.4.299-312; Faugloire E, 2009, J EXP PSYCHOL HUMAN, V35, P170, DOI 10.1037/0096-1523.35.1.170; Fontaine RJ, 1997, CAN J EXP PSYCHOL, V51, P1, DOI 10.1037/1196-1961.51.1.1; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; Hadders-Algra M, 1998, NEUROSCI BIOBEHAV R, V22, P501, DOI 10.1016/S0149-7634(97)00036-5; Hadders-Algra Mijna, 2003, Neural Plasticity, V10, P39, DOI 10.1155/NP.2003.39; HaddersAlgra M, 1996, J PHYSIOL-LONDON, V493, P273, DOI 10.1113/jphysiol.1996.sp021382; Haken H., 1983, ADV SYNERGETICS INST; Hodges NJ, 2002, HUM MOVEMENT SCI, V21, P231, DOI 10.1016/S0167-9457(02)00101-X; JOUFFROY J J, 1991, Science and Sports, V6, P129, DOI 10.1016/S0765-1597(05)80120-0; Kelso J A, 1984, Am J Physiol, V246, pR1000; KELSO JAS, 1988, HUM MOVEMENT SCI, V7, P27, DOI 10.1016/0167-9457(88)90003-6; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kelso JAS, 1981, B PSYCHON SOC, V18; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Lanzetta D, 2004, ARCH PHYS MED REHAB, V85, P279, DOI 10.1016/j.apmr.2003.05.004; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Marin L, 1999, HUM MOVEMENT SCI, V18, P31, DOI 10.1016/S0167-9457(98)00032-3; Marin L, 2011, MOV SPORT SCI, V74, P39, DOI [10.3917/sm.074.0039, DOI 10.3917/SM.074.0039]; Newell K., 1986, MOTOR DEV CHILDREN A; NEWELL KM, 1993, GAIT POSTURE, V1, P225, DOI 10.1016/0966-6362(93)90050-B; Nourrit D, 2003, J MOTOR BEHAV, V35, P151, DOI 10.1080/00222890309602130; Oullier O, 2004, MOTOR CONTROL, V8, P174, DOI 10.1123/mcj.8.2.174; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Oullier O, 2004, VARIABILITY MOVEMENT; Oullier O, 2006, VARIABILITY POSTURAL, P25; Oullier O, 2003, CAH MAISON RECH EN S; Park J, 2013, J PHYS THER SCI, V25, P1169, DOI 10.1589/jpts.25.1169; Pellegrini AM, 2004, HUM MOVEMENT SCI, V23, P447, DOI 10.1016/j.humov.2004.08.017; RICCIO GE, 1988, HUM MOVEMENT SCI, V7, P265, DOI 10.1016/0167-9457(88)90014-0; SCHONER G, 1992, J MOTOR BEHAV, V24, P29, DOI 10.1080/00222895.1992.9941599; Shea CH, 2016, PSYCHON B REV, V23, P361, DOI 10.3758/s13423-015-0915-3; Stafford T, 2014, PSYCHOL SCI, V25, P511, DOI 10.1177/0956797613511466; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; Van Der Fits IBM, 1998, NEUROSCI BIOBEHAV R, V22, P521, DOI 10.1016/S0149-7634(97)00039-0; van der Heide Jolanda C., 2005, Neural Plasticity, V12, P197; Varoqui D, 2007, POSTURAL COORDINATIO, P293; Varoqui D, 2006, STABILITY IN PHASE A, P231; Varoqui D, 2011, MOV SPORT SCI, V74, P89, DOI [10.3917/sm.074.0089, DOI 10.3917/SM.074.0089]; Varoqui D, 2011, MOTOR CONTROL, V15, P187, DOI 10.1123/mcj.15.2.187; Varoqui D, 2010, GAIT POSTURE, V32, P34, DOI 10.1016/j.gaitpost.2010.03.004; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403	60	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0236205	10.1371/journal.pone.0236205	http://dx.doi.org/10.1371/journal.pone.0236205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095774	gold, Green Submitted, Green Published			2022-12-26	WOS:000586649400071
J	Chang, CJ; Huang, YM; Hsieh, MH; Li, AF; Chen, SJ				Chang, Chia-Jui; Huang, Yi-Ming; Hsieh, Ming-Hung; Li, An-Fei; Chen, Shih-Jen			Flow signal change in polyps after anti-vascular endothelial growth factor therapy	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; AMPLITUDE-DECORRELATION ANGIOGRAPHY; COHERENCE TOMOGRAPHY ANGIOGRAPHY; VERTEPORFIN PHOTODYNAMIC THERAPY; RANIBIZUMAB THERAPY; EFFICACY; EVEREST; SAFETY	Optical coherence tomography angiography (OCTA) is a novel, non-invasive imaging tool used to detect vascular flow. The absence of a flow signal in OCTA in polyps revealed by indocyanine green angiography (ICGA) in patients with polypoidal choroidal vasculopathy (PCV) may indicate slow or compromised filling of blood flow from choroidal vessels. Naive patients with PCV treated with intravitreal injections of aflibercept (IVI-A) were enrolled in this study to validate the hypothesis that baseline flow may affect the outcome of polyp regression in ICGA. The flow signal of polyps in OCTA was detected by manual segmentation in the corresponding location by ICGA. Polyps were defined as high-flow if both OCTA and ICGA showed positive findings, and low-flow if OCTA showed a negative flow signal in 3 consecutive horizontal scans at the polyp area shown in ICGA. A total of 24 polyps were identified in 13 PCV patients at baseline. Of these 24 polyps, 22 (91.7%) were high-flow and 2 (8.3%) were low-flow. After 3 monthly IVI-A, all low-flow polyps had complete regression in ICGA. Among 17 (77%) high-flow polyps at baseline that had regression after treatment, 10 (58.8%) became low-flow, while 5 (22.7%) persistent polyps remained high-flow. Flow signal of polyps as detected by OCTA could be a predictive factor for treatment response in patients with PCV. Monitoring changes in flow signal after treatment is clinically relevant.	[Chang, Chia-Jui; Huang, Yi-Ming; Li, An-Fei; Chen, Shih-Jen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hsieh, Ming-Hung] Taipei City Hosp, Hoping Branch, Taipei, Taiwan; [Li, An-Fei; Chen, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Li, An-Fei] Cheng Hsin Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Chen, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Chen, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	sjchen96@gamil.com		Chen, Shih-Jen/0000-0001-9798-1578				Bo QY, 2019, JAMA OPHTHALMOL, V137, P642, DOI 10.1001/jamaophthalmol.2019.0449; Chen YT, 2018, LASER SURG MED, V50, P427, DOI 10.1002/lsm.22801; Cho HJ, 2015, JPN J OPHTHALMOL, V59, P29, DOI 10.1007/s10384-014-0349-x; Cho JH, 2020, RETINA-J RET VIT DIS, V40, P468, DOI 10.1097/IAE.0000000000002384; Fukuyama H, 2018, OPHTHALMOL RETINA, V2, P803, DOI 10.1016/j.oret.2017.11.016; Hikichi T, 2015, BRIT J OPHTHALMOL, V99, P817, DOI 10.1136/bjophthalmol-2014-305606; Huang CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37384-y; Huang YM, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/3479695; Inoue M, 2015, RETINA-J RET VIT DIS, V35, P2265, DOI 10.1097/IAE.0000000000000777; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kim JY, 2016, GRAEF ARCH CLIN EXP, V254, P1505, DOI 10.1007/s00417-015-3228-3; Koh A, 2017, JAMA OPHTHALMOL, V135, P1206, DOI 10.1001/jamaophthalmol.2017.4030; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Miura M, 2015, INVEST OPHTH VIS SCI, V56, P3179, DOI 10.1167/iovs.14-16252; Rebhun CB, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.6.4; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Suzuki M, 2016, AM J OPHTHALMOL, V166, P52, DOI 10.1016/j.ajo.2016.03.024; Tan CS, 2015, BRIT J OPHTHALMOL, V99, P624, DOI 10.1136/bjophthalmol-2014-305674; Tanaka K, 2017, BRIT J OPHTHALMOL, V101, P51, DOI 10.1136/bjophthalmol-2016-309264; Tokayer J, 2013, BIOMED OPT EXPRESS, V4, P1909, DOI 10.1364/BOE.4.001909; Tomiyasu T, 2016, INVEST OPHTH VIS SCI, V57, pOCT324, DOI 10.1167/iovs.15-18898; Wang M, 2016, INVEST OPHTH VIS SCI, V57, pOCT526, DOI 10.1167/iovs.15-18955; Wong TY, 2019, AM J OPHTHALMOL, V204, P80, DOI 10.1016/j.ajo.2019.02.027	23	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241230	10.1371/journal.pone.0241230	http://dx.doi.org/10.1371/journal.pone.0241230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095843	Green Published, gold			2022-12-26	WOS:000586649400057
J	Choi, J; Kim, S; Cho, T				Choi, Jiyoun; Kim, Sahyang; Cho, Taehong			An apparent-time study of an ongoing sound change in Seoul Korean: A prosodic account	PLOS ONE			English	Article							VOICE ONSET TIME; SEGMENTAL FOCUS; LEXICAL FOCUS; IMPLEMENTATION; CONTRAST; ENGLISH; STRESS; STOPS; TONOGENESIS; PERCEPTION	In present-day Seoul Korean, the primary phonetic feature for the lenis-aspirated stop distinction is shifting from VOT to F0. Some previous studies have considered this sound change to be a tonogenesis, whereby the low-level F0 perturbation has developed into tonal features (L for the lenis and H for the aspirated) in the segmental phonology. They, however, have examined the stop distinction only at a phrase- or utterance-initial position. We newly explore the sound change in relation to various prosodic structural factors (position and prominence). Apparent-time production data were recorded from four speaker groups: young female, young male, old female, old male. The way the speakers use VOT versus F0 indeed varies as a function of position and prominence. Crucially, in all groups, VOT is still used for the lenis-aspirated distinction phrase-medially due to the lenis stop voicing. This role of VOT, however, is found only in the non-prominent (unfocused) condition, in which the F0 difference is reduced to a low-level perturbation effect. In the prominent (focused) context in which tones come into play, the role of VOT diminishes, led by young female speakers. These can be interpreted as a prosodically-conditioned, complementary use of the features to maintain sufficient contrast. Importantly, however, the tonal difference under focus is not bidirectionally polarized, so that F0 is not lowered for the lenis stop. A lack of direct enhancement of the distinctive L tone weakens a possibility that F0 is transphonologized to the phonemic feature system of the language. As an alternative to the view that tonal features are newly introduced in the segmental phonology, we propose a prosodic account: the sound change is best characterized as a prosodically-conditioned change in the use of the segmental voicing feature (implemented by VOT) versus already available post-lexical tones in the intonational phonology of Korean.	[Choi, Jiyoun] Sookmyung Womens Univ, Dept Social Psychol, Seoul, South Korea; [Kim, Sahyang] Hongik Univ, Dept English Educ, Seoul, South Korea; [Cho, Taehong] Hanyang Univ, Hanyang Inst Phonet & Cognit Sci, Dept English Language & Literature, Seoul, South Korea	Sookmyung Women's University; Hongik University; Hanyang University	Cho, T (corresponding author), Hanyang Univ, Hanyang Inst Phonet & Cognit Sci, Dept English Language & Literature, Seoul, South Korea.	tcho@hanyang.ac.kr		Cho, Taehong/0000-0002-8148-745X	Sookmyung Women's University Research Grants [1-1903-2015]; Hongik University	Sookmyung Women's University Research Grants; Hongik University	This work was supported in part by Sookmyung Women's University Research Grants 1-1903-2015 awarded to the first author (J.C). The funder's url address is as follows: http://e.sookmyung.ac.kr/sites/sookmyungen/index.do.This work was supported by 2019 Hongik University Research Fund awarded to the second author (S.K). The funder's url address is as follows: http://en.hongik.ac.kr/index.do.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson AS, 2017, J PHONETICS, V63, P75, DOI 10.1016/j.wocn.2017.05.002; Adriaans F, 2017, J ACOUST SOC AM, V141, P3070, DOI 10.1121/1.4982246; Bang HY, 2018, J PHONETICS, V66, P120, DOI 10.1016/j.wocn.2017.09.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beckman ME, 1996, LANG COGNITIVE PROC, V11, P17, DOI 10.1080/016909696387213; Chen YY, 2008, J PHONETICS, V36, P724, DOI 10.1016/j.wocn.2008.06.003; Cho T., 2011, CONTINUUM COMPANION, P343; Cho T, 2019, J PHONETICS, V72, P52, DOI 10.1016/j.wocn.2018.11.002; Cho T, 2019, LINGUIST REV, V36, P85, DOI 10.1515/tlr-2018-2008; Cho T, 2016, LANG LINGUIST COMPAS, V10, P120, DOI 10.1111/lnc3.12178; Cho T, 2015, BLACKW HBK LINGUIST, P505; Cho T, 2009, J PHONETICS, V37, P466, DOI 10.1016/j.wocn.2009.08.001; Cho Taehong., 2000, CHICAGO LINGUISTICS, V36, P31, DOI 10.1121/1.1861893; Cho TH, 2005, J PHONETICS, V33, P121, DOI 10.1016/j.wocn.2005.01.001; Cho TH, 2002, J PHONETICS, V30, P193, DOI 10.1006/jpho.2001.0153; Cho TH, 2001, J PHONETICS, V29, P155, DOI 10.1006/jpho.2001.0131; Coetzee AW, 2018, J PHONETICS, V66, P185, DOI 10.1016/j.wocn.2017.09.009; Cristia A, 2014, J CHILD LANG, V41, P913, DOI 10.1017/S0305000912000669; Cutler Anne, 2012, NATIVE LISTENING LAN; Davidson L, 2016, J PHONETICS, V54, P35, DOI 10.1016/j.wocn.2015.09.003; de Jong K, 2004, J PHONETICS, V32, P493, DOI 10.1016/j.wocn.2004.05.002; de Jong K, 2002, J PHONETICS, V30, P53, DOI 10.1006/jpho.2001.0151; DEJONG KJ, 1995, J ACOUST SOC AM, V97, P491, DOI 10.1121/1.412275; EADY SJ, 1986, LANG SPEECH, V29, P233, DOI 10.1177/002383098602900304; Fletcher J., 2010, HDB PHONETIC SCI, P523; Fougeron C, 1997, J ACOUST SOC AM, V101, P3728, DOI 10.1121/1.418332; Gao JY, 2019, J PHONETICS, V77, DOI 10.1016/j.wocn.2019.100932; Greenhalgh RM, 2008, EUR J VASC ENDOVASC, V36, P680, DOI 10.1016/j.ejvs.2008.10.007; Hanson HM, 2009, J ACOUST SOC AM, V125, P425, DOI 10.1121/1.3021306; Jessen M.., 1999, PHONETICS PHONOLOGY, V44; Jun S.-A., 1996, UCLA WORKING PAPERS, V92, P97; Jun S.-A, 1996, PHONETICS PHONOLOGY; Jun S.-A., 1998, PHONOLOGY, V15, P189, DOI DOI 10.1017/S0952675798003571; Jun S.-A., 2014, PROSODIC TYPOLOGY 2, P520, DOI DOI 10.1093/ACPROF:OSO/9780199567300.003.0017; Jun Sun-Ah, 1998, P 5 INT C SPOK LANG, V4, P1295; Jun Sun-Ah, 2000, SPEECH SCI, V7, P143; Jun Sun-Ah, 2006, JAPANESE KOREAN LING, V14, P15; Kang KH, 2008, J ACOUST SOC AM, V124, P3909, DOI 10.1121/1.2988292; Kang YJ, 2014, J PHONETICS, V45, P76, DOI 10.1016/j.wocn.2014.03.005; Kang Y, 2013, LINGUA, V134, P62, DOI 10.1016/j.lingua.2013.06.002; Keating P., 2003, PHONETIC INTERPRETAT, P143, DOI DOI 10.1121/1.380986; Kim MR, 2002, J PHONETICS, V30, P77, DOI 10.1006/jpho.2001.0152; Kim S, 2018, J PHONETICS, V71, P65, DOI 10.1016/j.wocn.2018.07.004; KINGSTON J, 1994, LANGUAGE, V70, P419, DOI 10.2307/416481; Kingston John, 2011, BLACKWELL COMPANION, V4, P2304, DOI [10.1002/9781444335262.wbctp0097, DOI 10.1002/9781444335262.WBCTP0097]; Kirby JP, 2018, J PHONETICS, V71, P326, DOI 10.1016/j.wocn.2018.09.009; Kirby JP, 2016, J ACOUST SOC AM, V140, P2400, DOI 10.1121/1.4962445; Kirby JP, 2014, J PHONETICS, V43, P69, DOI 10.1016/j.wocn.2014.02.001; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Labov William, 1990, LANG VAR CHANGE, V2, P205, DOI [10. 1017/S09543945 00000338, DOI 10.1017/S0954394500000338]; Lee H, 2013, J PHONETICS, V41, P117, DOI 10.1016/j.wocn.2012.12.002; LEHISTE I, 1961, J ACOUST SOC AM, V33, P419, DOI 10.1121/1.1908681; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Oh E, 2011, J PHONETICS, V39, P59, DOI 10.1016/j.wocn.2010.11.002; R Core Team, 2013, R LANG ENV STAT COMP; Salmons JC, 2012, INITIATION SOUND CHA, P167; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; ShattuckHufnagel S, 1996, J PSYCHOLINGUIST RES, V25, P193, DOI 10.1007/BF01708572; Silva David., 2006, PHONOLOGY, V23, P287, DOI [DOI 10.1017/S0952675706000911, 10.1017/S0952675706000911]; Xu Y, 1999, J PHONETICS, V27, P55, DOI 10.1006/jpho.1999.0086	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240682	10.1371/journal.pone.0240682	http://dx.doi.org/10.1371/journal.pone.0240682			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091043	gold, Green Published			2022-12-26	WOS:000586647200032
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			Association between serum uric acid and spirometric pulmonary function in Korean adults: The 2016 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RISK; MORTALITY; DISEASE; HYPERURICEMIA; POPULATION	Background A limited number of epidemiological studies have investigated the association between serum uric acid and pulmonary function in the general population. However, the results have been inconclusive. Objectives This study was performed to investigate the association between serum uric acid and spirometric pulmonary function in general population. Methods Among the 8,150 participants who participated in the 2016 Korea National Health and Nutrition Examination Survey, 2,901 participants were analyzed in this study. Subjects were divided into four groups according to forced vital capacity (FVC)% predicted or forced expiratory volume in 1 second (FEV1) % predicted quartiles. Participants in the lowest quartile of FVC % predicted and FEV1% predicted were compared to those in the remaining quartiles according to age, education level, household income, smoking status, alcohol consumption, aerobic exercise, obesity, hypertension, diabetes, renal impairment, serum uric acid, and hyperuricemia. Multivariable logistic regression analyses were used to calculate the odds ratio (OR) of hyperuricemia for participants in the lowest quartile of FVC% and FEV1 predicted, with above covariates. Results In women, hyperuricemia was associated with lowest quartile of FVC% predicted (OR 1.71, 95% CI 1.06-2.75,p= 0.027) and FEV1 predicted (OR 1.70, 95% CI 1.06-2.74,p= 0.028) respectively, serving as above confounding variables. In men, hyperuricemia (OR 1.54, 95% CI 1.07-2.22,p= 0.021) was associated with the lowest quartile of FEV1% predicted, not FVC% predicted. According to median age, in women, age >= 56 years old with hyperuricemia was associated with lowest quartile of FVC% predicted (OR 1.85, 95% CI 1.04-3.28,p= 0.037) and FEV1% predicted (OR 1.99, 95% CI 1.11-3.75,p= 0.021), respectively. In men, age >= 56 years old with hyperuricemia was associated with lowest quartile of FEV1% predicted (OR 1.75, 95% CI 1.05-2.94,p= 0.033), not FCV% predicted. Conclusions Hyperuricemia was associated with lowest quartile of FEV1% or FVC% predicted in Korean general population. This correlation between hyperuricemia and low pulmonary function was more pronounced in women and older age.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr						Aida Y, 2011, INT J MED SCI, V8, P470, DOI 10.7150/ijms.8.470; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 1999, AM J PHYS, V276, pF122; [Anonymous], 2015, BMJ, V2015, ph1887; ANTON FM, 1986, METABOLISM, V35, P343; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bartziokas K, 2014, EUR RESPIR J, V43, P43, DOI 10.1183/09031936.00209212; Chen CY, 2016, MED SCI MONITOR, V22, P2501, DOI 10.12659/MSM.899852; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Colegio de Enfermeria de Valencia, 2012, ENF GEST CAS ENF INT, V98, P13; Darmawan G, 2017, ACTA MED INDONES, V49, P136; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; El Ridi R, 2017, J ADV RES, V8, P487, DOI 10.1016/j.jare.2017.03.003; ELSAYED NM, 1993, ARCH BIOCHEM BIOPHYS, V302, P228, DOI 10.1006/abbi.1993.1204; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Hankinson JL, 2015, EUR RESPIR J, V45, P1283, DOI 10.1183/09031936.00116814; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Journal of Supervision, 2004, SUPERVISION, V65, P7; Kamei K, 2016, CLIN EXP NEPHROL, V20, P904, DOI 10.1007/s10157-016-1228-1; Kim HY, 2017, KOREAN J INTERN MED, V32, P682, DOI 10.3904/kjim.2016.045; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li M, 2014, ATHEROSCLEROSIS, V232, P265, DOI 10.1016/j.atherosclerosis.2013.11.051; Lin JW, 2019, ENDOCR METAB IMMUNE, V19, P333, DOI 10.2174/1871530319666181129163802; Lin YK, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019535; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Ndrepepa G, 2018, CLIN CHIM ACTA, V484, P150, DOI 10.1016/j.cca.2018.05.046; Schaltegger S, 2016, ORGAN ENVIRON, V29, P3, DOI 10.1177/1086026615599806; Shaheen SO, 2018, THORAX, V73, P697, DOI 10.1136/thoraxjnl-2017-211230; Shaheen SO, 2014, THORAX, V69, P978, DOI 10.1136/thoraxjnl-2014-205751; Shiozawa A, 2017, J RHEUMATOL, V44, P388, DOI 10.3899/jrheum.160452; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Song JU, 2017, MOD RHEUMATOL, V27, P1057, DOI 10.1080/14397595.2017.1285981; Wan YF, 2014, ARCH MED RES, V45, P132, DOI 10.1016/j.arcmed.2013.11.006; Zheng RJ, 2017, CLIN LAB, V63, P1581, DOI 10.7754/Clin.Lab.2017.170311; Zuo T, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0379-z; 2005, EUR RESPIR J, V26, P319, DOI [DOI 10.1183/09031936.05.00034805, 10.1183/09031936.05.00034805]	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240987	10.1371/journal.pone.0240987	http://dx.doi.org/10.1371/journal.pone.0240987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091060	gold, Green Published			2022-12-26	WOS:000586647200020
J	Moodley, J; Constant, D; Mwaka, AD; Scott, SE; Walter, FM				Moodley, J.; Constant, D.; Mwaka, A. D.; Scott, S. E.; Walter, F. M.			Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa	PLOS ONE			English	Article							KNOWLEDGE; POPULATION; INTERVALS; STAGE; HIV	Background Breast and cervical cancer are leading causes of cancer burden in Sub-Saharan Africa (SSA). We measured breast and cervical cancer symptom and risk factor awareness and lay beliefs in Uganda and South Africa (SA). Methods Between August and December 2018 we conducted a cross-sectional survey of women >= 18 years in one urban and one rural site per country. Households were selected using systematic random sampling, then one woman per household randomly selected to participate. Data were collected by interviewers using electronic tablets customised with the locally validated African Women Awareness of Cancer (AWACAN) tool. This has unprompted questions (testing recall) followed by prompted questions (testing recognition) on risk factor, symptom awareness and lay beliefs for breast and cervical cancer. Mann Whitney and Kruskal Wallis tests were used to compare the association between socio-demographic variables and outcomes. Poisson regression with robust variance was conducted to identify independent socio-demographic predictors. Results Of the 1758 women interviewed, 90.8% had heard of breast and 89.4% of cervical cancer. 8.7% recalled at least one breast risk factor and 38.1% recalled at least one cervical cancer risk factor. 78.0% and 57.7% recalled at least one breast/cervical cancer symptom respectively. Recognition of risk factors and symptoms was higher than recall. Many women were unaware that HPV, HIV, and not being screened were cervical cancer risk factors (23.7%, 46.8%, 26.5% respectively). In SA, urban compared to rural women had significantly higher symptom and risk factor awareness for both cancers. In Uganda married women/living with a partner had higher awareness of breast cancer risk factors and cervical cancer symptoms compared to women not living with a partner. Women mentioned several lay beliefs (e.g. putting money in their bra as a breast cancer risk factor). Conclusion We identified gaps in breast and cervical cancer symptom and risk factor awareness. Our results provide direction for locally targeted cancer awareness intervention programs and serve as a baseline measure against which to evaluate interventions in SSA.	[Moodley, J.] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Moodley, J.; Constant, D.] Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa; [Moodley, J.] Univ Cape Town, Fac Hlth Sci, South African Med Res Council Gynaecol Canc Res C, Cape Town, South Africa; [Mwaka, A. D.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Scott, S. E.] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Oral Clin & Translat Sci, London, England; [Walter, F. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cape Town; University of Cape Town; University of Cape Town; Makerere University; University of London; King's College London; University of Cambridge	Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, South African Med Res Council Gynaecol Canc Res C, Cape Town, South Africa.	Jennifr.moodley@uct.ac.za	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022; Scott, Suzanne/A-4697-2009	Scott, Suzanne/0000-0001-5536-9612; Moodley, Jennifer/0000-0002-9398-5202; Walter, Fiona/0000-0002-7191-6476	Cancer Association of South Africa (CANSA); University of Cape Town; SA Medical Research Council; SA National Department of Health; GlaxoSmithKline Africa Non-Communicable Disease Open Lab [023]; UK Medical Research Council; Cancer Research UK [C8640/A23385]; MRC [MC_PC_16098] Funding Source: UKRI	Cancer Association of South Africa (CANSA); University of Cape Town; SA Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SA National Department of Health; GlaxoSmithKline Africa Non-Communicable Disease Open Lab; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research reported in this article was jointly supported by the Cancer Association of South Africa (CANSA), the University of Cape Town and, the SA Medical Research Council with funds received from the SA National Department of Health, GlaxoSmithKline Africa Non-Communicable Disease Open Lab (via a supporting grant Project Number: 023), the UK Medical Research Council (via the Newton Fund). Authors retained control of the final content of the publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the study participants for sharing their knowledge and experiences; Dr Jennifer Githaiga for her commitment, enthusiasm and support throughout the project; the project advisory committee members, field staff and community liaison managers for their support in data collection; our students for assistance in formatting tables and figures; the Outcome Registry Intervention and Operation Network (ORION) team, who developed and hosted the electronic surveys on their platform. FMW is Director and SES is co-investigator of the multi-institutional CanTest Collaborative, which is funded by Cancer Research UK (C8640/A23385).	Ali-Risasi C, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-30; Althobaiti A, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1857-7; [Anonymous], 1797, CRIT REV, V19, p[109, 109], DOI DOI 10.1111/sena.12290; [Anonymous], 2014, CHINA WATER RESOURCE, V1, P2; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Ataguba JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-48; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Dey Subhojit, 2015, Asian Pac J Cancer Prev, V16, P5243; Gatumo M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4642-9; Geremew AB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0471-1; GLOBOCAN, 2018, CANC TOD 2018; Hvidberg L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-581; Joko-Fru WY, 2020, INT J CANCER, V146, P1208, DOI 10.1002/ijc.32406; Koo MM, 2017, CANCER EPIDEMIOL, V48, P140, DOI 10.1016/j.canep.2017.04.010; Laplanehe J., 2006, OEUVRES COMPLETES, VVI, P135; Low EL, 2012, EUR J CANCER, V48, P3001, DOI 10.1016/j.ejca.2012.05.004; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; McCutchan GM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1972-8; McFarland DM, 2009, INT NURS REV, V56, P426, DOI 10.1111/j.1466-7657.2009.00742.x; McKenzie F, 2018, INT J CANCER, V142, P1568, DOI 10.1002/ijc.31187; Moodley J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220545; Moodley J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4219-7; Muthoni A, 2010, HEALTH CARE WOMEN IN, V31, P801, DOI 10.1080/07399331003628453; Mwaka AD, 2016, HEALTH EXPECT, V19, P854, DOI 10.1111/hex.12382; Naanyu V, 2015, WORLD J CLIN ONCOL, V6, P147, DOI 10.5306/wjco.v6.i5.147; National Department of Health (NDoH) Statistics South Africa (Stats SA) South African Medical Research & Council (SAMRC) & ICF, 2019, S AFR DEM HLTH SURV; Ngoma T, 2015, INT J CANCER, V136, P2875, DOI 10.1002/ijc.29348; Pillay AL, 2002, ETHNIC HEALTH, V7, P103, DOI 10.1080/1355785022000038588; Robbins HA, 2017, AIDS, V31, P1035, DOI 10.1097/QAD.0000000000001450; Sengayi-Muchengeti M, 2020, INT J CANCER, V147, P3037, DOI 10.1002/ijc.33120; Shahab L, 2018, EUR J CANCER, V103, P308, DOI 10.1016/j.ejca.2018.03.029; South African National Department of Health, 2017, CERV CANC PREV CONTR; Statistics South Africa, 2019, MID POP EST 2019 STA; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Tenkorang EY, 2011, CULT HEALTH SEX, V13, P1001, DOI 10.1080/13691058.2011.592218; Uganda Bureau of Statistics, 2019 STAT ABSTR; Waller J, 2004, BRIT J PSYCHOL, V95, P219, DOI 10.1348/000712604773952430; World Health Organization, 2020, CANCER MED-US; Worldbank, 2020, S AFR OV 2020	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240788	10.1371/journal.pone.0240788	http://dx.doi.org/10.1371/journal.pone.0240788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091035	gold, Green Submitted, Green Published			2022-12-26	WOS:000586647200064
J	Muzembo, BA; Ntontolo, NP; Ngatu, NR; Khatiwada, J; Ngombe, KL; Numbi, OL; Nzaji, KM; Maotela, KJ; Ngoyi, MJ; Suzuki, T; Wada, K; Ikeda, S				Muzembo, Basilua Andre; Ntontolo, Ngangu Patrick; Ngatu, Nlandu Roger; Khatiwada, Januka; Ngombe, Kabamba Leon; Numbi, Oscar Luboya; Nzaji, Kabamba Michel; Maotela, Kabinda Jeff; Ngoyi, Mukonkole Jean; Suzuki, Tomoko; Wada, Koji; Ikeda, Shunya			Local perspectives on Ebola during its tenth outbreak in DR Congo: A nationwide qualitative study	PLOS ONE			English	Article							INTERVIEWS; HEALTH	Background The Democratic Republic of Congo (DR Congo) struggled to end the tenth outbreak of Ebola virus disease (Ebola), which appeared in North Kivu in 2018. It was reported that rumors were hampering the response effort. We sought to identify any rumors that could have influenced outbreak containment and affected prevention in unaffected areas of DR Congo. Methods We conducted a qualitative study in DR Congo over a period of 2 months (from August 1 to September 30, 2019) using in-depth interviews (IDIs) and focus group discussions (FGDs). The participants were recruited from five regional blocks using purposeful sampling. Both areas currently undergoing outbreaks and presently unaffected areas were included. We collected participants' opinions, views, and beliefs about the Ebola virus. The IDIs (n = 60) were performed with key influencers (schoolteachers, religious and political leaders/analysts, and Ebola-frontline workers), following a semi-structured interview guide. FGDs (n = 10) were conducted with community members. Interviews were recorded with a digital voice recorder and simultaneous note-taking. Participant responses were categorized in terms of their themes and subthemes. Results We identified 3 high-level themes and 15 subthemes (given here in parentheses): (1) inadequate knowledge of the origin or cause of Ebola (belief in a metaphysical origin, insufficient awareness of Ebola transmission via an infected corpse, interpretation of disease as God's punishment, belief in nosocomial Ebola, poor hygiene, and bathing in the Congo River). Ebola was interpreted as (2) a plot by multinational corporations (fears of genocide, Ebola understood as a biological weapon, concerns over organ trafficking, and Ebola was taken to be the result of business actions). Finally Ebola was rumored to be subject to (3) politicization (political authorities seen as ambivalent, exclusion of some community leaders from response efforts, distrust of political authorities, and distrust in the healthcare system). Conclusions Due to the skepticism against Ebola countermeasures, it is critical to understand widespread beliefs about the disease to implement actions that will be effective, including integrating response with the unmet needs of the population.	[Muzembo, Basilua Andre; Khatiwada, Januka; Suzuki, Tomoko; Wada, Koji; Ikeda, Shunya] Int Univ Hlth & Welf, Sch Med, Dept Publ Hlth, Narita, Japan; [Muzembo, Basilua Andre] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Ntontolo, Ngangu Patrick] Protestant Univ Congo, Dept Family Med & Primary Hlth, Kinshasa, DEM REP CONGO; [Ntontolo, Ngangu Patrick] Inst Med Evangel IME, Kimpese, DEM REP CONGO; [Ngatu, Nlandu Roger] Kagawa Univ, Dept Publ Hlth, Fac Med, Miki, Kagawa, Japan; [Ngombe, Kabamba Leon] Univ Kamina, Dept Publ Hlth, Kamina, DEM REP CONGO; [Numbi, Oscar Luboya; Nzaji, Kabamba Michel] Univ Lubumbashi, Sch Publ Hlth, Lubumbashi, DEM REP CONGO; [Nzaji, Kabamba Michel] Minist Hlth, Res Unit Natl Vaccinat Program, Kinshasa, DEM REP CONGO; [Maotela, Kabinda Jeff] Ctr Natl Transfus Sanguine, Kinshasa, DEM REP CONGO; [Ngoyi, Mukonkole Jean] ISTM Lubumbashi, Res Unit, Lubumbashi, DEM REP CONGO	International University of Health & Welfare; Okayama University; Kagawa University	Muzembo, BA (corresponding author), Int Univ Hlth & Welf, Sch Med, Dept Publ Hlth, Narita, Japan.; Muzembo, BA (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	andersonbasilua@yahoo.fr	Andre, Muzembo Basil/ABD-2741-2021	Khatiwada, Januka/0000-0002-2211-8072; Basilua Andre, Muzembo/0000-0002-9814-9393; Suzuki, Tomoko/0000-0003-1420-2298	JSPS KAKENHI [19K19467]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 19K19467. The funder of this study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Biehl J, 2013, PEOPLE COME 1 CRITIC, P446; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Bunduki K, 2018, J INFECT DIS PREVE M, V6, P185, DOI [10.4172/2329-8731.1000185, DOI 10.4172/2329-8731.1000185]; Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5; Claude KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223104; Claude KM, 2018, LANCET, V392, P1399, DOI 10.1016/S0140-6736(18)32419-X; Earnshaw VA, 2019, J HEALTH PSYCHOL, V24, P219, DOI 10.1177/1359105316650507; Ebola Virus Disease: Democratic Republic of the Congo, 2020, EBOLA VIRUS DIS DEMO; Farrugia B, 2019, EARLY HUM DEV, V133, P69, DOI 10.1016/j.earlhumdev.2019.03.016; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Kasereka MC, 2019, PATHOG GLOB HEALTH, V113, P149, DOI 10.1080/20477724.2019.1650227; Kutalek R, 2015, LANCET GLOB HEALTH, V3, pE131, DOI 10.1016/S2214-109X(15)70010-0; Lo TQ, 2017, ANNU REV MED, V68, P359, DOI 10.1146/annurev-med-052915-015604; Mokuwa EY, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007666; Muela SH, 2002, SOC SCI MED, V55, P403; Muzembo BA, 2015, J OCCUP HEALTH, V57, P69, DOI 10.1539/joh.14-0111-OA; OP026, 2016, J CROHNS COLITIS, V10, pS21; Peterson, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2; Richards P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224511; Richards P, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003567; Schiavetti B, 2018, AM J TROP MED HYG, V98, P894, DOI 10.4269/ajtmh.17-0732; SMFM Consult Series #39, 2016, AM J OBSTET GYNECOL, V214, pB9; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Trapido J, 2019, LANCET INFECT DIS, V19, P457, DOI 10.1016/S1473-3099(19)30044-1; Tuite AR, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz063; Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Nguyen VK, 2019, NEW ENGL J MED, V380, P1298, DOI 10.1056/NEJMp1902682; Wang M, 2014, TRANSPORT RES C-EMER, V40, P290, DOI 10.1016/j.trc.2013.11.024; Wells CR, 2019, P NATL ACAD SCI USA, V116, P24366, DOI 10.1073/pnas.1913980116; World Health Organization, 2019, WHO EBOLA RESPONDER	31	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241120	10.1371/journal.pone.0241120	http://dx.doi.org/10.1371/journal.pone.0241120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091054	Green Published, gold			2022-12-26	WOS:000586647200003
J	Yoon, PW; Moon, JK; Yoon, JY; Lee, S; Lee, SJ; Kim, HJ; Kim, CH				Yoon, Pil Whan; Moon, Jun-Ki; Yoon, Jae Youn; Lee, Sunhyung; Lee, Soong Joon; Kim, Hee Joong; Kim, Chul-Ho			A novel arthroscopic classification of labral tear in hip dysplasia	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; ACETABULAR LABRUM	Background Acetabular labral tears cause of pain in patients with symptomatic hip dysplasia. To date, no structured grading system has been developed to evaluate labral tears in these patients. The present study describes a new system of grading labral tears in patients with acetabular dysplasia. Methods The data of 66 patients who underwent hip arthroscopy for symptomatic hip dysplasia from March 2014 to February 2018 were reviewed. Labral tears were classified into four groups, based on the occurrence of chondrolabral junction (CLJ) disruption, capsulolabral recess (CLR) disruption, and labral displacement. Labral tears without instability were classified as grade 1 or 2. Partial delamination or blistering of the labrum with minimal fraying at the CLJ was classified as grade 1, whereas labral tears with CLJ disruption were classified as grade 2. Unstable labral tears with CLR disruption followed by CLJ disruption, but without labral displacement, were classified as grade 3, whereas unstable labral tears with CLR and CLJ disruption, but with labral displacement, were classified as grade 4. The radiological and clinical characteristics of patients in each grade were determined including by simple radiographs and MRI/MR arthrography, as were concomitant findings, including rupture of the ligamentum teres, articular cartilage damage, and presence of a paralabral cyst. The surgical options selected for each grade and clinical outcomes, including modified Harris hip scores (mHHS) and Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) scores, were evaluated. Spearman's correlation analyses were performed to assess whether labral tear grade correlated with baseline characteristics, the incidence of concomitant injuries, and the severity of osteoarthritis (OA). The Wilcoxon test for paired data was performed to compare treatment results with pain scores. Results The study cohort included six men and 53 women of mean +/- SD age 39.9 +/- 13.0 years (range, 15-66 years). Of the 66 hips, seven (10.6%), 10 (15.2%), 30 (45.5%), and 19 (28.8%) were classified as grades 1-4, respectively. Symptom duration (P= 0.017), preoperative Tonnis OA grade (P< 0.001), cartilage damage (P< 0.001), and the presence of a paralabral cyst (P= 0.001) correlated significantly with baseline tear grade. In all groups, mHHS and WOMAC scores improved after surgical treatment. Conclusions Arthroscopic findings of labral tears in patients with hip dysplasia differed from the conventional classification. The classification system proposed in this study will likely be useful for determining the degree of labral tear in patients with hip dysplasia and for predicting treatment outcomes.	[Yoon, Pil Whan; Lee, Sunhyung] Ulsan Univ, Coll Med, Asan Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Moon, Jun-Ki] Hanyang Univ, Dept Orthoped Surg, Guri Hosp, Guri Si, Gyunggido, South Korea; [Yoon, Jae Youn] Dongguk Univ, Dept Orthoped Surg, Ilsan Hosp, Goyangsi, Gyeonggido, South Korea; [Lee, Soong Joon; Kim, Hee Joong] Seoul Natl Univ, Dept Orthoped Surg, Coll Med, Seoul, South Korea; [Kim, Chul-Ho] Gachon Univ, Dept Orthoped Surg, Gil Med Ctr, Incheon, South Korea	University of Ulsan; Asan Medical Center; Hanyang University; Dongguk University; NHIS Ilsan Hospital; Seoul National University (SNU); Gachon University	Kim, CH (corresponding author), Gachon Univ, Dept Orthoped Surg, Gil Med Ctr, Incheon, South Korea.	oschulhokim@gilhospital.com	Moon, Jun-Ki/AAA-4756-2022	Kim, Chul-Ho/0000-0001-9233-5358; Yoon, Pil Whan/0000-0001-7354-0989				Aliprandi A, 2019, ARCH ORTHOP TRAUM SU, V139, P675, DOI 10.1007/s00402-019-03112-y; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Cashin M, 2008, J BONE JOINT SURG BR, V90B, P1019, DOI 10.1302/0301-620X.90B8.20161; Chang JS., 2002, J KOREAN ORTHOP ASS, V37, P226, DOI [10.4055/jkoa.2002.37.2.226, DOI 10.4055/JKOA.2002.37.2.226]; Czerny C, 1996, RADIOLOGY, V200, P225, DOI 10.1148/radiology.200.1.8657916; Fayad TE, 2013, BONE JOINT J, V95B, P26, DOI 10.1302/0301-620X.95B11.33016; Field RE, 2011, J BONE JOINT SURG AM, V93A, P22, DOI 10.2106/JBJS.J.01710; Gene Ontology consortium, 2007, NUCL ACIDS RES S1, V36, P391; Hartig-Andreasen C, 2013, ACTA ORTHOP, V84, P60, DOI 10.3109/17453674.2013.765626; Ilizaliturri VM, 2008, ARTHROSCOPY, V24, P534, DOI 10.1016/j.arthro.2007.11.019; Jayasekera Narlaka, 2015, Open Orthop J, V9, P185, DOI 10.2174/1874325001509010185; Lage LA, 1996, ARTHROSCOPY, V12, P269, DOI 10.1016/S0749-8063(96)90057-2; M-P, 2012, FEMOROACETABULAR IMP, V1; MacDonald Glen C, 2009, Drug Des Devel Ther, V2, P105; Marin-Pena, 2012, FEMOROACETABULAR IMP, V1; Mimura T, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1426-3; Neumann G, 2007, OSTEOARTHR CARTILAGE, V15, P909, DOI 10.1016/j.joca.2007.02.002; Sandoval E, 2016, HIP INT, V26, P290, DOI 10.5301/hipint.5000336; Seldes RM, 2001, CLIN ORTHOP RELAT R, P232; Stelzeneder D, 2012, OSTEOARTHR CARTILAGE, V20, P661, DOI 10.1016/j.joca.2012.03.014	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240993	10.1371/journal.pone.0240993	http://dx.doi.org/10.1371/journal.pone.0240993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091048	Green Published, gold			2022-12-26	WOS:000586647200012
J	Arikawa, S; Dumazert, P; Messou, E; Burgos-Soto, J; Tiendrebeogo, T; Zahui, A; Horo, A; Minga, A; Becquet, R				Arikawa, Shino; Dumazert, Patricia; Messou, Eugene; Burgos-Soto, Juan; Tiendrebeogo, Thierry; Zahui, Angele; Horo, Apollinaire; Minga, Albert; Becquet, Renaud			Childbearing desire and reproductive behaviors among women living with HIV: A cross-sectional study in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL CONTRACEPTIVES; FERTILITY DESIRES; DRUG-INTERACTIONS; INFECTED WOMEN; POSITIVE WOMEN; TRANSMISSION; INTENTIONS; SERVICE	Introduction Evidence on childbearing desire and reproductive behaviors in women living with HIV on antiretroviral therapy (ART) is scarce, particularly in West Africa. We investigated the prevalence and associated factors of childbearing desire in HIV-infected women in care in Abidjan, Cote d'Ivoire and explored whether such desires were translated into behaviors related to contraceptive use and communication with health personnel. Methods A cross-sectional survey was conducted in two HIV-care facilities in Abidjan, Cote d'Ivoire in 2015. Eligible women were non-pregnant, non-menopausal, aged 18-49 years and diagnosed as HIV-infected. The outcomes were childbearing desire, prevalence of modern contraceptive use, unmet needs for family planning and intention of the last pregnancy since HIV diagnosis. Women wishing to conceive immediately were asked whether they had discussed their desire with HIV healthcare workers. Logistic regression models were used to assess the associations between the outcomes and women's characteristics. Results Of 1,631 women, 80% declared having childbearing desire. No association was found between women's childbearing desire and ART status or its duration. In multivariate models, younger age, being in a stable relationship and having no or only one child were significantly associated with increased childbearing desire. Of the women wishing to conceive immediately (n = 713), only 43% reported having had fertility-related dialogue with healthcare provider. Among sexually active women wanting to avoid or delay pregnancy (n = 650), unmet needs for family planning was 40%. Regarding the last pregnancy since HIV diagnosis, one in three women reported not having wanted a baby at that time. Conclusions Pregnancy desire in women living with HIV in Abidjan was extremely high. Integration of safe conception strategies as well as improvement of contraceptive uptake among women in need of family planning are of utmost importance to ensure optimal conception and to avoid transmission of HIV to the male partner or to the forthcoming child.	[Arikawa, Shino; Dumazert, Patricia; Burgos-Soto, Juan; Tiendrebeogo, Thierry; Becquet, Renaud] Univ Bordeaux, French Natl Res Inst Sustainable Dev IRD, Bordeaux Populat Hlth Res Ctr, INSERM,UMR 1219,Team IDLIC, Bordeaux, France; [Dumazert, Patricia; Messou, Eugene; Burgos-Soto, Juan; Zahui, Angele; Minga, Albert] Ctr Hosp Univ Treichville, ANRS Site Cote Ivoire, Programme PACCI, Abidjan, Cote Ivoire; [Messou, Eugene] Ctr Prise Charge Rech & Format CePReF Aconda VS, Abidjan, Cote Ivoire; [Horo, Apollinaire] Ctr Hosp Univ Yopougon, Serv Gynecol Obstet, Abidjan, Cote Ivoire; [Minga, Albert] Ctr Med Suivi Donneurs Sang CMSDS, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Arikawa, S (corresponding author), Univ Bordeaux, French Natl Res Inst Sustainable Dev IRD, Bordeaux Populat Hlth Res Ctr, INSERM,UMR 1219,Team IDLIC, Bordeaux, France.	shino.arikawa@u-bordeaux.fr	Becquet, Renaud/F-4837-2013	Becquet, Renaud/0000-0003-3277-0985; TIENDREBEOGO, Kiswend-Sida Thierry/0000-0002-9393-9732	National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID); French charity SIDACTION [15-2-AEQ-06-01]; West and Central Africa Region office of the United Nations Population Fund (UNFPA); French National Agency on AIDS research, ANRS [ANRS 12360 B92];  [5U01AI069919]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); French charity SIDACTION; West and Central Africa Region office of the United Nations Population Fund (UNFPA); French National Agency on AIDS research, ANRS; 	The study was conducted under the International epidemiology Database to Evaluate AIDS (IeDEA) West Africa collaboration grants funded by the National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Allergy and Infectious Diseases (NIAID); Grant number: 5U01AI069919 (Primary investigator: Francois Dabis).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support was provided by the French charity SIDACTION (Aide aux equipes 15-2-AEQ-06-01) and the West and Central Africa Region office of the United Nations Population Fund (UNFPA). Kiswend-Sida Thierry Tiendrebeogo was a PhD fellow from the French National Agency on AIDS research, ANRS (grant ANRS 12360 B92).	[Anonymous], 2013, SUMMARY RESULTS NATL, V11, P160; Antelman G, 2015, J FAM PLAN REPROD H, V41, DOI 10.1136/jfprhc-2013-100784; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; Joseph Davey D, 2018, AIDS BEHAV; Kaida A, 2011, AM J PUBLIC HEALTH, V101, P350, DOI 10.2105/AJPH.2009.177469; Kakaire O, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-27; Kirshenbaum SB, 2004, PERSPECT SEX REPRO H, V36, P106, DOI 10.1111/j.1931-2393.2004.tb00198.x; Loutfy MR, 2013, AIDS CARE, V25, P657, DOI 10.1080/09540121.2012.733332; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Matthews LT, 2018, AIDS BEHAV, V22, P1713, DOI 10.1007/s10461-017-1777-7; Mayhew SH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4514-2; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nanda K, 2017, AIDS, V31, P917, DOI 10.1097/QAD.0000000000001392; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Panozzo L, 2003, SWISS MED WKLY, V133, P124; Patel RC, 2018, EXPERT OPIN PHARMACO, V19, P1, DOI 10.1080/14656566.2017.1378345; Rochat TJ, 2014, AIDS, V28, pS331, DOI 10.1097/QAD.0000000000000333; Scarsi KK, 2016, DRUG SAFETY, V39, P1053, DOI 10.1007/s40264-016-0452-7; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; UNAIDS, 2018, 2014 PROGR REP SUBM; UNAIDS, 2018, COUNTR FACTSH COT IV; WHO, 2015, WHO REC ASS HIV TEST	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239859	10.1371/journal.pone.0239859	http://dx.doi.org/10.1371/journal.pone.0239859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085671	Green Published, gold			2022-12-26	WOS:000585943400020
J	Gray, N; Calleja, D; Wimbush, A; Miralles-Dolz, E; Gray, A; De Angelis, M; Derrer-Merk, E; Oparaji, BU; Stepanov, V; Clearkin, L; Ferson, S				Gray, Nicholas; Calleja, Dominic; Wimbush, Alexander; Miralles-Dolz, Enrique; Gray, Ander; De Angelis, Marco; Derrer-Merk, Elfriede; Oparaji, Bright Uchenna; Stepanov, Vladimir; Clearkin, Louis; Ferson, Scott			Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; WUHAN; CHINA	Testing is viewed as a critical aspect of any strategy to tackle epidemics. Much of the dialogue around testing has concentrated on how countries can scale up capacity, but the uncertainty in testing has not received nearly as much attention beyond asking if a test is accurate enough to be used. Even for highly accurate tests, false positives and false negatives will accumulate as mass testing strategies are employed under pressure, and these misdiagnoses could have major implications on the ability of governments to suppress the virus. The present analysis uses a modified SIR model to understand the implication and magnitude of misdiagnosis in the context of ending lockdown measures. The results indicate that increased testing capacity alone will not provide a solution to lockdown measures. The progression of the epidemic and peak infections is shown to depend heavily on test characteristics, test targeting, and prevalence of the infection. Antibody based immunity passports are rejected as a solution to ending lockdown, as they can put the population at risk if poorly targeted. Similarly, mass screening for active viral infection may only be beneficial if it can be sufficiently well targeted, otherwise reliance on this approach for protection of the population can again put them at risk. A well targeted active viral test combined with a slow release rate is a viable strategy for continuous suppression of the virus.	[Gray, Nicholas; Calleja, Dominic; Wimbush, Alexander; Miralles-Dolz, Enrique; Gray, Ander; De Angelis, Marco; Derrer-Merk, Elfriede; Oparaji, Bright Uchenna; Stepanov, Vladimir; Ferson, Scott] Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England; [Clearkin, Louis] Wirral & Liverpool Univ Teaching Hosp, Birkenhead, Merseyside, England	University of Liverpool	Gray, N (corresponding author), Univ Liverpool, Inst Risk & Uncertainty, Liverpool, Merseyside, England.	nickgray@liverpool.ac.uk	Gray, Nicholas/AAP-8528-2021	Miralles-Dolz, Enrique/0000-0003-2135-6084; Calleja, Dominic/0000-0002-1495-0950; Gray, Nicholas/0000-0002-0930-4575; Wimbush, Alexander/0000-0002-1719-7124; clearkin, louis/0000-0001-8365-1770; de Angelis, Marco/0000-0001-8851-023X; Gray, Ander/0000-0002-1585-0900	UK Engineering and Physical Science Research Council (EPSRC) IAA exploration award; EPSRC [EP/R511729/1]; Economic and Social Research Council (ESRC) Centre for Doctoral Training in Quantification and Management of Risk and Uncertainty in Complex Systems and Environments [EP/L015927/1]; UK Medical Research Council (MRC) "Treatment According to Response in Giant cEll arTeritis (TARGET)" [MR/N011775/1]; EPSRC programme grant "Digital twins for improved dynamic design" [EP/R006768/1]; EPSRC [EP/R006768/1] Funding Source: UKRI; MRC [MR/N011775/1] Funding Source: UKRI	UK Engineering and Physical Science Research Council (EPSRC) IAA exploration award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC) Centre for Doctoral Training in Quantification and Management of Risk and Uncertainty in Complex Systems and Environments; UK Medical Research Council (MRC) "Treatment According to Response in Giant cEll arTeritis (TARGET)"; EPSRC programme grant "Digital twins for improved dynamic design"(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been partially funded through the following grants: UK Engineering and Physical Science Research Council (EPSRC) IAA exploration award with grant number EP/R511729/1 (NG, AW, SF, MDA) EPSRC and Economic and Social Research Council (ESRC) Centre for Doctoral Training in Quantification and Management of Risk and Uncertainty in Complex Systems and Environments, EP/L015927/1 (AW, DC, EMD, AG, VS, EDM) UK Medical Research Council (MRC) "Treatment According to Response in Giant cEll arTeritis (TARGET)", MR/N011775/1 (BUO, LC, SF) EPSRC programme grant "Digital twins for improved dynamic design", EP/R006768/1 (NG, MDA, SF) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank EPSRC, ESRC and MRC for their continued support.	Adhanom T, 2020, WHO DIRECTOR GENERAL; Ai T, 2020, RADIOLOGY, V2019, P1, DOI [DOI 10.1148/RADIOL.20202006427233399, DOI 10.14358/PERS.80.2.000]; [Anonymous], 2020, TIMES T; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Cassaniti I, 2020, J MED VIROL, V92, P1724, DOI 10.1002/jmv.25800; Centers for Disease Control and Prevention, 2020, INT GUID COLL HANDL; Cronvall G, 2020, DEV NATL STRATEGY SE; Cummins E, 2020, WHY CORONAVIRUS TEST; David K, 2016, POINT OF CARE VERSUS; Dohla M, 2020, PUBLIC HEALTH, V182, P170, DOI 10.1016/j.puhe.2020.04.009; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; FIND, 2020, SARS COV 2 DIAGN PER; Gigerenzer G, 2002, CALCULATED RISKS KNO; Giordano G, 2020, MODELLING COVID 19 E; Grassly NC, 2020, REPORT 16 ROLE TESTI, P1; Green K., 2020, OXFORD COVID 19 EVID, P12; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hao Qiufa, 2020, Chinese Medical Sciences Journal, V35, P31, DOI 10.24920/003573; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Horton R, 2020, LANCET, V395, P1178, DOI 10.1016/S0140-6736(20)30850-3; Horton R, 2020, LANCET, V395, P1022, DOI 10.1016/S0140-6736(20)30727-3; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Johnson B, 2020, COMMUNICATION   0323; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Korea Disease Control and Prevention Agency, 2020, UPD COVID 19 REP KOR; Krumholz HM, 2020, YOU HAVE CORONAVIRUS; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Lichtenstein K, 2020, ARE CORONAVIRUS TEST; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Pan Y, 2020, CLIN CHEM, V66, P794, DOI 10.1093/clinchem/hvaa091; Patel NV, 2020, WHY ITS TOO EARLY ST; Porte L, 2020, EVALUATION NOVEL ANT; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Proctor K, 2020, IMMUNITY PASSPORTS C; Riley-Smith B, 2020, COMMUNICATION; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Sandford A., 2020, EURONEWS; Sheridan Cormac, 2020, Nat Biotechnol, V38, P382, DOI 10.1038/d41587-020-00002-2; UNCESCO, 2020, COVID 19 IMP ED; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yang Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100061	44	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240775	10.1371/journal.pone.0240775	http://dx.doi.org/10.1371/journal.pone.0240775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085693	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000585943400032
J	Piekarski, F; Gerdessen, L; Schmitt, E; Tanner, L; Wunderer, F; Neef, V; Meybohm, P; Zacharowski, K; Raimann, FJ				Piekarski, Florian; Gerdessen, Lara; Schmitt, Elke; Tanner, Linda; Wunderer, Florian; Neef, Vanessa; Meybohm, Patrick; Zacharowski, Kai; Raimann, Florian Juergen			Do we visually estimate intra-operative blood loss better with white or green sponges and is the deviation from the real blood loss clinically acceptable? Results from a simulated scenario study	PLOS ONE			English	Article							IN-VITRO EVALUATION; ACCURACY; QUANTIFICATION; SYSTEM	Background The intraoperative blood loss is estimated daily in the operating room and is mainly done by visual techniques. Due to local standards, the surgical sponge colours can vary (e.g. white in US, green in Germany). The influence of sponge colour on accuracy of estimation has not been in the focus of research yet. Material and methods A blood loss simulation study containing four "bleeding" scenarios each per sponge colour were created by using expired whole blood donation samples. The blood donations were applied to white and green surgical sponges after dilution with full electrolyte solution. Study participants had to estimate the absorbed blood loss in sponges in all scenarios. The difference to the reference blood loss was analysed. Multivariate linear regression analysis was performed to investigate other influence factors such as staff experience and sponge colour. Results A total of 53 anaesthesists participated in the study. Visual estimation correlated moderately with reference blood loss in white (Spearman's rho: 0.521; p = 3.748*10(-16)) and green sponges (Spearman's rho: 0.452; p = 4.683*10(-12)). The median visually estimated blood loss was higher in white sponges (250ml IRQ 150-412.5ml) than in green sponges (150ml IQR 100-300ml), compared to reference blood loss (103ml IQR 86-162.8). For both colour types of sponges, major under- and overestimation was observed. The multivariate statistics demonstrates that fabric colours have a significant influence on estimation (p = 3.04*10(-10)), as well as clinician's qualification level (p = 2.20*10(-10), p = 1.54*10(-08)) and amount of RBL to be estimated (p < 2*10(-16)). Conclusion The deviation of correct blood loss estimation was smaller with white surgical sponges compared to green sponges. In general, deviations were so severe for both types of sponges, that it appears to be advisable to refrain from visually estimating blood loss whenever possible and instead to use other techniques such as e.g. colorimetric estimation.	[Piekarski, Florian; Gerdessen, Lara; Schmitt, Elke; Tanner, Linda; Wunderer, Florian; Neef, Vanessa; Zacharowski, Kai; Raimann, Florian Juergen] Goethe Univ, Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Schmitt, Elke] Goethe Univ, Dept Med, Inst Biostat & Math Modelling, Frankfurt, Germany; [Meybohm, Patrick] Univ Hosp Wurzburg, Dept Anaesthesia & Crit Care, Wurzburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; University of Wurzburg	Piekarski, F (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.	florian.piekarski@kgu.de	Piekarski, Florian/AAO-7377-2021; Piekarski, Florian/GQA-9442-2022	Piekarski, Florian/0000-0002-4095-3573; Piekarski, Florian/0000-0002-4095-3573; Raimann, MHBA, Priv.-Doz. Dr. med. habil. Florian J./0000-0002-6597-9585; Zacharowski, Kai/0000-0002-0212-9110	University Hospital of Frankfurt	University Hospital of Frankfurt	We would like to thank the anaesthesiologists of the University Hospital of Frankfurt for their voluntary participation and support in the study. We thank the blood donors of the products that were donated and that were not suitable for transfusion but could here serve for a scientific purpose.	Al-Kadri HM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-110; Althoff FC, 2019, ANN SURG, V269, P794, DOI 10.1097/SLA.0000000000003095; Ambardekar S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-276; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Atukunda EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152408; Dildy GA, 2004, OBSTET GYNECOL, V104, P601, DOI 10.1097/01.AOG.0000137873.07820.34; Doctorvaladan SV, 2017, AJP REP, V7, pE93, DOI 10.1055/s-0037-1601382; Holmes AA, 2014, ANESTH ANALG, V119, P588, DOI 10.1213/ANE.0000000000000181; Homcha BE, 2017, SIMUL HEALTHC, V12, P314, DOI 10.1097/SIH.0000000000000246; Jaramillo S, 2020, BLOOD TRANSFUS-ITALY, V18, P20, DOI 10.2450/2019.0204-19; Jaramillo S, 2019, TRANSFUSION, V59, P508, DOI 10.1111/trf.15052; Khadilkar SS, 2016, J OBSTET GYN INDIA, V66, P307, DOI 10.1007/s13224-016-0888-9; Konig G, 2018, J CLIN MONIT COMPUT, V32, P303, DOI 10.1007/s10877-017-0016-0; Konig G, 2018, ANESTH ANALG, V126, P621, DOI 10.1213/ANE.0000000000002692; Konig G, 2014, ANESTH ANALG, V119, P595, DOI 10.1213/ANE.0000000000000198; Kordi Masoumeh, 2016, J Educ Health Promot, V5, P22, DOI 10.4103/2277-9531.184548; Lopez-Picado A, 2017, ANESTH ANALG, V125, P280, DOI 10.1213/ANE.0000000000001992; Mbachu II, 2017, INT J GYNECOL OBSTET, V137, P345, DOI 10.1002/ijgo.12133; McConnell Jamie S, 2007, Accid Emerg Nurs, V15, P101, DOI 10.1016/j.aaen.2007.02.006; Meybohm P, 2016, ANN SURG, V264, P203, DOI 10.1097/SLA.0000000000001747; Parayre I, 2015, INT J NURS STUD, V52, P1798, DOI 10.1016/j.ijnurstu.2015.06.015; Piekarski F, 2020, ANASTH INTENSIVMED, V61, P110, DOI 10.19224/ai2020.110; Ram GG, 2014, CHIN J TRAUMATOL, V17, P225, DOI 10.3760/cma.j.issn.1008-1275.2014.04.008; Rubenstein AF, 2018, AM J PERINATOL; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Sharareh Behnam, 2015, Open Orthop J, V9, P422, DOI 10.2174/1874325001509010422; Sukprasert Matchuporn, 2006, J Med Assoc Thai, V89 Suppl 4, pS54; Toledo P, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.881	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240808	10.1371/journal.pone.0240808	http://dx.doi.org/10.1371/journal.pone.0240808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085701	Green Published, gold			2022-12-26	WOS:000585943400044
J	Vishnukiran, T; Neeraja, CN; Jaldhani, V; Vijayalakshmi, P; Rao, PR; Subrahmanyam, D; Voleti, SR				Vishnukiran, T.; Neeraja, C. N.; Jaldhani, V.; Vijayalakshmi, P.; Raghuveer Rao, P.; Subrahmanyam, D.; Voleti, S. R.			A major pleiotropic QTL identified for yield components and nitrogen content in rice (Oryza sativaL.) under differential nitrogen field conditions	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; INBRED LINE POPULATION; USE EFFICIENCY; GRAIN-YIELD; AGRONOMIC TRAITS; LEAF TRAITS; L.; SIZE; VALIDATION; DISSECTION	To identify the genomic regions for yield and NUE of rice genotypes and lines with promising yield under low N, a recombinant inbred population (RIL) developed between BPT5204 (a mega variety known for its quality) and PTB1 (variety with high NUE) was evaluated for consecutive wet and dry seasons under low nitrogen (LN) and recommended nitrogen (RN) field conditions. A set of 291 RILs were characterized for 24 traits related to leaf, agro-morphological, yield, N content and nitrogen use efficiency indices. More than 50 RILs were found promising with grain yield >10 g under LN. Parental polymorphism survey with 297 SSRs and selective genotyping revealed five genomic regions associated with yield under LN, which were further saturated with polymorphic SSRs. Thirteen promising SSRs were identified out of 144 marker trait associations under LN using single marker analysis. Composite interval mapping showed 37 QTL under LN with five pleiotropic QTL. A major stable pleiotropic (RM13201-RM13209) from PTB1 spanning 825.4 kb region associated with straw N % (SNP) in both treatments across seasons and yield and yield related traits in WS appears to be promising for the MAS. Another major QTL (RM13181-RM13201) was found to be associated with only relative trait parameters of biomass, grain and grain nitrogen. These two major pleiotropic QTL (RM13201-RM13209 and RM13181-RM13201) on chromosome 2 were characterized for their positive allele effect and could be deployed for the development of rice varieties with NUE.	[Vishnukiran, T.; Neeraja, C. N.; Jaldhani, V.; Vijayalakshmi, P.; Raghuveer Rao, P.; Subrahmanyam, D.; Voleti, S. R.] Indian Inst Rice Res, ICAR, Hyderabad, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Rice Research	Neeraja, CN (corresponding author), Indian Inst Rice Res, ICAR, Hyderabad, India.	cnneeraja@gmail.com		JALDHANI, VEERENDRA/0000-0002-5206-7309; Neeraja, C N/0000-0002-2418-986X; Thuraga, Vishnukiran/0000-0002-2801-9323	National Initiative on Climate Resilient Agriculture (NICRA), Indian Council of Agricultural Research (ICAR), Ministry of Agriculture, Govt. of India [Phy/NICRA/2011-2012]	National Initiative on Climate Resilient Agriculture (NICRA), Indian Council of Agricultural Research (ICAR), Ministry of Agriculture, Govt. of India	National Initiative on Climate Resilient Agriculture (NICRA), Indian Council of Agricultural Research (ICAR), Ministry of Agriculture, Govt. of India [F. No. Phy/NICRA/2011-2012].	Akkareddy Srividhya, 2011, Journal of Crop Science and Biotechnology, V14, P45, DOI 10.1007/s12892-010-0023-x; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Ali J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061762; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2013, COMPUTER CD SOFTWARE, V16, P35; [Anonymous], 2010, STATA J, V10, P339; [Anonymous], 2012, REV DROIT UNION EURO, V1, P9, DOI DOI 10.4312/ALA.1.2.9-24; [Anonymous], 2007, PLOS ONE, V2, pe779; Bai XF, 2011, J GENET, V90, P209, DOI 10.1007/s12041-011-0057-y; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Bian JM, 2013, J GENET, V92, P281, DOI 10.1007/s12041-013-0267-6; Chandra B. Satish, 2009, Agricultural Science Digest, V29, P45; Cho YG, 2007, CROP SCI, V47, P2403, DOI 10.2135/cropsci2006.08.0509; Cyprien M, 2011, J RELIABILITY STAT S, V4, P119; Dai GJ, 2015, GENET MOL RES, V14, P10404, DOI 10.4238/2015.September.8.1; DEWEY DOUGLAS R., 1959, AGRON JOUR, V51, P515; Fageria NK, 2015, COMMUN SOIL SCI PLAN, V46, P1723, DOI 10.1080/00103624.2015.1043443; Fageria NK, 2010, J PLANT NUTR, V33, P1696, DOI 10.1080/01904167.2010.496892; Fageria NK, 2001, COMMUN SOIL SCI PLAN, V32, P1405, DOI 10.1081/CSS-100104202; Fang P, 2001, PLANT SOIL, V236, P237, DOI 10.1023/A:1012787510201; Feng Y, 2015, RICE SCI, V22, P108, DOI 10.1016/j.rsci.2015.05.014; Glass ADM, 2003, CRIT REV PLANT SCI, V22, P453, DOI [10.1080/713989757, 10.1080/07352680390243512]; Haefele SM, 2008, FIELD CROP RES, V107, P137, DOI 10.1016/j.fcr.2008.01.007; Nguyen HTT, 2016, EUPHYTICA, V212, P473, DOI 10.1007/s10681-016-1778-z; Haque M. A., 2016, American Journal of Plant Sciences, V7, P612, DOI 10.4236/ajps.2016.73054; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Hu ShiKai, 2012, Australian Journal of Crop Science, V6, P1737; Ishimaru K, 2001, THEOR APPL GENET, V102, P793, DOI 10.1007/s001220000467; Jewel ZA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040900; Jia BY, 2016, GENETIKA-BELGRADE, V48, P643, DOI 10.2298/GENSR1602643J; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Lim JH, 2014, MOL CELLS, V37, P149, DOI 10.14348/molcells.2014.2336; Liu TM, 2013, EUPHYTICA, V192, P145, DOI 10.1007/s10681-013-0929-8; Liu TM, 2011, J GENET, V90, P377, DOI 10.1007/s12041-011-0083-9; Liu TM, 2010, THEOR APPL GENET, V120, P933, DOI 10.1007/s00122-009-1222-z; Lorca AB, 2010, HARVARD INT LAW J, V51, P475; Lorieux M, 2007, COMPUTER DEMONSTRATI; Lu CF, 1997, THEOR APPL GENET, V94, P145, DOI 10.1007/s001220050393; Marathi B, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-137; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; Mei HW, 2006, THEOR APPL GENET, V112, P648, DOI 10.1007/s00122-005-0167-0; Metwally T. F., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V8, P27; Mhaskar N. V., 2005, Oryza, V42, P323; Moro B.M., 2015, INT J AGR SCI, V5, p878?885; Namai S, 2009, BREEDING SCI, V59, P269, DOI 10.1270/jsbbs.59.269; NAYAK BR, 2015, INT J BIORESOURCE EN, V1, P8; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; Ogawa S, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2119-5; Pitrez PMC, 2006, SCI MED, V16, P52; R Core Team, 2021, R LANGUAGE ENV STAT; Rabiei B, 2004, EUPHYTICA, V137, P325, DOI 10.1023/B:EUPH.0000040452.76276.76; Rao IS, 2011, MOL BREEDING, V28, P683, DOI 10.1007/s11032-011-9618-2; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Redona ED, 1998, THEOR APPL GENET, V96, P957, DOI 10.1007/s001220050826; Sabouri A, 2010, CEREAL RES COMMUN, V38, P317, DOI 10.1556/CRC.38.2010.3.2; Sandhu N, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-63; Sarla N., 2008, RICE GENET NEWSL, V24, P34, DOI DOI 10.1093/JHERED/ESR145; Selvaraju K, 2007, EUPHYTICA, V157, P35, DOI 10.1007/s10681-007-9394-6; Senthilvel S, 2008, J INTEGR PLANT BIOL, V50, P1108, DOI 10.1111/j.1744-7909.2008.00713.x; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shen B, 2011, J GENET, V90, P39, DOI 10.1007/s12041-011-0019-4; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Son YeJin, 2014, Natural Science, V6, P818; Suresh PB, 2012, EUPHYTICA, V187, P421, DOI 10.1007/s10681-012-0737-6; Swamy BPM, 2011, RICE SCI, V18, P178, DOI 10.1016/S1672-6308(11)60025-5; Swamy K. N., 2015, African Journal of Agricultural Research, V10, P4364, DOI 10.5897/AJAR2015.10323; Tong HH, 2011, MOL BREEDING, V28, P495, DOI 10.1007/s11032-010-9499-9; Tong Han-Hua, 2006, Acta Genetica Sinica, V33, P458, DOI 10.1016/S0379-4172(06)60073-5; Vijayalakshmi P, 2015, FIELD CROP RES, V179, P132, DOI 10.1016/j.fcr.2015.04.012; Vijayalakshmi P., 2013, Indian Journal of Plant Physiology, V18, P208, DOI 10.1007/s40502-013-0042-y; Vinod KK, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls028; Vishnukiran T, 2018, THESIS JAWAHARLAL NE, P1; Wang P, 2011, THEOR APPL GENET, V123, P1319, DOI 10.1007/s00122-011-1669-6; Wang Yu, 2009, Acta Agronomica Sinica, V35, P580, DOI 10.3724/SP.J.1006.2009.00580; Wei D, 2012, PLANT SOIL, V359, P45, DOI 10.1007/s11104-011-1105-3; Wei Dong, 2012, Australian Journal of Crop Science, V6, P986; Xia L, 2011, AFR J BIOTECHNOL, V10, P3731; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; YOSHIDA S, 1976, Soil Science and Plant Nutrition, V22, P207, DOI 10.1080/00380768.1976.10432983; Zang JP, 2008, SCI CHINA SER C, V51, P583, DOI 10.1007/s11427-008-0081-1; Zhan XD, 2015, GENE, V571, P263, DOI 10.1016/j.gene.2015.06.065; Zhang HJ, 2013, MOL BREEDING, V31, P181, DOI 10.1007/s11032-012-9782-z; Zhang YD, 2013, RICE SCI, V20, P400, DOI 10.1016/S1672-6308(13)60159-6; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255; Zhuang JY, 2002, THEOR APPL GENET, V105, P1137, DOI 10.1007/s00122-002-0974-5; Zou GH, 2005, THEOR APPL GENET, V112, P106, DOI 10.1007/s00122-005-0111-3; 2010, COLL LITERATURE, V37, P147	89	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240854	10.1371/journal.pone.0240854	http://dx.doi.org/10.1371/journal.pone.0240854			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079957	Green Published, gold			2022-12-26	WOS:000585940600005
J	Wagner, J; Chen, WH; Vrdoljak, G				Wagner, Jeff; Chen, Wenhao; Vrdoljak, Gordon			Vaping cartridge heating element compositions and evidence of high temperatures	PLOS ONE			English	Article							E-CIGARETTES; MECHANISMS	Background Identifying the functional materials inside vaping devices can help inform efforts to understand risk. While nicotine E-cigarette components and metals have been characterized in several previous studies, the internal component compositions of tetrahydrocannabinol (THC) cartridge designs are not as well known. The 2019-20 e-cigarette or vaping product use associated lung injury (EVALI) outbreak has been associated with THC devices containing vitamin E acetate (VEA), possibly mediated by chemical reactions with internal cartridge components and high filament temperatures. Methods We investigate the composition and internal components of 2019 EVALI patient-associated THC vaping devices compared to other THC and nicotine devices from 2016-19, specifically the metal, ceramic, and polymer components likely to be exposed to heat. To do this, we have disassembled forty-eight components from eight used and unused vaping devices under a microscope and analyzed them using X-ray fluorescence, scanning electron microscopy, and Fourier-transform infrared micro-spectroscopy. Conclusions The two THC cartridges used by EVALI patients exhibited evidence of localized high temperatures, including charring of the ceramic heating elements and damaged wire surfaces. The newer THC cartridges possessed more ceramic and polymer insulation than older THC or nicotine devices. The combination of ceramics, metals, and high temperatures in newer THC cartridges is consistent with conditions hypothesized to produce VEA reactions during vaping. Nickel and chromium components were detected in all devices, and others contained copper, lead, tin, gold, silicon-rich rubbers, or fluorinated microplastics. These components have the potential to thermally degrade and volatilize if heated sufficiently. These findings do not imply that harmful exposures would occur under all usage conditions, and are most relevant to harm reduction efforts based on avoiding higher internal temperatures. This study was limited to a small sample of cartridges obtained from investigations. Future work should test more device types and internal temperatures under controlled usage conditions.	[Wagner, Jeff] Calif Dept Publ Hlth, Environm Hlth Lab Branch, Outdoor Air Qual Sect, Richmond, CA 94804 USA; [Chen, Wenhao] Calif Dept Publ Hlth, Environm Hlth Lab Branch, Indoor Air Qual Sect, Richmond, CA USA; [Vrdoljak, Gordon] Calif Dept Publ Hlth, Food & Drug Lab Branch, Cannabis Testing Sect, Richmond, CA USA	California Department of Public Health; California Department of Public Health; California Department of Public Health	Wagner, J (corresponding author), Calif Dept Publ Hlth, Environm Hlth Lab Branch, Outdoor Air Qual Sect, Richmond, CA 94804 USA.	jeff.wagner@cdph.ca.gov		Wagner, Jeff/0000-0003-4337-622X				Agency for Toxic Substances and Disease Registry (ATSDR), 2018, TYOX PROF PERFL DRAF; [Anonymous], **NON-TRADITIONAL**; Arthur C., 2009, NOSORR30 NOAA; Attfield KR, 2020, AM J RESP CRIT CARE, V202, P1187, DOI 10.1164/rccm.202003-0654LE; Blount BC, 2020, NEW ENGL J MED, V382, P697, DOI 10.1056/NEJMoa1916433; Braga AH, 2016, APPL CATAL B-ENVIRON, V195, P16, DOI 10.1016/j.apcatb.2016.04.047; Butt YM, 2019, NEW ENGL J MED, V381, P1780, DOI 10.1056/NEJMc1913069; Chen WH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195925; Dibaji SAR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206937; Farsalinos KE, 2018, INHAL TOXICOL, V30, P321, DOI 10.1080/08958378.2018.1523262; Fowles J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062146; Giroud C, 2015, INT J ENV RES PUB HE, V12, P9988, DOI 10.3390/ijerph120809988; Heinzerling A, 2020, JAMA INTERN MED, V180, P861, DOI 10.1001/jamainternmed.2020.0664; Hess CA, 2017, ENVIRON RES, V152, P221, DOI 10.1016/j.envres.2016.09.026; Keane MA, 2003, J MATER SCI, V38, P4661, DOI 10.1023/A:1027406515132; Kwon E, 2008, ENVIRON SCI TECHNOL, V42, P2175, DOI 10.1021/es7026532; Meehan-Atrash J, 2019, ACS OMEGA, V4, P16111, DOI 10.1021/acsomega.9b02301; Mikheev VB, 2016, NICOTINE TOB RES, V18, P1895, DOI 10.1093/ntr/ntw128; Na CJ, 2019, ENVIRON RES, V174, P152, DOI 10.1016/j.envres.2019.04.025; Olmedo P, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2175; Reagan-Steiner S, 2020, LANCET RESP MED, V8, P1219, DOI 10.1016/S2213-2600(20)30321-0; Roland C.M, 2016, REINFORCEMENT ELASTO, DOI [10.1016/B978-0-12-803581-8.02163-9, DOI 10.1016/B978-0-12-803581-8.02163-9]; SHUSTERMAN DJ, 1993, OCCUP MED, V8, P519; Tang XC, 2015, ENVIRON SCI TECH LET, V2, P303, DOI 10.1021/acs.estlett.5b00256; Varlet V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25599; Wagner J, 2019, ENVIRON SCI TECHNOL, V53, P14496, DOI 10.1021/acs.est.9b05072; Wagner J, 2013, ENVIRON INT, V59, P16, DOI 10.1016/j.envint.2013.05.003; Wang ZM, 2011, AEROSOL SCI TECH, V45, P1060, DOI 10.1080/02786826.2011.580799; Webster TF, 2009, ENVIRON SCI TECHNOL, V43, P3067, DOI 10.1021/es803139w; Wen XS, 2017, ENERGIES, V10, DOI 10.3390/en10071054; Williams M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50441-4; Williams M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162904; Williams M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175430; Wu D, 2020, P NATL ACAD SCI USA, V117, P6349, DOI 10.1073/pnas.1920925117	34	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240613	10.1371/journal.pone.0240613	http://dx.doi.org/10.1371/journal.pone.0240613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075091	Green Published, gold			2022-12-26	WOS:000585920200041
J	Zheng, XC; Lu, ST; He, ZX; Huang, HH; Yao, ZC; Miao, YT; Cai, CQ; Zou, F				Zheng, Xianchong; Lu, Sitong; He, Zhanxin; Huang, Hehai; Yao, Zhuocheng; Miao, Yutian; Cai, Chunqing; Zou, Fei			MCU-dependent negative sorting of miR-4488 to extracellular vesicles enhances angiogenesis and promotes breast cancer metastatic colonization	ONCOGENE			English	Article							MICROENVIRONMENTAL REGULATION; NICHE FORMATION; EXOSOMES; UNIPORTER; FRACTALKINE; COMPONENT; PROTEIN	Based on Stephen Paget's well-established theory, both cell-autonomous and non-cell-autonomous mechanisms are crucial for metastasis. Although the mitochondrial calcium uniporter (MCU) has been suggested to be involved in breast cancer (BC) progression via cell-autonomous mechanisms, whether it assists the metastasis of BC cells through non-cell-autonomous mechanisms remains unclear. This study aimed to demonstrate that the MCU regulates BC metastatic colonization via non-cell-autonomous mechanisms. The results suggested that extracellular vesicles (EVs) derived from MCU-downregulated MDA-MB-231 cells suppressed angiogenesis in the metastatic niche in a nude mouse model, thereby hindering the colonization of BC cells. Mechanistically, we revealed that the MCU negatively correlated with miR-4488 in EVs derived from BC cells. Significantly, miR-4488 was determined to suppress angiogenesis of vascular endothelial cells by directly targeting angiogenic CX3CL1. Furthermore, we identified miR-4488 as being significantly downregulated in serum EVs from patients with triple-negative BC. Hence, this study suggests that MCU-dependent negative sorting of miR-4488 to EVs enhances angiogenesis in the metastatic niche and, thus, favors the metastatic colonization of BC cells.	[Zheng, Xianchong; Lu, Sitong; He, Zhanxin; Huang, Hehai; Yao, Zhuocheng; Miao, Yutian; Cai, Chunqing; Zou, Fei] Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Occupat Med, Guangzhou 510515, Peoples R China; [Zheng, Xianchong] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China	Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University	Cai, CQ; Zou, F (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Occupat Med, Guangzhou 510515, Peoples R China.	h_zcn@126.com; zfei@smu.edu.cn			National Natural Science Foundation of China [81671860, 81741131]; Natural Science Foundation of Guangdong Province [2015A030310100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	We thank Prof. Tiebang Kang and Prof. Hailin Tang from Sun Yat-Sen University Cancer Center for providing us BC clinical samples. We thank Dr. Sihua Qin from Clinical Laboratory, Nanfang Hospital of Southern Medical University for helping us on NTA. This work was supported by the National Natural Science Foundation of China under Grant 81671860 and 81741131; the Natural Science Foundation of Guangdong Province under Grant 2015A030310100.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bielenberg DR, 2015, CANCER J, V21, P267, DOI 10.1097/PPO.0000000000000138; Cha DJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07197; Cheng L, 2014, KIDNEY INT, V86, P433, DOI 10.1038/ki.2013.502; Corrigan L, 2014, J CELL BIOL, V206, P671, DOI 10.1083/jcb.201401072; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Curry MC, 2013, BIOCHEM BIOPH RES CO, V434, P695, DOI 10.1016/j.bbrc.2013.04.015; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Fan GC, 2014, BLOOD, V124, P3669, DOI 10.1182/blood-2014-10-607846; Fang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02583-0; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Garcia-Silva S, 2016, NAT CELL BIOL, V18, P911, DOI 10.1038/ncb3404; Hall DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096866; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Janas T, 2015, FEBS LETT, V589, P1391, DOI 10.1016/j.febslet.2015.04.036; Kavanagh EL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.82; Kornilov R, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2017.1422674; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Matamala N, 2015, CLIN CHEM, V61, P1098, DOI 10.1373/clinchem.2015.238691; Ozawa PMM, 2018, BREAST CANCER RES TR, V172, P713, DOI 10.1007/s10549-018-4925-5; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432; Ribatti D, 2006, CLIN EXP MED, V6, P145, DOI 10.1007/s10238-006-0117-4; Ribatti D, 2016, TRANSL ONCOL, V9, P453, DOI 10.1016/j.tranon.2016.07.002; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Szukiewicz D, 2013, MEDIAT INFLAMM, V2013, DOI [DOI 10.1155/2013/437576, 10.1155/2013/437576]; Takemoto-Kimura S, 2017, J NEUROCHEM, V141, P808, DOI 10.1111/jnc.14020; Tang SH, 2015, BIOCHEM BIOPH RES CO, V458, P186, DOI 10.1016/j.bbrc.2015.01.092; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Tosatto A, 2016, EMBO MOL MED, V8, P569, DOI 10.15252/emmm.201606255; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Volin MV, 2010, PATHOBIOLOGY, V77, P7, DOI 10.1159/000272949; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; You JJ, 2007, INVEST OPHTH VIS SCI, V48, P5290, DOI 10.1167/iovs.07-0187; Zhang Y, 2014, TRENDS CELL BIOL, V24, P153, DOI 10.1016/j.tcb.2013.09.007; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	46	15	16	3	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2020	39	46					6975	6989		10.1038/s41388-020-01514-6	http://dx.doi.org/10.1038/s41388-020-01514-6		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OQ9FF	33067576				2022-12-26	WOS:000578435000001
J	Niang, A; Sawadogo, SP; Dabire, RK; Tripet, F; Diabate, A				Niang, Abdoulaye; Sawadogo, Simon Peguedwinde; Dabire, Roch K.; Tripet, Frederic; Diabate, Abdoulaye			Assessment of the ecologically dependent post-zygotic isolation between Anopheles coluzzii and Anopheles gambiae	PLOS ONE			English	Article							MOLECULAR-FORMS; GENE FLOW; S FORMS; LARVAL COMPETITION; MALARIA MOSQUITO; MATING DECISIONS; IMMATURE STAGES; AEDES-AEGYPTI; DIVERGENCE; DIPTERA	Within the Anopheles gambiae complex, the sibling species An. coluzzii and An. gambiae are undergoing sympatric speciation. These species are characterized by rare hybrids in most of their geographical distribution. A strong assortative mating mediated by spatial swarm segregation has been shown whereas no intrinsic post-zygotic barriers have been found in laboratory conditions. To test the role of the hybridisation in reproductive isolation in natural populations transplant experiment are therefore needed to establish the significance of post-zygotic barriers. Previous studies indicated that predation is one of the major forces driving ecological divergence between An. gambiae and An. coluzzii. Here we extended these studies to their hybrids. Parental species and their F1 hybrids from reciprocal crosses were generated by the forced-mating technique as follows: female An. coluzzii x male An. coluzzii; female An. coluzzii x male An. gambiae; female An. gambiae x male An. coluzzii and female An. gambiae x Male An. gambiae. First instar larvae of each group from the crossing (here after An. coluzzii, Hybrid COL/GAM, Hybrid GAM/COL and An. gambiae, respectively) were transplanted in a field experiment with predation effect. Emergence success, development time of larvae and body size of the newly emerging adults were estimated as fitness components and then compared between parental species and F1 hybrids in absence and in presence of predators. Our findings confirm that An. coluzzii had higher fitness than An. gambiae in presence of predators versus in absence of predators. Moreover, the fitness of the F1 hybrid COL/GAM whose female parent was An. coluzzii matched that of An. coluzzii while that of the F1 reciprocal hybrid GAM/COL was similar to An. gambiae.	[Niang, Abdoulaye; Sawadogo, Simon Peguedwinde; Dabire, Roch K.; Diabate, Abdoulaye] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Niang, Abdoulaye; Tripet, Frederic] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele, Staffs, England	Keele University	Niang, A (corresponding author), Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.; Niang, A (corresponding author), Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele, Staffs, England.	bband79@yahoo.fr	; Tripet, Frederic/M-6693-2015	Niang, Abdoulaye/0000-0003-3196-3064; Tripet, Frederic/0000-0002-7939-0712; Sawadogo, Simon Peguedwinde/0000-0002-9414-4659	UK Medical Research Council [G1001336/1, 97014]; UK Department for International Development (DFID) Africa Research Leader grant [G1001336/1, 97014]; MRC [G1001336] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) Africa Research Leader grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a joint UK Medical Research Council: https://mrc.ukri.org/and the UK Department for International Development (DFID) Africa Research Leader grant to Abdoulaye Diabate and Frederic Tripet (Grant Reference No: G1001336/1, Grant ID: 97014).	Aboagye-antwi F, 2010, MALARIA J, V9, P1; Aboagye-Antwi F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005141; Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Alto BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045785; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; [Anonymous], 2015, J OPER OCEANOGR, V8, ps80, DOI 10.1080/1755876X.2015.1022329; [Anonymous], 1987, PUBLICATIONS S AFRIC; Barrera R, 1996, J NAT HIST, V30, P447, DOI 10.1080/00222939600770231; Beketov MA, 2007, ECOL ENTOMOL, DOI [10.1111/j.1365-2311.2006.00846.x, DOI 10.1111/J.1365-2311.2006.00846.X18185841]; Bernardo J, 1996, AM ZOOL, V36, P83; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Chandrasegaran K, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00025; Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012; Clemens J, 2017, J COMP PHYSIOL A, V203, P891, DOI 10.1007/s00359-017-1200-x; Clemens J, 2014, P NATL ACAD SCI USA, V111, P16562, DOI 10.1073/pnas.1412741111; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Costanzo KS, 2011, ECOL ENTOMOL, DOI [10.1111/j.1365-2311.2011.01313.x, DOI 10.1111/J.1365-2311.2011.01313.X]; Coyne JA, 2004, SPECIATIONAPPENDIX I; Dabire KR, 2013, MED VET ENTOMOL, V27, P298, DOI 10.1111/j.1365-2915.2012.01049.x; Diabate A, 2005, J MED ENTOMOL, V42, P548, DOI 10.1603/0022-2585(2005)042[0548:LDOTMF]2.0.CO;2; Diabate A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-5; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Eizadshenass S, 2015, GENOME, V58, P405, DOI 10.1139/gen-2015-0053; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Ferrari MCO, 2008, BEHAV ECOL, V19, P980, DOI 10.1093/beheco/arn056; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Gimonneau G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-65; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; Helversen D von, 1975, J COMP PHYSIOL, V104, P273, DOI [10.1007/BF01379053, DOI 10.1007/BF01379053]; Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199; Johnson N., 2008, NATURE ED, V1, P20; Kamali M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002960; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; Manoukis NC, 2006, J MED ENTOMOL, V43, P820, DOI 10.1603/0022-2585(2006)43[820:IVBSTK]2.0.CO;2; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Mayer F, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P451, DOI 10.1007/978-3-642-12425-9_21; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Mogi M, 1996, RAFFLES B ZOOL; MORI L, 1979, HEREDITY, V42, P353, DOI 10.1038/hdy.1979.38; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Munga S, 2007, J MED ENTOMOL, V44, P758, DOI 10.1603/0022-2585(2007)44[758:SOISOA]2.0.CO;2; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Roux O, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2430; Roux O, 2014, J ANIM ECOL, V83, P702, DOI 10.1111/1365-2656.12163; Roux O, 2013, FRESHWATER BIOL, V58, P1178, DOI 10.1111/fwb.12117; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Sawadogo PS, 2014, ACTA TROP, DOI [10.1016/j.actatropica.2013.10.015, DOI 10.1016/J.ACTATR0PICA.2013.10.015]; Sawadogo SP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-275; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Suleman M, 1982, MOSQUITO NEWS; Sunahara T, 2002, J VECTOR ECOL, V27, P8; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; von Helversen D., 1975, Journal Comp Physiol, V104, P301; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504	68	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240625	10.1371/journal.pone.0240625	http://dx.doi.org/10.1371/journal.pone.0240625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119635	Green Accepted, Green Published, gold			2022-12-26	WOS:000600013600082
J	Zin, PE; Saw, YM; Saw, TN; Cho, SM; Hlaing, SS; Noe, MTN; Kariya, T; Yamamoto, E; Lwin, KT; Win, HH; Hamajima, N				Zin, Poe Ei; Saw, Yu Mon; Saw, Thu Nandar; Cho, Su Myat; Hlaing, Su Su; Noe, May Thet Nu; Kariya, Tetsuyoshi; Yamamoto, Eiko; Lwin, Kay Thi; Win, Hla Hla; Hamajima, Nobuyuki			Assessment of quality of life among elderly in urban and peri-urban areas, Yangon Region, Myanmar	PLOS ONE			English	Article							OLDER-PEOPLE; WHOQOL-BREF; HEALTH; ADULTS; QOL	Background In the context of an aging population, quality of life (QOL) is an important consideration for the well-being of the elderly. However, there is limited information on the QOL of the elderly in Myanmar. This study aimed to explore the risk factors for low QOL among the elderly in urban and peri-urban areas of the Yangon Region, Myanmar. Methods A community-based, cross-sectional study was conducted among the elderly aged 60 years or older in two urban and two peri-urban townships in the Yangon Region from July to September 2019. A multi-stage sampling method was used to recruit study participants using a pre-tested questionnaire. A total of 616 (305 males and 311 females) elderly people were interviewed using a face-to-face interview technique. Multiple linear regression analysis was performed on the four domains (physical health, psychological health, social relationship, and environment) of QOL measured with the WHOQOL-BREF. Results Income level and having intimate friends influenced the QOL scores of the elderly in all domains, while education level and marital status influenced psychological health, social relationship, and environment domains. Social interaction with neighbors increased the QOL scores for physical health, social relationship, and environment domains. Living in peri-urban areas was associated with lower QOL scores for physical health, psychological health, and environment, while participation in group activities increased QOL scores in these domains. Having comorbidities affected the QOL for psychological health and environment domains, while the frequency of going out affected physical health, and the frequency of religious performance affected social relationship. Conclusion Residential location, education level, marital status, income, comorbidities, social interactions with neighbors and friends, participation in group activities, and frequencies of going out and religious activities should be considered in planning and implementing programs for the elderly in Myanmar. Peri-urban development, strengthening healthcare and social security systems, and encouraging social interaction and participation in group activities play critical roles in improving the QOL for elderly residing in Myanmar.	[Zin, Poe Ei; Saw, Yu Mon; Cho, Su Myat; Noe, May Thet Nu; Kariya, Tetsuyoshi; Yamamoto, Eiko; Hamajima, Nobuyuki] Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan; [Zin, Poe Ei; Lwin, Kay Thi] Univ Med 1, Dept Prevent & Social Med, Yangon, Myanmar; [Saw, Yu Mon; Kariya, Tetsuyoshi] Nagoya Univ, Asian Satellite Campuses Inst, Nagoya, Aichi, Japan; [Saw, Thu Nandar] Univ Tokyo, Dept Community & Global Hlth, Tokyo, Japan; [Hlaing, Su Su] South Dist Yangon Reg Hlth Dept, Yangon, Myanmar; [Noe, May Thet Nu] Minist Hlth & Sports, Dept Publ Hlth, Loikaw, Kayah State, Myanmar; [Win, Hla Hla] Univ Publ Hlth, Yangon, Myanmar	Nagoya University; Nagoya University; University of Tokyo	Saw, YM (corresponding author), Nagoya Univ, Dept Healthcare Adm, Grad Sch Med, Nagoya, Aichi, Japan.; Saw, YM (corresponding author), Nagoya Univ, Asian Satellite Campuses Inst, Nagoya, Aichi, Japan.	sawyumon@med.nagoya-u.ac.jp	KARIYA, TETSUYOSHI/L-4750-2017	KARIYA, TETSUYOSHI/0000-0002-7757-4251; Yamamoto, Eiko/0000-0002-0517-5091; Saw, Yu Mon/0000-0002-5038-0043; Cho, Su Myat/0000-0002-0118-648X	Ministry of Education, Science, Sports, and Culture of Japan [19K19703]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-inAid for Scientific Research [No. 19K19703] from the Ministry of Education, Science, Sports, and Culture of Japan.	Abdala GA., 2014, LIFE STYLE, V2, P25, DOI [10.19141/2237-3756/lifestyle.v2.n2.p25-51, DOI 10.19141/2237-3756/LIFESTYLE.V2.N2.P25-51, 10.19141/2237-3756/lifestyle.v2.n2.p.25-51, DOI 10.19141/2237-3756/LIFESTYLE.V2.N2.P.25-51]; Ankur Barua, 2007, Indian Journal of Community Medicine, V32, P146; Apidechkul T, 2011, SE ASIAN J TROP MED, V42, P1282; Baernholdt M, 2012, QUAL LIFE RES, V21, P527, DOI 10.1007/s11136-011-9954-z; Census Division Immigration and Manpower Department, 1986, BURM 1983 POP CENS; Datta P., 2015, INT J MED PUBLIC HLT, V5, P274; Dawson-Townsend K, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100424; Department of Population, POP CENS MYANM; Department of Population, 2014 MYANM POP HOUS; Gobbens RJJ, 2019, CLIN INTERV AGING, V14, P231, DOI 10.2147/CIA.S189560; Hongthong D, 2015, IRAN J PUBLIC HEALTH, V44, P479; Khan AR., 2014, OPEN MED J, V1, P29, DOI DOI 10.2174/1874220301401010029; Knodel JE, 2013, SIT OLD PERS MANM RE; Knodel J, 2017, GERONTOLOGIST, V57, P599, DOI 10.1093/geront/gnw211; Kumar SG, 2014, J CLIN DIAGN RES, V8, P54, DOI 10.7860/JCDR/2014/6996.3917; Levasseur M, 2004, DISABIL REHABIL, V26, P1206, DOI 10.1080/09638280412331270371; Maung Ismael Khin, 1986, POPULATION BURMA ANA; Min D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5296-x; Naing MM, 2010, ASIA J PUBLIC HLTH, V1, P4; National council of Social service (NCSS), UND QUAL KIF SEN; Oo MY, 2015, J HEALTH RES, V29, P235, DOI 10.14456/jhr.2015.14; Raggi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159293; Savirasarid N, 2009, J PHSYCHIAT ASS THAI, V54, P55; Sazlina SG, 2012, J NUTR HEALTH AGING, V16, P498, DOI 10.1007/s12603-012-0038-8; The Republic of the Union of Myanmar Department of Population Ministry of Immigration and Population, 2014 NYANM POP HOUS; The Republic of the Union of Myanmar Ministry of Immigration and population. Department of Population/ UNFPA, AG TRANS MYANM NAY P; United Nations, AG AS PAC OV; Van Nguyen T, 2017, J Prev Med Hyg, V58, pE63; Walker Alan, 2005, Eur J Ageing, V2, P2, DOI 10.1007/s10433-005-0500-0; Wang C, 2019, CLIN INTERV AGING, V14, P1285, DOI 10.2147/CIA.S205734; World Bank, 3 WORLD BANK GROUP; World Health Organisation, WHOQOL BREF INTR ADM; World Health Organization, 2018, LIF EXP MYANM WORLD	33	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241211	10.1371/journal.pone.0241211	http://dx.doi.org/10.1371/journal.pone.0241211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PG8YH	33119697	Green Published, gold			2022-12-26	WOS:000600013600095
J	Gul, R; Iqbal, S; Anwar, Z; Ahdi, SG; Ali, SH; Pirzada, S				Gul, Rafia; Iqbal, Samar; Anwar, Zahid; Ahdi, Saher Gul; Ali, Syed Hamza; Pirzada, Saima			Pre-pregnancy maternal BMI as predictor of neonatal birth weight	PLOS ONE			English	Article							BODY-MASS INDEX; RECOMMENDATIONS; PREVALENCE; OUTCOMES; GAIN	Introduction BMI is a tool to measure maternal nutritional status. Maternal malnutrition is frequently reported health problem especially during child bearing age and effects neonatal birth weight. Aim To determine relationship between prepregnancy maternal BMI and neonatal birth weight. Methods and material Prospective, cross sectional study conducted in Fatima Memorial Hospital, Lahore, Pakistan over a period of 1 year including 2766 mother-neonate pairs. All full term, live born neonates of both gender in early neonatal period (<72 hours) with documented maternal pre-pregnancy and/or first trimester BMI were enrolled. Data analysis using SPSS version 20, was performed. Results Data analysis of 2766 mother-neonates pairs showed that there were 32.9% overweight and 16.5% obese mothers. More than two third of all overweight and obese mothers were of age group between 26-35 years. Diabetes mellitus, hypertension, medical illness, uterine malformations and caesarean mode of delivery were more prevalent in obese mothers as 22.8%, 10.1%, 13.2%, 2.6% and 75.4% respectively. Mean birth weight, length and OFC increased with increasing maternal BMI. Comparing for normal weight mothers, underweight mothers were at increased risk of low birth weight (p< 0.01) and low risk of macrosomic neonates (p<0.01). However overweight and obese mothers were comparable to normal weight mothers for delivering macrosomic neonates (p 0.89 and p 0.66 respectively). Conclusions Our study highlights that direct relationship exists between maternal BMI and neonatal birth weight.	[Gul, Rafia; Iqbal, Samar; Anwar, Zahid; Ali, Syed Hamza; Pirzada, Saima] Fatima Mem Hosp, Dept Pediat, Lahore, Shadman, Pakistan; [Ahdi, Saher Gul] Combined Mil Hosp, Dept Pediat, Lahore, Pakistan		Gul, R (corresponding author), Fatima Mem Hosp, Dept Pediat, Lahore, Shadman, Pakistan.	docrafiagul@gmail.com	Anwar, Zahid/H-9738-2019	Anwar, Zahid/0000-0002-2637-7987; Gul, Rafia/0000-0002-0605-7089				[Anonymous], 2011, SPCI SVENSK PAPPERST, P6, DOI DOI 10.1186/1476-7120-9-6; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], 2018, GLOBAL NUTR REPORT; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Asif M, 2020, J OBES METAB SYNDR, V29, P58, DOI 10.7570/jomes19039; Calik KY, 2018, SAUDI J BIOL SCI, V25, P1085, DOI 10.1016/j.sjbs.2018.02.014; Dudenhausen JW, 2015, AM J OBSTET GYNECOL, V213, P591, DOI 10.1016/j.ajog.2015.06.016; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gondwe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206035; Guan P, 2019, J INT MED RES, V47, P4397, DOI 10.1177/0300060519861463; Hambidge KM, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4509-z; Haq IU, 2017, ANN PAK I MED SCI, V13, P231; Marciniak A, 2017, TAIWAN J OBSTET GYNE, V56, P133, DOI 10.1016/j.tjog.2017.01.001; Neumann K, 2017, GEBURTSH FRAUENHEILK, V77, P487, DOI 10.1055/s-0043-108763; Noor N., 2015, ARCH MED HLTH SCI, V3, P239; SHERIN A, 2014, KHYBER MED U J, V5, P59; Simko M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101751; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Tanzil Sana, 2016, J Ayub Med Coll Abbottabad, V28, P597; Upadhyay, 2011, Nepal Med Coll J, V13, P42; Vinturache A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0422-y; Yazdani Shahla, 2012, BMC Res Notes, V5, P34, DOI 10.1186/1756-0500-5-34	23	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240748	10.1371/journal.pone.0240748	http://dx.doi.org/10.1371/journal.pone.0240748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112877	gold, Green Published			2022-12-26	WOS:000588374000015
J	Kanigicherla, DAK; Bhogal, T; Stocking, K; Chinnadurai, R; Gray, S; Javed, S; Fortune, C; Augustine, T; Kalra, PA				Kanigicherla, Durga Anil K.; Bhogal, Talvinder; Stocking, Katie; Chinnadurai, Rajkumar; Gray, Simon; Javed, Saad; Fortune, Christien; Augustine, Titus; Kalra, Philip A.			Non-invasive cardiac stress studies may not offer significant benefit in pre-kidney transplant evaluation: A retrospective cohort study	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; MYOCARDIAL-PERFUSION; RISK STRATIFICATION; PROGNOSTIC VALUE; DISEASE; CANDIDATES; SURVIVAL; ANGIOGRAPHY; ASSOCIATION; EVENTS	Background Screening with cardiac non-invasive stress studies (NISS) prior to listing for kidney transplantation can help in identifying treatable coronary disease and is considered an integral part of pre-kidney transplant evaluation. However, few studies assessed their effectiveness in all patients evaluated for transplantation in clinical practice. To evaluate the role of NISS in pre-kidney transplant evaluation we analyzed their impact prior to waitlisting in 1053 adult CKD-5 patients consecutively evaluated in Greater Manchester, UK during a 6-year period. Methods 918 waitlisted patients were grouped based on presence or absence of Diabetes or Cardio-Vascular Disease (CVD): Group-1 (255 DM-/CVD-/NISS-), Group-2 (368 DM-/CVD-/NISS+) and Group-3 (295 with DM or CVD). Results Group-2 patients had longer 'time-to-listing' (5.5months in Group-1 vs 6.9months in 'Normal-NISS' vs 9.9months in 'Abnormal-NISS', p<0.01) but none with 'Abnormal-NISS' needed coronary revascularization before listing. NISS was followed by revascularization in 8 Group-3 patients (3%). In multi-variate analyses, there was no association of NISS on death or MACE in listed patients. During follow up, Transplantation was the most significant factor associated with improved outcomes in all subgroups (HR:0.97, p<0.001). 135 patients were considered unsuitable for waitlisting, with NISS influencing management in 11 of these patients (8%). Conclusions Pre-kidney transplant evaluation with NISS influenced clinical management in 19 of 1053 (2%) patients. Screening with NISS added limited benefit but contributes to significant delays in listing and adding resource implications. Further studies are needed to assess clinical and cost effectiveness of NISS in pretransplant evaluation to optimize outcomes and resources.	[Kanigicherla, Durga Anil K.; Bhogal, Talvinder; Gray, Simon; Augustine, Titus] Manchester Inst Nephrol & Transplantat, Manchester, Lancs, England; [Stocking, Katie] Univ Manchester, Fac Biol Med & Hlth, Ctr Biostat, Manchester, Lancs, England; [Chinnadurai, Rajkumar; Javed, Saad; Fortune, Christien; Kalra, Philip A.] Salford Royal NHS Fdn Trust, Hope Hosp, Dept Renal Med, Salford, Lancs, England; [Augustine, Titus] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England	University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester	Kanigicherla, DAK (corresponding author), Manchester Inst Nephrol & Transplantat, Manchester, Lancs, England.	durga.kanigicherla@mft.nhs.uk		Kanigicherla, Durga Anil/0000-0003-3011-7878; Chinnadurai, Rajkumar/0000-0003-3973-6595; Augustine, Titus/0000-0002-7391-1839; Gray, Simon/0000-0001-8396-3328				[Anonymous], 2013, EPILEPSY BEHAV, V28, pS87; Bangalore S, 2020, NEW ENGL J MED, V382, P1608, DOI 10.1056/NEJMoa1915925; Bhatti NK, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003648; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; De Lima JJG, 2003, HYPERTENSION, V42, P263, DOI 10.1161/01.HYP.0000087889.60760.87; Dudley C, 2011, NEPHRON CLIN PRACT, V118, pC209, DOI 10.1159/000328070; Dunn T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211161; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Gill JS, 2005, J AM SOC NEPHROL, V16, P808, DOI 10.1681/ASN.2004090810; Goyal A, 2019, CARDIORENAL MED, V9, P51, DOI 10.1159/000492731; Hage FG, 2007, AM J CARDIOL, V100, P1020, DOI 10.1016/j.amjcard.2007.04.045; Holley JL, 1998, AM J KIDNEY DIS, V32, P567, DOI 10.1016/S0272-6386(98)70018-6; Kasiske BL, 2006, J AM SOC NEPHROL, V17, P900, DOI 10.1681/ASN.2005090984; Kasiske BL, 2005, TRANSPLANTATION, V80, P815, DOI 10.1097/01.TP.0000173652.87417.CA; Kianda MN, 2011, CLIN TRANSPLANT, V25, P576, DOI 10.1111/j.1399-0012.2010.01317.x; Knoll Greg, 2005, CMAJ, V173, pS1, DOI 10.1503/cmaj.1041588; LE A, 1994, AM J KIDNEY DIS, V24, P65, DOI 10.1016/S0272-6386(12)80161-2; Lentine KL, 2008, CLIN J AM SOC NEPHRO, V3, P1115, DOI 10.2215/CJN.05351107; Lentine KL, 2012, J AM COLL CARDIOL, V60, P434, DOI 10.1016/j.jacc.2012.05.008; Lewis MS, 1999, J CARDIOVASC RISK, V6, P251; MANSKE CL, 1992, LANCET, V340, P998, DOI 10.1016/0140-6736(92)93010-K; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Morden NE, 2014, NEW ENGL J MED, V370, P589, DOI 10.1056/NEJMp1314965; Patel RK, 2008, AM J TRANSPLANT, V8, P1673, DOI 10.1111/j.1600-6143.2008.02281.x; Ping T, 2019, AM HEART J, V214, P175, DOI 10.1016/j.ahj.2019.05.008; Rabbat CG, 2003, J AM SOC NEPHROL, V14, P431, DOI 10.1097/01.ASN.0000047560.51444.3A; Sharma R, 2005, NEPHROL DIAL TRANSPL, V20, P2207, DOI 10.1093/ndt/gfi005; van Walraven C, 2010, CAN MED ASSOC J, V182, P666, DOI 10.1503/cmaj.091661; Villar E, 2004, NEPHROL DIAL TRANSPL, V19, P207, DOI 10.1093/ndt/gfg500; Wang LW, 2011, AM J KIDNEY DIS, V57, P476, DOI 10.1053/j.ajkd.2010.11.018; Welsh RC, 2011, TRANSPLANTATION, V91, P213, DOI 10.1097/TP.0b013e3181ff4f61; Weng FL, 2005, AM J KIDNEY DIS, V46, P734, DOI 10.1053/j.ajkd.2005.06.011; Winther S, 2015, JACC-CARDIOVASC IMAG, V8, P553, DOI 10.1016/j.jcmg.2014.12.028; Wu C, 2005, J AM SOC NEPHROL, V16, P3437, DOI 10.1681/ASN.2005040439; Wu DA, 2017, NEPHROL DIAL TRANSPL, V32, P890, DOI 10.1093/ndt/gfx036	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240912	10.1371/journal.pone.0240912	http://dx.doi.org/10.1371/journal.pone.0240912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33113550	Green Published, gold			2022-12-26	WOS:000588374000041
J	Kroker-Lobos, MF; Ford, ND; Gonzalez-Casanova, I; Martorell, R; Ramirez-Zea, M; Stein, AD				Kroker-Lobos, Maria F.; Ford, Nicole D.; Gonzalez-Casanova, Ines; Martorell, Reynaldo; Ramirez-Zea, Manuel; Stein, Aryeh D.			Improved nutrition in early life and pulse wave velocity and augmentation index in mid-adulthood: Follow-up of the INCAP Nutrition Supplementation Trial Longitudinal Study	PLOS ONE			English	Article							BLOOD-PRESSURE; ARTERIAL STIFFNESS; SHORT STATURE; CHILDHOOD GROWTH; HEART-DISEASE; FETAL-GROWTH; RISK; ATHEROSCLEROSIS; AGE; INFANT	Nutrition in pregnancy and early childhood affects later blood pressure and precursors of atherosclerosis, but its influence on arterial stiffness is unexplored. This study determines whether exposure to improved nutrition during early life influences Augmentation index (AI) and pulse wave velocity (PWV) in mid-adulthood. We included 1221 adults (37-54y) who participated in a cluster-randomized nutritional supplementation trial of a protein-energy beverage (Atole), conducted between 1969-1977 in Guatemala. The comparison group received Fresco, a low-calorie protein-free beverage. In 2015-17, we measured anthropometry (weight, height, and waist-to-height ratio); AI and PWV (using carotid-femoral tonometry); blood pressure; fasting plasma glucose and serum lipids; and sociodemographic characteristics. Based on patterns of exposure, we characterized participants as fully, partially or unexposed to the intervention from conception to their second birthday (the 'first 1000 days'). We fit pooled and sex-specific models using intention-to-treat, difference-in-difference regression analysis to test whether exposure to the supplement in the first 1000 days was associated with AI and PWV in adulthood adjusting for basal and current sociodemographic variables and current life-style and cardio-metabolic risk factors. Prevalence of obesity in men and women was 39.6% and 19.6%, and prevalence of hypertension was 44.0% and 36.0%, respectively. Women had higher AI (34.4 +/- 9.6%) compared to men (23.0 +/- 9.8%), but had similar PWV (7.60 +/- 1.13 m/s and 7.60 +/- 1.31, respectively). AI did not differ significantly across intervention groups. PWV was lower in individuals with full exposure to the supplement during the first 1000 days (-0.39m/s, 95% CI -0.87, 0.09; p = 0.1) compared to unexposed individuals. This difference was similar after adjusting for cardio-metabolic risk factors (-0.45m/s; 95%C-0.93, 0.01; p = 0.06). Exposure to improved nutrition during the first 1000 days was marginally associated with lower PWV, but not with AI.	[Kroker-Lobos, Maria F.; Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, INCAP Res Ctr Prevent Chron Dis, Guatemala City, Guatemala; [Ford, Nicole D.; Gonzalez-Casanova, Ines; Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Institute of Nutrition of Central America & Panama (INCAP); Emory University; Rollins School Public Health	Stein, AD (corresponding author), Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu	Stefanadis, Christodoulos/ABH-2232-2020; Gonzalez-Casanova, Ines/S-7398-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Gonzalez-Casanova, Ines/0000-0001-5747-8636; Kroker-Lobos, Maria F/0000-0001-8631-3101; Stein, Aryeh/0000-0003-1138-6458; Ford, Nicole/0000-0002-6463-5094	National Institutes of Health (USA) [HD-075784]	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (USA) under grant HD-075784. ADS received the award. https://www.nih.gov/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Brunner EJ, 2015, HYPERTENSION, V66, P294, DOI 10.1161/HYPERTENSIONAHA.115.05494; Canepa M, 2014, AM J HYPERTENS, V27, P1209, DOI 10.1093/ajh/hpu038; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; Duprez DA, 2009, ETHNIC DIS, V19, P243; Ecobici M, 2017, MAEDICA BUCHAR; Editorial, 2005, STATUTE LAW REV, V26, piii; Evelein AMV, 2011, AM J CLIN NUTR, V93, P712, DOI 10.3945/ajcn.110.002980; Ford ND, 2018, LANCET GLOB HEALTH, V6, pE875, DOI [10.1016/S2214-109X(18)30231-6, 10.1016/s2214-109x(18)30231-6]; Gatzka CD, 2001, J HYPERTENS, V19, P2197, DOI 10.1097/00004872-200112000-00013; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059371; Janner JH, 2010, AM J HYPERTENS, V23, P180, DOI 10.1038/ajh.2009.234; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Jerrard-Dunne P, 2008, J HYPERTENS, V26, P529, DOI 10.1097/HJH.0b013e3282f35265; Johansen NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037165; KANNAM JP, 1994, CIRCULATION, V90, P2241, DOI 10.1161/01.CIR.90.5.2241; Khoshdel AR, 2006, J HYPERTENS, V24, P1231, DOI 10.1097/01.hjh.0000234098.85497.31; Korhonen PE, 2017, J HYPERTENS, V35, P1170, DOI 10.1097/HJH.0000000000001300; Lacy PS, 2004, J HYPERTENS, V22, P1937, DOI 10.1097/00004872-200410000-00016; Lajous M, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv123; Langenberg C, 2005, INT J EPIDEMIOL, V34, P905, DOI 10.1093/ije/dyi071; Lantelme P, 2002, HYPERTENSION, V39, P1083, DOI 10.1161/01.HYP.0000019132.41066.95; LaRocca TJ, 2017, AGEING RES REV, V39, P106, DOI 10.1016/j.arr.2016.09.002; Lemogoum D, 2004, J HYPERTENS, V22, P511, DOI 10.1097/00004872-200403000-00013; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Little RJ, 2016, CLIN TRIALS, V13, P344, DOI 10.1177/1740774515626411; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Martin RM, 2005, ARTERIOSCL THROM VAS, V25, P1482, DOI 10.1161/01.ATV.0000170129.20609.49; Martin RM, 2003, AM J CLIN NUTR, V77, P1489, DOI 10.1093/ajcn/77.6.1489; MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S; Martorell R, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22952; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; MERCHANT K, 1990, AM J CLIN NUTR, V52, P280, DOI 10.1093/ajcn/52.2.280; National Heart Lung and Blood Institute Obesity Education Initiative, 2000, PRACT GUID ID EV TRE, DOI [10.1016/j.physleta.2015.01.006, DOI 10.1016/J.PHYSLETA.2015.01.006]; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; Reboussin DM, 2018, J AM COLL CARDIOL, V71, P2176, DOI 10.1016/j.jacc.2017.11.004; Rezvan PH, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0022-1; Saeedi P, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040548; Sainas G, 2016, J SPORT SCI MED, V15, P424; Sakurai M, 2007, J HYPERTENS, V25, P391, DOI 10.1097/HJH.0b013e3280115b7c; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Smulyan H, 1998, J AM COLL CARDIOL, V31, P1103, DOI 10.1016/S0735-1097(98)00056-4; Stein AD, 2008, ARCH PEDIAT ADOL MED, V162, P612, DOI 10.1001/archpedi.162.7.612; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; Van Marken Lichtenbelt WD, 1994, BR J NUTR, V72, P491, DOI [10.1079/bjn19940053, DOI 10.1079/BJN199400537986782]; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wamala SP, 1999, J INTERN MED, V245, P557, DOI 10.1046/j.1365-2796.1999.00454.x; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Zhong Q, 2018, ANGIOLOGY, V69, P617, DOI 10.1177/0003319717742544	57	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0239921	10.1371/journal.pone.0239921	http://dx.doi.org/10.1371/journal.pone.0239921			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108379	Green Published, gold			2022-12-26	WOS:000588372400022
J	Ji, YG; Shi, HF				Ji, Yonggang; Shi, Haifang			Bayesian variable selection in linear quantile mixed models for longitudinal data with application to macular degeneration	PLOS ONE			English	Article							REGRESSION-MODEL	This paper presents a Bayesian analysis of linear mixed models for quantile regression based on a Cholesky decomposition for the covariance matrix of random effects. We develop a Bayesian shrinkage approach to quantile mixed regression models using a Bayesian adaptive lasso and an extended Bayesian adaptive group lasso. We also consider variable selection procedures for both fixed and random effects in a linear quantile mixed model via the Bayesian adaptive lasso and extended Bayesian adaptive group lasso with spike and slab priors. To improve mixing of the Markov chains, a simple and efficient partially collapsed Gibbs sampling algorithm is developed for posterior inference. Simulation experiments and an application to the Age-Related Macular Degeneration Trial data to demonstrate the proposed methods.	[Ji, Yonggang; Shi, Haifang] Civil Aviat Univ China, Sch Sci, Tianjin, Peoples R China	Civil Aviation University of China	Shi, HF (corresponding author), Civil Aviat Univ China, Sch Sci, Tianjin, Peoples R China.	hfshi@cauc.edu.cn		Shi, Haifang/0000-0001-9486-9572; Ji, YongGang/0000-0002-5912-8231	Fundamental Research Funds for the Central Universities [3122014K013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The second author was supported by the Fundamental Research Funds for the Central Universities (Grant No.3122014K013).	Aghamohammadi A, 2017, STAT PAP, V58, P1035, DOI 10.1007/s00362-015-0737-4; Alhamzawi R, 2014, J STAT COMPUT SIM, V84, P868, DOI 10.1080/00949655.2012.731689; Alhamzawi R, 2012, STAT MODEL, V12, P279, DOI 10.1177/1471082X1101200304; Alshaybawee T, 2017, J APPL STAT, V44, P853, DOI 10.1080/02664763.2016.1189515; Armagan A, 2013, STAT SINICA, V23, P119, DOI 10.5705/ss.2011.048; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Bondell HD, 2010, BIOMETRICS, V66, P1069, DOI 10.1111/j.1541-0420.2010.01391.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Canay IA, 2011, ECONOMET J, V14, P368, DOI 10.1111/j.1368-423X.2011.00349.x; Carvalho CM, 2010, BIOMETRIKA, V97, P465, DOI 10.1093/biomet/asq017; Chen Z, 2003, BIOMETRICS, V59, P762, DOI 10.1111/j.0006-341X.2003.00089.x; Chernozhukov V, 2013, ECONOMETRICA, V81, P535, DOI 10.3982/ECTA8405; Galarza CE, 2017, STAT INTERFACE, V10, P471, DOI 10.4310/SII.2017.v10.n3.a10; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Geraci M, 2007, BIOSTATISTICS, V8, P140, DOI 10.1093/biostatistics/kxj039; Geraci M, 2014, STAT COMPUT, V24, P461, DOI 10.1007/s11222-013-9381-9; Graham BS, 2018, J ECONOMETRICS, V206, P305, DOI 10.1016/j.jeconom.2018.06.004; Griffin JE, 2010, BAYESIAN ANAL, V5, P171, DOI 10.1214/10-BA507; Harding M, 2009, ECON LETT, V104, P133, DOI 10.1016/j.econlet.2009.04.025; Ibrahim JG, 2011, BIOMETRICS, V67, P495, DOI 10.1111/j.1541-0420.2010.01463.x; Ji YG, 2012, COMPUT STAT DATA AN, V56, P827, DOI 10.1016/j.csda.2011.10.003; Kinney SK, 2007, BIOMETRICS, V63, P690, DOI 10.1111/j.1541-0420.2007.00771.x; Kobayashi G, 2017, BAYESIAN ANAL, V12, P161, DOI 10.1214/16-BA996; Koenker R, 2004, J MULTIVARIATE ANAL, V91, P74, DOI 10.1016/j.jmva.2004.05.006; Kozumi H, 2011, J STAT COMPUT SIM, V81, P1565, DOI 10.1080/00949655.2010.496117; Li Q, 2010, BAYESIAN ANAL, V5, P533, DOI 10.1214/10-BA521; Li Q, 2010, BAYESIAN ANAL, V5, P151, DOI 10.1214/10-BA506; LIU JS, 1994, BIOMETRIKA, V81, P27, DOI 10.1093/biomet/81.1.27; Lu Y., 2015, J MACH LEARN RES, V44, P277; Peng H, 2012, J MULTIVARIATE ANAL, V109, P109, DOI 10.1016/j.jmva.2012.02.005; Seber G.A., 1977, LINEAR REGRESSION AN; Sriram K, 2016, J R STAT SOC A STAT, V179, P177, DOI 10.1111/rssa.12111; van der Pas S, 2017, ELECTRON J STAT, V11, P3196, DOI 10.1214/17-EJS1316; van Dyk DA, 2008, J AM STAT ASSOC, V103, P790, DOI 10.1198/016214508000000409; Yan Y, 2017, WORKING PAPER; Yu KM, 2005, COMMUN STAT-THEOR M, V34, P1867, DOI 10.1080/03610920500199018; Yu KM, 2001, STAT PROBABIL LETT, V54, P437, DOI 10.1016/S0167-7152(01)00124-9	38	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241197	10.1371/journal.pone.0241197	http://dx.doi.org/10.1371/journal.pone.0241197			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104698	gold, Green Published			2022-12-26	WOS:000588370000048
J	Alcala Herrera, R; Sierra, MLF; Ruano, F				Alcala Herrera, Rafael; Fernandez Sierra, Maria Luisa; Ruano, Francisca			The suitability of native flowers as pollen sources for Chrysoperla lucasina (Neuroptera: Chrysopidae)	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LACEWINGS NEUROPTERA; CROP ENVIRONMENT; FOOD; CARNEA; PREDATORS; LANDSCAPE; PLANTS; CONSERVATION; RESTORATION	Green lacewings (Neuroptera: Chrysopidae) are key biological control agents found in a broad range of crops. Given the importance of enhancing their presence and conservation, in this study, we aim to identify and to determine the relative importance of the pollen consumed by Chrysoperla lucasina (Lacroix, 1936) from 29 pollen types offered by 51 native plant species sown in an experimental farm in Villarrubia in the south of Spain. For the purposes of this study, C. lucasina specimens were captured in the late spring of 2016 and 2017. The pollen types and other components in the alimentary canal of C. lucasina were microscopically identified using the transparency method, which is a novel technique applied to green lacewings captured in the field. The results show that (i) C. lucasina feeds on over half of the pollen types offered by the sown plant species, with no differences in behaviour by sex or year; (ii) Capsella bursa-pastoris was the most frequently identified pollen type in the alimentary canal; (iii) the majority of pollen types identified correspond to sown native plant species and not to surrounding plant species; and that (iv) most of the adults studied also consumed honeydew. Our feeding study has important implications for the selection of plant mixtures for ground cover restoration and flower vegetation strips in Mediterranean agroecosystems, which complements our previous findings on how C. lucasina use native plant species as host and reproduction sites. The plant species Capsella bursa-pastoris and Biscutella auriculata, which are best suited to provide pollen, host and reproduction sites for C. lucasina in late spring, should consequently be included in the proposed plant mixtures for Mediterranean agroecosystems.	[Alcala Herrera, Rafael; Fernandez Sierra, Maria Luisa] CSIC, Dept Environm Protect, Estn Expt Zaidin, Plant Protect Grp, Granada, Andalucia, Spain; [Ruano, Francisca] Univ Granada, Dept Zool, Granada, Andalucia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Granada	Alcala Herrera, R (corresponding author), CSIC, Dept Environm Protect, Estn Expt Zaidin, Plant Protect Grp, Granada, Andalucia, Spain.	rafa.alcala@eez.csic.es	Alcalá Herrera, Rafael/AAE-5372-2019	Alcalá Herrera, Rafael/0000-0002-9776-3375	Junta de Andalucia [P12-AGR-1419]; Consejo Superior de Investigaciones Cientificas [201840E055]	Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas	This study was funded by a grant awarded to FR and Mercedes Campos from the Junta de Andalucia (project P12-AGR-1419) and a grant from Consejo Superior de Investigaciones Cientificas (project 201840E055) to Mercedes Campos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez HA, 2019, AGR ECOSYST ENVIRON, V285, DOI 10.1016/j.agee.2019.106618; [Anonymous], 1999, B UE, P7; [Anonymous], 2019, CIRCULATION, V139, pe42; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Araj SE, 2015, BIOL CONTROL, V81, P15, DOI 10.1016/j.biocontrol.2014.11.003; Barbosa P.A., 1998, CONSERVATION BIOL CO; Bello Carlos Luis, 1999, Boletin de Entomologia Venezolana, V14, P77; Bertrand C, 2019, J APPL ECOL, V56, P2431, DOI 10.1111/1365-2664.13483; Bianchi FJJA, 2013, AGR FOREST ENTOMOL, V15, P12, DOI 10.1111/j.1461-9563.2012.00586.x; Bo T, 2013, ENTOMOL FENNICA, V24, P29; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; BOZSIK A, 1992, ACTA PHYTOPATHOL HUN, V27, P141; Brown H.P., 1979, Coleopterists Bulletin, V33, P104; Castro A.J., 2010, MICROSCOPY SCI TECHN, P607; Conway G, 2000, TRADEOFFS SYNERGIES, P538; Devetak Dusan, 2016, Trends in Entomology, V12, P29; DEVONPORT BF, 1976, FRESHWATER BIOL, V6, P167, DOI 10.1111/j.1365-2427.1976.tb01601.x; Dorta P, 2005, INVESTIG GEOGR-SPAIN, P23, DOI 10.14198/INGEO2005.38.02; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Duelli P., 1986, P165; Duelli P., 2001, P158, DOI 10.1017/CBO9780511666117.010; DUELLI P, 1980, BEHAV ECOL SOCIOBIOL, V7, P239, DOI 10.1007/BF00299370; Duelli P., 1984, P133; Frischie S., 2017, TRAIT BASED PRIORITI; Garcia MM, 2010, VEGETACION RESERVA B; Gomez J. A., 2017, Hungarian Geographical Bulletin, V66, P13, DOI 10.15201/hungeobull.66.1.2; Gruppe Axel, 2001, Beitraege zur Entomologie, V51, P517; Guzman-Alvarez JR, 2009, OLIVICULTURA ELAIOTE; Haaland C, 2011, INSECT CONSERV DIVER, V4, P60, DOI 10.1111/j.1752-4598.2010.00098.x; Hagen K. S, 1970, Boll Lab Ent agr Filippo Silvestri, V28, P113; Hagen K.S., 1972, INSECT MITE NUTRITIO, P323; HAGEN KS, 1976, ENVIRON ENTOMOL, V5, P458, DOI 10.1093/ee/5.3.458; HAGEN KS, 1970, CAN ENTOMOL, V102, P806, DOI 10.4039/Ent102806-7; Hatt S, 2017, EUR J ENTOMOL, V114, P66, DOI 10.14411/eje.2017.010; Holland JM, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0434-x; Holland JM, 2016, PEST MANAG SCI, V72, P1638, DOI 10.1002/ps.4318; Hynes H. B. N., 1941, TRANS ROY ENT SOC LONDON, V91, P459; Infante Garcia F., 1995, B RED ESPANOLA AEROB, P29; Jimenez-Alfaro B, 2020, NAT PLANTS, V6, P209, DOI 10.1038/s41477-020-0617-3; Jones Gretchen D., 2014, Journal of Pollination Ecology, V13, P203; Lacey M. E., 2006, AIR SPORA, DOI [10.1007/978-0-387-30253-9, 10.1007/s13398-014-0173-7.2]; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Liolios V, 2015, J APICULT RES, V54, P582, DOI 10.1080/00218839.2016.1173353; Lopez-Rodriguez MJ, 2012, INT REV HYDROBIOL, V97, P485, DOI 10.1002/iroh.201201541; Lopez-Rodriguez N, 2018, VIE MILIEU, V68, P263; M'Gonigle LK, 2015, ECOL APPL, V25, P1557, DOI 10.1890/14-1863.1; de Figueroa JMT, 2019, FRESHWATER BIOL, V64, P954, DOI 10.1111/fwb.13277; McEwen P.K., 1994, Antenna, V18, P148; MCEWEN PK, 1994, ENTOMOL EXP APPL, V70, P97, DOI 10.1007/BF02380636; McEwen PK, 2001, LACEWINGS CROP ENV; Monserrat V. J., 2016, Graellsia, V72, pE037, DOI 10.3989/graellsia.2016.v72.143; MONSERRAT VJ, 1994, ACTA OECOL, V15, P119; Nieto-Romero M, 2014, ENVIRON SCI POLICY, V37, P121, DOI 10.1016/j.envsci.2013.09.003; Nunes A, 2016, SCI TOTAL ENVIRON, V566, P722, DOI 10.1016/j.scitotenv.2016.05.136; Nunes Morgado L, 2014, EUR J ENTOMOL, V111, P143, DOI 10.14411/eje.2014.015; Paulian M., 2001, LACEWINGS CROP ENV, P498, DOI DOI 10.1017/CBO9780511666117.033; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Principi M.M., 1984, Series Entomologica (Dordrecht), V27, P76; Rega C, 2018, ECOL INDIC, V90, P653, DOI 10.1016/j.ecolind.2018.03.075; Resende ALS, 2017, BIOL CONTROL, V106, P40, DOI 10.1016/j.biocontrol.2016.12.007; Ridgway R.L., 1984, BIOL CHRYSOPIDAE, P220; Rijn P. C. J. van, 2012, IOBC/WPRS Bulletin, V75, P213; Rollin O, 2013, AGR ECOSYST ENVIRON, V179, P78, DOI 10.1016/j.agee.2013.07.007; Rousset A., 1984, BIOL CHRYSOPIDAE, P116; Rupprecht R., 1990, MAYFLIES STONEFLIES, P119; Science for Environment Policy Unit SC, 2017, AGRI ENV SCHEMES ENH, DOI [10.2779/633983, DOI 10.2779/633983]; Seree L, 2020, AGR FOREST ENTOMOL, V22, P274, DOI 10.1111/afe.12380; Shackelford G, 2013, BIOL REV, V88, P1002, DOI 10.1111/brv.12040; Siles G, 2017, SPAN J AGRIC RES, V15, DOI 10.5424/sjar/2017152-9753; SUNDBY R A, 1967, Entomophaga, V12, P475, DOI 10.1007/BF02376933; Szentkiralyi F., 2001, P82, DOI 10.1017/CBO9780511666117.006; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Valdes B., 1987, ATLAS POLINICO ANDAL; Villa M, 2019, AGR ECOSYST ENVIRON, V283, DOI 10.1016/j.agee.2019.106573; Villa M, 2016, AGR ECOSYST ENVIRON, V233, P262, DOI 10.1016/j.agee.2016.09.014; Villa M, 2016, BIOCONTROL, V61, P533, DOI 10.1007/s10526-016-9735-2; Villenave J, 2005, EUR J ENTOMOL, V102, P547, DOI 10.14411/eje.2005.078; Villenave J., 2006, ETUDE BIOECOLOGIE NE; Villenave J, 2006, EUR J ENTOMOL, V103, P771, DOI 10.14411/eje.2006.104; Villenave-Chasset Johanna, 2013, Symbioses, V29, P17; Wackers Felix L., 2012, P139; Wackers FL, 2005, PLANT FOOD CARNIVORO, DOI [10.1017/CBO9780511542220, DOI 10.1017/CBO9780511542220]; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	85	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0239847	10.1371/journal.pone.0239847	http://dx.doi.org/10.1371/journal.pone.0239847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095792	Green Published, gold			2022-12-26	WOS:000586649400018
J	Jayathilaka, R; Joachim, S; Mallikarachchi, V; Perera, N; Ranawaka, D				Jayathilaka, Ruwan; Joachim, Sheron; Mallikarachchi, Venuri; Perera, Nishali; Ranawaka, Dhanushika			Do chronic illnesses and poverty go hand in hand?	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURES; SRI-LANKA EVIDENCE; LOW-INCOME; CHRONIC DISEASES; ESSENTIAL MEDICINES; BURDEN; IMPACT; AFFORDABILITY; AVAILABILITY; CONSUMPTION	In the global context, the health and quality of life of people are adversely affected by either one or more types of chronic diseases. The chronic pain associated with diagnosed patients may include heavy medical expenditure along with the physical and mental suffering they undergo. Usually, unbearable amounts of medical expenses are incurred, to improve or sustain the health condition of the patient. Consequently, the heavy financial burden tends to push households from a comfortable or secure life, or even from bad to worse, towards the probability of becoming poor. Hence, this study is conducted to identify the impact chronic illnesses have on poverty using data from a national survey referred as the Household Income and Expenditure Survey (HIES), with data gathered by the Department of Census and Statistics (DCS) of Sri Lanka in 2016. As such, this study is the first of its kind in Sri Lanka, declaring the originality of the study based on data collected from the local arena. Accordingly, the study discovered that married females who do not engage in any type of economic activity, in the age category of 40-65, having an educational level of tertiary level or below and living in the urban sector have a higher likelihood of suffering from chronic diseases. Moreover, it was inferred that, if a person is deprived from access to basic education in the level of education, lives in the rural or estate sector, or suffers from a brain disease, cancer, heart disease or kidney disease, he is highly likely to be poor. Some insights concluded from this Sri Lankan case study can also be applied in the context of other developing countries, to minimise chronic illnesses and thereby the probability of falling into poverty.	[Jayathilaka, Ruwan; Joachim, Sheron; Mallikarachchi, Venuri; Perera, Nishali; Ranawaka, Dhanushika] Sri Lanka Inst Informat Technol, SLIIT Business Sch, Dept Business Management, Malabe, Sri Lanka	Sri Lanka Institute of Information Technology (SLIIT)	Jayathilaka, R (corresponding author), Sri Lanka Inst Informat Technol, SLIIT Business Sch, Dept Business Management, Malabe, Sri Lanka.	ruwan.j@sliit.lk	Jayathilaka, Ruwan/AAM-9667-2020	Jayathilaka, Ruwan/0000-0002-7679-4164; Perera, Nishali/0000-0001-5735-8140				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Almalki ZS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3554-3; [Anonymous], 2011, GLOBAL STATUS REPORT; [Anonymous], 2005, PREV CHRON DIS VIT I; Arrey AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159488; Bailey C, 2020, PALLIAT SUPPORT CARE, V18, P271, DOI 10.1017/S1478951519000841; Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Bloom DE, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/rpsp.2018.18, 10.26633/RPSP.2018.18]; Burki A. A., 2015, Pakistan Development Review, V54, P17; Christopher AS, 2018, AM J PUBLIC HEALTH, V108, P351, DOI [10.2105/AJPH.2017.304213, 10.2105/ajph.2017.304213]; Chung RY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140040; Clark NM, 2015, CLIN PEDIATR, V54, P353, DOI 10.1177/0009922815574073; Coats H, 2018, J PAIN SYMPTOM MANAG, V56, P530, DOI 10.1016/j.jpainsymman.2018.07.005; Costa-Font J, 2005, ECON HUM BIOL, V3, P188, DOI 10.1016/j.ehb.2005.05.004; DCS, 2016, HOUS INC EXP SURV 20; Druedahl LC, 2018, PHARMACY-BASEL, V6, DOI 10.3390/pharmacy6030073; Essue B, 2011, J HEALTH SERV RES PO, V16, P226, DOI 10.1258/jhsrp.2011.010159; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Fong JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222539; Font J, 2005, U BARCELONA ESPAI EC, V3, P188, DOI [10.1016/j.ehb.2005.05.004, DOI 10.1016/J.EHB.2005.05.004]; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Habibov Nazim, 2009, J Health Organ Manag, V23, P170; Jayasinghe M, 2020, J HAPPINESS STUD, DOI [10.1007/s10902-019-00163-1, DOI 10.1007/S10902-019-00163-1]; Jayasinghe M, 2019, J ASIA PAC ECON, V24, P208, DOI 10.1080/13547860.2019.1573716; Jayathilaka R, 2016, APPL ECON, V48, P2054, DOI 10.1080/00036846.2015.1114574; Kahn LS, 2015, CHRONIC ILLN, V11, P171, DOI 10.1177/1742395314559751; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kemp A, 2013, J HEALTH SERV RES PO, V18, P21, DOI 10.1258/jhsrp.2012.011184; Kim J, 2014, SOC WORK HEALTH CARE, V53, P932, DOI 10.1080/00981389.2014.955940; Kumara AS, 2017, SOC SCI MED, V195, P68, DOI 10.1016/j.socscimed.2017.11.015; Kumara AS, 2016, HEALTH POLICY PLANN, V31, P970, DOI 10.1093/heapol/czw021; Lan X, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3698-1; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Madurawala S., 2016, HEALTHCARE FINANCING, P143; Malon J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5673-5; McComb B, 2016, TALKING POVERTY WHAT; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; Ministry of Health Nutrition and Indigenous Medicine, 2019, SRI LANK ESS HLTH SE; Molla AA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2047-0; Murphy A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-38; NCCDPHP, 2019, CHRON DIS NAT CTR CH; Nguyen NTQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207960; Pallegedara A, 2018, INT J HEALTH ECON MA, V18, P301, DOI 10.1007/s10754-018-9235-2; Pallegedara A, 2018, INT J HEALTH PLAN M, V33, pE781, DOI 10.1002/hpm.2535; Parodi G, 2012, INT J MANPOWER, V33, P9, DOI 10.1108/01437721211212501; Pati S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-451; Peek ME, 2014, HEALTH SERV RES MANA, V1, DOI 10.1177/2333392814538775; Perruccio AV, 2012, J CLIN EPIDEMIOL, V65, P100, DOI 10.1016/j.jclinepi.2011.04.013; Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652; Raghupathi W, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030431; Shavers VL, 2010, J HEALTH CARE POOR U, V21, P177, DOI 10.1353/hpu.0.0255; Studenmund AH, 2006, USING ECONOMETRICS P, V5; Sultana Marufa, 2017, Chronic Dis Transl Med, V3, P112, DOI 10.1016/j.cdtm.2017.02.001; Swindle TM, 2015, CLIN PEDIATR, V54, P840, DOI 10.1177/0009922815589927; Wang HP, 2017, ASIA-PAC J PUBLIC HE, V29, P268, DOI 10.1177/1010539517700472; *WHO PUBL HLTH AG, 2005, PREV CHRON DIS VIT I; Wikipedia, 2020, NONC DIS; World Health Organization, 2018, NONC DIS; Zhang XH, 2009, J HEALTH ECON, V28, P91, DOI 10.1016/j.jhealeco.2008.08.001	62	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241232	10.1371/journal.pone.0241232	http://dx.doi.org/10.1371/journal.pone.0241232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095818	gold, Green Published			2022-12-26	WOS:000586649400070
J	Weng, ZX; Xu, YJ; Li, WN; Chen, JB; Zhong, M; Zhong, FS; Du, BW; Zhang, B; Huang, XH				Weng, Zhuoxian; Xu, Yongjie; Li, Weina; Chen, Jiebo; Zhong, Ming; Zhong, Fusheng; Du, Bingwang; Zhang, Bin; Huang, Xunhe			Genomic variations and signatures of selection in Wuhua yellow chicken	PLOS ONE			English	Article							GENETIC-VARIATION; IMMUNE-RESPONSES; PLUMAGE COLOR; MUTATIONS; BREEDS; VIRUS; HYBRIDIZATION; MODEL; WHITE; CD80	Wuhua yellow chicken (WHYC) is an important traditional yellow-feathered chicken from China, which is characterized by its white tail feathers, white flight feathers, and strong disease resistance. However, the genomic basis of these unique traits associated with WHYC is poorly understood. In this study, whole-genome resequencing was performed with an average coverage of 20.77-fold to investigate heritable variation and identify selection signals in WHYC. Reads were mapped onto the chicken reference genome (Galgal5) with a coverage of 85.95%. After quality control, 11,953,471 single nucleotide polymorphisms and 1,069,574 insertion/deletions were obtained. In addition, 41,408 structural variants and 33,278 copy number variants were found. Comparative genomic analysis of WHYC and other yellow-feathered chicken breeds showed that selected regions were enriched in genes involved in transport and catabolism, immune system, infectious diseases, signal transduction, and signaling molecules and interactions. Several genes associated with disease resistance were also identified, including IFNA, IFNB, CD86, IL18, IL11RA, VEGFC, and ATG10. Furthermore, our results suggest that PMEL and TYRP1 may contribute to the white feather coloring in WHYC. These findings can improve our understanding of the genetic characteristics of WHYC and may contribute to future breed improvement.	[Weng, Zhuoxian; Zhong, Fusheng; Zhang, Bin] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Peoples R China; [Weng, Zhuoxian; Xu, Yongjie; Li, Weina; Chen, Jiebo; Zhong, Ming; Du, Bingwang; Huang, Xunhe] Guangdong Prov Key Lab Conservat & Precis Utiliza, Meizhou, Peoples R China; [Weng, Zhuoxian; Xu, Yongjie; Li, Weina; Chen, Jiebo; Zhong, Ming; Zhong, Fusheng; Du, Bingwang; Huang, Xunhe] Guangdong Innovat Ctr Sci & Technol Wuhua Yellow, Meizhou, Peoples R China; [Xu, Yongjie; Li, Weina; Zhong, Ming; Zhong, Fusheng; Du, Bingwang; Huang, Xunhe] Jiaying Univ, Sch Life Sci, Meizhou, Peoples R China	Hunan Agricultural University; Jiaying University	Zhang, B (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Peoples R China.; Huang, XH (corresponding author), Guangdong Prov Key Lab Conservat & Precis Utiliza, Meizhou, Peoples R China.; Huang, XH (corresponding author), Guangdong Innovat Ctr Sci & Technol Wuhua Yellow, Meizhou, Peoples R China.; Huang, XH (corresponding author), Jiaying Univ, Sch Life Sci, Meizhou, Peoples R China.	zhb8236@126.com; hxh826@jyu.edu.cn	Huang, Xunhe/I-1231-2014	Huang, Xunhe/0000-0003-3795-2745	Science and Technology Planning Project of Guangdong Province [2015A020208020, 2016A030303068]; Special Fund for Applied Science and Technology of Meizhou [2019B0201003]; Provincial and municipal key construction projects in Jiaying University, Promotion Program of Higher Education in Guangdong Province about Key Construction Subjects (Agricultural Resources and Environment) (Guangdong Science and education Letter [2018]) [81]	Science and Technology Planning Project of Guangdong Province; Special Fund for Applied Science and Technology of Meizhou; Provincial and municipal key construction projects in Jiaying University, Promotion Program of Higher Education in Guangdong Province about Key Construction Subjects (Agricultural Resources and Environment) (Guangdong Science and education Letter [2018])	This research was funded by Science and Technology Planning Project of Guangdong Province (2015A020208020; 2016A030303068), Special Fund for Applied Science and Technology of Meizhou (2019B0201003) and Provincial and municipal key construction projects in Jiaying University, Promotion Program of Higher Education in Guangdong Province about Key Construction Subjects (Agricultural Resources and Environment) (Guangdong Science and education Letter [2018] NO.81).	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; [Anonymous], 2008, SOBORNOST ECR, V30, P25; [Anonymous], 2014, AM J THEOLOGY PHILOS, V35, P94; [Anonymous], 2015, ANN ONCOL, V26, pv174; Arya BD, 2018, NANOMEDICINE-UK, V13, P2261, DOI 10.2217/nnm-2018-0086; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Chen HY, 2011, FEMS IMMUNOL MED MIC, V63, P289, DOI 10.1111/j.1574-695X.2011.00850.x; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Degen WGJ, 2005, VACCINE, V23, P4212, DOI 10.1016/j.vaccine.2005.04.003; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Elferink MG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-391; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Fleming DS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2711-5; Gunnarsson U., 2015, PIGM CELL MELANOMA R, V24, P268, DOI DOI 10.1371/JOURNAL.PGEN.1004274; Gunnarsson U, 2007, GENETICS, V175, P867, DOI 10.1534/genetics.106.063107; Guo X, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0239-4; Hellstrom AR, 2010, PIGM CELL MELANOMA R, V23, P521, DOI 10.1111/j.1755-148X.2010.00700.x; Huang X, 2017, J JIAYING U, V35, P50; Huang X, 2017, GUANGDONG AGR SCI, V44, P106; Huang X, 2016, CHINA POULTRY, V38, P56; Huang XH, 2016, GUANGDONG AGR SCI, V43, P163; Huang XH, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6736-4; Huang XH, 2016, FRONT AGRIC SCI ENG, V3, P97, DOI 10.15302/J-FASE-2016102; HUDSON RR, 1992, GENETICS, V132, P583; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jia HongMin, 2020, Chinese Journal of Animal Nutrition, V32, P989, DOI 10.3969/j.issn.1006-267x.2020.03.003; Jin SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30172; Kaiser P, 1998, GENE, V207, P25, DOI 10.1016/S0378-1119(97)00600-8; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Kuang W, 2013, J JIAYING U, V31, P82; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JY, 2019, PIGM CELL MELANOMA R, V32, P381, DOI 10.1111/pcmr.12753; Li W, 2011, J ZHANJIANG NORMAL C, V32, P133; Lin SD, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010042; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu P, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0897-8; Liu YH, 2015, J VIROL, V89, P2287, DOI 10.1128/JVI.02760-14; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; Quicke KM, 2017, EUR J IMMUNOL, V47, P615, DOI 10.1002/eji.201646484; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; US Foodlink, 2016, US FOODLINK, V12, P1, DOI DOI 10.1016/j.jalz.2016.03.001; Veras L, 2016, ASIA PAC J CLIN ONCO, V12, pe196, DOI 10.1111/ajco.12129; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang F, 2020, J CELL BIOCHEM, V121, P1182, DOI 10.1002/jcb.29352; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Y, 2012, ANIM GENET, V43, P282, DOI 10.1111/j.1365-2052.2011.02308.x; Warren WC, 2017, G3-GENES GENOM GENET, V7, P109, DOI 10.1534/g3.116.035923; Weng ZhuoXian, 2018, Journal of Economic Animal, V22, P181; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zhang CY, 2019, EVOL APPL, V12, P610, DOI 10.1111/eva.12742; Zhang Q, 2016, GENOME BIOL EVOL, V8, P765, DOI 10.1093/gbe/evw032; Zhong F, 2012, CHINA POULTRY, V34, P61; Zhong FuSheng, 2014, Journal of Hunan Agricultural University, V40, P56; Zhou YT, 2019, J CELL BIOCHEM, V120, P6570, DOI 10.1002/jcb.27950; 2014, REG ANESTH PAIN MED, V9	69	6	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241137	10.1371/journal.pone.0241137	http://dx.doi.org/10.1371/journal.pone.0241137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095808	gold, Green Published			2022-12-26	WOS:000586649400025
J	Wu, YF; Wang, D; Wei, F; Xiong, F; Zhang, SS; Gong, ZJ; Shi, L; Li, XY; Xiang, B; Ma, J; Deng, H; He, Y; Liao, QJ; Zhang, WL; Li, XL; Li, Y; Guo, C; Zeng, ZY; Li, GY; Xiong, W				Wu, Yingfen; Wang, Dan; Wei, Fang; Xiong, Fang; Zhang, Shanshan; Gong, Zhaojian; Shi, Lei; Li, Xiayu; Xiang, Bo; Ma, Jian; Deng, Hao; He, Yi; Liao, Qianjin; Zhang, Wenling; Li, Xiaoling; Li, Yong; Guo, Can; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei			EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1	FASEB JOURNAL			English	Article						cytoskeletal dynamic assembly; EBV&#8208; miR&#8208; BART12; EMT; gastric carcinoma; nasopharyngeal carcinoma; TPPP1	VIRUS-ENCODED MICRORNAS; EPITHELIAL-MESENCHYMAL TRANSITION; COIL KINASE ROCK; NASOPHARYNGEAL CARCINOMA; MICROTUBULE DYNAMICS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; NAB-PACLITAXEL; METASTASIS; EXPRESSION	Epstein-Barr virus (EBV) infection leads to cancers with an epithelial origin, such as nasopharyngeal cancer and gastric cancer, as well as multiple blood cell-based malignant tumors, such as lymphoma. Interestingly, EBV is also the first virus found to carry genes encoding miRNAs. EBV encodes 25 types of pre-miRNAs which are finally processed into 44 mature miRNAs. Most EBV-encoded miRNAs were found to be involved in the occurrence and development of EBV-related tumors. However, the function of EBV-miR-BART12 remains unclear. The findings of the current study revealed that EBV-miR-BART12 binds to the 3'UTR region of Tubulin Polymerization-Promoting Protein 1 (TPPP1) mRNA and downregulates TPPP1, thereby promoting the invasion and migration of EBV-related cancers, such as nasopharyngeal cancer and gastric cancer. The mechanism underlying this process was found to be the inhibition of TPPP1 by EBV-miRNA-BART12, which, in turn, inhibits the acetylation of alpha-tubulin, and promotes the dynamic assembly of microtubules, remodels the cytoskeleton, and enhances the acetylation of beta-catenin. beta-catenin activates epithelial to mesenchymal transition (EMT). These two processes synergistically promote the invasion and metastasis of tumor cells. To the best of our knowledge, this is the first study to reveal the role of EBV-miRNA-BART12 in the development of EBV-related tumors as well as the mechanism underlying this process, and suggests potential targets and strategies for the treatment of EBV-related tumors.	[Wu, Yingfen; He, Yi; Liao, Qianjin; Li, Xiaoling; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wu, Yingfen; He, Yi; Liao, Qianjin; Li, Xiaoling; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Wang, Dan; Wei, Fang; Xiang, Bo; Ma, Jian; Zhang, Wenling; Li, Xiaoling; Guo, Can; Zeng, Zhaoyang; Li, Guiyuan; Xiong, Wei] Cent South Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Changsha, Peoples R China; [Xiong, Fang; Zhang, Shanshan] Cent South Univ, Xiangya Hosp, Dept Stomatol, Changsha, Peoples R China; [Gong, Zhaojian; Shi, Lei] Cent South Univ, Xiangya Hosp 2, Dept Oral & Maxillofacial Surg, Changsha, Peoples R China; [Li, Xiayu; Deng, Hao] Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Peoples R China; [Li, Yong] Baylor Coll Med, Dept Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Baylor College of Medicine	Xiong, W (corresponding author), Cent South Univ, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Xiong, W (corresponding author), Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China.	xiongwei@csu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Li, Yong/0000-0001-8838-1714	National Natural Science Foundation of China [81772928, 81702907, 81772901, 81803025, 81872278, 81972776]; Overseas Expertise Introduction Project for Discipline Innovation [111-2-12]; Natural Science Foundation of Hunan Province [2018JJ3815, 2018JJ3704, 2018SK21210, 2018SK21211, 2019JJ50354, 2019JJ50872, 2019JJ50778, 2020JJ4125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project for Discipline Innovation; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The National Natural Science Foundation of China, Grant/Award Number: 81772928, 81702907, 81772901, 81803025, 81872278 and 81972776; The Overseas Expertise Introduction Project for Discipline Innovation, Grant/Award Number: (111 Project):No. 111-2-12; The Natural Science Foundation of Hunan Province, Grant/Award Number: 2018JJ3815, 2018JJ3704, 2018SK21210, 2018SK21211, 2019JJ50354, 2019JJ50872, 2019JJ50778 and 2020JJ4125	Abdallah MOE, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00316; Ambrosio MR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-12; Asthana J, 2013, J BIOL CHEM, V288, P22516, DOI 10.1074/jbc.M113.489328; Bando H, 2018, EUR J CANCER, V91, P86, DOI 10.1016/j.ejca.2017.11.032; Bang YJ, 2017, LANCET ONCOL, V18, P1637, DOI 10.1016/S1470-2045(17)30682-4; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bo H, 2019, ONCOL REP, V41, P2431, DOI 10.3892/or.2019.7027; Bu HH, 2014, INT J PHARMACEUT, V471, P206, DOI 10.1016/j.ijpharm.2014.05.039; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Choi SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061286; Deng XY, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0428-0; Dolcetti R, 2013, SEMIN CANCER BIOL, V23, P441, DOI 10.1016/j.semcancer.2013.07.005; Fan CM, 2021, SCI CHINA LIFE SCI, V64, P534, DOI 10.1007/s11427-019-1735-4; Fan CM, 2019, J CANCER, V10, P3926, DOI 10.7150/jca.31345; Fan CM, 2019, CARCINOGENESIS, V40, P380, DOI 10.1093/carcin/bgy143; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; GELMON K, 1994, LANCET, V344, P1267, DOI 10.1016/S0140-6736(94)90754-4; Haakenson J, 2013, INT J MOL SCI, V14, P9514, DOI 10.3390/ijms14059514; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huh S, 2019, MOLECULES, V24, DOI 10.3390/molecules24213834; Iaconelli J, 2015, ACS CHEM BIOL, V10, P883, DOI 10.1021/cb500838r; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Inokawa Y, 2016, ANTICANCER RES, V36, P4639, DOI 10.21873/anticanres.11014; Jiang XJ, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01709-5; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kim H, 2015, CANCER LETT, V356, P733, DOI 10.1016/j.canlet.2014.10.023; Kinoshita J, 2014, ONCOL REP, V32, P89, DOI 10.3892/or.2014.3210; Kundranda Madappa N, 2015, Drug Des Devel Ther, V9, P3767, DOI 10.2147/DDDT.S88023; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; Li N, 2011, P NATL ACAD SCI USA, V108, P12851, DOI 10.1073/pnas.1017372108; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lian Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0918-9; Liu SL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5192-x; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Marquitz AR, 2014, J VIROL, V88, P1389, DOI 10.1128/JVI.02662-13; Meng H, 2015, ACS NANO, V9, P3540, DOI 10.1021/acsnano.5b00510; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Miyaushiro S, 2015, INTERNAL MED, V54, P1455, DOI 10.2169/internalmedicine.54.3917; Mo YZ, 2019, J CANCER, V10, P3789, DOI 10.7150/jca.31166; Mo YZ, 2019, J CANCER, V10, P2342, DOI 10.7150/jca.30454; Myachina F, 2017, DEVELOPMENT, V144, P4573, DOI 10.1242/dev.156109; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Nourse JP, 2012, J VIROL METHODS, V184, P46, DOI 10.1016/j.jviromet.2012.05.005; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Oh ST, 2004, VIROLOGY, V320, P330, DOI 10.1016/j.virol.2003.12.005; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Portis T, 2003, BLOOD, V102, P4166, DOI 10.1182/blood-2003-04-1018; Preusser M, 2007, ACTA NEUROPATHOL, V113, P213, DOI 10.1007/s00401-006-0173-6; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Rajesh R, 2011, PLOS ONE, V6; Ren DX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1144-6; Ribeiro J, 2017, CANCER LETT, V404, P37, DOI 10.1016/j.canlet.2017.07.010; Roschewski M, 2012, BEST PRACT RES CL HA, V25, P75, DOI 10.1016/j.beha.2012.01.005; Ross N, 2013, AM J BLOOD RES, V3, P210; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schofield AV, 2013, BIOCHEM BIOPH RES CO, V436, P571, DOI 10.1016/j.bbrc.2013.05.076; Schofield AV, 2013, J BIOL CHEM, V288, P7907, DOI 10.1074/jbc.M112.441048; Schofield AV, 2012, J BIOL CHEM, V287, P43620, DOI 10.1074/jbc.M112.394965; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Song YL, 2016, ONCOTARGET, V7, P36783, DOI 10.18632/oncotarget.9170; Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7; Tang T, 2020, MOL ONCOL, V14, P2251, DOI 10.1002/1878-0261.12703; Tang YY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0825-x; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Tu CF, 2018, CARCINOGENESIS, V39, P1517, DOI 10.1093/carcin/bgy108; Tu CF, 2017, J VIROL, V91, DOI 10.1128/JVI.00301-17; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WALLIN M, 1995, INT REV CYTOL, V157, P1, DOI 10.1016/S0074-7696(08)62155-5; Wang D, 2020, FASEB J, V34, P8012, DOI 10.1096/fj.202000039RR; Wei F, 2018, BRIT J CANCER, V118, P233, DOI 10.1038/bjc.2017.385; Wen X, 2018, THERANOSTICS, V8, P5676, DOI 10.7150/thno.28538; Worch S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-1; Wu CC, 2019, SCI CHINA LIFE SCI, V62, P640, DOI 10.1007/s11427-018-9461-5; Wu YF, 2019, J CANCER, V10, P2185, DOI 10.7150/jca.30222; Xiao K, 2016, J CANCER, V7, P214, DOI 10.7150/jca.13150; Xiong F, 2019, CHINESE MED J-PEKING, V132, P749, DOI 10.1097/CM9.0000000000000132; Yan QJ, 2015, ONCOTARGET, V6, P41766, DOI 10.18632/oncotarget.6155; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhao J, 2020, CANCER LETT, V477, P131, DOI 10.1016/j.canlet.2020.02.010; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18; Zhou X, 2017, P NATL ACAD SCI USA, V114, pE10667, DOI 10.1073/pnas.1710506114; Zhu KJ, 2020, CANCER LETT, V492, P11, DOI 10.1016/j.canlet.2020.07.028	93	16	16	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16205	16223		10.1096/fj.202001508R	http://dx.doi.org/10.1096/fj.202001508R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33094864				2022-12-26	WOS:000586258700001
J	Helble, JD; Mann, AO; Starnbach, MN				Helble, Jennifer D.; Mann, Alexander O.; Starnbach, Michael N.			Antigen-specific memory and naive CD4(+)T cells following secondaryChlamydia trachomatisinfection	PLOS ONE			English	Article							CD4 T-CELLS; MEDIATED PROTECTION; RNA-SEQ; INFECTION; RESPONSES; EFFECTOR; GENERATION; GENE	Memory antigen-specific CD4(+)T cells againstChlamydia trachomatisare necessary for protection against secondary genital tract infection. While it is known that naive antigen-specific CD4(+)T cells can traffic to the genital tract in an antigen-specific manner, these T cells are not protective during primary infection. Here, we sought to compare the differences between memory and naive antigen-specific CD4(+)T cells in the same mouse following secondary infection using transgenic CD4(+)T cells (NR1 T cells). Using RNA sequencing, we found that there were subtle but distinct differences between these two T cell populations. Naive NR1 T cells significantly upregulated cell cycle genes and were more proliferative than memory NR1 T cells in the draining lymph node. In contrast, memory NR1 T cells were more activated than naive NR1 T cells and were enriched in the genital tract. Together, our data provide insight into the differences between memory and naive antigen-specific CD4(+)T cells duringC.trachomatisinfection.	[Helble, Jennifer D.; Starnbach, Michael N.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Mann, Alexander O.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Starnbach, MN (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.	starnbach@hms.harvard.edu		Starnbach, Michael/0000-0003-4465-712X; Helble, Jennifer/0000-0003-3518-069X	National Institutes of Health [AI39558]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grant AI39558 to MS from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; [Anonymous], 2018, CTR DIS CONTROL SEXU; Coers J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001346; Davila SJ, 2014, J IMMUNOL, V192, P4284, DOI 10.4049/jimmunol.1303238; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gondek DC, 2009, J IMMUNOL, V183, P1313, DOI 10.4049/jimmunol.0900295; Helble JD, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00837-18; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jordan SJ, 2019, CYTOKINE, V113, P458, DOI 10.1016/j.cyto.2018.06.017; Jordan SJ, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00010-17; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Picard MD, 2015, CLIN VACCINE IMMUNOL, V22, P1206, DOI 10.1128/CVI.00247-15; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Roan NR, 2006, P NATL ACAD SCI USA, V103, P12069, DOI 10.1073/pnas.0603866103; Rogers PR, 2000, J IMMUNOL, V164, P2338, DOI 10.4049/jimmunol.164.5.2338; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tuncel J, 2019, J EXP MED, V216, P1328, DOI 10.1084/jem.20182002; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whitmire JK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000041; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240670	10.1371/journal.pone.0240670	http://dx.doi.org/10.1371/journal.pone.0240670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091023	gold, Green Published			2022-12-26	WOS:000586647200001
J	Szocs, I; Dobi, B; Lam, J; Orban-Kis, K; Hakkinen, U; Belicza, E; Bereczki, D; Vastagh, I				Szocs, Ildiko; Dobi, Balazs; Lam, Judit; Orban-Kis, Karoly; Hakkinen, Unto; Belicza, Eva; Bereczki, Daniel; Vastagh, Ildiko			Health related quality of life and satisfaction with care of stroke patients in Budapest: A substudy of the EuroHOPE project	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ISCHEMIC-STROKE; SOCIODEMOGRAPHIC CHARACTERISTICS; INPATIENT REHABILITATION; IMPORTANT DIFFERENCE; 15D; PREDICTORS; EQ-5D; ASSOCIATION; INSTRUMENTS	Background Disadvantaged socioeconomic status is associated with higher stroke incidence and mortality, and higher readmission rate. We aimed to assess the effect of socioeconomic factors on case fatality, health related quality of life (HRQoL), and satisfaction with care of stroke survivors in the framework of the European Health Care Outcomes, Performance and Efficiency (EuroHOPE) study in Hungary, one of the leading countries regarding stroke mortality. Methods We evaluated 200 consecutive patients admitted for first-ever ischemic stroke in a single center and performed a follow-up at 3 months after stroke. We recorded pre- and post-stroke socioeconomic factors, and assessed case fatality, HRQoL and patient satisfaction with the care received. Stroke severity at onset was scored by the National Institutes of Health Stroke scale (NIHSS), disability at discharge from acute care was evaluated by the modified Rankin Score (mRS). To evaluate HRQoL and patient satisfaction with care we used the EQ-5D-5L, 15D and EORTC IN PATSAT 32 questionnaires. Results At 3 months after stroke the odds of death was significantly increased by stroke severity (NIHSS, OR = 1.209, 95%CI: 1.125-1.299, p<0.001) and age (OR = 1.045, 95%CI: 1.003-1.089, p = 0.038). In a multiple linear regression model, independent predictors of HRQoL were age, disability at discharge, satisfaction with care, type of social dwelling after stroke, length of acute hospital stay and rehospitalization. Satisfaction with care was influenced negatively by stroke severity (Coef. = -1.111, 95%C.I.: -2.159- -0.062, p = 0.040), and positively by having had thrombolysis (Coef. = 25.635, 95%C.I.: 5.212-46.058, p = 0.016) and better HRQoL (Coef. = 22.858, 95%C.I.: 6.007-39.708, p = 0.009). Conclusion In addition to age, disability, and satisfaction with care, length of hospital stay and type of social dwelling after stroke also predicted HRQoL. Long-term outcome after stroke could be improved by reducing time spent in hospital, i.e. by developing home care rehabilitation facilities thus reducing the need for readmission to inpatient care.	[Szocs, Ildiko; Bereczki, Daniel; Vastagh, Ildiko] Semmelweis Univ, Dept Neurol, Budapest, Hungary; [Szocs, Ildiko; Dobi, Balazs; Bereczki, Daniel] MTA SE Neuroepidemiol Res Grp, Budapest, Hungary; [Dobi, Balazs] Eotvos Lorand Univ, Dept Probabil Theory & Stat, Budapest, Hungary; [Lam, Judit; Belicza, Eva] Semmelweis Univ, Hlth Serv Management Training Ctr, Budapest, Hungary; [Orban-Kis, Karoly] Univ Med & Pharm Tirgu Mures, Dept Physiol, Targu Mures, Romania; [Hakkinen, Unto] Finnish Inst Hlth & Welf, Helsinki, Finland; [Vastagh, Ildiko] Bajcsy Zsilinszky Hosp, Dept Neurol, Budapest, Hungary	Semmelweis University; Eotvos Lorand University; Semmelweis University; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Szocs, I (corresponding author), Semmelweis Univ, Dept Neurol, Budapest, Hungary.; Szocs, I (corresponding author), MTA SE Neuroepidemiol Res Grp, Budapest, Hungary.	szocsiko@gmail.com	Orban-Kis, Karoly/C-3087-2011	Orban-Kis, Karoly/0000-0002-7786-0899; Bereczki, Daniel/0000-0002-8374-0500; Szocs, Ildiko/0000-0003-0785-8280; Dobi, Balazs/0000-0002-1187-4104	EuroHOPE Research Grant - European Union, belonging into the seventh Framework Program (FP7) of the European Commission [241721]; National Brain Research Program [KITA-NAP-13-1-2013-0001]; Higher Education Institutional Excellence Program; New National Excellence Program of the Ministry of Human Resources of the Government of Hungary [UNKP-17-3]	EuroHOPE Research Grant - European Union, belonging into the seventh Framework Program (FP7) of the European Commission; National Brain Research Program; Higher Education Institutional Excellence Program; New National Excellence Program of the Ministry of Human Resources of the Government of Hungary	The work was supported by the EuroHOPE Research Grant [241721], financed by the European Union, belonging into the seventh Framework Program (FP7) of the European Commission (to IS, DB, JL, EB, UH and IV). It was also supported by grants from the National Brain Research Program (KITA-NAP-13-1-2013-0001, to DB), the Higher Education Institutional Excellence Program and the New National Excellence Program (UNKP-17-3, to DB) of the Ministry of Human Resources of the Government of Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Alanne S, 2015, QUAL LIFE RES, V24, P599, DOI 10.1007/s11136-014-0787-4; Andersen KK, 2011, STROKE, V42, P2806, DOI 10.1161/STROKEAHA.111.619049; Anderson C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub2; [Anonymous], 2000, SPENSER STUDIES, V14, P229; [Anonymous], 2011, BUNYAN STUDIES, V15, P11; [Anonymous], 1998, PACIFICA, V11, P249, DOI DOI 10.1177/1030570X9801100302; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Avendano M, 2006, J CLIN EPIDEMIOL, V59, P1285, DOI 10.1016/j.jclinepi.2006.03.010; Avendano M, 2004, STROKE, V35, P432, DOI 10.1161/01.STR.0000109225.11509.EE; Bentsen L, 2014, J STROKE CEREBROVASC, V23, P1944, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.002; Betts MB, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01407-y; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown AW, 2015, STROKE, V46, P1038, DOI 10.1161/STROKEAHA.114.007392; Carod-Artal FJ, 2009, CEREBROVASC DIS, V27, P204, DOI 10.1159/000200461; Cesaroni G, 2009, STROKE, V40, P2812, DOI 10.1161/STROKEAHA.108.542944; Chen PY, 2016, QUAL LIFE RES, V25, P1585, DOI 10.1007/s11136-015-1196-z; Chumbler NR, 2015, J TELEMED TELECARE, V21, P139, DOI 10.1177/1357633X15571995; Conroy BE, 2009, TOP STROKE REHABIL, V16, P34, DOI 10.1310/tsr1601-34; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Cumming TB, 2019, NEUROLOGY, V93, pE717, DOI 10.1212/WNL.0000000000007937; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; Elwood D, 2009, PM&R, V1, P147, DOI 10.1016/j.pmrj.2008.10.010; EORTC QOL Group, EORTC PATSAT32; EuroHope, 2016, ATL MAP REP EUROHOPE; Feeny D, 2005, ASSESSING QUALITY LI, V2, P406; Feeny D, 2019, INT J TECHNOL ASSESS, V35, P257, DOI 10.1017/S0266462319000412; Fjaertoft H, 2004, CLIN REHABIL, V18, P580, DOI 10.1191/0269215504cr773oa; Folyovich A, 2015, INT J PUBLIC HEALTH, V60, P487, DOI 10.1007/s00038-015-0674-y; Greenhill B, 2011, AM J POLIT SCI, V55, P990, DOI 10.1111/j.1540-5907.2011.00525.x; Grube MM, 2012, STROKE, V43, P3325, DOI 10.1161/STROKEAHA.112.669580; Hadi F, 2014, VALUE HEALTH, V17, pA784; Hakkinen U, 2013, HEALTH POLICY, V112, P100, DOI 10.1016/j.healthpol.2013.04.013; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Heiskanen J, 2016, EUR HEART J-QUAL CAR, V2, P193, DOI 10.1093/ehjqcco/qcw002; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Holmqvist LW, 2000, SCAND J REHABIL MED, V32, P173, DOI 10.1080/003655000750060922; Hopman WM, 2003, STROKE, V34, P801, DOI 10.1161/01.STR.0000057978.15397.6F; Janssen B., 2014, SELF REPORTED POPULA, P19; Katzan IL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012421; Kerr GD, 2011, CEREBROVASC DIS, V31, P57, DOI 10.1159/000320855; Kim SK, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0227-3; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kontodimopoulos N, 2012, EUR J HEALTH ECON, V13, P111, DOI 10.1007/s10198-010-0290-y; Lopez-Espuela F, 2015, BIOL RES NURS, V17, P461, DOI 10.1177/1099800414553658; Lunde L, 2013, EUR J HEALTH ECON, V14, P539, DOI 10.1007/s10198-012-0402-y; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mahesh PKB, 2018, NEUROL SCI, V39, P287, DOI 10.1007/s10072-017-3172-6; Malmivaara A, 2015, EUR J NEUROL, V22, P284, DOI 10.1111/ene.12560; Malmivaara A., 2013, 6 EUROHOPE, V6; Ramos-Lima MJM, 2018, CLINICS, V73, DOI 10.6061/clinics/2017/e418; Nunes HJM, 2017, REV BRAS ENFERM, V70, P415, DOI 10.1590/0034-7167-2016-0166; Moock J, 2008, QUAL LIFE RES, V17, P485, DOI 10.1007/s11136-008-9317-6; Mouelhi Y, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01344-w; Opara Jozef A, 2010, J Med Life, V3, P216; Owolabi MO, 2010, CEREBROVASC DIS, V29, P105, DOI 10.1159/000262305; RANKIN J, 1957, Scott Med J, V2, P200; Redfors P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0599-y; Richardson J, 2015, QUAL LIFE RES, V24, P2045, DOI 10.1007/s11136-015-0926-6; Rupel VP, 2019, EUR J HEALTH ECON, V20, pS109, DOI 10.1007/s10198-019-01068-9; Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1; Sand KM, 2016, EUR J NEUROL, V23, P1, DOI 10.1111/ene.12848; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Sintonen H, 1994, 41 NAT CTR HLTH PROV; Sintonen H., 2001, ARCH HELLENIC MED, V18, P156; Szocs I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212519; Szocs I, 2012, IDEGGYOGY SZEMLE, V65, P107; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Tu HTH, 2015, INT J STROKE, V10, P534, DOI 10.1111/ijs.12007; Tucker JL, 2000, MIL MED, V165, P72, DOI 10.1093/milmed/165.1.72; Vainiola T, 2010, INTENS CARE MED, V36, P2090, DOI 10.1007/s00134-010-1979-1; Vartiainen P, 2017, PAIN, V158, P1577, DOI 10.1097/j.pain.0000000000000954; Vastagh I, 2010, DIABETES-METAB RES, V26, P646, DOI 10.1002/dmrr.1133; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Wang RR, 2018, SCAND J CARING SCI, V32, P502, DOI 10.1111/scs.12533; Westerlind E, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-019-1584-z	79	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241059	10.1371/journal.pone.0241059	http://dx.doi.org/10.1371/journal.pone.0241059			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4AZ	33091092	gold, Green Published			2022-12-26	WOS:000586647200027
J	Bekki, S; Hashimoto, S; Yamasaki, K; Komori, A; Abiru, S; Nagaoka, S; Saeki, A; Suehiro, T; Kugiyama, Y; Beppu, A; Kuroki, T; Nakamura, M; Ito, M; Yatsuhashi, H				Bekki, Shigemune; Hashimoto, Satoru; Yamasaki, Kazumi; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Saeki, Akira; Suehiro, Tomoyuki; Kugiyama, Yuki; Beppu, Asami; Kuroki, Tamotsu; Nakamura, Minoru; Ito, Masahiro; Yatsuhashi, Hiroshi			Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN; OUTCOMES; PATHWAY	Background We examined serum kynurenine levels in patients with chronic hepatitis C virus infection, and the relationship between serum kynurenine and prognosis in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C. Methods We retrospectively analyzed 604 patients with HCC diagnosed between January 1999 and December 2015, and 288 patients without HCC who were seen at the National Hospital Organization Nagasaki Medical Center between October 2014 and November 2017. The association between serum kynurenine and prognosis was evaluated using the Cox's proportional hazards regression analysis. Results Patients with HCC had significantly higher values of serum kynurenine than patients without HCC (median: 557.1 vs. 464.2 ng/mL, p<0.001). Five-year survival rates of HCC patients with serum kynurenine >= 900 (n = 65), 600-899 (n = 194), and <600 ng/mL (n = 345) were 30.6%, 47.4%, and 61.4%, respectively (p = 0.001, log-rank test). Multivariate analysis identified serum kynurenine as an independent predictor for prognosis of HCC patients. The hazard ratio of serum kynurenine >= 900, and 600-899 compared with serum kynurenine <600 ng/mL were 1.91 (p<0.001) and 1.37 (p = 0.015), respectively. Conclusions A high level of serum kynurenine correlated with poor prognosis of HCC. Serum kynurenine levels may be a novel biomarker to predict the prognosis of patients with HCC. The development of drugs that inhibit kynurenine production is expected to help improve the prognosis of patients with HCC.	[Bekki, Shigemune; Hashimoto, Satoru; Yamasaki, Kazumi; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Saeki, Akira; Suehiro, Tomoyuki; Kugiyama, Yuki; Beppu, Asami; Kuroki, Tamotsu; Nakamura, Minoru; Ito, Masahiro; Yatsuhashi, Hiroshi] Natl Hosp Org Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan; [Bekki, Shigemune; Kuroki, Tamotsu; Nakamura, Minoru; Ito, Masahiro; Yatsuhashi, Hiroshi] Nagasaki Univ, Dept Viral Hepatitis, Grad Sch Biomed Sci, Nagasaki, Japan; [Hashimoto, Satoru] Japan Community Hlth Care Org Kyushu Hosp, Dept Gastroenterol, Kitakyushu, Fukuoka, Japan	Nagasaki University	Yatsuhashi, H (corresponding author), Natl Hosp Org Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan.; Yatsuhashi, H (corresponding author), Nagasaki Univ, Dept Viral Hepatitis, Grad Sch Biomed Sci, Nagasaki, Japan.	yatsuhashihiroshi@gmail.com		Bekki, Shigemune/0000-0003-3375-1372	Japan Agency for Medical Research and Development [JP19fk0210019]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This research was supported by Japan Agency for Medical Research and Development under Grant Number JP19fk0210019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Asghar K, 2015, EXP THER MED, V9, P901, DOI 10.3892/etm.2014.2146; Carvajal-Hausdorf DE, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0285-7; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Chacko S, 2016, BIOMED PHARMACOTHER, V84, P1679, DOI 10.1016/j.biopha.2016.10.078; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Forner A, 2014, BEST PRACT RES CL GA, V28, P855, DOI 10.1016/j.bpg.2014.08.002; Gautam US, 2018, P NATL ACAD SCI USA, V115, pE62, DOI 10.1073/pnas.1711373114; Gu Y, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0408-1; Herve C, 1996, J CHROMATOGR B, V675, P157, DOI 10.1016/0378-4347(95)00341-X; Hornyak L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00151; Jin HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10466; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Mabuchi R, 2016, LEUKEMIA LYMPHOMA, V57, P92, DOI 10.3109/10428194.2015.1041388; Mangaonkar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12940-0; Masaki A, 2018, CANCER SCI, V109, P74, DOI 10.1111/cas.13432; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pett SL, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx228; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Schwarcz R, 2017, NEUROPHARMACOLOGY, V112, P237, DOI 10.1016/j.neuropharm.2016.08.003; Shibata Y, 2017, HEMATOL ONCOL, V35, P637, DOI 10.1002/hon.2318; Spranger S, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-3; Stepien M, 2016, INT J CANCER, V138, P348, DOI 10.1002/ijc.29718; Trabado S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173615; Wainwright DA, 2014, CLIN CANCER RES, V20, P5290, DOI 10.1158/1078-0432.CCR-14-0514; Yu CP, 2018, CELL PHYSIOL BIOCHEM, V49, P134, DOI 10.1159/000492849; Zhai LJ, 2015, CLIN CANCER RES, V21, P5427, DOI 10.1158/1078-0432.CCR-15-0420	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241002	10.1371/journal.pone.0241002	http://dx.doi.org/10.1371/journal.pone.0241002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085694	gold, Green Published			2022-12-26	WOS:000585943400005
J	Parsonidis, P; Vlachou, I; Mamagkaki, A; Bouris, I; Daikopoulou, V; Papasotiriou, I				Parsonidis, Panagiotis; Vlachou, Ioanna; Mamagkaki, Alexandra; Bouris, Ioannis; Daikopoulou, Vasiliki; Papasotiriou, Ioannis			Evaluation of Tegaran Formula ZhenHua cytotoxicity against human cancer cell lines	PLOS ONE			English	Article							POLYPHENOLS; APOPTOSIS; P53	The aim of this study is to evaluate the potential health effects of Tegaran Formula ZhenHua, a nutritional supplement used mainly by cancer patients. Its active ingredients and cytotoxicity was assessed with analytical methods and viability assays, respectively. The analytical methods consisted of dissolution, disintegration, HPLC, LC/MS, GC/MS and NMR. Cytotoxicity was assessed by MTT, SRB, CVE colorimetric viability assays in 0, 24, 48 and 72h time points. The results indicate that Tegaran Formula ZhenHua supplement did not present any cytotoxic effects due to issues related to the capsules' solubility, distribution and identification of the active ingredient.	[Parsonidis, Panagiotis; Vlachou, Ioanna; Mamagkaki, Alexandra; Bouris, Ioannis; Daikopoulou, Vasiliki] Res Genet Canc Ctr SA, Ind Area Florina, Florina, Greece; [Papasotiriou, Ioannis] Res Genet Canc Ctr Int GmbH Headquarters, Baarerstr, Zug, Switzerland		Papasotiriou, I (corresponding author), Res Genet Canc Ctr Int GmbH Headquarters, Baarerstr, Zug, Switzerland.	papasotiriou.ioannis@rgcc-international.com		Parsonidis, Panagiotis/0000-0002-4922-3104				Albilescu M, 2015, PHYTOCHEMICALS ANTIT; [Anonymous], 2019, NEUE Z KARTELLRECHT, V7, P495; [Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Cao ZH, 2019, BIOTECHNOL ADV, V37, P223, DOI 10.1016/j.biotechadv.2018.12.001; Chen MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089288; Corbett GJ, 2012, ARAB ARCHAEOL EPIGR, V23, P174, DOI 10.1111/j.1600-0471.2012.00357.x; Jalili M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158545; Kehrer JP, 1994, NATURAL ANTIOXIDANTS, V2, P25; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Kuhnau J, 1976, FLAVONOIDS CLASS SEM; Lin TX, 2012, UROL ONCOL-SEMIN ORI, V30, P339, DOI 10.1016/j.urolonc.2010.04.011; Malik S, 2019, SOFTWARE ENGINEERING FOR EMBEDDED SYSTEMS: METHODS, PRACTICAL TECHNIQUES, AND APPLICATIONS, 2ND EDITION, P427, DOI 10.1016/B978-0-12-809448-8.00012-6; Marco ML, 2017, CURR OPIN BIOTECH, V44, P94, DOI 10.1016/j.copbio.2016.11.010; Nabavi SM, 2012, FOOD CHEM, V132, P931, DOI 10.1016/j.foodchem.2011.11.070; Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Song WO, 2007, J MED FOOD, V10, P571, DOI 10.1089/jmf.2006.0620; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Yakovlev AG, 2004, J BIOL CHEM, V279, P28367, DOI 10.1074/jbc.M313526200; Yang CS, 1997, ENVIRON HEALTH PERSP, V105, P971, DOI 10.2307/3433312; Yang LL, 2000, CANCER LETT, V157, P65, DOI 10.1016/S0304-3835(00)00477-8; Yang Zhenhua, 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P146; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240969	10.1371/journal.pone.0240969	http://dx.doi.org/10.1371/journal.pone.0240969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085705	gold, Green Published			2022-12-26	WOS:000585943400040
J	Chen, JF; Mishra, R; Yu, YQ; McDonald, JG; Eckert, KM; Gao, L; Mendelson, CR				Chen, Jingfei; Mishra, Ritu; Yu, Yaqin; McDonald, Jeffrey G.; Eckert, Kaitlyn M.; Gao, Lu; Mendelson, Carole R.			Decreased 11 beta-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling	FASEB JOURNAL			English	Article						11 beta-hydroxysteroid dehydrogenase type 1; cytokines; fetal lung development; glucocorticoids; steroid receptor coactivators (SRCs)	NF-KAPPA-B; PROTEIN-A GENE; CYCLIC ADENOSINE 3,5-MONOPHOSPHATE; PLATELET-ACTIVATING-FACTOR; BINDING-PROTEIN; C/EBP-BETA; TRANSCRIPTION FACTORS; TYPE-1 EXPRESSION; TARGETED DISRUPTION; CROSS-TALK	Our previous research revealed that steroid receptor coactivators (Src)-1 and -2 serve a critical cooperative role in production of parturition signals, surfactant protein A and platelet-activating factor, by the developing mouse fetal lung (MFL). To identify the global landscape of genes in MFL affected bySrc-1/-2double-deficiency, we conducted RNA-seq analysis of lungs from 18.5 days post-coitum (dpc)Src-1(-/-)/-2(-/-)(dKO)vs. WT fetuses. One of the genes most highly downregulated (similar to 4.8 fold) inSrc-1/-2dKO fetal lungs encodes 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which catalyzes conversion of inactive 11-dehydrocorticosterone to the glucocorticoid receptor (GR) ligand, corticosterone. Glucocorticoids were reported to upregulate 11 beta-HSD1 expression in various cell types via induction of C/EBP transcription factors. We observed thatC/ebp alpha andC/ebp beta mRNA and protein were markedly reduced inSrc-1/-2double-deficient (Src-1/-2(d/d)) fetal lungs, compared to WT. Moreover, glucocorticoid induction of11 beta-hsd1,C/ebp alpha and C/ebp beta in cultured MFL epithelial cells was prevented by the SRC family inhibitor, SI-2. Cytokines also contribute to the induction of 11 beta-HSD1. Expression of IL-1 beta and TNF alpha, which dramatically increased toward term in lungs of WT fetuses, was markedly reduced inSrc-1/-2(d/d)fetal lungs. Our collective findings suggest that impaired lung development and surfactant synthesis inSrc-1/-2(d/d)fetuses are likely caused, in part, by decreased GR and cytokine induction of C/EBP and NF-kappa B transcription factors. This results in reduced 11 beta-HSD1 expression and glucocorticoid signaling within the fetal lung, causing a break in the glucocorticoid-induced positive feedforward loop.	[Chen, Jingfei] Cent South Univ, Xiangya Hosp, Dept Obstet & Gynecol, Changsha, Peoples R China; [Chen, Jingfei; Mishra, Ritu; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Yu, Yaqin; Gao, Lu] Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [McDonald, Jeffrey G.; Eckert, Kaitlyn M.] Univ Texas Southwestern Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [McDonald, Jeffrey G.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX USA; [Gao, Lu] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai, Peoples R China; [Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Central South University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Naval Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shanghai Jiao Tong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Gao, L (corresponding author), Second Mil Med Univ, Dept Physiol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	Lu.gao@smmu.edu.cn; carole.mendelson@utsouthwestern.edu			NIH [R01-HL050022, P01HD087150, P01-HL020948]; Burroughs Wellcome Preterm Birth Grant [1019823]; National Natural Science Foundation of China (NSFC) [81771608]; National Key Research and Development Project [2017YFC1001404]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Preterm Birth Grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This work was supported by NIH grants R01-HL050022 (CRM) and P01HD087150 (CRM), Burroughs Wellcome Preterm Birth Grant #1019823 (CRM), NIH Grant P01-HL020948 (JGM), National Natural Science Foundation of China (NSFC) 81771608 (LG), National Key Research and Development Project No. 2017YFC1001404 (LG)	Alcorn JL, 1997, AM J RESP CELL MOL, V17, P672, DOI 10.1165/ajrcmb.17.6.2858; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; Bird AD, 2015, MOL ENDOCRINOL, V29, P158, DOI 10.1210/me.2014-1362; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Breed DR, 1997, ENDOCRINOLOGY, V138, P5527, DOI 10.1210/en.138.12.5527; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Esteves CL, 2014, J CLIN ENDOCR METAB, V99, pE160, DOI 10.1210/jc.2013-1708; Esteves CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075874; Frenkel RA, 1996, PROG LIPID RES, V35, P155, DOI 10.1016/0163-7827(96)00002-1; Gao B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180394; Gao L, 2015, J CLIN INVEST, V125, P2808, DOI 10.1172/JCI78544; Garbrecht MR, 2006, BIOL NEONATE, V89, P109, DOI 10.1159/000088653; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; HOFFMAN DR, 1988, LIPIDS, V23, P96, DOI 10.1007/BF02535287; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Hundertmark S, 2002, HORM METAB RES, V34, P537, DOI 10.1055/s-2002-35424; Hundertmark S, 2002, HORM METAB RES, V34, P545, DOI 10.1055/s-2002-35425; Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lajoie M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-231; Lee SK, 1999, MOL ENDOCRINOL, V13, P1924, DOI 10.1210/me.13.11.1924; Lee WK, 2020, ENDOCR-RELAT CANCER, V27, P209, DOI 10.1530/ERC-19-0482; LI F, 1995, AM J PHYSIOL-LUNG C, V269, pL241, DOI 10.1152/ajplung.1995.269.2.L241; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Li WJ, 2006, ENDOCRINOLOGY, V147, P2490, DOI 10.1210/en.2005-1626; Liu D, 2008, AM J PHYSIOL-LUNG C, V295, pL264, DOI 10.1152/ajplung.00069.2008; Liu DY, 2009, MOL ENDOCRINOL, V23, P772, DOI 10.1210/me.2008-0282; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Louet JF, 2010, CELL METAB, V12, P606, DOI 10.1016/j.cmet.2010.11.009; Mark M, 2004, P NATL ACAD SCI USA, V101, P4453, DOI 10.1073/pnas.0400234101; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Mendelson CR, 1998, BBA-MOL BASIS DIS, V1408, P132, DOI 10.1016/S0925-4439(98)00063-5; Mishra R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00037-18; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; ODOM MJ, 1987, ENDOCRINOLOGY, V121, P1155, DOI 10.1210/endo-121-3-1155; Provost PR, 2005, ENDOCRINOLOGY, V146, P2239, DOI 10.1210/en.2005-0077; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Rosenberg E, 2002, BBA-GENE STRUCT EXPR, V1575, P82, DOI 10.1016/S0167-4781(02)00287-7; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; SALOMON DS, 1979, ENDOCRINOLOGY, V104, P154, DOI 10.1210/endo-104-1-154; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seckl JR, 2001, ENDOCRINOLOGY, V142, P1371, DOI 10.1210/en.142.4.1371; SHIMIZU H, 1994, GENE, V149, P305; SMITH BT, 1973, STEROIDS, V22, P515, DOI 10.1016/0039-128X(73)90007-X; Song XZ, 2016, P NATL ACAD SCI USA, V113, P4970, DOI 10.1073/pnas.1604274113; Speirs HJL, 2004, J ENDOCRINOL, V181, P105, DOI 10.1677/joe.0.1810105; Stashi E, 2014, TRENDS ENDOCRIN MET, V25, P337, DOI 10.1016/j.tem.2014.05.004; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; TORDAY JS, 1976, STEROIDS, V27, P869, DOI 10.1016/0039-128X(76)90145-8; TORDAY JS, 1975, ENDOCRINOLOGY, V96, P1462, DOI 10.1210/endo-96-6-1462; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Winnay JN, 2006, ENDOCRINOLOGY, V147, P1322, DOI 10.1210/en.2005-0751; Xia CL, 1997, INT J BIOCHEM CELL B, V29, P1525, DOI 10.1016/S1357-2725(97)00083-6; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Yang Z, 2009, ENDOCRINE, V36, P404, DOI 10.1007/s12020-009-9245-4; Yang Z, 2009, J CLIN ENDOCR METAB, V94, P306, DOI 10.1210/jc.2008-1534; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Young PP, 1996, AM J PHYSIOL-LUNG C, V271, pL287, DOI 10.1152/ajplung.1996.271.2.L287; Young PP, 1997, MOL ENDOCRINOL, V11, P1082, DOI 10.1210/me.11.8.1082; Zhang ZQ, 2010, J BIOL CHEM, V285, P33092, DOI 10.1074/jbc.M110.130377	86	3	4	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16243	16261		10.1096/fj.202001809R	http://dx.doi.org/10.1096/fj.202001809R		OCT 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070362	Green Accepted			2022-12-26	WOS:000581166400001
J	Pons, S; Fournier, S; Chervin, C; Becard, G; Rochange, S; Frey, NFD; Pages, VP				Pons, Simon; Fournier, Sylvie; Chervin, Christian; Becard, Guillaume; Rochange, Soizic; Frei Dit Frey, Nicolas; Puech Pages, Virginie			Phytohormone production by the arbuscular mycorrhizal fungusRhizophagus irregularis	PLOS ONE			English	Article							ETHYLENE FORMATION; PLANT HORMONES; FUNGUS GLOMUS; LIQUID-CHROMATOGRAPHY; ROOT COLONIZATION; MASS-SPECTROMETRY; TROPAEOLUM-MAJUS; ABSCISIC-ACID; BIOSYNTHESIS; GROWTH	Arbuscular mycorrhizal symbiosis is a mutualistic interaction between most land plants and fungi of the glomeromycotina subphylum. The initiation, development and regulation of this symbiosis involve numerous signalling events between and within the symbiotic partners. Among other signals, phytohormones are known to play important roles at various stages of the interaction. During presymbiotic steps, plant roots exude strigolactones which stimulate fungal spore germination and hyphal branching, and promote the initiation of symbiosis. At later stages, different plant hormone classes can act as positive or negative regulators of the interaction. Although the fungus is known to reciprocally emit regulatory signals, its potential contribution to the phytohormonal pool has received little attention, and has so far only been addressed by indirect assays. In this study, using mass spectrometry, we analyzed phytohormones released into the medium by germinated spores of the arbuscular mycorrhizal fungusRhizophagus irregularis. We detected the presence of a cytokinin (isopentenyl adenosine) and an auxin (indole-acetic acid). In addition, we identified a gibberellin (gibberellin A(4)) in spore extracts. We also used gas chromatography to show thatR.irregularisproduces ethylene from methionine and the alpha-keto gamma-methylthio butyric acid pathway. These results highlight the possibility for AM fungi to use phytohormones to interact with their host plants, or to regulate their own development.	[Pons, Simon; Fournier, Sylvie; Becard, Guillaume; Rochange, Soizic; Frei Dit Frey, Nicolas; Puech Pages, Virginie] Univ Toulouse, CNRS, Lab Rech Sci Vegetales, UPS, Castanet Tolosan, France; [Pons, Simon; Fournier, Sylvie; Puech Pages, Virginie] Univ Toulouse, CNRS, Lab Rech Sci Vegetales, MetaboHub Metatoul AgromiX,UPS, Castanet Tolosan, France; [Chervin, Christian] Univ Toulouse, Genom & Biotechnol Fruits, Toulouse INP, INRA, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE	Frey, NFD; Pages, VP (corresponding author), Univ Toulouse, CNRS, Lab Rech Sci Vegetales, UPS, Castanet Tolosan, France.; Pages, VP (corresponding author), Univ Toulouse, CNRS, Lab Rech Sci Vegetales, MetaboHub Metatoul AgromiX,UPS, Castanet Tolosan, France.	puech@lrsv.ups-tlse.fr; frei-dit-frey@lrsv.ups-tlse.fr		CHERVIN, Christian/0000-0002-0913-6815; Pons, Simon/0000-0001-5850-1279; PUECH PAGES, virginie/0000-0003-4113-7970	ANR Mycormones [ANR-18-CE20-0001]; MetaboHUB network [ANR-11-INBS-0010]; Tulip LabEx [10-LABX-0041]; French ministry of Higher Education, Research and Innovation	ANR Mycormones(French National Research Agency (ANR)); MetaboHUB network; Tulip LabEx; French ministry of Higher Education, Research and Innovation	This work was partially financed by the ANR Mycormones (ANR-18-CE20-0001), MetaboHUB network (ANR-11-INBS-0010), the Tulip LabEx (10-LABX-0041), and the French ministry of Higher Education, Research and Innovation.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Martin-Rodriguez JA, 2011, NEW PHYTOL, V190, P193, DOI 10.1111/j.1469-8137.2010.03610.x; [Anonymous], 2015, BONE JOINT J B SA, V97-B, P1; BAREA JM, 1982, APPL ENVIRON MICROB, V43, P810, DOI 10.1128/AEM.43.4.810-813.1982; Barker SJ, 2000, J PLANT GROWTH REGUL, V19, P144; Becard G, 2004, CAN J BOT, V82, P1186, DOI [10.1139/b04-087, 10.1139/B04-087]; Besserer A, 2008, PLANT PHYSIOL, V148, P402, DOI 10.1104/pp.108.121400; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; BILLINGTON DC, 1979, BIOCHEM J, V182, P827, DOI 10.1042/bj1820827; Bitterlich M, 2014, PLANT J, V78, P877, DOI 10.1111/tpj.12515; Boivin S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01240; Booker MA, 2015, PLANT PHYSIOL, V169, P42, DOI 10.1104/pp.15.00672; Brundrett MC, 2018, NEW PHYTOL, V220, P1108, DOI 10.1111/nph.14976; Buendia L, 2019, NEW PHYTOL, V221, P2190, DOI 10.1111/nph.15551; Chabaud M, 2011, NEW PHYTOL, V189, P347, DOI 10.1111/j.1469-8137.2010.03464.x; Chague V, 2002, FEMS MICROBIOL ECOL, V40, P143, DOI [10.1016/S0168-6496(02)00222-2, 10.1111/j.1574-6941.2002.tb00946.x]; Chanclud E, 2016, MOL PLANT PATHOL, V17, P1289, DOI 10.1111/mpp.12393; Chen Y, 2020, PLANT SCI, V291, DOI 10.1016/j.plantsci.2019.110368; Choi J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16021-1; Choi J, 2018, ANNU REV PHYTOPATHOL, V56, P135, DOI 10.1146/annurev-phyto-080516-035521; CHOU TW, 1973, ARCH BIOCHEM BIOPHYS, V157, P73, DOI 10.1016/0003-9861(73)90391-3; de Mendiburu F., 2020, AGRICOLAE TUTORIAL V; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; ESCH H, 1994, PLANT SCI, V99, P9, DOI 10.1016/0168-9452(94)90115-5; Etemadi M, 2014, PLANT PHYSIOL, V166, P281, DOI 10.1104/pp.114.246595; Fang NB, 2015, EXP BIOL MED, V240, P488, DOI 10.1177/1535370214554545; Ferguson BJ, 2014, J CHEM ECOL, V40, P770, DOI 10.1007/s10886-014-0472-7; Foo E, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23656; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Fracetto GGM, 2013, SYMBIOSIS, V60, P155, DOI 10.1007/s13199-013-0251-1; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; GAY G, 1994, NEW PHYTOL, V128, P645, DOI 10.1111/j.1469-8137.1994.tb04029.x; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Giovannetti M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00480; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; GRAHAM JH, 1980, CAN J MICROBIOL, V26, P1340, DOI 10.1139/m80-222; Gutjahr C, 2015, SCIENCE, V350, P1521, DOI 10.1126/science.aac9715; Gutjahr C, 2014, CURR OPIN PLANT BIOL, V20, P26, DOI 10.1016/j.pbi.2014.04.003; Herivaux A, 2017, MBIO, V8, DOI 10.1128/mBio.01739-16; HOTTIGER T, 1991, ARCH MICROBIOL, V157, P18; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; Ishii T, 1996, J JPN SOC HORTIC SCI, V65, P525, DOI 10.2503/jjshs.65.525; JACOBSEN JV, 1970, PLANT PHYSIOL, V45, P631, DOI 10.1104/pp.45.5.631; Jentschel K, 2007, PHYSIOL PLANTARUM, V129, P320, DOI 10.1111/j.1399-3054.2006.00812.x; Karavolos MH, 2013, MOL MICROBIOL, V87, P455, DOI 10.1111/mmi.12110; Keymer A, 2018, CURR OPIN PLANT BIOL, V44, P137, DOI 10.1016/j.pbi.2018.04.005; Khatabi B, 2012, PLANT SIGNAL BEHAV, V7, P1634, DOI 10.4161/psb.22471; Kirwa HK, 2018, J AGR FOOD CHEM, V66, P11291, DOI 10.1021/acs.jafc.8b05101; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kong CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06429-1; Landgraf R, 2012, PLANT CELL ENVIRON, V35, P1344, DOI 10.1111/j.1365-3040.2012.02495.x; Lanfranco L, 2018, NEW PHYTOL, V220, P1031, DOI 10.1111/nph.15230; Le Marquer M, 2019, NEW PHYTOL, V222, P1030, DOI 10.1111/nph.15643; Liao DH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103146; Liu XD, 2019, MYCORRHIZA, V29, P581, DOI 10.1007/s00572-019-00916-z; Ludwig-Muller J, 2002, J PLANT PHYSIOL, V159, P517, DOI 10.1078/0176-1617-00731; LudwigMuller J, 1997, PLANT SCI, V125, P153, DOI 10.1016/S0168-9452(97)00064-2; MacLean AM, 2017, PLANT CELL, V29, P2319, DOI 10.1105/tpc.17.00555; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Makarov A, 2010, J CHROMATOGR A, V1217, P3938, DOI 10.1016/j.chroma.2010.02.022; Medina MJH, 2003, PLANT SCI, V164, P993, DOI 10.1016/S0168-9452(03)00083-9; Meixner C, 2005, PLANTA, V222, P709, DOI 10.1007/s00425-005-0003-4; Mohammadi K., 2011, J APPL ENV BIOL SCI, V1, P310; Morrison EN, 2015, MYCOLOGIA, V107, P245, DOI 10.3852/14-157; Mukherjee A, 2011, MOL PLANT MICROBE IN, V24, P260, DOI 10.1094/MPMI-06-10-0146; Nadal M, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.73; Nagahashi G, 2011, FUNGAL BIOL-UK, V115, P351, DOI 10.1016/j.funbio.2011.01.006; Nagata M, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1187356; OGAWA T, 1990, J FERMENT BIOENG, V69, P287, DOI 10.1016/0922-338X(90)90107-8; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; PRIMROSE SB, 1977, J GEN MICROBIOL, V98, P519, DOI 10.1099/00221287-98-2-519; R Core Team, 2020, R LANG ENV STAT COMP, DOI 11/44679/index.htm; Raudaskoski M, 2015, MYCORRHIZA, V25, P243, DOI 10.1007/s00572-014-0607-2; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Simura J, 2018, PLANT PHYSIOL, V177, P476, DOI 10.1104/pp.18.00293; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Spaepen S, 2014, NEW PHYTOL, V201, P850, DOI 10.1111/nph.12590; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Sugiura Y, 2020, P NATL ACAD SCI USA, V117, P25779, DOI 10.1073/pnas.2006948117; de Los Santos RT, 2011, PLANT SIGNAL BEHAV, V6, P755, DOI 10.4161/psb.6.5.15415; Urbanova T, 2013, TALANTA, V112, P85, DOI 10.1016/j.talanta.2013.03.068; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; Vidova V, 2017, ANAL CHIM ACTA, V964, P7, DOI 10.1016/j.aca.2017.01.059; Vives-Peris V, 2017, PLANT CELL REP, V36, P1971, DOI 10.1007/s00299-017-2214-0; Volpe V, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115505; Wang FF, 2017, CELL REP, V21, P2940, DOI 10.1016/j.celrep.2017.11.017; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wulff EG, 2010, ENVIRON MICROBIOL, V12, P649, DOI 10.1111/j.1462-2920.2009.02105.x; YANG SF, 1967, ARCH BIOCHEM BIOPHYS, V122, P481, DOI 10.1016/0003-9861(67)90222-6; YANG SF, 1967, J BIOL CHEM, V242, P5274; Zsogon A, 2008, SCI AGR, V65, P259, DOI 10.1590/S0103-90162008000300006	92	31	32	9	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240886	10.1371/journal.pone.0240886	http://dx.doi.org/10.1371/journal.pone.0240886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IA	33064769	Green Submitted, gold, Green Published			2022-12-26	WOS:000585918300023
J	Abdella, S; Berheto, TM; Tolera, G; Belete, W; Deressa, T; Feleke, A; Hsilassie, A; Gezahegn, N; Tadesse, D; Tefera, M; Dillnessa, E; Kinfu, A; Abate, E; Kifle, T				Abdella, Saro; Moshago Berheto, Tezera; Tolera, Getachew; Belete, Wudinesh; Deressa, Tekalign; Feleke, Altaye; Hsilassie, Abebe; Gezahegn, Nigussie; Tadesse, Demewoz; Tefera, Mengistu; Dillnessa, Enatenesh; Kinfu, Abiy; Abate, Ebba; Kifle, Tsigereda			Sero-prevalence of transfusion transmittable infections: HIV, Hepatitis B, C and Treponema pallidum and associated factors among blood donors in Ethiopia: A retrospective study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEROPREVALENCE; SYPHILIS; BANK; DAR	Background Blood transfusion is a therapeutic procedure that has proven to be effective in saving millions of lives. However, its safety is still a crucial issue that needs due attention. Unsafe blood transfusion is one of the sources of transmission for infectious agents. Therefore, the objective of this study was to assess the sero-prevalence of Transfusion Transmittable Infections (TTIs) such as Human immunodeficiency virus (HIV), Hepatitis B Virus (HBV), Hepatitis C virus (HCV), Treponema pallidum, and associated factors among blood donors in Ethiopia. Methods A retrospective cross-sectional study design was used to measure the prevalence of transfusion transmittable infections using data collected from 2014 to 2019 in fourteen blood bank facilities in Ethiopia. Screening of HIV, HBV and HCV was done by using the Enzyme-Linked Immunosorbent Assay (ELISA). Presence of Treponema pallidum infection was assessed using rapid plasma reagin (RPR). Records of blood donors were collected using a checklist from Central Blood Bank Laboratory (BBL) electronic database and reviewed. Data was entered, cleaned and analyzed using SPSS version 23. Logistic regression was fitted to identify factors associated with cumulative TTIs positivity, and for each of the transfusion transmittable infection. P value < 0.05 was considered statistically significant. Result A total of 554,954 blood donors in the fourteen blood bank facilities from 2014-2019 was included in the study. The overall sero-prevalence of HBV, Treponema pallidum, HIV and HCV, was 2.4%, 0.9%, 0.4% and 0.4% respectively. The prevalence of TTIs was comparatively higher in 2014, 5.70% and lowest in 2019, 3.40%. The odds of screening HBV in blood donors in age group of 35-39 and 40-44 were 1.2 [1.1, 1.3] and 1.3 [1.1, 1.5] respectively. The odds of screening HCV in blood donors in the age group of 25-34, 35-44 and 45-54 were 1.3 [1.1, 1.5], 1.3 [1.1, 1.7] and 1.7 [1.2, 2.2] respectively. The likelihood of having at least one infection among blood donors was 1.2 [1.1, 1.3] times in male blood donors compared to female. The odds of getting at least one TTI and Treponema pallidum in unemployed blood donors were 2.4 [2.0, 2.8] and 8.1 [6.1, 10.7] respectively. The probability of getting those who have at least one TTIs, HBV and Treponema pallidum were higher in blood donors those who live in Semi Urban and Rural parts of the country than those who live in Urban areas. The odds of having at least one TTI, HBV and HCV in blood donors with mobile mode of blood donation were 1.4 [1.3, 1.6], 1.6 [1.4, 1.8], and 1.6 [1.1, 2.2]. Conclusion The current magnitudes of TTIs are lower when compared to other previous studies conducted in Ethiopia. Older age, male, occupation, donations from mobile sites, residents of semi urban and rural settings were found to be strongly associated with sero-positivity of TTIs. Hence, strict donor screening and testing particularly taking the above factors into consideration is strongly recommended.	[Abdella, Saro; Moshago Berheto, Tezera; Tolera, Getachew; Belete, Wudinesh; Deressa, Tekalign; Feleke, Altaye; Hsilassie, Abebe; Gezahegn, Nigussie; Dillnessa, Enatenesh; Abate, Ebba; Kifle, Tsigereda] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Tadesse, Demewoz; Tefera, Mengistu; Kinfu, Abiy] Ethiopian Natl Blood Bank Serv, Addis Ababa, Ethiopia		Dillnessa, E (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	enattt@gmail.com						Abate M, 2016, ETHIOP J HEALTH SCI, V26, P155, DOI 10.4314/ejhs.v26i2.9; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2011, J NATL COMPR CANC NE, V9; [Anonymous], 2016, EVIDENCE, V8, pe1000; Apata I, 2014, AM J KIDNEY DIS, V63, pA26; Assefa A, 2013, INT J MED RES HEALTH, V2, P624, DOI 10.5958/j.2319-5886.2.3.110; Biadgo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180416; Birhaneselassie M, 2016, LAB MED, V47, P134, DOI 10.1093/labmed/lmw003; Bonja F, 2017, INT J BLOOD TRANSFUS, V7, P7, DOI DOI 10.5348/IJBTI-2017-29-OA-2; Eboumbou Moukoko Carole Else, 2014, BMC Hematol, V14, P5, DOI 10.1186/2052-1839-14-5; Gebregziabher H, PREDICTING SEROPREVA, P12; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Matee MIN, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-21; Mohammed Yusuf, 2016, BMC Res Notes, V9, P129, DOI 10.1186/s13104-016-1925-6; Morar MM, 2016, TRANSFUSION, V56, P3121, DOI 10.1111/trf.13816; Mulugeta H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4012-5; Nagalo MB, 2011, BLOOD TRANSFUS-ITALY, V9, P419, DOI 10.2450/2011.0112-10; Okoroiwu HU, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5555-x; Ozaras R, 2019, VIRAL HEPATITIS CHRO, DOI DOI 10.1007/978-3-030-03757-4; Patterson J, 2017, ENVIRON INNOV SOC TR, V24, P1, DOI 10.1016/j.eist.2016.09.001; Sadiq MA, FREQUENCY HEPATITIS, V28, P4; Saghir SAM, 2012, TROP J PHARM RES, V11, P132, DOI 10.4314/tjpr.v11i1.17; Shiferaw E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214755; Siraj N, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3174-x; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Teklemariam Zelalem, 2018, BMC Hematol, V18, P24, DOI 10.1186/s12878-018-0115-2; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Tigabu A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3950-2; Wairimu KM, PREVALENCE TRANSFUSI, P11; Walana W., 2014, British Microbiology Research Journal, V4, P1491, DOI 10.9734/BMRJ/2014/12160; Weimer A, 2019, TRANSFUSION, V59, P412, DOI 10.1111/trf.14949; World Health Organization, 2017, GLOB STAT REP BLOOD	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241086	10.1371/journal.pone.0241086	http://dx.doi.org/10.1371/journal.pone.0241086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119668	Green Published, gold			2022-12-26	WOS:000600013600001
J	Alao, MA; Maroushek, SR; Chan, YH; Asinobi, AO; Slusher, TM; Gbadero, DA				Alao, Michael A.; Maroushek, Stacene R.; Chan, Yiong Huak; Asinobi, Adanze O.; Slusher, Tina M.; Gbadero, Daniel A.			Treatment outcomes of Nigerian patients with tuberculosis: A retrospective 25-year review in a regional medical center	PLOS ONE			English	Review								Introduction Tuberculosis (TB) remains a global health challenge and leading infectious killer worldwide. The need for continuous evaluation of TB treatment outcomes becomes more imperative in the midst of a global economic meltdown substantially impacting resource-limited-settings. Methods This study retrospectively reviewed 25-years of treatment outcomes in 3,384 patients who were managed for TB at a tertiary hospital in Nigeria. Confirmed TB cases were given directly observed therapy of a short-course treatment regimen and monitored for clinical response. Results Out of 1,146,560 patients screened, there were 24,330 (2.1%) presumptive and 3,384 (13.9%) confirmed TB cases. The patients' mean age was 35.8 years (0.33-101 years). There were 1,902 (56.2%) male, 332(9.8%) pediatric, and 2,878 (85%) pulmonary TB cases. The annual mean measured treatment outcomes were as follows: adherence, 91.4(+/- 5.8) %; successful outcome, 75.3(+/- 8.8) % potentially unsatisfactory outcome, 14.8(+/- 7.2) %; and mortality 10.0(+/- 3.6) %. Female, extra-pulmonary TB (EPTB), newly diagnosed, and relapsed patients compliant with treatment had successful outcomes. Adulthood and HIV infection were mortality risk factors. Conclusion The mean annual successful treatment outcome is 75.3(+/- 8.8) %. Female, pediatric, EPTB, new, and relapsed patients were predisposed to successful treatment outcomes. Lessons learned will guide future program modifications.	[Alao, Michael A.; Slusher, Tina M.; Gbadero, Daniel A.] Bowen Univ, Dept Paediat, Teaching Hosp, Ogbomosho, Oyo State, Nigeria; [Alao, Michael A.; Slusher, Tina M.; Gbadero, Daniel A.] Bowen Univ, Coll Med, Iwo, Osun State, Nigeria; [Maroushek, Stacene R.; Slusher, Tina M.] Hennepin Healthcare, Minneapolis, MN USA; [Maroushek, Stacene R.; Slusher, Tina M.] Univ Minnesota, Minneapolis, MN USA; [Chan, Yiong Huak] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Asinobi, Adanze O.] Univ Coll Ibadan Hosp, Ibadan, Oyo State, Nigeria	University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore	Alao, MA; Slusher, TM (corresponding author), Bowen Univ, Dept Paediat, Teaching Hosp, Ogbomosho, Oyo State, Nigeria.; Alao, MA; Slusher, TM (corresponding author), Bowen Univ, Coll Med, Iwo, Osun State, Nigeria.; Slusher, TM (corresponding author), Hennepin Healthcare, Minneapolis, MN USA.; Slusher, TM (corresponding author), Univ Minnesota, Minneapolis, MN USA.	mikevikefountains@gmail.com; tslusher@umn.edu						[Anonymous], 2010, NAT TUB LEPR CONTR P; [Anonymous], 2012, DRUG DISCOV TODAY TE; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2007, WAR HIST, VXIV, P26; [Anonymous], 2011, QUALITY EXPLORATION, V11, P6; Daniel O J, 2006, Niger J Med, V15, P222; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Erhabor GE, 2003, J HLTH SCI, V3, P34; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Ibadin MO, 2001, ANN TROP PAEDIATR, V21, P141, DOI 10.1080/02724930120058205; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Koenig HG, 2004, J AM GERIATR SOC, V52, P554, DOI 10.1111/j.1532-5415.2004.52161.x; Kyu HH, 2018, LANCET INFECT DIS, V18, P1329, DOI 10.1016/S1473-3099(18)30625-X; Lienhardt C, 1998, INT J TUBERC LUNG D, V2, P712; Lorenz K A, 2005, J Palliat Med, V8, P774, DOI 10.1089/jpm.2005.8.774; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; The PLOS Medicine Editors, 2007, PLOS MED, V4, pe147, DOI 10.1371/journal.pmed.0040147; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, 2019, GLOB TUB REP; *WHO, 2005, GLOB TUB CONTR SURV; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0239225	10.1371/journal.pone.0239225	http://dx.doi.org/10.1371/journal.pone.0239225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119601	Green Published, gold			2022-12-26	WOS:000600013600116
J	Awuah, SP; Okai, I; Ntim, EA; Bedu-Addo, K				Awuah, Stephen Poku; Okai, Isaac; Ntim, Emmanuel Amankwah; Bedu-Addo, Kweku			Prevalence, placenta development, and perinatal outcomes of women with hypertensive disorders of pregnancy at Komfo Anokye Teaching Hospital	PLOS ONE			English	Article							BLOOD-PRESSURE; BIRTH-WEIGHT; GROWTH RESTRICTION; PREECLAMPSIA; RISK; FETAL; HISTORY	Background One of the most common medical problems associated with pregnancy is hypertension. Hypertensive disorders of pregnancy (HDP), which has been attributable to abnormal placentation may have adverse effects on both mother and foetus if left unchecked. The objective of this study was to determine the prevalence of this condition and its effect on placental morphology as well as maternal and perinatal outcomes. Materials and methods This was a prospective case-control study, conducted at Komfo Anokye Teaching Hospital (KATH), Ghana between February 2018 and July 2018. The progression of pregnancy in normotensive and hypertensive pregnant women, and the eventual perinatal outcomes were closely followed. Statistical analysis was performed using IMB-SPSS version 23. Associations were considered significant at p values of <= 0.05. Results From a total of 214 deliveries recorded during the period of study, 84 (39.25%) were hypertensives. Forty four (52%) of the hypertensives had preeclampsia, 28 (33.3%) had gestational hypertension, 6 (7.1%) had eclampsia, 4 (4.8%) had chronic hypertension, and 2 (2.4%) had preeclampsia superimposed on chronic hypertension. The frequency of placental haematoma, placental infarction, and placental calcification in the normotensives were significantly (p = 0.001) lower than that of the hypertensives. The mean placental weight (p = 0.01), placental volume (p = 0.001), placental diameter (p = 0.03), and placental thickness (p = 0.001) of the normotensives were significantly higher than those of the hypertensives. The number of normotensives in whom labour was induced, who had their babies delivered by caesarean section, and who were admitted after they had given birth were significantly (p = 0.001) lower than that of hypertensives who underwent similar procedures. No stillbirths were recorded in the normotensives compared with four in the hypertensives. The number of babies delivered to the normotensives who were admitted to the NICU was significantly (p = 0.001) lower than those delivered by hypertensives. Conclusion There was a high prevalence of hypertensive disorders of pregnancy in the study site. Pregnant women who developed HDP are at a risk of developing placental abnormalities that adversely affected perinatal outcomes. These adverse effects can be curtailed by embarking on a vigorous health education drive.	[Awuah, Stephen Poku; Ntim, Emmanuel Amankwah; Bedu-Addo, Kweku] KNUST, Sch Med & Dent, Dept Physiol, Kumasi, Ghana; [Okai, Isaac] KNUST, Sch Med & Dent, Dept Anat, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Bedu-Addo, K (corresponding author), KNUST, Sch Med & Dent, Dept Physiol, Kumasi, Ghana.	kwekuba@yahoo.com		bedu-addo, kweku/0000-0001-5479-0691				Abaidoo C, 2008, J SCI TECHNOL, V28, P1; Abdul H.B., 2012, JLUMHS, V11; Abhilasha D., 2012, INT J BIOL MED RES, V3, P1771; Adu-Bonsaffoh K, 2013, INT J GYNECOL OBSTET, V123, P110, DOI 10.1016/j.ijgo.2013.05.017; AHERNE W, 1966, J PATHOL BACTERIOL, V91, P123, DOI 10.1002/path.1700910117; Ahmed M, 2013, INT J REPROD CONTRAC, V2, P524; Al-Ghamdi SMG, 1999, ANN SAUDI MED, V19, P557, DOI 10.5144/0256-4947.1999.557; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; Amiel-Tison C, 2002, DEV MED CHILD NEUROL, V44, P643; [Anonymous], 2014, CLIN ADV HEMATOL ONC, V12, P3; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; [Anonymous], 2014, DABIQ, V3, P24; [Anonymous], 2000, ELECT COMMERCE  1211, V48, P1; Anorlu RI, 2005, AUST NZ J OBSTET GYN, V45, P278, DOI 10.1111/j.1479-828X.2005.00411.x; Arulkumaran S, 2016, FOREWORD FIGO TXB PR; Ashfaq Muhammad, 2005, J Ayub Med Coll Abbottabad, V17, P44; Baergen RN, 2011, PATHOLOGY UMBILICAL; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BOYD PA, 1985, BRIT J OBSTET GYNAEC, V92, P714, DOI 10.1111/j.1471-0528.1985.tb01454.x; Budiyono WIN, 2009, INT J ENG TECHNOL, V1, P109; Cincotta RB, 1998, INT J GYNECOL OBSTET, V60, P23, DOI 10.1016/S0020-7292(97)00241-5; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; CRAMER JC, 1995, DEMOGRAPHY, V32, P231, DOI 10.2307/2061742; Cunningham FG, 2005, WILLIAMS OBSTET; Das B, 1996, J OBSTET GYNAECOL IN, V46, P40; Dworkin Samuel F, 2011, J Evid Based Dent Pract, V11, P143, DOI 10.1016/j.jebdp.2011.06.002; Eskild A, 2010, BJOG-INT J OBSTET GY, V117, P1521, DOI 10.1111/j.1471-0528.2010.02701.x; Ezeigwe CO, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9462938; FEDRICK J, 1978, BRIT J OBSTET GYNAEC, V85, P1, DOI 10.1111/j.1471-0528.1978.tb15816.x; Ferrazzani S, 2011, EARLY HUM DEV, V87, P445, DOI 10.1016/j.earlhumdev.2011.03.005; Gaio DS, 2001, HYPERTENS PREGNANCY, V20, P269, DOI 10.1081/PRG-100107829; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gilbert-Barness E, 1993, Birth Defects Orig Artic Ser, V29, P113; Grindheim G, 2012, J HYPERTENS, V30, P342, DOI 10.1097/HJH.0b013e32834f0b1c; Harsh M, 1989, J OBSTET GYN INDIA, V39, P170; Kajantie E, 2010, INT J DEV BIOL, V54, P469, DOI 10.1387/ijdb.082833ek; Kurdukar M D, 2007, Indian J Pathol Microbiol, V50, P493; LAURINI R, 1994, ACTA OBSTET GYN SCAN, V73, P529, DOI 10.3109/00016349409006268; Little RE, 2003, EARLY HUM DEV, V71, P117, DOI 10.1016/S0378-3782(02)00118-4; MACPHERSON T, 1991, ARCH PATHOL LAB MED, V115, P672; Majumdar S., 2005, J ANAT SOC INDIA, V54, P1; MARTIKAINEN AM, 1989, INT J GYNECOL OBSTET, V30, P213, DOI 10.1016/0020-7292(89)90404-9; Masodkar A.R., 1985, J OBST GYNAECOL INDI, V35, P294; Nama V, 2011, J HYPERTENS, V29, P763, DOI 10.1097/HJH.0b013e328342cb02; Nathan HL, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020401; Navbir P., 2014, INT J BASIC APPL MED, V2, P120; Nelson Scott M, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P541, DOI 10.1586/14737167.6.5.541; NESS RB, 1994, EPIDEMIOL REV, V16, P298, DOI 10.1093/oxfordjournals.epirev.a036155; Okoye Helen Chioma, 2017, J Neonatal Perinatal Med, V10, P387, DOI 10.3233/NPM-16151; Pradeep S., 2011, INT J PHARM BIOSCIEN, V2, P975; Salgado SS, 2008, JCPSP-J COLL PHYSICI, V18, P213, DOI 04.2008/JCPSP.213216; Sankar KD, 2012, ANAT CELL BIOL, V45, P86, DOI 10.5115/acb.2012.45.2.86; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; Seffah JD, 2017, J GYNECOL NEONATAL B, V3, P8; Sibai B.M., 1990, CURR PROB OBST GYN F, V77, P514; Silva LM, 2008, HYPERTENSION, V52, P645, DOI 10.1161/HYPERTENSIONAHA.108.116632; Singh Swati, 2014, Niger Med J, V55, P384, DOI 10.4103/0300-1652.140377; Siromani S.M., 2015, IOSR J DENT MED SCI, V14, P23; Syahrowardi A., 2016, J PENELIT PENGEMB PE, V2, P89; Tangirala S, 2015, IAIM, V2, P35; TEASDALE F, 1987, PLACENTA, V8, P119, DOI 10.1016/0143-4004(87)90015-4; Thompson ML, 2009, PAEDIATR PERINAT EP, V23, P254, DOI 10.1111/j.1365-3016.2009.01027.x; Tran HA, 2005, AUST PRESCR, V28, P98, DOI 10.18773/austprescr.2005.076; Udainia A, 2001, JASI, V50, P24; Udainia A, 2004, J ANAT SOC INDIA, V53, P27; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Vats K, 2016, INT J REPROD CONTRAC, V5, P3773, DOI DOI 10.18203/2320-1770.IJRCOG20163494; Vinay Kumar, 2013, ANATOMICA KARNATAKA, V7, P18; Vrabie S. C., 2018, CONGENIT ANOM, P345; Walle TA, 2019, PREGNANCY HYPERTENS, V16, P79, DOI 10.1016/j.preghy.2019.03.007; Ward J.A., 2013, FAM MED MED SCI RES, V2, P108, DOI [10.4172/2327-4972.1000108, DOI 10.4172/2327-4972.1000108]; WOLFE HM, 1991, AM J OBSTET GYNECOL, V164, P1306, DOI 10.1016/0002-9378(91)90705-V; Yadav S, 1997, J Indian Med Assoc, V95, P548; Zia-Ur-Rehman M, 2013, PAK J MED HEALTH SCI, V7, P207	75	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0233817	10.1371/journal.pone.0233817	http://dx.doi.org/10.1371/journal.pone.0233817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119603	Green Published, Green Submitted, gold			2022-12-26	WOS:000600013600074
J	Thomas, V; Van Rooij, P; Meerpoel, C; Stegen, G; Wauters, J; Vanhaecke, L; Martel, A; Pasmans, F				Thomas, Valarie; Van Rooij, Pascale; Meerpoel, Celine; Stegen, Gwij; Wauters, Jella; Vanhaecke, Lynn; Martel, An; Pasmans, Frank			Instant killing of pathogenic chytrid fungi by disposable nitrile gloves prevents disease transmission between amphibians	PLOS ONE			English	Article							REAL-TIME PCR; BATRACHOCHYTRIUM-DENDROBATIDIS; CALCIUM LACTATE; SP-NOV; SALAMANDRIVORANS; CHYTRIDIOMYCOSIS; NITRATE; LATEX; MORTALITY; EXPOSURE	To prevent transmission of the pathogenic chytrid fungi Batrachochytrium dendrobatidis (Bd) and Batrachochytrium salamandrivorans (Bsal), hygiene protocols prescribe the single use of disposable gloves for handling amphibians. We discovered that rinse water from nitrile gloves instantly kills 99% of Bd and Bsal zoospores. Transmission experiments using midwife toads (Alytes obstetricans) and Bd, and Alpine newts (Ichthyosaura alpestris) and Bsal, show that the use of the same pair of gloves for 2 subsequent individuals does not result in significant transmission of any chytrid fungus. In contrast, handling infected amphibians bare-handed caused transmission of Bsal in 4 out of 10 replicates, but did not result in transmission of Bd. Based on the manufacturer's information, high resolution mass spectrometry (HRMS) and colorimetric tests, calcium lactate and calcium nitrate were identified as compounds with antifungal activity against both Bd and Bsal. These findings corroborate the importance of wearing gloves as an important sanitary measure in amphibian disease prevention. If the highly recommended single use of gloves is not possible, handling multiple post-metamorphic amphibians with the same pair of nitrile gloves should still be preferred above bare-handed manipulation.	[Thomas, Valarie; Van Rooij, Pascale; Meerpoel, Celine; Stegen, Gwij; Martel, An; Pasmans, Frank] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Wildlife Hlth Ghent, Merelbeke, Belgium; [Wauters, Jella; Vanhaecke, Lynn] Univ Ghent, Fac Vet Med, Chem Anal Lab, Merelbeke, Belgium	Ghent University; Ghent University	Pasmans, F (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Wildlife Hlth Ghent, Merelbeke, Belgium.	Frank.Pasmans@ugent.be	Pasmans, Frank/D-3667-2014; Vanhaecke, Lynn/N-1061-2017	Vanhaecke, Lynn/0000-0003-0400-2188; Thomas, Valarie/0000-0002-5136-6104; Wauters, Jella/0000-0002-7046-1764	Ghent University Special Research Fund [BOF13/PDO/130]	Ghent University Special Research Fund(Ghent University)	Financial support of PVR is funded by the Ghent University Special Research Fund (BOF13/PDO/130). URL https://www.ugent.be/en.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo JZ, 2013, ACTA HORTIC, V989, P199; Aguayo E, 2008, POSTHARVEST BIOL TEC, V47, P397, DOI 10.1016/j.postharvbio.2007.08.001; Anderson CD, 2003, EMULSION POLYMERISAT, V14; [Anonymous], NATL LIB MED; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2009, IPSJ T SYSTEM LSI DE, V2, P145; [Anonymous], INT PLANT NUTR I NUT; [Anonymous], 2013, IBM SPSS STAT WIND V; [Anonymous], 2020, CHEMSPIDER; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blooi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11788; Blooi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08037; Blooi M, 2013, J CLIN MICROBIOL, V51, P4173, DOI 10.1128/JCM.02313-13; Blooi M, 2013, FUNGAL BIOL-UK, V117, P156, DOI 10.1016/j.funbio.2013.01.004; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Byrne AQ, 2019, P NATL ACAD SCI USA, V116, P20382, DOI 10.1073/pnas.1908289116; Cashins Scott D., 2008, Herpetological Review, V39, P298; Cunningham AA, 2015, VET REC, V176, P468, DOI 10.1136/vr.h2264; Dafader NC, 1999, POLYM-PLAST TECHNOL, V38, P267, DOI 10.1080/03602559909351576; Dalbeck L, 2018, Z FELDHERPETOL, V25, P1; Farrer RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14742; Fitzpatrick LD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31800-z; Geiger CC, 2013, DIS AQUAT ORGAN, V103, P191, DOI 10.3354/dao02576; Gutleb AC, 2001, ENVIRON TOXICOL PHAR, V10, P119, DOI 10.1016/S1382-6689(01)00091-6; Johansson M, 2001, AQUAT TOXICOL, V54, P1, DOI 10.1016/S0166-445X(00)00182-X; Jones DK, 2016, ENVIRON POLLUT, V22, P159; Karraker NE, 2011, ENVIRON POLLUT, V159, P833, DOI 10.1016/j.envpol.2010.11.019; Kiebooms JAL, 2014, APPL ENVIRON MICROB, V80, P7433, DOI 10.1128/AEM.02370-14; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Martel A, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12707; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Mendez D, 2008, DIS AQUAT ORGAN, V82, P97, DOI 10.3354/dao01975; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; Oromi N, 2009, B ENVIRON CONTAM TOX, V82, P534, DOI 10.1007/s00128-009-9667-y; Ortiz-Santaliestra ME, 2007, ARCH ENVIRON CON TOX, V53, P639, DOI 10.1007/s00244-006-0277-y; Pasmans F, 2010, VLAAMS DIERGEN TIJDS, V79, P460; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Rahman SME, 2013, FOOD CONTROL, V30, P176, DOI 10.1016/j.foodcont.2012.06.041; Sabino-Pinto J, 2015, AMPHIBIA-REPTILIA, V36, P411, DOI 10.1163/15685381-00003008; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Schuytema GS, 1999, ARCH ENVIRON CON TOX, V36, P200, DOI 10.1007/s002449900461; SOBOTKA JM, 1994, J PHARMACOL TOXICOL, V32, P59, DOI 10.1016/1056-8719(94)90019-1; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tollefsen KE, 2015, AQUAT TOXICOL, V169, P58, DOI 10.1016/j.aquatox.2015.10.003; Van Rooij P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186269; Vanhaecke L, 2013, ANAL CHIM ACTA, V767, P118, DOI 10.1016/j.aca.2013.01.009; Wang M, 2015, CHEMOSPHERE, V139, P402, DOI 10.1016/j.chemosphere.2015.07.037; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	52	2	2	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241048	10.1371/journal.pone.0241048	http://dx.doi.org/10.1371/journal.pone.0241048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119670	Green Published, gold			2022-12-26	WOS:000600013600076
J	Crummett, LT				Crummett, Lisa T.			Acidification decreases microbial community diversity in the Salish Sea, a region with naturally high pCO(2)	PLOS ONE			English	Article							OCEAN ACIDIFICATION; SP NOV.; EMENDED DESCRIPTION; INCREASING LEVELS; CARBON; PHYTOPLANKTON; IMPACTS; MICROZOOPLANKTON; RESISTANCE; ROLES	Most literature exploring the biological effects of ocean acidification (OA) has focused on macroscopic organisms and far less is known about how marine microbial communities will respond. Studies of OA and microbial community composition and diversity have examined communities from a limited number of ocean regions where the ambient pH is near or above the global average. At San Juan Island (Salish Sea), a region that experiences naturally low pH (average = 7.8), the picoplankton (cell diameter is 0.2-2 mu m) community was predicted to show no response to experimental acidification in a three-week mesocosm experiment. Filtered seawater mesocosms were maintained via semicontinuous culturing. Three control mesocosms were maintained at pH 8.05 and three acidified mesocosms were maintained at pH 7.60. Total bacteria was quantified daily with a flow cytometer. Microbial communities were sampled every two days via filtration followed by DNA extraction, 16S rRNA amplification, and MiSeq sequencing. There was no significant difference in total bacteria between pH treatments throughout the experiment. Acidification significantly reduced Shannon's diversity over time. During the final week of the experiment, acidification resulted in a significant decrease in Shannon's diversity, Faith's phylogenetic distance, and Pielous's Evenness. ANCOM results revealed four bacterial ASVs (amplicon sequence variants), in families Flavobaceriaceae and Hyphomonadaceae that significantly decreased in relative frequency under acidification and two bacterial ASVs, in families Flavobacteriaceae and Alteromonadaceae, that significantly increased under acidification. This is the first OA study on the microbial community of the Salish Sea, a nutrient rich, low pH region, and the first of its kind to report a decrease in both picoplankton richness and evenness with acidification. These findings demonstrate that marine microbial communities that naturally experience acidic conditions are still sensitive to acidification.	[Crummett, Lisa T.] Soka Univ Amer, Life Sci, Aliso Viejo, CA 92656 USA		Crummett, LT (corresponding author), Soka Univ Amer, Life Sci, Aliso Viejo, CA 92656 USA.	lcrummett@soka.edu		Crummett, Lisa/0000-0002-8102-1924				Abell GCJ, 2005, FEMS MICROBIOL ECOL, V51, P265, DOI 10.1016/j.femsec.2004.09.001; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Alvarez-Fernandez S, 2018, PROG OCEANOGR, V165, P11, DOI 10.1016/j.pocean.2018.04.006; [Anonymous], 2018, LANCET GLOB HEALTH, V6, pE593, DOI 10.1016/S2214-109X(18)30239-0; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2019, CANCER DISCOV, V10, pOF5; Bergen B, 2016, ENVIRON MICROBIOL, V18, P4579, DOI 10.1111/1462-2920.13549; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins S, 2014, EVOL APPL, V7, P140, DOI 10.1111/eva.12120; Currie AR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01599; de Jong IG, 2011, BIOESSAYS, V33, P215, DOI 10.1002/bies.201000127; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edgar R. C., 2016, BIORXIV, DOI DOI 10.1101/074252; Evans TG, 2012, PHILOS T R SOC B, V367, P1733, DOI 10.1098/rstb.2012.0019; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely R. A., 2012, SCI SUMMARY OCEAN AC; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Field CB., 2004, GLOBAL CARBON CYCLE; FUHRMAN J, 1992, ENVIR SCI R, V43, P361; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Illumina, 16S MET SEQ LIB PREP; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kocaoglu Bunyamin, 2013, HIST STUDIES INT J H, V5, P252; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Liu C, 2015, INT J SYST EVOL MICR, V65, P3256, DOI 10.1099/ijsem.0.000402; Liu JW, 2010, AQUAT MICROB ECOL, V61, P291, DOI 10.3354/ame01446; Lowe AT, 2016, LIMNOL OCEANOGR, V61, P2122, DOI 10.1002/lno.10357; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mora C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001682; Murray JW, 2015, LIMNOL OCEANOGR, V60, P957, DOI 10.1002/lno.10062; Pardew J, 2018, ECOL EVOL, V8, P4292, DOI 10.1002/ece3.3971; Park S, 2012, ANTON LEEUW INT J G, V102, P669, DOI 10.1007/s10482-012-9765-4; Park S, 2014, INT J SYST EVOL MICR, V64, P657, DOI 10.1099/ijs.0.058776-0; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; Riebesell U., 2011, GUIDE BEST PRACTICES; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Schulz KG, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00064; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Ward CS, 2017, ISME J, V11, P1412, DOI 10.1038/ismej.2017.4; Yoon JH, 2006, INT J SYST EVOL MICR, V56, P1251, DOI 10.1099/ijs.0.63820-0; Zha SJ, 2017, FISH SHELLFISH IMMUN, V71, P393, DOI 10.1016/j.fsi.2017.10.034; Zhang R, 2013, BIOGEOSCIENCES, V10, P3679, DOI 10.5194/bg-10-3679-2013	61	3	3	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241183	10.1371/journal.pone.0241183	http://dx.doi.org/10.1371/journal.pone.0241183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112901	Green Published, gold			2022-12-26	WOS:000588374000050
J	Burani, C; Barnard, S; Wells, D; Pelosi, A; Valsecchi, P				Burani, Carlotta; Barnard, Shanis; Wells, Deborah; Pelosi, Annalisa; Valsecchi, Paola			Using judgment bias test in pet and shelter dogs (Canis familiaris): Methodological and statistical caveats	PLOS ONE			English	Article							COGNITIVE BIAS; AFFECTIVE STATE; ANIMAL EMOTION; KENNELED DOGS; WELFARE; BEHAVIOR; ENRICHMENT; PHYSIOLOGY; EXHIBIT; DESIGN	It is now widely agreed that a positive affective state is a crucial component of animal well-being. The judgment bias test represents a widespread tool used to assess animals' optimistic/pessimistic attitude and to evaluate their emotional state and welfare. Judgment bias tests have been used several times with dogs (Canis familiaris), in most cases using a spatial test with a bowl placed in ambiguous positions located between a relatively positive trained location (P) which contains a baited bowl and a relatively negative trained location (N) which contains an empty bowl. The latency to approach the bowl in the ambiguous locations is an indicator of the dog's expectation of a positive/negative outcome. However, results from such tests are often inconclusive. For the present study, the judgment bias test performance of 51 shelter dogs and 40 pet dogs was thoroughly analysed. A pattern emerged with shelter dogs behaving in a more pessimistic-like way than pet dogs. However, this difference between the two populations was detected only when analysing the raw latencies to reach the locations and not the more commonly applied adjusted score (i.e. average latency values). Furthermore, several methodological caveats were found. First of all, a non-negligible percentage of dogs did not pass the training phase, possibly due to the experimental paradigm not being fully suited for this species. Second, results showed a high intra-dog variability in response to the trained locations, i.e. the dogs' responses were not consistent throughout the test, suggesting that animals may not have fully learned the association between locations and their outcomes. Third, dogs did not always behave differently towards adjacent locations, raising doubts about the animals' ability to discriminate between locations. Finally, a potential influence of the researcher's presence on dogs' performance emerged from analyses. The implications of these findings and potential solutions are discussed.	[Burani, Carlotta; Pelosi, Annalisa] Univ Parma, Dipartimento Med & Chirurg, Parma, Italy; [Burani, Carlotta; Valsecchi, Paola] Univ Parma, Dipartimento Sci Chim Vita & Sostenibilita Ambien, Parma, Italy; [Barnard, Shanis; Wells, Deborah] Queens Univ Belfast, Anim Behav Ctr, Sch Psychol, Belfast, Antrim, North Ireland; [Barnard, Shanis] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	University of Parma; University of Parma; Queens University Belfast; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Burani, C (corresponding author), Univ Parma, Dipartimento Med & Chirurg, Parma, Italy.; Burani, C (corresponding author), Univ Parma, Dipartimento Sci Chim Vita & Sostenibilita Ambien, Parma, Italy.; Wells, D (corresponding author), Queens Univ Belfast, Anim Behav Ctr, Sch Psychol, Belfast, Antrim, North Ireland.	carlotta.burani@studenti.unipr.it; D.Wells@qub.ac.uk		Burani, Carlotta/0000-0003-0542-8228	University of Parma; BBSRC [BB.J021385/1]	University of Parma; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a doctoral grant to CB from the University of Parma and by a BBSRC grant (BB.J021385/1) to Dr Wells, Queen's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MH, 2012, COGN AFFECT BEHAV NE, V12, P373, DOI 10.3758/s13415-011-0076-4; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; Armstrong M, 2016, REV ECON STUD, V83, P26, DOI 10.1093/restud/rdv036; Barnard S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25224-y; Bateson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132602; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Bethell EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044387; Blanchette I, 2010, COGNITION EMOTION, V24, P561, DOI 10.1080/02699930903132496; Burman O., 2014, SOCIAL DOG BEHAV COG, P347, DOI [10.1016/B978-0-12-407818-5.00012-7, DOI 10.1016/B978-0-12-407818-5.00012-7]; Burman O, 2011, APPL ANIM BEHAV SCI, V132, P160, DOI 10.1016/j.applanim.2011.04.001; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Cockburn A, 2018, APPL ANIM BEHAV SCI, V201, P77, DOI 10.1016/j.applanim.2017.12.008; Coppola CL, 2006, PHYSIOL BEHAV, V87, P537, DOI 10.1016/j.physbeh.2005.12.001; Crump A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8080136; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Dupjan S, 2017, APPL ANIM BEHAV SCI, V187, P23, DOI 10.1016/j.applanim.2016.11.012; Duranton C, 2019, APPL ANIM BEHAV SCI, V211, P61, DOI 10.1016/j.applanim.2018.12.009; Gotlib IH, 1998, BEHAV THER, V29, P603, DOI 10.1016/S0005-7894(98)80020-8; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hall LEMS, 2017, J PHARMACOL TOX MET, V83, P21, DOI 10.1016/j.vascn.2016.09.005; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Harvey ND, 2020, APPL ANIM BEHAV SCI, V230, DOI 10.1016/j.applanim.2020.105025; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; Hintze S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23459-3; Iigaya K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165840; Karagiannis CI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0373-1; Kis A, 2015, HORM BEHAV, V69, P1, DOI 10.1016/j.yhbeh.2014.12.004; Lagisz M, 2020, NEUROSCI BIOBEHAV R, V118, P3, DOI 10.1016/j.neubiorev.2020.07.012; Lefebvre D, 2007, APPL ANIM BEHAV SCI, V104, P49, DOI 10.1016/j.applanim.2006.05.004; Lenkei R, 2018, BEHAV PROCESS, V157, P115, DOI 10.1016/j.beproc.2018.08.002; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; MacLeod AK, 1996, J ABNORM PSYCHOL, V105, P286, DOI 10.1037/0021-843X.105.2.286; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mertens PA, 1996, ANTHROZOOS, V9, P40, DOI 10.2752/089279396787001662; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Muller CA, 2012, ANIM COGN, V15, P1031, DOI 10.1007/s10071-012-0526-6; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Neville V, 2020, NEUROSCI BIOBEHAV R, V108, P269, DOI 10.1016/j.neubiorev.2019.11.008; Paul ES, 2011, EVOL HUM BEHAV, V32, P21, DOI 10.1016/j.evolhumbehav.2010.07.005; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pinheiro J, 2000, MIXED EFFECTS MODELS; Protopopova A, 2016, PHYSIOL BEHAV, V159, P95, DOI 10.1016/j.physbeh.2016.03.020; Raoult CMC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02197; Roelofs S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00119; Schick A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00272; Schoth DE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00171; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Soderstrom NC, 2015, PERSPECT PSYCHOL SCI, V10, P176, DOI 10.1177/1745691615569000; Taylor KD, 2007, ANIM WELFARE, V16, P435; Titulaer M, 2013, APPL ANIM BEHAV SCI, V147, P149, DOI 10.1016/j.applanim.2013.05.001; Valsecchi P., 2007, J VET BEHAV, V94, P88, DOI [10.1016/j.jveb.2007.04.017, DOI 10.1016/J.JVEB.2007.04.017]; Walker JK, 2014, APPL ANIM BEHAV SCI, V158, P46, DOI 10.1016/j.applanim.2014.06.010; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells DL, 2017, J COMP PSYCHOL, V131, P317, DOI 10.1037/com0000080; Wells DL, 2004, APPL ANIM BEHAV SCI, V85, P307, DOI 10.1016/j.applanim.2003.11.005; Willen RM, 2019, APPL ANIM BEHAV SCI, V217, P57, DOI 10.1016/j.applanim.2019.05.001	62	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241344	10.1371/journal.pone.0241344	http://dx.doi.org/10.1371/journal.pone.0241344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108399	Green Published, gold			2022-12-26	WOS:000588372400010
J	Achterhof, AB; Rozsnyai, Z; Reeve, E; Jungo, KT; Floriani, C; Poortvliet, RKE; Rodondi, N; Gussekloo, J; Streit, S				Achterhof, Alexandra B.; Rozsnyai, Zsofia; Reeve, Emily; Jungo, Katharina Tabea; Floriani, Carmen; Poortvliet, Rosalinde K. E.; Rodondi, Nicolas; Gussekloo, Jacobijn; Streit, Sven			Potentially inappropriate medication and attitudes of older adults towards deprescribing	PLOS ONE			English	Article							PEOPLES ATTITUDES; POLYPHARMACY; WILLINGNESS; VALIDATION; MEDICINES; CRITERIA	Introduction Multimorbidity and polypharmacy are current challenges when caring for the older population. Both have led to an increase of potentially inappropriate medication (PIM), illustrating the need to assess patients' attitudes towards deprescribing. We aimed to assess the prevalence of PIM use and whether this was associated with patient factors and willingness to deprescribe. Method We analysed data from the LESS Study, a cross-sectional study on self-reported medication and on barriers and enablers towards the willingness to deprescribe (rPATD questionnaire). The survey was conducted among multimorbid (>= 3 chronic conditions) participants >= 70 years with polypharmacy (>= 5 long-term medications). A subset of the Beers 2019 criteria was applied for the assessment of medication appropriateness. Results Data from 300 patients were analysed. The mean age was 79.1 years (SD 5.7). 53% had at least one PIM (men: 47.8%%, women: 60.4%%; p = 0.007). A higher number of medications was associated with PIM use (p = 0.002). We found high willingness to deprescribe in both participants with and without PIM. Willingness to deprescribe was not associated with PIM use (p = 0.25), nor number of PIMs (p = 0.81). Conclusion The willingness of older adults with polypharmacy towards deprescribing was not associated with PIM use in this study. These results suggest that patients may not be aware if they are taking PIMs. This implies the need for raising patients' awareness about PIMs through education, especially in females, in order to implement deprescribing in daily practice.	[Achterhof, Alexandra B.; Rozsnyai, Zsofia; Jungo, Katharina Tabea; Floriani, Carmen; Rodondi, Nicolas; Streit, Sven] Univ Bern, Inst Primary Hlth Care Bern BIHAM, Bern, Switzerland; [Achterhof, Alexandra B.; Jungo, Katharina Tabea] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland; [Reeve, Emily] Univ South Australia, Qual Use Med & Pharm Res Ctr, UniSA Clin & Hlth Sci, Adelaide, SA, Australia; [Reeve, Emily] Dalhousie Univ, Geriatr Med Res, Halifax, NS, Canada; [Reeve, Emily] Nova Scotia Hlth Author, Halifax, NS, Canada; [Reeve, Emily] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada; [Poortvliet, Rosalinde K. E.; Gussekloo, Jacobijn] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Rodondi, Nicolas] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Gussekloo, Jacobijn] Leiden Univ, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Leiden, Netherlands	University of Bern; University of Bern; University of South Australia; Dalhousie University; Dalhousie University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bern; University Hospital of Bern; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Streit, S (corresponding author), Univ Bern, Inst Primary Hlth Care Bern BIHAM, Bern, Switzerland.	sven.streit@biham.unibe.ch	Reeve, Emily/AFL-3604-2022; Gussekloo, Jacobijn/ABE-3879-2021; Jungo, Katharina Tabea/L-8856-2019	Reeve, Emily/0000-0002-1405-999X; Gussekloo, Jacobijn/0000-0001-7186-8278; Jungo, Katharina Tabea/0000-0002-1782-1345; Rodondi, Nicolas/0000-0001-9083-6896	Swiss Society of General Internal Medicine (SGAIM); NHMRC-ARC Dementia Research Development Fellowship	Swiss Society of General Internal Medicine (SGAIM); NHMRC-ARC Dementia Research Development Fellowship(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia)	This study was funded with a grant (PI Prof. S. Streit) by the Swiss Society of General Internal Medicine (SGAIM). ER is support-ed by a NHMRC-ARC Dementia Research Development Fellowship.	Al-Azayzih A, 2019, PHARM PRACT-GRANADA, V17, DOI 10.18549/PharmPract.2019.2.1439; Alhawassi TM, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1168-1; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2018, CANC DISCOV, V8, pOF6; Aubert CE, 2016, EUR J INTERN MED, V35, P35, DOI 10.1016/j.ejim.2016.05.022; Awad A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218174; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Chinese guidelines on prevention and treatment of dyslipidemia in adults, 2016, CHIN CIRC J, V16, P15, DOI [10.1016/j.atherosclerosis.2016.02.006, DOI 10.1016/J.ATHEROSCLEROSIS.2016.02.006]; Curtin D, 2019, THER ADV DRUG SAF, V10, DOI 10.1177/2042098619829431; Cvetkovic Z, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55070332; Dhalla IA, 2002, J AM GERIATR SOC, V50, P995, DOI 10.1046/j.1532-5415.2002.50252.x; Fajardo MA, 2019, BRIT J CLIN PHARMACO, V85, P1396, DOI 10.1111/bcp.13912; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Frank C, 2014, CAN MED ASSOC J, V186, P1369, DOI 10.1503/cmaj.131873; Galazzi A, 2016, INT J CLIN PHARM-NET, V38, P454, DOI 10.1007/s11096-016-0279-4; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Hafferty JD, 2018, J CLIN EPIDEMIOL, V94, P132, DOI 10.1016/j.jclinepi.2017.10.013; Holzer BM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-780; Jiron M, 2016, J AM GERIATR SOC, V64, P788, DOI 10.1111/jgs.14077; Komagamine J, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0788-1; Kua KP, 2019, INT J CLIN PHARM-NET, V41, P793, DOI 10.1007/s11096-019-00829-z; Liew TM, 2019, ANN FAM MED, V17, P257, DOI 10.1370/afm.2373; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; McCarthy LM, 2019, J AM GERIATR SOC, V67, P1023, DOI 10.1111/jgs.15800; Moen J, 2009, PATIENT EDUC COUNS, V74, P135, DOI 10.1016/j.pec.2008.08.019; Morin L, 2018, CLIN EPIDEMIOL, V10, P289, DOI 10.2147/CLEP.S153458; Morin L, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.06.011; National Institute for Clinical Effectiveness (NICE), 2016, MULT CLIN ASS MAN NI; NICE, 2015, MED OPT SAF EFF US M; Nothelle SK, 2019, INT J PHARM PRACTICE; Nusair MB, 2020, J PHARM HEALTH SERV, V11, P173, DOI 10.1111/jphs.12340; Nyborg G, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0608-z; Nyborg G, 2012, EUR J CLIN PHARMACOL, V68, P1085, DOI 10.1007/s00228-012-1223-8; Organization WH, 2015, SUMM WORLD REP AG HL; Qi K, 2015, INT J CLIN PHARM-NET, V37, P949, DOI 10.1007/s11096-015-0147-7; Reeve E, 2019, J AM GERIATR SOC, V67, P1204, DOI 10.1111/jgs.15804; Reeve E, 2018, JAMA INTERN MED, V178, P1673, DOI 10.1001/jamainternmed.2018.4720; Reeve E, 2017, EUR J INTERN MED, V38, P3, DOI 10.1016/j.ejim.2016.12.021; Reeve E, 2016, DRUG AGING, V33, P913, DOI 10.1007/s40266-016-0410-1; Reeve E, 2015, BRIT J CLIN PHARMACO, V80, P1254, DOI 10.1111/bcp.12732; Reeve E, 2015, EXPERT OPIN DRUG MET, V11, P491, DOI 10.1517/17425255.2015.1004310; Reeve E, 2014, MED J AUSTRALIA, V201, P386, DOI 10.5694/mja13.00200; Reeve E, 2013, J AM GERIATR SOC, V61, P1508, DOI 10.1111/jgs.12418; Rozsnyai Z, LESS STUDY PRIMARY C; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Scott S, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1127-x; Shi S, 2008, EUR J CLIN PHARMACOL, V64, P183, DOI 10.1007/s00228-007-0422-1; Sirois C, 2017, RES SOC ADMIN PHARM, V13, P864, DOI 10.1016/j.sapharm.2016.08.006; Wallace E, 2017, J GERONTOL A-BIOL, V72, P271, DOI 10.1093/gerona/glw140; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Xing XX, 2019, ANN PHARMACOTHER, P1	56	17	17	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240463	10.1371/journal.pone.0240463	http://dx.doi.org/10.1371/journal.pone.0240463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104695	Green Accepted, gold, Green Published			2022-12-26	WOS:000588370000053
J	Marolt, TP; Kramar, B; Rozman, KB; Suput, D; Milisav, I				Marolt, Tinkara Pirc; Kramar, Barbara; Rozman, Klara Bulc; Suput, Dusan; Milisav, Irina			Aripiprazole reduces liver cell division	PLOS ONE			English	Article							MECHANISMS; COCAINE; DISORDERS	Effects of aripiprazole on dopamine regulation are being tested as a treatment for patients with a dual diagnosis of schizophrenia and addictions, often cocaine dependence. Aripiprazole has one of the fewest side-effects among the second-generation antipsychotics. Nevertheless, severe aripiprazole hepatotoxicity was reported in persons with a history of cocaine and alcohol abuse. Here we report that therapeutically relevant aripiprazole concentrations, equal to laboratory alert levels in patients' serum, reduce the rate of hepatocytes' division. This could be an underlying mechanism of severe liver injury development in the patients with a history of alcohol and cocaine abuse, the two hepatotoxic agents that require increased ability of liver self-regeneration. Monitoring liver functions is, therefore, important in the cases when aripiprazole is co-prescribed or used with drugs with potential hepatotoxic effects.	[Marolt, Tinkara Pirc; Kramar, Barbara; Rozman, Klara Bulc; Suput, Dusan; Milisav, Irina] Univ Ljubljana, Fac Med, Inst Pathophysiol, Ljubljana, Slovenia; [Milisav, Irina] Univ Ljubljana, Fac Hlth Sci, Lab Oxidat Stress Res, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Milisav, I (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Ljubljana, Slovenia.; Milisav, I (corresponding author), Univ Ljubljana, Fac Hlth Sci, Lab Oxidat Stress Res, Ljubljana, Slovenia.	irina.milisav@mf.uni.lj.si	Suput, Dusan/AAR-7379-2021	Suput, Dusan/0000-0003-0128-5426; Bulc Rozman, Klara/0000-0003-3302-3738	Slovenian Research Agency [P3-0019]; H2020 Excellent Science [H2020-MSCA-ITN:721236 TREATMENT]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); H2020 Excellent Science	This work was supported by the Slovenian Research Agency in the form of funding awarded to DS, IM, adn KBR (research core funding no. P3-0019) and TPM. This work was also partially supported by H2020 Excellent Science in the form of project funding awarded to BK and IM (H2020-MSCA-ITN:721236 TREATMENT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade RJ, 2019, J HEPATOL, V70, P1222, DOI 10.1016/j.jhep.2019.02.014; [Anonymous], 2008, ED WEEK, V28, P5; [Anonymous], 2014, CANCER DISCOV, V4, pOF5; [Anonymous], 2009, EUROPEAN J ENDOVASCU, V37, pS1; [Anonymous], 2013, STUD AR TREATM METH; [Anonymous], 2017, J DEMOCRACY, V28, P63; [Anonymous], 2005, REV PRESCRIRE, V25, P363; Anton RF, 2017, ALCOHOL CLIN EXP RES, V41, P1370, DOI 10.1111/acer.13417; Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030; Bailly-Maitre B, 2002, CELL DEATH DIFFER, V9, P945, DOI 10.1038/sj.cdd.4401043; BAYLY AC, 1993, J CELL SCI, V104, P307; Beresford T, 2017, J CLIN PSYCHOPHARM, V37, P657, DOI 10.1097/JCP.0000000000000789; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Castanheira L, 2019, CLIN PSYCHOPHARM NEU, V17, P551, DOI 10.9758/cpn.2019.17.4.551; Christensen AP, 2018, BASIC CLIN PHARMACOL, V122, P293, DOI 10.1111/bcpt.12902; Gonzalez-Rodriguez A, 2009, HEPATOLOGY, V50, P216, DOI 10.1002/hep.22915; Gunia S, 2012, J CLIN PATHOL, V65, P715, DOI 10.1136/jclinpath-2011-200532; Haass-Koffler CL, 2018, ALCOHOL ALCOHOLISM, V53, P268, DOI 10.1093/alcalc/agx108; Haney M, 2011, PSYCHOPHARMACOLOGY, V216, P379, DOI 10.1007/s00213-011-2231-6; Hao W, 2013, COMP RISPERIDONE ARI; Jones B, 2013, J QUAL TECHNOL, V45, P121, DOI 10.1080/00224065.2013.11917921; Kubo A, 1999, CLIN CANCER RES, V5, P4279; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Lile JA, 2008, AM J DRUG ALCOHOL AB, V34, P721, DOI 10.1080/00952990802308262; LiverTox, 2012, CLIN RES INF DRUG IN; Lofwall MR, 2014, EXP CLIN PSYCHOPHARM, V22, P238, DOI 10.1037/a0035165; Miller IP, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100434; Monsalve M, 2019, METHODS MOL BIOL, V1890, P61, DOI 10.1007/978-1-4939-8900-3_6; O TM, 2018, OTOLARYNGOL CLIN N A, V51, pxvii; Papeleu Peggy, 2006, Methods Mol Biol, V320, P229; Pardo V, 2015, FOOD CHEM TOXICOL, V80, P298, DOI 10.1016/j.fct.2015.03.029; Park SH, 2013, CURR DRUG SAF, V8, P207, DOI 10.2174/1574886311308030011; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddymasu S, 2006, J PANCREAS, V7, P303; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; SCARINO ML, 1987, EXP CELL RES, V170, P15, DOI 10.1016/0014-4827(87)90113-3; Seven Hilal, 2017, Psychopharmacol Bull, V47, P53; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Tamura RE, 2012, CURR MOL MED, V12, P634; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Vinken M, 2013, CURR MED CHEM, V20, P3011, DOI 10.2174/0929867311320240006; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Winklbaur Bernadette, 2006, Dialogues Clin Neurosci, V8, P37; Xu JJ, 2004, CHEM-BIOL INTERACT, V150, P115, DOI 10.1016/j.cbi.2004.09.011; Zhu XQ, 2018, AUST NZ J PSYCHIAT, V52, P206, DOI 10.1177/0004867417743342	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240754	10.1371/journal.pone.0240754	http://dx.doi.org/10.1371/journal.pone.0240754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104743	gold, Green Published			2022-12-26	WOS:000588370000006
J	Snyder, JM; Zhong, G; Hogarth, C; Huang, WZ; Topping, T; LaFrance, J; Palau, L; Czuba, LC; Griswold, M; Ghiaur, G; Isoherranen, N				Snyder, Jessica M.; Zhong, Guo; Hogarth, Cathryn; Huang, Weize; Topping, Traci; LaFrance, Jeffrey; Palau, Laura; Czuba, Lindsay C.; Griswold, Michael; Ghiaur, Gabriel; Isoherranen, Nina			Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in mice	FASEB JOURNAL			English	Article						cytochrome P450; dermatitis; inflammation; retinoic acid; vitamin A	TRANS-RETINOIC ACID; VITAMIN-A; HUMAN CYTOCHROME-P450; HYDROXYLASES CYP26A1; METABOLISM; CELL; ENZYME; INHIBITION; BIOSYNTHESIS; OSTEOGENESIS	All-trans-retinoic acid (atRA), the active metabolite of vitamin A, is an essential signaling molecule in all chordates. Global knockouts of the atRA clearing enzymes Cyp26a1 or Cyp26b1 are embryonic lethal. In adult rodents, inhibition of Cyp26a1 and Cyp26b1 increases atRA concentrations and signaling. However, postnatal knockout of Cyp26a1 does not cause a severe phenotype. We hypothesized that Cyp26b1 is the main atRA clearing Cyp in postnatal mammals. This hypothesis was tested by generating tamoxifen-inducible knockout mouse models of Cyp26b1 alone or with Cyp26a1. Both mouse models showed dermatitis, blepharitis, and splenomegaly. Histology showed infiltration of inflammatory cells including neutrophils and T lymphocytes into the skin and hyperkeratosis/hyperplasia of the nonglandular stomach. The mice lacking both Cyp26a1 and Cyp26b1 also had a reduced lifespan, failed to gain weight, and showed fat atrophy. There were significant changes in vitamin A homeostasis. Postnatal knockout of Cyp26b1 resulted in increased atRA concentrations in the skin while the postnatal knockout of both Cyp26a1 and Cyp26b1 resulted in increased atRA concentrations in the liver, serum, skin, spleen, and intestines. This study demonstrates the paramount role of Cyp26b1 in regulating retinoid homeostasis in postnatal life.	[Snyder, Jessica M.] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA; [Zhong, Guo; Huang, Weize; LaFrance, Jeffrey; Czuba, Lindsay C.; Isoherranen, Nina] Univ Washington, Sch Pharm, Dept Pharmaceut, Hlth Sci Bldg,Room H-272M,Box 357610, Seattle, WA 98195 USA; [Hogarth, Cathryn; Topping, Traci; Griswold, Michael] Washington State Univ, Sch Mol Biosci, Pullman, WA USA; [Hogarth, Cathryn] La Trobe Univ, Sch Mol Sci, Dept Pharm & Biomed Sci, Wodonga, Vic, Australia; [Palau, Laura; Ghiaur, Gabriel] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; La Trobe University; Johns Hopkins University	Isoherranen, N (corresponding author), Univ Washington, Sch Pharm, Dept Pharmaceut, Hlth Sci Bldg,Room H-272M,Box 357610, Seattle, WA 98195 USA.	ni2@uw.edu		Huang, Weize/0000-0001-5903-721X; Czuba, Lindsay/0000-0001-9142-5706; Zhong, Guo/0000-0002-6056-9472	NIH [R01 GM111772, T32 DK007247, HD 10808]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants R01 GM111772 (to JS, CH, and NI), T32 DK007247 (to LC) and HD 10808 (M.G)	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Alonso S, 2017, EXP HEMATOL, V54, P17, DOI 10.1016/j.exphem.2017.07.004; BIESALSKI HK, 1989, TOXICOLOGY, V57, P117, DOI 10.1016/0300-483X(89)90161-3; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hampton AL, 2015, J AM ASSOC LAB ANIM, V54, P487; Hernandez D, 2020, LEUKEMIA, V34, P3077, DOI 10.1038/s41375-020-0790-4; Hogarth CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129718; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Isoherranen N, 2019, PHARMACOL THERAPEUT, V204, DOI 10.1016/j.pharmthera.2019.107400; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; KRETZSCHMAR R, 1975, ACTA DERM-VENEREOL, V55, P25; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; KURTZ PJ, 1984, TOXICOLOGY, V30, P115, DOI 10.1016/0300-483X(84)90122-7; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04; Minegishi Y, 2014, BIOCHEM BIOPH RES CO, V454, P12, DOI 10.1016/j.bbrc.2014.10.001; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Nilsson O, 2016, HORM METAB RES, V48, P737, DOI 10.1055/s-0042-114038; Nolte T, 2016, J TOXICOL PATHOL, V29, p1S, DOI 10.1293/tox.29.1S; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Raverdeau M, 2014, J IMMUNOL, V192, P2953, DOI 10.4049/jimmunol.1303245; Renne R, 2009, TOXICOL PATHOL, V37, p5S, DOI 10.1177/0192623309353423; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Senoo H, 2012, ANAT REC, V295, P1660, DOI 10.1002/ar.22555; Slavotinek AM, 2013, HUM MOL GENET, V22, P696, DOI 10.1093/hmg/dds477; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stevison F, 2017, DRUG METAB DISPOS, V45, P846, DOI 10.1124/dmd.117.075341; Stoppie P, 2000, J PHARMACOL EXP THER, V293, P304; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Thatcher JE, 2010, BIOCHEM PHARMACOL, V80, P903, DOI 10.1016/j.bcp.2010.05.023; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Treuting Piper M, 2015, Curr Protoc Mouse Biol, V5, P223, DOI 10.1002/9780470942390.mo140296; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; WHITE JA, 1994, DEVELOPMENT, V120, P1861; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Zhong G, 2019, J BIOL CHEM, V294, P11166, DOI 10.1074/jbc.RA119.009023	53	6	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15788	15804		10.1096/fj.202001734R	http://dx.doi.org/10.1096/fj.202001734R		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33105029	Green Submitted, Green Accepted			2022-12-26	WOS:000586269500001
J	Hubner, M; Zingg, T; Martin, D; Eckert, P; Demartines, N				Huebner, Martin; Zingg, Tobias; Martin, David; Eckert, Philippe; Demartines, Nicolas			Surgery for non-Covid-19 patients during the pandemic	PLOS ONE			English	Article							IMPACT	Background In the early phase of the Covid-19 pandemic, mainly data related to the burden of care required by infected patients were reported. The aim of this study was to illustrate the timeline of actions taken and to measure and analyze their impact on surgical patients. Method This is a retrospective review of actions to limit Covid-19 spread and their impact on surgical activity in a Swiss tertiary referral center. Data on patient care, human resources and hospital logistics were collected. Impact on surgical activity was measured by comparing 6-week periods before and after the first measures were taken. Results After the first Swiss Covid-19 case appeared on February 25, progressively restrictive measures were taken over a period of 23 days. Covid-19 positive inpatients increased from 5 to 131, and ICU patients from 2 to 31, between days 10 and 30, respectively, without ever overloading resources. A 43% decrease of elective visceral surgical procedures was observed after Covid-19 (295 vs 165, p<0.01), while the urgent operations (all specialties) decreased by 39% (1476 vs 897, p<0.01). Fifty-two and 38 major oncological surgeries were performed, respectively, representing a 27% decrease (p = 0.316). Outpatient consultations dropped by 59%, from 728 to 296 (p<0.01). Conclusion While allowing for maximal care of Covid-19 patients during the pandemic, the shift of resources limited the access to elective surgical care, with less impact on cancer care.	[Huebner, Martin; Zingg, Tobias; Martin, David; Demartines, Nicolas] Univ Lausanne UNIL, Univ Hosp CHUV, Dept Visceral Surg, Lausanne, Switzerland; [Eckert, Philippe] Univ Hosp CHUV, Hosp Direct, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Demartines, N (corresponding author), Univ Lausanne UNIL, Univ Hosp CHUV, Dept Visceral Surg, Lausanne, Switzerland.	demartines@chuv.ch	Zingg, Tobias/E-3246-2015	Zingg, Tobias/0000-0003-0905-2299; Demartines, Nicolas/0000-0002-1530-3114				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Aranda-Narvaez JM, 2020, CIR ESPAN, V98, P433, DOI 10.1016/j.ciresp.2020.04.031; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Di Fiore F, 2020, THESAURUS NATL CANCE; Elston JWT, 2017, PUBLIC HEALTH, V143, P60, DOI 10.1016/j.puhe.2016.10.020; Farid Y, 2020, BRIT J SURG, V107, pE300, DOI 10.1002/bjs.11738; Francis N, 2020, SURG ENDOSC, V34, P2327, DOI 10.1007/s00464-020-07565-w; Grass F, 2020, EJSO-EUR J SURG ONC, V46, P455, DOI 10.1016/j.ejso.2019.11.513; Martinez-Ramos C, 2009, TELEMED J E-HEALTH, V15, P531, DOI 10.1089/tmj.2009.0003; Nandra K, 2019, AM J SURG, V218, P476, DOI 10.1016/j.amjsurg.2018.09.020; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; Riley JS, 2020, AM SURGEON, V86, P1492, DOI 10.1177/0003134820949506; Sorbello M, 2020, ANAESTHESIA, V75, P724, DOI 10.1111/anae.15049; Sorensen MJ, 2020, ANN SURG, V272, pE174, DOI 10.1097/SLA.0000000000004125; Spinelli A, 2020, BRIT J SURG, V107, P785, DOI 10.1002/bjs.11627; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	17	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241331	10.1371/journal.pone.0241331	http://dx.doi.org/10.1371/journal.pone.0241331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095834	gold, Green Published			2022-12-26	WOS:000586649400029
J	Smith, N; Saunders, D; Lerner, M; Zalles, M; Mamedova, N; Cheong, D; Mohammadi, E; Yuan, T; Luo, Y; Hurst, RE; Greenwood-Van Meerveld, B; Towner, RA				Smith, Nataliya; Saunders, Debra; Lerner, Megan; Zalles, Michelle; Mamedova, Nadezda; Cheong, Daniel; Mohammadi, Ehsan; Yuan, Tian; Luo, Yi; Hurst, Robert E.; Greenwood-Van Meerveld, Beverley; Towner, Rheal A.			In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis	PLOS ONE			English	Article							FREE-RADICALS; MRI; PREVALENCE	Objectives To determine if the URO-MCP-1 mouse model for bladder IC/BPS is associated with in vivo bladder hyper-permeability, as measured by contrast-enhanced MRI (CE-MRI), and assess whether molecular-targeted MRI (mt-MRI) can visualize in vivo claudin-2 expression as a result of bladder hyper-permeability. Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic, painful condition of the bladder that affects primarily women. It is known that permeability plays a substantial role in IC/BPS. Claudins are tight junction membrane proteins that are expressed in epithelia and endothelia and form paracellular barriers and pores that determine tight junction permeability. Claudin-2 is a molecular marker that is associated with increased hyperpermeability in the urothelium. Materials and methods CE-MRI was used to measure bladder hyper-permeability in the URO-MCP-1 mice. A claudin-2-specific mt-MRI probe was used to assess in vivo levels of claudin-2. The mt-MRI probe consists of an antibody against claudin-2 conjugated to albumin that had Gd-DTPA (gadolinium diethylenetriamine pentaacetate) and biotin attached. Verification of the presence of the mt-MRI probe was done by targeting the biotin moiety for the probe with streptavidin-horse radish peroxidase (SA-HRP). Trans-epithelial electrical resistance (TEER) was also used to assess bladder permeability. Results The URO-MCP-1 mouse model for IC/BPS was found to have a significant increase in bladder permeability, following liposaccharide (LPS) exposure, compared to saline-treated controls. mt-MRI- and histologically-detectable levels of the claudin-2 probe were found to increase with LPS -induced bladder urothelial hyper-permeability in the URO-MCP-1 IC mouse model. Levels of protein expression for claudin-2 were confirmed with immunohistochemistry and immunofluorescence imaging. Claudin-2 was also found to highly co-localize with zonula occlidens-1 (ZO-1), a tight junction protein. Conclusion The combination of CE-MRI and TEER approaches were able to demonstrate hyper-permeability, a known feature associated with some IC/BPS patients, in the LPS-exposed URO-MCP-1 mouse model. This MRI approach could be clinically translated to establish which IC/BPS patients have bladder hyper-permeability and help determine therapeutic options. In addition, the in vivo molecular-targeted imaging approach can provide invaluable information to enhance our understanding associated with bladder urothelium hyper-permeability in IC/BPS patients, and perhaps be used to assist in developing further therapeutic strategies.	[Smith, Nataliya; Saunders, Debra; Zalles, Michelle; Mamedova, Nadezda; Cheong, Daniel; Towner, Rheal A.] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Lerner, Megan] Univ Oklahoma, Hlth Sci Ctr, Surg Res Lab, Oklahoma City, OK USA; [Zalles, Michelle; Mohammadi, Ehsan; Yuan, Tian; Greenwood-Van Meerveld, Beverley; Towner, Rheal A.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA; [Mohammadi, Ehsan; Yuan, Tian; Greenwood-Van Meerveld, Beverley] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK USA; [Luo, Yi] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Hurst, Robert E.] Univ Oklahoma, Dept Urol, Hlth Sci Ctr, Oklahoma City, OK USA; [Towner, Rheal A.] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Iowa; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Towner, RA (corresponding author), Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, 825 NE 13th St, Oklahoma City, OK 73104 USA.; Towner, RA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73104 USA.; Towner, RA (corresponding author), Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	Rheal-Towner@omrf.org		Cheong, Daniel/0000-0001-7036-7244; Towner, Rheal/0000-0001-7368-8983; Luo, Yi/0000-0002-4013-6805	Presbyterian Health Foundation; Department of Veterans Affairs [1IK6BX003610-01]	Presbyterian Health Foundation; Department of Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by the Presbyterian Health Foundation (RAT), and the Department of Veterans Affairs (Award 1IK6BX003610-01, BGVM).	Akiyama Y, 2019, INT J UROL, V26, P17, DOI 10.1111/iju.13969; Amoozadeh Y, 2018, AM J PHYSIOL-CELL PH, V314, pC366, DOI 10.1152/ajpcell.00234.2017; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Dafni H, 2002, NMR BIOMED, V15, P120, DOI 10.1002/nbm.724; de Souza PC, 2015, FREE RADICAL BIO MED, V87, P157, DOI 10.1016/j.freeradbiomed.2015.06.026; de Souza PC, 2015, AM J NUCL MED MOLEC, V5, P363; El-Sharkawey A., 2016, CALCULATE CORRECTED, DOI [10.13140/RG.2.1.1307.8008., DOI 10.13140/RG.2.1.1307.8008]; Freire VS, 2010, AM J PATHOL, V176, P288, DOI 10.2353/ajpath.2010.090552; Gonzalez EJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/120525; Greenwood-Van Meerveld B, 2018, UROLOGY, V116, DOI 10.1016/j.urology.2018.02.034; He T, 2013, AM J NUCL MED MOLEC, V3, P300; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P173; Montalbetti N, 2019, J NEUROPHYSIOL, V122, P1136, DOI 10.1152/jn.00306.2019; Montalbetti N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41971-y; Montalbetti N, 2015, AM J PHYSIOL-RENAL, V309, pF1070, DOI 10.1152/ajprenal.00200.2015; Parsons JK, 2007, UROLOGY, V69, P5, DOI 10.1016/j.urology.2006.05.050; Parsons JK, 2004, J UROLOGY, V171, P20, DOI 10.1097/01.ju.0000099890.35040.8d; Patnaik SS, 2017, ARCH GYNECOL OBSTET, V295, P1341, DOI 10.1007/s00404-017-4364-2; Rosenthal R, 2017, ACTA PHYSIOL, V219, P521, DOI 10.1111/apha.12742; Smith CA, 2006, CYTOM PART B-CLIN CY, V70B, P91, DOI 10.1002/cyto.b.20090; Suskind AM, 2013, J UROLOGY, V189, P141, DOI 10.1016/j.juro.2012.08.088; Tan JHL, 2020, STEM CELL REP, V14, P818, DOI 10.1016/j.stemcr.2020.03.013; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Towner RA, 2015, FREE RADICAL RES, V49, P1140, DOI 10.3109/10715762.2015.1050587; Towner RA, 2016, J UROLOGY, V195, P631, DOI 10.1016/j.juro.2015.08.077; Towner RA, 2015, J UROLOGY, V193, P1394, DOI 10.1016/j.juro.2014.10.120; Towner RA, 2013, FREE RADICAL BIO MED, V65, P828, DOI 10.1016/j.freeradbiomed.2013.08.172; Towner RA, 2013, BBA-MOL BASIS DIS, V1832, P2153, DOI 10.1016/j.bbadis.2013.08.004; Towner RA, 2013, FREE RADICAL BIO MED, V63, P351, DOI 10.1016/j.freeradbiomed.2013.05.026; Towner RA, 2012, DIABETES, V61, P2405, DOI 10.2337/db11-1540; Towner RA, 2010, FREE RADICAL BIO MED, V48, P691, DOI 10.1016/j.freeradbiomed.2009.12.012; Xu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152463	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0239282	10.1371/journal.pone.0239282	http://dx.doi.org/10.1371/journal.pone.0239282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095778	gold, Green Published			2022-12-26	WOS:000586649400008
J	Ford, ND; Martorell, R; Mehta, NK; Perrine, CG; Ramirez-Zea, M; Stein, AD				Ford, Nicole D.; Martorell, Reynaldo; Mehta, Neil K.; Perrine, Cria G.; Ramirez-Zea, Manuel; Stein, Aryeh D.			Lifecourse body mass index trajectories and cardio-metabolic disease risk in Guatemalan adults	PLOS ONE			English	Article							TO-HEIGHT RATIO; BLOOD-PRESSURE; LIFE-COURSE; CHILDHOOD GROWTH; IMPROVED NUTRITION; COHORT PROFILE; WEIGHT-GAIN; BIRTH; OBESITY; COUNTRIES	Little is known about body size over the life-course and non-communicable disease risk in low- and middle-income country populations. Our study explored the role of body mass index (BMI) trajectories from infancy through mid-adulthood on cardio-metabolic disease (CMD) risk factors in a prospective cohort of Guatemalan adults. Study participants were born in Guatemala from 1962-77 and have been followed prospectively since participating in a nutrition supplementation trial as children. Sex-specific BMI latent class trajectories were derived using latent class growth modeling from up to 22 possible BMI values from age 1 month to 42 years measured between 1969 and 2004. CMD risk factors were assessed in 2015-17 (at age 37-54 years) using anthropometry, blood glucose and lipids, and blood pressure. We used logistic regression to assess the role of BMI trajectory on CMD risk factors in 510 women and 346 men (N=856). We identified two BMI latent classes for women (low [n=287, 56.3%] and high [n=223, 43.7%]) and three classes for men (low [n=141, 40.8%], medium [n=160, 46.2%], and high [n=45, 13.0%]). Given the small percentage of men in the high BMI latent class, we collapsed the medium and high BMI latent classes for men (n=205, 59.1%). Among the most prevalent CMD risk factors at ages 37-54 years were abdominal obesity defined by waist-height ratio (99.6% of women and 87.3% of men), obesity defined by percent body fat (96.6% of women and 75.9% of men), low HDL-c (87.5% of women and 74.5% of men), and elevated triglycerides (78.3% of women and 73.6% of men). Except for obesity defined by BMI, we found no associations between BMI latent class and CMD risk factors in women. Among men, BMI latent class was not associated with CMD risk factors after controlling for current BMI. For the CMD risk factors we analyzed, the role of early life BMI on adult CMD appeared to be mediated by adult BMI among men-highlighting the need to establish and maintain healthy body weight over the life course.	[Ford, Nicole D.; Martorell, Reynaldo; Stein, Aryeh D.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Mehta, Neil K.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Perrine, Cria G.] US Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA USA; [Ramirez-Zea, Manuel] Inst Nutr Cent Amer & Panama, INCAP Res Ctr Prevent Chron Dis CIIPEC, Guatemala City, Guatemala	Emory University; Rollins School Public Health; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; Institute of Nutrition of Central America & Panama (INCAP)	Stein, AD (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	aryeh.stein@emory.edu		Stein, Aryeh/0000-0003-1138-6458; Ford, Nicole/0000-0002-6463-5094	National Institutes of Health [HD-075784]; Laney Graduate School at Emory University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laney Graduate School at Emory University	This work was supported by the National Institutes of Health (www.nih.gov; grant number HD-075784) and Laney Graduate School at Emory University (www.gs.emory.edu; to NDF). The funders had no role in: the design and conduct of this study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Adair LS, 2007, AM J HUM BIOL, V19, P327, DOI 10.1002/ajhb.20587; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; BARKER DJP, 1994, J ROY COLL PHYS LOND, V28, P544; Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Bryant CX, 2008, ACE LIFESTYLE WEIGHT; Buscot MJ, 2018, EUR HEART J, V39, P2263, DOI 10.1093/eurheartj/ehy161; Cheung YB, 2000, HYPERTENSION, V36, P795, DOI 10.1161/01.HYP.36.5.795; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper R, 2008, ATHEROSCLEROSIS, V200, P141, DOI 10.1016/j.atherosclerosis.2007.11.011; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Mutsert R, 2014, AM J EPIDEMIOL, V179, P1353, DOI 10.1093/aje/kwu052; Ford ND, 2018, LANCET GLOB HEALTH, V6, pE875, DOI [10.1016/S2214-109X(18)30231-6, 10.1016/s2214-109x(18)30231-6]; Ford ND, 2016, J NUTR, V146, P2368, DOI 10.3945/jn.116.236075; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hardy R, 2016, INT J EPIDEMIOL, V45, P1003, DOI 10.1093/ije/dyw101; Hediger ML, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.5.e60; Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584; Hoekstra T, 2011, LONGITUD LIFE COURSE, V2, P319; Institute for Health Metrics and Evaluation, 2015, GLOB BURD DIS 2015; Instituto de Nutricion de Centro America y Panama (INCAP), 2019, INF SIST VIG EP SAL; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Maluccio John A., 2005, Food and Nutrition Bulletin, V26, pS120; MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S; McCormick DP, 2010, J PEDIATR-US, V157, P15, DOI 10.1016/j.jpeds.2010.01.028; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in Adults, 2000, NIH PUBL; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ortigao-de-Sampaio MB, 1998, AIDS, V12, pF145; PACE N, 1945, J BIOL CHEM, V158, P685; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Ramirez-Zea M, 2010, J NUTR, V140, P397, DOI 10.3945/jn.109.114470; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Rtveladze K, 2014, PUBLIC HEALTH NUTR, V17, P233, DOI 10.1017/S1368980013000086; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Song MY, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2195; Stein AD, 2008, INT J EPIDEMIOL, V37, P716, DOI 10.1093/ije/dyn028; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; The IPAQ group, 2010, GUID DAT PROC AN INT; Tollman SM, 2016, INT J EPIDEMIOL, V45, P997, DOI 10.1093/ije/dyw109; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wibaek R, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002888; Wills AK, 2010, J HYPERTENS, V28, P679, DOI 10.1097/HJH.0b013e328335de7b; World Health Organization, GUAT METR AR STEPS 2	55	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240904	10.1371/journal.pone.0240904	http://dx.doi.org/10.1371/journal.pone.0240904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091024	gold, Green Published			2022-12-26	WOS:000586647200018
J	Hakanson, CA; Fredriksson, F; Lilja, HE				Arana Hakanson, Cecilia; Fredriksson, Fanny; Engstrand Lilja, Helene			Attention deficit hyperactivity disorder and educational level in adolescent and adult individuals after anesthesia and abdominal surgery during infancy	PLOS ONE			English	Article							EARLY EXPOSURE; BEHAVIORAL OUTCOMES; CHILDHOOD EXPOSURE; CHILDREN; ASSOCIATION; AGE; NEUROTOXICITY; PREVALENCE; APOPTOSIS; IMPACT	Aim Several studies in animal models have found that exposure to anesthetics in early life can cause cognitive dysfunction. Human studies show conflicting results and studies of cognitive function after anesthesia and neonatal surgery are scarce. The aim of this study was to investigate whether exposure to anesthesia and abdominal surgery during infancy was associated with cognitive dysfunction from the perspective of educational level, disposable income and attention deficit hyperactivity disorders (ADHD) in adolescent and adult individuals. Methods A cohort study with patients born 1976 to 2002 that underwent abdominal surgery during infancy at a pediatric surgical center were matched by age, sex, and gestational age to ten randomly selected individuals from the Swedish Medical Birth Register. Individuals with chromosomal aberrations were excluded. Data on highest level of education and annual disposable income were attained from Statistics Sweden and the diagnosis of ADHD were retrieved from the Swedish National Patient Register. Results 485 individuals and 4835 controls were included. Median gestational age was 38 weeks (24-44) and median age at surgery was seven days (0-365). Three hundred sixty-six individuals (70.0%) underwent surgery during the neonatal period (< 44 gestational weeks). Median operating time was 80 minutes (10-430). The mean age at follow-up was 28 years. Fisher's exact test for highest level of education for the exposed and unexposed groups were respectively: university 35% and 33%, upper secondary 44% and 47%, compulsory 21% and 20% (p = 0.6718). The median disposable income was 177.7 versus 180.9 TSEK respectively (p = 0.7532). Exposed individuals had a prevalence of ADHD of 5.2% and unexposed 4.4% (p = 0.4191). Conclusions This study shows that exposure to anesthesia and abdominal surgery during infancy is not associated with cognitive dysfunction from the perspective of educational level, disposable income and ADHD in adolescent and adult individuals. Further studies in larger cohorts at earlier gestational ages are needed to verify these findings.	[Arana Hakanson, Cecilia; Fredriksson, Fanny; Engstrand Lilja, Helene] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fredriksson, Fanny; Engstrand Lilja, Helene] Univ Childrens Hosp, Dept Pediat Surg, Uppsala, Sweden	Uppsala University	Hakanson, CA (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	cecilia.arana_hakanson@kbh.uu.se	Lilja, Helene Engstrand/AAR-6586-2021	Lilja, Helene Engstrand/0000-0002-1998-5212; Arana Hakanson, Cecilia/0000-0001-5271-8274	(CAH) HRH Crown Princess Lovisa's Association for Child Care [2017-00382, 2018-00455, 2019-00497]; Gillbergska Foundation; (CAH) Specific Clinical Research Funding from Uppsala County	(CAH) HRH Crown Princess Lovisa's Association for Child Care; Gillbergska Foundation; (CAH) Specific Clinical Research Funding from Uppsala County	This work was supported by (CAH) HRH Crown Princess Lovisa's Association for Child Care, http://www.kronprinsessanlovisa.se/, grantIDs: 2017-00382; 2018-00455; 2019-00497, (CAH) the Gillbergska Foundation, http://www.gillbergska.se/; and (CAH) Specific Clinical Research Funding from Uppsala County. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LE, 2020, J ATTEN DISORD, V24, P73, DOI 10.1177/1087054714566076; Backeljauw B, 2015, PEDIATRICS, V136, pE1, DOI 10.1542/peds.2014-3526; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Blau FD, 2017, J ECON LIT, V55, P789, DOI 10.1257/jel.20160995; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Broad KD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173413; Broad KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166784; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson F, 2016, BRIT J SURG, V103, P284, DOI 10.1002/bjs.10072; Giacobini M, 2018, J ATTEN DISORD, V22, P3, DOI 10.1177/1087054714554617; Glatz P, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.3470; Granstrom AL, 2016, ACTA PAEDIATR, V105, P1508, DOI 10.1111/apa.13594; Hansen TG, 2013, PEDIATR ANESTH, V23, P883, DOI 10.1111/pan.12225; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Hu DQ, 2017, ANESTHESIOLOGY, V127, P227, DOI 10.1097/ALN.0000000000001735; Ing C, 2017, ANESTH ANALG, V125, P1988, DOI 10.1213/ANE.0000000000002423; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Kleven H, 2019, AM ECON J-APPL ECON, V11, P181, DOI 10.1257/app.20180010; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Ludman L, 2001, J PEDIATR SURG, V36, P858, DOI 10.1053/jpsu.2001.23954; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lunardi N, 2010, NEUROTOX RES, V17, P179, DOI 10.1007/s12640-009-9088-z; Olsen EA, 2013, CURR OPIN ANESTHESIO, V26, P677, DOI 10.1097/ACO.0000000000000016; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Psaty BM, 2015, JAMA-J AM MED ASSOC, V313, P1515, DOI 10.1001/jama.2015.1149; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Rappaport BA, 2015, NEW ENGL J MED, V372, P796, DOI 10.1056/NEJMp1414786; Sanders RD, 2013, BRIT J ANAESTH, V110, P53, DOI 10.1093/bja/aet054; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Vutskits L, 2017, CURR OPIN ANESTHESIO, V30, P337, DOI 10.1097/ACO.0000000000000461; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wu J, 2016, ANESTHESIOLOGY, V124, P624, DOI 10.1097/ALN.0000000000000981; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010	45	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240891	10.1371/journal.pone.0240891	http://dx.doi.org/10.1371/journal.pone.0240891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085711	Green Published, gold			2022-12-26	WOS:000585943400038
J	Piovezan-Borges, AC; Valente-Neto, F; Tadei, WP; Hamada, N; Roque, FO				Piovezan-Borges, Ana C.; Valente-Neto, Francisco; Tadei, Wanderli P.; Hamada, Neusa; Roque, Fabio O.			Simulated climate change, but not predation risk, accelerates Aedes aegypti emergence in a microcosm experiment in western Amazonia	PLOS ONE			English	Article							MOSQUITOS	Climate change affects individual life-history characteristics and species interactions, including predator-prey interactions. While effects of warming onAedes aegyptiadults are well known, clarity the interactive effects of climate change (temperature and CO(2)concentration) and predation risk on the larval stage remains unexplored. In this study, we performed a microcosm experiment simulating temperature and CO(2)changes in Manaus, Amazonas, Brazil, for the year 2100. Simulated climate change scenarios (SCCS) were in accordance with the Fourth Assessment Report of Intergovernmental Panel on Climate Change (IPCC). Used SCCS were: Control (real-time current conditions in Manaus: average temperature is similar to 25.76 degrees C +/- 0.71 degrees C and similar to 477.26 +/- 9.38 parts per million by volume (ppmv) CO2); Light: increase of similar to 1,7 degrees C and similar to 218 ppmv CO2; Intermediate: increase of similar to 2.4 degrees C and similar to 446 ppmv CO2; and Extreme: increase of similar to 4.5 degrees C and similar to 861 ppmv CO2, all increases were relative to a Control SCCS. Light, Intermediate and Extreme SCCS reproduced, respectively, the B1, A1B, and A2 climatic scenarios predicted by IPCC (2007). We analyzedAedes aegyptilarval survivorship and adult emergence pattern with a factorial design combining predation risk (control and predator presence-Toxorhynchites haemorrhoidalislarvae) and SCCS. Neither SCCS nor predation risk affectedAedes aegyptilarval survivorship, but adult emergence pattern was affected by SCCS. Accordingly, our results did not indicate interactive effects of SCCS and predation risk on larval survivorship and emergence pattern ofAedes aegyptireared in SCCS in western Amazonia.Aedes aegyptiis resistant to SCCS conditions tested, mainly due to high larval survivorship, even under Extreme SCCS, and warmer scenarios increase adultAedes aegyptiemergence. Considering thatAedes aegyptiis a health problem in western Amazonia, an implication of our findings is that the use of predation cues as biocontrol strategies will not provide a viable means of controlling the accelerated adult emergence expected under the IPCC climatic scenarios.	[Piovezan-Borges, Ana C.; Valente-Neto, Francisco; Roque, Fabio O.] Univ Fed Mato Grosso do Sul UFMS, Inst Biociencias INBIO, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Tadei, Wanderli P.; Hamada, Neusa] Inst Nacl Pesquisas Amazonia INPA, Div Curso Entomol, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Roque, Fabio O.] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Australia	Universidade Federal de Mato Grosso do Sul; Institute Nacional de Pesquisas da Amazonia; James Cook University	Piovezan-Borges, AC (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Inst Biociencias INBIO, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil.	anacpborges3@gmail.com	Tadei, Wanderli Pedro/N-4486-2018; Neto, Francisco Valente/M-3991-2014	Tadei, Wanderli Pedro/0000-0002-0612-3285; Neto, Francisco Valente/0000-0002-5298-3753	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect); Fundo Brasileiro para Biodiversidade (FUNBIO); Instituto Humanize grant; CAPES [88882.317337/2019-01, 001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Fundo Brasileiro para Biodiversidade (FUNBIO); Instituto Humanize grant; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	ACPB received part of fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and part from Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (Fundect). ACPB was supported by Fundo Brasileiro para Biodiversidade (FUNBIO) and Instituto Humanize grant. FVN received a Postdoctoral fellowship #88882.317337/2019-01 from CAPES; NH (307849/2014-7; 308970/2019-5) and FOR are Conselho Nacional de Desenvolvimento Cientifico e Tecnolo gico (CNPQ) research fellow. This study was also, partially, financed by CAPES Finance Code 001. The views expressed in the present article are those of the authors and not necessarily those of any funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay Y, 2018, BEHAV ECOL, V29, P1402, DOI 10.1093/beheco/ary113; [Anonymous], 2021, LANG ENV STAT COMP; Bellamy SK, 2018, OECOLOGIA, V187, P233, DOI 10.1007/s00442-018-4107-5; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boukal DS, 2019, CURR OPIN INSECT SCI, V35, P88, DOI 10.1016/j.cois.2019.06.014; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Chandrasegaran K., 2019, FRONTIERS ECOLOGY EV, V7, P1; Chandrasegaran K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192104; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Dossena M, 2012, P ROY SOC B-BIOL SCI, V279, P3011, DOI 10.1098/rspb.2012.0394; Draper AM, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00072; Ezeakacha NF, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3391-1; Focks DA, 2007, J AM MOSQUITO CONTR, V23, P118, DOI 10.2987/8756-971X(2007)23[118:TABA]2.0.CO;2; Franklinos LHV, 2019, LANCET INFECT DIS, V19, pE302, DOI 10.1016/S1473-3099(19)30161-6; Gruner DS, 2017, OIKOS, V126, P8, DOI 10.1111/oik.03688; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Hermann SL, 2014, OECOLOGIA, V176, P669, DOI 10.1007/s00442-014-3069-5; Huston MA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P47; Iwamura T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16010-4; Juliano SA, 2010, OECOLOGIA, V162, P709, DOI 10.1007/s00442-009-1475-x; Laws AN, 2017, CURR OPIN INSECT SCI, V23, P28, DOI 10.1016/j.cois.2017.06.010; Leonel BF, 2015, J MED ENTOMOL, V52, P866, DOI 10.1093/jme/tjv068; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Marengo J, 2009, AMAZONIA GLOBAL GHAN, P566; Mordecai EA, 2019, ECOL LETT, V22, P1690, DOI 10.1111/ele.13335; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Ninkovic V, 2013, BIOL CONTROL, V65, P63, DOI 10.1016/j.biocontrol.2012.07.003; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Ofulla A. V. O., 2010, Lakes & Reservoirs Research and Management, V15, P255, DOI 10.1111/j.1440-1770.2010.00434.x; Pachauri R. K., 2007, CLIMATE CHANGE 2007, DOI [10.1038/446727a, DOI 10.1038/446727A]; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158; Roberts D, 2010, ENTOMOL EXP APPL, V135, P271, DOI 10.1111/j.1570-7458.2010.00993.x; Romero GQ, METAANALYSIS PREDATI, V6, DOI [10.1371/journal.pone.0020689, DOI 10.1371/JOURNAL.PONE.002068921695187]; Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213; STEFFAN WA, 1981, ANNU REV ENTOMOL, V26, P159, DOI 10.1146/annurev.en.26.010181.001111; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Vonesh JR, 2010, ISR J ECOL EVOL, V56, P263, DOI 10.1560/IJEE.56.3-4.263; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; World Health Organization W, 2017, MOSQ BORN DIS	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0241070	10.1371/journal.pone.0241070	http://dx.doi.org/10.1371/journal.pone.0241070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079970	Green Accepted, gold, Green Published			2022-12-26	WOS:000585940600021
J	Tu, YA; Yang, PK; Chen, SU; Yang, JH				Tu, Yi-An; Yang, Po-Kai; Chen, Shee-Uan; Yang, Jehn-Hsiahn			Optimal time interval between hysteroscopic polypectomy and frozen-thawed blastocyst transfer: A retrospective study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO-TRANSFER; INTRAUTERINE INSEMINATION; ENDOMETRIAL POLYPS; FRESH; IMPLANTATION; PREGNANCY; METAANALYSIS; INJURY; IVF	The optimal timing of frozen-thawed blastocyst transfer following hysteroscopic polypectomy is an important and unanswered clinical question. In this study, we conducted a retrospective survey of cases from an infertility center at an academic hospital. We reviewed the charts of all patients who received in-vitro fertilization and frozen-thawed blastocyst transfers (FBT) at the center from January 2009 to November 2019. One hundred and two patients with prior diagnosis of endometrial polyp that were treated with hysteroscopic polypectomy before received their first FBT at the center were identified as cases. Patients without prior diagnosis of endometrial polyp, and who received their first FBT at the center were defined as controls. Controls were enrolled at a 1-to-1 ratio to the cases. The cases and controls did not show differences in baseline characteristics, endometrial thickness, or the number of good blastocysts transferred. The clinical pregnancy rates and live birth rates were similar. Regarding the optimal interval between polypectomy and FBT, a cut-off of 120 days was identified from the ROC curve. A stratified analysis showed that when FBT was performed within an interval of 120 days after polypectomy, there were higher biochemical pregnancy rates (73.2%, 45.2%; OR 3.3;P= .007) and clinical pregnancy rates (64.8%, 41.9%; OR 2.54;P= .032), when compared with intervals greater than 120 days. There were no significant differences in implantation and live birth rates. In conclusion, pregnancy rates following FBT in patients who had received prior endometrial polypectomy were comparable to pregnancy rates after FBT in patients without endometrial polyp. Subgroup analysis showed that an interval greater than 120 days between hysteroscopic polypectomy and FBT was associated with decreased pregnancy rates. Patients who wish to receive embryo transfer after polypectomy should wait no longer than 120 days.	[Tu, Yi-An; Yang, Po-Kai; Chen, Shee-Uan; Yang, Jehn-Hsiahn] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tu, Yi-An; Yang, Po-Kai; Chen, Shee-Uan] Natl Taiwan Univ, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	jjhyang@gmail.com		Yang, Pokai/0000-0003-1818-5309; CHEN, SHEE-UAN/0000-0001-7592-3238; YANG, JEHN-HSIAHN/0000-0001-8648-0882; Tu, Yi-An/0000-0001-5578-2706	Ministry of Science and Technology of the Republic of China [MOST 107-2314-B-002-158-MY3]; National Taiwan University Hospital [NTUH 108-S4094, NTUH 109-S4467]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by the research grant MOST 107-2314-B-002-158-MY3 from the Ministry of Science and Technology of the Republic of China, and the research grant NTUH 108-S4094 and NTUH 109-S4467 from National Taiwan University Hospital.	Aharon D, 2019, J MINIM INVAS GYN, V26, P1083, DOI 10.1016/j.jmig.2018.10.019; Pacheco LA, 2019, EUR J OBSTET GYN R B, V243, P173, DOI 10.1016/j.ejogrb.2019.09.023; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Annan John Jude Kweku, 2013, J Clin Med Res, V5, P269, DOI 10.4021/jocmr1008w; [Anonymous], 2020, J ULTRAS MED, V39, pE1, DOI 10.1002/jum.15187; Bar G, 2020, ARCH GYNECOL OBSTET, V301, P817, DOI 10.1007/s00404-019-05424-1; Bosch E, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00067; Bosdou JK, 2019, HUM REPROD, V34, P491, DOI 10.1093/humrep/dey388; Bosteels J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009461.pub4; Bosteels J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009461.pub3; Bourdon M, 2018, HUM REPROD, V33, P905, DOI 10.1093/humrep/dey041; Brady M, 2019, HIV MED, V20, pS2, DOI 10.1111/hiv.12718; Chen SU, 2014, J CLIN ENDOCR METAB, V99, pE971, DOI 10.1210/jc.2013-3794; Danhof NA, 2018, HUM REPROD, V33, P1866, DOI 10.1093/humrep/dey268; Du HL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023002; Eryilmaz OG, 2012, ARCH GYNECOL OBSTET, V285, P1753, DOI 10.1007/s00404-012-2238-1; Gallos ID, 2018, REPROD BIOMED ONLINE, V37, P542, DOI 10.1016/j.rbmo.2018.08.025; Gao J, 2018, FERTIL STERIL, V109, P97, DOI 10.1016/j.fertnstert.2017.09.033; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Healy MW, 2016, FERTIL STERIL, V105, P93, DOI 10.1016/j.fertnstert.2015.09.015; Huang CC, 2012, HUM REPROD, V27, P2036, DOI 10.1093/humrep/des141; Huang TC, 2020, J FORMOS MED ASSOC, V119, P1642, DOI 10.1016/j.jfma.2019.12.006; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Kamath MS, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012856.pub2; Karimzade MA, 2010, ARCH GYNECOL OBSTET, V281, P499, DOI 10.1007/s00404-009-1166-1; Kort JD, 2017, FERTIL STERIL, V107, P575, DOI 10.1016/j.fertnstert.2017.01.004; Kuang YP, 2015, FERTIL STERIL, V104, P62, DOI 10.1016/j.fertnstert.2015.03.022; Lensen S, 2019, FERTIL STERIL, V111, P1094, DOI 10.1016/j.fertnstert.2019.04.017; Liang Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/757184; Liu WJ, 2019, J OBSTET GYNAECOL RE, V45, P619, DOI 10.1111/jog.13872; Maheshwari A, 2018, HUM REPROD UPDATE, V24, P35, DOI 10.1093/humupd/dmx031; Munro MG, 2019, FERTIL STERIL, V111, P629, DOI 10.1016/j.fertnstert.2019.02.008; Olesen MS, 2019, FERTIL STERIL, V112, P1015, DOI 10.1016/j.fertnstert.2019.08.010; Pena JE, 2002, HUM REPROD, V17, P83, DOI 10.1093/humrep/17.1.83; Pereira N, 2016, FERTIL STERIL, V105, P539, DOI 10.1016/j.fertnstert.2015.10.028; Pirtea P, 2019, FERTIL STERIL, V111, P1117, DOI 10.1016/j.fertnstert.2019.04.007; Poikkeus P, 2002, HUM REPROD, V17, P1901, DOI 10.1093/humrep/17.7.1901; Rackow BW, 2011, FERTIL STERIL, V95, P2690, DOI 10.1016/j.fertnstert.2010.12.034; Roque M, 2019, HUM REPROD UPDATE, V25, P2, DOI 10.1093/humupd/dmy033; Roque M, 2015, FERTIL STERIL, V103, P1190, DOI 10.1016/j.fertnstert.2015.01.045; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Santos-Ribeiro S, 2016, FERTIL STERIL, V105, P1202, DOI 10.1016/j.fertnstert.2015.12.140; Sarkar P, 2018, MINERVA GINECOL, V70, P716, DOI 10.23736/S0026-4784.18.04281-8; Silva ACJDRE, 2005, J REPROD MED, V50, P501; Singh B, 2020, FERTIL STERIL, V113, P252, DOI 10.1016/j.fertnstert.2019.12.007; Smith ADAC, 2015, JAMA-J AM MED ASSOC, V314, P2654, DOI 10.1001/jama.2015.17296; Vitagliano A, 2018, J GYNECOL OBSTET HUM, V47, P33, DOI 10.1016/j.jogoh.2017.11.001; Vitagliano A, 2018, FERTIL STERIL, V109, P84, DOI 10.1016/j.fertnstert.2017.09.021; Wei DM, 2019, LANCET, V393, P1310, DOI 10.1016/S0140-6736(18)32843-5; Wong KM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011184.pub2; Yang JH, 2017, REPROD BIOMED ONLINE, V34, P285, DOI 10.1016/j.rbmo.2016.12.012; Yang JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144857; Yang JH, 2013, FERTIL STERIL, V99, P2092, DOI 10.1016/j.fertnstert.2013.01.137; Zhang HX, 2019, J MINIM INVAS GYN, V26, P618, DOI 10.1016/j.jmig.2018.10.024	54	2	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240882	10.1371/journal.pone.0240882	http://dx.doi.org/10.1371/journal.pone.0240882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079974	gold, Green Published			2022-12-26	WOS:000585940600026
J	Eustace, NJ; Anderson, JC; Warram, JM; Widden, HN; Pedersen, RT; Alrefai, H; Patel, Z; Hicks, PH; Placzek, WJ; Gillespie, GY; Hjelmeland, AB; Willey, CD				Eustace, Nicholas J.; Anderson, Joshua C.; Warram, Jason M.; Widden, Hayley N.; Pedersen, Rune T.; Alrefai, Hasan; Patel, Zeel; Hicks, Patricia H.; Placzek, William J.; Gillespie, G. Yancey; Hjelmeland, Anita B.; Willey, Christopher D.			A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma	ONCOGENE			English	Article							PI3K PATHWAY; RADIATION SENSITIVITY; MOLECULAR-MECHANISMS; CANCER; RESISTANCE; PHOSPHORYLATION; APOPTOSIS; PEPTIDE; CALCIUM; GROWTH	Glioblastoma (GBM) is an aggressive malignancy with limited effectiveness of standard of care therapies including surgery, radiation, and temozolomide chemotherapy necessitating novel therapeutics. Unfortunately, GBMs also harbor several signaling alterations that protect them from traditional therapies that rely on apoptotic programmed cell death. Because almost all GBM tumors have dysregulated phosphoinositide signaling as part of that process, we hypothesized that peptide mimetics derived from the phospholipid binding domain of Myristoylated alanine-rich C-kinase substrate (MARCKS) could serve as a novel GBM therapeutic. Using molecularly classified patient-derived xenograft (PDX) lines, cultured in stem-cell conditions, we demonstrate that cell permeable MARCKS effector domain (ED) peptides potently target all GBM molecular classes while sparing normal human astrocytes. Cell death mechanistic testing revealed that these peptides produce rapid cytotoxicity in GBM that overcomes caspase inhibition. Moreover, we identify a GBM-selective cytolytic death mechanism involving plasma membrane targeting and intracellular calcium accumulation. Despite limited relative partitioning to the brain, tail-vein peptide injection revealed tumor targeting in intracranially implanted GBM PDX. These results indicate that MARCKS ED peptide therapeutics may overcome traditional GBM resistance mechanisms, supporting further development of similar agents.	[Eustace, Nicholas J.; Anderson, Joshua C.; Alrefai, Hasan; Patel, Zeel; Hicks, Patricia H.; Willey, Christopher D.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Warram, Jason M.] Univ Alabama Birmingham, Dept Otolaryngol, Birmingham, AL USA; [Widden, Hayley N.; Placzek, William J.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Pedersen, Rune T.] ChemoMetec, DK-3450 Allerod, Denmark; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Hjelmeland, Anita B.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Willey, CD (corresponding author), Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA.	cwilley@uabmc.edu		Eustace, Nicholas/0000-0002-2483-7863; Placzek, William/0000-0003-4096-8617; Alrefai, Hasan/0000-0002-7240-8748; Gillespie, George/0000-0001-6436-9542; Anderson, Joshua/0000-0002-6977-9054; Pedersen, Rune Troelsgaard/0000-0002-0655-1351	National Institutes of Health (UAB MSTP training Grant) [T32GM008361]; National Institutes of Health (UAB Training Program in Brain Tumor Biology) [T32NS048039]; American Cancer Society [RSG-14-071-01-TBG]; UAB Physician Scientist Training Program Medical Student Summer Research Training Program; UAB Department of Radiation Oncology	National Institutes of Health (UAB MSTP training Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (UAB Training Program in Brain Tumor Biology)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); UAB Physician Scientist Training Program Medical Student Summer Research Training Program; UAB Department of Radiation Oncology	This work was supported by funding from the National Institutes of Health (the UAB MSTP training Grant: T32GM008361 and the UAB Training Program in Brain Tumor Biology: T32NS048039), the American Cancer Society RSG-14-071-01-TBG, the UAB Physician Scientist Training Program Medical Student Summer Research Training Program, and an intramural research grant from the UAB Department of Radiation Oncology.	Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Boohaker RJ, 2012, CURR MED CHEM, V19, P3794; Brudvig JJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00407; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.407; Chen CH, 2017, ONCOGENE, V36, P3588, DOI 10.1038/onc.2016.510; Chen CH, 2014, AM J RESP CRIT CARE, V190, P1127, DOI 10.1164/rccm.201408-1505OC; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collatz MB, 1997, CELL CALCIUM, V21, P453, DOI 10.1016/S0143-4160(97)90056-7; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; de Boer E, 2016, MOL IMAGING BIOL, V18, P232, DOI 10.1007/s11307-015-0892-y; Denley A, 2009, MOL CANCER RES, V7, P1132, DOI 10.1158/1541-7786.MCR-09-0068; Dinca A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020263; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fong LWR, 2017, CANCER METAST REV, V36, P737, DOI 10.1007/s10555-017-9709-6; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gimple RC, 2019, CANCER DISCOV, V9, P1248, DOI 10.1158/2159-8290.CD-19-0061; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; Haar CP, 2012, NEUROCHEM RES, V37, P1192, DOI 10.1007/s11064-011-0701-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iqbal S, 2020, ACS CHEM NEUROSCI, V11, P1944, DOI 10.1021/acschemneuro.0c00139; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Kastelowitz N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04494-y; Keoni Chanel Li, 2015, J Cell Death, V8, P1, DOI 10.4137/JCD.S23844; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Langhans J, 2017, ONCOGENESIS, V6, DOI 10.1038/s41389-017-0004-8; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Nichol D, 2015, NEURO-ONCOLOGY, V17, P1183, DOI 10.1093/neuonc/nov124; Panzarini E, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.51; Rohrbach TD, 2017, ONCOL LETT, V13, P1216, DOI 10.3892/ol.2016.5550; Rohrbach TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140870; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tanabe A, 2006, BIOCHEM BIOPH RES CO, V345, P156, DOI 10.1016/j.bbrc.2006.04.082; Tchoghandjian A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.214; Toulany M, 2015, SEMIN CANCER BIOL, V35, P180, DOI 10.1016/j.semcancer.2015.07.003; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen PY, 2012, NEURO-ONCOLOGY, V14, P819, DOI 10.1093/neuonc/nos117; Wijaya J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122544; Willey CD, 2015, SEMIN RADIAT ONCOL, V25, P273, DOI 10.1016/j.semradonc.2015.05.008; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	53	5	5	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2020	39	46					6961	6974		10.1038/s41388-020-01511-9	http://dx.doi.org/10.1038/s41388-020-01511-9		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OQ9FF	33077834	Green Accepted			2022-12-26	WOS:000579741400002
J	Hardcastle, SJ; Jimenez-Castuera, R; Maxwell-Smith, C; Bulsara, MK; Hince, D				Hardcastle, Sarah J.; Jimenez-Castuera, Ruth; Maxwell-Smith, Chloe; Bulsara, Max K.; Hince, Dana			Fitbit wear-time and patterns of activity in cancer survivors throughout a physical activity intervention and follow-up: Exploratory analysis from a randomised controlled trial	PLOS ONE			English	Article							BREAST-CANCER; HEALTH; PARTICIPATION; BEHAVIORS	Objective There has been growing interest in the use of smart wearable technology to promote physical activity (PA) behaviour change. However, little is known concerning PA patterns throughout an intervention or engagement with trackers. The objective of the study was to explore patterns of Fitbit-measured PA and wear-time over 24-weeks and their relationship to changes in Actigraph-derived moderate-to-vigorous PA (MVPA). Methods Twenty-nine intervention participants (88%) from thewearableactivitytechnologyandaction-planning (WATAAP) trial in colorectal and endometrial cancer survivors accepted a Fitbit friend request from the research team to permit monitoring of Fitbit activity. Daily steps and active minutes were recorded for each participant over the 12-week intervention and throughout the follow-up period to 24-weeks. Accelerometer (GT9X) derived MVPA was assessed at end of intervention (12-weeks) and end of follow-up (24-weeks). Results Fitbit wear-time over the 24-weeks of data was remarkably consistent, with median adherence score of 100% for all weeks. During the intervention, participants recorded a median 8006 steps/day. Daily step count was slightly increased through week-13 to week-24 with a median of 8191 steps/day (p= 0.039). Actigraph and Fitbit derived measures were highly correlated but demonstrated poor agreement overall. Fitbit measured activity was closest to MVPA measured using Freedson cut-points as no bias was observed. Conclusions Step count was maintained throughout the trial displaying promise for the effectiveness of smart-wearable interventions to reduce sedentary behaviour beyond the intervention period. Further worthwhile work should compare more advanced smart-wearable technology with accelerometers in order to improve agreement and explore less resource-intensive methods to assess PA that could be scalable.	[Hardcastle, Sarah J.] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Hardcastle, Sarah J.; Bulsara, Max K.; Hince, Dana] Univ Notre Dame, Inst Hlth Res, Fremantle, WA, Australia; [Jimenez-Castuera, Ruth] Univ Extremadura, Fac Sport Sci, Caceres, Spain; [Maxwell-Smith, Chloe] Curtin Univ, Sch Psychol, Perth, WA, Australia	Dublin City University; University of Notre Dame Australia; Universidad de Extremadura; Curtin University	Hardcastle, SJ (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland.; Hardcastle, SJ (corresponding author), Univ Notre Dame, Inst Hlth Res, Fremantle, WA, Australia.	Sarah.hardcastle@dcu.edu.ie		Jimenez Castuera, Ruth/0000-0002-1377-6495; Hardcastle, Sarah/0000-0001-8378-3781	Tonkinson Colorectal Cancer Research Fund [57838]; Junta of Extremadura, Spain; St. John of God Gynecologic Oncology Research Group, Western Australia	Tonkinson Colorectal Cancer Research Fund; Junta of Extremadura, Spain; St. John of God Gynecologic Oncology Research Group, Western Australia	SH received a grant from the Tonkinson Colorectal Cancer Research Fund (#57838) for the larger trial. RJC received a grant from the Junta of Extremadura, Spain to sponsor her role in the study. We also acknowledge the small grant from the St. John of God Gynecologic Oncology Research Group, Western Australia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bluethmann SM, 2015, BREAST CANCER RES TR, V149, P331, DOI 10.1007/s10549-014-3255-5; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Burke LE, 2011, J AM DIET ASSOC, V111, P92, DOI 10.1016/j.jada.2010.10.008; Cadmus-Bertram L, 2015, JMIR MHEALTH UHEALTH, V3, P82, DOI 10.2196/mhealth.4229; Cadmus-Bertram LA, 2015, AM J PREV MED, V49, P414, DOI 10.1016/j.amepre.2015.01.020; Coughlin SS, 2016, J ENV HLTH SCI, V2; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119; Grym K, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2187-9; Hamer J, 2017, CAN MED ASSOC J, V189, pE268, DOI 10.1503/cmaj.160464; Hardcastle SJ, 2019, INT J BEHAV MED, V26, P551, DOI 10.1007/s12529-019-09808-0; Hardcastle SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210039; Hardcastle SJ, 2017, PSYCHO-ONCOLOGY, V26, P1099, DOI 10.1002/pon.4288; Hardcastle SJ, 2017, PSYCHO-ONCOLOGY, V26, P199, DOI 10.1002/pon.4111; Hartman SJ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.8503; Hartman SJ, 2018, CANCER-AM CANCER SOC, V124, P192, DOI 10.1002/cncr.30987; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hermsen S, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.7311; Kirk MA, 2018, AM J HLTH PROMOT, P1, DOI 10.1177/0890117118816278; Lyons EJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3469; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Maxwell-Smith C, 2021, PSYCHO-ONCOLOGY, V30, P221, DOI 10.1002/pon.5553; Maxwell-Smith C, 2018, INT J CLIN HLTH PSYC, V18, P124, DOI 10.1016/j.ijchp.2018.03.003; Maxwell-Smith C, 2017, PSYCHO-ONCOLOGY, V26, P808, DOI 10.1002/pon.4234; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Pope ZC, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060140; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Schmid D, 2014, ANN ONCOL, V25, P1293, DOI 10.1093/annonc/mdu012; Simblett S, 2018, J MED INTERNET RES, V20, DOI 10.2196/10480; Stephenson A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0561-4; Stewart J, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004016687211	34	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240967	10.1371/journal.pone.0240967	http://dx.doi.org/10.1371/journal.pone.0240967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075100	gold, Green Published			2022-12-26	WOS:000585920200015
J	La, TM; Tachibana, H; Li, SA; Abe, T; Seiriki, S; Nagaoka, H; Takashima, E; Takeda, T; Ogawa, D; Makino, S; Asanuma, K; Watanabe, M; Tian, XF; Ishibe, S; Sakane, A; Sasaki, T; Wada, J; Takei, K; Yamada, H				La, The Mon; Tachibana, Hiromi; Li, Shun-Ai; Abe, Tadashi; Seiriki, Sayaka; Nagaoka, Hikaru; Takashima, Eizo; Takeda, Tetsuya; Ogawa, Daisuke; Makino, Shin-ichi; Asanuma, Katsuhiko; Watanabe, Masami; Tian, Xuefei; Ishibe, Shuta; Sakane, Ayuko; Sasaki, Takuya; Wada, Jun; Takei, Kohji; Yamada, Hiroshi			Dynamin 1 is important for microtubule organization and stabilization in glomerular podocytes	FASEB JOURNAL			English	Article						dynamin; microtubules; podocyte; primary process	MECHANOCHEMICAL ENZYME; CRYSTAL-STRUCTURE; KIDNEY; PROTEIN; PHAGOCYTOSIS; CYTOSKELETON; NOCODAZOLE; HOMOLOGY; TUBULIN; COMPLEX	Dynamin 1 is a neuronal endocytic protein that participates in vesicle formation by scission of invaginated membranes. Dynamin 1 is also expressed in the kidney; however, its physiological significance to this organ remains unknown. Here, we show that dynamin 1 is crucial for microtubule organization and stabilization in glomerular podocytes. By immunofluorescence and immunoelectron microscopy, dynamin 1 was concentrated at microtubules at primary processes in rat podocytes. By immunofluorescence of differentiated mouse podocytes (MPCs), dynamin 1 was often colocalized with microtubule bundles, which radially arranged toward periphery of expanded podocyte. In dynamin 1-depleted MPCs by RNAi, alpha-tubulin showed a dispersed linear filament-like localization, and microtubule bundles were rarely observed. Furthermore, dynamin 1 depletion resulted in the formation of discontinuous, short acetylated alpha-tubulin fragments, and the decrease of microtubule-rich protrusions. Dynamins 1 and 2 double-knockout podocytes showed dispersed acetylated alpha-tubulin and rare protrusions. In vitro, dynamin 1 polymerized around microtubules and cross-linked them into bundles, and increased their resistance to the disassembly-inducing reagents Ca(2+)and podophyllotoxin. In addition, overexpression and depletion of dynamin 1 in MPCs increased and decreased the nocodazole resistance of microtubules, respectively. These results suggest that dynamin 1 supports the microtubule bundle formation and participates in the stabilization of microtubules.	[La, The Mon; Abe, Tadashi; Seiriki, Sayaka; Takeda, Tetsuya; Takei, Kohji; Yamada, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, 2-5-1 Shikata Cho, Okayama 7008558, Japan; [Tachibana, Hiromi; Ogawa, Daisuke; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Li, Shun-Ai; Watanabe, Masami] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Nagaoka, Hikaru; Takashima, Eizo] Ehime Univ, Div Malaria Res, Proteo Sci Ctr, Matsuyama, Ehime, Japan; [Makino, Shin-ichi; Asanuma, Katsuhiko] Chiba Univ, Grad Sch Med, Dept Nephrol, Chiba, Japan; [Tian, Xuefei; Ishibe, Shuta] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06510 USA; [Sakane, Ayuko; Sasaki, Takuya] Tokushima Univ, Grad Sch Med Sci, Dept Biochem, Tokushima, Japan; [Sakane, Ayuko] Inst PostLED Photon, Dept Interdisciplinary Res Med & Photon, Tokushima, Japan	Okayama University; Okayama University; Okayama University; Ehime University; Chiba University; Yale University; Tokushima University	Yamada, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	hiroyama@md.okayama-u.ac.jp	YAMADA, Hiroshi/B-2251-2011; WADA, Jun/B-2023-2011; Yamada, Hiroshi/AGZ-4497-2022	YAMADA, Hiroshi/0000-0002-9328-3446; WADA, Jun/0000-0003-1468-5170; Yamada, Hiroshi/0000-0002-9328-3446; Makino, Shin-ichi/0000-0003-0135-0435; nagaoka, hikaru/0000-0003-2167-1754; Takei, Kohji/0000-0002-6555-9425	MEXT | Japan Society for the Promotion of Science (JSPS) [JP19H03225, JP17K08808, JP19K07084]; Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP19H03225, JP17K08808 and JP19K07084; Okayama University Central Research Laboratory; Ehime University Proteo-Science Center (PROS)	Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Bai XB, 2013, J CELL BIOL, V203, P895, DOI 10.1083/jcb.201308068; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; BONNE D, 1985, J BIOL CHEM, V260, P2819; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Elie A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09964; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Khalil R, 2019, J PATHOL, V247, P177, DOI 10.1002/path.5181; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kurklinsky S, 2011, J NEUROCHEM, V117, P48, DOI 10.1111/j.1471-4159.2011.07169.x; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NAKATA T, 1993, J CELL SCI, V105, P1; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prezel E, 2018, MOL BIOL CELL, V29, P154, DOI 10.1091/mbc.E17-06-0429; Schiffer M, 2015, NAT MED, V21, P601, DOI 10.1038/nm.3843; SCHILSTRA MJ, 1989, J BIOL CHEM, V264, P8827; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Sever S, 2018, KIDNEY INT, V93, P1298, DOI 10.1016/j.kint.2017.12.028; Sever S, 2013, TRAFFIC, V14, P1194, DOI 10.1111/tra.12116; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; TAKEMURA R, 1992, J CELL SCI, V103, P953; TAKEMURA R, 1995, MOL BIOL CELL, V6, P981, DOI 10.1091/mbc.6.8.981; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; TORRE E, 1994, J BIOL CHEM, V269, P32411; VASMANT D, 1984, ANAT REC, V210, P17, DOI 10.1002/ar.1092100104; Yamada H, 2013, J NEUROSCI, V33, P4514, DOI 10.1523/JNEUROSCI.2762-12.2013; Zhang RH, 2020, NAT CELL BIOL, V22, P674, DOI 10.1038/s41556-020-0519-7; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	43	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16449	16463		10.1096/fj.202001240RR	http://dx.doi.org/10.1096/fj.202001240RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070431	hybrid, Green Published			2022-12-26	WOS:000581167100001
J	Tyabji, Z; Wagh, T; Patankar, V; Jabado, RW; Sutaria, D				Tyabji, Zoya; Wagh, Tanmay; Patankar, Vardhan; Jabado, Rima W.; Sutaria, Dipani			Catch composition and life history characteristics of sharks and rays (Elasmobranchii) landed in the Andaman and Nicobar Islands, India	PLOS ONE			English	Article							PATTERNS; GROWTH; WATERS; SEA; CHONDRICHTHYANS; EXPLOITATION; CHIMERAS; STINGRAY; ATOLL; GULF	Detailed information on shark and ray fisheries in the Andaman and Nicobar Islands, India are limited, including information on the diversity and biological characteristics of these species. We carried out fish landing surveys in South Andamans from January 2017 to May 2018, a comprehensive and cost-effective way to fill this data gap. We sampled 5,742 individuals representing 57 shark and ray species landed from six types of fishing gears. Of the 36 species of sharks and 21 species of rays landed, six species of sharks (Loxodon macrorhinus, Carcharhinus amblyrhynchos, Sphyrna lewini, C. albimarginatus, C. brevipinna, and Paragaleus randalli) comprised 83.35% of shark landings, while three species of rays (Pateobatis jenkinsii, Himantura leoparda and H. tutul) comprised 48.82% of ray landings, suggesting a species dominance in the catch or fishing region. We provide insights into the biology of species with extensions in maximum size for seven shark species. Additionally, we document an increase in the known ray diversity for the islands and for India with three previously unreported ray species. We found that amongst sharks, mature individuals of small-bodied species (63.48% males of total landings of species less than 1.5 m total length when mature) and immature individuals of larger species (84.79% males of total landings of species larger than 1.5 m total length when mature) were mostly landed; whereas for rays, mature individuals were predominantly landed (80.71% males of total landings) likely reflecting differences in habitat preferences along life-history stages across species and fishing gear. The largest size range in sharks was recorded in landings from pelagic longlines and gillnets. Further, the study emphasizes the overlap between critical habitats and fishing grounds, where immature sharks and gravid females were landed in large quantities which might be unsustainable in the long-term. Landings were female-biased in C. amblyrhynchos, S. lewini and P. jenkinsii, and male-biased in L. macrorhinus and H. leoparda, indicating either spatio-temporal or gear-specific sexual segregation in these species. Understanding seasonal and biological variability in the shark and ray landings over a longer study period across different fisheries will inform future conservation and fishery management measures for these species in the Andaman and Nicobar Islands.	[Tyabji, Zoya] North Wandoor, Andaman Nicobar Environm Team, South Andaman, Andaman & Nicob, India; [Tyabji, Zoya; Wagh, Tanmay; Patankar, Vardhan] Wildlife Conservat Soc, Bengaluru, Karnataka, India; [Jabado, Rima W.] Elasmo Project, Dubai, U Arab Emirates; [Sutaria, Dipani] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	James Cook University	Tyabji, Z (corresponding author), North Wandoor, Andaman Nicobar Environm Team, South Andaman, Andaman & Nicob, India.; Tyabji, Z (corresponding author), Wildlife Conservat Soc, Bengaluru, Karnataka, India.	zoya.tyabji@gmail.com		Jabado, Rima/0000-0001-6239-6723	Rufford Foundation [21010-1]; Conservation Leadership Programme [03332917]	Rufford Foundation; Conservation Leadership Programme	The Rufford Foundation (Rufford Small Grant: 21010-1) and Conservation Leadership Programme (Future Conservationist Award: 03332917) provided funding to ZT to carry out this study. The funders had no role in the study design,	Akhilesh K.V., 2011, DEEP SEA FISHING CHO; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Arunrugstichai S, 2018, J FISH BIOL, V92, P1487, DOI 10.1111/jfb.13605; Barnes A, 2018, AQUAT CONSERV, V28, P1374, DOI 10.1002/aqc.2940; Bhargava AK, 2002, MANAGEMENT SCOMBROID, P165; Bradley D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172370; BRANSTETTER S, 1987, COPEIA, P964; Castro J. I., 1983, SHARKS N AM WATERS; Christensen J, 2014, MARE PUBL SER, V12, P1, DOI 10.1007/978-94-017-8727-7_1; Compagno L, FIELD GUIDE SHARKS W; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Duncan KM, 2006, MAR ECOL PROG SER, V312, P211, DOI 10.3354/meps312211; Ebert D.A., 2015, POCKET GUIDE SHARKS; Economakis AE, 1998, ENVIRON BIOL FISH, V51, P129, DOI 10.1023/A:1007416813214; Hacohen-Domene A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227797; Hasan MDM, 2018, J AQUATIC MARINE BIO, V7, P136, DOI [10.15406/jamb.2018.07.00199, DOI 10.15406/JAMB.2018.07.00199]; Henderson AC, 2007, SURVEY STATUS UTILIZ; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hornby C, 2015, RECONSTRUCTION ANDAM, V2015, P1; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jabado R.W., 2015, SHARKS ARABIAN SEAS; Jabado R.W., 2019, WEDGEFISHES GIANT GU; Jabado RW, 2018, FISH FISH, V19, P1043, DOI 10.1111/faf.12311; Jabado RW, 2015, BIOL CONSERV, V181, P190, DOI 10.1016/j.biocon.2014.10.032; Jaini M, 2018, ENVIRON CONSERV, V45, P41, DOI [10.1017/S037689291700042X, 10.1017/s037689291700042x]; Jayaprakash AA, 2002, MANAGEMENT SCOMBROID, P155; Kar AB, 2011, BYCATCH TUNA LONGLIN, V19; Karnad D, 2020, AMBIO, V49, P616, DOI 10.1007/s13280-019-01203-z; Karnad D, 2014, ORYX, V48, P218, DOI 10.1017/S0030605312001251; Kirubasankar R., 2013, Asian Fisheries Science, V26, P167; Kumar R. R., 2015, WORLD J FISH MARINE, V7, P479, DOI [10.5829/IDOSI.WJFMS.2015.7.6.101184, DOI 10.5829/IDOSI.WJFMS.2015.7.6.101184]; Kumar RR, 2018, ACTA ICHTHYOL PISCAT, V48, P289, DOI 10.3750/AIEP/02336; Kumar RR, 2016, ACTA ICHTHYOLOGICA P, V46; Kyne PM, 2020, AQUAT CONSERV, P1; Last P. R., 2016, P1; Manjaji BM., 1837, THESIS; MCKIBBEN JN, 1986, B MAR SCI, V38, P89; Mohamad Kasim H., 1991, Journal of the Marine Biological Association of India, V33, P213; Mohamed KS, 2016, CURR SCI INDIA, V110, P584, DOI 10.18520/cs/v110/i4/584-594; Mohanraj G., 2009, Asian Fisheries Science, V22, P607; Moore ABM, 2012, J FISH BIOL, V80, P1619, DOI 10.1111/j.1095-8649.2011.03210.x; Nalesso E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213741; Nithyanandan R, 2009, DEV ISLAND FISHERIES, P1; Okes N, OVERVIEW MAJOR SHARK; Oliver S, 2015, MAR POLICY, V54, P86, DOI 10.1016/j.marpol.2014.12.017; PARSONS GR, 1985, COPEIA, P80; Patankar V, 2015, HUM ECOL, V43, P697, DOI 10.1007/s10745-015-9781-x; Pradeep H. D., 2017, Journal of Threatened Taxa, V9, P10899, DOI 10.11609/jott.3315.9.11.10899-10903; Pradeep HD, 2017, MAR BIODIVERS, V47, P535, DOI 10.1007/s12526-016-0499-9; Prokofiev AM, 2019, J ICHTHYOL+, V59, P113, DOI 10.1134/S0032945219010144; Rajan PT, 2003, ZOOLOGICAL SURVEY IN, P1; Rajan PT, 2016, J ANDAMAN SCI ASS, V21, P221; Ramachandran S., 2000, ANDAMAN NICOBAR LAKS; Roberts Tyson R., 2006, Natural History Bulletin of the Siam Society, V54, P285; Roy SD., 2010, INDIAN J ANIM SCI, V80, P57; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Simpfendorfer CA, 2009, ENVIRON CONSERV, V36, P97, DOI 10.1017/S0376892909990191; Smith WD, 2008, MAR FRESHWATER RES, V59, P575, DOI 10.1071/MF07020; STEVENS JD, 1984, PROC R SOC SER B-BIO, V222, P79, DOI 10.1098/rspb.1984.0050; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tyabji Z, 2018, BIODIVERS DATA J, V6, DOI 10.3897/BDJ.6.e28593; Valinassab T, 2006, J MAR BIOL ASSOC UK, V86, P1455, DOI 10.1017/S0025315406014512; Varghese S, 2007, BYCATCH SHARKS INCID; Vianna GMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060331; Walker TI, 2007, MAR FRESHWATER RES, V58, P67, DOI 10.1071/MF06074; White WT, 2013, ZOOTAXA, V 3752, P172, DOI 10.11646/zootaxa.3752.1.10; Yamaguchi A, 2000, ENVIRON BIOL FISH, V57, P221, DOI 10.1023/A:1007558324902; Zacharia P. U., 2017, CMFRI MAR FISHER POL, V6, P1; Zar JH, 1999, BIOSTATISTICAL ANAL	71	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0231069	10.1371/journal.pone.0231069	http://dx.doi.org/10.1371/journal.pone.0231069			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119595	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000600013600109
J	Gao, JQ; Li, JY; Wang, MQ				Gao, Jiaqi; Li, Jiayuan; Wang, Mengqiao			Time series analysis of cumulative incidences of typhoid and paratyphoid fevers in China using both Grey and SARIMA models	PLOS ONE			English	Article							CLIMATE-CHANGE; PROVINCE; RISK; DIAGNOSIS; DISEASES	Typhoid and paratyphoid fevers are common enteric diseases causing disability and death in China. Incidence data of typhoid and paratyphoid between 2004 and 2016 in China were analyzed descriptively to explore the epidemiological features such as age-specific and geographical distribution. Cumulative incidence of both fevers displayed significant decrease nationally, displaying a drop of 73.9% for typhoid and 86.6% for paratyphoid in 2016 compared to 2004. Cumulative incidence fell in all age subgroups and the 0-4 years-old children were the most susceptible ones in recent years. A cluster of three southwestern provinces (Yunnan, Guizhou, and Guangxi) were the top high-incidence regions. Grey model GM (1,1) and seasonal autoregressive integrated moving average (SARIMA) model were employed to extract the long-term trends of the diseases. Annual cumulative incidence for typhoid and paratyphoid were formulated by GM (1,1) as (x) over cap (t)=-14.98(e(-0.10(t-2004)) - e(-0.10(t-2005))) and (x) over cap (t)=-4.96(e(-0.19(t-2004)) - e(-0.19(t-2005))) respectively. SARIMA (0,1,7) x (1,0,1)(12) was selected among a collection of constructed models for high R-2 and low errors. The predictive models for both fevers forecasted cumulative incidence to continue the slightly downward trend and maintain the cyclical seasonality in near future years. Such data-driven insights are informative and actionable for the prevention and control of typhoid and paratyphoid fevers as serious infectious diseases.	[Gao, Jiaqi; Li, Jiayuan; Wang, Mengqiao] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Peoples R China; [Gao, Jiaqi; Li, Jiayuan; Wang, Mengqiao] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China	Sichuan University; Sichuan University	Wang, MQ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Peoples R China.	mengqiaowang@gmail.com	li, jia/GVT-7587-2022	Wang, Mengqiao/0000-0002-3391-7507	Basic Research Grant from the Department of Science and Technology of Sichuan Province [2019YJ0035]	Basic Research Grant from the Department of Science and Technology of Sichuan Province	Research by Mengqiao Wang is funded by a Basic Research Grant from the Department of Science and Technology of Sichuan Province (Grant number: 2019YJ0035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, Nurs Res, V68, pE21, DOI 10.1097/NNR.0000000000000351; [Anonymous], 2019, Cancer Discov, V9, pOF3, DOI 10.1158/2159-8290.CD-NB2018-158; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Anwar MY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1602-1; Arya SC, 2012, T ROY SOC TROP MED H, V106, P776, DOI 10.1016/j.trstmh.2012.09.001; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeRoeck D, 2008, EXPERT REV VACCINES, V7, P547, DOI 10.1586/14760584.7.5.547; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Fu T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52044-5; Gibani MM, 2018, CURR OPIN INFECT DIS, V31, P440, DOI [10.1097/QCO.0000000000000479, 10.1097/qco.0000000000000479]; Gu H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05928-3; Hui-Yu H, 2017, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V29, P436, DOI 10.16250/j.32.1374.2017088; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Lee CC, 2007, ENVIRON MONIT ASSESS, V132, P351, DOI 10.1007/s10661-006-9539-4; Li K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35685-w; Liu Hai-xia, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P328; Liu L, 2016, EPIDEMIOL INFECT, V144, P144, DOI [10.1017/S0950268815001144, 10.1017/S0950268815001582]; Liu Q, 2019, INFECT DRUG RESIST, V12, P2311, DOI 10.2147/IDR.S207809; Liu ZD, 2018, ENVIRON RES, V167, P718, DOI 10.1016/j.envres.2018.08.030; Lunguya O, 2012, T ROY SOC TROP MED H, V106, P348, DOI 10.1016/j.trstmh.2012.03.006; Mahmod WE, 2014, ENVIRON MONIT ASSESS, V186, P1063, DOI 10.1007/s10661-013-3439-1; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; McIver LJ, 2016, ASIA-PAC J PUBLIC HE, V28, P576, DOI 10.1177/1010539516660190; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Naheed A, 2010, INT J INFECT DIS, V14, pE93, DOI 10.1016/j.ijid.2009.11.023; Obaro SK, 2017, EXPERT REV VACCINES, V16, P249, DOI 10.1080/14760584.2017.1255553; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Safaeian M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-6; Stanaway JD, 2019, LANCET INFECT DIS, V19, P369, DOI 10.1016/S1473-3099(18)30685-6; Wang JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002112; Wang L X, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P1504, DOI 10.3760/cma.j.issn.0254-6450.2017.11.013; Wang LX, 2012, CHINESE MED J-PEKING, V125, P455, DOI 10.3760/cma.j.issn.0366-6999.2012.03.010; WHO, 2018, NEWSR TYPH; Yan C Q, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P633, DOI 10.3760/cma.j.issn.0254-6450.2019.06.006; Yang XB, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011787; Zhang LP, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030262; Zhang X, 2013, COLLOID SURFACE A, V435, P85, DOI 10.1016/j.colsurfa.2012.12.056	39	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241217	10.1371/journal.pone.0241217	http://dx.doi.org/10.1371/journal.pone.0241217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112899	gold, Green Published			2022-12-26	WOS:000588374000032
J	Borchert, C; Herman, A; Roth, M; Brooks, AC; Friedenberg, SG				Borchert, Corie; Herman, Adam; Roth, Megan; Brooks, Aimee C.; Friedenberg, Steven G.			RNA sequencing of whole blood in dogs with primary immune-mediated hemolytic anemia (IMHA) reveals novel insights into disease pathogenesis	PLOS ONE			English	Article							PHOSPHOLIPID SCRAMBLASE 1; GENE-EXPRESSION; PROGNOSTIC-FACTORS; INDOLEAMINE 2,3-DIOXYGENASE; CELL; SEQ; PAI-1; AUTOANTIBODIES; CLASSIFICATION; IDENTIFICATION	Immune-mediated hemolytic anemia (IMHA) is a life-threatening autoimmune disorder characterized by a self-mediated attack on circulating red blood cells. The disease occurs naturally in both dogs and humans, but is significantly more prevalent in dogs. Because of its shared features across species, dogs offer a naturally occurring model for studying IMHA in people. In this study, we used RNA sequencing of whole blood from treatment-naive dogs to study transcriptome-wide changes in gene expression in newly diagnosed animals compared to healthy controls. We found many overexpressed genes in pathways related to neutrophil function, coagulation, and hematopoiesis. In particular, the most highly overexpressed gene in cases was a phospholipase scramblase, which mediates the externalization of phosphatidylserine from the inner to the outer leaflet of cell membranes. This family of genes has been shown to be critically important for programmed cell death of erythrocytes as well as the initiation of the clotting cascade. Unexpectedly, we found marked underexpression of many genes related to lymphocyte function. We also identified groups of genes that are highly associated with the inflammatory response and red blood cell regeneration in affected dogs. We did not find any genes that distinguished dogs that lived vs. those that died at 30 days following diagnosis, nor did we find any relevant genomic signatures of microbial organisms in the blood of affected animals. Future studies are warranted to validate these findings and assess their implication in developing novel therapeutic approaches for dogs and humans with IMHA.	[Borchert, Corie; Roth, Megan; Friedenberg, Steven G.] Univ Minnesota, Dept Vet Clin Sci, Coll Vet Med, St Paul, MN 55455 USA; [Herman, Adam] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Brooks, Aimee C.] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Friedenberg, SG (corresponding author), Univ Minnesota, Dept Vet Clin Sci, Coll Vet Med, St Paul, MN 55455 USA.	fried255@umn.edu		Friedenberg, Steven/0000-0002-7510-2322	American Kennel Club Canine Health Foundation [02348]; NIH Special Emphasis Research Career Award [K01 OD027058]; Division of Comparative Medicine, Office of Research Infrastructure Programs	American Kennel Club Canine Health Foundation; NIH Special Emphasis Research Career Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Comparative Medicine, Office of Research Infrastructure Programs	This study was funded by a grant to SGF from the American Kennel Club Canine Health Foundation (akcchf.org; 02348). SGF is also supported by an NIH Special Emphasis Research Career Award (nih.gov; K01 OD027058) in Pathology and Comparative Medicine sponsored by the Division of Comparative Medicine, Office of Research Infrastructure Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amengual O, 2013, MOD RHEUMATOL, V23, P81, DOI 10.1007/s10165-012-0642-9; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2016, NUCL ACIDS RES, V44, pD7; [Anonymous], 2013, NUCL ACIDS RES, V41, pD43; [Anonymous], 2015, PULSE INT, V16, P1; [Anonymous], 2012, BEST GEH 16 O METH R, V46, P1, DOI DOI 10.1016/J.RENENE.2012.02.031; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, JLSRF, V3, pA104; Baluta Monica Mariana, 2015, Maedica (Bucur), V10, P147; BARKER RN, 1991, CLIN EXP IMMUNOL, V85, P33, DOI 10.1111/j.1365-2249.1991.tb05678.x; Barker RN, 1997, BLOOD, V90, P2701, DOI 10.1182/blood.V90.7.2701.2701_2701_2715; BARKER RN, 1995, VET IMMUNOL IMMUNOP, V47, P225, DOI 10.1016/0165-2427(94)05407-J; Barkerm RN, 2008, CLIN EXP IMMUNOL, V85, P33; Berentsen S, 2018, SEMIN HEMATOL, V55, P141, DOI 10.1053/j.seminhematol.2018.04.002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bukh J, 2011, P NATL ACAD SCI USA, V108, P12563, DOI 10.1073/pnas.1107612108; Burgess K, 2000, J VET INTERN MED, V14, P456, DOI 10.1892/0891-6640(2000)014&lt;0456:TOIHAI&gt;2.3.CO;2; BURKA ER, 1968, BIOCHIM BIOPHYS ACTA, V166, P672, DOI 10.1016/0005-2787(68)90374-2; Carr AP, 2002, J VET INTERN MED, V16, P504, DOI 10.1892/0891-6640(2002)016&lt;0504:PFFMAT&gt;2.3.CO;2; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Da Costa L, 2013, BLOOD REV, V27, P167, DOI 10.1016/j.blre.2013.04.003; Day MJ, 1999, VET IMMUNOL IMMUNOP, V69, P215, DOI 10.1016/S0165-2427(99)00055-0; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; do Nascimento NC, 2018, VET RES, V49, DOI 10.1186/s13567-018-0546-6; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Englert JA, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0981-6; Fecho K, 2019, CTS-CLIN TRANSL SCI, V12, P86, DOI 10.1111/cts.12591; Friedenberg SG, 2017, MAMM GENOME, V28, P56, DOI 10.1007/s00335-016-9671-6; Friedenberg SG, 2016, AM J VET RES, V77, P693, DOI 10.2460/ajvr.77.7.693; Garden OA, 2019, J VET INTERN MED, V33, P313, DOI 10.1111/jvim.15441; Goggs R, 2012, VET J, V191, P347, DOI 10.1016/j.tvjl.2011.03.015; Grammatikos AP, 2014, CLIN IMMUNOL, V150, P192, DOI 10.1016/j.clim.2013.12.002; HEALY AM, 1994, J BIOL CHEM, V269, P19095; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Horgan JE, 2009, J VET EMERG CRIT CAR, V19, P254, DOI 10.1111/j.1476-4431.2009.00419.x; Iwamoto S, 2001, AM J HEMATOL, V68, P106, DOI 10.1002/ajh.1161; Jarvis BDW, 1997, INT J SYST BACTERIOL, V47, P895, DOI 10.1099/00207713-47-3-895; Jeong TD, 2017, HLA, V89, P47, DOI 10.1111/tan.12943; Joehanes R, 2012, PHYSIOL GENOMICS, V44, P59, DOI 10.1152/physiolgenomics.00130.2011; Johnson V, 2016, VET IMMUNOL IMMUNOP, V180, P15, DOI 10.1016/j.vetimm.2016.08.010; Kalfa TA, 2016, HEMATOL-AM SOC HEMAT, P690, DOI 10.1182/asheducation-2016.1.690; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Karagianni AE, 2012, AM J VET RES, V73, P1403, DOI 10.2460/ajvr.73.9.1403; Katsuyama T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01088; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Khatoon Z, 2014, DRUG DEVELOP RES, V75, P324, DOI 10.1002/ddr.21215; Kidd L, 2014, J VET EMERG CRIT CAR, V24, P311, DOI 10.1111/vec.12186; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kjelgaard-Hansen M, 2011, J VET INTERN MED, V25, P76, DOI 10.1111/j.1939-1676.2010.0642.x; KLAG AR, 1993, J AM VET MED ASSOC, V202, P783; Kodigepalli KM, 2015, FEBS LETT, V589, P3, DOI 10.1016/j.febslet.2014.11.036; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Ling TT, 2015, EUR J MED CHEM, V102, P9, DOI 10.1016/j.ejmech.2015.07.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loskutoff DJ, 1998, ARTERIOSCL THROM VAS, V18, P1, DOI 10.1161/01.ATV.18.1.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAYUMI M, 1992, LEUKEMIA LYMPHOMA, V7, P243, DOI 10.3109/10428199209053629; McAlees TJ, 2010, AUST VET J, V88, P25, DOI 10.1111/j.1751-0813.2009.00537.x; McCullough S, 2003, VET CLIN N AM-SMALL, V33, P1295, DOI 10.1016/j.cvsm.2003.08.003; Mellett AM, 2010, J VET INTERN MED, V24, P755; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Michel M, 2011, EXPERT REV HEMATOL, V4, P607, DOI 10.1586/EHM.11.60; Milkins C, 2013, TRANSFUSION MED, V23, P3, DOI 10.1111/j.1365-3148.2012.01199.x; Miller SA, 2004, JAVMA-J AM VET MED A, V224, P232, DOI 10.2460/javma.2004.224.232; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mostafavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068141; Mufti GJ, 2018, HEMATOL ONCOL CLIN N, V32, P595, DOI 10.1016/j.hoc.2018.03.002; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nakata R, 2003, MICROBES INFECT, V5, P947, DOI 10.1016/S1286-4579(03)00180-1; National Joint Committee for the Communication Needs of Persons With Severe Disabilities, 1992, ASHA S7, V34, P1; Nelp MT, 2018, P NATL ACAD SCI USA, V115, P3249, DOI 10.1073/pnas.1719190115; Pantaleo A, 2008, AUTOIMMUN REV, V7, P457, DOI 10.1016/j.autrev.2008.03.017; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piek CJ, 2008, J VET INTERN MED, V22, P366, DOI 10.1111/j.1939-1676.2008.0060.x; Piek CJ, 2011, VET QUART, V31, P129, DOI 10.1080/01652176.2011.604979; Poulsen M, 2010, ENV MICROBIOL REP, V2, P534, DOI 10.1111/j.1758-2229.2009.00098.x; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Rauen T, 2012, J BIOL CHEM, V287, P42525, DOI 10.1074/jbc.M112.425371; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Reimer ME, 1999, J AM ANIM HOSP ASSOC, V35, P384, DOI 10.5326/15473317-35-5-384; Rets A, 2019, INT J LAB HEMATOL, V41, P95, DOI 10.1111/ijlh.13014; Ricci F, 2005, BIOSENS BIOELECTRON, V21, P389, DOI 10.1016/j.bios.2004.12.001; Scagnelli AM, 2018, JAVMA-J AM VET MED A, V252, P1108, DOI 10.2460/javma.252.9.1108; Seki T, 1996, J CELL PHYSIOL, V168, P648; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shettihalli AK, 2013, CHEM RES TOXICOL, V26, P918, DOI 10.1021/tx400090h; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith DB, 2016, J GEN VIROL, V97, P2894, DOI 10.1099/jgv.0.000612; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki E, 2010, J RHEUMATOL, V37, P1639, DOI 10.3899/jrheum.091420; Swann JW, 2019, J VET INTERN MED, V33, P1141, DOI 10.1111/jvim.15463; Swann JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168296; Tan E, 2012, VET CLIN PATH, V41, P45, DOI 10.1111/j.1939-165X.2011.00391.x; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; The Gene Ontology Consortium, 2019, NUCL ACIDS RES, V47, pD330; Thorndike R. L., 1953, PSYCHOMETRIKA, V18, P267, DOI [10.1007/BF02289263, DOI 10.1007/BF02289263]; Vaughan DE, 2005, J THROMB HAEMOST, V3, P1879, DOI 10.1111/j.1538-7836.2005.01420.x; Vousden KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38842-x; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Weinkle TK, 2005, JAVMA-J AM VET MED A, V226, P1869, DOI 10.2460/javma.2005.226.1869; Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu C, 2017, PSYCHIAT CLIN NEUROS, V71, P663, DOI 10.1111/pcn.12550; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; Zhang Xiaohong, 2014, TECHNOLOGY VIEWS, V24, P14; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3; [No title captured]; [No title captured]; 2012, SURG OBES RELAT DIS, V8	124	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240975	10.1371/journal.pone.0240975	http://dx.doi.org/10.1371/journal.pone.0240975			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091028	gold, Green Published			2022-12-26	WOS:000586647200039
J	Maeda, K				Maeda, Koki			Use of corn stover as bulking agent in dairy manure composting toward Japanese circular dairy farming	PLOS ONE			English	Article							NITRATE-NITROGEN CONCENTRATION; DENITRIFIER COMMUNITY; BIOGAS PRODUCTION; MATURE COMPOST; SWINE MANURE; PRETREATMENT; VIABILITY; PATHOGENS; EMISSION; ETHANOL	In response to the recent development of ear corn feeding systems and the shortage of bulking agents for manure composting in the Hokkaido region, the plausibility of using corn stover (a residue of ear corn harvesting) as an alternative bulking agent for dairy manure composting was tested. The temperature profile, quality of the final product, and greenhouse gas emissions were evaluated and compared with the values obtained from manure that used wheat straw, a typical bulking agent. A sufficiently high temperature profile (>70 degrees C) and active organic matter degradation were achieved by mixing in corn stover. After active organic matter degradation for 8 weeks, CO(2)production was significantly lower and the stable final products were obtained. The total solids level increased significantly, to 48.8-50.4%, while the C/N ratio dropped significantly, from 19.9-21.8 to 11.2-12.8. Methane emission from the corn-stover-based pile was 0.36% of initial volatile solids, while nitrous oxide emission was 0.58% of initial N, proving that the use of corn stover can mitigate greenhouse gas emission and that its mitigating effect was comparable to those of other bulking agents. Together, the results showed that the use of corn stover can be a suitable alternative bulking agent for dairy manure composting and can serve as part of an ecologically friendly and "circular" method of dairy farming.	[Maeda, Koki] NARO, Dairy Res Div, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan	National Agriculture & Food Research Organization - Japan	Maeda, K (corresponding author), NARO, Dairy Res Div, Hokkaido Agr Res Ctr, Sapporo, Hokkaido, Japan.	k_maeda@affrc.go.jp	MAEDA, Koki/D-7869-2011	MAEDA, Koki/0000-0002-2353-0042	National Agriculture and Food Research Organization (NARO)	National Agriculture and Food Research Organization (NARO)	The author thanks Dr. Eiko Nemoto and Dr. Tomoko Oshita for providing the corn stover collection data. This work was supported by the National Agriculture and Food Research Organization (NARO).	Adler PR, 2015, BIOENERG RES, V8, P1310, DOI 10.1007/s12155-015-9593-2; Barberi P, 2002, WEED RES, V42, P177, DOI 10.1046/j.1365-3180.2002.00277.x; BEDWELL CL, 1995, J VET DIAGN INVEST, V7, P527, DOI 10.1177/104063879500700418; Blanco-Canqui H, 2009, SOIL SCI SOC AM J, V73, P418, DOI 10.2136/sssaj2008.0141; Bondesson PM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-11; Chen C, 2013, MECH MACH THEORY, V59, P96, DOI 10.1016/j.mechmachtheory.2012.09.004; Dias BO, 2010, BIORESOURCE TECHNOL, V101, P1239, DOI 10.1016/j.biortech.2009.09.024; Eghball B, 2000, COMPOST SCI UTIL, V8, P46; Fukumoto Y, 2003, BIORESOURCE TECHNOL, V89, P109, DOI 10.1016/S0960-8524(03)00060-9; Grewal SK, 2006, APPL ENVIRON MICROB, V72, P565, DOI 10.1128/AEM.72.1.565-574.2006; Hanajima D, 2020, ANIMAL SCI J, V91, DOI [10.1111/asj.13323, DOI 10.1111/ASJ.1332331797498]; Hanajima D, 2014, ANIM SCI J, V85, P919, DOI 10.1111/asj.12223; Harada H, 2000, SOIL SCI PLANT NUTR, V46, P97, DOI 10.1080/00380768.2000.10408766; Harada H, 2001, SOIL SCI PLANT NUTR, V47, P601, DOI 10.1080/00380768.2001.10408423; Huet J, 2012, BIORESOURCE TECHNOL, V114, P428, DOI 10.1016/j.biortech.2012.03.031; Iqbal MK, 2010, BIORESOURCE TECHNOL, V101, P1913, DOI 10.1016/j.biortech.2009.10.030; Konno E, 2012, NOSON KENKYU, V115, P38; Konno E, 2011, NOSON KENKYU, V113, P53; Larney FJ, 2003, J ENVIRON QUAL, V32, P1105, DOI 10.2134/jeq2003.1105; Maeda K, 2018, CHEMOSPHERE, V206, P310, DOI 10.1016/j.chemosphere.2018.04.169; Maeda K, 2011, MICROB BIOTECHNOL, V4, P700, DOI 10.1111/j.1751-7915.2010.00236.x; Maeda K, 2010, MICROB ECOL, V59, P25, DOI 10.1007/s00248-009-9547-3; Martin G, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0390-x; National Greenhouse Gas Inventory Report of JAPAN, 2019, NAT GREENH GAS INV R; Noble R, 2004, PLANT PATHOL, V53, P548, DOI 10.1111/j.0032-0862.2004.01059.x; Otsu E., 2012, Japanese Journal of Grassland Science, V58, P95; Petrolia DR, 2008, BIOMASS BIOENERG, V32, P603, DOI 10.1016/j.biombioe.2007.12.012; Ryschawy J, 2017, NUTR CYCL AGROECOSYS, V108, P5, DOI 10.1007/s10705-016-9815-9; SAS Institute I, 2001, SAS STAT USERS GUIDE; Sasaki H, 2006, ANIM SCI J, V77, P545, DOI 10.1111/j.1740-0929.2006.00384.x; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Shi J, 2013, BIORESOURCE TECHNOL, V136, P574, DOI 10.1016/j.biortech.2013.02.073; Shinners KJ, 2007, BIOMASS BIOENERG, V31, P211, DOI 10.1016/j.biombioe.2006.04.007; Tiquia SM, 1997, BIORESOURCE TECHNOL, V62, P37, DOI 10.1016/S0960-8524(97)00080-1; Tompkins DK, 1998, COMPOST SCI UTIL, V6, P30; Van Zanten HHE, 2019, GLOB FOOD SECUR-AGR, V21, P18, DOI 10.1016/j.gfs.2019.06.003; Vuorinen AH, 2000, BIORESOURCE TECHNOL, V75, P133, DOI 10.1016/S0960-8524(00)00042-0; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150; Wilhelm WW, 2004, AGRON J, V96, P1, DOI 10.2134/agronj2004.0001; Willers HC, 1998, BIORESOURCE TECHNOL, V64, P47, DOI 10.1016/S0960-8524(97)00151-X; Zhou SX, 2012, ENERGY, V46, P644, DOI 10.1016/j.energy.2012.07.017; Zhu NW, 2007, BIORESOURCE TECHNOL, V98, P9, DOI 10.1016/j.biortech.2005.12.003	42	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241064	10.1371/journal.pone.0241064	http://dx.doi.org/10.1371/journal.pone.0241064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091921	Green Published, gold			2022-12-26	WOS:000586647200036
J	Gao, LW; Zhu, HT; Liu, CY; Lv, ZX; Fan, XM; Zhang, YW				Gao, Li-Wei; Zhu, Hong-Tao; Liu, Cai-Yun; Lv, Zhi-Xiang; Fan, Xiao-Man; Zhang, Ye-Wang			A highly active heparinase I fromBacteroides cellulosilyticus: Cloning, high level expression, and molecular characterization	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; FLAVOBACTERIUM-HEPARINUM; PURIFICATION; DEGRADATION; RESIDUE; LYASES	As one of the most extensively studied glycosaminoglycan lyases, heparinase I has been used in producing low or ultra-low molecular weight heparin. Its' important applications are to neutralize the heparin in human blood and analyze heparin structure in the clinic. However, the low productivity and activity of the enzyme have greatly hindered its applications. In this study, a novel Hep-I fromBacteroides cellulosilyticus(BcHep-I) was successfully cloned and heterologously expressed inE.coliBL21 (DE3) as a soluble protein. The molecular mass and isoelectric point (pI) of the enzyme are 44.42 kDa and 9.02, respectively. And the characterization of BcHep-I after purified with Ni-NTA affinity chromatography suggested that it is a mesophilic enzyme. BcHep-I can be activated by 1 mM Ca2+, Mg2+, and Mn2+, while severely inhibited by Zn2+, Co2+, and EDTA. The specific activity of the enzyme was 738.3 U center dot mg(-1)which is the highest activity ever reported. TheK(m)andV(max)were calculated as 0.17 mg center dot mL(-1)and 740.58 U center dot mg(-1), respectively. Besides, the half-life of 300 min at 30 degrees C showed BcHep-I has practical applications. Homology modeling and substrate docking revealed that Gln15, Lys74, Arg76, Lys104, Arg149, Gln208, Tyr336, Tyr342, and Lys338 were mainly involved in the substrate binding of Hep-I, and 11 hydrogen bonds were formed between heparin and the enzyme. These results indicated that BcHep-I with high activity has great potential applications in the industrial production of heparin, especially in the clinic to neutralize heparin.	[Gao, Li-Wei; Zhu, Hong-Tao; Lv, Zhi-Xiang] Nantong Univ, Affiliated Danyang Hosp, Peoples Hosp Danyang, Danyang, Jiangsu, Peoples R China; [Liu, Cai-Yun; Fan, Xiao-Man; Zhang, Ye-Wang] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China	Nantong University; Jiangsu University	Zhang, YW (corresponding author), Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China.	zhangyewagn@ujs.edu.cn	Zhang, Ye-Wang/E-6119-2015	Zhang, Ye-Wang/0000-0003-0873-0721				Ameer GA, 1999, BIOTECHNOL BIOENG, V62, P602, DOI 10.1002/(SICI)1097-0290(19990305)62:5<602::AID-BIT12>3.0.CO;2-M; [Anonymous], 2018, J CANC RES THER, V14, pS622; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chao YP, 2003, J BIOCHEM, V134, P365, DOI 10.1093/jb/mvg154; Chen S, 2013, APPL MICROBIOL BIOT, V97, P2907, DOI 10.1007/s00253-012-4145-6; Chen Y, 2005, BIOCHEM ENG J, V23, P155, DOI 10.1016/j.bej.2004.12.001; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; COOLBEAR T, 1992, BIOCHEM J, V287, P367, DOI 10.1042/bj2870367; Cordula CR, 2014, MOL BIOSYST, V10, P54, DOI 10.1039/c3mb70370c; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Han J, 2018, BIOPROC BIOSYST ENG, V41, P1051, DOI 10.1007/s00449-018-1934-z; Han YH, 2009, J BIOL CHEM, V284, P34019, DOI 10.1074/jbc.M109.025338; Hou FR, 2017, FOOD CHEM, V218, P207, DOI 10.1016/j.foodchem.2016.09.064; Huang J, 2012, PROTEIN EXPRES PURIF, V83, P169, DOI 10.1016/j.pep.2012.03.016; Hyun YJ, 2012, CARBOHYD RES, V359, P37, DOI 10.1016/j.carres.2012.05.023; Jiang MZ, 2018, EUR FOOD RES TECHNOL, V244, P1995, DOI 10.1007/s00217-018-3111-7; Kim WS, 2004, J BIOCHEM MOL BIOL, V37, P684; Korir AK, 2009, ANAL BIOANAL CHEM, V393, P155, DOI 10.1007/s00216-008-2412-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li FL, 2018, INT J BIOL MACROMOL, V113, P1073, DOI 10.1016/j.ijbiomac.2018.03.016; Liu CY, 2020, PREP BIOCHEM BIOTECH, V50, P477, DOI 10.1080/10826068.2019.1709977; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Luo YD, 2007, ARCH BIOCHEM BIOPHYS, V460, P17, DOI 10.1016/j.abb.2007.01.029; Ma XL, 2006, J CHROMATOGR B, V843, P209, DOI 10.1016/j.jchromb.2006.06.015; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Olaofe OA, 2010, BIOCHEM ENG J, V52, P19, DOI 10.1016/j.bej.2010.06.013; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; SASISEKHARAN R, 1995, BIOCHEMISTRY-US, V34, P14441, DOI 10.1021/bi00044a022; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Shpigel E, 1999, BIOTECHNOL BIOENG, V65, P17, DOI 10.1002/(SICI)1097-0290(19991005)65:1<17::AID-BIT3>3.3.CO;2-P; Shriver Z, 1999, J BIOL CHEM, V274, P4082, DOI 10.1074/jbc.274.7.4082; Thomas JG, 1996, J BIOL CHEM, V271, P11141, DOI 10.1074/jbc.271.19.11141; Xia JJ, 2018, BIOPROC BIOSYST ENG, V41, P739, DOI 10.1007/s00449-018-1907-2; YANG VC, 1985, J BIOL CHEM, V260, P1849; Ye FC, 2009, BIOCHEM ENG J, V46, P193, DOI 10.1016/j.bej.2009.05.007; Yu P, 2016, BIOCHEM ENG J, V114, P240, DOI 10.1016/j.bej.2016.07.011; Zhang C, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0553-3	40	4	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240920	10.1371/journal.pone.0240920	http://dx.doi.org/10.1371/journal.pone.0240920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079966	Green Published, gold			2022-12-26	WOS:000585940600022
J	Gashaye, KT; Tsegaye, AT; Abebe, SM; Woldetsadik, MA; Ayele, TA; Gashaw, ZM				Gashaye, Kiros Terefe; Tsegaye, Adino Tesfahun; Abebe, Solomon Mekonnen; Woldetsadik, Mulat Adefris; Ayele, Tadesse Awoke; Gashaw, Zelalem Mengistu			Determinants of long acting reversible contraception utilization in Northwest Ethiopia: An institution-based case control study	PLOS ONE			English	Article							UNINTENDED PREGNANCY; YOUNG-WOMEN; IUD USE; IMPLANTS; ATTITUDES; SAFETY	Background Though long-acting reversible contraceptives (LARCs) are highly effective, have minimal side effects, require minimal follow-up, and are low cost, only 10% of contraceptives used in Ethiopia are LARCs. The reason for this low uptake is not understood at the country or regional level. Therefore, this study identified determinants of LARC utilization in Northwest Ethiopia. Methods A facility-based unmatched case control study, using LARC users as cases and short- acting reversible contraception (SARC) users as controls, had been conducted at fourteen public health institutions in Northwest Ethiopia. A systematic random sampling technique was used to select participants with a 1:2 case to control ratio (n = 1167). Binary logistic regression analysis was used to identify determinants of LARC utilization among family planning service users. Results Wealth status [AOR:1.87, 95%CI (1.08, 3.24)], history of abortion [AOR:2.69, 95%CI (1.41, 5.12)], limiting family size [AOR: 2.38, 95%CI (1.01, 5.62)], good knowledge about LARCs [AOR: 2.52, 95%CI (1.17, 5.41)], method convenience [AOR: 0.23, 95%CI (0.16, 0.34)], good availability of method [AOR:0.10 (0.05, 0.19)], less frequent visits to health facility [AOR:2.95, 95% CI(1.89, 4.62)], health care providers advice [AOR:10.69, 95%CI (3.27, 34.87)], partner approval [AOR:0.66, 95%CI (0.45, 0.97)], and favorable attitude towards LARCs [AOR:13.0, 95%CI (8.60, 19.72)] were significantly associated with LARC utilization. Conclusion Professional support, favorable attitude towards LARC use, high economic status, history of abortion, advantage of less frequent visits, having good knowledge towards LARC and interest of limiting births were significantly associated with LARC Utilization. On the other hand, perceived method convenience, and contraception availability were inversely associated with it. Family planning education about the benefits of LARC should be done by health providers and media. Male involvement in the counselling and decision making about the advantage of using LARC may improve the negative influence of partners on LARC utilization. It is also recommended that, future qualitative research further explore perceptions of LARC use.	[Gashaye, Kiros Terefe; Woldetsadik, Mulat Adefris; Gashaw, Zelalem Mengistu] Univ Gondar, Sch Med, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tsegaye, Adino Tesfahun; Ayele, Tadesse Awoke] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Abebe, Solomon Mekonnen] Univ Gondar, Inst Publ Hlth, Dept Nutr, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Gashaye, KT (corresponding author), Univ Gondar, Sch Med, Dept Obstet & Gynecol, Coll Med & Hlth Sci, Gondar, Ethiopia.	hemenkiros2@gmail.com			Pre-Publication Support Service (PREPSS)	Pre-Publication Support Service (PREPSS)	The authors are very grateful that Pre-Publication Support Service (PREPSS) supported the development of this manuscript by providing pre-publication peer-review and copy editing. We would like to acknowledge the study participants for their time and willingness to participate.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alemayehu M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0229-7; Alemayehu M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-6; [Anonymous], 2011, FAM PLANN GLOB HDB P; [Anonymous], 2020, BMC PUBLIC HEALTH; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Asker C, 2006, J FAM PLAN REPROD H, V32, P89, DOI 10.1783/147118906776276170; Bailey MJ, 2014, CESIFO ECON STUD, V60, P312, DOI 10.1093/cesifo/ifu011; Berek S, 2012, BEREK NOVAKS GYNECOL; Black KI, 2010, BEST PRACT RES CL OB, V24, P443, DOI 10.1016/j.bpobgyn.2010.02.002; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Bongaarts J., 2012, FAMILY PLANNING PROG; Bracken J, 2014, EUR J CONTRACEP REPR, V19, P276, DOI 10.3109/13625187.2014.917623; Bulto GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-46; Carey MS, 2012, OBSTET GYNAECOL, V14, P223, DOI 10.1111/j.1744-4667.2012.00126.x; Central statstical agency of Ethiopia, 2007, POP HOUS CENS ETH; Crede S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-197; Dhont N, 2009, EUR J CONTRACEP REPR, V14, P420, DOI 10.3109/13625180903340584; Gariepy AM, 2014, CONTRACEPTION, V90, P174, DOI 10.1016/j.contraception.2014.03.010; Garrett CC, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0227-9; Gebreyesus B, 2015, AM J ADV NURS RES, V2, P36; Gilmore K, 2015, J ADOLESCENT HEALTH, V56, P658, DOI 10.1016/j.jadohealth.2015.02.016; Greenberg KB, 2013, J ADOLESCENT HEALTH, V52, P372, DOI 10.1016/j.jadohealth.2012.11.003; Habtamu A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4445-3; Haimovich S, 2009, EUR J CONTRACEP REPR, V14, P187, DOI 10.1080/13625180902741436; Hoffman BL., 2016, WILLIAMS GYNECOLOGY; Hubacher D, 2015, CONTRACEPTION, V92, P382, DOI 10.1016/j.contraception.2015.06.115; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Hubachera D., 2008, Contraception, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Joshi R, 2015, INT J GYNECOL OBSTET, V131, pS60, DOI 10.1016/j.ijgo.2015.04.024; Katz KR, 2002, INT FAM PLAN PERSPEC, V28, P26, DOI 10.2307/3088272; Kohan Shahnaz, 2014, Iran J Nurs Midwifery Res, V19, P451; Kumari SS, 2016, J OBSTET GYN INDIA, V66, P149, DOI 10.1007/s13224-016-0866-2; Leaf healthcare, 2015, CISC VIS NETW IND GL, P1; Madden T, 2011, CONTRACEPTION, V84, P571, DOI 10.1016/j.contraception.2011.03.018; Mavranezouli I, 2008, HUM REPROD, V23, P1338, DOI 10.1093/humrep/den091; Mekonnen G, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.98.3421; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Meskele M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-109; Mestad R, 2011, CONTRACEPTION, V84, P493, DOI 10.1016/j.contraception.2011.03.001; Moreau C, 2014, CONTRACEPTION, V89, P9, DOI 10.1016/j.contraception.2013.10.003; Moreau C, 2013, FERTIL STERIL, V100, P451, DOI 10.1016/j.fertnstert.2013.04.002; Mota K, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0209-y; Mutombo N, 2014, REPROD HLTH J, V11, P1; Mutombo N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004643; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Peipert JF, 2011, OBSTET GYNECOL, V117, P1105, DOI 10.1097/AOG.0b013e31821188ad; Schwingl PJ, 2000, FERTIL STERIL, V73, P923, DOI 10.1016/S0015-0282(00)00482-9; Stoddard A, 2011, DRUGS, V71, P969, DOI 10.2165/11591290-000000000-00000; Melka AS, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.246.5835; Teferra AS, 2015, SCIENCE, V3, P143; Teferra AS., 2015, SCI J PUBLIC HLTH, V3, P143, DOI DOI 10.11648/J.SJPH; Tsegaye Tegenu P.D, 2013, EXPONENTIAL POPULATI; White K, 2013, WOMEN HEALTH ISS, V23, pE257, DOI 10.1016/j.whi.2013.05.001; Winner B, 2012, OBSTET GYNECOL SURV, V67, P552; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; World Health Organization, 2011, FAMILY PLANNING GLOB; Xu HN, 2012, OBSTET GYNECOL, V120, P21, DOI 10.1097/AOG.0b013e318259565a; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	64	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240816	10.1371/journal.pone.0240816	http://dx.doi.org/10.1371/journal.pone.0240816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3QJ	33079973	gold, Green Published			2022-12-26	WOS:000585940600028
J	Oh, GS; Yoon, J; Kim, G; Kim, GH; Kim, DS; Choi, B; Chang, EJ; Lee, ES; Kim, SW				Oh, Gyun-Sik; Yoon, Jin; Kim, Gukhan; Kim, Geun Hyang; Kim, Dong Seop; Choi, Bongkun; Chang, Eun-Ju; Lee, Eun-Sook; Kim, Seung-Whan			Regulation of adipocyte differentiation by clusterin-mediated Kruppel-like factor 5 stabilization	FASEB JOURNAL			English	Article						adipogenesis; clusterin; ubiquitination	NF-KAPPA-B; TUMOR-SUPPRESSOR; APOLIPOPROTEIN-J; ADIPOGENIC DIFFERENTIATION; DIABETES-MELLITUS; FACTOR KLF5; EXPRESSION; FAT; DEGRADATION; INHIBITION	Clusterin (CLU) is a heterodimeric glycoprotein involved in a range of biological processes. We investigated the function of CLU as a novel regulator of adipogenesis. CLU expression increased during 3T3-L1 preadipocyte differentiation. CLU overexpression promoted adipogenic differentiation of preadipocytes and increased the mRNA levels of adipogenic markers including peroxisome proliferator-activated receptor gamma (Pparg) and CCAAT enhancer-binding protein alpha (Cebpa). Conversely, knockdown of CLU attenuated adipogenesis and reduced transcript levels ofPpargandCebpa. However, the promoter activities of both thePpargand theCebpagene were not affected by alteration of CLU expression on its own. Additionally, the protein level of Kruppel-like factor 5 (KLF5), an upstream transcription factor ofPpargandCebpainvolved in adipogenic differentiation, was upregulated by CLU overexpression, although the mRNA level ofKlf5was not altered by changes in the expression level of CLU. Cycloheximide chase assay showed that the increased level of KLF5 by CLU overexpression was due to decreased degradation of KLF5 protein. Interestingly, CLU increased the stability of KLF5 by decreasing KLF5 ubiquitination. CLU inhibited the interaction between KLF5 and F-box/WD repeat-containing protein 7, which is an E3 ubiquitin ligase that targets KLF5. The adipogenic role of CLU was also addressed in mesenchymal stem cells (MSCs) andClu(-/-)mouse embryonic fibroblasts (MEFs). Furthermore, CLU enhanced KLF5-mediated transcriptional activation of both theCebpaand thePpargpromoter. Taken together, these results suggest that CLU is a novel regulator of adipocyte differentiation by modulating the protein stability of the adipogenic transcription factor KLF5.	[Oh, Gyun-Sik; Yoon, Jin; Kim, Gukhan; Kim, Geun Hyang; Kim, Dong Seop; Lee, Eun-Sook; Kim, Seung-Whan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea; [Oh, Gyun-Sik; Yoon, Jin; Kim, Dong Seop; Lee, Eun-Sook; Kim, Seung-Whan] Univ Ulsan, Biomed Inst Technol, Seoul, South Korea; [Choi, Bongkun; Chang, Eun-Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea; [Kim, Gukhan] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Kim, Geun Hyang] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of Ulsan; University of Ulsan; University of Ulsan; Asan Medical Center; Cold Spring Harbor Laboratory; Regeneron	Kim, SW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pharmacol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea.	swkim7@amc.seoul.kr		Kim, Seung-Whan/0000-0001-6983-0481; Kim, Dong Seop/0000-0002-3053-5810	National Research Foundation of Korea (NRF) [NRF-2015R1A2A2A01006403, NRF-2018R1A2B6007013]; Ministry of Health and Welfare (MOHW) [HI15C-0377-020016]; Asan Institute for Life Sciences, Asan Medical Center [2020IL0012]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Health and Welfare (MOHW); Asan Institute for Life Sciences, Asan Medical Center	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2015R1A2A2A01006403 and NRF-2018R1A2B6007013; Ministry of Health and Welfare (MOHW), Grant/Award Number: HI15C-0377-020016; Asan Institute for Life Sciences, Asan Medical Center, Grant/Award Number: 2020IL0012	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Bae CH, 2018, CLIN EXP OTORHINOLAR, V11, P124, DOI 10.21053/ceo.2017.00493; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Bettuzzi S, 2009, ADV CANCER RES, V104, P1, DOI 10.1016/S0065-230X(09)04001-9; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Devauchelle V, 2006, J IMMUNOL, V177, P6471, DOI 10.4049/jimmunol.177.9.6471; Diakiw SM, 2013, IUBMB LIFE, V65, P999, DOI 10.1002/iub.1233; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Essabbani A, 2010, J BIOL CHEM, V285, P4273, DOI 10.1074/jbc.C109.057133; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gao Y, 2015, CURR TOP MED CHEM, V15, P699, DOI 10.2174/1568026615666150302105052; Gil SY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2896; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Hamam D, 2015, STEM CELLS DEV, V24, P417, DOI 10.1089/scd.2014.0331; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Ito H, 2004, INT J OBESITY, V28, P242, DOI 10.1038/sj.ijo.0802528; Jang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35884; Kim G, 2011, BIOCHEM BIOPH RES CO, V408, P720, DOI 10.1016/j.bbrc.2011.04.111; Klouckova J, 2016, PHYSIOL RES, V65, P481, DOI 10.33549/physiolres.933121; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lechner S, 2013, DIFFERENTIATION, V85, P20, DOI 10.1016/j.diff.2012.11.001; Liu GD, 2018, CELL PHYSIOL BIOCHEM, V45, P1003, DOI 10.1159/000487295; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Liu XF, 2014, INTEGR BIOL-UK, V6, P511, DOI 10.1039/c3ib40265g; Luan Yi, 2014, World J Biol Chem, V5, P216, DOI 10.4331/wjbc.v5.i2.216; Malkki H, 2014, NAT REV NEUROL, V10, P243, DOI [10.1038/nrneurol.2013.250, 10.1038/nrneurol.2014.63, 10.1038/nrneurol.2014.209, 10.1038/nrneurol.2014.61, 10.1038/nrneurol.2014.168, 10.1038/nrneurol.2013.267, 10.1038/nrneurol.2014.21, 10.1038/nrneurol.2014.142]; Oh GS, 2015, BIOCHEM BIOPH RES CO, V465, P501, DOI 10.1016/j.bbrc.2015.08.047; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Pettersson C, 2011, J INTERN MED, V269, P306, DOI 10.1111/j.1365-2796.2010.02292.x; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Senol-Cosar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10686; Seo HY, 2013, ENDOCRINOLOGY, V154, P1722, DOI 10.1210/en.2012-2009; Shim YJ, 2011, J LEUKOCYTE BIOL, V90, P761, DOI 10.1189/jlb.0311110; Siersbaek R, 2011, COLD SH Q B, V76, P247, DOI 10.1101/sqb.2011.76.010512; Takase O, 2008, KIDNEY INT, V73, P567, DOI 10.1038/sj.ki.5002563; Tellez T, 2016, CURR MED CHEM, V23, P4297, DOI 10.2174/0929867323666161024150540; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2011, MOL CELL BIOL, V31, P1214, DOI 10.1128/MCB.01347-10; Won JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103351; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Xu M, 2015, INT J CLIN EXP MED, V8, P12476; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	51	10	11	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16276	16290		10.1096/fj.202000551RR	http://dx.doi.org/10.1096/fj.202000551RR		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33078455				2022-12-26	WOS:000581557400001
J	Zhou, WL; Qi, ZY; Chen, J; Tan, ZJ; Wang, HY; Wang, CY; Yi, ZX				Zhou, Wanlai; Qi, Zhiyong; Chen, Jing; Tan, Zhijian; Wang, Hongying; Wang, Chaoyun; Yi, Zhenxie			Rooting ability of rice seedlings increases with higher soluble sugar content from exposure to light	PLOS ONE			English	Article							LATERAL ROOT; GROWTH; NITROGEN; PHOTOSYNTHESIS; ELONGATION	Rooting ability of rice seedling for mechanical transplanting has a large impact on grain yield. This study explored the relationship between endogenous soluble sugar content and rooting ability of rice seedlings. We placed 15-day-old rice seedlings in controlled environment cabinets with stable light and sampled after 0, 3, 6, 9, 12, and 24 hours of light to measure their soluble sugar content, nitrate content, starch content, soluble protein content and rooting ability. The soluble sugar content of the rice seedlings before rooting increased rapidly from 65.1 mg g(-1)to 126.3 mg g(-1)in the first 9 hours of light and then tended to stabilize; however, few significant changes in the other physiological indices were detected. With the light exposure time increasing from 3 hours to 12 hours, the rooting ability measured with fresh weight, dry weight, total length, and number of new roots increased by 91.7%, 120.0%, 60.6% and 30.3%, respectively. Rooting ability was related more closely to soluble sugar content than to nitrate-nitrogen content of rice seedlings before rooting and their correlation coefficients were 0.8582-0.8684 and 0.7045-0.7882, respectively. The stepwise regression analysis revealed that the soluble sugar content before rooting explained 73.6%-75.4% of the variance, and the nitrate-nitrogen content explained an additional 7.3%-14.2% of the variance in rooting ability, indicating that compared with nitrate-nitrogen content, soluble sugar content of rice seedlings before rooting was more dominant in affecting rooting ability. This study provides direct evidence of the relationship between the rooting ability and endogenous soluble sugar content of rice seedlings.	[Zhou, Wanlai; Qi, Zhiyong] Chinese Acad Agr Sci, Inst Urban Agr, Chengdu, Sichuan, Peoples R China; [Zhou, Wanlai; Tan, Zhijian; Wang, Hongying; Wang, Chaoyun] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Zhou, Wanlai; Chen, Jing; Yi, Zhenxie] Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Urban Agriculture, CAAS; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Hunan Agricultural University	Wang, CY (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.; Yi, ZX (corresponding author), Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China.	ibfcwcy@139.com; yizhenxie@126.com			Young Scientists Fund of the National Natural Science Foundation of China [31701372]; Natural Science Foundation of Hunan Province [2018JJ3583]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This research and the APC was funded by the Young Scientists Fund of the National Natural Science Foundation of China, grant number 31701372 (http://www.nsfc.gov.cn/) and the Natural Science Foundation of Hunan Province, grant number 2018JJ3583 (http://61.187.87.55/egrantweb/#).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AJICL, V1, pxix; AZCONBIETO J, 1983, PLANT PHYSIOL, V73, P681, DOI 10.1104/pp.73.3.681; Bai RP, 2011, CHINESE AGR MECH, V233, P15; BINGHAM IJ, 1993, PHYSIOL PLANTARUM, V88, P149, DOI 10.1111/j.1399-3054.1993.tb01772.x; Chen JinHong, 1998, Acta Agriculturae Zhejiangensis, V10, P179; Ding CL, 1981, ROOTING MAT DYNAMICS, P1; Ding Y, 2001, J NANGJING AGR U, V24, P1; Guinn G, 1980, PREDICTING PHOTOSYNT, V2, P1; [何强 HE Qiang], 2006, [杂交水稻, Hybrid Rice], V21, P75; Hu XingMing, 2004, Chinese Journal of Rice Science, V18, P396; Jampeetong A, 2009, ENVIRON EXP BOT, V66, P153, DOI 10.1016/j.envexpbot.2009.01.006; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jarvis B. C., 1986, New root formation in plants and cuttings, P191; Kurata T, 1998, PLANT PHYSIOL, V118, P793, DOI 10.1104/pp.118.3.793; Kurata T, 1997, J PLANT PHYSIOL, V151, P346, DOI 10.1016/S0176-1617(97)80263-5; Li H.S., 2005, PRINCIPLES TECHNIQUE; Ling L., 2005, JIANGSU AGR SCI, V3, P14; Magana RH, 2009, ANN BOT-LONDON, V103, P1025, DOI 10.1093/aob/mcp043; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; NEALES TF, 1968, BOT REV, V34, P107, DOI 10.1007/BF02872604; Pound MP, 2013, PLANT PHYSIOL, V162, P1802, DOI 10.1104/pp.113.221531; Ren W, 2009, J NUCL AGR SCI, V23, P1070; Ren WanJun, 2011, Journal of Zhejiang University (Agriculture and Life Sciences), V37, P103; RUFTY TW, 1983, PLANT PHYSIOL, V73, P428, DOI 10.1104/pp.73.2.428; Takahashi F, 2003, J PLANT RES, V116, P83, DOI 10.1007/s10265-002-0074-2; Tong FD, 1997, J ZHEJIANG AGR U, V23, P74; WALKER DA, 1976, CURR TOP CELL REGUL, V11, P203; Wang XB, 2002, ACTA BOT SIN, V44, P678; Wang YL, 1997, ACTA AGRONOMICA SINI, V23, P609; Wen HN, 2000, ROOTING ADVANTAGE RI, P3; Wu Zheng-jing, 2007, Xibei Zhiwu Xuebao, V27, P705; Xia S.-F., 1982, Acta Phytophysiologia Sinica, V8, P141; Xia SF, 1981, ACTA PHYTOPHYSIOLOGI; Xiong F. S., 1994, Acta Agronomica Sinica, V20, P52; Xu FuXian, 2003, Acta Agronomica Sinica, V29, P188; Xu FuXian, 2002, Southwest China Journal of Agricultural Sciences, V15, P34; Yu HQ, 1997, J MIANYANG COLL EC T, V14, P99; Zeng HF, 1986, ANHUI AGR SCI, V30, P38; Zheng JiaKui, 1996, Chinese Journal of Rice Science, V10, P51; Zhou GuangSheng, 2005, Scientia Agricultura Sinica, V38, P2571; [周晚来 Zhou Wanlai], 2016, [华北农学报, Acta Agriculturae Boreali-Sinica], V31, P191; Zhou WanLai, 2011, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V19, P1319, DOI 10.3724/SP.J.1011.2011.01319; 2003, CAN J DIABETES S2, V27	43	1	1	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0241060	10.1371/journal.pone.0241060	http://dx.doi.org/10.1371/journal.pone.0241060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079962	Green Published, gold			2022-12-26	WOS:000585940600004
J	Xu, YX; Li, XH; Cheng, Y; Yang, MG; Wang, RR				Xu, Yixin; Li, Xuehan; Cheng, Yan; Yang, Mingan; Wang, Rurong			Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion	FASEB JOURNAL			English	Article						acute lung injury; ferroptosis; lipid peroxidation; reperfusion injury	CELL-DEATH; LIPID-PEROXIDATION; FATTY-ACIDS; INJURY; IRON; IDENTIFICATION; MECHANISM; LUNGS	Lung ischemia-reperfusion (IR) injury is a common clinical pathology associated with high mortality. Ferroptosis, a novel mode of cell death elicited by iron-dependent phospholipid peroxidation, has been implicated in ischemic events. Acyl-CoA synthetase long-chain family member 4 (ACSL4) is one of the main enzymes in pro-ferroptotic lipid metabolism. In this study, the involvement of ferroptotic death in different durations of reperfusion was evaluated by assessing the iron content, malondialdehyde, and glutathione levels, ferroptosis-related protein expression, and mitochondria morphology. The roles of ferroptosis-specific inhibitor, liproxastin-1 (Lip-1), and ACSL4 modulation in a preventive regimen were assessed in vivo and in vitro. The hallmarks of pulmonary function, such as histological lung injury score, wet/dry ratio, and oxygenation index, were evaluated as well. Results showed that lung IR increased the tissue iron content and lipid peroxidation accumulation, along with key protein (GPX4 and ACSL4) expression alteration during reperfusion. Pretreatment with Lip-1 inhibited ferroptosis and ameliorated lung IR-induced injury in animal and cell models. In addition, administering ACSL4 inhibitor rosiglitazone before ischemia diminished the ferroptotic damage in IR-injured lung tissue, consistent with the protective effect of ACSL4 knockdown on lung epithelial cells subjected to hypoxia/reoxygenation. Thus, this study delineated that IR-induced ferroptotic cell death in lung tissue and ACSL4 were correlated with this process. Inhibition of ferroptosis and ACSL4 mitigated the ferroptotic damage in IR-induced lung injury by reducing lipid peroxidation and increasing the glutathione and GPX4 levels.	[Xu, Yixin; Li, Xuehan; Wang, Rurong] Chinese Acad Med Sci, Sichuan Univ, Res Units West China 2018RU12, Dept Anesthesiol,West China Hosp, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Xu, Yixin; Li, Xuehan; Cheng, Yan] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Peoples R China; [Yang, Mingan] San Diego State Univ, Sch Publ Hlth, Div Biostat & Epidemiol, San Diego, CA 92182 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Sichuan University; California State University System; San Diego State University	Wang, RR (corresponding author), Chinese Acad Med Sci, Sichuan Univ, Res Units West China 2018RU12, Dept Anesthesiol,West China Hosp, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	wangrurong@scu.edu.cn			Science and Technology Department of Sichuan Province [2017SZ0147]; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [2018HXFH029]	Science and Technology Department of Sichuan Province; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University	Science and Technology Department of Sichuan Province, Grant/Award Number: 2017SZ0147; 1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, Grant/Award Number: 2018HXFH029	Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; AYENE IS, 1993, ARCH BIOCHEM BIOPHYS, V303, P307, DOI 10.1006/abbi.1993.1288; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Dong H, 2020, AGING-US, V12, P12943, DOI 10.18632/aging.103378; Drefs M, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8325754; Fischer S, 2000, AM J RESP CRIT CARE, V162, P1932, DOI 10.1164/ajrccm.162.5.9910064; Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Halade GV, 2017, AM J PHYSIOL-HEART C, V313, pH89, DOI 10.1152/ajpheart.00040.2017; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/nchembio.2238, 10.1038/NCHEMBIO.2238]; Kanou T, 2018, J HEART LUNG TRANSPL, V37, P1261, DOI 10.1016/j.healun.2018.04.005; Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304; Li WJ, 2019, J CLIN INVEST, V129, P2293, DOI 10.1172/JCI126428; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x; Liu J, 2020, CELL CHEM BIOL, V27, P420, DOI 10.1016/j.chembiol.2020.02.005; Liu XG, 2017, CELL DEATH DIFFER, V24, P683, DOI 10.1038/cdd.2017.1; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Mayr L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15646-6; Muller T, 2017, CELL MOL LIFE SCI, V74, P3631, DOI 10.1007/s00018-017-2547-4; Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232; Qayumi A K, 1992, J Invest Surg, V5, P115, DOI 10.3109/08941939209012428; Shologu N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102996; Stammberger U, 2000, ANN THORAC SURG, V69, P1532, DOI 10.1016/S0003-4975(00)01228-5; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Wang MH, 2012, J SURG RES, V173, P153, DOI 10.1016/j.jss.2010.08.053; Wang X, 2019, AM J RESP CELL MOL, V61, P244, DOI 10.1165/rcmb.2018-0207OC; Wei S, 2020, ENVIRON RES, V188, DOI 10.1016/j.envres.2020.109824; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wu YQ, 2012, INT J MOL MED, V30, P1294, DOI 10.3892/ijmm.2012.1161; Xiong YQ, 2018, BIOCHEM BIOPH RES CO, V506, P578, DOI 10.1016/j.bbrc.2018.10.098; Yamada N, 2020, AM J TRANSPLANT, V20, P1606, DOI 10.1111/ajt.15773; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yoshida M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10991-7; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zhao GC, 1997, AM J RESP CELL MOL, V16, P293, DOI 10.1165/ajrcmb.16.3.9070614; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	43	43	47	10	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16262	16275		10.1096/fj.202001758R	http://dx.doi.org/10.1096/fj.202001758R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070393				2022-12-26	WOS:000581166200001
J	Aprea, MC; Nuvolone, D; Petri, D; Voller, F; Bertelloni, S; Aragona, I				Aprea, Maria Cristina; Nuvolone, Daniela; Petri, Davide; Voller, Fabio; Bertelloni, Silvano; Aragona, Ida			Human biomonitoring to assess exposure to thallium following the contamination of drinking water	PLOS ONE			English	Article							REFERENCE VALUES; TRACE-ELEMENTS; BIRTH-WEIGHT; HEALTH; URINE; POPULATION; METALS; BLOOD; PLANT; POLLUTION	In 2014, in some parts of the water distribution system of the municipality of Pietrasanta (Tuscany, Italy), thallium (Tl) levels above the recommended limits were measured and some restrictions to water usage for drinking and food preparation were imposed. The study aimed to assess Tl exposure and possible health effects by means of a human biomonitoring survey. In the 2014-2016 time frame, 2154 urine and 254 hair samples were taken from different population groups and from a control group. The levels of Tl found in urine and hair were statistically higher in exposed groups than in controls and compared to the reference values for the general population. Concentrations in urine were significantly associated with the geographical origin of the sample, the consumption of drinking water and food grown in local gardens. A significant association was found between urine and hair. No positive associations were found between the Tl levels in hair or urine and several self-reported symptoms and health effects, except for sleep disturbance. The study indicates that the concentration of Tl in drinking water can be traced by urine analysis. Urine and hair have proven to be biological matrices that can be effectively used for the evaluation of Tl exposure. To date, the study represents the most extensive human biomonitoring campaign for the evaluation of the Tl exposure available at international level.	[Aprea, Maria Cristina] Hlth Agcy South East Tuscany, Dept Prevent, Publ Hlth Lab, Siena, Italy; [Nuvolone, Daniela; Petri, Davide; Voller, Fabio] Reg Hlth Agcy Tuscany, Unit Epidemiol, Florence, Italy; [Bertelloni, Silvano] Univ Hosp, Pediat Div, Dept Obstet Gynecol & Pediat, Pisa, Italy; [Aragona, Ida] Hlth Agcy North West Tuscany, Dept Prevent, Pisa, Italy	University of Pisa; Azienda Ospedaliero Universitaria Pisana	Aprea, MC (corresponding author), Hlth Agcy South East Tuscany, Dept Prevent, Publ Hlth Lab, Siena, Italy.	cristina.aprea@uslsudest.toscana.it			Tuscany Region [1259]	Tuscany Region(Regione Toscana)	This research was funded by Tuscany Region (grant number 1259 of 22 December 2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work. Funding was provided to the institutions where the authors work as a support for carrying out the sampling, sample analysis and statistical analysis. No author received a salary from the funder.	[Anonymous], 2019, CDC NHANES 4 NAT REP; ANSES Agence nationale de securite sanitaire de l'alimentation de l'environnement et du travail, 2013, AVIS ANS REL REL EV; Aprea MC, 2018, TOXICOL LETT, V298, P177, DOI 10.1016/j.toxlet.2018.07.004; ATSDR Agency for Toxic Substances and Disease Registry, ATSDR AG TOX SUBST D; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Batista BL, 2009, FORENSIC SCI INT, V192, P88, DOI 10.1016/j.forsciint.2009.08.003; Benedict SR, 1936, J BIOL CHEM, V114, P515; Bocca B, 2010, RAPID COMMUN MASS SP, V24, P2363, DOI 10.1002/rcm.4650; BROCKHAUS A, 1981, INT ARCH OCC ENV HEA, V48, P375, DOI 10.1007/BF00378686; Campanella B, 2016, SCI TOTAL ENVIRON, V548, P33, DOI 10.1016/j.scitotenv.2016.01.010; Chellini E, 2017, SCI TOTAL ENVIRON, V584, P348, DOI 10.1016/j.scitotenv.2016.12.178; Curkovic M, 2013, ARH HIG RADA TOKSIKO, V64, P385, DOI 10.2478/10004-1254-64-2013-2300; DOLGNER R, 1983, INT ARCH OCC ENV HEA, V52, P79, DOI 10.1007/BF00380610; EPA U.S. Environmental Protection Agency, TOX REV THALL COMP; Gil F, 2015, FOOD CHEM TOXICOL, V80, P287, DOI 10.1016/j.fct.2015.03.025; Goulle JP, 2005, FORENSIC SCI INT, V153, P39, DOI 10.1016/j.forsciint.2005.04.020; Hoet P, 2013, CLIN CHEM LAB MED, V51, P839, DOI 10.1515/cclm-2012-0688; Hu XB, 2015, J REPROD MED, V60, P21; Rodriguez-Mercado JJ, 2013, DRUG CHEM TOXICOL, V36, P369, DOI 10.3109/01480545.2012.710633; Karbowska B, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5647-y; KRAHWINKEL W, 1988, J NUCL MED, V29, P1582; Morton J, 2014, TOXICOL LETT, V231, P179, DOI 10.1016/j.toxlet.2014.08.019; Nisse C, 2017, INT J HYG ENVIR HEAL, V220, P341, DOI 10.1016/j.ijheh.2016.09.020; Pearson AJ, 2020, FOOD ADDIT CONTAM A, V37, P451, DOI 10.1080/19440049.2019.1704445; Peter ALJ, 2005, ENVIRON INT, V31, P493, DOI 10.1016/j.envint.2004.09.003; Saravanabhavan G, 2017, INT J HYG ENVIR HEAL, V220, P189, DOI 10.1016/j.ijheh.2016.10.006; SHERLOCK JC, 1986, FOOD ADDIT CONTAM, V3, P363, DOI 10.1080/02652038609373603; Tobin DJ., 2005, IMPORTANT BIOMONITOR; Violante N, 2000, MICROCHEM J, V67, P397, DOI 10.1016/S0026-265X(00)00099-0; WHO, 2005, WAT SAF PLANS MAN DR; WHO/IPCS, 1996, THALL ENV HLTH CRIT; WHO (World Health Organization), 1996, BIOL MON CHEM EXP WO; Xia W, 2016, ENVIRON HEALTH PERSP, V124, P164, DOI 10.1289/ehp.1409202; Xiao TF, 2007, APPL GEOCHEM, V22, P919, DOI 10.1016/j.apgeochem.2007.02.008; Xiao TF, 2012, SCI TOTAL ENVIRON, V421, P51, DOI 10.1016/j.scitotenv.2011.04.008; Xiao TF, 2004, SCI TOTAL ENVIRON, V318, P223, DOI 10.1016/S0048-9697(03)00448-0; Yu HY, 2018, ENVIRON POLLUT, V241, P626, DOI 10.1016/j.envpol.2018.05.090; ZHOU DX, 1985, J ENVIRON HEALTH, V48, P14	38	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241223	10.1371/journal.pone.0241223	http://dx.doi.org/10.1371/journal.pone.0241223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119651	Green Published, gold			2022-12-26	WOS:000600013600052
J	Brito, PM; Figueiredo, FJ; Leal, MEC				Brito, Paulo M.; Figueiredo, Francisco J.; Leal, Maria Eduarda C.			A revision of Laeliichthys ancestralis Santos, 1985 (Teleostei: Osteoglossomorpha) from the Lower Cretaceous of Brazil: Phylogenetic relationships and biogeographical implications	PLOS ONE			English	Article							NORTH-AMERICA; FISH OTOLITHS; OSTEOGLOSSIDAE; MORPHOLOGY; PALEOCENE; OSTEOLOGY; SCALES; EOCENE; FOSSIL; BEDS	A re-description of the freshwater, Early Cretaceous osteoglossomorph Laeliichthys ancestralis Santos, 1985, from the Sanfranciscana Basin of Brazil, is provided. New anatomical details and a revised diagnosis, as well as a new phylogeny are presented. A phylogenetic analysis places this taxon within the Osteoglossomorpha most likely as a member of the Notopteroidei. Within this clade Laeliichthys is the sister-taxon of the Notopteridae. The subfamily Laeliichthyinae is elevated to family rank. The revised phylogenetic position revealed in this study has important consequences on the biogeography of Notopteroidei as it extends their distribution to western Gondwana, prior to the separation of South America and Africa, and extends the evolutionary origins of notopteroid lineages by at least similar to 27 Myr before their first appearance in the fossil record.	[Brito, Paulo M.; Figueiredo, Francisco J.] Univ Estado Rio De Janeiro, Inst Biol IBRAG, Dept Zool, Rio De Janeiro, RJ, Brazil; [Leal, Maria Eduarda C.] Aarhus Univ, Fac Hlth, Aarhus, Denmark	Universidade do Estado do Rio de Janeiro; Aarhus University	Brito, PM (corresponding author), Univ Estado Rio De Janeiro, Inst Biol IBRAG, Dept Zool, Rio De Janeiro, RJ, Brazil.	pbritopaleo@yahoo.com.br		Brito, Paulo/0000-0002-4853-8630	CNPq [310101/2017-4]; Prociencia fellowship; 601 FAPERJ [E-26/202.890/2018]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Prociencia fellowship; 601 FAPERJ	PMB is supported by the CNPq [grant #310101/2017-4], 601 FAPERJ [grant #E-26/202.890/2018], and a Prociencia fellowship.	Amaral CRL, 2019, J S AM EARTH SCI, V96, DOI 10.1016/j.jsames.2019.102360; Arai M, 1995, AT 14 C BRAS PAL UB, P1; Arratia G., 2008, MESOZOIC FISHES 4 HO, P40; Arratia Gloria, 1999, P265; Bittencourt J.S., 2015, GEONOMOS, V23, P39, DOI [10.18285/geonomos.v23i2.710, DOI 10.18285/GEONOMOS.V23I2.710]; Bonde N, 2008, GEOL SOC SPEC PUBL, V295, P253, DOI 10.1144/SP295.14; Bonde Niels, 1997, Aarhus Geoscience, V6, P33; Bonde Niels, 1996, P273; Brito Paulo M., 2008, P279; Capobianco A, 2019, PAPERS PALAEONTOLOGY, P1; Capobianco A, 2019, BIOL REV, V94, P662, DOI 10.1111/brv.12473; Cavin L, 2001, ZOOL J LINN SOC-LOND, V133, P25, DOI 10.1006/zjls.2000.0284; Cavin L., 2017, 250 MILLION YEARS EV; DAGET J., 1964, MEM MUS NAT HIST NATUR NOUV SERIE SERIE A ZOOL, V31, P163; Forey Peter L., 2010, P215; Forey PL, 1997, S AFR J SCI, V93, P564; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; GREENWOOD P. HUMPHREY, 1966, BULL AMER MUS NATUR HBT, V131, P341; Haddoumi H, 2016, GONDWANA RES, V29, P290, DOI 10.1016/j.gr.2014.12.004; Hilton EJ, 2003, ZOOL J LINN SOC-LOND, V137, P1, DOI 10.1046/j.1096-3642.2003.00032.x; Hilton EJ, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180031; Ibrahim N, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.928.47517; Jordan DS, 1923, STANFORD U PUBL U BS, V3, P77, DOI [10.5962/bhl.title.161386, DOI 10.5962/BHL.TITLE.161386]; LAUDER G V, 1983, Bulletin of the Museum of Comparative Zoology, V150, P95; Lavoue S, 2019, ZOOLOGICAL J LINNEAN, V188, P1; Lavoue S, 2016, MOL PHYLOGENET EVOL, V99, P34, DOI 10.1016/j.ympev.2016.03.008; Li G.- Q., 1999, MESOZOIC FISHES, P369; Li G-Q, 1996, PHYLOGENY OSTEOGLOSS, P163; Li GQ, 1996, J VERTEBR PALEONTOL, V16, P198; Li GQ, 1997, J PALEONTOL, V71, P1109; Li GQ, 1997, J VERTEBR PALEONTOL, V17, P487; Li Guo-qing, 1996, P285; Lima M.R., 1979, 2 SRG, P203; Lopez-Arbarello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039370; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg John G., 1998, P49; Machado MR, 2004, THESIS, P1; Maisey JG, 2000, CRETACEOUS RES, V21, P281, DOI 10.1006/cres.1999.0195; MEUNIER FJ, 1984, ANN SCI NAT ZOOL, V6, P111; Meunier FJ, 2004, CYBIUM, V28, P225; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Newbrey MG, 2000, J VERTEBR PALEONTOL, V20, P12, DOI 10.1671/0272-4634(2000)020[0012:ANSOJT]2.0.CO;2; Nolf D, 2008, BULL INST R SC N B-S, V78, P239; Patterson C., 1993, P621; Patterson C, 1977, B AM MUS NAT HIST, V158, P81; Patterson C, 1977, MAJOR PATTERNS VERTE, VA, P579, DOI [10.1007/978-1-4684-8851-7_21, DOI 10.1007/978-1-4684-8851-7_21]; RANA RS, 1988, GEOBIOS-LYON, V21, P465; Regan CT, 1909, ANN MAGAZINE NATURAL, V47, P75, DOI [DOI 10.1080/00222931108693067, 10.1080/00222931108693067]; Sanders M., 1934, Verh Geol Mijnb Gen, V11, P1; Santos RS, 1985, C BRAS PAL, V8, P161; Schrank E, 2002, PALAEONTOLOGY, V45, P33, DOI 10.1111/1475-4983.00226; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Taverne, 1979, OSTOLOGIE PHYLOGENES; TAVERNE L, 1978, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V42, P1; TAVERNE L, 1998, MISCELLANEA, V7, P67; Wilson MVH, 2008, GEOL SOC SPEC PUBL, V295, P185, DOI 10.1144/SP295.12; Xu GH, 2009, ZOOL J LINN SOC-LOND, V157, P83, DOI 10.1111/j.1096-3642.2009.00532.x; Zhang JY, 1998, J VERTEBR PALEONTOL, V18, P280	58	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241009	10.1371/journal.pone.0241009	http://dx.doi.org/10.1371/journal.pone.0241009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119676	Green Published, gold			2022-12-26	WOS:000600013600039
J	Hu, LT; Zhang, ML; Yang, ZQ; Fan, Y; Li, JX; Wang, HL; Lubale, C				Hu, Litang; Zhang, Menglin; Yang, Zhengqiu; Fan, Yong; Li, Jixiu; Wang, Hongliang; Lubale, Celestin			Estimating dewatering in an underground mine by using a 3D finite element model	PLOS ONE			English	Article							GROUNDWATER INFLOW; PIT	Groundwater inflow to an underground mine will seriously affect its mining plan and engineering geology safety. Groundwater models are powerful tools commonly used in the mines to develop dewatering strategies. Many mines in the Kolwezi area have been present since the 1950s, and groundwater flow patterns have been significantly influenced by mining activities. A mining plan is developed for an underground mine with overturned syncline strata in Kolwezi, Congo. Previous groundwater models using layered homogeneous media lowered model accuracies. A new three-dimensional groundwater model using FEFLOW, consisting of a combined regionally and locally geology models integrating 16 hydrogeological cross-sections and borehole logging data, are formulated to predict the underground dewatering in the study area. A 31-days pumping tests with 3 pumping wells and 28 observation wells are carried out to estimate the hydrogeological properties. The simulated water level data match the observed data rather well. Under 8 scenarios of possible well designs, the model predicts a possible dewatering capacity greater 23,900 m(3)/d at the initial stage of mining. The concept of the model and its application can be a reference for other mines with complex geology for mining safety in the region of interest.	[Hu, Litang; Zhang, Menglin; Yang, Zhengqiu] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Hu, Litang; Zhang, Menglin; Yang, Zhengqiu] Beijing Normal Univ, Engn Res Ctr Groundwater Pollut Control & Remedia, Minist Educ, Beijing, Peoples R China; [Fan, Yong] China ENFI Engn Corp, Beijing, Peoples R China; [Li, Jixiu] Jinchuan Grp Co Ltd, Beijing Rd, Jinchang City, Gansu, Peoples R China; [Wang, Hongliang] North China Engn Invest Inst Co Ltd, Shijiazhuang, Hebei, Peoples R China; [Wang, Hongliang] Technol Innovat Ctr Mine Groundwater Safety Hebei, Shijiazhuang, Hebei, Peoples R China; [Lubale, Celestin] Ruashi Min SAS, Ruashi Mine Site, Lubumbashi, Lualaba, DEM REP CONGO	Beijing Normal University; Beijing Normal University	Hu, LT (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Hu, LT (corresponding author), Beijing Normal Univ, Engn Res Ctr Groundwater Pollut Control & Remedia, Minist Educ, Beijing, Peoples R China.; Fan, Y (corresponding author), China ENFI Engn Corp, Beijing, Peoples R China.	litanghu@bnu.edu.cn; fany@enfi.com.cn		Hu, Litang/0000-0002-3888-6324	Jinchuan Group Co., Ltd; North China Engineering Investigation Institute Co., Ltd; National Natural Science Foundation Project of China [41877173]; National Water Pollution Control and Treatment Science and Technology Major Project [2018NX07109-003]	Jinchuan Group Co., Ltd; North China Engineering Investigation Institute Co., Ltd; National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); National Water Pollution Control and Treatment Science and Technology Major Project	Jinchuan Group Co., Ltd and Ruashi Mining SAS are funding hydrogeology researches, and they carried out data analysis, methodology and project administration. North China Engineering Investigation Institute Co., Ltd is responsible for the field investigations and carried out data collection and analysis. China ENFI Engineering Corporation is responsible for the design of dewatering plan and data analysis. This research is also partially financially supported by the National Natural Science Foundation Project of China (Grant Number: 41877173) and the National Water Pollution Control and Treatment Science and Technology Major Project (Grant No. 2018NX07109-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J PROSTHET DENT, V11, pe1; Bahrami S, 2014, ENVIRON MONIT ASSESS, V186, P8573, DOI 10.1007/s10661-014-4025-x; Benndorf J, 2014, INT J MIN RECLAM ENV, V28, P231, DOI 10.1080/17480930.2013.817046; Bochenska T, 2000, ENVIRON GEOL, V39, P587, DOI 10.1007/s002540050470; Bodeux S, 2017, ENG GEOL, V217, P71, DOI 10.1016/j.enggeo.2016.12.007; Cailteux JLH, 2018, J AFR EARTH SCI, V140, P76, DOI 10.1016/j.jafrearsci.2017.12.029; Chen CX, 2003, HYDROGEOL J, V11, P275, DOI 10.1007/s10040-002-0225-5; DHI, 2018, TECHNICAL REPORT; Diersch HJG, 2014, FEFLOW FINITE ELEMEN, VXXXV, DOI 10.1111/gwat.12285; Francois A, 1978, CARTE GEOLOGIQUE REG; Francois A, 1973, EXTREMITE OCCIDENTAL; Garzonio CA, 2014, ROCK MECH ROCK ENG, V47, P905, DOI 10.1007/s00603-013-0444-1; Hassen I, 2016, J HYDROL, V539, P223, DOI 10.1016/j.jhydrol.2016.05.034; Hu LT, 2010, ENG GEOL, V114, P144, DOI 10.1016/j.enggeo.2010.04.011; Jiang SM, 2013, ENVIRON EARTH SCI, V69, P187, DOI 10.1007/s12665-012-1946-y; Krcmar D, 2014, MINE WATER ENVIRON, V33, P376, DOI 10.1007/s10230-014-0273-9; Mendelsohn, 1961, GEOLOGY N RHODESIAN, P351; Mu WP, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7389-3; Murdoch LC, 2012, HYDROGEOL J, V20, P27, DOI 10.1007/s10040-011-0773-7; Nkulu CBL, 2018, NAT SUSTAIN, V1, P495, DOI 10.1038/s41893-018-0139-4; Pujades E, 2014, ENG GEOL, V178, P15, DOI 10.1016/j.enggeo.2014.06.007; Schrader A, 2014, ENVIRON EARTH SCI, V72, P3549, DOI 10.1007/s12665-014-3263-0; Straskraba V, 1985, IMWA P, P579; Yihdego Yohannes, 2018, International Journal of Mining and Mineral Engineering, V9, P321; Yihdego Y, 2018, J APPL WATER ENG RES, V6, P329, DOI 10.1080/23249676.2017.1287022; Yihdego Y, 2017, MINE WATER ENVIRON, V36, P114, DOI 10.1007/s10230-016-0419-z; Yihdego Y, 2015, ENVIRON EARTH SCI, V73, P4119, DOI 10.1007/s12665-014-3697-4	27	5	5	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0239682	10.1371/journal.pone.0239682	http://dx.doi.org/10.1371/journal.pone.0239682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119587	Green Published, gold			2022-12-26	WOS:000600013600005
J	Johnson, JE; Laparra, V; Perez-Suay, A; Mahecha, MD; Camps-Valls, G				Johnson, J. Emmanuel; Laparra, Valero; Perez-Suay, Adrian; Mahecha, Miguel D.; Camps-Valls, Gustau			Kernel methods and their derivatives: Concept and perspectives for the earth system sciences	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; COMPONENT ANALYSIS; PRINCIPAL CURVES; PARAMETERS; TUTORIAL; FLUXES; SITES	Kernel methods are powerful machine learning techniques which use generic non-linear functions to solve complex tasks. They have a solid mathematical foundation and exhibit excellent performance in practice. However, kernel machines are still considered black-box models as the kernel feature mapping cannot be accessed directly thus making the kernels difficult to interpret. The aim of this work is to show that it is indeed possible to interpret the functions learned by various kernel methods as they can be intuitive despite their complexity. Specifically, we show that derivatives of these functions have a simple mathematical formulation, are easy to compute, and can be applied to various problems. The model function derivatives in kernel machines is proportional to the kernel function derivative and we provide the explicit analytic form of the first and second derivatives of the most common kernel functions with regard to the inputs as well as generic formulas to compute higher order derivatives. We use them to analyze the most used supervised and unsupervised kernel learning methods: Gaussian Processes for regression, Support Vector Machines for classification, Kernel Entropy Component Analysis for density estimation, and the Hilbert-Schmidt Independence Criterion for estimating the dependency between random variables. For all cases we expressed the derivative of the learned function as a linear combination of the kernel function derivative. Moreover we provide intuitive explanations through illustrative toy examples and show how these same kernel methods can be applied to applications in the context of spatio-temporal Earth system data cubes. This work reflects on the observation that function derivatives may play a crucial role in kernel methods analysis and understanding.	[Johnson, J. Emmanuel; Laparra, Valero; Perez-Suay, Adrian; Mahecha, Miguel D.; Camps-Valls, Gustau] Univ Valencia, Image Proc Lab, Valencia, Spain; [Mahecha, Miguel D.] Max Planck Inst Biogeochem, Jena, Germany	University of Valencia; Max Planck Society	Johnson, JE (corresponding author), Univ Valencia, Image Proc Lab, Valencia, Spain.	juan.johnson@uv.es	Mahecha, Miguel D/F-2443-2010; , Gustavo/ABC-1706-2022; Camps-Valls, Gustavo/A-2532-2011; Laparra, Valero/AAD-1937-2019	Mahecha, Miguel D/0000-0003-3031-613X; Camps-Valls, Gustavo/0000-0003-1683-2138; Laparra, Valero/0000-0001-7531-9890; Johnson, Juan Emmanuel/0000-0002-6739-0053	European Research Council [GCV 647423]	European Research Council(European Research Council (ERC)European Commission)	GCV 647423 European Research Council https://erc.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821, DOI DOI 10.1234/12345678; Alaoui A., 2015, P 28 INT C NEURAL IN, P775; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2010, DIABETES CARE S1, V31, pS11; Arbogast LFA, 1800, CALCUL DERIVATIONS M; ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; BAKER CR, 1973, T AM MATH SOC, V186, P273, DOI 10.2307/1996566; Bakir G, 2003, LEARNING FIND PRE IM, P449; Blix K, 2015, INT GEOSCI REMOTE SE, P996, DOI 10.1109/IGARSS.2015.7325936; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bueso D, 2020, IEEE T GEOSCI REMOTE, V58, P5752, DOI 10.1109/TGRS.2020.2969813; Burges C, 1998, GEOMETRY INVARIANCE; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Camps-Valls G., 2009, KERNEL METHODS REMOT, DOI [10.1002/9780470748992.fmatter/summary, DOI 10.1002/9780470748992, 10.1002/9780470748992]; Camps-Valls G, 2019, NATL SCI REV, V6, P616, DOI 10.1093/nsr/nwz028; Camps-Valls G, 2016, IEEE GEOSC REM SEN M, V4, P58, DOI 10.1109/MGRS.2015.2510084; Camps-Valls G, 2015, INT GEOSCI REMOTE SE, P4416, DOI 10.1109/IGARSS.2015.7326806; Capobianco L, 2009, IEEE T GEOSCI REMOTE, V47, P3822, DOI 10.1109/TGRS.2009.2020910; Charlton AB, 2002, GEOGRAPHICALLY WEIGH; Chen S, 2000, IEE P-VIS IMAGE SIGN, V147, P213, DOI 10.1049/ip-vis:20000360; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cremers D, 2003, PATTERN RECOGN, V36, P1929, DOI 10.1016/S0031-3203(03)00056-6; Cucker F, 2002, B AM MATH SOC, V39, P1; Dorigo W, 2017, REMOTE SENS ENVIRON, V203, P185, DOI 10.1016/j.rse.2017.07.001; DUIN RPW, 1976, IEEE T COMPUT, V25, P1175, DOI 10.1109/TC.1976.1674577; EM-DAT, 2008, EM DAT INT DIS DAT; Johnson JE, 2020, IEEE GEOSCI REMOTE S, V17, P391, DOI 10.1109/LGRS.2019.2921476; Flach M, 2018, BIOGEOSCIENCES, V15, P6067, DOI 10.5194/bg-15-6067-2018; Fukumizu K, 2004, J MACH LEARN RES, V5, P73; Girolami M, 2002, NEURAL COMPUT, V14, P669, DOI 10.1162/089976602317250942; Gnecco G, 2009, COMPUT OPTIM APPL, V42, P265, DOI 10.1007/s10589-007-9108-y; Gomez-Chova L, 2012, IEEE GEOSCI REMOTE S, V9, P312, DOI 10.1109/LGRS.2011.2167212; Gretton A, 2005, J MACH LEARN RES, V6, P2075; Gretton A, 2005, LECT NOTES ARTIF INT, V3734, P63; Gretton A, 2012, J MACH LEARN RES, V13, P723; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; Izquierdo-Verdiguier E, 2017, IEEE T NEUR NET LEAR, V28, P1466, DOI 10.1109/TNNLS.2016.2530403; Jung M, 2020, BIOGEOSCIENCES, V17, P1343, DOI 10.5194/bg-17-1343-2020; Kim J, 2012, J MACH LEARN RES, V13, P2529; Kim KI, 2005, IEEE T PATTERN ANAL, V27, P1351, DOI 10.1109/TPAMI.2005.181; KIMELDORF G, 1971, J MATH ANAL APPL, V33, P82, DOI 10.1016/0022-247X(71)90184-3; Kjems U, 2002, NEUROIMAGE, V15, P772, DOI 10.1006/nimg.2001.1033; Kwok JTY, 2004, IEEE T NEURAL NETWOR, V15, P1517, DOI 10.1109/TNN.2004.837781; Lai PL, 2000, IEEE IJCNN, P614; Lampert CH, 2008, FOUND TRENDS COMPUT, V4, P193, DOI 10.1561/0600000027; Laparra V, 2015, IEEE J-STSP, V9, P1026, DOI 10.1109/JSTSP.2015.2417833; Laparra V, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714400073; Laparra V, 2012, NEURAL COMPUT, V24, P2751, DOI 10.1162/NECO_a_00336; Lin Y, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071129; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Mahecha MD, 2020, EARTH SYST DYNAM, V11, P201, DOI 10.5194/esd-11-201-2020; Mahecha MD, 2010, PATTERN RECOGN LETT, V31, P2309, DOI 10.1016/j.patrec.2010.06.021; Manton JH, 2014, FOUND TRENDS SIGNAL, V8, P1, DOI 10.1561/2000000050; Martens B, 2017, GEOSCI MODEL DEV, V10, P1903, DOI 10.5194/gmd-10-1903-2017; Martino L, 2017, GROUP IMPORTANCE SAM; Mchutchon A., 2011, ADV NEURAL INFORM PR, V24, P1341; Miralles DG, 2019, ANN NY ACAD SCI, V1436, P19, DOI 10.1111/nyas.13912; Ozertem U, 2011, J MACH LEARN RES, V12, P1249; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Perez-Suay A, 2017, APPL SOFT COMPUT; Peters J, 2017, ADAPT COMPUT MACH LE; Quadrianto N., 2009, ADV NEURAL INFORM PR, P1289; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Riesz F., 1955, FUNCTIONAL ANAL; Rojo-Alvarez J. L., 2017, DIGITAL SIGNAL PROCE; Rosipal R, 2002, J MACH LEARN RES, V2, P97, DOI 10.1162/15324430260185556; Sasaki H, 2017, PR MACH LEARN RES, V54, P204; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Scholkopf B, 2001, LECT NOTES ARTIF INT, V2111, P416, DOI 10.1007/3-540-44581-1_27; Seeger Matthias, 2004, Int J Neural Syst, V14, P69, DOI 10.1142/S0129065704001899; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Silverman B.W., 1986, DENSITY ESTIMATION S; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tramontana G, 2016, BIOGEOSCIENCES, V13, P4291, DOI 10.5194/bg-13-4291-2016; Vapnik V., 1998, STAT LEARNING THEORY; Verrelst J, 2012, IEEE T GEOSCI REMOTE, V50, P1832, DOI 10.1109/TGRS.2011.2168962; Wahba G, 2006, SPLINES NONPARAMETRI; Xing H, 2017, IEEE-ACM T AUDIO SPE, V25, P124, DOI 10.1109/TASLP.2016.2623563; Xu M, 2017, IEEE T IMAGE PROCESS, V26, P369, DOI 10.1109/TIP.2016.2628583; Zscheischler J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035001	82	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0235885	10.1371/journal.pone.0235885	http://dx.doi.org/10.1371/journal.pone.0235885			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119617	Green Published, gold, Green Submitted			2022-12-26	WOS:000600013600017
J	Birindwa, AM; Gonzales-Siles, L; Norden, R; Geravandi, S; Manegabe, JT; Morisho, L; Mushobekwa, SS; Andersson, R; Skovbjerg, S				Muhandule Birindwa, Archippe; Gonzales-Siles, Lucia; Norden, Rickard; Geravandi, Shadi; Tumusifu Manegabe, Jeaniere; Morisho, Lambert; Saili Mushobekwa, Stay; Andersson, Rune; Skovbjerg, Susann			High bacterial and viral load in the upper respiratory tract of children in the Democratic Republic of the Congo	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; ERA	Background Respiratory pathogens including Streptococcus pneumoniae and Haemophilus influenzae, are implicated in the pathogenicity of acute lower respiratory infection (ALRI). These are also commonly found in both healthy and sick children. In this study, we describe the first data on the most frequent bacteria and viruses detected in the nasopharynx of children from the general population in the Eastern DR Congo. Methods From January 2014 to June 2015, nasopharyngeal samples from 375 children aged from 2 to 60 months attending health centres for immunisation or growth monitoring were included in the study. Multiplex real-time PCR assays were used for detection of 15 different viruses and 5 bacterial species and for determination of pneumococcal serotypes/serogroups in the nasopharyngeal secretions. Results High levels of S. pneumoniae were detected in 77% of cases, and H. influenzae in 51%. Rhinovirus and enterovirus were the most commonly found viruses, while respiratory syncytial virus (RSV) was rare (1%). Co-occurrence of both bacteria and viruses at high levels was detected in 33% of the children. The pneumococcal load was higher in those children who lived in a dwelling with an indoor kitchen area with an open fire, i.e. a kitchen with an open fire for cooking located inside the dwelling with the resultant smoke passing to the living room and/or bedrooms; this was also higher in children from rural areas as compared to children from urban areas or children not living in a dwelling with an indoor kitchen area with an open fire/not living in this type of dwelling. Immunization with 2-3 doses of PCV13 was associated with lower rates of pneumococcal detection. Half of the identified serotypes were non-PCV13 serotypes. The most common non-PCV13 serotypes/serogroups were 15BC, 10A, and 12F, while 5, 6, and 19F were the most prevalent PCV13 serotypes/serogroups. Conclusions The burden of respiratory pathogens including S. pneumoniae in Congolese children was high but relatively few children had RSV. Non-PCV13 serotypes/serogroups became predominant soon after PCV13 was introduced in DR Congo.	[Muhandule Birindwa, Archippe; Gonzales-Siles, Lucia; Norden, Rickard; Geravandi, Shadi; Andersson, Rune; Skovbjerg, Susann] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Muhandule Birindwa, Archippe; Tumusifu Manegabe, Jeaniere; Morisho, Lambert] Panzi Hosp, Bukavu, Rep Congo; [Muhandule Birindwa, Archippe] Univ Evangelique Afrique, Bukavu, Rep Congo; [Muhandule Birindwa, Archippe; Saili Mushobekwa, Stay] Inst Super Tech Med, Uvira, Rep Congo; [Norden, Rickard; Andersson, Rune; Skovbjerg, Susann] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Birindwa, AM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.; Birindwa, AM (corresponding author), Panzi Hosp, Bukavu, Rep Congo.; Birindwa, AM (corresponding author), Univ Evangelique Afrique, Bukavu, Rep Congo.; Birindwa, AM (corresponding author), Inst Super Tech Med, Uvira, Rep Congo.	archippe.muhandule.birindwa@gu.se	Gonzales Strömberg, Lucia/GYQ-8934-2022	Gonzales Strömberg, Lucia/0000-0001-7441-8483; Andersson, Rune/0000-0002-8133-1199; Muhandule Birindwa, Archippe/0000-0002-0666-9763; Norden, Rickard/0000-0002-3866-7228	Gothenburg University Research Fund for starting up research in global health	Gothenburg University Research Fund for starting up research in global health	This study was supported by the Gothenburg University Research Fund for starting up research in global health. The funding body had no role in the design of the study, the collection, analysis or interpretation of data, nor in writing of the manuscript.	Abaye G, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4283-3; Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Andersson ME, 2014, SCAND J INFECT DIS, V46, P897, DOI 10.3109/00365548.2014.951681; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Baillie VL, 2020, J CLIN VIROL, V125, DOI 10.1016/j.jcv.2020.104288; Benet T, 2017, CLIN INFECT DIS, V65, P604, DOI 10.1093/cid/cix378; Birindwa AM, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1332-3; Bortz K, 2019, INFECT DIS CHILDREN, V32, P20; Dananche C, 2020, CLIN INFECT DIS, V70, P875, DOI 10.1093/cid/ciz277; Dubourg G, 2019, EXPERT REV ANTI-INFE, V17, P437, DOI 10.1080/14787210.2019.1621168; Dunne EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224392; Elfving K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146054; Emgard M, 2019, INT J INFECT DIS, V81, P156, DOI 10.1016/j.ijid.2019.01.035; Esposito S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/591580; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Goga Ameena E, 2009, Health Res Policy Syst, V7, P18, DOI 10.1186/1478-4505-7-18; Gonzales-Siles L, 2019, J MED MICROBIOL, V68, P1173, DOI 10.1099/jmm.0.001022; Gonzalez-Diaz A, 2020, CLIN MICROBIOL INFEC, V26, P753, DOI 10.1016/j.cmi.2019.10.034; Heath CJ, 2018, AM J TROP MED HYG, V98, P1046, DOI 10.4269/ajtmh.16-0813; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Kaur R, 2016, PEDIATR INFECT DIS J, V35, P901, DOI 10.1097/INF.0000000000001206; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lindstrand A, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0166018, 1]; Man WH, 2019, LANCET RESP MED, DOI 10.1016/S2213-2600(18)30449-1; Moe N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159196; Negash A. A., 2019, OPEN FORUM INFECT DI; Ngocho JS, 2020, J INFECTION, V81, P213, DOI 10.1016/j.jinf.2020.06.013; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; Piralam B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232151; Prill MM, 2012, PEDIATR INFECT DIS J, V31, P235, DOI 10.1097/INF.0b013e31823e07fe; Principi N, 2018, CURR INFECT DIS REP, V20, DOI 10.1007/s11908-018-0607-z; Roca A, 2015, VACCINE, V33, P7144, DOI 10.1016/j.vaccine.2015.11.012; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Spichak TV, 2016, EUR J PEDIATR, V175, P1951, DOI 10.1007/s00431-016-2791-x; Tahamtan A, 2020, EXPERT REV RESP MED, V14, P415, DOI 10.1080/17476348.2020.1724095; Thors V, 2019, PEDIATR INFECT DIS J, V38, P533, DOI 10.1097/INF.0000000000002256; Usuf E, 2019, CLIN INFECT DIS, V68, P1512, DOI 10.1093/cid/ciy726; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240922	10.1371/journal.pone.0240922	http://dx.doi.org/10.1371/journal.pone.0240922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119683	gold, Green Published			2022-12-26	WOS:000600013600055
J	Noer, NK; Pagter, M; Bahrndorff, S; Malmendal, A; Kristensen, TN				Noer, Natasja Krog; Pagter, Majken; Bahrndorff, Simon; Malmendal, Anders; Kristensen, Torsten Nygaard			Impacts of thermal fluctuations on heat tolerance and its metabolomic basis in Arabidopsis thaliana, Drosophila melanogaster, and Orchesella cincta	PLOS ONE			English	Article							FLIES SARCOPHAGA-CRASSIPALPIS; CLIMATIC STRESS RESISTANCE; COLD HARDENING RESPONSE; PHENOTYPIC PLASTICITY; FREEZING TOLERANCE; ACCLIMATION RESPONSES; GEOGRAPHIC-VARIATION; NATURAL-POPULATIONS; GENETIC-VARIATION; CLINAL VARIATION	Temperature varies on a daily and seasonal scale and thermal fluctuations are predicted to become even more pronounced under future climate changes. Studies suggest that plastic responses are crucial for species' ability to cope with thermal stress including variability in temperature, but most often laboratory studies on thermal adaptation in plant and ectotherm organisms are performed at constant temperatures and few species included. Recent studies using fluctuating thermal regimes find that thermal performance is affected by both temperature mean and fluctuations, and that plastic responses likely will differ between species according to life strategy and selective past. Here we investigate how acclimation to fluctuating or constant temperature regimes, but with the same mean temperature, impact on heat stress tolerance across a plant (Arabidopsis thaliana) and two arthropod species (Orchesella cincta and Drosophila melanogaster) inhabiting widely different thermal microhabitats and with varying capability for behavioral stress avoidance. Moreover, we investigate the underlying metabolic responses of acclimation using NMR metabolomics. We find increased heat tolerance for D. melanogaster and A. thaliana exposed to fluctuating acclimation temperatures, but not for O. cincta. The response was most pronounced for A. thaliana, which also showed a stronger metabolome response to thermal fluctuations than both arthropods. Generally, sugars were more abundant across A. thaliana and D. melanogaster when exposed to fluctuating compared to constant temperature, whereas amino acids were less abundant. This pattern was not evident for O. cincta, and generally we do not find much evidence for similar metabolomics responses to fluctuating temperature acclimation across species. Differences between the investigated species' ecology and different ability to behaviorally thermoregulate may have shaped their physiological responses to thermal fluctuations.	[Noer, Natasja Krog; Pagter, Majken; Bahrndorff, Simon; Kristensen, Torsten Nygaard] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark; [Malmendal, Anders] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark	Aalborg University; Roskilde University	Noer, NK (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	nkn@bio.aau.dk	Malmendal, Anders/F-1198-2017	Malmendal, Anders/0000-0002-8413-9717; Noer, Natasja Krog/0000-0002-4430-0342; Bahrndorff, Simon/0000-0002-0838-4008	Danish Council for Independent Research [DFF-8021-00014B]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by a grant from the Danish Council for Independent Research (DFF-8021-00014B) to T.N.K.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Alemu T, 2017, BIOL J LINN SOC, V122, P765, DOI 10.1093/biolinnean/blx092; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Annunziata MG, 2018, J EXP BOT, V69, P4881, DOI 10.1093/jxb/ery276; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2019, R LANG ENV STAT COMP; Armstrong JJ, 2020, AM J BOT, V107, P489, DOI 10.1002/ajb2.1442; Bahrndorff S, 2006, J INSECT PHYSIOL, V52, P951, DOI 10.1016/j.jinsphys.2006.06.005; Bahrndorff S, 2009, FUNCT ECOL, V23, P233, DOI 10.1111/j.1365-2435.2009.01541.x; Bahrndorff S, 2009, FUNCT ECOL, V23, P340, DOI 10.1111/j.1365-2435.2008.01503.x; Berg JM, 2011, BIOCHEMISTRY, V7th, P663, DOI [10.1021/bi101523x, DOI 10.1021/BI101523X]; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Bozinovic F, 2016, J COMP PHYSIOL B, V186, P581, DOI 10.1007/s00360-016-0980-6; Bozinovic F, 2011, PHYSIOL BIOCHEM ZOOL, V84, P543, DOI 10.1086/662551; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw A.D., 1972, EVOL BIOL, V5, P25, DOI DOI 10.1007/978-1-4757-0256-9_2; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colinet H, 2006, PHYSIOL ENTOMOL, V31, P234, DOI 10.1111/j.1365-3032.2006.00511.x; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; Cox JE, 2017, GENETICS, V206, P1169, DOI 10.1534/genetics.117.200014; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; de Vries J, 2020, PLANT J, V103, P1025, DOI 10.1111/tpj.14782; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edenhofer O., 2014, CONTRIBUTION WORKING; Fallis LC, 2014, J EVOLUTION BIOL, V27, P557, DOI 10.1111/jeb.12321; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hasanuzzaman M, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P169, DOI 10.5772/54833; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Hemme D, 2014, PLANT CELL, V26, P4270, DOI 10.1105/tpc.114.130997; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Huey RB, 2002, INTEGR COMP BIOL, V42, P415, DOI 10.1093/icb/42.3.415; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jensen A, 2019, FUNCT ECOL, V33, P833, DOI 10.1111/1365-2435.13291; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kelty JD, 1996, PHYSIOL ENTOMOL, V21, P283, DOI 10.1111/j.1365-3032.1996.tb00866.x; Kingsolver JG, 2020, CURR OPIN INSECT SCI, V41, P17, DOI 10.1016/j.cois.2020.05.005; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Kristensen TN, 2020, ANN NY ACAD SCI, V1476, P5, DOI 10.1111/nyas.13974; Kristensen TN, 2016, INSECT SCI, V23, P771, DOI 10.1111/1744-7917.12239; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lalouette L, 2007, FEBS J, V274, P1759, DOI 10.1111/j.1742-4658.2007.05723.x; Li JM, 2016, OECOLOGIA, V182, P755, DOI 10.1007/s00442-016-3699-x; Liao HX, 2016, OIKOS, V125, P905, DOI 10.1111/oik.02372; Liefting M, 2008, BIOL J LINN SOC, V94, P265, DOI 10.1111/j.1095-8312.2008.00969.x; MacLean HJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0548; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Manenti T, 2015, J EVOLUTION BIOL, V28, P2078, DOI 10.1111/jeb.12735; Manenti T, 2014, J EVOLUTION BIOL, V27, P2113, DOI 10.1111/jeb.12463; Manenti T, 2017, ECOL EVOL, V7, P2716, DOI 10.1002/ece3.2904; Manna C, 1997, J NUTR, V127, P286, DOI 10.1093/jn/127.2.286; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Michaud M. Robert, 2010, P91, DOI 10.1017/CBO9780511675997.005; Moghadam NN, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0628; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Mollo L, 2011, PLANT CELL TISS ORG, V107, P141, DOI 10.1007/s11240-011-9966-y; Oostra V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03384-9; Orsted M, 2018, BIOL J LINN SOC, V123, P155, DOI 10.1093/biolinnean/blx120; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Overgaard J, 2014, J INSECT PHYSIOL, V62, P46, DOI 10.1016/j.jinsphys.2014.01.009; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Ramos-Ruiz R, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1670553; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Renault D, 2004, PHYSIOL ENTOMOL, V29, P139, DOI 10.1111/j.0307-6962.2004.00377.x; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Salachan PV, 2017, J EXP BIOL, V220, P4471, DOI 10.1242/jeb.165308; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scheepens JF, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply043; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schou MF, 2014, J EVOLUTION BIOL, V27, P1859, DOI 10.1111/jeb.12436; Schou MF, 2017, AM J PHYSIOL-REG I, V312, pR211, DOI 10.1152/ajpregu.00268.2016; Sgro CM, 2010, J EVOLUTION BIOL, V23, P2484, DOI 10.1111/j.1420-9101.2010.02110.x; Sgro CM, 2016, ANNU REV ENTOMOL, V61, P433, DOI 10.1146/annurev-ento-010715-023859; Sorensen JG, 2016, CURR OPIN INSECT SCI, V17, P98, DOI 10.1016/j.cois.2016.08.003; Sorensen JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep30975; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Taiz L., 2015, PLANT PHYSL DEV; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Van Dooremalen C, 2013, GLOBAL CHANGE BIOL, V19, P975, DOI 10.1111/gcb.12081; van Heerwaarden B, 2014, J EVOLUTION BIOL, V27, P2541, DOI 10.1111/jeb.12510; Vazquez DP, 2017, BIOL REV, V92, P22, DOI 10.1111/brv.12216; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang HS, 2006, CRYOBIOLOGY, V53, P206, DOI 10.1016/j.cryobiol.2006.06.003; Wani S.H, 2020, HEAT STRESS TOLERANC; Zhang NN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv101; Zhen Y, 2008, NEW PHYTOL, V177, P419, DOI 10.1111/j.1469-8137.2007.02262.x; Zuther E, 2012, PLANT CELL ENVIRON, V35, P1860, DOI 10.1111/j.1365-3040.2012.02522.x	110	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0237201	10.1371/journal.pone.0237201	http://dx.doi.org/10.1371/journal.pone.0237201			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119606	Green Submitted, Green Published, gold			2022-12-26	WOS:000600013600115
J	Rich, SN; Cook, RL; Yaghjyan, L; Francois, K; Puttkammer, N; Robin, E; Bae, J; Joseph, N; Pessoa-Brandao, L; Delcher, C				Rich, Shannan N.; Cook, Robert L.; Yaghjyan, Lusine; Francois, Kesner; Puttkammer, Nancy; Robin, Ermane; Bae, Jungjun; Joseph, Nadjy; Pessoa-Brandao, Luisa; Delcher, Chris			Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017	PLOS ONE			English	Article							VIROLOGICAL FAILURE; DRUG-RESISTANCE	Studies of viral suppression on first-line antiretroviral therapy (ART) in persons living with human immunodeficiency virus (PLHIV) in Haiti are limited, particularly among PLHIV outside of the Ouest department, where the capital Port-au-Prince is located. This study described the prevalence and risk factors for delayed viral suppression among PLHIV in all geographic departments of Haiti between 2013 and 2017. Individuals who received viral load testing 3 to 12 months after ART initiation were included. Data on demographics and clinical care were obtained from the Haitian Active Longitudinal Tracking of HIV database. Multivariable logistic regression was performed to predict delayed viral suppression, defined as a viral load >= 1000 HIV-1 RNA copies/mL after at least 3 months on ART. Viral load test results were available for 3,368 PLHIV newly-initiated on ART. Prevalence of delayed viral suppression was 40%, which is slightly higher than previous estimates in Haiti. In the multivariable analysis, delayed viral suppression was significantly associated with younger age, receiving of care in the Ouest department, treatment with lamivudine (3TC), zidovudine (AZT), and nevirapine (NVP) combined ART regimen, and CD4 counts below 200 cells/mm(3). In conclusion, this study was the first to describe and compare differences in delayed viral suppression among PLHIV by geographic department in Haiti. We identified populations to whom public health interventions, such as more frequent viral load testing, drug resistance testing, and ART adherence counseling should be targeted.	[Rich, Shannan N.; Cook, Robert L.; Yaghjyan, Lusine] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32611 USA; [Rich, Shannan N.; Cook, Robert L.; Yaghjyan, Lusine] Univ Florida, Coll Med, Gainesville, FL 32611 USA; [Rich, Shannan N.] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL 32611 USA; [Francois, Kesner; Robin, Ermane] Minist Sante Publ & Populat, Programme Natl Lutte SIDA, Port Au Prince, Haiti; [Puttkammer, Nancy] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth I TECH, Seattle, WA 98195 USA; [Bae, Jungjun; Delcher, Chris] Univ Kentucky, Coll Pharm, Inst Pharmaceut Outcomes & Policy, Lexington, KY USA; [Joseph, Nadjy; Pessoa-Brandao, Luisa; Delcher, Chris] Natl Alliance State & Terr AIDS Directors, Port Au Prince, Haiti; [Delcher, Chris] Univ Kentucky, Coll Pharm, Dept Pharm Practice & Sci, Lexington, KY USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; University of Kentucky; University of Kentucky	Rich, SN (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL 32611 USA.; Rich, SN (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32611 USA.; Rich, SN (corresponding author), Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL 32611 USA.	shannanrich@ufl.edu		Bae, Jungjun/0000-0002-8975-4073; Rich, Shannan/0000-0002-1203-2443	National Alliance of State and Territorial AIDS Directors [ID00017061]	National Alliance of State and Territorial AIDS Directors	This work was supported by a grant (ID00017061) from the National Alliance of State and Territorial AIDS Directors to CD. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Uria G, 2012, TROP MED INT HEALTH, V17, P1152, DOI 10.1111/j.1365-3156.2012.02982.x; Auld AF, MORBIDITY MORTALITY; Ayele T, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0132-4; Cesar C, 2015, LANCET HIV, V2, pE492, DOI 10.1016/S2352-3018(15)00183-6; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Charles M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17375; Chun HM, 2017, J INFECT DIS, V216, pS808, DOI 10.1093/infdis/jix404; Delcher Chris, 2016, J Registry Manag, V43, P10; ESRI, 2019, ARCGIS PRO 2 3; Haile-Selassie H, 2017, WHO HIV DRUG RESISTA; Hare AQ, 2014, AIDS BEHAV, V18, P2219, DOI 10.1007/s10461-014-0849-1; Hermans LE, 2018, LANCET INFECT DIS, V18, P188, DOI 10.1016/S1473-3099(17)30681-3; Jean SS, 1999, PEDIATR INFECT DIS J, V18, P58, DOI 10.1097/00006454-199901000-00014; Kerschberger B, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20092; Louis FJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192077; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Mbuagbaw L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub4; McNairy ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175521; Pannus P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005475; Ruperez M, 2015, J ANTIMICROB CHEMOTH, V70, P2639, DOI 10.1093/jac/dkv143; SAS Institute, 2015, SAS STAT 9 4 US GUID; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2016, ANNEX 10 WHO CLIN ST	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240817	10.1371/journal.pone.0240817	http://dx.doi.org/10.1371/journal.pone.0240817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119631	gold, Green Published			2022-12-26	WOS:000600013600070
J	Yu, KW; Liu, PW; Venkatachalam, D; Hopkinson, BM; Lechtreck, KF				Yu, Kewei; Liu, Peiwei; Venkatachalam, Dipna; Hopkinson, Brian M.; Lechtreck, Karl F.			The BBSome restricts entry of tagged carbonic anhydrase 6 into the cis-flagellum of Chlamydomonas reinhardtii	PLOS ONE			English	Article							CONCENTRATING MECHANISM; NONPHOTOTACTIC MUTANT; PROTEINS; IFT; LOCALIZATION; EXPRESSION; ASYMMETRY; REVEALS; IDENTIFICATION; APPARATUS	The two flagella of Chlamydomonas reinhardtii are of the same size and structure but display functional differences, which are critical for flagellar steering movements. However, biochemical differences between the two flagella have not been identified. Here, we show that fluorescence protein-tagged carbonic anhydrase 6 (CAH6-mNG) preferentially localizes to the trans-flagellum, which is organized by the older of the two flagella-bearing basal bodies. The uneven distribution of CAH6-mNG is established early during flagellar assembly and restored after photobleaching, suggesting that it is based on preferred entry or retention of CAH6-mNG in the trans-flagellum. Since CAH6-mNG moves mostly by diffusion, a role of intraflagellar transport (IFT) in establishing its asymmetric distribution is unlikely. Interestingly, CAH6-mNG is present in both flagella of the non-phototactic bardet-biedl syndrome 1 (bbs1) mutant revealing that the BBSome is involved in establishing CAH6-mNG flagellar asymmetry. Using dikaryon rescue experiments, we show that the de novo assembly of CAH6-mNG in flagella is considerably faster than the removal of ectopic CAH6-mNG from bbs flagella. Thus, different rates of flagellar entry of CAH6-mNG rather than its export from flagella is the likely basis for its asymmetric distribution. The data identify a novel role for the C. reinhardtii BBSome in preventing the entry of CAH6-mNG specifically into the cis-flagellum.	[Yu, Kewei; Liu, Peiwei; Venkatachalam, Dipna; Lechtreck, Karl F.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Hopkinson, Brian M.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Liu, Peiwei] Yale Univ, Sch Med, New Haven, CT USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Yale University	Lechtreck, KF (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	lechtrek@uga.edu		Hopkinson, Brian/0000-0002-0844-0794	National Institute of General Medical Sciences of the National Institutes of Health [R01GM110413]; National Science Foundation [OPP 1744760]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health (https://www.nih.gov/) under Award Number R01GM110413 (to K.L.) and by the National Science Foundation grant (https://www.nsf.gov/) under Award Number OPP 1744760 (to B.M.H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arias-Darraz L, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1052924; Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; Bahn YS, 2005, CURR BIOL, V15, P2013, DOI 10.1016/j.cub.2005.09.047; BEECH PL, 1991, PROTOPLASMA, V164, P23, DOI 10.1007/BF01320812; Cao MQ, 2015, ELIFE, V4, DOI 10.7554/eLife.05242; Choi HI, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4942756; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Dean S, 2016, P NATL ACAD SCI USA, V113, pE5135, DOI 10.1073/pnas.1604258113; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Gee CW, 2017, P NATL ACAD SCI USA, V114, P4537, DOI 10.1073/pnas.1700139114; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; HOEK C. VAN DEN, 1995, ALGAE INTRO PHYCOLOG; HOLMES JA, 1989, J CELL SCI, V94, P273; Hopkinson BM, 2015, J EXP BIOL, V218, P2039, DOI 10.1242/jeb.118182; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; HORST CJ, 1993, J CELL BIOL, V120, P733, DOI 10.1083/jcb.120.3.733; KAMIYA R, 1984, J CELL BIOL, V98, P97, DOI 10.1083/jcb.98.1.97; KAMIYA R, 1987, EXP CELL RES, V173, P299, DOI 10.1016/0014-4827(87)90357-0; KING SM, 1990, J BIOL CHEM, V265, P19807; Lamb MR, 1999, GENETICS, V153, P721; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Lechtreck KF, 2016, METHODS MOL BIOL, V1454, P83, DOI 10.1007/978-1-4939-3789-9_6; Lechtreck KF, 2013, J CELL BIOL, V201, P249, DOI 10.1083/jcb.201207139; Lechtreck KF, 2013, METHOD ENZYMOL, V524, P265, DOI 10.1016/B978-0-12-397945-2.00015-9; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Leptos KC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.158101; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Mackinder LCM, 2017, CELL, V171, P133, DOI 10.1016/j.cell.2017.08.044; Maric D, 2011, J BIOL CHEM, V286, P33109, DOI 10.1074/jbc.M111.240895; MELKONIAN M, 1987, QUINZAINE LITTERAIRE, P10; Mitra M, 2004, PLANT PHYSIOL, V135, P173, DOI 10.1104/pp.103.037283; Mitsuhashi S, 2000, J BIOL CHEM, V275, P5521, DOI 10.1074/jbc.275.8.5521; Mittelmeier TM, 2015, CYTOSKELETON, V72, P113, DOI 10.1002/cm.21220; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Ogino T, 2016, J COMP NEUROL, V524, P2982, DOI 10.1002/cne.24001; PAZOUR GJ, 1995, J CELL BIOL, V131, P427, DOI 10.1083/jcb.131.2.427; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Ruffer U, 1997, CELL MOTIL CYTOSKEL, V37, P111, DOI 10.1002/(SICI)1097-0169(1997)37:2<111::AID-CM3>3.0.CO;2-B; Schoppmeier J, 2003, J PHYCOL, V39, P918, DOI 10.1046/j.1529-8817.2003.03031.x; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Singh SK, 2020, ELIFE, V9, DOI 10.7554/eLife.53322; Strenkert D, 2019, P NATL ACAD SCI USA, V116, P2374, DOI 10.1073/pnas.1815238116; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; WETHERBEE R, 1988, PROTOPLASMA, V145, P47, DOI 10.1007/BF01323255; Wingfield JL, 2018, ESSAYS BIOCHEM, V62, P753, DOI 10.1042/EBC20180030; Wingfield JL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070079; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yamano T, 2009, J BASIC MICROB, V49, P42, DOI 10.1002/jobm.200800352; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468	63	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240887	10.1371/journal.pone.0240887	http://dx.doi.org/10.1371/journal.pone.0240887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119622	gold, Green Published			2022-12-26	WOS:000600013600092
J	Codagnone, C; Bogliacino, F; Gomez, C; Charris, R; Montealegre, F; Liva, G; Lupianez-Villanueva, F; Folkvord, F; Veltri, GA				Codagnone, Cristiano; Bogliacino, Francesco; Gomez, Camilo; Charris, Rafael; Montealegre, Felipe; Liva, Giovanni; Lupianez-Villanueva, Francisco; Folkvord, Frans; Veltri, Giuseppe A.			Assessing concerns for the economic consequence of the COVID-19 response and mental health problems associated with economic vulnerability and negative economic shock in Italy, Spain, and the United Kingdom	PLOS ONE			English	Article							INTERVENTIONS; STRESS; CRIME	Many different countries have been under lockdown or extreme social distancing measures to control the spread of COVID-19. The potentially far-reaching side effects of these measures have not yet been fully understood. In this study we analyse the results of a multi-country survey conducted in Italy (N = 3,504), Spain (N = 3,524) and the United Kingdom (N = 3,523), with two separate analyses. In the first analysis, we examine the elicitation of citizens' concerns over the downplaying of the economic consequences of the lockdown during the COVID-19 pandemic. We control for Social Desirability Bias through a list experiment included in the survey. In the second analysis, we examine the data from the same survey to predict the level of stress, anxiety and depression associated with being economically vulnerable and having been affected by a negative economic shock. To accomplish this, we have used a prediction algorithm based on machine learning techniques. To quantify the size of this affected population, we compare its magnitude with the number of people affected by COVID-19 using measures of susceptibility, vulnerability and behavioural change collected in the same questionnaire. We find that the concern for the economy and for "the way out" of the lockdown is diffuse and there is evidence of minor underreporting. Additionally, we estimate that around 42.8% of the populations in the three countries are at high risk of stress, anxiety, and depression, based on their level of economic vulnerability and their exposure to a negative economic shock.	[Codagnone, Cristiano] Univ Milan, Milan, Italy; [Codagnone, Cristiano; Liva, Giovanni; Lupianez-Villanueva, Francisco; Folkvord, Frans] Open Evidence Res, Barcelona, Spain; [Codagnone, Cristiano; Lupianez-Villanueva, Francisco] Univ Oberta Catalunya, Fac Informat & Commun Sci, Barcelona, Spain; [Bogliacino, Francesco; Gomez, Camilo; Charris, Rafael; Montealegre, Felipe] Univ Nacl Colombia, Bogota, Colombia; [Bogliacino, Francesco; Gomez, Camilo; Charris, Rafael; Montealegre, Felipe; Folkvord, Frans] Ctr Invest Desarrollo, Bogota, Colombia; [Folkvord, Frans] Tilburg Univ, Tillburg Sch Humanities & Digital Sci, Tilburg, Netherlands; [Veltri, Giuseppe A.] Univ Trento, Trento, Italy	University of Milan; UOC Universitat Oberta de Catalunya; Universidad Nacional de Colombia; Tilburg University; University of Trento	Bogliacino, F (corresponding author), Univ Nacl Colombia, Bogota, Colombia.; Bogliacino, F (corresponding author), Ctr Invest Desarrollo, Bogota, Colombia.	fbogliacino@unal.edu.co	Lupiáñez-Villanueva, Francisco/N-1178-2019; Veltri, Giuseppe Alessandro/R-1984-2018	Lupiáñez-Villanueva, Francisco/0000-0001-5361-7678; Veltri, Giuseppe Alessandro/0000-0002-9472-2236; Bogliacino, Francesco/0000-0001-8874-8846; Charris, Rafael/0000-0002-5994-7894; Folkvord, Frans/0000-0001-7602-3792; Montealegre, Felipe/0000-0001-7744-2200	BDI-Schlesinger Group	BDI-Schlesinger Group	Funding has been provided by Open Evidence and BDI-Schlesinger Group.	Alwan NA, 2020, LANCET, V395, P1036, DOI 10.1016/S0140-6736(20)30667-X; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, LANCET INFECT DIS, V20, P511, DOI 10.1016/S1473-3099(20)30298-X; [Anonymous], 2011, DIABETES CARE, V34, pS11; [Anonymous], 2020, IEEE SENS J, DOI [10.1016/j.ijid.2020.03.017, DOI 10.1109/JSEN.2020.2965086]; [Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0914-4, DOI 10.1038/S41591-020-0914-432367062]; Atkeson A., 2020, W26867 NAT BUR EC RE, DOI [10.1097/PHH.0000000000001131, DOI 10.1097/PHH.000000000000113132011593]; Barro RJ., 2020, CORONAVIRUS GREAT IN; Bavel J.J.V., 2020, NAT HUM BEHAV, DOI [10.1038/s41562-020-0884-z, DOI 10.1038/S41562-020-0884-Z32355299]; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Beck AT, 2009, DEPRESSION: CAUSES AND TREATMENT, SECOND EDITION, P1; Bignon V, 2017, ECON J, V127, P19, DOI 10.1111/ecoj.12270; Blair G, 2012, POLIT ANAL, V20, P47, DOI 10.1093/pan/mpr048; Brooks S.K., 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8,10227, 10.1016/S0140-6736]; Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186; COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5; Coibion O., 2020, LABOR MARKETS COVID, DOI [10.1080/00365521.2020.1802773, DOI 10.1080/00365521.2020.180277332757858]; Colbourn T, 2020, LANCET PUBLIC HEALTH, V5, pE236, DOI 10.1016/S2468-2667(20)30072-4; Correia S, 2020, ELECT J, DOI DOI 10.2139/SSRN.3561560; De Natale G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051564; Dix-Carneiro R, 2018, AM ECON J-APPL ECON, V10, P158, DOI 10.1257/app.20170080; Drozd L. A., 2020, RESPONDING COVID 19, DOI 10.21799/frbp.wp.2020.14; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Fetzer T., 2020, HARVARD BUSINESS SCH, DOI [10.31234/osf.io/3kfmh, DOI 10.31234/OSF.IO/3KFMH]; Goldman-Mellor SJ, 2010, INT J MENT HEALTH, V39, P6, DOI 10.2753/IMH0020-7411390201; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Heffner J, 2020, PSYARXIV; Indolfi C, 2020, OUTBREAK COVID 19 IT, DOI [10.1016/j.jaccas.2020.03.012, DOI 10.1016/J.JACCAS.2020.03.01232835287]; Kissler SM, 2020, DIS, V368, P860, DOI [DOI 10.1038/s41591-020-0843-2, 10.1126/science, DOI 10.1093/CID/CIAA248]; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Legido-Quigley H, 2020, LANCET, V395, P848, DOI 10.1016/S0140-6736(20)30551-1; Liu JJ, 2020, LANCET CHILD ADOLESC, V4, P347, DOI 10.1016/S2352-4642(20)30096-1; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; McPhetres J., 2020, PSYARXIV, DOI [10.31234/osf.io/zhjkp, DOI 10.31234/OSF.IO/ZHJKP]; McSweeny K., 2007, NZ MED J; Nagar H., 2020, NATURE REV CLIN ONCO, P1, DOI 10.1038/s41571-019-0287-0; Pisano GP, 2020, HARVARD BUS REV; Rand D.G., 2020, FIGHTING COVID 19 MI, DOI [10.31234/osf.io/uhbk9, DOI 10.31234/OSF.IO/UHBK9, 10.31234/OSF.IO/UHBK9]; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Romer P., 2020, NY TIMES; ROY D, 2020, ASIAN J PSYCHIAT, V0051, DOI DOI 10.1016/J.AJP.2020.10208332283510; Shah AK, 2015, PSYCHOL SCI, V26, P402, DOI 10.1177/0956797614563958; Stanczyk L., 2020, SECURING JUSTICE HLT, P1; Sunstein CR, 2018, COST-BENEFIT REVOLUTION; Surico P, 2020, EC PANDEMIC COVID 19; Tang B, 2020, INT J INFECT DIS, V95, P288, DOI 10.1016/j.ijid.2020.03.018; Wahlbeck K, 2012, WORLD PSYCHIATRY, V11, P139; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	56	66	66	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240876	10.1371/journal.pone.0240876	http://dx.doi.org/10.1371/journal.pone.0240876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108374	Green Published, gold, Green Submitted			2022-12-26	WOS:000588372400003
J	Sperber, J; Nyberg, A; Krifors, A; Skorup, P; Lipcsey, M; Castegren, M				Sperber, Jesper; Nyberg, Axel; Krifors, Anders; Skorup, Paul; Lipcsey, Miklos; Castegren, Markus			Pre-exposure to mechanical ventilation and endotoxemia increases Pseudomonas aeruginosa growth in lung tissue during experimental porcine pneumonia	PLOS ONE			English	Article							PULMONARY ALVEOLAR MACROPHAGE; BACTERIAL CLEARANCE; IN-VIVO; DEFENSE; MODEL; LIPOPOLYSACCHARIDE; INHIBITION; SURFACTANT; TOLERANCE; MORTALITY	Background Immune system suppression during critical care contributes to the risk of acquired bacterial infections with Pseudomonas (P.) aeruginosa. Repeated exposure to endotoxin can attenuate systemic inflammatory cytokine responses. Mechanical ventilation affects the systemic inflammatory response to various stimuli. Aim To study the effect of pre-exposure to mechanical ventilation with and without endotoxin-induced systemic inflammation on P. aeruginosa growth and wet-to-dry weight measurements on lung tissue and plasma and bronchoalveolar lavage levels of tumor necrosis factor alpha, interleukins 6 and 10. Methods Two groups of pigs were exposed to mechanical ventilation for 24 hours before bacterial inoculation and six h of experimental pneumonia (total experimental time 30 h): A(30h+Etx) (n = 6, endotoxin 0.063 mu g x kg(-1) x h(-1)) and B-30h (n = 6, saline). A third group, C-6h (n = 8), started the experiment at the bacterial inoculation unexposed to endotoxin or mechanical ventilation (total experimental time 6 h). Bacterial inoculation was performed by tracheal instillation of 1x10(11) colony-forming units of P. aeruginosa. Bacterial cultures and wet-to-dry weight ratio analyses were done on lung tissue samples postmortem. Separate group comparisons were done between A(30h+Etx) vs.B-30h (Inflammation) and B-30h vs. C-6h (Ventilation Time) during the bacterial phase of 6 h. Results P. aeruginosa growth was highest in A(30h+Etx), and lowest in C-6h (Inflammation and Ventilation Time both p<0.05). Lung wet-to-dry weight ratios were highest in A(30h+Etx) and lowest in B-30h (Inflammation p<0.01, Ventilation Time p<0.05). C-6h had the highest TNF-alpha levels in plasma (Ventilation Time p<0.01). No differences in bronchoalveolar lavage variables between the groups were observed. Conclusions Mechanical ventilation and systemic inflammation before the onset of pneumonia increase the growth of P. aeruginosa in lung tissue. The attenuated growth of P. aeruginosa in the non-pre-exposed animals (C-6h) was associated with a higher systemic TNF-alpha production elicited from the bacterial challenge.	[Sperber, Jesper; Nyberg, Axel] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Sperber, Jesper; Nyberg, Axel; Skorup, Paul] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Krifors, Anders] Uppsala Univ, Ctr Clin Res, Reg Vastmanland, Uppsala, Sweden; [Krifors, Anders; Castegren, Markus] Karolinska Inst, Dept Physiol & Pharmacol, FyFa, Stockholm, Sweden; [Lipcsey, Miklos] Uppsala Univ, Dept Surg Sci, Hedenstierna Lab, Anesthesiol & Intens Care,CIRRUS, Uppsala, Sweden; [Castegren, Markus] Karolinska Univ Hosp, Perioperat Med & Intens Care PMI, Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Sperber, J (corresponding author), Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.; Sperber, J (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	jesper.sperber@regionsormland.se		Sperber, Jesper/0000-0001-8731-6953; Krifors, Anders/0000-0003-1230-0492; skorup, paul/0000-0002-5407-6612	Sormland County Council; Uppsala University Hospital; Family Olinder-Nielsens Foundation	Sormland County Council; Uppsala University Hospital; Family Olinder-Nielsens Foundation	The RD funds of the Sormland County Council and Uppsala University Hospital and the Family Olinder-Nielsens Foundation contributed with financial support to the main investigator JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, AM J PHYSIOL-LUNG C, V311, pL970; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Castegren M, 2015, CRIT CARE RESUSC, V17, P174; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Chang CC, 1996, AM J PHYSIOL-GASTR L, V271, pG539, DOI 10.1152/ajpgi.1996.271.4.G539; CHASE HM, 1979, SURG FORUM, V30, P165; Davies Claire A, 2003, Methods Mol Biol, V225, P305; DRINKWATER DC, 1981, ANN THORAC SURG, V32, P235, DOI 10.1016/S0003-4975(10)61044-2; Giampietri A, 2000, CYTOKINE, V12, P417, DOI 10.1006/cyto.1999.0576; GOLDSTEIN E, 1974, J CLIN INVEST, V54, P519, DOI 10.1172/JCI107788; GREEN GM, 1964, J EXP MED, V119, P167, DOI 10.1084/jem.119.1.167; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; HORGAN MJ, 1993, AM J PHYSIOL, V264, pH1161, DOI 10.1152/ajpheart.1993.264.4.H1161; Iba T, 2019, J THROMB HAEMOST, V17, P283, DOI 10.1111/jth.14371; JACOBS RF, 1986, AM REV RESPIR DIS, V134, P745; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kolomaznik M, 2017, PHYSIOL RES, V66, pS147, DOI 10.33549/physiolres.933672; KOSTKA J, 1962, FOLIA MICROBIOL, V7, P191, DOI 10.1007/BF02928241; LAFORCE FM, 1973, J LAB CLIN MED, V82, P634; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Mason CM, 1997, J INFECT DIS, V176, P1293, DOI 10.1086/514125; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Murphey ED, 2007, SHOCK, V27, P289, DOI 10.1097/01.shk.0000245024.93740.28; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Putensen C, 2007, ANESTHESIOLOGY, V106, P1085, DOI 10.1097/01.anes.0000265424.07486.8c; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Reid KBM, 1998, IMMUNOBIOLOGY, V199, P200, DOI 10.1016/S0171-2985(98)80027-2; ROBIN ED, 1954, ARCH INTERN MED, V93, P713, DOI 10.1001/archinte.1954.00240290071008; Sawa T, 1997, J IMMUNOL, V159, P2858; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; SHENNIB H, 1984, AM REV RESPIR DIS, V130, P444; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Soni S, 2016, THORAX, V71, P1020, DOI 10.1136/thoraxjnl-2015-208032; Sperber J, 2015, BMC PULM MED, P15, DOI [10.1186/s12890-015-0004-4, DOI 10.1186/S12890-015-0004-425887940]; Sperber J, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0152-3; Sperber J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083182; TILSON MD, 1977, SURGERY, V82, P130; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; van Kaam AH, 2004, AM J RESP CRIT CARE, V169, P1046, DOI 10.1164/rccm.200312-1779OC; WHITE JC, 1986, J INFECT DIS, V153, P202, DOI 10.1093/infdis/153.2.202; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240753	10.1371/journal.pone.0240753	http://dx.doi.org/10.1371/journal.pone.0240753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108383	Green Published, gold			2022-12-26	WOS:000588372400005
J	Zhan, CJ; Tse, CK; Fu, YX; Lai, ZK; Zhang, HJ				Zhan, Choujun; Tse, Chi K.; Fu, Yuxia; Lai, Zhikang; Zhang, Haijun			Modeling and prediction of the 2019 coronavirus disease spreading in China incorporating human migration data	PLOS ONE			English	Article							TRANSMISSION	This study integrates the daily intercity migration data with the classic Susceptible-Exposed-Infected-Removed (SEIR) model to construct a new model suitable for describing the dynamics of epidemic spreading of Coronavirus Disease 2019 (COVID-19) in China. Daily intercity migration data for 367 cities in China were collected from Baidu Migration, a mobile-app based human migration tracking data system. Early outbreak data of infected, recovered and death cases from official source (from January 24 to February 16, 2020) were used for model fitting. The set of model parameters obtained from best data fitting using a constrained nonlinear optimisation procedure was used for estimation of the dynamics of epidemic spreading in the following months. The work was completed on February 19, 2020. Our results showed that the number of infections in most cities in China would peak between mid February to early March 2020, with about 0.8%, less than 0.1% and less than 0.01% of the population eventually infected in Wuhan, Hubei Province and the rest of China, respectively. Moreover, for most cities outside and within Hubei Province (except Wuhan), the total number of infected individuals is expected to be less than 300 and 4000, respectively.	[Zhan, Choujun] South China Normal Univ, Sch Comp, Guangzhou, Peoples R China; [Tse, Chi K.] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Fu, Yuxia; Lai, Zhikang] Sun Yat Sen Univ, Sch Comp Sci & Engn, Nanfang Coll, Guangzhou, Peoples R China; [Zhang, Haijun] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China	South China Normal University; City University of Hong Kong; Nanfang College, Guangzhou; Sun Yat Sen University; Harbin Institute of Technology; University Town of Shenzhen	Tse, CK (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	chitse@cityu.edu.hk		Tse, Chi/0000-0002-0462-3999	National Science Foundation of China [61703355]; Science and Technology Program of Guangdong [201904010224]; City University of Hong Kong under Special Fund [9380114]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong; City University of Hong Kong under Special Fund	CZ was supported by the National Science Foundation of China Project 61703355 (http://www.nsfc.gov.cn/) and the Science and Technology Program of Guangdong 201904010224. CKT was supported by the City University of Hong Kong under Special Fund 9380114 (https://www.cityu.edu.hk/).	[Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, BAIDU MIGRATION; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Chakrabarti D, 2008, ACM T INFORM SYST SE, V10, DOI 10.1145/1284680.1284681; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Diekmann O., 2013, PRINCETON SERIES THE; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Koetsier J, 2020, AI PREDICTS CORONAVI; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Small M, 2005, PHYSICA A, V351, P499, DOI 10.1016/j.physa.2005.01.009; Small M, 2005, INT J BIFURCAT CHAOS, V15, P1745, DOI 10.1142/S0218127405012776; Wang Y, 2003, SYM REL DIST SYST, P25; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	17	28	28	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241171	10.1371/journal.pone.0241171	http://dx.doi.org/10.1371/journal.pone.0241171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108386	Green Published, gold, Green Submitted			2022-12-26	WOS:000588372400026
J	Kazibudzki, PT; Trojanowski, TW				Kazibudzki, Pawel Tadeusz; Trojanowski, Tomasz Witold			Examination of marketing mix performance in relation to sustainable development of the Poland's confectionery industry	PLOS ONE			English	Article							DECISION-MAKING; LIKERT SCALES; FOOD; CONSUMPTION; IMPACT	The conventional concept of marketing mix does not take into account the idea of sustainable development. The basic objective of this examination is to analyze and evaluate the performance of selected marketing mix elements from the perspective of the Poland's confectionery industry's sustainable development. The questionnaire survey was designed for this purpose. The purpose of the research questions was to evaluate a degree of development for selected elements of marketing mix from the perspective of sustainable development of the Poland's confectionery industry. Thus, a novel development ratio based on the distance from exemplary performance was proposed. Next, aseminal approach to pairwise comparisons technique was applied for the importance evaluation of each survey question in order to provide a weighted average Mean Development Ratio (MdeR) for each element of marketing mix. In this process the seminal methodology for pairwise comparisons was applied i.e. a non-heuristic approach to pairwise comparisons technique with verifiable accuracy and reliability. In consequence, assuming that all elements of marketing mix have some designated importance in the process of sustainable development, a total weighted average MdeR for performance of all elements of marketing mix was computed and evaluated. Noticeably, the total weighted average MdeR for performance of all elements of marketing mix cannot be considered as satisfactory from the perspective of sustainable development of the Poland's confectionery industry.	[Kazibudzki, Pawel Tadeusz] Opole Univ Technol, Fac Econ & Management, Opole, Poland; [Trojanowski, Tomasz Witold] Jan Kochanowski Univ Humanities & Sci, Dept Management, Kielce, Poland	Opole University of Technology; Jan Kochanowski University	Kazibudzki, PT (corresponding author), Opole Univ Technol, Fac Econ & Management, Opole, Poland.	p.kazibudzki@po.edu.pl	Trojanowski, Tomasz/O-7673-2019; Kazibudzki, Pawel Tadeusz/I-8529-2019	Trojanowski, Tomasz/0000-0001-9781-5545; Kazibudzki, Pawel Tadeusz/0000-0003-1203-4235	Opole University of Technology	Opole University of Technology	The article processing charge was funded by Opole University of Technology and Jan Kochanowski University in Kielce. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen I.E., 2007, QUAL PROG, V40, P64, DOI DOI 10.1111/J.1365-2929.2004.02012.X; Allen M. J., 1979, INTRO MEASUREMENT TH; Alvandi S, 2016, INT J SUSTAIN ENG, V9, P354, DOI 10.1080/19397038.2016.1161095; Amin-Chaudhry A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092586; [Anonymous], 2012, Prescrire Int, V21, P183; [Anonymous], 2019, 2018 IMP REP, P1; [Anonymous], 2020, MARS SUST GEN PLAN, P1; [Anonymous], 2020, SUST REP 2019, P1; [Anonymous], 2007, YWNO NAUKA TECHNOL J, V14, P5; [Anonymous], 2019, EXPERT TOOL; [Anonymous], 2019, 2018 CSR REP, P1; [Anonymous], 2014, DIABETES CARE, V1, pS14; [Anonymous], 2020, CREAT SHAR VAL M COM, P1; [Anonymous], 2014, INTELLIGENCE, V45, P1; BELZ F.-M., 2010, SUSTAINABILITY MARKE; Berger-Walliser G, 2018, AM BUS LAW J, V55, P167, DOI 10.1111/ablj.12119; Bolarinwa Oladimeji Akeem, 2015, Niger Postgrad Med J, V22, P195, DOI 10.4103/1117-1936.173959; Brown J. D., 2001, USING SURVEYS LANGUA; Caputo P, 2014, SUSTAINABILITY-BASEL, V6, P631, DOI 10.3390/su6020631; Carre F, 2002, GEODERMA, V110, P241, DOI 10.1016/S0016-7061(02)00233-1; Choi Y, 2015, SUSTAINABILITY-BASEL, V7, P13610, DOI 10.3390/su71013610; Cichosz Grazyna, 2012, Bromatologia i Chemia Toksykologiczna, V45, P181; Derqui B, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8070693; Diane Martin, 2012, SUSTAINABLE MARKETIN; Dong YC, 2008, EUR J OPER RES, V186, P229, DOI 10.1016/j.ejor.2007.01.044; DYER JS, 1990, MANAGE SCI, V36, P249, DOI 10.1287/mnsc.36.3.249; Dyer RF, 1991, ANAL APPROACH MARKET; EMERY B., 2012, SUSTAINABLE MARKETIN; Engelseth P., 2016, International Journal on Food System Dynamics, V7, P229; Fan T, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082830; FDI World Dent Federation, 2016, INT DENT J, V66, P9, DOI 10.1111/idj.12232; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Ferrero Grupa, 2019, WSPOLNE WARTOCI TWOR, P1; Forman EH, 2001, OPER RES, V49, P469, DOI 10.1287/opre.49.4.469.11231; FULLER D., 1999, SUSTAINABLE MARKETIN; Gallo A, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9112044; Garnett T, 2013, P NUTR SOC, V72, P29, DOI 10.1017/S0029665112002947; Glavas A, 2015, J BUS ETHICS, V127, P623, DOI 10.1007/s10551-014-2067-1; Govindan K, 2018, INT J PROD ECON, V195, P419, DOI 10.1016/j.ijpe.2017.03.003; Hao MH, 2019, FOREST ECOL MANAG, V440, P40, DOI 10.1016/j.foreco.2019.03.006; Heath MTP, 2012, INT J CONSUM STUD, V36, P656, DOI 10.1111/j.1470-6431.2011.01043.x; Humanism, 2009, REPUBLICS LETT J STU, V1, P1, DOI DOI 10.1111/j.1728-4457.2009.00312.x; Hunt SD, 2011, J ACAD MARKET SCI, V39, P7, DOI 10.1007/s11747-010-0196-3; Izsak C, 2001, MAR ECOL PROG SER, V215, P69, DOI 10.3354/meps215069; J-A-NdeC Condorcet, 1785, TEXTE ESSAI APPL ANA; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Jianu I, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010023; Jones P, 2008, MARK INTELL PLAN, V26, P123, DOI 10.1108/02634500810860584; Kadirov D, 2008, THESIS U WAIKATO; Kazibudzki PT, 2019, E M EKON MANAG, V22, P195, DOI 10.15240/tul/001/2019-4-013; Kemper JA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030780; Kennedy EB, 2016, RES TECHNOL MANAGE, V59, P40, DOI 10.1080/08956308.2016.1185342; Kosiewicz-Latoszek L, 2011, CUKIER RYZYKO OTYOCI, V92, P181; LANG T., 2016, FOOD WARS GLOBAL BAT, V2nd; Larsson SC, 2006, AM J CLIN NUTR, V84, P1171, DOI 10.1093/ajcn/84.5.1171; Leitner KE, 2012, BALANCED SUSTAINABIL; Lewis R, 1989, APPLICATIONS ANAL HI, P155, DOI 10.1007/978-3-642-50244-6_10; Likert R., 1932, ARCH PSYCHOL, V140, P5, DOI DOI 10.1108/17538331211269648; Lim WM, 2016, MARKETING THEOR, V16, P232, DOI 10.1177/1470593115609796; Litwin M.S., 1995, MEASURE SURVEY RELIA, DOI 10.4135/9781483348957; Marsden T, 2014, EARTHSCAN FOOD AGRIC, P1; Martin J., 1973, DESIGN MAN COMPUTER; Martinez M. G., 2013, OPEN INNOVATION FOOD; Maspex Wadowice Group-juices, JUIC NECT DRINKS PAS; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Moller K, 2006, J MARKET MANAG, V22, P439, DOI 10.1362/026725706776861181; Munoz-Pascual L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11061689; Noble G, 2014, J SOC MARKET, V4, P4, DOI 10.1108/JSOCM-12-2012-0049; Orban-Mihalyko E, 2019, CENT EUR J OPER RES, V27, P133, DOI 10.1007/s10100-017-0495-6; Oreskes Naomi, 2011, MERCHANTS DOUBT HAND; Ottman J., 2011, NEW RULES GREEN MARK; Pape J, 2011, J CONSUM POLICY, V34, P25, DOI 10.1007/s10603-010-9151-4; Peattie K, 2010, ENV MARKETING MANAGE; Peattie K., 2010, MARKETING REV ST GAL, V27, P8, DOI DOI 10.1007/S11621-010-0085-7; Pomering A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10092992; Pomering A, 2017, CSR SUSTAIN ETHIC, P171, DOI 10.1007/978-3-319-44700-1_10; Pomering A, 2017, AUSTRALAS MARK J, V25, P157, DOI 10.1016/j.ausmj.2017.04.011; Pomering A, 2009, CORP COMMUN, V14, P420, DOI 10.1108/13563280910998763; Popovic D., 2006, J TARGETING MEASUREM, V14, P260, DOI DOI 10.1057/PALGRAVE.JT.5740186; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Rudawska E, 2018, SUSTAINABLE MARKETIN, DOI [10.1108/9781787540385, DOI 10.1108/9781787540385]; Saaty T., 2001, ANAL HIERARCHY PROCE; Saaty TL, 2008, RACSAM REV R ACAD A, V102, P251, DOI 10.1007/BF03191825; Schaltegger S, 2016, ORGAN ENVIRON, V29, P3, DOI 10.1177/1086026615599806; Soler C, 2012, SUSTAINABILITY-BASEL, V4, P294, DOI 10.3390/su4030294; Starczewski T, 2017, J APPL MATH COMPUT, V16, P105, DOI 10.17512/jamcm.2017.3.10; Stecker R, 2006, PHILOS COMPASS, V1, P1, DOI 10.1111/j.1747-9991.2006.00007.x; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Todorovic V, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103481; Tomashevskii IL, 2015, EUR J OPER RES, V240, P774, DOI 10.1016/j.ejor.2014.07.050; Tomashevskii I, 2021, J OPER RES SOC, V72, P78, DOI 10.1080/01605682.2019.1650621; van Erp-Baart M.-A., 1998, Journal of Food Composition and Analysis, V11, P161, DOI 10.1006/jfca.1998.0571; Woodford M., 2012, 17967 NAT BUR EC RES; World Health Organization, 2015, GUID SUG INT AD CHIL; Wu HP, 2017, J SOC SERV RES, V43, P527, DOI 10.1080/01488376.2017.1329775	95	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240893	10.1371/journal.pone.0240893	http://dx.doi.org/10.1371/journal.pone.0240893			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104757	Green Published, gold			2022-12-26	WOS:000588370000043
J	Salam, MA; Paul, SC; Zain, RAMM; Bhowmik, S; Nath, MR; Siddiqua, SA; Das Aka, T; Iqbal, MA; Kadir, WR; Ahamad, RB; Khaleque, A; Rak, AE; Amin, MFM				Salam, Mohammed Abdus; Paul, Shujit Chandra; Zain, Rabiatul Adawiyah M. Mohamad; Bhowmik, Snahasish; Nath, Mithun Rani; Siddiqua, Sadia Afrin; Das Aka, Tutun; Iqbal, Muhammad Anwar; Kadir, Wan Rashidah; Ahamad, Rozita Binti; Khaleque, Abdul; Rak, Aweng Eh; Amin, Mohamad Faiz Mohd			Trace metals contamination potential and health risk assessment of commonly consumed fish of Perak River, Malaysia	PLOS ONE			English	Article							FRESH-WATER FISH; SEDIMENT ACCUMULATION FACTORS; HEAVY-METALS; MARINE FISH; BIOACCUMULATION; POLLUTION; EXPOSURE; INSECTS; LAKE; PB	The rapid growth of industrial and agricultural activities in Malaysia are leading to the impairment of most of the rivers in recent years through realising various trace metals. This leads to toxicity, particularly when the toxic has entered the food chain. Perak River is one of the most dynamic rivers for the Malaysian population. Therefore, in consideration of the safety issue, this study was conducted to assess the concentration of such metals (Cd, Cu, Zn, Fe, and Pb) in the muscles of most widely consumed fish species (Barbonymus schwanenfeldii, Puntius bulum, Puntius daruphani, Hexanematichthys sagor, Channa striatus, Mystacoleucus marginatus, and Devario regina) from different locations of Perak River, Malaysia by employing inductively coupled plasma optical emission spectroscopy (ICP-OES). Among the trace metals, Fe and Cd were found to be the highest (29.33-148.01 mu g/g) and lowest (0.16-0.49 mu g/g) concentration in all of the studied species, respectively. Although the estimated daily intakes (mu g/kg/day) of Cd (0.65-0.85), Fe (79.27-352.00) and Pb (0.95-12.17) were higher than their reference, the total target hazard quotients values suggested that the local residents would not experience any adverse health effects from its consumption. In contrast, the target cancer risk value suggested that all fish species posed a potential cancer risk due to Cd and cumulative cancer risk values, strongly implying that continuous consumption of studied fish species would cause cancer development to its consumers.	[Salam, Mohammed Abdus; Iqbal, Muhammad Anwar] Noakhali Sci & Technol Univ, Dept Environm Sci & Disaster Management, Noakhali, Bangladesh; [Salam, Mohammed Abdus; Zain, Rabiatul Adawiyah M. Mohamad; Rak, Aweng Eh; Amin, Mohamad Faiz Mohd] Univ Malaysia Kelantan, Fac Earth Sci, Jeli Campus, Jeli, Kelantan, Malaysia; [Paul, Shujit Chandra; Bhowmik, Snahasish; Nath, Mithun Rani] Noakhali Sci & Technol Univ, Dept Appl Chem & Chem Engn, Noakhali, Bangladesh; [Siddiqua, Sadia Afrin] Bangladesh Agr Univ, Dept Anim Breeding & Genet, Mymensingh, Bangladesh; [Das Aka, Tutun] Noakhali Sci & Technol Univ, Dept Pharm, Noakhali, Bangladesh; [Kadir, Wan Rashidah; Ahamad, Rozita Binti] Forest Res Inst Malaysia FRIM, Forest Biotechnol Div, Kepong, Selangor, Malaysia; [Khaleque, Abdul] Independent Univ, Sch Environm Sci & Management, Dhaka, Bangladesh	Noakhali Science & Technology University (NSTU); Universiti Malaysia Kelantan; Noakhali Science & Technology University (NSTU); Bangladesh Agricultural University (BAU); Noakhali Science & Technology University (NSTU); Institute Penyelidikan Perhutanan Malaysia; Independent University Bangladesh (IUB)	Salam, MA (corresponding author), Noakhali Sci & Technol Univ, Dept Environm Sci & Disaster Management, Noakhali, Bangladesh.; Salam, MA (corresponding author), Univ Malaysia Kelantan, Fac Earth Sci, Jeli Campus, Jeli, Kelantan, Malaysia.	s_salam1978@yahoo.com	Paul, Shujit Chandra/AAJ-5784-2020; Rak, Aweng A/L Eh/D-7115-2019; Amin, Mohamad Faiz Mohd/AAL-6357-2020; Iqbal, Muhammad Anwar/GPC-6548-2022	Paul, Shujit Chandra/0000-0003-4007-1615; Rak, Aweng A/L Eh/0000-0003-2093-5113; Amin, Mohamad Faiz Mohd/0000-0002-4283-1975; Iqbal, Muhammad Anwar/0000-0001-7321-7153				Ahmad NI, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.32697; Ahmad NI, 2015, ENVIRON SCI POLLUT R, V22, P3672, DOI 10.1007/s11356-014-3538-8; Ahmed MK, 2015, CHEMOSPHERE, V128, P284, DOI 10.1016/j.chemosphere.2015.02.016; Ahmed Q, 2015, FRONT LIFE SCI, V8, P71, DOI 10.1080/21553769.2014.961617; Al-Mahaqeri A., 2015, INT J RES STUD SCI E, V2, P9; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2010, J SCH NURS S, V26, p3S; [Anonymous], 2013, BU L REV ANNEX PERSP, V93, P45; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Aydogan Z, 2017, ENVIRON SCI POLLUT R, V24, P9566, DOI 10.1007/s11356-017-8629-x; Babio N, 2018, CAN MED ASSOC J, V190, pE808, DOI 10.1503/cmaj.180791; Bank W., 2021, WORLD BANK COUNTRY L; Bhattacharya PT, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/5464373; Canli M, 2003, ENVIRON POLLUT, V121, P129, DOI 10.1016/S0269-7491(02)00194-X; Cao SZ, 2014, SCI TOTAL ENVIRON, V472, P1001, DOI 10.1016/j.scitotenv.2013.11.124; China Food and Drug Administration, 2012, 27622017 GB CHIN FOO; Construction Industry Development Board (CIDB), 2017, 22 AS CONTR C SEOUL, V22nd; Crespo-Lopez ME, 2007, ENVIRON INT, V33, P141, DOI 10.1016/j.envint.2006.08.005; DeForest DK, 2007, AQUAT TOXICOL, V84, P236, DOI 10.1016/j.aquatox.2007.02.022; Department of Environment (DOE), 2014, MAL ENV QUAL REP, DOI [10.3103/S0967091215070116, DOI 10.3103/S0967091215070116]; Djikanovic V, 2018, ENVIRON POLLUT, V241, P1167, DOI 10.1016/j.envpol.2018.06.054; FAO, 2013, WEB REPORT, P1; FAO, 2018, NATURE RESOURCES; Fischer W, 1984, FAO SPECIES IDENTIF, V51; Hashim Rohasliney, 2014, Tropical Life Sciences Research, V25, P21; Hosseini M, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4464-z; HTUNHAN M, 1978, J FISH BIOL, V13, P369, DOI 10.1111/j.1095-8649.1978.tb03445.x; International Commission for the Protection of Danube River (ICPDR), 2011, MAGAZINE DANUBE RIVE; Isibor PO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62024-9; Islam MS, 2015, HUM ECOL RISK ASSESS, V21, P986, DOI 10.1080/10807039.2014.950172; Islam MS, 2015, ARCH ENVIRON CON TOX, V68, P92, DOI 10.1007/s00244-014-0079-6; Ismail Siti Norasikin, 2018, Biodiversitas, V19, P279; Jalal K.C.A., 2013, Oriental Journal of Chemistry, V29, P1553; Jiang ZG, 2018, ECOTOX ENVIRON SAFE, V157, P1, DOI 10.1016/j.ecoenv.2018.03.078; Kajian Temporal Kepekatan Logam Terpilih S, 2009, MALAYSIAN J ANAL SCI, V13, P100; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Koopmans BN, 1964, J MALAYSIAN BRANCH R, V37, P175; Kottelat M, 2005, RAFFLES B ZOOL, P139; Kottelat M., 1993, FRESHWATER FISHES W; Kumar P., 2010, GERF B BIOSCI, V1, P41, DOI DOI 10.1016/J.AQUAT0X.2003.11.010; Kushairi A, 2018, J OIL PALM RES, V30, P163, DOI 10.21894/jopr.2018.0030; Latunde-Dada GO, 2016, J AGR FOOD CHEM, V64, P8420, DOI 10.1021/acs.jafc.6b03286; Leung HM, 2014, MAR POLLUT BULL, V78, P235, DOI 10.1016/j.marpolbul.2013.10.028; Li J, 2013, ENVIRON SCI POLLUT R, V20, P2937, DOI 10.1007/s11356-012-1207-3; Liang Y, 1999, WATER RES, V33, P2690, DOI 10.1016/S0043-1354(98)00473-4; Liu XM, 2013, SCI TOTAL ENVIRON, V463, P530, DOI 10.1016/j.scitotenv.2013.06.064; Luszczek-Trojnar E, 2013, ENVIRON SCI POLLUT R, V20, P3122, DOI 10.1007/s11356-012-1210-8; MAFF, 2000, AQUAT ENV MONIT REP; Malaysian Food and Regulation (MFR), 1985, MAL LAW FOOD DRUGS; Medeirosa RJ, 2014, TOXICOL REP, V1, P353, DOI 10.1016/j.toxrep.2014.06.005; Mendil D, 2010, FOOD CHEM TOXICOL, V48, P865, DOI 10.1016/j.fct.2009.12.023; Muyibi SA, 2008, WATER RESOUR MANAG, V22, P485, DOI 10.1007/s11269-007-9174-z; NORDBERG GF, 1975, ARCH PATHOL, V99, P192; NYSDOH, 2007, HOP PREC AR CONT APP; Olsson P-E, 1998, METAL METABOLISM AQU, DOI [10.1007/978-1-4757-2761-6_10, DOI 10.1007/978-1-4757-2761-6_10]; Ozmen M, 2008, ECOTOX ENVIRON SAFE, V70, P163, DOI 10.1016/j.ecoenv.2007.05.011; Ptashynski MD, 2002, AQUAT TOXICOL, V58, P229, DOI 10.1016/S0166-445X(01)00239-9; Roberts, 1989, MEM CALIF ACAD SCI, V14, P210; Salam MA, 2019, GLOB J ENVIRON SCI M, V5, P225, DOI 10.22034/gjesm.2019.02.08; Salam MA, 2019, POLLUTION, V5, P637, DOI 10.22059/poll.2019.274543.570; Salam MA, 2019, HYDROLOGY-BASEL, V6, DOI 10.3390/hydrology6020030; Saleh A, 2018, INT J ENG TECHNOLOGY, DOI [10.14419/ijet.v7i2.29.14270, DOI 10.14419/IJET.V7I2.29.14270]; Sankar TV, 2006, CHEMOSPHERE, V65, P583, DOI 10.1016/j.chemosphere.2006.02.038; Sara K, 2002, INT NUCL INFORM SYST, V33, P67; Shazili Noor Azhar M., 2006, Aquatic Ecosystem Health & Management, V9, P137, DOI 10.1080/14634980600724023; Silbergeld EK, 2000, AM J IND MED, V38, P316, DOI 10.1002/1097-0274(200009)38:3<316::AID-AJIM11>3.0.CO;2-P; Sobhanardakani S, 2017, MAR POLLUT BULL, V123, P34, DOI 10.1016/j.marpolbul.2017.09.033; Sow AY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42753-2; Sriuttha M, 2017, HUM ECOL RISK ASSESS, V23, P350, DOI 10.1080/10807039.2016.1248893; Tracey GA, 1996, ARCH ENVIRON CON TOX, V30, P467; U.S. Fish and Wildlife Service, 2004, INV SPEC PROGR SNAK; United States Environmental Protection Agency, 2001, 540R022002 US EPA; US EPA, 2015, US EPA INT RISK INF; US-EPA, 2000, GUID ASS CHEM CONT D, V3rd; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; WHO/FAO, 1984, LIST MAX LEV REC CON; Zakeyuddin MS, 2017, SAINS MALAYS, V46, P833, DOI 10.17576/jsm-2017-4606-01; Zhao S, 2012, MAR POLLUT BULL, V64, P1163, DOI 10.1016/j.marpolbul.2012.03.023	78	5	6	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241320	10.1371/journal.pone.0241320	http://dx.doi.org/10.1371/journal.pone.0241320			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104734	gold, Green Published			2022-12-26	WOS:000588370000015
J	Tendler, S; Kanter, L; Lewensohn, R; Ortiz-Villalon, C; Viktorsson, K; De Petris, L				Tendler, Salomon; Kanter, Lena; Lewensohn, Rolf; Ortiz-Villalon, Cristian; Viktorsson, Kristina; De Petris, Luigi			The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy	PLOS ONE			English	Article							CELL LUNG-CANCER; INTRATUMORAL HETEROGENEITY; DIFFERENTIATION; METASTASIS	Objectives The aim was to analyse the tumor expression of Notch1, Hes1, Ascl1, and DLL3 in Small-Cell Lung Cancer (SCLC) and each such biomarker's potential association with clinical characteristics and prognosis after platinum-doublet chemotherapy (PDCT). Material and methods The protein expression of the biomarkers was evaluated using immunohistochemistry. Patients were categorized according to their sensitivity to first line PDCT: with a Progression-free survival (PFS) >= 3 months after completion of treatment considered "sensitive" and < 3 months after completion of treatment considered "refractory". PFS and overall survival were computed using Kaplan-Meier curves with 95% confidence interval. Results and conclusion The study included 46 patients, with 21 and 25 of the patients having "sensitive" and "refractory" disease, respectively. The majority of patients had a high DLL3 expression (n = 38), while a minority had Notch 1-high expression (n = 10). The chi-square test showed that there was a statistically significant negative association between Notch1 and Ascl1 expression (p = 0.013). The overall survival for patients with Notch1- high vs. low expression was 8.1 vs. 12.4 months, respectively (p = 0.036). Notch1 expression was an independent prognostic factor in the multivariate analysis (p = 0.02). No other biomarker showed any prognostic impact in this highly selected SCLC cohort. DLL3 is highly expressed in the majority of advanced staged SCLC cases, as expected. In the same patient population, Notch1 expression might have a potential prognostic implication, by driving a non-neuroendocrine differentiation process. Given the small number of cases with Notch1 high expression, the results of this study needs to be confirmed on a larger cohort.	[Tendler, Salomon; Kanter, Lena; Lewensohn, Rolf; Ortiz-Villalon, Cristian; Viktorsson, Kristina; De Petris, Luigi] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Tendler, Salomon; Kanter, Lena; Lewensohn, Rolf; Viktorsson, Kristina; De Petris, Luigi] Karolinska Univ Hosp, Theme Canc Patient Area Head & Neck Lung & Skin C, Stockholm, Sweden; [Ortiz-Villalon, Cristian] Karolinska Univ Hosp, Pathol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tendler, S (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Tendler, S (corresponding author), Karolinska Univ Hosp, Theme Canc Patient Area Head & Neck Lung & Skin C, Stockholm, Sweden.	salomon.tendler@ki.se	Ortiz-Villalon, Cristian/AAC-1874-2021		Stockholm Cancer Society [161283, 171123, 154102, 174093]; Swedish Cancer Society [CAN 2015/401, CAN 2018/597]; Stockholm County Council [20160287, 20180404]; Erling Persson Family Foundation; Karolinska FOUU	Stockholm Cancer Society; Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Erling Persson Family Foundation; Karolinska FOUU	This study was supported by grants from the Stockholm Cancer Society (#161283, #171123, #154102, #174093), the Swedish Cancer Society (CAN 2015/401; CAN 2018/597), the Stockholm County Council (#20160287, #20180404), The Erling Persson Family Foundation and Karolinska FOUU funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2017, THAI HEART J     JAN, V30, P1; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; Ardizzoni A, 2014, EUR J CANCER, V50, P2211, DOI 10.1016/j.ejca.2014.06.002; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Fujino K, 2015, AM J PATHOL, V185, P3164, DOI 10.1016/j.ajpath.2015.08.018; Garassino MC, 2011, LUNG CANCER, V72, P378, DOI 10.1016/j.lungcan.2010.09.009; Gazdar AF, 2017, NAT REV CANCER, V17, P725, DOI 10.1038/nrc.2017.87; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Goos JACM, 2013, BRIT J CANCER, V109, P2445, DOI 10.1038/bjc.2013.608; Hassan WA, 2014, LUNG CANCER, V86, P304, DOI 10.1016/j.lungcan.2014.10.007; Ito T, 2018, J THORAC DIS, V10, P1272, DOI 10.21037/jtd.2018.03.61; Kikuchi H, 2017, ONCOTARGET, V8, P10348, DOI 10.18632/oncotarget.14411; Leonetti A, 2019, CELL ONCOL, V42, P261, DOI 10.1007/s13402-019-00441-3; Lim JS, 2017, NATURE, V545, P360, DOI 10.1038/nature22323; Morimoto M, 2012, DEVELOPMENT, V139, P4365, DOI 10.1242/dev.083840; Nowell CS, 2017, NAT REV CANCER, V17, P145, DOI 10.1038/nrc.2016.145; Owen DH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0745-2; Rossi A, 2016, J THORAC DIS, V8, P2360, DOI 10.21037/jtd.2016.09.28; Rudin CM, 2019, NAT REV CANCER, V19, P289, DOI 10.1038/s41568-019-0133-9; Rudin CM, 2017, LANCET ONCOL, V18, P42, DOI [10.1016/S1470-2045(16)30565-4, 10.1016/s1470-2045(16)30565-4]; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Tanaka K, 2018, LUNG CANCER, V115, P116, DOI 10.1016/j.lungcan.2017.11.018; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240973	10.1371/journal.pone.0240973	http://dx.doi.org/10.1371/journal.pone.0240973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104707	Green Published, gold			2022-12-26	WOS:000588370000041
J	Porto, AC; Blumetti, TP; Santos, IDDO; Calsavara, VF; Neto, JPD; Braga, JCT				Porto, Ana Carolina; Blumetti, Tatiana Pinto; de Abranches Oliveira Santos Filho, Ivan Dunshee; Calsavara, Vinicius Fernando; Duprat Neto, Joao Pedreira; Tavoloni Braga, Juliana Casagrande			Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil	PLOS ONE			English	Article							NECK MELANOMA; MALIGNANT-MELANOMA; HEAD; SURVIVAL; LOCATION; FEATURES; SITES	Background/Objectives Scalp melanoma is a subgroup of melanomas on the head and neck, historically associated with worst prognosis. Knowledge of the usual presentation of scalp melanoma can help to understand the reasons for the poor outcomes of treatment. This is the first publication to describe the clinical, histopathological and epidemiological profile of patients with scalp melanoma in a Latin American population. Methods A cross-sectional study was performed of all primary cutaneous melanoma seen by the A.C.Camargo Cancer Center between 2008 and 2018, using an electronic health records to access clinical and pathology data. Results When compared to trunk and limbs, increasing age is expected for patients with scalp melanoma (10.865; CI (95%) = [8.303; 13.427]). Regarding risk of invasion, scalp melanomas have a higher chance to be invasive than in situ (OR = 1.783; CI (95%) = [1.196; 2.657]) and present with higher Breslow thickness (OR = 3.005; CI (95%) = [2.507; 3.601]). Scalp site was significantly associated with male sex (OR = 3.750; CI (95%) = [2.533; 5.554]), perineural invasion (OR = 13.739; CI (95%) = [5.919; 31.895]), ulceration (OR = 2.311; CI (95%) = [1.488; 3.588]), and mitosis (OR = 2.366; CI (95%) = [1.701; 3.292]), when compared to trunk and limbs melanoma. Conclusion In the present study, head and neck melanomas represented 14.9% of all melanomas, a frequency slightly lower than that described in the literature and the mean age of melanoma on the scalp found was lower than that reported in the literature. These results could be explained by the demographic characteristics of Brazil, which has a population with a lower life expectancy compared to the European and North American population. Scalp melanomas occurred in older men, were diagnosed with greater Breslow thickness and were associated with the presence of perineural invasion, mitosis and ulceration.	[Porto, Ana Carolina; Blumetti, Tatiana Pinto; de Abranches Oliveira Santos Filho, Ivan Dunshee; Duprat Neto, Joao Pedreira; Tavoloni Braga, Juliana Casagrande] AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil; [Calsavara, Vinicius Fernando] AC Camargo Canc Ctr, Ctr Epidemiol & Stat Canc, Sao Paulo, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center	Porto, AC (corresponding author), AC Camargo Canc Ctr, Cutaneous Oncol Dept, Sao Paulo, Brazil.	carolsporto1@hotmail.com	Braga, Juliana/M-2997-2014; Calsavara, Vinicius Fernando/G-9450-2016; Pedreira Duprat Neto, Joao/I-4198-2015	Braga, Juliana/0000-0002-1378-6992; Calsavara, Vinicius Fernando/0000-0003-2332-5863; Santos Filho, Ivan/0000-0003-1956-1214; Pedreira Duprat Neto, Joao/0000-0001-8968-4506				Benati E, 2017, J EUR ACAD DERMATOL, V31, pE528, DOI 10.1111/jdv.14395; Cicchiello M, 2016, AUSTRALAS J DERMATOL, V57, P97, DOI 10.1111/ajd.12416; Dabouz F, 2015, BRIT J DERMATOL, V172, P707, DOI 10.1111/bjd.13489; de Giorgi V, 2012, MELANOMA RES, V22, P402, DOI 10.1097/CMR.0b013e3283577b96; Fadaki N, IS HEAD NECK MELANOM, DOI [10.1245/s10434-013-2977-7, DOI 10.1245/S10434-013-2977-7]; GARBE C, 1995, CANCER-AM CANCER SOC, V75, P2492, DOI 10.1002/1097-0142(19950515)75:10<2492::AID-CNCR2820751015>3.0.CO;2-W; Gillgren P, 2000, LARYNGOSCOPE, V110, P1498, DOI 10.1097/00005537-200009000-00017; Huismans AM, 2014, ANN SURG ONCOL, V21, P3985, DOI 10.1245/s10434-014-3829-9; Juzeniene A, 2012, J EUR ACAD DERMATOL, V26, P821, DOI 10.1111/j.1468-3083.2011.04162.x; Lachiewicz AM, 2008, ARCH DERMATOL, V144, P515, DOI 10.1001/archderm.144.4.515; Maher NG, 2017, J EUR ACAD DERMATOL, V31, P2016, DOI 10.1111/jdv.14381; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Pasquali S, 2015, HEAD NECK-J SCI SPEC, V37, P1596, DOI 10.1002/hed.23801; Richard MA, 1999, ARCH DERMATOL, V135, P269, DOI 10.1001/archderm.135.3.269; Sparks DS, 2017, J SURG ONCOL, V115, P449, DOI 10.1002/jso.24535; Tas F, 2017, MELANOMA RES, V27, P387, DOI 10.1097/CMR.0000000000000351; Terakedis BE, 2014, J AM ACAD DERMATOL, V70, P435, DOI 10.1016/j.jaad.2013.10.028; Tseng WH, 2011, J SURG RES, V167, P192, DOI 10.1016/j.jss.2010.10.008; URIST MM, 1984, ANN SURG, V200, P769, DOI 10.1097/00000658-198412000-00017; Wiesner T, 2015, AM J SURG PATHOL, V39, P1357, DOI 10.1097/PAS.0000000000000451; Xie C, 2017, AUSTRALAS J DERMATOL, V58, P181, DOI 10.1111/ajd.12437	21	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240864	10.1371/journal.pone.0240864	http://dx.doi.org/10.1371/journal.pone.0240864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095773	Green Published, gold			2022-12-26	WOS:000586649400063
J	Eckford-Soper, LK; Canfield, DE				Eckford-Soper, Lisa Kathleen; Canfield, Donald E.			The global explosion of eukaryotic algae: The potential role of phosphorus?	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; DIFFUSIVE BOUNDARY-LAYERS; NUTRIENT-UPTAKE; GROWTH-RATE; PHYTOPLANKTON COMMUNITIES; CHEMICAL-COMPOSITION; ATMOSPHERIC OXYGEN; TRANSPORTER GENE; CELL-SIZE; MARINE	There arose one of the most important ecological transitions in Earth's history approximately 750 million years ago during the middle Neoproterozoic Era (1000 to 541 million years ago, Ma). Biomarker evidence suggests that around this time there was a rapid shift from a predominantly bacterial-dominated world to more complex ecosystems governed by eukaryotic primary productivity. The resulting 'Rise of the algae' led to dramatically altered food webs that were much more efficient in terms of nutrient and energy transfer. Yet, what triggered this ecological shift? In this study we examined the theory that it was the alleviation of phosphorus (P) deficiency that gave eukaryotic alga the prime opportunity to flourish. We performed laboratory experiments on the cyanobacteriumSynechocystis salinaand the eukaryotic algaeTetraselmis suecicaand examined their ability to compete for phosphorus. Both these organisms co-occur in modern European coastal waters and are not known to have any allelopathic capabilities. The strains were cultured in mono and mixed cultures in chemostats across a range of dissolved inorganic phosphorus (DIP) concentrations to reflect modern and ancient oceanic conditions of 2 mu M P and 0.2 mu M P, respectively. Our results show that the cyanobacteria outcompete the algae at the low input (0.2 mu M P) treatment, yet the eukaryotic algae were not completely excluded and remained a constant background component in the mixed-culture experiments. Also, despite their relatively large cell size, the algaeT.suecicahad a high affinity for DIP. With DIP input concentrations resembling modern-day levels (2 mu M), the eukaryotic algae could effectively compete against the cyanobacteria in terms of total biomass production. These results suggest that the availability of phosphorus could have influenced the global expansion of eukaryotic algae. However, P limitation does not seem to explain the complete absence of eukaryotic algae in the biomarker record before ca. 750 Ma.	[Eckford-Soper, Lisa Kathleen; Canfield, Donald E.] Univ Southern Denmark, Dept Biol, Nordcee, Odense M, Denmark	University of Southern Denmark	Eckford-Soper, LK (corresponding author), Univ Southern Denmark, Dept Biol, Nordcee, Odense M, Denmark.	lisasoper@biology.sdu.dk	Eckford-Soper, Lisa/D-2500-2015; Canfield, Don/C-1735-2012	Eckford-Soper, Lisa/0000-0003-1118-1962; Canfield, Don/0000-0001-7602-8366	Villum Foundation [16518]	Villum Foundation(Villum Fonden)	This work was funded by Villum Foundation (grant 16518) https://veluxfoundations.dk/en.The funding was awarded to the author D.E. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Trejos E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08918; Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; Agic H, 2017, PRECAMBRIAN RES, V297, P101, DOI 10.1016/j.precamres.2017.04.042; Aksnes DL, 2011, MAR ECOL PROG SER, V440, P41, DOI 10.3354/meps09355; Allen JF, 2019, TRENDS PLANT SCI, V24, P1022, DOI 10.1016/j.tplants.2019.07.007; [Anonymous], 2006, AM FOREIGN POLICY IN, V28, P159, DOI 10.1080/10803920600663576; [Anonymous], 2015, RHEUMATOLOGY, V54, pii5; Arin L, 2002, J PLANKTON RES, V24, P1019, DOI 10.1093/plankt/24.10.1019; Bjerrum CJ, 2002, NATURE, V417, P159, DOI 10.1038/417159a; Blossom HE, 2014, AQUAT TOXICOL, V157, P159, DOI 10.1016/j.aquatox.2014.10.006; Blumenberg M, 2012, PRECAMBRIAN RES, V196, P113, DOI 10.1016/j.precamres.2011.11.010; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Brocks JJ, 2018, EMERG TOP LIFE SCI, V2, P181, DOI 10.1042/ETLS20180039; Brocks JJ, 2017, NATURE, V548, P578, DOI 10.1038/nature23457; Caceres C, 2019, ISME J, V13, P2834, DOI 10.1038/s41396-019-0473-1; Calvo-Diaz A, 2006, AQUAT MICROB ECOL, V42, P159, DOI 10.3354/ame042159; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; CANTER HM, 1990, NEW PHYTOL, V114, P247, DOI 10.1111/j.1469-8137.1990.tb00397.x; Carstensen A, 2018, PLANT PHYSIOL, V177, P271, DOI 10.1104/pp.17.01624; CEMBELLA AD, 1984, CRC CR REV MICROBIOL, V11, P13, DOI 10.3109/10408418409105902; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; CHISHOLM SW, 1976, J PHYCOL, V12, P210, DOI 10.1111/j.1529-8817.1976.tb00504.x; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Cohen PA, 2018, EMERG TOP LIFE SCI, V2, P173, DOI 10.1042/ETLS20170145; Dall'Olmo G, 2011, BIOGEOSCIENCES, V8, P3423, DOI 10.5194/bg-8-3423-2011; Derry LA, 2015, GEOPHYS RES LETT, V42, P8538, DOI 10.1002/2015GL065333; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; DROOP MR, 1973, J PHYCOL, V9, P264; Duhamel S, 2017, PROG OCEANOGR, V151, P261, DOI 10.1016/j.pocean.2016.12.007; EPPLEY RW, 1968, J PHYCOL, V4, P151, DOI 10.1111/j.1529-8817.1968.tb04689.x; EPPLEY RW, 1981, CAN B FISH AQUAT SCI, P251; Escaravage V, 1996, J EXP MAR BIOL ECOL, V198, P55, DOI 10.1016/0022-0981(95)00165-4; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Falkowski P. G., 2007, AQUATIC PHOTOSYNTHES; Fanesi A, 2014, PLANT CELL ENVIRON, V37, P512, DOI 10.1111/pce.12176; Fehling J, 2005, HARMFUL ALGAE, V4, P763, DOI 10.1016/j.hal.2004.11.002; Feingersch R, 2012, ISME J, V6, P827, DOI 10.1038/ismej.2011.149; FENCHEL T, 1980, MICROBIAL ECOL, V6, P1, DOI 10.1007/BF02020370; Fiksen O, 2013, LIMNOL OCEANOGR, V58, P193, DOI 10.4319/lo.2013.58.1.0193; Filstrup CT, 2017, INLAND WATERS, V7, P385, DOI 10.1080/20442041.2017.1375176; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Flannery EN, 2014, ORG GEOCHEM, V77, P115, DOI 10.1016/j.orggeochem.2014.10.008; FLYNN KJ, 1993, J APPL PHYCOL, V5, P465, DOI 10.1007/BF02182739; Garcia NS, 2016, ISME J, V10, P2715, DOI 10.1038/ismej.2016.50; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gernon TM, 2016, NAT GEOSCI, V9, P242, DOI 10.1038/NGEO2632; GIOVANARDI F, 1992, SCIENCE OF THE TOTAL ENVIRONMENT, SUPPLEMENT 1992, P211; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Grant S., 2014, THESIS; Hakanson L, 2010, J COASTAL RES, V26, P412, DOI 10.2112/08-1121.1; Hammond JP, 2008, J EXP BOT, V59, P93, DOI 10.1093/jxb/erm221; Hansen H. P., 1999, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984.CH10]; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; Hillebrand H, 1999, LIMNOL OCEANOGR, V44, P440, DOI 10.4319/lo.1999.44.2.0440; Holland H.D., 1984, CHEM EVOLUTION ATMOS; HUDSON RJM, 1993, DEEP-SEA RES PT I, V40, P129, DOI 10.1016/0967-0637(93)90057-A; Huot Y, 2007, BIOGEOSCIENCES, V4, P853, DOI 10.5194/bg-4-853-2007; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; JACKSON GA, 1980, NATURE, V284, P439, DOI 10.1038/284439a0; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Javaux EJ, 2017, J PALEONTOL, V91, P199, DOI 10.1017/jpa.2016.124; Jones C, 2015, GEOLOGY, V43, P135, DOI 10.1130/G36044.1; Karl DM, 2014, ANNU REV MAR SCI, V6, P279, DOI 10.1146/annurev-marine-010213-135046; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kujawinski EB, 2017, LIMNOL OCEANOGR LETT, V2, P119, DOI 10.1002/lol2.10043; Laakso TA, 2014, EARTH PLANET SC LETT, V388, P81, DOI 10.1016/j.epsl.2013.11.049; LAROCHE J, 1993, J PHYCOL, V29, P767; LeGresley M., 2010, MICROSCOPIC MOL METH, P25; Lin SJ, 2016, J PHYCOL, V52, P10, DOI 10.1111/jpy.12365; Lindemann C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00026; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lonborg C, 2009, MAR CHEM, V113, P219, DOI 10.1016/j.marchem.2009.02.003; Lopez JS, 2016, J PLANKTON RES, V38, P1052, DOI 10.1093/plankt/fbv120; Otero-Ferrer JL, 2018, BIOGEOSCIENCES, V15, P6199, DOI 10.5194/bg-15-6199-2018; Luo GM, 2015, GEOCHIM COSMOCHIM AC, V151, P150, DOI 10.1016/j.gca.2014.12.022; Luo QY, 2016, ORG GEOCHEM, V99, P23, DOI 10.1016/j.orggeochem.2016.05.004; MacIntyre S, 1998, COAST ESTUAR STUD, V54, P561; Martinez A, 2012, ENVIRON MICROBIOL, V14, P1363, DOI 10.1111/j.1462-2920.2011.02612.x; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Mena C, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01698; Moczydlowska M, 2011, PALAEONTOLOGY, V54, P721, DOI 10.1111/j.1475-4983.2011.01054.x; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Monod J, 1942, RECHERCHES CROISSANC, P911; Mousing EA, 2018, LIMNOL OCEANOGR, V63, P1298, DOI 10.1002/lno.10772; Nan Chunrong, 2004, Journal of Ocean University of China, V3, P56, DOI 10.1007/s11802-004-0009-8; Not F, 2012, ADV BOT RES, V64, P1, DOI 10.1016/B978-0-12-391499-6.00001-3; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Paczkowska J, 2019, MAR ENVIRON RES, V151, DOI 10.1016/j.marenvres.2019.104778; Peacock MB, 2013, MAR ECOL PROG SER, V473, P79, DOI 10.3354/meps10069; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Ploug H, 1999, LIMNOL OCEANOGR, V44, P1959, DOI 10.4319/lo.1999.44.8.1959; Ploug H, 1999, LIMNOL OCEANOGR, V44, P1949, DOI 10.4319/lo.1999.44.8.1949; Porter S, 2011, GEOLOGY, V39, P607, DOI 10.1130/focus062011.1; Post AF, 2005, AQUAT ECOL SER, V3, P87; Ratti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077349; Reinhard CT, 2017, NATURE, V541, P386, DOI 10.1038/nature20772; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Rengefors K, 2003, LIMNOL OCEANOGR, V48, P1167, DOI 10.4319/lo.2003.48.3.1167; Rengefors K, 2001, J PLANKTON RES, V23, P435, DOI 10.1093/plankt/23.4.435; Reynolds CS, 2006, ECOL BIODIVERS CONS, P145, DOI 10.1017/CBO9780511542145.005; Righetti D, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6253; Rii YM, 2016, LIMNOL OCEANOGR, V61, P806, DOI 10.1002/lno.10255; RIVKIN RB, 1985, MAR BIOL, V88, P189, DOI 10.1007/BF00397166; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shields-Zhou G., 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/GSATG102A.1; Shishlyannikov SM, 2011, LIMNOL OCEANOGR-METH, V9, P478, DOI 10.4319/lom.2011.9.478; Sigee DC, 1999, HYDROBIOLOGIA, V395, P161, DOI 10.1023/A:1017097502124; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Suslova EA, 2017, RUSS GEOL GEOPHYS+, V58, P516, DOI 10.1016/j.rgg.2016.09.027; TETT P, 1975, LIMNOL OCEANOGR, V20, P587, DOI 10.4319/lo.1975.20.4.0587; Tett P., 1988, CRC HDB LAB MODEL SY, VII, P177; The I, 2015, NAT COMMUN, V6, P1, DOI DOI 10.1038/NCOMMS7971; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Wides A, 2018, ARXIV180600272; Yin LM, 2005, PRECAMBRIAN RES, V141, P49, DOI 10.1016/j.precamres.2005.08.001; Zubkov MV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4776; Zumberge JA, 2020, GEOBIOLOGY, V18, P326, DOI 10.1111/gbi.12378	129	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0234372	10.1371/journal.pone.0234372	http://dx.doi.org/10.1371/journal.pone.0234372			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091058	gold, Green Submitted, Green Published			2022-12-26	WOS:000586647200054
J	Tsukui, T; Sakakura, K; Taniguchi, Y; Yamamoto, K; Seguchi, M; Jinnouchi, H; Wada, H; Fujita, H				Tsukui, Takunori; Sakakura, Kenichi; Taniguchi, Yousuke; Yamamoto, Kei; Seguchi, Masaru; Jinnouchi, Hiroyuki; Wada, Hiroshi; Fujita, Hideo			Factors associated with poor clinical outcomes of ST-elevation myocardial infarction in patients with door-to-balloon time < 90 minutes	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; NO-REFLOW PHENOMENON; THROMBUS-ASPIRATION; SYNTAX SCORE; ANGIOPLASTY; MORTALITY; IMPACT; DETERMINANTS; REPERFUSION; PREDICTION	Background Recent guidelines for ST-elevation myocardial infarction (STEMI) recommended the door-to-balloon time (DTBT) <90 minutes. However, some patients could have poor clinical outcomes in spite of DTBT <90 minutes, which suggest the importance of therapeutic targets except DTBT. The purpose of this study was to find factors associated with poor clinical outcomes in STEMI patients with DTBT Methods This retrospective study included 383 STEMI patients with DTBT <90 minutes. The primary endpoint was the major adverse cardiac events (MACE) defined as the composite of all-cause death, acute myocardial infarction, and acute heart failure requiring hospitalization. Result The median follow-up duration was 281 days, and the cumulative incidence of MACE was 16.2%. In the multivariate Cox hazard model, low body mass index (< 20 kg/m(2)) (vs. >20 kg/m(2): HR 2.80, 95% CI 1.39-5.64, p = 0.004), history of previous myocardial infarction (HR 2.39, 95% CI 1.06-5.37, p = 0.04), and Killip class 3 or 4 (vs. Killip class 1 or 2: HR 2.39, 95% CI 1.30-4.40, p = 0.005) were significantly associated with MACE. In another multivariate Cox hazard model, flow worsening during percutaneous coronary intervention (PCI) (HR 3.24, 95% CI 1.79-5.86, p<0.001) and use of mechanical support (HR 3.15, 95% CI 1.71-5.79, p<0.001) were significantly associated with MACE, whereas radial approach (HR 0.54, 95% CI 0.32-0.92, p = 0.02) was inversely associated with MACE. Conclusion Low body mass index, Killip class 3/4, history of previous myocardial infarction, use of mechanical support, and flow worsening were significantly associated with MACE, whereas radial-access was inversely associated with MACE. It is important to avoid flow worsening during primary PCI even when appropriate DTBT was achieved.	[Tsukui, Takunori; Sakakura, Kenichi; Taniguchi, Yousuke; Yamamoto, Kei; Seguchi, Masaru; Jinnouchi, Hiroyuki; Wada, Hiroshi; Fujita, Hideo] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama, Japan	Jichi Medical University	Sakakura, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama, Japan.	ksakakura@jichi.ac.jp	Sakakura, Kenichi/AAK-4564-2020; FUJITA, HIDEO/AHC-6839-2022	Sakakura, Kenichi/0000-0003-3566-0394; Fujita, Hideo/0000-0002-4901-3502				Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Akgun T, 2015, CLIN APPL THROMB-HEM, V21, P712, DOI 10.1177/1076029614521281; ANDERSON JL, 1993, CIRCULATION, V87, P1829, DOI 10.1161/01.CIR.87.6.1829; Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; Antoniucci D, 2001, AM HEART J, V142, P684, DOI 10.1067/mhj.2001.117778; Aronson D, 2010, INT J CARDIOL, V145, P476, DOI 10.1016/j.ijcard.2009.12.029; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; BROWN CG, 1987, ANN EMERG MED, V16, P183, DOI 10.1016/S0196-0644(87)80013-6; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; Carrick D, 2014, J AM COLL CARDIOL, V63, P2088, DOI 10.1016/j.jacc.2014.02.530; Cura FA, 2001, AM J CARDIOL, V88, P124, DOI 10.1016/S0002-9149(01)01605-8; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; DeGeare VS, 2001, AM J CARDIOL, V87, P1035, DOI 10.1016/S0002-9149(01)01457-6; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Gupta Sanjiv, 2016, Indian Heart J, V68, P539, DOI 10.1016/j.ihj.2016.04.006; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Hibi K, 2018, JACC-CARDIOVASC INTE, V11, P1545, DOI 10.1016/j.jcin.2018.03.021; Hoebers LP, 2013, EUR J HEART FAIL, V15, P425, DOI 10.1093/eurjhf/hfs182; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Kaltoft A, 2010, J AM COLL CARDIOL, V55, P867, DOI 10.1016/j.jacc.2009.09.052; Kim DW, 2017, INT HEART J, V58, P674, DOI 10.1536/ihj.16-448; Kimura K, 2019, CIRC J, V83, P1085, DOI 10.1253/circj.CJ-19-0133; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Mehta SR, 2012, J AM COLL CARDIOL, V60, P2490, DOI 10.1016/j.jacc.2012.07.050; Miyachi H, 2016, HEART VESSELS, V31, P1740, DOI 10.1007/s00380-015-0791-9; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Nallamothu BK, 2015, LANCET, V385, P1114, DOI 10.1016/S0140-6736(14)61932-2; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Noguchi M, 2018, HEART VESSELS, V33, P1139, DOI 10.1007/s00380-018-1164-y; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Osman M, 2020, AM HEART J, V224, P98, DOI 10.1016/j.ahj.2020.03.014; Parikh R, 2009, INT J CLIN PRACT, V63, P398, DOI 10.1111/j.1742-1241.2008.01920.x; Sandoval Y, 2020, CIRCULATION, V141, P1434, DOI 10.1161/CIRCULATIONAHA.120.045708; Santoro GM, 2008, EUR J HEART FAIL, V10, P780, DOI 10.1016/j.ejheart.2008.06.004; Shiomi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3257; Stone GW, 2005, JAMA-J AM MED ASSOC, V293, P1063, DOI 10.1001/jama.293.9.1063; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Tsukui T, 2018, HEART VESSELS, V33, P498, DOI 10.1007/s00380-017-1089-x; Vanhaverbeke M, 2018, CLIN CARDIOL, V41, P1201, DOI 10.1002/clc.23017; Watanabe Y, 2016, INT HEART J, V57, P697, DOI 10.1536/ihj.16-170; Zafirovska B, 2019, CATHETER CARDIO INTE, V93, P25, DOI 10.1002/ccd.27711	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241251	10.1371/journal.pone.0241251	http://dx.doi.org/10.1371/journal.pone.0241251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091051	Green Published, gold			2022-12-26	WOS:000586647200023
J	Young, BD; Serrano, XM; Rosales, SM; Miller, MW; Williams, D; Traylor-Knowles, N				Young, Benjamin D.; Serrano, Xaymara M.; Rosales, Stephanie M.; Miller, Margaret W.; Williams, Dana; Traylor-Knowles, Nikki			Innate immune gene expression inAcropora palmatais consistent despite variance in yearly disease events	PLOS ONE			English	Article							AMINO-ACID OXIDASE; NF-KAPPA-B; RNA-SEQ; INFECTIOUS-DISEASES; LBP/BPI GENES; BAND DISEASE; CORAL; RECEPTOR; PROTEIN; IDENTIFICATION	Coral disease outbreaks are expected to increase in prevalence, frequency and severity due to climate change and other anthropogenic stressors. This is especially worrying for the Caribbean branching coralAcropora palmatawhich has already seen an 80% decrease in cover primarily due to disease. Despite the importance of this keystone species, there has yet to be a characterization of its transcriptomic response to disease exposure. In this study we provide the first transcriptomic analysis of 12A.palmatagenotypes and their symbiont Symbiodiniaceae exposed to disease in 2016 and 2017. Year was the primary driver of gene expression variance forA.palmataand the Symbiodiniaceae. We hypothesize that lower expression of ribosomal genes in the coral, and higher expression of transmembrane ion transport genes in the Symbiodiniaceae indicate that a compensation or dysbiosis may be occurring between host and symbiont. Disease response was the second driver of gene expression variance forA.palmataand included a core set of 422 genes that were significantly differentially expressed. Of these, 2 genes (a predicted cyclin-dependent kinase 11b and aspartate 1-decarboxylase) showed negative Log2 fold changes in corals showing transmission of disease, and positive Log2 fold changes in corals showing no transmission of disease, indicating that these may be important in disease resistance. Co-expression analysis identified two modules positively correlated to disease exposure, one enriched for lipid biosynthesis genes, and the other enriched in innate immune genes. The hub gene in the immune module was identified as D-amino acid oxidase, a gene implicated in phagocytosis and microbiome homeostasis. The role of D-amino acid oxidase in coral immunity has not been characterized but could be an important enzyme for responding to disease. Our results indicate thatA.palmatamounts a core immune response to disease exposure despite differences in the disease type and virulence between 2016 and 2017. These identified genes may be important for future biomarker development in this Caribbean keystone species.	[Young, Benjamin D.; Traylor-Knowles, Nikki] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Serrano, Xaymara M.] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Serrano, Xaymara M.; Rosales, Stephanie M.; Williams, Dana] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL USA; [Miller, Margaret W.; Williams, Dana] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Miami, FL USA; [Miller, Margaret W.] SECORE Int, Miami, FL USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA	Traylor-Knowles, N (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	ntraylorknowles@rsmas.miami.edu			NOAA's Coral Reef Conservation Program (CRCP) [S8KMCRPP00, ID31194]; OAR NOAA omics initiative	NOAA's Coral Reef Conservation Program (CRCP); OAR NOAA omics initiative	NOAA's Coral Reef Conservation Program (CRCP) Project/Task#S8KMCRPP00, ID31194, and the OAR NOAA omics initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aills L, 2008, SURG OBES RELAT DIS, V4, pS73, DOI 10.1016/j.soard.2008.03.002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson DA, 2016, PEERJ, V4, DOI 10.7717/peerj.1616; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2019, LANCET GLOB HEALTH, V7, pE1, DOI 10.1016/S2214-109X(18)30536-9; [Anonymous], 2018, LANCET HAEMATOL, V5, pE127, DOI 10.1016/S2352-3026(18)30037-1; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baker DM, 2018, ISME J, V12, P921, DOI 10.1038/s41396-018-0046-8; Baron OL, 2016, DEV COMP IMMUNOL, V57, P20, DOI 10.1016/j.dci.2015.11.006; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baumann J, 2014, J EXP MAR BIOL ECOL, V461, P469, DOI 10.1016/j.jembe.2014.09.017; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burns JHR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072466; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/512926; Chi YY, 2009, BIOCHEM BIOPH RES CO, V386, P493, DOI 10.1016/j.bbrc.2009.06.061; Choudhary S, 2011, J BIOL CHEM, V286, P37187, DOI 10.1074/jbc.M111.224923; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Daniels CA, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00062; DAvanzo B, 1996, EPIDEMIOLOGY, V7, P312, DOI 10.1097/00001648-199605000-00018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hou J, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00037; Howells EJ, 2020, CORAL REEFS, V39, P771, DOI 10.1007/s00338-020-01946-2; Hu BQ, 2017, FISH SHELLFISH IMMUN, V60, P436, DOI 10.1016/j.fsi.2016.12.013; Huang BY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01826; Hubler MJ, 2016, J NUTR BIOCHEM, V34, P1, DOI 10.1016/j.jnutbio.2015.11.002; Irukayama-Tomobe Y, 2009, P NATL ACAD SCI USA, V106, P3930, DOI 10.1073/pnas.0811844106; Jackson J., 2014, STATUS TRENDS CARIBB; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kemp KM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01035-17; Kitchen SA, 2019, G3-GENES GENOM GENET, V9, P1633, DOI 10.1534/g3.119.400125; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laphanuwat P, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00023; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Libro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081821; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mao YZ, 2013, FISH SHELLFISH IMMUN, V35, P642, DOI 10.1016/j.fsi.2013.05.025; Mawani R, 2004, ARIEL-REV INT ENGL, V35, P31; Mera H, 2018, ENVIRON MICROBIOL, V20, P431, DOI 10.1111/1462-2920.13958; Morris LA, 2019, TRENDS MICROBIOL, V27, P678, DOI 10.1016/j.tim.2019.03.004; Mydlarz LD, 2010, J EXP BIOL, V213, P934, DOI 10.1242/jeb.037580; Nakamura H, 2012, INFECT IMMUN, V80, P1546, DOI 10.1128/IAI.06214-11; National Marine Fisheries Service, 2015, REC PLAN ELKH ACR PA; Nie L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01523; Nieduszynski CA, WHOLE GENOME ANAL AN, P8; OBARA K, 1992, EUR J BIOCHEM, V209, P1, DOI 10.1111/j.1432-1033.1992.tb17254.x; Ocampo ID, 2015, IMMUNOGENETICS, V67, P515, DOI 10.1007/s00251-015-0854-1; OTSUKAFUCHINO H, 1992, COMP BIOCHEM PHYS C, V101, P607, DOI 10.1016/0742-8413(92)90094-N; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Parkinson JE, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12687; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peixoto RS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00341; Priyathilaka TT, 2019, FISH SHELLFISH IMMUN, V84, P802, DOI 10.1016/j.fsi.2018.10.062; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rosales SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54855-y; Sasabe J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00933; Sasabe J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.125, 10.1038/nmicrobiol.2016.125]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao YN, 2015, DEV COMP IMMUNOL, V52, P88, DOI 10.1016/j.dci.2015.04.015; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sun HT, 2018, ADV NEUR IN, V31; Sutherland KP, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0205; Tagliafico A, 2017, MAR ECOL PROG SER, V573, P129, DOI 10.3354/meps12177; Thakur NL, 2003, AQUAT MICROB ECOL, V31, P77, DOI 10.3354/ame031077; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tilahun B, 2015, JMIR MED INF, V3, DOI 10.2196/medinform.4106; Toledo-Hernandez C, 2014, ISJ-INVERT SURVIV J, V11, P319; Tracy AM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1718; Wang YL, 2009, J BIOCHEM, V145, P331, DOI 10.1093/jb/mvn177; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Weis VM, 2019, INTEGR COMP BIOL, V59, P845, DOI 10.1093/icb/icz067; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiens M, 2005, J BIOL CHEM, V280, P27949, DOI 10.1074/jbc.M504049200; Wilkinson S, 2011, AUTOPHAGY, V7, P1295, DOI 10.4161/auto.7.11.16646; Williams LM, 2018, DEV COMP IMMUNOL, V79, P128, DOI 10.1016/j.dci.2017.10.016; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Wright RM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1540-2; Zhang Y, 2017, MAR POLLUT BULL, V124, P660, DOI 10.1016/j.marpolbul.2017.03.047	98	6	6	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0228514	10.1371/journal.pone.0228514	http://dx.doi.org/10.1371/journal.pone.0228514			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091033	gold, Green Submitted, Green Published			2022-12-26	WOS:000586647200062
J	Demissie, SD; Kozuki, N; Olorunsaiye, CZ; Gebrekirstos, P; Mohammed, S; Kiapi, L; Chantler, T; Karafillakis, E; Landegger, J				Demissie, Shiferaw Dechasa; Kozuki, Naoko; Olorunsaiye, Comfort Z.; Gebrekirstos, Petros; Mohammed, Siraj; Kiapi, Lilian; Chantler, Tracey; Karafillakis, Emilie; Landegger, Justine			Community engagement strategy for increased uptake of routine immunization and select perinatal services in north-west Ethiopia: A descriptive analysis	PLOS ONE			English	Article								Background Routine immunization coverage has stagnated over the past decade and fallen short of WHO targets in Ethiopia. Community engagement strategies that reach beyond traditional health systems may reduce dropout and increase coverage. This evaluation assesses changes in immunization, postpartum family planning, and antenatal care coverage after implementation of an enhanced community engagement and defaulter tracing strategy, entitled "Fifth Child" project, across two districts in Benishangul-Gumuz Regional State (BGRS), Ethiopia. Methods and findings A formative evaluation was conducted to examine the contribution of the strategy on immunization, postpartum family planning and antenatal care utilization in Assosa and Bambasi districts of BGRS. The quantitative findings are presented here. Routine and project-specific data were analyzed to assess changes in uptake of childhood vaccinations, postpartum family planning and antenatal care. Between January 2013 and December 2016, pentavalent-3 coverage increased from 63% to 84% in Assosa, and from 78% to 93% in Bambasi. Similarly, measles vaccine coverage increased from 77% to 81% in Assosa, and from 59% to 86% in Bambasi. Approximately 54% of all eligible infants across both woredas defaulted on scheduled vaccinations at least once during the period. Among defaulting children, 84% were identified and subsequently caught up on the vaccinations missed. Secondary outcomes of postpartum family planning and antenatal care also increased in both woredas. Conclusion The "Fifth Child" project likely contributed to enhanced immunization performance and increased utilization of immunization and select perinatal health services in two woredas of BGRS. Further research is required in order to determine the impact of this community engagement strategy.	[Demissie, Shiferaw Dechasa; Gebrekirstos, Petros; Mohammed, Siraj] Int Rescue Comm, Addis Ababa, Ethiopia; [Kozuki, Naoko; Olorunsaiye, Comfort Z.; Landegger, Justine] Int Rescue Comm, New York, NY 10018 USA; [Kiapi, Lilian] Int Rescue Comm, London, England; [Chantler, Tracey; Karafillakis, Emilie] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Kozuki, N (corresponding author), Int Rescue Comm, New York, NY 10018 USA.	naoko.kozuki@rescue.org		Chantler, Tracey/0000-0001-7776-7339; Kozuki, Naoko/0000-0003-2850-3956; Olorunsaiye, Comfort Z./0000-0003-4725-0448; Karafillakis, Emilie/0000-0001-8648-906X	International Initiative for Impact Evaluation (3ie); Pfizer Foundation	International Initiative for Impact Evaluation (3ie); Pfizer Foundation	International Initiative for Impact Evaluation (3ie) (https://www.3ieimpact.org) and Pfizer Foundation supported the study to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animaw W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-464; [Anonymous], 2017, ETH DEM HLTH SURV 20; [Anonymous], 2016, ADDR GAP EQ QUAL HLT; [Anonymous], 2015, HLTH SECT TRANSF PLA; [Anonymous], 2017, 5 CHILD PROJ INT REP; [Anonymous], 2012, ETH DEM HLTH SURV 20; Casey RM, 2016, GLOBAL ROUTINE VACCI; Chantler T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040667; Etana B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-566; Fetene N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156438; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2078-6; Legesse E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0345-4; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Okwaraji YB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-476; Ozawa S, 2016, HEALTH AFFAIR, V35, P199, DOI 10.1377/hlthaff.2015.1086; Tadesse H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-150; Tesfaye F., 2014, INT J PUB HLTH SCI I, V3, P185; WHO, 2017, EST CHILD CAUS DEATH; WHO, 2017, IMM COV FACTSH REV M; World Health Organization, 2013, GLOB VACC ACT PLAN M; World Health Organization, 2016, 2015 ASS REP GLOB VA	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0237319	10.1371/journal.pone.0237319	http://dx.doi.org/10.1371/journal.pone.0237319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119604	Green Published, gold			2022-12-26	WOS:000600013600040
J	Romero-Gonzalez, LE; Perez-Morales, D; Cortes-Avalos, D; Vazquez-Guerrero, E; Paredes-Hernandez, DA; de los Santos, PE; Villa-Tanaca, L; De la Cruz, MA; Bustamante, VH; Ibarra, JA				Romero-Gonzalez, Luis E.; Perez-Morales, Deyanira; Cortes-Avalos, Daniel; Vazquez-Guerrero, Edwin; Paredes-Hernandez, Denisse A.; de los Santos, Paulina; Villa-Tanaca, Lourdes; De la Cruz, Miguel A.; Bustamante, Victor H.; Ibarra, J. Antonio			The Salmonella Typhimurium InvF-SicA complex is necessary for the transcription of sopB in the absence of the repressor H-NS	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; PATHOGENICITY ISLAND 1; CONTROLS EXPRESSION; SECRETION SYSTEM; CHAPERONE SICA; DNA-BINDING; GENES; VIRULENCE; HILD; FAMILY	Expression of virulence factors in non-typhoidal Salmonella enterica depends on a wide variety of general and specific transcriptional factors that act in response to multiple environmental signals. Expression of genes for cellular invasion located in the Salmonella pathogenicity island 1 (SPI-1) is tightly regulated by several transcriptional regulators arrayed in a cascade, while repression of this system is exerted mainly by H-NS. In SPI-1, H-NS represses the expression mainly by binding to the regulatory region of hilA and derepression is exercised mainly by HilD. However, the possible regulatory role of H-NS in genes downstream from HilD and HilA, such as those regulated by InvF, has not been fully explored. Here the role of H-NS on the expression of sopB, an InvF dependent gene encoded in SPI-5, was evaluated. Our data show that InvF is required for the expression of sopB even in the absence of H-NS. Furthermore, in agreement with previous results on other InvF-regulated genes, we found that the expression of sopB requires the InvF/SicA complex. Our results support that SicA is not required for DNA binding nor for increasing affinity of InvF to DNA in vitro. Moreover, by using a bacterial two-hybrid system we were able to identify interactions between SicA and InvF. Lastly, protein-protein interaction assays suggest that InvF functions as a monomer. Derived from these results we postulate that the InvF/SicA complex does not act on sopB as an anti-H-NS factor; instead, it seems to induce the expression of sopB by acting as a classical transcriptional regulator.	[Romero-Gonzalez, Luis E.; Cortes-Avalos, Daniel; Vazquez-Guerrero, Edwin; Paredes-Hernandez, Denisse A.; de los Santos, Paulina; Villa-Tanaca, Lourdes; Ibarra, J. Antonio] Inst Politecn Nacl, Lab Genet Microbiana, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Perez-Morales, Deyanira; Bustamante, Victor H.] Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Cuernavaca, Morelos, Mexico; [De la Cruz, Miguel A.] Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Infecciosas & Para, Hosp Pediat, Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Ibarra, JA (corresponding author), Inst Politecn Nacl, Lab Genet Microbiana, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.	jaig19@gmail.com	Ibarra, J. Antonio/R-2030-2018; de los Santos, Paulina Estrada/AAE-8582-2021; de los Santos, Paulina Estrada/S-1238-2018; Pérez-Morales, Deyanira/AAW-3219-2021; Bustamante, Victor/GXF-0780-2022	Ibarra, J. Antonio/0000-0002-5016-0622; de los Santos, Paulina Estrada/0000-0003-2407-0284; de los Santos, Paulina Estrada/0000-0003-2407-0284; Pérez-Morales, Deyanira/0000-0003-3128-2138; De la Cruz, Miguel A./0000-0001-6909-2941	Consejo Nacional de Ciencia y Tecnologia (Proyecto Apoyado por el Fondo Sectorial de Investigacion para la Educacion CONACYT) [A1-S-25438]; Secretaria de Investigacion y Posgrado [SIP 2020-0728]; Consejo Nacional de Ciencia y Tecnologia [CONACYT 254531]; Direccion General de Asuntos del Personal Academico de la UNAM [IN202418]; CONACYT [619402, 935269, 618908]; COFAA; BEIFI-IPN fellowship	Consejo Nacional de Ciencia y Tecnologia (Proyecto Apoyado por el Fondo Sectorial de Investigacion para la Educacion CONACYT); Secretaria de Investigacion y Posgrado; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico de la UNAM; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); COFAA; BEIFI-IPN fellowship	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia (Proyecto Apoyado por el Fondo Sectorial de Investigacion para la Educacion CONACYT A1-S-25438), Secretaria de Investigacion y Posgrado (SIP 2020-0728) and COFAA to JAI, from Consejo Nacional de Ciencia y Tecnologia (CONACYT 254531) and Direccion General de Asuntos del Personal Academico de la UNAM (IN202418) to VHB. LER-G, DC-A and EV-G obtained a grant for graduate studies from CONACYT (619402, 935269 and 618908, respectively). LER-G, DC-A and DAPH enjoyed a BEIFI-IPN fellowship.	Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; Ibarra JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056977; Ares MA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00013; Banda MM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49192-z; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Basturea GN, 2008, J BACTERIOL, V190, P2279, DOI 10.1128/JB.01705-07; Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Colgan AM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006258; Daines DA, 2000, J BACTERIOL, V182, P5267, DOI 10.1128/JB.182.18.5267-5270.2000; Darwin KH, 1999, J BACTERIOL, V181, P4949; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; De la Cruz MA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00807; De la Cruz MA, 2007, MOL MICROBIOL, V66, P727, DOI 10.1111/j.1365-2958.2007.05958.x; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dmitrova M, 1998, MOL GEN GENET, V257, P205; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; dos Santos AMP, 2019, CURR MICROBIOL, V76, P762, DOI 10.1007/s00284-018-1510-4; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Haselbeck AH, 2017, CURR OPIN INFECT DIS, V30, P498, DOI 10.1097/QCO.0000000000000398; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HOVEY AK, 1995, J BACTERIOL, V177, P4427, DOI 10.1128/jb.177.15.4427-4436.1995; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Ibarra JA, 2003, J BACTERIOL, V185, P2835, DOI 10.1128/JB.185.9.2835-2847.2003; Ilyas B, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00428; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kim JS, 2014, FEMS MICROBIOL LETT, V350, P146, DOI 10.1111/1574-6968.12315; Knodler LA, 2015, CURR OPIN MICROBIOL, V23, P23, DOI 10.1016/j.mib.2014.10.010; Knodler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084681; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lahiri C, 2014, J THEOR BIOL, V363, P188, DOI 10.1016/j.jtbi.2014.08.013; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Cortez-Sanchez JL, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy006; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Martinez LC, 2014, J BACTERIOL, V196, P3746, DOI 10.1128/JB.01799-14; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; Munson GP, 2001, INFECT IMMUN, V69, P186, DOI 10.1128/IAI.69.1.186-193.2001; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Paredes-Amaya CC, 2018, J BIOL CHEM, V293, P6578, DOI 10.1074/jbc.RA117.001421; Perez-Morales D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006497; Schechter LM, 2003, INFECT IMMUN, V71, P5432, DOI 10.1128/IAI.71.9.5432-5435.2003; Singh K, 2016, ANNU REV MICROBIOL, V70, P199, DOI 10.1146/annurev-micro-102215-095301; Smith C, 2016, MBIO, V7, DOI 10.1128/mBio.01024-16; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; Vazquez-Guerrero E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007215; WHO, 2016, EST GLOB BURD FOODB	60	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240617	10.1371/journal.pone.0240617	http://dx.doi.org/10.1371/journal.pone.0240617			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119619	Green Published, gold			2022-12-26	WOS:000600013600126
J	Simo, N; Kuate-Tegueu, C; Ngankou-Tchankeu, S; Doumbe, J; Maiga, Y; Cesari, M; Dartigues, JF; Kengne, AP; Tabue-Teguo, M				Simo, Nadine; Kuate-Tegueu, Callixte; Ngankou-Tchankeu, Steve; Doumbe, Jacques; Maiga, Youssoufa; Cesari, Matteo; Dartigues, Jean-Francois; Kengne, Andre-Pascal; Tabue-Teguo, Maturin			Correlates of diabetic polyneuropathy of the elderly in Sub-Saharan Africa	PLOS ONE			English	Article							ACUTE AXONAL POLYNEUROPATHY; GLOMERULAR-FILTRATION-RATE; PERIPHERAL NEUROPATHY; RISK-FACTORS; OLDER-PEOPLE; PREVALENCE; MELLITUS; MANIFESTATIONS; POPULATION; DIAGNOSIS	Background Diabetic polyneuropathy is associated with significant physical disability among older adults. However, their frequency and correlates are not well known in the older adults in Sub-Saharan-Africa. The objectives were to evaluate the hospital-based prevalence of diabetic polyneuropathy and identify its correlates in older adults. Methods Over a period of 5 months, a cross-sectional survey was carried out at Douala Laquintinie Hospital (DLH), a main reference hospital in Douala, the economic capital of Cameroon. Participants in our study group comprised all patients with type 2 diabetes, whatever the reason for their reporting to the hospital. Diabetic Polyneuropathy was defined according to a Diabetic Neuropathy Examination score > 3/16. Results A total of 159 older adults with diabetes were examined during this recruitment period, among whom 106 (66.7%) were women. The mean age was 68.3 +/- 6.5 years. Diabetes median duration was 108 months. For all patients assessed using the Diabetic Neuropathy Examination score, polyneuropathy was reported in 31.4%; among them, polyneuropathy proved symptomatic in 78% of them. Correlates of polyneuropathy were glycated hemoglobin (p = 0.049), HIV infection (p = 0.031) and albuminuria (p< 0.001), even after adjustment for age, gender and duration of diabetes. Conclusion A third of older adults with diabetes who visited our hospital were diagnosed with prevalent diabetes-related polyneuropathy. It shows that early detection is required through routine screening and regular follow-up examinations in order to reduce the risk of disability and improve the quality of life in elderly diabetics.	[Simo, Nadine; Tabue-Teguo, Maturin] Univ Antilles, Equipe LAMIA, CHU Guadeloupe, Fouillole, Guadeloupe, France; [Kuate-Tegueu, Callixte] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Ngankou-Tchankeu, Steve] Univ Montagnes, Inst Super Sci Sante, Bangangte, Cameroon; [Doumbe, Jacques] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Maiga, Youssoufa] Hop Gabriel Toure CHU, Serv Neurol, Bamako, Mali; [Cesari, Matteo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy; [Dartigues, Jean-Francois; Tabue-Teguo, Maturin] Univ Bordeaux, INSERM U 1219, Bordeaux, France; [Kengne, Andre-Pascal] South African Med Res Council South Africa, Cape Town, South Africa	CHU Guadeloupe; Universite des Antilles; University of Yaounde I; IRCCS Ca Granda Ospedale Maggiore Policlinico; UDICE-French Research Universities; Universite de Bordeaux	Tabue-Teguo, M (corresponding author), Univ Antilles, Equipe LAMIA, CHU Guadeloupe, Fouillole, Guadeloupe, France.; Tabue-Teguo, M (corresponding author), Univ Bordeaux, INSERM U 1219, Bordeaux, France.	tabue.maturin@gmail.com		Kengne, Andre Pascal/0000-0002-5183-131X				Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Aring AM, 2005, AM FAM PHYSICIAN, V71, P2123; Barbosa AP, 2001, DIABETES METAB, V27, P496; Belinga LEE, 2018, J PUBLIC HEALTH AFR, V9, DOI 10.4081/jphia.2018.761; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Centner CM, 2013, LANCET NEUROL, V12, P295, DOI 10.1016/S1474-4422(13)70002-4; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272; Hanewinckel R, 2016, EUR J EPIDEMIOL, V31, P5, DOI 10.1007/s10654-015-0094-6; Hoffman EM, 2015, NEUROLOGY, V84, P1644, DOI 10.1212/WNL.0000000000001492; Janghorbani M, 2006, ACTA NEUROL SCAND, V114, P384, DOI 10.1111/j.1600-0404.2006.00716.x; Jarmuzewska EA, 2007, EUR NEUROL, V57, P91, DOI 10.1159/000098058; Kong APS, 2006, KIDNEY INT, V69, P383, DOI 10.1038/sj.ki.5000061; Kuate-Tegueu C, 2015, J NEUROL SCI, V355, P108, DOI 10.1016/j.jns.2015.05.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061053; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; Mbouemboue OP, 2018, MED SANTE TROP, V28, P379, DOI 10.1684/mst.2018.0851; Meijer JWG, 2003, DIABETES CARE, V26, P697, DOI 10.2337/diacare.26.3.697; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Morley JE, 2014, J AM MED DIR ASSOC, V15, P853, DOI 10.1016/j.jamda.2014.10.001; Nomura T, 2018, J DIABETES INVEST, V9, P186, DOI 10.1111/jdi.12658; Peer N, 2014, DIABETES RES CLIN PR, V103, P197, DOI 10.1016/j.diabres.2013.11.006; Sinclair A, 2013, J AM MED DIR ASSOC, V14, P777, DOI 10.1016/j.jamda.2013.09.001; Sinclair A, 2012, J AM MED DIR ASSOC, V13, P497, DOI 10.1016/j.jamda.2012.04.012; Sinnreich M, 2005, NEUROLOGIST, V11, P63, DOI 10.1097/01.nrl.0000156314.24508.ed; Suzuki M, 2013, HAND CLINIC, V115, P803, DOI 10.1016/B978-0-444-52902-2.00046-1; TABARAUD F, 1990, J NEUROL SCI, V97, P195, DOI 10.1016/0022-510X(90)90218-C; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Tesfaye S, 2005, NEW ENGL J MED, V352, P341, DOI 10.1056/NEJMoa032782; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Teunissen LL, 2000, J NEUROL, V247, P195, DOI 10.1007/s004150050562; Vandenbulcke M, 1999, ACTA NEUROL BELG, V99, P198; Vinik A, 2006, NAT CLIN PRACT ENDOC, V2, P269, DOI 10.1038/ncpendmet0142; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; VINIK AI, 1992, DIABETES CARE, V15, P1926, DOI 10.2337/diacare.15.12.1926; Werfalli M, 2016, LANCET DIABETES ENDO, V4, P72, DOI 10.1016/S2213-8587(15)00363-0; Wohrle JC, 1998, ARCH NEUROL-CHICAGO, V55, P1329, DOI 10.1001/archneur.55.10.1329; Yeboah K, 2016, J CLIN TRANSL ENDOCR, V5, P26, DOI 10.1016/j.jcte.2016.07.001	42	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240602	10.1371/journal.pone.0240602	http://dx.doi.org/10.1371/journal.pone.0240602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119646	Green Published, gold			2022-12-26	WOS:000600013600113
J	Landmesser, ME; Raup-Konsavage, WM; Lehman, HL; Stairs, DB				Landmesser, Mary E.; Raup-Konsavage, Wesley M.; Lehman, Heather L.; Stairs, Douglas B.			Loss of p120ctn causes EGFR-targeted therapy resistance and failure	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; E-CADHERIN; PROGNOSTIC VALUE; P120-CATENIN EXPRESSION; ACQUIRED-RESISTANCE; REDUCED EXPRESSION; COLORECTAL-CANCER; POOR SURVIVAL	Epidermal growth factor receptor (EGFR) plays a vital role in cell division and survival signaling pathways. EGFR is activated in nearly every cancer type, and its high expression in tumors is correlated with poor patient outcome. Altogether, EGFR is a prime candidate as a therapeutic target. While targeted EGFR therapy is initially effective in 75% of patients, a majority of patients relapse within the first year due to poorly understood mechanisms of resistance. p120-catenin (p120ctn) has recently been implicated as a biomarker for EGFR therapy. In previous studies, we demonstrated that p120ctn is a tumor suppressor and its loss is capable of inducing cancer. Furthermore, p120ctn down-regulation synergizes with EGFR overexpression to cause a highly invasive cell phenotype. The purpose of this present study was to investigate whether p120ctn down-regulation induced EGFR therapeutic resistance. Using human esophageal keratinocytes, we have found that EGFR-targeting compounds are toxic to cells overexpressing EGFR. Interestingly, these therapies do not cause toxicity in cells with EGFR overexpression and decreased p120ctn expression. These data suggest that decreased p120ctn causes resistance to EGFR therapy. We believe these findings are of utmost importance, as there is an unmet need to discover mechanisms of EGFR resistance.	[Landmesser, Mary E.; Stairs, Douglas B.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA; [Raup-Konsavage, Wesley M.] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA; [Lehman, Heather L.] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania	Stairs, DB (corresponding author), Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA.	dbs18@psu.edu		Stairs, Douglas/0000-0002-4875-6582; Raup-Konsavage, Wesley/0000-0001-9413-9852	American Cancer Society [RSG-16-219-01-TBG]; Department of Pathology Researcher-Initiated Grant; ET Program Development Award from the Penn State Cancer Institute; Penn State Cancer Institute; Highmark Community Health Reinvestment Grant	American Cancer Society(American Cancer Society); Department of Pathology Researcher-Initiated Grant; ET Program Development Award from the Penn State Cancer Institute; Penn State Cancer Institute; Highmark Community Health Reinvestment Grant	This research was supported by a Research Scholar Grant, RSG-16-219-01-TBG, from the American Cancer Society, a Department of Pathology Researcher-Initiated Grant, as well as an ET Program Development Award and a Program Project Development Award, both from the Penn State Cancer Institute and Highmark Community Health Reinvestment Grant (all to DBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Ayyappan S, 2013, ANTICANCER RES, V33, P4139; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; Dillon DA, 1998, AM J PATHOL, V152, P75; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; Greve G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1967-5; Ishizaki Y, 2004, J DERMATOL SCI, V34, P99, DOI 10.1016/j.jdermsci.2003.12.001; Kallakury BVS, 2001, CANCER, V92, P2786, DOI 10.1002/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koedel U, 2000, J INFECT DIS, V182, P1437, DOI 10.1086/315877; Lee HS, 2016, GUT LIVER, V10, P340, DOI 10.5009/gnl15465; Lehman Heather L, 2018, Oncotarget, V9, P11180, DOI 10.18632/oncotarget.24358; Lehman HL, 2015, AM J PATHOL, V185, P240, DOI 10.1016/j.ajpath.2014.09.008; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Liu Y, 2018, APPL IMMUNOHISTO M M, V26, P64, DOI 10.1097/PAI.0000000000000381; Lo Muzio L, 2013, OR SURG OR MED OR PA, V115, P789, DOI 10.1016/j.oooo.2013.03.006; Ma LW, 2012, J CLIN PATHOL, V65, P315, DOI 10.1136/jclinpath-2011-200516; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; Nakopoulou L, 2000, ANTICANCER RES, V20, P4571; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Okawa T, 2007, GENE DEV, V21, P2788, DOI 10.1101/gad.1544507; OZAWA S, 1989, CANCER, V63, P2169, DOI 10.1002/1097-0142(19890601)63:11<2169::AID-CNCR2820631117>3.0.CO;2-W; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Raup-Konsavage WM, 2018, CANNABIS CANNABINOID, V3, P272, DOI 10.1089/can.2018.0065; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Rigante D, 2017, CLIN RHEUMATOL, V36, P463, DOI 10.1007/s10067-016-3317-7; Russo A, 2015, ONCOTARGET, V6, P26814, DOI 10.18632/oncotarget.4254; Sacco AG, 2016, ONCOTARGETS THER, V9, P1927, DOI 10.2147/OTT.S93720; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shimazui T, 1996, CANCER RES, V56, P4154; Shishodia Shishir, 2004, Cancer Treat Res, V119, P139; Skoudy A, 1996, INT J CANCER, V68, P14, DOI 10.1002/(SICI)1097-0215(19960927)68:1<14::AID-IJC3>3.0.CO;2-#; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Steeghs N, 2007, ANN SURG ONCOL, V14, P942, DOI 10.1245/s10434-006-9227-1; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Syrigos KN, 1998, EUR J CANCER, V34, P2037, DOI 10.1016/S0959-8049(98)00279-2; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Yang YL, 2012, CHINESE MED J-PEKING, V125, P450, DOI 10.3760/cma.j.issn.0366-6999.2012.03.009; Zaniboni A, 2016, CANCER CHEMOTH PHARM, V78, P233, DOI 10.1007/s00280-016-3032-8; Zhai B, 2008, WORLD J GASTROENTERO, V14, P5665, DOI 10.3748/wjg.14.5665; Zhu HT, 2018, J THORAC DIS, V10, P5328, DOI 10.21037/jtd.2018.09.18	52	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241299	10.1371/journal.pone.0241299	http://dx.doi.org/10.1371/journal.pone.0241299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112928	Green Published, gold			2022-12-26	WOS:000588374000037
J	Lim, GE; Son, SA; Hur, B; Park, JK				Lim, Go-Eun; Son, Sung-Ae; Hur, Bock; Park, Jeong-Kil			Evaluation of the relationship between non-caries cervical lesions and the tooth and periodontal tissue: An ex-vivo study using micro-computed tomography	PLOS ONE			English	Article							PROGRESSION	The purpose of this study was to analyze the relationship between the height and depth of buccal non-carious cervical lesions (NCCLs) and the relationship between the size of buccal NCCLs and clinical crown-root ratio of both buccal and lingual (palatal) sides using micro-computed tomography (micro-CT) images of the teeth and periodontal tissues from the cadavers. The micro-CT images of 56 teeth and their supporting tissues were obtained from 17 cadavers. From these images, the height and depth of NCCLs and the length of the buccal and lingual (palatal) clinical crowns were measured, and the conventional/modified clinical crown-root ratios were calculated. The height and depth ratio of NCCLs were analyzed statistically with the conventional/modified crown-root ratios by Pearson's correlation and multiple regression. According to the Pearson's correlation, the height and depth of buccal NCCLs were positively correlated with the modified buccal clinical crown-root ratio (p < 0.001 and p = 0.013, respectively). The regression model composed of variables of crown-root ratios explained the height of buccal NCCLs, and the prominent factor of the model was the modified buccal clinical crown-root ratio (p < 0.001). Moreover, the depth of buccal NCCLs was also explained by the regression model, and its prominent factor was the proportion of modified buccal and lingual (palatal) clinical crowns (p = 0.004). The buccal NCCLs were related to the crown-root ratios; particularly, the level of buccal gingival margin could be associated with the formation of buccal NCCLs.	[Lim, Go-Eun; Son, Sung-Ae; Hur, Bock; Park, Jeong-Kil] Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea	Pusan National University; Pusan National University Hospital	Park, JK (corresponding author), Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea.	jeongkil@pusan.ac.kr		Son, sungae/0000-0002-8421-4000; Park, Jeongkil/0000-0001-6333-8138; Lim, Go Eun/0000-0001-8426-0907	Pusan National University	Pusan National University(Pusan National University)	This study was supported by 2-year Research Grant of Pusan National University.	Addy M, 2003, INT DENT J, V53, P177, DOI 10.1111/j.1875-595X.2003.tb00768.x; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Aw TC, 2002, J AM DENT ASSOC, V133, P725, DOI 10.14219/jada.archive.2002.0268; Borcic J, 2005, J ORAL REHABIL, V32, P504, DOI 10.1111/j.1365-2842.2005.01455.x; Brandini DA, 2012, J PROSTHET DENT, V108, P298, DOI 10.1016/S0022-3913(12)60180-2; Duangthip D, 2017, AM J DENT, V30, P212; Grippo J O, 1991, J Esthet Dent, V3, P14, DOI 10.1111/j.1708-8240.1991.tb00799.x; Hur B, 2011, J ORAL REHABIL, V38, P469, DOI 10.1111/j.1365-2842.2010.02172.x; Jakupovic Selma, 2016, Eur J Dent, V10, P413, DOI 10.4103/1305-7456.184166; Jakupovic Selma, 2014, Acta Inform Med, V22, P241, DOI 10.5455/aim.2014.22.241-245; Litonjua LA, 2003, J AM DENT ASSOC, V134, P845, DOI 10.14219/jada.archive.2003.0282; Miller N, 2003, J CLIN PERIODONTOL, V30, P828, DOI 10.1034/j.1600-051X.2003.00378.x; PENNY RE, 1979, J PROSTHET DENT, V42, P34, DOI 10.1016/0022-3913(79)90327-5; Rajapakse PS, 2007, J CLIN PERIODONTOL, V34, P1046, DOI 10.1111/j.1600-051X.2007.01149.x; Rees JS, 2003, EUR J ORAL SCI, V111, P149, DOI 10.1034/j.1600-0722.2003.00018.x; Rees JS, 2002, J ORAL REHABIL, V29, P188, DOI 10.1046/j.1365-2842.2002.00836.x; Teixeira DNR, 2018, J DENT, V76, P93, DOI 10.1016/j.jdent.2018.06.017; Sawlani K, 2014, THESIS; Sawlani K, 2016, J PROSTHET DENT, V115, P571, DOI 10.1016/j.prosdent.2015.10.021; Soares P, J RES DENT, V1, P140, DOI [10.19177/jrd.v1e22013140-153, DOI 10.19177/JRD.V1E22013140-153]; Sugita I, 2017, J DENT, V57, P51, DOI 10.1016/j.jdent.2016.12.004; Vandana Kharidhi Laxman, 2016, J Indian Soc Periodontol, V20, P12, DOI 10.4103/0972-124X.168484	22	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240979	10.1371/journal.pone.0240979	http://dx.doi.org/10.1371/journal.pone.0240979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112900	gold, Green Published			2022-12-26	WOS:000588374000073
J	Liu, GY; Yang, ZP; Du, J; He, AL; Yang, HH; Xue, GY; Yu, CW; Zhang, YT				Liu, Gaoyuan; Yang, Zhanping; Du, Jun; He, Ailing; Yang, Huanhuan; Xue, Guangyuan; Yu, Congwen; Zhang, Yuting			Adding NBPT to urea increases N use efficiency of maize and decreases the abundance of N-cycling soil microbes under reduced fertilizer-N rate on the North China Plain	PLOS ONE			English	Article							NITRIFICATION INHIBITORS; NITROUS-OXIDE; AMMONIA VOLATILIZATION; WINTER-WHEAT; EMISSIONS; N2O; COMMUNITIES; IMPACT; YIELD; DENITRIFICATION	Urease inhibitor (UI) and nitrification inhibitor (NI) can reduce N losses from agricultural soils but effects of inhibitors on N cycle are unclear. A field experiment was conducted with maize to test effects of UI (N-(n-Butyl) thiophosphoric, NBPT) and NI (3,4-dimethylepyrazolephosphate, DMPP) on N uptake and N-cycling soil microbes. Five treatments were imposed: no N fertilizer input (CK), conventional fertilization (CF) and 80% of urea input with NBPT (80%U+UI), with DMPP (80%U+NI) and with half NBPT and half DMPP (80%U+1/2(UI+NI)). There were no significant differences in biomass between 80%U+UI, 80%U+NI and CF but harvest index was increased under 80%U+UI and 80%U+NI. Compared to CF, N use efficiency of grain under 80%U+UI was increased by 7.1%, whereas grain yield and N uptake under 80%U+1/2(UI+NI) were decreased by 8.2% and 9.4%, respectively. The peak soil NO3--N content was at about 15 days after fertilization (DAF) under CF but 30 DAF under the inhibitor treatments. In soils of 80%U+UI, the activities of urease and nitrate reductase were decreased between 15-45 DAF and between 5-30 DAF. The abundance of N-cycling soil microbes was affected: 80%U+UI and 80%U+NI reduced the copies of the amoA AOA and nir genes at about 15 days and reduced the copies of the amoA AOB gene at about 30 days. Correlation analysis indicated that there were significant positive relationships between amoA AOB gene and NH4+-N, as well as between nirK gene and NO3--N. Overall, urea applied with NBPT has greater potential for improving maize N use efficiency and inhibiting nitrification under reduced fertilizer-N applications.	[Liu, Gaoyuan; Yang, Zhanping; Du, Jun; He, Ailing; Yang, Huanhuan; Xue, Guangyuan; Zhang, Yuting] Henan Acad Agr Sci, Inst Plant Nutr & Environm Resources, Zhengzhou, Peoples R China; [Yu, Congwen] Pingdingshan Acad Agr Sci, Inst Agr Res Ctr, Pingdingshan, Peoples R China	Henan Academy of Agricultural Sciences	Zhang, YT (corresponding author), Henan Acad Agr Sci, Inst Plant Nutr & Environm Resources, Zhengzhou, Peoples R China.	zhytsj@sohu.com			National Key Research and Development Program of China [2018YFD0200605]; Henan Postdoctoral Science Foundation	National Key Research and Development Program of China; Henan Postdoctoral Science Foundation	This study was supported by the National Key Research and Development Program of China (2018YFD0200605) and Henan Postdoctoral Science Foundation.	Abalos D, 2014, AGR ECOSYST ENVIRON, V189, P136, DOI 10.1016/j.agee.2014.03.036; Akiyama H, 2010, GLOBAL CHANGE BIOL, V16, P1837, DOI 10.1111/j.1365-2486.2009.02031.x; [Anonymous], 2011, ETUDES FRANCAISES, V47, P91; [Anonymous], 2017, EVOL PSYCHIAT, V82, P1, DOI DOI 10.18637/JSS.V082.I13; Azam F, 2002, BIOL FERT SOILS, V35, P54, DOI 10.1007/s00374-001-0441-5; Castellano-Hinojosa A, 2020, J PLANT NUTR SOIL SC, V183, P99, DOI 10.1002/jpln.201900038; Chen YL, 2014, FEMS MICROBIOL ECOL, V89, P67, DOI 10.1111/1574-6941.12336; Chen Z, 2010, MICROB ECOL, V60, P850, DOI 10.1007/s00248-010-9700-z; Dai Y, 2013, SCI TOTAL ENVIRON, V465, P125, DOI 10.1016/j.scitotenv.2012.08.091; Das S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01702; Dong D, 2018, SOIL TILL RES, V180, P82, DOI 10.1016/j.still.2018.02.010; Feng JF, 2016, AGR ECOSYST ENVIRON, V231, P218, DOI 10.1016/j.agee.2016.06.038; Fiorentino N, 2016, BIOL FERT SOILS, V52, P523, DOI 10.1007/s00374-016-1095-7; Frame W, 2017, AGRON J, V109, P378, DOI 10.2134/agronj2016.08.0464; Fu QL, 2020, BIOL FERT SOILS, V56, P185, DOI 10.1007/s00374-019-01411-5; Gioacchini P, 2002, BIOL FERT SOILS, V36, P129, DOI 10.1007/s00374-002-0521-1; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hayden HL, 2010, SOIL BIOL BIOCHEM, V42, P1774, DOI 10.1016/j.soilbio.2010.06.015; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Hu B, 2014, ECOTOX ENVIRON SAFE, V110, P41, DOI 10.1016/j.ecoenv.2014.08.007; Hu XK, 2013, ENVIRON POLLUT, V176, P198, DOI 10.1016/j.envpol.2013.01.040; Kastl EM, 2015, BIOL FERT SOILS, V51, P57, DOI 10.1007/s00374-014-0948-1; Li YY, 2018, SOIL BIOL BIOCHEM, V116, P290, DOI 10.1016/j.soilbio.2017.10.023; Ligi T, 2014, ECOL ENG, V72, P47, DOI 10.1016/j.ecoleng.2013.07.015; Linquist BA, 2013, FIELD CROP RES, V154, P246, DOI 10.1016/j.fcr.2013.08.014; Liu HY, 2019, PLANT SOIL, V445, P39, DOI 10.1007/s11104-018-3860-x; Liu Z, 2018, FIELD CROP RES, V221, P196, DOI 10.1016/j.fcr.2018.03.001; Lu R.K, 2000, ANAL METHOD SOIL AGR; Martins MR, 2017, AGR ECOSYST ENVIRON, V247, P54, DOI 10.1016/j.agee.2017.06.021; Meng Q.F., 2018, ADV AGRON, P85; Nations F, 2015, WORLD FERTILIZER TRE; Ni K, 2014, AGR ECOSYST ENVIRON, V197, P184, DOI 10.1016/j.agee.2014.08.007; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Qiao CL, 2015, GLOBAL CHANGE BIOL, V21, P1249, DOI 10.1111/gcb.12802; Rock L, 2011, SOIL BIOL BIOCHEM, V43, P2397, DOI 10.1016/j.soilbio.2011.08.016; Staley C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00634; Trenkel M.E., 2010, SLOW CONTROLLED RELE; Xu CL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01234; Zaman M, 2008, BIOL FERT SOILS, V44, P693, DOI 10.1007/s00374-007-0252-4; Zaman M, 2009, SOIL BIOL BIOCHEM, V41, P1270, DOI 10.1016/j.soilbio.2009.03.011; Zanin L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01007; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zhao T, 2006, J AGROENVIRONMENT SC, V26, P779; Zhao Y, 2017, FIELD CROP RES, V205, P55, DOI 10.1016/j.fcr.2016.12.023	44	5	5	10	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240925	10.1371/journal.pone.0240925	http://dx.doi.org/10.1371/journal.pone.0240925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112905	Green Published, gold			2022-12-26	WOS:000588374000061
J	Tanaka, T; Yamaguchi, T; Sakamoto, Y				Tanaka, Takuma; Yamaguchi, Takayuki; Sakamoto, Yohei			Estimation of the percentages of undiagnosed patients of the novel coronavirus (SARS-CoV-2) infection in Hokkaido, Japan by using birth-death process with recursive full tracing	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; EPIDEMIC MODELS; CONTACT; TRANSMISSION; AGENT	Estimating the percentages of undiagnosed and asymptomatic patients is essential for controlling the outbreak of SARS-CoV-2, and for assessing any strategy for controlling the disease. In this paper, we propose a novel analysis based on the birth-death process with recursive full tracing. We estimated the numbers of undiagnosed symptomatic patients and the lower bound of the number of total infected individuals per diagnosed patient before and after the declaration of the state of emergency in Hokkaido, Japan. The median of the estimated number of undiagnosed symptomatic patients per diagnosed patient decreased from 1.7 to 0.77 after the declaration, and the median of the estimated lower bound of the number of total infected individuals per diagnosed patient decreased from 4.2 to 2.4. We will discuss the limitations and possible expansions of the model.	[Tanaka, Takuma] Shiga Univ, Grad Sch Data Sci, Hikone, Shiga, Japan; [Tanaka, Takuma; Yamaguchi, Takayuki] Shiga Univ, Ctr Data Sci Educ & Res, Hikone, Shiga, Japan; [Sakamoto, Yohei] Jikei Univ, Grad Sch Med, Sch Med, Minato Ku, Tokyo, Japan	Shiga University; Shiga University; Jikei University	Tanaka, T (corresponding author), Shiga Univ, Grad Sch Data Sci, Hikone, Shiga, Japan.; Tanaka, T (corresponding author), Shiga Univ, Ctr Data Sci Educ & Res, Hikone, Shiga, Japan.	takuma.tanaka@gmail.com		Tanaka, Takuma/0000-0003-1898-8064	JSPS KAKENHI [JP19K19429]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TY: JSPS KAKENHI Grant Number JP19K19429 https://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetzhanov AR, 2020, ESTIMATION ACTUAL IN; [Anonymous], THE JAPAN TIMES; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Ball FG, 2015, MATH BIOSCI, V266, P23, DOI 10.1016/j.mbs.2015.05.007; Ball FG, 2011, ADV APPL PROBAB, V43, P1048, DOI 10.1239/aap/1324045698; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eurosurveillance editorial team, 2020, Euro Surveill, V25, DOI [10.2807/1560-7917.ES.2020.25.12.2003261, 10.2807/1560-7917.ES.2020.25.10.2003121]; Hokkaido Government, SIT COVID 19 HOKK PR; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; Klinkenberg D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000012; Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167; Kupferschmidt K., SCIENCE; Kwok KO, 2019, COMPUT STRUCT BIOTEC, V17, P186, DOI 10.1016/j.csbj.2019.01.003; Li CY, 2020, EMERG INFECT DIS, V26, P1626, DOI 10.3201/eid2607.200718; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Muller J, 2007, MATH POPUL STUD, V14, P211, DOI 10.1080/08898480701612857; Muller J, 2016, MATH BIOSCI, V282, P204, DOI 10.1016/j.mbs.2016.10.010; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Muller J, 2003, J APPL PROBAB, V40, P980, DOI 10.1239/jap/1067436095; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Okolie A, 2020, MATH BIOSCI, V321, DOI 10.1016/j.mbs.2020.108320; Pan J, 2020, EFFECTIVENESS CONTRO, DOI [10.1101/2020.02.19.20025387, DOI 10.1101/2020.02.19.20025387]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Saurabh S, 2017, AFR HEALTH SCI, V17, P225, DOI 10.4314/ahs.v17i1.28; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241170	10.1371/journal.pone.0241170	http://dx.doi.org/10.1371/journal.pone.0241170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112895	Green Published, Green Submitted, gold			2022-12-26	WOS:000588374000030
J	Kung, CP; Cottrell, KA; Ryu, S; Bramel, ER; Kladney, RD; Bao, EA; Freeman, EC; Sabloak, T; Maggi, L; Weber, JD				Kung, Che-Pei; Cottrell, Kyle A.; Ryu, Sua; Bramel, Emily R.; Kladney, Raleigh D.; Bao, Emily A.; Freeman, Eric C.; Sabloak, Thwisha; Maggi Jr., Leonard; Weber, Jason D.			Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer	ONCOGENE			English	Article							GENOMIC LANDSCAPE; RNA; INTERFERON; STRESS; SUPPRESSES; EXPRESSION; DIVERSITY; APOPTOSIS	Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer. Unlike other types of breast cancer that can be effectively treated by targeted therapies, no such targeted therapy exists for all TNBC patients. The ADAR1 enzyme carries out A-to-I editing of RNA to prevent sensing of endogenous double-stranded RNAs. ADAR1 is highly expressed in breast cancer including TNBC. Here, we demonstrate that expression of ADAR1, specifically its p150 isoform, is required for the survival of TNBC cell lines. In TNBC cells, knockdown of ADAR1 attenuates proliferation and tumorigenesis. Moreover, ADAR1 knockdown leads to robust translational repression. ADAR1-dependent TNBC cell lines also exhibit elevated IFN stimulated gene expression. IFNAR1 reduction significantly rescued the proliferative defects of ADAR1 loss. These findings establish ADAR1 as a novel therapeutic target for TNBC tumors.	[Kung, Che-Pei; Cottrell, Kyle A.; Ryu, Sua; Bramel, Emily R.; Kladney, Raleigh D.; Bao, Emily A.; Freeman, Eric C.; Sabloak, Thwisha; Maggi Jr., Leonard; Weber, Jason D.] Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; [Weber, Jason D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Weber, JD (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.; Weber, JD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Siteman Canc Ctr, St Louis, MO 63110 USA.	jweber@wustl.edu	Kung, Che-Pei/I-6276-2019	Kung, Che-Pei/0000-0002-1150-4998; Weber, Jason/0000-0002-1069-6983; Bramel, Emily/0000-0003-2593-2579; Maggi, Leonard/0000-0003-0138-0984	National Institute of Health [R01CA190986, F32GM131514, TL1TR002344]; Department of Defense [W81XWH-18-1-0025]; Longer Life Foundation: A RGA/Washington University partnership	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Longer Life Foundation: A RGA/Washington University partnership	This work was supported by R01CA190986 (JDW), F32GM131514 (KAC), and TL1TR002344 (C-PK) from the National Institute of Health, and W81XWH-18-1-0025 from the Department of Defense (JDW). This work was supported by the Longer Life Foundation: A RGA/Washington University partnership. We thank Kazuko Nishikura (The Wistar Institute) for providing ADAR1 expressing constructs. The results shown here are in whole or part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.	Ademuyiwa F, 2017, BREAST CANCER RES TR, V161, P491, DOI 10.1007/s10549-016-4062-y; Anantharaman A, 2017, FEBS LETT, V591, P2890, DOI 10.1002/1873-3468.12795; Anders Carey K, 2016, Am Soc Clin Oncol Educ Book, V35, P34, DOI 10.14694/EDBK_159135; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Binothman N, 2017, EBIOMEDICINE, V21, P65, DOI 10.1016/j.ebiom.2017.06.023; Brenot A, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0042-x; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dave B, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw292; Doherty MR, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1136-x; Doherty MR, 2017, P NATL ACAD SCI USA, V114, P13792, DOI 10.1073/pnas.1713728114; Forys JT, 2014, CELL REP, V7, P514, DOI 10.1016/j.celrep.2014.03.026; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gannon HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07824-4; Garrido-Castro AC, 2019, CANCER DISCOV, V9, P176, DOI 10.1158/2159-8290.CD-18-1177; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holcik M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00264; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Kung CP, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00762; Lan Q, 2019, ONCOGENE, V38, P2814, DOI 10.1038/s41388-018-0624-2; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li Y, 2017, ELIFE, V6, DOI [10.7554/eLife.29914, 10.7554/eLife.25687]; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu HY, 2019, NAT MED, V25, P95, DOI 10.1038/s41591-018-0302-5; Liu HY, 2017, DEV CELL, V41, P392, DOI 10.1016/j.devcel.2017.04.024; Lo PK, 2018, ELIFE, V7, DOI 10.7554/eLife.31334; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; McFarland JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06916-5; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Nakano M, 2017, J BIOL CHEM, V292, P4873, DOI 10.1074/jbc.M117.775684; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng XX, 2018, CANCER CELL, V33, P817, DOI 10.1016/j.ccell.2018.03.026; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pujantell M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13580-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagredo EA, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0185-4; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Shigeyasu K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99976; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; SILVERMAN RH, 1983, J VIROL, V46, P1051, DOI 10.1128/JVI.46.3.1051-1055.1983; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Song In Hye, 2017, Tumour Biol, V39, p1010428317734816, DOI 10.1177/1010428317734816; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200	52	16	17	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					189	202		10.1038/s41388-020-01515-5	http://dx.doi.org/10.1038/s41388-020-01515-5		OCT 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33110236	Green Accepted			2022-12-26	WOS:000582768100002
J	Li, HW; Zhao, LX; Lau, YS; Zhang, C; Han, RZ				Li, Haiwen; Zhao, Lixia; Lau, Yeh Siang; Zhang, Chen; Han, Renzhi			Genome-wide CRISPR screen identifies LGALS2 as an oxidative stress-responsive gene with an inhibitory function on colon tumor growth	ONCOGENE			English	Article							MOUSE MODEL; CANCER; COLITIS; INACTIVATION; INFLAMMATION; GALECTINS; TISSUE; ROLES; STAT3; ROS	Colorectal cancer is the third leading cause of cancer-related deaths in the United States and the third most common cancer in men and women. Around 20% colon cancer cases are closely linked with colitis. Both environmental and genetic factors are thought to contribute to colon inflammation and tumor development. However, the genetic factors regulating colitis and colon tumorigenesis remain elusive. Since reactive oxygen species (ROS) is vitally involved in tissue inflammation and tumorigenesis, here we employed a genome-wide CRISPR knockout screening approach to systemically identify the genetic factors involved in the regulation of oxidative stress. Next generation sequencing (NGS) showed that over 600 gRNAs including the ones targeting LGALS2 were highly enriched in cells survived after sublethal H2O2 challenge. LGALS2 encodes the glycan-binding protein Galectin 2 (Gal2), which is predominantly expressed in the gastrointestinal tract and downregulated in human colon tumors. To examine the role of Gal2 in colitis, we employed the dextran sodium sulfate (DSS)-induced acute colitis model in mice with (WT) or without Lgals2 (Gal2-KO) and showed that Gal2 deficiency ameliorated DSS-induced colitis. We further demonstrated that Gal2-KO mice developed significantly larger tumors than WT mice using Azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colorectal cancer model. We found that STAT3 phosphorylation was significantly increased in Gal2-deficient tumors as compared to those in WT mice. Gal2 overexpression decreased the proliferation of human colon tumor epithelial cells and blunted H2O2-induced STAT3 phosphorylation. Overall, our results demonstrate that Gal2 plays a suppressive role in colon tumor growth and highlights the therapeutic potential of Gal2 in colon cancer.	[Li, Haiwen; Zhao, Lixia; Lau, Yeh Siang; Zhang, Chen; Han, Renzhi] Ohio State Univ, Wexner Med Ctr, Biophys Grad Program, Davis Heart & Lung Res Inst,Biomed Sci Grad Progr, Columbus, OH 43210 USA; [Lau, Yeh Siang] Sunway Univ, Sch Healthcare & Med Sci, Bandar Sunway 47500, Selangor, Malaysia	University System of Ohio; Ohio State University; Sunway University	Han, RZ (corresponding author), Ohio State Univ, Wexner Med Ctr, Biophys Grad Program, Davis Heart & Lung Res Inst,Biomed Sci Grad Progr, Columbus, OH 43210 USA.	renzhi.han@osumc.edu		Han, Renzhi/0000-0002-8202-9186	US National Institutes of Health [R01 HL116546]; Parent Project Muscular Dystrophy award	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy award	RH is supported by US National Institutes of Health Grant (R01 HL116546) and a Parent Project Muscular Dystrophy award. We thank Dr Chao Liu for assistance in bioinformatic analysis.	Akoumianakis I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5055; Aran D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01027-z; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Blaser H, 2016, TRENDS CELL BIOL, V26, P249, DOI 10.1016/j.tcb.2015.12.002; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; COOPER HS, 1993, LAB INVEST, V69, P238; Diniz TC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/171756; Dubreuil MM, 2020, CELL REP, V30, P1417, DOI 10.1016/j.celrep.2020.01.013; Fang BL, 2014, CANCERS, V6, P494, DOI 10.3390/cancers6010494; Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Guo JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007982; Han J, 2018, CELL REP, V23, P596, DOI 10.1016/j.celrep.2018.03.045; Hokama A, 2008, WORLD J GASTROENTERO, V14, P5133, DOI 10.3748/wjg.14.5133; Houessinon A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0526-2; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Jung JH, 2012, J GASTROENTEROL, V47, P37, DOI 10.1007/s00535-011-0463-1; Kalthoff S, 2010, J BIOL CHEM, V285, P5993, DOI 10.1074/jbc.M109.075770; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Kim SW, 2013, CELL ONCOL, V36, P169, DOI 10.1007/s13402-013-0124-x; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; Langbein S, 2007, HISTOPATHOLOGY, V51, P681, DOI 10.1111/j.1365-2559.2007.02852.x; Li HW, 2019, FASEB J, V33, P2928, DOI 10.1096/fj.201801173R; Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; Orsolic N, 2014, EUR J NUTR, V53, P1217, DOI 10.1007/s00394-013-0622-7; Paclik D, 2008, J MOL MED, V86, P1395, DOI 10.1007/s00109-007-0290-2; Park RJ, 2017, NAT GENET, V49, P193, DOI 10.1038/ng.3741; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Prasad S, 2017, CANCER LETT, V387, P95, DOI 10.1016/j.canlet.2016.03.042; Sakakura M, 2018, FEBS J, V285, P1129, DOI 10.1111/febs.14397; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen YJ, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1137.1137; Srivastava J, 2016, MOL CARCINOGEN, V55, P1889, DOI 10.1002/mc.22438; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Takaishi S, 2007, CANCER SCI, V98, P284, DOI 10.1111/j.1349-7006.2007.00392.x; Tamura M, 2016, J BIOCHEM, V160, P233, DOI 10.1093/jb/mvw029; Tamura M, 2015, BIOCHEM BIOPH RES CO, V457, P712, DOI 10.1016/j.bbrc.2015.01.055; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tong Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034959; Xu J, 2018, J PATHOL CLIN RES, V4, P135, DOI 10.1002/cjp2.92; Xu J, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0069-z; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yildirim C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124347; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965	52	14	14	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					177	188		10.1038/s41388-020-01523-5	http://dx.doi.org/10.1038/s41388-020-01523-5		OCT 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33110234	hybrid, Green Published			2022-12-26	WOS:000582768100005
J	Doukyu, N; Ishikawa, M				Doukyu, Noriyuki; Ishikawa, Makoto			Cholesterol oxidase from Rhodococcus erythropolis with high specificity toward beta-cholestanol and pytosterols	PLOS ONE			English	Article							ORGANIC-SOLVENT; SEQUENCE-ANALYSIS; EXPRESSION; PURIFICATION; PEROXIDATION; CLONING	Two genes (choRI and choRII) encoding cholesterol oxidases belonging to the vanillyl-alcohol oxidase (VAO) family were cloned on the basis of putative cholesterol oxidase gene sequences in the genome sequence data of Rhodococcus erythropolis PR4. The genes corresponding to the mature enzymes were cloned in a pET vector and expressed in Escherichia coli. The two cholesterol oxidases produced from the recombinant E. coli were purified to examine their properties. The amino acid sequence of ChoRI showed significant similarity (57%) to that of ChoRII. ChoRII was more stable than ChoRI in terms of pH and thermal stability. The substrate specificities of these enzymes differed distinctively from one another. Interestingly, the activities of ChoRII toward beta-cholestanol, beta-sitosterol, and stigmasterol were 2.4-, 2.1-, and 1.7-fold higher, respectively, than those of cholesterol. No cholesterol oxidases with high activity toward these sterols have been reported so far. The cholesterol oxidation products from these two enzymes also differed. ChoRI and ChoRII oxidized cholesterol to form cholest-4-en-3-one and 6 beta-hydroperoxycholest-4-en-3-one, respectively.	[Doukyu, Noriyuki] Toyo Univ, Dept Life Sci, Itakura Machi, Gunma, Japan; [Doukyu, Noriyuki; Ishikawa, Makoto] Toyo Univ, Grad Sch Life Sci, Itakura Machi, Gunma, Japan; [Doukyu, Noriyuki] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University; Toyo University; Toyo University	Doukyu, N (corresponding author), Toyo Univ, Dept Life Sci, Itakura Machi, Gunma, Japan.; Doukyu, N (corresponding author), Toyo Univ, Grad Sch Life Sci, Itakura Machi, Gunma, Japan.; Doukyu, N (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.	doukyu@toyo.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [S1101017]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (https://www.mext.go.jp/en/index.htm).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono R, 1996, BIOSCI BIOTECH BIOCH, V60, P1146; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; ARIMA K, 1969, AGR BIOL CHEM TOKYO, V33, P1636, DOI 10.1080/00021369.1969.10859516; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cho HJ, 1995, APPL MICROBIOL BIOT, V44, P133, DOI 10.1007/BF00164492; DANG HS, 1990, J CHEM SOC PERK T 1, P789, DOI 10.1039/p19900000789; DIETH S, 1995, TETRAHEDRON LETT, V36, P2243, DOI 10.1016/0040-4039(95)00235-5; Doukyu N, 1998, APPL ENVIRON MICROB, V64, P1929; Doukyu N, 1999, BIOCHEM J, V341, P621, DOI 10.1042/0264-6021:3410621; Doukyu N, 2001, APPL MICROBIOL BIOT, V57, P146, DOI 10.1007/s002530100753; Doukyu N, 2008, APPL MICROBIOL BIOT, V80, P59, DOI 10.1007/s00253-008-1526-y; Doukyu N, 2015, J BIOSCI BIOENG, V120, P24, DOI 10.1016/j.jbiosc.2014.12.003; Doukyu N, 2009, APPL MICROBIOL BIOT, V82, P479, DOI 10.1007/s00253-008-1775-9; Hamada T, 2008, J BIOSCI BIOENG, V106, P357, DOI 10.1263/jbb.106.357; KAZANDJIAN RZ, 1986, BIOTECHNOL BIOENG, V28, P417, DOI 10.1002/bit.260280315; Klink M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073333; KomukaiNakamura S, 1996, J FERMENT BIOENG, V82, P570, DOI 10.1016/S0922-338X(97)81254-8; MacLachlan J, 2000, J STEROID BIOCHEM, V72, P169, DOI 10.1016/S0960-0760(00)00044-3; Mathieu JM, 2012, BIOTECHNOL BIOENG, V109, P2409, DOI 10.1002/bit.24506; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Paniangvait P, 1995, J FOOD SCI, V60, P1159, DOI 10.1111/j.1365-2621.1995.tb04548.x; Piubelli L, 2008, J BIOL CHEM, V283, P24738, DOI 10.1074/jbc.M802321200; Puglielli L, 2005, J CLIN INVEST, V115, P2556, DOI 10.1172/JCI23610; PURCELL JP, 1993, BIOCHEM BIOPH RES CO, V196, P1406, DOI 10.1006/bbrc.1993.2409; Sagermann M, 2010, J STRUCT BIOL, V170, P32, DOI 10.1016/j.jsb.2010.01.012; Seyama Yousuke, 2003, Journal of Medicinal Food, V6, P217, DOI 10.1089/10966200360716634; SMITH AG, 1974, J CHROMATOGR, V101, P373, DOI 10.1016/S0021-9673(00)82854-X; Teng JI, 1996, STEROIDS, V61, P627, DOI 10.1016/S0039-128X(96)00135-3; Urai M, 2007, CARBOHYD RES, V342, P927, DOI 10.1016/j.carres.2007.02.002; UWAJIMA T, 1974, AGR BIOL CHEM TOKYO, V38, P1149, DOI 10.1080/00021369.1974.10861299; van der Geize R, 2000, APPL ENVIRON MICROB, V66, P2029, DOI 10.1128/AEM.66.5.2029-2036.2000; Xue P, 2006, APPL MICROBIOL BIOT, V71, P824, DOI 10.1007/s00253-005-0204-6	32	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241126	10.1371/journal.pone.0241126	http://dx.doi.org/10.1371/journal.pone.0241126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104755	Green Published, gold			2022-12-26	WOS:000588370000008
J	Cheikhi, AM; Johnson, ZI; Julian, DR; Wheeler, S; Feghali-Bostwick, C; Conley, YP; Lyons-Weiler, J; Yates, CC				Cheikhi, Amin M.; Johnson, Zariel, I; Julian, Dana R.; Wheeler, Sarah; Feghali-Bostwick, Carol; Conley, Yvette P.; Lyons-Weiler, James; Yates, Cecelia C.			Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; DERMAL FIBROBLASTS; CLINICAL-FEATURES; SKIN-DISEASE; CHEMOKINE; DIFFUSE; RECEPTOR; ASSOCIATION; MATRIX-METALLOPROTEINASE-9; METALLOPROTEINASES	Fibrosis is a chronic disease with heterogeneous clinical presentation, rate of progression, and occurrence of comorbidities. Systemic sclerosis (scleroderma, SSc) is a rare rheumatic autoimmune disease that encompasses several aspects of fibrosis, including highly variable fibrotic manifestation and rate of progression. The development of effective treatments is limited by these variabilities. The fibrotic response is characterized by both chronic inflammation and extracellular remodeling. Therefore, there is a need for improved understanding of which inflammation-related genes contribute to the ongoing turnover of extracellular matrix that accompanies disease. We have developed a multi-tiered method using Naive Bayes modeling that is capable of predicting level of disease and clinical assessment of patients based on expression of a curated 60-gene panel that profiles inflammation and extracellular matrix production in the fibrotic disease state. Our novel modeling design, incorporating global and parametric-based methods, was highly accurate in distinguishing between severity groups, highlighting the importance of these genes in disease. We refined this gene set to a 12-gene index that can accurately identify SSc patient disease state subsets and informs knowledge of the central regulatory pathways in disease progression.	[Cheikhi, Amin M.; Johnson, Zariel, I; Julian, Dana R.; Conley, Yvette P.; Yates, Cecelia C.] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Julian, Dana R.; Yates, Cecelia C.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Wheeler, Sarah; Yates, Cecelia C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Feghali-Bostwick, Carol] Med Univ South Carolina, Dept Rheumatol & Immunol, Charleston, SC 29425 USA; [Lyons-Weiler, James] Univ Pittsburgh, Genom & Prote Core Labs, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yates, CC (corresponding author), McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.; Yates, CC (corresponding author), Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA.; Yates, CC (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA.	cey4@pitt.edu		Conley, Yvette/0000-0002-1784-6067; Yates, Cecelia/0000-0002-8240-7773; Wheeler, Sarah/0000-0002-7851-9836	University of Pittsburgh School of Nursing; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [5R01AR068317]	University of Pittsburgh School of Nursing; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by University of Pittsburgh School of Nursing in the form of funding for CCY and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health in the form of a grant awarded to CCY (5R01AR068317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Akcora BO, 2018, BBA-MOL BASIS DIS, V1864, P804, DOI 10.1016/j.bbadis.2017.12.001; Altorok N, 2015, ANN RHEUM DIS, V74, P1612, DOI 10.1136/annrheumdis-2014-205303; [Anonymous], 2016, FORTUNE, V15, pF29; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; [Anonymous], 2017, LANCET HIV, V2, pe115; Antonelli A, 2012, J RHEUMATOL, V39, P979, DOI 10.3899/jrheum.111132; Arai M, 2013, J DERMATOL SCI, V69, P250, DOI 10.1016/j.jdermsci.2012.10.010; Basha O, 2018, NUCLEIC ACIDS RES, V46, pD522, DOI 10.1093/nar/gkx981; BOLSTER MB, 1993, BAILLIERE CLIN RHEUM, V7, P79, DOI 10.1016/S0950-3579(05)80269-9; Castellone Maria D, 2017, Front Biosci (Schol Ed), V9, P31; Nguyen CTH, 2018, ALLERGOL INT, V67, P487, DOI 10.1016/j.alit.2018.02.011; da C F Pinto Pedro Henrique, 2016, Surg Neurol Int, V7, pS785; Ding J, 2014, WOUND REPAIR REGEN, V22, P622, DOI 10.1111/wrr.12208; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Farina G, 2010, ARTHRITIS RHEUM-US, V62, P580, DOI 10.1002/art.27220; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Guan CY, 2019, EXP CELL RES, V378, P182, DOI 10.1016/j.yexcr.2019.03.018; Hasegawa M, 2013, MOD RHEUMATOL, V23, P1076, DOI [10.1007/s10165-012-0795-6, 10.3109/s10165-012-0795-6]; Hasegawa M, 2011, CLIN RHEUMATOL, V30, P231, DOI 10.1007/s10067-010-1610-4; Hesselstrand R, 2002, CLIN EXP RHEUMATOL, V20, P301; Hesselstrand R, 2012, RHEUMATOLOGY, V51, P915, DOI 10.1093/rheumatology/ker442; Hocking AM, 2015, ADV WOUND CARE, V4, P623, DOI 10.1089/wound.2014.0579; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Jiang H, 2006, STAT APPL GENET MOL, V5; Johnson ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114017; Jordan R, 2008, CANCER INFORM, V6, P389; Kim WU, 2005, ARTHRITIS RES THER, V7, pR71, DOI 10.1186/ar1454; Kodera M, 2005, J RHEUMATOL, V32, P629; Koren YC, 2003, IEEE S INF 2003 OCT; Kuroda K, 1997, ARCH DERMATOL RES, V289, P567, DOI 10.1007/s004030050241; Lafyatis R, 2014, NAT REV RHEUMATOL, V10, P706, DOI 10.1038/nrrheum.2014.137; Lakota K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3827; Leask A, 2015, SEMIN IMMUNOPATHOL, V37, P559, DOI 10.1007/s00281-015-0508-2; Lindahl GE, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-80; James LW, 2005, CANCER INFORM, V1, P53; Mendoza FA, 2016, EXPERT OPIN ORPHAN D, V4, P31, DOI 10.1517/21678707.2016.1114454; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Morelli S, 1997, J RHEUMATOL, V24, P81; Mullenbrock S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120588; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ostojic P, 2006, CLIN RHEUMATOL, V25, P453, DOI 10.1007/s10067-005-0041-0; Otteby KE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4410; Patel Satish, 2004, Appl Bioinformatics, V3, P49; Perez-Bocanegra C, 2010, RHEUMATOLOGY, V49, P1112, DOI 10.1093/rheumatology/keq046; Rabquer BJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3242; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Ramos IT, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.007453; Rice LM, 2015, ARTHRITIS RHEUMATOL, V67, P3004, DOI 10.1002/art.39287; Robert S, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160107; Rodriguez LR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21889-7; Ruzehaji N, 2016, ANN RHEUM DIS, V75, P2175, DOI 10.1136/annrheumdis-2015-208029; Sargent JL, 2016, ARTHRITIS RHEUMATOL, V68, P2003, DOI 10.1002/art.39658; Sargent JL, 2010, J INVEST DERMATOL, V130, P694, DOI 10.1038/jid.2009.318; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Su YJ, 2015, ADV WOUND CARE, V4, P631, DOI 10.1089/wound.2014.0559; Sun YH, 2019, CURR MED SCI, V39, P645, DOI 10.1007/s11596-019-2086-3; Svegliati S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004592; Toba H, 2017, AM J PHYSIOL-HEART C, V312, pH375, DOI 10.1152/ajpheart.00633.2016; Tokuda A, 2000, J IMMUNOL, V164, P2745, DOI 10.4049/jimmunol.164.5.2745; Tomimura S, 2008, J DERMATOL SCI, V52, P47, DOI 10.1016/j.jdermsci.2008.04.013; Toubi E, 2002, CLIN EXP RHEUMATOL, V20, P221; Tsamardinos I, 2006, MACH LEARN, V65, P31, DOI 10.1007/s10994-006-6889-7; Wang HD, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13317; Wang L, 2018, EUR HEART J, V39, P1818, DOI 10.1093/eurheartj/ehy085; Wei J, 2012, ARTHRITIS RHEUM-US, V64, P2734, DOI 10.1002/art.34424; Wei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013778; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yanaba K, 2013, CLIN RHEUMATOL, V32, P43, DOI 10.1007/s10067-012-2089-y; Yang XB, 2011, AM J RESP CELL MOL, V45, P127, DOI 10.1165/rcmb.2010-0265OC; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; Yates CC, 2010, AM J PATHOL, V176, P1743, DOI 10.2353/ajpath.2010.090564; Yates-Binder CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040812; Zhao ST, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0067-8; Zhao X, 2019, NAT METAB, V1, P147, DOI 10.1038/s42255-018-0008-5	76	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240986	10.1371/journal.pone.0240986	http://dx.doi.org/10.1371/journal.pone.0240986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095822	Green Published, gold			2022-12-26	WOS:000586649400062
J	Leigh, JP; Fiest, K; Brundin-Mather, R; Plotnikoff, K; Soo, A; Sypes, EE; Whalen-Browne, L; Ahmed, SB; Burns, KEA; Fox-Robichaud, A; Kupsch, S; Longmore, S; Murthy, S; Niven, DJ; Rochwerg, B; Stelfox, HT				Leigh, Jeanna Parsons; Fiest, Kirsten; Brundin-Mather, Rebecca; Plotnikoff, Kara; Soo, Andrea; Sypes, Emma E.; Whalen-Browne, Liam; Ahmed, Sofia B.; Burns, Karen E. A.; Fox-Robichaud, Alison; Kupsch, Shelly; Longmore, Shelly; Murthy, Srinivas; Niven, Daniel J.; Rochwerg, Bram; Stelfox, Henry T.			A national cross-sectional survey of public perceptions of the COVID-19 pandemic: Self-reported beliefs, knowledge, and behaviors	PLOS ONE			English	Article							RISK PERCEPTION; INFORMATION; OUTBREAK; HEALTH; FEAR; SARS	Introduction Efforts to mitigate the global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing Corona Virus Disease-19 (COVID-19) have largely relied on broad compliance with public health recommendations yet navigating the high volume of evolving information can be challenging. We assessed self-reported public perceptions related to COVID-19 including, beliefs (e.g., severity, concerns, health), knowledge (e.g., transmission, information sources), and behaviors (e.g., physical distancing) to understand perspectives in Canada and to inform future public health initiatives. Methods We administered a national online survey aiming to obtain responses from 2000 adults in Canada. Respondent sampling was stratified by age, sex, and region. We used descriptive statistics to summarize responses and tested for regional differences using chi-squared tests, followed by weighted logistic regression. Results We collected 1,996 eligible questionnaires between April 26(th) and May 1(st), 2020. One-fifth (20%) of respondents knew someone diagnosed with COVID-19, but few had tested positive themselves (0.6%). Negative impacts of pandemic conditions were evidenced in several areas, including concerns about healthcare (e.g. sufficient equipment, 52%), pandemic stress (45%), and worsening social (49%) and mental/emotional (39%) health. Most respondents (88%) felt they had good to excellent knowledge of virus transmission, and predominantly accessed (74%) and trusted (60%) Canadian news television, newspapers/magazines, or non-government news websites for COVID-19 information. We found high compliance with distancing measures (80% reported self-isolating or always physical distancing). We identified associations between region and self-reported beliefs, knowledge, and behaviors related to COVID-19. Discussion We found that information about COVID-19 is largely acquired through domestic news sources, which may explain high self-reported compliance with prevention measures. The results highlight the broader impact of a pandemic on the general public's overall health and wellbeing, outside of personal infection. The study findings should be used to inform public health communications during COVID-19 and future pandemics.	[Leigh, Jeanna Parsons] Dalhousie Univ, Fac Hlth, Sch Hlth Adm, Halifax, NS, Canada; [Leigh, Jeanna Parsons; Fiest, Kirsten; Brundin-Mather, Rebecca; Plotnikoff, Kara; Soo, Andrea; Sypes, Emma E.; Whalen-Browne, Liam; Kupsch, Shelly; Longmore, Shelly; Niven, Daniel J.; Stelfox, Henry T.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Fiest, Kirsten; Niven, Daniel J.; Stelfox, Henry T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Fiest, Kirsten; Niven, Daniel J.; Stelfox, Henry T.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Ahmed, Sofia B.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ahmed, Sofia B.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Burns, Karen E. A.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Burns, Karen E. A.] St Michaels Hosp, Unity Hlth Toronto, Toronto, ON, Canada; [Burns, Karen E. A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Fox-Robichaud, Alison; Rochwerg, Bram] McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada; [Fox-Robichaud, Alison] Hamilton Hlth Sci, Hamilton, ON, Canada; [Murthy, Srinivas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Rochwerg, Bram] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada	Dalhousie University; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University; University of British Columbia; McMaster University	Leigh, JP (corresponding author), Dalhousie Univ, Fac Hlth, Sch Hlth Adm, Halifax, NS, Canada.; Leigh, JP (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	J.ParsonsLeigh@dal.ca	Parsons-Leigh, Jeanna/AAT-1642-2020	Fox-Robichaud, Alison/0000-0001-9912-3606; Murthy, Srinivas/0000-0002-9476-839X; Stelfox, Henry/0000-0003-1231-1490; Whalen-Browne, Liam/0000-0002-1335-9413; Plotnikoff, Kara/0000-0001-5293-388X	Canadian Institutes of Health Research Canadian 2019 Novel Coronavirus (COVID-2019) Rapid Research Funding Opportunity [RN420046-439965]; STFC [ST/R000484/1, ST/L00061X/1] Funding Source: UKRI	Canadian Institutes of Health Research Canadian 2019 Novel Coronavirus (COVID-2019) Rapid Research Funding Opportunity; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Canadian Institutes of Health Research Canadian 2019 Novel Coronavirus (COVID-2019) Rapid Research Funding Opportunity - Operating Grant (grant number RN420046-439965) to JPL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani AS, 2017, J INFECT PUBLIC HEAL, V10, P534, DOI 10.1016/j.jiph.2016.11.015; [Anonymous], 2004, SCRUTINY 2 ISSUES EN, V9, P19; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Bangerter A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049806; Bener A, 2004, J R SOC PROMO HEALTH, V124, P167, DOI 10.1177/146642400412400408; Betsch C, 2020, NAT HUM BEHAV, V4, P438, DOI 10.1038/s41562-020-0866-1; Braunack-Mayer AJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-501; Breton CT, 2020, POLICY OPTIONS POLIT; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Research Insights Counci, 2019, COVID 19 PUBL OP RES; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; Gerwin LE, 2012, J LAW MED ETHICS, V40, P630, DOI 10.1111/j.1748-720X.2012.00695.x; Government of Canada, 2020, COR DIS COVID 19; Government of Canada, 2020, COVID 19 SNAPSH MON; Government of Canada, 2020, INF PREV CONTR COVID; Gruzd A., 2020, INOCULATING INFODEMI; Hagerty Sarah L, 2020, Brain Behav Immun Health, V5, P100078, DOI 10.1016/j.bbih.2020.100078; Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479; Henrich N, 2011, HEALTH PROMOT PRACT, V12, P610, DOI 10.1177/1524839910363536; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Keller TR G, 2020, CONVERSATION; Kelvin DJ, 2020, J INFECT DEV COUNTR, V14, P1, DOI 10.3855/jidc.12496; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Lohiniva AL, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.13.2000317; Marshall GS, 2013, S D MED, P52; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469; Mykhalovskiy E, 2006, CAN J PUBLIC HEALTH, V97, P42, DOI 10.1007/BF03405213; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; R Core Team, 2020, R LANG ENV STAT COMP; Reintjes R, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0151258, 10.1371/journal.pone.0]; Rochwerg Bram, 2020, Crit Care Explor, V2, pe0098, DOI 10.1097/CCE.0000000000000098; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Statistics Canada, 2017, CENS PROF 2016; Thielking M, 2020, STAT NEWS; van der Weerd W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-575; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; WHO, 2020, NOV COR CHIN DIS OUT; World Health Organization, 2020, SURV TOOL GUID RAP S; World Health Organization, 2020, ARCH WHO TIM COVID 1; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	52	43	43	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241259	10.1371/journal.pone.0241259	http://dx.doi.org/10.1371/journal.pone.0241259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095836	Green Published, gold			2022-12-26	WOS:000586649400024
J	Radcliffe, RA; Dowell, R; Odell, AT; Richmond, PA; Bennett, B; Larson, C; Kechris, K; Saba, LM; Rudra, P; Wen, S				Radcliffe, Richard A.; Dowell, Robin; Odell, Aaron T.; Richmond, Phillip A.; Bennett, Beth; Larson, Colin; Kechris, Katerina; Saba, Laura M.; Rudra, Pratyaydipta; Wen, Shi			Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance	PLOS ONE			English	Article							ACUTE FUNCTIONAL TOLERANCE; ALCOHOL-INTOXICATION; ACTIN CYTOSKELETON; MYELIN-DEFICIENT; CONNECTIVITY MAP; FRONTAL-CORTEX; RNA-SEQ; EXPRESSION; GENES; SENSITIVITY	We have been using the Inbred Long- and Short-Sleep mouse strains (ILS, ISS) and a recombinant inbred panel derived from them, the LXS, to investigate the genetic underpinnings of acute ethanol tolerance which is considered to be a risk factor for alcohol use disorders (AUDs). Here, we have used RNA-seq to examine the transcriptome of whole brain in 40 of the LXS strains 8 hours after a saline or ethanol "pretreatment" as in previous behavioral studies. Approximately 1/3 of the 14,184 expressed genes were significantly heritable and many were unique to the pretreatment. Several thousand cis- and trans-eQTLs were mapped; a portion of these also were unique to pretreatment. Ethanol pretreatment caused differential expression (DE) of 1,230 genes. Gene Ontology (GO) enrichment analysis suggested involvement in numerous biological processes including astrocyte differentiation, histone acetylation, mRNA splicing, and neuron projection development. Genetic correlation analysis identified hundreds of genes that were correlated to the behaviors. GO analysis indicated that these genes are involved in gene expression, chromosome organization, and protein transport, among others. The expression profiles of the DE genes and genes correlated to AFT in the ethanol pretreatment group (AFT-Et) were found to be similar to profiles of HDAC inhibitors. Hdac1, a cis-regulated gene that is located at the peak of a previously mapped QTL for AFT-Et, was correlated to 437 genes, most of which were also correlated to AFT-Et. GO analysis of these genes identified several enriched biological process terms including neuron-neuron synaptic transmission and potassium transport. In summary, the results suggest widespread genetic effects on gene expression, including effects that are pretreatment-specific. A number of candidate genes and biological functions were identified that could be mediating the behavioral responses. The most prominent of these was Hdac1 which may be regulating genes associated with glutamatergic signaling and potassium conductance.	[Radcliffe, Richard A.; Bennett, Beth; Larson, Colin; Saba, Laura M.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA; [Radcliffe, Richard A.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Dowell, Robin; Odell, Aaron T.; Richmond, Phillip A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Dowell, Robin] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO USA; [Dowell, Robin] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Kechris, Katerina; Wen, Shi] Univ Colorado, Dept Biostat & Informat, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Rudra, Pratyaydipta] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Oklahoma State University System; Oklahoma State University - Stillwater	Radcliffe, RA (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.; Radcliffe, RA (corresponding author), Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA.	richard.radcliffe@cuanschutz.edu	Rudra, Pratyaydipta/AAG-9607-2020; Saba, Laura/R-9533-2018	RICHMOND, PHILLIP/0000-0003-1882-6014; DOWELL, ROBIN/0000-0001-7665-9985; Rudra, Pratyaydipta/0000-0002-1089-7283; Saba, Laura/0000-0001-9649-1294	National Institute of Alcohol Abuse and Alcoholism [R01AA021131, R01AA016957, R24AA013162]; National Institute of Drug Abuse [P30DA044223]	National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	RAR: R01AA016957; National Institute of Alcohol Abuse and Alcoholism; https://www.niaaa.nih.gov/LMS, KK: P30DA044223; National Institute of Drug Abuse; https://www.drugabuse.gov/LMS: R24AA013162; National Institute of Alcohol Abuse and Alcoholism; https://www.niaaa.nih.gov/KK: R01AA021131; National Institute of Alcohol Abuse and Alcoholism; https://www.niaaa.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2016, LANCET ONCOL, V17, pe198; Baker JA, 2017, ALCOHOL, V58, P139, DOI 10.1016/j.alcohol.2016.08.008; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Belknap JK, 2001, MAMM GENOME, V12, P893, DOI 10.1007/s00335-001-2074-2; Bell RL, 2009, PHARMACOL BIOCHEM BE, V94, P131, DOI 10.1016/j.pbb.2009.07.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett B, 2006, GENES BRAIN BEHAV, V5, P404, DOI 10.1111/j.1601-183X.2005.00174.x; Bennett B, 2015, ALCOHOL CLIN EXP RES, V39, P611, DOI 10.1111/acer.12678; Bujarski S, 2015, ALCOHOL CLIN EXP RES, V39, P1193, DOI 10.1111/acer.12737; Campagnoni A, 2001, BRAIN PATHOL, V11, P74; Chen WY, 2019, ALCOHOL, V78, P79, DOI 10.1016/j.alcohol.2019.02.005; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; Crews FT, 2016, PHARMACOL REV, V68, P1074, DOI 10.1124/pr.115.012138; Cromer JR, 2010, EXP CLIN PSYCHOPHARM, V18, P329, DOI 10.1037/a0019591; de Bruin NMWJ, 2013, BEHAV BRAIN RES, V236, P157, DOI 10.1016/j.bbr.2012.08.048; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DOOLITTLE DP, 1977, J HERED, V68, P331, DOI 10.1093/oxfordjournals.jhered.a108850; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Erwin VG, 1996, J PHARMACOL EXP THER, V279, P1310; Farris SP, 2015, MOL PSYCHIATR, V20, P1438, DOI 10.1038/mp.2014.159; Fillmore MT, 2012, PSYCHOL ADDICT BEHAV, V26, P693, DOI 10.1037/a0026110; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Hines Lisa M, 2005, Dialogues Clin Neurosci, V7, P153; Hu W, 2008, J PHARMACOL EXP THER, V326, P792, DOI 10.1124/jpet.108.137521; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INAGAWA K, 1988, BEHAV NEURAL BIOL, V50, P184, DOI 10.1016/S0163-1047(88)90871-0; Iwamoto K, 2004, NEUROSCI RES, V49, P379, DOI 10.1016/j.neures.2004.04.002; Kamens HM, 2012, ALCOHOL, V46, P463, DOI 10.1016/j.alcohol.2012.03.001; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koenig L, 2020, ADDICT BIOL, V25, DOI 10.1111/adb.12758; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewohl JM, 2000, ALCOHOL CLIN EXP RES, V24, P1873, DOI 10.1111/j.1530-0277.2000.tb01993.x; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Liu JW, 2007, ALCOHOL CLIN EXP RES, V31, P1460, DOI 10.1111/j.1530-0277.2007.00444.x; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu FX, 2018, EXP NEUROL, V299, P65, DOI 10.1016/j.expneurol.2017.10.005; MacLaren R, 2019, NEUROSCIENCE, V398, P206, DOI 10.1016/j.neuroscience.2018.11.048; Martinez-Lopez MJ, 2005, MOL CELL NEUROSCI, V28, P599, DOI 10.1016/j.mcn.2004.09.016; Matosin N, 2018, BIOL PSYCHIAT, V83, P821, DOI 10.1016/j.biopsych.2018.01.021; Mayfield RD, 2002, J NEUROCHEM, V81, P802, DOI 10.1046/j.1471-4159.2002.00860.x; MCCLEARN GE, 1973, BEHAV GENET, V3, P409; MCCLEARN GE, 1981, DEV ANIMAL MODELS PH, P147; McClearn GE, 1962, P 3 INT C ALC ROAD T; McClintick JN, 2013, ALCOHOL, V47, P505, DOI 10.1016/j.alcohol.2013.07.002; Melendez RI, 2012, ADDICT BIOL, V17, P351, DOI 10.1111/j.1369-1600.2011.00357.x; Mellanby E., 1919, SPECIAL REPORT SERIE, V31, P3; Morud J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181084; Mulligan MK, 2017, ALCOHOL, V58, P61, DOI 10.1016/j.alcohol.2016.09.001; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; O'Brien MA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00402; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Padula AE, 2015, NEUROPSYCHOPHARMACOL, V40, P1928, DOI 10.1038/npp.2015.42; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Ponomarev I, 2004, ALCOHOL CLIN EXP RES, V28, P991, DOI 10.1097/01.ALC.0000131978.79857.5E; Ponomarev I, 2002, J PHARMACOL EXP THER, V302, P257, DOI 10.1124/jpet.302.1.257; Ponomarev I, 2017, ALCOHOL, V60, P95, DOI 10.1016/j.alcohol.2017.01.016; Ponomarev I, 2013, ALCOHOL RES-CURR REV, V35, P69; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Radcliffe RA, 2005, ALCOHOL CLIN EXP RES, V29, p90A, DOI 10.1097/01.alc.0000179208.05882.1f; Radcliffe RA, 2006, PHARMACOL BIOCHEM BE, V84, P524, DOI 10.1016/j.pbb.2006.06.018; Radcliffe RA, 2013, ALCOHOL CLIN EXP RES, V37, P2019, DOI 10.1111/acer.12188; Rietschel M, 2013, ANN NY ACAD SCI, V1282, P39, DOI 10.1111/j.1749-6632.2012.06794.x; Rinker JA, 2017, ALCOHOL, V58, P33, DOI 10.1016/j.alcohol.2016.05.007; Rosenbloom MJ, 2008, ALCOHOL RES HEALTH, V31, P362; Rothenfluh A, 2013, CURR OPIN NEUROBIOL, V23, P507, DOI 10.1016/j.conb.2013.01.027; Rudra P, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1539-6; Saba LM, 2011, NEUROPHARMACOLOGY, V60, P1269, DOI 10.1016/j.neuropharm.2010.12.019; SCHUCKIT MA, 1980, J STUD ALCOHOL, V41, P242, DOI 10.15288/jsa.1980.41.242; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Smith ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146257; Sokolov BP, 2003, J NEUROSCI RES, V72, P756, DOI 10.1002/jnr.10631; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; van der Vaart AD, 2017, ALCOHOL, V58, P93, DOI 10.1016/j.alcohol.2016.07.010; Wang F, 2020, NAT NEUROSCI, V23, P481, DOI 10.1038/s41593-020-0588-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnault V, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.4; Wilhelm CJ, 2014, NEUROSCIENCE, V279, P168, DOI 10.1016/j.neuroscience.2014.08.041; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100; Xiang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134907; Zhang DL, 2016, J PHARMACOL EXP THER, V358, P31, DOI 10.1124/jpet.116.232231; Zhou ZF, 2013, P NATL ACAD SCI USA, V110, P16963, DOI 10.1073/pnas.1309839110; Ziebarth JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031805	97	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240253	10.1371/journal.pone.0240253	http://dx.doi.org/10.1371/journal.pone.0240253			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095786	gold, Green Published			2022-12-26	WOS:000586649400043
J	Spatz, ES; Bernheim, SM; Horwitz, LI; Herrin, J				Spatz, Erica S.; Bernheim, Susannah M.; Horwitz, Leora, I; Herrin, Jeph			Community factors and hospital wide readmission rates: Does context matter?	PLOS ONE			English	Article							LOW SOCIOECONOMIC-STATUS; HEALTH; RISK; ASSOCIATION; OUTCOMES	Background The environment in which a patient lives influences their health outcomes. However, the degree to which community factors are associated with readmissions is uncertain. Objective To estimate the influence of community factors on the Centers for Medicare & Medicaid Services risk-standardized hospital-wide readmission measure (HWR)-a quality performance measure in the U.S. Research design We assessed 71 community variables in 6 domains related to health outcomes: clinical care; health behaviors; social and economic factors; the physical environment; demographics; and social capital. Subjects Medicare fee-for-service patients eligible for the HWR measure between July 2014-June 2015 (n = 6,790,723). Patients were linked to community variables using their 5-digit zip code of residence. Methods We used a random forest algorithm to rank variables for their importance in predicting HWR scores. Variables were entered into 6 domain-specific multivariable regression models in order of decreasing importance. Variables with P-values <0.10 were retained for a final model, after eliminating any that were collinear. Results Among 71 community variables, 19 were retained in the 6 domain models and in the final model. Domains which explained the most to least variance in HWR were: physical environment (R-2 = 15%); clinical care (R-2 = 12%); demographics (R-2 = 11%); social and economic environment (R-2 = 7%); health behaviors (R-2 = 9%); and social capital (R-2 = 8%). In the final model, the 19 variables explained more than a quarter of the variance in readmission rates (R-2 = 27%). Conclusions Readmissions for a wide range of clinical conditions are influenced by factors relating to the communities in which patients reside. These findings can be used to target efforts to keep patients out of the hospital.	[Spatz, Erica S.; Herrin, Jeph] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Spatz, Erica S.; Bernheim, Susannah M.] Yale Yale New Haven Hlth Ctr Outcomes Res & Evalu, New Haven, CT 06510 USA; [Bernheim, Susannah M.] Yale Sch Med, Div Med, New Haven, CT USA; [Horwitz, Leora, I] NYU Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Horwitz, Leora, I] NYU, Ctr Healthcare Innovat & Delivery Sci, Grossman Sch Med New York, New York, NY USA; [Horwitz, Leora, I] NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY USA	Yale University; Yale University; New York University; New York University; New York University	Spatz, ES (corresponding author), Yale Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Spatz, ES (corresponding author), Yale Yale New Haven Hlth Ctr Outcomes Res & Evalu, New Haven, CT 06510 USA.	Erica.spatz@yale.edu			Agency for Healthcare Research and Quality [1 R01 HS022882 01]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by a grant from the Agency for Healthcare Research and Quality, titled: Understanding Hospital Readmission Rates: Patient, Hospital and Community Effects, awarded to SMB, LIH, and JH (1 R01 HS022882 01).	Angraal S, 2018, AM J MED, V131, P1324, DOI 10.1016/j.amjmed.2018.06.013; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Area Health Resources Files (AHRF) 2013-2014, AREA HLTH RES FIL AH; Assari S, 2018, SOCIETIES, V8, DOI 10.3390/soc8020026; Assari S, 2018, SOC ISS POLICY REV, V12, P112, DOI 10.1111/sipr.12042; Assari S, 2018, J RACIAL ETHN HEALTH, V5, P375, DOI 10.1007/s40615-017-0381-x; Aswani MS, 2018, HEALTH SERV RES, V53, P4416, DOI 10.1111/1475-6773.13030; Berkowitz SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4273; Bradley EH, 2016, HEALTH AFFAIR, V35, P760, DOI 10.1377/hlthaff.2015.0814; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brewster AL, 2019, POPUL HEALTH MANAG, V22, P40, DOI 10.1089/pop.2018.0030; Brewster AL, 2018, HEALTH SERV RES, V53, P2892, DOI 10.1111/1475-6773.12775; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Damiani G, 2015, CLIN INTERV AGING, V10, P237, DOI 10.2147/CIA.S71165; Desai NR, 2016, JAMA-J AM MED ASSOC, V316, P2647, DOI 10.1001/jama.2016.18533; Fisher ES, 2014, JAMA-J AM MED ASSOC, V312, P2093, DOI 10.1001/jama.2014.13815; Fraze T, 2016, HEALTH AFFAIR, V35, P2109, DOI 10.1377/hlthaff.2016.0727; Gaskin DJ, 2018, MED CARE, V56, P934, DOI 10.1097/MLR.0000000000000988; Herrin J, 2015, HEALTH SERV RES, V50, P20, DOI 10.1111/1475-6773.12177; Horwitz LI, 2017, MED CARE, V55, P528, DOI 10.1097/MLR.0000000000000713; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Hsiao YL, 2018, J HEALTH ORGAN MANAG, V32, P638, DOI 10.1108/JHOM-09-2017-0228; Hu JH, 2018, AM J MED QUAL, V33, P493, DOI 10.1177/1062860617753063; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jung D, 2018, J AM GERIATR SOC, V66, P1158, DOI 10.1111/jgs.15366; Kangovi S, 2014, J GEN INTERN MED, V29, P283, DOI 10.1007/s11606-013-2571-5; Kangovi S, 2013, HEALTH AFFAIR, V32, P1196, DOI 10.1377/hlthaff.2012.0825; Kern LM, 2016, ANN INTERN MED, V164, P395, DOI 10.7326/M14-2633; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Krumholz HM, 2014, ANN INTERN MED, V161, P833, DOI 10.7326/M14-2308; McCarthy D, 2013, JAMA-J AM MED ASSOC, V309, P351, DOI 10.1001/jama.2013.1; Nagasako EM, 2014, HEALTH AFFAIR, V33, P786, DOI 10.1377/hlthaff.2013.1148; North Carolina Department of Health and Human Services (NCDHHS), MED EXP HLTH OPP PIL; Riley Wayne J, 2012, Trans Am Clin Climatol Assoc, V123, P167; Shahu A, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012277; Taylor M., PARTNERING LOCAL SNF; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Vest JR, 2015, J AM MED INFORM ASSN, V22, P435, DOI 10.1136/amiajnl-2014-002760; Villanueva C, 2013, J COMMUN HEALTH, V38, P690, DOI 10.1007/s10900-013-9666-0; Welsch R, 1980, REGRESSION DIAGNOSTI	40	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240222	10.1371/journal.pone.0240222	http://dx.doi.org/10.1371/journal.pone.0240222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ON4BV	33095775	Green Published, gold			2022-12-26	WOS:000586649400066
J	Liu, M; Li, DD; Hu, J; Liu, DY; Ma, ZL; Cheng, XY; Zhao, CZ; Liu, Q				Liu, Mei; Li, Dandan; Hu, Jun; Liu, Dongyan; Ma, Zhiliang; Cheng, Xinying; Zhao, Chunzhang; Liu, Qing			Altitudinal pattern of shrub biomass allocation in Southwest China	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; ABOVEGROUND BIOMASS; ENVIRONMENTAL-FACTORS; GLOBAL PATTERNS; ALPINE MEADOW; ROOT; GRASSLAND; PLANTS; WATER; DEGRADATION	Shrubs play an important role in the global carbon cycle and are particularly sensitive to climate change. However, the altitudinal pattern of biomass allocation in mountainous shrubs and its responses to climate change are still unclear. In this study, biomass accumulation and allocation of the shrub community and their relationships with climatic factors were investigated in 331 sampling sites along an extensive altitudinal gradient (311-4911 m) in Southwest China. The results showed that the above-ground biomass (AGB) and the total biomass (TB) of the shrub community decreased quadratically (R-2= 0.107) and linearly (R-2= 0.024) from 9.86 to 0.15 kg center dot m(-2)and 15.61 to 0.26 kg center dot m(-2)with increasing altitude, respectively. However, the below-ground biomass (BGB) and TB of the herb layer increased quadratically with increasing altitudes (R-2= 0.136 and 0.122, respectively.P<0.001). The root/shoot ratio (R/S) of the community and its component synusiae increased gradually with increasing altitudes (P<0.001). The standardized major axis (SMA) indicated an isometric relationship between AGB and BGB for the whole shrub community, but allometric relationships were found for the shrub and herb layer. Redundancy analysis and Pearson correlation analysis showed that the biomass and R/S were significantly correlated with mean annual temperature (MAT), mean annual precipitation (MAP) and reconnaissance drought index (RDI). These findings indicate that shrub biomass allocation is strongly affected by the altitude, MAT and MAP and support the isometric relationship of AGB and BGB partitioning at the community level on mountainous shrub biomes.	[Liu, Mei; Li, Dandan; Hu, Jun; Liu, Dongyan; Cheng, Xinying; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; [Liu, Mei; Li, Dandan; Hu, Jun; Liu, Dongyan; Cheng, Xinying; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China; [Liu, Mei] Sichuan Univ, Coll Life Sci, Chengdu, Peoples R China; [Liu, Mei] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Sichuan, Peoples R China; [Liu, Mei; Hu, Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Zhiliang] China West Normal Univ, Coll Life Sci, Nanchong, Peoples R China; [Zhao, Chunzhang] Chengdu Univ Technol, Inst Ecol Environm, Chengdu, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Mianyang Teachers' College; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China West Normal University; Chengdu University of Technology	Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.; Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China.; Zhao, CZ (corresponding author), Chengdu Univ Technol, Inst Ecol Environm, Chengdu, Peoples R China.	zhaochzh04@126.com; liuqing@cib.ac.cn	liu, dong/GRJ-9115-2022; Ma, Zhiliang/GXV-4296-2022		National Key R&D Program of China [2017YFC0505000]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA20020401, XDA5050300, XDA05050303]; National Science and Technology Basic Work Project [2015FY110300]; National Natural Science Foundation of China [31971637, 41930654]; west light foundation of the CAS [2017XBZG_XBQNXZ_B009]	National Key R&D Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Basic Work Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); west light foundation of the CAS(Chinese Academy of Sciences)	This work was supported by the National Key R&D Program of China (2017YFC0505000), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA20020401, XDA5050300, XDA05050303), the National Science and Technology Basic Work Project (2015FY110300), the National Natural Science Foundation of China (31971637,41930654), the west light foundation of the CAS (2017XBZG_XBQNXZ_B009).	[Anonymous], 2011, INT J GEOGRAPHICAL I, V25, P1737; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BRAY J. R., 1963, CANADIAN JOUR BOT, V41, P65, DOI 10.1139/b63-007; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chen QQ, 2013, CHINESE SCI BULL, V58, P1551, DOI 10.1007/s11434-012-5100-8; Chen YY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015921; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; CONNOLLYMCCARTHY BJ, 1985, FOREST SCI, V31, P1011; Ding Jianlin, 2014, Chinese Journal of Applied and Environmental Biology, V20, P254, DOI 10.3724/SP.J.1145.2014.00254; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Falster D.S., 2006, USERS GUIDE SMATR ST; FAO, 2000, 56 FAO; Gao Qiao, 2014, Chinese Journal of Plant Ecology, V38, P355, DOI 10.3724/SP.J.1258.2014.00032; Hu Hui-Feng, 2006, Zhiwu Shengtai Xuebao, V30, P539; Huaxun L, 1981, ACTA GEOGRAPHICA SIN, V36, P267; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Hutchings Michael J., 1997, P161, DOI 10.1016/B978-012083490-7/50008-6; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 1999, ALPINE PLANT LIFE FU, P1; Li QY, 2015, OBSERVATION INVESTIG; Li Y, 2008, J VEG SCI, V19, P245, DOI 10.3170/2007-8-18365; Lie ZY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28899-5; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Niu Cun-yang, 2013, Shengtaixue Zazhi, V32, P1980; Oksanen A, **DATA OBJECT**; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rastetter EB, 2004, BIOGEOCHEMISTRY, V69, P37, DOI 10.1023/B:BIOG.0000031035.52498.21; Reich PB, 2014, P NATL ACAD SCI USA, V111, P13721, DOI 10.1073/pnas.1216053111; Sa WJ, 2012, CHINESE SCI BULL, V57, P3573, DOI 10.1007/s11434-012-5287-8; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snyman HA, 2005, J ARID ENVIRON, V60, P457, DOI 10.1016/j.jaridenv.2004.06.006; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Tang XL, 2018, P NATL ACAD SCI USA, V115, P4021, DOI 10.1073/pnas.1700291115; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; Tsakiris G., 2005, EUROPEAN WATER, V9, P3; Vangelis H, 2013, J ARID ENVIRON, V88, P130, DOI 10.1016/j.jaridenv.2012.07.020; Wang D, 2017, EUR J SOIL SCI, V68, P212, DOI 10.1111/ejss.12414; [王娓 WANG Wei], 2008, [干旱区研究, Arid Zone Research], V25, P90, DOI 10.3724/SP.J.1148.2008.00090; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; WOODWARD FI, 1975, NEW PHYTOL, V74, P323, DOI 10.1111/j.1469-8137.1975.tb02620.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu ZY, 1995, CHINESE VEGETATION; Xie ZQ, 2019, STUDIES CARBON BUDGE; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang Y. P., 1992, SICHUAN FOREST; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x	61	2	2	9	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240861	10.1371/journal.pone.0240861	http://dx.doi.org/10.1371/journal.pone.0240861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091074	Green Published, gold			2022-12-26	WOS:000586647200070
J	Ong, JX; Kwan, CC; Cicinelli, MV; Fawzi, AA				Ong, Janice X.; Kwan, Changyow C.; Cicinelli, Maria V.; Fawzi, Amani A.			Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; RETINAL PLEXUSES; OCT ANGIOGRAPHY; QUANTIFICATION; CORRELATE; DENSITY	Purpose To identify objective optical coherence tomography angiography (OCTA) parameters that characterize the spectrum of non-proliferative diabetic retinopathy (NPDR), especially those that distinguish moderate from severe NPDR. Methods Sixty eyes of 60 patients with treatment-naive NPDR (mild: 21, moderate: 21, severe: 18), 23 eyes with diabetes and no retinopathy, and 24 healthy control eyes were enrolled. OCTA slabs were segmented into superficial (SCP), middle (MCP), and deep capillary plexus (DCP) and thresholded by a new method based on DCP skeletonized vessel length. The foveal avascular zone (FAZ) area, parafoveal vessel density (VD), and adjusted flow index (AFI) from all three capillary layers and the vessel length density (VLD) of the SCP were compared between each severity group, after adjusting for age and image quality. Results All vessel density markers decreased with increasing severity of NPDR. SCP VD and VLD demonstrated significant differences between eyes with diabetes with no retinopathy and mild NPDR (p= 0.001 andp< 0.001, respectively), as well as between moderate vs. severe NPDR (p= 0.004 andp= 0.009, respectively). MCP VD significantly decreased between moderate and severe NPDR (p= 0.01). AFI significantly increased in the SCP and showed a decreasing trend in the MCP and DCP with increasing NPDR severity. Conclusions Changes in the SCP VD, SCP VLD, and MCP VD can distinguish severe NPDR from lower-risk stages. SCP changes may be more reliable due to their lower susceptibility to noise and projection artifacts. Thresholding OCTA images based on DCP skeletonized vessel length showed less variability in moderate and severe NPDR. Additional studies are warranted to validate this new thresholding method.	[Ong, Janice X.; Kwan, Changyow C.; Cicinelli, Maria V.; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021; cicinelli, maria vittoria/M-1611-2019	fawzi, amani/0000-0002-9568-3558; cicinelli, maria vittoria/0000-0003-2938-0409	National Eye Institute [1R01EY030121-A1]; Illinois Society for the Prevention of Blindness	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Illinois Society for the Prevention of Blindness	Research in this publication was supported by the following two grants: (1) Funding from the National Eye Institute (https://www.nei.nih.gov/grants-and-training) received by author A. A.F. (1R01EY030121-A1). (2) Grant from the Illinois Society for the Prevention of Blindness (https://eyehealthillinois.org/research-grants/) received by author C.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optovue Inc. provided research instrument and technical support with no involvement in research funding, design, recruitment, or manuscript production.	Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; Aiello LM, 2003, AM J OPHTHALMOL, V136, P122, DOI 10.1016/S0002-9394(03)00219-8; Alam M, 2020, RETINA-J RET VIT DIS, V40, P322, DOI 10.1097/IAE.0000000000002373; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], 2015, UROLOGY PRACTICE, V2, P17; [Anonymous], 2017, LANCET HIV, V2, pe115; Ashraf M, 2018, INVEST OPHTH VIS SCI, V59, P4292, DOI 10.1167/iovs.18-24142; Bek T, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0909-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhanushali D, 2016, INVEST OPHTH VIS SCI, V57, pOCT519, DOI 10.1167/iovs.15-18901; Choi W, 2017, RETINA-J RET VIT DIS, V37, P11, DOI 10.1097/IAE.0000000000001250; Chu ZD, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.066008; Chun LY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223142; Durbin MK, 2017, JAMA OPHTHALMOL, V135, P370, DOI 10.1001/jamaophthalmol.2017.0080; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fawzi AA, 2017, JAMA OPHTHALMOL, V135, P377, DOI 10.1001/jamaophthalmol.2017.0149; Fayed AE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217109; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P1411, DOI 10.1001/jamaophthalmol.2016.4272; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Khadamy J, 2018, J OPHTHAL VIS RES, V13, P487, DOI 10.4103/jovr.jovr_57_18; Li L, 2019, ACTA OPHTHALMOL, V97, P240, DOI 10.1111/aos.14076; Mehta N, 2019, AM J OPHTHALMOL, V205, P54, DOI 10.1016/j.ajo.2019.03.008; Nentwich MM, 2015, WORLD J DIABETES, V6, P489, DOI 10.4239/wjd.v6.i3.489; Nesper PL, 2019, INVEST OPHTH VIS SCI, V60, P694, DOI 10.1167/iovs.18-25478; Nesper PL, 2017, INVEST OPHTH VIS SCI, V58, P307, DOI 10.1167/iovs.17-21787; Onishi AC, 2018, INVEST OPHTH VIS SCI, V59, P2167, DOI 10.1167/iovs.17-23304; Park JJ, 2016, RETINA-J RET VIT DIS, V36, P2039, DOI 10.1097/IAE.0000000000001077; Rosen RB, 2019, AM J OPHTHALMOL, V203, P103, DOI 10.1016/j.ajo.2019.01.012; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Samara WA, 2017, OPHTHALMOLOGY, V124, P235, DOI 10.1016/j.ophtha.2016.10.008; Samara WA, 2015, RETINA-J RET VIT DIS, V35, P2188, DOI 10.1097/IAE.0000000000000847; Sambhav K, 2017, EUR J OPHTHALMOL, V27, P716, DOI 10.5301/ejo.5000948; Shahlaee A, 2016, AM J OPHTHALMOL, V161, P50, DOI 10.1016/j.ajo.2015.09.026; Shen CY, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0778-2; SNMMI Newsline, 2016, J NUCL MED, V57, p19N; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Terheyden JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230260; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang M, 2016, INVEST OPHTH VIS SCI, V57, P5101, DOI 10.1167/iovs.16-19776	42	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240064	10.1371/journal.pone.0240064	http://dx.doi.org/10.1371/journal.pone.0240064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091032	Green Published, gold			2022-12-26	WOS:000586647200056
J	Yasuda, M; Sato, H; Hashimoto, K; Osada, U; Hariya, T; Nakayama, H; Asano, T; Suzuki, N; Okabe, T; Yamazaki, M; Uematsu, M; Munakata, M; Nakazawa, T				Yasuda, Masayuki; Sato, Hajime; Hashimoto, Kazuki; Osada, Urara; Hariya, Takehiro; Nakayama, Hiroko; Asano, Toshifumi; Suzuki, Noriyuki; Okabe, Tatsu; Yamazaki, Mai; Uematsu, Megumi; Munakata, Masanori; Nakazawa, Toru			Carotid artery intima-media thickness, HDL cholesterol levels, and gender associated with poor visual acuity in patients with branch retinal artery occlusion	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SEX-DIFFERENCES; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ESTROGEN-RECEPTOR; RISK-FACTORS; BLOOD-FLOW; 17-BETA-ESTRADIOL; ATHEROSCLEROSIS	Purpose To investigate factors associated with poor visual acuity (VA) in branch retinal artery occlusion (BRAO). Methods This was a retrospective cross-sectional study of 72 eyes with BRAO of 72 patients. For statistical comparison, we divided the patients into worse-VA (decimal VA < 0.5) and better-VA (decimal VA > = 0.5) groups. We examined the association of clinical findings, including blood biochemical test data and carotid artery ultrasound parameters, with poor VA. Results Median age, hematocrit, hemoglobin and high-density lipoprotein (HDL) differed significantly between the groups (P= 0.018,P< 0.01,P< 0.01, andP= 0.025). There was a tendency towards higher median IMT-Bmax in the worse-VA group (worse-VA vs. better-VA: 2.70 mm vs. 1.60 mm,P= 0.152). Spearman's rank correlation test revealed that logMAR VA was significantly correlated to IMT-Bmax (rs = 0.31,P< 0.01) and IMT-Cmax (rs = 0.24,P= 0.035). Furthermore, logMAR VA was significantly correlated to HDL level (rs = -0.33,P< 0.01). Multivariate logistic regression analysis revealed that IMT-Bmax (odds ratio [OR] = 2.70,P= 0.049), HDL level (OR = 0.91,P= 0.032), and female gender (OR = 15.63,P= 0.032) were independently associated with worse VA in BRAO. Conclusions We found that increased IMT-Bmax, decreased HDL, and female sex were associated with poor VA in BRAO patients. Our findings might suggest novel risk factors for visual dysfunction in BRAO and may provide new insights into the pathomechanisms underlying BRAO.	[Yasuda, Masayuki; Hashimoto, Kazuki; Osada, Urara; Hariya, Takehiro; Asano, Toshifumi; Suzuki, Noriyuki; Okabe, Tatsu; Yamazaki, Mai; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan; [Sato, Hajime] Yaotome Sato Hajime Eye Clin, Sendai, Miyagi, Japan; [Nakayama, Hiroko] JR Sendai Hosp, Dept Ophthalmol, Sendai, Miyagi, Japan; [Okabe, Tatsu; Uematsu, Megumi] Tohoku Rosai Hosp, Dept Ophthalmol, Sendai, Miyagi, Japan; [Yamazaki, Mai] Seiryo Eye Clin, Sendai, Miyagi, Japan; [Munakata, Masanori] Tohoku Rosai Hosp, Div Hypertens, Sendai, Miyagi, Japan; [Munakata, Masanori] Tohoku Rosai Hosp, Res Ctr Lifestyle Related Dis, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Dept Ophthalm Imaging & Informat Analyt, Grad Sch Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Dept Retinal Dis Control, Grad Sch Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Dept Ophthalm Imaging & Informat Analyt, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Dept Retinal Dis Control, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp			JST grants from JSPS KAKENHI [17H04349, 19K18831]	JST grants from JSPS KAKENHI	This paper was supported in part by JST grants from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 17H04349) and Grant-in-Aid for Early-Career Scientists (M.Y. 19K18831). The funding organization had no role in the design or conduct of this research.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Amarenco P, 2008, ATHEROSCLEROSIS, V196, P489, DOI 10.1016/j.atherosclerosis.2007.07.033; Andersen Morten Nonboe, 2005, J Stroke Cerebrovasc Dis, V14, P215, DOI 10.1016/j.jstrokecerebrovasdis.2005.06.002; [Anonymous], 2019, CIRCULATION, V2019; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Curb JD, 2004, AM J EPIDEMIOL, V160, P150, DOI 10.1093/aje/kwh177; Ebrahim S, 1999, STROKE, V30, P841, DOI 10.1161/01.STR.30.4.841; Forey BA, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-26; Gatti A, 2009, DIABETES CARE, V32, P1550, DOI 10.2337/dc09-0256; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Haast RAM, 2012, J CEREBR BLOOD F MET, V32, P2100, DOI 10.1038/jcbfm.2012.141; Hayreh SS, 2017, OPHTHALMOL RETINA, V1, P12, DOI 10.1016/j.oret.2016.08.003; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1928, DOI 10.1016/j.ophtha.2009.03.006; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1188, DOI 10.1016/j.ophtha.2009.01.015; He BM, 2013, J CELL BIOCHEM, V114, P2431, DOI 10.1002/jcb.24581; Hermann DM, 2012, ATHEROSCLEROSIS, V224, P84, DOI 10.1016/j.atherosclerosis.2012.06.019; Iglseder B, 2005, STROKE, V36, P1212, DOI 10.1161/01.STR.0000166196.31227.91; Inoue Kazuo, 2007, J Stroke Cerebrovasc Dis, V16, P14, DOI 10.1016/j.jstrokecerebrovasdis.2006.08.001; Kaja S, 2003, INVEST OPHTH VIS SCI, V44, P3155, DOI 10.1167/iovs.02-1204; Katakami N, 2018, J ATHEROSCLEROSIS TH, P43141; Konno S, 2016, INT J CARDIOL, V203, P874, DOI 10.1016/j.ijcard.2015.11.080; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Maeda K, 2013, J STROKE CEREBROVASC, V22, P1070, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.006; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Mason JO, 2008, AM J OPHTHALMOL, V146, P455, DOI 10.1016/j.ajo.2008.05.009; Mathiesen EB, 2011, STROKE, V42, P972, DOI 10.1161/STROKEAHA.110.589754; Morgantini C, 2011, DIABETES, V60, P2617, DOI 10.2337/db11-0378; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Morito N, 2008, J CARDIOL, V51, P25, DOI 10.1016/j.jjcc.2007.09.003; Munaut C, 2001, BRIT J OPHTHALMOL, V85, P877, DOI 10.1136/bjo.85.7.877; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Opremcak E, 2008, RETINA-J RET VIT DIS, V28, P226, DOI 10.1097/IAE.0b013e31814b1d6e; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Polak JF, 2016, GLOB HEART, V11, P295, DOI 10.1016/j.gheart.2016.08.006; R Core Team, 2020, R LANG ENV STAT COMP; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Richard G, 1999, OPHTHALMOLOGY, V106, P768, DOI 10.1016/S0161-6420(99)90165-3; Rina M, 2015, GRAEF ARCH CLIN EXP, V253, P2285, DOI 10.1007/s00417-015-3123-y; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Rosfors S, 1998, STROKE, V29, P1378, DOI 10.1161/01.STR.29.7.1378; Russo R, 2008, PROG BRAIN RES, V173, P583, DOI 10.1016/S0079-6123(08)01144-8; Saba L, 2012, ATHEROSCLEROSIS, V220, P294, DOI 10.1016/j.atherosclerosis.2011.08.048; Sawada H, 2000, FASEB J, V14, P1202, DOI 10.1096/fasebj.14.9.1202; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Sojkova J, 2010, STROKE, V41, P273, DOI 10.1161/STROKEAHA.109.566810; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Touboul PJ, 2005, STROKE, V36, P1741, DOI 10.1161/01.STR.0000174490.23495.57; Ueshima K, 2010, CIRC J, V74, P2132, DOI 10.1253/circj.CJ-10-0232; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Wang YQ, 2015, GRAEF ARCH CLIN EXP, V253, P17, DOI 10.1007/s00417-014-2657-8; Wei QQ, 2018, DRUG DES DEV THER, V12, P2715, DOI 10.2147/DDDT.S176349; Weiss JN, 2010, UNDERSEA HYPERBAR M, V37, P167; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Yu BL, 2010, IMMUNOL CELL BIOL, V88, P285, DOI 10.1038/icb.2009.112; Yuzurihara D, 2004, JPN J OPHTHALMOL, V48, P490, DOI 10.1007/s10384-004-0102-y; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240977	10.1371/journal.pone.0240977	http://dx.doi.org/10.1371/journal.pone.0240977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091078	Green Published, gold			2022-12-26	WOS:000586647200077
J	Johnson, SU; Ebrahimi, OV; Hoffart, A				Johnson, Sverre Urnes; Ebrahimi, Omid V.; Hoffart, Asle			PTSD symptoms among health workers and public service providers during the COVID-19 outbreak	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ACUTE RESPIRATORY SYNDROME; PSYCHOLOGICAL IMPACT; HOSPITAL WORKERS; RISK-FACTORS; TRAUMA; SARS	In the frontline of the pandemic stand healthcare workers and public service providers, occupations which have proven to be associated with increased mental health problems during pandemic crises. This cross-sectional, survey-based study collected data from 1773 healthcare workers and public service providers throughout Norway between March 31, 2020 and April 7, 2020, which encompasses a timeframe where all non-pharmacological interventions (NPIs) were held constant. Post-traumatic stress disorder (PTSD), anxiety and depression were assessed by the Norwegian version of the PTSD checklist (PCL-5), General Anxiety Disorder-7, and Patient Health Questionnaire-9 (PHQ- 9), respectively. Health anxiety and specific predictors were assessed with specific items. Multiple regression analysis was used for predictor analysis. A total of 28.9% of the sample had clinical or subclinical symptoms of PTSD, and 21.2% and 20.5% were above the established cut-offs for anxiety and depression. Those working directly in contrast to indirectly with COVID-19 patients had significantly higher PTSD symptoms. Worries about job and economy, negative metacognitions, burnout, health anxiety and emotional support were significantly associated with PTSD symptoms, after controlling for demographic variables and psychological symptoms. Health workers and public service providers are experiencing high levels of PTSD symptoms, anxiety and depression during the COVID-19 pandemic. Health workers working directly with COVID-19 patients have significantly higher levels of PTSD symptoms and depression compared to those working indirectly. Appropriate action to monitor and reduce PTSD, anxiety, and depression among these groups of individuals working in the frontline of pandemic with crucial societal roles should be taken immediately.	[Johnson, Sverre Urnes; Ebrahimi, Omid V.; Hoffart, Asle] Univ Oslo, Dept Psychol, Oslo, Norway; [Johnson, Sverre Urnes; Ebrahimi, Omid V.; Hoffart, Asle] Modum Bad Psychiat Hosp, Vikersund, Norway	University of Oslo	Johnson, SU (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.; Johnson, SU (corresponding author), Modum Bad Psychiat Hosp, Vikersund, Norway.	s.u.johnson@psykologi.uio.no		Ebrahimi, Omid V./0000-0002-8335-2217				[Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0914-4, DOI 10.1038/S41591-020-0914-432367062]; Ardino V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.3402/ejpt.v4i0.21382; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Cohen J.E., 1988, STAT POWER ANAL BEHA; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Ebrahimi OV, 2020, MENTAL HLTH IMPACT N, DOI [10.31234/osf.io/kjzsp, DOI 10.31234/OSF.IO/KJZSP]; Elham Essa B, 2016, J CROHNS COLITIS, V10, DOI 10.3855/jidc.6925; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gold JA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1815; Goldstein RB, 2016, SOC PSYCH PSYCH EPID, V51, P1137, DOI 10.1007/s00127-016-1208-5; Goulia P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-322; Heir T, 2019, BJPSYCH OPEN, V5, DOI 10.1192/bjo.2019.62; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hocking, 2013, METHODS APPL LINEAR; Hoffart A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.589127; Holmes EA, LANCET PSYCHIAT, DOI [10.1016/S2215-0366(20)30168-1, DOI 10.1016/S2215-0366(20)30168-132304649]; Horowitz L. M., 2000, INVENTORY INTERPERSO; Johnson M. S., 2020, PARENTING PAND UNPUB; Johnson SU, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01713; Jung H, 2020, WORKPLACE HEALTH SAF, V68, P337, DOI 10.1177/2165079919897693; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim Woojin, 2019, J Prev Med Public Health, V52, P345, DOI 10.3961/jpmph.19.116; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Markowitz JC, 2009, J PSYCHIATR PRACT, V15, P133, DOI 10.1097/01.pra.0000348366.34419.28; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; McLaughlin KA, 2015, BIOL PSYCHIAT, V77, P375, DOI 10.1016/j.biopsych.2014.03.028; Mealer M, 2009, DEPRESS ANXIETY, V26, P1118, DOI 10.1002/da.20631; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Nordahl H, 2019, INT J COGN THER, V12, P292, DOI 10.1007/s41811-019-00056-4; Roscoe J. T., 1975, FUNDAMENTAL RES STAT; Roussis P, 2008, ANXIETY STRESS COPIN, V21, P213, DOI 10.1080/10615800801889600; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; SPSS I, 2019, IBM SPSS STAT MAC OS; Statistisk sentralbyra, 2020, HELS SOS PERS 2020; Takarangi MKT, 2017, CLIN PSYCHOL SCI, V5, P131, DOI 10.1177/2167702616649348; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; van Ameringen M, 2008, CNS NEUROSCI THER, V14, P171, DOI 10.1111/j.1755-5949.2008.00049.x; Wells A., 2009, METACOGNITIVE THERAP; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504	48	102	103	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241032	10.1371/journal.pone.0241032	http://dx.doi.org/10.1371/journal.pone.0241032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085716	Green Published, Green Submitted, gold			2022-12-26	WOS:000585943400046
J	Minguet, EG				Minguet, Eugenio Gomez			Ares-GT: Design of guide RNAs targeting multiple genes for CRISPR-Cas experiments	PLOS ONE			English	Article							TOOL	Guide RNA design for CRISPR genome editing of gene families is a challenging task as usually good candidate sgRNAs are tagged with low scores precisely because they match several locations in the genome, thus time-consuming manual evaluation of targets is required. To address this issues, I have developed ARES-GT, a Python local command line tool compatible with any operative system. ARES-GT allows the selection of candidate sgRNAs that match multiple input query sequences, in addition of candidate sgRNAs that specifically match each query sequence. It also contemplates the use of unmapped contigs apart from complete genomes thus allowing the use of any genome provided by user and being able to handle intraspecies allelic variability and individual polymorphisms. ARES-GT is available at GitHub (https://github.com/eugomin/ARES-GT.git).				mingueteg@gmail.com						Aliaga-Franco N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01150; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2016, NUCL ACIDS RES, V44, pD7; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Gan X, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.167, 10.1038/nplants.2016.167]; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiao W-B, 2019, BIORXIV, P738880, DOI [10.1101/738880, DOI 10.1101/738880]; Keough KC, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1783-3; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Liu H, 2017, MOL PLANT, V10, P530, DOI 10.1016/j.molp.2017.01.003; Bernabe-Orts JM, 2019, PLANT BIOTECHNOL J, V17, P1971, DOI 10.1111/pbi.13113; Pliatsika V, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0035-z; Swarts DC, 2017, MOL CELL, V66, P221, DOI 10.1016/j.molcel.2017.03.016; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	24	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241001	10.1371/journal.pone.0241001	http://dx.doi.org/10.1371/journal.pone.0241001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085710	Green Submitted, gold, Green Published			2022-12-26	WOS:000585943400006
J	Xie, MH; Zhong, YZ; Lin, LL; Zhang, GL; Su, WH; Ni, WL; Qu, MJ; Chen, HL				Xie, Minghui; Zhong, Yongzhi; Lin, Lulu; Zhang, Guangling; Su, Weihua; Ni, Wanli; Qu, Mingjing; Chen, Haoliang			Evaluation of reference genes for quantitative real-time PCR normalization in the scarab beetleHolotrichia oblita	PLOS ONE			English	Article							ENDOGENOUS REFERENCE GENES; TRIBOLIUM-CASTANEUM; EXPRESSION ANALYSIS; BETA-ACTIN; RT-QPCR; SELECTION; IDENTIFICATION; VALIDATION; RNA; FALDERMANN	Quantitative real-time polymerase chain reaction (qPT-PCR) is commonly used to analyze gene expression, however, the accuracy of the normalized results is affected by the expression stability of reference genes.Holotrichia oblita(Coleoptera: Scarabaeidae) causes serious damage to crops. Reliable reference genes inH.oblitaare needed for qRT-PCR analysis. Therefore, we evaluated 13 reference genes under biotic and abiotic conditions. RefFinder provided a comprehensive stability ranking, and geNorm suggested the optimal number of reference genes for normalization.RPL13aandRPL18were the most suitable reference genes for developmental stages, tissues, and temperature treatments;RPL13aandRPS3were the most suitable for pesticide and photoperiod treatments;RPS18andRPL18were the most suitable for the two sexes. We validated the normalized results using odorant-binding protein genes as target genes in different tissues. Compared with the selected suitable reference genes, the expression ofOBP1in antennae, abdomen, and wings, andOBP2in antennae and wings were overestimated due to the instability ofACTb. These results identified several reliable reference genes inH.oblitafor normalization, and are valuable for future molecular studies.	[Xie, Minghui; Zhong, Yongzhi; Lin, Lulu; Zhang, Guangling; Su, Weihua; Chen, Haoliang] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China; [Ni, Wanli] Anhui Acad Agr Sci, Crop Res Inst, Hefei, Anhui, Peoples R China; [Qu, Mingjing] Shandong Peanut Res Inst, Qingdao, Shandong, Peoples R China	Anhui Academy of Agricultural Sciences; Anhui Academy of Agricultural Sciences	Chen, HL (corresponding author), Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China.	chenhaoliang@aaas.org.cn		Chen, Haoliang/0000-0002-8997-3129; xie, minghui/0000-0002-6443-9608	National Key Research and Development Program of China [2018YFD0201009]; Anhui Provincial Natural Science Foundation [1908085QC137]; Anhui Technical System of Wheat Industry [AHCYTX-02]	National Key Research and Development Program of China; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Technical System of Wheat Industry	This research was funded by the National Key Research and Development Program of China (No. 2018YFD0201009), Anhui Provincial Natural Science Foundation (No. 1908085QC137), and Anhui Technical System of Wheat Industry (Grant No. AHCYTX-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174210; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen HL, 2019, J KANSAS ENTOMOL SOC, V92, P376, DOI 10.2317/0022-8567-92.1.376; Chen HL, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev070; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Gao ZH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221420; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guo W, 2017, J ECON ENTOMOL, V110, P41, DOI 10.1093/jee/tow241; Huang LK, 2014, GENE, V553, P158, DOI 10.1016/j.gene.2014.10.017; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jiang HC, 2015, INT J MOL SCI, V16, P21591, DOI 10.3390/ijms160921591; Kosakyan A, 2019, SCI REP, V9, P1, DOI 10.1038/s41598-018-37186-2; Lauber MA, 2009, J PROTEOME RES, V8, P4193, DOI 10.1021/pr801114k; LI KB, 2017, ENV INNOVATION SOC T, V0024, P00001, DOI DOI 10.1016/J.CBD.2017.07.001; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Li Wei-Zheng, 2009, Acta Ecologica Sinica, V29, P293; Liang C, 2019, J ASIA-PAC ENTOMOL, V22, P1115, DOI 10.1016/j.aspen.2019.07.011; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Lu ZC, 2014, FLA ENTOMOL, V97, P597, DOI 10.1653/024.097.0235; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Nonis A, 2014, ANAL BIOANAL CHEM, V406, P3533, DOI 10.1007/s00216-014-7687-x; Paim Rafaela M., 2012, BMC Research Notes, V5, DOI 10.1186/1756-0500-5-128; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Sang W, 2015, ENVIRON ENTOMOL, V44, P418, DOI 10.1093/ee/nvv010; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Shakeel M, 2018, BIOTECHNOL LETT, V40, P227, DOI 10.1007/s10529-017-2465-4; Shakeel M, 2015, J ASIA-PAC ENTOMOL, V18, P123, DOI 10.1016/j.aspen.2015.01.001; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stephan L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211172; Su YL, 2013, J ECON ENTOMOL, V106, P1446, DOI 10.1603/EC12459; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Tan QQ, 2015, BREASTFEED MED, V10, pe0118693, DOI 10.1371/journal.pone.0118693; Toutges MJ, 2010, J AGR FOOD CHEM, V58, P8948, DOI 10.1021/jf101603j; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084795; Wang CQ, 2019, INT J BIOL MACROMOL, V136, P359, DOI 10.1016/j.ijbiomac.2019.06.013; Wang YH, 2014, J CONSTR STEEL RES, V94, P1, DOI 10.1016/j.jcsr.2013.11.004; Wei H., 1989, UNDERGROUND PESTS CH; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yin J, 2019, INSECT BIOCHEM MOLEC, V104, P11, DOI 10.1016/j.ibmb.2018.11.002; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhang ZP, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020124; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhou SM, 2018, FISH SHELLFISH IMMUN, V81, P338, DOI 10.1016/j.fsi.2018.07.021	56	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240972	10.1371/journal.pone.0240972	http://dx.doi.org/10.1371/journal.pone.0240972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085726	Green Published, gold			2022-12-26	WOS:000585943400034
J	Makurumidze, R; Buyze, J; Decroo, T; Lynen, L; de Rooij, M; Mataranyika, T; Sithole, N; Takarinda, KC; Apollo, T; Hakim, J; Van Damme, W; Rusakaniko, S				Makurumidze, Richard; Buyze, Jozefien; Decroo, Tom; Lynen, Lutgarde; de Rooij, Madelon; Mataranyika, Trevor; Sithole, Ngwarai; Takarinda, Kudakwashe C.; Apollo, Tsitsi; Hakim, James; Van Damme, Wim; Rusakaniko, Simbarashe			Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe	PLOS ONE			English	Article							UNIVERSAL TEST; INTERVENTIONS; ADHERENCE; CARE; ADOLESCENTS; OUTCOMES; LINKAGE; ADULTS	Background Since the scale-up of the HIV "Treat All" recommendation, evidence on its real-world effect on predictors of attrition (either death or lost to follow-up) is lacking. We conducted a retrospective study using Zimbabwe ART program data to assess the association between "Treat All" and, patient-mix, programmatic characteristics, retention and predictors of attrition. Methods We used patient-level data from the electronic patient monitoring system (ePMS) from the nine districts, which piloted the "Treat All" recommendation. We compared patient-mix, programme characteristics, retention and predictors of attrition (lost to follow-up, death or stopping ART) in two cohorts; before (April/May 2016) and after (January/February 2017) "Treat All". Retention was estimated using survival analysis. Predictors of attrition were determined using a multivariable Cox regression model. Interactions were used to assess the change in predictors of attrition before and after "Treat All". Results We analysed 3787 patients, 1738 (45.9%) and 2049 (54.1%) started ART before and after "Treat All", respectively. The proportion of men was higher after "Treat All" (39.4.% vs 36.2%, p = 0.044). Same-day ART initiation was more frequent after "Treat All" (43.2% vs 16.4%; p<0.001) than before. Retention on ART was higher before "Treat All" (p<0.001). Among non-pregnant women and men, the adjusted hazard ratio (aHR) of attrition after compared to before "Treat All" was 1.73 (95%CI: 1.30-2.31). The observed hazard of attrition for women being pregnant at ART initiation decreased by 17% (aHR: 1.73*0.48 = 0.83) after "Treat All". Being male (vs female; aHR: 1.45; 95%CI: 1.12-1.87) and WHO Stage IV (vs WHO Stage I-III; aHR: 2.89; 95%CI: 1.16-7.11) predicted attrition both before and after "Treat All" implementation. Conclusion Attrition was higher after "Treat All"; being male, WHO Stage 4, and pregnancy predicted attrition in both before and after Treat All. However, pregnancy became a less strong risk factor for attrition after "Treat All" implementation.	[Makurumidze, Richard; de Rooij, Madelon; Hakim, James; Rusakaniko, Simbarashe] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Makurumidze, Richard; Buyze, Jozefien; Decroo, Tom; Lynen, Lutgarde; Van Damme, Wim] Inst Trop Med, Antwerp, Belgium; [Makurumidze, Richard; Van Damme, Wim] Free Univ Brussels VUB, Fac Med & Pharm, Gerontol, Brussels, Belgium; [Decroo, Tom] Res Fdn Flanders, Brussels, Belgium; [Mataranyika, Trevor; Sithole, Ngwarai; Takarinda, Kudakwashe C.; Apollo, Tsitsi] Minist Hlth & Child Care, AIDS & TB Unit, Harare, Zimbabwe; [Takarinda, Kudakwashe C.] Int Union TB & Lung Dis, Paris, France	University of Zimbabwe; Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel	Makurumidze, R (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe.; Makurumidze, R (corresponding author), Inst Trop Med, Antwerp, Belgium.; Makurumidze, R (corresponding author), Free Univ Brussels VUB, Fac Med & Pharm, Gerontol, Brussels, Belgium.	rmakurumidze@ext.itg.be	Van Damme, Wim/F-7404-2011; Decroo, Tom/AAV-7208-2020; Lynen, Lutgarde/A-1212-2014; Makurumidze, Richard/AAC-9621-2021; Lynen, Lutgarde/AAT-9180-2020	Van Damme, Wim/0000-0002-6344-3007; Decroo, Tom/0000-0002-1205-1484; Lynen, Lutgarde/0000-0001-7183-4895; Makurumidze, Richard/0000-0001-6490-1818; Lynen, Lutgarde/0000-0001-7183-4895	Institute of Tropical Medicine - Belgian Development Cooperation (DGD)	Institute of Tropical Medicine - Belgian Development Cooperation (DGD)	Richard Makurumidze receives a PhD scholarship grant from the Institute of Tropical Medicine, funded by the Belgian Development Cooperation (DGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaj M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25239; [Anonymous], 2017, JAP CLASS ES CANC, V14, P1, DOI [DOI 10.1007/s10388-016-0551-7, DOI 10.1093/GERONT/GNY014]; Brazier E, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25331; Brown LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210126; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chanda BC, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2142-1; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Chihana ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207656; de Jong J, 2013, MED TEACH, V35, pE1181, DOI 10.3109/0142159X.2013.797570; Dorward J, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25479; Girum T, 2020, AIDS RES THER, V17, DOI 10.1186/s12981-020-00274-3; Havlir D, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25455; Hirasen K, 2020, THER CLIN RISK MANAG, V16, P169, DOI 10.2147/TCRM.S227290; Kabogo Joseph, 2018, BMC Res Notes, V11, P134, DOI 10.1186/s13104-018-3205-0; Kerschberger B, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25458; Kerschberger B, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25401; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Labhardt ND, 2018, JAMA-J AM MED ASSOC, V319, P1103, DOI 10.1001/jama.2018.1818; Lilian RR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227572; MacPherson P, 2015, TROP MED INT HEALTH, V20, P1015, DOI 10.1111/tmi.12517; Mahachi N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25321; Makurumidze R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222309; Makurumidze Richard, 2017, 19 INT C AIDS STIS A; Ministry of Health and Child Care (MoHCC), 2019, 2019 NAT HIV EST; Ministry of Health and Child Care (MOHCC) Zimbabwe, 2019, ZIMB POP BAS HIV IMP; MoHCC, 2017, OP SERV DEL MAN PREV; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Perriat D, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25048; Rosen S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002912; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Ross J, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25279; Schwitters AM, 2017, MORBIDITY MORTALITY; Shaw S, 2016, JAIDS-J ACQ IMM DEF, V72, P387, DOI 10.1097/QAI.0000000000000977; Sibanda Euphemia, 2018, C RETROVIRUSES OPPOR; Simms V, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002360; Stafford KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218555; StataCorp, 2019, STAT REL 16 STAT SOF; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tymejczyk O, 2019, J INFECT DIS, V10027, P1, DOI [10.1093/infdis/jiz547, DOI 10.1093/INFDIS/JIZ54731682261]; Tymejczyk O, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002822; UN Joint Programme on HIV/AIDS (UNAIDS), 2020, GLOB AIDS UPD; United Nations Joint Programme on HIV/ AIDS, 2014, 90 90 90 AMB TREATM; United States of America President's Emergency Plan for AIDS Relief (PEPFAR), 2019, COUNTR OP PLAN 2019, P80; Vrazo AC, 2018, TROP MED INT HEALTH, V23, P136, DOI 10.1111/tmi.13014; Willis N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6447-4; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240865	10.1371/journal.pone.0240865	http://dx.doi.org/10.1371/journal.pone.0240865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075094	Green Published, gold, Green Submitted			2022-12-26	WOS:000585920200023
J	Vollherbst, DF; Gebhart, P; Kargus, S; Burger, A; Kuhle, R; Gunther, P; Hoffmann, J; Bendszus, M; Mohlenbruch, MA				Vollherbst, Dominik F.; Gebhart, Philipp; Kargus, Steffen; Burger, Astrid; Kuehle, Reinald; Guenther, Patrick; Hoffmann, Juergen; Bendszus, Martin; Moehlenbruch, Markus A.			Image-guided percutaneous sclerotherapy of venous malformations of the head and neck: Clinical and MR-based volumetric mid-term outcome	PLOS ONE			English	Article							COMPLICATIONS; DIAGNOSIS; CLASSIFICATION; FOAM	Objective To report the clinical and MRI-based volumetric mid-term outcome after image guided percutaneous sclerotherapy (PS) of venous malformations (VM) of the head and neck. Methods A retrospective analysis of a prospectively maintained database was performed, including patients with VM of the head and neck who were treated with PS. Only patients with available pre- and post-interventional MRI were included into this study. Clinical outcome, which was subjectively assessed by the patients, their parents (for paediatric patients) and/or the physicians, was categorized as worse, unchanged, minor or major improvement. Radiological outcome, determined by MRI-based volumetric measurements, was categorized as worse (>10% increase), unchanged (<= 10% increase to <10% decrease), minor (>= 10% to <25% decrease), intermediate (>= 25% to <50% decrease) or major improvement (>= 50% decrease). Results Twenty-seven patients were treated in 51 treatment sessions. After a mean follow-up of 31 months, clinical outcome was worse for 7.4%, unchanged for 3.7% of the patients, while there was minor and major improvement for 7.4% and 81.5%, respectively. In the volumetric imaging analysis 7.4% of the VMs were worse and 14.8% were unchanged. Minor improvement was observed in 22.2%, intermediate improvement in 44.4% and major improvement in 11.1%. The rate of permanent complications was 3.7%. Conclusion PS can be an effective therapy to treat the symptoms of patients with VMs of the head and neck and to downsize the VMs. MRI-based volumetry can be used to objectively follow the change in size of the VMs after PS. Relief of symptoms frequently does not require substantial volume reduction.	[Vollherbst, Dominik F.; Gebhart, Philipp; Bendszus, Martin; Moehlenbruch, Markus A.] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Kargus, Steffen; Kuehle, Reinald; Hoffmann, Juergen] Heidelberg Univ Hosp, Dept Oral & Maxillofacial Surg, Heidelberg, Germany; [Burger, Astrid; Guenther, Patrick] Heidelberg Univ Hosp, Dept Pediat Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mohlenbruch, MA (corresponding author), Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany.	markus.moehlenbruch@med.uni-heidelberg.de						Alexander MD, 2016, ACTA RADIOL, V57, P205, DOI 10.1177/0284185115575779; Berenguer B, 1999, PLAST RECONSTR SURG, V104, P1, DOI 10.1097/00006534-199907000-00001; Bourgouin P, 2018, J VASC INTERV RADIOL, V29, P809, DOI 10.1016/j.jvir.2017.12.028; Dompmartin A, 2010, PHLEBOLOGY, V25, P224, DOI 10.1258/phleb.2009.009041; Enjolras Odile, 1997, Journal of Dermatology (Tokyo), V24, P701; Filippiadis DK, 2017, CARDIOVASC INTER RAD, V40, P1141, DOI 10.1007/s00270-017-1703-4; Gelczer RK, 1998, J ULTRAS MED, V17, P531; Horbach SER, 2018, CARDIOVASC INTER RAD, V41, P1494, DOI 10.1007/s00270-018-1999-8; Ierardi AM, 2010, VASC ENDOVASC SURG, V44, P282, DOI 10.1177/1538574410362117; Khaitovich B, 2019, CARDIOVASC INTER RAD, V42, P1695, DOI 10.1007/s00270-019-02338-y; Lee BB, 2004, J AM COLL SURGEONS, V198, P549, DOI 10.1016/j.jamcollsurg.2003.12.013; Legiehn GM, 2008, RADIOL CLIN N AM, V46, P545, DOI 10.1016/j.rcl.2008.02.008; Matsuhisa Akiyuki, 2016, Ann Vasc Dis, V9, P66, DOI 10.3400/avd.cr.15-00058; Mimura H, 2009, EUR RADIOL, V19, P2474, DOI 10.1007/s00330-009-1442-2; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Orlando JL, 2010, DERMATOLOGY, V220, P376, DOI 10.1159/000305525; Park H, 2019, ARCH PLAST SURG-APS, V46, P23, DOI 10.5999/aps.2018.00458; Patel SB, 2015, J VASC SURG-VENOUS L, V3, P312, DOI 10.1016/j.jvsv.2014.07.010; Qiu YJ, 2013, VASC ENDOVASC SURG, V47, P454, DOI 10.1177/1538574413492390; Seront E, 2018, OTOLARYNG CLIN N AM, V51, P173, DOI 10.1016/j.otc.2017.09.003; Costa JRS, 2011, J ORAL MAXIL SURG, V69, pE88, DOI 10.1016/j.joms.2010.06.204; Spence J, 2010, AM J NEURORADIOL, V31, P955, DOI 10.3174/ajnr.A1940; Spence J, 2011, HEAD NECK-J SCI SPEC, V33, P125, DOI 10.1002/hed.21410; Tessari L, 2001, DERMATOL SURG, V27, P58, DOI 10.1111/j.1524-4725.2001.00192.x; Wang X. J., 2017, ENV DEV SUSTAIN, V4, P1; Yun WS, 2009, J VASC SURG, V50, P581, DOI 10.1016/j.jvs.2009.03.058; Zhang W, 2013, BRIT J PHARMACOL, V170, P1210, DOI 10.1111/bph.12355; Zheng JW, 2013, INT J CLIN EXP MED, V6, P377	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241347	10.1371/journal.pone.0241347	http://dx.doi.org/10.1371/journal.pone.0241347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119700	Green Published, gold			2022-12-26	WOS:000600013600047
J	Flash, ML; Renwick, M; Gilkerson, JR; Stevenson, MA				Flash, Meredith L.; Renwick, Michelle; Gilkerson, James R.; Stevenson, Mark A.			Descriptive analysis of Thoroughbred horses born in Victoria, Australia, in 2010; barriers to entering training and outcomes on exiting training and racing	PLOS ONE			English	Article							PERFORMANCE; WASTAGE	The reasons for Thoroughbred (TB) horses not entering training or exiting the racing industry, are of interest to regulators, welfare groups and the broader community. Speculation about the outcomes of these horses threatens the community acceptance, or social license, of the TB breeding and racing industries. A representative survey of the 2010 Victorian born TB foal crop was used to determine the outcomes and reasons for exit for horses that had not entered training, or had exited training and racing by eight years of age. Horses exported for racing or breeding (4%), or that were still actively racing (7%) at the start of the follow up period were excluded from the study. An online questionnaire was sent to breeders or trainers of 3,176 TB horses eligible for enrolment in the study. Of the 2,005 (63%) responses received, the two most frequent outcomes were that the horse had either been retired or rehomed (65%), or deceased (16%). For the 1,637 TB horses that had entered training, the majority of retirements were voluntary (59%), followed by involuntary retirements due to health disorders (28%). For TBs that did not have an industry record of entering training (n = 368), death (34%), or retirement or being rehomed (27%), were the most frequent barriers to entering training. The median age of retirement for TBs that raced was five (Q1 4; Q3 6) years regardless of sex, or whether their first race start was at two, three or four years of age. Relatively large numbers of horses voluntarily retiring at five-years of age suggests that industry-level, rather than individual horse-level factors are the predominant influences on racing career duration.	[Flash, Meredith L.; Renwick, Michelle; Gilkerson, James R.; Stevenson, Mark A.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne	Flash, ML (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	flashm@student.unimelb.edu.au		Flash, Meredith/0000-0002-5120-8632; Gilkerson, James/0000-0003-1801-4817	Racing Victoria	Racing Victoria	This research was funded by Racing Victoria, in the form of a thesis stipend. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.	Algalita Marine Research Foundation, 2008, ANN REPORT; Anon, 2018, RACING AUSTR FACT BO; Anon, 2016, WHAT IS HORSE WASTAG; Anon, 2017, RACING AUSTR SIZE SC; Anon, 2018, SIZE SCOPE VICTORIAN; Anon, 2019, WHAT ARE ANIMAL WELF; [Anonymous], 2019, AUSTR RULES RACING; [Anonymous], 2005, DTSCH Z PHILOS, V53, P69; Bailey CJ, 1999, AM J VET RES, V60, P1196; Bourke J, 1995, P ANN SEM EQ BRANCH; Dohoo I, 2012, METHODS EPIDEMOLOGIC; Flash ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237003; Flash ML, 2020, UNPUB; Fox Koob S, 2019, SYDNEY MORNING HERAL; Gemmell N., 2017, AUSTRALIAN; Gunningham N, 2004, LAW SOCIAL INQUIRY, V29, P307, DOI 10.1086/423681; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Lash TL, 2009, APPL QUANTITATIVE BI; Lynch M., 2019, SYDNEY MORNING HERAL; Manning J., 2012, SYDNEY MORNING HERAL; More SJ, 1999, AUST VET J, V77, P105, DOI 10.1111/j.1751-0813.1999.tb11678.x; Parkin TDH, 2006, EQUINE VET J, V38, P98, DOI 10.2746/042516406776563279; Perkins NR, 2005, NEW ZEAL VET J, V53, P59, DOI 10.1080/00480169.2005.36470; Reed SK, 2020, EQUINE VET EDUC, V32, P82, DOI 10.1111/eve.13185; Thomson PC, 2014, AUST VET J, V92, P303, DOI 10.1111/avj.12204; Tigerlily DJ., 2019, SYDNEY MORNING HERAL; Wahlquist C., 2019, GUARDIAN; Wilsher S, 2006, EQUINE VET J, V38, P113, DOI 10.2746/042516406776563305	28	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241273	10.1371/journal.pone.0241273	http://dx.doi.org/10.1371/journal.pone.0241273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112903	Green Published, gold			2022-12-26	WOS:000588374000068
J	Zamboni, P; Malagoni, AM; Menegatti, E; Ragazzi, R; Tavoni, V; Tessari, M; Beggs, CB				Zamboni, Paolo; Malagoni, Anna Maria; Menegatti, Erica; Ragazzi, Riccardo; Tavoni, Valentina; Tessari, Mirko; Beggs, Clive B.			Central venous pressure estimation from ultrasound assessment of the jugular venous pulse	PLOS ONE			English	Article								Objectives Acquiring central venous pressure (CVP), an important clinical parameter, requires an invasive procedure, which poses risk to patients. The aim of the study was to develop a non-invasive methodology for determining mean-CVP from ultrasound assessment of the jugular venous pulse. Methods In thirty-four adult patients (age = 60 +/- 12 years; 10 males), CVP was measured using a central venous catheter, with internal jugular vein (IJV) cross-sectional area (CSA) variation along the cardiac beat acquired using ultrasound. The resultant CVP and IJV-CSA signals were synchronized with electrocardiogram (ECG) signals acquired from the patients. Autocorrelation signals were derived from the IJV-CSA signals using algorithms in R (open-source statistical software). The correlation r-values for successive lag intervals were extracted and used to build a linear regression model in which mean-CVP was the response variable and the lagging autocorrelation r-values and mean IJV-CSA, were the predictor variables. The optimum model was identified using the minimum AIC value and validated using 10-fold cross-validation. Results While the CVP and IJV-CSA signals were poorly correlated (mean r = -0.018, SD = 0.357) due to the IJV-CSA signal lagging behind the CVP signal, their autocorrelation counterparts were highly positively correlated (mean r = 0.725, SD = 0.215). Using the lagging autocorrelation r-values as predictors, mean-CVP was predicted with reasonable accuracy (r(2) = 0.612), with a mean-absolute-error of 1.455 cmH(2)O, which rose to 2.436 cmH(2)O when cross-validation was performed. Conclusions Mean-CVP can be estimated non-invasively by using the lagged autocorrelation r-values of the IJV-CSA signal. This new methodology may have considerable potential as a clinical monitoring and diagnostic tool.	[Zamboni, Paolo; Malagoni, Anna Maria; Menegatti, Erica; Tavoni, Valentina; Tessari, Mirko] Univ Hosp Ferrara, HUB Ctr Reg Emilia Romagna Venous & Lymphat Disor, Ferrara, Italy; [Ragazzi, Riccardo] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Beggs, Clive B.] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England	University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; Leeds Beckett University	Beggs, CB (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	c.beggs@leedsbeckett.ac.uk			Italian Ministry of Health [RF-2013-02358029]	Italian Ministry of Health(Ministry of Health, Italy)	The study was funded by the Italian Ministry of Health (ref: RF-2013-02358029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Amelard R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40150; Applefeld M.M., 1990, CLIN METHODS HIST PH; Beggs CB, 2020, DIAGNOSTICS UNPUB; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennan JM, 2007, AM J CARDIOL, V99, P1614, DOI 10.1016/j.amjcard.2007.01.037; Chatfield C., 2016, ANAL TIME SERIES INT; Chiaco JMSC, 2013, CLEV CLIN J MED, V80, P638, DOI 10.3949/ccjm.80a.13039; Conn Robert D, 2012, Mo Med, V109, P150; Demeria DD, 2004, CHEST, V126, p747S, DOI 10.1378/chest.126.4_MeetingAbstracts.747S; Deol GR, 2011, CHEST, V139, P95, DOI 10.1378/chest.10-1301; Figg KK, 2009, ANESTH ANALG, V108, P1209, DOI 10.1213/ane.0b013e318196482c; Garg N., 2000, J INDIAN ACAD CLIN M, V1, P261; Gilbert M, 2018, ANAEST INTENS CARE M, V19, P189, DOI 10.1016/j.mpaic.2018.01.004; Hossein-Nejad H, 2016, J CLIN ULTRASOUND, V44, P312, DOI 10.1002/jcu.22339; Keller AS, 2009, J HOSP MED, V4, P350, DOI 10.1002/jhm.503; Killu K, 2017, FUNDAMENTAL CRITICAL; Lipton B, 2000, AM J EMERG MED, V18, P432, DOI 10.1053/ajem.2000.7335; Magder S, 2006, CRIT CARE MED, V34, P2224, DOI 10.1097/01.CCM.0000227646.98423.98; Marino P.L., 2014, ICU BOOK; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Muller KH, 2012, TRENDS PHARMACOL SCI, V33, P89, DOI 10.1016/j.tips.2011.10.004; Nicolaides AN, 2011, FUNCT NEUROL, V26, P229; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Roger C, 2017, BRIT J ANAESTH, V118, P223, DOI 10.1093/bja/aew386; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sathish N, 2016, ANN CARD ANAESTH, V19, P405, DOI 10.4103/0971-9784.185520; Sisini F, 2016, ULTRASOUND MED BIOL, V42, P1750, DOI 10.1016/j.ultrasmedbio.2016.03.002; Sisini F, 2015, ULTRASOUND MED BIOL, V41, P1334, DOI 10.1016/j.ultrasmedbio.2014.12.666; Sondergaard S, 2016, CURR OPIN ANESTHESIO, V29, P179, DOI 10.1097/ACO.0000000000000305; Team-R-Core, 2013, R LANG ENV STAT COMP; Uthoff H, 2012, ULTRASCHALL MED, V33, P256; Ward KR, 2006, RESUSCITATION, V70, P238, DOI 10.1016/j.resuscitation.2005.12.013; Yuan WD, 2016, PHARMAZIE, V71, P94, DOI 10.1691/ph.2016.5709; Zamboni P, 2018, ULTRASOUND MED BIOL, V44, P726, DOI 10.1016/j.ultrasmedbio.2017.11.001; Zamboni P, 2012, J APPL PHYSIOL, V112, P904, DOI 10.1152/japplphysiol.00712.2011; 2018, CURR OPIN TOXICOL, V10	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240057	10.1371/journal.pone.0240057	http://dx.doi.org/10.1371/journal.pone.0240057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112871	gold, Green Published, Green Accepted			2022-12-26	WOS:000588374000055
J	Begni, V; Sanson, A; Pfeiffer, N; Brandwein, C; Inta, D; Talbot, SR; Riva, MA; Gass, P; Mallien, AS				Begni, Veronica; Sanson, Alice; Pfeiffer, Natascha; Brandwein, Christiane; Inta, Dragos; Talbot, Steven R.; Riva, Marco Andrea; Gass, Peter; Mallien, Anne Stephanie			Social isolation in rats: Effects on animal welfare and molecular markers for neuroplasticity	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; ISOLATION-REARED RATS; BDNF MESSENGER-RNA; PREFRONTAL CORTEX; CHRONIC STRESS; IMMUNOREACTIVE CELLS; PREPULSE INHIBITION; NEUROTROPHIC FACTOR; NEURAL MECHANISMS; GENE-EXPRESSION	Early life stress compromises brain development and can contribute to the development of mental illnesses. A common animal model used to study different facets of psychiatric disorders is social isolation from early life on. In rats, this isolation can induce long-lasting alterations in molecular expression and in behavior. Since social isolation models severe psychiatric symptoms, it is to be expected that it affects the overall wellbeing of the animals. As also promoted by the 3Rs principle, though, it is pivotal to decrease the burden of laboratory animals by limiting the number of subjects (reduce, replace) and by improving the animals' wellbeing (refine). The aim of this study was therefore to test possible refinement strategies such as resocialization and mere adult social isolation. We examined whether the alternatives still triggered the necessary phenotype while minimizing the stress load on the animals. Interestingly, we did not find reduced wellbeing-associated burrowing performance in isolated rats. The hyperactive phenotype seen in socially isolated animals was observed for rats undergoing the adult-only isolation, but resocializing ameliorated the locomotor abnormality. Isolation strongly affected markers of neuroplasticity in the prefrontal cortex independent of timing: mRNA levels of Arc, Bdnf and the pool of Bdnf transcripts with the 3' long UTR were reduced in all groups. Bdnf splice variant IV expression was reduced in lifelong-isolated animals. Some of these deficits normalized after resocialization; likewise, exon VI Bdnf mRNA levels were reduced only in animals persistently isolated. Conversely, social deprivation did not affect the expression of Gad67 and Pvb, two GABAergic markers, whereas changes occurred in the expression of dopamine d1 and d2 receptors. As adult isolation was sufficient to trigger the hyperactive phenotype and impaired neuroplasticity in the prefrontal cortex, it could be a candidate for a refinement strategy for certain research questions. To fully grade the severity of post-weaning social isolation and the alternatives, adult isolation and resocialization, a more profound and multimodal assessment approach is necessary.	[Begni, Veronica; Sanson, Alice; Riva, Marco Andrea] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Pfeiffer, Natascha; Brandwein, Christiane; Inta, Dragos; Gass, Peter; Mallien, Anne Stephanie] Heidelberg Univ, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Med Fac Mannheim, Mannheim, Germany; [Inta, Dragos] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Talbot, Steven R.] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany	University of Milan; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Basel; Hannover Medical School	Gass, P (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Med Fac Mannheim, Mannheim, Germany.	anne.mallien@zi-mannheim.de		Sanson, Alice/0000-0001-8200-1717	Deutsche Forschungsgemeinschaft (Forschergruppe 2591 'Severity assessment in animal based research', project P05); Italian Ministry of University and Research [PRIN 2017AY8BP4]; Italian Ministry of University and Research (PON "Ricerca e Innovazione" PerMedNet project) [ARS01_01226]	Deutsche Forschungsgemeinschaft (Forschergruppe 2591 'Severity assessment in animal based research', project P05)(German Research Foundation (DFG)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of University and Research (PON "Ricerca e Innovazione" PerMedNet project)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Forschergruppe 2591 'Severity assessment in animal based research', project P05) to P.G. and by grants from the Italian Ministry of University and Research (PRIN 2017AY8BP4 and PON "Ricerca e Innovazione" PerMedNet project ARS01_01226) to M.A.R.	Abdelrahman A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50682-3; Adzic M, 2009, J ENDOCRINOL, V202, P87, DOI 10.1677/JOE-08-0509; Allen P, 2019, NEUROSCI BIOBEHAV R, V99, P90, DOI 10.1016/j.neubiorev.2019.02.004; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Andersen SL, 2015, DEV PSYCHOPATHOL, V27, P477, DOI 10.1017/S0954579415000103; Andrews N, 2012, EUR J PAIN, V16, P485, DOI 10.1016/j.ejpain.2011.07.012; [Anonymous], 2019, GEOFORUM, V102, P1, DOI 10.1016/j.geoforum.2019.03.005; Bagalkot TR, 2015, NEUROSCIENCE, V311, P444, DOI 10.1016/j.neuroscience.2015.10.024; Baj G, 2011, P NATL ACAD SCI USA, V108, P16813, DOI 10.1073/pnas.1014168108; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Begni V, 2017, CLIN SCI, V131, P123, DOI 10.1042/CS20160009; Bennett MR, 2014, PROG NEUROBIOL, V112, P80, DOI 10.1016/j.pneurobio.2013.10.005; Calabrese F, 2017, ACS CHEM NEUROSCI, V8, P817, DOI 10.1021/acschemneuro.6b00392; Cattaneo A, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.214; Cattaneo A, 2015, J STEROID BIOCH MOL; Coley AA, 2018, PROG NEURO-PSYCHOPH, V82, P187, DOI 10.1016/j.pnpbp.2017.11.016; Cook N, 2003, NINETEEN CENT MUSIC, V27, P3; Deacon RMJ, 2009, BEHAV BRAIN RES, V200, P128, DOI 10.1016/j.bbr.2009.01.007; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Di Liberto V, 2018, NEUROBIOL DIS, V118, P9, DOI 10.1016/j.nbd.2018.06.010; Egerton A, 2016, SCHIZOPHR RES, V176, P171, DOI 10.1016/j.schres.2016.06.005; Filipovic D, 2013, NEUROSCIENCE, V236, P47, DOI 10.1016/j.neuroscience.2013.01.033; Filipovic D, 2018, NEUROSCIENCE, V371, P384, DOI 10.1016/j.neuroscience.2017.12.020; Filipovic D, 2017, BRAIN STRUCT FUNCT, V222, P1, DOI 10.1007/s00429-016-1218-9; Fogaca MV, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00087; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; GENTSCH C, 1988, PHYSIOL BEHAV, V43, P13, DOI 10.1016/0031-9384(88)90091-1; GEYER MA, 1993, BIOL PSYCHIAT, V34, P361, DOI 10.1016/0006-3223(93)90180-L; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Harte MK, 2007, J NEURAL TRANSM, V114, P893, DOI 10.1007/s00702-007-0627-6; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Hermes G, 2011, PHYSIOL BEHAV, V104, P354, DOI 10.1016/j.physbeh.2010.12.019; HOLSON RR, 1991, PHYSIOL BEHAV, V49, P1107, DOI 10.1016/0031-9384(91)90338-O; Howes OD, 2017, BIOL PSYCHIAT, V81, P9, DOI 10.1016/j.biopsych.2016.07.014; Ieraci A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6212983; Inta D, 2014, HIPPOCAMPUS, V24, P424, DOI 10.1002/hipo.22236; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; King MV, 2009, SYNAPSE, V63, P476, DOI 10.1002/syn.20624; Kokare DM, 2010, NEUROPHARMACOLOGY, V58, P1009, DOI 10.1016/j.neuropharm.2010.01.006; Koska I, 2019, EPILEPSIA, V60, P2114, DOI 10.1111/epi.16330; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Kumstel S, 2020, ANN N Y ACAD SCI; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Levine JB, 2007, NEUROSCIENCE, V145, P42, DOI 10.1016/j.neuroscience.2006.11.063; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li M, 2016, BEHAV BRAIN RES, V313, P177, DOI 10.1016/j.bbr.2016.07.025; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Lukkes J, 2009, J NEUROSCI, V29, P9955, DOI 10.1523/JNEUROSCI.0854-09.2009; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; Lukkes JL, 2009, HORM BEHAV, V55, P248, DOI 10.1016/j.yhbeh.2008.10.014; LUONI A, 2014, INT J NEUROPSYCHOPH, V18, P4, DOI DOI 10.1093/ijnp/pyu061; Meng QX, 2010, NEUROSCI LETT, V480, P25, DOI 10.1016/j.neulet.2010.05.067; Meyer-Lindenberg A, 2014, WORLD PSYCHIATRY, V13, P143, DOI 10.1002/wps.20121; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; Mikics E, 2018, NEUROPSYCHOPHARMACOL, V43, P235, DOI 10.1038/npp.2017.142; Misiak B, 2017, NEUROSCI BIOBEHAV R, V75, P393, DOI 10.1016/j.neubiorev.2017.02.015; Mora F, 2012, BRAIN RES, V1476, P71, DOI 10.1016/j.brainres.2011.12.049; Murinova J, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00101; Nikolaienko O, 2018, SEMIN CELL DEV BIOL, V77, P33, DOI 10.1016/j.semcdb.2017.09.006; Ohnuma T, 2000, NEUROREPORT, V11, P3133, DOI 10.1097/00001756-200009280-00019; Perovic M, 2013, AGE, V35, P2057, DOI 10.1007/s11357-012-9495-6; Pinheiro JBD, 2020, R CORE TEAM NLME LIN; Pisu MG, 2011, BEHAV BRAIN RES, V222, P73, DOI 10.1016/j.bbr.2011.03.021; POTEGAL M, 1989, DEV PSYCHOBIOL, V22, P159, DOI 10.1002/dev.420220206; Preece MA, 2004, NEUROSCIENCE, V123, P725, DOI 10.1016/j.neuroscience.2003.10.008; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhart V, 2015, NEUROBIOL DIS, V77, P220, DOI 10.1016/j.nbd.2015.03.011; Reinwald JR, 2018, BIOL PSYCHIAT, V84, P116, DOI 10.1016/j.biopsych.2017.12.010; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Roberts L, 2003, BRAIN RES, V991, P271, DOI 10.1016/j.brainres.2003.08.022; Rousseaud A, 2015, J MOL NEUROSCI, V56, P758, DOI 10.1007/s12031-014-0487-0; Seffer D, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00102; Selten JP, 2017, SCHIZOPHRENIA BULL, V43, P287, DOI 10.1093/schbul/sbw180; Shinohara R, 2018, MOL PSYCHIATR, V23, P1717, DOI 10.1038/mp.2017.177; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Steward O, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00101; Strekalova T, 2010, PROG NEURO-PSYCHOPH, V34, P348, DOI 10.1016/j.pnpbp.2009.12.014; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Tulogdi A, 2014, DEV PSYCHOBIOL, V56, P49, DOI 10.1002/dev.21090; Vale AL, 1997, PSYCHOPHARMACOLOGY, V133, P127, DOI 10.1007/s002130050382; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; van Dijk RM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230141; Vanderschuren LJMJ, 2016, NEUROSCI BIOBEHAV R, V70, P86, DOI 10.1016/j.neubiorev.2016.07.025; Vanderschuren LJMJ, 2014, CURR TOP BEHAV NEURO, V16, P189, DOI 10.1007/7854_2013_268; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Wall VL, 2012, PHYSIOL BEHAV, V107, P440, DOI 10.1016/j.physbeh.2012.09.002; Weiss IC, 2000, BEHAV NEUROSCI, V114, P364, DOI 10.1037/0735-7044.114.2.364; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7; WRIGHT IK, 1991, PHYSIOL BEHAV, V50, P1129, DOI 10.1016/0031-9384(91)90572-6; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zueger A, 2005, NEUROSCI LETT, V374, P142, DOI 10.1016/j.neulet.2004.10.040	97	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240439	10.1371/journal.pone.0240439	http://dx.doi.org/10.1371/journal.pone.0240439			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108362	Green Published, gold			2022-12-26	WOS:000588372400038
J	Kimball, SR; Davis, TA				Kimball, Scot R.; Davis, Teresa A.			The 2020 FASEB Virtual Science Research Conference on Nutrient Sensing and Metabolic Signaling, August 10-11, 2020	FASEB JOURNAL			English	Editorial Material									[Kimball, Scot R.] Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Davis, Teresa A.] Baylor Coll Med, ARS, USDA, Dept Pediat,Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Baylor College of Medicine; United States Department of Agriculture (USDA)	Kimball, SR (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.; Davis, TA (corresponding author), Baylor Coll Med, ARS, USDA, Dept Pediat,Childrens Nutr Res Ctr, 1100 Bates St, Houston, TX 77030 USA.	skimball@psu.edu; tdavis@bcm.edu			 [R13 DK126105]		NIH/NIDDk, Grant/Award Number: R13 DK126105		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15627	15629		10.1096/fj.202002259	http://dx.doi.org/10.1096/fj.202002259		OCT 2020	3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33107626	Bronze, Green Accepted			2022-12-26	WOS:000586268500001
J	Leite, HP; Pinto, IP; Oliveira, LG; Costa, EOA; da Cruz, AS; Silva, DDE; da Silva, CC; Caetano, AR; da Cruz, AD				Leite Filho, Hugo Pereira; Pinto, Irene Plaza; Oliveira, Lorraynne Guimaraes; Alves Costa, Emilia Oliveira; da Cruz, Alex Silva; Silva, Daniela de Melo e; da Silva, Claudio Carlos; Caetano, Alexandre Rodrigues; da Cruz, Aparecido Divino			Deviation from Mendelian transmission of autosomal SNPs can be used to estimate germline mutations in humans exposed to ionizing radiation	PLOS ONE			English	Article							DNA-DAMAGE; GOIANIA; CELLS; AGE	We aimed to estimate the rate of germline mutations in the offspring of individuals accidentally exposed to Cesium-137 ionizing radiation. The study included two distinct groups: one of cases, consisting of males and females accidentally exposed to low doses of ionizing radiation of Cs-137, and a control group of non-exposed participants. The cases included 37 people representing 11 families and 15 children conceived after the accident. Exposed families incurred radiation absorbed doses in the range of 0.2 to 0.5 Gray. The control group included 15 families and 15 children also conceived after 1987 in Goiania with no history of radiation exposure. DNA samples from peripheral blood were analyzed with the Affymetrix GeneChip(R) CytoScanHD((TM)) to estimate point mutations in autosomal SNPs. A set of scripts previously developed was used to detect de novo mutations by comparing parent and offspring genotypes at the level of each SNP marker. Overall numbers of observed Mendelian deviations were statistically significant between the exposed and control groups. Our retrospective transgenerational DNA analysis showed a 44.0% increase in the burden of SNP mutations in the offspring of cases when compared to controls, based on the average of MFMD for the two groups. Parent-of-origin and type of nucleotide substitution were also inferred. This proved useful in a retrospective estimation of the rate of de novo germline mutations in a human population accidentally exposed to low doses of radiation from Cesium-137. Our results suggested that observed burden of germline mutations identified in offspring was a potentially useful biomarker of effect to estimate parental exposure to low doses of IR and could become an important marker suitable for biomonitoring human population exposed to environmental mutagens.	[Leite Filho, Hugo Pereira; da Silva, Claudio Carlos; da Cruz, Aparecido Divino] Univ Fed Goias, Programa Posgrad Biotecnol & Biodiversidade, Goiania, Go, Brazil; [Leite Filho, Hugo Pereira; da Silva, Claudio Carlos] Univ Estadual Goias, Anapolis, Go, Brazil; [Pinto, Irene Plaza; Oliveira, Lorraynne Guimaraes; Alves Costa, Emilia Oliveira; da Cruz, Alex Silva; Silva, Daniela de Melo e; da Silva, Claudio Carlos; da Cruz, Aparecido Divino] Pontificia Univ Catolica Goias, Escola Ciencias Agr & Biol, Genet, Nucleo Pesquisa Replicon, Goiania, Go, Brazil; [Oliveira, Lorraynne Guimaraes; Silva, Daniela de Melo e; da Cruz, Aparecido Divino] Univ Fed Goias, Programa Posgrad Genet & Biol Mol, Goiania, Go, Brazil; [da Silva, Claudio Carlos; da Cruz, Aparecido Divino] Secretaria Saude Publ Estado Goias, Lab Estadual Saude Publ Dr Giovanni Cysneiros, Lab Genet Mol & Citogenet Humana, Goiania, Go, Brazil; [Caetano, Alexandre Rodrigues] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Estadual de Goias; Pontificia Universidade Catolica de Goias; Universidade Federal de Goias; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	da Cruz, AD (corresponding author), Univ Fed Goias, Programa Posgrad Biotecnol & Biodiversidade, Goiania, Go, Brazil.; da Cruz, AD (corresponding author), Pontificia Univ Catolica Goias, Escola Ciencias Agr & Biol, Genet, Nucleo Pesquisa Replicon, Goiania, Go, Brazil.; da Cruz, AD (corresponding author), Univ Fed Goias, Programa Posgrad Genet & Biol Mol, Goiania, Go, Brazil.; da Cruz, AD (corresponding author), Secretaria Saude Publ Estado Goias, Lab Estadual Saude Publ Dr Giovanni Cysneiros, Lab Genet Mol & Citogenet Humana, Goiania, Go, Brazil.	acruz@pucgoias.edu.br	Pinto, Irene/GMW-8507-2022; da Cruz, Alex Silva/AAS-7677-2021; da Cruz, Aparecido Divino/K-6701-2015; da Cruz, Alex Silva ASC/K-6704-2015; Rodrigues Caetano, Alexandre/B-5227-2017	da Cruz, Alex Silva/0000-0002-4736-945X; da Cruz, Aparecido Divino/0000-0003-0753-3814; da Cruz, Alex Silva ASC/0000-0002-4736-945X; Leite Filho, Hugo/0000-0003-0920-2402; Oliveira, Lorraynne/0000-0001-9553-7027; Rodrigues Caetano, Alexandre/0000-0002-3419-7337				Adewoye AB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7684; Costa EOA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23813-5; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2001, PUB PAPERS, V1, P10; [Anonymous], 2017, CLUSTER CLUSTER ANAL; [Anonymous], 1988, MAURITIUS LAW REV, V1, P1; [Anonymous], 1987, LOS ANGELES TIM 0401, P3; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; Brovarets' OO, 2015, J BIOMOL STRUCT DYN, V33, P2716, DOI 10.1080/07391102.2015.1092886; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; da Cruz AD, 1997, ENVIRON MOL MUTAGEN, V30, P385, DOI 10.1002/(SICI)1098-2280(1997)30:4<385::AID-EM3>3.0.CO;2-I; da Cruz ASP, 2010, STUDIES GOIANIA, V37, P799; da Silva CC, 2002, CHROMOSOME RES, V10, P233, DOI 10.1023/A:1015248206540; DACRUZ AD, 1994, MUTAT RES-ENVIR MUTA, V313, P57, DOI 10.1016/0165-1161(94)90033-7; daCruz AD, 1996, ENVIRON MOL MUTAGEN, V27, P165; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Gao ZY, 2019, P NATL ACAD SCI USA, V116, P9491, DOI 10.1073/pnas.1901259116; Gao ZY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002355; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Husson F., 2010, EXPLORATORY MULTIVAR, DOI DOI 10.1201/B10345; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; International Atomic Energy Agency (IAEA), 1988, RAD ACC GOIAN, P1; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Kassambra A., 2017, STHDA; LUCKEHUHLE C, 1982, RADIAT RES, V89, P298, DOI 10.2307/3575776; Lyons DM, 2017, MOL BIOL EVOL, V34, P3205, DOI 10.1093/molbev/msx251; MAITY A, 1994, RADIOTHER ONCOL, V31, P1, DOI 10.1016/0167-8140(94)90408-1; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Nakamura N, 2013, ANNU REV GENET, V47, P33, DOI 10.1146/annurev-genet-111212-133501; Nunes HF, 2013, GENET MOL RES, V12, P28, DOI 10.4238/2013.January.16.6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Rana S, 2010, J PHARM BIOALLIED SC, V2, P189, DOI 10.4103/0975-7406.68500; Rate Lynch M., 2010, P NATL ACAD SCI, V107, P961; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Skandalis A, 1997, ENVIRON MOL MUTAGEN, V29, P107; STRAUME T, 1991, HEALTH PHYS, V60, P71, DOI 10.1097/00004032-199101000-00011; TOBEY RA, 1975, NATURE, V254, P245, DOI 10.1038/254245a0; Vertes A, 2003, HDB NUCL CHEM, P1647; Vromen Suzanne, 2004, EUROPEAN J POLITICAL, V3, P183; WALTERS RA, 1974, BIOPHYS J, V14, P99, DOI 10.1016/S0006-3495(74)70002-9; Wong WS, 2016, NAT COMMUN, V7, P1; Xu YJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-331; Zahir FR, 2015, CURR PROTOC HUM GENE, V85, P8131; [No title captured]	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0233941	10.1371/journal.pone.0233941	http://dx.doi.org/10.1371/journal.pone.0233941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108378	Green Published, gold, Green Submitted			2022-12-26	WOS:000588372400014
J	Kyprianidou, M; Panagiotakos, D; Faka, A; Kambanaros, M; Makris, KC; Christophi, CA				Kyprianidou, Maria; Panagiotakos, Demosthenes; Faka, Antigoni; Kambanaros, Maria; Makris, Konstantinos C.; Christophi, Costas A.			Prevalence of multimorbidity in the Cypriot population; A cross-sectional study (2018-2019)	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CHRONIC DISEASES; PRIMARY-CARE; HEALTH-CARE; EPIDEMIOLOGY; PATTERNS; CYPRUS; ADULTS	Background Multimorbidity is defined as the co-existence of two or more chronic conditions. As life expectancy is increasing so does the prevalence of multimorbidity. Our aim was to estimate the prevalence of multimorbidity in Cyprus and identify the most prevalent diseases. Methods A representative sample of n = 1140 individuals over 18 years old was surveyed during 2018-2019. Demographic characteristics as well as the presence of chronic conditions, including mental disorders, were collected through a standardized questionnaire. Diseases were classified according to the International Classification of Diseases, 10(th) Revision (ICD-10). Results The age and gender standardized prevalence of multimorbidity was 28.6%. Multimorbidity was associated with age (p<0.001), with the highest rate observed among people aged 65+ years old (68.9%). Multimorbidity was higher in women than men (28.2% vs. 22.5%, p < .001) but similar in urban and rural regions (26.4% vs. 23.8%, p = 0.395). The most prevalent chronic diseases among people with multimorbidity were hyperlipidemia (44.7%), followed by hypertension (37.5%), gastric reflux (23.9%), and thyroid diseases (22.2%), while the most common combinations of diseases were in the circulatory and endocrine systems. The profile of the multimorbid individual indicated this to be a person at an older age with a higher BMI, a current smoker with a higher salary. Conclusions More than one quarter of the general population of Cyprus has multimorbidity, and this rate is almost 70% among the elderly. Multimorbidity is relatively common even in younger ages too. This underlines the need for prevention strategies and health awareness programs for the entire population.	[Kyprianidou, Maria; Makris, Konstantinos C.; Christophi, Costas A.] Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus; [Panagiotakos, Demosthenes] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Faka, Antigoni] Harokopio Univ, Sch Environm Geog & Appl Econ, Dept Geog, Athens, Greece; [Kambanaros, Maria] Cyprus Univ Technol, Dept Rehabil Sci, Limassol, Cyprus	Cyprus International Institute for Environmental & Public Health; Cyprus University of Technology; Harokopio University Athens; Harokopio University Athens; Cyprus University of Technology	Kyprianidou, M (corresponding author), Cyprus Univ Technol, Cyprus Int Inst Environm & Publ Hlth, Limassol, Cyprus.	kyprianidou.maria.ky@gmail.com	Panagiotakos, Demosthenes/C-9776-2013; Makris, Konstantinos/GNP-4408-2022	Panagiotakos, Demosthenes/0000-0001-8583-153X; Makris, Konstantinos/0000-0001-5251-8619				Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Ahmadi B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002756; [Anonymous], 2018, Cancer Discov, V8, pOF6, DOI 10.1158/2159-8290.CD-NB2017-158; [Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12, DOI DOI 10.1158/2159-8290.CD-RW2016-234; [Anonymous], 2014, ANN FAM MED, V12, piii; Anton-Culver H, 2016, CANCER EPIDEMIOL, V44, P195, DOI 10.1016/j.canep.2016.06.004; Avicenna Between, 2015, DOCUMENTI STUDI TRAD, V26, P211; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Chen H, 2018, ARCH GERONTOL GERIAT, V79, P32, DOI 10.1016/j.archger.2018.07.008; de Carvalho JN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174322; Demetriou CA, 2018, CLIN GENET, V93, P656, DOI 10.1111/cge.13168; European Commission, 2018, ED TRAIN MON 2018, DOI [10.2766/218608, DOI 10.2766/218608]; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fox R, 2007, BMJ-BRIT MED J, V334, P1013, DOI 10.1136/bmj.39212.467037.BE; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Knowles A, 2015, PHILOSOPHIA-J CONT F, V5, P1; Kumar DV, 2019, INT J MED BIOMED STU, V3, P76, DOI [10.32553/ijmbs.v3i6.301, DOI 10.32553/IJMBS.V3I6.301]; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Mounce LTA, 2018, ANN FAM MED, V16, P322, DOI 10.1370/afm.2271; Nunes BP, 2016, ARCH GERONTOL GERIAT, V67, P130, DOI 10.1016/j.archger.2016.07.008; Ornstein SM, 2013, J AM BOARD FAM MED, V26, P518, DOI 10.3122/jabfm.2013.05.130012; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Panagiotakos DB, 2015, INT J CARDIOL, V180, P178, DOI 10.1016/j.ijcard.2014.11.206; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Rizza A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-113; Romana GQ, 2020, EUR J PUBLIC HEALTH, V30, P16, DOI 10.1093/eurpub/ckz118; Singh K, 2019, J PUBLIC HEALTH-UK, V41, P80, DOI 10.1093/pubmed/fdy017; Turabian JL, 2018, NOTES THEORY MULTIMO; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; WHO (World Health Organization), 2003, INV MENT HLTH, P3, DOI 10.1093/heapro/dar059; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0239835	10.1371/journal.pone.0239835	http://dx.doi.org/10.1371/journal.pone.0239835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8VY	33104700	Green Published, gold			2022-12-26	WOS:000588370000054
J	Sikdar, S; Mukherjee, A; Marsili, M				Sikdar, Sandipan; Mukherjee, Animesh; Marsili, Matteo			Unsupervised ranking of clustering algorithms by INFOMAX	PLOS ONE			English	Article							VALIDATION; NETWORK	Clustering and community detection provide a concise way of extracting meaningful information from large datasets. An ever growing plethora of data clustering and community detection algorithms have been proposed. In this paper, we address the question of ranking the performance of clustering algorithms for a given dataset. We show that, for hard clustering and community detection, Linsker's Infomax principle can be used to rank clustering algorithms. In brief, the algorithm that yields the highest value of the entropy of the partition, for a given number of clusters, is the best one. We show indeed, on a wide range of datasets of various sizes and topological structures, that the ranking provided by the entropy of the partition over a variety of partitioning algorithms is strongly correlated with the overlap with a ground truth partition The codes related to the project are available in https://github.com/Sandipan99/Ranking_cluster_algorithms.	[Sikdar, Sandipan] Rhein Westfal TH Aachen, Aachen, Germany; [Mukherjee, Animesh] Indian Inst Technol Kharagpur, Kharagpur, W Bengal, India; [Marsili, Matteo] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	RWTH Aachen University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Abdus Salam International Centre for Theoretical Physics (ICTP)	Sikdar, S (corresponding author), Rhein Westfal TH Aachen, Aachen, Germany.	sandipan.sikdar@cssh.rwth-aachen.de	Marsili, Matteo/AAX-2124-2021	sikdar, sandipan/0000-0001-8957-7364	Sandwich Training Educational Programme (STEP); Simons foundation under Simons Visitor programme; Simons foundation under Simons Associateship Programme; Simons foundation through Simons Visitor programme; Simons foundation through Simons Associate programme; ICTP-IAEA Sandwich Training Educational Programme (STEP)	Sandwich Training Educational Programme (STEP); Simons foundation under Simons Visitor programme; Simons foundation under Simons Associateship Programme; Simons foundation through Simons Visitor programme; Simons foundation through Simons Associate programme; ICTP-IAEA Sandwich Training Educational Programme (STEP)	SS was supported by Sandwich Training Educational Programme (STEP) and Simons foundation under Simons Visitor programme. AM was supported by Simons foundation under Simons Associateship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SS and AM would like to acknowledge Simons foundation for financial support through Simons Visitor and Simons Associate programme respectively. SS would also like to acknowledge ICTP-IAEA Sandwich Training Educational Programme (STEP) for financial support.	Cardoso JF, 1997, INFOMAX MAXIMUM LIKE; Cortez P, 2009, DECIS SUPPORT SYST, V47, P547, DOI 10.1016/j.dss.2009.05.016; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; Fogel J, 2009, COMPUT HUM BEHAV, V25, P153, DOI 10.1016/j.chb.2008.08.006; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Frey B., 2007, MULTI DATABASE RETRI, Vvol. 315, ppp, DOI [DOI 10.1126/SCIENCE.1136800, 10.1126/science.1136800]; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Ghosh S, 2011, ACTA PHYS POL B PR S, V4, P123, DOI 10.5506/APhysPolBSupp.4.123; Giada L, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.061101; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hric D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062805; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; KING B, 1967, J AM STAT ASSOC, V62, P86, DOI 10.2307/2282912; Kleinberg J., 2003, ADV NEURAL INFORM PR, P463; Lange T, 2004, NEURAL COMPUT, V16, P1299, DOI 10.1162/089976604773717621; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Mallah C., 2013, SIGNAL PROCESS PATTE, V5, P45; Marsili M., 2002, Quantitative Finance, V2, P297, DOI 10.1088/1469-7688/2/4/305; Redmond M, 2002, EUR J OPER RES, V141, P660, DOI 10.1016/S0377-2217(01)00264-8; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Shamir O, 2007, NIPS, P1297; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P184, DOI 10.1099/00221287-17-1-184; Sokal R. R., 1973, PRINCIPLES PRACTICE; Wagner S, 2007, COMP CLUSTERING OVER; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Waugh S. G, 1995, EXTENDING BENCHMARKI; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]; Zhao Y, 2005, DATA MIN KNOWL DISC, V10, P141, DOI 10.1007/s10618-005-0361-3	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0239331	10.1371/journal.pone.0239331	http://dx.doi.org/10.1371/journal.pone.0239331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104709	Green Published, gold			2022-12-26	WOS:000588370000026
J	Karwelat, D; Schmeck, B; Ringel, M; Benedikter, BJ; Hubner, K; Beinborn, I; Maisner, A; Schulte, LN; Vollmeister, E				Karwelat, Diana; Schmeck, Bernd; Ringel, Marc; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Maisner, Andrea; Schulte, Leon N.; Vollmeister, Evelyn			Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection	FASEB JOURNAL			English	Article						air&#8208; liquid interface; apicobasal polarity; post&#8208; viral bacterial infection; Streptococcus pneumoniae	HUMAN CARTILAGE GP-39; STREPTOCOCCUS-PNEUMONIAE; IMMUNE-RESPONSE; E-CADHERIN; PROTEIN; CELLS; BACTERIAL; CHI3L1; YKL-40; PATHOGENESIS	Infections of the lung are among the leading causes of death worldwide. Despite the preactivation of innate defense programs during viral infection, secondary bacterial infection substantially elevates morbidity and mortality rates. Particularly problematic are co-infections with influenza A virus (IAV) and the major bacterial pathogen Streptococcus pneumoniae. However, the molecular processes underlying the severe course of such co-infections are not fully understood. Previously, the absence of secreted glycoprotein Chitinase-3-like 1 (CHI3L1) was shown to increase pneumococcal replication in mice. We therefore hypothesized that an IAV preinfection decreases CHI3L1 levels to promote pneumococcal infection. Indeed, in an air-liquid interface model of primary human bronchial epithelial cells (hBECs), IAV preinfection interfered with apical but not basolateral CHI3L1 release. Confocal time-lapse microscopy revealed that the gradual loss of apical CHI3L1 localization during co-infection with influenza and S. pneumoniae coincided with the disappearance of goblet as well as ciliated cells and increased S. pneumoniae replication. Importantly, extracellular restoration of CHI3L1 levels using recombinant protein significantly reduced bacterial load in influenza preinfected bronchial models. Thus, recombinant CHI3L1 may provide a novel therapeutic means to lower morbidity and mortality associated with post-influenza pneumococcal infections.	[Karwelat, Diana; Schmeck, Bernd; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Schulte, Leon N.; Vollmeister, Evelyn] Univ Giessen & Marburg Lung Ctr, Inst Lung Res, Hesse, Germany; [Karwelat, Diana; Schmeck, Bernd; Benedikter, Birke J.; Huebner, Kathleen; Beinborn, Isabell; Schulte, Leon N.; Vollmeister, Evelyn] Philipps Univ Marburg, German Ctr Lung Res DZL, Hesse, Germany; [Schmeck, Bernd] Philipps Univ Marburg, Dept Pulm & Crit Care Med, Univ Med Ctr Marburg, Univ Giessen & Marburg Lung Ctr, Hesse, Germany; [Schmeck, Bernd; Schulte, Leon N.] German Ctr Lung Res DZL, Marburg, Hesse, Germany; [Schmeck, Bernd] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Hesse, Germany; [Ringel, Marc; Maisner, Andrea] Philipps Univ Marburg, Inst Virol, Marburg, Hesse, Germany; [Karwelat, Diana] Bayer AG, Mechanist Toxicol Pharmaceut, Berlin, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Bayer AG	Vollmeister, E (corresponding author), Philipps Univ Marburg, Inst Lung Res, Hans Meerwein Str 2, D-35043 Marburg, Hesse, Germany.	evelyn.vollmeister@uni-marburg.de	Vollmeister, Evelyn/ABA-7940-2021	Vollmeister, Evelyn/0000-0002-0539-7874; Schmeck, Bernd/0000-0002-2767-3606; Schulte, Leon/0000-0001-6814-9344	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) [JPI-AMR-FKZ 01Kl1702, ERACoSysMed2-SysMed-COPDFKZ 031L0140, Med CAPSYSFKZ 01ZX1304E]; Deutsche Forschungsgemeinschaft [SFB/TR-84 TP C01]; Von-Behring-Rontgen-Stiftung [66-LV07]; Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics) [519/03/00.001-[0003] s]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Von-Behring-Rontgen-Stiftung; Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics)	has been funded in part by the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, JPI-AMR-FKZ 01Kl1702; ERACoSysMed2-SysMed-COPDFKZ 031L0140; e:Med CAPSYSFKZ 01ZX1304E), the Deutsche Forschungsgemeinschaft (SFB/TR-84 TP C01), the Von-Behring-Rontgen-Stiftung (66-LV07), and the Hessisches Ministerium fur Wissenschaft und Kunst (LOEWE Medical RNomics 519/03/00.001-[0003] s) to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Areshkov PO, 2012, INT J BIOL SCI, V8, P39, DOI 10.7150/ijbs.8.39; Bhardwaj R, 2015, J IMMUNOL, V194, P2862, DOI 10.4049/jimmunol.1400874; Bohr S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140440; Brekman A, 2014, AM J RESP CELL MOL, V51, P688, DOI 10.1165/rcmb.2013-0363OC; Breyne K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01143; Calbo E, 2010, INT J ANTIMICROB AG, V35, P107, DOI 10.1016/j.ijantimicag.2009.10.002; Cawcutt K, 2017, CURR OPIN CRIT CARE, V23, P385, DOI 10.1097/MCC.0000000000000435; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Ciledag A, 2018, TUBERK TORAK, V66, P273, DOI 10.5578/tt.67319; Coopman P, 2016, CELL MOL LIFE SCI, V73, P3535, DOI 10.1007/s00018-016-2260-8; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Deng JC, 2013, INFLUENZA OTHER RESP, V7, P24, DOI 10.1111/irv.12174; Deutschmann C, 2019, CLIN IMMUNOL, V199, P12, DOI 10.1016/j.clim.2018.12.005; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Fikry EM, 2019, BIOMED PHARMACOTHER, V110, P878, DOI 10.1016/j.biopha.2018.12.041; Frasca D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00071; Fu Y, 2016, CYTOKINE, V86, P10, DOI 10.1016/j.cyto.2016.07.003; Galeas-Pena M, 2019, BIOL CHEM, V400, P443, DOI 10.1515/hsz-2018-0304; Gao N, 2015, INFECT IMMUN, V83, P4154, DOI 10.1128/IAI.00980-15; Gomez JL, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00800-2017; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Han FC, 2009, INFECT IMMUN, V77, P3100, DOI 10.1128/IAI.00204-09; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Hozumi H, 2017, J RHEUMATOL, V44, P1394, DOI 10.3899/jrheum.170373; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Janke BH, 2014, VET PATHOL, V51, P410, DOI 10.1177/0300985813513043; Kang MJ, 2015, AM J RESP CELL MOL, V53, P863, DOI 10.1165/rcmb.2014-0366OC; Kim J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213686; Kim MJ, 2019, ALLERGY, V74, P685, DOI 10.1111/all.13661; Komori M, 2011, PEDIATR RES, V69, P101, DOI 10.1203/PDR.0b013e3182055237; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lai TW, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0338-3; Lee CJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10638; Lee CG, 2010, ALLERGY ASTHMA IMMUN, V2, P20, DOI 10.4168/aair.2010.2.1.20; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lee DH, 2019, MOL THER-NUCL ACIDS, V16, P63, DOI 10.1016/j.omtn.2019.02.007; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lim YK, 2019, DIAGN MICR INFEC DIS, V94, P50, DOI 10.1016/j.diagmicrobio.2018.11.014; Lin HW, 2019, ENDOCR-RELAT CANCER, V26, P73, DOI 10.1530/ERC-18-0300; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; MILLIS AJT, 1986, J CELL PHYSIOL, V127, P366, DOI 10.1002/jcp.1041270304; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mora R, 2002, J VIROL, V76, P3544, DOI 10.1128/JVI.76.7.3544-3553.2002; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; RITCHEY MB, 1976, J VIROL, V18, P738, DOI 10.1128/JVI.18.2.738-744.1976; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Stoops EH, 2014, J AM SOC NEPHROL, V25, P1375, DOI 10.1681/ASN.2013080883; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tian PW, 2015, J TRANSL INTERN MED, V3, P89, DOI 10.1515/jtim-2015-0013; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; van Aalst M, 2018, TRAVEL MED INFECT DI, V24, P89, DOI 10.1016/j.tmaid.2018.05.016; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wu NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39668; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929	72	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16432	16448		10.1096/fj.201902988RR	http://dx.doi.org/10.1096/fj.201902988RR		OCT 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33095949	hybrid			2022-12-26	WOS:000583913000001
J	Lauermann, P; Gebest, J; Pfeiffer, S; Feltgen, N; Bemme, S; Hoerauf, H; van Oterendorp, C				Lauermann, Peer; Gebest, Julia; Pfeiffer, Sebastian; Feltgen, Nicolas; Bemme, Sebastian; Hoerauf, Hans; van Oterendorp, Christian			Influence of pars plana vitrectomy for macular surgery on the medium term intraocular pressure	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; EPIRETINAL MEMBRANE; RISK-FACTORS; 23-GAUGE; ELEVATION; 20-GAUGE; LENS; MECHANISM; OUTCOMES; HOLE	Purpose To evaluate the long-term effect of 20 and 23 gauge pars plana vitrectomy (PPV) on intraocular pressure (IOP). Methods Study type: Monocentric retrospective cohort study. 249 eyes of 249 patients undergoing PPV due to epiretinal membrane (EM), idiopathic macular hole (IMH) or vitreoretinal traction (VT) were included. The fellow eye served as control. Exclusion criteria were factors known to influence the IOP, such as cataract surgery during follow-up, extended use of steroids, cryotherapy and silicone oil endotamponade. The relative change of IOP (operated vs. fellow eye) at 6-12 months after surgery was defined as primary endpoint. Secondary endpoints were the relative change of IOP at 3-6 and 12-24 months. Possible influencing cofactors were analysed using ANCOVA. Results The primary endpoint did not show a significant IOP reduction of the operated eye relative to the fellow eye (P = 0.089, n = 84). However, the IOP of the operated eye alone was significantly reduced at 6-12 and 12-24 months after surgery (-0.75 +/- 2.80 and -1.22 +/- 3.29 mmHg, P = 0.008 and 0.007, respectively). The IOP of the fellow eye was also significantly reduced at the 12-24 months period (-0.75 +/- 2.73 mmHg, P = 0.008). In the subgroup analysis, sclerotomy size was a significant influencing cofactor, leading to lower IOP after 20G compared to 23G vitrectomy (P = 0.04). Conclusion Pars plana vitrectomy did not induce a significant long-term IOP reduction relative to the contralateral eye. However, we observed a IOP lowering potential in 20G vitrectomy.	[Lauermann, Peer; Gebest, Julia; Feltgen, Nicolas; Bemme, Sebastian; Hoerauf, Hans; van Oterendorp, Christian] Univ Med Ctr Goettingen, Dept Ophthalmol, Gottingen, Germany; [Pfeiffer, Sebastian] Univ Med Ctr Goettingen, Dept Med Stat, Gottingen, Germany	University of Gottingen; University of Gottingen	Lauermann, P (corresponding author), Univ Med Ctr Goettingen, Dept Ophthalmol, Gottingen, Germany.	peer.lauermann@med.uni-goettingen.de						Ahn SJ, 2012, EYE, V26, P796, DOI 10.1038/eye.2012.23; Benz MS, 2004, ARCH OPHTHALMOL-CHIC, V122, P705, DOI 10.1001/archopht.122.5.705; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Chen CJ, 1998, OPHTHALMOLOGY, V105, P94, DOI 10.1016/S0161-6420(98)91470-1; Chen PP, 1997, OPHTHALMIC SURG LAS, V28, P37; Desai UR, 1997, OPHTHALMOLOGY, V104, P781, DOI 10.1016/S0161-6420(97)30233-4; Fine HF, 2007, OPHTHALMOLOGY, V114, P1197, DOI 10.1016/j.ophtha.2007.02.020; Framme C, 2012, ACTA OPHTHALMOL, V90, P744, DOI 10.1111/j.1755-3768.2011.02251.x; Fujikawa M, 2014, GRAEF ARCH CLIN EXP, V252, P389, DOI 10.1007/s00417-013-2475-4; Gupta OP, 2008, AM J OPHTHALMOL, V146, P193, DOI 10.1016/j.ajo.2008.04.010; HAN DP, 1989, OPHTHALMOLOGY, V96, P1357; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; Ki-I Y, 2013, JPN J OPHTHALMOL, V57, P57, DOI 10.1007/s10384-012-0207-7; Koreen L, 2012, RETINA-J RET VIT DIS, V32, P160, DOI 10.1097/IAE.0b013e318217fffb; Krishnan R, 2013, EYE, V27, P72, DOI 10.1038/eye.2012.227; Lalezary M, 2014, OPHTHALMOLOGY, V121, P1983, DOI 10.1016/j.ophtha.2014.04.008; Lalezary M, 2011, RETINA-J RET VIT DIS, V31, P679, DOI 10.1097/IAE.0b013e3181ff0d5a; Luk FOJ, 2009, RETINA-J RET VIT DIS, V29, P218, DOI 10.1097/IAE.0b013e31818ba9ca; Machemer R, 1971, Trans Am Acad Ophthalmol Otolaryngol, V75, P813; Mi CW, 2015, RETINA-J RET VIT DIS, V35, P2543, DOI 10.1097/IAE.0000000000000641; Parravano M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009080.pub2; Schechet SA, 2017, RETINA-J RET VIT DIS, V37, P873, DOI 10.1097/IAE.0000000000001263; Shields RA, 2019, ASIA-PAC J OPHTHALMO, V8, P36, DOI 10.22608/APO.2018398; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Steel DHW, 2013, EYE, V27, pS1, DOI 10.1038/eye.2013.212; Toyokawa N, 2015, AM J OPHTHALMOL, V159, P727, DOI 10.1016/j.ajo.2015.01.010; WEINBERG RS, 1976, A GRAEF ARCH KLIN EX, V200, P157, DOI 10.1007/BF00414365; Wimpissinger B, 2008, BRIT J OPHTHALMOL, V92, P1483, DOI 10.1136/bjo.2008.140509; Wu L, 2014, RETINA-J RET VIT DIS, V34, P1985, DOI 10.1097/IAE.0000000000000189; Yamamoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167303; Yamashita T, 2007, J GLAUCOMA, V16, P220, DOI 10.1097/IJG.0b013e31802d6e16; Yu AL, 2010, GRAEF ARCH CLIN EXP, V248, P1407, DOI 10.1007/s00417-010-1409-7; Zhang JL, 2015, ASIA-PAC J OPHTHALMO, V4, P367, DOI 10.1097/APO.0000000000000139	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241005	10.1371/journal.pone.0241005	http://dx.doi.org/10.1371/journal.pone.0241005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095828	Green Published, gold			2022-12-26	WOS:000586649400011
J	Song, JH; Eum, DY; Park, SY; Jin, YH; Shim, JW; Park, SJ; Kim, MY; Park, SJ; Heo, K; Choi, YJ				Song, Joong-Hyun; Eum, Da-Young; Park, Soon-Yong; Jin, Yun-Ho; Shim, Jae-Woong; Park, Shin-Ji; Kim, Min-Young; Park, Seong-Jun; Heo, Kyu; Choi, Yoo-Jin			Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells	PLOS ONE			English	Article							CROSS-TALK; ACTIVATION; STAT3	Ginsenoside Rg3 (Rg3) has been studied in several cancer models and is suggested to act through various pharmacological effects. We investigated the anticancer properties of Rg3 through myeloid-derived suppressor cell (MDSC) modulation in FM3A mouse mammary carcinoma cells. The effects of Rg3 on MDSCs and consequent changes in cancer stem-like cells (CSCs) and epithelial-mesenchymal transition (EMT) were evaluated by diverse methods. MDSCs promoted cancer by enhancing breast cancer stemness and promoting EMT. Rg3 at a dose without obvious cytotoxicity downregulated MDSCs and repressed MDSC-induced cancer stemness and EMT. Mechanistic investigations suggested that these inhibitory effects of Rg3 on MDSCs and corresponding cancer progression depend upon suppression of the STAT3-dependent pathway, tumor-derived cytokines, and the NOTCH signaling pathway. In a mouse model, MDSCs accelerated tumor progression, and Rg3 delayed tumor growth, which is consistent with the results ofin vitroexperiments. These results indicated that Rg3 could effectively inhibit the progression of breast cancer. The anticancer effect of Rg3 might be partially due to its downregulation of MDSCs and consequent repression of cancer stemness and EMT in breast cancer. Hence, we suggest the regulation of MDSCs through Rg3 treatment as an effective therapeutic strategy for breast cancer patients.	[Song, Joong-Hyun; Eum, Da-Young; Park, Soon-Yong; Jin, Yun-Ho; Shim, Jae-Woong; Park, Shin-Ji; Kim, Min-Young; Park, Seong-Jun; Heo, Kyu; Choi, Yoo-Jin] Dongnam Inst Radiol & Med Sci, Dept Res Ctr, Busan, South Korea	Korea Institute of Radiological & Medical Sciences	Choi, YJ (corresponding author), Dongnam Inst Radiol & Med Sci, Dept Res Ctr, Busan, South Korea.	cyj5325@dirams.re.kr	jin, yun/GQZ-6618-2022	Heo, Kyu/0000-0001-8833-4731	National Research Foundation of Korea (DIRAMS) grant - Korea government (MSIP) [50590-2020]	National Research Foundation of Korea (DIRAMS) grant - Korea government (MSIP)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (DIRAMS) grant funded by the Korea government (MSIP) (50590-2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2000, CLIN CANCER RES, V6, P1755; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; [Anonymous], 2005, PSYCHOL HEALTH MED, V5, P263; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Chen XP, 2011, INT J CLIN ONCOL, V16, P519, DOI 10.1007/s10147-011-0222-6; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ham SW, 2019, J ETHNOPHARMACOL, V236, P393, DOI 10.1016/j.jep.2019.03.031; Jeon C, 2011, J GINSENG RES, V35, P462, DOI 10.5142/jgr.2011.35.4.462; Kim HS, 2004, ARCH PHARM RES, V27, P429, DOI 10.1007/BF02980085; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Ostrand-Rosenberg S, 2018, J IMMUNOL, V200, P422, DOI 10.4049/jimmunol.1701019; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Panni RZ, 2014, CANCER IMMUNOL IMMUN, V63, P513, DOI 10.1007/s00262-014-1527-x; Park D, 2011, ENVIRON TOXICOL PHAR, V31, P397, DOI 10.1016/j.etap.2011.01.008; Peng DJ, 2016, CANCER RES, V76, P3156, DOI 10.1158/0008-5472.CAN-15-2528; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sica A, 2017, CANCER IMMUNOL IMMUN, V66, P1025, DOI 10.1007/s00262-017-1997-8; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sun MY, 2017, INT J MOL MED, V39, P507, DOI 10.3892/ijmm.2017.2857; Tang YC, 2018, INT J ONCOL, V52, P127, DOI 10.3892/ijo.2017.4183; Toor SM, 2017, CANCER IMMUNOL IMMUN, V66, P753, DOI 10.1007/s00262-017-1977-z; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Wang JJ, 2018, CANCER LETT, V415, P73, DOI 10.1016/j.canlet.2017.11.037; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xu TM, 2008, CHINESE MED J-PEKING, V121, P1394, DOI 10.1097/00029330-200808010-00012; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; 2018, CURR OPIN TOXICOL, V10	35	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240533	10.1371/journal.pone.0240533	http://dx.doi.org/10.1371/journal.pone.0240533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091036	Green Published, gold			2022-12-26	WOS:000586647200043
J	Yang, H; Zhu, H; Fu, HM				Yang, Hui; Zhu, Hui; Fu, Haiming			Numerical calculation and analysis of filtration performance of an effective novel structural fiber for PM2.5	PLOS ONE			English	Article							CROSS-SECTIONAL SHAPE; DEPOSITION; COLLECTION; EFFICIENCY; FILTERS; NANOPARTICLES; OPTIMIZATION; DISPERSION; PARTICLES; MEMBRANES	In this study, a novel fiber with slit-crescent-shaped cross-section is proposed to enhance the filtration performance of PM(2.5)in fibrous filtration. The collection efficiency of this fiber is simulated by using a Brownian dynamics simulation technique, and its filtration pressure drop is obtained by numerically solving Navier-Stokes equation with Fluent software. A parametric study is performed to improve the optimum filtration performance of the slit-crescent-shaped fiber via adjusting its structural parameters (dimensionless center-to-center spacing and slit width). Results indicate that at the optimal condition, i.e., when dimensionless slit width ranges from 0.2 to 0.4, collection efficiency is enhanced by 13.1%-101.1% relative to the circular fiber for particles ranging from 0.1 mu m to 2.5 mu m for the slit-crescent-shaped fiber under various dimensionless center-to-center spacing, and filtration pressure drop is reduced by up to 14.4%. In addition, quality factor is introduced to evaluate the comprehensive filtration performance of the slit-crescent-shaped fiber with different structural parameters, and results show that large dimensionless slit width and small dimensionless center-to-center spacing lead to a much higher quality factor than the circular fiber, especially for particles lager than 0.5 mu m. The numerical results obtained in this work are conducive to designing high efficiency fibrous filters.	[Yang, Hui; Fu, Haiming] Donghua Univ, Coll Environm Sci & Engn, Shanghai, Peoples R China; [Yang, Hui; Zhu, Hui] Guilin Univ Aerosp Technol, Coll Energy & Bldg Environm, Guilin, Peoples R China	Donghua University; Guilin University of Aerospace Technology	Fu, HM (corresponding author), Donghua Univ, Coll Environm Sci & Engn, Shanghai, Peoples R China.	fhm@dhu.edu.cn		Yang, Hui/0000-0001-8783-0178	National Natural Science Foundation of China [41371445, 51178094]; Natural Science Foundation of Guangxi Zhuang Autonomous Region [2017GXNSFAA198184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Zhuang Autonomous Region(National Natural Science Foundation of Guangxi Province)	This study was financially supported by the National Natural Science Foundation of China (Grant No. 41371445, 51178094, URL: http://www.nsfc.gov.cn/english/site_1/index.html) and Natural Science Foundation of Guangxi Zhuang Autonomous Region (Grant No. 2017GXNSFAA198184, URL: http://gkg.kjt.gxzf.gov.cn/egrantweb/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no authors received a salary from the funders.	[Anonymous], 2007, V WOOLF B, V26, P50; Bodnar T., 2017, ADV MATH FLUID MECH; Bortolassi ACC, 2019, MAT SCI ENG C-MATER, V102, P718, DOI 10.1016/j.msec.2019.04.094; Chen S, 2002, COMPUT MECH, V28, P152, DOI 10.1007/s00466-001-0289-4; Crowe CT, 2011, MULTIPHASE FLOWS DRO, DOI [10.1201/b11103, DOI 10.1201/B11103]; Davies CN., 1973, AIR FILTRATION; Fotovati S, 2011, J HAZARD MATER, V186, P1503, DOI 10.1016/j.jhazmat.2010.12.027; [顾丛汇 Gu Conghui], 2014, [化工学报, CIESC Journal], V65, P2137; Hosseinalipour SM, 2019, J MECH SCI TECHNOL, V33, P2307, DOI 10.1007/s12206-018-1231-4; Hosseini SA, 2011, POWDER TECHNOL, V212, P425, DOI 10.1016/j.powtec.2011.06.025; [黄浩凯 Huang Haokai], 2017, [中国科学院大学学报, Journal of University of Chinese Academy of Sciences], V34, P210; Inagaki M, 2001, KAGAKU KOGAKU RONBUN, V27, P113, DOI 10.1252/kakoronbunshu.27.113; Inthavong K, 2016, J AEROSOL SCI, V96, P56, DOI 10.1016/j.jaerosci.2016.02.010; Jin XM, 2017, ADV POWDER TECHNOL, V28, P1193, DOI 10.1016/j.apt.2017.02.005; LEE KW, 1982, AEROSOL SCI TECH, V1, P35; Leung WWF, 2012, SEP PURIF TECHNOL, V92, P174, DOI 10.1016/j.seppur.2011.02.020; LI A, 1992, AEROSOL SCI TECH, V16, P209, DOI 10.1080/02786829208959550; Li W, 2016, ADV POWDER TECHNOL, V27, P638, DOI 10.1016/j.apt.2016.02.018; Lin KC, 2017, COMPUT FLUIDS, V156, P534, DOI 10.1016/j.compfluid.2017.08.011; Munson B.R., 2012, FUNDAMENTALS FLUID M, V7th; Przekop R, 2008, AEROSOL SCI TECH, V42, P483, DOI 10.1080/02786820802187077; Rabiee MB, 2015, PARTICUOLOGY, V21, P90, DOI 10.1016/j.partic.2014.11.010; Raynor PC, 2002, AEROSOL SCI TECH, V36, P1118, DOI 10.1080/02786820290092159; Shou D., 2015, J NANOMATER, V16, P351; Viswanathan G, 2004, ADV MATER, V16, P2045, DOI 10.1002/adma.200400463; Wang HM, 2014, AEROSOL SCI TECH, V48, P207, DOI 10.1080/02786826.2013.868595; Wang J, 2008, AEROSOL SCI TECH, V42, P722, DOI 10.1080/02786820802249133; Wang J, 2009, J NANOPART RES, V11, P185, DOI 10.1007/s11051-008-9422-z; Wang K, 2015, AEROSOL SCI TECH, V49, P75, DOI 10.1080/02786826.2014.1003278; Wang N, 2014, SEP PURIF TECHNOL, V126, P44, DOI 10.1016/j.seppur.2014.02.017; Wang WX, 2012, AEROSOL SCI TECH, V46, P843, DOI 10.1080/02786826.2012.671559; Longest PW, 2007, AEROSOL SCI TECH, V41, P380, DOI 10.1080/02786820701203223; Xu MM, 2020, ENVIRON RES, V183, DOI 10.1016/j.envres.2019.109066; Yang C. F., 2012, BIOCH PHYSL OPEN ACC, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0033870; Yang M, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105745; Yun KM, 2010, SEP PURIF TECHNOL, V75, P340, DOI 10.1016/j.seppur.2010.09.002; Zhu C, 2000, POWDER TECHNOL, V112, P149, DOI 10.1016/S0032-5910(99)00315-0; [朱辉 Zhu Hui], 2019, [中国环境科学, China Environmental Science], V39, P565	38	0	0	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240941	10.1371/journal.pone.0240941	http://dx.doi.org/10.1371/journal.pone.0240941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091026	Green Published, gold			2022-12-26	WOS:000586647200065
J	Green, MS; Peer, V; Schwartz, N; Nitzan, D				Green, Manfred S.; Peer, Victoria; Schwartz, Naama; Nitzan, Dorit			The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal-a comparison of age-specific and age-adjusted CFRs between seven countries	PLOS ONE			English	Article								Background Crude case-fatality rates (CFRs) for COVID-19 vary widely between countries. There are serious limitations in the CFRs when making comparisons. We examined how the age distribution of the cases is responsible for the COVID-19 CFR differences between countries. Methods COVID-19 cases and deaths, by ten-year age-groups, were available from the reports of seven countries. The overall and age-specific CFRs were computed for each country. The age-adjusted CFRs were computed by the direct method, using the combined number of cases in all seven countries in each age group as the standard population. A meta-analytic approach was used to obtain pooled age-specific CFRs. Findings The crude overall CFRs varied between 0.82% and 14.2% in the seven countries and the variation in the age-specific CFRs were much smaller. There was wide variation in the age distribution of the cases between countries. The ratio of the crude CFR for the country with the highest CFR to that with the lowest (6.28) was much lower for the age-adjusted CFRs rates (2.57). Conclusions The age structure of the cases explains much of differences in the crude CFRs between countries and adjusting for age substantially reduces this variation. Other factors such as the definition of cases, coding of deaths and the standard of healthcare are likely to account for much of the residual variation. It is misleading to compare the crude COVID-19 CFRs between countries and should be avoided. At the very least, age-specific and age-adjusted CFRs should be used for comparisons.	[Green, Manfred S.; Peer, Victoria; Schwartz, Naama] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Nitzan, Dorit] WHO, European Reg, Copenhagen, Denmark	University of Haifa; World Health Organization	Green, MS (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	manfred.s.green@gmail.com		Peer, Victoria/0000-0003-1291-0928; Nitzan, Dorit/0000-0002-4280-2939; Green, Manfred S./0000-0002-9753-5612				[Anonymous], WORLD POP AG 2019; [Anonymous], NY TIMES; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; China CDC (Chinese Center for Disease Control and Prevention), 2020, EP CHAR OUTBR 2019 N, V2, P2020; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lipsitch M, 2020, LANCET INFECT DIS, V20, P775, DOI [10.1016/S1473-3099(20)30246-2, 10.1016/S1473-3099(20)30245-0]; Lipsitch M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003846; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m3327, 10.1136/bmj.m1327]; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600; Public Health Agency of Canada, COR DIS 2019 COVID 1; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Yang S, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.66	14	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241031	10.1371/journal.pone.0241031	http://dx.doi.org/10.1371/journal.pone.0241031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085731	gold, Green Published, Green Submitted			2022-12-26	WOS:000585943400048
J	Reed, O; Jubber, I; Griffin, J; Noon, AP; Goodwin, L; Hussain, S; Cumberbatch, MG; Catto, JWF				Reed, Oliver; Jubber, Ibrahim; Griffin, Jon; Noon, Aidan P.; Goodwin, Louise; Hussain, Syed; Cumberbatch, Marcus G.; Catto, James W. F.			Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes	PLOS ONE			English	Article							RISK; MORTALITY; METAANALYSIS	Objectives Up to 10% of Bladder Cancers may arise following occupational exposure to carcinogens. We hypothesised that different cancer phenotypes reflected different patterns of occupational exposure. Methods Consecutive participants, with bladder cancer, self-completed a structured questionnaire detailing employment, tasks, exposures, smoking, lifestyle and family history. Our primary outcome was association between cancer phenotype and occupational details. Results We collected questionnaires from 536 patients, of whom 454 (85%) participants (352 men and 102 women) were included. Women were less likely to be smokers (68% vs. 81% Chi sq. p<0.001), but more likely than men to inhale environmental tobacco smoke at home (82% vs. 74% p = 0.08) and use hair dye (56% vs. 3%, p<0.001). Contact with potential carcinogens occurred in 282 (62%) participants (mean 3.1 per worker (range 0-14)). High-grade cancer was more common than low-grade disease in workers from the steel, foundry, metal, engineering and transport industries (p<0.05), and in workers exposed to crack detection dyes, chromium, coal/oil/gas by-products, diesel fumes/fuel/aircraft fuel and solvents (such as trichloroethylene). Higher staged cancers were frequent in workers exposed to Chromium, coal products and diesel exhaust fumes/fuel (p<0.05). Various workers (e.g. exposed to diesel fuels or fumes (Cox, HR 1.97 (95% CI 1.31-2.98) p = 0.001), employed in a garage (HR 2.19 (95% CI 1.31-3.63) p = 0.001), undertaking plumbing/gas fitting/ventilation (HR 2.15 (95% CI 1.15-4.01) p = 0.017), undertaking welding (HR 1.85 (95% CI 1.24-2.77) p = 0.003) and exposed to welding materials (HR 1.92 (95% CI 1.27-2.91) p = 0.002)) were more likely to have disease progression and receive radical treatment than others. Fewer than expected deaths were seen in healthcare workers (HR 0.17 (95% CI 0.04-0.70) p = 0.014). Conclusions We identified multiple occupational tasks and contacts associated with bladder cancer. There were some associations with phenotype, although our study design precludes robust assessment.	[Reed, Oliver; Jubber, Ibrahim; Goodwin, Louise; Cumberbatch, Marcus G.; Catto, James W. F.] Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England; [Griffin, Jon] Sheffield Teaching Hosp NHS Trust, Dept Pathol, Sheffield, S Yorkshire, England; [Noon, Aidan P.; Catto, James W. F.] Sheffield Teaching Hosp NHS Trust, Dept Urol, Sheffield, S Yorkshire, England; [Hussain, Syed] Univ Sheffield, Acad Oncol Unit, Western Pk, Sheffield, S Yorkshire, England; [Cumberbatch, Marcus G.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Peter Maccallum Cancer Center	Catto, JWF (corresponding author), Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England.; Catto, JWF (corresponding author), Sheffield Teaching Hosp NHS Trust, Dept Urol, Sheffield, S Yorkshire, England.	j.catto@sheffield.ac.uk	; Noon, Aidan/L-9804-2013	catto, james/0000-0003-2787-8828; Griffin, Jon/0000-0003-3969-7637; Noon, Aidan/0000-0002-5999-173X	Yorkshire Cancer Research [S310, S385]	Yorkshire Cancer Research	JWFC received project grant awards to perform this work from Yorkshire Cancer Research (yorkshirecancerresearch.org.uk, Numbers S310: Epigenetic carcinogenesis in the urothelium: development of a model system and examination of candidate occupational carcinogens and S385: The Yorkshire Cancer Research Bladder Cancer Patient Reported Outcomes Survey). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Benbrahim-Tallaa L, 2012, LANCET ONCOL, V13, P663, DOI 10.1016/S1470-2045(12)70280-2; Boffetta P, 2001, EPIDEMIOLOGY, V12, P125, DOI 10.1097/00001648-200101000-00021; Bourke L, 2017, EUR UROL, V71, P915, DOI 10.1016/j.eururo.2016.12.022; CARTWRIGHT RA, 1983, CARCINOGENESIS, V4, P111, DOI 10.1093/carcin/4.1.111; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Cumberbatch MG, 2017, BJU INT, V119, P100, DOI 10.1111/bju.13561; Cumberbatch MG, 2016, EUR UROL, V70, P458, DOI 10.1016/j.eururo.2015.06.042; Cumberbatch MGK, 2015, JAMA ONCOL, V1, P1282, DOI 10.1001/jamaoncol.2015.3209; Cumberbatch MGK, 2018, EUR UROL, V74, P784, DOI 10.1016/j.eururo.2018.09.001; Freedman ND, 2011, JAMA-J AM MED ASSOC, V306, P737, DOI 10.1001/jama.2011.1142; Freeman LEB, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp89, 10.1289/EHP89]; Hurst Carolyn, 2018, Cancer Cell, V34, P350, DOI 10.1016/j.ccell.2018.07.013; Jubber I, 2020, EUR UROL, V77, P583, DOI 10.1016/j.eururo.2019.10.010; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Larre S, 2013, EUR UROL, V63, P1049, DOI 10.1016/j.eururo.2012.12.062; Linton KD, 2013, J UROLOGY, V189, P828, DOI 10.1016/j.juro.2012.09.084; Noon AP, 2013, BRIT J CANCER, V108, P1534, DOI 10.1038/bjc.2013.106; Noon AP, 2018, EUR UROL FOCUS, V4, P725, DOI 10.1016/j.euf.2016.06.014; Noon AP, 2012, OCCUP ENVIRON MED, V69, P300, DOI 10.1136/oemed-2011-100379; Paner GP, 2018, EUR UROL, V73, P560, DOI 10.1016/j.eururo.2017.12.018; Pesch B, 2011, BJU INT, V108, P546, DOI 10.1111/j.1464-410X.2010.09971.x; Porru S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094566; Robertson AG, 2018, CELL, V174, P1033, DOI 10.1016/j.cell.2018.07.036; Rushton L, 2010, BRIT J CANCER, V102, P1428, DOI 10.1038/sj.bjc.6605637; Svatek RS, 2014, EUR UROL, V66, P253, DOI 10.1016/j.eururo.2014.01.006; Zlotta AR, 2011, EUR UROL, V59, P1026, DOI 10.1016/j.eururo.2011.03.027	28	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239338	10.1371/journal.pone.0239338	http://dx.doi.org/10.1371/journal.pone.0239338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085669	Green Published, Green Accepted, gold			2022-12-26	WOS:000585943400022
J	Dat, VQ; Toan, PK; van Doorn, HR; Thwaites, CL; Nadjm, B				Dat, Vu Quoc; Toan, Phan Khanh; van Doorn, H. Rogier; Thwaites, C. Louise; Nadjm, Behzad			Purchase and use of antimicrobials in the hospital sector of Vietnam, a lower middle-income country with an emerging pharmaceuticals market	PLOS ONE			English	Article							ANTIBIOTIC CONSUMPTION	Introduction Antimicrobial use is associated with emergence of antimicrobial resistance. We report hospital antimicrobial procurement, as a surrogate for consumption in humans, expenditure and prices in public hospitals in Vietnam, a lower middle-income country with a high burden of drug resistant infections. Method Data on antimicrobial procurement were obtained from tender-winning bids from provincial health authorities and public hospitals with detailed bids representing 28.7% (1.68 / 5.85 billion US $) of total hospital medication spend in Vietnam. Antimicrobials were classified using the Anatomical Therapeutic Chemical (ATC) Index and the 2019 WHO Access, Watch, Reserve (AWaRe) groups. Volume was measured in number of Defined Daily Doses (DDD). Antimicrobial prices were presented per DDD. Results Expenditure on systemic antibacterials and antifungals accounted for 28.6% (US $482.6 million/US $1.68 billion) of the total drug bids. 83% of antibacterials (572,698,014 DDDs) by volume (accounting for 45.5% of the antibacterials spend) were domestically supplied. Overall, the most procured antibacterials by DDD were second generation cephalosporins, combinations of penicillins and beta-lactamase inhibitors, and penicillins with extended spectrum. For parenteral antibacterials this was third generation cephalosporins. The average price for antibacterials was US $15.6, US $0.86, US $0.4 and US $11.7 per DDD for Reserve, Watch, Access and non-recommended/unclassified group antibacterials, respectively. Conclusions Antimicrobials accounted for a substantial proportion of the funds spent for medication in public hospitals in Vietnam. The pattern of antibacterial consumption was similar to other countries. The high prices of Reserve group and non-recommended/unclassified antibacterials suggests a need for a combination of national pricing and antimicrobial stewardship policies to ensure appropriate accessibility.	[Dat, Vu Quoc; Toan, Phan Khanh] Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam; [Dat, Vu Quoc] Hanoi Med Univ Hosp, Hanoi, Vietnam; [Dat, Vu Quoc; van Doorn, H. Rogier; Thwaites, C. Louise; Nadjm, Behzad] Univ Oxford, Clin Res Unit, Wellcome Africa Asia Programme, Hanoi, Vietnam; [van Doorn, H. Rogier; Thwaites, C. Louise] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Nadjm, Behzad] MRC Gambia London Sch Hyg & Trop Med, Fajara, Gambia	Hanoi Medical University; Hanoi Medical University; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Dat, VQ (corresponding author), Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam.; Dat, VQ (corresponding author), Hanoi Med Univ Hosp, Hanoi, Vietnam.; Dat, VQ (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Africa Asia Programme, Hanoi, Vietnam.	datvq@hmu.edu.vn	van Doorn, H. Rogier/H-3080-2019; Dat, Vu Quoc/L-8899-2017	van Doorn, H. Rogier/0000-0002-9807-1821; Dat, Vu Quoc/0000-0002-5904-5970	Wellcome Trust of Great Britain [106680/Z/14/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the Wellcome Trust of Great Britain (106680/Z/14/Z).	Alpern JD, 2017, CLIN INFECT DIS, V65, P1848, DOI 10.1093/cid/cix634; Angelino A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14090976; Anh Tuan Nguyen, 2009, Southern Med Review, V2, P2; [Anonymous], 2005, LANCET, V365, P579; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Business Monitor International Ltd, 2016, VIET PHARM HEALTHC R; Drug Administration of Vietnam, 2018, SUMM BID WINN RES NA; Embrey MA, 2013, MDS 3 MANAGING ACCES; European Centre for Disease Prevention and Control, 2018, ANT CONS ANN EP REP; General Statistics Office, 2018, STAT SUMM BOOK VIETN; Hsia YF, 2019, LANCET GLOB HEALTH, V7, pE861, DOI 10.1016/S2214-109X(19)30071-3; Mao WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117710; Ministry of Health, 2019, REP HEALTHC SYST 201; Ministry of Health, 2016, BIDD SUPPL DRUGS PUB; National Institute for Health and Care Excellence (NICE), 2020, CEPH 2020; Nguyen H, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000082; OECD, 2017, HLTH GLANC 2017 OECD; Sharland M, 2018, LANCET INFECT DIS, V18, P18, DOI 10.1016/S1473-3099(17)30724-7; The Prime Minister, 2014, DEC APPR NAT STRAT D; The World Bank Group, 2019, WORLD DEV IND EXCH R; Nguyen TA, 2017, HEALTH POLICY PLANN, V32, P647, DOI 10.1093/heapol/czw174; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Versporten A, 2018, LANCET GLOB HEALTH, V6, pE619, DOI [10.1016/S2214-109X(18)30186-4, 10.1016/s2214-109x(18)30186-4]; Viet Nam Ministry of Health, 2018, DET REG GUID LIST PH; Vietnam's Prime Minister, 2013, APPR NAT STRAT PROT; VU HT, 2016, SPRINGERPLUS, V5, DOI DOI 10.1186/S40064-016-3200-727652076; Dat VQ, 2017, J CRIT CARE, V42, P109, DOI 10.1016/j.jcrc.2017.07.020; Dat VQ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2582-7; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; *WHO COLL CTR DRUG, 2017, GUID ATC CLASS DDD A; WHO Collaborating Centre for Drug Statistics Methodology, 2018, ATC CLASS IND DDDS 2; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; WHO International Working Group for Drug Statistics Methodology, 2003, WHAT IS DRUG UT RES; WHO (World Health Organization), 2018, REP SURV ANT CONS 20; World Health Organisation, 2017, WHO MOD LIST ESS MED; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2019, 2019 AWARE CLASS ANT; World Health Organization, 2015, INT MED PROD PRIC GU; World Health Organization, 2018, GLOB HLTH EXP DAT HL; Yin J, 2018, J ANTIMICROB CHEMOTH, V73, P814, DOI 10.1093/jac/dkx469	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240830	10.1371/journal.pone.0240830	http://dx.doi.org/10.1371/journal.pone.0240830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079967	Green Published, gold			2022-12-26	WOS:000585940600009
J	Usui, C; Kawakami, R; Tanisawa, K; Ito, T; Tabata, H; Iizuka, S; Kawamura, T; Midorikawa, T; Sawada, SS; Torii, S; Sakamoto, S; Suzuki, K; Ishii, K; Oka, K; Muraoka, I; Higuchi, M				Usui, Chiyoko; Kawakami, Ryoko; Tanisawa, Kumpei; Ito, Tomoko; Tabata, Hiroki; Iizuka, Satoshi; Kawamura, Takuji; Midorikawa, Taishi; Sawada, Susumu S.; Torii, Suguru; Sakamoto, Shizuo; Suzuki, Katsuhiko; Ishii, Kaori; Oka, Koichiro; Muraoka, Isao; Higuchi, Mitsuru			Visceral fat and cardiorespiratory fitness with prevalence of pre-diabetes/diabetes mellitus among middle-aged and elderly Japanese people: WASEDA'S Health Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; RISK-FACTORS; ADIPOSE-TISSUE; MEN; EPIDEMIOLOGY; PREDICTOR; POWER; EAST	The relationships between cardiorespiratory fitness (CRF) measurements not confounded by adiposity and the prevalence of pre-diabetes mellitus (pre-DM) and diabetes mellitus (DM) are not well known. Thus, we aimed to investigate the associations of visceral fat (VF) and CRF with the prevalence of pre-DM/DM among Japanese adults. The study included 970 individuals (327 women and 643 men) who were 40-87 years old and had complete health examinations, abdominal fat area, and fitness data from WASEDA'S Health Study during 2015-2018. The VF area was measured using magnetic resonance imaging. CRF was measured using a cycle ergometer and was defined as VO(2)peak divided by fat free mass. The pre-DM/DM was identified based on the questionnaire and fasting blood tests. The odds ratios (ORs) and 95% confidence intervals (CIs) for prevalence of pre-DM/DM were calculated. Seventy-three participants had pre-DM and 48 participants had DM. Compared to the low VF group, the high VF group had a higher prevalence of pre-DM/DM (OR: 1.87, 95% CI: 1.18-2.96), although no significant relationship was observed between CRF and pre-DM/DM prevalence (Pfor trend = 0.239). The sub-group analyses also revealed no significant relationship between CRF and pre-DM/DM prevalence in the low VF group (Pfor trend = 0.979), although CRF values were inversely related to the prevalence of pre-DM/DM in the high VF group (Pfor trend = 0.024). Although CRF was not independently related to the prevalence of pre-DM/DM after adjusting for adiposity, higher VF values were related to a higher prevalence of pre-DM/DM. In addition, CRF levels were inversely associated with the prevalence of pre-DM/DM only among high VF individuals.	[Usui, Chiyoko; Kawakami, Ryoko; Tanisawa, Kumpei; Kawamura, Takuji; Sawada, Susumu S.; Torii, Suguru; Sakamoto, Shizuo; Suzuki, Katsuhiko; Ishii, Kaori; Oka, Koichiro; Muraoka, Isao; Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Saitama, Japan; [Ito, Tomoko; Tabata, Hiroki; Iizuka, Satoshi; Midorikawa, Taishi] Waseda Univ, Waseda Inst Sport Sci, Saitama, Japan; [Tabata, Hiroki] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Iizuka, Satoshi] Japan Inst Sports Sci, Dept Sport Sci, Tokyo, Japan; [Midorikawa, Taishi] JF Oberlin Univ, Coll Hlth & Welf, Tokyo, Japan	Waseda University; Waseda University; Juntendo University	Usui, C (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.	c.usui@aoni.waseda.jp	Sawada, Susumu S/L-4173-2019; Kawakami, Ryoko/K-8149-2019	Sawada, Susumu S/0000-0002-7272-0790; Kawakami, Ryoko/0000-0001-8211-1553; Tanisawa, Kumpei/0000-0002-9334-7104; Tabata, Hiroki/0000-0001-9396-5247; Usui, Chiyoko/0000-0002-8189-8312; Iizuka, Satoshi/0000-0002-0480-3754	Japan Society for the Promotion of Science [26242070, 18H03198, 19H04008]; Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology [S1511017]; Institute of Stress Science, Public Health Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology; Institute of Stress Science, Public Health Research Foundation	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [26242070, I. Muraoka; 18H03198, M. Higuchi; 19H04008, I. Muraoka] and the Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology [S1511017], part of a collaborative research project with Institute of Stress Science, Public Health Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention Division of Diabetes Translation, 2017, MAPS TRENDS DIAGN DI; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chan ZL, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13079; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Dencker M, 2010, ACTA PAEDIATR, V99, P1854, DOI 10.1111/j.1651-2227.2010.01952.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FUJIMOTO WY, 1995, OBES RES, V3, pS179, DOI 10.1002/j.1550-8528.1995.tb00461.x; Granados A, 2019, DIABETES OBES METAB, V21, P267, DOI 10.1111/dom.13513; Haneda M, 2018, J DIABETES INVEST, V9, P657, DOI 10.1111/jdi.12810; Huth C, 2016, J PHYSIOL BIOCHEM, V72, P435, DOI 10.1007/s13105-016-0488-2; Imboden MT, 2020, MED SCI SPORT EXER, V52, P1532, DOI 10.1249/MSS.0000000000002289; International Diabetes Federation, 2019, IDF DIAB ATL 9; Ito T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010006; Jukarainen S, 2017, J CLIN ENDOCR METAB, V102, P1520, DOI 10.1210/jc.2016-3435; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kawakami R, 2018, J EPIDEMIOL, V28, P266, DOI [10.2188/jea.je20170017, 10.2188/jea.JE20170017]; Kawakami R, 2014, J EPIDEMIOL, V24, P25, DOI 10.2188/jea.JE20130076; Kim K, 2008, METABOLISM, V57, P1181, DOI 10.1016/j.metabol.2008.04.009; Kong APS, 2013, NAT REV ENDOCRINOL, V9, P537, DOI 10.1038/nrendo.2013.102; Krachler B, 2015, EUR J PREV CARDIOL, V22, P1171, DOI 10.1177/2047487314557962; Kuwahara K, 2014, PLOS ONE, V9, P1, DOI 10.1371/journal.pone.0098508; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Liu L, 2018, CURR MED RES OPIN, V34, P123, DOI 10.1080/03007995.2017.1364226; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; McMurray RG, 2011, ANN HUM BIOL, V38, P647, DOI 10.3109/03014460.2011.598561; Murakami K, 2006, AM J CLIN NUTR, V83, P1161, DOI 10.1093/ajcn/83.5.1161; Nagano M, 2004, METABOLISM, V53, P644, DOI 10.1016/j.metabol.2003.11.023; Osman AF, 2000, J AM COLL CARDIOL, V36, P2126, DOI 10.1016/S0735-1097(00)00985-2; Palmisano BT, 2017, ADV EXP MED BIOL, V1043, P227, DOI 10.1007/978-3-319-70178-3_12; Qiu SH, 2019, OBESITY, V27, P315, DOI 10.1002/oby.22368; Racette SB, 2006, DIABETES CARE, V29, P673, DOI 10.2337/diacare.29.03.06.dc05-1605; Savonen K, 2012, INT J OBESITY, V36, P1135, DOI 10.1038/ijo.2011.212; Usui C, 2010, J NUTR SCI VITAMINOL, V56, P109, DOI 10.3177/jnsv.56.109; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zaccardi F, 2015, ATHEROSCLEROSIS, V243, P131, DOI 10.1016/j.atherosclerosis.2015.09.016; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0241018	10.1371/journal.pone.0241018	http://dx.doi.org/10.1371/journal.pone.0241018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079960	Green Published, gold			2022-12-26	WOS:000585940600023
J	Wouldes, TA; Woodward, LJ				Wouldes, Trecia A.; Woodward, Lianne J.			Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months	PLOS ONE			English	Article							NEONATAL ABSTINENCE SYNDROME; PREGNANT-WOMEN; FOLLOW-UP; BUPRENORPHINE; CHILDREN; HEROIN; GROWTH; MANAGEMENT; COCAINE; MOTHERS	The abuse of prescription opioids and heroin by women of childbearing age over the past decade has resulted in a five-fold increase in the number of infants born opioid-dependent. Daily opioid substitution treatment with methadone is associated with less maternal illicit opioid use and improved antenatal care. However, research on the neurobehavioral effects of daily prenatal exposure to methadone on the infant is limited. Using the NICU Network Neurobehavioral Scale (NNNS), we compared the neurobehavior at birth of 86 infants born to opioid-dependent mothers receiving methadone treatment (MMT) with 103 infants unexposed to methadone. Generalized linear models, adjusted for covariates, showed methadone exposed infants had significantly poorer attention, regulation, and quality of movement. They were also significantly more excitable, more easily aroused, exhibited more non-optimal reflexes, hypertonicity, and total signs of stress abstinence. Maternal MMT was also associated with more indices of neonatal abstinence, including: CNS, visual, genitourinary (GI), and state. Latent profile analysis of the NNNS summary scores revealed four distinct neurobehavioral profiles with infants characterized by the most disturbed neurobehavior at birth having the poorest clinical outcomes at birth, and poorer cognitive and motor development at 24 months of age.	[Wouldes, Trecia A.] Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Woodward, Lianne J.] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand	University of Auckland; University of Canterbury	Wouldes, TA (corresponding author), Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland, New Zealand.	t.wouldes@auckland.ac.nz	Wouldes, Trecia/AFU-6559-2022	Wouldes, Trecia/0000-0002-6609-8464	Lottery Health Research [AP91256]; Cure Kids New Zealand [9518]; Wayne Francis Charitable Trust	Lottery Health Research; Cure Kids New Zealand; Wayne Francis Charitable Trust	This study was funded by Lottery Health Research (AP91256) https://www.communitymatters.govt.nz/lottery-grants-board/LJW and TAW, Cure Kids New Zealand (#9518) https://cure.org/curekids/LJW, and The Wayne Francis Charitable Trust https://wfct.org.nz LJW The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayley N., 1969, BAYLEY SCALES INFANT; Bayley N, 1993, TRAINING MANUAL BAYL; Bellis David J., 1993, Journal of Addictive Diseases, V12, P7, DOI 10.1300/J069v12n01_02; Berlin CM, 1998, PEDIATRICS, V101, P1079; Brogly SB, 2014, AM J EPIDEMIOL, V180, P673, DOI 10.1093/aje/kwu190; Bunikowski R, 1998, EUR J PEDIATR, V157, P724, DOI 10.1007/s004310050923; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; CHASNOFF IJ, 1984, DEV MED CHILD NEUROL, V26, P484; CHASNOFF IJ, 1986, NEUROBEH TOXICOL TER, V8, P357; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Conradt E, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0128; Coyle MG, 2012, ADDICTION, V107, P63, DOI 10.1111/j.1360-0443.2012.04040.x; Davie-Gray A, 2013, NEUROTOXICOL TERATOL, V38, P46, DOI 10.1016/j.ntt.2013.04.006; Finnegan L P, 1978, Ann N Y Acad Sci, V311, P135, DOI 10.1111/j.1749-6632.1978.tb16770.x; Finnegan LP, 1981, SUBSTANCE ABUSE CLIN; Friedman MA, 2004, PEDIATR CLIN N AM, V51, P599, DOI 10.1016/j.pcl.2004.01.011; Gaalema DE, 2012, ADDICTION, V107, P53, DOI 10.1111/j.1360-0443.2012.04039.x; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.2307/2334349; Gottheil Edward, 1993, Journal of Addictive Diseases, V12, P45, DOI 10.1300/J069v12n04_04; HANS SL, 1989, ANN NY ACAD SCI, V562, P195, DOI 10.1111/j.1749-6632.1989.tb21018.x; HARPER RG, 1974, PEDIATRICS, V54, P300; Heller NA, 2017, DEV PSYCHOBIOL, V59, P574, DOI 10.1002/dev.21532; JOHNSON HL, 1984, INFANT BEHAV DEV, V7, P115, DOI 10.1016/S0163-6383(84)80027-2; Jones HE, 2005, DRUG ALCOHOL DEPEN, V79, P1, DOI 10.1016/j.drugalcdep.2004.11.013; Jones HE, 2012, ADDICTION, V107, P5, DOI 10.1111/j.1360-0443.2012.04035.x; Jones HE, 2012, DRUGS, V72, P747, DOI 10.2165/11632820-000000000-00000; KALTENBACH K, 1979, PHARMACOL BIOCHEM BE, V11, P15; Kaltenbach K, 2012, ADDICTION, V107, P45, DOI 10.1111/j.1360-0443.2012.04038.x; Konijnenberg C, 2016, EARLY HUM DEV, V101, P91, DOI 10.1016/j.earlhumdev.2016.08.013; Larson JJ, 2019, PEDIATRICS, V18, P18; Laursen B., 2012, HDB DEV RES METHODS; Lester BM, 2004, PEDIATRICS, V113, P631; Lester BM, 1998, ANN NY ACAD SCI, V846, P296, DOI 10.1111/j.1749-6632.1998.tb09746.x; Levine TA, 2018, EARLY HUM DEV, V116, P68, DOI 10.1016/j.earlhumdev.2017.11.010; LIPSITZ PJ, 1975, CLIN PEDIATR, V14, P592, DOI 10.1177/000992287501400613; Liu J, 2010, PEDIATRICS, V125, pE90, DOI 10.1542/peds.2009-0204; Mascola MA, 2017, OBSTET GYNECOL, V130, pE81, DOI 10.1097/AOG.0000000000002235; McGlone L, 2015, EARLY HUM DEV, V91, P19, DOI 10.1016/j.earlhumdev.2014.10.006; Messinger DS, 2004, PEDIATRICS, V113, P1677, DOI 10.1542/peds.113.6.1677; Minozzi S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006318.pub3; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Patrick SW, 2015, J PERINATOL, V35, P667, DOI 10.1038/jp.2015.63; ROSEN TS, 1982, J PEDIATR-US, V101, P192, DOI 10.1016/S0022-3476(82)80115-7; ROSEN TS, 1988, ANN NY ACAD SCI, V533, P89, DOI 10.1111/j.1749-6632.1988.tb37236.x; Salihu HM, 2015, AM J PERINAT, V32, P289, DOI 10.1055/s-0034-1384642; Salisbury AL, 2012, ADDICTION, V107, P36, DOI 10.1111/j.1360-0443.2012.04037.x; Sanlorenzo LA, 2018, CURR OPIN PEDIATR, V30, P182, DOI 10.1097/MOP.0000000000000589; SOULE AB, 1974, PEDIATRICS, V54, P583; Sucharew H, 2012, PAEDIATR PERINAT EP, V26, P344, DOI 10.1111/j.1365-3016.2012.01288.x; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Tronick EZ, 2004, PEDIATRICS, V113, P676; United Nations Office on Drugs and Crime (UNODC), 2017, WORLD DRUG REP; VANBAAR AL, 1994, ACTA PAEDIATR, V83, P40; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; *WHO, 1997, COMP INT DIAGN INT C; WILSON GS, 1989, ANN NY ACAD SCI, V562, P183, DOI 10.1111/j.1749-6632.1989.tb21017.x; Winkelman TNA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3520; Wouldes TA, 2016, NEUROPATHOLOGY DRUG, V3, P577; Wouldes TA, 2010, NEUROTOXICOL TERATOL, V32, P406, DOI 10.1016/j.ntt.2010.01.007	61	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240905	10.1371/journal.pone.0240905	http://dx.doi.org/10.1371/journal.pone.0240905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064777	gold, Green Published			2022-12-26	WOS:000585918300010
J	Yuyama, K; Sun, H; Mikami, D; Mioka, T; Mukai, K; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Mikami, Daisuke; Mioka, Tetsuo; Mukai, Katsuyuki; Igarashi, Yasuyuki			Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release	FASEB JOURNAL			English	Article						amyloid-ss; ceramide; exosome; LAPTM4B	ACID CERAMIDASE; AMYLOID-BETA; LAPTM4B; MODEL; PTDINS(4,5)P-2; TRAFFICKING; ACTIVATION; RESISTANCE; VESICLES; ROLES	Exosomes are extracellular vesicles that mediate the transport of intracellular molecules, including neurodegenerative agents. Exogenously administrated ceramides have been implicated in the acceleration of exosome production by neurons; however, the molecular machinery involved in this process is unknown. Here, we found that ceramides, especially those consisting of long fatty acids, were internalized into the endocytic pathway in neuroblastoma SH-SY5Y cells to induce exosome secretion through lysosome-associated protein transmembrane 4B (LAPTM4B). Knockdown of LAPTM4B inhibited the ceramide-mediated increase in exosome release completely. Fluorescence microscopy observations indicated that exogenous ceramides promote the transport of multivesicular bodies to the plasma membranes in a LAPTM4B-dependent manner. Similarly, inhibition of acid ceramidase, which tends to induce intracellular ceramide accumulation, increased exosome production by SH-SY5Y cells in a LAPTM4B-dependent manner. Furthermore, the level of amyloid-ss protein (Ass) was decreased in neuronal cells following treatment with exogenous ceramide or inhibition of acid ceramidase, and this effect was attributed to the LAPTM4B-dependent efflux of Ass-containing exosomes. Overall, these findings reveal the novel machinery involved in exosome secretion regulated by ceramides and LAPTM4B, and may contribute to efforts to ameliorate the cellular accumulation of neurodegenerative agents such as Ass.	[Yuyama, Kohei; Sun, Hui; Mikami, Daisuke; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Sapporo, Hokkaido, Japan; [Mioka, Tetsuo] Hokkaido Univ, Grad Sch Life Sci, Inst Genet Med, Div Mol Interact, Sapporo, Hokkaido, Japan; [Mukai, Katsuyuki] Daicel Corp, R&D Headquarters, Tokyo, Japan	Hokkaido University; Hokkaido University; Daicel Corporation	Yuyama, K (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lipid Biofunct Sect, Kita Ku, Kita 21,Nishi 11, Sapporo, Hokkaido 0010021, Japan.	kyuyama@pharm.hokudai.ac.jp			Industry Creation Departments Funding by Daicel Corporation [8607011, PCS8617001]	Industry Creation Departments Funding by Daicel Corporation	This work was supported by Industry Creation Departments Funding (8607011, PCS8617001) provided by Daicel Corporation to the Lipid Biofunction Section of Hokkaido University	Blom T, 2015, NAT CHEM BIOL, V11, P799, DOI [10.1038/NCHEMBIO.1889, 10.1038/nchembio.1889]; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hogue DL, 2002, BIOCHEM J, V365, P721, DOI 10.1042/BJ20020205; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Huang Y, 2004, EUR J NEUROSCI, V20, P3489, DOI 10.1111/j.1460-9568.2004.03852.x; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li L, 2011, ANAT REC, V294, P1135, DOI 10.1002/ar.21421; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Tan XJ, 2015, J CELL SCI, V128, P4047, DOI 10.1242/jcs.175208; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vella LJ, 2008, VET IMMUNOL IMMUNOP, V124, P385, DOI 10.1016/j.vetimm.2008.04.002; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072; Yuyama K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53394-w; Yuyama Kohei, 2016, BioMolecular Concepts, V7, P53, DOI 10.1515/bmc-2015-0033; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zhou KC, 2018, ACS CENTRAL SCI, V4, P548, DOI 10.1021/acscentsci.7b00582	42	9	9	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16022	16033		10.1096/fj.202001599R	http://dx.doi.org/10.1096/fj.202001599R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090522				2022-12-26	WOS:000581155800001
J	Dell, A; Curry, M; Yarnell, K; Starbuck, G; Wilson, PB				Dell, Andrew; Curry, Mark; Yarnell, Kelly; Starbuck, Gareth; Wilson, Philippe B.			Genetic analysis of the endangered Cleveland Bay horse: A century of breeding characterised by pedigree and microsatellite data	PLOS ONE			English	Article							VISUALIZING PHYLOGENETIC TREES; POPULATION-STRUCTURE; TYRANNOSAURUS-REX; DIVERSITY; CONSERVATION; VARIABILITY; MANAGEMENT; LINEAGES	The Cleveland Bay horse is one of the oldest equines in the United Kingdom, with pedigree data going back almost 300 years. The studbook is essentially closed and because of this, there are concerns about loss of genetic variation across generations. The breed is one of five equine breeds listed as "critical" (<300 registered adult breeding females) by the UK Rare Breeds Survival Trust in their annual Watchlist. Due to their critically endangered status, the current breadth of their genetic diversity is of concern, and assessment of this can lead to improved breed management strategies. Herein, both genealogical and molecular methods are combined in order to assess founder representation, lineage, and allelic diversity. Data from 15 microsatellite loci from a reference population of 402 individuals determined a loss of 91% and 48% of stallion and dam lines, respectively. Only 3 ancestors determine 50% of the genome in the living population, with 70% of maternal lineage being derived from 3 founder females, and all paternal lineages traced back to a single founder stallion. Methods and theory are described in detail in order to demonstrate the scope of this analysis for wider conservation strategies. We quantitatively demonstrate the critical nature of the genetic resources within the breed and offer a perspective on implementing this data in considered breed management strategies.	[Dell, Andrew; Curry, Mark] Univ Lincoln, Dept Biol Sci, Brayford Way, Lincoln, England; [Dell, Andrew; Wilson, Philippe B.] Rare Breeds Survival Trust, Stoneleigh Pk, Stoneleigh, Warwick, England; [Yarnell, Kelly; Starbuck, Gareth; Wilson, Philippe B.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, Notts, England	University of Lincoln; Nottingham Trent University	Dell, A (corresponding author), Univ Lincoln, Dept Biol Sci, Brayford Way, Lincoln, England.; Dell, A; Wilson, PB (corresponding author), Rare Breeds Survival Trust, Stoneleigh Pk, Stoneleigh, Warwick, England.; Wilson, PB (corresponding author), Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, Notts, England.	andy.dell@btinternet.com; PhilippeWilson@rbst.org.uk	Wilson, Philippe B./N-2414-2019	Wilson, Philippe B./0000-0003-0207-2246; Starbuck, Gareth/0000-0002-6281-9885; Dell, Andrew/0000-0002-8054-2023	Rare Breeds Survival Trust; University of Lincoln	Rare Breeds Survival Trust; University of Lincoln	AD was funded by the Rare Breeds Survival Trust, and a PhD Studentship from the University of Lincoln.	Aberle K, 2004, BERL MUNCH TIERARZTL; Achmann R, 2004, ANIM GENET, V35, P285, DOI 10.1111/j.1365-2052.2004.01157.x; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Ansari-Mahyari S, POWER QTL MAPPING US; Belkhir K, 2004, LAB GENOME POPUL INT, P5000; Bijma P, 1999, GENETICS; Boichard D, 1997, GENET SEL EVOL, V29, P5, DOI 10.1051/gse:19970101; Boyd MM, 1907, J HERED, DOI 10.1093/jhered/os-3.1.255; Brinkmann L, 2012, J EXP BIOL, V215, P1061, DOI 10.1242/jeb.064832; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Chikhi L, 2004, MAMMALIAN GENOMICS, P539, DOI 10.1079/9780851999104.0539; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Cornuet JM, 1996, GENETICS, V144, P2001; Cunningham EP, 2005, EAAP PUBLIC, P15; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Dent AA, 1978, CLEVELAND BAY HORSES; Donnelly P., 2000, GENETICS; EMMERSON S., 1984, CLEVEL BAY HORSE SOC; Fairfax-Blakeborough J., 1950, EVOLUTION IMPORTANCE; Fox-Clipsham LY, 2011, VET REC, V169, P655, DOI 10.1136/vr.100235; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Groeneveld E, 2009, GENET MOL RES, V8, P1158, DOI 10.4238/vol8-3gmr648; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P378, DOI 10.1111/j.1439-0388.2005.00546.x; Gutierrez JP, 2005, J ANIM BREED GENET, DOI 10.1111/j.1439-0388.2005.00512.x; Hill WG, 1987, MOL EVOLUTIONARY GEN, DOI 10.1017/s001667230002735x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; J-M G., 1962, POPUL, DOI 10.2307/1525780; Johnson D., 2008, HORSE BREEDS; Juras R, 2003, ACTA AGR SCAND A-AN, V53, P180, DOI 10.1080/09064700310012971; Khanshour A, 2013, J HERED, V104, P386, DOI 10.1093/jhered/est003; Khanshour AM, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11100174; Khanshour AM, 2013, AUST J ZOOL, V61, P357, DOI 10.1071/ZO13062; LACY RC, 1989, ZOO BIOL, V8, P111, DOI 10.1002/zoo.1430080203; Lacy RC, 1995, ZOO BIOL, V14, P565, DOI 10.1002/zoo.1430140609; Lacy RC, 2000, BOTTLENOSE DOLPHIN R; Lacy RC, 2000, ZOO BIOL, DOI 10.1002/1098-2361(2000)19:4&LT;279::AID-ZOO5&GT;3.0.CO;2-V; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luis C, 2007, ANIM GENET, V38, P20, DOI 10.1111/j.1365-2052.2006.01545.x; Luis C, 2007, J HERED, V98, P232, DOI 10.1093/jhered/esm009; MACCLUER JW, 1983, J HERED, V74, P394, DOI 10.1093/oxfordjournals.jhered.a109824; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; McGahern AM, 2006, ANIM GENET, V37, P498, DOI 10.1111/j.1365-2052.2006.01506.x; Mills LS, 1997, J WILDL MANAGE, DOI 10.2307/3802439; Nei M., 1987, MOL EVOLUTIONARY GEN; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearl MC, 2000, J WILDL MANAGE, DOI 10.2307/3803113; Petersen JL, 2014, J HERED, V105, P148, DOI 10.1093/jhered/est079; Pritchard JK, 2007, DOCUMENTATION STRUCT; Prystupa JM, 2012, J HERED, V103, P380, DOI 10.1093/jhered/ess003; Reese HH, 1918, BREEDS LIGHT HORSES; Sorensen AC, 2005, J DAIRY SCI, V88, P1865, DOI 10.3168/jds.S0022-0302(05)72861-7; Valera M, 2005, LIVEST PROD SCI, V95, P57, DOI 10.1016/j.livprodsci.2004.12.004; WALLING G., 1994, CLEVEL BAY HORSE SOC; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weir BS, 1984, EVOLUTION N Y, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S., 1978, EVOLUTION GENETICS P; Zechner P, 2002, LIVEST PROD SCI, V77, P137, DOI 10.1016/S0301-6226(02)00079-9	59	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240410	10.1371/journal.pone.0240410	http://dx.doi.org/10.1371/journal.pone.0240410			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119607	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000600013600051
J	Last, M				Last, Mark			The first wave of COVID-19 in Israel-Initial analysis of publicly available data	PLOS ONE			English	Article								The first case of COVID-19 was confirmed in Israel on February 21, 2020. Within approximately 30 days, the total number of confirmed cases climbed up to 1, 000, accompanied by a doubling period of less than 3 days. About one week later, after this number exceeded 4, 000 cases, and following some extreme lockdown measures taken by the Israeli government, the daily infection rate started a sharp decrease from the peak value of 1, 131 down to slightly more than 100 new confirmed cases on April 30. Motivated by this encouraging data, similar to the trends observed in many other countries, along with the growing economic pressures, the Israeli government has quickly lifted most of its emergency regulations. Throughout May, the daily number of new cases stayed at a very low level of 20-40 until at the end of May it started a steady increase, exceeding 1, 000 by the end of June and 2, 000 on July 22. As suggested by some experts and popular media, this disturbing trend may be even a part of a "second wave". This article attempts to analyze the data available on Israel at the end of July 2020, compared to three European countries (Greece, Italy, and Sweden), in order to understand the local dynamics of COVID-19, assess the effect of the implemented intervention measures, and discuss some plausible scenarios for the foreseeable future.	[Last, Mark] Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel	Ben Gurion University	Last, M (corresponding author), Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel.	mlast@bgu.ac.il						ANDERSON R M, 1991; [Anonymous], 2020, DW CORONAVIRUS TESTS; Bachner M, 2020, TIMES ISRAEL    0602; Encyclopaedia Britannica, CAS FAT RAT DEF EX E; Hofstede G., CULTURES CONSEQUENCE; Housen T., 2020, CONVERSATION, V13, P6; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Modi C, 2020, TOTAL COVID 19 MORTA; The Gertner Institute, 2020, GERTNER I COVID 19 S; Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872; Huynh TLD, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010338; Huynh TLD, 2020, ECON BULL, V40, P758	13	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240393	10.1371/journal.pone.0240393	http://dx.doi.org/10.1371/journal.pone.0240393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119605	gold, Green Published, Green Submitted			2022-12-26	WOS:000600013600002
J	Liu, WG; Feng, M; Jayasuriya, CT; Peng, H; Zhang, L; Guan, YJ; Froehlich, JA; Terek, RM; Chen, Q				Liu, Wenguang; Feng, Meng; Jayasuriya, Chathuraka T.; Peng, Hang; Zhang, Long; Guan, Yingjie; Froehlich, John A.; Terek, Richard M.; Chen, Qian			Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling	FASEB JOURNAL			English	Article						cartilage; mesenchymal stem cells; osteoarthritis; TGF&#8208; beta	MESENCHYMAL PROGENITOR CELLS; ARTICULAR CHONDROCYTES; STEM-CELLS; DIFFERENTIATION; INHIBITION; EXPRESSION; GENE	Human osteoarthritis cartilage contains chondrocytes (OAC) and mesenchymal stromal cells (OA-MSC). Here, we found that TGF-beta had different effects on OA-MSC and OAC, and revealed its lateral signaling mechanism in OA. RNAseq analysis indicated that OA-MSC expressed the same level of Bone Morphogenetic Protein (BMP) Receptor-1A as OAC but only 1/12 of Transforming Growth Factor beta (TGF-beta) Receptor-1. While TGF-beta specifically activated SMAD2 in OAC, it also activated BMP signaling-associated SMAD1 in OA-MSC. While TGF-beta stimulated chondrogenesis in OAC, it induced hypertrophy, mineralization, and MMP-13 in OA-MSC. Inhibiting TGF-beta R1 suppressed MMP-13 in OA-MSC but stimulated it in OAC. In contrast, by specifically targeting BMPR1A/ACVR1 in both cell types, LDN193189 inhibits cartilage degeneration through suppressing hypertrophy and MMP-13 in a mouse osteoarthritis model. Thus, LDN193189, a drug under development to inhibit constitutive BMP signaling during heterotopic ossification, may be re-purposed for OA treatment.	[Liu, Wenguang; Peng, Hang; Zhang, Long] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian, Peoples R China; [Liu, Wenguang; Feng, Meng; Jayasuriya, Chathuraka T.; Zhang, Long; Guan, Yingjie; Froehlich, John A.; Terek, Richard M.; Chen, Qian] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthoped, 1 Hoppin St,Suite 402A, Providence, RI 02903 USA; [Feng, Meng] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 1, Xian, Peoples R China	Xi'an Jiaotong University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Xi'an Jiaotong University	Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Orthoped, 1 Hoppin St,Suite 402A, Providence, RI 02903 USA.	Qian_Chen@Brown.edu	zhang, long/AAW-8390-2021	zhang, long/0000-0003-0091-6695	NIH [P30GM122732, 1R61AR076807-01, R01 CA166089]; China Scholarship Council [201606280090]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	The authors gratefully acknowledge financial support from NIH (P30GM122732, 1R61AR076807-01) to Q.C, (R01 CA166089) to R.M.T, and China Scholarship Council (201606280090) to W.L.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; BUYSE G, 1995, EUR J PEDIATR, V154, P694, DOI 10.1007/BF02276711; Byfield SD, 2004, TRENDS CELL BIOL, V14, P107; Chen CG, 2014, ARTHRITIS RHEUM, V64, P3278; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Fan Z, 2004, CLIN EXP RHEUMATOL, V22, P103; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Hu N, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1949-0; Jayasuriya CT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25395-8; Lane NE, 2017, OSTEOARTHR CARTILAGE, V25, P209, DOI 10.1016/j.joca.2016.09.025; Li J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3887; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Padilha EC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00234; Pignolo RJ, 2013, PEDIATR ENDOCR REV P, V10, P437; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Wang TY, 2016, ANN RHEUM DIS, V75, pE72, DOI 10.1136/annrheumdis-2016-210312; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	34	12	12	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16552	16566		10.1096/fj.202001448R	http://dx.doi.org/10.1096/fj.202001448R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33118211	Green Accepted			2022-12-26	WOS:000586840600001
J	Lyons, K; Murphy, CT; Franck, JA				Lyons, Kathleen; Murphy, Christin T.; Franck, Jennifer A.			Flow over seal whiskers: Importance of geometric features for force and frequency response	PLOS ONE			English	Article							HARBOR; SENSITIVITY; CYLINDER; WAKE	The complex undulated geometry of seal whiskers has been shown to substantially modify the turbulent structures directly downstream, resulting in a reduction of hydrodynamic forces as well as modified vortex-induced-vibration response when compared with smooth whiskers. Although the unique hydrodynamic response has been well documented, an understanding of the fluid flow effects from each geometric feature remains incomplete. In this computational investigation, nondimensional geometric parameters of the seal whisker morphology are defined in terms of their hydrodynamic relevance, such that wavelength, aspect ratio, undulation amplitudes, symmetry and undulation off-set can be varied independently of one another. A two-factor fractional factorial design of experiments procedure is used to create 16 unique geometries, each of which dramatically amplifies or attenuates the geometric parameters compared with the baseline model. The flow over each unique topography is computed with a large-eddy simulation at a Reynolds number of 500 with respect to the mean whisker thickness and the effects on force and frequency are recorded. The results determine the specific fluid flow impact of each geometric feature which will inform both biologists and engineers who seek to understand the impact of whisker morphology or lay out a framework for biomimetic design of undulated structures.	[Lyons, Kathleen; Franck, Jennifer A.] Univ Wisconsin, Dept Engn Phys, Madison, WI 53715 USA; [Murphy, Christin T.] Naval Undersea Warfare Ctr, Newport, RI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command	Lyons, K (corresponding author), Univ Wisconsin, Dept Engn Phys, Madison, WI 53715 USA.	lyons6@wisc.edu		Franck, Jennifer/0000-0001-8456-5153; Lyons, Kathleen/0000-0003-4099-2721	Office of Naval Research through the Summer Faculty Research Fellowship; Office of Naval Research through Naval Research Enterprise Internship Program	Office of Naval Research through the Summer Faculty Research Fellowship(Office of Naval Research); Office of Naval Research through Naval Research Enterprise Internship Program(Office of Naval Research)	The authors wish to thank the Office of Naval Research for funding through the Summer Faculty Research Fellowship and the Naval Research Enterprise Internship Program.	AHMED A, 1992, PHYS FLUIDS A-FLUID, V4, P1959, DOI 10.1063/1.858365; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Antony J, 2003, DESIGN EXPT ENG SCI; Beem H, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/1/014012; Beem HR, 2015, J FLUID MECH, V783, P306, DOI 10.1017/jfm.2015.513; DEARDORFF JW, 1970, J FLUID MECH, V41, P453, DOI 10.1017/S0022112070000691; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Ginter CC, 2010, MAR MAMMAL SCI, V26, P733, DOI 10.1111/j.1748-7692.2009.00365.x; Haller G, 2005, J FLUID MECH, V525, P1, DOI 10.1017/S0022112004002526; Hanke W, 2010, J EXP BIOL, V213, P2665, DOI 10.1242/jeb.043216; Jung UH, 2016, J MECH SCI TECHNOL, V30, P1171, DOI 10.1007/s12206-016-0221-7; Kim H, 2017, AIP ADV, V7, DOI 10.1063/1.5008658; Lam K, 2004, J FLUID STRUCT, V19, P321, DOI 10.1016/j.jfluidstructs.2003.12.010; Lam K, 2009, J FLUID MECH, V620, P195, DOI 10.1017/S0022112008004217; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Liu G, 2019, BIOINSPIR BIOMIM, V14, DOI 10.1088/1748-3190/ab34fe; Mason RL, 2003, STAT DESIGN ANAL EXP, V2nd; Morrison HE, 2016, J COMPUT SCI-NETH, V17, P394, DOI 10.1016/j.jocs.2016.04.004; Murphy CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07676-w; Murphy CT, 2015, J EXP BIOL, V218, P2463, DOI 10.1242/jeb.118240; Murphy CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069872; Rinehart A, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa8885; Schulte-Pelkum N, 2007, J EXP BIOL, V210, P781, DOI 10.1242/jeb.02708; Wang SF, 2017, INT J HEAT FLUID FL, V68, P31, DOI 10.1016/j.ijheatfluidflow.2017.09.006; Wang SF, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2117-9; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; Wieskotten S, 2011, J EXP BIOL, V214, P1922, DOI 10.1242/jeb.053926; Witte M, 2012, RESULTS DFG PRIORITY, P271; Zhang W, 2005, EXP FLUIDS, V38, P824, DOI 10.1007/s00348-005-0981-9	30	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241142	10.1371/journal.pone.0241142	http://dx.doi.org/10.1371/journal.pone.0241142			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119653	gold, Green Published			2022-12-26	WOS:000600013600101
J	Tison, L; Duer, A; Pucikova, V; Greggers, U; Menzel, R				Tison, Lea; Duer, Aron; Pucikova, Vanda; Greggers, Uwe; Menzel, Randolf			Detrimental effects of clothianidin on foraging and dance communication in honey bees	PLOS ONE			English	Article							CHRONIC EXPOSURE; NEONICOTINOID PESTICIDES; HYMENOPTERA; INSECTICIDES; POLLINATORS; BEHAVIOR; IMMUNITY; INSECTS; HEALTH	Ongoing losses of pollinators are of significant international concern because of the essential role they have in our ecosystem, agriculture, and economy. Both chemical and non-chemical stressors have been implicated as possible contributors to their decline, but the increasing use of neonicotinoid insecticides has recently emerged as particularly concerning. In this study, honey bees were exposed orally to sublethal doses of the neonicotinoid clothianidin in the field in order to assess its effects on the foraging behavior, homing success, and dance communication. The foraging span and foraging activity at the contaminated feeder decreased significantly due to chronic exposure at field-realistic concentrations. Electrostatic field of dancing bees was measured and it was revealed that the number of waggle runs, the fanning time and the number of stop signals were significantly lower in the exposed colony. No difference was found in the homing success and the flight duration between control and treated bees released at a novel location within the explored area. However, a negative effect of the ambient temperature, and an influence of the location of the trained feeder was found. Finally, the residues of clothianidin accumulated in the abdomens of exposed foraging bees over time. These results show the adverse effects of a chronic exposure to sublethal doses of clothianidin on foraging and dance communication in honey bees.	[Tison, Lea; Duer, Aron; Pucikova, Vanda; Greggers, Uwe; Menzel, Randolf] Free Univ, Inst Biol Neurobiol, Berlin, Germany	Free University of Berlin	Tison, L (corresponding author), Free Univ, Inst Biol Neurobiol, Berlin, Germany.	lea.tison@gmail.com		Tison, Lea/0000-0003-4822-2983	Freie Universitat Berlin; Deutsche Forschungsgemeinschaft [Me 365/42 -1]; DAAD Postgraduate Scholarship	Freie Universitat Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD Postgraduate Scholarship	The Freie Universitat Berlin, The Deutsche Forschungsgemeinschaft [Me 365/42 -1], and a DAAD Postgraduate Scholarship to LT supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EPPO PP1 PP1 170 4 S; [Anonymous], 2018, EFSA SUPPORT PUBL, V15, p1378E, DOI DOI 10.2903/SP.EFSA.2018.EN-1378; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], **DATA OBJECT**; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Butler D, 2018, NATURE, V555, P150, DOI 10.1038/d41586-018-02639-1; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Christen V, 2016, ENVIRON SCI TECHNOL, V50, P4071, DOI 10.1021/acs.est.6b00678; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; European Food Safety Authority, 2013, HOL APPR RISK ASS MU; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Fournier A, 2014, J ECON ENTOMOL, V107, P38, DOI 10.1603/EC13087; Franklin MT, 2004, J ECON ENTOMOL, V97, P369, DOI 10.1603/0022-0493-97.2.369; Georgiadis PT, 2012, JULIUS-KUHN-ARCH, V437, P134, DOI 10.5073/jka.2012.437.039; Greggers U, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0528; Henry M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5359; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jin NX, 2015, J EXP BIOL, V218, P2821, DOI 10.1242/jeb.123612; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lesnoff M, 2012, R PACKAGE VERSION, V1, P3; Menzel R, 2017, LEARNING MEMORY COMP, P389; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Piiroinen S, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0246; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pistorius J, 2008, JULIUS KUHN ARCH, P423; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Rolke D, 2016, ECOTOXICOLOGY, V25, P1648, DOI 10.1007/s10646-016-1725-8; ROTHE U, 1989, J COMP PHYSIOL B, V158, P739, DOI 10.1007/BF00693012; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmuck R, 2016, ECOTOXICOLOGY, V25, P1617, DOI 10.1007/s10646-016-1734-7; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Therneau TM, 2000, SPRINGER SCI BUSINES; Tison L, 2019, ECOTOX ENVIRON SAFE, V180, P139, DOI 10.1016/j.ecoenv.2019.05.007; Tison L, 2017, J EXP BIOL, V220, P3695, DOI 10.1242/jeb.154518; Tison L, 2016, ENVIRON SCI TECHNOL, V50, P7218, DOI 10.1021/acs.est.6b02658; Tomizawa M, 2011, J AGR FOOD CHEM, V59, P2825, DOI 10.1021/jf1019455; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Von Frisch K, 1967, DANCE LANGUAGE ORIEN, V1; Wood TJ, 2017, ENVIRON SCI POLLUT R, V24, P17285, DOI 10.1007/s11356-017-9240-x; Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	59	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241134	10.1371/journal.pone.0241134	http://dx.doi.org/10.1371/journal.pone.0241134			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119662	Green Published, gold			2022-12-26	WOS:000600013600033
J	Wu, B; Jiang, SS; Wang, XH; Zhong, S; Bi, YM; Yi, DZ; Liu, G; Hu, FF; Dou, GJ; Chen, Y; Wu, Y; Dong, JJ				Wu, Bo; Jiang, Shanshan; Wang, Xinhui; Zhong, Sheng; Bi, Yiming; Yi, Dazhuang; Liu, Ge; Hu, Fangfei; Dou, Gaojing; Chen, Yong; Wu, Yi; Dong, Jiajun			Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609	PLOS ONE			English	Article							EXPRESSION; RECURRENCE; ADJUVANT; SURGERY; SYSTEM; TUMORS	Objective Our study is to identify DEGs (Differentially Expressed Genes), comprehensively investigate hub genes, annotate enrichment functions and key pathways of Non-functional pituitary adenomas (NFPAs), and also to verify STO-609 therapeutic effect. Methods The gene expression level of NFPA and normal tissues were compared to identify the DEGs (Differential expressed genes) based on gene expression profiles (GSE2175, GSE26966 and GSE51618). Enrichment functions, pathways and key genes were identified by carrying out GO (Gene Ontology), KEGG (Kyoto Encyclopedia of Genes and Genomes) analysis and PPI (Protein-Protein Interation) network analysis. Moreover, experiments in vitro were conducted to verify the anti-NFPAs effects of STO-609. Results 169 over-expression genes and 182 low expression genes were identified among 3 datasets. Dopaminergic synapse and vibrio cholerae infection pathways have distinctly changed in NFPA tissues. The Ca2+/CaM pathway played important roles in NFPA. Four hub proteins encoded by genes CALM1, PRDM10, RIPK4 and MAD2L1 were recognized as hub proteins. In vitro, assays showed that STO-609 induced apoptosis of NFPA cells to inhibit the hypophysoma cellular viability, diffusion and migration. Conclusion Four hub proteins, encoded by gene CALM1, PRDM10, RIPK4 and MAD2L1, played important roles in NFPA development. The Ca2+/CaM signaling pathway had significant alternations during NFPA forming process, the STO-609, a selective CaM-KK inhibitor, inhibited NFPA cellular viability, proliferation and migration. Meanwhile, NFPA was closely related to parkinson's disease (PD) in many aspects.	[Wu, Bo; Wang, Xinhui; Dou, Gaojing] Jilin Univ, Clin Coll, Changchun, Peoples R China; [Wu, Bo] First Hosp Jilin Univ, Dept Orthoped, Changchun, Peoples R China; [Jiang, Shanshan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Wang, Xinhui] First Hosp Jilin Univ, Dept Oncol, Changchun, Peoples R China; [Zhong, Sheng] Sun Yat Sen Univ, Canc Hosp, Dept Neurosurg, Guangzhou, Peoples R China; [Bi, Yiming; Yi, Dazhuang; Chen, Yong] Jilin Univ, Bethune Hosp 1, Dept Neurosurg, Changchun, Peoples R China; [Liu, Ge; Hu, Fangfei] Jilin Univ, Coll Pharm, Changchun, Peoples R China; [Dou, Gaojing] First Hosp Jilin Univ, Dept Breast Surg, Changchun, Peoples R China; [Wu, Yi; Dong, Jiajun] Jiangmen Cent Hosp, Dept Neurosug, Jiangmen, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Institute of Zoology, CAS; Jilin University; Sun Yat Sen University; Jilin University; Jilin University; Jilin University	Wu, Y; Dong, JJ (corresponding author), Jiangmen Cent Hosp, Dept Neurosug, Jiangmen, Peoples R China.	wuyi_jiangmen@163.com; dongjj_jiangmen@163.com			Science and Technology Planning Project of Jiangmen, China [2018630100110019805]	Science and Technology Planning Project of Jiangmen, China	This study was supported by the Science and Technology Planning Project of Jiangmen, China (2018630100110019805).	ASA SL, 1992, CAN J NEUROL SCI, V19, P228, DOI 10.1017/S0317167100042311; Azizmohammadi S, HIGH LEVEL EXPRESSIO; Bhatoe HS, MOVEMENT DISORDERS C; Chang EF, 2008, J NEUROSURG, V108, P736, DOI 10.3171/JNS/2008/108/4/0736; Cheng HW, 2016, INT J NEUROSCI, V126, P299, DOI 10.3109/00207454.2015.1015722; Dai CX, 2013, SCI CHINA LIFE SCI, V56, P163, DOI 10.1007/s11427-012-4433-5; Ding ZM, 2015, TURK NEUROSURG, V25, P298, DOI 10.5137/1019-5149.JTN.9812-13.1; Faesen AC, BASIS CATALYTIC ASSE; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Forsti A, GENETIC VARIATION MA; Franken NA, CLONOGENIC ASSAY CEL; Galland F, 2010, ENDOCR-RELAT CANCER, V17, P361, DOI 10.1677/ERC-10-0018; Heim D, 2015, ONCOGENE, V34, P385, DOI 10.1038/onc.2013.551; Henriett B, 2011, PITUITARY, V14, P112, DOI 10.1007/s11102-010-0268-x; Hofvander J, RECURRENT PRDM10 GEN; Hohenauer T, PRDM FAMILY EXPANDIN; Huang X, PHOSPHORYLATION DISH; Iglesias P, 2017, EUR J INTERN MED, V41, P62, DOI 10.1016/j.ejim.2017.03.023; Jayes FCL, 2000, ENDOCRINOLOGY, V141, P2377, DOI 10.1210/en.141.7.2377; JUDD AM, 1988, ENDOCRINOLOGY, V123, P2341, DOI 10.1210/endo-123-5-2341; Kim HS, FUNCTIONAL INTERACTI; Kukimoto-Niino M, 2011, J BIOL CHEM, V286, P22570, DOI 10.1074/jbc.M111.251710; Lentini L, SIMULTANEOUS REDUCTI; Liang M, 2015, TUMOR BIOL, V36, P7085, DOI 10.1007/s13277-015-3420-4; Liu DQ, INCREASED RIPK4 EXPR; Lo YL, BREAST CANC RISK ASS; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marko NF, 2012, J CLIN NEUROSCI, V19, P1535, DOI 10.1016/j.jocn.2012.01.038; MARTINEZ AJ, 1988, PATHOL RES PRACT, V183, P613, DOI 10.1016/S0344-0338(88)80023-2; Mercado M, 2017, ENDOCRINOL DIAB NUTR, V64, P384, DOI 10.1016/j.endinu.2017.05.009; Meylan E, RIP4 DIK PKK NOVEL M; Michaelis KA, 2011, ENDOCRINOLOGY, V152, P3603, DOI 10.1210/en.2011-0109; Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937; Olsson DS, 2017, ENDOCR-RELAT CANCER, V24, P227, DOI 10.1530/ERC-16-0518; Park JA, EXPRESSION PATTERNS; Rubinfeld H, 2012, ENDOCRINE, V42, P285, DOI 10.1007/s12020-012-9682-3; Sadik ZHA, 2017, WORLD NEUROSURG, V100, P361, DOI 10.1016/j.wneu.2017.01.028; Schibler A, HISTONE H3K4 METHYLA; Shandilya J, REGULATION AURORA B; Shandilya J, WT1 INTERACTS MAD2 R; Suliman M, 2001, CLIN ENDOCRINOL, V54, P317, DOI 10.1046/j.1365-2265.2001.01195.x; Thondam SK, IMPULSE CONTROL DISO; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Trovato M, 2013, ENDOCRINE, V44, P735, DOI 10.1007/s12020-013-9950-x; Xu ZZ, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0840-y; Zhan XQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0069-6; Zhang L, IDENTIFYING TMEM59 R; Ziemba BP, 2016, BIOCHEMISTRY-US, V55, P6395, DOI 10.1021/acs.biochem.6b00908	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240230	10.1371/journal.pone.0240230	http://dx.doi.org/10.1371/journal.pone.0240230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119597	Green Published, gold			2022-12-26	WOS:000600013600072
J	Cuomo, RE; Purushothaman, V; Li, JW; Cai, MX; Mackey, TK				Cuomo, Raphael E.; Purushothaman, Vidya; Li, Jiawei; Cai, Mingxiang; Mackey, Timothy K.			Sub-national longitudinal and geospatial analysis of COVID-19 tweets	PLOS ONE			English	Article								Objectives According to current reporting, the number of active coronavirus disease 2019 (COVID-19) infections is not evenly distributed, both spatially and temporally. Reported COVID-19 infections may not have properly conveyed the full extent of attention to the pandemic. Furthermore, infection metrics are unlikely to illustrate the full scope of negative consequences of the pandemic and its associated risk to communities. Methods In an effort to better understand the impacts of COVID-19, we concurrently assessed the geospatial and longitudinal distributions of Twitter messages about COVID-19 which were posted between March 3rd and April 13th and compared these results with the number of confirmed cases reported for sub-national levels of the United States. Geospatial hot spot analysis was also conducted to detect geographic areas that might be at elevated risk of spread based on both volume of tweets and number of reported cases. Results Statistically significant aberrations of high numbers of tweets were detected in approximately one-third of US states, most of which had relatively high proportions of rural inhabitants. Geospatial trends toward becoming hotspots for tweets related to COVID-19 were observed for specific rural states in the United States. Discussion Population-adjusted results indicate that rural areas in the U.S. may not have engaged with the COVID-19 topic until later stages of an outbreak. Future studies should explore how this dynamic can inform future outbreak communication and health promotion.	[Cuomo, Raphael E.; Purushothaman, Vidya; Mackey, Timothy K.] Univ Calif San Diego, Dept Anesthesiol, San Diego Sch Med, La Jolla, CA 92093 USA; [Cuomo, Raphael E.; Purushothaman, Vidya; Li, Jiawei; Mackey, Timothy K.] Global Hlth Policy Inst, San Diego, CA 94158 USA; [Purushothaman, Vidya] Univ Calif San Diego, Masters Program Publ Hlth, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Li, Jiawei; Cai, Mingxiang; Mackey, Timothy K.] Univ Calif San Diego, Dept Healthcare Res & Policy, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cuomo, RE (corresponding author), Univ Calif San Diego, Dept Anesthesiol, San Diego Sch Med, La Jolla, CA 92093 USA.; Cuomo, RE (corresponding author), Global Hlth Policy Inst, San Diego, CA 94158 USA.	racuomo@ucsd.edu	Li, Jiawei/GXM-4151-2022; Mackey, Tim/H-9156-2013	Mackey, Tim/0000-0002-2191-7833; Cuomo, Raphael/0000-0002-8179-0619	California HIV/AIDS Research Program [R00RG2400]	California HIV/AIDS Research Program	This research was funded by a grant from the California HIV/AIDS Research Program (Award #R00RG2400).	Andersen M., 2020, EARLY EVIDENCE SOCIA; [Anonymous], 2020, LANCET DIGIT HEALTH, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Chen N, 2020, ARXIV200805900; CSSE JHU, 2020, NOV COR COV 19 CAS, V5, P2020; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fricker Jr RD, 2007, STAT MED RES NET; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Keshava SN, 2020, J CLIN INTERVENTIONA; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Mackey TK, 2020, MACHINE LEARNING DET; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Paul R, 2020, J RURAL HEALTH, V36, P591, DOI 10.1111/jrh.12486; Rai B, 2020, COVID 19 INDIA PREDI; Ramirez IJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113856; Singh L., 2020, ARXIV200313907; Sjodin H, 2020, PREDICTING NUMBER CO; Sood S, 2020, RES HUMAN MED ED, P23; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; U. S. Census Bureau, 2012, AM COMM SURV 5 YEAR	22	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241330	10.1371/journal.pone.0241330	http://dx.doi.org/10.1371/journal.pone.0241330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112922	Green Published, gold			2022-12-26	WOS:000588374000026
J	Wittink, H; Blatter, T; Outermans, J; Volkers, M; Westers, P; Verschuren, O				Wittink, Harriet; Blatter, Tim; Outermans, Jacqueline; Volkers, Mariella; Westers, Paul; Verschuren, Olaf			Feasibility, reproducibility and validity of the 10 meter Shuttle Test in mild to moderately impaired people with stroke	PLOS ONE			English	Article							CARDIOPULMONARY EXERCISE TEST; FUNCTIONAL WALK TESTS; AEROBIC CAPACITY; 6-MINUTE WALK; RECOMMENDATIONS; RELIABILITY; FITNESS	Background There currently is no field test available for measuring maximal exercise capacity in people with stroke. Objective To determine the feasibility, reproducibility and validity of the Shuttle Test (ST) to measure exercise capacity in people with stroke. Design Longitudinal study design. Setting Rehabilitation department, day care centres from a nursing home and private practices specialized in neuro rehabilitation. Subjects People with subacute or chronic stroke. Interventions A standardized protocol was used to determine feasibility, reproducibility and validity of the 10-meter Shuttle Test (10mST). Main measures Number of shuttles completed, 1(st)Ventilatory Threshold (1(st)VT). Results The associations of the number of shuttles completed and cardiopulmonary capacity as measured with a portable gas analyser were r > 0.7, confirming good convergent validity in subacute and chronic people with stroke. Criterion validity, however, indicates it is not a valid test for measuring maximal cardiopulmonary capacity (VO2max). Only 60% of participants were able to reach the 1(st)VT. Higher cardiopulmonary capacity and a higher total score of the lower extremity Motricity Index contributed significantly to a higher number of shuttles walked (p = 0.001). Conclusions The Shuttle Test may be a safe and useful exercise test for people after stroke, but may not be appropriate for use with people who walk slower than 2 km/h or 0.56 m/s.	[Wittink, Harriet; Blatter, Tim; Outermans, Jacqueline] Utrecht Univ Appl Sci, Res Grp Lifestyle & Hlth, Utrecht, Netherlands; [Volkers, Mariella; Verschuren, Olaf] Univ Utrecht, UMC Utrecht Brain Ctr & Ctr Excellence Rehabil Me, Utrecht, Netherlands; [Westers, Paul] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Wittink, H (corresponding author), Utrecht Univ Appl Sci, Res Grp Lifestyle & Hlth, Utrecht, Netherlands.	harriet.wittink@hu.nl		Wittink, Harriet/0000-0001-5592-2879	SIA RAAK Publiek [RAAK.PUB03.015]	SIA RAAK Publiek	this project was funded by SIA RAAK Publiek: RAAK.PUB03.015 (Dutch Organisation of Scientific Research: http://regieorgaan-sia.nl).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American College of Sportsmedicine, 2000, ACSMS GUIDELINES EXE; [Anonymous], 1989, STROKE, V20, P1407; [Anonymous], 2015, RESUSCITATION, V95, pe1; [Anonymous], 2013, GAZETTE SUPREME PEOP, V02, P20; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Bernhardt J, 2019, NEUROREHAB NEURAL RE, V33, P959, DOI 10.1177/1545968319888642; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Bongers BC, 2016, PHYS THER, V96, P679, DOI 10.2522/ptj.20150082; Boyne P, 2017, TOP STROKE REHABIL, V24, P149, DOI 10.1080/10749357.2016.1209831; Demeurisse G, 1979, Brux Med, V59, P87; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Eng JJ, 2002, STROKE, V33, P756, DOI 10.1161/hs0302.104195; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1697, DOI 10.1053/apmr.2002.36395; Marzolini S, 2016, J STROKE CEREBROVASC, V25, P2222, DOI 10.1016/j.jstrokecerebrovasdis.2016.04.016; Nolan PB, 2014, INT J SPORTS MED, V35, P1024, DOI 10.1055/s-0034-1367065; Outermans JC, 2018, EUR J PHYS REHAB MED, V54, P837, DOI 10.23736/S1973-9087.18.04987-0; Overstreet BS, 2017, J SPORT MED PHYS FIT, V57, P227, DOI 10.23736/S0022-4707.16.06049-7; Pang MYC, 2005, CHEST, V127, P495, DOI 10.1378/chest.127.2.495; Riebe D, 2015, MED SCI SPORT EXER, V47, P2473, DOI 10.1249/MSS.0000000000000664; Rossiter HB, 2006, J APPL PHYSIOL, V100, P764, DOI 10.1152/japplphysiol.00932.2005; Salbach NM, 2014, NEUROREHAB NEURAL RE, V28, P111, DOI 10.1177/1545968313498826; Tang A, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-23; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; van Bloemendaal M, 2012, ARCH PHYS MED REHAB, V93, P163, DOI 10.1016/j.apmr.2011.08.012; Verschuren O, 2006, PHYS THER, V86, P1107, DOI 10.1093/ptj/86.8.1107; Vogler AJ, 2010, J SPORT SCI, V28, P733, DOI 10.1080/02640410903582776; Wittink H, 2017, J REHABIL MED, V49, P689, DOI 10.2340/16501977-2260; World Health Organisation, AG LIF COURS WHAT HL	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239203	10.1371/journal.pone.0239203	http://dx.doi.org/10.1371/journal.pone.0239203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112909	Green Published, gold			2022-12-26	WOS:000588374000023
J	Glennemeier, K; Packard, S; Spyreas, G				Glennemeier, Karen; Packard, Stephen; Spyreas, Greg			Dramatic long-term restoration of an oak woodland due to multiple, sustained management treatments	PLOS ONE			English	Article							FLORISTIC QUALITY ASSESSMENT; WHITE-TAILED DEER; PRAIRIE RESTORATION; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; PLANT DIVERSITY; FOREST; FIRE; PERFORMANCE; GRASSLAND	We measured 34 years of plant community change in a degraded oak woodland undergoing ecological management. Management included regular prescribed fire, control of white-tailed deer populations, repeated sowing of a diverse seed mix, and removal of invasive plants. We tracked change with several conservation metrics. Time series analysis showed no significant changes over time in either plant species richness or the Shannon-Weiner diversity index. Floristic Quality Assessment measures-the Floristic Quality Index (FQI), Cover-weighted FQI, and the Mean Coefficient of Conservatism (Mean C)-all increased dramatically over time, such that their values now surpass those of the highest quality representative of this habitat in the region. Cover-weighted FQI had the added benefit of being quick to respond (negatively and positively) to short-term management changes during the study. This sensitivity highlights its utility for adaptive management, enabling timely, data-driven changes to ongoing management regimes. Plant community composition showed striking changes during the study period, as species of high conservation value replaced weedier species. As a group, conservative woodland species are notoriously slow to recover from degradation, making this flora's recovery particularly notable. A mid-study cessation of management immediately stalled the woodland's recovery according to Floristic Quality metrics, but the restoration quickly returned to its positive trajectory with the resumption of management treatments. These results illustrate that impressive plant biodiversity restoration can be achieved, even in highly degraded contemporary oak ecosystems, if ecological management is comprehensive and if it is sustained over time.	[Glennemeier, Karen] Habitat Res LLC, Wilmette, IL 60091 USA; [Packard, Stephen] North Branch Restorat Project, Northbrook, IL USA; [Spyreas, Greg] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Glennemeier, K (corresponding author), Habitat Res LLC, Wilmette, IL 60091 USA.	kglennemeier@gmail.com			Illinois Nature Preserves Commission; Illinois Department of Transportation; Forest Preserves of Cook County; North Branch Restoration Project	Illinois Nature Preserves Commission; Illinois Department of Transportation; Forest Preserves of Cook County; North Branch Restoration Project	SP's field work was partially supported by the Illinois Nature Preserves Commission (https://www2.illinois.gov/dnr/INPC/Pages/default.aspx).GS was partially supported by the Illinois Department of Transportation (http://idot.illinois.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KG received no direct financial support for her work on this study but is currently affiliated with Habitat Research LLC, a commercial company that did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.; Thanks to Linda Masters, John Balaban, Jane Balaban, Steve Apfelbaum, Alan Haney, Laurel Ross, Karen Rodriguez, Robbie Sliwinski, Eriko Kojima, and Sai Ramakrishna for their help collecting vegetation data and to John Taft and the Forest Preserves of Cook County staff for comments and advice on this manuscript. We are grateful to Brian von Dohlen for statistical advice. Many thanks to the Forest Preserves of Cook County, the North Branch Restoration Project, and the Somme volunteers for their ongoing land stewardship and support of this work.	Abrams MD, 2003, BIOSCIENCE, V53, P927, DOI 10.1641/0006-3568(2003)053[0927:WHATWO]2.0.CO;2; ABRAMS MD, 1992, BIOSCIENCE, V42, P346, DOI 10.2307/1311781; Allison SK, 2002, ECOLOGICAL RESTORATI, V20, P10; Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Anderson Roger C., 2007, Ecological Restoration, V25, P99, DOI 10.3368/er.25.2.99; [Anonymous], 2009, J STUDY CHRISTIAN CU, V22, P9; Bacone JA, 2007, MICH BOT, V46, P65; Bassett TJ, 2020, FOREST ECOL MANAG, V464, DOI 10.1016/j.foreco.2020.118047; Bonello JE, 2020, RESTOR ECOL, V28, P215, DOI 10.1111/rec.13062; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Bourdaghs M, 2006, WETLANDS, V26, P718, DOI 10.1672/0277-5212(2006)26[718:PAPOTF]2.0.CO;2; Bowles M, 2006, NAT AREA J, V26, P17, DOI 10.3375/0885-8608(2006)26[17:TTEOSR]2.0.CO;2; Bowles ML, 1998, NAT AREA J, V18, P14; Brudvig LA, 2017, J APPL ECOL, V54, P1013, DOI 10.1111/1365-2664.12940; Brudvig LA, 2011, RESTOR ECOL, V19, P24, DOI 10.1111/j.1526-100X.2010.00675.x; Cohen MJ, 2004, ECOL APPL, V14, P784, DOI 10.1890/02-5378; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Curtis JT, 1959, VEGETATION WISCONSIN; DAVISON SE, 1982, B TORREY BOT CLUB, V109, P64, DOI 10.2307/2484469; DECALESTA DS, 1994, J WILDLIFE MANAGE, V58, P711, DOI 10.2307/3809685; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; Doherty JM, 2014, ECOL ENG, V65, P101, DOI 10.1016/j.ecoleng.2013.07.056; Ebinger JE, 1991, FOREST SUCCESSION PR, P375; Enders W, 2008, APPL ECONOMETRIC TIM; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Foster BL, 2007, RESTOR ECOL, V15, P652, DOI 10.1111/j.1526-100X.2007.00277.x; Gardner D, 1995, ERIGENIA, V14, P18; Hamilton AJ, 2005, J ENVIRON MANAGE, V75, P89, DOI 10.1016/j.jenvman.2004.11.012; Hansen MJ, 2014, APPL VEG SCI, V17, P63, DOI 10.1111/avsc.12051; Herman B., 2019, THESIS; Holzmueller EJ, 2009, NAT AREA J, V29, P255, DOI 10.3375/043.029.0305; Hutchinson TF, 2005, CAN J FOREST RES, V35, P877, DOI 10.1139/X04-189; INHD, 2020, ILLINOIS NATURAL HER; Jog S, 2006, NAT AREA J, V26, P149, DOI 10.3375/0885-8608(2006)26[149:FQAAIO]2.0.CO;2; Jones JM, 1995, URBAN DEER PROBLEM S, P58; Koziol L, 2017, J APPL ECOL, V54, P1301, DOI 10.1111/1365-2664.12843; Kraft LS, 2004, FOREST ECOL MANAG, V199, P219, DOI 10.1016/j.foreco.2004.05.044; Maginel CJ, 2016, ECOL INDIC, V67, P58, DOI 10.1016/j.ecolind.2016.02.035; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Masters LA, 1994, ERIGENIA, V13, P141; Matlack GR, 2005, J ECOL, V93, P50, DOI 10.1111/j.1365-2745.2004.00947.x; MATLACK GR, 1994, ECOLOGY, V75, P1491, DOI 10.2307/1937472; Matthews JW, 2008, ENVIRON MANAGE, V41, P130, DOI 10.1007/s00267-007-9002-5; Matthews JW, 2010, J APPL ECOL, V47, P1128, DOI 10.1111/j.1365-2664.2010.01862.x; Matthews JW, 2009, ECOL APPL, V19, P2093, DOI 10.1890/08-1371.1; McClain WE, 2010, CASTANEA, V75, P461, DOI 10.2179/09-007.1; McIndoe Janna M., 2008, Proceedings of the Indiana Academy of Science, V117, P16; Meiners SJ, 2002, ECOGRAPHY, V25, P215, DOI 10.1034/j.1600-0587.2002.250209.x; Meissen JC, 2020, RESTOR ECOL, V28, P807, DOI 10.1111/rec.13013; METZGER F, 1984, AM MIDL NAT, V112, P209, DOI 10.2307/2425428; Middleton EL, 2012, RESTOR ECOL, V20, P218, DOI 10.1111/j.1526-100X.2010.00752.x; Middleton EL, 2010, RESTOR ECOL, V18, P181, DOI 10.1111/j.1526-100X.2008.00501.x; Miller SJ, 2006, ECOL INDIC, V6, P313, DOI 10.1016/j.ecolind.2005.03.012; Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2; National Research Council, 2001, COMP WETL LOSS CLEAN; Packard S, 2005, TALLGRASS RESTORATIO; Packard S, 1994, RESTORING HERB LAYER; Pepoon H. S., 1927, ANNOTATED FLORA CHIC; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; R Core Team, 2018, R LANG ENV STAT COMP; Reed HE, 2005, ECOL APPL, V15, P1560, DOI 10.1890/04-0407; Reemts CM, 2019, ECOL RESTOR, V37, P233, DOI 10.3368/er.37.4.233; Reid JL, 2020, NAT AREA J, V40, P23, DOI 10.3375/043.040.0104; Rocchio J, 2007, FLORISTIC QUALITY AS; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Sivicek VA, 2011, ECOL INDIC, V11, P1251, DOI 10.1016/j.ecolind.2011.01.003; Smart Alexander J., 2011, Great Plains Research, V21, P181; SPERRY TM, 1994, NAT AREA J, V14, P124; Spieles DJ, 2006, ENVIRON MANAGE, V38, P837, DOI 10.1007/s00267-005-0294-z; SPSS, 2018, SPSS STAT WIND; Spyreas G, 2006, ECOL APPL, V16, P1351, DOI 10.1890/1051-0761(2006)016[1351:FCVNUF]2.0.CO;2; Spyreas G, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2825; Spyreas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160693; Spyreas G, 2012, J APPL ECOL, V49, P339, DOI 10.1111/j.1365-2664.2011.02100.x; Swink F., 1994, PLANTS CHICAGO REGIO; Taft JB, 2006, BIOL CONSERV, V131, P42, DOI 10.1016/j.biocon.2006.02.006; Taft JB, 2019, ECOL RESTOR, V37, P8, DOI 10.3368/er.37.1.8; TILGHMAN NG, 1989, J WILDLIFE MANAGE, V53, P524, DOI 10.2307/3809172; Wilhelm G, 1988, NATURAL AREA ASSESSM; Wilhelm G., 2017, FLORA CHICAGO REGION	81	3	3	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241061	10.1371/journal.pone.0241061	http://dx.doi.org/10.1371/journal.pone.0241061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095813	gold, Green Published			2022-12-26	WOS:000586649400037
J	Sheftel, CM; Hernandez, LL				Sheftel, Celeste M.; Hernandez, Laura L.			Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation	PLOS ONE			English	Article							REUPTAKE INHIBITORS; BONE LOSS; TISSUE TRANSGLUTAMINASE; PRENATAL EXPOSURE; REGULATES PTHRP; IN-VIVO; LACTATION; RECEPTOR; ACTIVATION; BREAST	Mammary-derived serotonin has been implicated in breast-to-bone communication during lactation by increasing parathyroid hormone related-protein (PTHrP) in the mammary gland. It is well established that PTHrP acts on the bone to liberate calcium for milk synthesis during lactation; however, the mechanism of serotonin's regulation of PTHrP has not been fully elucidated. Recently, serotonylation has been shown to be involved in a variety of physiological processes mediated by serotonin. Therefore, we investigated whether serotonylation is involved in serotonin's regulation of PTHrP in the mammary gland using lactogenically differentiated mouse mammary epithelial cells. We investigated the effect of increased intracellular serotonin using the antidepressant fluoxetine or 5-hydroxytryptophan (serotonin precursor), with or without transglutaminase inhibition and the corresponding action on PTHrP induction and activity. Treatment with fluoxetine or 5-hydroxytryptophan significantly increased intracellular serotonin concentrations and subsequently increased PTHrP gene expression, which was reduced with transglutaminase inhibition. Furthermore, we determined that transglutaminase activity is increased with lactogenic differentiation and 5-hydroxytryptophan or fluoxetine treatment. We investigated whether RhoA, Rac1, and Rab4 were potential serotonylation target proteins. We speculate that RhoA is potentially a serotonylation target protein. Our data suggest that serotonin regulates PTHrP induction in part through the process of serotonylation under lactogenic conditions in mouse mammary epithelial cells.	[Sheftel, Celeste M.; Hernandez, Laura L.] Univ Wisconsin, Mol & Cellular Pharmacol Training Program, Madison, WI 53706 USA; [Sheftel, Celeste M.; Hernandez, Laura L.] Univ Wisconsin, Dept Anim & Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Mol & Cellular Pharmacol Training Program, Madison, WI 53706 USA.; Hernandez, LL (corresponding author), Univ Wisconsin, Dept Anim & Dairy Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu	Hernandez, Laura/AAA-4284-2022	Sheftel, Celeste/0000-0002-6096-1626; Hernandez, Laura/0000-0001-7591-5203	Molecular and Cellular Pharmacology T32 training grant [NIH: GM00868816]; Metabolism and Nutrition Training Program T32 training grant [NIH: DK007665];  [NICHD: R01HD094759];  [USDA/NIFA:2016-6701524584]	Molecular and Cellular Pharmacology T32 training grant; Metabolism and Nutrition Training Program T32 training grant; ; 	This work was supported by NICHD: R01HD094759 and USDA/NIFA:2016-6701524584 (L.L. Hernandez), Molecular and Cellular Pharmacology T32 training grant NIH: GM00868816, and Metabolism and Nutrition Training Program T32 training grant NIH: DK007665.	Al-Zoairy R, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-016-0201-1; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; [Anonymous], 2009, TANZAN J HLTH RES, V11, piii; Ardeshirpour L, 2006, BONE, V38, P787, DOI 10.1016/j.bone.2005.11.009; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Benmansour S, 1999, J NEUROSCI, V19, P10494; BOADLEBIBER MC, 1993, PROG BIOPHYS MOL BIO, V60, P1, DOI 10.1016/0079-6107(93)90009-9; Cabrera-Vera TM, 1998, J PHARMACOL EXP THER, V286, P1474; Clarke MV, 2015, ENDOCRINOLOGY, V156, P3203, DOI 10.1210/en.2015-1345; Collier RJ, 2012, DOMEST ANIM ENDOCRIN, V43, P161, DOI 10.1016/j.domaniend.2012.03.006; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Davanzo R, 2011, BREASTFEED MED, V6, P89, DOI 10.1089/bfm.2010.0019; Drabsch Y, 2011, J MAMMARY GLAND BIOL, V16, P97, DOI 10.1007/s10911-011-9217-1; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Edgar VA, 1999, EUR J PHARMACOL, V372, P65; El-Hashash AHK, 2006, DEV BIOL, V290, P13, DOI 10.1016/j.ydbio.2005.10.010; Farrelly LA, 2019, NATURE, V567, P535, DOI 10.1038/s41586-019-1024-7; Fazzino F, 2009, INT IMMUNOPHARMACOL, V9, P463, DOI 10.1016/j.intimp.2009.01.011; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Grzeskowiak LE, 2012, REPROD TOXICOL, V34, P101, DOI 10.1016/j.reprotox.2012.03.003; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; Hansen HH, 1998, EUR J PHARMACOL, V352, P307, DOI 10.1016/S0014-2999(98)00349-5; Hernandez LL, 2011, J ENDOCRINOL, V209, P45, DOI 10.1530/JOE-10-0452; Hernandez LL, 2012, AM J PHYSIOL-ENDOC M, V302, pE1009, DOI 10.1152/ajpendo.00666.2011; Hinz M, 2012, NEUROPSYCH DIS TREAT, V8, P323, DOI 10.2147/NDT.S33259; Hummerich R, 2010, NEUROCHEM INT, V57, P67, DOI 10.1016/j.neuint.2010.04.020; Humphreys RC, 1997, CELL GROWTH DIFFER, V8, P839; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Katt William P, 2018, Oncotarget, V9, P34379, DOI 10.18632/oncotarget.26193; Katt WP, 2018, DRUG DISCOV TODAY, V23, P575, DOI 10.1016/j.drudis.2018.01.037; Keillor JW, 2016, EXPERT OPIN THER PAT, V26, P49, DOI 10.1517/13543776.2016.1115836; Keillor JW, 2015, TRENDS PHARMACOL SCI, V36, P32, DOI 10.1016/j.tips.2014.10.014; Kim W, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00440; Kovacs CS, 2017, J BONE MINER RES, V32, P676, DOI 10.1002/jbmr.3090; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kumar A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3085; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kumar M, 2019, PSYCHIAT RES, V276, P39, DOI 10.1016/j.psychres.2019.04.006; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Laporta J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140425; Laporta J, 2014, MOL ENDOCRINOL, V28, P1866, DOI 10.1210/me.2014-1204; Laporta J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110190; Martin-Ventura JL, 2008, ATHEROSCLEROSIS, V198, P264, DOI 10.1016/j.atherosclerosis.2008.02.017; Mamillapalli R, 2010, J ENDOCRINOL, V204, P287, DOI 10.1677/JOE-09-0183; Marshall AM, 2014, J MAMMARY GLAND BIOL, V19, P139, DOI 10.1007/s10911-013-9304-6; Martel F, 2006, PHARMACOL RES, V54, P73, DOI 10.1016/j.phrs.2006.04.005; Mi Z, 2017, NEUROPHARMACOLOGY, V117, P93, DOI 10.1016/j.neuropharm.2017.01.034; Muma NA, 2015, ACS CHEM NEUROSCI, V6, P961, DOI 10.1021/cn500329r; Ortuno MJ, 2016, NAT MED, V22, P1170, DOI 10.1038/nm.4166; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Penumatsa KC, 2014, AM J PHYSIOL-LUNG C, V306, pL309, DOI 10.1152/ajplung.00321.2013; Penumatsa K, 2014, CELL SIGNAL, V26, P2818, DOI 10.1016/j.cellsig.2014.09.002; Pinheiro IL, 2019, BEHAV BRAIN RES, V357, P65, DOI 10.1016/j.bbr.2017.07.038; Popova NK, 2006, BIOESSAYS, V28, P495, DOI 10.1002/bies.20412; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; RAHMAN MK, 1982, JPN J PHARMACOL, V32, P803, DOI 10.1254/jjp.32.803; Shaltiel G, 2005, AM J MED GENET B, V136B, P106, DOI 10.1002/ajmg.b.30167; Shih JC, 2004, NEUROTOXICOLOGY, V25, P21, DOI 10.1016/S0161-813X(03)00112-8; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Tsapakis EM, 2012, EUR PSYCHIAT, V27, P156, DOI 10.1016/j.eurpsy.2010.10.006; VanHouten J, 2004, J CLIN INVEST, V113, P598, DOI 10.1172/JCI200418776; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Watts SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005682; Weaver SR, 2018, ENDOCRINOLOGY, V159, P2850, DOI 10.1210/en.2018-00279; Weaver SR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15508-0; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Weissman AM, 2004, AM J PSYCHIAT, V161, P1066, DOI 10.1176/appi.ajp.161.6.1066; Woodrow JP, 2006, ENDOCRINOLOGY, V147, P4010, DOI 10.1210/en.2005-1616; Wysolmerski JJ, 2010, ANN NY ACAD SCI, V1192, P161, DOI 10.1111/j.1749-6632.2009.05249.x; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	79	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241192	10.1371/journal.pone.0241192	http://dx.doi.org/10.1371/journal.pone.0241192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095824	Green Published, gold, Green Submitted			2022-12-26	WOS:000586649400061
J	Bluhm, A; Christandl, M; Gesmundo, F; Klausen, FR; Mancinska, L; Steffan, V; Franca, DS; Werner, AH				Bluhm, Andreas; Christandl, Matthias; Gesmundo, Fulvio; Ravn Klausen, Frederik; Mancinska, Laura; Steffan, Vincent; Stilck Franca, Daniel; Werner, Albert H.			SARS-CoV-2 transmission routes from genetic data: A Danishcase study	PLOS ONE			English	Article							PHYLOGENETIC NETWORK ANALYSIS	Background The first cases of COVID-19 caused by the SARS-CoV-2 virus were reported in China in December 2019. The disease has since spread globally. Many countries have instated measures to slow the spread of the virus. Information about the spread of the virus in a country can inform the gradual reopening of a country and help to avoid a second wave of infections. Our study focuses on Denmark, which is opening up when this study is performed (end-May 2020) after a lockdown in mid-March. Methods We perform a phylogenetic analysis of 742 publicly available Danish SARS-CoV-2 genome sequences and put them into context using sequences from other countries. Results Our findings are consistent with several introductions of the virus to Denmark from independent sources. We identify several chains of mutations that occurred in Denmark. In at least one case we find evidence that the virus spread from Denmark to other countries. A number of the mutations found in Denmark are non-synonymous, and in general there is a considerable variety of strains. The proportions of the most common haplotypes remain stable after lockdown. Conclusion Employing phylogenetic methods on Danish genome sequences of SARS-CoV-2, we exemplify how genetic data can be used to trace the introduction of a virus to a country. This provides alternative means for verifying existing assumptions. For example, our analysis supports the hypothesis that the virus was brought to Denmark by skiers returning from Ischgl. On the other hand, we identify transmission routes which suggest that Denmark was part of a network of countries among which the virus was being transmitted. This challenges the common narrative that Denmark only got infected from abroad. Our analysis concerning the ratio of haplotypes does not indicate that the major haplotypes appearing in Denmark have a different degree of virality.	[Bluhm, Andreas; Christandl, Matthias; Gesmundo, Fulvio; Ravn Klausen, Frederik; Mancinska, Laura; Steffan, Vincent; Stilck Franca, Daniel; Werner, Albert H.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark	University of Copenhagen	Christandl, M (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	christandl@math.ku.dk	; Werner, Albert/J-8449-2016	Steffan, Vincent/0000-0003-4913-6833; Gesmundo, Fulvio/0000-0001-6402-021X; Bluhm, Andreas/0000-0003-4796-7633; Mancinska, Laura/0000-0001-9727-4961; Werner, Albert/0000-0003-0134-5257; Stilck Franca, Daniel/0000-0001-9699-5994; Klausen, Frederik Ravn/0000-0001-7815-4315	VILLUM FONDEN via the QMATH Centre of Excellence [10059]; VILLUM FONDEN [25452]	VILLUM FONDEN via the QMATH Centre of Excellence(Villum Fonden); VILLUM FONDEN(Villum Fonden)	All authors acknowledge financial support from VILLUM FONDEN via the QMATH Centre of Excellence (Grant no. 10059). AHW is supported by VILLUM FONDEN with a Villum Young Investigator Grant (Grant No. 25452). See https://veluxfoundations.dk/en for the webpage of VILLUM FONDEN. The authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amt der Tiroler Landesregierung, 2020, ISCHGL CHRON; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Danish Broadcasting Corporation, 2020, DR NEWS GYMN LUKK EF; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Embaetti landlaeknis, 2020, SKIOASV OIO ISCHGL A; Forster P, 2020, P NATL ACAD SCI USA, V117, P12524, DOI 10.1073/pnas.2007433117; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Grubaugh ND, 2020, CELL, V182, P794, DOI 10.1016/j.cell.2020.06.040; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hodcroft E, 2020, CLADE NAMING DEFINIT; Issa E, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00266-20; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lee K, 2009, GLOB INST, P1; Mavian C, 2020, P NATL ACAD SCI USA, V117, P12522, DOI 10.1073/pnas.2007295117; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2020, BIORXIV, DOI [10.1101/2020.04.17.046086, DOI 10.1101/2020.04.17.04608632669681]; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Singer J., 2020, COV GLUE WEB APPL TR, DOI [10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; SSI, 2020, COVID 19 DANM EP OV; SSI, 2020, COVID 19 DENM EP OV; Statens Serum Institut, 2020, OV; Statsministeriet Pressemode, 2020, PRESS COVID 19 6 APR; Statsministeriet Pressemode, 2020, PRESS COVID 19 11 MA; Statsministeriet Pressemode, 2020, PRESS COVID 19 10 MA; Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094; Sundhedsstyrelsen nyheder, 2020, COVID 19 NYE ANB BOR; Sundhedsstyrelsen nyheder, 2020, PERS BLEV UND RIGSH; TV2, 2020, DANSK SMITT MED COR; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex025; Wright ES, 2016, R J, V8, P352; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241405	10.1371/journal.pone.0241405	http://dx.doi.org/10.1371/journal.pone.0241405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119657	Green Submitted, gold, Green Published			2022-12-26	WOS:000600013600038
J	Elsobky, Y; El Afandi, G; Abdalla, E; Byomi, A; Reddy, G				Elsobky, Yumna; El Afandi, Gamal; Abdalla, Ehsan; Byomi, Ahmed; Reddy, Gopal			Possible ramifications of climate variability on HPAI-H5N1 outbreak occurrence: Case study from the Menoufia, Egypt	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; H5N1 OUTBREAKS; A(H5N1) VIRUS; SUBTYPE H5N1; EVOLUTION; PERSISTENCE; POULTRY; RISK; TEMPERATURE; IMPACT	Long endemicity of the Highly Pathogenic Avian Influenza (HPAI) H5N1 subtype in Egypt poses a lot of threats to public health. Contrary to what is previously known, outbreaks have been circulated continuously in the poultry sectors all year round without seasonality. These changes call the need for epidemiological studies to prove or deny the influence of climate variability on outbreak occurrence, which is the aim of this study. This work proposes a modern approach to examine the degree to which the HPAI-H5N1disease event is being influenced by climate variability as a potential risk factor using generalized estimating equations (GEEs). GEE model revealed that the effect of climate variability differs according to the timing of the outbreak occurrence. Temperature and relative humidity could have both positive and negative effects on disease events. During the cold seasons especially in the first quarter, higher minimum temperatures, consistently show higher risks of disease occurrence, because this condition stimulates viral activity, while lower minimum temperatures support virus survival in the other quarters of the year with the highest negative effect in the third quarter. On the other hand, relative humidity negatively affects the outbreak in the first quarter of the year as the humid weather does not support viral circulation, while the highest positive effect was found in the second quarter during which low humidity favors the disease event.	[Elsobky, Yumna; Byomi, Ahmed] Univ Sadat City, Dept Hyg & Zoonosis, Fac Vet Med, Sadat City, Egypt; [El Afandi, Gamal] Tuskegee Univ, Coll Agr Environm & Nutr Sci, Tuskegee, AL 36088 USA; [El Afandi, Gamal] Al Azhar Univ, Astron & Meteorol Dept, Fac Sci, Cairo, Egypt; [Abdalla, Ehsan] Tuskegee Univ, Dept Grad Publ Hlth, Coll Vet Med, Tuskegee, AL 36088 USA; [Reddy, Gopal] Tuskegee Univ, Coll Vet Med, Pathobiol Dept, Tuskegee, AL 36088 USA	Egyptian Knowledge Bank (EKB); University of Sadat City; Tuskegee University; Egyptian Knowledge Bank (EKB); Al Azhar University; Tuskegee University; Tuskegee University	Elsobky, Y (corresponding author), Univ Sadat City, Dept Hyg & Zoonosis, Fac Vet Med, Sadat City, Egypt.	yumna.elsobky@vet.usc.edu.eg	El Afandi, Gamal/AAZ-4973-2021; Elsobky, Yumna/AAD-7529-2021	El Afandi, Gamal/0000-0002-5235-026X; Elsobky, Yumna/0000-0001-6881-3479				Abdelwhab EM, 2016, INFECT GENET EVOL, V40, P80, DOI 10.1016/j.meegid.2016.02.023; Access Evolved Universal Terrestrial Radio, 2010, 36 3GPP TS, pV9; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2007, PLOS ONE, V2, pe779; Arafa A, 2012, ARCH VIROL, V157, P1931, DOI 10.1007/s00705-012-1385-9; Arafa AS, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.13.21085; Arafa AS, 2012, AVIAN DIS, V56, P849, DOI 10.1637/10152-040812-Reg.1; Arafa A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0477-7; Biswas PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098471; Cappelle J, 2010, ECOHEALTH, V7, P283, DOI 10.1007/s10393-010-0347-5; Chepete H, 2006, AGR ENG INT CIGR J, DOI [10.13031/2013.18408, DOI 10.13031/2013.18408]; Czarick M, 2008, POULTRY PRODUCTION IN HOT CLIMATES: 2ND EDITION, P80, DOI 10.1079/9781845932589.0080; [DCI] Food and Agriculture Organization, 2016, **DATA OBJECT**; Delquigny T, 2004, IMPACT AVIAN INFLUEN, P2004, DOI [10.18356/877ef4ac-en, DOI 10.18356/877EF4AC-EN]; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; El-Zoghby EF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-203; ElMasry I, 2017, TRANSBOUND EMERG DIS, V64, P805, DOI 10.1111/tbed.12440; Gilbert M, 2008, REV SCI TECH OIE, V27, P459, DOI 10.20506/rst.27.2.1821; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Hafez MH, 2010, POULTRY SCI, V89, P1609, DOI 10.3382/ps.2010-00708; Kayali G, 2016, EMERG INFECT DIS, V22, P379, DOI 10.3201/eid2203.150593; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Morin CW, 2018, ENVIRON INT, V119, P241, DOI 10.1016/j.envint.2018.06.018; Mu J. E., 2014, British Journal of Environment and Climate Change, V4, P166, DOI 10.9734/BJECC/2014/8888; Mu JH, 2011, CLIMATE CHANGE INFLU; National Aeronautics and Space Administration, 2019, POWER REL 8; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Salaheldin AH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00528; Si YL, 2010, ECOL SOC, V15, DOI 10.5751/es-03622-150326; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tran CC, 2013, ISPRS INT J GEO-INF, V2, P1106, DOI 10.3390/ijgi2041106; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; World Health Organization (WHO), 2015, INFL HUM AN INT SUMM; Zhang ZJ, 2014, INT J ENV RES PUB HE, V11, P6388, DOI 10.3390/ijerph110606388; Zhang ZJ, 2012, VET J, V192, P417, DOI 10.1016/j.tvjl.2011.08.012; Zhao XY, 2016, DISCRETE DYN NAT SOC, V2016, DOI 10.1155/2016/7871251	43	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240442	10.1371/journal.pone.0240442	http://dx.doi.org/10.1371/journal.pone.0240442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119614	gold, Green Published			2022-12-26	WOS:000600013600031
J	Sundman, AS; Pertille, F; Coutinho, LL; Jazin, E; Guerrero-Bosagna, C; Jensen, P				Sundman, Ann-Sofie; Pertille, Fabio; Lehmann Coutinho, Luiz; Jazin, Elena; Guerrero-Bosagna, Carlos; Jensen, Per			DNA methylation in canine brains is related to domestication and dog-breed formation	PLOS ONE			English	Article							GENOMIC ANALYSES; GENE-EXPRESSION; BEHAVIOR; EPIGENETICS; EVOLUTION; ASSOCIATION; MUTATIONS; SELECTION; VARIANTS; PATTERNS	Epigenetic factors such as DNA methylation act as mediators in the interaction between genome and environment. Variation in the epigenome can both affect phenotype and be inherited, and epigenetics has been suggested to be an important factor in the evolutionary process. During domestication, dogs have evolved an unprecedented between-breed variation in morphology and behavior in an evolutionary short period. In the present study, we explore DNA methylation differences in brain, the most relevant tissue with respect to behavior, between wolf and dog breeds. We optimized a combined method of genotype-by-sequencing (GBS) and methylated DNA immunoprecipitation (MeDIP) for its application in canines. Genomic DNA from the frontal cortex of 38 dogs of 8 breeds and three wolves was used. GBS and GBS-MeDIP libraries were prepared and sequenced on Illuma HiSeq2500 platform. The reduced sample represented 1.18 +/- 0.4% of the total dog genome (2,4 billion BP), while the GBS-MeDIP covered 11,250,788 +/- 4,042,106 unique base pairs. We find substantial DNA methylation differences between wolf and dog and between the dog breeds. The methylation profiles of the different groups imply that epigenetic factors may have been important in the speciation from dog to wolf, but also in the divergence of different dog breeds. Specifically, we highlight methylation differences in genes related to behavior and morphology. We hypothesize that these differences are involved in the phenotypic variation found among dogs, whereas future studies will have to find the specific mechanisms. Our results not only add an intriguing new dimension to dog breeding but are also useful to further understanding of epigenetic involvement.	[Sundman, Ann-Sofie; Pertille, Fabio; Guerrero-Bosagna, Carlos; Jensen, Per] Linkoping Univ, IFM Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden; [Pertille, Fabio; Lehmann Coutinho, Luiz] Univ Sao Paulo, Luiz de Queiroz Coll Agr ESALQ, Anim Sci & Pastures Dept, Anim Biotechnol Lab, Sao Paulo, Brazil; [Jazin, Elena] Uppsala Univ, EBC, Dept Organismal Biol, Uppsala, Sweden	Linkoping University; Universidade de Sao Paulo; Uppsala University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden.	per.jensen@liu.se	Pértille, Fábio/L-2837-2016	Pértille, Fábio/0000-0002-7214-9184; Jensen, Per/0000-0001-5491-0649	European Research Council [322206]; Sao Paulo Research Foundation [2016/20440-3, 2018/13600-0]	European Research Council(European Research Council (ERC)European Commission); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	PJ received funding from the European Research Council, grant number 322206. FP received funding from Sao Paulo Research Foundation, grant numbers 2016/20440-3 and 2018/13600-0.	Agnvall B, 2018, APPL ANIM BEHAV SCI, V205, P227, DOI 10.1016/j.applanim.2017.09.006; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Anastasiadi D, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0205-1; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Banlaki Z, 2017, MOL GENET GENOMICS, V292, P685, DOI 10.1007/s00438-017-1305-5; Bell CG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01586-1; Bell CG, 2012, EPIGENETICS-US, V7, P1188, DOI 10.4161/epi.22127; Belteky J, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0384-z; Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111; Brocal J, 2018, J ANAT, V233, P255, DOI 10.1111/joa.12822; Bromberg KD, 2008, FRONT BIOSCI-LANDMRK, V13, P4544, DOI 10.2741/3022; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Caminsky Natasha, 2014, F1000Res, V3, P282, DOI 10.12688/f1000research.5654.1; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chacon-Sanchez MI, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01551; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cimarelli G, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00549; Cropley JE, 2012, P ROY SOC B-BIOL SCI, V279, P2347, DOI 10.1098/rspb.2011.2646; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Elston GN, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00002; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Ge SX, 2018, BIORXIV; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Guerrero-Bosagna C, 2015, METHODSX, V2, P432, DOI 10.1016/j.mex.2015.10.006; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Insurance Institute for Highway Safety, 2010, STATUS REP, V45; Jablonka E, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0135; Jensen P, 2015, J EXP BIOL, V218, P32, DOI 10.1242/jeb.106799; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Koch IJ, 2016, MOL ECOL, V25, P1838, DOI 10.1111/mec.13480; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2013, MOL BIOL EVOL, V30, P1867, DOI 10.1093/molbev/mst088; Liang ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13282; Lienhard M, 2014, BIOINFORMATICS, V30, P284, DOI 10.1093/bioinformatics/btt650; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindblad-Toh K, 2005, NATURE, P438, DOI 10.1038/nj7049-438b; McDermott JE, 2018, MOL CELL NEUROSCI, V92, P50, DOI 10.1016/j.mcn.2018.06.008; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Miklosi A., 2015, DOG BEHAV EVOLUTION; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Natt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096376; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; Omote H, 2016, ANNU REV PHARMACOL, V56, P385, DOI 10.1146/annurev-pharmtox-010814-124816; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; Parker HG, 2012, MAMM GENOME, V23, P19, DOI 10.1007/s00335-011-9387-6; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Persson ME, 2015, GENES BRAIN BEHAV, V14, P337, DOI 10.1111/gbb.12194; Pertille F, 2019, EPIGENETICS-US, V14, P685, DOI 10.1080/15592294.2019.1609868; Pertille F, 2017, J EXP BIOL, V220, P3579, DOI 10.1242/jeb.157891; Pertille F, 2016, SCI REP-UK, V6, DOI 10.1038/srep26929; Ratnu VS, 2017, J NEUROSCI RES, V95, P301, DOI 10.1002/jnr.23886; Riffault B, 2014, J NEUROSCI, V34, P13516, DOI 10.1523/JNEUROSCI.2069-14.2014; Riyahi S, 2015, EPIGENETICS-US, V10, P516, DOI 10.1080/15592294.2015.1046027; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roth LS, 2015, J VET BEHAV CLIN APP; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2015, GENOME BIOL EVOL, V7, P1296, DOI 10.1093/gbe/evv073; Skinner MK, 2014, GENOME BIOL EVOL, V6, P1972, DOI 10.1093/gbe/evu158; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; Smith TA, 2016, MOL ECOL, V25, P1883, DOI 10.1111/mec.13561; Sundman AS, 2016, GENES BRAIN BEHAV, V15, P750, DOI 10.1111/gbb.12317; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Takahashi N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.8; Thompson MJ, 2017, AGING-US, V9, P1055, DOI 10.18632/aging.101211; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Xiao YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086344, 10.1371/journal.pone.0095875]; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7; Zapata I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2936-3	80	6	7	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240787	10.1371/journal.pone.0240787	http://dx.doi.org/10.1371/journal.pone.0240787			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119634	Green Published, gold			2022-12-26	WOS:000600013600059
J	Zwaans, BMM; Nicolai, HE; Chancellor, MB; Lamb, LE				Zwaans, Bernadette M. M.; Nicolai, Heinz E.; Chancellor, Michael B.; Lamb, Laura E.			Prostate cancer survivors with symptoms of radiation cystitis have elevated fibrotic and vascular proteins in urine	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TISSUE INHIBITORS; LIVER FIBROSIS; TIMP-1; METALLOPROTEINASES; EXPRESSION; DIAGNOSIS; DISEASE	Radiation for pelvic cancers can result in severe bladder damage and radiation cystitis (RC), which is characterized by chronic inflammation, fibrosis, and vascular damage. RC development is poorly understood because bladder biopsies are difficult to obtain. The goal of this study is to gain understanding of molecular changes that drive radiation-induced cystitis in cancer survivors using urine samples from prostate cancer survivors with history of radiation therapy. 94 urine samples were collected from prostate cancer survivors with (n = 85) and without (n = 9) history of radiation therapy. 15 patients with radiation history were officially diagnosed with radiation cystitis. Levels of 47 different proteins were measured using Multiplex Luminex. Comparisons were made between non-irradiated and irradiated samples, and within irradiated samples based on radiation cystitis diagnosis, symptom scores or hematuria. Statistical analysis was performed using Welch's t-test. In prostate cancer survivors with history of radiation therapy, elevated levels of PAI 1, TIMP1, TIMP2, HGF and VEGF-A were detected in patients that received a radiation cystitis diagnosis. These proteins were also increased in patients suffering from hematuria or high symptom scores. No inflammatory proteins were detected in the urine, except in patients with gross hematuria and end stage radiation cystitis. Active fibrosis and vascular distress is detectable in the urine through elevated levels of associated proteins. Inflammation is only detected in urine of patients with end-stage radiation cystitis disease. These results suggest that fibrosis and vascular damage drive the development of radiation cystitis and could lead to the development of more targeted treatments.	[Zwaans, Bernadette M. M.; Chancellor, Michael B.; Lamb, Laura E.] William Beaumont Hosp, Dept Urol, Royal Oak, MI 48072 USA; [Zwaans, Bernadette M. M.; Chancellor, Michael B.; Lamb, Laura E.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Nicolai, Heinz E.] Univ Chile, Dept Urol, Santiago, Chile; [Nicolai, Heinz E.] Hosp Clin San Borja Arriaran, Santiago, Chile	Beaumont Health; Oakland University; Universidad de Chile; Universidad de Chile	Lamb, LE (corresponding author), William Beaumont Hosp, Dept Urol, Royal Oak, MI 48072 USA.; Lamb, LE (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA.	Laura.Lamb@beaumont.org		Zwaans, Bernadette/0000-0002-4717-5751	U CanCer Vive Foundation; NIDDK K01 Career development award [DK114334]	U CanCer Vive Foundation; NIDDK K01 Career development award	This study was supported by the U CanCer Vive Foundation (https://ucancervive.com/; BMMZ, LEL, MBC), and NIDDK K01 Career development award DK114334 (https://www.niddk.nih.gov/; BMMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; American Cancer Society, 2020, CANC FACTS FIG 2020; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; [Anonymous], 2018, AM J KIDNEY DIS, V71, pS31; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Armbruster CE, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00327-18; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chakraborty S, 2013, EXPERT OPIN INV DRUG, V22, P499, DOI 10.1517/13543784.2013.778972; Day JW, 2018, BRIT J HOSP MED, V79, P694, DOI 10.12968/hmed.2018.79.12.694; Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Ikeda Y, 2018, NEUROUROL URODYNAM, V37, P2441, DOI 10.1002/nau.23721; Jaal J, 2006, J UROLOGY, V175, P1529, DOI 10.1016/S0022-5347(05)00658-0; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P1575, DOI 10.1046/j.1538-7836.2003.00279.x; Kanai AJ, 2002, AM J PHYSIOL-RENAL, V283, pF1304, DOI 10.1152/ajprenal.00228.2002; Kim J, 2020, INVESTIG CLIN UROL, V61, pS8, DOI 10.4111/icu.2020.61.S1.S8; Lamb LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185686; Lin H.W., 2010, J VAC SCI TECHNOL B, V28, pL5; Manoury B, 2006, INT J IMMUNOPATH PH, V19, P471, DOI 10.1177/039463200601900303; Margel D, 2011, EUR UROL, V59, P113, DOI 10.1016/j.eururo.2010.10.008; Martin SE, 2019, UROLOGY, V131, P190, DOI 10.1016/j.urology.2019.05.034; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nie QH, 2006, WORLD J GASTROENTERO, V12, P3044, DOI 10.3748/wjg.v12.i19.3044; Panganiban RAM, 2011, ACTA PHARMACOL SIN, V32, P12, DOI 10.1038/aps.2010.90; Shioya S, 2018, EXP THER MED, V16, P3070, DOI 10.3892/etm.2018.6550; Takawale A, 2017, HYPERTENSION, V69, P1092, DOI 10.1161/HYPERTENSIONAHA.117.09045; Vera PL, 2018, UROLOGY, V116, P55, DOI 10.1016/j.urology.2018.02.039; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Zwaans BMM, 2018, UROLOGY, V120, P180, DOI 10.1016/j.urology.2018.07.025; Zwaans Bernadette M M, 2016, Adv Radiat Oncol, V1, P333, DOI 10.1016/j.adro.2016.07.004; Zwaans Bernadette M M, 2016, Rev Urol, V18, P57, DOI 10.3909/riu0700; Zwaans BMM, 2016, UROLOGY, V88, P14, DOI 10.1016/j.urology.2015.11.001; Zwaans BMM, PHYSL REPORTS, V8, pe14377	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241388	10.1371/journal.pone.0241388	http://dx.doi.org/10.1371/journal.pone.0241388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119677	gold, Green Published			2022-12-26	WOS:000600013600107
J	Jayathilaka, R; Joachim, S; Mallikarachchi, V; Perera, N; Ranawaka, D				Jayathilaka, Ruwan; Joachim, Sheron; Mallikarachchi, Venuri; Perera, Nishali; Ranawaka, Dhanushika			Chronic diseases: An added burden to income and expenses of chronically-ill people in Sri Lanka	PLOS ONE			English	Article							HEALTH-CARE EXPENDITURES; CHRONIC ILLNESS; HOUSEHOLDS; IMPACT; MULTIMORBIDITY; CONSUMPTION; INEQUALITY; ETHNICITY; MEDICINES; PROGRAMS	In the global context, health and the quality of life of people are adversely affected by either one or more types of chronic diseases. This paper investigates the differences in the level of income and expenditure between chronically-ill people and non-chronic population. Data were gathered from a national level survey conducted namely, the Household Income and Expenditure Survey (HIES) by the Department of Census and Statistics (DCS) of Sri Lanka. These data were statistically analysed with one-way and two-way ANOVA, to identify the factors that cause the differences among different groups. For the first time, this study makes an attempt using survey data, to examine the differences in the level of income and expenditure among chronically-ill people in Sri Lanka. Accordingly, the study discovered that married females who do not engage in any type of economic activity (being unemployed due to the disability associated with the respective chronic illness), in the age category of 40-65, having an educational level of tertiary education or below and living in the urban sector have a higher likelihood of suffering from chronic diseases. If workforce population is compelled to lose jobs, it can lead to income insecurity and impair their quality of lives. Under above findings, it is reasonable to assume that most health care expenses are out of pocket. Furthermore, the study infers that chronic illnesses have a statistically proven significant differences towards the income and expenditure level. This has caused due to the interaction of demographic and socio-economic characteristics associated with chronic illnesses. Considering private-public sector partnerships that enable affordable access to health care services for all as well as implementation of commercial insurance and community-based mutual services that help ease burden to the public, are vital when formulating effective policies and strategies related to the healthcare sector. Sri Lanka is making strong efforts to support its healthcare sector and public, which was affected by the coronavirus (COVID-19) in early 2020. Therefore, findings of this paper will be useful to gain insights on the differences of chronic illnesses towards the income and expenditure of chronically-ill patients in Sri Lanka.	[Jayathilaka, Ruwan; Joachim, Sheron; Mallikarachchi, Venuri; Perera, Nishali; Ranawaka, Dhanushika] Sri Lanka Inst Informat Technol, SLIIT Business Sch, Dept Business Management, Malabe, Sri Lanka	Sri Lanka Institute of Information Technology (SLIIT)	Jayathilaka, R (corresponding author), Sri Lanka Inst Informat Technol, SLIIT Business Sch, Dept Business Management, Malabe, Sri Lanka.	ruwan.j@sliit.lk	Jayathilaka, Ruwan/AAM-9667-2020	Jayathilaka, Ruwan/0000-0002-7679-4164				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aflaki S, 2011, CONSTR BUILD MATER, V25, P2094, DOI 10.1016/j.conbuildmat.2010.11.028; Almalki ZS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3554-3; [Anonymous], 2012, EPIDEMIOLOGY MONITOR, V33, P9; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2007, WHO B, V85, P279; [Anonymous], 2014, DIABETES CARE, V1, pS14; August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022; Bailey C, 2020, PALLIAT SUPPORT CARE, V18, P271, DOI 10.1017/S1478951519000841; Bambra C, 2005, SOC SCI MED, V60, P1905, DOI 10.1016/j.socscimed.2004.09.002; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Bloom DE, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/rpsp.2018.18, 10.26633/RPSP.2018.18]; Burki A. A., 2015, Pakistan Development Review, V54, P17; Cerveira A, 2017, PROCEDIA STRUCT INTE, V5, P1116, DOI 10.1016/j.prostr.2017.07.099; Christopher AS, 2018, AM J PUBLIC HEALTH, V108, P351, DOI [10.2105/AJPH.2017.304213, 10.2105/ajph.2017.304213]; Coats H, 2018, J PAIN SYMPTOM MANAG, V56, P530, DOI 10.1016/j.jpainsymman.2018.07.005; Costa-Font J, 2005, ECON HUM BIOL, V3, P188, DOI 10.1016/j.ehb.2005.05.004; DCS, 2016, HOUS INC EXP SURV 20; Essue B, 2011, J HEALTH SERV RES PO, V16, P226, DOI 10.1258/jhsrp.2011.010159; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Fisher RA, 1921, J AGR SCI, V11, P107, DOI 10.1017/S0021859600003750; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Fong JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222539; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Habibov Nazim, 2009, J Health Organ Manag, V23, P170; Hoffman JIE, 2019, BASIC BIOSTATISTICS, P419; Iversen G.R., 1987, QUANTITATIVE APPL SO; Jayasinghe M, 2020, J HAPPINESS STUD, DOI [10.1007/s10902-019-00163-1, DOI 10.1007/S10902-019-00163-132834767]; Jayasinghe M, 2019, J ASIA PAC ECON, V24, P208, DOI 10.1080/13547860.2019.1573716; Jayathilaka R, 2016, APPL ECON, V48, P2054, DOI 10.1080/00036846.2015.1114574; Kemp A, 2013, J HEALTH SERV RES PO, V18, P21, DOI 10.1258/jhsrp.2012.011184; Kim J, 2014, SOC WORK HEALTH CARE, V53, P932, DOI 10.1080/00981389.2014.955940; Kumara AS, 2017, SOC SCI MED, V195, P68, DOI 10.1016/j.socscimed.2017.11.015; Kumara AS, 2016, HEALTH POLICY PLANN, V31, P970, DOI 10.1093/heapol/czw021; Kutner MH, 2011, APPL LINEAR STAT MOD; Lan X, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3698-1; Lee JH, 2011, NUTR DIET, V68, P248, DOI 10.1111/j.1747-0080.2011.01554.x; Lino VTS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071712; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Madurawala S., 2016, HEALTHCARE FINANCING, P143; Malon J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5673-5; Ministry of Health Nutrition and Indigenous Medicine., 2019, SRI LANK ESS HLTH SE; Molla AA, 2010, BMC HEALTH SERV RES, V17, P94; Molugaram K., 2017, STAT TECHNIQUES TRAN, DOI DOI 10.1016/j.ijid.2020.03.040; Molugaram K., 2017, STAT TECHNIQUES TRAN, P451, DOI 10.1016/b978-0-12-811555-8.00011-8; Murphy A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-38; Niedoba T, 2016, MIN SCI, V23, P43, DOI 10.5277/msc162304; Pallegedara A, 2018, INT J HEALTH ECON MA, V18, P301, DOI 10.1007/s10754-018-9235-2; Pallegedara A, 2018, INT J HEALTH PLAN M, V33, pE781, DOI 10.1002/hpm.2535; Pati S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-451; Perruccio AV, 2012, J CLIN EPIDEMIOL, V65, P100, DOI 10.1016/j.jclinepi.2011.04.013; Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652; Ramsey P.H., 1980, J EDUC STATIST, V5, P337, DOI DOI 10.3102/10769986005004337; Schoen C, 2009, HEALTH AFFAIR, V28, pW1, DOI 10.1377/hlthaff.28.1.w1; Shavers VL, 2010, J HEALTH CARE POOR U, V21, P177, DOI 10.1353/hpu.0.0255; Siegel AF, 2016, PRACTICAL BUSINESS STATISTICS, 7TH EDITION, P469, DOI 10.1016/B978-0-12-804250-2.00015-8; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Solutions S, 2002, ANOVA ANV VAR; Sultana Marufa, 2017, Chronic Dis Transl Med, V3, P112, DOI 10.1016/j.cdtm.2017.02.001; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Wang HP, 2017, ASIA-PAC J PUBLIC HE, V29, P268, DOI 10.1177/1010539517700472; World Health Organization, 2018, NONC DIS; World Health Organization, 2005, PREV CHORN DIS VIT I; Zhang XH, 2009, J HEALTH ECON, V28, P91, DOI 10.1016/j.jhealeco.2008.08.001	67	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239576	10.1371/journal.pone.0239576	http://dx.doi.org/10.1371/journal.pone.0239576			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33113548	gold, Green Published			2022-12-26	WOS:000588374000047
J	Chen, FF; Xiao, M; Chen, C; Chen, C; Yan, ZW; Han, HJ; Zhang, SL; Yue, FL; Gao, R; Lv, XY				Chen, Fangfang; Xiao, Meng; Chen, Cheng; Chen, Chen; Yan, Ziwei; Han, Huijie; Zhang, Shuailei; Yue, Feilong; Gao, Rui; Lv, Xiaoyi			Discrimination of alcohol dependence based on the convolutional neural network	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SEROTONIN TRANSPORTER; POSTTRAUMATIC-STRESS; CLINICAL-APPLICATION; 5-HT3 RECEPTOR; UNITED-STATES; ASSOCIATION; GENES; DISORDER; GENETICS	In this paper, a total of 20 sites of single nucleotide polymorphisms (SNPs) on the serotonin 3 receptor A gene (HTR3A) and B gene (HTR3B) are used for feature fusion with age, education and marital status information, and the grid search-support vector machine (GS-SVM), the convolutional neural network (CNN) and the convolutional neural network combined with long and short-term memory (CNN-LSTM) are used to classify and discriminate between alcohol-dependent patients (AD) and the non-alcohol-dependent control group. The results show that 19 SNPs combined with academic qualifications have the best discrimination effect. In the GS-SVM, the area under the receiver operating characteristic (ROC) curve (AUC) is 0.87, the AUC of CNN-LSTM is 0.88, and the performance of the CNN model is the best, with an AUC of 0.92. This study shows that the CNN model can more accurately discriminate AD than the SVM to treat patients in time.	[Chen, Fangfang; Chen, Cheng; Chen, Chen; Yan, Ziwei; Zhang, Shuailei; Gao, Rui; Lv, Xiaoyi] Xinjiang Univ, Coll Informat Sci & Engn, Urumqi, Xinjiang, Peoples R China; [Xiao, Meng] Fourth Peoples Hosp Urumqi, Urumqi, Xinjiang, Peoples R China; [Han, Huijie] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Yue, Feilong; Lv, Xiaoyi] Xinjiang Univ, Coll Software, Urumqi, Xinjiang, Peoples R China; [Lv, Xiaoyi] Xinjiang Univ, Key Lab Signal Detect & Proc, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Shanghai Jiao Tong University; Xinjiang University; Xinjiang University	Chen, C; Lv, XY (corresponding author), Xinjiang Univ, Coll Informat Sci & Engn, Urumqi, Xinjiang, Peoples R China.; Lv, XY (corresponding author), Xinjiang Univ, Coll Software, Urumqi, Xinjiang, Peoples R China.; Lv, XY (corresponding author), Xinjiang Univ, Key Lab Signal Detect & Proc, Urumqi, Xinjiang, Peoples R China.	chenchengoptics@gmail.com; xjuwawj01@163.com		Chen, Cheng/0000-0002-6739-1937	Science and Technology Project on aid to Xinjiang Uygur Autonomous Region [2019E0215]	Science and Technology Project on aid to Xinjiang Uygur Autonomous Region	This work has been supported by the Science and Technology Project on aid to Xinjiang Uygur Autonomous Region under Grant 2019E0215.	Abd El Hamid MM, 2016, CAIRO INT BIOM ENG, P5, DOI 10.1109/CIBEC.2016.7836087; Adebileje SA, 2017, MAGN RESON CHEM, V55, P318, DOI 10.1002/mrc.4532; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Alzubi R, 2018, 2018 24 INT C AUT CO; Alzubi R, 2018, IEEE ACCESS, V6, DOI 10.1109/ACCESS.2017.2778268; Andersen AM, 2017, JAMA PSYCHIAT, V74, P1153, DOI 10.1001/jamapsychiatry.2017.2269; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12, DOI DOI 10.1158/2159-8290.CD-RW2016-234; [Anonymous], 2019, CIRCULATION, V2019; Bae S. H., 2016, DETECTION CLASSIFICA; Beison A, 2017, J BEHAV ADDICT, V6, P84, DOI 10.1556/2006.6.2017.016; Celli J, 2017, HUM MUTAT, V38, P137, DOI 10.1002/humu.23136; Chen BW, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00167; Chen LJ, 2019, SYST BIOL REPROD MED, V65, P75, DOI 10.1080/19396368.2018.1472315; Chuang L-Y, 2010, WORLD C ENG 2012 JUL; Dawson DA, 2005, ADDICTION, V100, P281, DOI 10.1111/j.1360-0443.2004.00964.x; Deepak S, 2019, COMPUT BIOL MED, V111, DOI 10.1016/j.compbiomed.2019.103345; Deng N, 2017, ONCOTARGET, V8, P110635, DOI 10.18632/oncotarget.22372; Enoch MA, 2011, MOL PSYCHIATR, V16, P1139, DOI 10.1038/mp.2010.94; Eraslan G, 2016, DEEPWAS DIRECTLY INT; Feng B, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0416-0; Fuller-Thomson E, 2016, SUBST USE MISUSE, V51, P1451, DOI 10.1080/10826084.2016.1181089; Gao T, 2018, PERS UBIQUIT COMPUT, V22, P1039, DOI 10.1007/s00779-018-1144-3; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Goldstein B, 2017, J CLIN PSYCHOL, V73, P319, DOI 10.1002/jclp.22332; Griffin TJ, 2000, ANAL CHEM, V72, P3298, DOI 10.1021/ac991390e; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hazra A, 2016, INDIAN J DERMATOL, V61, P593, DOI 10.4103/0019-5154.193662; Hua JT, 2017, B26 CIGARETTES CIGAR, pA3072; Ji AL, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5276-1; Ji XZ, 2019, SYST BIOL REPROD MED, V65, P258, DOI 10.1080/19396368.2019.1590479; Jiao Yasen, 2016, [Quantitative Biology, 定量生物学], V4, P320; Kasnavi SA, 2017, INDIAN J ANIM SCI, V87, P1226; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kingma DP., 2014, ADAM METHOD STOCHAST; Liu QS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121330; Mohon A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy011; Montanez CAC, 2018, IEEE IJCNN; Oh SL, 2018, COMPUT BIOL MED, V102, P278, DOI 10.1016/j.compbiomed.2018.06.002; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Panigrahi Jyotiprakash, 2019, Emerging Technologies in Data Mining and Information Security. Proceedings of IEMIS 2018. Advances in Intelligent Systems and Computing (AISC 814), P635, DOI 10.1007/978-981-13-1501-5_56; Paulus DJ, 2017, PSYCHIAT RES, V251, P69, DOI 10.1016/j.psychres.2017.02.011; Rehm J, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0081-2; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1476, DOI 10.1109/TPAMI.2016.2601099; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7; Seneviratne C, 2013, HUM GENET, V132, P1165, DOI 10.1007/s00439-013-1319-y; Shahzadi I, 2018, IEEE EMBS CONF BIO, P633, DOI 10.1109/IECBES.2018.8626704; Sobolev V, 2019, ARCH DERMATOL RES, V311, P309, DOI 10.1007/s00403-019-01904-1; Stickel F, 2017, J HEPATOL, V66, P195, DOI 10.1016/j.jhep.2016.08.011; Studer J, 2019, ADDICTION, V114, P1556, DOI 10.1111/add.14647; Sun Q, 2019, J PHYS C SERIES; Tomida S, 2002, J BIOSCI BIOENG, V93, P470, DOI 10.1263/jbb.93.470; Uhmn S, 2007, 2007 FRONTIERS CONVE; Ujike Hiroshi, 2008, Japanese Journal of Alcohol Studies & Drug Dependence, V43, P87; Van der Elst W, 2012, ARCH CLIN NEUROPSYCH, V27, P433, DOI 10.1093/arclin/acs045; Wahyuningrum RT, 2019, 2019 IEEE 10 INT C A; Walfish S., 2006, PHARM TECHNOLOGY, V30, P82; Wang Y, 2017, CLIN GENET, V91, P849, DOI 10.1111/cge.12926; Wu S, 2019, SCHOLARS ACAD J BIOS; Xu YH, 2016, AM J DRUG ALCOHOL AB, V42, P316, DOI 10.3109/00952990.2016.1160098; Yang G., 2019, MEAN FIELD THEORY BA; Yang HH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00192; Yang JK, 2014, HUM GENET, V133, P905, DOI 10.1007/s00439-014-1431-7; Yoon Y, 2003, CLIN CHEM LAB MED, V41, P529, DOI 10.1515/CCLM.2003.080; Zhang LN, 2017, INFRARED PHYS TECHN, V86, P116, DOI 10.1016/j.infrared.2017.08.020; Zheng PF, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1179-z	67	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241268	10.1371/journal.pone.0241268	http://dx.doi.org/10.1371/journal.pone.0241268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108388	Green Published, gold			2022-12-26	WOS:000588372400009
J	Tetteh, J; Nuertey, BD; Dwomoh, D; Udofia, EA; Mohammed, S; Adjei-Mensah, E; Yawson, AE				Tetteh, John; Nuertey, Benjamin D.; Dwomoh, Duah; Udofia, Emilia Asuquo; Mohammed, Sheriff; Adjei-Mensah, Evelyn; Yawson, Alfred Edwin			Teenage pregnancy and experience of physical violence among women aged 15-19 years in five African countries: Analysis of complex survey data	PLOS ONE			English	Article							PERINATAL OUTCOMES; ABSTINENCE; BIRTH; ADOLESCENTS; PREVENTION; PREVALENCE; ADULT	Background Pregnant teenage women are prime targets of violence against women perpetrated by intimate partners, family members, and miscreants in their neighborhoods. This study estimated the prevalence of Teenage pregnancy (TP) and Physical Violence (PV) and further assessed the relationship between TP and PV in five Low-and-Middle-Income Countries (LMICs). Methods The study was conducted among five LIMCs (Burkina Faso, Kenya, Malawi, Nigeria, and Tanzania) using data from the most recent Demographic and Health Surveys conducted in these countries. Modified Poisson with the robust standard error was used to quantify the association between TP and PV. All analyses adjusted for the complex survey design structure (clustering, weighting, and stratification). Results The analysis involved a total of 26055 adolescent women aged 15-19 years across the five countries. The overall prevalence of TP was 25.4% (95%CI = 24.4-26.4) with the highest prevalence occurring among Malawians [29.0% (95%CI = 27.4-30.7)]. Meanwhile, the prevalence of TP among older adolescents (18-19 years) was approximately two-thirds significantly higher compared with young adolescents [aPR(95%CI) = 1.60[1.49-1.71)]. The prevalence of PV among teenagers across the five countries was 24.2% (95%CI = 22.3-26.2). The highest prevalence of PV was recorded among Nigerian adolescent women [31.8% (95%CI = 28.5-35.3)]. The prevalence of PV among adolescent women who were pregnant was approximately 5-folds significant compared to those who were not pregnant (adjusted prevalence ratio; aPR = 4.70; 95% CI: 3.86-5.73; p<0.0001). Conclusion There was a high prevalence of pregnancy among older teenagers aged 18-19 years. Close to a quarter of teenage women ever experienced physical violence. Pregnant teenage women ever experience of physical violence was very high compared to non-pregnant peers. Intervention should target PV and TP by adopting a gender-sensitive approach to eliminate physical violence, particularly among teenagers to prevent TP.	[Tetteh, John; Nuertey, Benjamin D.; Udofia, Emilia Asuquo; Adjei-Mensah, Evelyn; Yawson, Alfred Edwin] Univ Ghana, Med Sch, Coll Hlth Sci, Dept Community Hlth, Accra, Ghana; [Dwomoh, Duah; Yawson, Alfred Edwin] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Mohammed, Sheriff] Korle Bu Teaching Hosp, Natl Cardiothorac Ctr, Accra, Ghana	University of Ghana; University of Ghana	Yawson, AE (corresponding author), Univ Ghana, Med Sch, Coll Hlth Sci, Dept Community Hlth, Accra, Ghana.; Yawson, AE (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana.	aeyawson@ug.edu.gh	Udofia, Emilia Asuquo/AAQ-6729-2020; Tetteh, John/AEU-3066-2022	Udofia, Emilia Asuquo/0000-0002-7279-1839; Tetteh, John/0000-0002-1986-4103				Abebe AM, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3124847; [Anonymous], 2014, FRONTIERS ARCHITECTU, V3, P1, DOI DOI 10.1520/C1557-03R13.2; [Anonymous], 2016, CLIN PHARM THER S1, V99, pS5; Bennett SE, 2005, J ADOLESCENT HEALTH, V36, P72, DOI 10.1016/j.jadohealth.2003.11.097; Briggs MM, 2007, J OBSTET GYNAECOL CA, V29, P546, DOI 10.1016/S1701-2163(16)32506-3; Buse K, 2016, LANCET GLOB HEALTH, V4, pE599, DOI 10.1016/S2214-109X(16)30138-3; Cabezon C, 2005, J ADOLESCENT HEALTH, V36, P64, DOI 10.1016/j.jadohealth.2003.10.011; Callaghan JEM, 2015, FEM PSYCHOL, V25, P506, DOI 10.1177/0959353515590691; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Croft TN, GUIDE DHS STAT; Cunnington AJ, 2001, J FAM PLAN REPROD H, V27, P36, DOI 10.1783/147118901101194877; de Haas B, 2017, SEX EDUC-SEX SOC LEA, V17, P529, DOI 10.1080/14681811.2017.1315933; Demir S C, 2000, J Pediatr Adolesc Gynecol, V13, P177, DOI 10.1016/S1083-3188(00)00062-0; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; DHS, PROT PRIV DHS SURV R; Duran S, 2019, COMMUNITY MENT HLT J, V55, P1202, DOI 10.1007/s10597-019-00433-5; Every Woman Every Child, 2016, GLOB STRAT WOM CHILD; Ezegwui HU, 2012, NIGER J CLIN PRACT, V15, P147, DOI 10.4103/1119-3077.97289; Geist Ruth R, 2006, J Pediatr Adolesc Gynecol, V19, P189; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Goossens G., 2015, PSYCHIAT DANUB, V27, P499; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Haldre K, 2007, EUR J OBSTET GYN R B, V131, P45, DOI 10.1016/j.ejogrb.2006.05.002; Hanna B, 2001, J ADV NURS, V34, P456, DOI 10.1046/j.1365-2648.2001.01774.x; ICF International, DEM HLTH SURV SAMPL; Jann B, ALPHAWGT STATA MODUL; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; Karai A, 2019, J MATERN-FETAL NEO M, V32, P2376, DOI 10.1080/14767058.2018.1438393; Kassa GM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218259; Kawakita T, 2016, J PEDIATR ADOL GYNEC, V29, P130, DOI 10.1016/j.jpag.2015.08.006; Kean N, 2020, J MATERN-FETAL NEO M, V33, P598, DOI 10.1080/14767058.2018.1498478; Loto O M, 2004, J Obstet Gynaecol, V24, P395, DOI 10.1080/01443610410001685529; Mahavarkar SH, 2008, J OBSTET GYNAECOL, V28, P604, DOI 10.1080/01443610802281831; Medhi R, 2016, ADOLESC HEALTH MED T, V7, P37, DOI 10.2147/AHMT.S91853; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Nuertey BD, POSTGRAD MED J GHANA, V7; Okoro DC, 2020, AFRICAN WOMEN SHAME; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; PARKER B, 1994, OBSTET GYNECOL, V84, P323; Plan international, TEEN PREGN; Restrepo Martínez Miguel, 2017, rev.colomb.psiquiatr., V46, P74, DOI [10.1016/j.rcpeng.2017.05.003, 10.1016/j.rcp.2016.05.004]; Saltzman Linda E, 2003, Matern Child Health J, V7, P31, DOI 10.1023/A:1022589501039; Santelli JS, 2017, J ADOLESCENT HEALTH, V61, P400, DOI 10.1016/j.jadohealth.2017.06.001; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Sodje J. D. K., 2016, Journal of Medicine and Biomedical Research, V15, P109; Thaithae S, 2011, J PEDIATR ADOL GYNEC, V24, P342, DOI 10.1016/j.jpag.2011.02.009; The world Bank, MEASURE DHS DEM HLTH; Timur H, 2016, J PEDIATR ADOL GYNEC, V29, P18, DOI 10.1016/j.jpag.2015.05.002; Traisrisilp K, 2015, J OBSTET GYNAECOL RE, V41, P1726, DOI 10.1111/jog.12789; Trivedi SS, 2007, TROP DOCT, V37, P85, DOI 10.1258/004947507780609437; Turkay U, 2020, J MATERN-FETAL NEO M, V33, P1353, DOI 10.1080/14767058.2018.1519016; UN, 2019, POP DIV WORLD POP PR; UNFPA, 2015, GIRLH NOT MOTH PREV; Unicef, 2009, CHILDR FAM TRANS YOU; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wong SPW, 2020, J PEDIATR ADOL GYNEC, V33, P153, DOI 10.1016/j.jpag.2019.10.006; World Health Organization, 2018, AD PREGN KEY FACTS F; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4; Zer S, 2019, J PEDIATR ADOL GYNEC, V32, P622, DOI 10.1016/j.jpag.2019.08.003	59	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0241348	10.1371/journal.pone.0241348	http://dx.doi.org/10.1371/journal.pone.0241348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8WV	33108400	gold, Green Published			2022-12-26	WOS:000588372400004
J	Gallot, A; Sauzet, S; Desouhant, E				Gallot, Aurore; Sauzet, Sandrine; Desouhant, Emmanuel			Kin recognition: Neurogenomic response to mate choice and sib mating avoidance in a parasitic wasp	PLOS ONE			English	Article							GOOD-GENES; SEX DETERMINATION; SOCIAL-BEHAVIOR; RNA-SEQ; EVOLUTION; BRAIN; PATTERNS; STIMULATION; HYMENOPTERA; EXPRESSION	Sib mating increases homozygosity, which therefore increases the risk of inbreeding depression. Selective pressures have favoured the evolution of kin recognition and avoidance of sib mating in numerous species, including the parasitoid wasp Venturia canescens. We studied the female neurogenomic response associated with sib mating avoidance after females were exposed to courtship displays by i) unrelated males or ii) related males or iii) no courtship (controls). First, by comparing the transcriptional responses of females exposed to courtship displays to those exposed to controls, we saw a rapid and extensive transcriptional shift consistent with social environment. Second, by comparing the transcriptional responses of females exposed to courtship by related to those exposed to unrelated males, we characterized distinct and repeatable transcriptomic patterns that correlated with the relatedness of the courting male. Network analysis revealed 3 modules of specific 'sib-responsive' genes that were distinct from other 'courtship-responsive' modules. Therefore, specific neurogenomic states with characteristic brain transcriptomes associated with different behavioural responses affect sib mating avoidance behaviour.	[Gallot, Aurore; Sauzet, Sandrine; Desouhant, Emmanuel] Univ Lyon 1, Univ Lyon, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France; [Sauzet, Sandrine] Univ Montpellier, Inst Genet Humaine, Biol Repetit Sequences, UMR 9002,CNRS, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Gallot, A (corresponding author), Univ Lyon 1, Univ Lyon, CNRS, Lab Biometrie & Biol Evolut,UMR 5558, Villeurbanne, France.	aurore.gallot@univ-lyon1.fr			Agence Nationale de la Recherche [ANR-17-CE02-0004-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (https://anr.fr/en/) JCJC AVOIDINBRED (ANR-17-CE02-0004-01) attributed to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat I, 2009, BEHAV ECOL SOCIOBIOL, V63, P563, DOI 10.1007/s00265-008-0691-4; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ANDERSON WW, 1974, AM NAT, V108, P709, DOI 10.1086/282949; Andersson Malte, 1994; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; BEAUCHAMP GK, 1985, SCI AM, V253, P86, DOI 10.1038/scientificamerican0785-86; Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloch NI, 2018, NAT ECOL EVOL, V2, P1772, DOI 10.1038/s41559-018-0682-4; BOYSE EA, 1987, TRENDS GENET, V3, P97, DOI 10.1016/0168-9525(87)90192-2; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Chuine A, 2015, BIOL J LINN SOC, V114, P279, DOI 10.1111/bij.12421; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; Couto A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00048; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Cummings ME, 2015, ANIM BEHAV, V103, P249, DOI 10.1016/j.anbehav.2015.02.021; Derstine NT, 2018, INSECT SOC, V65, P581, DOI 10.1007/s00040-018-0649-0; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Dulcis D, 2017, NEURON, V95, P1319, DOI 10.1016/j.neuron.2017.08.023; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Filteau M, 2013, MOL BIOL EVOL, V30, P1384, DOI 10.1093/molbev/mst053; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hosken DJ, 2003, EVOL BIOL, V33, P173; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Imhof M, 1998, MOL ECOL, V7, P915, DOI 10.1046/j.1365-294x.1998.00382.x; Immonen E, 2012, P ROY SOC B-BIOL SCI, V279, P1359, DOI 10.1098/rspb.2011.1644; Juni N, 2009, J NEUROGENET, V23, P329, DOI 10.1080/01677060802471601; Kelber C, 2010, DEV NEUROBIOL, V70, P222, DOI 10.1002/dneu.20782; Krupp JJ, 2013, NEURON, V79, P54, DOI 10.1016/j.neuron.2013.05.019; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Leobold M, 2018, GENOME BIOL EVOL, V10, P1745, DOI 10.1093/gbe/evy127; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MANNING CJ, 1992, NATURE, V360, P581, DOI 10.1038/360581a0; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; McKenzie SK, 2016, P NATL ACAD SCI USA, V113, P14091, DOI 10.1073/pnas.1610800113; McNeill MS, 2016, GENES BRAIN BEHAV, V15, P305, DOI 10.1111/gbb.12275; Metzger M, 2010, J ANIM ECOL; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nishikawa M, 2012, J COMP NEUROL, V520, P1584, DOI 10.1002/cne.23001; Pichon A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501150; POTTS W., 1991, NATURE, V352, P6336; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Ramsey ME, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00062; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; Rittschof CC, 2016, CURR TOP DEV BIOL, V119, P157, DOI 10.1016/bs.ctdb.2016.04.001; Rosengarten RD, 2011, CURR BIOL, V21, pR82, DOI 10.1016/j.cub.2010.11.061; ROSS KG, 1993, GENETICS, V135, P843; Ryan MJ, 2013, ANNU REV ECOL EVOL S, V44, P437, DOI 10.1146/annurev-ecolsys-110512-135901; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; SALT G, 1976, ECOL ENTOMOL, V1, P63, DOI 10.1111/j.1365-2311.1976.tb01205.x; Simmons LW, 2003, J EVOLUTION BIOL, V16, P624, DOI 10.1046/j.1420-9101.2003.00572.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Singer TL, 1998, AM ZOOL, V38, P394; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taketa DA, 2015, DEV COMP IMMUNOL, V48, P254, DOI 10.1016/j.dci.2014.03.014; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Todd EV, 2016, MOL ECOL, V25, P1224, DOI 10.1111/mec.13526; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; TURNER ME, 1983, EVOLUTION, V37, P714, DOI 10.1111/j.1558-5646.1983.tb05593.x; van Santen Marlies C.P., 2002, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V13, P87; van Wilgenburg E, 2011, J EVOLUTION BIOL, V24, P1188, DOI 10.1111/j.1420-9101.2011.02248.x; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Veltsos P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02232-6; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whitney O, 2014, SCIENCE, V346, P1334, DOI 10.1126/science.1256780; Yamazaki K, 1999, P NATL ACAD SCI USA, V96, P1522, DOI 10.1073/pnas.96.4.1522; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2012, ANNU REV GENET, V46, P591, DOI 10.1146/annurev-genet-110711-155517; Zube C, 2008, ARTHROPOD STRUCT DEV, V37, P469, DOI 10.1016/j.asd.2008.05.004; 2001, J TRAUMA, V51, P1	85	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241128	10.1371/journal.pone.0241128	http://dx.doi.org/10.1371/journal.pone.0241128			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104752	Green Published, gold			2022-12-26	WOS:000588370000007
J	Pavlikova, N; Sramek, J; Jelinek, M; Halada, P; Kovar, J				Pavlikova, Nela; Sramek, Jan; Jelinek, Michael; Halada, Petr; Kovar, Jan			Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ORGANOCHLORINE PESTICIDES; ER STRESS; BILIVERDIN REDUCTASE; IRON CHELATORS; CCT CHAPERONIN; EXPRESSION; MECHANISM; APOPTOSIS; MORTALIN	Many compounds have the potential to harm pancreatic beta-cells; organochlorine pollutants belong to those compounds. In this work, we aimed to find markers of acute toxicity of p,p'-DDT exposure among proteins expressed in NES2Y human pancreatic beta-cells employing 2-D electrophoresis. We exposed NES2Y cells to a high concentration (150 mu M, LC96 after 72 hours) of p,p'-DDT for 24 and 30 hours and determined proteins with changed expression using 2-D electrophoresis. We have found 22 proteins that changed their expression. They included proteins involved in ER stress (GRP78, and endoplasmin), mitochondrial proteins (GRP75, ECHM, IDH3A, NDUS1, and NDUS3), proteins involved in the maintenance of the cell morphology (EFHD2, TCPA, NDRG1, and ezrin), and some other proteins (HNRPF, HNRH1, K2C8, vimentin, PBDC1, EF2, PCNA, biliverdin reductase, G3BP1, FRIL, and HSP27). The proteins we have identified may serve as indicators of p,p'-DDT toxicity in beta-cells in future studies, including long-term exposure to environmentally relevant concentrations.	[Pavlikova, Nela; Sramek, Jan; Jelinek, Michael; Kovar, Jan] Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic; [Pavlikova, Nela; Sramek, Jan; Jelinek, Michael; Kovar, Jan] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic; [Halada, Petr] Czech Acad Sci, BioCeV Inst Microbiol, Vestec, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Pavlikova, N (corresponding author), Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic.; Pavlikova, N (corresponding author), Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic.	nela.pavlikova@lf3.cuni.cz	Jelínek, Michael/Y-7391-2018; Halada, Petr/H-3330-2014; Pavlikova, Nela/AAL-1103-2021; Pavlíková, Nela/W-7000-2018; Sramek, Jan/W-7092-2018	Jelínek, Michael/0000-0001-6831-2113; Halada, Petr/0000-0002-7229-3450; Pavlikova, Nela/0000-0001-7468-1505; Pavlíková, Nela/0000-0001-7468-1505; Sramek, Jan/0000-0003-0218-7238	Charles University in Prague, Czech Republic [UNCE 204015, PROGRES Q36]; European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	Charles University in Prague, Czech Republic(Czech Republic Government); European Regional Development Fund(European Commission)	This work was supported by the research projects UNCE 204015 and PROGRES Q36 of Charles University in Prague, Czech Republic, and by the project BIOCEV CZ.1.05/1.1.00/02.0109 from the European Regional Development Fund. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Andel Michal, 2014, Vnitr Lek, V60, P684; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2007, AM J PHYSIOL-GASTR L, V293, pG1300; Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Buranrat B, 2015, ONCOL REP, V34, P2790, DOI 10.3892/or.2015.4250; Carravieri A, 2017, ENVIRON POLLUT, V228, P464, DOI 10.1016/j.envpol.2017.05.053; Chen LG, 2017, SCI TOTAL ENVIRON, V577, P405, DOI 10.1016/j.scitotenv.2016.10.227; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chinese Allergic Rhinitis Research Collaboration group, 2015, CHIN ARCH OTOLARYNGO, V22, P379; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; De Long NE, 2014, J AFFECT DISORDERS, V166, P6, DOI 10.1016/j.jad.2014.04.063; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Henriquez-Hernandez LA, 2014, ENVIRON RES, V135, P48, DOI 10.1016/j.envres.2014.05.036; Huh YH, 2015, ONCOTARGET, V6, P13060, DOI 10.18632/oncotarget.3637; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Jusko TA, 2012, EPIDEMIOLOGY, V23, P689, DOI 10.1097/EDE.0b013e31825fb61d; Kaisari S, 2017, P NATL ACAD SCI USA, V114, P956, DOI 10.1073/pnas.1620451114; Kartalovic B, 2016, FOOD ADDIT CONTAM B, V9, P299, DOI 10.1080/19393210.2016.1234004; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Kuo WC, 2010, ONCOGENE, V29, P1374, DOI 10.1038/onc.2009.417; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lee SJ, 2017, CELL BIOL INT, V41, P514, DOI 10.1002/cbin.10750; Lee YM, 2017, DIABETES, V66, P2669, DOI 10.2337/db17-0188; Lee YM, 2014, SCI TOTAL ENVIRON, V496, P219, DOI 10.1016/j.scitotenv.2014.07.039; Lenzen S, 2017, BBA-GEN SUBJECTS, V1861, P1929, DOI 10.1016/j.bbagen.2017.05.013; LIEGL U, 1994, CLIN INVESTIGATOR, V72, P1027, DOI 10.1007/BF00577749; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mathur V, 2002, ENVIRON INT, V28, P331, DOI 10.1016/S0160-4120(02)00031-4; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; National coordination centre- Pharmacovigilance programme of India, 2017, NEWSLETTER, V7, P13; Nemcova-Furstova V, 2011, CELL PHYSIOL BIOCHEM, V27, P525, DOI 10.1159/000329954; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Onabid MA, 2017, INT J ADV COMPUT SC, V8, P12; Park KR, 2017, BIOCHEM BIOPH RES CO, V483, P442, DOI 10.1016/j.bbrc.2016.12.124; Pavlikova N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54579-z; Pavlikova N, 2015, CELL MOL BIOL LETT, V20, P919, DOI 10.1515/cmble-2015-0054; Pavlikova N, 2015, ENVIRON RES, V142, P257, DOI 10.1016/j.envres.2015.06.046; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Ploteau S, 2016, ENVIRON INT, V97, P125, DOI 10.1016/j.envint.2016.08.011; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Vives M, 1998, DIABETOLOGIA, V41, pA101; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Weiszenstein M, 2016, PLOS ONE, V11, P14	56	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0229430	10.1371/journal.pone.0229430	http://dx.doi.org/10.1371/journal.pone.0229430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104727	gold, Green Published			2022-12-26	WOS:000588370000016
J	Dorsch, R; Ojeda, J; Salgado, M; Monti, G; Collado, B; Tomckowiack, C; Tejeda, C; Muller, A; Eberhard, T; Klaasen, HLBM; Hartmann, K				Dorsch, Roswitha; Ojeda, Javier; Salgado, Miguel; Monti, Gustavo; Collado, Bernadita; Tomckowiack, Camillo; Tejeda, Carlos; Muller, Ananda; Eberhard, Theo; Klaasen, Henricus L. B. M.; Hartmann, Katrin			Cats shedding pathogenic Leptospira spp.-An underestimated zoonotic risk?	PLOS ONE			English	Article							CLINICAL LEPTOSPIROSIS; INTERROGANS; PREVALENCE; ANTIBODIES; SEROEPIDEMIOLOGY; COMMUNITIES; FEATURES; WATER; DOGS	Shedding of DNA of pathogenic Leptospira spp. has been documented in naturally infected cats in several countries, but urinary shedding of infectious Leptospira spp. has only recently been proven. The climate in Southern Chile is temperate rainy with high annual precipitations which represents ideal preconditions for survival of Leptospira spp., especially during spring and summer. The aims of this study were to investigate shedding of pathogenic Leptospira spp. in outdoor cats in Southern Chile, to perform molecular characterization of isolates growing in culture, and to assess potential risk factors associated with shedding. Urine samples of 231 outdoor cats from rural and urban areas in southern Chile were collected. Urine samples were investigated for pathogenic Leptospira spp. by 4 techniques: qPCR targeting the lipL32 gene, immunomagnetic separation (IMS)-coupled qPCR (IMS-qPCR), direct culture and IMS-coupled culture. Positive urine cultures were additionally confirmed by PCR. Multilocus sequence typing (MLST) was used to molecularly characterize isolates obtained from positive cultures. Overall, 36 urine samples (15.6%, 95% confidence interval (CI) 11.4-20.9) showed positive results. Eighteen (7.8%, 95% CI 4.9-12.1), 30 (13%, 95% CI 9.2-18), 3 (1.3%, 0.3-3.9) and 4 cats (1.7%; 95% CI 0.5-4.5) were positive in qPCR, IMS-qPCR, conventional culture, and IMS-coupled culture, respectively. MLST results of 7 culture-positive cats revealed sequences that could be assigned to sequence type 17 (6 cats) and sequence type 27 (1 cat) corresponding to L. interrogans (Pathogenic Leptospira Subgroup 1). Shedding of pathogenic Leptospira spp. by cats might be an underestimated source of infection for other species including humans. The present study is the first one reporting growth of leptospires from feline urine in culture in naturally infected cats in South-America and characterisation of culture-derived isolates. So far, very few cases of successful attempts to culture leptospires from naturally infected cats are described worldwide.	[Dorsch, Roswitha; Hartmann, Katrin] Ludwig Maximilians Univ Munchen, Med Kleintier Klin, Munich, Germany; [Ojeda, Javier; Muller, Ananda] Univ Austral Chile, Fac Ciencias Veterinarias, Inst Ciencias Clin, Valdivia, Chile; [Salgado, Miguel; Monti, Gustavo; Collado, Bernadita; Tejeda, Carlos] Univ Austral Chile, Fac Ciencias Veterinarias, Inst Med Prevent Vet, Valdivia, Chile; [Tomckowiack, Camillo] Univ Austral Chile, Fac Ciencias Veterinarias, Escuela Graduados, Valdivia, Chile; [Eberhard, Theo] Univ Appl Sci Munich, Munich, Germany; [Klaasen, Henricus L. B. M.] MSD Anim Hlth, Dept Global Compan Anim R&D, Boxmeer, Netherlands; [Muller, Ananda] Ross Univ, Dept Biomed Sci, Sch Vet Med, Basseterre, St Kitts & Nevi	University of Munich; Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Merck & Company; Intervet International B.V.	Dorsch, R (corresponding author), Ludwig Maximilians Univ Munchen, Med Kleintier Klin, Munich, Germany.	roswitha.dorsch@imu.de		Enrique Monti, Gustavo/0000-0002-7869-4095; Dorsch, Roswitha/0000-0002-7508-5411	Gobierno Regional de Los Rios, Chile [FIC 15-8, BIP 30421496]	Gobierno Regional de Los Rios, Chile	The Bavarian Academic Center for Latin America supported the study by paying for travel expenses (between Valdivia and Munich on two occasions) for planning the study. The Direccion de Investigacion y Desarollo of the Universidad Austral de Chile supported the study by covering part of the costs for the material necessary for sampling and part of additional costs, e.g. transport and compensation of owners for study participation. For compensation, all included cats were vaccinated and dewormed. MSD Animal health provided the resources for sampling, clinical investigation of cats and laboratory investigations. Part of the laboratory work was funded by Proyecto FIC 15-8 (codigo BIP 30421496) del Gobierno Regional de Los Rios, Chile.	Alashraf AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230048; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Arbour J, 2012, J AM ANIM HOSP ASSOC, V48, P256, DOI 10.5326/JAAHA-MS-5748; Azocar-Aedo L, 2016, ZOONOSES PUBLIC HLTH, V63, P328, DOI 10.1111/zph.12236; Azocar-Aedo Lucia, 2014, Animals (Basel), V4, P612, DOI 10.3390/ani4040612; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benacer D, 2016, ACTA TROP, V157, P162, DOI 10.1016/j.actatropica.2016.01.031; Benacer D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1400-1; BRYSON DG, 1976, J SMALL ANIM PRACT, V17, P459, DOI 10.1111/j.1748-5827.1976.tb06986.x; Chan KW, 2014, VECTOR-BORNE ZOONOT, V14, P118, DOI 10.1089/vbz.2013.1324; CHILDS JE, 1992, AM J PUBLIC HEALTH, V82, P597, DOI 10.2105/AJPH.82.4.597; Diaz James H, 2014, J La State Med Soc, V166, P186; Dzieciol Monika, 2010, BMC Res Notes, V3, P251, DOI 10.1186/1756-0500-3-251; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Fernanades CPH, 2008, HYBRIDOMA, V27, P381, DOI 10.1089/hyb.2008.0029; Hartmann K, 2013, J FELINE MED SURG, V15, P576, DOI 10.1177/1098612X13489217; Hua KK, 2016, TROP BIOMED, V33, P276; Jorge S, 2018, MEM I OSWALDO CRUZ, V113, P80, DOI 10.1590/0074-02760170130; Lantz P G, 2000, Biotechnol Annu Rev, V5, P87, DOI 10.1016/S1387-2656(00)05033-X; LARSSON CE, 1985, INT J ZOONOSES, V12, P111; LARSSON CE, 1984, INT J ZOONOSES, V11, P161; Lelu M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0341-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lilenbaum W, 2014, TRANSBOUND EMERG DIS, V61, P63, DOI 10.1111/tbed.12233; Major A, 2014, INT J ENV RES PUB HE, V11, P7242, DOI 10.3390/ijerph110707242; Markovich JE, 2012, J VET INTERN MED, V26, P688, DOI 10.1111/j.1939-1676.2012.00900.x; Miraglia F, 2012, TROP ANIM HEALTH PRO, V45, P117, DOI 10.1007/s11250-012-0181-6; Miyazato Katia Eiko, 2013, Int Arch Med, V6, P23, DOI 10.1186/1755-7682-6-23; Morales MA, 2006, AVANCES CIENCIAS VET, V21, P27; Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666; Mylonakis ME, 2005, VET REC, V156, P615, DOI 10.1136/vr.156.19.615; Ojeda J, 2018, J VET MED SCI, V80, P1305, DOI 10.1292/jvms.16-0361; Perret C, 2005, REV MED CHILE, V133, P426; Petrakovsky J, 2014, INT J ENV RES PUB HE, V11, P10770, DOI 10.3390/ijerph111010770; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez J, 2014, J VET INTERN MED, V28, P284, DOI 10.1111/jvim.12287; RUBINI ME, 1957, J BIOL CHEM, V225, P869; Salgado M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0369-x; Shafei MN, 2012, INT J COLLAB RES INT, V4, P395; Silva-Diaz H, 2015, REV CHIL INFECTOL, V32, P530, DOI 10.4067/S0716-10182015000600006; Smee N, 2013, J AM ANIM HOSP ASSOC, V49, P1, DOI 10.5326/JAAHA-MS-5943; Sprissler F, 2019, TRANSBOUND EMERG DIS, V66, P948, DOI 10.1111/tbed.13110; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Su HP, 2011, EMERG INFECT DIS, V17, P1322, DOI 10.3201/eid1707.101050; Terrazas S, 2012, REV CHIL INFECTOL, V29, P641, DOI 10.4067/S0716-10182012000700009; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Tomckowiack C, 2020, J VET DIAGN INVESTIG; Weis S, 2017, J FELINE MED SURG, V19, P470, DOI 10.1177/1098612X16634389; World Health Organization, 2003, HUM LEPT GUID DIAGN; Xu YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20020; Zhang Z, 2018, PRACTICAL STAT POWER; 2019, J CROHNS COLITIS S1, V13	54	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0239991	10.1371/journal.pone.0239991	http://dx.doi.org/10.1371/journal.pone.0239991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091006	Green Published, gold			2022-12-26	WOS:000586647200059
J	Spaeth, A; Tebyani, M; Haussler, D; Teodorescu, M				Spaeth, Alex; Tebyani, Maryam; Haussler, David; Teodorescu, Mircea			Spiking neural state machine for gait frequency entrainment in a flexible modular robot	PLOS ONE			English	Article							SMALL CIRCUITS; PRINCIPLES; NETWORK; WALKING; SIGNALS	We propose a modular architecture for neuromorphic closed-loop control based on bistable relaxation oscillator modules consisting of three spiking neurons each. Like its biological prototypes, this basic component is robust to parameter variation but can be modulated by external inputs. By combining these modules, we can construct a neural state machine capable of generating the cyclic or repetitive behaviors necessary for legged locomotion. A concrete case study for the approach is provided by a modular robot constructed from flexible plastic volumetric pixels, in which we produce a forward crawling gait entrained to the natural frequency of the robot by a minimal system of twelve neurons organized into four modules.	[Spaeth, Alex; Tebyani, Maryam; Teodorescu, Mircea] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Spaeth, Alex; Haussler, David; Teodorescu, Mircea] Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Spaeth, A (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.; Spaeth, A (corresponding author), Univ Calif Santa Cruz, Genom Inst, Santa Cruz, CA 95064 USA.	atspaeth@ucsc.edu		Tebyani, Maryam/0000-0001-5477-2805; Spaeth, Alex/0000-0003-0702-3945	Schmidt Family Futures	Schmidt Family Futures	This research was supported by a grant made to the Braingeneers research group by Schmidt Family Futures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmane N, 2020, NEURAL NETWORKS, V121, P366, DOI 10.1016/j.neunet.2019.09.024; Berendes V, 2016, J EXP BIOL, V219, P3781, DOI 10.1242/jeb.146720; Bidaye SS, 2018, J NEUROPHYSIOL, V119, P459, DOI 10.1152/jn.00658.2017; Bing ZS, 2020, NEURAL NETWORKS, V121, P21, DOI 10.1016/j.neunet.2019.05.019; Chen G, 2019, IEEE T COGN DEV SYST, V11, P1, DOI 10.1109/TCDS.2017.2712712; Cheung KC, 2013, SCIENCE, V341, P1219, DOI 10.1126/science.1240889; Cramer N, 2017, IEEE INT C INT ROBOT, P2730; Diehl P. U., 2016, P IEEE INT C REB COM, P1, DOI DOI 10.1109/ICRC.2016.7738691; Donati E, 2014, BIOMED CIRC SYST C, P512, DOI 10.1109/BioCAS.2014.6981775; Egbert MD, 2020, IEEE T NEUR NET LEAR, V31, P1084, DOI 10.1109/TNNLS.2019.2917471; Ermentrout B, 1996, NEURAL COMPUT, V8, P979, DOI 10.1162/neco.1996.8.5.979; Fan JZ, 2016, J BIONIC ENG, V13, P30, DOI 10.1016/S1672-6529(14)60157-8; Habu Y, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO), P2075, DOI 10.1109/ROBIO.2018.8664855; Hille B., 1992, ION CHANNELS EXCITAB; Hunt A, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/055004; Izhikevich EM, 1999, IEEE T NEURAL NETWOR, V10, P499, DOI 10.1109/72.761707; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Katz PS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0057; Korkmaz D, 2021, J MAR ENG TECHNOL, V20, P125, DOI 10.1080/20464177.2019.1638703; Liang DC, 2019, IEEE J EM SEL TOP C, V9, P679, DOI 10.1109/JETCAS.2019.2951442; Lobov SA, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00088; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2014, ANNU REV NEUROSCI, V37, P329, DOI 10.1146/annurev-neuro-071013-013958; Maruyama A, 2015, ADV BIOMED ENG, V4, P48, DOI 10.14326/abe.4.48; Milde M, 2017, P 2017 IEEE INT S CI, P1; Naris M, 2020, BIOL CYBERN, V114, P23, DOI 10.1007/s00422-019-00811-y; Rackauckas C., 2017, J OPEN RES STW, V5, P15, DOI 10.5334/jors.151; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Rinberg A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002857; Roy K, 2019, NATURE, V575, P607, DOI 10.1038/s41586-019-1677-2; Shilnikov A, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056214; Sima J, 2020, NEURAL NETWORKS, V128, P199, DOI 10.1016/j.neunet.2020.05.006; Spaeth A, 2020, 2020 3RD IEEE INTERNATIONAL CONFERENCE ON SOFT ROBOTICS (ROBOSOFT), P46, DOI 10.1109/RoboSoft48309.2020.9116007; Sterling P., 2015, PRINCIPLES NEURAL DE; Strohmer B, 2020, FRONT NEUROROBOTICS, V14, DOI 10.3389/fnbot.2020.00041; Vonasek V, 2015, ROBOT AUTON SYST, V68, P116, DOI 10.1016/j.robot.2015.01.006; Wang XJ, 2018, C IND ELECT APPL, P1108; Webb B, 2020, SCIENCE, V368, P244, DOI 10.1126/science.aaz6869; Wiggins S., 2003, INTRO APPL NONLINEAR, V2nd ed.; Yu JZ, 2014, IEEE T NEUR NET LEAR, V25, P441, DOI 10.1109/TNNLS.2013.2280596; Zhen M, 2015, CURR OPIN NEUROBIOL, V33, P117, DOI 10.1016/j.conb.2015.03.009	43	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240267	10.1371/journal.pone.0240267	http://dx.doi.org/10.1371/journal.pone.0240267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085673	Green Published, gold, Green Submitted			2022-12-26	WOS:000585943400052
J	Sahajpal, NS; Mondal, AK; Ananth, S; Njau, A; Ahluwalia, P; Jones, K; Ahluwalia, M; Okechukwu, N; Savage, NM; Kota, V; Rojiani, AM; Kolhe, R				Sahajpal, Nikhil Shri; Mondal, Ashis K.; Ananth, Sudha; Njau, Allan; Ahluwalia, Pankaj; Jones, Kimya; Ahluwalia, Meenakshi; Okechukwu, Nwogbo; Savage, Natasha M.; Kota, Vamsi; Rojiani, Amyn M.; Kolhe, Ravindra			Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; CLASSIFICATION; VALIDATION; LEUKEMIA	The extensively employed limited-gene coverage NGS panels lead to clinically inadequate molecular profiling of myeloid neoplasms. The aim of the present investigation was to assess performance and clinical utility of a comprehensive DNA panel for myeloid neoplasms. Sixty-one previously well characterized samples were sequenced using TSO500 library preparation kit on NextSeq550 platform. Variants with a VAF >= 5% and a total read depth of >50X were filtered for analysis. The following results were recorded-for clinical samples: clinical sensitivity (97%), specificity (100%), precision (100%) and accuracy (99%) whereas reference control results were 100% for analytical sensitivity, specificity, precision and accuracy, with high intra- and inter-run reproducibility. The panel identified 880 variants across 292 genes, of which, 749 variants were in genes not covered in the 54 gene panel. The investigation revealed 14 variants in ten genes, and at least one was present in 96.2% patient samples that were pathogenic/ likely pathogenic in myeloid neoplasms. Also, 15 variants in five genes were found to be pathogenic/ likely pathogenic in other tumor types. Further, the TMB and MSI scores ranged from 0-7 and 0-9, respectively. The high analytical performance and clinical utility of this comprehensive NGS panel makes it practical and clinically relevant for adoption in clinical laboratories for routine molecular profiling of myeloid neoplasms.	[Sahajpal, Nikhil Shri; Mondal, Ashis K.; Ananth, Sudha; Njau, Allan; Ahluwalia, Pankaj; Jones, Kimya; Ahluwalia, Meenakshi; Okechukwu, Nwogbo; Savage, Natasha M.; Rojiani, Amyn M.; Kolhe, Ravindra] Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA 30912 USA; [Njau, Allan] Aga Khan Univ Hosp, Dept Pathol, Nairobi, Kenya; [Kota, Vamsi] Augusta Univ, Med Coll Georgia, Dept Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kolhe, R (corresponding author), Augusta Univ, Dept Pathol, Med Coll Georgia, Augusta, GA 30912 USA.	rkolhe@augusta.edu	Ahluwalia, Pankaj/AAG-1949-2021; Mondal, Ashis/AAU-4444-2021	Ahluwalia, Pankaj/0000-0003-0060-6152; Njau, Allan/0000-0002-3566-0629; kota, vamsi/0000-0002-5290-9289; KOLHE, RAVINDRA/0000-0002-8283-2403				Aguilera-Diaz A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227986; Albring JC, 2017, BONE MARROW TRANSPL, V52, P317, DOI 10.1038/bmt.2016.274; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Buchhalter I, 2019, INT J CANCER, V144, P848, DOI 10.1002/ijc.31878; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Chalmers ZR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0424-2; Di Resta Chiara, 2018, EJIFCC, V29, P4; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Grumbt B, 2013, TRANSFUS MED HEMOTH, V40, P196, DOI 10.1159/000351267; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; National Comprehensive Cancer Network, 2019, ACUTE MYELOID LEUKEM; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Schranz Katrin, 2018, Oncotarget, V9, P30128, DOI 10.18632/oncotarget.25729; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Thomas M, 2017, ARCH PATHOL LAB MED, V141, P759, DOI 10.5858/arpa.2016-0547-RA; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Vrijenhoek T, 2015, EUR J HUM GENET, V23, P1142, DOI 10.1038/ejhg.2014.279; Walker CJ, 2017, LEUKEMIA, V31, P1474, DOI 10.1038/leu.2017.97; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240976	10.1371/journal.pone.0240976	http://dx.doi.org/10.1371/journal.pone.0240976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075099	Green Published, gold			2022-12-26	WOS:000585920200040
J	Hershow, RB; Reyes, HLM; Ha, TV; Chander, G; Mai, NVT; Sripaipan, T; Frangakis, C; Dowdy, DW; Latkin, C; Hutton, HE; Pettifor, A; Maman, S; Go, VF				Hershow, Rebecca B.; Reyes, H. Luz McNaughton; Ha, Tran Viet; Chander, Geetanjali; Mai, Nguyen Vu Tuyet; Sripaipan, Teerada; Frangakis, Constantine; Dowdy, David W.; Latkin, Carl; Hutton, Heidi E.; Pettifor, Audrey; Maman, Suzanne; Go, Vivian F.			Alcohol use, depressive symptoms, and intimate partner violence perpetration: A longitudinal analysis among men with HIV in northern Vietnam	PLOS ONE			English	Article							TIMELINE FOLLOWBACK; RISK-FACTORS; NEIGHBORHOOD VIOLENCE; SOCIAL DESIRABILITY; CONSUMPTION; DRINKING; PREVALENCE; HEALTH; ASSOCIATIONS; CHALLENGES	Background While the link between alcohol use and male-perpetrated intimate partner violence (IPV) has been well-established, research is needed to test whether psychosocial factors interact with alcohol use to exacerbate IPV perpetration. We tested whether depressive symptoms influenced the strength and/or direction of the alcohol-IPV relationship among men with HIV in Vietnam. Methods This study is a secondary analysis using data from a randomized controlled trial conducted in Thai Nguyen, Vietnam. Participants were clinic patients with HIV and hazardous alcohol use. Questionnaires were administered at baseline, three, six, and 12 months. Alcohol use was assessed as proportion of days alcohol abstinent. Analyses were restricted to males who reported being married/cohabitating at baseline (N = 313). Multilevel growth models were used to test whether time-varying depressive symptoms modified the time-varying effect of alcohol use on IPV perpetration. Results Time-varying depressive symptoms modified the effect of proportion of days alcohol abstinent on IPV perpetration. However, the pattern of effect modification was not as expected, as reporting depressive symptoms weakened the alcohol-IPV relationship. At times when participants screened negative for depressive symptoms, those who reported higher proportion of days alcohol abstinent than usual had significantly lower odds of IPV perpetration (Odds Ratio [OR] = 0.17, 95% Confidence Interval 0.06, 0.45, p = 0.0004). At times when participants screened positive for depressive symptoms, there was no observed effect of alcohol use on IPV perpetration (OR = 4.28, 95% CI 0.80, 22.78, p = 0.09). Conclusion The findings highlight the complex nature of the alcohol-IPV relationship and the need to investigate the intersection between hazardous drinking, mental health, and IPV. Men who concurrently report depressive symptoms and heightened alcohol use may be socially isolated from an intimate partner or experiencing fatigue, leading to less alcohol-related IPV perpetration. Mental health interventions addressing depression and alcohol misuse integrated into HIV services may reduce IPV perpetration.	[Hershow, Rebecca B.; Reyes, H. Luz McNaughton; Ha, Tran Viet; Sripaipan, Teerada; Maman, Suzanne; Go, Vivian F.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Ha, Tran Viet; Mai, Nguyen Vu Tuyet] Univ North Carolina Vietnam, Yen Hoa Hlth Clin, Hanoi, Vietnam; [Chander, Geetanjali; Frangakis, Constantine; Dowdy, David W.; Latkin, Carl] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chander, Geetanjali; Dowdy, David W.; Latkin, Carl] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Frangakis, Constantine] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Latkin, Carl] Johns Hopkins Univ, Dept Hlth Behav & Soc, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hutton, Heidi E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mai, Nguyen Vu Tuyet] Vinmec Hlth Care Syst, Hanoi, Vietnam	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Hershow, RB (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA.	rhershow@live.unc.edu		Pettifor, Audrey/0000-0002-3387-0817; Hershow, Rebecca/0000-0002-8492-3747	National Institute on Drug Abuse of the National Institutes of Health [R01 DA037440]; University of North Carolina at Chapel Hill Center for AIDS Research [P30 AI050410]; National Institute of Allergy and Infectious Diseases [T32 AI007001]	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of North Carolina at Chapel Hill Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute on Drug Abuse (https://www.drugabuse.gov/) of the National Institutes of Health under grant R01 DA037440 (VFG). This work was also supported by the University of North Carolina at Chapel Hill Center for AIDS Research (http://unccfar.org/) under grant P30 AI050410 (grant recipient not an author) and the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) under grant T32 AI007001 (grant recipient not an author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, REC ALC PER CAPT 15; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2014, OPT VIET NAMS HIV RE; Arseniou S, 2014, PSYCHIAT CLIN NEUROS, V68, P96, DOI 10.1111/pcn.12097; Tran BX, 2013, DRUG ALCOHOL DEPEN, V127, P39, DOI 10.1016/j.drugalcdep.2012.06.009; Behrens C.B, 1998, MEASURING VIOLENCE R; Benebo FO, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0628-7; Beyer K, 2015, TRAUMA VIOLENCE ABUS, V16, P16, DOI 10.1177/1524838013515758; Luu BN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-731; Birkley EL, 2015, CLIN PSYCHOL REV, V37, P40, DOI 10.1016/j.cpr.2015.01.002; Blashill AJ, 2015, AIDS BEHAV, V19, P981, DOI 10.1007/s10461-014-0925-6; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown SL, 2008, SOC SCI RES, V37, P73, DOI 10.1016/j.ssresearch.2007.06.002; Celio MA, 2016, ALCOHOL CLIN EXP RES, V40, P638, DOI 10.1111/acer.12988; Crane CA, 2016, TRAUMA VIOLENCE ABUS, V17, P520, DOI 10.1177/1524838015584374; Cunradi Carol B, 2014, J Drug Educ, V44, P19, DOI 10.1177/0047237915573527; Dasgupta A, 2018, AM J MENS HEALTH, V12, P1084, DOI 10.1177/1557988318775844; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fals-Stewart W, 2005, J CONSULT CLIN PSYCH, V73, P239, DOI 10.1037/0022-006X.73.2.239; Ferrer Victoria, 2004, Psykhe, V13, P141; Fiellin DA, 2013, J STUD ALCOHOL DRUGS, V74, P500, DOI 10.15288/jsad.2013.74.500; Fischer JL, 2005, ADDICT BEHAV, V30, P1496, DOI 10.1016/j.addbeh.2005.03.004; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gilchrist G, 2017, DRUG ALCOHOL REV, V36, P34, DOI 10.1111/dar.12436; Glynn TR, 2019, AIDS BEHAV, V23, P2956, DOI 10.1007/s10461-019-02619-0; Go VF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.17115; Go VF, 2013, INT J DRUG POLICY, V24, P304, DOI 10.1016/j.drugpo.2012.12.003; Hahn JA, 2012, ALCOHOL CLIN EXP RES, V36, P854, DOI 10.1111/j.1530-0277.2011.01669.x; Hatcher AM, 2022, SOC SCI MED, V295, DOI 10.1016/j.socscimed.2019.112637; Hershow RB, 2020, SUBST USE MISUSE, V55, P1237, DOI 10.1080/10826084.2020.1732422; Hershow RB, 2020, J INTERPERS VIOLENCE, V35, P5905, DOI 10.1177/0886260517724834; Hershow RB, 2020, AIDS BEHAV, V24, P2555, DOI 10.1007/s10461-020-02813-5; Hershow RB, 2018, SUBST USE MISUSE, V53, P1084, DOI 10.1080/10826084.2017.1392986; Horton P, 2011, MEN MASC, V14, P542, DOI 10.1177/1097184X11409362; Jansen HAFM, 2016, INT J PUBLIC HEALTH, V61, P923, DOI 10.1007/s00038-016-0879-8; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levintow SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191548; Li Y, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18845; Lincoln M, 2016, DRUG ALCOHOL DEPEN, V159, P1, DOI 10.1016/j.drugalcdep.2015.10.030; Machisa MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150986; MAIURO RD, 1988, J CONSULT CLIN PSYCH, V56, P17, DOI 10.1037/0022-006X.56.1.17; May MT, 2015, JAIDS-J ACQ IMM DEF, V69, P348, DOI 10.1097/QAI.0000000000000603; McMahon JM, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0248-9; Medeiros GC, 2020, HARV REV PSYCHIAT; Murshid NS, 2018, J INTERPERS VIOLENCE, V33, P211, DOI 10.1177/0886260515604413; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; National Committee for AIDS Drugs and Prostitution Prevention and Control, 2014, VIETN AIDS RESP PROG; Nguyen TD, 2006, VIOLENCE AGAINST WOM, V12, P732, DOI 10.1177/1077801206291555; Okafor CN, 2018, AIDS BEHAV, V22, P3962, DOI 10.1007/s10461-018-2227-x; Pacific Women in Politics, 2019, NAT WOM MPS; Parker Robert N., 1995, ALCOHOL HOMICIDE DEA; Pence BW, 2012, J AFFECT DISORDERS, V143, P208, DOI 10.1016/j.jad.2012.05.056; Perinelli E, 2016, J CLIN PSYCHOL, V72, P534, DOI 10.1002/jclp.22284; Phil RO, 2002, BIOL BASES ADDICTION; Quigley BM, 2000, ALCOHOL CLIN EXP RES, V24, P1003, DOI 10.1097/00000374-200007000-00010; Quigley BM, 2018, PSYCHOL ADDICT BEHAV, V32, P770, DOI 10.1037/adb0000390; Reed E, 2009, J COMMUN HEALTH, V34, P328, DOI 10.1007/s10900-009-9161-9; Reyes HLM, 2012, J RES ADOLESCENCE, V22, P526, DOI 10.1111/j.1532-7795.2012.00799.x; Reyes HLM, 2012, PREV SCI, V13, P340, DOI 10.1007/s11121-011-0215-8; Rydstrom H, 2003, VIOLENCE AGAINST WOM, V9, P676, DOI 10.1177/1077801203009006004; Satyanarayana VA, 2015, ASIAN J PSYCHIATR, V15, P38, DOI 10.1016/j.ajp.2015.04.014; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; Straus Murray A, 2004, Violence Vict, V19, P507; Sugarman DB, 1997, J INTERPERS VIOLENCE, V12, P275, DOI 10.1177/088626097012002008; Sutton D, 2018, J INTERPERS VIOLENCE; Tol WA, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0728-z; Nguyen TQ, 2016, J GAY LESBIAN MENT H, V20, P173, DOI 10.1080/19359705.2015.1080204; Tschann JM, 2005, J ADOLESCENT HEALTH, V37, P11, DOI 10.1016/j.jadohealth.2004.07.009; Vakili S, 2008, ADDICT BEHAV, V33, P1123, DOI 10.1016/j.addbeh.2008.03.009; White HR, 2002, J STUD ALCOHOL, V63, P205, DOI 10.15288/jsa.2002.63.205; Wilson IM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-881; World Health Organization, 2021, GLOB REG EST VIOL WO; Yount KM, 2016, MEN MASC, V19, P64, DOI 10.1177/1097184X15572896; Yount KM, 2014, ANN EPIDEMIOL, V24, P333, DOI 10.1016/j.annepidem.2014.02.004; Yu RQ, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002995, 10.1371/journal.pmed.1002995.r001, 10.1371/journal.pmed.1002995.r002, 10.1371/journal.pmed.1002995.r003, 10.1371/journal.pmed.1002995.r004, 10.1371/journal.pmed.1002995.r005]; Zhang HXQ, 2002, WOMEN STUD INT FORUM, V25, P443, DOI 10.1016/S0277-5395(02)00281-9; Zhao MM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7526-2; 2014, GLOB STAT REP VIOL, P1	82	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240674	10.1371/journal.pone.0240674	http://dx.doi.org/10.1371/journal.pone.0240674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064780	gold, Green Published			2022-12-26	WOS:000585918300005
J	Janssen, LHC; Kullberg, MLJ; Verkuil, B; van Zwieten, N; Wever, MCM; van Houtum, LAEM; Wentholt, WGM; Elzinga, BM				Janssen, Loes H. C.; Kullberg, Marie-Louise J.; Verkuil, Bart; van Zwieten, Noa; Wever, Mirjam C. M.; van Houtum, Lisanne A. E. M.; Wentholt, Wilma G. M.; Elzinga, Bernet M.			Does the COVID-19 pandemic impact parents' and adolescents' well-being? An EMA-study on daily affect and parenting	PLOS ONE			English	Article							GENERALIZED ANXIETY; NEGATIVE AFFECT; UNCERTAINTY; INTOLERANCE; DEPRESSION; STRESS; VALIDITY; VARIABILITY; PERCEPTIONS; EXPERIENCE	Due to the COVID- 19 outbreak in the Netherlands (March 2020) and the associated social distancing measures, families were enforced to stay at home as much as possible. Adolescents and their families may be particularly affected by this enforced proximity, as adolescents strive to become more independent. Yet, whether these measures impact emotional well-being in families with adolescents has not been examined. In this ecological momentary assessment study, we investigated if the COVID-19 pandemic affected positive and negative affect of parents and adolescents and parenting behaviors (warmth and criticism). Additionally, we examined possible explanations for the hypothesized changes in affect and parenting. To do so, we compared daily reports on affect and parenting that were gathered during two periods of 14 consecutive days, once before the COVID-19 pandemic (2018-2019) and once during the COVID-19 pandemic. Multilevel analyses showed that only parents' negative affect increased as compared to the period before the pandemic, whereas this was not the case for adolescents' negative affect, positive affect and parenting behaviors (from both the adolescent and parent perspective). In general, intolerance of uncertainty was linked to adolescents' and parents' negative affect and adolescents' positive affect. However, Intolerance of uncertainty, nor any pandemic related characteristics (i.e. living surface, income, relatives with COVID-19, hours of working at home, helping children with school and contact with COVID-19 patients at work) were linked to the increase of parents' negative affect during COVID-19. It can be concluded that on average, our sample (consisting of relatively healthy parents and adolescents) seems to deal fairly well with the circumstances. The substantial heterogeneity in the data however, also suggest that whether or not parents and adolescents experience (emotional) problems can vary from household to household. Implications for researchers, mental health care professionals and policy makers are discussed.	[Janssen, Loes H. C.; Kullberg, Marie-Louise J.; Verkuil, Bart; van Zwieten, Noa; Wever, Mirjam C. M.; van Houtum, Lisanne A. E. M.; Wentholt, Wilma G. M.; Elzinga, Bernet M.] Leiden Univ, Inst Psychol, Dept Clin Psychol, Leiden, Netherlands; [Janssen, Loes H. C.; Verkuil, Bart; Wever, Mirjam C. M.; van Houtum, Lisanne A. E. M.; Wentholt, Wilma G. M.; Elzinga, Bernet M.] Leiden Univ, Leiden Inst Brain & Cognit LIBC, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Janssen, LHC (corresponding author), Leiden Univ, Inst Psychol, Dept Clin Psychol, Leiden, Netherlands.; Janssen, LHC (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit LIBC, Leiden, Netherlands.	l.h.c.janssen@fsw.leidenuniv.nl		Kullberg, Marie-Louise/0000-0003-0660-5505; Janssen, Loes/0000-0003-3543-6026; van Houtum, Lisanne/0000-0002-2368-093X	Netherlands Organization for Scientific Research [453-15006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The study was supported by a personal research grant from the Netherlands Organization for Scientific Research awarded to Bernet Elzinga (VICI; Unravelling the Impact of Emotional Maltreatment on the Developing Brain 453-15006). https://www.nwo.nl/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai S, 2017, SOC DEV, V26, P813, DOI 10.1111/sode.12229; Bliese P, 2016, PACKAGE MULTILEVEL; Bolger N, 2013, INTENSIVE LONGITUDIN; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Buhr K, 2006, J ANXIETY DISORD, V20, P222, DOI 10.1016/j.janxdis.2004.12.004; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; Crum AJ, 2017, ANXIETY STRESS COPIN, V30, P379, DOI 10.1080/10615806.2016.1275585; DIENSTBIER RA, 1989, PSYCHOL REV, V96, P84, DOI 10.1037/0033-295X.96.1.84; DIX T, 1991, PSYCHOL BULL, V110, P3, DOI 10.1037/0033-2909.110.1.3; Dore BP, 2017, PERS SOC PSYCHOL B, V43, P729, DOI 10.1177/0146167217695558; Dugas MJ, 1998, BEHAV RES THER, V36, P215, DOI 10.1016/S0005-7967(97)00070-3; Ebesutani C, 2012, J PSYCHOPATHOL BEHAV, V34, P191, DOI 10.1007/s10862-011-9273-2; Eid M, 1999, J PERS SOC PSYCHOL, V76, P662, DOI 10.1037/0022-3514.76.4.662; Epkins CC, 2016, PARENT-SCI PRACT, V16, P125, DOI 10.1080/15295192.2016.1134991; Flook L, 2011, CHILD DEV, V82, P454, DOI 10.1111/j.1467-8624.2010.01521.x; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Granic I., 2003, BLACKWELL HDB ADOLES, P60, DOI [10.1002/9780470756607.ch4, DOI 10.1002/9780470756607.CH4]; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Hickey EJ, 2020, FAM PROCESS, V59, P636, DOI 10.1111/famp.12432; Hoffman L, 2015, MULTIVAR APPL SER, P1; Houben M, 2015, PSYCHOL BULL, V141, P901, DOI 10.1037/a0038822; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Jamieson JP, 2018, ANXIETY STRESS COPIN, V31, P245, DOI 10.1080/10615806.2018.1442615; Jeong H, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016048; Khawaja NG, 2010, CLIN PSYCHOL-UK, V14, P97, DOI 10.1080/13284207.2010.502542; Korelitz KE, 2016, J YOUTH ADOLESCENCE, V45, P1973, DOI 10.1007/s10964-016-0524-0; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuppens P, 2010, J PERS SOC PSYCHOL, V99, P1042, DOI 10.1037/a0020962; Ladouceur R, 1998, J ANXIETY DISORD, V12, P139, DOI 10.1016/S0887-6185(98)00002-4; Ladouceur R, 2000, BEHAV RES THER, V38, P933, DOI 10.1016/S0005-7967(99)00133-3; Lamb M. E., 2013, HDB FATHER INVOLVEME; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Maciejewski DF, 2014, J ABNORM CHILD PSYCH, V42, P515, DOI 10.1007/s10802-013-9797-x; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Meeten F, 2012, BEHAV RES THER, V50, P690, DOI 10.1016/j.brat.2012.08.003; Pluess M, 2010, DEV PSYCHOL, V46, P379, DOI 10.1037/a0015203; Pottie CG, 2008, J FAM PSYCHOL, V22, P855, DOI 10.1037/a0013604; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey MA, 2015, DEV REV, V36, P58, DOI 10.1016/j.dr.2015.01.003; Reichart C.G., 2000, VERTALING K SADS; Repetti R, 2009, CURR DIR PSYCHOL SCI, V18, P106, DOI 10.1111/j.1467-8721.2009.01618.x; Rosen NO, 2009, HEALTH COMMUN, V24, P228, DOI 10.1080/10410230902804125; Rueger SY, 2011, PARENT-SCI PRACT, V11, P1, DOI 10.1080/15295192.2011.539503; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L., 2002, HDB PARENTING CHILDR, P103, DOI DOI 10.4324/9781410612137; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Lissa CJ, 2019, DEV PSYCHOL, V55, P377, DOI 10.1037/dev0000612; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilson C, 2011, J ANXIETY DISORD, V25, P71, DOI 10.1016/j.janxdis.2010.08.005; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Zlomke KR, 2009, J CHILD FAM STUD, V18, P670, DOI 10.1007/s10826-009-9269-7	57	91	91	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240962	10.1371/journal.pone.0240962	http://dx.doi.org/10.1371/journal.pone.0240962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064778	Green Published, gold			2022-12-26	WOS:000585918300024
J	Grant-McAuley, W; Fogel, JM; Galai, N; Clarke, W; Breaud, A; Marzinke, MA; Mbwambo, J; Likindikoki, S; Aboud, S; Donastorg, Y; Perez, M; Barrington, C; Davis, W; Kerrigan, D; Eshleman, SH				Grant-McAuley, Wendy; Fogel, Jessica M.; Galai, Noya; Clarke, William; Breaud, Autumn; Marzinke, Mark A.; Mbwambo, Jessie; Likindikoki, Samuel; Aboud, Said; Donastorg, Yeycy; Perez, Martha; Barrington, Clare; Davis, Wendy; Kerrigan, Deanna; Eshleman, Susan H.			Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; PREVENTION; INFECTION; AFRICA; TRIAL; THERAPY; STIGMA; RISK; MEN	Objective Female sex workers (FSW) have increased risk of HIV infection. Antiretroviral treatment (ART) can improve HIV outcomes and prevent HIV transmission. We analyzed antiretroviral (ARV) drug use and HIV drug resistance among HIV-positive FSW in the Dominican Republic and Tanzania. Methods Plasma samples collected at study entry with viral loads >1,000 copies/mL were tested for ARV drugs and HIV drug resistance. ARV drug testing was performed using a qualitative assay that detects 22 ARV drugs in five classes. HIV genotyping was performed using the ViroSeq HIV-1 Genotyping System. Phylogenetic analyses were performed to determine HIV subtype and assess transmission clusters. Results Among 410 FSW, 144 (35.1%) had viral loads >1,000 copies/mL (DR: n = 50; Tanzania: n = 94). ARV drugs were detected in 36 (25.0%) of 144 samples. HIV genotyping results were obtained for 138 (95.8%) cases. No transmission clusters were observed in either country. HIV drug resistance was detected in 54 (39.1%) of 138 samples (31/35 [88.6%] with drugs detected; 23/103 [22.3%] without drugs detected); 29/138 (21.0%) had multi-class resistance (MCR). None with MCR had integrase strand transfer inhibitor resistance. In eight cases, one or more ARV drug was detected without corresponding resistance mutations; those women were at risk of acquiring additional drug resistance. Using multivariate logistic regression, resistance was associated with ARV drug detection (p<0.001), self-reported ART (full adherence [p = 0.034]; partial adherence [p<0.001]), and duration of HIV infection (p = 0.013). Conclusions In this cohort, many women were on ART, but were not virally suppressed. High levels of HIV drug resistance, including MCR, were observed. Resistance was associated with detection of ARV drugs, self-report of ART with full or partial adherence, and duration of HIV infection. These findings highlight the need for better HIV care among FSW to improve their health, reduce HIV drug resistance, and decrease risk of transmission to others.	[Grant-McAuley, Wendy; Fogel, Jessica M.; Clarke, William; Breaud, Autumn; Marzinke, Mark A.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Galai, Noya] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Galai, Noya] Univ Haifa, Dept Stat, Har Hakarmel, Israel; [Mbwambo, Jessie; Likindikoki, Samuel] Muhimibili Univ Hlth & Allied Sci, Dept Psychiat, Dar Es Salaam, Tanzania; [Aboud, Said] Muhimibili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Donastorg, Yeycy; Perez, Martha] Inst Dermatol & Cirugia Piel, Unidad Invest Vacunas, Santo Domingo, Dominican Rep; [Barrington, Clare] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Davis, Wendy; Kerrigan, Deanna] Amer Univ, Ctr Hlth Risk & Soc, Washington, DC 20016 USA	Johns Hopkins University; Johns Hopkins University; University of Haifa; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; University of North Carolina; University of North Carolina Chapel Hill; American University	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu	Barrington, Clare/AAM-4909-2021; Galai, Noya/HII-8086-2022	Greenawalt, Wendy/0000-0002-7002-3676	National Institute of Mental Health (NIMH) [R01-MH110158]; HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); Office of AIDS Research of the National Institutes of Health (NIH) [UM1-AI068613]	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of AIDS Research of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Mental Health (NIMH, http://www.nimh.nih.gov); R01-MH110158 (DK). Additional support was provided by the HIV Prevention Trials Network (HPTN, http://www.hptn.org) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID, http://www.niaid.nih.gov), National Institute on Drug Abuse (NIDA, http://www.drugabuse.gov), and Office of AIDS Research (http://www.oar.nih.gov), of the National Institutes of Health (NIH); UM1-AI068613 (SHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, PROTOCOLOS NACL ATEN; [Anonymous], 2019, DOMINICAN REPUBLIC C; [Anonymous], 2009, TANZANIA NATL GUIDEL; [Anonymous], 2019, UNAIDS GLOBAL HIV AI; [Anonymous], 2018, TREATMENT ALL STRATE; [Anonymous], 2016, HIV SEQUENCE DATABAS; [Anonymous], 2005, CARRIBEAN GUIDELINES; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bello G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01340; Boulle A, 2007, ANTIVIR THER, V12, P753; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Chen I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167629; Chen I, 2015, JAIDS-J ACQ IMM DEF, V69, P446, DOI 10.1097/QAI.0000000000000633; Clutter DS, 2016, INFECT GENET EVOL, V46, P292, DOI 10.1016/j.meegid.2016.08.031; Coetzee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188606; Cowan FM, 2017, JAIDS-J ACQ IMM DEF, V74, P375, DOI 10.1097/qai.0000000000001255; da Costa LM, 2020, AIDS RES HUM RETROV, V36, P99, DOI [10.1089/aid.2019.0243, 10.1089/AID.2019.0243]; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Fogel JM, 2019, AIDS BEHAV, V23, P2101, DOI 10.1007/s10461-018-2379-8; Fogel JM, 2017, JAIDS-J ACQ IMM DEF, V74, P158, DOI 10.1097/QAI.0000000000001229; Fogel JM, 2013, J INFECT DIS, V208, P1624, DOI 10.1093/infdis/jit390; Grelotti DJ, 2013, LANCET INFECT DIS, V13, P10, DOI 10.1016/S1473-3099(12)70294-3; Gruskin S, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18000, 10.7448/IAS.16.3.18726]; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hakim AJ, 2020, SEX TRANSM INFECT, V96, P143, DOI 10.1136/sextrans-2019-053961; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2017, JAIDS-J ACQ IMM DEF, V74, pS60, DOI 10.1097/qai.0000000000001203; Kerrigan D, 2016, AIDS BEHAV, V20, P1919, DOI 10.1007/s10461-016-1376-z; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lopez P, 2015, AIDS RES HUM RETROV, V31, P679, DOI [10.1089/aid.2014.0304, 10.1089/AID.2014.0304]; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Marzinke MA, 2014, CLIN CHIM ACTA, V433, P157, DOI 10.1016/j.cca.2014.03.016; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Montgomery ET, 2017, AIDS BEHAV, V21, P481, DOI 10.1007/s10461-016-1609-1; Namale G, 2019, SEX TRANSM INFECT, V95, P405, DOI 10.1136/sextrans-2018-053854; Palumbo PJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223829; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Pulerwitz J, 2014, LANCET GLOB HEALTH, V2, pE311, DOI 10.1016/S2214-109X(14)70219-0; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Rose R, 2017, AIDS RES HUM RETROV, V33, P211, DOI [10.1089/aid.2016.0205, 10.1089/AID.2016.0205]; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Shannon K, 2018, LANCET, V392, P698, DOI 10.1016/S0140-6736(18)31439-9; Talbott JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000543; Zablotska IB, 2013, JAIDS-J ACQ IMM DEF, V62, P334, DOI 10.1097/QAI.0b013e31827e854a; Zhang YF, 2018, JAIDS-J ACQ IMM DEF, V79, P315, DOI 10.1097/QAI.0000000000001793; Zhang YF, 2018, AIDS, V32, P1301, DOI 10.1097/QAD.0000000000001839; Zulliger R, 2015, JAIDS-J ACQ IMM DEF, V69, P216, DOI 10.1097/QAI.0000000000000590	53	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240890	10.1371/journal.pone.0240890	http://dx.doi.org/10.1371/journal.pone.0240890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119663	gold, Green Published			2022-12-26	WOS:000600013600042
J	Pamphlett, R; Cherepanoff, S; Too, LK; Jew, SK; Doble, PA; Bishop, DP				Pamphlett, Roger; Cherepanoff, Svetlana; Too, Lay Khoon; Kum Jew, Stephen; Doble, Philip A.; Bishop, David P.			The distribution of toxic metals in the human retina and optic nerve head: Implications for age-related macular degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIUM; SYSTEMIC EXPOSURE; MERCURY-VAPOR; MECHANISMS; LEAD; CADMIUM; ACCUMULATION; GENOTOXICITY; TRANSPORT; ELEMENTS	Objective Toxic metals are suspected to play a role in the pathogenesis of age-related macular degeneration. However, difficulties in detecting the presence of multiple toxic metals within the intact human retina, and in separating primary metal toxicity from the secondary uptake of metals in damaged tissue, have hindered progress in this field. We therefore looked for the presence of several toxic metals in the posterior segment of normal adult eyes using elemental bioimaging. Methods Paraffin sections of the posterior segment of the eye from seven tissue donors (age range 54-74 years) to an eye bank were examined for toxic metals in situ using laser ablation-inductively coupled plasma-mass spectrometry, a technique that detects multiple elements in tissues, as well as the histochemical technique of autometallography that demonstrates inorganic mercury, silver, and bismuth. No donor had a visual impairment, and no significant retinal abnormalities were seen on post mortem fundoscopy and histology. Results Metals found by laser ablation-inductively coupled plasma-mass spectrometry in the retinal pigment epithelium and choriocapillaris were lead (n = 7), nickel (n = 7), iron (n = 7), cadmium (n = 6), mercury (n = 6), bismuth (n = 5), aluminium (n = 3), and silver (n = 1). In the neural retina, mercury was present in six samples, and iron in one. Metals detected in the optic nerve head were iron (N = 7), mercury (N = 7), nickel (N = 4), and aluminium (N = 1). No gold or chromium was seen. Autometallography demonstrated probable inorganic mercury in the retinal pigment epithelium of one donor. Conclusion Several toxic metals are taken up by the human retina and optic nerve head. Injury to the retinal pigment epithelium from toxic metals could damage the neuroprotective functions of the retinal pigment epithelium and allow toxic metals to enter the outer neural retina. These findings support the hypothesis that accumulations of toxic metals in the retina could contribute to the pathogenesis of age-related macular degeneration.	[Pamphlett, Roger; Kum Jew, Stephen] Univ Sydney, Discipline Pathol, Sch Med Sci, Brain & Mind Ctr, Sydney, NSW, Australia; [Pamphlett, Roger; Cherepanoff, Svetlana] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Cherepanoff, Svetlana] St Vincents Hosp, Sydpath, Sydney, NSW, Australia; [Cherepanoff, Svetlana] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Too, Lay Khoon] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Doble, Philip A.; Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Discipline Pathol, Sch Med Sci, Brain & Mind Ctr, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	Too, Lay Khoon/L-2653-2018; Bishop, David/F-2891-2019	Too, Lay Khoon/0000-0002-5340-5744; Bishop, David/0000-0002-6533-4410; Pamphlett, Roger/0000-0003-3326-7273	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council [DP170100036, DP190102361, DE180100194]; National Institute of Health [R21AR072950]	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council(Australian Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	No specific funding for this project was received. RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests. PAD is supported by Australian Research Council Discovery Project Grants DP170100036 and DP190102361. DPB is supported by an Australian Research Council Discovery Early Career Researcher Award DE180100194. PAD and DPB are supported by a National Institute of Health Grant R21AR072950. LKT was supported by Doctors Shirley and John Sarks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberami S, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107718; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Andrade V M, 2017, Adv Neurobiol, V18, P227, DOI 10.1007/978-3-319-60189-2_12; Bilak S, 2019, HUM EXP TOXICOL, V38, P814, DOI 10.1177/0960327119842637; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Bridges CC, 2007, TOXICOL APPL PHARM, V221, P251, DOI 10.1016/j.taap.2007.03.004; BRUININK A, 1992, TOXICOL IN VITRO, V6, P285, DOI 10.1016/0887-2333(92)90018-M; Cameron Keyuna S., 2011, Reviews on Environmental Health, V26, P81, DOI 10.1515/REVEH.2011.012; Cherepanoff S, 2018, INVEST OPHTH VIS SCI, V59; Cheung N, 2007, ARCH OPHTHALMOL-CHIC, V125, P1241, DOI 10.1001/archopht.125.9.1241; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; Curcio CA, 1998, INVEST OPHTH VIS SCI, V39, P1085; Danscher G, 2000, J HISTOCHEM CYTOCHEM, V48, P1503, DOI 10.1177/002215540004801107; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; Eichenbaum JW, 2000, J TOXICOL-CLIN TOXIC, V38, P377, DOI 10.1081/CLT-100100946; Ekinci M, 2014, MED SCI MONITOR, V20, P1284, DOI 10.12659/MSM.890756; El-Sherbeeny AM, 2006, CUTAN OCUL TOXICOL, V25, P173, DOI 10.1080/15569520600860215; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Gaillet S, 2015, FOOD CHEM TOXICOL, V77, P58, DOI 10.1016/j.fct.2014.12.019; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hosoya K, 2013, ADV EXP MED BIOL, V763, P85; HUTTON M, 1986, SCI TOTAL ENVIRON, V57, P129, DOI 10.1016/0048-9697(86)90018-5; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Keizman D, 2017, CANCER EPIDEM BIOMAR, V26, P743, DOI 10.1158/1055-9965.EPI-16-0759; KHAYAT A, 1984, ACTA PHARMACOL TOX, V55, P145; Khayat A, 1983, J APPL TOXICOL, V3, P66, DOI 10.1002/jat.2550030203; Kim Hyun Soo, 2015, J Cancer Prev, V20, P232, DOI 10.15430/JCP.2015.20.4.232; Klotz K, 2017, DTSCH ARZTEBL INT, V114, P653, DOI 10.3238/arztebl.2017.0653; Lin SY, 2017, ANN ONCOL, V28, P2575, DOI 10.1093/annonc/mdx402; Lin SY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050902; Mackenzie PJ, 2008, CAN J OPHTHALMOL, V43, P308, DOI 10.3129/i08-042; MANDYBUR TI, 1979, TOXICOL APPL PHARM, V50, P163, DOI 10.1016/0041-008X(79)90504-0; Mao BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20728-z; Mecklenburg L, 2007, TOXICOL PATHOL, V35, P252, DOI 10.1080/01926230601178199; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228226; Pamphlett R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220859; Park Jung-Duck, 2012, J Prev Med Public Health, V45, P344, DOI 10.3961/jpmph.2012.45.6.344; Park SJ, 2015, OPHTHALMOLOGY, V122, P129, DOI 10.1016/j.ophtha.2014.07.039; POTTS AM, 1976, EXP EYE RES, V22, P487, DOI 10.1016/0014-4835(76)90186-X; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; ROSS JF, 1994, TOXICOL APPL PHARM, V124, P191, DOI 10.1006/taap.1994.1023; Sarks S, 2007, INVEST OPHTH VIS SCI, V48, P968, DOI 10.1167/iovs.06-0443; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Toimela TA, 2001, TOXICOL IN VITRO, V15, P7, DOI 10.1016/S0887-2333(00)00057-6; Too LK, 2017, ACTA HISTOCHEM, V119, P142, DOI 10.1016/j.acthis.2016.12.003; Tsolaki E, 2019, MATERIALS, V12, DOI 10.3390/ma12193126; ULSHAFER RJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P113, DOI 10.1001/archopht.1990.01070030119041; van Elteren JT, 2018, ANAL CHEM, V90, P2896, DOI 10.1021/acs.analchem.7b05134; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Warfvinge K, 1996, TOXICOLOGY, V107, P189, DOI 10.1016/0300-483X(95)03257-G; Warfvinge K, 2000, ENVIRON RES, V83, P102, DOI 10.1006/enrs.1999.4029; Wills NK, 2008, EXP EYE RES, V86, P41, DOI 10.1016/j.exer.2007.09.005; Wu EW, 2014, ENVIRON RES, V133, P178, DOI 10.1016/j.envres.2014.05.023; Wu XY, 2016, ENVIRON SCI POLLUT R, V23, P8244, DOI 10.1007/s11356-016-6333-x; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	62	10	10	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241054	10.1371/journal.pone.0241054	http://dx.doi.org/10.1371/journal.pone.0241054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119674	Green Published, gold			2022-12-26	WOS:000600013600087
J	Lugobe, HM; Muhindo, R; Kayondo, M; Wilkinson, I; Agaba, DC; McEniery, C; Okello, S; Wylie, BJ; Boatin, AA				Lugobe, Henry Mark; Muhindo, Rose; Kayondo, Musa; Wilkinson, Ian; Agaba, David Collins; McEniery, Carmel; Okello, Samson; Wylie, Blair J.; Boatin, Adeline A.			Risks of adverse perinatal and maternal outcomes among women with hypertensive disorders of pregnancy in southwestern Uganda	PLOS ONE			English	Article								Introduction Hypertensive disorders of pregnancy (HDP) are a leading cause of global perinatal (fetal and neonatal) and maternal morbidity and mortality. We sought to describe HDP and determine the magnitude and risk factors for adverse perinatal and maternal outcomes among women with HDP in southwestern Uganda. Methods We prospectively enrolled pregnant women admitted for delivery and diagnosed with HDP at a tertiary referral hospital in southwestern Uganda from January 2019 to November 2019, excluding women with pre-existing hypertension. The participants were observed and adverse perinatal and maternal outcomes were documented. We used multivariable logistic regression models to determine independent risk factors associated with adverse perinatal and maternal outcomes. Results A total of 103 pregnant women with a new-onset HDP were enrolled. Almost all women, 93.2% (n = 96) had either pre-eclampsia with severe features or eclampsia. The majority, 58% (n = 60) of the participants had an adverse perinatal outcome (36.9% admitted to the neonatal intensive care unit (ICU), 20.3% stillbirths, and 1.1% neonatal deaths). Fewer participants, 19.4% (n = 20) had an adverse maternal outcome HELLP syndrome (7.8%), ICU admission (3%), and postpartum hemorrhage (3%). In adjusted analyses, gestational age of < 34 weeks at delivery and birth weight <2.5kg were independent risk factors for adverse perinatal outcomes while referral from another health facility and eclampsia were independent risk factors for adverse maternal outcomes. Conclusion Among women with HDP at our institution, majority had preeclampsia with severe symptoms or eclampsia and an unacceptably high rate of adverse perinatal and maternal outcomes; over a fifth of the mothers experiencing stillbirth. This calls for improved antenatal surveillance of women with HDP and in particular improved neonatal and maternal critical care expertise at delivering facilities. Earlier detection and referral, as well as improvement in initial management at lower level health units and on arrival at the referral site is imperative.	[Lugobe, Henry Mark; Kayondo, Musa; Agaba, David Collins] Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda; [Muhindo, Rose; Okello, Samson] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Wilkinson, Ian; McEniery, Carmel] Univ Cambridge, Cambridge, England; [Wylie, Blair J.] Harvard Med Sch, Div Maternal Fetal Med, Dept Obstet & Gynecol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Boatin, Adeline A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA	Mbarara University of Science & Technology; Mbarara University of Science & Technology; University of Cambridge; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lugobe, HM (corresponding author), Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda.	henrylugobe@must.ac.ug	Okello, Samson/I-1877-2019	Okello, Samson/0000-0001-7377-6094; wilkinson, ian/0000-0001-6598-9399	Fogarty International Center of the National Institutes of Health [D43TW010128]; Office of AIDS Research, Office of the Director (OAR/NIH) of the National Institutes of Health [D43TW010128]; National Institute of Mental Health (NIMH/NIH) of the National Institutes of Health [D43TW010128]; National Institute of Neurological Disorders and Stroke (NINDS/NIH) of the National Institutes of Health [D43TW010128]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research, Office of the Director (OAR/NIH) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH/NIH) of the National Institutes of Health; National Institute of Neurological Disorders and Stroke (NINDS/NIH) of the National Institutes of Health	Research reported in this publication was supported by the Fogarty International Center and co-founding partners (NIH Common Fund, Office of Strategic Coordination, Office of the Director (OD/OSC/CF/NIH); Office of AIDS Research, Office of the Director (OAR/NIH); National Institute of Mental Health (NIMH/NIH); and National Institute of Neurological Disorders and Stroke (NINDS/NIH)) of the National Institutes of Health under Award Number D43TW010128 to HML. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629; Adu-Bonsaffoh K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1575-2; Adu-Bonsaffoh K, 2014, INT J GYNECOL OBSTET, V127, P238, DOI 10.1016/j.ijgo.2014.06.010; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2014, PAN AFR MED J S1; [Anonymous], 2018, HYPERTENSION, V72, P24, DOI [10.1161/HYPERTENSIONAHA.117.10803, DOI 10.1161/HYPERTENSIONAHA.117.10803]; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 2019, MONTHLY NEWSLETTER M; Asseffa NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213240; Barton JR, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.030; Berhe AK, 2019, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2708-6; Bridwell M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2361-0; Cruz MO, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.033; Dassah ET, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223478; Ganzevoort W, 2011, BEST PRACT RES CL OB, V25, P463, DOI 10.1016/j.bpobgyn.2011.01.004; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Li X, 2018, J CLIN HYPERTENS, V20, P1049, DOI 10.1111/jch.13302; Magee L., 2016, FIGO TXB PREGNANCY H; Mersha AG, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2617-8; Mugyenyi GR, 2020, PAN AFR MED J; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5; Ngonzi J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0986-9; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; Olusanya BO, 2012, HYPERTENS PREGNANCY, V31, P120, DOI 10.3109/10641955.2010.525280; Roberge S, 2017, AM J OBSTET GYNECOL, V216, P110, DOI 10.1016/j.ajog.2016.09.076; Seyom E, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0135-5; Sibai BM, 2006, SEMINARS PERINATOLOG; Sliwa K, 2014, CARDIOVASC RES, V101, P554, DOI 10.1093/cvr/cvu012; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; van Esch JJA, 2017, J MATERN-FETAL NEO M, V30, P2789, DOI 10.1080/14767058.2016.1263295; World Health Organization, 2005, WORLD HLTH REP 2005; Yamamoto R, 2018, J OBSTET GYNAECOL RE, V44, P1221, DOI 10.1111/jog.13650	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0241207	10.1371/journal.pone.0241207	http://dx.doi.org/10.1371/journal.pone.0241207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112915	gold, Green Published			2022-12-26	WOS:000588374000045
J	Mori, Y; Yoshikawa, E; Futatsubashi, M; Ouchi, Y				Mori, Yutaro; Yoshikawa, Etsuji; Futatsubashi, Masami; Ouchi, Yasuomi			Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction	PLOS ONE			English	Article							LATERAL PREMOTOR; DISEASE PATIENTS; BLOOD-FLOW; MOTOR; GAIT; ACTIVATION; MOVEMENTS; CORTEX; CEREBELLUM; BINDING	It has been reported that the cerebellar vermis is equally involved in both motor imagery about axial movement and the actual execution of postural balance in healthy human subjects, but this finding is yet to be explored in Parkinson's disease (PD). We therefore investigated the neuronal responses during observation of standing posture, imagination of standing and the assumption of an upright posture in ten drug-naive PD patients using positron emission tomography (PET) with [O-15]H2O and evaluated dopamine dysfunction by measuring the level of dopamine transporter binding of [C-11]CFT. Within-group statistical parametric mapping (SPM) analysis showed similar cerebellar activation during imagination of standing and its real execution between the PD and control groups (12 healthy subjects); i.e., increases in regional cerebral blood flow (rCBF) were observed in the anterior cerebellar vermis during motor imagination and the posterior vermis during standing. A comparison between the groups showed that the motor execution of standing significantly activated the superior part of the posterior vermis (declive VI) and the paracentral sulcus region in the PD patients, while the prefrontal cortices were deactivated during standing (p<0.001 uncorrected). Correlation analysis within the PD group revealed that the postural rCBF increases in the cerebellar vermis (pyramis) were negatively correlated with putaminal [C-11]CFT binding (p<0.01, r = 0.94) and that the postural rCBF reductions in the orbitofrontal cortex were positively correlated with caudate [C-11]CFT binding (p<0.05, r = 0.70). These results suggest that while the neural circuits for postural imagery and execution are intact in PD, standing performance, which requires more recruitment of dopaminergic control, may result in compensatory overstimulation of the cerebellar vermis and paracentral foot area in PD patients. Hyperactivity in these areas along with mesocortical hypofunction may be pathophysiological aspects of postural control in PD patients. Hence, our findings would help understand the modifications observed within the neural networks in relationship with postural performance, and possible compensatory mechanisms in PD.	[Mori, Yutaro; Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Dept Biofunct Imaging, Hamamatsu, Shizuoka, Japan; [Yoshikawa, Etsuji; Futatsubashi, Masami] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Futatsubashi, Masami] Hamamatsu Med Photon Fdn, Hamamatsu Pet Imaging Ctr, Hamamatsu, Shizuoka, Japan; [Ouchi, Yasuomi] Hamamatsu Med Ctr, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu Photonics; Hamamatsu Photonics; Hamamatsu University School of Medicine	Ouchi, Y (corresponding author), Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Dept Biofunct Imaging, Hamamatsu, Shizuoka, Japan.; Ouchi, Y (corresponding author), Hamamatsu Med Ctr, Hamamatsu, Shizuoka, Japan.	ouchi@hama-med.ac.jp			JSPS KAKENHI [JP16H06402]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported partly by JSPS KAKENHI Grant Numbers JP16H06402 (Willdynamics). E.Y. and M.F. receive support via salary and are research employees with Hamamatsu Photonics K.K. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Obesity (Silver Spring), V22 Suppl 2, pS40, DOI 10.1002/oby.20822; Baier B, 2009, BRAIN, V132, P2114, DOI 10.1093/brain/awp165; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Desmond JE, 1997, J NEUROSCI, V17, P9675; DIENER HC, 1989, PROG BRAIN RES, V80, P481; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; Ouchi Y, 1999, ANN NEUROL, V46, P723, DOI 10.1002/1531-8249(199911)46:5<723::AID-ANA7>3.0.CO;2-R; Ouchi Y, 2005, NEUROIMAGE, V24, P70, DOI 10.1016/j.neuroimage.2004.07.044; Ouchi Y, 2004, NEUROIMAGE, V22, P155, DOI 10.1016/j.neuroimage.2003.12.035; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Ouchi Y, 2001, BRAIN, V124, P784, DOI 10.1093/brain/124.4.784; Ouchi Y, 1999, ANN NEUROL, V45, P601, DOI 10.1002/1531-8249(199905)45:5<601::AID-ANA8>3.0.CO;2-0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; RAICHLE ME, 1983, J NUCL MED, V24, P790; Rascol O, 1997, BRAIN, V120, P103, DOI 10.1093/brain/120.1.103; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Samuel M, 2001, NEUROREPORT, V12, P821, DOI 10.1097/00001756-200103260-00040; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; SCHNIDER A, 1995, BRAIN, V118, P485, DOI 10.1093/brain/118.2.485; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sveinbjornsdottir S, 2016, J NEUROCHEM, V139, P318, DOI 10.1111/jnc.13691; Watanabe M, 2002, IEEE T NUCL SCI, V49, P634, DOI 10.1109/TNS.2002.1039541; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	37	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240998	10.1371/journal.pone.0240998	http://dx.doi.org/10.1371/journal.pone.0240998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8XL	33112886	gold, Green Published			2022-12-26	WOS:000588374000044
J	Ladinovic, D; Pinkas, D; Sopin, T; Raska, O; Liska, F; Raska, I; Vacik, T				Ladinovic, Dijana; Pinkas, Daniel; Sopin, Tijana; Raska, Otakar; Liska, Frantisek; Raska, Ivan; Vacik, Tomas			Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling	PLOS ONE			English	Article							CYCLIN D1; HISTONE; TRANSCRIPTION; PROLIFERATION; PLURIPOTENCY; INHIBITORS; TARGET; GENE	A precisely balanced activity of canonical Wnt signaling is essential for a number of biological processes and its perturbation leads to developmental defects or diseases. Here, we demonstrate that alternative isoforms of the KDM2A and KDM2B lysine demethylases have the ability to negatively regulate canonical Wnt signaling. These KDM2A and KDM2B isoforms (KDM2A-SF and KDM2B-SF) lack the N-terminal demethylase domain, but they still have the ability to bind to CpG islands in promoters and to interact with their protein partners via their other functional domains. We have observed that KDM2A-SF and KDM2B-SF bind to the promoters of axin 2 and cyclin D1, two canonical Wnt signaling target genes, and repress their activity. Moreover, KDM2A-SF and KDM2B-SF are both able to strongly repress a Wnt-responsive luciferase reporter. The transcriptional repression mediated by KDM2A-SF and KDM2B-SF, but also by KDM2A-LF, is dependent on their DNA binding domain, while the N-terminal demethylase domain is dispensable for this process. Surprisingly, KDM2B-LF is unable to repress both the endogenous promoters and the luciferase reporter. Finally, we show that both KDM2A-SF and KDM2B-SF are able to interact with TCF7L1, one of the transcriptional mediators of canonical Wnt signaling. KDM2A-SF and KDM2B-SF are thus likely to negatively affect the transcription of canonical Wnt signaling target genes by binding to their promoters and by interacting with TCF7L1 and other co-repressors.	[Ladinovic, Dijana; Pinkas, Daniel; Sopin, Tijana; Raska, Otakar; Liska, Frantisek; Raska, Ivan; Vacik, Tomas] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Ladinovic, Dijana; Pinkas, Daniel; Sopin, Tijana; Raska, Otakar; Liska, Frantisek; Raska, Ivan; Vacik, Tomas] Gen Univ Hosp Prague, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Vacik, T (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.	tomas.vacik@if1.cuni.cz			Grant Agency of Czech Republic [19-19779S, 1707164S]; Charles University [Progres Q28]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Charles University	YES: This work was supported by the Grant Agency of Czech Republic (19-19779S, 1707164S) and the project of Charles University (Progres Q28).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Andricovich J, 2016, J CLIN INVEST, V126, P905, DOI 10.1172/JCI84014; [Anonymous], 2013, J HEART FAILURE, V14, P422; Aruna DS, 2010, ASIAN PAC J CANCER P, V11, P539; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Borgel J, 2017, NUCLEIC ACIDS RES, V45, P1114, DOI 10.1093/nar/gkw979; Boulard M, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0069-1; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dhar SS, 2014, J BIOL CHEM, V289, P7483, DOI 10.1074/jbc.M113.521625; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Gates LA, 2017, TRENDS BIOCHEM SCI, V42, P977, DOI 10.1016/j.tibs.2017.10.004; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Janzer A, 2012, J BIOL CHEM, V287, P30984, DOI 10.1074/jbc.M112.341040; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kawakami E, 2015, MECH DEVELOP, V135, P31, DOI 10.1016/j.mod.2014.10.001; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ladinovic D, 2017, NUCLEUS-PHILA, V8, P563, DOI 10.1080/19491034.2017.1342915; Lu L, 2015, DEV CELL, V33, P660, DOI 10.1016/j.devcel.2015.04.006; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Patel P, 2017, CURR TOP DEV BIOL, V123, P277, DOI 10.1016/bs.ctdb.2016.11.011; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Stamos JL, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A007898; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torres-del-Pliego E, 2013, CURR RHEUMATOL REP, V15, DOI [10.1007/s11926-013-0373-8, 10.1007/s11926-0130373-8]; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vacik T, 2018, NUCLEUS-PHILA, V9, P431, DOI 10.1080/19491034.2018.1498707; Vacik T, 2011, GENE DEV, V25, P1783, DOI 10.1101/gad.17227011; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Zaghi M, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01291; Zhou ZW, 2017, CELL REP, V21, P2160, DOI 10.1016/j.celrep.2017.10.091	43	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0236612	10.1371/journal.pone.0236612	http://dx.doi.org/10.1371/journal.pone.0236612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104714	Green Published, Green Submitted, gold			2022-12-26	WOS:000588370000018
J	Hu, QJ; Masuda, T; Kuramitsu, S; Tobo, T; Sato, K; Kidogami, S; Nambara, S; Ueda, M; Tsuruda, Y; Kuroda, Y; Ito, S; Oki, E; Mori, M; Mimori, K				Hu, Qingjiang; Masuda, Takaaki; Kuramitsu, Shotaro; Tobo, Taro; Sato, Kuniaki; Kidogami, Shinya; Nambara, Sho; Ueda, Masami; Tsuruda, Yusuke; Kuroda, Yosuke; Ito, Shuhei; Oki, Eiji; Mori, Masaki; Mimori, Koshi			Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REPRESSES E-CADHERIN; LYSYL OXIDASE; ANOIKIS RESISTANCE; CELLS; EXPRESSION; GENE; METASTASIS; PLASTIN3; SNAIL	Background Peritoneal dissemination (PD) frequently occurs in gastric cancer (GC) and is incurable. In this study, we aimed to identify novel PD-associated genes and clarify their clinical and biological significance in GC. Materials and methods We identified LOXL1 as a PD-associated candidate gene by in silico analysis of GC datasets (highly disseminated peritoneal GC cell line and two freely available GC datasets, GSE15459 and TCGA). Next, we evaluated the clinical significance of LOXL1 expression using RT-qPCR and immunohistochemistry staining (IHC) in a validation cohort (Kyushu cohort). Moreover, we performed gene expression analysis, including gene set enrichment analysis (GSEA) with GSE15459 and TCGA datasets. Finally, we performed a series of in vitro experiments using GC cells. Results In silico analysis showed that LOXL1 was overexpressed in tumor tissues of GC patients with PD and in highly disseminated peritoneal GC cells, relative to that in the control GC patients and cells, respectively. High expression of LOXL1 was a poor prognostic factor in the TCGA dataset. Next, IHC showed that LOXL1 was highly expressed in GC cells. High LOXL1 mRNA expression was associated with poorly differentiated histological type, lymph node metastasis, and was an independent poor prognostic factor in the Kyushu validation cohort. Moreover, LOXL1 expression was positively correlated with the EMT (epithelial-mesenchymal transition) gene set in GSEA. Finally, LOXL1-overexpressing GC cells changed their morphology to a spindle-like form. LOXL1 overexpression reduced CDH1 expression; increased the expression of VIM, CDH2, SNAI2, and PLS3; and promoted the migration capacity of GC cells. Conclusions LOXL1 is associated with PD in GC, possibly through the induction of EMT.	[Hu, Qingjiang; Masuda, Takaaki; Kuramitsu, Shotaro; Sato, Kuniaki; Kidogami, Shinya; Nambara, Sho; Ueda, Masami; Tsuruda, Yusuke; Kuroda, Yosuke; Ito, Shuhei; Mimori, Koshi] Kyushu Univ, Dept Surg, Beppu Hosp, Beppu, Oita, Japan; [Hu, Qingjiang; Oki, Eiji; Mori, Masaki] Kyushu Univ Hosp, Dept Surg & Sci, Fukuoka, Japan; [Tobo, Taro] Kyushu Univ, Dept Clin Lab Med, Beppu Hosp, Beppu, Oita, Japan	Kyushu University; Kyushu University; Kyushu University	Mimori, K (corresponding author), Kyushu Univ, Dept Surg, Beppu Hosp, Beppu, Oita, Japan.	kmimori@beppu.kyushu-u.ac.jp		Mimori, Koshi/0000-0003-3897-9974; Sato, Kuniaki/0000-0001-6014-1911	Japan Society for the Promotion of Science (JSPS) [JP19K16718, JP16H01576, JP15H04921, JP16K10543, JP16K07177, JP16K19107, JP15H05791, JP26293303, JP17K16454, JP17K16521, JP17K10593, JP17K19608, JP17ck0106160, JP18ae0101016, JP18cm0106504, JP18kk0205003, JP18ck0106259, 15H05912, hp170227]; OITA Cancer Research Foundation; Daiwa Securities Health Foundation; Eli Lilly Japan K.K. Grant; Japanese Foundation for Multidisciplinary Treatment of Cancer	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); OITA Cancer Research Foundation; Daiwa Securities Health Foundation; Eli Lilly Japan K.K. Grant(Eli Lilly); Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer)	This work was supported in part by the following grants and foundations: Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Science Research (grant numbers JP19K16718, JP16H01576, JP15H04921, JP16K10543, JP16K07177, JP16K19107, JP15H05791, JP26293303, JP17K16454, JP17K16521, JP17K10593, JP17K19608, JP17ck0106160, JP18ae0101016, JP18cm0106504, JP18kk0205003, and JP18ck0106259), Grant-in-Aid for Scientific Research on Innovative Areas (15H05912); Priority Issue on Post-K computer (hp170227); OITA Cancer Research Foundation, Daiwa Securities Health Foundation; Eli Lilly Japan K.K. Grant, Japanese Foundation for Multidisciplinary Treatment of Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boufraqech M, 2016, CLIN CANCER RES, V22, P4491, DOI 10.1158/1078-0432.CCR-15-2461; Hajra KM, 2002, CANCER RES, V62, P1613; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu Q, 2018, ANN SURG ONCOL, V25, P745, DOI 10.1245/s10434-017-6292-6; Kanda M, 2016, WORLD J GASTROENTERO, V22, P6829, DOI 10.3748/wjg.v22.i30.6829; Kasashima H, 2018, DIGESTION, V98, P238, DOI 10.1159/000489558; Kasashima H, 2016, GASTRIC CANCER, V19, P431, DOI 10.1007/s10120-015-0510-3; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Kraft-Sheleg O, 2016, DEV CELL, V36, P550, DOI 10.1016/j.devcel.2016.02.009; Kurashige J, 2019, ONCOL LETT, V17, P2393, DOI 10.3892/ol.2018.9819; Kurashige J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22371; Kurashige J, 2015, CARCINOGENESIS, V36, P133, DOI 10.1093/carcin/bgu232; Lim B, 2016, ONCOTARGET, V7, P8055, DOI 10.18632/oncotarget.6977; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Ma L, 2018, BIOMED PHARMACOTHER, V107, P1728, DOI 10.1016/j.biopha.2018.08.156; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Martin A, 2015, EMBO J, V34, P1090, DOI 10.15252/embj.201489975; Masuda TA, 2005, INT J ONCOL, V26, P721; Merino D, 2015, ONCOGENE, V34, P3926, DOI 10.1038/onc.2014.313; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326; Zeltz C, 2019, CANCERS, V11, P1	34	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241140	10.1371/journal.pone.0241140	http://dx.doi.org/10.1371/journal.pone.0241140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095806	gold, Green Published			2022-12-26	WOS:000586649400034
J	Sugimoto, M; Murakami, K; Fujiwara, A; Asakura, K; Masayasu, S; Sasaki, S				Sugimoto, Minami; Murakami, Kentaro; Fujiwara, Aya; Asakura, Keiko; Masayasu, Shizuko; Sasaki, Satoshi			Association between diet-related greenhouse gas emissions and nutrient intake adequacy among Japanese adults	PLOS ONE			English	Article							ENVIRONMENTAL-IMPACT; FOOD; HEALTH; ENERGY; MEN; CONSUMPTION; FOOTPRINTS; MORTALITY; ADHERENCE; QUALITY	Objectives A growing number of Western studies have been exploring sustainable and healthy dietary patterns that target to reduce diet-related greenhouse gas emissions (GHGE) and to achieve nutritional needs. However, research is limited among Asian populations, where food sources for diet-related GHGE differ from those in Western populations. This study aimed to investigate associations between diet-related GHGE and the prevalence of inadequate nutritional intake. Methods A cross-sectional study was carried out among 392 healthy Japanese volunteers aged 20-69 years. Dietary intake was assessed by four-non-consecutive day diet record. Diet-related GHGE was estimated using the Global Link Input-Output model and adjusted for energy intake by residual method. Prevalence of inadequacy was defined as a percentage of participants with nutrient intake outside the Tentative Dietary Goal for Preventing Lifestyle-Related Disease or below the Estimated Average Requirement defined by the Dietary Reference Intakes (DRIs) for Japanese. The association between diet-related GHGE and the prevalence of inadequacy of the usual intake of each nutrient was examined using logistic regression models. Results Participants with higher diet-related GHGE had overall better adherence to the DRIs. Intakes of all selected nutrients were positively associated with diet-related GHGE, except for carbohydrate, total fat, and saturated fat. With increasing quartile of diet-related GHGE, the prevalence of inadequacy decreased for protein, dietary fiber, potassium, vitamins A, B-6, and C, thiamin, riboflavin, calcium, magnesium, iron, and zinc, while that for sodium increased. Conclusions Diets with lower diet-related GHGE did not have better adherence to the DRIs compared to diets with higher diet-related GHGE among Japanese adults. Drastic dietary change or other strategies such as improving the food system would be needed to achieve a sustainable and healthy diet among Japanese.	[Sugimoto, Minami; Sasaki, Satoshi] Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Div Hlth Sci & Nursing, Tokyo, Japan; [Murakami, Kentaro; Fujiwara, Aya; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Fujiwara, Aya] Natl Inst Biomed Innovat Hlth & Nutr, Dept Nutr Epidemiol & Shokuiku, Tokyo, Japan; [Asakura, Keiko] Toho Univ, Sch Med, Dept Environm & Occupat Hlth, Tokyo, Japan; [Masayasu, Shizuko] Ikurien Naka, Ibaraki, Japan	University of Tokyo; University of Tokyo; Toho University	Sasaki, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Social & Prevent Epidemiol, Div Hlth Sci & Nursing, Tokyo, Japan.; Sasaki, S (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan.	stssasak@m.u-tokyo.ac.jp	Sugimoto, Minami/AAR-4033-2020; Fujiwara, Aya/AAA-2632-2019	Sugimoto, Minami/0000-0002-3692-2707; Fujiwara, Aya/0000-0001-9928-1946	Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [H23-Jyunkankitou (seishuu)-ippan-001]; Japan Society for the Promotion of Science [18J21618]	Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The present study was supported by a Health and Labour Sciences Research Grant (H23-Jyunkankitou (seishuu)-ippan-001) from the Ministry of Health, Labour and Welfare, Japan and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (18J21618) from the Japan Society for the Promotion of Science.	Asakura K, 2016, PUBLIC HEALTH NUTR, V19, P2011, DOI 10.1017/S1368980015003249; Asakura K, 2014, BRIT J NUTR, V112, P1195, DOI 10.1017/S0007114514001779; Biesbroek S, 2017, BRIT J NUTR, V118, P69, DOI 10.1017/S0007114517001878; Biesbroek S, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-27; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; FAO, 2010, BIODIVERSITY SUSTAIN; FAO/WHO, 1988, REPORT JOINT FAO WHO; Fujiwara A, 2019, J EPIDEMIOL, V29, P414, DOI 10.2188/jea.JE20180036; Fujiwara A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101474; Government of Japan, 2016, PLAN GLOBAL WARMING; Green RF, 2018, SCI TOTAL ENVIRON, V643, P1411, DOI 10.1016/j.scitotenv.2018.06.258; Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92; Haubrock J, 2011, J NUTR, V141, P914, DOI 10.3945/jn.109.120394; Heller MC, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab0ac; Hyland JJ, 2017, PUBLIC HEALTH NUTR, V20, P726, DOI 10.1017/S1368980016002573; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Institute of Medicine Food and Nutrition Board, 2000, DIETARY REFERENCE IN; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Mbow C, 2019, NATURE; Mertens E, 2019, J CLEAN PROD, V237, DOI 10.1016/j.jclepro.2019.117827; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Ministry of Health Labour and Welfare, 2015, DIETARY REFERENCE IN; Ministry of Health Labour and Welfare, 2020, DIETARY REFERENCE IN, DOI DOI 10904750/000586553.PDF; Ministry of Health Labour and Welfare, 2013, NAT HLTH NUTR SURV J; Monsivais P, 2015, AM J CLIN NUTR, V102, P138, DOI 10.3945/ajcn.114.090639; MORI S, 1981, Japanese Journal of Nutrition, V39, P243; Murakami K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091150; Murakami K, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0338-x; Murakami K, 2015, BRIT J NUTR, V114, P1294, DOI 10.1017/S0007114515002706; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Nansai K, 2009, ECON SYST RES, V21, P267, DOI 10.1080/09535310903541587; Okubo H, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0047-7; Olivier J, 2017, TRENDS GLOBAL CO2 TO; Owaki Atsuko, 1996, Japanese Journal of Nutrition, V54, P11; Rose D, 2019, AM J CLIN NUTR, V109, P526, DOI 10.1093/ajcn/nqy327; Saito A, 2019, J NUTR SCI, V8, DOI 10.1017/jns.2019.9; Sasaki S, 2011, LANCET, V378, P1205, DOI 10.1016/S0140-6736(11)61220-8; Science and Technology Agency, 2015, STAND TABL FOOD COMP; Seconda L, 2018, CLIMATIC CHANGE, V148, P155, DOI 10.1007/s10584-018-2195-1; Sjors C, 2017, PUBLIC HEALTH NUTR, V20, P3381, DOI 10.1017/S1368980017002300; Song GB, 2017, SCI TOTAL ENVIRON, V577, P289, DOI 10.1016/j.scitotenv.2016.10.184; Souverein OW, 2011, EUR J CLIN NUTR, V65, pS92, DOI 10.1038/ejcn.2011.93; Sugimoto M, 2021, PUBLIC HEALTH NUTR, V24, P973, DOI 10.1017/S1368980019004750; Taguchi C, 2019, J NUTR SCI VITAMINOL, V65, P192, DOI 10.3177/jnsv.65.192; Temme EHM, 2015, PUBLIC HEALTH NUTR, V18, P2433, DOI 10.1017/S1368980014002821; Tokudome Yuko, 2002, J Epidemiol, V12, P85; van de Kamp ME, 2018, FOOD RES INT, V104, P14, DOI 10.1016/j.foodres.2017.06.006; van Dooren C, 2015, SUSTAINABILITY-BASEL, V7, P12837, DOI 10.3390/su70912837; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2018, EUR J CLIN NUTR, V72, P951, DOI 10.1038/s41430-017-0080-z; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; WHO, 2006, GUIDELINES FOOD FORT; Willett W, 2012, NUTR EPIDEMIOLOGY, P274; World Health Organization, 2015, GUID SUG INT AD CHIL; Yip CSC, 2018, EUR J CLIN NUTR, V72, P18, DOI 10.1038/ejcn.2017.117; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; 2019, MOL THER NUCL ACIDS, V18, P1	58	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240803	10.1371/journal.pone.0240803	http://dx.doi.org/10.1371/journal.pone.0240803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095787	gold, Green Published			2022-12-26	WOS:000586649400048
J	Zhao, C; Feng, ZQ; He, HZ; Zang, D; Du, H; Huang, HL; Du, YL; He, J; Zhou, YJ; Nie, YQ				Zhao, Chong; Feng, Zhiqiang; He, Hongzhen; Zang, Dan; Du, Hong; Huang, Hongli; Du, Yanlei; He, Jie; Zhou, Yongjian; Nie, Yuqiang			Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray	PLOS ONE			English	Article							MISMATCH REPAIR PROTEIN; PHASE-III TRIAL; MICROSATELLITE INSTABILITY; E-CADHERIN; ADJUVANT CHEMOTHERAPY; SUBTYPES; CAPECITABINE; OUTCOMES; COMPLEX; SURGERY	Recently, the Cancer Genome Atlas and Asian Cancer Research Group propose two new classifications system of gastric cancer by using multi-platforms of molecular analyses. However, these highly complicated and cost technologies have not yet been translated into full clinical utility. In addition, the clinicians are expected to gain more guidance of treatment for different molecular subtypes. In this study, we developed a panel of gastric cancer patients in population from Southern China using commercially accessible TMA and immunohistochemical technology. A cohort of 259 GC patients was classified into 4 subtypes on the basis of expression of mismatch repair proteins (PMS2, MLH1, MSH2, and MSH6), E-cadherin and p21 protein. We observed that the subtypes presented distinct prognosis. dMMR-like subtype was associated with the best prognosis, and E-cadherin-a subtype was associated with the worst prognosis. Patients with p21-High and p21-Ligh subtypes had intermediate overall survival. In multivariate analysis, the dMMR-like subtype remained an independent prediction power for overall survival in the model. We described a molecular classification of gastric cancers using clinically applicable assay. The biological relevance of the four subtypes was illustrated by significant differences in prognosis. Our molecular classification provided an effective and inexpensive screening tool for improving prognostic models. Nevertheless, our study should be considered preliminary and carries a limited predictive value as a single-center retrospective study.	[Zhao, Chong; Feng, Zhiqiang; He, Hongzhen; Huang, Hongli; Du, Yanlei; He, Jie; Zhou, Yongjian; Nie, Yuqiang] South China Univ Technol, Guangzhou Peoples Hosp 1, Med Sch, Dept Gastroenterol, Guangzhou, Peoples R China; [Zhao, Chong; Feng, Zhiqiang; He, Hongzhen; Huang, Hongli; Du, Yanlei; He, Jie; Zhou, Yongjian; Nie, Yuqiang] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou Digest Dis Ctr, Dept Gastroenterol, Guangzhou, Peoples R China; [Zang, Dan] Xinxiang Med Univ, Dept Pathol, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China; [Du, Hong] South China Univ Technol, Guangzhou Peoples Hosp 1, Med Sch, Dept Pathol, Guangzhou, Peoples R China	South China University of Technology; Guangzhou Medical University; Xinxiang Medical University; South China University of Technology	Zhou, YJ; Nie, YQ (corresponding author), South China Univ Technol, Guangzhou Peoples Hosp 1, Med Sch, Dept Gastroenterol, Guangzhou, Peoples R China.; Zhou, YJ; Nie, YQ (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou Digest Dis Ctr, Dept Gastroenterol, Guangzhou, Peoples R China.	eyzhouyongjian@scut.edu.cn; eynieyuqiang@scut.edu.cn			National Natural Science Foundation of China [81871905, 81700486]; Natural Science Foundation of Guangdong, China [2020A1515010953]; Science and Technology Program of Guangzhou, Chian [201906010052, 202002030288]; Fundamental Research Funds for the Central Universities, SCUT [2017BQ113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong, China(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou, Chian; Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81871905, No. 81700486), the Natural Science Foundation of Guangdong, China (2020A1515010953), the Science and Technology Program of Guangzhou, Chian (201906010052, 202002030288), and the Fundamental Research Funds for the Central Universities, SCUT (2017BQ113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2017, AM J SURG PATHOL, V41, P106, DOI 10.1097/PAS.0000000000000756; [Anonymous], 2013, B HIST EDUCACION, V47, P28; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berlth F, 2014, WORLD J GASTROENTERO, V20, P5679, DOI 10.3748/wjg.v20.i19.5679; Chen YC, 2016, PATHOL ONCOL RES, V22, P197, DOI 10.1007/s12253-015-9996-6; Choi YY, 2014, J SURG ONCOL, V110, P129, DOI 10.1002/jso.23618; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dietmaier W, 1997, CANCER RES, V57, P4749; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garg K, 2009, AM J SURG PATHOL, V33, P925, DOI 10.1097/PAS.0b013e318197a046; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Graziano F, 2004, ANN ONCOL, V15, P489, DOI 10.1093/annonc/mdh108; Hayashi T, 2006, DIS COLON RECTUM, V49, pS23, DOI 10.1007/s10350-006-0722-z; Heo YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46216-6; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jawhari A, 1997, GASTROENTEROLOGY, V112, P46, DOI 10.1016/S0016-5085(97)70218-X; Kim H, 2011, J GASTROEN HEPATOL, V26, P585, DOI 10.1111/j.1440-1746.2010.06487.x; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Lee HJ, 2013, J CANCER RES THER, V9, P80, DOI 10.4103/0973-1482.110382; Lee J, 2017, ONCOTARGET, V8, P66305, DOI 10.18632/oncotarget.19985; Lee J, 2012, J CLIN ONCOL, V30, P268, DOI 10.1200/JCO.2011.39.1953; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li N, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0433-6; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Seo HM, 2009, J SURG ONCOL, V99, P143, DOI 10.1002/jso.21220; Setia N, 2016, MODERN PATHOL, V29, P772, DOI 10.1038/modpathol.2016.55; Shi XP, 2014, CLIN CANCER RES, V20, P151, DOI 10.1158/1078-0432.CCR-13-1063; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva EM, 2008, GASTRIC CANCER, V11, P149, DOI 10.1007/s10120-008-0468-5; Skarlos DV, 2007, ANTICANCER RES, V27, P2973; Sohn BH, 2017, CLIN CANC RES; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Uchikado Y, 2011, GASTRIC CANCER, V14, P41, DOI 10.1007/s10120-011-0004-x; Wang ZS, 2014, TUMOR BIOL, V35, P1357, DOI 10.1007/s13277-013-1185-1; Warneke VS, 2013, DIAGN MOL PATHOL, V22, P127, DOI 10.1097/PDM.0b013e318284188e; Wesolowski R, 2009, LANCET ONCOL, V10, P903, DOI 10.1016/S1470-2045(09)70136-6; Zhao C, 2016, ONCOGENE, V35, P5916, DOI 10.1038/onc.2016.114; Zhu HF, 2016, GENE, V579, P52, DOI 10.1016/j.gene.2015.12.050	46	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0238836	10.1371/journal.pone.0238836	http://dx.doi.org/10.1371/journal.pone.0238836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095797	gold, Green Published			2022-12-26	WOS:000586649400019
J	Saunajoki, A; Auvinen, J; Saarela, V; Uusitalo, JJ; Leiviska, I; Keinanen-Kiukaanniemi, S; Liinamaa, MJ; Timonen, M				Saunajoki, Anni; Auvinen, Juha; Saarela, Ville; Uusitalo, Janne-Joonas; Leiviska, Ilmari; Keinanen-Kiukaanniemi, Sirkka; Liinamaa, M. Johanna; Timonen, Markku			Association of glucose metabolism and retinopathy signs in non-diabetic individuals in midlife-The Northern Finland Birth Cohort 1966 study	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; DIABETIC-RETINOPATHY; RISK-FACTORS; ATHEROSCLEROSIS RISK; INSULIN SENSITIVITY; VESSEL DIAMETERS; VASCULAR CALIBER; PLASMA-GLUCOSE; PREVALENCE; POPULATION	Diabetic retinopathy is a microvascular complication of hyperglycaemia. Little is known about the association of glucose metabolism and retinopathy signs in the non-diabetic middle-aged population. We studied prevalence of retinopathy in a subsample of Northern Finland Birth Cohort study (NFBC1966) of 1809 subjects, at 47 years of age, without previously diagnosed type 2 diabetes and/or blood pressure-lowering medication. All participants underwent clinical evaluations including an oral glucose tolerance test (glucose and insulin values measured at 0, 30, 60 and 120 min) and HbA(1c). The retinopathy signs were diagnosed by fundus photographs and classified according to the Eurodiab classification scheme. The overall prevalence of newly diagnosed retinopathy was 1.4%. The retinopathy signs were significantly associated with increased 30 min, 1-h and 2-h glucose levels and 2-h insulin level in an OGTT. After adjustment with systolic blood pressure, only 30 min glucose, 1-h glucose and 2-h insulin levels were associated with retinopathy signs. Our findings show the potential role of 30 min and 1-h post-load glucose and 2-h insulin levels as risk factors for retinopathy lesions among the participants without previously diagnosed diabetes or hypertensive medication.	[Saunajoki, Anni; Auvinen, Juha; Keinanen-Kiukaanniemi, Sirkka; Timonen, Markku] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Auvinen, Juha; Saarela, Ville; Uusitalo, Janne-Joonas; Leiviska, Ilmari; Liinamaa, M. Johanna; Timonen, Markku] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Auvinen, Juha; Saarela, Ville; Uusitalo, Janne-Joonas; Leiviska, Ilmari; Liinamaa, M. Johanna; Timonen, Markku] Univ Oulu, Oulu, Finland; [Auvinen, Juha; Timonen, Markku] Healthcare & Social Serv Oulunkaari, Ii, Finland; [Saarela, Ville; Uusitalo, Janne-Joonas; Leiviska, Ilmari; Liinamaa, M. Johanna] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka] Healthcare & Social Serv Selanne, Pyhajarvi, Finland; [Keinanen-Kiukaanniemi, Sirkka] Healthcare & Social Serv City Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Saunajoki, A (corresponding author), Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland.	anni.saunajoki@student.oulu.fi			State Research Financing of the Expert Responsibility area of Oulu; University of Oulu [24000692]; Oulu University Hospital [24301140]; ERDF European Regional Development Fund [539/2010 A31592]; Emil Aaltonen Foundation; Orion Research Foundation sr; Oulu Medical Research Foundation	State Research Financing of the Expert Responsibility area of Oulu; University of Oulu; Oulu University Hospital; ERDF European Regional Development Fund(European Commission); Emil Aaltonen Foundation; Orion Research Foundation sr; Oulu Medical Research Foundation	This research was supported by State Research Financing of the Expert Responsibility area of Oulu. NFBC1966 received financial support from University of Oulu Grant no. 24000692, Oulu University Hospital Grant no. 24301140, ERDF European Regional Development Fund Grant no. 539/2010 A31592. The study was supported by grants from Emil Aaltonen Foundation, Orion Research Foundation sr and Oulu Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter A, 2013, OPHTHAL EPIDEMIOL, V20, P220, DOI 10.3109/09286586.2013.809770; ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; [Anonymous], 2018, Lancet Oncol, V19, pe581, DOI 10.1016/S1470-2045(18)30748-4; Bao YCK, 2020, CURR EYE RES, V45, P173, DOI 10.1080/02713683.2019.1659977; Bhargava M, 2014, ACTA OPHTHALMOL, V92, pe602, DOI 10.1111/aos.12446; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Cugati S, 2006, EYE, V20, P1239, DOI 10.1038/sj.eye.6702085; Cunningham ET, 2005, OPHTHALMOLOGY, V112, P1747, DOI 10.1016/j.ophtha.2005.06.007; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Gavin JR, 1997, DIABETES CARE, V20, P1183; Geneid M, 2019, ACTA OPHTHALMOL, V97, P532, DOI 10.1111/aos.13992; Ikram MK, 2006, DIABETES, V55, P506, DOI 10.2337/diabetes.55.02.06.db05-0546; Inzucchi SE, 2012, NEW ENGL J MED, V367, P542, DOI 10.1056/NEJMcp1103643; Kawasaki R, 2006, OPHTHALMOLOGY, V113, P1378, DOI 10.1016/j.ophtha.2006.02.052; Kifley A, 2007, AM J OPHTHALMOL, V143, P1024, DOI 10.1016/j.ajo.2007.01.034; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P1568, DOI 10.1001/archophthalmol.2010.298; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MOSS SE, 1991, DIABETES CARE, V14, P119, DOI 10.2337/diacare.14.2.119; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Ojaimi E, 2011, OPHTHALMOLOGY, V118, P656, DOI 10.1016/j.ophtha.2010.08.007; Paddock E, 2018, DIABETES CARE, V41, P1212, DOI 10.2337/dc17-1900; Rajala U, 1998, DIABETES CARE, V21, P1664, DOI 10.2337/diacare.21.10.1664; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tapp RJ, 2003, DIABETES CARE, V26, P1731, DOI 10.2337/diacare.26.6.1731; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	35	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240983	10.1371/journal.pone.0240983	http://dx.doi.org/10.1371/journal.pone.0240983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091029	Green Published, gold			2022-12-26	WOS:000586647200069
J	Fois, A; Boucher-Lafleur, AM; Legault, JT; Renaud, C; Morin, C; Des Rosiers, C; Coderre, L; Laprise, C; Lesage, S				Fois, Adrien; Boucher-Lafleur, Anne-Marie; Thompson Legault, Julie; Renaud, Christian; Morin, Charles; Des Rosiers, Christine; Coderre, Lise; Laprise, Catherine; Lesage, Sylvie		LSFC Consortium	Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients	PLOS ONE			English	Article							C-OXIDASE DEFICIENCY; CHILDREN; LRPPRC; IMMUNITY; FORM; CELL; PP1	Leigh Syndrome French Canadian (LSFC) is a rare autosomal recessive metabolic disorder characterized by severe lactic acidosis crises and early mortality. LSFC patients carry mutations in the Leucine Rich Pentatricopeptide Repeat Containing (LRPPRC) gene, which lead to defects in the respiratory chain complexes and mitochondrial dysfunction. Mitochondrial respiration modulates cellular metabolic activity, which impacts many cell types including the differentiation and function of immune cells. Hence, we postulated that, in addition to neurological and metabolic disorders, LSFC patients may show impaired immune activity. To gain insight into the quality of the immune response in LSFC patients, we examined the response to the measles, mumps and rubella (MMR) vaccine by measuring antibody titers to MMR in the plasma. In a cohort of eight LSFC patients, the response to the MMR vaccine was variable, with some individuals showing antibodies to all three viruses, while others had antibodies to two or fewer viruses. These results suggest that the mutations in the LRPPRC gene present in LSFC patients may affect the immune response to vaccines. Monitoring vaccine response in this fragile population should be considered to ensure full protection against pathogens.	[Fois, Adrien; Coderre, Lise; Lesage, Sylvie] Maisonneuve Rosemont Hosp, Res Ctr, Immunol Oncol Sect, Montreal, PQ, Canada; [Fois, Adrien; Renaud, Christian; Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Boucher-Lafleur, Anne-Marie; Laprise, Catherine] Univ Quebec Chicoutimi, Ctr Intersectoriel Sante Durable, Saguenay, PQ, Canada; [Thompson Legault, Julie; Des Rosiers, Christine] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Morin, Charles] Hop Chicoutimi, Chicoutimi, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal	Lesage, S (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, Immunol Oncol Sect, Montreal, PQ, Canada.; Lesage, S (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.	sylvie.lesage@umontreal.ca		Lesage, Sylvie/0000-0002-0968-2795	La fondation du grand defi Pierre Lavoie; Leigh Syndrome French Canadian Biobank; Departement de microbiologie, infectiologie et immunologie at the University of Montreal	La fondation du grand defi Pierre Lavoie; Leigh Syndrome French Canadian Biobank; Departement de microbiologie, infectiologie et immunologie at the University of Montreal	This work was supported by funds from La fondation du grand defi Pierre Lavoie, awarded to SL. https://www.fondationgdpl.com/soumettre-un-projet/The Canada Research Chair in Environment and Genetic of Respiratory Disorders and Allergy (chairholder : Catherine Laprise) financially support the Leigh Syndrome French Canadian Biobank. https://www.chairs-chaires.gc.ca/home-accueil-eng.aspx SL is a Research Scholars Emeritus awardee from the Fonds de recherche Quebec - Sante. http://www.frqs.gouv.qc.ca/en/AF holds a scholarship from the Departement de microbiologie, infectiologie et immunologie at the University of Montreal. https://microbiologie.umontreal.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burelle Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120767; Canada PHAo, 2020, VACC COV CAN CHILDR; Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007; Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976; Eom S, 2017, PEDIATR NEUROL, V66, P82, DOI 10.1016/j.pediatrneurol.2016.10.006; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; Gillim-Ross L, 2006, CLIN MICROBIOL REV, V19, P614, DOI 10.1128/CMR.00005-06; Han VX, 2017, CHILD NEUROL OPEN, V4; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5; Kingsley JD, 2006, PEDIATRICS, V118, pE460, DOI 10.1542/peds.2005-1257; Kotecha S, 2019, BMJ CASE REP, V12; Kruk SK, 2019, J ALLER CL IMM-PRACT, V7, P2415, DOI 10.1016/j.jaip.2019.03.046; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Leitner WW, 1999, VACCINE, V18, P765, DOI 10.1016/S0264-410X(99)00271-6; Liang Y, 2014, HUM VACC IMMUNOTHER, V10, P1382, DOI 10.4161/hv.28334; Majzoub K, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080758; Marilou Kiely NB, 2017, ENQUETE COUVERTURE V; Menni F, 2012, VACCINE, V30, P7161, DOI 10.1016/j.vaccine.2012.10.012; MERANTE F, 1993, AM J HUM GENET, V53, P481; Mesman AW, 2014, CELL HOST MICROBE, V16, P31, DOI 10.1016/j.chom.2014.06.008; MMR-161 Study Group, 2018, Vaccine, V36, P5781, DOI 10.1016/j.vaccine.2018.07.076; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Moss WJ, 2017, LANCET, V390, P2490, DOI 10.1016/S0140-6736(17)31463-0; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Poethko-Muller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042867; Quebec SeSs, 2019, VACC VACC CONTR ROUG; Refolo G, 2019, HEPATOLOGY, V69, P34, DOI 10.1002/hep.30149; Ruiz M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123231; Sasarman F, 2015, HUM MOL GENET, V24, P480, DOI 10.1093/hmg/ddu468; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Shirts BH, 2013, CLIN VACCINE IMMUNOL, V20, P443, DOI 10.1128/CVI.00503-12; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; sociaux TMdlSedS, 2019, MEASL MUMPS RUB CHIC; Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Vesikari T, 2007, PEDIATR INFECT DIS J, V26, P632, DOI 10.1097/INF.0b013e3180616c8f; Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309; Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0239860	10.1371/journal.pone.0239860	http://dx.doi.org/10.1371/journal.pone.0239860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085679	gold, Green Published			2022-12-26	WOS:000585943400043
J	Tasuji, T; Reese, E; van Mulukom, V; Whitehouse, H				Tasuji, Tara; Reese, Elaine; van Mulukom, Valerie; Whitehouse, Harvey			Band of mothers: Childbirth as a female bonding experience	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EVENT CENTRALITY; POSTNATAL DEPRESSION; PERSONAL GROWTH; BIRTH TRAUMA; SELF; IDENTITY; LIFE; RUMINATION; PREGNANCY	Does the experience of childbirth create social bonds among first-time mothers? Previous research suggests that sharing emotionally intense or painful experiences with others leads to "identity fusion," a visceral feeling of oneness with a group that predicts strong forms of prosocial action and self-sacrifice for other group members. This study compared identity fusion with other mothers during pregnancy versus after childbirth in a sample of 164 U.S. women. Eighty-nine mothers in our sample were pregnant with their firstborn, and 75 mothers had given birth to their firstborn up to 6 months prior to the time of data collection. Results demonstrated that identity fusion with other mothers was higher for postpartum mothers than for antenatal mothers. As predicted, among postpartum mothers, those who thought that their childbirth was more painful than a typical childbirth experience reported greater identity fusion with mothers who reported having had a very difficult birth. Postpartum mothers' ruminative thought about the birth mediated the association between level of dysphoria and identity fusion, and identity fusion moderated the association between postpartum mothers' ruminative and reflective thought about the birth and their posttraumatic growth in complex ways. These findings provide evidence that perceived sharedness of the childbirth experience and thoughts about the birth are important to the process of identity fusion with other mothers, and highlight the importance of post-event processing for psychological health.	[Tasuji, Tara; van Mulukom, Valerie; Whitehouse, Harvey] Univ Oxford, Ctr Study Social Cohes, Oxford, England; [Reese, Elaine] Univ Otago, Dept Psychol, Dunedin, New Zealand; [van Mulukom, Valerie] Coventry Univ, Ctr Trust, Peace & Social Relat, Coventry, W Midlands, England	University of Oxford; University of Otago; Coventry University	Tasuji, T (corresponding author), Univ Oxford, Ctr Study Social Cohes, Oxford, England.; Reese, E (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	tara.tasuji@gmail.com; ereese@psy.otago.ac.nz		Whitehouse, Harvey/0000-0001-6935-6724	European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme [694986]	European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme(European Research Council (ERC))	This work was supported by an Advanced Grant entitled `Ritual Modes: Divergent Modes of Ritual, Social Cohesion, Prosociality, and Conflict' (agreement no. 694986) from the European Research Council (ERC) under the European Union's Horizon 2020 Research and Innovation Programme awarded to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alehagen S, 2005, J PSYCHOSOM OBST GYN, V26, P153, DOI 10.1080/0144361040023072; Allbaugh LJ, 2016, ANXIETY STRESS COPIN, V29, P21, DOI 10.1080/10615806.2015.1015422; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Ayers S, 2016, PSYCHOL MED, V46, P1121, DOI 10.1017/S0033291715002706; Ayers S, 2017, J REPROD INFANT PSYC, V35, P427, DOI 10.1080/02646838.2017.1386874; Ayers S, 2015, J REPROD INFANT PSYC, V33, P282, DOI 10.1080/02646838.2015.1004164; Ayers S, 2009, J AFFECT DISORDERS, V119, P200, DOI 10.1016/j.jad.2009.02.029; BAILEY KG, 1988, PSYCHOTHERAPY, V25, P132, DOI 10.1037/h0085309; Barton S, 2013, J TRAUMA STRESS, V26, P718, DOI 10.1002/jts.21863; Bayrampour H, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-100; Bayrampour H, 2012, J MIDWIFERY WOM HEAL, V57, P445, DOI 10.1111/j.1542-2011.2012.00188.x; Beck CT, 2004, NURS RES, V53, P28, DOI 10.1097/00006199-200401000-00005; Bell AF, 2014, J MIDWIFERY WOM HEAL, V59, P35, DOI 10.1111/jmwh.12101; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Boals A, 2011, APPL COGNITIVE PSYCH, V25, P817, DOI 10.1002/acp.1753; Boals A, 2010, J LOSS TRAUMA, V15, P518, DOI 10.1080/15325024.2010.519271; Buhrmester MD, 2015, SELF IDENTITY, V14, P253, DOI 10.1080/15298868.2014.992465; Buhrmester MD, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00054; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Cann A, 2011, ANXIETY STRESS COPIN, V24, P137, DOI 10.1080/10615806.2010.529901; Carolan Mary, 2005, Health Care Women Int, V26, P764, DOI 10.1080/07399330500230987; Corkin MT, 2021, CURR PSYCHOL, V40, P919, DOI 10.1007/s12144-018-0014-5; Corkin MT, 2018, J CHILD FAM STUD, V27, P653, DOI 10.1007/s10826-017-0903-5; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Farley D, 2019, MED HYPOTHESES, V128, P86, DOI 10.1016/j.mehy.2019.05.003; Foa EB, 2016, PSYCHOL ASSESSMENT, V28, P1166, DOI 10.1037/pas0000258; Habermas T, 2000, PSYCHOL BULL, V126, P748, DOI 10.1037//0033-2909.126.5.748; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Henderson J, 2013, BIRTH-ISS PERINAT C, V40, P1, DOI 10.1111/birt.12022; Iles J, 2011, J ANXIETY DISORD, V25, P520, DOI 10.1016/j.janxdis.2010.12.006; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Jong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145611; Karlsdottir SI, 2018, WOMEN BIRTH, V31, pE178, DOI 10.1016/j.wombi.2017.09.007; Kavanagh CM, 2019, EUR J SOC PSYCHOL, V49, P461, DOI 10.1002/ejsp.2514; Kozinszky Z, 2015, J AFFECT DISORDERS, V176, P95, DOI 10.1016/j.jad.2015.01.044; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; McAdams DP, 2001, PERS SOC PSYCHOL B, V27, P474, DOI 10.1177/0146167201274008; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Newson M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160427; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; NOLENHOEKSEMA S, 1993, J ABNORM PSYCHOL, V102, P20, DOI 10.1037/0021-843X.102.1.20; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Paez D, 2015, J PERS SOC PSYCHOL, V108, P711, DOI 10.1037/pspi0000014; Pals JL, 2006, J PERS, V74, P1079, DOI 10.1111/j.1467-6494.2006.00403.x; Pals JL, 2004, PSYCHOL INQ, V15, P65; Richert R.A., 2005, MIND RELIG PSYCHOL C, P127; Sawyer A, 2015, J REPROD INFANT PSYC, V33, P294, DOI 10.1080/02646838.2014.981801; Sawyer A, 2012, PSYCHOL HEALTH, V27, P362, DOI 10.1080/08870446.2011.578745; Sawyer A, 2009, PSYCHOL HEALTH, V24, P457, DOI 10.1080/08870440701864520; Schuettler D, 2011, J LOSS TRAUMA, V16, P180, DOI 10.1080/15325024.2010.519273; Segal K, 2018, SELF IDENTITY, V17, P574, DOI 10.1080/15298868.2018.1458645; Spielman V, 2009, HEALTH SOC WORK, V34, P201, DOI 10.1093/hsw/34.3.201; Swann WB, 2012, PSYCHOL REV, V119, P441, DOI 10.1037/a0028589; Swann WB, 2009, J PERS SOC PSYCHOL, V96, P995, DOI 10.1037/a0013668; Taubman-Ben-Ari O, 2012, J HAPPINESS STUD, V13, P801, DOI 10.1007/s10902-011-9291-5; Taubman-Ben-Ari O, 2010, J PSYCHOL, V144, P185, DOI 10.1080/00223980903472268; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Whitehouse H, 2018, BEHAV BRAIN SCI, V41, DOI 10.1017/S0140525X18000249; Whitehouse H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44292; Whitehouse H, 2014, P NATL ACAD SCI USA, V111, P17783, DOI 10.1073/pnas.1416284111; Whitehouse H, 2014, CURR ANTHROPOL, V55, P674, DOI 10.1086/678698; Windridge KC, 1999, BIRTH-ISS PERINAT C, V26, P16, DOI 10.1046/j.1523-536x.1999.00016.x; Wolfe T, 2015, INT J MENT HEALTH PR, V17, P78, DOI 10.1080/13642529.2015.1008799; Yildiz PD, 2017, J AFFECT DISORDERS, V208, P634, DOI 10.1016/j.jad.2016.10.009; Zasloff E, 2007, ACTA OBSTET GYN SCAN, V86, P1328, DOI 10.1080/00016340701657209; Zumeta L, 2016, AN PSICOL-SPAIN, V32, P717, DOI 10.6018/analesps.32.3.261651	69	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240175	10.1371/journal.pone.0240175	http://dx.doi.org/10.1371/journal.pone.0240175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3RJ	33085666	Green Published, gold			2022-12-26	WOS:000585943400025
J	Wu, DC; Jha, P; Lam, T; Brown, P; Gelband, H; Nagelkerke, N; Birnboim, HC; Reid, A				Wu, Daphne C.; Jha, Prabhat; Lam, Teresa; Brown, Patrick; Gelband, Hellen; Nagelkerke, Nico; Birnboim, H. Chaim; Reid, Angus		Action Beat Coronavirus	Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative survey	PLOS ONE			English	Article								Random population-based surveys to estimate prevalence of SARS-CoV2 infection causing coronavirus disease (COVID-19) are useful to understand distributions and predictors of the infection. In April 2020, the first-ever nationally representative survey in Canada polled 4,240 adults age 18 years and older about self-reported COVID experience in March, early in the epidemic. We examined the levels and predictors of COVID symptoms, defined as fever plus difficulty breathing/shortness of breath, dry cough so severe that it disrupts sleep, and/or loss of sense of smell; and testing for SARS-CoV-2 by respondents and/or household members. About 8% of Canadians reported that they and/or one or more household members experienced COVID symptoms. Symptoms were more common in younger than in older adults, and among visible minorities. Overall, only 3% of respondents and/or household members reported testing for SARS-CoV-2. Being tested was associated with having COVID symptoms, Indigenous identity, and living in Quebec. Periodic nationally representative surveys of symptoms, as well as SARS-CoV-2 antibodies, are required in many countries to understand the pandemic and prepare for the future.	[Wu, Daphne C.; Jha, Prabhat; Brown, Patrick; Gelband, Hellen; Nagelkerke, Nico; Birnboim, H. Chaim] Univ Toronto, Unity Hlth Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada; [Wu, Daphne C.; Jha, Prabhat; Brown, Patrick; Gelband, Hellen; Nagelkerke, Nico; Birnboim, H. Chaim] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lam, Teresa; Reid, Angus] Angus Reid Inst, Vancouver, BC, Canada; [Brown, Patrick] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada; [Birnboim, H. Chaim] DeltaDNA Biosci Inc, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Jha, P (corresponding author), Univ Toronto, Unity Hlth Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON, Canada.; Jha, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	Prabhat.jha@utoronto.ca		Wu, Daphne C./0000-0002-6700-9996; Jha, Prabhat/0000-0001-7067-8341	Bill and Melinda Gates Foundation [OPP1159622]; Canadian Institutes of Health Research [FDN 154277]; Angus Reid Institute	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angus Reid Institute	PJ received funding from the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org; grant number: OPP1159622) and the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/e/193.html; grant number: FDN 154277), and AR is funded by the Angus Reid Institute (http://angusreid.org/).The Angus Reid Institute collected the data used in this study and reviewed the manuscript. The funders (Bill and Melinda Gates Foundation and Canadian Institutes of Health Research) provided support in the form of salaries for authors (DCW, HG), but did not have any additional role in the study design, data collection and analysis, decision to public, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Angus Reid Institute, 2020, INC COVID INF CAN NE; Canadian Life and Health Insurance Association, 2014, CLHIA REP LONG TERM; Centers for Disease Control and Prevention, 2020, COVIDVIEW WEEKL SURV; Chan ANT, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2016259; Eggertson L, 2020, CMAJ NEWS; Forum Research Mainstreet Research, 2020, COVID STUD ONT WAV 2; Graham J., 2020, CNN HLTH; Gudbjartsson DF, 2020, NEJM, DOI 10.1056/NEJMoa2026116; Hallal P, 2020, REMARKABLE VARIABILI; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Office for National Statistics, 2020, CORONAVIRUS COVID 19; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Statistics Canada, 2020, TABLE 17 10 0005 01; Statistics Canada, 2019, AB ID PERS; Statistics Canada, 2020, VIS MIN PERS; Tenforde MW, 2020, MMWR MORBIDITY MORTA, V69; Ward H., 2020, MEDRXIV, DOI DOI 10.1101/2020.08.12.20173690	17	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0240778	10.1371/journal.pone.0240778	http://dx.doi.org/10.1371/journal.pone.0240778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085714	gold, Green Published, Green Submitted			2022-12-26	WOS:000585943400054
J	Botwe, AK; Owusu-Agyei, S; Asghar, M; Hammar, U; Oppong, FB; Gyaase, S; Dosoo, D; Jakpa, G; Boamah, E; Twumasi, MF; Osier, F; Farnert, A; Asante, KP				Botwe, Akua Kyerewaa; Owusu-Agyei, Seth; Asghar, Muhammad; Hammar, Ulf; Oppong, Felix Boakye; Gyaase, Stephaney; Dosoo, David; Jakpa, Gabriel; Boamah, Ellen; Twumasi, Mieks Frenken; Osier, Faith; Farnert, Anna; Asante, Kwaku Poku			Profiles ofPlasmodium falciparuminfections detected by microscopy through the first year of life in Kintampo a high transmission area of Ghana	PLOS ONE			English	Article							MALARIA TRANSMISSION; AFRICAN INFANTS; ASYMPTOMATIC PARASITEMIA; PLASMODIUM; ANTIBODIES; CHILDREN; INFECTION; RISK; ASSOCIATION; SETTINGS	Although malaria mortality among children under five years of age is high, the characteristics of their infection patterns are not well described. The aim of this study was to examine the longitudinal sequence pattern ofPlasmodium falciparuminfections in the first year of life within a birth cohort in Kintampo, Ghana (N = 1855). Infants were monitored at home with monthly sampling and also at the clinic for any febrile illness between 2008 and 2011. Light microscopy was performed on monthly scheduled visits and febrile ill visits over twelve months of follow-ups (n = 19231). Microscopy-positive visits accompanied with or without symptoms were rare during the first five months of life but were common from six to twelve months of age. Among 1264 infants with microscopy data over a minimum of eight monthly visits and also throughout in sick visits, some were microscopy negative (36%), and others positive: only-symptomatic (35%), alternating (22%) and only-asymptomatic (7%). The median age of microscopic infection was seven months for the alternating group and eight months for both the only-symptomatic and only-asymptomatic groups. The alternating group had the highest cumulative incidence of microscopic infections, the lowest age at first infection and 87 different infection patterns. Parasite densities detected by microscopy were significantly higher for symptomatic versus asymptomatic infection. We conclude that infants in malaria endemic areas experience diverse infection profiles throughout their first year of life. Further investigations should include submicroscopic reservoir and may shed more light on the factors that determine susceptibility to malaria during infancy.	[Botwe, Akua Kyerewaa; Owusu-Agyei, Seth; Oppong, Felix Boakye; Gyaase, Stephaney; Dosoo, David; Jakpa, Gabriel; Boamah, Ellen; Twumasi, Mieks Frenken; Asante, Kwaku Poku] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Botwe, Akua Kyerewaa; Asghar, Muhammad; Farnert, Anna] Karolinska Inst, Div Infect Dis, Dept Med Solna, Stockholm, Sweden; [Botwe, Akua Kyerewaa; Osier, Faith] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Owusu-Agyei, Seth] Univ Hlth & Allied Sci, Inst Hlth Res, Ho, Ghana; [Asghar, Muhammad; Farnert, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Asghar, Muhammad; Farnert, Anna] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Hammar, Ulf] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Unit Biostat, Stockholm, Sweden; [Osier, Faith] Heidelberg Univ Hosp, Heidelberg, Germany	Kintampo Health Research Centre; Karolinska Institutet; Kenya Medical Research Institute; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Ruprecht Karls University Heidelberg	Botwe, AK (corresponding author), Kintampo Hlth Res Ctr, Kintampo, Ghana.; Botwe, AK (corresponding author), Karolinska Inst, Div Infect Dis, Dept Med Solna, Stockholm, Sweden.; Botwe, AK (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya.	akua.agyeman-budu@kintampo-hrc.org	Asghar, Muhammad/C-6730-2013	Asghar, Muhammad/0000-0002-9017-2206; Farnert, Anna/0000-0001-7583-282X; Oppong, Felix Boakye/0000-0002-3146-9958	DELTAS Africa Initiative [DEL-15-003]	DELTAS Africa Initiative	AKB was funded by DELTAS Africa Initiative [DEL-15-003]. URL: https://kemri-wellcome.org/news/deltas-africa-programmes.The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Afolabi BM, 2001, AM J TROP MED HYG, V65, P822, DOI 10.4269/ajtmh.2001.65.822; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; Amoako N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112868; [Anonymous], 2018, WHO MAL TERM; [Anonymous], 2015, GUID TREATM MAL; [Anonymous], 2019, WORLD MALARIA REPORT; Apinjoh TO, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv012; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Awine T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1094-z; Ayanful-Torgby R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1640-8; Bartoloni A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.026; BINKA FN, 1994, T ROY SOC TROP MED H, V88, P381, DOI 10.1016/0035-9203(94)90391-3; Buchwald AG, 2019, CLIN INFECT DIS, V68, P106, DOI 10.1093/cid/ciy427; Ceesay SJ, 2015, EMERG INFECT DIS, V21, P1114, DOI 10.3201/eid2107.142036; Coalson JE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1587-9; Crompton PD, 2008, J INFECT DIS, V198, P1265, DOI 10.1086/592224; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dobbs KR, 2016, PARASITOLOGY, V143, P129, DOI 10.1017/S0031182015001626; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; Franks S, 2001, J INFECT DIS, V183, P796, DOI 10.1086/318834; HOGH B, 1995, INFECT IMMUN, V63, P4034; Homann MV, 2017, EBIOMEDICINE, V25, P66, DOI 10.1016/j.ebiom.2017.10.003; Kangoye DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107965; Kangoye DT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1260-3; Kangoye DT, 2016, VACCINE, V34, P160, DOI 10.1016/j.vaccine.2015.10.058; Khattab A, 2007, PARASITOL RES, V101, P767, DOI 10.1007/s00436-007-0548-1; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Liljander A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013649; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; McLean ARD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186577; Morassin B, 2002, AM J TROP MED HYG, V66, P503, DOI 10.4269/ajtmh.2002.66.503; Natama HM, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2315-4; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Nweneka CV, 2004, J TROP PEDIATRICS, V50, P114, DOI 10.1093/tropej/50.2.114; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; PASVOL G, 1977, NATURE, V270, P171, DOI 10.1038/270171a0; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Riley EM, 1999, IMMUNOL TODAY, V20, P228, DOI 10.1016/S0167-5699(99)01456-5; Sehgal V M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P105, DOI 10.1016/0035-9203(89)90616-0; Sylvester Boniphace, 2018, BMC Res Notes, V11, P232, DOI 10.1186/s13104-018-3339-0; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115	53	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240814	10.1371/journal.pone.0240814	http://dx.doi.org/10.1371/journal.pone.0240814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075074	Green Published, gold			2022-12-26	WOS:000585920200036
J	Hansen, KUI; Siegerist, F; Daniel, S; Schindler, M; Iervolino, A; Blumenthal, A; Daniel, C; Amann, K; Zhou, WB; Endlich, K; Endlich, N				Hansen, Kerrin Ursula Ingeborg; Siegerist, Florian; Daniel, Sophie; Schindler, Maximilian; Iervolino, Anna; Blumenthal, Antje; Daniel, Christoph; Amann, Kerstin; Zhou, Weibin; Endlich, Karlhans; Endlich, Nicole			Prolonged podocyte depletion in larval zebrafish resembles mammalian focal and segmental glomerulosclerosis	FASEB JOURNAL			English	Article						FSGS; glomerulus; podocyte injury; zebrafish model organism	PARIETAL EPITHELIAL-CELL; MECHANICAL FORCES; INJURY; REGENERATION; PROTEINURIA; REVEALS; DISEASE; HEART; MODEL	Focal and segmental glomerulosclerosis (FSGS) is a histological pattern frequently found in patients with nephrotic syndrome that often progress to end-stage kidney disease. The initial step in development of this histologically defined entity is injury and ultimately depletion of podocytes, highly arborized interdigitating cells on the glomerular capillaries with important function for the glomerular filtration barrier. Since there are still no causal therapeutic options, animal models are needed to develop new treatment strategies. Here, we present an FSGS-like model in zebrafish larvae, an eligible vertebrate model for kidney research. In a transgenic zebrafish strain, podocytes were depleted, and the glomerular response was investigated by histological and morphometrical analysis combined with immunofluorescence staining and ultrastructural analysis by transmission electron microscopy. By intravenous injection of fluorescent high-molecular weight dextran, we confirmed leakage of the size selective filtration barrier. Additionally, we observed severe podocyte foot process effacement of remaining podocytes, activation of proximal tubule-like parietal epithelial cells identified by ultrastructural cytomorphology, and expression of proximal tubule markers. These activated cells deposited extracellular matrix on the glomerular tuft which are all hallmarks of FSGS. Our findings indicate that glomerular response to podocyte depletion in larval zebrafish resembles human FSGS in several important characteristics. Therefore, this model will help to investigate the disease development and the effects of potential drugs in a living organism.	[Hansen, Kerrin Ursula Ingeborg; Siegerist, Florian; Daniel, Sophie; Schindler, Maximilian; Iervolino, Anna; Blumenthal, Antje; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Friedrich Loeffler Str 23c, D-17487 Greifswald, Germany; [Iervolino, Anna] Biogem Res Inst Gaetano Salvatore, Ariano Irpino, Italy; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, Erlangen, Germany; [Zhou, Weibin] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	Greifswald Medical School; University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai	Endlich, N (corresponding author), Univ Med Greifswald, Inst Anat & Cell Biol, Friedrich Loeffler Str 23c, D-17487 Greifswald, Germany.	nicole.endlich@uni-greifswald.de	Siegerist, Florian/GLT-5780-2022; Daniel, Christoph/AAK-2136-2021	Siegerist, Florian/0000-0003-1629-4982; Schindler, Maximilian/0000-0001-8549-510X; Iervolino, Anna/0000-0003-0450-9587; Endlich, Karlhans/0000-0001-6052-6061	Bundesministerium fur Bildung und Forschung (BMBF) [01GM1518B]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: 01GM1518B	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Dijkman H, 2005, KIDNEY INT, V68, P1562, DOI 10.1111/j.1523-1755.2005.00568.x; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Holderied A, 2015, LAB INVEST, V95, P273, DOI 10.1038/labinvest.2014.160; Kato Y, 2020, TOXICOL SCI, V174, P241, DOI 10.1093/toxsci/kfaa009; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4661, DOI 10.1016/0006-2952(88)90335-8; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Kriz W, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00207; Kuppe C, 2019, KIDNEY INT, V96, P80, DOI 10.1016/j.kint.2019.01.037; Kuppe C, 2015, KIDNEY INT, V88, P990, DOI 10.1038/ki.2015.116; Macary G, 2010, VIRCHOWS ARCH, V456, P325, DOI 10.1007/s00428-009-0840-9; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; McKee Robert A, 2015, Curr Pathobiol Rep, V3, P171; Miceli R, 2014, CELL DEV BIOL, V3, P1; Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012; Neal CR, 2005, J AM SOC NEPHROL, V16, P1223, DOI 10.1681/ASN.2004100822; Ohtaka A, 2002, AM J KIDNEY DIS, V39, P475, DOI 10.1053/ajkd.2002.31391; Pandey G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061290; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Romoli S, 2018, KIDNEY INT, V94, P1111, DOI 10.1016/j.kint.2018.08.013; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Siegerist F, 2017, ACTA PHYSIOL, V220, P167, DOI 10.1111/apha.12754; Siegerist F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43655; Smeets B, 2004, J AM SOC NEPHROL, V15, P928, DOI 10.1097/01.ASN.0000120559.09189.82; Steenbergen PJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051269; Sun H, 2014, EBIOMEDICINE, V1, P107, DOI 10.1016/j.ebiom.2014.11.009; Suzuki T, 2009, AM J PATHOL, V174, P1675, DOI 10.2353/ajpath.2009.080789; Westhoff JH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00583; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yin CY, 2012, HEPATOLOGY, V56, P1958, DOI 10.1002/hep.25757; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776	44	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15961	15974		10.1096/fj.202000724R	http://dx.doi.org/10.1096/fj.202000724R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33070374	Green Submitted, hybrid			2022-12-26	WOS:000581165100001
J	Tomar, S; Dehingia, N; Dey, AK; Chandurkar, D; Raj, A; Silverman, JG				Tomar, Shweta; Dehingia, Nabamallika; Dey, Arnab K.; Chandurkar, Dharmendra; Raj, Anita; Silverman, Jay G.			Associations of intimate partner violence and reproductive coercion with contraceptive use in Uttar Pradesh, India: How associations differ across contraceptive methods	PLOS ONE			English	Article							UNINTENDED PREGNANCY; ABORTION; SAMPLE; HIV	Intimate partner violence (IPV) and reproductive coercion (RC)-largely in the form of pressuring pregnancy-appear to contribute to low use of contraceptives in India; however, little is known about the extent to which these experiences differentially affect use of specific contraceptive methods. The current study assessed the association of IPV and RC with specific contraceptive methods (Intrauterine Devices [IUDs], pills, condoms) among a large population-based sample of currently married women (15-49 years, n = 1424) living in Uttar Pradesh. Outcomes variables included past year modern contraceptive use and type of contraceptive used. Primary independent variables included lifetime experience of RC by current husband or in-laws, and lifetime experiences of physical IPV and sexual IPV by current husband. Multivariate logistic regression models were developed to determine the effect of each form of abuse on women's contraceptive use. Approximately 1 in 7 women (15.1%) reported experiencing RC from their current husband or in-laws ever in their lifetime, 37.4% reported experience of physical IPV and 8.3% reported experience of sexual IPV by their current husband ever in their lifetime. Women experiencing RC were less likely to use any modern contraceptive (AOR: 0.18; 95% CI: 0.9-0.36). Such women also less likely to report pill and condom use but were more likely to report IUD use. Neither form of IPV were associated with either overall or method specific contraceptive use. Study findings highlight that RC may influence contraceptive use differently based on type of contraceptive, with less detectable, female-controlled contraceptives such as IUD preferred in the context of women facing RC. Unfortunately, IUD uptake remains low in India. Increased access and support for use, particularly for women contending with RC, may be important for improving women's control over contraceptive use and reducing unintended pregnancy.	[Tomar, Shweta; Dehingia, Nabamallika; Dey, Arnab K.; Raj, Anita; Silverman, Jay G.] Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Tomar, Shweta; Dehingia, Nabamallika; Dey, Arnab K.] Univ Calif San Diego, Joint Doctoral Program, San Diego, CA 92103 USA; [Chandurkar, Dharmendra] Sambodhi Res & Commun Pvt Ltd, Noida, Uttar Pradesh, India	University of California System; University of California San Diego; University of California System; University of California San Diego	Tomar, S (corresponding author), Univ Calif San Diego, Sch Med, Ctr Gender Equ & Hlth, Div Global Publ Hlth, La Jolla, CA 92093 USA.; Tomar, S (corresponding author), Univ Calif San Diego, Joint Doctoral Program, San Diego, CA 92103 USA.	stomar@health.ucsd.edu	Dehingia, Nabamallika/AAY-5588-2021; Dehingia, Nabamallika/AAF-1639-2021	Dehingia, Nabamallika/0000-0003-1787-9050; Dey, Arnab K./0000-0003-4585-3130; Tomar, Shweta/0000-0001-6991-1206	Bill and Melinda Gates Foundation [OPP1083531, INV-002967]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation Grant No. OPP1083531 (Monitoring and Evaluating the Uttar Pradesh Technical Support Unit) and INV-002967 (EMERGE-FP measures project). The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; [Anonymous], 2015, WHO UN SUST DEV SUMM; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; Askew I, 2017, GLOB HEALTH-SCI PRAC, V5, P658, DOI 10.9745/GHSP-D-17-00121; Baiden F, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0310-x; Bellizzi S, 2015, HUM REPROD, V30, P973, DOI 10.1093/humrep/deu348; Cleland J, 2017, CONTRACEPTION, V95, P519, DOI 10.1016/j.contraception.2017.03.009; Deering KN, 2013, SEX TRANSM DIS, V40, P168, DOI 10.1097/OLQ.0b013e31827df174; Fanslow J, 2008, AUST NZ J OBSTET GYN, V48, P83, DOI 10.1111/j.1479-828X.2007.00805.x; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Grindlay K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201663; Guliani H, 2014, HEALTH POLICY PLANN, V29, P589, DOI 10.1093/heapol/czt045; IIPS ICF, 2017, IND NAT FAM HLTH SUR; Kumar G, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2473-6; Loll D, 2019, INT PERSPECT SEX R H, V45, P1, DOI 10.1363/45e7419; Miller E, 2016, CONTRACEPTION, V94, P58, DOI 10.1016/j.contraception.2016.02.009; Miller E, 2014, CONTRACEPTION, V89, P122, DOI 10.1016/j.contraception.2013.10.011; Miller Elizabeth, 2010, Expert Rev Obstet Gynecol, V5, P511, DOI 10.1586/eog.10.44; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Montgomery MR, 2000, DEMOGRAPHY, V37, P155, DOI 10.2307/2648118; Ochako R, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0168-2; Panchanadeswaran S, 2008, INT J DRUG POLICY, V19, P106, DOI 10.1016/j.drugpo.2007.11.013; Patel SN, 2014, AIDS BEHAV, V18, P1970, DOI 10.1007/s10461-014-0792-1; Raj Anita, 2015, Int J Gynaecol Obstet, V130 Suppl 3, pE56, DOI 10.1016/j.ijgo.2015.03.013; Santhya KG., 2016, UNDERSTANDING LIVES; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Silverman JG, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100484; Silverman JG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001723; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; Tancredi DJ, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0216-z; WHO, 2005, MULT STUD WOM HLTH D; Zachor H, 2018, HEALTH EDUC RES, V33, P175, DOI 10.1093/her/cyy007	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0241008	10.1371/journal.pone.0241008	http://dx.doi.org/10.1371/journal.pone.0241008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064775	Green Published, gold			2022-12-26	WOS:000585918300002
J	Chaumeau, V; Kajeechiwa, L; Kulabkeeree, T; Vishwakarma, RK; Wasisakun, P; Hsel, SN; Oo, K; Dah, T; Sawasdichai, S; Trakoolchengkaew, M; Phanaphadungtham, M; Inta, A; Akararungrot, Y; Lee, NY; Kankew, P; Wiladphaingern, J; Mukaka, M; Delmas, G; Nosten, F				Chaumeau, Victor; Kajeechiwa, Ladda; Kulabkeeree, Thithiworada; Vishwakarma, Ramesh Kumar; Wasisakun, Praphan; Hsel, Saw Nay; Oo, Kyi; Dah, Tee; Sawasdichai, Sunisa; Trakoolchengkaew, Muesuwa; Phanaphadungtham, Monthicha; Inta, Aritsara; Akararungrot, Yanada; Lee, Naw Yu; Kankew, Prasan; Wiladphaingern, Jacher; Mukaka, Mavuto; Delmas, Gilles; Nosten, Francois			Impact of outdoor residual spraying on the biting rate of malaria vectors: A pilot study in four villages in Kayin state, Myanmar	PLOS ONE			English	Article							ADULT AEDES-ALBOPICTUS; PYRETHROID INSECTICIDES; CULEX-QUINQUEFASCIATUS; TRIATOMA-INFESTANS; BARRIER TREATMENTS; BED NETS; ANOPHELES; POPULATIONS; DELTAMETHRIN; EFFICACY	Outdoor and early mosquito biters challenge the efficacy of bed-nets and indoor residual spraying on the Thailand-Myanmar border. Outdoor residual spraying is proposed for the control of exophilic mosquito species. The objective of this study was to assess the impact of outdoor residual spraying on the biting rate of malaria vectors in Kayin state, Myanmar. Outdoor residual spraying using lambda-cyhalothrin was carried out in two villages in December 2016 (beginning of the dry season) and two villages were used as a control. Malaria mosquitoes were captured at baseline and monthly for four months after the intervention using human-landing catch and cow-baited trap collection methods. The impact of outdoor residual spraying on human-biting rate was estimated with propensity score adjusted generalized linear mixed-effect regressions. At baseline, mean indoor and outdoor human-biting rate estimates ranged between 2.12 and 29.16 bites /person /night, and between 0.20 and 1.72 bites /person /night in the intervention and control villages respectively. Using model output, we estimated that human-biting rate was reduced by 91% (95%CI = 88-96, P <0.0001) immediately after outdoor residual spraying. Human-biting rate remained low in all sprayed villages for 3 months after the intervention. Malaria vector populations rose at month 4 in the intervention villages but not in the controls. This coincided with the expected end of insecticide mist residual effects, thereby suggesting that residual effects are important determinants of intervention outcome. We conclude that outdoor residual spraying with a capsule suspension of lambda-cyhalothrin rapidly reduced the biting rate malaria vectors in this area where pyrethroid resistance has been documented.	[Chaumeau, Victor; Kajeechiwa, Ladda; Kulabkeeree, Thithiworada; Wasisakun, Praphan; Hsel, Saw Nay; Oo, Kyi; Dah, Tee; Sawasdichai, Sunisa; Trakoolchengkaew, Muesuwa; Phanaphadungtham, Monthicha; Inta, Aritsara; Akararungrot, Yanada; Lee, Naw Yu; Kankew, Prasan; Wiladphaingern, Jacher; Delmas, Gilles; Nosten, Francois] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand; [Chaumeau, Victor; Vishwakarma, Ramesh Kumar; Mukaka, Mavuto; Delmas, Gilles; Nosten, Francois] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Vishwakarma, Ramesh Kumar; Mukaka, Mavuto] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Chaumeau, V (corresponding author), Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Mae Sot, Thailand.; Chaumeau, V (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.	victor@shoklo-unit.com	Chaumeau, Victor/AAZ-5422-2021	Chaumeau, Victor/0000-0003-0171-2176; Nosten, Francois/0000-0002-7951-0745; Vishwakarma, Ramesh/0000-0003-2458-2802	Wellcome Trust [101148]; Bill and Melinda Gates Foundation [GH OPP 1177406]; Wellcome Trust of Great Britain	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by the Wellcome Trust [101148]; and the Bill and Melinda Gates Foundation [GH OPP 1177406]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the team of the entomology department of the Shoklo Malaria Research Unit for their work, the local communities for their support to the study and the Thai Meteorological Department for sharing their data. The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, supported by the Wellcome Trust of Great Britain.	Adekunle AI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003595; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; [Anonymous], 2007, PESTICIDES SE ASIA E; Ashley EA, 2019, J INFECT DIS, V220, P100, DOI 10.1093/infdis/jiz052; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Boyd MF, 1949, MALARIOLOGY; Cecere MC, 2006, J MED ENTOMOL, V43, P902, DOI 10.1603/0022-2585(2006)43[902:CTOEOP]2.0.CO;2; Chaumeau V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159160; Chaumeau V, 2018, J INFECT DIS; Chaumeau V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231251; Chaumeau Victor, 2018, Wellcome Open Res, V3, P109, DOI 10.12688/wellcomeopenres.14761.4; Chaumeau V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2102-z; Cheah PY, 2010, INT HEALTH, V2, P123, DOI 10.1016/j.inhe.2010.02.001; Chu CS, 2016, EXPERT REV ANTI-INFE, V14, P885, DOI 10.1080/14787210.2016.1220304; Cilek JE, 2008, J AM MOSQUITO CONTR, V24, P263, DOI 10.2987/5653.1; Cilek JE, 2006, J AM MOSQUITO CONTR, V22, P725, DOI 10.2987/8756-971X(2006)22[725:REOPFA]2.0.CO;2; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Daam MA, 2019, ECOTOX ENVIRON SAFE, V181, P534, DOI 10.1016/j.ecoenv.2019.06.038; Dewald JR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1534-9; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; European Food Safety Agency, 2014, PEER REV PEST RISK A; Fantke P, 2013, ENVIRON SCI TECHNOL, V47, P3548, DOI 10.1021/es303525x; Garros C, 2004, AM J TROP MED HYG, V70, P583, DOI 10.4269/ajtmh.2004.70.583; Gurtler RE, 2004, B WORLD HEALTH ORGAN, V82, P196; He LM, 2008, REV ENVIRON CONTAM T, V195, P71, DOI 10.1007/978-0-387-77030-7_3; Hill BD, 1991, J AGR FOOD CHEM, P39; Hornsby A.G., 1996, PESTIC PROP ENV, DOI [10.1007/978-1-4612-2316-0/COVER, DOI 10.1007/978-1-4612-2316-0/COVER]; Hougard JM, 2003, B WORLD HEALTH ORGAN, V81, P324; Hurst TP, 2012, J MED ENTOMOL, V49, P1021, DOI 10.1603/ME11278; International Programme on Chemical Safety and World Health Organization, 1990, CYHAL LAMBD CYHAL HL; Ismail I A, 1975, Acta Trop, V32, P206; James S P, 1899, Ind Med Gaz, V34, P428; JEFFERY GM, 1952, AM J TROP MED HYG, V1, P612, DOI 10.4269/ajtmh.1952.1.612; Kenko N.D.B., 2017, EMERG SCI J, V1, P49, DOI DOI 10.28991/IJSE-01112; Khan, 2003, KOREAN J BIOL SCI, V7, P165, DOI [10.1080/12265071.2003.9647700, DOI 10.1080/12265071.2003.9647700]; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Laabs V, 2007, CHEMOSPHERE, V67, P975, DOI 10.1016/j.chemosphere.2006.10.067; Landier J, 2018, LANCET, V391, P1916, DOI [10.1016/S0140-6736(18)30792-X, 10.1016/s0140-6736(18)30792-x]; LUDVIK GF, 1950, J ECON ENTOMOL, V43, P516, DOI 10.1093/jee/43.4.516; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; MADDEN AH, 1947, J ECON ENTOMOL, V40, P119, DOI 10.1093/jee/40.1.119; MEEK SR, 1995, ANN TROP MED PARASIT, V89, P135, DOI 10.1080/00034983.1995.11812944; Morgan K, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P327, DOI 10.5772/55709; NAIR CP, 1951, T ROY SOC TROP MED H, V44, P741, DOI 10.1016/0035-9203(51)90010-7; PERICH MJ, 1993, MED VET ENTOMOL, V7, P363, DOI 10.1111/j.1365-2915.1993.tb00706.x; Pongtavornpinyo W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-229; Rattanarithikul R, 1995, J AM MOSQUITO CONTR, V11, P428; Rattanarithikul Rampa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1; Richards SL, 2017, J MED ENTOMOL, V54, P1659, DOI 10.1093/jme/tjx152; Robson C, 2020, FIELD GUIDE BIRDS S; Sieke C, 2008, JOINT FAOWHO M PESTI; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-363; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-364; SOMBOON P, 1995, T ROY SOC TROP MED H, V89, P248, DOI 10.1016/0035-9203(95)90525-1; Somboon Pradya, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P3; Sriwichai P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1295-x; Trout RT, 2007, J MED ENTOMOL, V44, P470, DOI 10.1603/0022-2585(2007)44[470:EOTPIA]2.0.CO;2; Unlu I, 2018, J MED ENTOMOL, V55, P472, DOI 10.1093/jme/tjx216; Walton C, 2007, INFECT GENET EVOL, V7, P93, DOI 10.1016/j.meegid.2006.05.001	61	0	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240598	10.1371/journal.pone.0240598	http://dx.doi.org/10.1371/journal.pone.0240598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119645	Green Published, gold			2022-12-26	WOS:000600013600075
J	Mehdipour, M; Kia, HD; Najafi, A; Mohammadi, H; Alvarez-Rodriguez, M				Mehdipour, Mahdieh; Daghigh Kia, Hossein; Najafi, Abouzar; Mohammadi, Hossein; Alvarez-Rodriguez, Manuel			Effect of crocin and naringenin supplementation in cryopreservation medium on post-thaw rooster sperm quality and expression of apoptosis associated genes	PLOS ONE			English	Article							OXIDATIVE STRESS; IN-VIVO; FERTILITY; SEMEN; SPERMATOZOA; DYSFUNCTION; CYSTEAMINE; HYALURONAN; FETUIN	The aim of our study was to examine the effects of crocin (0.5 (C0.5), 1 (C1) and 1.5 (C1.5) mM) and naringenin (50 (N50), 100 (N100) and 150 (N150) mu M) in cryopreservation extender for freezing rooster semen. Sperm motility, viability, abnormalities, membrane functionality, active mitochondria, apoptosis status, lipid peroxidation (LP), GPX, SOD, TAC, the mRNA expression of pro-apoptotic (CASPASE 3) and anti-apoptotic (Bcl-2) genes, fertile eggs, hatched eggs and hatching rate were investigated following freeze-thawing. C1 and N100 resulted in higher (P < 0.05) total motility and progressive motility in comparison to the control group. The C1 and N100 groups improved viability, membrane functionality and reduced lipid peroxidation. We found higher values for active mitochondria with C1 and N100 compared to control group. The C1 and N100 groups showed lower percentages of early apoptosis when compared with control group. Also, C1 and N100 had higher TAC, compared to the control group. The mRNA expressions of BCL-2 in the C1 and N100 groups were significantly higher than that of other treatments. The expression of CASPASES 3 was significantly reduced in C1 and N100 group (P < 0.05) when compared to control group. Significantly higher percentages of fertile eggs, hatched eggs and hatching rate were observed in C1 and N100 compared to the control group. In conclusion, crocin at 1 mM and naringenin at 100 mu M seem to improve the post-thawing rooster semen quality, fertility and could protect the sperm by reducing the pro-apoptotic (CASPASE 3) and increasing anti-apoptotic (Bcl-2) genes.	[Mehdipour, Mahdieh; Daghigh Kia, Hossein; Mohammadi, Hossein] Univ Tabriz, Dept Anim Sci, Coll Agr, Tabriz, Iran; [Najafi, Abouzar] Univ Tehran, Dept Anim & Poultry Sci, Coll Aburaihan, Tehran, Iran; [Alvarez-Rodriguez, Manuel] Linkoping Univ, Fac Med & Hlth Sci, BKH Obstet & Gynaecol, Dept Biomed & Clin Sci BKV, Linkoping, Sweden; [Mohammadi, Hossein] Arak Univ, Fac Agr & Nat Resources, Dept Anim Sci, Arak, Iran	University of Tabriz; University of Tehran; Linkoping University; Arak University	Kia, HD (corresponding author), Univ Tabriz, Dept Anim Sci, Coll Agr, Tabriz, Iran.	daghighkia@tabrizu.ac.ir	Alvarez-Rodriguez, Manuel/F-8834-2010; Mehdipour, Mahdieh/J-7213-2019; Najafi, Abouzar/J-7194-2019	Alvarez-Rodriguez, Manuel/0000-0003-0120-354X; Mehdipour, Mahdieh/0000-0002-2685-8043; Najafi, Abouzar/0000-0003-2610-2278; Mohammadi, Hoseein/0000-0001-7333-2098				Agarwal A, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-126; Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; Akain P. P, 2016, SMALL RUMINANT RES, V137, P117; Ansari M, 2017, THERIOGENOLOGY, V92, P69, DOI 10.1016/j.theriogenology.2017.01.014; Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749; Bucak MN, 2013, CRYOBIOLOGY, V67, P34, DOI 10.1016/j.cryobiol.2013.04.007; Burrows W, 1937, COLLECTION SPERMATOZ, V16, P19; Carneiro JAM, 2018, ANIM REPROD SCI, V192, P107, DOI 10.1016/j.anireprosci.2018.02.020; Das SC, 2006, REPRODUCTION, V132, P781, DOI 10.1530/rep.1.01177; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Donoghue AM, 2000, ANIM REPROD SCI, V62, P213, DOI 10.1016/S0378-4320(00)00160-3; Du Plessis SS, 2015, J ASSIST REPROD GEN, V32, P509, DOI 10.1007/s10815-014-0425-7; Feyzi S, 2018, POULTRY SCI, V97, P2582, DOI 10.3382/ps/pey067; Garner D.L., 2000, REPROD FARM ANIMALS, V7th ed., P96, DOI [10.1002/9781119265306.ch7, DOI 10.1002/9781119265306.CH7]; Heidary Mohammad, 2008, Urol J, V5, P255; Kapoor R, 2014, TOXICOL REP, V1, P569, DOI 10.1016/j.toxrep.2014.08.002; Kapoor R, 2013, APOPTOSIS, V18, P9, DOI 10.1007/s10495-012-0781-7; Khan RU, 2011, WORLD POULTRY SCI J, V67, P297, DOI 10.1017/S0043933911000316; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JA, 2006, POULTRY SCI, V85, P232, DOI 10.1093/ps/85.2.232; Mardani Mohammad, 2014, Iran J Reprod Med, V12, P343; Mata-Campuzano M, 2015, THERIOGENOLOGY, V83, P520, DOI 10.1016/j.theriogenology.2014.10.018; Mehdipour M, 2018, THERIOGENOLOGY, V116, P89, DOI 10.1016/j.theriogenology.2018.05.013; Mershiba SD, 2013, MOL BIOL REP, V40, P3681, DOI 10.1007/s11033-012-2444-8; Mostafa HE, 2016, INT J EXP PATHOL, V97, P37, DOI 10.1111/iep.12168; Najafi A, 2019, CRYOBIOLOGY, V87, P47, DOI 10.1016/j.cryobiol.2019.02.006; Najafi A, 2019, ANIM REPROD SCI, V201, P32, DOI 10.1016/j.anireprosci.2018.12.006; Najafi A, 2019, POULTRY SCI, V98, P440, DOI 10.3382/ps/pey353; Najafi A, 2018, ANIM REPROD SCI, V195, P168, DOI 10.1016/j.anireprosci.2018.05.021; Najafi D, 2018, CRYOBIOLOGY, V82, P37, DOI 10.1016/j.cryobiol.2018.04.011; Nandi S, 2016, POULTRY SCI, V95, P1905, DOI 10.3382/ps/pew133; Partyka A, 2013, CRYOBIOLOGY, V67, P132, DOI 10.1016/j.cryobiol.2013.06.002; POLGE C, 1951, NATURE, V167, P949, DOI 10.1038/167949b0; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Sapanidou V, 2015, THERIOGENOLOGY, V84, P1273, DOI 10.1016/j.theriogenology.2015.07.005; Sariozkan S, 2015, ANDROLOGIA, V47, P138, DOI 10.1111/and.12236; Sariozkan S, 2015, CRYOBIOLOGY, V71, P119, DOI 10.1016/j.cryobiol.2015.04.011; Sharideh H, 2020, THERIOGENOLOGY, V142, P355, DOI 10.1016/j.theriogenology.2019.10.011; Shojaeian K, 2018, THERIOGENOLOGY, V108, P16, DOI 10.1016/j.theriogenology.2017.11.019; Tuncer PB, 2014, REPROD DOMEST ANIM, V49, P746, DOI 10.1111/rda.12359; Venkatraman M, 2008, BIOL PHARM BULL, V31, P1639, DOI 10.1248/bpb.31.1639; Wang JC, 2012, BIOL TRACE ELEM RES, V146, P354, DOI 10.1007/s12011-011-9268-6; Yen FL, 2009, PHARM RES-DORDR, V26, P893, DOI 10.1007/s11095-008-9791-0; Yu J, 2005, J AGR FOOD CHEM, V53, P2009, DOI 10.1021/jf0484632; Zhandi M, 2017, REPROD DOMEST ANIM, V52, P1004, DOI 10.1111/rda.13014	46	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0241105	10.1371/journal.pone.0241105	http://dx.doi.org/10.1371/journal.pone.0241105			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119667	Green Published, Green Submitted, gold			2022-12-26	WOS:000600013600048
J	Jensen, EM; Horsberg, TE; Sevatdal, S; Helgesen, KO				Myhre Jensen, Elena; Horsberg, Tor Einar; Sevatdal, Sigmund; Helgesen, Kari Olli			Trends in de-lousing of Norwegian farmed salmon from 2000-2019-Consumption of medicines, salmon louse resistance and non-medicinal control methods	PLOS ONE			English	Article							LICE LEPEOPHTHEIRUS-SALMONIS; SEA LICE; REDUCED SENSITIVITY; BIOASSAYS; KROYER	The salmon louse Lepeophtheirus salmonis has been a substantial obstacle in Norwegian farming of Atlantic salmon for decades. With a limited selection of available medicines and frequent delousing treatments, resistance has emerged among salmon lice. Surveillance of salmon louse sensitivity has been in place since 2013, and consumption of medicines has been recorded since the early 80's. The peak year for salmon lice treatments was 2015, when 5.7 times as many tonnes of salmonids were treated compared to harvested. In recent years, non-medicinal methods of delousing farmed fish have been introduced to the industry. By utilizing data on the annual consumption of medicines, annual frequency of medicinal and non-medicinal treatments, the aim of the current study was to describe the causative factors behind salmon lice sensitivity in the years 2000-2019, measured through toxicity tests-bioassays. The sensitivity data from 2000-2012 demonstrate the early emergence of resistance in salmon lice along the Norwegian coast. Reduced sensitivity towards azamethiphos, deltamethrin and emamectin benzoate was evident from 2009, 2009 and 2007, respectively. The annual variation in medicine consumption and frequency of medicinal treatments correlated well with the evolution in salmon louse sensitivity. The patterns are similar, with a relatively small response delay from the decline in the consumption of medicines in Norway (2016 and onward) to the decline in measured resistance among salmon louse (2017 and onward). 2017 was the first year in which non-medicinal treatments out-numbered medicinal delousing treatments as well as the peak year in numbers of cleanerfish deployed. This study highlights the significance of avoiding heavy reliance on a few substance groups to combat ectoparasites, this can be a potent catalyst for resistance evolution. Further, it demonstrates the importance of transparency in the global industry, which enables the industry to learn from poor choices in the past.	[Myhre Jensen, Elena; Horsberg, Tor Einar] Norwegian Univ Life Sci NMBU, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway; [Sevatdal, Sigmund] VESO Vikan, Namsos, Norway; [Helgesen, Kari Olli] Norwegian Vet Inst, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute	Jensen, EM (corresponding author), Norwegian Univ Life Sci NMBU, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway.	elena.myhre.jensen@nmbu.no			Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre [NFR 203513/O30]	Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre	The study was financially supported by the Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre, grant number NFR 203513/O30. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and provided only financial support in the form of salaries to [EMJ]. One of the authors of the study [SS] is employed by the commercial company VESO, Oslo, Norway, and contributed to study design, data collection and preparation of the manuscript. The company VESO, however, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Andrews M, 2020, AQUACULTURE, V514, DOI 10.1016/j.aquaculture.2019.734511; [Anonymous], 2020, SJOMATEKSPORT 107 MI; [Anonymous], 2004, J EUROPEAN BAPTIST S, V4, P5; [Anonymous], 2020, CLEANERFISH LUMPFISH; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Bakke MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26420-6; Carmona-Antonanzas G, 2019, PEST MANAG SCI, V75, P527, DOI 10.1002/ps.5151; Devine G.J., 2000, CALIGUS, V6, P12; Espedal PG, 2013, AQUACULTURE, V416, P111, DOI 10.1016/j.aquaculture.2013.09.001; Evans J, 2019, SEA LICE REPORT; Fjortoft HB, 2019, AQUACULT ENV INTERAC, V11, P459, DOI 10.3354/aei00322; Fjortoft HB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14681-6; Gismervik K, 2019, VET ANIM SCI, V8, DOI 10.1016/j.vas.2019.100081; Goverment, 2017, FORSKRIFT ENDRING FO; Grave K, 2004, DIS AQUAT ORGAN, V60, P123, DOI 10.3354/dao060123; Groner ML, 2019, AQUACULT ENV INTERAC, V11, P507, DOI 10.3354/aei00324; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Helgesen K.O., 2020, SURVEILLANCE PROGRAM; Helgesen KO, 2017, AQUACULTURE, V468, P135, DOI 10.1016/j.aquaculture.2016.10.012; Helgesen KO, 2015, AQUACULT REP, V1, P37, DOI 10.1016/j.aqrep.2015.01.001; Heuch PA, 2000, AQUAC RES, V31, P805, DOI 10.1046/j.1365-2109.2000.00512.x; Jensen EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178068; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Kaur K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12384-6; Kaur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149264; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Litleskaret I, 2019, BRUK LEGEMIDLER FISK; Ljungfeldt LER, 2017, EVOL APPL, V10, P1007, DOI 10.1111/eva.12505; Nilsson J, 2019, VET ANIM SCI, V8, DOI 10.1016/j.vas.2019.100076; Overton K, 2019, REV AQUACULT, V11, P1398, DOI 10.1111/raq.12299; Overton K, 2019, AQUACULTURE, V505, P41, DOI 10.1016/j.aquaculture.2019.02.046; R Core Team, 2020, R LANG ENV STAT COMP; Sevatdal S, 2005, AQUACULTURE, V244, P19, DOI 10.1016/j.aquaculture.2004.11.009; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240894	10.1371/journal.pone.0240894	http://dx.doi.org/10.1371/journal.pone.0240894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119627	Green Published, gold			2022-12-26	WOS:000600013600050
J	Cattafesta, M; Petarli, GB; Zandonade, E; Bezerra, OMDA; de Abreu, SMR; Salaroli, LB				Cattafesta, Monica; Petarli, Glenda Blaser; Zandonade, Eliana; de Paula Alves Bezerra, Olivia Maria; Ribeiro de Abreu, Sandra Marlene; Salaroli, Luciane Bresciani			Energy contribution of NOVA food groups and the nutritional profile of the Brazilian rural workers' diets	PLOS ONE			English	Article							ULTRA-PROCESSED FOODS; CONSUMPTION; QUALITY; URBAN; PRODUCTS; POPULATION; OBESITY; IMPACT	We estimated the caloric contribution of minimally processed foods, processed culinary ingredients, processed foods and ultra-processed foods in Brazilian farmers' diets and their association with the nutritional profile of the diet. It is an epidemiological study of cross-sectional, analytical and quantitative design with 740 farmers adults of Southeastern Brazil. Food intake data were obtained by applying three 24-hour recalls and were classified according to the degree and purpose of processing. The largest caloric contribution came from the group of minimally processed foods (64.7%), followed by ultra-processed foods (17.7%), processed culinary ingredients (12.4%), and processed foods (5.2%). Individuals in the fourth quartile of caloric contribution from minimally processed foods showed lower energy consumption (beta -0.16, P0.001) and greater consumption of all 15 micronutrients analyzed. In contrast to what was identified for this food group, the higher caloric contribution from ultra-processed foods was associated with a greater caloric content of the diet (beta 0.17, P0.001) and lower consumption of all 23 analyzed nutrients. Therefore, the caloric contribution from the consumption of ultra-processed foods in the rural area is still lower than the national average. However, measures aimed at delaying isocaloric exchanges for the group of ultra-processed foods must be carried out, maintaining the local food culture, since this group had worse nutritional levels. In addition, incentives to the greater consumption of minimally processed foods should be carried out, due to their nutritional quality.	[Cattafesta, Monica; Petarli, Glenda Blaser; Zandonade, Eliana; Salaroli, Luciane Bresciani] Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil; [de Paula Alves Bezerra, Olivia Maria] Univ Fed Ouro Preto, Dept Family Med Mental & Collect Hlth, Ouro Preto, MG, Brazil; [Ribeiro de Abreu, Sandra Marlene] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, Porto, Portugal	Universidade Federal do Espirito Santo; Universidade Federal de Ouro Preto; Universidade do Porto	Salaroli, LB (corresponding author), Univ Fed Espirito Santo, Grad Program Collect Hlth, Vitoria, ES, Brazil.	lucianebresciani@gmail.com		Blaser Petarli, Glenda/0000-0002-6828-1238; Cattafesta, Monica/0000-0002-8973-622X; Abreu, Sandra/0000-0002-6722-1575	Research and Innovation Support Foundation of Espirito Santo (FAPES) [FAPES/CNPq/Decit -SCTIE-MS/SESA no 05/2015 -PPSUS]	Research and Innovation Support Foundation of Espirito Santo (FAPES)	This research was funded by Research and Innovation Support Foundation of Espirito Santo (FAPES), URL: https://fapes.es.gov.br/with grant number FAPES/CNPq/Decit -SCTIE-MS/SESA no 05/2015 -PPSUS (Research Program for Brazilian Health Unic System) received by LBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade GC, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020218; [Anonymous], 2018, Cancer Discov, V8, pOF6, DOI 10.1158/2159-8290.CD-NB2017-158; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2014, BRAS GUIA AL POP BRA, V2nd; [Anonymous], 2011, TABELA BRASILEIRA CO; Araujo M. C., 2013, REV SAUDE PUBL, V47, P177, DOI [10.1590/S0034-89102013000700004, DOI 10.1590/S0034-89102013000700004]; AssociacAo Brasileira de Empresas de Pesquisa (ABEP), 2014, CRIT CLASS EC BRAS C; Bezerra Ilana Nogueira, 2013, Rev Saude Publica, V47 Suppl 1, p200S, DOI 10.1590/S0034-89102013000700006; Bielemann RM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005572; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Botelho R, 2018, CRIT REV FOOD SCI, V58, P639, DOI 10.1080/10408398.2016.1209159; Brumby S, 2013, J RURAL HEALTH, V29, P311, DOI 10.1111/jrh.12001; Canella DS, 2018, REV SAUDE PUBL, V52, DOI [10.11606/s1518-8787.2018052000111, 10.11606/S1518-8787.2018052000111]; Canella DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092752; Carvalho EO, 2011, CIENC SAUDE COLETIVA, V16, P179, DOI 10.1590/S1413-81232011000100021; Cattafesta M, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00542-y; Cediel G, 2018, PUBLIC HEALTH NUTR, V21, P125, DOI 10.1017/S1368980017001161; Centers for Disease Control and Prevention (CDC), 2010, FOOD DES; Claro RM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00104715; Crovetto M, 2014, REV MED CHILE, V142, P850, DOI 10.4067/S0034-98872014000700005; Louzada MLD, 2018, PUBLIC HEALTH NUTR, V21, P94, DOI 10.1017/S1368980017001434; Louzada MLD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006211; Louzada MLD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006132; da Luz TC, 2020, CIENC SAUDE COLETIVA, V25, P3919, DOI 10.1590/1413-812320202510.36022018; Dadalto GG, 2016, TRANSFORMACOES AGR C; Dean WR, 2011, J NUTR EDUC BEHAV, V43, P426, DOI 10.1016/j.jneb.2010.07.001; Dutko P., 2012, ERR140 USDA EC RES S; ESTEVE E. V., 2017, NEGOCIO COMIDA QUEM; Fanzo J, 2018, PHYSIOL BEHAV, V193, P291, DOI 10.1016/j.physbeh.2018.05.014; Fernandes MP, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000267, 10.11606/s1518-8787.2018052000267]; Fernandez-Armesto F., 2004, COMIDA HIST, V1st; Rodrigues LPF, 2016, ECOL FOOD NUTR, V55, P365, DOI 10.1080/03670244.2016.1188090; Food and Agriculture Organization (FAO), GUID COLL INF FOOD P, P44; Food and Nutrition Board (FNB) Health and Medicine Division (HMD), 1991, DIET REF INT TABL AP; Instituto Brasileiro de Geografia e Estatistica, 2006, CENS AGR 2006; International Network of Food Data Systems (INFOODS), 2015, INT FOOD COMP TABL D; Jaime PC, 2015, EPIDEMIOL SERV SAUDE, V24, P267, DOI 10.5123/S1679-49742015000200009; Lenardson JD, 2015, CURR OBES REP, V4, P46, DOI 10.1007/s13679-014-0136-5; Lucan SC, 2012, CHILD OBES, V8, P484, DOI 10.1089/chi.2012.0063; Maia EG, 2020, PUBLIC HEALTH NUTR, V23, P579, DOI 10.1017/S1368980019003586; Marron-Ponce JA, 2018, PUBLIC HEALTH NUTR, V21, P87, DOI 10.1017/S1368980017002129; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA., 2016, WORLD NUTR, V7, P28; Monteiro CA., 2012, WORLD NUTR, V3, P527; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006; Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009; Nardocci M, 2019, CAN J PUBLIC HEALTH, V110, P4, DOI 10.17269/s41997-018-0130-x; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Petarli GB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225416; Poti JM, 2015, AM J CLIN NUTR, V101, P1251, DOI 10.3945/ajcn.114.100925; Poulain JP., 2013, SOCIOLOGIAS ALIMENTA, V2<feminine; Rauber F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232676; Reinaldo EDF, 2015, INTERCIENCIA, V40, P8; Salaroli LB, 2019, EXPERIENCIAS EXITOSA, P32; Schmidt A, 2015, COMIDA SOCIABILIDADE, V3, P195; Sichieri R, 2008, CAD SAUDE PUBLICA, V24, pS209, DOI 10.1590/S0102-311X2008001400002; Steele EM, 2018, PUBLIC HEALTH NUTR, V21, P114, DOI 10.1017/S1368980017001574; Steele EM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009892; Triches Rozane Marcia, 2015, Cuad. Desarro. Rural, V12, P55, DOI 10.11144/Javeriana.cdr12-75.asac; Tripathy JP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3489-8; United Nations Educational Scientific and Cultural Organization (UNESCO), 2010, CONV SAF INT CULT HE; Vandevijvere S, 2013, OBES REV, V14, P135, DOI 10.1111/obr.12082; WHO, 2003, WHO TECH REP SER, V916, P1; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; World Cancer Research Fund (WCRF) American Institute for Cancer Research (AICR), 2007, FOOD NUTR PHYS ACT P, P6; World Health Organization, 2018, HLTH DIET; Zeng QY, 2018, APPETITE, V120, P409, DOI 10.1016/j.appet.2017.09.027	71	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240756	10.1371/journal.pone.0240756	http://dx.doi.org/10.1371/journal.pone.0240756			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112887	Green Published, gold			2022-12-26	WOS:000588374000046
J	Ahmad, S; Khan, Z; Al-Sweih, N; Alfouzan, W; Joseph, L; Asadzadeh, M				Ahmad, Suhail; Khan, Ziauddin; Al-Sweih, Noura; Alfouzan, Wadha; Joseph, Leena; Asadzadeh, Mohammad			Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity	PLOS ONE			English	Article							MOLECULAR-BASIS; EPIDEMIOLOGY; RESISTANCE; FUNGEMIA; INFECTIONS; MUTATIONS; SURVEILLANCE; MECHANISMS; EMERGENCE; GLABRATA	Objective Candida kefyr causes invasive candidiasis in immunocompromised patients, particularly among those with oncohematological diseases. This study determined the prevalence of C. kefyr among yeast isolates collected during 2011-2018 in Kuwait. Antifungal susceptibility testing (AST) and genotypic heterogeneity among C. kefyr was also studied. Methods Clinical C. kefyr isolates recovered from bloodstream and other specimens during 2011 to 2018 were retrospectively analyzed. All C. kefyr isolates were identified by CHROMagar Candida, Vitek2 and PCR amplification of rDNA. AST was performed by Etest. Molecular basis of resistance to fluconazole and echinocandins was studied by PCR-sequencing of ERG11 and FKS1, respectively. Genotypic heterogeneity was determined with microsatellite-/minisatellite-based primers and for 27 selected isolates by PCR-sequencing of IGS1 region of rDNA. Results Among 8257 yeast strains, 69 C. kefyr (including four bloodstream) isolates were detected by phenotypic and molecular methods. Isolation from urine and respiratory samples from female and male patients was significantly different (P = 0.001). Four isolates showed reduced susceptibility to amphotericin B and one isolate to all (amphotericin B, fluconazole, voriconazole and caspofungin/micafungin) antifungals tested. Fluconazole-resistant isolate contained only synonymous mutations in ERG11. Echinocandin-resistant isolate contained wild-type hotspot-1 and hotspot-2 of FKS1. Fingerprinting with microsatellite-/minisatellite-based primers identified only three types. IGS1 sequencing identified seven haplotypes among 27 selected isolates. Conclusions The overall prevalence of C. kefyr among clinical yeast isolates and among candidemia cases was recorded as 0.83% and 0.32%, respectively. The frequency of isolation of C. kefyr from bloodstream and other invasive samples was stable during the study period. The C. kefyr isolates grown from invasive (bloodstream, bronchoalveolar lavage, abdominal drain fluid, peritonial fluid and gastric fluid) samples and amphotericin B-resistant isolates were genotypically heterogeneous strains.	[Ahmad, Suhail; Khan, Ziauddin; Al-Sweih, Noura; Alfouzan, Wadha; Joseph, Leena; Asadzadeh, Mohammad] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University	Ahmad, S (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	suhail_ah@hsc.edu.kw	Alfouzan, Wadha A/GRA-2552-2022; Alfouzan, Wadha/AAR-8290-2021; Ahmad, Suhail/AAJ-5456-2021	Asadzadeh, Mohammad/0000-0002-3270-055X; Alfouzan, Wadha/0000-0002-4501-5316; asadzadeh, Mohammad/0000-0002-9151-1505	Kuwait University Research Sector [MI 01/15]	Kuwait University Research Sector	This study was supported by Kuwait University Research Sector grant no. MI 01/15	Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Ahmad S, 2003, MED MYCOL, V41, P487, DOI 10.1080/1369378031000147458; Ahmad S, 2020, MYCOSES, V63, P104, DOI 10.1111/myc.13022; Ahmad S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-230; Ahmad S, 2012, MED MYCOL, V50, P244, DOI 10.3109/13693786.2011.597446; Al-Sweih N, 2019, MYCOSES, V62, P51, DOI 10.1111/myc.12846; [Anonymous], 2007, REV CUB ALIMENT NU S, V17, pS20; Arendrup MC, 2017, J INFECT DIS, V216, pS445, DOI 10.1093/infdis/jix131; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223920; Asadzadeh M, 2017, MICROB DRUG RESIST, V23, P966, DOI 10.1089/mdr.2016.0336; Asadzadeh M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00247; Asadzadeh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142880; Barchiesi F, 1999, J ANTIMICROB CHEMOTH, V43, P295, DOI 10.1093/jac/43.2.295; Basmaciyan L, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1612661; Bretagne S, 2017, J ANTIMICROB CHEMOTH, V72, P1784, DOI 10.1093/jac/dkx045; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Clancy CJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01909-17; CLSI, 2017, M60 CLSI; Colombo AL, 2017, CURR OPIN INFECT DIS, V30, P528, DOI [10.1097/QCO.0000000000000411, 10.1097/qco.0000000000000411]; Couzigou C, 2014, MED MYCOL CASE REP, V5, P12, DOI 10.1016/j.mmcr.2014.04.002; Dagi HT, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0153-1; Diba K, 2018, MICROB PATHOGENESIS, V125, P240, DOI 10.1016/j.micpath.2018.09.026; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Direkze S, 2012, BONE MARROW TRANSPL, V47, P465, DOI 10.1038/bmt.2011.112; Dufresne SF, 2014, J CLIN MICROBIOL, V52, P1830, DOI 10.1128/JCM.00131-14; Fekkar A, 2013, ANTIMICROB AGENTS CH, V57, P2380, DOI 10.1128/AAC.02037-12; Fisher JF, 2011, CLIN INFECT DIS, V52, pS457, DOI 10.1093/cid/cir112; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Gomez-Lopez A, 2010, DIAGN MICR INFEC DIS, V66, P116, DOI 10.1016/j.diagmicrobio.2009.06.007; Hamzavi SS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4372-x; Healey KR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11128; Jamal WY, 2014, INT J INFECT DIS, V26, P167, DOI 10.1016/j.ijid.2014.05.031; Jung DS, 2015, EMERG INFECT DIS, V21, P1942, DOI 10.3201/eid2111.150404; Kapitan M, 2019, CURR TOP MICROBIOL, V422, P265, DOI 10.1007/82_2018_117; Karstrup CC, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0329-5; Khan Z, 2015, J MYCOL MED, V25, P71, DOI 10.1016/j.mycmed.2014.04.002; Khan ZU, 2007, J CLIN MICROBIOL, V45, P2025, DOI 10.1128/JCM.00222-07; Khan Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213532; Khan Z, 2018, INFECTION, V46, P641, DOI 10.1007/s15010-018-1164-y; Khan Z, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01926-17, 10.1128/aac.01926-17]; Lortholary O, 2017, INTENS CARE MED, V43, P652, DOI 10.1007/s00134-017-4743-y; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Menezes RD, 2019, MED MYCOL, V57, P588, DOI 10.1093/mmy/myy101; Montravers P, 2011, CLIN MICROBIOL INFEC, V17, P1061, DOI 10.1111/j.1469-0691.2010.03360.x; Ostrosky-Zeichner L, 2013, CLIN INFECT DIS, V56, P1733, DOI 10.1093/cid/cit140; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Pfaller MA, 2004, DIAGN MICR INFEC DIS, V48, P101, DOI 10.1016/j.diagmicrobio.2003.09.009; Pfaller MA, 2019, OPEN FORUM INFECT DI, V6, pS79, DOI 10.1093/ofid/ofy358; Pfaller Michael A, 2014, PLoS One, V9, pe101510, DOI 10.1371/journal.pone.0101510; Reuter CWM, 2005, CLIN INFECT DIS, V41, P1365, DOI 10.1086/497079; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Staab JF, 2014, ANTIMICROB AGENTS CH, V58, P5421, DOI 10.1128/AAC.00096-14; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wang E, 2015, J ANTIMICROB CHEMOTH, V70, P2362, DOI 10.1093/jac/dkv087; Ward TL, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00140-17; Zepelin MBV, 2007, J ANTIMICROB CHEMOTH, V60, P424, DOI 10.1093/jac/dkm145	58	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2020	15	10							e0240426	10.1371/journal.pone.0240426	http://dx.doi.org/10.1371/journal.pone.0240426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8WV	33108361	Green Published, gold			2022-12-26	WOS:000588372400020
J	Kang, YJ; Kim, S; Lee, J; Won, H; Nam, GH; Kwak, M				Kang, Yang Jae; Kim, Soonok; Lee, Jungho; Won, Hyosig; Nam, Gi-Heum; Kwak, Myounghai			Identification of plastid genomic regions inferring species identity from de novo plastid genome assembly of 14 Korean-native Iris species (Iridaceae)	PLOS ONE			English	Article							PHYLOGENY; DNA; ANGIOSPERMS	Iris is one of the largest genera in the family Iridaceae, comprising hundreds of species, including numerous economically important horticultural plants used in landscape gardening and herbal medicine. Improved taxonomic classification of Iris species, particularly the endangered Korean-native Iris, is needed for correct species delineation. To this end, identification of diverse genetic markers from Iris genomes would facilitate molecular identification and resolve ambiguous classifications from molecular analyses; however, only two Iris plastid genomes, from Iris gatesii and Iris sanguinea, have been sequenced. Here, we used high-throughput next-generation sequencing, combined with Sanger sequencing, to construct the plastid genomes of 14 Korean-native Iris species with one outgroup and predict their gene content. Using these data, combined with previously published plastid genomes from Iris and one outgroup (Sisyrinchium angustifolium), we constructed a Bayesian phylogenetic tree showing clear speciation among the samples. We further identified sub-genomic regions that have undergone neutral evolution and accurately recapitulate Bayesian-inferred speciation. These contain key markers that could be used to identify and classify Iris samples into taxonomic clades. Our results confirm previously reported speciation patterns and resolve questionable relationships within the Iris genus. These data also provide a valuable resource for studying genetic diversity and refining phylogenetic relationships between Iris species.	[Kang, Yang Jae] Gyeongsang Natl Univ, BK4 Program, Div Bio & Med Big Data Dept, Jinju, South Korea; [Kang, Yang Jae] Gyeongsang Natl Univ, Div Life Sci Dept, Jinju, South Korea; [Kim, Soonok; Nam, Gi-Heum; Kwak, Myounghai] Natl Inst Biol Resources, Incheon, South Korea; [Lee, Jungho] Green Plant Inst, Yongin, South Korea; [Won, Hyosig] Daegu Univ, Dept Biol Sci, Gyongsan, Gyungbuk, South Korea	Gyeongsang National University; Gyeongsang National University; National Institute of Biological Resources; Daegu University	Kwak, M (corresponding author), Natl Inst Biol Resources, Incheon, South Korea.	mhkwak@korea.kr		Kwak, Myounghai/0000-0002-3022-6823	National Institute of Biological Resources (NIBR) [NIBR201905102]	National Institute of Biological Resources (NIBR)	MHK - NIBR201905102 - grant from the National Institute of Biological Resources (NIBR) -https://www.nibr.go.kr -No.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; [Anonymous], 2014, GAZZETTA UFFICIALE R, V32, P47; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19591-9; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Guo JY, 2013, SYST BOT, V38, P987, DOI 10.1600/036364413X674724; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; James W, 1992, IRIS OF CHINA; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee H. J., 2013, SIGMUL BUNRYU HAG HO, V43; Lee HJ, 2017, MITOCHONDRIAL DNA A, V28, P15, DOI 10.3109/19401736.2015.1106521; Li PR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00111; Lim KY, 2007, ANN BOT-LONDON, V100, P219, DOI 10.1093/aob/mcm116; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; Mathew B, 1981, THE IRIS; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shaw J, 2014, AM J BOT, V101, P1987, DOI 10.3732/ajb.1400398; Sim J.K., 2007, IRIDACEAE JUSS GENER, P1326; Son OGyeong, 2015, KOREAN JOURNAL OF PLANT TAXONOMY, V45, P243, DOI 10.11110/kjpt.2015.45.3.243; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Tillie N, 2000, ANN BOT, V1, P105, DOI [10.4462/annbotrm-9068, DOI 10.4462/ANNBOTRM-9068]; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang H, 2010, MINI-REV MED CHEM, V10, P643, DOI 10.2174/138955710791384027; Wheelerl AS, 2014, SYST BOT, V39, P759, DOI 10.1600/036364414X681482; Wheelwright NT, 2016, BOTANY, V94, P543, DOI 10.1139/cjb-2016-0004; Wilson CA, 2004, MOL PHYLOGENET EVOL, V33, P402, DOI 10.1016/j.ympev.2004.06.013; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; 박지혜, 2017, Journal of Species Research, V6, P76; Zhao Y, 2000, FLORA CHINA, V24, P297; 2005, EUROPEAN J PUBLIC HL, V0015, P00128	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241178	10.1371/journal.pone.0241178	http://dx.doi.org/10.1371/journal.pone.0241178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104732	Green Published, gold			2022-12-26	WOS:000588370000036
J	Zhang, J; Zhu, M; Ruan, L; Jiang, C; Yang, Q; Chang, Q; Huang, X				Zhang, Juan; Zhu, Min; Ruan, Lu; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin			Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model	FASEB JOURNAL			English	Article						angiogenesis; rapamycin; retinopathy of prematurity; vaso&#8208; obliteration	ANGIOGENESIS; PREMATURITY; GROWTH; BEVACIZUMAB; TARGET; ANGIOPOIETIN-1; REACTIVATION; INHIBITION; METABOLISM; MECHANISMS	Retinopathy of prematurity (ROP) is a vision-threatening disorder characterized with retinal vaso-obliteration in phase 1 and pathological neovascularization (NV) in phase 2. However, there has been no effective and safe treatment for ROP. Current management is mainly focused on the reduction of abnormal NV in phase 2, and anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment, yet, with great risks of late recurrence and systemic side effects. It has been reported that the severity of vaso-obliteration in phase 1 largely influences subsequent NV, suggesting that it may be a promising target to develop novel treatments for ROP. Here, we investigated the therapeutic potential and safety of early rapamycin intervention in treating phase 1 ROP and possible underlying mechanisms using the mouse model of oxygen-induced retinopathy (OIR). We found that intravitreal injection of rapamycin at postnatal day 7 (P7) significantly reduced retinal avascular area, increased vascular density, and reversed the suppression of deep capillaries development in phase 1 of OIR mice. Rapamycin treatment not only reduced vascular apoptosis, but also promoted proliferation and tip cell functions. Additionally, rapamycin did not interfere with normal retinal vascular development. Further investigation showed that Ang1/Tie2 pathway might be involved in rapamycin's vascular protection in phase 1 OIR retinas. Moreover, early rapamycin treatment at P7 had long-term protective effects of reducing retinal NV and avascular area, as well as enhancing vascular maturity in phase 2 of OIR mice. Together, our data suggest that rapamycin may be a safe and promising strategy for early intervention of ROP.	[Zhang, Juan; Zhu, Min; Ruan, Lu; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin] Fudan Univ, Shanghai Med Coll, Eye & Ear Nose & Throat Hosp, Shanghai, Peoples R China; [Zhang, Juan; Zhu, Min; Jiang, Chen; Yang, Qian; Chang, Qing; Huang, Xin] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China	Fudan University; Fudan University	Chang, Q; Huang, X (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, 83 Fenyang Rd, Shanghai, Peoples R China.	qngchang@aliyun.com; fd2017huangxin@163.com			National Natural Science Foundation of China [NSFC81870670]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by the National Natural Science Foundation of China [NSFC81870670]	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chan-Ling T, 2018, PROG RETIN EYE RES, V62, P77, DOI 10.1016/j.preteyeres.2017.09.002; Chong ZZ, 2011, TRENDS CARDIOVAS MED, V21, P151, DOI 10.1016/j.tcm.2012.04.005; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dejneka NS, 2004, MOL VIS, V10, P964; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hu J, 2012, ARCH OPHTHALMOL-CHIC, V130, P1000, DOI 10.1001/archophthalmol.2012.592; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Kanda S, 2005, CANCER RES, V65, P6820, DOI 10.1158/0008-5472.CAN-05-0522; Kim CB, 2016, EYE BRAIN, V8, P67, DOI 10.2147/EB.S94447; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Lutty GA, 2011, INVEST OPHTH VIS SCI, V52, P4039, DOI 10.1167/iovs.10-6798; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Selvam S, 2018, PROG RETIN EYE RES, V63, P1, DOI 10.1016/j.preteyeres.2017.11.001; Seront E, 2019, CURR OPIN HEMATOL, V26, P185, DOI 10.1097/MOH.0000000000000498; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Sinha SS, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2008.02.004; Smith LE, 2013, CLIN PERINATOL, V40, P201, DOI 10.1016/j.clp.2013.02.002; Stahl A, 2008, FEBS LETT, V582, P3097, DOI 10.1016/j.febslet.2008.08.005; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tee AR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030880; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wong RK, 2015, RETINA-J RET VIT DIS, V35, P675, DOI 10.1097/IAE.0000000000000578; Wu WC, 2015, JAMA OPHTHALMOL, V133, P391, DOI 10.1001/jamaophthalmol.2014.5373; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Yagasaki R, 2014, BIOL PHARM BULL, V37, P1838, DOI 10.1248/bpb.b14-00487; Yamaguchi M, 2016, INVEST OPHTH VIS SCI, V57, P2264, DOI 10.1167/iovs.15-17411; Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838	42	3	3	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					15822	15836		10.1096/fj.202001295R	http://dx.doi.org/10.1096/fj.202001295R		OCT 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33103304				2022-12-26	WOS:000586261400001
J	Kim, MC; Lee, JI; Kim, JH; Kim, HJ; Cho, YK; Jeon, WK; Kim, BI; Sohn, W				Kim, Min Chul; Lee, Jeong In; Kim, Jung Hee; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik; Sohn, Won			Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; OXIDATIVE STRESS; LIPID-PEROXIDATION; INSULIN-RESISTANCE; SUPPLEMENTATION; NAFLD; INFLAMMATION; ASSOCIATION; GLUCOSE; MARKERS	This study aimed to investigate the relationship between serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). A cross-sectional study was conducted using nationally representative samples from the Korea National Health and Nutrition Examination Survey 2010. Significant hepatic fibrosis was defined as Fibrosis-4 (FIB-4) index>1.3. Zinc level was measured using inductively coupled plasma mass spectrometry. Univariable and multivariable logistic regression analyses were performed to assess risk factors for significant hepatic fibrosis in patients with NAFLD. A total of 300 patients with NAFLD were analyzed in this study. The mean serum zinc level was 139.8 +/- 29.9 mu g/dL. FIB-4 index was significantly increased as the serum zinc level decreased (Adjusted correlation coefficient = -0.177, p = 0.003). Significant liver fibrosis was observed in 62 patients (21%). The multivariable analysis showed that significant liver fibrosis in NAFLD was associated with diabetes mellitus (odds ratio [OR], 3.25; 95% confidence interval [CI], 1.71-6.19; p0.001), male (OR, 2.59; 95% CI, 1.31-5.12; p = 0.006), and zinc level <140 mu g/dL (OR, 2.14; 95% CI, 1.16-3.94; p = 0.015). There was an inverse relationship between serum zinc level and FIB-4 index in NAFLD. Low levels of serum zinc were an independent risk factor for significant hepatic fibrosis in NAFLD.	[Kim, Min Chul; Lee, Jeong In; Kim, Hong Joo; Cho, Yong Kyun; Jeon, Woo Kyu; Kim, Byung Ik; Sohn, Won] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Gastroenterol,Sch Med, Seoul, South Korea; [Kim, Jung Hee] Hallym Univ, Dept Internal Med, Div Gastroenterol, Dongtan Sacred Heart Hosp, Dongtan, Gyeonngi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University	Sohn, W (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Gastroenterol,Sch Med, Seoul, South Korea.; Kim, JH (corresponding author), Hallym Univ, Dept Internal Med, Div Gastroenterol, Dongtan Sacred Heart Hosp, Dongtan, Gyeonngi Do, South Korea.	mazyyang5@gmail.com; wonsohn1@gmail.com		Sohn, Won/0000-0003-3284-2715				Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], 2014, NEUROSURG FOCUS, V36, pA1; Asprouli E, 2019, BIOL TRACE ELEM RES, V188, P326, DOI 10.1007/s12011-018-1432-9; Cabre M, 2000, CLIN EXP PHARMACOL P, V27, P694, DOI 10.1046/j.1440-1681.2000.03322.x; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; Dieck HT, 2003, J NUTR, V133, P1004, DOI 10.1093/jn/133.4.1004; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Grungreiff K, 2016, ANN HEPATOL, V15, P7, DOI 10.5604/16652681.1184191; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Himoto T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010088; Hiraoka A, 2020, HEPATOL RES, V50, P92, DOI 10.1111/hepr.13430; Ito T, 2020, EUR J GASTROEN HEPAT, V32, P748, DOI 10.1097/MEG.0000000000001587; Iwata K, 2014, J CLIN BIOCHEM NUTR, V55, P147, DOI 10.3164/jcbn.14-33; Kang Y. James, 2005, Molecular Aspects of Medicine, V26, P391, DOI 10.1016/j.mam.2005.07.002; Kelishadi R, 2010, METAB SYNDR RELAT D, V8, P505, DOI 10.1089/met.2010.0020; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Kosari Farid, 2019, Iran J Pathol, V14, P17, DOI 10.30699/IJP.14.1.17; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x; Martinez SS, 2017, J NUTR, V147, P556, DOI 10.3945/jn.116.243832; Matsuoka S, 2009, J CLIN BIOCHEM NUTR, V45, P292, DOI 10.3164/jcbn.08-246; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mousavi SN, 2018, BIOL TRACE ELEM RES, V181, P288, DOI 10.1007/s12011-017-1059-2; Olechnowicz J, 2018, J PHYSIOL SCI, V68, P19, DOI 10.1007/s12576-017-0571-7; PRAMOOLSINSAP C, 1994, J GASTROENTEROL, V29, P610, DOI 10.1007/BF02365444; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sun WJ, 2016, HEPATOL RES, V46, P862, DOI 10.1111/hepr.12647; Takagi H, 2001, J VIRAL HEPATITIS, V8, P367, DOI 10.1046/j.1365-2893.2001.00311.x; Toshimitsu K, 2007, NUTRITION, V23, P46, DOI 10.1016/j.nut.2006.09.004; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wei CC, 2018, FASEB J, V32, P6666, DOI 10.1096/fj.201800463; Wiernsperger N, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-70; Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9; Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302; Zhou ZX, 2002, EXP BIOL MED, V227, P214, DOI 10.1177/153537020222700310; Zolfaghari H, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.188083	40	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0240195	10.1371/journal.pone.0240195	http://dx.doi.org/10.1371/journal.pone.0240195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095789	Green Published, gold			2022-12-26	WOS:000586649400006
J	Sasaki, K; Yamamoto, S; Mutoh, T				Sasaki, Kazumasu; Yamamoto, Shuzo; Mutoh, Tatsushi			Noninvasive assessment of fluid responsiveness for emergency abdominal surgery in dogs with pulmonary hypertension: Insights into high-risk companion animal anesthesia	PLOS ONE			English	Article							PULSE PRESSURE VARIATION; STROKE VOLUME VARIATION; RAPID INHALATION INDUCTION; CARDIAC-OUTPUT; TRANSPULMONARY THERMODILUTION; MASK INDUCTION; ELECTRICAL VELOCIMETRY; HEMODYNAMIC MANAGEMENT; NITROUS-OXIDE; HEART-FAILURE	Objective Optimizing cardiac stroke volume during high-risk surgical anesthesia is of particular interest with regard to a therapeutic target to reduce the incidence of postoperative complications. However, intensive fluid management in critically ill small animals with pulmonary hypertension (PH) has been empirically performed, and thus it can be challenging. Stroke volume variation (SVV) has been used as a dynamic preload predictor of fluid responsiveness. We hypothesized that if SVV exhibited robust reliability in the setting of hemodynamically unstable condition, it would provide more precise information on fluid resuscitation to translate it into veterinary anesthesia. Thus the aim of this study was to investigate the utility of SVV measured by the electrical velocimetry (EV) method for predicting fluid responsiveness in dogs with PH. Methods Sixteen dogs undergoing emergency abdominal surgery and diagnosed with PH secondary to myxomatous mitral valve disease (MMVD) on preoperative transthoracic echocardiogram were included. Dogs were randomly assigned to 2 groups with and without inotropic cardiac support with dobutamine. Hemodynamic measurements including stroke volume and SVV derived from the EV device were performed under general anesthesia before (baseline) and after surgery (fluid challenge with a colloid solution defined by a SV increase of >= 10%). Results In both groups, SVV elevated significantly after abdominal surgery compared with baseline. In dobutamine infused group, the SVV values decreased significantly after fluid challenge (P < 0.05) with a greater number of responders than saline infused control group (P < 0.01). Receiver operating curve analysis of SVV confirmed high positive predictive value for dogs during dobutamine infusion (P < 0.05; cut-off value of 15%; specificity 90%, sensitivity 82%). Conclusions Noninvasive EV monitoring may be useful for the prediction of fluid responsiveness in critically ill dogs with left-sided heart failure-related PH. This normalization of dynamic preload indices, which could be achieved more precisely under inotropic support, may prevent further detrimental consequence of fluid loading.	[Sasaki, Kazumasu; Mutoh, Tatsushi] Sendai Anim Care & Res Ctr, Small Anim Emergency & Crit Care Serv, Sendai, Miyagi, Japan; [Sasaki, Kazumasu] Akita Cerebrospinal & Cardiovasc Ctr, Akita, Japan; [Yamamoto, Shuzo; Mutoh, Tatsushi] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Tohoku University	Mutoh, T (corresponding author), Sendai Anim Care & Res Ctr, Small Anim Emergency & Crit Care Serv, Sendai, Miyagi, Japan.; Mutoh, T (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.	tmutoh@tohoku.ac.jp		Mutoh, Tatsushi/0000-0001-7770-379X; Sasaki, Kazumasu/0000-0003-3895-9973				Beaumier A, 2018, J VET INTERN MED, V32, P944, DOI 10.1111/jvim.15126; Bernstein DP, 2005, MED BIOL ENG COMPUT, V43, P443, DOI 10.1007/BF02344724; Bouchacourt JP, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0329-z; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18&lt;311:ASOMCM&gt;2.0.CO;2; Derichard A, 2009, BRIT J ANAESTH, V103, P678, DOI 10.1093/bja/aep267; Diniz MS, 2014, J VET EMERG CRIT CAR, V24, P681, DOI 10.1111/vec.12246; Drozdzynska MJ, 2018, VET ANAESTH ANALG, V45, P22, DOI 10.1016/j.vaa.2017.06.001; Endo Y, 2017, VET ANAESTH ANALG, V44, P1303, DOI 10.1016/j.vaa.2017.07.007; Endo Y, 2017, J VET MED SCI, V79, P1437, DOI 10.1292/jvms.16-0287; Fantoni DT, 2017, VET ANAESTH ANALG, V44, P710, DOI 10.1016/j.vaa.2016.11.011; FERRARIO M, 1994, AM J CARDIOL, V74, P329, DOI 10.1016/0002-9149(94)90398-0; Ghio S, 2018, INT J CARDIOL, V270, P331, DOI 10.1016/j.ijcard.2018.06.032; Goncalves LA, 2020, VET ANAESTH ANALG, V47, P28, DOI 10.1016/j.vaa.2019.08.047; Goya S, 2018, VET ANAESTH ANALG, V45, P432, DOI 10.1016/j.vaa.2018.03.010; Hansson K, 2002, VET RADIOL ULTRASOUN, V43, P568, DOI 10.1111/j.1740-8261.2002.tb01051.x; Hollenberg SM, 2011, AM J RESP CRIT CARE, V183, P847, DOI 10.1164/rccm.201006-0972CI; Itami T, 2016, VET ANAESTH ANALG, V43, P388, DOI 10.1111/vaa.12331; Jeong DM, 2017, ANESTH ANALG, V125, P1158, DOI 10.1213/ANE.0000000000002056; Keene BW, 2019, J VET INTERN MED, V33, P1127, DOI 10.1111/jvim.15488; Kerbaul F, 2004, CRIT CARE MED, V32, P1035, DOI 10.1097/01.CCM.0000120052.77953.07; Konstam MA, 2018, CIRCULATION, V137, pE578, DOI 10.1161/CIR.0000000000000560; Kutter APN, 2016, J VET EMERG CRIT CAR, V26, P531, DOI 10.1111/vec.12439; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Lee JY, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.11.012; LEIER CV, 1978, CIRCULATION, V58, P466, DOI 10.1161/01.CIR.58.3.466; Mutoh T, 1997, AM J VET RES, V58, P885; Mutoh T, 2007, VET REC, V160, P152, DOI 10.1136/vr.160.5.152; Mutoh T, 1995, J VET MED SCI, V57, P1007, DOI 10.1292/jvms.57.1007; Mutoh T, 2002, AM J VET RES, V63, P1022, DOI 10.2460/ajvr.2002.63.1022; Mutoh T, 2001, AM J VET RES, V62, P1727, DOI 10.2460/ajvr.2001.62.1727; Mutoh T, 1995, J VET MED SCI, V57, P1121, DOI 10.1292/jvms.57.1121; Mutoh T, 2001, J VET MED A, V48, P223, DOI 10.1046/j.1439-0442.2001.00350.x; Mutoh T, 2007, STROKE, V38, P3218, DOI 10.1161/STROKEAHA.107.484634; Mutoh T, 2019, J NEUROSURG ANESTH, V31, P422, DOI 10.1097/ANA.0000000000000519; Mutoh T, 2015, AM J MED SCI, V350, P415, DOI 10.1097/MAJ.0000000000000561; Mutoh T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0482-4; Mutoh T, 2014, STROKE, V45, P1280, DOI 10.1161/STROKEAHA.114.004739; Mutoh T, 2012, J NEUROSURG ANESTH, V24, P203, DOI 10.1097/ANA.0b013e318242e52e; Mutoh T, 2010, NEUROCRIT CARE, V13, P331, DOI 10.1007/s12028-010-9383-9; Mutoh T, 2009, J NEUROSURG ANESTH, V21, P218, DOI 10.1097/ANA.0b013e3181a4cd8b; Mutoh T, 2009, STROKE, V40, P2368, DOI 10.1161/STROKEAHA.109.547463; Nakashima T, 2020, CLIN EXP PHARMACOL P, V47, P1014, DOI 10.1111/1440-1681.13262; Noel-Morgan J, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00053; Pagnamenta A, 2003, CRIT CARE MED, V31, P1140, DOI 10.1097/01.CCM.0000060126.75746.32; Payseur JD, 2016, J PHARMACOL TOX MET, V81, P115, DOI 10.1016/j.vascn.2016.03.007; Rathore A, 2017, TURK J ANAESTHESIOL, V45, P210, DOI 10.5152/TJAR.2017.04568; Reinero C, 2020, J VET INTERN MED, V34, P549, DOI 10.1111/jvim.15725; Sasaki K, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00171; Sasaki K, 2018, MED SCI MONITOR, V24, P7736, DOI 10.12659/MSM.910135; Sasaki K, 2018, CLIN EXP PHARMACOL P, V45, P983, DOI 10.1111/1440-1681.12968; Sasaki K, 2017, VET ANAESTH ANALG, V44, P719, DOI 10.1016/j.vaa.2016.11.001; Sasaki K, 2017, VET ANAESTH ANALG, V44, P7, DOI 10.1111/vaa.12380; Tao JP, 2015, GENET MOL RES, V14, P6649, DOI 10.4238/2015.June.18.8; THOMAS WP, 1993, J VET INTERN MED, V7, P247, DOI 10.1111/j.1939-1676.1993.tb01015.x; Ventetuolo Corey E, 2014, Ann Am Thorac Soc, V11, P811, DOI 10.1513/AnnalsATS.201312-446FR; Vezzosi T, 2018, J VET INTERN MED, V32, P1541, DOI 10.1111/jvim.15253; Vickers Andrew J, 2006, J Soc Integr Oncol, V4, P194, DOI 10.2310/7200.2006.023; Vos JJ, 2015, CAN J ANESTH, V62, P1153, DOI 10.1007/s12630-015-0464-2; Whitley E, 2002, CRIT CARE, V6, P335; Zamanian RT, 2007, CRIT CARE MED, V35, P2037, DOI 10.1097/01.CCM.0000280433.74246.9E; [No title captured]	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241234	10.1371/journal.pone.0241234	http://dx.doi.org/10.1371/journal.pone.0241234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095826	gold, Green Published			2022-12-26	WOS:000586649400067
J	Pinho, RH; Leach, MC; Minto, BW; Rocha, FD; Luna, SPL				Pinho, Renata Haddad; Leach, Matthew C.; Minto, Bruno Watanabe; Rocha, Fabiana Del Lama; Loureiro Luna, Stelio Pacca			Postoperative pain behaviours in rabbits following orthopaedic surgery and effect of observer presence	PLOS ONE			English	Article							ZEALAND WHITE-RABBITS; INFLAMMATORY PAIN; BUPRENORPHINE; ANALGESIA; SCALE; CARPROFEN; HYPERALGESIA; EXPOSURE; ANIMALS; MODEL	Rabbits are widely used in studies focusing on pain. However, pain is undertreated in this species and one possible factor to explain this is the lack of evaluation methods. The objective of this study was to identify behaviours related to orthopaedic pain in rabbits and to evaluate the influence of the presence of an observer on these behaviours. Twenty-eight rabbits undergoing orthopaedic surgery and filmed 24 hours before surgery, and 1 hour (before rescue analgesia), 4 hours (3 hours after rescue analgesia), and 24 hours post-recovery were observed in the presence and absence of an observer. The frequency and/or duration of behaviours were compared over time and between the presence and absence of the observer using the Friedman and Wilcoxon tests respectively. Data are expressed as median and interquartile range and a significant difference was considered when p<0.05. At 1 hour post-recovery, the rabbits showed reduced activity, hopping, change posture, position in the cage, explore, and open eyes in both the presence and absence of the observer. In the absence of the observer, quadrupedal posture, interact with pinecone, and eat carrot also decreased, while wince behaviour increased. In the presence of the observer, before surgery, the rabbits were less active (Presence-280; 162-300, Absence-300; 300-300) and presented a lower duration of explore (Presence-3; 0-32, Absence-40; 4-63). Post-recovery the rabbits flinched less (Presence-0; 0-0, Absence-0; 0-1) and suspended the affected limb less (Presence-0; 0-0, Absence-0; 0-65). After rescue analgesia the rabbits put weight on and raised the affected limb less (Presence-0; 0-0, Absence-0; 0-2) and licked the affected area less (Presence-0; 0-0, Absence-0; 0-2). These findings demonstrate that the presence of the observer inhibited pain-free behaviours in the rabbits, leading to a false impression of pain, and after the surgery the rabbits masked some pain signs related to the affected area.	[Pinho, Renata Haddad] Sao Paulo State Univ Unesp, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil; [Leach, Matthew C.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Minto, Bruno Watanabe; Rocha, Fabiana Del Lama] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, Dept Vet Clin & Surg, Jaboticabal, SP, Brazil; [Loureiro Luna, Stelio Pacca] Sao Paulo State Univ Unesp, Sch Vet Med & Anim Sci, Dept Vet Surg & Anim Reprod, Botucatu, SP, Brazil	Universidade Estadual Paulista; Newcastle University - UK; Universidade Estadual Paulista; Universidade Estadual Paulista	Luna, SPL (corresponding author), Sao Paulo State Univ Unesp, Sch Vet Med & Anim Sci, Dept Vet Surg & Anim Reprod, Botucatu, SP, Brazil.	stelio.pacca@unesp.br	Luna, Stelio P L/C-4527-2013; Pinho, Renata/ABC-6520-2020; minto, bruno w/G-1186-2012	Luna, Stelio P L/0000-0001-5312-9076; Pinho, Renata/0000-0001-5625-9538; minto, bruno w/0000-0002-8808-4127	FAPESP (Sao Paulo Research Foundation) [2017/12815-0, 2018/17839-7]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	S.P.L.L. - Financial support by FAPESP (Sao Paulo Research Foundation) - thematic project no. 2017/12815-0 R.H.P. - Was sponsored by FAPESP (Sao Paulo Research Foundation) master degree grant no. 2018/17839-7 http://www.fapesp.br/en/ FAPESP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, STUDIES ROMANTICISM, V55, P29; Barter LS, 2013, J AM ASSOC LAB ANIM, V52, P44; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Benato L, 2020, VET REC, V186, DOI 10.1136/vr.105071; Benato L, 2019, VET ANAESTH ANALG, V46, P151, DOI 10.1016/j.vaa.2018.10.007; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brondani JT, 2012, ARQ BRAS MED VET ZOO, V64, P1529, DOI 10.1590/S0102-09352012000600019; Buisman M, 2016, J FELINE MED SURG, V18, P643, DOI 10.1177/1098612X15591590; Cooper CS, 2009, J AM ASSOC LAB ANIM, V48, P279; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Davis H, 1997, PSYCHON B REV, V4, P118, DOI 10.3758/BF03210783; DC T, 2020, NAT PROD COMMUN, V15, P1, DOI DOI 10.1080/15567249.2020.1729900; de Oliveira FA, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0200-0; DiVincenti L, 2016, JAVMA-J AM VET MED A, V248, P795, DOI 10.2460/javma.248.7.795; Dong H, 2008, J NEUROSCI METH, V168, P76, DOI 10.1016/j.jneumeth.2007.09.028; Evangelista MC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55693-8; Farnworth MJ, 2011, ANIM WELFARE, V20, P225; Finka LR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46330-5; FLECKNELL PA, 1984, LAB ANIM, V18, P147, DOI 10.1258/002367784780891226; Flecknell Paul, 2018, Veterinary Clinics of North America Exotic Animal Practice, V21, P83, DOI 10.1016/j.cvex.2017.08.003; Gallego M, 2019, J SMALL ANIM PRACT, V60, P631, DOI 10.1111/jsap.12866; Great Britain Home Office Great Britain Parliament House of Commons, 2019, ANN STAT SCI PROC LI; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Hedenqvist P, 2016, RES VET SCI, V107, P123, DOI 10.1016/j.rvsc.2016.05.010; Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525; Hubrecht RC, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100754; Izer JM, 2018, J INVESTIG SURG, V1939, P1, DOI 10.1080/08941939.2018.1457191; Johnson CA, 2003, CONTEMP TOP LAB ANIM, V42, P27; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; LEHNER PN, 1987, J ANIM SCI, V65, P1213, DOI 10.2527/jas1987.6551213x; LESTER LS, 1985, BEHAV NEUROSCI, V99, P756, DOI 10.1037/0735-7044.99.4.756; McBride EA, 2017, J SMALL ANIM PRACT, V58, P423, DOI 10.1111/jsap.12681; McLennan KM, 2016, APPL ANIM BEHAV SCI, V176, P19, DOI 10.1016/j.applanim.2016.01.007; Mullan SM, 2007, VET REC, V160, P516, DOI 10.1136/vr.160.15.516; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V28, P353, DOI 10.1016/0168-1591(91)90167-V; Poggiagliolmi S, 2011, J VET BEHAV, V6, P343, DOI 10.1016/j.jveb.2010.12.001; Reid J, 2007, ANIM WELFARE, V16, P97; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Schnellbacher RW, 2017, AM J VET RES, V78, P1359, DOI 10.2460/ajvr.78.12.1359; Shuster L, 1984, Journal of Equine Veterinary Science, V4, P233, DOI 10.1016/S0737-0806(84)80153-7; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Taylor PM, 2007, RES VET SCI, V83, P369, DOI 10.1016/j.rvsc.2007.01.007; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Tuyttens FAM, 2016, APPL ANIM BEHAV SCI, V181, P27, DOI 10.1016/j.applanim.2016.04.019; Vacca V, 2014, PAIN, V155, P388, DOI 10.1016/j.pain.2013.10.027; van Driel KS, 2005, BEHAV BRAIN RES, V159, P243, DOI 10.1016/j.bbr.2004.11.005; Wagner AE, 2008, JAVMA-J AM VET MED A, V233, P109, DOI 10.2460/javma.233.1.109; Wagner MC, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1027-2; Watson W., 2011, CLIN IMMUNOL S1, V7, pS7; Weary DM, 2006, APPL ANIM BEHAV SCI, V100, P64, DOI 10.1016/j.applanim.2006.04.013; Weaver LA, 2010, J AM ASSOC LAB ANIM, V49, P845; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; Zulkifli I, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-25	57	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240605	10.1371/journal.pone.0240605	http://dx.doi.org/10.1371/journal.pone.0240605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091089	gold, Green Published			2022-12-26	WOS:000586647200050
J	Tamura, K; Chiu, YW; Shiohara, A; Hori, Y; Tomita, T				Tamura, Kensuke; Chiu, Yung-Wen; Shiohara, Azusa; Hori, Yukiko; Tomita, Taisuke			EphA4 regulates A beta production via BACE1 expression in neurons	FASEB JOURNAL			English	Article						Alzheimer&apos; s disease; A&#946; BACE1; EphA4	AMYLOID-BETA; ALZHEIMERS-DISEASE; MOUSE MODELS; SAM DOMAIN; SECRETASE; PROTEIN; PHOSPHORYLATION; RECEPTORS; OLIGOMERS; KINASE	Several lines of evidence suggest that the aggregation and deposition of amyloid-beta peptide (A beta) initiate the pathology of Alzheimer's disease (AD). Recently, a genome-wide association study demonstrated that a single-nucleotide polymorphism proximal to the EPHA4 gene, which encodes a receptor tyrosine kinase, is associated with AD risk. However, the molecular mechanism of EphA4 in the pathogenesis of AD, particularly in A beta production, remains unknown. Here, we performed several pharmacological and biological experiments both in vitro and in vivo and demonstrated that EphA4 is responsible for the regulation of A beta production. Pharmacological inhibition of EphA4 signaling and knockdown of Epha4 led to increased A beta levels accompanied by increased expression of beta-site APP cleaving enzyme 1 (BACE1), which is an enzyme responsible for A beta production. Moreover, EPHA4 overexpression and activation of EphA4 signaling via ephrin ligands decreased A beta levels. In particular, the sterile-alpha motif domain of EphA4 was necessary for the regulation of A beta production. Finally, EPHA4 mRNA levels were significantly reduced in the brains of AD patients, and negatively correlated with BACE1 mRNA levels. Our results indicate a novel mechanism of A beta regulation by EphA4, which is involved in AD pathogenesis.	[Tamura, Kensuke; Chiu, Yung-Wen; Shiohara, Azusa; Hori, Yukiko; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan	University of Tokyo	Hori, Y; Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan.	yukiko-hori@mol.f.u-tokyo.ac.jp; taisuke@mol.f.u-tokyo.ac.jp			Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED) [JP18dm0207014]; MEXT \ Japan Society for the Promotion of Science (JSPS) [15H02492, 19H01015, 16K18871]	Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan-Taiwan Exchange Association; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP18dm0207014; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H02492, 19H01015 and 16K18871	Allen M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.89; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Castello MA, 2014, AGEING RES REV, V13, P10, DOI 10.1016/j.arr.2013.10.001; Dai DD, 2014, BBA-PROTEINS PROTEOM, V1844, P1729, DOI 10.1016/j.bbapap.2014.07.002; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Huan XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074040; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kimura K, 2011, P NATL ACAD SCI USA, V108, P9981, DOI 10.1073/pnas.1107592108; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Liang LY, 2019, ONCOGENE, V38, P6567, DOI 10.1038/s41388-019-0931-2; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Matsui C, 2012, BRAIN PATHOL, V22, P776, DOI 10.1111/j.1750-3639.2012.00587.x; Miyagawa T, 2016, HUM MOL GENET, V25, P2948, DOI 10.1093/hmg/ddw146; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Noberini R, 2012, CELL ADHES MIGR, V6, P102, DOI 10.4161/cam.19620; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Ohno M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00022; Rosenberger AFN, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0079-9; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Vargas LM, 2018, BBA-MOL BASIS DIS, V1864, P1148, DOI 10.1016/j.bbadis.2018.01.023; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Wang MH, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.185; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823	56	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16383	16396		10.1096/fj.202001510R	http://dx.doi.org/10.1096/fj.202001510R		OCT 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33090569	Green Submitted			2022-12-26	WOS:000586225200001
J	Woodruff, G; Phillips, N; Carromeu, C; Guicherit, O; White, A; Johnson, M; Zanella, F; Anson, B; Lovenberg, T; Bonaventure, P; Harrington, AW				Woodruff, Grace; Phillips, Naomi; Carromeu, Cassiano; Guicherit, Oivin; White, Alistair; Johnson, McCay; Zanella, Fabian; Anson, Blake; Lovenberg, Timothy; Bonaventure, Pascal; Harrington, Anthony W.			Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids	PLOS ONE			English	Article							OSCILLATIONS; MUTATION; MODEL	Human induced Pluripotent Stem Cells (iPSCs) are a powerful tool to dissect the biology of complex human cell types such as those of the central nervous system (CNS). However, robust, high-throughput platforms for reliably measuring activity in human iPSC-derived neuronal cultures are lacking. Here, we assessed 3D cultures of cortical neurons and astrocytes displaying spontaneous, rhythmic, and highly synchronized neural activity that can be visualized as calcium oscillations on standard high-throughput fluorescent readers as a platform for CNS-based discovery efforts. Spontaneous activity and spheroid structure were highly consistent from well-to-well, reference compounds such as TTX, 4-AP, AP5, and NBQX, had expected effects on neural spontaneous activity, demonstrating the presence of functionally integrated neuronal circuitry. Neurospheroid biology was challenged by screening the LOPAC((R) 1280)library, a collection of 1280 pharmacologically active small molecules. The primary screen identified 111 compounds (8.7%) that modulated neural network activity across a wide range of neural and cellular processes and 16 of 17 compounds chosen for follow-up confirmed the primary screen results. Together, these data demonstrate the suitability and utility of human iPSC-derived neurospheroids as a screening platform for CNS-based drug discovery.	[Woodruff, Grace; Phillips, Naomi; Lovenberg, Timothy; Bonaventure, Pascal; Harrington, Anthony W.] Neurosci Discovery LLC, Janssen Res & Dev, San Diego, CA 92121 USA; [Carromeu, Cassiano; Guicherit, Oivin; White, Alistair; Johnson, McCay; Zanella, Fabian; Anson, Blake] StemoniX Inc, Maple Grove, MN USA		Harrington, AW (corresponding author), Neurosci Discovery LLC, Janssen Res & Dev, San Diego, CA 92121 USA.	aharrin1@its.jnj.com						[Anonymous], 2015, JAMA FACIAL PLAST SU, V17, P316, DOI [10.1001/jamafacial.2014.952, DOI 10.1001/JAMAFACIAL.2014.952]; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dravid SM, 2004, BRAIN RES, V1006, P8, DOI 10.1016/j.brainres.2004.01.059; Koga K, 2010, J NEUROSCI RES, V88, P2252, DOI 10.1002/jnr.22382; Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MURPHY TH, 1992, J NEUROSCI, V12, P4834; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Sirenko O, 2019, TOXICOL SCI, V167, P58, DOI 10.1093/toxsci/kfy218; Suguitan Jr AL, 2011, PLOS ONE, V6; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Virdee JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15171-5; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Woodruff G, 2013, CELL REP, V5, P974, DOI 10.1016/j.celrep.2013.10.018	20	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0240991	10.1371/journal.pone.0240991	http://dx.doi.org/10.1371/journal.pone.0240991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091047	gold, Green Published			2022-12-26	WOS:000586647200015
J	Palloni, A; McEniry, M; Huangfu, YY; Beltran-Sanchez, H				Palloni, Alberto; McEniry, Mary; Huangfu, Yiyue; Beltran-Sanchez, Hiram			Impacts of the 1918 flu on survivors' nutritional status: A double quasi-natural experiment	PLOS ONE			English	Article							HUMAN-MILK; MORTALITY; DISEASE; PATTERNS; EXPOSURE; INTRAUTERINE; EQUATIONS; COUNTRIES; IMMUNITY; ORIGINS	Robust empirical evidence supports the idea that embryonic and, more generally, intrauterine disruptions induced by the 1918-flu pandemic had long-term consequences on adult health status and other conditions. In this paper we assess the 1918-flu long-term effects not just ofin uteroexposure but also during infancy and early childhood. A unique set of events that took place in Puerto Rico during 1918-1919 generated conditions of a "double quasi-natural experiment". We exploit these conditions to empirically identify effects of exposure to the 1918 flu pandemic and those of the devastation left by an earthquake-tsunami that struck the island in 1918. Because the earthquake-tsunami affected mostly the Western coast of the island whereas early (in uteroand postnatal) exposure to the flu was restricted to those born in the interval 1917-1920, we use geographic variation to identify the effects of the quake and timing of birth variation to identify those of the flu. We benefit from availability of information on markers of nutritional status in a nationally representative sample of individuals aged 75 and older in 2002. We make two contributions. First, unlike most fetal-origins research that singles out early nutritional status as adeterminant of adult health, we hypothesize that the 1918 flu damaged the nutritional status of adult survivors who, at the time of the flu, werein uteroor infants. Second, we target markers of nutritional status largely set when the adult survivors were infants and young children. Estimates of effects of the pandemic are quite large mostly among females and those who were exposed to the earthquake-tsunami. Impacts of the flu in areas less affected by the earthquake are smaller but do vary by area flu severity. These findings constitute empirical evidence supporting the conjecture that effects of the 1918 flu and/or the earthquake are associated not just with disruption experienced during the fetal period but also postnatally.	[Palloni, Alberto; McEniry, Mary; Huangfu, Yiyue] Univ Wisconsin, Ctr Demog & Hlth Aging, Madison, WI 53706 USA; [Beltran-Sanchez, Hiram] Univ Calif Los Angeles, Populat Res Ctr, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles	Palloni, A (corresponding author), Univ Wisconsin, Ctr Demog & Hlth Aging, Madison, WI 53706 USA.	alberto.palloni@cchs.csic.es		palloni, alberto/0000-0002-2263-2207	National Institute on Aging; National Institute of Child Health and Development; Fogarty International Center Global Research Training in Population and Health; European Research Council [R01-AG016209, R03-AG015673, R01-AG018016, R37-AG025216, RO1-AG056608, RO1-AG052030, D43-TW001586, R24HD047873, P30-AG-017266, R24 HD041022]; European Union [788582]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center Global Research Training in Population and Health; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission)	This work was supported by the National Institute on Aging (https://www.nia.nih.gov/), National Institute of Child Health and Development (https://www.nichd.nih.gov), Fogarty International Center Global Research Training in Population and Health (https://www.fic.nih.gov) and European Research Council (https://erc.europa.eu/) via the following project grants R01-AG016209 (AP), R03-AG015673(AP), R01-AG018016(AP), R37-AG025216 (AP), RO1-AG056608 (AP;HBS), RO1-AG052030(AP;HBS); D43-TW001586(AP), R24HD047873(AP), P30-AG-017266(AP), R24 HD041022(UCLA:HBS); European Union Horizon 2020 Research and Innovation Programme, Project No 788582(AP).	Almond D, 2006, J POLIT ECON, V114, P672, DOI 10.1086/507154; [Anonymous], 2008, EARLY HUMAN DEV, V120, P53; [Anonymous], 1983, REGIONAL MODEL LIFE; Azambuja MIR, 2004, TEX HEART I J, V31, P14; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BARKER DJP, 1989, J EPIDEMIOL COMMUN H, V43, P237, DOI 10.1136/jech.43.3.237; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Butz WP, 1981, FAMILY COMMUNITY PRO; Chowell G, 2014, EMERG INFECT DIS, V20, P1803, DOI 10.3201/eid2011.130632; Chowell G, 2010, J INFECT DIS, V202, P567, DOI 10.1086/654897; CHUMLEA WC, 1992, J GERONTOL, V47, pM197, DOI 10.1093/geronj/47.6.M197; Clark V.S., 1930, PORTO RICO ITS PROBL; CLINE MG, 1989, HUM BIOL, V61, P415; Colquhoun D, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140216; Coutant R, 1998, J CLIN ENDOCR METAB, V83, P1070, DOI 10.1210/jc.83.4.1070; de Wit CC, 2013, J PEDIATR-US, V162, P415, DOI 10.1016/j.jpeds.2012.10.014; Enserink M, 2007, SCIENCE, V315, P582, DOI 10.1126/science.315.5812.582; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Field CJ, 2005, J NUTR, V135, P1; FISHER R. A., 1935, The design of experiments.; Gilbert SL, 2020, CONSERV BIOL, V34, P289, DOI 10.1111/cobi.13401; Gluckman, 2011, PLASTICITY ROBUSTNES; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gluckman PD, 2005, FETAL MATRIX EVOLUTI; Goldman N, 2001, SOC SCI MED, V52, P53, DOI 10.1016/S0277-9536(00)00122-2; Government US, 1919, ANN REP WAR DEP ANN, P220; Headey D, 2020, LANCET, V396, P519, DOI 10.1016/S0140-6736(20)31647-0; Helgertz J, 2019, DEMOGRAPHY, V56, P1389, DOI 10.1007/s13524-019-00799-x; HUTT C, 1972, HUM DEV, V15, P153, DOI 10.1159/000271239; JOHANSSON SR, 1987, POP STUD-J DEMOG, V41, P207, DOI 10.1080/0032472031000142776; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Karbownik K, 2019, J LABOR ECON, V37, P949, DOI 10.1086/702652; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Lv Z., 2008, PLOS ONE, V3, pe3933; Mamelund S., 2003, EFFECTS SPANISH INFL; Martorell Reynaldo, 1999, Food and Nutrition Bulletin, V20, P288; Mazumder B, 2010, J DEV ORIG HLTH DIS, V1, P26, DOI 10.1017/S2040174409990031; McEniry M, 2006, PREHCO PROTOCO UNPUB; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Moore KL., 2008, DEV HUMAN CLIN ORIEN; More VS., 2017, INT J REPROD CONTRAC, V6, P5523, DOI [10.18203/2320-1770.ijrcog20175273, DOI 10.18203/2320-1770.IJRCOG20175273]; Morel M.-F., 1991, DECLINE MORTALITY EU, P196; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Oeppen J, 2010, ESTIMATING REPROD NU; Palloni A, 2005, J GERONTOL A-BIOL, V60, P804, DOI 10.1093/gerona/60.6.804; PALLONI A, 1986, POP STUD-J DEMOG, V40, P215, DOI 10.1080/0032472031000142036; Palloni A, 2006, PUERTO RICO CENSUS P, DOI [10.3886/ICPSR04343.v1, DOI 10.3886/ICPSR04343.V1;2006]; Palloni A, 2011, INT HANDB POPUL, V2, P101, DOI 10.1007/978-90-481-9996-9_5; Rosenfeld CS, 2016, DEV ORIGINS HLTH DIS; Scrimshaw Nevin S., 1997, Food and Nutrition Bulletin, V18, P1; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; SCRIMSHAW NS, 1968, INTERACTION NUTR INF; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Vollmer S, 2017, 242 COR RES CTR; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0232805	10.1371/journal.pone.0232805	http://dx.doi.org/10.1371/journal.pone.0232805			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3QJ	33079928	Green Submitted, Green Published, gold			2022-12-26	WOS:000585940600010
J	Hiroyasu, EGM; Yotsumoto, Y				Gallego Hiroyasu, Elisa M.; Yotsumoto, Yuko			Older adults preserve accuracy but not precision in explicit and implicit rhythmic timing	PLOS ONE			English	Article							AGE-RELATED-CHANGES; TIME-ESTIMATION; WORKING-MEMORY; PERCEPTION; DURATION; ATTENTION; DISCRIMINATION; JUDGMENTS; INTERVAL; SYSTEM	Aging brings with it several forms of neurophysiological and cognitive deterioration, but whether a decline in temporal processing is part of the aging process is unclear. The current study investigated whether this timing deficit has a cause independent of those of memory and attention using rhythmic stimuli that reduce the demand for these higher cognitive functions. In Study 1, participants took part in two rhythmic timing tasks: explicit and implicit. Participants had to distinguish regular from irregular sequences while processing temporal information explicitly or implicitly. Results showed that while the accuracy in the implicit timing task was preserved, older adults had more noise in their performance in the explicit and implicit tasks. In Study 2, participants took part in a dual-implicit task to explore whether the performance of temporal tasks differed with increasing task difficulty. We found that increasing task difficulty magnifies age-related differences.	[Gallego Hiroyasu, Elisa M.; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan	University of Tokyo	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	yuko@fechner.c.u-tokyo.ac.jp		Gallego Hiroyasu, Elisa M./0000-0003-3014-9183; Yotsumoto, Yuko/0000-0001-7408-0339	Japan Society for the Promotion of Science KAKENHI [19H01771, 19H05308, 17K18693]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Japan Society for the Promotion of Science KAKENHI (Grant #19H01771, #19H05308, #17K18693) to YY. https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, INT J TRANSIT JUST, V7, P1, DOI 10.1093/IJTJ/--IJS039; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Bangert AS, 2012, J INT NEUROPSYCH SOC, V18, P1052, DOI 10.1017/S1355617712000860; Bartholomew AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143873; Baudouin A, 2006, ACTA PSYCHOL, V121, P285, DOI 10.1016/j.actpsy.2005.07.004; Begel V, 2017, NEUROPSYCHOLOGIA, V94, P129, DOI 10.1016/j.neuropsychologia.2016.11.022; Block RA, 1998, PSYCHOL AGING, V13, P584, DOI 10.1037/0882-7974.13.4.584; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Brainard DH, 1997, SPAT VIS, P433; Breska A, 2018, P NATL ACAD SCI USA, V115, P12283, DOI 10.1073/pnas.1810596115; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Capizzi M, 2012, COGNITION, V123, P293, DOI 10.1016/j.cognition.2012.02.005; Coelho M, 2004, J INT NEUROPSYCH SOC, V10, P332, DOI 10.1017/S1355617704103019; Cope TE, 2014, NEUROPSYCHOLOGIA, V52, P73, DOI 10.1016/j.neuropsychologia.2013.09.039; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik FIM, 1999, PERCEPT PSYCHOPHYS, V61, P549, DOI 10.3758/BF03211972; Droit-Volet S, 2015, Q J EXP PSYCHOL, V68, P2216, DOI 10.1080/17470218.2015.1012087; Droit-Volet S, 2019, ACTA PSYCHOL, V193, P180, DOI 10.1016/j.actpsy.2019.01.004; Droit-Volet S, 2016, J EXP CHILD PSYCHOL, V150, P141, DOI 10.1016/j.jecp.2016.05.010; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gil S, 2011, ACTA PSYCHOL, V136, P354, DOI 10.1016/j.actpsy.2010.12.010; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; Henry MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15801; JASP Team, 2019, JASP VERS 0 11 1 COM; Lustig C, 2011, BRAIN COGNITION, V77, P298, DOI 10.1016/j.bandc.2011.07.007; Marchand WR, 2011, NEUROIMAGE, V55, P194, DOI 10.1016/j.neuroimage.2010.12.030; Marchant JL, 2013, CEREB CORTEX, V23, P1290, DOI 10.1093/cercor/bhs095; Matthews WJ, 2016, PSYCHOL BULL, V142, P865, DOI 10.1037/bul0000045; McCormack T, 1999, DEV PSYCHOL, V35, P1143, DOI 10.1037/0012-1649.35.4.1143; Merchant H, 2016, CURR OPIN BEHAV SCI, V8, P22, DOI 10.1016/j.cobeha.2016.01.006; Mioni G, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00017; Perbal S, 2002, AGING NEUROPSYCHOL C, V9, P201, DOI 10.1076/anec.9.3.201.9609; Perrachione TK, 2017, J SPEECH LANG HEAR R, V60, P1959, DOI 10.1044/2017_JSLHR-L-15-0446; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Teki S, 2011, J NEUROSCI, V31, P3805, DOI 10.1523/JNEUROSCI.5561-10.2011; Teo WP, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00284; Todd NPM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00444; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Turgeon M, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnagi.2010.00102, 10.3389/fnagi.2016.00102]; Turgeon M, 2012, PSYCHOL AGING, V27, P1152, DOI 10.1037/a0029925; Vanneste S, 1999, EXP AGING RES, V25, P49, DOI 10.1080/036107399244138; VV.AA, 2012, COMPOSITE MAT HDB CM, V3, P1, DOI DOI 10.1007/S13244-011-0135-Y; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Wearden JH, 1997, J EXP PSYCHOL HUMAN, V23, P962; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Zanto TP, 2011, J NEUROSCI, V31, P12461, DOI 10.1523/JNEUROSCI.1149-11.2011; 2014, FRONT PSYCHOL, V5, P1	52	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240863	10.1371/journal.pone.0240863	http://dx.doi.org/10.1371/journal.pone.0240863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IS	33075063	Green Published, gold			2022-12-26	WOS:000585920200028
J	Tu, C; Pi, YQ; Xing, S; Ling, Y				Tu, Chao; Pi, Yingqi; Xing, Shan; Ling, Yang			Integrated analysis of long non-coding RNAs and mRNA profiles reveals potential sex-dependent biomarkers of bevacizumab/erlotinib response in advanced lung cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; DOUBLE-BLIND; ERLOTINIB; CHEMOTHERAPY; EGFR; INHIBITORS; THERAPY; PATHWAY; MULTICENTER; COMBINATION	Background While lung cancer patient outcomes are well-recognized to vary as a function of patient sex, there has been insufficient research regarding the relationship between patient sex and EGFR(Epidermal growth factor receptor) response efficacy. The present study therefore sought to identify novel sex-related biomarkers of bevacizumab/erlotinib (BE) responses in non-small cell lung cancer (NSCLC) patients. Methods The exon array data in the Gene Expression Omnibus (GEO) dataset were analyzed in order to identify patterns of mRNA and lncRNA expression associated with BE resistance in NSCLC. These differentially expressed (DE) lncRNAs and mRNAs were identified via DE Analysis Filtering. These DE mRNAs were then assessed for their potential functional roles via pathway enrichment analyses, with overlapping functions possibly associated with the BE resistance. The mRNAs in these overlapping groups were then assessed for their correlations with patient survival, and lncRNA-mRNA co-expression networks were generated for each patient subset. A protein-protein interaction (PPI) network was also generated based upon these DE mRNAs. Results In females we identified 172 DE lncRNAs and 1766 DE mRNAs associated with BE responses, while in males we identified 78 DE lncRNAs and 485 DE mRNAs associated with such responses. Based on the overlap between these two datasets, we identified a total of 37 GO functions and 18 pathways associated with BE responses. Co-expression and PPI networks suggested that the key lncRNAs and mRNAs associated with these BE response mechanisms weredifferent in the male and female patients. Conclusions This work is the first to conduct a global profiling of the relationship between lncRNA and mRNA expression patterns, patient sex, and BE responses in individuals suffering from NSCLC. Together these results suggest that the integrative lncRNA-mRNA expression analyses may offer invaluable new therapeutic insights that can guide the tailored treatment of lung cancer in order to ensure optimal BE responses.	[Tu, Chao] Soochow Univ, Affiliated Hosp 3, Dept Internal Med, Changzhou, Jiangsu, Peoples R China; [Pi, Yingqi] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Clin Lab, Shenzhen, Peoples R China; [Xing, Shan] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Clin Lab,Canc Ctr, Guangzhou, Peoples R China; [Ling, Yang] Soochow Univ, Changzhou Tumor Hosp, Affiliated Hosp 3, Dept Oncol, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Soochow University - China	Tu, C (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Internal Med, Changzhou, Jiangsu, Peoples R China.; Ling, Y (corresponding author), Soochow Univ, Changzhou Tumor Hosp, Affiliated Hosp 3, Dept Oncol, Changzhou, Jiangsu, Peoples R China.	tcmedical21@126.com; 2559512439@qq.com						[Anonymous], 2019, REPROD MED S1, V39, pe1; Arrieta O, 2013, REV INVEST CLIN, V65, pS5; Brugger W, 2011, J CLIN ONCOL, V29, P4113, DOI 10.1200/JCO.2010.31.8162; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Casado-Vela J, 2011, CLIN TRANSL ONCOL, V13, P617, DOI 10.1007/s12094-011-0707-9; Chen S, 2018, P NATL ACAD SCI USA, V115, pE11671, DOI 10.1073/pnas.1803718115; Coleman OI, 2018, GASTROENTEROLOGY, V155, P1539, DOI 10.1053/j.gastro.2018.07.028; Conforti F, 2019, JNCI-J NATL CANCER I, V111, P772, DOI 10.1093/jnci/djz094; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Harami-Papp H, 2016, ONCOTARGET, V7, P67183, DOI 10.18632/oncotarget.11594; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Huang YH, 2015, BBA-REV CANCER, V1855, P193, DOI 10.1016/j.bbcan.2015.01.003; Johnson BE, 2013, J CLIN ONCOL, V31, P3926, DOI 10.1200/JCO.2012.47.3983; Khorkova O, 2015, ADV DRUG DELIVER REV, V87, P15, DOI 10.1016/j.addr.2015.05.012; Kim SY, 2019, TUBERC RESPIR DIS, V82, P62, DOI 10.4046/trd.2018.0004; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522; Lavoie S, 2018, GASTROENTEROLOGY, V155, P1309, DOI 10.1053/j.gastro.2018.10.011; Li XM, 2016, ONCOTARGET, V7, P23197, DOI 10.18632/oncotarget.8099; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Makhoul I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168550; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Okoniewski MJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040006; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pellatt AJ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1566-8; Qi WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055637; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Saito H, 2019, LANCET ONCOL, V20, P625, DOI 10.1016/S1470-2045(19)30035-X; Schabath MB, 2014, CANCER CONTROL, V21, P51, DOI 10.1177/107327481402100107; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Song W, 2016, ONCOTARGET, V7, P83735, DOI 10.18632/oncotarget.13407; Tsiouda T, 2020, J CANCER, V11, P3407, DOI 10.7150/jca.40196; Wainer Z, 2018, CLIN LUNG CANCER, V19, pE933, DOI 10.1016/j.cllc.2018.08.004; Wainer Z, 2012, J NUCL MED, V53, P1676, DOI 10.2967/jnumed.112.105197; Wang F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-90; Wang SX, 2019, INT J CANCER, V145, P2840, DOI 10.1002/ijc.32327; Xie Y, 2018, CELL BIOCHEM FUNCT, V36, P413, DOI 10.1002/cbf.3361; Yu HY, 2017, ONCOTARGET, V8, P94440, DOI 10.18632/oncotarget.21772; Zappa F, 2012, LUNG CANCER, V78, P239, DOI 10.1016/j.lungcan.2012.08.017; Zhao BH, 2018, LUNG CANCER, V122, P10, DOI 10.1016/j.lungcan.2018.05.011	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2020	15	10							e0240633	10.1371/journal.pone.0240633	http://dx.doi.org/10.1371/journal.pone.0240633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3IS	33075110	Green Published, gold			2022-12-26	WOS:000585920200007
J	Karaivanov, A				Karaivanov, Alexander			A social network model of COVID-19	PLOS ONE			English	Article								I construct a dynamic social-network model of the COVID-19 epidemic which embeds the SIR epidemiological model onto a graph of person-to-person interactions. The standard SIR framework assumes uniform mixing of infectious persons in the population. This abstracts from important elements of realism and locality: (i) people are more likely to interact with members of their social networks and (ii) health and economic policies can affect differentially the rate of viral transmission via a person's social network vs. the population as a whole. The proposed network-augmented (NSIR) model allows the evaluation, via simulations, of (i) health and economic policies and outcomes for all or subset of the population: lockdown/distancing, herd immunity, testing, contact tracing; (ii) behavioral responses and/or imposing or lifting policies at specific times or conditional on observed states. I find that viral transmission over a network-connected population can proceed slower and reach lower peak than transmission via uniform mixing. Network connections introduce uncertainty and path dependence in the epidemic dynamics, with a significant role for bridge links and superspreaders. Testing and contact tracing are more effective in the network model. If lifted early, distancing policies mostly shift the infection peak into the future, with associated economic costs. Delayed or intermittent interventions or endogenous behavioral responses generate a multi-peaked infection curve, a form of 'curve flattening', but may have costlier economic consequences by prolonging the epidemic duration.	[Karaivanov, Alexander] Simon Fraser Univ, Dept Econ, Burnaby, BC, Canada	Simon Fraser University	Karaivanov, A (corresponding author), Simon Fraser Univ, Dept Econ, Burnaby, BC, Canada.	akaraiva@sfu.ca	Karaivanov, Alexander/AAX-4761-2021	Karaivanov, Alexander/0000-0002-5184-3126				Adam D., 2020, CORONAVIRUS 2 SARS C; Althouse BM, 2020, STOCHASTICITY HETERO; Alvarez F, 2020, WORKING PAPER; American Diabetes Association, 2010, DIABETES CARE S, V37, pS14; Anderson S., 2020, ESTIMATING IMPACT CO; Atkeson A., 2020, 26867 NAT BUR EC RES, DOI [10.3386/w26867, DOI 10.3386/W26867]; Azzimonti Maria, 2020, WORKING PAPER; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; Chang R., 2020, COVID EC, V14, P33; DOOB JL, 1945, T AM MATH SOC, V58, P455, DOI 10.2307/1990339; Dottori M, 2015, PHYSICA A, V434, P25, DOI 10.1016/j.physa.2015.04.007; Farboodi M., 2020, WORKING PAPER; Fernandez-Villaverde J., 2020, ESTIMATING SIMULATIN; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keppo J, 2020, WORKING PAPER; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kuchler T., 2020, W26990 NAT BUR EC RE, DOI DOI 10.3386/W26990; McGee R, 2020, SEIRSPLUS PYTHON COD; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mongey S., 2020, WORKING PAPER; Newman M, 2002, ARXIVCONDMAT0205009; Pastor-Satorras R, 2000, ARXIVCONDMAT0010317; Reich O, 2020, WORKING PAPER; Streeck H, 2020, INFECT FATALITY RATE; Toxvaerd F, 2020, WORKING PAPER; Tsiotas D, 2020, PHYSICS-BASEL, V2, P325, DOI 10.3390/physics2020017; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Zhao P, 2020, SOCIAL NETWORK MODEL	30	30	30	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240878	10.1371/journal.pone.0240878	http://dx.doi.org/10.1371/journal.pone.0240878			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119621	Green Published, gold			2022-12-26	WOS:000600013600098
J	Morishita, H; Okawa, K; Ishii, M; Mizoi, K; Ito, M; Arakawa, H; Yano, K; Ogihara, T				Morishita, Hiroki; Okawa, Kozue; Ishii, Misaki; Mizoi, Kenta; Ito, Masa-aki; Arakawa, Hiroshi; Yano, Kentaro; Ogihara, Takuo			Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein	PLOS ONE			English	Article							DRUG-INTERACTIONS; HIGH-AFFINITY; PHARMACOKINETICS; SERTRALINE; CLARITHROMYCIN; TRANSPORTERS; EXPRESSION; DIGOXIN	Drug-drug interaction was suggested to have played a role in the recent death due to cardiac arrest of a patient taking pimozide, sertraline and aripiprazole antipsychotic/antidepressant combination therapy. Here, we investigated the possible involvement of P-glycoprotein (P-gp)-mediated interaction among these drugs, using in vitro methods. ATPase assay confirmed that pimozide is a P-gp substrate, and might act as a P-gp inhibitor at higher concentrations. The maximum transport rate (J(max)) and half-saturation concentration (K-t) for the carrier-mediated transport estimated by means of pimozide efflux assay using P-gp-overexpressing LLC-GA5-CoL150 cells were 84.9 +/- 8.9 pmol/min/mg protein, and 10.6 +/- 4.7 mu M, respectively. These results indicate that pimozide is a good P-gp substrate, and it appears to have the potential to cause drug-drug interactions in the digestive tract at clinically relevant gastrointestinal concentrations. Moreover, sertraline or aripiprazole significantly decreased the efflux ratio of pimozide in LLC-GA5-CoL150 cells. Transport studies using Caco-2 cell monolayers were consistent with the results in LLC-GA5-CoL150 cells, and indicate that P-gp-mediated drug-drug interaction may occur in the gastrointestinal tract. Thus, P-gp inhibition by sertraline and/or aripiprazole may increase the gastrointestinal permeability of co-administered pimozide, resulting in an increased blood concentration of pimozide, which is known to be associated with an increased risk of QT prolongation, a life-threatening side effect.	[Morishita, Hiroki; Ogihara, Takuo] Takasaki Univ Hlth & Welf, Grad Sch Pharmaceut Sci, Lab Clin Pharmacokinet, Nakaorui Machi, Takasaki, Gunma, Japan; [Morishita, Hiroki] Saiseikai Maebashi Hosp, Dept Pharm, Kamishinden Machi, Maebashi, Gumma, Japan; [Okawa, Kozue; Ishii, Misaki; Mizoi, Kenta; Yano, Kentaro; Ogihara, Takuo] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Biopharmaceut, Nakaorui Machi, Takasaki, Gunma, Japan; [Ito, Masa-aki] Takasaki Univ Hlth & Welf, Fac Pharm, Lab Pharmacol, Nakaorui Machi, Takasaki, Gunma, Japan; [Arakawa, Hiroshi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa, Japan; [Yano, Kentaro] Yokohama Univ Pharm, Lab Drug Metab & Pharmacokinet, Totsuka Ku, Yokohama, Kanagawa, Japan	Kanazawa University	Ogihara, T (corresponding author), Takasaki Univ Hlth & Welf, Grad Sch Pharmaceut Sci, Lab Clin Pharmacokinet, Nakaorui Machi, Takasaki, Gunma, Japan.; Ogihara, T (corresponding author), Takasaki Univ Hlth & Welf, Fac Pharm, Lab Biopharmaceut, Nakaorui Machi, Takasaki, Gunma, Japan.	togihara@takasaki-u.ac.jp			Laboratory of Biopharmaceutics, Department of Phamacology, Faculty of Pharmacy, Takasaki University of Health and Walfare; Gunma Yakugakunetwork	Laboratory of Biopharmaceutics, Department of Phamacology, Faculty of Pharmacy, Takasaki University of Health and Walfare; Gunma Yakugakunetwork	This research was supported by the Laboratory of Biopharmaceutics, Department of Phamacology, Faculty of Pharmacy, Takasaki University of Health and Walfare, and by the Gunma Yakugakunetwork.	Alderman J, 2005, CLIN THER, V27, P1050, DOI 10.1016/j.clinthera.2005.07.013; Benet LZ, 2009, MOL PHARMACEUT, V6, P1631, DOI 10.1021/mp900253n; Bunai Y, 2015, LEGAL MED-TOKYO, V17, P279, DOI 10.1016/j.legalmed.2015.03.003; Desta Z, 1999, CLIN PHARMACOL THER, V65, P10, DOI 10.1016/S0009-9236(99)70117-7; Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2017, GUID IND WAIV IN VIV; Gessner A, 2019, CLIN PHARMACOL THER, V105, P1386, DOI 10.1002/cpt.1360; Gulisano M, 2011, NEUROL SCI, V32, P1213, DOI 10.1007/s10072-011-0678-1; Gurley BJ, 2008, MOL NUTR FOOD RES, V52, P772, DOI 10.1002/mnfr.200700081; Kang JS, 2000, EUR J PHARMACOL, V392, P137, DOI 10.1016/S0014-2999(00)00123-0; Kim JY, 2018, ANTICANCER RES, V38, P5685, DOI 10.21873/anticanres.12905; Liu XD, 2019, ADV EXP MED BIOL, V1141, P241, DOI 10.1007/978-981-13-7647-4_5; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; Muller F, 2011, PHARMACOGENOMICS, V12, P1017, DOI [10.2217/PGS.11.44, 10.2217/pgs.11.44]; Nagasaka Y, 2012, BIOPHARM DRUG DISPOS, V33, P304, DOI 10.1002/bdd.1801; Ogihara T, 1996, PHARMACEUT RES, V13, P1828, DOI 10.1023/A:1016081007981; Ogihara T, 2006, DRUG METAB PHARMACOK, V21, P238, DOI 10.2133/dmpk.21.238; Pyka Alina, 2006, Acta Pol Pharm, V63, P159; Rapeport WG, 1996, J CLIN PSYCHIAT, V57, P16; Rengelshausen J, 2003, BRIT J CLIN PHARMACO, V56, P32, DOI 10.1046/j.1365-2125.2003.01824.x; Saruwatari J, 2012, J CLIN PSYCHOPHARM, V32, P195, DOI 10.1097/JCP.0b013e318248ddb9; Spina E, 2016, PHARMACOL RES, V106, P72, DOI 10.1016/j.phrs.2016.02.014; Spina E, 2015, J NEURAL TRANSM, V122, P5, DOI 10.1007/s00702-014-1300-5; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Takano M, 2006, PHARMACOL THERAPEUT, V109, P137, DOI 10.1016/j.pharmthera.2005.06.005; Tomono T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200015; van Vloten Willem A, 2003, Dermatol Online J, V9, P3; Wang JS, 2008, BIOL PHARM BULL, V31, P231, DOI 10.1248/bpb.31.231; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yano K, 2014, DRUG METAB PHARMACOK, V29, P254, DOI 10.2133/dmpk.DMPK-13-RG-072	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0232438	10.1371/journal.pone.0232438	http://dx.doi.org/10.1371/journal.pone.0232438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119612	Green Submitted, gold, Green Published			2022-12-26	WOS:000600013600112
J	Zhang, JY; Wang, YP; Zhao, YF; Zhang, Y; Zhang, JY; Ma, HR; Han, YZ				Zhang, Jingying; Wang, Yaping; Zhao, Yanfei; Zhang, Yun; Zhang, Jiayue; Ma, Haoran; Han, Yuzhu			Transcriptome analysis reveals Nitrogen deficiency induced alterations in leaf and root of three cultivars of potato (Solanum tuberosum L.)	PLOS ONE			English	Article							CYTOSOLIC GLUTAMINE-SYNTHETASE; USE EFFICIENCY; YIELD; EXPRESSION; REMOBILIZATION; ASSIMILATION; WHEAT	Nitrogen (N) is a key element for the production of potato. The N uptake efficiency, N use efficiency and increased N utilization efficiency can be decreased by N deficiency treatment. We performed this study to investigate the association between transcriptomic profiles and the efficiencies of N in potato. Potato cultivars "Yanshu 4" (short for Y), "Xiabodi" (cv. Shepody, short for X) and "Chunshu 4" (short for C) were treated with sufficient N fertilizer and deficient N fertilizer. Then, the growth parameters and tuber yield were recorded; the contents of soluble sugar and protein were measured; and the activities of enzymes were detected. Leaf and root transcriptomes were analyzed and differentially expressed genes (DEGs) in response to N deficiency were identified. The results showed that N deficiency decreased the nitrate reductase (NR), glutamine synthetase (GS) and root activity. Most of the DEGs between N-treated and N-deficiency participate the processes of transport, nitrate transport, nitrogen compound transport and N metabolism in C and Y, not in X, indicating the cultivar-dependent response to N deficiency. DEGs like glutamate dehydrogenase (StGDH), glutamine synthetase (StGS) and carbonic anhydrase (StCA) play key roles in these processes mentioned above. DEGs related to N metabolism showed a close relationship with the N utilization efficiency (UTE), but not with N use efficiency (NUE). The Major Facilitator Superfamily (MFS) members, like nitrate transporter 2.4 (StNRT2.4), 2.5 (StNRT2.5) and 2.7 (StNRT2.7), were mainly enriched in the processes associated with response to stresses and defense, indicating that N deficiency induced stresses in all cultivars.	[Zhang, Jingying; Wang, Yaping; Zhao, Yanfei; Zhang, Yun; Zhang, Jiayue; Ma, Haoran; Han, Yuzhu] Jilin Agr Univ, Coll Hort, Changchun, Peoples R China	Jilin Agricultural University	Han, YZ (corresponding author), Jilin Agr Univ, Coll Hort, Changchun, Peoples R China.	hanyuzhu@jlau.edu.cn	zhao, yan/GWC-9174-2022		Jilin development and Reform Commission Project [20160601]; Project of science and Technology Department of Jilin Province [20180201001NY]	Jilin development and Reform Commission Project; Project of science and Technology Department of Jilin Province	The authors are grateful to Jilin Agricultural University Comprehensive Experimental Platform. This research was funded by Jilin development and Reform Commission Project (20160601) and Project of science and Technology Department of Jilin Province (20180201001NY).The funders had no role in study design, data collection and analysis, decision to publish.	AHMED N. U., 2017, INT J NATURAL SOCIAL, V4, P60; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2018, ACTA AGR BOREALI SIN, V35; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Brener-Raffalli K, 2018, BIORXIV, DOI [10.1101/398602, 10. 1101/398602]; Cao YG, 2016, ANAL METHODS-UK, V8, P790, DOI 10.1039/c5ay02630j; Dai XL, 2013, FIELD CROP RES, V154, P100, DOI 10.1016/j.fcr.2013.07.024; Errebhi M, 1998, AM J POTATO RES, V75, P93; Galvez JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26090; Gao X, 2015, FIELD CROP RES, V181, P60, DOI 10.1016/j.fcr.2015.07.009; Gao YJ, 2019, PLANT BIOTECHNOL J, V17, P1209, DOI 10.1111/pbi.13046; Getahun, 2017, GENETIC DIVERSITY PO; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Guilherme EA, 2019, PLANT SOIL, P1; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; Hu MY, 2018, PLANT BIOTECHNOL J, V16, P1858, DOI 10.1111/pbi.12921; Jozefowicz AM, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700231; Kant S, 2018, SEMIN CELL DEV BIOL, V74, P89, DOI 10.1016/j.semcdb.2017.08.034; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kotur Z, 2017, ISR J PLANT SCI, V64, P21, DOI 10.1080/07929978.2016.1246147; Kotur Z, 2012, NEW PHYTOL, V194, P724, DOI 10.1111/j.1469-8137.2012.04094.x; Lea PJ, 2011, NITROGEN METABOLISM; Lezhneva L, 2014, PLANT J, V80, P230, DOI 10.1111/tpj.12626; Liu H, 2018, SCI HORTIC-AMSTERDAM, V236, P10, DOI 10.1016/j.scienta.2018.03.027; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Nawaz MA, 2017, PLANT GROWTH REGUL, V82, P233, DOI 10.1007/s10725-017-0254-7; Nieto CO, 2016, NITROGEN USE EFFICIE; Raven P.H., 2005, BIOL PLANTS; Tang DY, 2018, J INTEGR PLANT BIOL, V60, P85, DOI 10.1111/jipb.12519; Thomsen HC, 2014, TRENDS PLANT SCI, V19, P656, DOI 10.1016/j.tplants.2014.06.002; Thunyamada S, 2017, 13 INT S PLANT BIOR; Tiwari JK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58167-4; Tiwari JK, 2017, COMPEND PL GENOME, P171, DOI 10.1007/978-3-319-66135-3_11; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trehan S. P., 2013, Potato Journal, V40, P1; Xie XF, 2018, AM J POTATO RES, V95, P157, DOI 10.1007/s12230-017-9621-1; Yin LJ, 2018, FIELD CROP RES, V221, P90, DOI 10.1016/j.fcr.2018.02.015; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zareabyaneh H, 2015, ENVIRON EARTH SCI, V74, P3385, DOI 10.1007/s12665-015-4374-y; Zhang FF, 2015, J INTEGR AGR, V14, P1295, DOI 10.1016/S2095-3119(14)60957-6; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Ziadi N, 2016, P 2016 INT NITR IN C	43	22	24	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2020	15	10							e0240662	10.1371/journal.pone.0240662	http://dx.doi.org/10.1371/journal.pone.0240662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PG8YH	33119630	gold, Green Published			2022-12-26	WOS:000600013600065
J	Benshaul-Tolonen, A; Aguilar-Gomez, S; Batzer, NH; Cai, R; Nyanza, EC				Benshaul-Tolonen, Anja; Aguilar-Gomez, Sandra; Batzer, Naomi Heller; Cai, Rebecca; Nyanza, Elias Charles			Period teasing, stigma and knowledge: A survey of adolescent boys and girls in Northern Tanzania	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; SCHOOL ABSENTEEISM; GENDER-DIFFERENCES; MENSTRUATION; ATTITUDES; EDUCATION; MENARCHE; EXPERIENCES; MANAGEMENT; HUSBANDS	Emerging evidence suggests that menstruation-related teasing is a common experience among adolescent girls with ramifications on their school participation, yet empirical evidence on the prevalence and determinants of period teasing in schools remain scarce. Menstrual hygiene research and policies almost exclusively focus on girls and women, leading to a dearth of knowledge of male attitudes. We conducted the first quantitative survey of period teasing in schools in sub-Saharan Africa, focusing on 432 male and 524 female students in four co-educational secondary schools in northern Tanzania. Period teasing is prevalent; 13% of girls have experienced period teasing, and more than 80% fear being teased, especially by male classmates. Girls' fears are associated with insufficient menstrual hygiene management resources and practices. Girls cope by reducing school attendance, participation, and concentration in the classroom during periods. Boys engage in period teasing because they perceive periods as embarrassing, especially visible markers of periods (odor or stains). Social norms, such as peer behavior and home restrictions on menstruating women, are associated with more teasing. Boys believe it is strongly inappropriate for girls to reveal period status or to discuss periods with males, including male teachers. In contrast, boys are well informed about basic biological facts of menstruation (scoring 60% on a knowledge quiz, not statistically different from the girls) and have received information from school curricula and health workers. Lack of suitable menstrual hygiene practices and restrictive social norms is correlated with period teasing, which hinders gender equality in educational opportunities. Providing narrowly bio-medical focused education about menstruation may not be enough to reduce period teasing in contexts with period stigma.	[Benshaul-Tolonen, Anja] Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA; [Aguilar-Gomez, Sandra; Batzer, Naomi Heller; Cai, Rebecca] Columbia Univ, New York, NY USA; [Nyanza, Elias Charles] Catholic Univ Hlth & Allied Sci, Dept Environm & Occupat Hlth, Mwanza, Tanzania	Columbia University; Columbia University	Benshaul-Tolonen, A (corresponding author), Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA.	atolonen@barnard.edu	Nyanza, Elias Charles/F-3009-2018	Nyanza, Elias Charles/0000-0002-8358-7358	Barnard College Presidential Research Award; Columbia University The Collaborative to Advance Equity through Research (CAETR) Seed Grant; Columbia University The Earth Institute	Barnard College Presidential Research Award; Columbia University The Collaborative to Advance Equity through Research (CAETR) Seed Grant; Columbia University The Earth Institute	AT received funding from Barnard College Presidential Research Award and Columbia University The Collaborative to Advance Equity through Research (CAETR) Seed Grant. SAG and NB received funding from Columbia University The Earth Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://barnard.edu/events/presidential-research-award-applications https://www.earth.columbia.edu/	Allen KR, 2011, J FAM ISSUES, V32, P129, DOI 10.1177/0192513X10371609; [Anonymous], 2020, Cancer Discov, V10, pOF8, DOI 10.1158/2159-8290.CD-ND2020-008; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Benshaul-Tolonen A., 2019, PUPIL ABSENTEEISM ME; Benshaul-Tolonen A, 2019, SANITARY PRODUCTS AB; Bloom SS, 2000, J BIOSOC SCI, V32, P237, DOI 10.1017/S0021932000002376; Chang YT, 2012, J CLIN NURS, V21, P513, DOI 10.1111/j.1365-2702.2011.03700.x; Chang YT, 2009, J CLIN NURS, V18, P2040, DOI 10.1111/j.1365-2702.2008.02545.x; Cheng CY, 2007, NURS HEALTH SCI, V9, P127, DOI 10.1111/j.1442-2018.2007.00312.x; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Dolan CS, 2014, J INT DEV, V26, P643, DOI 10.1002/jid.2917; Expert Panel on Gastrointestinal Imaging:, 2019, J Am Coll Radiol, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Girod C, 2017, J URBAN HEALTH, V94, P835, DOI 10.1007/s11524-017-0189-3; Grant M, 2013, COMP EDUC REV, V57, P260, DOI 10.1086/669121; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Hong J, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e34; Kothari B, 2010, INDIAN ANTHR, V40, P43; Mahon T., 2015, Waterlines, V34, P7, DOI 10.3362/1756-3488.2015.002; Mason L, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0435-x; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Mensch BS, 1998, STUD FAMILY PLANN, V29, P167, DOI 10.2307/172157; Montgomery P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166122; Mrina RD, 2009, THESIS; Ngilangwa DP, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.10922; Peranovic T, 2017, SEX ROLES, V77, P113, DOI 10.1007/s11199-016-0701-3; Phillips-Howard PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013229; Plan International UK CS, ON 5 UK GIRLS TEAS B; Rebacz E, 2009, COLLEGIUM ANTROPOL, V33, P23; Selamawit Tamiru, 2015, Waterlines, V34, P92, DOI 10.3362/1756-3488.2015.009; Shah V, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6599-2; Singh KK, 1998, STUD FAMILY PLANN, V29, P388, DOI 10.2307/172251; Sommer M, 2015, ARCH SEX BEHAV, V44, P583, DOI 10.1007/s10508-014-0406-z; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; UNESCO, OUT OF SCH RAT AD YO; UNICEF, 2017, MENSTR HYG MAN ETH N; Wong WC, 2013, J CLIN NURS, V22, P3320, DOI 10.1111/jocn.12462	40	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0239914	10.1371/journal.pone.0239914	http://dx.doi.org/10.1371/journal.pone.0239914			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112868	Green Published, gold			2022-12-26	WOS:000588374000075
J	Biermann, O; Tran, PB; Viney, K; Caws, M; Lonnroth, K; Annerstedt, KS				Biermann, Olivia; Phuong Bich Tran; Viney, Kerri; Caws, Maxine; Lonnroth, Knut; Annerstedt, Kristi Sidney			Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey with National Tuberculosis Programme managers and document review	PLOS ONE			English	Review							BENEFITS	Background The World Health Organization (WHO) stresses the importance of active case-finding (ACF) for early detection of tuberculosis (TB), especially in the 30 high-burden countries that account for almost 90% of cases globally. Objective To describe the attitudes of National TB Programme (NTP) managers related to ACF policy development, implementation and scale-up in the 30 high-burden countries, and to review national TB strategic plans. Methods This was a mixed-methods study with an embedded design: A cross-sectional survey with NTP managers yielded quantitative and qualitative data. A review of national TB strategic plans complemented the results. All data were analyzed in parallel and merged in the interpretation of the findings. Results 23 of the 30 NTP managers (77%) participated in the survey and 22 (73%) national TB strategic plans were reviewed. NTP managers considered managers in districts and regions key stakeholders for both ACF policy development and implementation. Different types of evidence were used to inform ACF policy, while there was a particular demand for local evidence. The NSPs reflected the NTP managers' unanimous agreement on the need for ACF scale-up, but not all included explicit aims and targets related to ACF. The NTP managers recognized that ACF may decrease health systems costs in the long-term, while acknowledging the risk for increased health system costs in the short-term. About 90% of the NTP managers declared that financial and human resources were currently lacking, while they also elaborated on strategies to overcome resource constraints. Conclusion NTP managers stated that ACF should be scaled up but reported resource constraints. Strategies to increase resources exist but may not yet have been fully implemented, e.g. generating local evidence including from operational research for advocacy. Managers in districts and regions were identified as key stakeholders whose involvement could help improve ACF policy development, implementation and scale-up.	[Biermann, Olivia; Phuong Bich Tran; Viney, Kerri; Lonnroth, Knut; Annerstedt, Kristi Sidney] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Viney, Kerri] Australian Natl Univ, Coll Hlth & Med, Res Sch Populat Hlth, Canberra, ACT, Australia; [Caws, Maxine] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Caws, Maxine] Birat Nepal Med Trust, Kathmandu, Nepal	Karolinska Institutet; Australian National University; Liverpool School of Tropical Medicine	Biermann, O (corresponding author), Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden.	olivia.biermann@ki.se	Lonnroth, Knut/H-5470-2017; Annerstedt, Kristi/AAJ-8678-2020	Lonnroth, Knut/0000-0001-6944-0256; Annerstedt, Kristi/0000-0002-8798-4027; Biermann, Olivia/0000-0002-5978-0211	European Union-Horizon [733174]	European Union-Horizon	This work was supported by the European Union-Horizon 2020-funded IMPACT-TB project (grant 733174). Funder website: https://ec.europa.eu/programmes/horizon2020/en.The grant was received by MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Biermann O, DOUBLE EDGED SWORD P; Boateng GO, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00149; Chakaya JM, 2020, INT J INFECT DIS, V92, pS51, DOI 10.1016/j.ijid.2020.02.021; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA16; El-Jardali F, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-2; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gonzalez Block Miguel A, 2003, Health Res Policy Syst, V1, P1, DOI 10.1186/1478-4505-1-1; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gurung SC, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0603-z; Harper I, 1996, TUBERCLE LUNG DIS, V77, P384, DOI 10.1016/S0962-8479(96)90107-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kasonde JM, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-31; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Li J, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0365-4; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Marks GB, 2019, NEW ENGL J MED, V381, P1347, DOI 10.1056/NEJMoa1902129; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; Orem Juliet Nabyonga, 2012, BMC Public Health, V12, P109, DOI 10.1186/1471-2458-12-109; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Shewade HD, 2020, INT J TUBERC LUNG D, V24, P464, DOI 10.5588/ijtld.19.0744; Shewade HD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213345; Shewade HD, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1494897; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; The World Bank, CLASS COUNTR INC; UN, 2018, AFESE; United Nations, 2015, 2030 AG SUST DEV; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; WHO, 2015, END TB STRAT GLOB ST; WHO, 2019, GLOB TB REP 2019; WHO, 2017, MIN C TB; WHO, 2008, IMPL WHO STOP TB STR; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization, 2015, US HIGH BURD COUNTR; World Health Organization, 2020, SCREEN PROGR SHORT G; 2014, REG ANESTH PAIN MED, V9	45	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240696	10.1371/journal.pone.0240696	http://dx.doi.org/10.1371/journal.pone.0240696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112890	Green Published, Green Accepted, gold			2022-12-26	WOS:000588374000056
J	Civaner, MM				Civaner, M. Murat			A follow-up study on the effects of an educational intervention against pharmaceutical promotion	PLOS ONE			English	Article							UNDERGRADUATE MEDICAL-EDUCATION; HIDDEN CURRICULUM; NURSING-STUDENTS; OF-INTEREST; INDUSTRY; ATTITUDES; PHYSICIANS; POLICIES; PRESCRIBERS; KNOWLEDGE	Background The promotion strategies of pharmaceutical companies create many problems including irrational prescribing, diminished trust in the patient-physician relationship and unnecessary increases in pharmaceutical costs. Educating prescribers is known to be one of the few potentially effective measures to counteract those impacts. However such educational programs are limited in the literature, and their effectiveness against the effects of hidden curriculum in the long term is unknown. This study aims to evaluate the effectiveness of an education program both in the short term and the long term after the students have been exposed to informal and hidden curriculum and various pharmaceutical promotion methods. Methods A longitudinal and controlled study was carried out in a school of medicine in Turkey where there are no restrictive policies for pharmaceutical promotion. A survey was applied to 123 students who attended the class throughout the terms of 2011-12, 2012-13, and 2013-14, evaluating the pre-educational status of students' opinions of promotion and any post-educational changes. A follow-up study four years later asked those three cohorts to fill out the same survey to see the possible effects of the clinical environment and various promotion methods. Also, the opinions of all 518 sixth-year students who had not taken the class in those three terms were compared to the educated students. Results The program was significantly effective in the short term in changing students' opinions and attitudes positively towards recognizing companies' discourse and promotion strategies. But in the long term, the education lost its ability to convince students of the importance of not getting financial support for scientific activities from pharmaceutical companies (p:0.006) and carrying out research (p<0.001). In addition, although the educated students were more aware that trivial gifts could influence prescriptions compared to the uneducated 6th year students (p<0.001), the difference between them and the uneducated students generally becomes less significant when they encounter the clinical environment. The study also evaluated students highly-exposed to promotion; for this sub-group, the educated students kept their consciousness level about the influences of trivial gifts (p<0.001) while the uneducated students were confident that they were immune to the influence of trivial gifts. Conclusions The education program could be used for creating awareness of, increasing skepticism towards, and inculcating disapproval about pharmaceutical promotion practices. However, the effectiveness of the educational intervention is susceptible to erosion after exposure to the informal and hidden curriculum together with exposure to promotion. The impact of role-models, organizational culture, and institutional policies could be important aspects to be addressed for sustaining the effectiveness of such education programs.	[Civaner, M. Murat] Bursa Uludag Univ, Dept Med Eth & Hist Med, Sch Med, Bursa, Turkey	Uludag University	Civaner, MM (corresponding author), Bursa Uludag Univ, Dept Med Eth & Hist Med, Sch Med, Bursa, Turkey.	mcivaner@gmail.com		Civaner, M. Murat/0000-0001-5376-3499	Uludag University Scientific Researches and Projects Unit [HDP(T)-2015/31]	Uludag University Scientific Researches and Projects Unit	This study was financially supported by Uludag University Scientific Researches and Projects Unit (No. HDP(T)-2015/31).	AE K B, 2017, PEDIAT DERMATOL, V34, pS203, DOI [10.1111/pde.13142, DOI 10.1111/PDE.13142]; Alvero R, 2007, TEACHING CRITICAL AP; Alves TL, 2019, SCI ENG ETHICS, V25, P1167, DOI 10.1007/s11948-018-0041-5; Angell M., 2005, TRUTH DRUG CO THEY D; [Anonymous], 2015, FORBES; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12, DOI DOI 10.1158/2159-8290.CD-RW2016-234; Ashmore R, 2007, NURS EDUC TODAY, V27, P551, DOI 10.1016/j.nedt.2006.08.016; Bank W., 1993, COMMUNICATION; Brody H, 2007, HOOKED ETHICMED PR; budras Corinna, 2008, FRANKFURTER ALLGEMEI, V7, pC5; Buman MP, 2011, J PHYS ACT HEALTH, V8, pS257, DOI 10.1123/jpah.8.s2.s257; Civaner M, 2006, MARKETING METHODS PH; Civaner MM, 2016, J BIOETHIC INQ, V13, P261, DOI 10.1007/s11673-016-9704-6; Civaner M, 2008, NURS ETHICS, V15, P396, DOI 10.1177/0969733007088364; Civaner M, 2012, HEALTH POLICY, V106, P225, DOI 10.1016/j.healthpol.2012.05.006; Elliot C, 2011, BEYAZ ONLUK SIYAH SA; Epstein AJ, 2013, MED CARE, V51, P199, DOI 10.1097/MLR.0b013e318277eb19; Goldie J, 2008, MED TEACH, V30, P513, DOI 10.1080/01421590801995225; Goozner M, 2004, 800 MILLION (DOLLAR) PILL: THE TRUTH BEHIND THE COST OF NEW DRUGS, P1; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Hafferty FW, 2009, HDB SOCIOLOGY MED ED, P26; Institute for Health & Socio-Economic Policy, 2016, R D SMOK PRIOR MARK; Kahwati L, 2017, J CONTIN EDUC HEALTH, V37, P129, DOI 10.1097/CEH.0000000000000150; Kao AC, 2011, ACAD MED, V86, P1454, DOI 10.1097/ACM.0b013e3182303895; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Koch C, 2020, J GEN INTERN MED, V35, P473, DOI 10.1007/s11606-019-05420-w; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; Lewis S, 2001, CAN MED ASSOC J, V165, P783; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; Mansfield P., 2019, HLTH SKEPTICISM IS N; Mansfield PR, 2006, PLOS MED, V3, P1988, DOI 10.1371/journal.pmed.0030451; Marchand B, 2011, 3 INT C IMPR US MED; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; Mintzes B, 2005, ED INITIATIVES MED P; Monaghan MS, 2003, TEACH LEARN MED, V15, P14, DOI 10.1207/S15328015TLM1501_04; Moynihan, 2005, SELLING SICKNESS WOR; Moynihan CK, 2018, J AM BOARD FAM MED, V31, P645, DOI 10.3122/jabfm.2018.04.170242; Mulder H, 2019, MED TEACH, V41, P36, DOI 10.1080/0142159X.2018.1436760; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Nayak V., 2011, ONLINE J HLTH ALLIED, V10, P1; Norris P, 2005, DRUG PROMOTION WHAT; O'Donoghue AC, 2015, J HEALTH COMMUN, V20, P1330, DOI 10.1080/10810730.2015.1018649; PALMISANO P, 1980, J MED EDUC, V55, P453; Prescrire, 2020, DRUGS 2019 BRIEF REV; Sarikaya O, 2009, ADV HEALTH SCI EDUC, V14, P713, DOI 10.1007/s10459-009-9153-7; Shankar P Ravi, 2012, BMC Res Notes, V5, P8, DOI 10.1186/1756-0500-5-8; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Silveira GL., 2019, HLTH PROF ED, V5, P198, DOI DOI 10.1016/J.HPE.2018.07.003; Slattery-Moschka K, 2005, SIDE EFFECTS; Stanley AG, 2005, BRIT J CLIN PHARMACO, V59, P464, DOI 10.1111/j.1365-2125.2005.02374.x; Statista TSP, 2017, GLOB PHARM IND STAT; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; The European Federation of Pharmaceutical Industries, 2018, PHARM IND FIG KEY DA; Tichelaar J, 2010, EUR J CLIN PHARMACOL, V66, P407, DOI 10.1007/s00228-009-0743-3; US Government Accountability Office, 2017, DRUG IND PROF RES DE; Vinson D C, 1993, Fam Med, V25, P31; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WHO, 2002, POL PERSP MED; Wilkes MS, 2001, ACAD MED, V76, P1271, DOI 10.1097/00001888-200112000-00026; Wofford James L, 2005, BMC Med Educ, V5, P5, DOI 10.1186/1472-6920-5-5; World Bank, 2003, INNOVATIONS HLTH SER	62	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2020	15	10							e0240713	10.1371/journal.pone.0240713	http://dx.doi.org/10.1371/journal.pone.0240713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OP8XL	33112908	Green Published, gold			2022-12-26	WOS:000588374000043
J	Chen, HL; Chen, G; Pan, Y; Jin, XX				Chen, Hualin; Chen, Gang; Pan, Yang; Jin, Xiaoxiang			Three-gene prognostic biomarkers for seminoma identified by weighted gene co-expression network analysis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EXPRESSION; ASSOCIATION; PACKAGE; BREAST; ITGAM	Testicular germ cell tumors (TGCTs) are common in young males, and seminoma accounts for a large proportion of TGCTs. However, there are limited records on the exploration of novel biomarkers for seminoma. Hence, we aimed to identify new biomarkers associated with overall survival in seminoma. mRNA-seq and clinical traits of TGCTs were downloaded from UCSC XENA and analyzed by weighted gene co-expression network analysis. After intersection with differentially expressed genes in GSE8607, common genes were subjected to protein-protein interaction (PPI) network construction and enrichment analyses. Then, the top 10 common genes were investigated by Kaplan-Meier (KM) survival analyses and univariate Cox regression analyses. Ultimately, TYROBP, CD68, and ITGAM were considered three prognostic biomarkers in seminoma. Based on correlation analysis between these genes and immune infiltrates, we suggest that the three biomarkers influence the survival of seminoma patients, possibly through regulating the infiltration of immune cells. In conclusion, our study demonstrated that TYROBP, CD68, and ITGAM could be regarded as prognostic biomarkers and therapeutic targets for seminoma patients.	[Chen, Hualin; Chen, Gang; Pan, Yang; Jin, Xiaoxiang] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China	Chongqing Medical University	Chen, G (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China.	chengang2308@163.com		Chen, Gang/0000-0002-9901-1927	Chongqing Science and Technology Commission [cstc2015shmszx120067]	Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC)	Corresponding author GC received the award Grant number: cstc2015shmszx120067 Full name of the funder: Chongqing Science and Technology Commission URL of the funder website: http://kjj.cq.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; [Anonymous], 2017, FERTIL STERIL S, V108, pe1; Ascierto PA, 2017, BIOMED CENTRAL; Boguslawska J, 2016, J UROLOGY, V195, P1892, DOI 10.1016/j.juro.2015.11.050; Capocaccia R, 2015, ANN ONCOL, V26, P1263, DOI 10.1093/annonc/mdv131; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen X, 2021, BRIEF BIOINFORM, V22, P485, DOI 10.1093/bib/bbz159; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Chen YH, 2019, ONCOTARGETS THER, V12, P3683, DOI 10.2147/OTT.S199115; Chin C., 2014, BMC SYSTEM BIOL, V8, P4; Chistiakov DA, 2017, LAB INVEST, V97, P4, DOI 10.1038/labinvest.2016.116; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Fankhauser CD, 2015, BRIT J CANCER, V113, P411, DOI 10.1038/bjc.2015.244; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Horwich A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5526; Hvarness T, 2013, J REPROD IMMUNOL, V100, P135, DOI 10.1016/j.jri.2013.10.005; Kirkley A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04978-z; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liu PF, 2015, PATHOL ONCOL RES, V21, P1077, DOI 10.1007/s12253-015-9926-7; Lyu TJ, 2020, INT J CANCER, V146, P1553, DOI 10.1002/ijc.32673; Ohtani Haruo, 2007, Cancer Immun, V7, P4; Okada K, 2003, INT J ONCOL, V23, P1615; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruf CG, 2014, UROLOGIC ONCOLOGY SE; Sadigh S, 2020, AM J CLIN PATHOL, V153, P387, DOI 10.1093/ajcp/aqz184; Salama A, 2019, APPL IMMUNOHISTOCHEM; Sfakianakis S, 2014, IEEE J BIOMED HEALTH, V18, P773, DOI 10.1109/JBHI.2013.2295262; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Terada T, 2017, J CLIN UROL, V10, P271, DOI 10.1177/2051415816647655; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang B, 2019, ONCOL LETT, V18, P3527, DOI 10.3892/ol.2019.10681; Wei JC, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00176; Yang J, 2020, AGING-US, V12, P6518, DOI 10.18632/aging.103100; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028	43	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0240943	10.1371/journal.pone.0240943	http://dx.doi.org/10.1371/journal.pone.0240943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104706	Green Published, gold			2022-12-26	WOS:000588370000022
J	Goodson, ML; Knotts, TA; Campbell, EL; Snyder, CA; Young, BM; Privalsky, ML				Goodson, Michael L.; Knotts, Trina A.; Campbell, Elsie L.; Snyder, Chelsea A.; Young, Briana M.; Privalsky, Martin L.			Specific ablation of the NCoR corepressor delta splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; NUCLEAR RECEPTORS; OXIDATIVE-PHOSPHORYLATION; LIPID-SYNTHESIS; RETINOIC ACID; SMRT; ALPHA; TRANSCRIPTION; REPRESSION; ISOFORMS	The NCoR corepressor plays critical roles in mediating transcriptional repression by both nuclear receptors and non-receptor transcription factors. Alternative mRNA splicing of NCoR produces a series of variants with differing molecular and biological properties. The NCoR omega splice-variant inhibits adipogenesis whereas the NCoR delta splice-variant promotes it, and mice bearing a splice-specific knockout of NCoR omega display enhanced hepatic steatosis and overall weight gain on a high fat diet as well as a greatly increased resistance to diet-induced glucose intolerance. We report here that the reciprocal NCoR delta splice-specific knock-out mice display the contrary phenotypes of reduced hepatic steatosis and reduced weight gain relative to the NCoR omega-/- mice. The NCoR delta-/- mice also fail to demonstrate the strong resistance to diet-induced glucose intolerance exhibited by the NCoR omega-/- animals. The NCoR delta and omega variants possess both unique and shared transcriptional targets, with expression of certain hepatic genes affected in opposite directions in the two mutants, others altered in one but not the other genotype, and yet others changed in parallel in both NCoR delta-/- and NCoR omega-/- animals versus WT. Gene set expression analysis (GSEA) identified a series of lipid, carbohydrate, and amino acid metabolic pathways that are likely to contribute to their distinct steatosis and glucose tolerance phenotypes. We conclude that alternative-splicing of the NCoR corepressor plays a key role in the regulation of hepatic energy storage and utilization, with the NCoR delta and NCoR omega variants exerting both opposing and shared functions in many aspects of this phenomenon and in the organism as a whole.	[Goodson, Michael L.; Campbell, Elsie L.; Snyder, Chelsea A.; Young, Briana M.; Privalsky, Martin L.] Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Knotts, Trina A.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Goodson, Michael L.; Knotts, Trina A.] Univ Calif Davis, Mouse Metab Phenotyping Ctr, Microbiome & Host Response Core, Davis, CA 95616 USA; [Goodson, Michael L.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Snyder, Chelsea A.] Gilead Sci, Foster City, CA USA; [Young, Briana M.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Gilead Sciences; University of California System; University of California Davis	Goodson, ML (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.; Goodson, ML (corresponding author), Univ Calif Davis, Mouse Metab Phenotyping Ctr, Microbiome & Host Response Core, Davis, CA 95616 USA.; Goodson, ML (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.	mlgoodson@ucdavis.edu	Goodson, Michael L/G-4175-2010	Goodson, Michael/0000-0002-3464-490X	Public Health Services/National Institutes of Health [NIEHST32-ES007059, NIDDK52528, U24 DK09293]; American Diabetes Association [ADA712BS151]	Public Health Services/National Institutes of Health; American Diabetes Association(American Diabetes Association)	MLP: Funded in part by Public Health Services/National Institutes of Health award NIDDK52528 and American Diabetes Association award ADA712BS151. CAS: Funded in part by Public Health Services/National Institutes of Health NIEHST32-ES007059. Funding of the UC Davis Mouse Biology Program was in part through Public Health Services/National Institutes of Health Grant U24 DK09293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; [Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P1202, DOI 10.15585/mmwr.mm6543a6; [Anonymous], 2003, J Pain Palliat Care Pharmacother, V17, P273; [Anonymous], 2013, JEMDSA, V18, P106; [Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2005, ANN FAM MED S1, V3, pS2; Araki O, 2009, MOL ENDOCRINOL, V23, P308, DOI 10.1210/me.2008-0311; Astapova I, 2013, BBA-GEN SUBJECTS, V1830, P3876, DOI 10.1016/j.bbagen.2012.07.001; B'chir W, 2018, ENDOCRINOLOGY, V159, P2153, DOI 10.1210/en.2018-00115; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Faist F, 2009, BIOSCIENCE REP, V29, P143, DOI 10.1042/BSR20080093; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Goodson ML, 2014, MOL CELL BIOL, V34, P4104, DOI 10.1128/MCB.00554-14; Goodson ML, 2011, J BIOL CHEM, V286, P44988, DOI 10.1074/jbc.M111.291625; Goodson Michael L, 2007, Nucl Recept Signal, V5, pe002; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Guo MMWC, 2014, AM J CLIN EXP UROL, V2, P169; Harrus D, 2018, THYROID, V28, P1708, DOI 10.1089/thy.2017.0551; Hsia EY, 2010, ADV DRUG DELIVER REV, V62, P1227, DOI 10.1016/j.addr.2010.09.016; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Hudson GM, 2015, J BIOL CHEM, V290, P18237, DOI 10.1074/jbc.M115.661058; Jepsen K, 2002, J CELL SCI, V115, P689; Jonas BA, 2007, MOL ENDOCRINOL, V21, P1924, DOI 10.1210/me.2007-0035; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Jornayvaz FR, 2012, ENDOCRINOLOGY, V153, P583, DOI 10.1210/en.2011-1793; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Kim YH, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa014; LENTI G, 1974, MINERVA MED, V65, P3041; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Liang N, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00411; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malartre M, 2006, DEV BIOL, V292, P333, DOI 10.1016/j.ydbio.2006.01.007; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Mengeling BJ, 2012, MOL CELL ENDOCRINOL, V351, P306, DOI 10.1016/j.mce.2012.01.006; Mengeling BJ, 2011, J BIOL CHEM, V286, P4236, DOI 10.1074/jbc.M110.200964; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ordentlich P, 2001, CURR TOP MICROBIOL, V254, P101; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Privalsky ML, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0781-2; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Seol W, 1996, MOL ENDOCRINOL, V10, P1646, DOI 10.1210/me.10.12.1646; Short S, 2005, BIOCHEM BIOPH RES CO, V334, P845, DOI 10.1016/j.bbrc.2005.06.175; Snyder CA, 2015, MOL CELL ENDOCRINOL, V413, P228, DOI 10.1016/j.mce.2015.06.036; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Team R.C, R LANG ENV STAT COMP; Tran M, 2018, HEPATOL COMMUN, V2, P765, DOI 10.1002/hep4.1203; Vella KR, 2014, MOL CELL BIOL, V34, P1564, DOI 10.1128/MCB.00129-14; Vluggens A, 2012, CURR DRUG METAB, V13, P1422, DOI 10.2174/138920012803762710; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zhang LD, 2013, CANCER RES, V73, P246, DOI 10.1158/0008-5472.CAN-12-2241; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	68	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2020	15	10							e0241238	10.1371/journal.pone.0241238	http://dx.doi.org/10.1371/journal.pone.0241238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OP8VY	33104749	gold, Green Published			2022-12-26	WOS:000588370000050
J	Tadic, B; Melnik, R				Tadic, Bosiljka; Melnik, Roderick			Modeling latent infection transmissions through biosocial stochastic dynamics	PLOS ONE			English	Article								The events of the recent SARS-CoV-2 epidemics have shown the importance of social factors, especially given the large number of asymptomatic cases that effectively spread the virus, which can cause a medical emergency to very susceptible individuals. Besides, the SARS-CoV-2 virus survives for several hours on different surfaces, where a new host can contract it with a delay. These passive modes of infection transmission remain an unexplored area for traditional mean-field epidemic models. Here, we design an agent-based model for simulations of infection transmission in an open system driven by the dynamics of social activity; the model takes into account the personal characteristics of individuals, as well as the survival time of the virus and its potential mutations. A growing bipartite graph embodies this biosocial process, consisting of active carriers (host) nodes that produce viral nodes during their infectious period. With its directed edges passing through viral nodes between two successive hosts, this graph contains complete information about the routes leading to each infected individual. We determine temporal fluctuations of the number of exposed and the number of infected individuals, the number of active carriers and active viruses at hourly resolution. The simulated processes underpin the latent infection transmissions, contributing significantly to the spread of the virus within a large time window. More precisely, being brought by social dynamics and exposed to the currently existing infection, an individual passes through the infectious state until eventually spontaneously recovers or otherwise is moves to a controlled hospital environment. Our results reveal complex feedback mechanisms that shape the dependence of the infection curve on the intensity of social dynamics and other sociobiological factors. In particular, the results show how the lockdown effectively reduces the spread of infection and how it increases again after the lockdown is removed. Furthermore, a reduced level of social activity but prolonged exposure of susceptible individuals have adverse effects. On the other hand, virus mutations that can gradually reduce the transmission rate by hopping to each new host along the infection path can significantly reduce the extent of the infection, but can not stop the spreading without additional social strategies. Our stochastic processes, based on graphs at the interface of biology and social dynamics, provide a new mathematical framework for simulations of various epidemic control strategies with high temporal resolution and virus traceability.	[Tadic, Bosiljka] Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia; [Tadic, Bosiljka] Complex Sci Hub, Vienna, Austria; [Melnik, Roderick] Wilfrid Laurier Univ, Lab M2NeT, Interdisciplinary Res Inst MS2Discovery, Waterloo, ON, Canada; [Melnik, Roderick] Wilfrid Laurier Univ, Dept Math, Interdisciplinary Res Inst MS2Discovery, Waterloo, ON, Canada; [Melnik, Roderick] BCAM Basque Ctr Appl Math, Bilbao, Spain	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Wilfrid Laurier University; Wilfrid Laurier University; Basque Center for Applied Mathematics (BCAM)	Tadic, B (corresponding author), Jozef Stefan Inst, Dept Theoret Phys, Ljubljana, Slovenia.; Tadic, B (corresponding author), Complex Sci Hub, Vienna, Austria.	Bosiljka.Tadic@ijs.si	MELNIK, RODERICK/AAT-9345-2021	Melnik, Roderick/0000-0002-1560-6684	Slovenian Research Agency [P1-0044]; Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Research Chairs (CRC) Program; BERC 2018-2021 program; Spanish Ministry of Science, Innovation, and Universities through the Agencia Estatal de Investigacion (AEI) BCAM Severo Ochoa excellence accreditation [SEV-2017-0718]; Basque Government fund AI in BCAM [2019/00432]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); BERC 2018-2021 program; Spanish Ministry of Science, Innovation, and Universities through the Agencia Estatal de Investigacion (AEI) BCAM Severo Ochoa excellence accreditation(Spanish Government); Basque Government fund AI in BCAM	B.T. work is supported by the Slovenian Research Agency (research code funding number P1-0044). R.M. research was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada and Canada Research Chairs (CRC) Program and he is also acknowledging the support of the BERC 2018-2021 program and Spanish Ministry of Science, Innovation, and Universities through the Agencia Estatal de Investigacion (AEI) BCAM Severo Ochoa excellence accreditation SEV-2017-0718, and the Basque Government fund AI in BCAM EXP. 2019/00432.	Adam D, 2020, NATURE, V583, P346, DOI 10.1038/d41586-020-02009-w; Allen L, 2008, INTRO STOCHASTIC EPI; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2019, CIRCULATION, V2019; Aschwanden M, 2012, THEORETICAL MODELS S; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; Burda Z, 2020, ARXIV200615583; Cai J, 2020, EMERG INFECT DIS, V26, P1343, DOI 10.3201/eid2606.200412; Castella F, 2020, ARXIV200306967V4; Chang SL, 2020, ARXIV200310218V1; Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004; Christopoulos DT, 2020, NOVEL APPROACH ESTIM; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Dankulov MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12197; Doms R.W., 2016, VIRAL PATHOGENESIS P, P29, DOI 10.1016/B978-0-12-800964-2.00003-3; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Enyoh CE, 2020, INDIRECT EXPOSURE NO; Ferris MT, 2016, VIRAL PATHOGENESIS, P169; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Grant A, 2020, REPROD NUMBER R COVI; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Jackson ML, 2020, LOW IMPACT SOCIAL DI; Johnson JR., 2016, VIRAL PATHOGENESIS, P157, DOI [10.1016/b978-0-12-800964-2.00012-4, DOI 10.1016/B978-0-12-800964-2.00012-4]; Kermack WO, 1927, P ROY SOC LOND A MAT, P115700; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lahiri D, 2020, IMPACT COVID 19 RELA; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Lu C, 2020, GENETIC RISK FACTORS; Lythgoe KA, 2020, BIORXIV; Magal P, 2020, PREDICTING NUMBER RE; Mitrovic M, 2012, PHYSICA A, V391, P5264, DOI 10.1016/j.physa.2012.06.004; Muller SA., 2020, MODUS COVID BERICHT, DOI [10.14279/DEPOSITONCE-10553, DOI 10.14279/DEPOSITONCE-10553]; Paiva HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236386; Rotkirch, 2020, ARXIV200413553; Suvakov M, 2014, CONDENS MATTER PHYS, V17, DOI 10.5488/CMP.17.33801; Tadi B, 2017, CYBEREMOTIONS, P207; Tadi B, 2013, ADV COMPUTATIONAL MO, P177; Tadic B, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.032307; Tadic B, 2013, ENTROPY-SWITZ, V15, P5084, DOI 10.3390/e15125084; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Vankadari N, 2020, GENE, V752, DOI 10.1016/j.gene.2020.144792; Viswanath NC, 2020, PREDICTION COVID 19; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wolfram C, 2020, COMPLEX SYST, V29, P87, DOI 10.25088/ComplexSystems.29.1.87; World Health Organization Team, MOD TRANSM VIR CAUS; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Xia HX, 2011, INT J KNOWL SYST SCI, V2, P72, DOI 10.4018/jkss.2011100106; Zhang YH, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110195; Zhao J, 2020, BIORXIV; 2012, BIOPRESERV BIOBANK, V10	54	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2020	15	10							e0241163	10.1371/journal.pone.0241163	http://dx.doi.org/10.1371/journal.pone.0241163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4BV	33095815	Green Submitted, Green Published, gold			2022-12-26	WOS:000586649400004
J	Murato, Y; Hayama, Y; Shimizu, Y; Sawai, K; Yamamoto, T				Murato, Yoshinori; Hayama, Yoko; Shimizu, Yumiko; Sawai, Kotaro; Yamamoto, Takehisa			Evaluation of sampling methods for effective detection of infected pig farms during a disease outbreak	PLOS ONE			English	Article								Emergency surveillance following an outbreak of transboundary animal diseases such as classical swine fever (CSF), is conducted to find another new infection as early as possible. Although larger sample sizes can help achieve higher disease surveillance sensitivity, the sample size is limited by the availability of resources in an emergency situation. Moreover, the recent CSF outbreak reported in Japan was associated with fewer clinical signs; this emphasizes the importance of detecting infected farms by surveillance. In this study, we aimed to identify effective and labor-efficient sampling methods showing high probabilities of detecting infection, by simulating infection and sampling in pigsties. We found that impartial sampling, which involves selection of pigs to be sampled from the four corners and the center of the pigsty, and random sampling showed comparable probabilities of detection. Impartial sampling involves sample collection without pig identification and random selection. Owing to its simplicity, impartial sampling is labor-efficient and thus a possible substitute for random sampling. In a group-housing pigsty, testing five pigs from five pens showed a higher detection probability than testing five pigs from one pen. These results suggest preferable surveillance methods for conducting emergency surveillance of infectious diseases.	[Murato, Yoshinori; Hayama, Yoko; Shimizu, Yumiko; Sawai, Kotaro; Yamamoto, Takehisa] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Yamamoto, T (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Viral Dis & Epidemiol Res Div, Tsukuba, Ibaraki, Japan.	mtbook@affrc.go.jp		Sawai, Kotaro/0000-0003-1085-5144; Yamamoto, Takehisa/0000-0002-8707-0639	Ministry of Agriculture, Forestry and Fisheries of Japan [JPJ008617.18065101, JPJ008617, 20319390]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was conducted under the research project on "Regulatory research projects for food safety, animal health and plant protection (JPJ008617.18065101 and JPJ008617. 20319390)" funded by the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, LANCET PSYCHIAT, V6, P187, DOI 10.1016/S2215-0366(19)30051-3; [Anonymous], 1998, ISCHE NEWS PH, V34, P1; Blome S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040086; Cameron A., 2003, Animal disease surveillance and survey systems: methods and applications, P47, DOI 10.1002/9780470344866.ch4; Cameron AR, 1998, PREV VET MED, V34, P19, DOI 10.1016/S0167-5877(97)00073-1; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; Food and Agriculture Organization of the United Nations, 2014, FAO ANIMAL PRODUCTIO; Kameyama K, 2019, J VET MED SCI, V81, P1277, DOI 10.1292/jvms.19-0133; Klinkenberg D, 2002, EPIDEMIOL INFECT, V128, P293, DOI 10.1017/S0950268801006537; Ministry of Agriculture Forestry and Fisheries, 2019, LIV IND STAT; Ministry of Agriculture Forestry and Fisheries, 2020, SPEC DOM AN INF DIS; Ministry of Agriculture Forestry and Fisheries, 2019, INT REP EP INV CLASS; Nishi T, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.01362-18, 10.1128/mra.01362-18]; Postel A, 2019, EMERG INFECT DIS, V25, P1228, DOI 10.3201/eid2506.181578; World Organisation for Animal Health (OIE), 2019, TERR AN HLTH COD	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241177	10.1371/journal.pone.0241177	http://dx.doi.org/10.1371/journal.pone.0241177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091063	gold, Green Published			2022-12-26	WOS:000586647200031
J	Oyeleye, AO; Yusoff, SFM; Abd Rahim, IN; Leow, ATC; Saidi, NB; Normi, YM				Oyeleye, Ayokunmi Omolola; Yusoff, Siti Faridah Mohd; Abd Rahim, Izzah Nadiah; Leow, Adam Thean Chor; Saidi, Noor Baity; Normi, Yahaya M.			Effective refolding of a cysteine rich glycoside hydrolase family 19 recombinant chitinase fromStreptomyces griseusby reverse dilution and affinity chromatography	PLOS ONE			English	Article							INCLUSION-BODIES; BINDING DOMAIN; PROTEINS; SOLUBILIZATION; PRESSURE; RECOVERY; ARGININE	Conventional refolding methods are associated with low yields due to misfolding and high aggregation rates or very dilute proteins. In this study, we describe the optimization of the conventional methods of reverse dilution and affinity chromatography for obtaining high yields of a cysteine rich recombinant glycoside hydrolase family 19 chitinase fromStreptomyces griseusHUT6037 (SgChiC). SgChiC is a potential biocontrol agent and a reference enzyme in the study and development of chitinases for various applications. The overexpression of SgChiC was previously achieved by periplasmic localization from where it was extracted by osmotic shock and then purified by hydroxyapatite column chromatography. In the present study, the successful refolding and recovery of recombinant SgChiC (r-SgChiC) from inclusion bodies (IB) by reverse dilution and column chromatography methods is respectively described. Approximately 8 mg of r-SgChiC was obtained from each method with specific activities of 28 and 52 U/mg respectively. These yields are comparable to that obtained from a 1 L culture volume of the same protein isolated from the periplasmic space ofE.coliBL21 (DE3) as described in previous studies. The higher yields obtained are attributed to the successful suppression of aggregation by a stepwise reduction of denaturant from high, to intermediate, and finally to low concentrations. These methods are straight forward, requiring the use of fewer refolding agents compared with previously described refolding methods. They can be applied to the refolding of other cysteine rich proteins expressed as inclusion bodies to obtain high yields of actively folded proteins. This is the first report on the recovery of actively folded SgChiC from inclusion bodies.	[Oyeleye, Ayokunmi Omolola; Yusoff, Siti Faridah Mohd; Abd Rahim, Izzah Nadiah; Leow, Adam Thean Chor; Saidi, Noor Baity; Normi, Yahaya M.] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Oyeleye, Ayokunmi Omolola; Leow, Adam Thean Chor; Normi, Yahaya M.] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang, Selangor, Malaysia; [Oyeleye, Ayokunmi Omolola] Forestry Res Inst Nigeria, Biomed Res Ctr, Ibadan, Oyo State, Nigeria	Universiti Putra Malaysia; Universiti Putra Malaysia	Normi, YM (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia.; Normi, YM (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang, Selangor, Malaysia.	normi_yahaya@upm.edu.my	Saidi, Noor Baity/A-8423-2017	Saidi, Noor Baity/0000-0002-0715-2133; Mohd Yahaya, Normi/0000-0003-0707-7361	Universiti Putra Malaysia through the Putra Postgraduate Initiative Grant [9631700]; Organization for Women in Science for the Developing World (OWSD)	Universiti Putra Malaysia through the Putra Postgraduate Initiative Grant; Organization for Women in Science for the Developing World (OWSD)	This work is supported by Universiti Putra Malaysia through the Putra Postgraduate Initiative Grant (No. 9631700) awarded to AOO and YMN. The Organization for Women in Science for the Developing World (OWSD) awarded Ph.D. scholarship to AOO. Both organisations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; [Anonymous], 2012, REGEN MED S3, V7, pS14; Azwanida N., 2015, MED AROMAT PLANTS, V4, P2167, DOI [10.4172/2167-0412.1000196, DOI 10.4172/2167-0412.1000196]; Balduino KN, 2011, MOL BIOTECHNOL, V48, P228, DOI 10.1007/s12033-010-9363-5; Baumgarten T, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00270-18; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Bevacizumab Wins Cost Effectiveness Contest in First Line, 2015, AM HLTH DRUG BENEFIT, V8, P10; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Chakraborty A, 2005, J COLLOID INTERF SCI, V287, P312, DOI 10.1016/j.jcis.2005.01.071; Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024; Chura-Chambi RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211162; Fan JY, 2016, PROTEIN EXPRES PURIF, V125, P68, DOI 10.1016/j.pep.2015.09.007; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Gautam S, 2012, RECENT PAT BIOTECHNO; Gu ZY, 2002, PROTEIN EXPRES PURIF, V25, P174, DOI 10.1006/prep.2002.1624; Gupta SK, 2016, CRIT REV BIOTECHNOL, V36, P1089, DOI 10.3109/07388551.2015.1084264; Hoell IA, 2006, FEBS J, V273, P4889, DOI 10.1111/j.1742-4658.2006.05487.x; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Ito L, 2011, PROTEIN ENG DES SEL, V24, P269, DOI 10.1093/protein/gzq101; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; Itoh Y, 2016, FAMILY 19 CHITINASE, P8451; Itoh Y, 2006, APPL MICROBIOL BIOT, V72, P1176, DOI 10.1007/s00253-006-0405-7; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawase T, 2006, BIOSCI BIOTECH BIOCH, V70, P988, DOI 10.1271/bbb.70.988; Kezuka Y, 2006, J MOL BIOL, V358, P472, DOI 10.1016/j.jmb.2006.02.013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langenhof M, 2005, J CHROMATOGR A, V1069, P195, DOI 10.1016/j.chroma.2005.01.063; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Oganesyan N, 2004, PHARMOGENOMICS; Ogura K, 2013, PROTEIN ENG DES SEL, V26, P409, DOI 10.1093/protein/gzt012; Ohno T, 1996, J BACTERIOL, V178, P5065, DOI 10.1128/jb.178.17.5065-5070.1996; Ostermeier M, 1996, J BIOL CHEM, V271, P10616, DOI 10.1074/jbc.271.18.10616; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Rinas U, 2017, TRENDS BIOCHEM SCI, V42, P726, DOI 10.1016/j.tibs.2017.01.005; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Rodrigues D, 2014, J BIOTECHNOL, V173, P98, DOI 10.1016/j.jbiotec.2013.12.006; Santos CA, 2012, PROTEIN EXPRES PURIF, V82, P284, DOI 10.1016/j.pep.2012.01.010; Sarker A, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1053-9; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200; Suguitan Jr AL, 2011, PLOS ONE, V6; To EWH, 2003, INT J ORAL MAX SURG, V32, P104, DOI 10.1054/ijom.2001.0217; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11; Veldkamp CT, 2007, PROTEIN EXPRES PURIF, V52, P202, DOI 10.1016/j.pep.2006.09.009; Watanabe T, 1999, MICROBIOL-SGM, V145, P3353, DOI 10.1099/00221287-145-12-3353; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yamaguchi H, 2014, BIOMOLECULES, V4, P235, DOI 10.3390/biom4010235	61	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2020	15	10							e0241074	10.1371/journal.pone.0241074	http://dx.doi.org/10.1371/journal.pone.0241074			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ON4AZ	33091044	gold, Green Published, Green Accepted			2022-12-26	WOS:000586647200060
J	Arnould, L; Guillemin, M; Seydou, A; Gabrielle, PH; Bourredjem, A; Kawasaki, R; Binquet, C; Bron, AM; Creuzot-Garcher, C				Arnould, Louis; Guillemin, Martin; Seydou, Alassane; Gabrielle, Pierre-Henry; Bourredjem, Abderrahmane; Kawasaki, Ryo; Binquet, Christine; Bron, Alain M.; Creuzot-Garcher, Catherine			Association between the retinal vascular network and retinal nerve fiber layer in the elderly: The Montrachet study	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; VESSEL DIAMETER; FRACTAL DIMENSION; DISC SIZE; THICKNESS; CALIBER; DETERMINANTS; GEOMETRY; RISK	Purpose To investigate the association between the characteristics of the retinal vascular network in the elderly and retinal nerve fiber layer (RNFL) thickness in a population-based study. Methods We conducted a population-based study, the Montrachet study (Maculopathy Optic Nerve, nuTRition neurovAsCular, and HEarT disease), in participants aged >= 75 years. RNFL thickness was assessed with spectral-domain optical coherence tomography (SD-OCT). Analysis of the retinal vascular network was performed by means of the Singapore "I" Vessel Assessment (SIVA) software based on fundus photography. Results Data from 970 participants were suitable for analysis. Patients with optic neuropathy were excluded. In multivariable analysis, each standard deviation (SD) decrease in the caliber of the six largest arterioles and veins in zone B and the six largest arterioles and veins in zone C was associated with a decrease in global RNFL thickness (beta = -1.62 mu m,P= 0.001; beta = -2.39 mu m,P< 0.001; beta = -1.56 mu m,P= 0.002; and beta = -2.64 mu m,P< 0.001, respectively). Conclusions Our study found that decreased retinal vessels caliber were associated with a decreased RNFL thickness in the elderly without optic neuropathy.	[Arnould, Louis; Guillemin, Martin; Gabrielle, Pierre-Henry; Bron, Alain M.; Creuzot-Garcher, Catherine] Univ Hosp, Dept Ophthalmol, Dijon, France; [Arnould, Louis; Seydou, Alassane; Bourredjem, Abderrahmane; Binquet, Christine] INSERM, CIC1432, Clin Epidemiol Unit, Dijon, France; [Arnould, Louis; Seydou, Alassane; Bourredjem, Abderrahmane; Binquet, Christine] Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France; [Arnould, Louis; Seydou, Alassane; Gabrielle, Pierre-Henry; Bron, Alain M.; Creuzot-Garcher, Catherine] Univ Bourgogne Franche Comte, INRAE, CNRS, Ctr Sci Gout & Alimentat,AgroSup Dijon, Dijon, France; [Kawasaki, Ryo] Osaka Univ, Grad Sch Med, Dept Vis Informat, Suita, Osaka, Japan	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Osaka University	Arnould, L (corresponding author), Univ Hosp, Dept Ophthalmol, Dijon, France.; Arnould, L (corresponding author), INSERM, CIC1432, Clin Epidemiol Unit, Dijon, France.; Arnould, L (corresponding author), Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France.; Arnould, L (corresponding author), Univ Bourgogne Franche Comte, INRAE, CNRS, Ctr Sci Gout & Alimentat,AgroSup Dijon, Dijon, France.	louis.arnould@chu-dijon.fr	Arnould, Louis/AAG-2207-2021; Binquet, Christine/E-8953-2018; Kawasaki, Ryo/B-7266-2009; GABRIELLE, Pierre-Henry/Y-4971-2018	Binquet, Christine/0000-0002-9417-5754; Kawasaki, Ryo/0000-0002-7492-6303; GABRIELLE, Pierre-Henry/0000-0002-9688-4845; Alassane, Seydou/0000-0001-8958-6834	Programme Hospitalier de Recherche Clinique; Regional Council of Burgundy; INRA; CNRS; Universite de Bourgogne; FEDER (European Funding for Regional Economic Development); French Government [ANR-11-LABX-0021-01]; Regional Council of Burgundy France (PARI Agrale 1)	Programme Hospitalier de Recherche Clinique; Regional Council of Burgundy(Region Bourgogne-Franche-Comte); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Bourgogne; FEDER (European Funding for Regional Economic Development); French Government; Regional Council of Burgundy France (PARI Agrale 1)(Region Bourgogne-Franche-Comte)	This study was supported by an interregional grant (Programme Hospitalier de Recherche Clinique) and the Regional Council of Burgundy; by INRA, CNRS, Universite de Bourgogne, Regional Council of Burgundy France (PARI Agrale 1), FEDER (European Funding for Regional Economic Development); and a French Government grant managed by the French National Research Agency (ANR) under the "Investissements d'Avenir" program, ANR-11-LABX-0021-01-LipSTIC Labex.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Amerasinghe N, 2008, INVEST OPHTH VIS SCI, V49, P5397, DOI 10.1167/iovs.08-2142; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; Arnould L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194694; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Carpineto P, 2016, EYE, V30, P673, DOI 10.1038/eye.2016.13; Chauhan BC, 2015, OPHTHALMOLOGY, V122, P1786, DOI 10.1016/j.ophtha.2015.06.001; CHEN HC, 1994, EYE, V8, P97, DOI 10.1038/eye.1994.19; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, INVEST OPHTH VIS SCI, V52, P9629, DOI 10.1167/iovs.11-7481; Cheung Carol Yim-lui, 2012, J Diabetes Sci Technol, V6, P595; Chiquet C, ACTA OPHTHALMOL; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Creuzot-Garcher C, 2016, ACTA OPHTHALMOL, V94, pE90, DOI 10.1111/aos.12842; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Dumskyj MJ, 1996, CURR EYE RES, V15, P625, DOI 10.3109/02713689609008902; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gofas-Salas E, 2019, BIOMED OPT EXPRESS, V10, P2730, DOI 10.1364/BOE.10.002730; Grauslund J, 2010, OPHTHALMOLOGY, V117, P1400, DOI 10.1016/j.ophtha.2009.10.047; Hao H, 2012, INVEST OPHTH VIS SCI, V53, P5799, DOI 10.1167/iovs.11-9326; Hart WE, 1999, INT J MED INFORM, V53, P239, DOI 10.1016/S1386-5056(98)00163-4; Higashide T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147782; Ikram MK, 2005, INVEST OPHTH VIS SCI, V46, P1182, DOI 10.1167/iovs.04-1459; Jeon SJ, 2016, INVEST OPHTH VIS SCI, V57, P4008, DOI 10.1167/iovs.16-19525; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kawasaki R, 2011, NEUROLOGY, V76, P1766, DOI 10.1212/WNL.0b013e31821a7d7d; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P84, DOI 10.1016/j.ophtha.2012.07.007; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Lee SH, 2019, RETINA-J RET VIT DIS, V39, P1810, DOI 10.1097/IAE.0000000000002216; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Lim HB, 2019, JAMA OPHTHALMOL; Masters BR, 2004, ANNU REV BIOMED ENG, V6, P427, DOI 10.1146/annurev.bioeng.6.040803.140100; Mauschitz MM, 2018, OPHTHALMOLOGY, V125, P1526, DOI 10.1016/j.ophtha.2018.03.026; Mitchell P, 2005, OPHTHALMOLOGY, V112, P245, DOI 10.1016/j.ophtha.2004.08.015; Nagai-Kusuhara A, 2008, BRIT J OPHTHALMOL, V92, P186, DOI 10.1136/bjo.2007.127480; Schuster AKG, 2016, GRAEF ARCH CLIN EXP, V254, P2011, DOI 10.1007/s00417-016-3422-y; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Tham YC, 2013, INVEST OPHTH VIS SCI, V54, P7309, DOI 10.1167/iovs.13-12796; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wu RY, 2013, OPHTHALMOLOGY, V120, P77, DOI 10.1016/j.ophtha.2012.07.063; Yamashita T, 2017, J GLAUCOMA, V26, P34, DOI 10.1097/IJG.0000000000000550; Zhao L, 2014, ACTA OPHTHALMOL, V92, pE35, DOI 10.1111/aos.12240; Zheng YF, 2009, INVEST OPHTH VIS SCI, V50, P4091, DOI 10.1167/iovs.09-3444; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	52	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241055	10.1371/journal.pone.0241055	http://dx.doi.org/10.1371/journal.pone.0241055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085730	gold, Green Published			2022-12-26	WOS:000585943400012
J	Guo, SM; Zhang, FX; Chen, Y; Chen, YT; Shushakova, N; Yao, Y; Zeng, R; Li, JH; Lu, X; Chen, RJ; Haller, H; Gueler, F; Xu, G; Rong, S				Guo, Shuiming; Zhang, Fuxiang; Chen, Ying; Chen, Yuetao; Shushakova, Nelli; Yao, Ying; Zeng, Rui; Li, Junhua; Lu, Xia; Chen, Rongjun; Haller, Hermann; Gueler, Faikah; Xu, Gang; Rong, Song			Pre-ischemic renal lavage protects against renal ischemia-reperfusion injury by attenuation of local and systemic inflammatory responses	FASEB JOURNAL			English	Article						hypoxic; reoxygenation; inflammation; macrophage; pre-ischemic renal lavage; renal IRI	HYPOXIA; IMPACT; CELLS	Postischemic acute kidney injury (AKI) is a common clinical complication and often fatal, with no effective treatment available. Little is known about the role of leukocytes trapped in renal vessels during ischemia-reperfusion injury (IRI) in the postischemic AKI. We designed a new animal model in rats with preforming renal artery lavage prior to IRI to investigate the effect of diminishing the residual circulating leukocytes on kidney damage and inflammation. Moreover, the functional changes of macrophages in hypoxia reoxygenation condition were also analyzed. We found pre-ischemic renal lavage significantly decreased the serum creatinine and blood urea nitrogen levels, and downregulated the mRNA and protein expressions in kidneys and urinary secretion of kidney injury molecule-1 of rats after IRI. The renal pathological damage caused by IRI was also ameliorated by pre-ischemic renal lavage, as evidenced by fewer cast formation, diminished morphological signs of AKI in the tissue at 24 hours after IRI. Pre-ischemic renal lavage reduced the numbers of infiltrating CD68(+)macrophages and MPO(+)neutrophils. The mRNA expression of pro-inflammatory mediator in IRI kidneys and the levels of pro-inflammatory cytokines in circulatory system and urine were also reduced due to pre-ischemic lavage. Compared with nontreated rats with IRI, pre-ischemic renal lavage significantly reduced the phosphorylation levels of ERK and p65 subunit of NF-kappa B in the kidney after IRI. In addition, we found hypoxia/reoxygenation could promote the expression of pro-inflammatory mediators and inhibit the expression of anti-inflammatory factors by regulating ERK/NF-kappa B signaling pathway. Thus, pre-ischemic renal lavage could clearly reduce the renal damage after IRI by attenuating inflammation, and macrophages trapped in renal vessels during IRI could be important pathogenic factors driving tissue injury.	[Guo, Shuiming; Yao, Ying; Zeng, Rui; Li, Junhua; Xu, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China; [Zhang, Fuxiang] Shandong First Med Univ, Shandong Prov Qianfoshan Hosp, Hosp 1, ICU, Jinan, Peoples R China; [Chen, Ying] First Peoples Hosp Yichang, Dept Nephrol, Yichang, Peoples R China; [Chen, Yuetao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Resp,Div Internal Med, Wuhan, Peoples R China; [Shushakova, Nelli; Haller, Hermann; Gueler, Faikah; Rong, Song] Hannover Med Sch, Dept Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Lu, Xia] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Organ Transplantat, Wuhan, Peoples R China; [Chen, Rongjun] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany	Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Huazhong University of Science & Technology; Hannover Medical School; Huazhong University of Science & Technology; Hannover Medical School	Guo, SM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Nephrol,Div Internal Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.; Rong, S (corresponding author), Hannover Med Sch, Dept Nephrol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gsm91@163.com; rong.song@mh-hannover.de	Zeng, Rui/GRY-0646-2022	Zeng, Rui/0000-0003-1188-3198; /0000-0001-9985-1515	Huazhong University of Science and Technology [2014KYQD01, 2018YJJA04]	Huazhong University of Science and Technology	Huazhong University of Science and Technology, Grant/Award Number: 2014KYQD01 and 2018YJJA04	Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Barrera-Chimal J, 2018, KIDNEY INT, V93, P1344, DOI 10.1016/j.kint.2017.12.016; Cao Q, 2018, J AM SOC NEPHROL, V29, P961, DOI 10.1681/ASN.2017070774; Chen JC, 2018, J AM SOC NEPHROL, V29, P2372, DOI 10.1681/ASN.2017121272; Doi K, 2016, KIDNEY INT, V89, P555, DOI 10.1016/j.kint.2015.11.019; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Gueler F, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026609.45827.3D; Han HI, 2019, PEDIATR NEPHROL, V34, P561, DOI 10.1007/s00467-017-3883-1; Haydar D, 2019, J IMMUNOL, V203, P1021, DOI 10.4049/jimmunol.1801228; Henze AT, 2016, J CLIN INVEST, V126, P3672, DOI 10.1172/JCI84427; Huber R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29914; Jia P, 2020, FASEB J, V34, P11729, DOI 10.1096/fj.201903222RR; Kanno M, 2018, NEPHROLOGY, V23, P1046, DOI 10.1111/nep.13169; Kavvadas P, 2018, KIDNEY INT, V94, P126, DOI 10.1016/j.kint.2018.01.031; Liang H, 2019, INFLAMM RES, V68, P325, DOI 10.1007/s00011-019-01221-3; Luo R, 2019, NEPHROL DIAL TRANSPL, V34, P1549, DOI 10.1093/ndt/gfy169; Masola V, 2018, FASEB J, V32, P742, DOI 10.1096/fj.201700597R; Molema G, 2012, SEMIN NEPHROL, V32, P145, DOI 10.1016/j.semnephrol.2012.02.001; Nishikawa H, 2018, KIDNEY INT, V93, P599, DOI 10.1016/j.kint.2017.09.017; Raup-Konsavage WM, 2018, KIDNEY INT, V93, P365, DOI 10.1016/j.kint.2017.08.014; Smith SF, 2019, KIDNEY INT, V95, P50, DOI 10.1016/j.kint.2018.10.009; Snodgrass RG, 2016, J BIOL CHEM, V291, P413, DOI 10.1074/jbc.M115.686709; Trzepizur W, 2018, METABOLISM, V84, P44, DOI 10.1016/j.metabol.2017.11.008; Yan Y, 2020, AM J PHYSIOL-RENAL, V318, pF878, DOI 10.1152/ajprenal.00567.2019; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	26	2	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2020	34	12					16307	16318		10.1096/fj.201902943R	http://dx.doi.org/10.1096/fj.201902943R		OCT 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PA5YX	33089923	hybrid			2022-12-26	WOS:000582257100001
J	Lee, DK; Frye, A; Louis, M; Koshy, AN; Tosif, S; Yii, M; Ma, R; Nikfarjam, M; Perini, MV; Bellomo, R; Weinberg, L				Lee, Dong-Kyu; Frye, Ashlee; Louis, Maleck; Koshy, Anoop Ninan; Tosif, Shervin; Yii, Matthew; Ma, Ronald; Nikfarjam, Mehrdad; Perini, Marcos Vinicius; Bellomo, Rinaldo; Weinberg, Laurence			Postoperative complications and hospital costs following small bowel resection surgery	PLOS ONE			English	Article							COLORECTAL SURGERY; MORTALITY; COHORT; MORBIDITY; OUTCOMES	Background Postoperative complications after major gastrointestinal surgery are a major contributor to hospital costs. Thus, reducing postoperative complications is a key target for cost-containment strategies. We aimed to evaluate the relationship between postoperative complications and hospital costs following small bowel resection. Methods Postoperative complications were recorded for 284 adult patients undergoing major small bowel resection surgery between January 2013 and June 2018. Complications were defined and graded according to the Clavien-Dindo classification system. In-hospital cost of index admission was calculated using an activity-based costing methodology; it was reported in US dollars at 2019 rates. Regression modeling was used to investigate the relationships among a priori selected perioperative variables, complications, and costs. Findings The overall complication prevalence was 81.6% (95% CI: 85.7-77.5). Most complications (69%) were minor, but 22.9% of patients developed a severe complication (Clavien-Dindo grades III or IV). The unadjusted median total hospital cost for patients with any complication was 70% higher than patients without complications (median [IQR] USD 19,659.64 [13,545.81-35,407.14] vs. 11,551.88 [8,849.46-15,329.87], P < 0.001). The development of 1, 2, 3, and >= 4 complications increased hospital costs by 11%, 41%, 50%, and 195%, respectively. Similarly, more severe complications incurred higher hospital costs (P < 0.001). After adjustments were made (for the Charlson Comorbidity Index, anemia, surgical urgency and technique, intraoperative fluid administration, blood transfusion, and hospital readmissions), a greater number and increased severity of complications were associated with a higher adjusted median hospital cost. Patients who experienced complications had an adjusted additional median cost of USD 4,187.10 (95% CI: 1,264.89-7,109.31, P = 0.005) compared to those without complications. Conclusions Postoperative complications are a key target for cost-containment strategies. Our findings demonstrate a high prevalence of postoperative complications following small bowel resection surgery and quantify their associated increase in hospital costs.	[Lee, Dong-Kyu] Korea Univ, Guro Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Frye, Ashlee; Louis, Maleck; Tosif, Shervin; Yii, Matthew; Weinberg, Laurence] Austin Hlth, Dept Anesthesia, Heidelberg, Vic, Australia; [Koshy, Anoop Ninan] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia; [Ma, Ronald] Austin Hlth, Business Intelligence Unit, Heidelberg, Vic, Australia; [Nikfarjam, Mehrdad; Perini, Marcos Vinicius; Weinberg, Laurence] Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Heidelberg, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Data Analyt Res & Evaluat DARE Ctr, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia	Korea University; Korea University Medicine (KU Medicine); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Weinberg, L (corresponding author), Austin Hlth, Dept Anesthesia, Heidelberg, Vic, Australia.; Weinberg, L (corresponding author), Univ Melbourne, Austin Hlth, Dept Surg, Heidelberg, Vic, Australia.	laurence.weinberg@austin.org.au	Perini, Marcos/D-4616-2019; Perini, Marcos/AAW-2837-2021; Koshy, Anoop/ADH-9706-2022	Perini, Marcos/0000-0002-0165-1564; Bellomo, Rinaldo/0000-0002-1650-8939; Tosif, Shervin/0000-0001-9196-9332; Nikfarjam, Mehrdad/0000-0003-4866-276X; Louis, Maleck/0000-0001-7698-6302				Agha R, 2019, INT J SURG, V72, P156, DOI 10.1016/j.ijsu.2019.11.002; Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; [Anonymous], SMALL INT CANC INC S; [Anonymous], CANC STAT FACTS SMAL; Asa Z, 2013, SURG ENDOSC, V27, P3748, DOI 10.1007/s00464-013-2960-1; Australian Taxation Office, CONS PRIC IND CPI RA; Australian Taxation Office, DAIL EXCH RAT 2019 2; Cosic L, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016054; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Koenker R, 2020, QUANTREG QUANTILE RE; Kong CH, 2015, ANZ J SURG, V85, P403, DOI 10.1111/ans.13066; Longo WE, 2000, DIS COLON RECTUM, V43, P83, DOI 10.1007/BF02237249; Louis M, 2020, ANN MED SURG, V54, P37, DOI 10.1016/j.amsu.2020.03.013; Moghadamyeghaneh Z, 2015, AM J SURG, V210, P276, DOI 10.1016/j.amjsurg.2014.12.038; Myles PS, 2018, NEW ENGL J MED, V378, P2263, DOI 10.1056/NEJMoa1801601; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Pang QY, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-018-1551-y; Scott JW, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.0480; Straatman J, 2015, DIGEST SURG, V32, P150, DOI 10.1159/000371861; Vonlanthen R, 2011, ANN SURG, V254, P907, DOI 10.1097/SLA.0b013e31821d4a43; Wancata LM, 2017, J GASTROINTEST SURG, V21, P363, DOI 10.1007/s11605-016-3307-8; Wang J, 2018, HPB, V20, P423, DOI 10.1016/j.hpb.2017.11.001; Zheng Liu, 2019, GASTROENTEROL REP, V8, P151	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2020	15	10							e0241020	10.1371/journal.pone.0241020	http://dx.doi.org/10.1371/journal.pone.0241020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3RJ	33085700	Green Published, gold			2022-12-26	WOS:000585943400026
J	Sanikini, H; Muller, DC; Chadeau-Hyam, M; Murphy, N; Gunter, MJ; Cross, AJ				Sanikini, Harinakshi; Muller, David C.; Chadeau-Hyam, Marc; Murphy, Neil; Gunter, Marc J.; Cross, Amanda J.			Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort	PLOS ONE			English	Article							MASS INDEX; ABDOMINAL OBESITY; MALE PREDOMINANCE; MILLION WOMEN; HORMONE USE; ADENOCARCINOMA; METAANALYSIS; ESTROGEN; CARDIA; POPULATION	Background Obesity has been positively associated with upper gastrointestinal cancers, but prospective data by subtype/subsite are limited. Obesity influences hormonal factors, which may play a role in these cancers. We examined anthropometry, body fat and reproductive factors in relation to oesophageal and gastric cancer by subtype/subsite in the UK Biobank cohort. Methods Among 458,713 UK Biobank participants, 339 oesophageal adenocarcinomas, 124 oesophageal squamous cell carcinomas, 137 gastric cardia and 92 gastric non-cardia cancers were diagnosed during a mean of 6.5 years follow-up. Cox models estimated multivariable hazard ratios (HRs) and 95% confidence intervals (CIs). Results Body mass index (BMI), hip circumference, waist circumference, waist-to-hip ratio, waist-to-height ratio, total body fat and trunk fat were positively associated with oesophageal adenocarcinoma (highest vs lowest category: HR = 2.33, 95%-CI:1.65-3.28; HR = 1.56, 95%-CI:1.15-2.13; HR = 2.30, 95%-CI:1.47-3.57; HR = 1.71, 95%-CI:1.01-2.90; HR = 2.87, 95%-CI:1.88-4.38; HR = 1.96, 95%-CI:1.30-2.96; HR = 2.34, 95%-CI:1.70-3.22, respectively). Although there were no statistically significant associations in combined sex analyses, BMI (HR = 1.83, 95%-CI:1.00-3.37), waist circumference (HR = 2.21, 95%-CI:1.27-3.84) and waist-to-hip ratio (HR = 1.92, 95%-CI:1.11-3.29) were associated with gastric cardia cancer in men; however, mutual adjustment attenuated the associations for BMI and waist-to-hip ratio. For oesophageal squamous cell carcinoma, statistically significant inverse associations were observed among women for BMI, hip circumference, waist circumference, waist-to-height ratio, total body fat and trunk fat, although they were based on small numbers. In addition, older age at first (HR = 0.44, 95%-CI:0.22-0.88) and last live birth (HR = 0.44, 95%-CI:0.22-0.87) were inversely associated with oesophageal squamous cell carcinoma and having a stillbirth/miscarriage/termination was positively associated (HR = 1.84, 95%-CI:1.10-3.07). Conclusions Obesity and abdominal obesity specifically may be a risk factor for oesophageal adenocarcinoma and gastric cardia cancer in men. Some reproductive factors may be associated with oesophageal squamous cell carcinoma in women.	[Sanikini, Harinakshi; Muller, David C.; Chadeau-Hyam, Marc; Cross, Amanda J.] Imperial Coll London, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Murphy, Neil; Gunter, Marc J.] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France	Imperial College London; World Health Organization; International Agency for Research on Cancer (IARC)	Sanikini, H (corresponding author), Imperial Coll London, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England.	h.sanikini@imperial.ac.uk	Chadeau, Marc/AAN-7586-2021; Muller, David/V-8207-2017; Murphy, Neil/E-1189-2017	Chadeau, Marc/0000-0001-8341-5436; Muller, David/0000-0002-2350-0417; Gunter, Marc/0000-0001-5472-6761; Murphy, Neil/0000-0003-3347-8249	Stand Up to Cancer campaign for Cancer Research UK [C53889/A20189]	Stand Up to Cancer campaign for Cancer Research UK	Research was funded by Stand Up to Cancer campaign for Cancer Research UK (Grant number: C53889/A20189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khyatt W, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4030-5; [Anonymous], 2017, PHARMACOEPIDEMIO SS2, V26, P1, DOI DOI 10.1007/s11665-016-2478-5; Bahmanyar S, 2008, BRIT J CANCER, V98, P1295, DOI 10.1038/sj.bjc.6604283; Barberio AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08159-w; Bodelon C, 2011, CANCER PREV RES, V4, P840, DOI 10.1158/1940-6207.CAPR-10-0389; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Chandanos E, 2008, EUR J CANCER, V44, P2397, DOI 10.1016/j.ejca.2008.07.031; Chen Y, 2013, CANCER EPIDEM BIOMAR, V22, P1395, DOI 10.1158/1055-9965.EPI-13-0042; Corley DA, 2008, CANCER EPIDEM BIOMAR, V17, P352, DOI 10.1158/1055-9965.EPI-07-0748; Donohoe CL, 2014, THER ADV GASTROENTER, V7, P38, DOI 10.1177/1756283X13501786; Du X, 2017, BIOSCIENCE REP, V37, DOI [10.1042/BSR20160474, 10.1042/bsr20160474]; Duell EJ, 2010, AM J EPIDEMIOL, V172, P1384, DOI 10.1093/aje/kwq321; Engeland A, 2004, CANCER CAUSE CONTROL, V15, P837, DOI 10.1023/B:CACO.0000043434.21558.ea; Frank A.P, 2018, J LIPID RES; Freedman ND, 2010, CANCER-AM CANCER SOC, V116, P1572, DOI 10.1002/cncr.24880; Freisling H, 2017, BRIT J CANCER, V116, P1486, DOI 10.1038/bjc.2017.106; Green J, 2012, BRIT J CANCER, V106, P210, DOI 10.1038/bjc.2011.525; Kalayarasan R, 2008, DIS ESOPHAGUS, V21, P298, DOI 10.1111/j.1442-2050.2007.00767.x; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Lagergren J, 2011, NAT REV GASTRO HEPAT, V8, P340, DOI 10.1038/nrgastro.2011.73; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lin YL, 2015, CANCER CAUSE CONTROL, V26, P1825, DOI 10.1007/s10552-015-0675-4; Liu L, 2004, ANTICANCER RES, V24, P2919; Lu Y, 2012, BRIT J CANCER, V107, P564, DOI 10.1038/bjc.2012.285; MacInnis RJ, 2006, INT J CANCER, V118, P2628, DOI 10.1002/ijc.21638; McCarthy CE, 2017, ONCOL REP, V38, P1915, DOI 10.3892/or.2017.5867; Merry AHH, 2007, GUT, V56, P1503, DOI 10.1136/gut.2006.116665; Murphy N, 2018, NAT REV GASTRO HEPAT, V15, P659, DOI 10.1038/s41575-018-0038-1; O'Doherty MG, 2012, GUT, V61, P1261, DOI 10.1136/gutjnl-2011-300551; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Sanikini H, 2019, INT J CANC; Smith M, 2008, INT J CANCER, V122, P1604, DOI 10.1002/ijc.23198; Steffen A, 2015, INT J CANCER, V137, P646, DOI 10.1002/ijc.29432; Steffen A, 2009, CANCER EPIDEM BIOMAR, V18, P2079, DOI 10.1158/1055-9965.EPI-09-0265; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sukocheva OA, 2013, DIS ESOPHAGUS, V26, P628, DOI 10.1111/dote.12000; Townsend PP., 1988, HLTH DEPRIVATION INE; Turati F, 2013, ANN ONCOL, V24, P609, DOI 10.1093/annonc/mds244; UK Biobank, 2006, UK BIOB PROT LARG SC; UK Biobank, TOWNS DEPR IND RECR; Wang BJ, 2016, DIS ESOPHAGUS, V29, P448, DOI 10.1111/dote.12349; Wang ZS, 2016, INT J CANCER, V138, P2837, DOI 10.1002/ijc.30024; World Cancer Research Fund and American Institue for Cancer Research, 2016, DIET NUTR PHYS ACT O; World Cancer Research Fund and American Institue for Cancer Research, 2018, DIET NUTR PHYS ACTIV; Xie SH, 2016, CLIN GASTROENTEROL H, V14, P338, DOI 10.1016/j.cgh.2015.10.005	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2020	15	10							e0240413	10.1371/journal.pone.0240413	http://dx.doi.org/10.1371/journal.pone.0240413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OM3QJ	33079929	Green Published, gold			2022-12-26	WOS:000585940600008
J	Zhang, QY; Zhou, W; Yu, S; Ju, YJ; To, SKY; Wong, AST; Jiao, YF; Poon, TCW; Tam, KY; Lee, LTO				Zhang, Qingyu; Zhou, Wei; Yu, Shan; Ju, Yaojun; To, Sally Kit Yan; Wong, Alice Sze Tsai; Jiao, Yufei; Poon, Terence Chuen Wai; Tam, Kin Yip; Lee, Leo Tsz On			Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation	ONCOGENE			English	Article							FATTY-ACID OXIDATION; TYROSINE KINASE; BREAST-CANCER; C-SRC; ACTIVATION; INHIBITION; STRESS; CELLS; ACSL1; LINKS	As a result of the hostile microenvironment, metabolic alterations are required to enable the malignant growth of cancer cells. To understand metabolic reprogramming during metastasis, we conducted shotgun proteomic analysis of highly metastatic (HM) and non-metastatic (NM) ovarian cancer cells. The results suggest that the genes involved in fatty-acid (FA) metabolism are upregulated, with consequent increases of phospholipids with relatively short FA chains (myristic acid, MA) in HM cells. Among the upregulated proteins, ACSL1 expression could convert the lipid profile of NM cells to that similar of HM cells and make them highly aggressive. Importantly, we demonstrated that ACSL1 activates the AMP-activated protein kinase and Src pathways via protein myristoylation and finally enhances FA beta oxidation. Patient samples and tissue microarray data also suggested that omentum metastatic tumours have higher ACSL1 expression than primary tumours and a strong association with poor clinical outcome. Overall, our data reveal that ACSL1 enhances cancer metastasis by regulating FA metabolism and myristoylation.	[Zhang, Qingyu; Yu, Shan; Lee, Leo Tsz On] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China; [Zhang, Qingyu] Guangdong Med Univ, Affiliated Hosp, Dept Obstet & Gynaecol, Zhanjiang 524001, Guangdong, Peoples R China; [Zhou, Wei] China Pharmaceut Univ, Sch Tradit Chinese Pharm, State Key Lab Nat Med, Nanjing 210009, Peoples R China; [Ju, Yaojun; Poon, Terence Chuen Wai; Tam, Kin Yip] Univ Macau, Fac Hlth Sci, Prote Metabol & Drug Dev Core, Taipa, Macau, Peoples R China; [To, Sally Kit Yan; Wong, Alice Sze Tsai] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China; [Jiao, Yufei] Harbin Med Univ, Affiliated Hosp 2, Dept Pathol, Harbin 150001, Peoples R China; [Lee, Leo Tsz On] Univ Macau, Fac Hlth Sci, Ctr Reprod Dev & Aging, Taipa, Macau, Peoples R China	University of Macau; Guangdong Medical University; China Pharmaceutical University; University of Macau; University of Hong Kong; Harbin Medical University; University of Macau	Lee, LTO (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China.; Lee, LTO (corresponding author), Univ Macau, Fac Hlth Sci, Ctr Reprod Dev & Aging, Taipa, Macau, Peoples R China.	LTOLee@um.edu.mo	Lee, Leo T.O./AAB-1581-2021; Wong, Alice/AFJ-4595-2022; Tam, Kin/A-7812-2011	Wong, Alice/0000-0002-0676-6475; Tam, Kin/0000-0001-5507-8524	Science and Technology Development Fund, Macau SAR [0016/2020/A1]; University of Macau [MYRG2019-00075-FHS]; Hong Kong Research Grant Council [GRF17105919]	Science and Technology Development Fund, Macau SAR; University of Macau; Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work and LTOL were funded by The Science and Technology Development Fund, Macau SAR (File no. 0016/2020/A1) and University of Macau (File. no. MYRG2019-00075-FHS). ASTW was supported by Hong Kong Research Grant Council grant GRF17105919. We acknowledge the Animal Research Core Facility from University of Macau for their support in the animal experiments.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cui M, 2014, BIOCHEM BIOPH RES CO, V444, P270, DOI 10.1016/j.bbrc.2014.01.051; Das U, 2012, CURR CANCER DRUG TAR, V12, P667, DOI 10.2174/156800912801784857; Deng L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1201-x; Dian C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14847-3; Dirat B, 2010, ENDOCR DEV, V19, P45, DOI 10.1159/000316896; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Jeon Sang-Min, 2012, Cell Logist, V2, P197; Kim S, 2017, CANCER RES, V77, P6950, DOI 10.1158/0008-5472.CAN-17-0981; Kim S, 2017, J BIOL CHEM, V292, P18422, DOI [10.1074/jbc.M117.798827, 10.1074/jbc.m117.798827]; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Lopez-Mejia IC, 2017, MOL CELL, V68, P336, DOI 10.1016/j.molcel.2017.09.034; Mizrachy-Schwartz S, 2011, J BIOL CHEM, V286, P15268, DOI 10.1074/jbc.M110.211813; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Park JH, 2016, CELL REP, V14, P2154, DOI 10.1016/j.celrep.2016.02.004; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Pengetnze Y, 2003, BIOCHEM BIOPH RES CO, V309, P377, DOI 10.1016/j.bbrc.2003.08.012; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Sanchez-Martinez R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11612-3; Sulejmani Essilvo, 2018, Oncoscience, V5, P3, DOI 10.18632/oncoscience.391; Tang Y, 2018, ONCOL LETT, V16, P1390, DOI 10.3892/ol.2018.8843; Thinon E, 2016, ACS CHEM BIOL, V11, P2165, DOI 10.1021/acschembio.6b00371; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; To SKY, 2017, ONCOGENE, V36, P5927, DOI 10.1038/onc.2017.185; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Tucker SL, 2014, CLIN CANCER RES, V20, P3280, DOI 10.1158/1078-0432.CCR-14-0445; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wang Y, 2017, BIOCHEM BIOPH RES CO, V484, P565, DOI 10.1016/j.bbrc.2017.01.126; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Yen MC, 2017, ONCOL REP, V37, P3253, DOI 10.3892/or.2017.5610; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	38	12	13	4	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2021	40	1					97	111		10.1038/s41388-020-01516-4	http://dx.doi.org/10.1038/s41388-020-01516-4		OCT 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PR5VS	33082557				2022-12-26	WOS:000582339900002
J	Mottaleb, KA; Mainuddin, M; Sonobe, T				Mottaleb, Khondoker Abdul; Mainuddin, Mohammed; Sonobe, Tetsushi			COVID-19 induced economic loss and ensuring food security for vulnerable groups: Policy implications from Bangladesh	PLOS ONE			English	Article								At present nearly half of the world's population is under some form of government restriction to curb the spread of COVID-19, an extremely contagious disease. In Bangladesh, in the wake of five deaths and 48 infections from COVID-19, between March 24 and May 30, 2020, the government imposed a nationwide lockdown. While this lockdown restricted the spread of COVID-19, in the absence of effective support, it can generate severe food and nutrition insecurity for daily wage-based workers. Of the 61 million employed labor force in Bangladesh, nearly 35% of them are paid on a daily basis. This study examines the food security and welfare impacts of the COVID-19 induced lockdown on daily wage workers both in the farm and nonfarm sectors in Bangladesh. Using information from more than 50,000 respondents complied with the 2016-17 Household Income and Expenditure Survey (HIES) in Bangladesh, this study estimates daily wage rates as Bangladesh Taka (BDT) 272.2 in the farm sector and BDT 361.5 in the nonfarm sector. Using the estimated daily wage earnings, this study estimates that a one-day complete lockdown generates a US$64.2 million equivalent economic loss only considering the wage loss of the daily wage workers. After estimating the daily per capita food expenditure separately for farm and nonfarm households, this study estimates a minimum compensation package for the daily wage-based farm and nonfarm households around the US $ 1 per day per household to ensure minimum food security for the daily wage-based worker households.	[Mottaleb, Khondoker Abdul] Int Maize & Wheat Improvement Ctr CIMMYT, Socioecon Program, Texcoco, Mexico; [Mainuddin, Mohammed] CSIRO Land & Water, Surface Water & Basin Outcomes Grp, Water Secur Program, Black Mt Labs, Canberra, ACT, Australia; [Sonobe, Tetsushi] Asian Dev Bank Inst, Chiyoda Ku, Tokyo, Japan	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mottaleb, KA (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Socioecon Program, Texcoco, Mexico.	k.mottaleb@cgiar.org	Mainuddin, Mohammed/I-8667-2012	Mainuddin, Mohammed/0000-0002-6057-5688				Abiad A, 2020, COVID 19 DEV EC, P86; Ahmed M, 2020, DAILY PROTHOM A 0502; [Anonymous], 2020, DAILY PROTHOM A 0530, P1; [Anonymous], 2020, DAILY PROTHOM A 0507; [Anonymous], 2017, PREL REP HOUS INC EX; [Anonymous], 2019, THE ECONOMIST; [Anonymous], 2020, BUSINESS STANDARD, P1; [Anonymous], **NON-TRADITIONAL**; Balagtas JV, 2014, AGR ECON-BLACKWELL, V45, P303, DOI 10.1111/agec.12066; BBS, 2018, LAB FORC SURV BANGL; BBS, 2015, REP LAB FORC SURV LF, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; BGMEA, 2020, IMP COVID 19 BANGL R, P1; British Council, 2020, MISS PILL CULT CONTR; Chowdhury SK, 2020, DAILY ITTEFAQ   0505; Demartini Gianluca, 2020, P ACM HUMAN COMPUTER, P1; Dev BYSM, 2020, ADDRESSING COVID 19, P1; Dunford D., 2020, BBC, V9, P462; ECLAC and ILO, 2020, LCTS202046 ECLAC ILO; FAO, 2019, SUSTAINABLE FOOD AND AGRICULTURE: AN INTEGRATED APPROACH, P1, DOI 10.1016/C2016-0-01212-3; FAO, 2020, ONL DAT CROP PROD YI, P1; FAO IFAD UNICEF WFP WHO, 2019, STAT FOOD SEC NUTR W, DOI [10.1109/JSTARS.2014.2300145, DOI 10.1109/JSTARS.2014.2300145]; FAOSTAT, 2020, PROD PRIC ANN, P1; Fathi N, 2020, SAFETY 1 BANGLADESH, P1; FSIN [Food Security Information Network], 2020, GLOB REP FOOD CRIS J; Government of Bangladesh, 2019, BANGL EC REV 2019; Government of Bangladesh, 2015, NAT NUTR POL 2015; Government of India, 2019, ANN REP PER LAB FORC; Govt. Bangladesh, 2020, COVID 19 BANGL MULT; Hamilton PC, 2020, COVID 19 FOOD SECURI, P1; He X, 2020, NAT MED, P26, DOI [10.1038/s41591-019-0732-8, DOI 10.1038/S41591-019-0732-8]; Hossain ST, 2020, J AGR SCI-SRI LANKA, V15, P116, DOI 10.4038/jas.v15i2.8794; Huyghe P, 2020, ROUTL ADV SOCIOL, P1; International Labour Organization, 2020, ILO MON COVID 19 WOR; International Monetary Fund (IMF), 2020, WORLD EC OUTL APR 20; Laborde D, 2020, TRACKING GOVT RESPON; LeClercq C.., 2020, WORLD EC OUTLOOK UPD; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Mallick D, 2010, WORLD DEV, V38, P593, DOI 10.1016/j.worlddev.2009.11.004; Mengoup FE, 2020, 2026 PB MENG FE; Mottaleb KA, 2019, WOMEN STUD INT FORUM, V76, DOI 10.1016/j.wsif.2019.102272; Mottaleb KA, 2011, ECON DEV CULT CHANGE, V60, P67, DOI 10.1086/661218; OECD, 2020, COR WORLD EC RISK OE; Quasem M. A., 2011, Bangladesh Development Studies, V34, P59; Raihan S, 2020, SANEM THINK ALOUD, V6, P1; Readon T, 2020, COVID 19 MAY DISRUPT, P1; Rim A., 2020, AGE DEPENDENT INDEPE, P1; Roser M, 2019, OUR WORLD DATA, P1; Schmidhuber J., 2020, COVID 19 CHANNELS TR; Sumner A., 2020, ESTIMATES IMPACT COV; UN, 2019, UN DEC EC RES 2021 2, P1; UNDP, 2020, ASS REP IMP COVID 19; UNICEF & WHO, 2017, STAT FOOD SEC NUTR W; Vella F, 1998, J HUM RESOUR, V33, P127, DOI 10.2307/146317; Vyas M, 2020, JOB LOSSES MAY HAVE, P44; WFP, 2020, COVID 19 WILL DOUBL, P3; Wiesmann DD, 2006, FOOD POLICY; World Bank, 2020, DATABANK POP EST PRO; World Bank, 2018, POV SHAR PROSP 2018; World Health Organization, 2018, GLOBAL ACTION PLAN P, DOI DOI 10.1016/J.JPOLMOD.2006.06.007; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; World Meteorological Organization (WMO), 2020, WMB GREENH GAS B, V16, P1; Worldometer, 2020, COR CAS, DOI DOI 10.1101/2020.01.23.20018549V2; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	64	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2020	15	10							e0240709	10.1371/journal.pone.0240709	http://dx.doi.org/10.1371/journal.pone.0240709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OM3IA	33064771	gold, Green Published			2022-12-26	WOS:000585918300018
